Identifier,StructureData,,,,,,,,,,,,,,,Polymer EntityData,,,,,,
Entry ID,EM Resolution (Å),Experimental Method,Matthews Coefficient,Percent Solvent Content,Crystallization Method,pH,Crystal Growth Procedure,Temp (K),DOI,Ligand,PDB ID,Molecular Weight per Deposited Model,Resolution (Å),High Resolution Limit,Structure Title,Sequence,Source Organism,Gene Name,Macromolecule Name,Entity ID,Entry Id (Polymer Entity Identifiers),
"2HE9",,"X-RAY DIFFRACTION",2.03,39.3,"VAPOR DIFFUSION, HANGING DROP",,"Well solution: 21% Peg 3350, 0.25M potassium sulfate; Protein solution: 50 mM Tris pH 7.5, 100 mM NaCl, 1 mM DTT, 15 mg/mL protein, VAPOR DIFFUSION, HANGING DROP, temperature 298.0K",298,"10.1371/journal.pbio.1000439",,"2HE9",42.53,"2","2","Structure of the peptidylprolyl isomerase domain of the human NK-tumour recognition protein","MGSSHHHHHHSSGLVPRGSPQCHFDIEINREPVGRIMFQLFSDICPKTCKNFLCLCSGEKGLGKTTGKKLCYKGSTFHRVVKNFMIQGGDFSEGNGKGGESIYGGYFKDENFILKHDRAFLLSMANRGKHTNGSQFFITTKPAPHLDGVHVVFGLVISGFEVIEQIENLKTDAASRPYADVRVIDCGVLATK","Homo sapiens","NKTR","NK-tumor recognition protein","1","2HE9"
"2HEA",,"X-RAY DIFFRACTION",2,38,,,,,"10.1006/jmbi.1997.1365",,"2HEA",14.7,"1.8","1.8","CONTRIBUTION OF WATER MOLECULES IN THE INTERIOR OF A PROTEIN TO THE CONFORMATIONAL STABILITY","KVFERCELARTLKRLGMDGYRGISLANWMCLAKWESGYNTRATNYNAGDRSTDYGIFQINSRYWCNDGKTPGAVNACHLSCSALLQDNIADAVACAKRVVRDPQGARAWVAWRNRCQNRDVRQYVQGCGV","Homo sapiens","HUMAN LYSOZYME WITH ILE 106, LYZ, LZM","LYSOZYME","1","2HEA"
"2HEB",,"X-RAY DIFFRACTION",2,38,,,,,"10.1006/jmbi.1997.1365",,"2HEB",14.7,"2.2","2.2","CONTRIBUTION OF WATER MOLECULES IN THE INTERIOR OF A PROTEIN TO THE CONFORMATIONAL STABILITY","KVFERCELARTLKRLGMDGYRGASLANWMCLAKWESGYNTRATNYNAGDRSTDYGIFQINSRYWCNDGKTPGAVNACHLSCSALLQDNIADAVACAKRVVRDPQGIRAWVAWRNRCQNRDVRQYVQGCGV","Homo sapiens","HUMAN LYSOZYME WITH ILE 23 REP, LYZ, LZM","LYSOZYME","1","2HEB"
"2HEC",,"X-RAY DIFFRACTION",1.99,38,,,,,"10.1006/jmbi.1997.1365",,"2HEC",14.7,"1.8","1.8","CONTRIBUTION OF WATER MOLECULES IN THE INTERIOR OF A PROTEIN TO THE CONFORMATIONAL STABILITY","KVFERCELARTLKRLGMDGYRGISLANWMCLAKWESGYNTRATNYNAGDRSTDYGAFQINSRYWCNDGKTPGAVNACHLSCSALLQDNIADAVACAKRVVRDPQGIRAWVAWRNRCQNRDVRQYVQGCGV","Homo sapiens","HUMAN LYSOZYME WITH ILE 56 REP, LYZ, LZM","LYSOZYME","1","2HEC"
"2HED",,"X-RAY DIFFRACTION",1.96,37,,,,,"10.1006/jmbi.1997.1365",,"2HED",14.7,"1.8","1.8","CONTRIBUTION OF WATER MOLECULES IN THE INTERIOR OF A PROTEIN TO THE CONFORMATIONAL STABILITY","KVFERCELARTLKRLGMDGYRGISLANWMCLAKWESGYNTRATNYNAGDRSTDYGIFQANSRYWCNDGKTPGAVNACHLSCSALLQDNIADAVACAKRVVRDPQGIRAWVAWRNRCQNRDVRQYVQGCGV","Homo sapiens","HUMAN LYSOZYME WITH ILE 59 REP, LYZ, LZM","LYSOZYME","1","2HED"
"2HEE",,"X-RAY DIFFRACTION",2,38,,,,,"10.1006/jmbi.1997.1365",,"2HEE",14.69,"1.8","1.8","CONTRIBUTION OF WATER MOLECULES IN THE INTERIOR OF A PROTEIN TO THE CONFORMATIONAL STABILITY","KVFERCELARTLKRLGMDGYRGISLANWMCLAKWESGYNTRATNYNAGDRSTDYGIFQGNSRYWCNDGKTPGAVNACHLSCSALLQDNIADAVACAKRVVRDPQGIRAWVAWRNRCQNRDVRQYVQGCGV","Homo sapiens","HUMAN LYSOZYME WITH ILE 59 REP, LYZ, LZM","LYSOZYME","1","2HEE"
"2HEF",,"X-RAY DIFFRACTION",1.99,38,,,,,"10.1006/jmbi.1997.1365",,"2HEF",14.7,"1.8","1.8","CONTRIBUTION OF WATER MOLECULES IN THE INTERIOR OF A PROTEIN TO THE CONFORMATIONAL STABILITY","KVFERCELARTLKRLGMDGYRGISLANWMCLAKWESGYNTRATNYNAGDRSTDYGIFQINSRYWCNDGKTPGAVNACHLSCSALLQDNAADAVACAKRVVRDPQGIRAWVAWRNRCQNRDVRQYVQGCGV","Homo sapiens","HUMAN LYSOZYME WITH ILE 89 REP, LYZ, LZM","LYSOZYME","1","2HEF"
"2HEH",,"X-RAY DIFFRACTION",3.3,63,,7,"37% PEG400, 0.2M NaCl, 0.1M HEPES, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 291K, pH 7.00",291,,,"2HEH",43.75,"2.15","2.15","Crystal Structure of the KIF2C motor domain","MGSSHHHHHHSSGLVPRGSSFPNWEFARMIKEFRATLECHPLTMTDPIEEHRICVCVRKRPLNKQELAKKEIDVISIPSKCLLLVHEPKLKVDLTKYLENQAFCFDFAFDETASNEVVYRFTARPLVQTIFEGGKATCFAYGQTGSGKTHTMGGDLSGKAQNASKGIYAMASRDVFLLKNQPCYRKLGLEVYVTFFEIYNGKLFDLLNKKAKLRVLEDGKQQVQVVGLQEHLVNSADDVIKMIDMGSACRTSGQTFANSNSSRSHACFQIILRAKGRMHGKFSLVDLAGNERGADTSSADRQTRMEGAEINKSLLALKECIRALGQNKAHTPFRESKLTQVLRDSFIGENSRTCMIATISPGISSCEYTLNTLRYADRVKELSPHSG","Homo sapiens","KIF2C, KNSL6","KIF2C protein","1","2HEH"
"2HEI",,"X-RAY DIFFRACTION",2.1,37.04,"VAPOR DIFFUSION, SITTING DROP",4.5,"25% P3350, 0.1M NaOAc, pH 4.5, vapor diffusion, sitting drop, temperature 291K",291,,,"2HEI",40.74,"1.55","1.55","Crystal structure of human RAB5B in complex with GDP","GSASKICQFKLVLLGESAVGKSSLVLRFVKGQFHEYQESTIGAAFLTQSVCLDDTTVKFEIWDTAGQERYHSLAPMYYRGAQAAIVVYDITNQETFARAKTWVKELQRQASPSIVIALAGNKADLANKRMVEYEEAQAYADDNSLLFMETSAKTAMNVNDLFLAIAKKLPKSEPQNLGG","Homo sapiens","RAB5B","Ras-related protein Rab-5B","1","2HEI"
"2HF5",,"SOLUTION NMR",,,,,,,"10.1110/ps.072777107",,"2HF5",7.79,,,"The structure and function of a novel two-site calcium-binding fragment of calmodulin","AELQDMINEVDADGNGTIDFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTNLG","Homo sapiens","CALM1, CALM, CAM, CAM1, CALM2, CAM2, CAMB, CALM3, CAM3, CAMC, CAMIII","Calmodulin","1","2HF5"
"2HF6",,"SOLUTION NMR",,,,,,,"10.1016/j.jmb.2008.12.083",,"2HF6",17.05,,,"Solution structure of human zeta-COP","MEALILEPSLYTVKAILILDNDGDRLFAKYYDDTYPSVKEQKAFEKNIFNKTHRTDSEIALLEGLTVVYKSSIDLYFYVIGSSYENELMLMAVLNCLFDSLSQMLRKNVEKRALLENMEGLFLAVDEIVDGGVILESDPQQVVHRVALR","Homo sapiens","COPZ1, COPZ, CGI-120, HSPC181","Coatomer subunit zeta-1","1","2HF6"
"2HFF",,"X-RAY DIFFRACTION",2.42,49.21,,,"Crystals were grown in hanging drops with 1:1 ratio of protein to well solution consisting of 100 mM Hepes, pH 7.5, 20% PEG 10K, and then frozen in mother liquor with 25% PEG 400",,"10.1182/blood-2006-03-011031",,"2HFF",95.44,"1.95","1.95","Crystal structure of CB2 Fab","DIQMTQSPSSLSASVGDRVTITCRASQDVSTAVAWYQQKPGKAPKLLIYSASFLYSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSRITPPTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"CB2 Fab, light chain","1","2HFF"
,,,,,,,,,,,,,,,,"EVQLVESGGGLVQPGGSLRLSCAASGFTISSNSIHWVRQAPGKGLEWVAWITPSDGNTDYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCARRVCYNRLGVCAGGMDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTH","Homo sapiens",,"CB2 Fab, heavy chain","2","2HFF"
"2HFP",,"X-RAY DIFFRACTION",2.11,41.67,,,"Two microliters of protein solution (10 mg/mL, 1 peptide fragment) was added to two microliters of well (2% Peg400, 1.6 Molar ammonium sulfate, 100 mM Mes 6.5) and hung over 1000 microliters well in a 2 + 2 hanging drop crystallization setup , temperature 298.0K",298,"10.1016/j.bmcl.2006.08.003","NSI","2HFP",36.03,"2","2","Crystal Structure of PPAR Gamma with N-sulfonyl-2-indole carboxamide ligands","MSYYHHHHHHPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","2HFP"
,,,,,,,,,,,,,,,,"HSSLTERHKILHRLLQEGSPS",,,"SRC Peptide Fragment","2","2HFP"
"2HFT",,"X-RAY DIFFRACTION",2.39,48.44,,7.5,"pH 7.5",,"10.1006/jmbi.1996.0073",,"2HFT",24.79,"1.69","1.69","THE CRYSTAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF HUMAN TISSUE FACTOR AT 1.7 ANGSTROMS RESOLUTION","SGTTNTVAAYNLTWKSTNFKTILEWEPKPVNQVYTVQISTKSGDWKSKCFYTTDTECDLTDEIVKDVKQTYLARVFSYPAGNVESTGSAGEPLYENSPEFTPYLETNLGQPTIQSFEQVGTKVNVTVEDERTLVRRNNTFLSLRDVFGKDLIYTLYYWKSSSQEKGEFRSGKKTAKTNTNEFLIDVDKGENYCFSVQAVIPSRTVNRKSTDSPVECMG","Homo sapiens","F3","HUMAN TISSUE FACTOR","1","2HFT"
"2HFW",,"X-RAY DIFFRACTION",2.18,43.53,"VAPOR DIFFUSION, HANGING DROP",5.8,"0.2 M ammonium acetate, 0.1 M sodium acetate, 30% PEG 4K, pH 5.8, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1002/prot.21403",,"2HFW",29.61,"2.5","2.5","Structural and kinetic analysis of proton shuttle residues in the active site of human carbonic anhydrase III","MAKEWGYASHNGPDHWHELFPNAKGENQSPIELHTKDIRHDPSLQPWSVSYDGGSAKTILNNGHTCNVVFDDTYDRSMLRGGPLPGPYRLRQFHLHWGSSDDHGSEHTVDGVKYAAELHLVHWNPKYNTFKEALKQRDGIAVIGIFLKIGHENGEFQIFLDALDKIKTKGKEAPFTKFDPSSLFPASRDYWTYQGSFTTPPCEECIVWLLLKEPMTVSSDQMAKLRSLLSSAENEPPVPLVSNWRPPQPINNRVVRASFK","Homo sapiens","CA3","Carbonic anhydrase 3","1","2HFW"
"2HG8",,"X-RAY DIFFRACTION",2.31,46.64,"VAPOR DIFFUSION, HANGING DROP",7,"PEG1500, HEPES, DTT, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 294K",294,"10.1074/jbc.M607552200",,"2HG8",83.52,"1.8","1.8","Crystal Structure of Cys315Ala mutant of human mitochondrial branched chain aminotransferase complexed with its substrate mimic, N-methyl leucine.","ASSSFKAADLQLEMTQKPHKKPGPGEPLVFGKTFTDHMLMVEWNDKGWGQPRIQPFQNLTLHPASSSLHYSLQLFEGMKAFKGKDQQVRLFRPWLNMDRMLRSAMRLCLPSFDKLELLECIRRLIEVDKDWVPDAAGTSLYVRPVLIGNEPSLGVSQPRRALLFVILCPVGAYFPGGSVTPVSLLADPAFIRAWVGGVGNYKLGGNYGPTVLVQQEALKRGCEQVLWLYGPDHQLTEVGTMNIFVYWTHEDGVLELVTPPLNGVILPGVVRQSLLDMAQTWGEFRVVERTITMKQLLRALEEGRVREVFGSGTAAQVCPVHRILYKDRNLHIPTMENGPELILRFQKELKEIQYGIRAHEWMFPV","Homo sapiens","BCAT2, BCATM, ECA40, BCT2","Branched-chain-amino-acid aminotransferase, mitochondrial","1","2HG8"
"2HGF",,"SOLUTION NMR",,,,,,,"10.1016/s0969-2126(98)00012-4",,"2HGF",11.4,,,"HAIRPIN LOOP CONTAINING DOMAIN OF HEPATOCYTE GROWTH FACTOR, NMR, MINIMIZED AVERAGE STRUCTURE","GQRKRRNTIHEFKKSAKTTLIKIDPALKIKTKKVNTADQCANRCTRNKGLPFTCKAFVFDKARKQCLWFPFNSMSSGVKKEFGHEFDLYENKDYIRN","Homo sapiens","HGF, HPTA","HEPATOCYTE GROWTH FACTOR","1","2HGF"
"2HGL",,"SOLUTION NMR",,,,,,,"10.1093/nar/gkl488",,"2HGL",15.03,,,"NMR structure of the first qRRM domain of human hnRNP F","MGSSHHHHHHSSGLVPRGSHMASMTGGQQMGRGSMMLGPEGGEGFVVKLRGLPWSCSVEDVQNFLSDCTIHDGAAGVHFIYTREGRQSGEAFVELGSEDDVKMALKKDRESMGHRYIEVFKSHRTEMDWVLKHSGP","Homo sapiens","HNRPF, HNRNPF","Heterogeneous nuclear ribonucleoprotein F","1","2HGL"
"2HGM",,"SOLUTION NMR",,,,,,,"10.1093/nar/gkl488",,"2HGM",13.78,,,"NMR structure of the second qRRM domain of human hnRNP F","MGSSHHHHHHSSGLVPRGSHMASMTGGQQMGRGSNSADSANDGFVRLRGLPFGCTKEEIVQFFSGLEIVPNGITLPVDPEGKITGEAFVQFASQELAEKALGKHKERIGHRYIEVFKSSQEEVRSY","Homo sapiens","HNRPF, HNRNPF","Heterogeneous nuclear ribonucleoprotein F","1","2HGM"
"2HGN",,"SOLUTION NMR",,,,,,,"10.1093/nar/gkl488",,"2HGN",15.06,,,"NMR structure of the third qRRM domain of human hnRNP F","MGSSHHHHHHSSGLVPRGSHMASMTGGQQMGRGSGDSEFTVQSTTGHCVHMRGLPYKATENDIYNFFSPLNPVRVHIEIGPDGRVTGEADVEFATHEEAVAAMSKDRANMQHRYIELFLNSTTGASNGAYSSQVMQGMG","Homo sapiens","HNRPF, HNRNPF","Heterogeneous nuclear ribonucleoprotein F","1","2HGN"
"2HGS",,"X-RAY DIFFRACTION",3.34,63.2,,6,"pH 6.0",,"10.1093/emboj/18.12.3204",,"2HGS",53.42,"2.1","2.1","HUMAN GLUTATHIONE SYNTHETASE","MATNWGSLLQDKQQLEELARQAVDRALAEGVLLRTSQEPTSSEVVSYAPFTLFPSLVPSALLEQAYAVQMDFNLLVDAVSQNAAFLEQTLSSTIKQDDFTARLFDIHKQVLKEGIAQTVFLGLNRSDYMFQRSADGSPALKQIEINTISASFGGLASRTPAVHRHVLSVLSKTKEAGKILSNNPSKGLALGIAKAWELYGSPNALVLLIAQEKERNIFDQRAIENELLARNIHVIRRTFEDISEKGSLDQDRRLFVDGQEIAVVYFRDGYMPRQYSLQNWEARLLLERSHAAKCPDIATQLAGTKKVQQELSRPGMLEMLLPGQPEAVARLRATFAGLYSLDVGEEGDQAIAEALAAPSRFVLKPQREGGGNNLYGEEMVQALKQLKDSEERASYILMEKIEPEPFENCLLRPGSPARVVQCISELGIFGVYVRQEKTLVMNKHVGHLLRTKAIEHADGGVAAGVAVLDNPYPV","Homo sapiens","GSS","PROTEIN (GLUTATHIONE SYNTHETASE)","1","2HGS"
"2HGT",,"X-RAY DIFFRACTION",2.53,51.47,,,,,,,"2HGT",36.08,"2.2","2.2","STRUCTURE OF THE HIRUGEN AND HIRULOG 1 COMPLEXES OF ALPHA-THROMBIN","TFGSGEADCGLRPLFEKKSLEDKTERELLESYIDGR","Homo sapiens","F2","ALPHA-THROMBIN (SMALL SUBUNIT)","1","2HGT"
,,,,,,,,,,,,,,,,"IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFGE","Homo sapiens","F2","ALPHA-THROMBIN (LARGE SUBUNIT)","2","2HGT"
,,,,,,,,,,,,,,,,"FPR",,,"Hirulog","3","2HGT"
,,,,,,,,,,,,,,,,"PGGGGNGDFEEIPEEYL",,,"Hirulog","4","2HGT"
"2HGW",,"X-RAY DIFFRACTION",2.37,48.09,"VAPOR DIFFUSION, HANGING DROP",7,"PEG1500, DTT, HEPES pH7.0, VAPOR DIFFUSION, HANGING DROP, temperature 294K",294,"10.1074/jbc.M607552200",,"2HGW",84.19,"1.98","1.98","Crystal structure of Cys318Ala mutant of human mitochondrial branched chain aminotransferase","ASSSFKAADLQLEMTQKPHKKPGPGEPLVFGKTFTDHMLMVEWNDKGWGQPRIQPFQNLTLHPASSSLHYSLQLFEGMKAFKGKDQQVRLFRPWLNMDRMLRSAMRLCLPSFDKLELLECIRRLIEVDKDWVPDAAGTSLYVRPVLIGNEPSLGVSQPRRALLFVILCPVGAYFPGGSVTPVSLLADPAFIRAWVGGVGNYKLGGNYGPTVLVQQEALKRGCEQVLWLYGPDHQLTEVGTMNIFVYWTHEDGVLELVTPPLNGVILPGVVRQSLLDMAQTWGEFRVVERTITMKQLLRALEEGRVREVFGSGTACQVAPVHRILYKDRNLHIPTMENGPELILRFQKELKEIQYGIRAHEWMFPV","Homo sapiens","BCAT2, BCATM, ECA40, BCT2","Branched-chain-amino-acid aminotransferase, mitochondrial","1","2HGW"
"2HGX",,"X-RAY DIFFRACTION",2.31,46.75,"VAPOR DIFFUSION, HANGING DROP",7,"PEG1500, DTT, HEPES, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 294K",294,"10.1074/jbc.M607552200",,"2HGX",83.58,"1.8","1.8","Crystal structure of Cys315Ala mutant of human mitochondrial branched chain aminotransferase","ASSSFKAADLQLEMTQKPHKKPGPGEPLVFGKTFTDHMLMVEWNDKGWGQPRIQPFQNLTLHPASSSLHYSLQLFEGMKAFKGKDQQVRLFRPWLNMDRMLRSAMRLCLPSFDKLELLECIRRLIEVDKDWVPDAAGTSLYVRPVLIGNEPSLGVSQPRRALLFVILCPVGAYFPGGSVTPVSLLADPAFIRAWVGGVGNYKLGGNYGPTVLVQQEALKRGCEQVLWLYGPDHQLTEVGTMNIFVYWTHEDGVLELVTPPLNGVILPGVVRQSLLDMAQTWGEFRVVERTITMKQLLRALEEGRVREVFGSGTAAQVCPVHRILYKDRNLHIPTMENGPELILRFQKELKEIQYGIRAHEWMFPV","Homo sapiens","BCAT2, BCATM, ECA40, BCT2","Branched-chain-amino-acid aminotransferase, mitochondrial","1","2HGX"
"2HH2",,"SOLUTION NMR",,,,,,,"10.1016/j.str.2007.03.006",,"2HH2",11.09,,,"Solution structure of the fourth KH domain of KSRP","GAMAPGGEMTFSIPTHKCGLVIGRGGENVKAINQQTGAFVEISRQLPPNGDPNFKLFIIRGSPQQIDHAKQLIEEKIEGPLCPVGPGPGGPGPAGPMGPFNPGPFNQ","Homo sapiens","KHSRP, FUBP2","KH-type splicing regulatory protein","1","2HH2"
"2HH3",,"SOLUTION NMR",,,,,,,"10.1016/j.str.2007.03.006",,"2HH3",10.85,,,"Solution structure of the third KH domain of KSRP","GAMATGSRIGGGIDVPVPRHSVGVVIGRSGEMIKKIQNDAGVRIQFKQDDGTGPEKIAHIMGPPDRCEHAARIINDLLQSLRSGPPGPPGGPGMPPGGRGRGRGQG","Homo sapiens","KHSRP, FUBP2","KH-type splicing regulatory protein","1","2HH3"
"2HH4",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M602691200",,"2HH4",5.82,,,"NMR structure of human insulin mutant GLY-B8-D-SER, HIS-B10-ASP PRO-B28-LYS, LYS-B29-PRO, 20 structures","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","insulin A chain","1","2HH4"
,,,,,,,,,,,,,,,,"FVNQHLCSSDLVEALYLVCGERGFFYTKPT","Homo sapiens","INS","insulin B chain","2","2HH4"
"2HH5",,"X-RAY DIFFRACTION",2.33,47.24,"VAPOR DIFFUSION, SITTING DROP",7,"0.2M ZnAcetate, 20% PEG-3350, 150mM Sodium Chloride, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.bmcl.2006.07.033","GNQ","2HH5",50.39,"1.8","1.8","Crystal Structure of Cathepsin S in complex with a Zinc mediated non-covalent arylaminoethyl amide","NRILPDSVDWREKGCVTEVKYQGSCGACWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEI","Homo sapiens","CTSS","Cathepsin S","1","2HH5"
"2HHA",,"X-RAY DIFFRACTION",3,58.95,"VAPOR DIFFUSION, HANGING DROP",8,"PEG 4000, SODIUM ACETATE, TRIS, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.bmcl.2006.07.061","3TP","2HHA",174.88,"2.35","2.35","The structure of DPP4 in complex with an oxadiazole inhibitor","TRKTYTLTDYLKNTYRLKLYSLRWISDHEYLYKQENNILVFNAEYGNSSVFLENSTFDEFGHSINDYSISPDGQFILLEYNYVKQWRHSYTASYDIYDLNKRQLITEERIPNNTQWVTWSPVGHKLAYVWNNDIYVKIEPNLPSYRITWTGKEDIIYNGITDWVYEEEVFSAYSALWWSPNGTFLAYAQFNDTEVPLIEYSFYSDESLQYPKTVRVPYPKAGAVNPTVKFFVVNTDSLSSVTNATSIQITAPASMLIGDHYLCDVTWATQERISLQWLRRIQNYSVMDICDYDESSGRWNCLVARQHIEMSTTGWVGRFRPSEPHFTLDGNSFYKIISNEEGYRHICYFQIDKKDCTFITKGTWEVIGIEALTSDYLYYISNEYKGMPGGRNLYKIQLSDYTKVTCLSCELNPERCQYYSVSFSKEAKYYQLRCSGPGLPLYTLHSSVNDKGLRVLEDNSALDKMLQNVQMPSKKLDFIILNETKFWYQMILPPHFDKSKKYPLLLDVYAGPCSQKADTVFRLNWATYLASTENIIVASFDGRGSGYQGDKIMHAINRRLGTFEVEDQIEAARQFSKMGFVDNKRIAIWGWSYGGYVTSMVLGSGSGVFKCGIAVAPVSRWEYYDSVYTERYMGLPTPEDNLDHYRNSTVMSRAENFKQVEYLLIHGTADDNVHFQQSAQISKALVDVGVDFQAMWYTDEDHGIASSTAHQHIYTHMSHFIKQCFSLP","Homo sapiens","DPP4, ADCP2, CD26","Hypothetical protein DPP4","1","2HHA"
"2HHF",,"X-RAY DIFFRACTION",2.09,41.17,"VAPOR DIFFUSION, HANGING DROP",7,"Peg1500, Hepes, pH 7.0, H2O2, VAPOR DIFFUSION, HANGING DROP, temperature 294K",294,"10.1074/jbc.M607552200",,"2HHF",83.6,"1.8","1.8","X-ray crystal structure of oxidized human mitochondrial branched chain aminotransferase (hBCATm)","ASSSFKAADLQLEMTQKPHKKPGPGEPLVFGKTFTDHMLMVEWNDKGWGQPRIQPFQNLTLHPASSSLHYSLQLFEGMKAFKGKDQQVRLFRPWLNMDRMLRSAMRLCLPSFDKLELLECIRRLIEVDKDWVPDAAGTSLYVRPVLIGNEPSLGVSQPRRALLFVILCPVGAYFPGGSVTPVSLLADPAFIRAWVGGVGNYKLGGNYGPTVLVQQEALKRGCEQVLWLYGPDHQLTEVGTMNIFVYWTHEDGVLELVTPPLNGVILPGVVRQSLLDMAQTWGEFRVVERTITMKQLLRALEEGRVREVFGSGTACQVCPVHRILYKDRNLHIPTMENGPELILRFQKELKEIQYGIRAHEWMFPV","Homo sapiens","BCAT2, BCATM, ECA40, BCT2","Branched-chain-amino-acid aminotransferase, mitochondrial","1","2HHF"
,,,,,,,,,,,,,,,,"ASSSFKAADLQLEMTQKPHKKPGPGEPLVFGKTFTDHMLMVEWNDKGWGQPRIQPFQNLTLHPASSSLHYSLQLFEGMKAFKGKDQQVRLFRPWLNMDRMLRSAMRLCLPSFDKLELLECIRRLIEVDKDWVPDAAGTSLYVRPVLIGNEPSLGVSQPRRALLFVILCPVGAYFPGGSVTPVSLLADPAFIRAWVGGVGNYKLGGNYGPTVLVQQEALKRGCEQVLWLYGPDHQLTEVGTMNIFVYWTHEDGVLELVTPPLNGVILPGVVRQSLLDMAQTWGEFRVVERTITMKQLLRALEEGRVREVFGSGTACQVCPVHRILYKDRNLHIPTMENGPELILRFQKELKEIQYGIRAHEWMFPV","Homo sapiens","BCAT2, BCATM, ECA40, BCT2","Branched-chain-amino-acid aminotransferase, mitochondrial","2","2HHF"
"2HHJ",,"X-RAY DIFFRACTION",2,37.97,"VAPOR DIFFUSION, HANGING DROP",7.5,"PEG6000, TEMPERATURE 289K, pH 7.50, VAPOR DIFFUSION, HANGING DROP",289,"10.1074/jbc.M606421200",,"2HHJ",63.4,"1.5","1.5","Human bisphosphoglycerate mutase complexed with 2,3-bisphosphoglycerate (15 days)","MSKYKLIMLRHGEGAWNKENRFCSWVDQKLNSEGMEEARNCGKQLKALNFEFDLVFTSVLNRSIHTAWLILEELGQEWVPVESSWRLNERHYGALIGLNREQMALNHGEEQVRLWRRSYNVTPPPIEESHPYYQEIYNDRRYKVCDVPLDQLPRSESLKDVLERLLPYWNERIAPEVLRGKTILISAHGNSSRALLKHLEGISDEDIINITLPTGVPILLELDENLRAVGPHQFLGDQEAIQAAIKKVEDQGKVKQAKKLEHHHHHH","Homo sapiens","BPGM","Bisphosphoglycerate mutase","1","2HHJ"
"2HHL",,"X-RAY DIFFRACTION",2.35,47.66,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.2M lithium sulfate monohydrate, 0.1M bis-tris, 25% w/v PEG 3350, pH 5.5, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,"10.1007/s10969-007-9036-1",,"2HHL",98.33,"2.1","2.1","Crystal structure of the human small CTD phosphatase 3 isoform 1","MSLRQVIPIPSPPAKYLLPEVTVLDYGKKCVVIDLDETLVHSSFKPISNADFIVPVEIDGTIHQVYVLKRPHVDEFLQRMGQLFECVLFTASLAKYADPVADLLDRWGVFRARLFRESCVFHRGNYVKDLSRLGRELSKVIIVDNSPASYIFHPENAVPVQSWFDDMTDTELLDLIPFFEGLSREDDEGHHHHHH","Homo sapiens","CTDSPL, C3orf8, NIF1, NIFL, YA22, SCP3","CTD small phosphatase-like protein","1","2HHL"
"2HHM",,"X-RAY DIFFRACTION",2.75,55.26,,,,,"10.1073/pnas.89.21.10031",,"2HHM",60.68,"2.1","2.1","STRUCTURE OF INOSITOL MONOPHOSPHATASE, THE PUTATIVE TARGET OF LITHIUM THERAPY","ADPWQECMDYAVTLARQAGEVVCEAIKNEMNVMLKSSPVDLVTATDQKVEKMLISSIKEKYPSHSFIGEESVAAGEKSILTDNPTWIIDPIDGTTNFVHRFPFVAVSIGFAVNKKIEFGVVYSCVEGKMYTARKGKGAFCNGQKLQVSQQEDITKSLLVTELGSSRTPETVRMVLSNMEKLFCIPVHGIRSVGTAAVNMCLVATGGADAYYEMGIHCWDVAGAGIIVTEAGGVLMDVTGGPFDLMSRRVIAANNRILAERIAKEIQVIPLQRDDED","Homo sapiens","IMPA1, IMPA","INOSITOL MONOPHOSPHATASE","1","2HHM"
"2HHN",,"X-RAY DIFFRACTION",2.82,56.36,"VAPOR DIFFUSION, HANGING DROP",6.5,"20% PEG-8000, 0.4M Lithium Sulfate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 278K",278,"10.1016/j.bmcl.2006.07.033","GNQ","2HHN",49.74,"1.55","1.55","Cathepsin S in complex with non covalent arylaminoethyl amide.","NRILPDSVDWREKGCVTEVKYQGSCGACWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEI","Homo sapiens","CTSS","Cathepsin S","1","2HHN"
"2HHO",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M602691200",,"2HHO",5.82,,,"NMR structure of human insulin mutant GLY-B8-SER, HIS-B10-ASP PRO-B28-LYS, LYS-B29-PRO, 20 structures","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","Insulin A chain","1","2HHO"
,,,,,,,,,,,,,,,,"FVNQHLCSSDLVEALYLVCGERGFFYTKPT","Homo sapiens","INS","Insulin B chain","2","2HHO"
"2HI4",,"X-RAY DIFFRACTION",2.51,51.02,"VAPOR DIFFUSION, HANGING DROP",8.5,"PEG3350, Tris, ammonium nitrate, Cymal-6 (cyclohexyl-hexyl-beta-D-maltoside), C12E8 (octaethyleneglycol mono-n-dodecyl ether) , pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1074/jbc.M611692200","BHF","2HI4",57.18,"1.95","1.95","Crystal Structure of Human Microsomal P450 1A2 in complex with alpha-naphthoflavone","MAVLKGLRPRVPKGLKSPPEPWGWPLLGHVLTLGKNPHLALSRMSQRYGDVLQIRIGSTPVLVLSRLDTIRQALVRQGDDFKGRPDLYTSTLITDGQSLTFSTDSGPVWAARRRLAQNALNTFSIASDPASSSSCYLEEHVSKEAKALISRLQELMAGPGHFDPYNQVVVSVANVIGAMCFGQHFPESSDEMLSLVKNTHEFVETASSGNPLDFFPILRYLPNPALQRFKAFNQRFLWFLQKTVQEHYQDFDKNSVRDITGALFKHSKKGPRASGNLIPQEKIVNLVNDIFGAGFDTVTTAISWSLMYLVTKPEIQRKIQKELDTVIGRERRPRLSDRPQLPYLEAFILETFRHSSFLPFTIPHSTTRDTTLNGFYIPKKCCVFVNQWQVNHDPELWEDPSEFRPERFLTADGTAINKPLSEKMMLFGMGKRRCIGEVLAKWEIFLFLAILLQQLEFSVPPGVKVDLTPIYGLTMKHARCEHVQARRFSINHHHH","Homo sapiens","CYP1A2","Cytochrome P450 1A2","1","2HI4"
"2HI8",,"X-RAY DIFFRACTION",2.19,43.84,"VAPOR DIFFUSION, SITTING DROP",8.5,"PEG 4000, Calcium chloride, TRIS, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1107/S0907444907009961",,"2HI8",34.41,"1.64","1.64","human formylglycine generating enzyme, C336S mutant, bromide co-crystallization","LAHSKMVPIPAGVFTMGTDDPQIKQDGEAPARRVTIDAFYMDAYEVSNTEFEKFVNSTGYLTEAEKFGDSFVFEGMLSEQVKTNIQQAVAAAPWWLPVKGANWRHPEGPDSTILHRPDHPVLHVSWNDAVAYCTWAGKRLPTEAEWEYSCRGGLHNRLFPWGNKLQPKGQHYANIWQGEFPVTNTGEDGFQGTAPVDAFPPNGYGLYNIVGNAWEWTSDWWTVHHSVEETLNPKGPPSGKDRVKKGGSYMSHRSYCYRYRCAARSQNTPDSSASNLGFRCAADRLP","Homo sapiens","SUMF1, PSEC0152, UNQ3037/PRO9852","Sulfatase-modifying factor 1","1","2HI8"
,,,,,,,,,,,,,,,,"CTPSR",,,"CTPSR","2","2HI8"
"2HI9",,"X-RAY DIFFRACTION",2.8,56.11,"VAPOR DIFFUSION, HANGING DROP",7,"66.7mM tri-potassium citrate, 6.7% PEG3350, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 296K",296,"10.1074/jbc.M701074200",,"2HI9",123.48,"2.3","2.3","Crystal Structure of human native protein C inhibitor","SRRDFTFDLYRALASAAPSQNIFFSPVSISMSLAMLSLGAGSSTKMQILEGLGLNLQKSSEKELHRGFQQLLQELNQPRDGFQLSLGNALFTDLVVDLQDTFVSAMKTLYLADTFPTNFRDSAGAMKQINDYVAKQTKGKIVDLLKNLDSNAVVIMVNYIFFKAKWETSFNHKGTQEQDFYVTSETVVRVPMMSREDQYHYLLDRNLSCRVVGVPYQGNATALFILPSEGKMQQVENGLSEKTLRKWLKMFKKRQLELYLPKFSIEGSYQLEKVLPSLGISNVFTSHADLSGISNHSNIQVSEMVHKAVVEVDESGTRAAAATGTIFTFRSARLNSQRLVFNRPFLMFIVDNNILFLGKVNRP","Homo sapiens","SERPINA5, PCI, PLANH3, PROCI","Plasma serine protease inhibitor","1","2HI9"
"2HIB",,"X-RAY DIFFRACTION",2.28,46.17,"VAPOR DIFFUSION, SITTING DROP",8.5,"PEG 4000, Calcium iodide, TRIS, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1107/S0907444907009961",,"2HIB",34.01,"2","2","human formylglycine generating enzyme, C336S mutant, iodide co-crystallization","LAHSKMVPIPAGVFTMGTDDPQIKQDGEAPARRVTIDAFYMDAYEVSNTEFEKFVNSTGYLTEAEKFGDSFVFEGMLSEQVKTNIQQAVAAAPWWLPVKGANWRHPEGPDSTILHRPDHPVLHVSWNDAVAYCTWAGKRLPTEAEWEYSCRGGLHNRLFPWGNKLQPKGQHYANIWQGEFPVTNTGEDGFQGTAPVDAFPPNGYGLYNIVGNAWEWTSDWWTVHHSVEETLNPKGPPSGKDRVKKGGSYMSHRSYCYRYRCAARSQNTPDSSASNLGFRCAADRLP","Homo sapiens","SUMF1, PSEC0152, UNQ3037/PRO9852","Sulfatase-modifying factor 1","1","2HIB"
"2HIU",,"SOLUTION NMR",,,,,,,"10.1038/nsb0295-129",,"2HIU",5.82,,,"NMR STRUCTURE OF HUMAN INSULIN IN 20% ACETIC ACID, ZINC-FREE, 10 STRUCTURES","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","INSULIN","1","2HIU"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFYTPKT","Homo sapiens","INS","INSULIN","2","2HIU"
"2HIW",,"X-RAY DIFFRACTION",2.16,42.93,,5.5,"18-20% PEG4000, 100mM MES pH5.5, 200mM MgCl2, VAPOR DIFFUSION, HANGING DROP, temperature 298K, pH 5.50",298,"10.1016/j.chembiol.2006.05.015","7MP","2HIW",67.28,"2.2","2.2","Crystal Structure of Inactive Conformation Abl Kinase Catalytic Domain Complexed with Type II Inhibitor","GAMDPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGK","Homo sapiens","ABL1, ABL, JTK7","Proto-oncogene tyrosine-protein kinase ABL1","1","2HIW"
"2HIZ",,"X-RAY DIFFRACTION",2.79,55.85,,,"1.0M ammonium phosphate, 0.1M ammonium citrate pH
5.6, 293 K",,"10.1016/j.bmcl.2006.09.092","LIJ","2HIZ",153.04,"2.5","2.5","Crystal Structure of human beta-secretase (BACE) in the presence of an inhibitor","MASMTGGQQMGRGSMAGVLPAHGTQHGIRLPLRSGLGGAPLGLRLPRETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDES","Homo sapiens","BACE, BACE1, KIAA1149","Beta-secretase 1","1","2HIZ"
"2HJ8",,"SOLUTION NMR",,,,,,,,,"2HJ8",10.11,,,"Solution NMR structure of the C-terminal domain of the interferon alpha-inducible ISG15 protein from Homo sapiens. Northeast Structural Genomics target HR2873B","MDEPLSILVRNNKGRSSTYEVRLTQTVAHLKQQVSGLEGVQDDLFWLTFEGKPLEDQLPLGEYGLKPLSTVFMNLRLRGGLEHHHHHH","Homo sapiens","ISG15, G1P2, UCRP","Interferon-induced 17 kDa protein","1","2HJ8"
"2HJW",,"X-RAY DIFFRACTION",2.46,49.92,"HANGING DROP",6.5,"AMMONIUM SULFATE, MES, pH 6.5, HANGING DROP, temperature 293K",293,"10.1002/prot.21611",,"2HJW",63.78,"2.5","2.5","Crystal Structure of the BC domain of ACC2","MRGSGSMRPSMSGLHLVKRGREHKKLDLHRDFTVASPAEFVTRFGGDRVIEKVLIANNGIAAVKCMRSIRRWAYEMFRNERAIRFVVMVTPEDLKANAEYIKMADHYVPVPGGPNNNNYANVELIVDIAKRIPVQAVWAGWGHASENPKLPELLCKNGVAFLGPPSEAMWALGDKIASTVVAQTLQVPTLPWSGSGLTVEWTEDDLQQGKRISVPEDVYDKGCVKDVDEGLEAAERIGFPLMIKASEGGGGKGIRKAESAEDFPILFRQVQSEIPGSPIFLMKLAQHARHLEVQILADQYGNAVSLFGRDCSIQRRHQKIVEEAPATIAPLAIFEFMEQCAIRLAKTVGYVSAGTVEYLYSQDGSFHFLELNPRLQVEHPCTEMIADVNLPAAQLQIAMGVPLHRLKDIRLLYGESPWGVTPISFETPSNPPLARGHVIAARITSENPDEGFKPSSGTVQELNFRSSKNVWGYFSVAATGGLHEFADSQFGHCFSWGENREEAISNMVVALKELSIRGDFRTTVEYLINLLETESFQNNDIDTGWLDYLIAEKVQAEKPDIMLGVLEHHHHHH","Homo sapiens","ACACB, ACC2, ACCB","Acetyl-CoA carboxylase 2","1","2HJW"
"2HK5",,"X-RAY DIFFRACTION",3.07,59.89,"VAPOR DIFFUSION, HANGING DROP",7,"0.5-3.0M Ammonium Sulfate or Sodium Formate or 18 - 28% PEG 10K + 0.1M HEPES or Tris, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 288K",288,"10.1016/j.bmcl.2006.08.132","1BM","2HK5",31.4,"2","2","Hck Kinase in Complex with Lck targetted Inhibitor PG-1009247","AQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFE","Homo sapiens","HCK","Tyrosine-protein kinase HCK","1","2HK5"
"2HKK",,"X-RAY DIFFRACTION",2.08,40.87,"VAPOR DIFFUSION, HANGING DROP",7.7,"Tris.HCl pH 7.7-7.8 , sodium 4-(hydroxymercury)benzoate , VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.bmcl.2006.11.027","ALE","2HKK",29.74,"1.9","1.9","Carbonic anhydrase activators: Solution and X-ray crystallography for the interaction of andrenaline with various carbonic anhydrase isoforms","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","2HKK"
"2HKN",,"X-RAY DIFFRACTION",1.93,36.25,"VAPOR DIFFUSION, SITTING DROP",4.5,"25% PEG 3350, 0.05M sodium citrate, pH 4.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1016/j.molcel.2006.07.013",,"2HKN",20.62,"1.87","1.87","Crystal structure of the CAP-Gly domain of human Dynactin-1 (p150-Glued)","GSHMSAEASARPLRVGSRVEVIGKGHRGTVAYVGATLFATGKWVGVILDEAKGKNDGTVQGRKYFTCDEGHGIFVRQSQIQVFEDGADTTSPETPDS","Homo sapiens","DCTN1","Dynactin-1","1","2HKN"
"2HKO",,"X-RAY DIFFRACTION",3.64,66.24,,6.3,"5% PEG 8K, 10 mM MgCl2, 150 mM NaCl, 50 mM Na2HPO4/KH2PO4 pH 6.33, 2mM DTT, VAPOR DIFFUSION, HANGING DROP, temperature 289K, pH 6.30",289,"10.1073/pnas.0606381103",,"2HKO",74.67,"2.8","2.8","Crystal structure of LSD1","SGVEGAAFQSRLPHDRMTSQEAACFPDIISGPQQTQKVFLFIRNRTLQLWLDNPKIQLTFEATLQQLEAPYNSDTVLVHRVHSYLERHGLINFGIYKRIKPLPTKKTGKVIIIGSGVSGLAAARQLQSFGMDVTLLEARDRVGGRVATFRKGNYVADLGAMVVTGLGGNPMAVVSKQVNMELAKIKQKCPLYEANGQAVPKEKDEMVEQEFNRLLEATSYLSHQLDFNVLNNKPVSLGQALEVVIQLQEKHVKDEQIEHWKKIVKTQEELKELLNKMVNLKEKIKELHQQYKEASEVKPPRDITAEFLVKSKHRDLTALCKEYDELAETQGKLEEKLQELEANPPSDVYLSSRDRQILDWHFANLEFANATPLSTLSLKHWDQDDDFEFTGSHLTVRNGYSCVPVALAEGLDIKLNTAVRQVQYTASGCEVIAVNTRSTSQTFIYKCDAVLCTLPLGVLKQQPPAVQFVPPLPEWKTSAVQRMGFGNLNKVVLCFDRVFWDPSVNLFGHVGSTTASRGELFLFWNLYKAPILLALVAGEAAGIMENISDDVIVGRCLAILKGIFGSSAVPQPKETVVSRWRADPWARGSYSYVAAGSSGNDYDLMAQPITPGPSIPGAPQPIPRLFFAGEHTIRNYPATVHGALLSGLREAGRIADQFLGAMYT","Homo sapiens","AOF2, KDM1A, KDM1, KIAA0601, LSD1","Lysine-specific histone demethylase 1","1","2HKO"
"2HKY",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M607321200",,"2HKY",14.71,,,"NMR solution structure of human RNase 7","MKPKGMTSSQWFKIQHMQPSPQACNSAMKNINKHTKRCKDLNTFLHEPFSSVAATCQTPKIACKNGDKNCHQSHGPVSLTMCKLTSGKYPNCRYKEKRQNKSYVVACKPPQKKDSQQFHLVPVHLDRVL","Homo sapiens","RNASE7, UNQ2516/PRO6006","Ribonuclease 7","1","2HKY"
"2HL3",,"X-RAY DIFFRACTION",1.82,32.42,"VAPOR DIFFUSION, SITTING DROP",4.5,"25% PEG 3350, 0.05M Sodium Citrate, pH 4.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1016/j.molcel.2006.07.013",,"2HL3",21.56,"2.03","2.03","Crystal structure of the A49M mutant CAP-Gly domain of human Dynactin-1 (p150-Glued) in complex with human EB1 C-terminal hexapeptide","GSHMSAEASARPLRVGSRVEVIGKGHRGTVAYVGMTLFATGKWVGVILDEAKGKNDGTVQGRKYFTCDEGHGIFVRQSQIQVFEDGADTTSPETPDS","Homo sapiens","DCTN1","Dynactin-1","1","2HL3"
,,,,,,,,,,,,,,,,"EEQEEY",,,"Microtubule-associated protein RP/EB family member 1","2","2HL3"
"2HL4",,"X-RAY DIFFRACTION",2.07,40.53,"VAPOR DIFFUSION, HANGING DROP",8.4,"2.5M Ammonium Sulphate, 0.3M Sodium Chloride, 0.1M Tris-HCl, 5mM mercury-parahydroxybenzoate, pH 8.4, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.bmcl.2006.12.099","CL, BO1","2HL4",30.01,"1.55","1.55","Crystal structure analysis of human carbonic anhydrase II in complex with a benzenesulfonamide derivative","SHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","2HL4"
"2HLW",,"SOLUTION NMR",,,,,,,"10.1021/bi060631r",,"2HLW",19.33,,,"Solution Structure of the Human Ubiquitin-conjugating Enzyme Variant Uev1a","MPGEVQASYLKSQSKLSDEGRLEPRKFHCKGVKVPRNFRLLEELEEGQKGVGDGTVSWGLEDDEDMTLTRWTGMIIGPPRTIYENRIYSLKIECGPKYPEAPPFVRFVTKINMNGVNSSNGVVDPRAISVLAKWQNSYSIKVVLQELRRLMMSKENMKLPQPPEGQCYSN","Homo sapiens","UEV1, UBE2V1, CROC1, UBE2V, P/OKcl.19","Ubiquitin-conjugating enzyme E2 variant 1","1","2HLW"
"2HLZ",,"X-RAY DIFFRACTION",2.8,55.8,"VAPOR DIFFUSION, SITTING DROP",4.2,"17% PEG8000, 5mM Cobalt Chloride, 200mM ammonium sulfate, 100mM NaCitrate, pH 4.2, vapor diffusion, sitting drop, temperature 291K",291,,,"2HLZ",137.23,"1.85","1.85","Crystal Structure of human ketohexokinase","GSSHHHHHHSSGLVPRGSQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTILSLLGAPCAFMGSMAPGHVADFVLDDLRRYSVDLRYTVFQTTGSVPIATVIINEASGSRTILYYDRSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV","Homo sapiens","KHK","Ketohexokinase","1","2HLZ"
,,,2.8,55.8
"2HM1",,"X-RAY DIFFRACTION",2.1,41.41,,,"Hanging drop, 14-26 % PEG 750MME, sodium acetate
pH 4.6-5.2, 293",,"10.1016/j.bmcl.2006.09.091","LIQ","2HM1",46.09,"2.2","2.2","Crystal Structure of human beta-secretase (BACE) in the presence of an inhibitor (2)","MRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDESRSHHHHHH","Homo sapiens","BACE, BACE1, KIAA1149","Beta-secretase 1","1","2HM1"
"2HM2",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M605458200",,"2HM2",10.12,,,"Solution structure of ASC2","MGTKREAILKVLENLTPEELKKFKMKLGTVPLREGFERIPRGALGQLDIVDLTDKLVASYYEDYAAELVVAVLRDMRMLEEAARLQRAA","Homo sapiens","POP1, PYDC1, ASC2, ASCI, PYC1","Pyrin-only protein 1","1","2HM2"
"2HMB",,"X-RAY DIFFRACTION",2.47,50.27,,,,,"10.2210/pdb2hmb/pdb","PLM","2HMB",15,"2.1","2.1","THREE-DIMENSIONAL STRUCTURE OF RECOMBINANT HUMAN MUSCLE FATTY ACID-BINDING PROTEIN","VDAFLGTWKLVDSKNFDDYMKSLGVGFATRQVASMTKPTTIIEKNGDILTLKTHSTFKNTEISFKLGVEFDETTADDRKVKSIVTLDGGKLVHLQKWDGQETTLVRELIDGKLILTLTHGTAVCTRTYEKEA","Homo sapiens","FABP3, FABP11, MDGI","MUSCLE FATTY ACID BINDING PROTEIN","1","2HMB"
"2HNC",,"X-RAY DIFFRACTION",2.08,40.76,"VAPOR DIFFUSION, HANGING DROP",8.2,"2.5 M Ammonium Sulphate, 0.3 M Sodium Chloride, 0.1 M Tris-HCl pH 8.2, 5 mM 4-(hydroxymercurybenzoate)., VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.bmcl.2006.09.022","1SA","2HNC",29.91,"1.55","1.55","Crystal structure of the human carbonic anhydrase II in complex with the 5-amino-1,3,4-thiadiazole-2-sulfonamide inhibitor.","SHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","2HNC"
"2HNP",,"X-RAY DIFFRACTION",3.13,60.71,,,,,,,"2HNP",37.37,"2.85","2.85","CRYSTAL STRUCTURE OF HUMAN PROTEIN TYROSINE PHOSPHATASE 1B","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPCRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTCGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","PROTEIN-TYROSINE PHOSPHATASE-1B","1","2HNP"
"2HNQ",,"X-RAY DIFFRACTION",3.12,60.58,,,,,,,"2HNQ",37.61,"2.85","2.85","CRYSTAL STRUCTURE OF HUMAN PROTEIN TYROSINE PHOSPHATASE 1B","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPCRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTCGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","PROTEIN-TYROSINE PHOSPHATASE-1B","1","2HNQ"
"2HNT",,"X-RAY DIFFRACTION",2.37,48.18,,,,,,,"2HNT",33.46,"2.5","2.5","CRYSTALLOGRAPHIC STRUCTURE OF HUMAN GAMMA-THROMBIN","TFGSGEADCGLRPLFEKKSLEDKTERELLESYIDGR","Homo sapiens","F2","GAMMA-THROMBIN","1","2HNT"
,,,,,,,,,,,,,,,,"IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTR","Homo sapiens","F2","GAMMA-THROMBIN","2","2HNT"
,,,,,,,,,,,,,,,,"NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK","Homo sapiens","F2","GAMMA-THROMBIN","3","2HNT"
,,,,,,,,,,,,,,,,"GQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFGE","Homo sapiens","F2","GAMMA-THROMBIN","4","2HNT"
"2HNX",,"X-RAY DIFFRACTION",2.16,43.14,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1M HEPES pH 7.5, 1.6M tri-sodium citrate pH 6.5 or 20% PEG 10000, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1107/S1744309106038656","PLM","2HNX",15.65,"1.5","1.5","Crystal Structure of aP2","RGSHMCDAFVGTWKLVSSENFDDYMKEVGVGFATRKVAGMAKPNMIISVNGDVITIKSESTFKNTEISFILGQEFDEVTADDRKVKSTITLDGGVLVHVQKWDGKSTTIKRKREDDKLVVECVMKGVTSTRVYERA","Homo sapiens","FABP4","Fatty acid-binding protein, adipocyte","1","2HNX"
"2HO2",,"X-RAY DIFFRACTION",1.86,33.74,"VAPOR DIFFUSION, SITTING DROP",7.4,"1.85M Ammonium Sulfate, 0.1M HEPES, pH 7.4, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.jmb.2007.06.064",,"2HO2",5.29,"1.33","1.33","Structure of human FE65-WW domain in complex with hMena peptide.","GSDLPAGWMRVQDTSGTYYWHIPTGTTQWEPPGRASPS","Homo sapiens","APBB1, FE65, RIR","Amyloid beta A4 protein-binding family B member 1","1","2HO2"
,,,,,,,,,,,,,,,,"PPPPPPPPPL",,,"Protein enabled homolog","2","2HO2"
"2HOC",,"X-RAY DIFFRACTION",2.08,40.75,"VAPOR DIFFUSION, HANGING DROP",8.2,"Ammonium Sulphate, Sodium Chloride, Tris-HCl, 4-(hydroxymercurybenzoate), pH 8.2, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.bmcl.2006.09.022","1CN","2HOC",30.41,"2.1","2.1","Crystal structure of the human carbonic anhydrase II in complex with the 5-(4-amino-3-chloro-5-fluorophenylsulfonamido)-1,3,4-thiadiazole-2-sulfonamide inhibitor","SHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","2HOC"
"2HOG",,"X-RAY DIFFRACTION",2.33,47.24,"VAPOR DIFFUSION, HANGING DROP",6.8,"13% PEG 8K, 0.1M Ammonium sulfate, 2% glycerol, 0.1M cacodylate, pH 6.8, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.bmcl.2006.08.118","710","2HOG",37.22,"1.9","1.9","crystal structure of Chek1 in complex with inhibitor 20","AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGFSKHIQSNLDFSPVNSASRTPGSGWSKEHHHHHH","Homo sapiens","CHEK1, CHK1","Serine/threonine-protein kinase Chk1","1","2HOG"
"2HP4",,"X-RAY DIFFRACTION",3.12,60.58,"VAPOR DIFFUSION",6.5,"25.5% PEG 8000, 0.085M Sodium Cacodylate, 0.17M Ammonium Sulphate, 15% Glycerol, 3% Ethylene Glycol, pH 6.50, VAPOR DIFFUSION, temperature 291K",291,"10.1002/prot.21176",,"2HP4",26.54,"2.1","2.1","Computational design and crystal structure of an enhanced affinity mutant human CD8-alpha-alpha co-receptor","SQFRVSPLDRTWNLGETVELKCQVLLSNPTSGASWLFQPRGAAASPTFLLYLNQNKPKAAEGLDTQRFSGKRLGDTFVLTLSDFRRENEGYYFCSALSNSIMYFSHFVPVFLPA","Homo sapiens","CD8A, MAL","T-cell surface glycoprotein CD8 alpha chain","1","2HP4"
"2HP8",,"SOLUTION NMR",,,,,,,"10.1006/jmbi.1997.1438",,"2HP8",8.89,,,"SOLUTION STRUCTURE OF HUMAN P8-MTCP1, A CYSTEINE-RICH PROTEIN ENCODED BY THE MTCP1 ONCOGENE,REVEALS A NEW ALPHA-HELICAL ASSEMBLY MOTIF, NMR, 30 STRUCTURES","GSPGIHMPQKDPCQKQACEIQKCLQANSYMESKCQAVIQELRKCCAQYPKGRSVVCSGFEKEEEENLTRKSASKGIHRD","Homo sapiens","CMC4, C6.1B, MTCP1, MTCP1NB","Cx9C motif-containing protein 4","1","2HP8"
"2HPA",,"X-RAY DIFFRACTION",2.71,54.66,,10,"pH 10",,"10.1074/jbc.273.46.30406","PT3","2HPA",162.34,"2.9","2.9","STRUCTURAL ORIGINS OF L(+)-TARTRATE INHIBITION OF HUMAN PROSTATIC ACID PHOSPHATASE","KELKFVTLVFRHGDRSPIDTFPTDPIKESSWPQGFGQLTQLGMEQHYELGEYIRKRYRKFLNESYKHEQVYIRSTDVDRTLMSAMTNLAALFPPEGVSIWNPILLWQPIPVHTVPLSEDQLLYLPFRNCPRFQELESETLKSEEFQKRLHPYKDFIATLGKLSGLHGQDLFGIWSKVYDPLYCESVHNFTLPSWATEDTMTKLRELSELSLLSLYGIHKQKEKSRLQGGVLVNEILNHMKRATQIPSYKKLIMYSAHDTTVSGLQMALDVYNGLLPPYASCHLTELYFEKGEYFVEMYYRNETQHEPYPLMLPGCSPSCPLERFAELVGPVIPQDWSTECMT","Homo sapiens","ACP3, ACPP","PROTEIN (ACID PHOSPHATASE)","1","2HPA"
"2HQ6",,"X-RAY DIFFRACTION",2.76,55.49,,,"Protein is 20 mg/mL, in buffer containing 50 mM Tris pH 8.0, 500 mM NaCl, 5 mM BME; hanging drop, 1+1; precipitant is 20% Peg 3350, 0.2M NaI (no buffer); cryo was 20% glycerol, temperature 298.0K",298,"10.1371/journal.pbio.1000439",,"2HQ6",20.92,"1.75","1.75","Structure of the Cyclophilin_CeCYP16-Like Domain of the Serologically Defined Colon Cancer Antigen 10 from Homo Sapiens","MGSSHHHHHHSSGLVPRGSEPPTNGKVLLKTTAGDIDIELWSKEAPKACRNFIQLCLEAYYDNTIFHRVVPGFIVQGGDPTGTGSGGESIYGAPFKDEFHSRLRFNRRGLVAMANAGSHDNGSQFFFTLGRADELNNKHTIFGKVTGDTVYNMLRLSEVDIDDDERPHNPHKIKSCEVLFNPFDD","Homo sapiens","SDCCAG10, CWC27, UNQ438/PRO871","Serologically defined colon cancer antigen 10","1","2HQ6"
"2HQE",,"X-RAY DIFFRACTION",1.99,38.1,"VAPOR DIFFUSION, SITTING DROP",4.2,"2 micor liter drops containing equal volumes of protein solution (10.0 mg/ml) and precipitate solution (20% PEG 8000, 100.0 MM Phosphate, 0.1M Hepes), pH 4.2, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,,,"2HQE",55.88,"2","2","Crystal structure of human P100 Tudor domain: Large fragment","PVEEVMPVLEEKERSASYKPVFVTEITDDLHFYVQDVETGTQFQKLMENMRNDIASHPPVEGSYAPRRGEFCIAKFVDGEWYRARVEKVESPAKIHVFYIDYGNREVLPSTRLGTLSPAFSTRVLPAQATEYAFAFIQVPQDDDARTDAVDSVVRDIQNTQCLLNVEHLSAGCPHVTLQFADSKGDVGLGLVKEGLVMVEVRKEKQFQKVITEYLNAQESAKSARLNLWRYGDFRADDADEFGYSR","Homo sapiens","SND1, TDRD11","P100 Co-activator tudor domain","1","2HQE"
"2HQQ",,"X-RAY DIFFRACTION",3.75,67.17,"VAPOR DIFFUSION, HANGING DROP",5.7,"0.7M ammonium sulphate, 0.5M lithium sulphate, 0.1M sodium citrate, pH 5.7, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1107/S0907444908041115",,"2HQQ",33.06,"1.86","1.86","Crystal structure of human ketohexokinase complexed to different sugar molecules","MEEKQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFVLDDLRRYSVDLRYTVFQTTGSVPIATVIINEASGSRTILYYDRSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV","Homo sapiens","KHK","Ketohexokinase","1","2HQQ"
"2HQU",,"X-RAY DIFFRACTION",1.68,26.93,"VAPOR DIFFUSION, HANGING DROP",7.5,"18-20% PEG 3350, 0.1M Na-Hepes, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.febslet.2007.09.005","DUP","2HQU",54.85,"2.2","2.2","Human dUTPase in complex with alpha,beta-iminodUTP and magnesium ion","MPCSEETPAISPSKRARPAEVGGMQLRFARLSEHATAPTRGSARAAGYDLYSAYDYTIPPMEKAVVKTDIQIALPSGCYGRVAPRSGLAAKHFIDVGAGVIDEDYRGNVGVVLFNFGKEKFEVKKGDRIAQLICERIFYPEIEEVQALDDTERGSGGFGSTGKN","Homo sapiens","DUTN, DUT","Deoxyuridine 5'-triphosphate nucleotidohydrolase","1","2HQU"
"2HQX",,"X-RAY DIFFRACTION",,,"MODIFIED MICROBATCH",7.9,"1.0 MICROLITER DROPS CONTAINING EQUAL VOLUMES OF PROTEIN CONCENTRATE (11.0 MG/ML) AND RESERVOIR SOLUTION CONTAINING 1.06M AMMONIUM SULFATE, 200.0 MM LITHIUM SULFATE, 0.1M TRIS PH 7.9, MODIFIED MICROBATCH, temperature 291K",291,,,"2HQX",55.88,"1.42","1.42","Crystal structure of human P100 tudor domain conserved region","PVEEVMPVLEEKERSASYKPVFVTEITDDLHFYVQDVETGTQFQKLMENMRNDIASHPPVEGSYAPRRGEFCIAKFVDGEWYRARVEKVESPAKIHVFYIDYGNREVLPSTRLGTLSPAFSTRVLPAQATEYAFAFIQVPQDDDARTDAVDSVVRDIQNTQCLLNVEHLSAGCPHVTLQFADSKGDVGLGLVKEGLVMVEVRKEKQFQKVITEYLNAQESAKSARLNLWRYGDFRADDADEFGYSR","Homo sapiens","SND1, TDRD11","P100 CO-ACTIVATOR TUDOR DOMAIN","1","2HQX"
"2HR7",,"X-RAY DIFFRACTION",4.74,74.03,,8.5,"1.5-1.65 M ammonium sulfate, 2 % PEG 400, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K, pH 8.50",291,"10.1073/pnas.0605395103",,"2HR7",122.96,"2.32","2.32","Insulin receptor (domains 1-3)","HLYPGEVCPGMDIRNNLTRLHELENCSVIEGHLQILLMFKTRPEDFRDLSFPKLIMITDYLLLFRVYGLESLKDLFPNLTVIRGSRLFFNYALVIFEMVHLKELGLYNLMNITRGSVRIEKNNELCYLATIDWSRILDSVEDNHIVLNKDDNEECGDICPGTAKGKTNCPATVINGQFVERCWTHSHCQKVCPTICKSHGCTAEGLCCHSECLGNCSQPDDPTKCVACRNFYLDGRCVETCPPPYYHFQDWRCVNFSFCQDLHHKCKNSRRQGCHQYVIHNNKCIPECPSGYTMNSSNLLCTPCLGPCPKVCHLLEGEKTIDSVTSAQELRGCTVINGSLIINIRGGNNLAAELEANLGLIEEISGYLKIRRSYALVSLSFFRKLRLIRGETLEIGNYSFYALDNQNLRQLWDWSKHNLTITQGKLFFHYNPKLCLSEIHKMEEVSGTKGRQERNDIALKTNGDKASCENELLKFSYIRTSFDKIS","Homo sapiens","INSR","Insulin receptor","1","2HR7"
"2HR9",,"SOLUTION NMR",,,,,,,"10.1016/j.abb.2007.08.021",,"2HR9",20.69,,,"Solution structure of human translationally controlled tumor protein","MIIYRDLISHDEMFSDIYKIREIADGLCLEVEGKMVSRTEGNIDDSLIGGNASAEGPEGEGTESTVITGVDIVMNHHLQETSFTKEAYKKYIKDYMKSIKGKLEEQRPERVKPFMTGAAEQIKHILANFKNYQFFIGENMNPDGMVALLDYREDGVTPYMIFFKDGLEMEKCLEHHHHHH","Homo sapiens","TPT1","Translationally-controlled tumor protein","1","2HR9"
"2HRB",,"X-RAY DIFFRACTION",2.43,49.31,"VAPOR DIFFUSION, SITTING DROP",7,"1.8M tri-ammonium citrate, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,,,"2HRB",31.56,"1.9","1.9","Crystal Structure of human Carbonyl Reductase 3, complexed with NADP+","GSRVALVTGANRGIGLAIARELCRQFSGDVVLTARDVARGQAAVQQLQAEGLSPRFHQLDIDDLQSIRALRDFLRKEYGGLNVLVNNAAVAFKSDDPMPFDIKAEMTLKTNFFATRNMCNELLPIMKPHGRVVNISSLQCLRAFENCSEDLQERFHSETLTEGDLVDLMKKFVEDTKNEVHEREGWPNSPYGVSKLGVTVLSRILARRLDEKRKADRILVNACCPGPVKTDMDGKDSIRTVEEGAETPVYLALLPPDATEPQGQLVHDKVVQNW","Homo sapiens","CBR3, SDR21C2","Carbonyl reductase [NADPH] 3","1","2HRB"
"2HRC",,"X-RAY DIFFRACTION",2.76,55.45,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.05 M calcium chloride, 0.1 M Bis-Tris, 30% v/v PEG MME 550, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1073/pnas.0606144104",,"2HRC",85.37,"1.7","1.7","1.7 angstrom structure of human ferrochelatase variant R115L","RKPKTGILMLNMGGPETLGDVHDFLLRLFLDRDLMTLPIQNKLAPFIAKRLTPKIQEQYRRIGGGSPIKIWTSKQGEGMVKLLDELSPNTAPHKYYIGFRYVHPLTEEAIEEMERDGLERAIAFTQYPQYSCSTTGSSLNAIYRYYNQVGRKPTMKWSTIDRWPTHHLLIQCFADHILKELDHFPLEKRSEVVILFSAHSLPMSVVNRGDPYPQEVSATVQKVMERLEYCNPYRLVWQSKVGPMPWLGPQTDESIKGLCERGRKNILLVPIAFTSDHIETLYELDIEYSQVLAKECGVENIRRAESLNGNPLFSKALADLVHSHIQSNELCSKQLTLSCPLCVNPVCRETKSFFTSQQL","Homo sapiens","FECH","Ferrochelatase","1","2HRC"
"2HRE",,"X-RAY DIFFRACTION",2.65,53.66,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.1 M Bis-Tris, 0.2 M Magnesium Chloride, 25% PEG 3350, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1073/pnas.0606144104",,"2HRE",169.61,"2.5","2.5","Structure of human ferrochelatase variant E343K with protoporphyrin IX bound","RKPKTGILMLNMGGPETLGDVHDFLLRLFLDRDLMTLPIQNKLAPFIAKRRTPKIQEQYRRIGGGSPIKIWTSKQGEGMVKLLDELSPNTAPHKYYIGFRYVHPLTEEAIEEMERDGLERAIAFTQYPQYSCSTTGSSLNAIYRYYNQVGRKPTMKWSTIDRWPTHHLLIQCFADHILKELDHFPLEKRSEVVILFSAHSLPMSVVNRGDPYPQEVSATVQKVMERLEYCNPYRLVWQSKVGPMPWLGPQTDESIKGLCERGRKNILLVPIAFTSDHIKTLYELDIEYSQVLAKECGVENIRRAESLNGNPLFSKALADLVHSHIQSNELCSKQLTLSCPLCVNPVCRETKSFFTSQQL","Homo sapiens","FECH","Ferrochelatase","1","2HRE"
"2HRF",,"SOLUTION NMR",,,,,,,"10.1073/pnas.0606189103",,"2HRF",19.79,,,"Solution Structure of Cu(I) P174L HSco1","SFTGKPLLGGPFSLTTHTGERKTDKDYLGQWLLIYFGFTHCPDVCLEELEKMIQVVDEIDSITTLPDLTPLFISIDPERDTKEAIANYVKEFSPKLVGLTGTREEVDQVARAYRVYYSPGPKDEDEDYIVDHTIIMYLIGPDGEFLDYFGQNKRKGEIAASIATHMRPYRKKS","Homo sapiens","SCO1, SCOD1","SCO1 protein homolog, mitochondrial","1","2HRF"
"2HRL",,"X-RAY DIFFRACTION",2.22,44.6,"VAPOR DIFFUSION, SITTING DROP",6.5,"200mM sodium acetate, 100mM sodium cacodylate, 30 % w/v PEG 8000, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1074/jbc.M601714200",,"2HRL",16.11,"1.85","1.85","Siglec-7 in complex with GT1b","GQKSNRKDYSLTMQSSVTVQEGMCVHVRCSFSYPVDSQTDSDPVHGYWFRAGNDISWKAPVATNNPAWAVQEETRDRFHLLGDPQTKNCTLSIRDARMSDAGRYFFRMEKGNIKWNYKYDQLSVNVT","Homo sapiens","SIGLEC7, AIRM1","Sialic acid-binding Ig-like lectin 7","1","2HRL"
"2HRN",,"SOLUTION NMR",,,,,,,"10.1073/pnas.0606189103",,"2HRN",19.79,,,"Solution Structure of Cu(I) P174L-HSco1","SFTGKPLLGGPFSLTTHTGERKTDKDYLGQWLLIYFGFTHCPDVCLEELEKMIQVVDEIDSITTLPDLTPLFISIDPERDTKEAIANYVKEFSPKLVGLTGTREEVDQVARAYRVYYSPGPKDEDEDYIVDHTIIMYLIGPDGEFLDYFGQNKRKGEIAASIATHMRPYRKKS","Homo sapiens","SCO1, SCOD1","SCO1 protein homolog, mitochondrial","1","2HRN"
"2HRQ",,"X-RAY DIFFRACTION",2.9,57.51,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1 M Citrate pH 5.5, 8-11% PEG 3350, 0.1-0.4M Lithium Sulfate, 0.1M Lithium Chloride, 0.1M Sodium Chloride, 5% Glycerol, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,"10.1021/bi700246n",,"2HRQ",359.41,"2.7","2.7","Crystal structure of Human Liver Carboxylesterase 1 (hCE1) in covalent complex with the nerve agent Soman (GD)","SSPPVVDTVHGKVLGKFVSLEGFAQPVAIFLGIPFAKPPLGPLRFTPPQPAEPWSFVKNATSYPPMCTQDPKAGQLLSELFTNRKENIPLKLSEDCLYLNIYTPADLTKKNRLPVMVWIHGGGLMVGAASTYDGLALAAHENVVVVTIQYRLGIWGFFSTGDEHSRGNWGHLDQVAALRWVQDNIASFGGNPGSVTIFGESAGGESVSVLVLSPLAKNLFHRAISESGVALTSVLVKKGDVKPLAEQIAITAGCKTTTSAVMVHCLRQKTEEELLETTLKMKFLSLDLQGDPRESQPLLGTVIDGMLLLKTPEELQAERNFHTVPYMVGINKQEFGWLIPMLMSYPLSEGQLDQKTAMSLLWKSYPLVCIAKELIPEATEKYLGGTDDTVKKKDLFLDLIADVMFGVPSVIVARNHRDAGAPTYMYEFQYRPSFSSDMKPKTVIGDHGDELFSVFGAPFLKEGASEEEIRLSKMVMKFWANFARNGNPNGEGLPHWPEYNQKEGYLQIGANTQAAQKLKDKEVAFWTNLFAK","Homo sapiens","CES1, CES2, SES1","Liver carboxylesterase 1","1","2HRQ"
"2HRR",,"X-RAY DIFFRACTION",2.9,57.53,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1 M Citrate pH 5.5, 8-11% PEG 3350, 0.1-0.4M Lithium Sulfate, 0.1M Lithium Chloride, 0.1M Sodium Chloride, 5% Glycerol, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,"10.1021/bi700246n",,"2HRR",179.53,"2.7","2.7","Crystal structure of Human Liver Carboxylesterase 1 (hCE1) in covalent complex with the nerve agent Tabun (GA)","SSPPVVDTVHGKVLGKFVSLEGFAQPVAIFLGIPFAKPPLGPLRFTPPQPAEPWSFVKNATSYPPMCTQDPKAGQLLSELFTNRKENIPLKLSEDCLYLNIYTPADLTKKNRLPVMVWIHGGGLMVGAASTYDGLALAAHENVVVVTIQYRLGIWGFFSTGDEHSRGNWGHLDQVAALRWVQDNIASFGGNPGSVTIFGESAGGESVSVLVLSPLAKNLFHRAISESGVALTSVLVKKGDVKPLAEQIAITAGCKTTTSAVMVHCLRQKTEEELLETTLKMKFLSLDLQGDPRESQPLLGTVIDGMLLLKTPEELQAERNFHTVPYMVGINKQEFGWLIPMLMSYPLSEGQLDQKTAMSLLWKSYPLVCIAKELIPEATEKYLGGTDDTVKKKDLFLDLIADVMFGVPSVIVARNHRDAGAPTYMYEFQYRPSFSSDMKPKTVIGDHGDELFSVFGAPFLKEGASEEEIRLSKMVMKFWANFARNGNPNGEGLPHWPEYNQKEGYLQIGANTQAAQKLKDKEVAFWTNLFAK","Homo sapiens","CES1, CES2, SES1","Liver carboxylesterase 1","1","2HRR"
"2HSH",,"X-RAY DIFFRACTION",1.89,34.95,"VAPOR DIFFUSION, HANGING DROP",3.8,"50% MPD, 10 mM sodium acetate, 8% H2O2, pH 3.8, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/bi061878r",,"2HSH",11.83,"1.35","1.35","Crystal structure of C73S mutant of human thioredoxin-1 oxidized with H2O2","MVKQIESKTAFQEALDAAGDKLVVVDFSATWCGPCKMIKPFFHSLSEKYSNVIFLEVDVDDCQDVASECEVKSMPTFQFFKKGQKVGEFSGANKEKLEATINELV","Homo sapiens","TXN, TRDX, TRX, TRX1","Thioredoxin","1","2HSH"
"2HSP",,"SOLUTION NMR",,,,,,,"10.1016/0092-8674(93)90583-c",,"2HSP",8.25,,,"SOLUTION STRUCTURE OF THE SH3 DOMAIN OF PHOSPHOLIPASE CGAMMA","GSPTFKCAVKALFDYKAQREDELTFIKSAIIQNVEKQEGGWWRGDYGGKKQLWFPSNYVEEMVNPEGIHRD","Homo sapiens","GRB2, PLCG1, PLC1","PHOSPHOLIPASE C-GAMMA (SH3 DOMAIN)","1","2HSP"
"2HST",,"SOLUTION NMR",,,,,,,"10.1111/j.1742-4658.2007.05949.x",,"2HST",15.93,,,"Solution structure of the middle domain of human eukaryotic translation termination factor eRF1","LSDDSKFGFIVIDGSGALFGTLQGNTREVLHKFTVDLPKKHGRGGQSALRFARLRMEKRHNYVRKVAETAVQLFISGDKVNVAGLVLAGSADFKTELSQSDMFDQRLQSKVLKLVDISYGGENGFNQAIELSTEVLEHHHHHH","Homo sapiens","ETF1, ERF1, RF1, SUP45L1","Eukaryotic peptide chain release factor subunit 1","1","2HST"
"2HT6",,"X-RAY DIFFRACTION",2.57,52.07,"VAPOR DIFFUSION, HANGING DROP",7.5,"20% PEG 8000, 0.1 M HEPES, 0.1 M sodium chloride, 0.5 mM magnesium chloride, 1 mM DTT, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 292K",292,"10.1016/j.febslet.2006.09.067",,"2HT6",40.16,"2.4","2.4","Crystal structure of Human Gem G-domain bound to GDP","GSGNTYYRVVLIGEQGVGKSTLANIFAGVHDSMDSDCEVLGEDTYERTLMVDGESATIILLDMWENKGENEWLHDHCMQVGDAYLIVYSITDRASFEKASELRIQLRRARQTEDIPIILVGNKSDLVRCREVSVSEGRACAVVFDCKFIETSAAVQHNVKELFEGIVRQVRLRR","Homo sapiens","GEM, KIR","GTP-binding protein GEM","1","2HT6"
"2HTF",,"SOLUTION NMR",,,,,,,"10.1021/bi7007728",,"2HTF",11.42,,,"The solution structure of the BRCT domain from human polymerase reveals homology with the TdT BRCT domain","GTPPSTRFPGVAIYLVEPRMGRSRRAFLTGLARSKGFRVLDACSSEATHVVMEETSAEEAVSWQERRMAAAPPGCTPPALLDISWLTESLGAGQPVPVECRHRLE","Homo sapiens","POLM, polmu","DNA polymerase mu","1","2HTF"
"2HU6",,"X-RAY DIFFRACTION",2.15,42.72,"VAPOR DIFFUSION, SITTING DROP",8,"0.1 M Tris-HCl, 30% PEG 6000, pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1016/j.bmc.2006.07.028","37A","2HU6",18.33,"1.32","1.32","Crystal structure of human MMP-12 in complex with acetohydroxamic acid and a bicyclic inhibitor","MGPVWRKHYITYRINNYTPDMNREDVDYAIRKAFQVWSNVTPLKFSKINTGMADILVVFARGAHGDDHAFDGKGGILAHAFGPGSGIGGDAHFDEDEFWTTHSGGTNLFLTAVHEIGHSLGLGHSSDPKAVMFPTYKYVDINTFRLSADDIRGIQSLYG","Homo sapiens","MMP12, HME","Macrophage metalloelastase","1","2HU6"
"2HUP",,"X-RAY DIFFRACTION",2.8,55.2,"VAPOR DIFFUSION, SITTING DROP",8.5,"25% PEG8000, 0.2M NaCl, 0.1M Tris-HCl, pH 8.5, vapor diffusion, sitting drop, temperature 291K, VAPOR DIFFUSION, SITTING DROP",291,,,"2HUP",45.69,"2.05","2.05","Crystal structure of human RAB43 in complex with GDP","MGSSHHHHHHSSGLVPRGSGDPDEQYDFLFKLVLVGDASVGKTCVVQRFKTGAFSERQGSTIGVDFTMKTLEIQGKRVKLQIWDTAGQERFRTITQSYYRSANGAILAYDITKRSSFLSVPHWIEDVRKYAGSNIVQLLIGNKSDLSELREVSLAEAQSLAEHYDILCAIETSAKDSSNVEEAFLRVATELIMRHGGPLFS","Homo sapiens","RAB43, RAB41","RAS-related protein RAB-43","1","2HUP"
"2HUW",,"X-RAY DIFFRACTION",2.06,40.17,"VAPOR DIFFUSION, HANGING DROP",6,"Ligand (cpYVN) was added to a 1.5 molar excess to a solution of 50 mg/ml Grb2-SH2 in 50 mM sodium cacodylate at PH 6.0.  This solution was mixed with an equal volume of 4% (v/v) PEG 400, 2.0 M (NH4)2PO4., VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1002/anie.200600844","YVN","2HUW",28.52,"1.9","1.9","X-ray crystal structure of the Grb2 SH2 domain complexed to a constrained and cyclopropane-derived ligand","IEMKPHPWFFGKIPRAKAEEMLSKQRHDGAFLIRESESAPGDFSLSVKFGNDVQHFKVLRDGAGKYFLWVVKFNSLNELVDYHRSTSVSRNQQIFLRDIEQVPQQPTYVQHHHHHH","Homo sapiens","GRB2, ASH","Growth factor receptor-bound protein 2","1","2HUW"
"2HUZ",,"X-RAY DIFFRACTION",2.26,45.65,"VAPOR DIFFUSION, HANGING DROP",6.5,"25% PEG4K, 0.2M NH4SO4, 0.1M Na Acetate pH4.6, 0.1M Yttrium Chloride, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 300K",300,,,"2HUZ",41.55,"2.67","2.67","Crystal structure of GNPNAT1","MKPDETPMFDPSLLKEVDWSQNTATFSPAISPTHPGEGLVLRPLCTADLNRGFFKVLGQLTETGVVSPEQFMKSFEHMKKSGDYYVTVVEDVTLGQIVATATLIIEHKFIHSCAKRGRVEDVVVSDECRGKQLGKLLLSTLTLLSKKLNCYKITLECLPQNVGFYKKFGYTVSEENYMCRRFLK","Homo sapiens","GNPNAT1, GNA1","Glucosamine 6-phosphate N-acetyltransferase","1","2HUZ"
"2HV1",,"SOLUTION NMR",,,,,,,,,"2HV1",27.91,,,"HADDOCK structure of ARNT PAS-B Homodimer","GAMDNVCQPTEFISRHNIEGIFTFVDHRCVATVGYQPQELLGKNIVEFCHPEDQQLLRDSFQQVVKLKGQVLSVMFRFRSKNQEWLWMRTSSFTFQNPYSDEIEYIICTNTNVKNSSQE","Homo sapiens","ARNT, BHLHE2","Aryl hydrocarbon receptor nuclear translocator","1","2HV1"
"2HV5",,"X-RAY DIFFRACTION",2.19,43.41,"VAPOR DIFFUSION, HANGING DROP",5,"PEG 6000 25%, 120mM citrate buffer, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.jmb.2006.08.011","ZST","2HV5",37.06,"1.59","1.59","Human Aldose Reductase complexed with inhibitor zopolrestat after three days soaking (3days_soaked_3)","MASRILLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGKEFFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAKHNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVCALLSCTSHKDYPFHEEF","Homo sapiens","AKR1B1, ALDR1, ALR2","Aldose reductase","1","2HV5"
"2HV6",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, HANGING DROP",6.8,"0.2mM Mg Formate, 5% glycerol, 17.5% PEG3350 (w/v), 0.1 M Bistris, pH 6.8, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.molcel.2006.07.027",,"2HV6",73.66,"1.9","1.9","Crystal structure of the phosphotyrosyl phosphatase activator","MAEGERQPPPDSSEEAPPATQNFIIPKKEIHTVPDMGKWKRSQAYADYIGFILTLNEGVKGKKLTFEYRVSEAIEKLVALLNTLDRWIDETPPVDQPSRFGNKAYRTWYAKLDEEAENLVATVVPTHLAAAVPEVAVYLKESVGNSTRIDYGTGHEAAFAAFLCCLCKIGVLRVDDQIAIVFKVFNRYLEVMRKLQKTYRMEPAGSQGVWGLDDFQFLPFIWGSSQLIDHPYLEPRHFVDEKAVNENHKDYMFLECILFITEMKTGPFAEHSNQLWNISAVPSWSKVNQGLIRMYKAECLEKFPVIQHFKFGSLLPIHPVTSG","Homo sapiens","PPP2R4, PTPA","Protein phosphatase 2A, regulatory subunit B","1","2HV6"
"2HV7",,"X-RAY DIFFRACTION",2.04,39.67,"VAPOR DIFFUSION, HANGING DROP",6.8,"0.2 mM Na Formate, 5% glycerol, 16% PEG3350 (w/v), 50 mM Glycine, 0.1 M BisTris, pH 6.8, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.molcel.2006.07.027",,"2HV7",296.26,"2.5","2.5","Crystal structure of phosphotyrosyl phosphatase activator bound to ATPgammaS","MAEGERQPPPDSSEEAPPATQNFIIPKKEIHTVPDMGKWKRSQAYADYIGFILTLNEGVKGKKLTFEYRVSEAIEKLVALLNTLDRWIDETPPVDQPSRFGNKAYRTWYAKLDEEAENLVATVVPTHLAAAVPEVAVYLKESVGNSTRIDYGTGHEAAFAAFLCCLCKIGVLRVDDQIAIVFKVFNRYLEVMRKLQKTYRMEPAGSQGVWGLDDFQFLPFIWGSSQLIDHPYLEPRHFVDEKAVNENHKDYMFLECILFITEMKTGPFAEHSNQLWNISAVPSWSKVNQGLIRMYKAECLEKFPVIQHFKFGSLLPIHPVTSG","Homo sapiens","PPP2R4, PTPA","Protein phosphatase 2A, regulatory subunit B","1","2HV7"
"2HVC",,"X-RAY DIFFRACTION",2.33,47.25,"VAPOR DIFFUSION, SITTING DROP",7.2,"mixing the protein solution(5mg/ml) with equal volume of the reservoir solution with 0.4M Na2HPO4, 0.4M K2HPO4, as the primary precipitators. pH 7.2, VAPOR DIFFUSION, SITTING DROP, temperature 289K",289,"10.1107/S1744309106039340","LGD","2HVC",29.54,"2.1","2.1","The Crystal Structure of Ligand-binding Domain (LBD) of human Androgen Receptor in Complex with a selective modulator LGD2226","CQPIFLNVLEAIEPGVVCAGHDNNQPDSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWMGLMVFAMGWRSFTNVNSRMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKNQKFFDELRMNYIKELDRIIACKRKNPTSCSRRFYQLTKLLDSVQPIARELHQFTFDLLIKSHMVSVDFPEMMAEIISVQVPKILSGKVKPIYFHT","Homo sapiens","AR, DHTR, NR3C4","Androgen receptor","1","2HVC"
"2HVD",,"X-RAY DIFFRACTION",2.85,56.5,"VAPOR DIFFUSION, SITTING DROP",6,"2.4 M AMMONIUM SULPHATE,10 MM ADP, 20 MM MGCL2, 4 MM DTT, 0.1 M MES, pH 6.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1007/s10863-006-9043-0",,"2HVD",52.79,"2.15","2.15","Human nucleoside diphosphate kinase A complexed with ADP","MANCERTFIAIKPDGVQRGLVGEIIKRFEQKGFRLVGLKFMQASEDLLKEHYVDLKDRPFFAGLVKYMHSGPVVAMVWEGLNVVKTGRVMLGETNPADSKPGTIRGDFCIQVGRNIIHGSDSVESAEKEIGLWFHPEELVDYTSCAQNWIYE","Homo sapiens","NME1, NDPKA, NM23","Nucleoside diphosphate kinase A","1","2HVD"
"2HVE",,"X-RAY DIFFRACTION",2.9,56.9,"VAPOR DIFFUSION, SITTING DROP",6,"2.4 M AMMONIUM SULPHATE, 10 MM ADP, 20 MM MGCL2, 4 MM DTT, 0.1 M MES, pH 6.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1007/s10863-006-9043-0",,"2HVE",52.7,"2.402","2.402","S120G mutant of human nucleoside diphosphate kinase A complexed with ADP","MANCERTFIAIKPDGVQRGLVGEIIKRFEQKGFRLVGLKFMQASEDLLKEHYVDLKDRPFFAGLVKYMHSGPVVAMVWEGLNVVKTGRVMLGETNPADSKPGTIRGDFCIQVGRNIIHGGDSVESAEKEIGLWFHPEELVDYTSCAQNWIYE","Homo sapiens","NME1, NDPKA, NM23","Nucleoside diphosphate kinase A","1","2HVE"
"2HVL",,"X-RAY DIFFRACTION",3.96,68.93,"VAPOR DIFFUSION, HANGING DROP",6.7,"Sodium/Potassium phosphate, acetate, pH 6.7, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/bi801724n",,"2HVL",35.6,"2.4","2.4","Crystal structure of the HePTP catalytic domain C270S mutant","MGSDKIHHHHHHMNTPREVTLHFLRTAGHPLTRWALQRQPPSPKQLEEEFLKIPSNFVSPEDLDIPGHASKDRYKTILPNPQSRVCLGRAQSQEDGDYINANYIRGYDGKEKVYIATQGPMPNTVSDFWEMVWQEEVSLIVMLTQLREGKEKCVHYWPTEEETYGPFQIRIQDMKECPEYTVRQLTIQYQEERRSVKHILFSAWPDHQTPESAGPLLRLVAEVEESPETAAHPGPIVVHSSAGIGRTGCFIATRIGCQQLKARGEVDILGIVCQLRLDRGGMIQTAEQYQFLHHTLALYAGQLPEEPSP","Homo sapiens","PTPN7","Tyrosine-protein phosphatase non-receptor type 7","1","2HVL"
"2HVN",,"X-RAY DIFFRACTION",2.18,42.94,"VAPOR DIFFUSION, HANGING DROP",5,"PEG 6000 25%, 120mM cirtrate buffer, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.jmb.2006.08.011","ZST","2HVN",37.06,"1.58","1.58","Human Aldose Reductase-zopolrestat complex obtained by cocrystallisation after one day (1day_cocryst)","MASRILLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGKEFFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAKHNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVCALLSCTSHKDYPFHEEF","Homo sapiens","AKR1B1, ALDR1, ALR2","Aldose reductase","1","2HVN"
"2HVO",,"X-RAY DIFFRACTION",2.2,43.44,"VAPOR DIFFUSION, HANGING DROP",5,"25% PEG 6000, 120mM citrate buffer, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.jmb.2006.08.011","ZST","2HVO",37.06,"1.65","1.65","Human Aldose Reductase-zopolrestat complex obtained by cocrystallisation (10days_cocryst)","MASRILLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGKEFFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAKHNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVCALLSCTSHKDYPFHEEF","Homo sapiens","AKR1B1, ALDR1, ALR2","Aldose reductase","1","2HVO"
"2HVX",,"X-RAY DIFFRACTION",2.7,54.49,"VAPOR DIFFUSION, HANGING DROP",8.5,"30% PEG4000, 0.2 Na Acetate, 0.1 bistris propane, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1021/jm0700619","DRX","2HVX",25.42,"2.6","2.6","Discovery of Potent, Orally Active, Nonpeptide Inhibitors of Human Mast Cell Chymase by Using Structure-Based Drug Design","IIGGTECKPHSRPYMAYLEIVTSNGPSKFCGGFLIRRNFVLTAAHCAGRSITVTLGAHNITEEEDTWQKLEVIKQFRHPKYNTSTLHHDIMLLKLKEKASLTLAVGTLPFPSQKNFVPPGRMCRVAGWGRTGVLKPGSDTLQEVKLRLMDPQACSHFRDFDHNLQLCVGNPRKTKSAFKGDSGGPLLCAGAAQGIVSYGRSDAKPPAVFTRISHYQPWINQILQAN","Homo sapiens","CMA1, CYH, CYM","Chymase","1","2HVX"
"2HVZ",,"SOLUTION NMR",,,,,,,"10.1038/sj.emboj.7601385",,"2HVZ",11.34,,,"Solution structure of the RRM domain of SR rich factor 9G8","MKVYVGNLGTGAGKGELERAFSYYGPLRTVWIARNPPGFAFVEFEDPRDAEDAVRGLDGKVICGSRVRVELSTGMPRRSRFDRPPARRKLLEVLFNGPLEH","Homo sapiens","SFRS7, SRSF7","Splicing factor, arginine/serine-rich 7","1","2HVZ"
"2HW1",,"X-RAY DIFFRACTION",3.69,66.71,"VAPOR DIFFUSION, HANGING DROP",5.7,"0.7M ammonium sulphate, 0.5M lithium sulphate, 0.1M sodium citrate, pH 5.7, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1107/S0907444908041115",,"2HW1",33.64,"2.1","2.1","Crystal structure of human ketohexokinase complexed to different sugar molecules","MEEKQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFVLDDLRRYSVDLRYTVFQTTGSVPIATVIINEASGSRTILYYDRSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV","Homo sapiens","KHK","Ketohexokinase","1","2HW1"
"2HW4",,"X-RAY DIFFRACTION",2.21,44.41,"VAPOR DIFFUSION, HANGING DROP",6.5,"1.9 M Sodium Formate, 0.1 M Bis-tris propane, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1074/jbc.C600231200",,"2HW4",16.95,"1.9","1.9","Crystal structure of human phosphohistidine phosphatase","MHHHHHHSSGVDLGTENLYFQSMDLALIPDVDIDSDGVFKYVLIRVHSAPRSGAPAAESKEIVRGYKWAEYHADIYDKVSGDMQKQGCDCECLGGGRISHQSQDKKIHVYGYSMAYGPAQHAISTEKIKAKYPDYEVTWANDGY","Homo sapiens","PHPT1, PHP14, CGI-202, HSPC141","14 kDa phosphohistidine phosphatase","1","2HW4"
"2HW5",,"X-RAY DIFFRACTION",2.77,55.58,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2M sodium formate, 0.1M Bis-Tris propane, 20 % PEG3350, 10 % Ethylene Glycol, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,,,"2HW5",188.23,"2.55","2.55","The crystal structure of human enoyl-coenzyme A (CoA) hydratase short chain 1, ECHS1","MHHHHHHSSGVDLGTENLYFQSMASGANFEYIIAEKRGKNNTVGLIQLNRPKALNALCDGLIDELNQALKIFEEDPAVGAIVLTGGDKAFAAGADIKEMQNLSFQDCYSSKFLKHWDHLTQVKKPVIAAVNGYAFGGGCELAMMCDIIYAGEKAQFAQPEILIGTIPGAGGTQRLTRAVGKSLAMEMVLTGDRISAQDAKQAGLVSKICPVETLVEEAIQCAEKIASNSKIVVAMAKESVNAAFEMTLTEGSKLEKKLFYSTFATDDRKEGMTAFVEKRKANFKDQ","Homo sapiens","ECHS1","Enoyl-CoA hydratase","1","2HW5"
"2HW6",,"X-RAY DIFFRACTION",2.77,55.65,"VAPOR DIFFUSION",5.6,"20% PEG3350, 0.2M Ammonium sulfate, pH 5.6, VAPOR DIFFUSION, temperature 293K",293,"10.1038/sj.emboj.7601285",,"2HW6",69.15,"2.5","2.5","Crystal structure of Mnk1 catalytic domain","GSTDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKG","Homo sapiens","MKNK1, MNK1","MAP kinase-interacting serine/threonine-protein kinase 1","1","2HW6"
"2HW7",,"X-RAY DIFFRACTION",3.25,62.1,"VAPOR DIFFUSION",7.6,"Polyacrylic acid, pH 7.6, VAPOR DIFFUSION, temperature 293K",293,"10.1038/sj.emboj.7601285",,"2HW7",36.14,"2.71","2.71","Crystal Structure of Mnk2-D228G in complex with Staurosporine","GSTDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQR","Homo sapiens","MKNK2, MNK2, GPRK7","MAP kinase-interacting serine/threonine-protein kinase 2","1","2HW7"
"2HW9",,"X-RAY DIFFRACTION",2.94,58.16,"VAPOR DIFFUSION, HANGING DROP",7.5,"Ammonium Sulfate, Sodium Formate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298.15K",298.15,"10.1016/j.jmb.2007.05.065",,"2HW9",33.64,"1.6","1.6","Crystal structure of Lys12Cys/Cys117Val mutant of human acidic fibroblast Growth factor at 1.60 angstrom resolution.","HHHHHHFNLPPGNYKKPCLLYCSNGGHFLRILPDGTVDGTRDRSDQHIQLQLSAESVGEVYIKSTETGQYLAMDTDGLLYGSQTPNEECLFLERLEENHYNTYISKKHAEKNWFVGLKKNGSVKRGPRTHYGQKAILFLPLPVSSD","Homo sapiens","FGF1, FGFA","Heparin-binding growth factor 1","1","2HW9"
"2HWA",,"X-RAY DIFFRACTION",2.94,58.19,"VAPOR DIFFUSION, HANGING DROP",7.5,"Ammonium Sulfate, Sodium Formate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298.15K",298.15,"10.1016/j.jmb.2007.05.065",,"2HWA",33.59,"1.65","1.65","Crystal structure of Lys12Thr/Cys117Val mutant of human acidic fibroblast growth factor at 1.65 angstrom resolution.","HHHHHHFNLPPGNYKKPTLLYCSNGGHFLRILPDGTVDGTRDRSDQHIQLQLSAESVGEVYIKSTETGQYLAMDTDGLLYGSQTPNEECLFLERLEENHYNTYISKKHAEKNWFVGLKKNGSVKRGPRTHYGQKAILFLPLPVSSD","Homo sapiens","FGF1, FGFA","Heparin-binding growth factor 1","1","2HWA"
"2HWL",,"X-RAY DIFFRACTION",2.58,52.41,"VAPOR DIFFUSION, HANGING DROP",7.5,"25% PEG 4000, 100 mM HEPES sodium salt buffer, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.bpc.2006.08.005",,"2HWL",69.65,"2.4","2.4","Crystal structure of thrombin in complex with fibrinogen gamma' peptide","TFGSGEADCGLRPLFEKKSLEDKTERELLESYIDGR","Homo sapiens","F2","Prothrombin","1","2HWL"
,,,,,,,,,,,,,,,,"IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYEANIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFGE","Homo sapiens","F2","Prothrombin","2","2HWL"
,,,,,,,,,,,,,,,,"PAETEYDSLYPEDD",,,"Fibrinogen gamma' peptide","3","2HWL"
"2HWM",,"X-RAY DIFFRACTION",2.92,57.82,"VAPOR DIFFUSION, HANGING DROP",7.5,"Ammonium Sulfate, Sodium Formate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298.15K",298.15,"10.1016/j.jmb.2007.05.065",,"2HWM",33.49,"1.6","1.6","Crystal structure of Lys12Val/Cys117Val mutant of human acidic fibroblast growth factor at 1.60 angstrom resolution","HHHHHHFNLPPGNYKKPVLLYCSNGGHFLRILPDGTVDGTRDRSDQHIQLQLSAESVGEVYIKSTETGQYLAMDTDGLLYGSQTPNEECLFLERLEENHYNTYISKKHAEKNWFVGLKKNGSVKRGPRTHYGQKAILFLPLPVSSD","Homo sapiens","FGF1, FGFA","Heparin-binding growth factor 1","1","2HWM"
"2HWQ",,"X-RAY DIFFRACTION",2.13,47.07,"VAPOR DIFFUSION, HANGING DROP",8,"28.25% PEG3350, 0.016M sodium citrate, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/jm060663c","DRY","2HWQ",62.52,"1.97","1.97","Structural basis for the structure-activity relationships of Peroxisome Proliferator-Activated Receptor agonists","ESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","2HWQ"
"2HWR",,"X-RAY DIFFRACTION",2.41,49.06,"VAPOR DIFFUSION, HANGING DROP",8,"28% PEG3350, 0.016M sodium citrate, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/jm060663c","DRD","2HWR",62.54,"2.34","2.34","Structural basis for the structure-activity relationships of Peroxisome Proliferator-Activated Receptor agonists","ESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","2HWR"
"2HWW",,"X-RAY DIFFRACTION",1.93,36.14,"VAPOR DIFFUSION, SITTING DROP",7.6,"Jeffamine 2000 32%, 0.1M Hepes pH 7.6, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1038/sj.emboj.7601377",,"2HWW",61.78,"1.8","1.8","Structure of PIN domain of human SMG6","MELEIRPLFLVPDTNGFIDHLASLARLLESRKYILVVPLIVINELDGLAKGQETDHRAGGYARVVQEKARKSIEFLEQRFESRDSCLRALTSRGNELESIAFRSEDITGQLGNNDDLILSCCLHYCKDKAKDFMPASKEEPIRLLREVVLLTDDRNLRVKALTRNVPVRDIPAFLTWAQVG","Homo sapiens","EST1A, SMG6, C17orf31, KIAA0732","Telomerase-binding protein EST1A","1","2HWW"
"2HWX",,"X-RAY DIFFRACTION",2.31,46.66,"VAPOR DIFFUSION, SITTING DROP",7.6,"20% Jeffamine 2000, 0.1M Hepes 7.6, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1038/sj.emboj.7601377",,"2HWX",20.57,"1.9","1.9","Structure of human SMG6 E1282C PIN domain mutant.","MELEIRPLFLVPDTNGFIDHLASLARLLESRKYILVVPLIVINCLDGLAKGQETDHRAGGYARVVQEKARKSIEFLEQRFESRDSCLRALTSRGNELESIAFRSEDITGQLGNNDDLILSCCLHYCKDKAKDFMPASKEEPIRLLREVVLLTDDRNLRVKALTRNVPVRDIPAFLTWAQVG","Homo sapiens","EST1A, SMG6, C17orf31, KIAA0732","Telomerase-binding protein EST1A","1","2HWX"
"2HWY",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, SITTING DROP",5.5,"20% PEG 4000, 100 mM citrate pH 5.5 , VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1038/sj.emboj.7601377",,"2HWY",36.64,"2.75","2.75","Structure of PIN domain of human SMG5.","MSPYLVPDTQALCHHLPVIRQLATSGRFIVIIPRTVIDGLDLLKKEHPGARDGIRYLEAEFKKGNRYIRCQKEVGKSFERHKLKRQDADAWTLYKILDSCKQLTLAQGAGEEDPSGMVTIITGLPLDNPSVLSGPMQAALQAAAHASVDIKNVLDFYKQWKEIG","Homo sapiens","SMG5, EST1B, KIAA1089","Protein SMG5","1","2HWY"
"2HXK",,"X-RAY DIFFRACTION",1.66,25.13,"VAPOR DIFFUSION, HANGING DROP",7,"32% PEG 1500, 50 mM sodium phosphate, ethanol, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/bi061878r",,"2HXK",35.56,"1.65","1.65","Crystal structure of S-nitroso thioredoxin","MVKQIESKTAFQEALDAAGDKLVVVDFSATWCGPCKMIKPFFHSLSEKYSNVIFLEVDVDDCQDVASECEVKCMPTFQFFKKGQKVGEFSGANKEKLEATINELV","Homo sapiens","TXN, TRDX, TRX, TRX1","Thioredoxin","1","2HXK"
"2HXL",,"X-RAY DIFFRACTION",2.33,47.2,"VAPOR DIFFUSION, HANGING DROP",6.8,"13% PEG 8K, 0.1M ammonium sulfate, 2% glycerol, 0.1M cacodylate buffer at pH6.8, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.bmcl.2006.08.053","422","2HXL",37.18,"1.8","1.8","crystal structure of Chek1 in complex with inhibitor 1","AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGFSKHIQSNLDFSPVNSASRTPGSGWSKEHHHHHH","Homo sapiens","CHEK1, CHK1","Serine/threonine-protein kinase Chk1","1","2HXL"
"2HXM",,"X-RAY DIFFRACTION",2.05,40.04,"VAPOR DIFFUSION, HANGING DROP",8,"44.2 mg/ml protein sample, 16.8 mM inhibitor, 5% DMSO, 0.22 M potassium Thiocyanate, 20% w/v PEG 3350, 100mM Tris HCl, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1093/nar/gkl747","302","2HXM",25.89,"1.3","1.3","Complex of UNG2 and a small Molecule synthetic Inhibitor","MEFFGESWKKHLSGEFGKPYFIKLMGFVAEERKHYTVYPPPHQVFTWTQMCDIKDVKVVILGQDPYHGPNQAHGLCFSVQRPVPPPPSLENIYKELSTDIEDFVHPGHGDLSGWAKQGVLLLNAVLTVRAHQANSHKERGWEQFTDAVVSWLNQNSNGLVFLLWGSYAQKKGSAIDRKRHHVLQTAHPSPLSVYRGFFGCRHFSKTNELLQKSGKKPIDWKEL","Homo sapiens","UNG, DGU, UNG15, UNG1","Uracil-DNA glycosylase","1","2HXM"
"2HXP",,"X-RAY DIFFRACTION",2.49,50.68,"VAPOR DIFFUSION, SITTING DROP",5.5,"25% PEG 3350, 0.1M Bis-Tris, 0.2M Ammonium Sulphate, pH 5.5, VAPOR DIFFUSION, SITTING DROP, temperature 298.0K",298,"10.1007/s10969-007-9036-1",,"2HXP",17.78,"1.83","1.83","Crystal Structure of the human phosphatase (DUSP9)","SLASFPVQILPNLYLGSARDSANLESLAKLGIRYILNVTPNLPNFFEKNGDFHYKQIPISDHWSQNLSRFFPEAIEFIDEALSQNCGVLVHSLAGVSRSVTVTVAYLMQKLHLSLNDAYDLVKRKKSNISPNFNFMGQLLDFERSLREGHHHHHH","Homo sapiens","DUSP9, MKP4","Dual specificity protein phosphatase 9","1","2HXP"
"2HXQ",,"X-RAY DIFFRACTION",2.35,47.74,"VAPOR DIFFUSION, HANGING DROP",6.8,"13% PEG 8K, 0.1M ammonium sulfate, 2% glycerol, 0.1M cacodylate buffer at pH 6.8, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.bmcl.2006.08.053","373","2HXQ",37.18,"2","2","crystal structure of Chek1 in complex with inhibitor 2","AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGFSKHIQSNLDFSPVNSASRTPGSGWSKEHHHHHH","Homo sapiens","CHEK1, CHK1","Serine/threonine-protein kinase Chk1","1","2HXQ"
"2HXS",,"X-RAY DIFFRACTION",1.84,33.13,"VAPOR DIFFUSION, HANGING DROP",7.5,"20% PEG 3360, 100 mM NaCl, 100 mM Potassium Acetate, 5% glycerol, 20 mM HEPES, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"2HXS",20.53,"1.1","1.1","Crystal Structure of Rab28A GTPase in the Inactive (GDP-3'P-Bound) Form","GSHMRQLKIVVLGDGASGKTSLTTCFAQETFGKQYKQTIGLDFFLRRITLPGNLNVTLQIWDIGGQTIGGKMLDKYIYGAQGVLLVYDITNYQSFENLEDWYTVVKKVSEESETQPLVALVGNKIDLEHMRTIKPEKHLRFCQENGFSSHFVSAKTGDSVFLCFQKVAAEILGIKLNK","Homo sapiens","RAB28","Ras-related protein Rab-28","1","2HXS"
"2HXY",,"X-RAY DIFFRACTION",3.96,68.97,"VAPOR DIFFUSION",7.5,"Ammonium Citrate, pH 7.5, VAPOR DIFFUSION, temperature 277K",277,"10.1126/science.1131981",,"2HXY",179.27,"3.3","3.3","Crystal structure of human apo-eIF4AIII","MTKVEFETSEEVDVTPTFDTMGLREDLLRGIYAYGFEKPSAIQQRAIKQIIKGRDVIAQSQSGTGKTATFSISVLQCLDIQVRETQALILAPTRELAVQIQKGLLALGDYMNVQCHACIGGTNVGEDIRKLDYGQHVVAGTPGRVFDMIRRRSLRTRAIKMLVLDEADEMLNKGFKEQIYDVYRYLPPATQVVLISATLPHEILEMTNKFMTDPIRILVKRDELTLEGIKQFFVAVEREEWKFDTLCDLYDTLTITQAVIFCNTKRKVDWLTEKMREANFTVSSMHGDMPQKERESIMKEFRSGASRVLISTDVWARGLDVPQVSLIINYDLPNNRELYIHRIGRSGRYGRKGVAINFVKNDDIRILRDIEQYYSTQIDEMPMNVADLILE","Homo sapiens","DDX48, EIF4A3, KIAA0111","Probable ATP-dependent RNA helicase DDX48","1","2HXY"
"2HXZ",,"X-RAY DIFFRACTION",3.86,68.11,"VAPOR DIFFUSION, SITTING DROP",5,"1.0M Lithium Chloride, 30% PEG 6000, pH 5.0, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1021/jm060701s",,"2HXZ",74.38,"1.9","1.9","Crystal Structure of Cathepsin S in complex with a Nonpeptidic Inhibitor (Hexagonal spacegroup)","NRILPDSVDWREKGCVTEVKYQGSCGACWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEI","Homo sapiens","CTSS","Cathepsin S","1","2HXZ"
"2HY0",,"X-RAY DIFFRACTION",2.31,46.78,"VAPOR DIFFUSION, HANGING DROP",6.8,"13% PEG 8K, 0.1M ammonium sulfate, 2% glycerol, 0.1M cacodylate buffer at pH 6.8, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.bmcl.2006.08.053","306","2HY0",37.21,"1.7","1.7","crystal structure of chek1 in complex with inhibitor 22","AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGFSKHIQSNLDFSPVNSASRTPGSGWSKEHHHHHH","Homo sapiens","CHEK1, CHK1","Serine/threonine-protein kinase Chk1","1","2HY0"
"2HY3",,"X-RAY DIFFRACTION",2.42,49.09,"VAPOR DIFFUSION, HANGING DROP",8,"12% PEG3350, 0.1M Tris, 0.3M NaCl, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1007/s10969-007-9036-1",,"2HY3",73.06,"2.6","2.6","Crystal structure of the human tyrosine receptor phosphate gamma in complex with vanadate","SLPIPDDMEAIPVKQFVKHIGELYSNNQHGFSEDFEEVQRCTADMNITAEHSNHPENKHKNRYINILAYDHSRVKLRPLPGKDSKHSDYINANYVDGYNKAKAYIATQGPLKSTFEDFWRMIWEQNTGIIVMITNLVEKGRRKCDQYWPTENSEEYGNIIVTLKSTKIHACYTVRRFSIRNTKVKKGQKGNPKGRQNERVVIQYHYTQWPDMGVPEYALPVLTFVRRSSAARMPETGPVLVHCSAGVGRTGTYIVIDSMLQQIKDKSTVNVLGFLKHIRTQRNYLVQTEEQYIFIHDALLEAILGKETEVSSN","Homo sapiens","PTPRG, PTPG","Receptor-type tyrosine-protein phosphatase gamma","1","2HY3"
"2HY8",,"X-RAY DIFFRACTION",2.44,49.61,"VAPOR DIFFUSION, HANGING DROP",6.5,"1:1 ration of protein and precipitant. Precipitant: 0.13 M PIPES pH 6.5, 1.5 M NaCl, 23% PEG 4000, 10 mM DTT, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,,,"2HY8",33.78,"2","2","PAK1 complex with ST2001","SDEEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLTPLIAAAKEATKNNH","Homo sapiens","PAK1","Serine/threonine-protein kinase PAK 1","1","2HY8"
"2HYN",,"SOLUTION NMR",,,,,,,"10.1002/prot.21091",,"2HYN",30.57,,,"Complete ensemble of NMR structures of unphosphorylated human phospholamban pentamer","MEKVQYLTRSAIRRASTIEMPQQARQKLQNLFINFCLILICLLLICIIVMLL","Homo sapiens","PLN, PLB","Cardiac phospholamban","1","2HYN"
"2HYU",,"X-RAY DIFFRACTION",2.86,56.92,"hanging drop",5,"1,6 hexanediol, pH 5.0, hanging drop, temperature 290K",290,"10.1074/jbc.M604502200",,"2HYU",36.71,"1.86","1.86","Human Annexin A2 with heparin tetrasaccharide bound","NFDAERDALNIETAIKTKGVDEVTIVNILTNRSNAQRQDIAFAYQRRTKKELASALKSALSGHLETVILGLLKTPAQYDASELKASMKGLGTDEDSLIEIICSRTNQELQEINRVYKEMYKTDLEKDIISDTSGDFRKLMVALAKGRRAEDGSVIDYELIDQDARDLYDAGVKRKGTDVPKWISIMTERSVPHLQKVFDRYKSYSPYDMLESIRKEVKGDLENAFLNLVQCIQNKPLYFADRLYDSMKGKGTRDKVLIRIMVSRSEVDMLKIRSEFKRKYGKSLYYYIQQDTKGDYQKALLYLCGGDD","Homo sapiens","ANXA2, ANX2, ANX2L4, CAL1H, LPC2D","Annexin A2","1","2HYU"
"2HYV",,"X-RAY DIFFRACTION",2.84,56.62,"hanging drop",5,"1,6 hexanediol, pH 5.0, hanging drop, temperature 290K",290,"10.1074/jbc.M604502200",,"2HYV",36.96,"1.42","1.42","Human Annexin A2 with heparin hexasaccharide bound","NFDAERDALNIETAIKTKGVDEVTIVNILTNRSNAQRQDIAFAYQRRTKKELASALKSALSGHLETVILGLLKTPAQYDASELKASMKGLGTDEDSLIEIICSRTNQELQEINRVYKEMYKTDLEKDIISDTSGDFRKLMVALAKGRRAEDGSVIDYELIDQDARDLYDAGVKRKGTDVPKWISIMTERSVPHLQKVFDRYKSYSPYDMLESIRKEVKGDLENAFLNLVQCIQNKPLYFADRLYDSMKGKGTRDKVLIRIMVSRSEVDMLKIRSEFKRKYGKSLYYYIQQDTKGDYQKALLYLCGGDD","Homo sapiens","ANXA2, ANX2, ANX2L4, CAL1H, LPC2D","Annexin A2","1","2HYV"
"2HYW",,"X-RAY DIFFRACTION",2.86,57.04,"hanging drop",8.5,"PEG 8000, pH 8.5, hanging drop, temperature 290K",290,"10.1074/jbc.M604502200",,"2HYW",71.27,"2.1","2.1","Human Annexin A2 with Calcium bound","NFDAERDALNIETAIKTKGVDEVTIVNILTNRSNAQRQDIAFAYQRRTKKELASALKSALSGHLETVILGLLKTPAQYDASELKASMKGLGTDEDSLIEIICSRTNQELQEINRVYKEMYKTDLEKDIISDTSGDFRKLMVALAKGRRAEDGSVIDYELIDQDARDLYDAGVKRKGTDVPKWISIMTERSVPHLQKVFDRYKSYSPYDMLESIRKEVKGDLENAFLNLVQCIQNKPLYFADRLYDSMKGKGTRDKVLIRIMVSRSEVDMLKIRSEFKRKYGKSLYYYIQQDTKGDYQKALLYLCGGDD","Homo sapiens","ANXA2, ANX2, ANX2L4, CAL1H, LPC2D","Annexin A2","1","2HYW"
"2HYY",,"X-RAY DIFFRACTION",2.39,48.57,"VAPOR DIFFUSION, HANGING DROP",,"16 % PEG 8000, 1M MES pH 6.75, 0.2 M MgAcetate, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1107/S0907444906047287","STI","2HYY",128.69,"2.4","2.4","Human Abl kinase domain in complex with imatinib (STI571, Glivec)","VSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES","Homo sapiens","ABL1, ABL, JTK7","Proto-oncogene tyrosine-protein kinase ABL1","1","2HYY"
"2HZ0",,"X-RAY DIFFRACTION",2.35,47.6,"VAPOR DIFFUSION, HANGING DROP",,"28 % PEG 4000, 0.1 M Tris.HCl pH 8.0, 0.2 M NaAcetate, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1107/S0907444906047287","GIN","2HZ0",63.53,"2.1","2.1","Abl kinase domain in complex with NVP-AEG082","VSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF","Homo sapiens","ABL1, ABL, JTK7","Proto-oncogene tyrosine-protein kinase ABL1","1","2HZ0"
"2HZ4",,"X-RAY DIFFRACTION",2.61,52.86,"VAPOR DIFFUSION, HANGING DROP",,"12 % PEG 8000, 0.1 M HEPES pH 7.5, 0.2 M MgAcetate, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1107/S0907444906047287","4ST","2HZ4",96.45,"2.8","2.8","Abl kinase domain unligated and in complex with tetrahydrostaurosporine","VSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES","Homo sapiens","ABL1, ABL, JTK7","Proto-oncogene tyrosine-protein kinase ABL1","1","2HZ4"
"2HZ5",,"X-RAY DIFFRACTION",4.05,69.6,"VAPOR DIFFUSION, HANGING DROP",7.6,"28% PEG 4000, 0.1M CeCl, 0.1M Tris, pH 7.6, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.bbrc.2006.08.161",,"2HZ5",24.32,"2.1","2.1","Crystal structure of human dynein light chain Dnlc2A","MGHHHHHHGSMAEVEETLKRLQSQKGVQGIIVVNTEGIPIKSTMDNPTTTQYASLMHSFILKARSTVRDIDPQNDLTFLRIRSKKNEIMVAPDKDYFLIVIQNPTE","Homo sapiens","DNLC2A, DYNLRB1, BITH, DNCL2A, ROBLD1, HSPC162","Dynein light chain 2A, cytoplasmic","1","2HZ5"
"2HZ6",,"X-RAY DIFFRACTION",4.06,69.68,"VAPOR DIFFUSION, HANGING DROP",6.5,"3-3.5% PEG 20000, 0.1M PIPES, 3% MPD, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1073/pnas.0606480103",,"2HZ6",41.19,"3.1","3.1","The crystal structure of human IRE1-alpha luminal domain","GSSTVTLPETLLFVSTLDGSLHAVSKRTGSIKWTLKEDPVLQVPTHVEEPAFLPDPNDGSLYTLGSKNNEGLTKLPFTIPELVQASPCRSSDGILYMGKKQDIWYVIDLLTGEKQQTLSSAFADSLSPSTSLLYLGRTEYTITMYDTKTRELRWNATYFDYAASLPEDDVDYKMSHFVSNGDGLVVTVDSESGDVLWIQNYASPVVAFYVWQREGLRKVMHINVAVETLRYLTFMSGEVGRITKWKYPFPKETEAKSKLTPTLYVGKYSTSLYASPSMVHEGVAVVPRGSTLPLLEGPQTDGVTIGDKGESVITPSTDVKFDPGLKSKNKLNYLRNYWLLIGHHETPLSASTKMLERFPNNLPKHRENV","Homo sapiens","ERN1, IRE1","Endoplasmic reticulum to nucleus signalling 1 isoform 1 variant","1","2HZ6"
"2HZ9",,"X-RAY DIFFRACTION",2.93,58.04,"VAPOR DIFFUSION, HANGING DROP",7.5,"Ammonium Sulfate, Sodium Formate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298.15K",298.15,"10.1016/j.jmb.2007.05.065",,"2HZ9",33.56,"1.7","1.7","Crystal structure of Lys12Val/Asn95Val/Cys117Val mutant of human acidic fibroblast growth factor at 1.70 angstrom resolution.","HHHHHHFNLPPGNYKKPVLLYCSNGGHFLRILPDGTVDGTRDRSDQHIQLQLSAESVGEVYIKSTETGQYLAMDTDGLLYGSQTPNEECLFLERLEENHYVTYISKKHAEKNWFVGLKKNGSVKRGPRTHYGQKAILFLPLPVSSD","Homo sapiens","FGF1, FGFA","Heparin-binding growth factor 1","1","2HZ9"
"2HZC",,"X-RAY DIFFRACTION",1.97,37.66,"VAPOR DIFFUSION, HANGING DROP",6.5,"21% PEGmme550, 200mM Zn acetate, 0.1M MES pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.jmb.2006.11.077",,"2HZC",10.04,"1.47","1.47","Crystal structure of the N-terminal RRM of the U2AF large subunit","GPLGSARRLYVGNIPFGITEEAMMDFFNAQMRLGGLTQAPGNPVLAVQINQDKNFAFLEFRSVDETTQAMAFDGIIFQGQSLKIRRP","Homo sapiens","U2AF2, U2AF65","Splicing factor U2AF 65 kDa subunit","1","2HZC"
"2HZD",,"SOLUTION NMR",,,,,,,"10.1073/pnas.0607171103",,"2HZD",9.55,,,"NMR structure of the DNA-binding TEA domain and insights into TEF-1 function","MDNDAEGVWSPDIEQSFQEALSIYPPCGRRKIILSDEGKMYGRNELIARYIKLRTGKTRTRKQVSSHIQVLARRKSRDLVPR","Homo sapiens","TEAD1, TCF13, TEF1","Transcriptional enhancer factor TEF-1","1","2HZD"
"2HZI",,"X-RAY DIFFRACTION",3.08,60.1,"VAPOR DIFFUSION, HANGING DROP",,"0.9 M NaAcetate, 0.1 M NaCacodylate pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1107/S0907444906047287","JIN","2HZI",64.96,"1.7","1.7","Abl kinase domain in complex with PD180970","GAMDPSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES","Homo sapiens","ABL1, ABL, JTK7","Proto-oncogene tyrosine-protein kinase ABL1","1","2HZI"
"2HZP",,"X-RAY DIFFRACTION",2.22,44.64,"Microbatch under oil",8,"A 9.2 mg/ml kynureninase solution in 50 mM HEPES pH 5.2, 0.2 mM PLP was mixed in equal parts with 0.1 M Tris-Cl pH 8.0, 0.05 M MgCl2, 25% PEG 3000, Microbatch under oil, temperature 298K",298,"10.1021/bi0616697",,"2HZP",56.82,"2","2","Crystal Structure of Homo Sapiens Kynureninase","MRGSHHHHHHGMASMTGGQQMGRDLYDDDDKDHPFTMEPSSLELPADTVQRIAAELKCHPTDERVALHLDEEDKLRHFRECFYIPKIQDLPPVDLSLVNKDENAIYFLGNSLGLQPKMVKTYLEEELDKWAKIAAYGHEVGKRPWITGDESIVGLMKDIVGANEKEIALMNALTVNLHLLMLSFFKPTPKRYKILLEAKAFPSDHYAIESQLQLHGLNIEESMRMIKPREGEETLRIEDILEVIEKEGDSIAVILFSGVHFYTGQHFNIPAITKAGQAKGCYVGFDLAHAVGNVELYLHDWGVDFACWCSYKYLNAGAGGIAGAFIHEKHAHTIKPALVGWFGHELSTRFKMDNKLQLIPGVCGFRISNPPILLVCSLHASLEIFKQATMKALRKKSVLLTGYLEYLIKHNYGKDKAATKKPVVNIITPSHVEERGCQLTITFSVPNKDVFQELEKRGVVCDKRNPNGIRVAPVPLYNSFHDVYKFTNLLTSILDSAETKN","Homo sapiens","KYNU","Kynureninase","1","2HZP"
"2HZQ",,"X-RAY DIFFRACTION",2.16,43.7,"VAPOR DIFFUSION, HANGING DROP",7.5,"1.1 M lithium sulfate, 0.1 M ammonium formate, 0.075 M Hepes/NaOH, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1074/jbc.M703552200","STR","2HZQ",20.3,"1.8","1.8","Crystal structure of human apolipoprotein D (ApoD) in complex with progesterone","FHLGKCPNPPVQENFDVNKYPGRWYEIEKIPTTFENGRCIQANYSLMENGKIKVLNQELRADGTVNQIEGEATPVNLTEPAKLEVKFSWFMPSAPYHILATDYENYALVYSCTSISQSFHVDFAWILARNVALPPETVDSLKNILTSNNIDVKKMTVTDQVNCPKLSAHHHHHH","Homo sapiens","APOD","Apolipoprotein D","1","2HZQ"
"2HZR",,"X-RAY DIFFRACTION",2.15,43.5,"VAPOR DIFFUSION, HANGING DROP",7.5,"1.1 M lithium sulfate, 0.1 M ammonium formate, 0.075 M Hepes/NaOH, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1074/jbc.M703552200",,"2HZR",19.99,"1.8","1.8","Crystal structure of human apolipoprotein D (ApoD)","FHLGKCPNPPVQENFDVNKYPGRWYEIEKIPTTFENGRCIQANYSLMENGKIKVLNQELRADGTVNQIEGEATPVNLTEPAKLEVKFSWFMPSAPYHILATDYENYALVYSCTSISQSFHVDFAWILARNVALPPETVDSLKNILTSNNIDVKKMTVTDQVNCPKLSAHHHHHH","Homo sapiens","APOD","Apolipoprotein D","1","2HZR"
"2I03",,"X-RAY DIFFRACTION",2.86,57.05,"VAPOR DIFFUSION",,"VAPOR DIFFUSION",,"10.1021/jm060777o","AXD","2I03",337.41,"2.4","2.4","Crystal structure of human dipeptidyl peptidase 4 (DPP IV) with potent alkynyl cyanopyrrolidine (ABT-279)","SRKTYTLTDYLKNTYRLKLYSLRWISDHEYLYKQENNILVFNAEYGNSSVFLENSTFDEFGHSINDYSISPDGQFILLEYNYVKQWRHSYTASYDIYDLNKRQLITEERIPNNTQWVTWSPVGHKLAYVWNNDIYVKIEPNLPSYRITWTGKEDIIYNGITDWVYEEEVFSAYSALWWSPNGTFLAYAQFNDTEVPLIEYSFYSDESLQYPKTVRVPYPKAGAVNPTVKFFVVNTDSLSSVTNATSIQITAPASMLIGDHYLCDVTWATQERISLQWLRRIQNYSVMDICDYDESSGRWNCLVARQHIEMSTTGWVGRFRPSEPHFTLDGNSFYKIISNEEGYRHICYFQIDKKDCTFITKGTWEVIGIEALTSDYLYYISNEYKGMPGGRNLYKIQLSDYTKVTCLSCELNPERCQYYSVSFSKEAKYYQLRCSGPGLPLYTLHSSVNDKGLRVLEDNSALDKMLQNVQMPSKKLDFIILNETKFWYQMILPPHFDKSKKYPLLLDVYAGPCSQKADTVFRLNWATYLASTENIIVASFDGRGSGYQGDKIMHAINRRLGTFEVEDQIEAARQFSKMGFVDNKRIAIWGWSYGGYVTSMVLGSGSGVFKCGIAVAPVSRWEYYDSVYTERYMGLPTPEDNLDHYRNSTVMSRAENFKQVEYLLIHGTADDNVHFQQSAQISKALVDVGVDFQAMWYTDEDHGIASSTAHQHIYTHMSHFIKQCFS","Homo sapiens","DPP4, ADCP2, CD26","Dipeptidyl peptidase 4","1","2I03"
"2I07",,"X-RAY DIFFRACTION",3.33,63.12,"VAPOR DIFFUSION, SITTING DROP",7.8,"PEG-MME 2000, sodium acetate, 
Bis-Tris propane, taurine, pH 7.8, VAPOR DIFFUSION, SITTING DROP, temperature 303K",303,"10.1038/nature05172",,"2I07",176.29,"4","4","Human Complement Component C3b","SPMYSIITPNILRLESEETMVLEAHDAQGDVPVTVTVHDFPGKKLVLSSEKTVLTPATNHMGNVTFTIPANREFKSEKGRNKFVTVQATFGTQVVEKVVLVSLQSGYLFIQTDKTIYTPGSTVLYRIFTVNHKLLPVGRTVMVNIENPEGIPVKQDSLSSQNQLGVLPLSWDIPELVNMGQWKIRAYYENSPQQVFSTEFEVKEYVLPSFEVIVEPTEKFYYIYNEKGLEVTITARFLYGKKVEGTAFVIFGIQDGEQRISLPESLKRIPIEDGSGEVVLSRKVLLDGVQNLRAEDLVGKSLYVSATVILHSGSDMVQAERSGIPIVTSPYQIHFTKTPKYFKPGMPFDLMVFVTNPDGSPAYRVPVAVQGEDTVQSLTQGDGVAKLSINTHPSQKPLSITVRTKKQELSEAEQATRTMQALPYSTVGNSNNYLHLSVLRTELRPGETLNVNFLLRMDRAHEAKIRYYTYLIMNKGRLLKAGRQVREPGQDLVVLPLSITTDFIPSFRLVAYYTLIGASGQREVVADSVWVDVKDSCVGSLVVKSGQSEDRQPVPGQQMTLKIEGDHGARVVLVAVDKGVFVLNKKNKLTQSKIWDVVEKADIGCTPGSGKDYAGVFSDAGLTFTSSSGQQTAQRAELQCPQPAA","Homo sapiens","C3, CPAMD1","Complement C3b","1","2I07"
,,,,,,,,,,,,,,,,"SNLDEDIIAEENIVSRSEFPESWLWNVEDLKEPPKNGISTKLMNIFLKDSITTWEILAVSMSDKKGICVADPFEVTVMQDFFIDLRLPYSVVRNEQVEIRAVLYNYRQNQELKVRVELLHNPAFCSLATTKRRHQQTVTIPPKSSLSVPYVIVPLKTGLQEVEVKAAVYHHFISDGVRKSLKVVPEGIRMNKTVAVRTLDPERLGREGVQKEDIPPADLSDQVPDTESETRILLQGTPVAQMTEDAVDAERLKHLIVTPSGCGEENMIGMTPTVIAVHYLDETEQWEKFGLEKRQGALELIKKGYTQQLAFRQPSSAFAAFVKRAPSTWLTAYVVKVFSLAVNLIAIDSQVLCGAVKWLILEKQKPDGVFQEDAPVIHQEMIGGLRNNNEKDMALTAFVLISLQEAKDICEEQVNSLPGSITKAGDFLEANYMNLQRSYTVAIAGYALAQMGRLKGPLLNKFLTTAKDKNRWEDPGKQLYNVEATSYALLALLQLKDFDFVPPVVRWLNEQRYYGGGYGSTQATFMVFQALAQYQKDAPDHQELNLDVSLQLPSRSSKITHRIHWESASLLRSEETKENEGFTVTAEGKGQGTLSVVTMYHAKAKDQLTCNKFDLKVTIKPAPETEKRPQDAKNTMILEICTRYRGDQDATMSILDISMMTGFAPDTDDLKQLANGVDRYISKYELDKAFSDRNTLIIYLDKVSHSEDDCLAFKVHQYFNVELIQPGAVKVYAYYNLEESCTRFYHPEKEDGKLNKLCRDELCRCAEENCFIQKSDDKVTLEERLDKACEPGVDYVYKTRLVKVQLSNDFDEYIMAIEQTIKSGSDEVQVGQQRTFISPIKCREALKLEEKKHYLMWGLSSDFWGEKPNLSYIIGKDTWVEHWPEEDECQDEENQKQCQDLGAFTESMVVFGCPN","Homo sapiens","C3, CPAMD1","Complement C3b","2","2I07"
"2I08",,"X-RAY DIFFRACTION",1.97,37.41,"VAPOR DIFFUSION, HANGING DROP",7.5,"36% (v/v) PEG 400, 100 mM HEPES, 200 mM CaCl2, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 294K",294,,,"2I08",8.96,"2","2","Solvation effect in conformational changes of EF-hand proteins: X-ray structure of Ca2+-saturated double mutant Q41L-K75I of N-domain of calmodulin","MDQLTEEQIAEFKEAFSLYDKDGDGTITTKELGTVMRSLGLNPTEAELQDMINEVDADGNGTIDFPEFLTMMARIMKY","Homo sapiens","CALM1, CALM, CAM, CAM1","Calmodulin","1","2I08"
"2I0E",,"X-RAY DIFFRACTION",3.14,60.83,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1 M ADA, 2.5 M sodium acetate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 286K",286,"10.1021/bi061128h","PDS","2I0E",82.47,"2.6","2.6","Structure of catalytic domain of human protein kinase C beta II complexed with a bisindolylmaleimide inhibitor","TTNTVSKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKACGRNAENFDRFFTRHPPVLTPPDQEVIRNIDQSEFEGFSFVNSEFLKPEVKS","Homo sapiens","PRKCB, PKCB, PRKCB1","Protein Kinase C-beta II","1","2I0E"
"2I0G",,"X-RAY DIFFRACTION",2.46,49.94,"VAPOR DIFFUSION, HANGING DROP",8,"0.1M Tris, pH 8.0, 2M sodium chloride, 4% PEG 6000, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1021/jm060491j","I0G","2I0G",59.02,"2.5","2.5","Benzopyrans are Selective Estrogen Receptor beta Agonists (SERBAs) with Novel Activity in Models of Benign Prostatic Hyperplasia","MHHHHHHRELLLDALSPEQLVLTLLEAEPPHVLISRPSAPFTEASMMMSLTKLADKELVHMISWAKKIPGFVELSLFDQVRLLESCWMEVLMMGLMWRSIDHPGKLIFAPDLVLDRDEGKCVEGILEIFDMLLATTSRFRELKLQHKEYLCVKAMILLNSSMYPLVTATQDADSSRKLAHLLNAVTDALVWVIAKSGISSQQQSMRLANLLMLLSHVRHASNKGMEHLLNMKCKNVVPVYDLLLEMLNAHVLRGCKS","Homo sapiens","ESR2, ESTRB, NR3A2","Estrogen receptor beta","1","2I0G"
"2I0H",,"X-RAY DIFFRACTION",2.85,56.88,"VAPOR DIFFUSION, HANGING DROP",7,"SODIUM CITRATE, AMMONIUM SULFATE, HEPES, PH 7.00, VAPOR DIFFUSION, HANGING DROP, temperature 284K",284,"10.1016/j.bmcl.2006.08.074","222","2I0H",43.24,"2","2","The structure of p38alpha in complex with an arylpyridazinone","GSHMLEMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES","Homo sapiens","MAPK14, CSBP, CSBP1, CSBP2, MXI2, CSPB1, SAPK2A","Mitogen-activated protein kinase 14","1","2I0H"
"2I0J",,"X-RAY DIFFRACTION",2.32,46.94,"VAPOR DIFFUSION, HANGING DROP",8,"0.1M Tris, 0.2M magnesium chloride, 20% PEG 4000, 10% ethylene glycol, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 289.0K",289,"10.1021/jm060491j","I0G","2I0J",112.4,"2.9","2.9","Benzopyrans are Selective Estrogen Receptor beta Agonists (SERBAs) with Novel Activity in Models of Benign Prostatic Hyperplasia","NSLALSLTADQMVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLESAWLEILMIGLVWRSMEHPGKLLFAPNLLLDRNQGKSVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGMEHLYSMKSKNVVPLYDLLLEMLDAH","Homo sapiens","ESR1, ESR, NR3A1","Estrogen receptor alpha","1","2I0J"
"2I0V",,"X-RAY DIFFRACTION",2.45,49.72,"VAPOR DIFFUSION, HANGING DROP",5.2,"PEG 3350, sodium acetate, Li2SO4, pH 5.2, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1074/jbc.M608183200","6C3","2I0V",38.5,"2.8","2.8","c-FMS tyrosine kinase in complex with a quinolone inhibitor","GVDYKYKQKPKYQVRWKIIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDRRERD","Homo sapiens","CSF1R","cFMS tyrosine kinase","1","2I0V"
,,,,,,,,,,,,,,,,,"Homo sapiens","CSF1R"
"2I0Y",,"X-RAY DIFFRACTION",2.4,48.8,"VAPOR DIFFUSION, HANGING DROP",5.2,"PEG 3350, sodium acetate, Li2SO4, pH 5.2, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1074/jbc.M608183200","5CN","2I0Y",38.4,"1.9","1.9","cFMS tyrosine kinase (FGF KID) in complex with an arylamide inhibitor","GVDYKYKQKPKYQVRWKIIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDRRERD","Homo sapiens","CSF1R","cFMS Tyrosine Kinase","1","2I0Y"
,,,,,,,,,,,,,,,,,"Homo sapiens","CSF1R"
"2I16",,"X-RAY DIFFRACTION",2.16,42.97,,5,"pH 5.0",,"10.1107/S0907444906041035","LDT","2I16",37.44,"0.81","0.81","Human aldose reductase in complex with NADP+ and the inhibitor IDD594 at temperature of 15K","MASRILLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGKEFFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAKHNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVCALLSCTSHKDYPFHEEF","Homo sapiens","AKR1B1, ALDR1, ALR2","Aldose reductase","1","2I16"
"2I17",,"X-RAY DIFFRACTION",2.16,43.06,,5,"pH 5.0",,"10.1107/S0907444906041035","LDT","2I17",37.44,"0.81","0.81","Human aldose reductase in complex with NADP+ and the inhibitor IDD594 at temperature of 60K","MASRILLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGKEFFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAKHNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVCALLSCTSHKDYPFHEEF","Homo sapiens","AKR1B1, ALDR1, ALR2","Aldose reductase","1","2I17"
"2I1B",,"X-RAY DIFFRACTION",3.33,63.01,,,,,"10.1073/pnas.86.24.9667",,"2I1B",17.4,"2","2","CRYSTALLOGRAPHIC REFINEMENT OF INTERLEUKIN-1 BETA AT 2.0 ANGSTROMS RESOLUTION","APVRSLNCTLRDSQQKSLVMSGPYELKALHLQGQDMEQQVVFSMSFVQGEESNDKIPVALGLKEKNLYLSCVLKDDKPTLQLESVDPKNYPKKKMEKRFVFNKIEINNKLEFESAQFPNWYISTSQAENMPVFLGGTKGGQDITDFTMQFVSS","Homo sapiens","IL1B, IL1F2","INTERLEUKIN-1 BETA","1","2I1B"
"2I1M",,"X-RAY DIFFRACTION",2.38,48.29,"VAPOR DIFFUSION, HANGING DROP",5.2,"PEG 3350, sodium acetate, Li2SO4, pH 5.2, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1074/jbc.M608183200","5CN","2I1M",37.95,"1.8","1.8","cFMS tyrosine kinase (tie2 KID) in complex with an arylamide inhibitor","GVDYKYKQKPKYQVRWKIIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDRRERD","Homo sapiens","CSF1R","Macrophage colony-stimulating factor 1 receptor","1","2I1M"
,,,,,,,,,,,,,,,,,"Homo sapiens","CSF1R"
"2I1N",,"X-RAY DIFFRACTION",2.55,51.74,"VAPOR DIFFUSION, SITTING DROP",,"1.0M LiSO4;  0.5M TMAO, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1110/ps.062657507",,"2I1N",21.98,"1.85","1.85","Crystal structure of the 1st PDZ domain of Human DLG3","SMFKYEEIVLERGNSGLGFSIAGGIDNPHVPDDPGIFITKIIPGGAAAMDGRLGVNDCVLRVNEVDVSEVVHSRAVEALKEAGPVVRLVVRRRQPPPEETSV","Homo sapiens","DLG3, KIAA1232","Discs, large homolog 3","1","2I1N"
"2I1V",,"X-RAY DIFFRACTION",3.27,62.39,"VAPOR DIFFUSION, SITTING DROP",7.5,"PEG 4000, ethylene glycol, Tris, phosphate, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1016/j.jmb.2007.03.038",,"2I1V",60.8,"2.5","2.5","Crystal structure of PFKFB3 in complex with ADP and Fructose-2,6-bisphosphate","MPLELTQSRVQKIWVPVDHRPSLPRSCGPKLTNSPTVIVMVGLPARGKTYISKKLTRYLNWIGVPTKVFNVGEYRREAVKQYSSYNFFRPDNEEAMKVRKQCALAALRDVKSYLAKEGGQIAVFDATNTTRERRHMILHFAKENDFKAFFIESVCDDPTVVASNIMEVKISSPDYKDCNSAEAMDDFMKRISCYEASYQPLDPDKCDRDLSLIKVIDVGRRFLVNRVQDHIQSRIVYYLMNIHVQPRTIYLCRHGENEHNLQGRIGGDSGLSSRGKKFASALSKFVEEQNLKDLRVWTSQLKSTIQTAEALRLPYEQWKALNEIDAGVCEELTYEEIRDTYPEEYALREQDKYYYRYPTGESYQDLVQRLEPVIMELERQENVLVICHQAVLRCLLAYFLDKSAEEMPYLKCPLHTVLKLTPVAYGCRVESIYLNVESVCTHRERSEDAKKGPNPLMRRNSVTPLASPEPTKKPRINSFEEHVASTSAALPSCLPPEVPTQLPGQNMKGSRSSADSSRKH","Homo sapiens","PFKFB3","6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3","1","2I1V"
"2I1Y",,"X-RAY DIFFRACTION",2.23,48.56,"VAPOR DIFFUSION, SITTING DROP",6,"25% PEG3350, 100 MM BIS-TRIS, 200 MM AMMONIUM ACETATE, PH 6.0, 10% GLYCEROL, VAPOR DIFFUSION, SITTING DROP, temperature 294K",294,"10.1007/s10969-007-9036-1",,"2I1Y",68.77,"2.23","2.23","Crystal structure of the phosphatase domain of human PTP IA-2","SLEPAQANMDISTGHMILAYMEDHLRNRDRLAKEWQALCAYQAEPNTCATAQGEGNIKKNRHPDFLPYDHARIKLKVESSPSRSDYINASPIIEHDPRMPAYIATQGPLSHTIADFWQMVWESGCTVIVMLTPLVEDGVKQCDRYWPDEGASLYHVYEVNLVSEHIWCEDFLVRSFYLKNVQTQETRTLTQFHFLSWPAEGTPASTRPLLDFRRKVNKCYRGRSCPIIVHCSDGAGRTGTYILIDMVLNRMAKGVKEIDIAATLEHVRDQRPGLVRSKDQFEFALTAVAEEVNAILKALPQ","Homo sapiens","PTPRN, ICA3, ICA512","Receptor-type tyrosine-protein phosphatase","1","2I1Y"
"2I2Z",,"X-RAY DIFFRACTION",2.55,51.74,"EVAPORATION, vapor diffusion, sitting drop",7.5,"31-34% (w/v) PEG 3350, 50mM potassium phosphate (pH 7.5). Crystals grew spontaneously as clusters of rods after three days. Technique of streak-seeding was used to improve crystal quality., EVAPORATION, vapor diffusion, sitting drop, temperature 293K",293,"10.1016/j.jsb.2006.08.015","SAL","2I2Z",67.89,"2.7","2.7","Human serum albumin complexed with myristate and aspirin","DAHKSEVAHRFKDLGEENFKALVLIAFAQYLQQCPFEDHVKLVNEVTEFAKTCVADESAENCDKSLHTLFGDKLCTVATLRETYGEMADCCAKQEPERNECFLQHKDDNPNLPRLVRPEVDVMCTAFHDNEETFLKKYLYEIARRHPYFYAPELLFFAKRYKAAFTECCQAADKAACLLPKLDELRDEGKASSAKQRLKCASLQKFGERAFKAWAVARLSQRFPKAEFAEVSKLVTDLTKVHTECCHGDLLECADDRADLAKYICENQDSISSKLKECCEKPLLEKSHCIAEVENDEMPADLPSLAADFVESKDVCKNYAEAKDVFLGMFLYEYARRHPDYSVVLLLRLAKTYETTLEKCCAAADPHECYAKVFDEFKPLVEEPQNLIKQNCELFEQLGEYKFQNALLVRYTKKVPQVSTPTLVEVSRNLGKVGSKCCKHPEAKRMPCAEDYLSVVLNQLCVLHEKTPVSDRVTKCCTESLVNRRPCFSALEVDETYVPKEFNAETFTFHADICTLSEKERQIKKQTALVELVKHKPKATKEQLKAVMDDFAAFVEKCCKADDKETCFAEEGKKLVAASQAALGL","Homo sapiens","ALB, GIG20, GIG42, PRO0903, PRO1708, PRO2044, PRO2619, PRO2675, UNQ696/PRO1341","Serum albumin","1","2I2Z"
"2I30",,"X-RAY DIFFRACTION",2.52,51.24,"EVAPORATION, vapor diffusion, sitting drop",7.5,"31% PEG 3350, 0.05M potassium phosphate, pH 7.5, EVAPORATION, vapor diffusion, sitting drop, temperature 293K",293,"10.1016/j.jsb.2006.08.015","SAL","2I30",67.99,"2.9","2.9","Human serum albumin complexed with myristate and salicylic acid","DAHKSEVAHRFKDLGEENFKALVLIAFAQYLQQCPFEDHVKLVNEVTEFAKTCVADESAENCDKSLHTLFGDKLCTVATLRETYGEMADCCAKQEPERNECFLQHKDDNPNLPRLVRPEVDVMCTAFHDNEETFLKKYLYEIARRHPYFYAPELLFFAKRYKAAFTECCQAADKAACLLPKLDELRDEGKASSAKQRLKCASLQKFGERAFKAWAVARLSQRFPKAEFAEVSKLVTDLTKVHTECCHGDLLECADDRADLAKYICENQDSISSKLKECCEKPLLEKSHCIAEVENDEMPADLPSLAADFVESKDVCKNYAEAKDVFLGMFLYEYARRHPDYSVVLLLRLAKTYETTLEKCCAAADPHECYAKVFDEFKPLVEEPQNLIKQNCELFEQLGEYKFQNALLVRYTKKVPQVSTPTLVEVSRNLGKVGSKCCKHPEAKRMPCAEDYLSVVLNQLCVLHEKTPVSDRVTKCCTESLVNRRPCFSALEVDETYVPKEFNAETFTFHADICTLSEKERQIKKQTALVELVKHKPKATKEQLKAVMDDFAAFVEKCCKADDKETCFAEEGKKLVAASQAALGL","Homo sapiens","ALB, GIG20, GIG42, PRO0903, PRO1708, PRO2044, PRO2619, PRO2675, UNQ696/PRO1341","Serum albumin","1","2I30"
"2I38",,"SOLUTION NMR",,,,,,,"10.1038/sj.emboj.7601385",,"2I38",16.85,,,"Solution structure of the RRM of SRp20","MQYKLILNGKTLKGETTTEAVDAATAEKVFKQYANDNGVDGEWTYDDATKTFTVTEGSHHHHHHMHRDSCPLDCKVYVGNLGNNGNKTELERAFGYYGPLRSVWVARNPPGFAFVEFEDPRDAADAVRDLDGRTLCGCRVRVELSNGEKR","Homo sapiens","spg and SFRS3, SRSF3, SFRS3, SRP20","Fusion protein consists of immunoglobulin G-Binding Protein G and Splicing factor, arginine/serine-rich 3","1","2I38"
"2I3B",,"SOLUTION NMR",,,,,,,"10.1016/j.jmb.2007.01.001",,"2I3B",20.61,,,"Solution Structure of a Human Cancer-Related Nucleoside Triphosphatase","ARHVFLTGPPGVGKTTLIHKASEVLKSSGVPVDGFYTEEVRQGGRRIGFDVVTLSGTRGPLSRVGLEPPPGKRECRVGQYVVDLTSFEQLALPVLRNADCSSGPGQRVCVIDEIGKMELFSQLFIQAVRQTLSTPGTIILGTIPVPKGKPLALVEEIRNRKDVKVFNVTKENRNHLLPDIVTCVQSSRK","Homo sapiens","CDRT1, NTPCR, C1orf57","Human Cancer-Related NTPase","1","2I3B"
"2I3C",,"X-RAY DIFFRACTION",3.8,67.6,"VAPOR DIFFUSION, HANGING DROP",,"PROTEIN SOLUTION (10 MG/ML PROTEIN,
0.050 M SODIUM CHLORIDE, 0.0003 M TCEP, 0.005 M Tris PH 8.0)
MIXED IN A 1:1 RATIO WITH THE WELL SOLUTION
(1.344 M K2HPO4, 0.056 M NaH2PO4)
CRYOPROTECTED WITH WELL SOLUTION WITH 25% Ethylene glycol, vapor diffusion, hanging drop, temperature 277K",277,"10.1073/pnas.0607817104",,"2I3C",73.27,"2.8","2.8","Crystal Structure of an Aspartoacylase from Homo Sapiens","AIATSCHIAEEHIQKVAIFGGTHGNELTGVFLVKHWLENGAEIQRTGLEVKPFITNPRAVKKCTRYIDCDLNRIFDLENLGKKMSEDLPYEVRRAQEINHLFGPKDSEDSYDIIFDLHNTTSNMGCTLILEDSRNNFLIQMFHYIKTSLAPLPCYVYLIEHPSLKYATTRSIAKYPVGIEVGPQPQGVLRADILDQMRKMIKHALDFIHHFNEGKEFPPCAIEVYKIIEKVDYPRDENGEIAAIIHPNLQDQDWKPLHPGDPMFLTLDGKTIPLGGDCTVYPVFVNEAAYYEKKEAFAKTTKLTLNAKSIRCCLH","Homo sapiens","ASPA, ACY2, ASP","Aspartoacylase","1","2I3C"
"2I3H",,"X-RAY DIFFRACTION",2.29,46.26,"VAPOR DIFFUSION, HANGING DROP",6.5,"Lithium sulfate, PEG 3350, Bis-tris, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/cb600276q",,"2I3H",31.37,"1.62","1.62","Structure of an ML-IAP/XIAP chimera bound to a 4-mer peptide (AVPW)","MGSSHHHHHHSSGEVPRGSHMLETEEEEEEGAGATLSRGPAFPGMGSEELRLASFYDWPLTAEVPPELLAAAGFFHTGHQDKVRCFFCYGGLQSWKRGDDPWTEHAKWFPGCQFLLRSKGQEYINNIHLTHSL","Homo sapiens","BIRC7, KIAP, LIVIN, MLIAP, RNF50, UNQ5800/PRO19607/PRO21344","Baculoviral IAP repeat-containing protein 7","1","2I3H"
,,,,,,,,,,,,,,,,"AVPW",,,"AVPW peptide","2","2I3H"
"2I3I",,"X-RAY DIFFRACTION",2.33,47.2,"VAPOR DIFFUSION, HANGING DROP",6.5,"Lithium sulfate, PEG 3350, Bis-tris, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/cb600276q","618","2I3I",31.42,"2.3","2.3","Structure of an ML-IAP/XIAP chimera bound to a peptidomimetic","MGSSHHHHHHSSGEVPRGSHMLETEEEEEEGAGATLSRGPAFPGMGSEELRLASFYDWPLTAEVPPELLAAAGFFHTGHQDKVRCFFCYGGLQSWKRGDDPWTEHAKWFPGCQFLLRSKGQEYINNIHLTHSL","Homo sapiens","BIRC7, KIAP, LIVIN, MLIAP, RNF50, UNQ5800/PRO19607/PRO21344","Baculoviral IAP repeat-containing protein 7","1","2I3I"
"2I3R",,"X-RAY DIFFRACTION",2.15,42.74,"VAPOR DIFFUSION, HANGING DROP",8,"21% PEG 8000, 220 mM MgCl2, 1% BME, 0.1% BOG, 5mM DTT, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1107/S0907444906037784",,"2I3R",72.65,"1.85","1.85","Engineered catalytic domain of protein tyrosine phosphatase HPTPbeta","SDRPLSVHLNLGQKGNRKTSCPIKINQFEGHFMKLQADSNYLLSKEYEELKDVGRNQSCDIALLPENRGKNRYNNILPYDATRVKLSNVDDDPCSDYINASYIPGNNFRREYIVTQGPLPGTKDDFWKMVWEQNVHNIVMVTQCVEKGRVKCDHYWPADQDSLYYGDLILQMLSESVLPEWTIREFKICGEEQLDAHRLIRHFHYTVWPDHGVPETTQSLIQFVRTVRDYINRSPGAGPTVVHCSAGVGRTGTFIALDRILQQLDSKDSVDIYGAVHDLRLHRVHMVQTECQYVYLHQCVRDVLRARKLRSEQ","Homo sapiens","PTPRB, PTPB","Receptor-type tyrosine-protein phosphatase beta","1","2I3R"
"2I3U",,"X-RAY DIFFRACTION",2.21,44.32,"VAPOR DIFFUSION, HANGING DROP",8,"21% PEG 8000, 220 mM MgCl2, 1% BME, 0.1% BOG, 5mM DTT, VAPOR DIFFUSION, HANGING DROP, temperature 278K",278,"10.1107/S0907444906037784",,"2I3U",36.29,"1.85","1.85","Structural studies of protein tyrosine phosphatase beta catalytic domain in complex with inhibitors","SDRPLSVHLNLGQKGNRKTSCPIKINQFEGHFMKLQADSNYLLSKEYEELKDVGRNQSCDIALLPENRGKNRYNNILPYDATRVKLSNVDDDPCSDYINASYIPGNNFRREYIVTQGPLPGTKDDFWKMVWEQNVHNIVMVTQCVEKGRVKCDHYWPADQDSLYYGDLILQMLSESVLPEWTIREFKICGEEQLDAHRLIRHFHYTVWPDHGVPETTQSLIQFVRTVRDYINRSPGAGPTVVHCSAGVGRTGTFIALDRILQQLDSKDSVDIYGAVHDLRLHRVHMVQTECQYVYLHQCVRDVLRARKLRSEQ","Homo sapiens","PTPRB, PTPB","Receptor-type tyrosine-protein phosphatase beta","1","2I3U"
"2I3Y",,"X-RAY DIFFRACTION",2.3,46.47,"VAPOR DIFFUSION, SITTING DROP",8,"20% PEG 3350, 0.2 M sodium formate, 5% ETHYLENE GLYCOL, pH 8, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,,,"2I3Y",24.65,"2","2","Crystal structure of human glutathione peroxidase 5","MHHHHHHSSGVDLGTENLYFQSMKMDCHKDEKGTIYDYEAIALNKNEYVSFKQYVGKHILFVNVATYCGLTAQYPELNALQEELKPYGLVVLGFPCNQFGKQEPGDNKEILPGLKYVRPGGGFVPSFQLFEKGDVNGEKEQKVFSFLKHSCPHPSEILGTFKSISWDPVKVHDIRWNFEKFLVGPDGIPVMRWSHRATVSSVKTDILAYLKQFKT","Homo sapiens","GPX5","Epididymal secretory glutathione peroxidase","1","2I3Y"
"2I46",,"X-RAY DIFFRACTION",4.2,70.68,"VAPOR DIFFUSION, HANGING DROP",5.6,"3.5 M Sodium formate, 0.1 M sodium citrate, pH 5.6, 10 mM DTT, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1038/nature05454",,"2I46",35.12,"2.7","2.7","Crystal structure of human TPP1","SGRLVLRPWIRELILGSETPSSPRAGQLLEVLQDAEAAVAGPSHAPDTSDVGATLLVSDGTHSVRCLVTREALDTSDWEEKEFGFRGTEGRLLLLQDCGVHVQVAEGGAPAEFYLQVDRFSLLPTEQPRLRVPGCNQDLDVQKKLYDCLEEHLSESTSSNA","Homo sapiens","ACD, PIP1, PTOP, TINT1, TPP1","Adrenocortical dysplasia protein homolog","1","2I46"
"2I47",,"X-RAY DIFFRACTION",2.32,46.9,"VAPOR DIFFUSION, SITTING DROP",5.4,"20% PEG4000, 20% isopropanol, 0.1M sodium Citrate, pH 5.4, VAPOR DIFFUSION, SITTING DROP, temperature 292K",292,"10.1016/j.bmcl.2006.10.004","KGY","2I47",132.5,"1.9","1.9","Crystal structure of catalytic domain of TACE with inhibitor","VKRRADPDPMKNTCKLLVVADHRFYRYMGRGEESTTTNYLIELIDRVDDIYRNTAWDNAGFKGYGIQIEQIRILKSPQEVKPGEKHYNMAKSYPNEEKDAWDVKMLLEQFSFDIAEEASKVCLAHLFTYQDFDMGTLGLAYVGSPRANSHGGVCPKAYYSPVGKKNIYLNSGLTSTKNYGKTILTKEADLVTTHELGHNFGAEHDPDGLAECAPNEDQGGKYVMYPIAVSGDHENNKMFSQCSKQSIYKTIESKAQECFQERSNKVCGNSRVDEGEECDPGSHHHHHH","Homo sapiens","ADAM17, CSVP, TACE","ADAM 17","1","2I47"
"2I4E",,"X-RAY DIFFRACTION",2.14,42.46,"VAPOR DIFFUSION, HANGING DROP",8,"21% PEG 8000, 220 mM MgCl2, 1% BME, 0.1% BOG, 5mM DTT, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1107/S0907444906037784",,"2I4E",72.81,"1.75","1.75","Structural studies of protein tyrosine phosphatase beta catalytic domain in complex with inhibitors","SDRPLSVHLNLGQKGNRKTSCPIKINQFEGHFMKLQADSNYLLSKEYEELKDVGRNQSCDIALLPENRGKNRYNNILPYDATRVKLSNVDDDPCSDYINASYIPGNNFRREYIVTQGPLPGTKDDFWKMVWEQNVHNIVMVTQCVEKGRVKCDHYWPADQDSLYYGDLILQMLSESVLPEWTIREFKICGEEQLDAHRLIRHFHYTVWPDHGVPETTQSLIQFVRTVRDYINRSPGAGPTVVHCSAGVGRTGTFIALDRILQQLDSKDSVDIYGAVHDLRLHRVHMVQTECQYVYLHQCVRDVLRARKLRSEQ","Homo sapiens","PTPRB, PTPB","Receptor-type tyrosine-protein phosphatase beta","1","2I4E"
"2I4G",,"X-RAY DIFFRACTION",2.19,43.93,"VAPOR DIFFUSION, HANGING DROP",8.1,"20% PEG 8000, 200 mM MgCl2, 80 mM NH4OAc, 1% BME, 0.1% BOG, 5mM DTT, pH 8.1, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1107/S0907444906037784",,"2I4G",36.86,"1.65","1.65","Structural studies of protein tyrosine phosphatase beta catalytic domain in complex with a sulfamic acid (soaking experiment)","SDRPLSVHLNLGQKGNRKTSCPIKINQFEGHFMKLQADSNYLLSKEYEELKDVGRNQSCDIALLPENRGKNRYNNILPYDATRVKLSNVDDDPCSDYINASYIPGNNFRREYIVTQGPLPGTKDDFWKMVWEQNVHNIVMVTQCVEKGRVKCDHYWPADQDSLYYGDLILQMLSESVLPEWTIREFKICGEEQLDAHRLIRHFHYTVWPDHGVPETTQSLIQFVRTVRDYINRSPGAGPTVVHCSAGVGRTGTFIALDRILQQLDSKDSVDIYGAVHDLRLHRVHMVQTECQYVYLHQCVRDVLRARKLRSEQ","Homo sapiens","PTPRB, PTPB","Receptor-type tyrosine-protein phosphatase beta","1","2I4G"
"2I4H",,"X-RAY DIFFRACTION",1.96,37.22,"VAPOR DIFFUSION, HANGING DROP",8.1,"20% PEG 8000, 220 mM MgCl2, 80 mM NH4OAc, 1% BME, 0.1% BOG, 5mM DTT, pH 8.1, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1107/S0907444906037784",,"2I4H",36.88,"2.15","2.15","Structural studies of protein tyrosine phosphatase beta catalytic domain co-crystallized with a sulfamic acid inhibitor","SDRPLSVHLNLGQKGNRKTSCPIKINQFEGHFMKLQADSNYLLSKEYEELKDVGRNQSCDIALLPENRGKNRYNNILPYDATRVKLSNVDDDPCSDYINASYIPGNNFRREYIVTQGPLPGTKDDFWKMVWEQNVHNIVMVTQCVEKGRVKCDHYWPADQDSLYYGDLILQMLSESVLPEWTIREFKICGEEQLDAHRLIRHFHYTVWPDHGVPETTQSLIQFVRTVRDYINRSPGAGPTVVHCSAGVGRTGTFIALDRILQQLDSKDSVDIYGAVHDLRLHRVHMVQTECQYVYLHQCVRDVLRARKLRSEQ","Homo sapiens","PTPRB, PTPB","Receptor-type tyrosine-protein phosphatase beta","1","2I4H"
"2I4I",,"X-RAY DIFFRACTION",3.51,64.99,"VAPOR DIFFUSION",7.5,"1.75M Na formate, 0.1M Tris pH 7.5, 20mM ATPgS and MgCl2, VAPOR DIFFUSION, temperature 277K",277,"10.1016/j.jmb.2007.06.050",,"2I4I",47.47,"2.2","2.2","Crystal Structure of human DEAD-box RNA helicase DDX3X","SMVEATGNNCPPHIESFSDVEMGEIIMGNIELTRYTRPTPVQKHAIPIIKEKRDLMACAQTGSGKTAAFLLPILSQIYSDGPGEALRAMKENGRYGRRKQYPISLVLAPTRELAVQIYEEARKFSYRSRVRPCVVYGGADIGQQIRDLERGCHLLVATPGRLVDMMERGKIGLDFCKYLVLDEADRMLDMGFEPQIRRIVEQDTMPPKGVRHTMMFSATFPKEIQMLARDFLDEYIFLAVGRVGSTSENITQKVVWVEESDKRSFLLDLLNATGKDSLTLVFVETKKGADSLEDFLYHEGYACTSIHGDRSQRDREEALHQFRSGKSPILVATAVAARGLDISNVKHVINFDLPSDIEEYVHRIGRTGRVGNLGLATSFFNERNINITKDLLDLLVEAKQEVPSWLENMAYEHHYKG","Homo sapiens","DDX3X, DBX, DDX3","ATP-dependent RNA helicase DDX3X","1","2I4I"
"2I4J",,"X-RAY DIFFRACTION",2.51,50.93,"VAPOR DIFFUSION, SITTING DROP",8,"0.8 M NaCitrate, 0.15 M Tris, pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1074/jbc.M702316200","DRJ","2I4J",65.51,"2.1","2.1","Crystal structure of the complex between PPARgamma and the agonist LT160 (ureidofibrate derivative)","GSHMAEISSDIDQLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDL","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","2I4J"
"2I4K",,"SOLUTION NMR",,,,,,,"10.1091/mbc.e04-06-0504",,"2I4K",14.7,,,"Solution Structure of the PX domain of Sorting Nexin 1","QFDLTVGITDPEKIGDGMNAYVAYKVTTQTSLPLFRSKQFAVKRRFSDFLGLYEKLSEKHSQNGFIVPPPPEKSLIGMTKVKVGKEDSSSAEFLEKRRAALERYLQRIVNHPTMLQDPDVREFLEKEE","Homo sapiens","SNX1","Sorting nexin-1","1","2I4K"
"2I4P",,"X-RAY DIFFRACTION",2.66,53.79,"VAPOR DIFFUSION, SITTING DROP",8,"0.8 M NaCitrate, 0.15 M Tris, pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1074/jbc.M702316200","DRH","2I4P",65.51,"2.1","2.1","Crystal structure of the complex between PPARgamma and the partial agonist LT127 (ureidofibrate derivative). Structure obtained from crystals of the apo-form soaked for 30 days.","GSHMAEISSDIDQLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDL","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","2I4P"
"2I4Q",,"X-RAY DIFFRACTION",3.23,61.88,,,,,"10.1016/j.bmc.2007.05.069","UA4","2I4Q",74.73,"2.3","2.3","Human renin/PF02342674 complex","NTTSSVILTNYMDTQYYGEIGIGTPPQTFKVVFDTGSSNVWVPSSKCSRLYTACVYHKLFDASDSSSYKHNGTELTLRYSTGTVSGFLSQDIITVGGITVTQMFGEVTEMPALPFMLAEFDGVVGMGFIEQAIGRVTPIFDNIISQGVLKEDVFSFYYNRDSENSQSLGGQIVLGGSDPQHYEGNFHYINLIKTGVWQIQMKGVSVGSSTLLCEDGCLALVDTGASYISGSTSSIEKLMEALGAKKRLFDYVVKCNEGPTLPDISFHLGGKEYTLTSADYVFQESYSSKKLCTLAIHAMDIPPPTGPTWALGATFIRKFYTEFDRRNNRIGFALAR","Homo sapiens","REN","Renin","1","2I4Q"
"2I4Z",,"X-RAY DIFFRACTION",2.6,52.7,"VAPOR DIFFUSION, SITTING DROP",8,"0.8 M NaCitrate, 0.15 M Tris.  
Crystals of the apo-form have been soaked for 6 hours in a solution containing the ligand, pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1074/jbc.M702316200","DRH","2I4Z",65.51,"2.25","2.25","Crystal structure of the complex between PPARgamma and the partial agonist LT127 (ureidofibrate derivative). This structure has been obtained from crystals soaked for 6 hours.","GSHMAEISSDIDQLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDL","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","2I4Z"
"2I50",,"SOLUTION NMR",,,,,,,"10.1016/j.jmb.2007.04.015",,"2I50",14.68,,,"Solution Structure of Ubp-M Znf-UBP domain","GSHMPVCRHIRKGLEQGNLKKALVNVEWNICQDCKTDNKVKDKAEEETEEKPSVWLCLKCGHQGCGRNSQEQHALKHYLTPRSEPHCLVLSLDNWSVWCYVCDNEVQYCSSNQLGQVVDYVRKQAS","Homo sapiens","USP16, MSTP039","Ubiquitin carboxyl-terminal hydrolase 16","1","2I50"
"2I53",,"X-RAY DIFFRACTION",2.36,40.7,"VAPOR DIFFUSION, SITTING DROP",7.5,"Ammonium sulfate, PEG 400, HEPES, PH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.jmb.2006.11.057",,"2I53",30.46,"1.5","1.5","Crystal structure of Cyclin K","GSVTSANLDHTKPCWYWDKKDLAHTPSQLEGLDPATEARYRREGARFIFDVGTRLGLHYDTLATGIIYFHRFYMFHSFKQFPRYVTGACCLFLAGKVEETPKKCKDIIKTARSLLNDVQFGQFGDDPKEEVMVLERILLQTIKFDLQVEHPYQFLLKYAKQLKGDKNKIQKLVQMAWTFVNDSLCTTLSLQWEPEIIAVAVMYLAGRLCKFEIQEWTSKPMYRRWWEQFVQDVPVDVLEDICHQILDLYSQGKQQMPH","Homo sapiens","CCNK, CPR4","Cyclin K","1","2I53"
"2I59",,"SOLUTION NMR",,,,,,,"10.1073/pnas.0801508105",,"2I59",16.51,,,"Solution structure of RGS10","SMQSLKSTAKWAASLENLLEDPEGVKRFREFLKKEFSEENVLFWLACEDFKKMQDKTQMQEKAKEIYMTFLSSKASSQVNVEGQSRLNEKILEEPHPLMFQKLQDQIFNLMKYDSYSRFLKSDLFLKHKRTEEEEEDL","Homo sapiens","RGS10","Regulator of G-protein signaling 10","1","2I59"
"2I5C",,"X-RAY DIFFRACTION",2.2,44.8,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1M Bis-Tris pH 6.5, 28% PEG 2000 MME, VAPOR DIFFUSION, HANGING DROP, temperature 297.15K",297.15,"10.1186/1472-6807-7-80",,"2I5C",39.09,"1.75","1.75","Crystal structure of the C-terminal PH domain of pleckstrin in complex with D-myo-Ins(1,2,3,4,5)P5","GSFTGVIIKQGCLLKQGHRRKNWKVRKFILREDPAYLHYYDPAGAEDPLGAIHLRGCVVTSVESNSNGRKSEEENLFEIITADEVHYFLQAATPKERTEWIKAIQMASR","Homo sapiens","PLEK, P47","Pleckstrin","1","2I5C"
"2I5D",,"X-RAY DIFFRACTION",1.89,34.96,"VAPOR DIFFUSION",7.5,"27% PEG 3350 
100mM HEPES pH 7.5, VAPOR DIFFUSION, temperature 293K",293,"10.1107/S1744309106041790",,"2I5D",21.75,"1.63","1.63","Crystal Structure of Human Inosine Triphosphate Pyrophosphatase","GSHMAASLVGKKIVFVTGNAKKLEEVVQILGDKFPCTLVAQKIDLPEYQGEPDEISIQKCQEAVRQVQGPVLVEDTCLCFNALGGLPGPYIKWFLEKLKPEGLHQLLAGFEDKSAYALCTFALSTGDPSQPVRLFRGRTSGRIVAPRGCQDFGWDPCFQPDGYEQTYAEMPKAEKNAVSHRFRALLELQEYFGSLAA","Homo sapiens","ITPA, C20orf37, My049, OK/SW-cl.9","inosine triphosphate pyrophosphohydrolase","1","2I5D"
"2I5F",,"X-RAY DIFFRACTION",1.9,35.6,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1 M Bis-Tris pH 6.5   
28% PEG 2000 MME   
, VAPOR DIFFUSION, HANGING DROP, temperature 297.15K",297.15,"10.1186/1472-6807-7-80","5IP","2I5F",13.03,"1.35","1.35","Crystal structure of the C-terminal PH domain of pleckstrin in complex with D-myo-Ins(1,2,3,5,6)P5","GSFTGVIIKQGCLLKQGHRRKNWKVRKFILREDPAYLHYYDPAGAEDPLGAIHLRGCVVTSVESNSNGRKSEEENLFEIITADEVHYFLQAATPKERTEWIKAIQMASR","Homo sapiens","PLEK, P47","Pleckstrin","1","2I5F"
"2I5O",,"SOLUTION NMR",,,,,,,"10.1038/sj.embor.7400901",,"2I5O",4.49,,,"Solution Structure of the Ubiquitin-Binding Zinc Finger (UBZ) Domain of the Human DNA Y-Polymerase Eta","GSHMAAEDQVPCEKCGSLVPVWDMPEHMDYHFALELQKS","Homo sapiens","POLH, RAD30, RAD30A, XPV","DNA polymerase eta","1","2I5O"
"2I5T",,"X-RAY DIFFRACTION",2.2,42.5,"VAPOR DIFFUSION, HANGING DROP",,"PROTEIN SOLUTION (10 MG/ML PROTEIN, 0.050 M SODIUM CHLORIDE, 0.003 M SODIUM AZIDE, 0.0003 M TCEP, 0.005 M BISTRIS PH 7.0) MIXED IN A 1:1 RATIO WITH THE WELL SOLUTION (28% PEG 2K, 0.20 M POTASSIUM GLUTAMATE, 0.1 M MES/ACETATE PH 5.5) CRYOPROTECTED WITH 10% ETHYLENE GLYCOL IN WELL SOLUTION, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1002/prot.21719",,"2I5T",42.35,"2.01","2.01","Crystal Structure of hypothetical protein LOC79017 from Homo sapiens","SANSGCKDVTGPDEESFLYFAYGSNLLTERIHLRNPSAAFFCVARLQDFKLDFGNSQGKTSQTWHGGIATIFQSPGDEVWGVVWKMNKSNLNSLDEQEGVKSGMYVVIEVKVATQEGKEITCRSYLMTNYESAPPSPQYKKIICMGAKENGLPLEYQEKLKAIEPNDYTGKVSEEIEDIIKKGETQTL","Homo sapiens","C7orf24, GGCT, CRF21","Protein C7orf24","1","2I5T"
"2I5W",,"X-RAY DIFFRACTION",3.04,59.53,"VAPOR DIFFUSION, HANGING DROP",6,"16-18% PEG 8000, 150 mM CaCl2, 100 mM sod. cacodylate pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1073/pnas.0603644103",,"2I5W",42.36,"2.6","2.6","Structure of hOGG1 crosslinked to DNA sampling a normal G adjacent to an oxoG","GGTAGACCTGGA",,,"5'-D(*GP*GP*TP*AP*GP*AP*CP*CP*TP*GP*GP*A)-3'","1","2I5W"
,,,,,,,,,,,,,,,,"CCAGGTCTAC",,,"5'-D(P*CP*CP*AP*GP*(G42)P*TP*CP*TP*AP*C)-3'","2","2I5W"
,,,,,,,,,,,,,,,,"SEFGHRTLASTPALWASIPCPRSELRLDLVLPSGQSFRWREQSPAHWSGVLADQVWTLTQTEEQLHCTVYRGDKSQASRPTPDELEAVRKYFQLDVTLAQLYHHWGSVDSHFQEVAQKFQGVRLLRQDPIECLFSFICSSCNNIARITGMVERLCQAFGPRLIQLDDVTYHGFPSLQALAGPEVEAHLRKLGLGYRARYVSASARAILEEQGGLAWLQQLRESSYEEAHKALCILPGVGTKVADCICLMALDKPQAVPVDVHMWHIAQRDYSWHPTTSQAKGPSPQTNKELGNFFRSLWGPYAGWAQAVLFSADL","Homo sapiens","OGG1, MMH, MUTM, OGH1","N-glycosylase/DNA lyase","3","2I5W"
"2I5X",,"X-RAY DIFFRACTION",2.12,41.9,"VAPOR DIFFUSION, HANGING DROP",8,"21% PEG 8000, 220 mM MgCl2, 1% BME, 0.1% BOG, 5mM DTT, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1107/S0907444906037784",,"2I5X",73.07,"1.7","1.7","Engineering the PTPbeta catalytic domain with improved crystallization properties","SDRPLSVHLNLGQKGNRKTSCPIKINQFEGHFMKLQADSNYLLSKEYEELKDVGRNQSCDIALLPENRGKNRYNNILPYDATRVKLSNVDDDPCSDYINASYIPGNNFRREYIVTQGPLPGTKDDFWKMVWEQNVHNIVMVTQCVEKGRVKCDHYWPADQDSLYYGDLILQMLSESVLPEWTIREFKICGEEQLDAHRLIRHFHYTVWPDHGVPETTQSLIQFVRTVRDYINRSPGAGPTVVHCSAGVGRTGTFIALDRILQQLDSKDSVDIYGAVHDLRLHRVHMVQTECQYVYLHQCVRDVLRARKLRSEQ","Homo sapiens","PTPRB, PTPB","Receptor-type tyrosine-protein phosphatase beta","1","2I5X"
"2I65",,"X-RAY DIFFRACTION",2.12,41.87,"VAPOR DIFFUSION, HANGING DROP",6.5,"100 mM MES, 10% PEG 4000, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1074/jbc.M606365200",,"2I65",62.09,"1.9","1.9","Structural Basis for the Mechanistic Understanding Human CD38 Controlled Multiple Catalysis","KREAEARWRQTWSGPGTTKRFPETVLARCVKYTEIHPEMRHVDCQSVWDAFKGAFISKHPCDITEEDYQPLMKLGTQTVPCNKILLWSRIKDLAHQFTQVQRDMFTLEDTLLGYLADDLTWCGEFDTSKINYQSCPDWRKDCSNNPVSVFWKTVSRRFAEAACDVVHVMLDGSRSKIFDKDSTFGSVQVHNLQPEKVQTLEAWVIHGGREDSRDLCQDPTIKELESIISKRNIQFSCKNIYRPDKFLQCVKNPEDSSCTSEI","Homo sapiens","CD38","ADP-ribosyl cyclase 1","1","2I65"
"2I66",,"X-RAY DIFFRACTION",2.27,45.73,"VAPOR DIFFUSION, HANGING DROP",6.5,"100 mM MES, 12% PEG 4000, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 298.0K",298,"10.1074/jbc.M606365200",,"2I66",63.05,"1.7","1.7","Structural Basis for the Mechanistic Understanding Human CD38 Controlled Multiple Catalysis","KREAEARWRQTWSGPGTTKRFPETVLARCVKYTEIHPEMRHVDCQSVWDAFKGAFISKHPCDITEEDYQPLMKLGTQTVPCNKILLWSRIKDLAHQFTQVQRDMFTLEDTLLGYLADDLTWCGEFDTSKINYQSCPDWRKDCSNNPVSVFWKTVSRRFAEAACDVVHVMLDGSRSKIFDKDSTFGSVEVHNLQPEKVQTLEAWVIHGGREDSRDLCQDPTIKELESIISKRNIQFSCKNIYRPDKFLQCVKNPEDSSCTSEI","Homo sapiens","CD38","ADP-ribosyl cyclase 1","1","2I66"
"2I67",,"X-RAY DIFFRACTION",2.16,43.06,"VAPOR DIFFUSION, HANGING DROP",6.5,"100 mM MES, 12% PEG 4000, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1074/jbc.M606365200",,"2I67",62.44,"1.71","1.71","Structural Basis for the Mechanistic Understanding Human CD38 Controlled Multiple Catalysis","KREAEARWRQTWSGPGTTKRFPETVLARCVKYTEIHPEMRHVDCQSVWDAFKGAFISKHPCDITEEDYQPLMKLGTQTVPCNKILLWSRIKDLAHQFTQVQRDMFTLEDTLLGYLADDLTWCGEFDTSKINYQSCPDWRKDCSNNPVSVFWKTVSRRFAEAACDVVHVMLDGSRSKIFDKDSTFGSVEVHNLQPEKVQTLEAWVIHGGREDSRDLCQDPTIKELESIISKRNIQFSCKNIYRPDKFLQCVKNPEDSSCTSEI","Homo sapiens","CD38","ADP-ribosyl cyclase 1","1","2I67"
"2I6A",,"X-RAY DIFFRACTION",2.24,45.05,"VAPOR DIFFUSION, HANGING DROP",7.2,"PEG 4000, 0.1 M MgCl2, pH 7.2, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/jm060189a","5I5","2I6A",156.53,"2.2","2.2","Human Adenosine Kinase in Complex With 5'-Deoxy-5-Iodotubercidin","MTSVRENILFGMGNPLLDISAVVDKDFLDKYSLKPNDQILAEDKHKELFDELVKKFKVEYHAGGSTQNSIKVAQWMIQQPHKAATFFGCIGIDKFGEILKRKAAEAHVDAHYYEQNEQPTGTCAACITGDNRSLIANLAAANCYKKEKHLDLEKNWMLVEKARVCYIAGFFLTVSPESVLKVAHHASENNRIFTLNLSAPFISQFYKESLMKVMPYVDILFGNETEAATFAREQGFETKDIKEIAKKTQALPKMNSKRQRIVIFTQGRDDTIMATESEVTAFAVLDQDQKEIIDTNGAGDAFVGGFLSQLVSDKPLTECIRAGHYAASIIIRRTGCTFPEKPDFH","Homo sapiens","ADK","Adenosine kinase","1","2I6A"
"2I6B",,"X-RAY DIFFRACTION",2.27,45.87,"VAPOR DIFFUSION, HANGING DROP",7.4,"PEG4000, 0.1 M MgCl2, pH 7.4, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/jm060189a","89I","2I6B",78.31,"2.3","2.3","Human Adenosine Kinase in Complex with An Acetylinic Inhibitor","MTSVRENILFGMGNPLLDISAVVDKDFLDKYSLKPNDQILAEDKHKELFDELVKKFKVEYHAGGSTQNSIKVAQWMIQQPHKAATFFGCIGIDKFGEILKRKAAEAHVDAHYYEQNEQPTGTCAACITGDNRSLIANLAAANCYKKEKHLDLEKNWMLVEKARVCYIAGFFLTVSPESVLKVAHHASENNRIFTLNLSAPFISQFYKESLMKVMPYVDILFGNETEAATFAREQGFETKDIKEIAKKTQALPKMNSKRQRIVIFTQGRDDTIMATESEVTAFAVLDQDQKEIIDTNGAGDAFVGGFLSQLVSDKPLTECIRAGHYAASIIIRRTGCTFPEKPDFH","Homo sapiens","ADK","Adenosine kinase","1","2I6B"
"2I6K",,"X-RAY DIFFRACTION",2.07,40.62,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.2M Magnesium Acetate, 0.1M Sodium Cacodylate, 20% PEG 8000, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.jmb.2006.10.092",,"2I6K",56.11,"2","2","Crystal structure of human type I IPP isomerase complexed with a substrate analog","MGHHHHHHMPEINTNHLDKQQVQLLAEMCILIDENDNKIGAETKKNCHLNENIEKGLLHRAFSVFLFNTENKLLLQQRSDAKITFPGCFTNTCCSHPLSNPAELEESDALGVRRAAQRRLKAELGIPLEEVPPEEINYLTRIHYKAQSDGIWGEHEIDYILLVRMNVTLNPDPNEIKSYCYVSKEELKELLKKAASGEIKITPWFKIIAATFLFKWWDNLNHLNQFVDHEKIYRM","Homo sapiens","IDI1","Isopentenyl-diphosphate delta-isomerase 1","1","2I6K"
"2I6Q",,"X-RAY DIFFRACTION",2.27,45.78,"VAPOR DIFFUSION, HANGING DROP",7,"35% PEG 1000, 0.025 M sodium malonate, 0.0375 M imidazole, 0.0375 M boric acid, 3% 
xylitol, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.str.2006.08.008",,"2I6Q",60,"2.1","2.1","Complement component C2a","HHHHHHGSKIQIQRSGHLNLYLLLDCSQSVSENDFLIFKESASLMVDRIFSFEINVSVAIITFASEPKVLMSVLNDNSRDMTEVISSLENANYKDHENGTGTNTYAALNSVYLMMNNQMRLLGMETMAWQEIRHAIILLTDGKSNMGGSPKTAVDHIREILNINQKRNDYLDIYAIGVGKLDVDWRELNELGSKKDGERHAFILQDTKALHQVFEHMLDVSKLTDTICGVGNMSANASDQERTPWHVTIKPKSQETCRGALISDQWVLTAAHCFRDGNDHSLWRVNVGDPKSQWGKEFLIEKAVISPGFDVFAKKNQGILEFYGDDIALLKLAQKVKMSTHARPICLPCTMEANLALRRPQGSTCRDHENELLNKQSVPAHFVALNGSKLNINLKMGVEWTSCAEVVSQEKTMFPNLTDVREVVTDQFLCSGTQEDESPCKGESGGAVFLERRFRFFQVGLVSWGLYNPCLGSADKNSRKRAPRSKVPPPRDFHINLFRMQPWLRQHLGDVLNFLPL","Homo sapiens","C2a, C2","Complement C2a fragment","1","2I6Q"
"2I6S",,"X-RAY DIFFRACTION",2.2,44.18,"hanging drop vapor diffusion",7,"35% PEG 1000, 0.025 M sodium malonate, 0.0375 M imidazole, 0.0375 M boric acid, 20 mM LiCl, pH 7.0, hanging drop vapor diffusion, temperature 293K",293,"10.1016/j.str.2006.08.008",,"2I6S",60.65,"2.7","2.7","Complement component C2a","HHHHHHGSKIQIQRSGHLNLYLLLDCSQSVSENDFLIFKESASLMVDRIFSFEINVSVAIITFASEPKVLMSVLNDNSRDMTEVISSLENANYKDHENGTGTNTYAALNSVYLMMNNQMRLLGMETMAWQEIRHAIILLTDGKSNMGGSPKTAVDHIREILNINQKRNDYLDIYAIGVGKLDVDWRELNELGSKKDGERHAFILQDTKALHQVFEHMLDVSKLTDTICGVGNMSANASDQERTPWHVTIKPKSQETCRGALISDQWVLTAAHCFRDGNDHSLWRVNVGDPKSQWGKEFLIEKAVISPGFDVFAKKNQGILEFYGDDIALLKLAQKVKMSTHARPICLPCTMEANLALRRPQGSTCRDHENELLNKQSVPAHFVALNGSKLNINLKMGVEWTSCAEVVSQEKTMFPNLTDVREVVTDQFLCSGTQEDESPCKGESGGAVFLERRFRFFQVGLVSWGLYNPCLGSADKNSRKRAPRSKVPPPRDFHINLFRMQPWLRQHLGDVLNFLPL","Homo sapiens","C2a, C2","Complement C2a fragment","1","2I6S"
"2I6T",,"X-RAY DIFFRACTION",2.53,51.47,"VAPOR DIFFUSION, HANGING DROP",,"26% PEG3350, 0.2 M ammonium sulfate, 0.1 M sodium cacodylate, pH 5.2 in protein buffer comprising of 20 mM Tris-HCl, pH 8.0, 500 mM NaCl, 5% glycerol, 10 mM dithiothreitol, VAPOR DIFFUSION, HANGING DROP, temperature 298.0K",298,,,"2I6T",66.67,"2.1","2.1","Orthorhombic Structure of the LDH domain of Human Ubiquitin-conjugating Enzyme E2-like Isoform A","GSSKSWANHENKTVNKITVVGGGELGIACTLAISAKGIADRLVLLDLSEGTKGATMDLEIFNLPNVEISKDLSASAHSKVVIFTVNSLGSSQSYLDVVQSNVDMFRALVPALGHYSQHSVLLVASQPVEIMTYVTWKLSTFPANRVIGIGCNLDSQRLQYIITNVLKAQTSGKEVWVIGEQGEDKVLTWSGQEEVVSHTSQVQLSNRAMELLRVKGQRSWSVGLSVADMVDSIVNNKKKVHSVSALAKGYYDINSEVFLSLPCILGTNGVSEVIKTTLKEDTVTEKLQSSASSIHSLQQQLKL","Homo sapiens","UEVLD, UEV3","UBIQUITIN-CONJUGATING ENZYME E2-LIKE ISOFORM A","1","2I6T"
"2I75",,"X-RAY DIFFRACTION",2.01,38.9,"VAPOR DIFFUSION, SITTING DROP",6.8,"0.1M HEPES, 0.1 M NaCl, 1.3 M (NH4)SO4.  , pH 6.8, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.cell.2008.11.038",,"2I75",36.87,"2.45","2.45","Crystal Structure of Human Protein Tyrosine Phosphatase N4 (PTPN4)","SMEEKLENEPDFQYIPEKAPLDSVHQDDHSLRESMIQLAEGLITGTVLTQFDQLYRKKPGMTMSCAKLPQNISKNRYRDISPYDATRVILKGNEDYINANYINMEIPSSSIINQYIACQGPLPHTCTDFWQMTWEQGSSMVVMLTTQVERGRVKCHQYWPEPTGSSSYGCYQVTCHSEEGNTAYIFRKMTLFNQEKNESRPLTQIQYIAWPDHGVPDDSSDFLDFVCHVRNKRAGKEEPVVVHCSAGIGRTGVLITMETAMCLIECNQPVYPLDIVRTMRDQRAMMIQTPSQYRFVCEAILKVYEEGFVKPLTTSTNKLT","Homo sapiens","PTPN4","Tyrosine-protein phosphatase non-receptor type 4","1","2I75"
"2I78",,"X-RAY DIFFRACTION",2.82,56.41,"VAPOR DIFFUSION",,"VAPOR DIFFUSION",,,,"2I78",337.45,"2.5","2.5","Crystal structure of human dipeptidyl peptidase IV (DPP IV) complexed with ABT-341, a cyclohexene-constrained phenethylamine inhibitor","SRKTYTLTDYLKNTYRLKLYSLRWISDHEYLYKQENNILVFNAEYGNSSVFLENSTFDEFGHSINDYSISPDGQFILLEYNYVKQWRHSYTASYDIYDLNKRQLITEERIPNNTQWVTWSPVGHKLAYVWNNDIYVKIEPNLPSYRITWTGKEDIIYNGITDWVYEEEVFSAYSALWWSPNGTFLAYAQFNDTEVPLIEYSFYSDESLQYPKTVRVPYPKAGAVNPTVKFFVVNTDSLSSVTNATSIQITAPASMLIGDHYLCDVTWATQERISLQWLRRIQNYSVMDICDYDESSGRWNCLVARQHIEMSTTGWVGRFRPSEPHFTLDGNSFYKIISNEEGYRHICYFQIDKKDCTFITKGTWEVIGIEALTSDYLYYISNEYKGMPGGRNLYKIQLSDYTKVTCLSCELNPERCQYYSVSFSKEAKYYQLRCSGPGLPLYTLHSSVNDKGLRVLEDNSALDKMLQNVQMPSKKLDFIILNETKFWYQMILPPHFDKSKKYPLLLDVYAGPCSQKADTVFRLNWATYLASTENIIVASFDGRGSGYQGDKIMHAINRRLGTFEVEDQIEAARQFSKMGFVDNKRIAIWGWSYGGYVTSMVLGSGSGVFKCGIAVAPVSRWEYYDSVYTERYMGLPTPEDNLDHYRNSTVMSRAENFKQVEYLLIHGTADDNVHFQQSAQISKALVDVGVDFQAMWYTDEDHGIASSTAHQHIYTHMSHFIKQCFS","Homo sapiens","DPP4, ADCP2, CD26","Dipeptidyl peptidase IV","1","2I78"
"2I7A",,"X-RAY DIFFRACTION",2.55,51.69,"VAPOR DIFFUSION, HANGING DROP",4.6,"25% PEG4K, 0.2M NH4SO4, 0.1M Na-Ac, 10 mg/mL protein solution, cryoprotected with 25% glycerol, pH 4.6, VAPOR DIFFUSION, HANGING DROP, temperature 298.0K",298,,,"2I7A",20.45,"1.8","1.8","Domain IV of Human Calpain 13","MGSSHHHHHHSSGLVPRGSDIDATQLQGLLNQELLTGPPGDMFSLDECRSLVALMELKVNGRLDQEEFARLWKRLVHYQHVFQKVQTSPGVLLSSDLWKAIENTDFLRGIFISRELLHLVTLRYSDSVGRVSFPSLVCFLMRLEAMAKTFRNLSKDGKGLYLTEMEWMSLVMYN","Homo sapiens","CAPN13","Calpain 13","1","2I7A"
"2I7B",,"X-RAY DIFFRACTION",2.3,46.52,,,"6-8 mg/ml GTB/A268T, 70 mM N-(2-acetamido)-2-iminodiacetic acid (ADA), pH 7.5, 50 mM CH3COONa, pH 4.6, 40 mM NaCl, 5-8 mM MnCl2, 2.5% (w/v) 2-methyl-2,4-pentanediol (MPD), 5% (w/v) glycerol, 2% (w/v) PEG 4000 and 0.3-0.5 mM",,"10.1111/j.1537-2995.2007.01203.x",,"2I7B",34.84,"1.99","1.99","Structure of the naturally occuring mutant of human ABO(H) Blood group B glycosyltransferase: GTB/A268T","MVSLPRMVYPQPKVLTPCRKDVLVVTPWLAPIVWEGTFNIDILNEQFRLQNTTIGLTVFAIKKYVAFLKLFLETAEKHFMVGHRVHYYVFTDQPAAVPRVTLGTGRQLSVLEVGAYKRWQDVSMRRMEMISDFCERRFLSEVDYLVCVDVDMEFRDHVGVEILTPLFGTLHPSFYGSSREAFTYERRPQSQAYIPKDEGDFYYMGTFFGGSVQEVQRLTRACHQAMMVDQANGIEAVWHDESHLNKYLLRHKPTKVLSPEYLWDQQLLGWPAVLRKLRFTAVPKNHQAVRNP","Homo sapiens","ABO","alpha 1-3-galactosyltransferase","1","2I7B"
"2I7D",,"X-RAY DIFFRACTION",2.32,46.95,"VAPOR DIFFUSION, HANGING DROP",4.5,"50mM KH2PO4, 2-15% w/v PEG 8000, pH 4.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,,,"2I7D",45.92,"1.2","1.2","Structure of Human cytosolic deoxyribonucleotidase in complex with deoxyuridine, AlF4 and Mg2+","RSVRVLVDMDGVLADFEAGLLRGFRRRFPEEPHVPLEQRRGFLAREQYRALRPDLADKVASVYEAPGFFLDLEPIPGALDAVREMNDLPDTQVFICTSPLLKYHHCVGEKYRWVEQHLGPQFVERIILTRDKTVVLGDLLIDDKDTVRGQEETPSWEHILFTCCHNRHLVLPPTRRRLLSWSDNWREILDSKR","Homo sapiens","NT5C, DNT1, UMPH2","5'(3')-deoxyribonucleotidase, cytosolic type","1","2I7D"
"2I7K",,"SOLUTION NMR",,,,,,,"10.1016/j.bbrc.2007.04.139",,"2I7K",13.92,,,"Solution Structure of the Bromodomain of Human BRD7 Protein","MEEVEQTPLQEALNQLMRQLQRKDPSAFFSFPVTDFIAPGYSMIIKHPMDFSTMKEKIKNNDYQSIEELKDNFKLMCTNAMIYNKPETIYYKAAKKLLHSGMKILSQERLEHHHHHH","Homo sapiens","BRD7, BP75, CELTIX1","Bromodomain-containing protein 7","1","2I7K"
"2I7N",,"X-RAY DIFFRACTION",3.07,59.95,"VAPOR DIFFUSION, SITTING DROP",7.5,"25% PEG400, 0.2M CaCl, 0.1M Na HEPES, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1074/jbc.M701915200",,"2I7N",81.97,"1.9","1.9","Crystal structure of human PANK1 alpha: the catalytic core domain in complex with AcCoA","PPFPWFGMDIGGTLVKLVYFEPKDITAEEEQEEVENLKSIRKYLTSNTAYGKTGIRDVHLELKNLTMCGRKGNLHFIRFPSCAMHRFIQMGSEKNFSSLHTTLCATGGGAFKFEEDFRMIADLQLHKLDELDCLIQGLLYVDSVGFNGKPECYYFENPTNPELCQKKPYCLDNPYPMLLVNMGSGVSILAVYSKDNYKRVTGTSLGGGTFLGLCCLLTGCETFEEALEMAAKGDSTNVDKLVKDIYGGDYERFGLQGSAVASSFGNMMSKEKRDSISKEDLARATLVTITNNIGSIARMCALNENIDRVVFVGNFLRINMVSMKLLAYAMDFWSKGQLKALFLEHEGYFGAVGALLELFK","Homo sapiens","PANK1, PANK","Pantothenate kinase 1","1","2I7N"
"2I7P",,"X-RAY DIFFRACTION",2.46,50.05,"VAPOR DIFFUSION, SITTING DROP",8.5,"1M Tris, 50% PEG3350, 2M NH4Citrate, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1074/jbc.M701915200",,"2I7P",163.74,"2.05","2.05","Crystal structure of human PANK3 in complex with AcCoA","VPRGSPWFGMDIGGTLVKLSYFEPIDITAEEEQEEVESLKSIRKYLTSNVAYGSTGIRDVHLELKDLTLFGRRGNLHFIRFPTQDLPTFIQMGRDKNFSTLQTVLCATGGGAYKFEKDFRTIGNLHLHKLDELDCLVKGLLYIDSVSFNGQAECYYFANASEPERCQKMPFNLDDPYPLLVVNIGSGVSILAVHSKDNYKRVTGTSLGGGTFLGLCSLLTGCESFEEALEMASKGDSTQADKLVRDIYGGDYERFGLPGWAVASSFGNMIYKEKRESVSKEDLARATLVTITNNIGSVARMCAVNEKINRVVFVGNFLRVNTLSMKLLAYALDYWSKGQLKALFLEHEGYFGAVGALLGLPN","Homo sapiens","PANK3","Pantothenate kinase 3","1","2I7P"
"2I7Q",,"X-RAY DIFFRACTION",2.7,53.6,"VAPOR DIFFUSION, SITTING DROP",6.5,"25% PEG3350, 0.1M Ammonium sulfate, 0.1M bis-Tris, pH 6.5, vapor diffusion, sitting drop, temperature 291K",291,,,"2I7Q",47.02,"1.9","1.9","Crystal structure of Human Choline Kinase A","MGSSHHHHHHSSGLVPRGSPQPPADEQPEPRTRRRAYLWCKEFLPGAWRGLREDEFHISVIRGGLSNMLFQCSLPDTTATLGDEPRKVLLRLYGAILQMRSCNKEGSEQAQKENEFQGAEAMVLESVMFAILAERSLGPKLYGIFPQGRLEQFIPSRRLDTEELSLPDISAEIAEKMATFHGMKMPFNKEPKWLFGTMEKYLKEVLRIKFTEESRIKKLHKLLSYNLPLELENLRSLLESTPSPVVFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSYNYRGFDIGNHFCEWMYDYSYEKYPFFRANIRKYPTKKQQLHFISSYLPAFQNDFENLSTEEKSIIKEEMLLEVNRFALASHFLWGLWSIVQAKISSIEFGYMDYAQARFDAYFHQKRKLGV","Homo sapiens","CHKA, CHK, CKI","Choline kinase alpha","1","2I7Q"
,,,2.7,53.6
"2I7T",,"X-RAY DIFFRACTION",2.41,48.92,"VAPOR DIFFUSION, SITTING DROP",6.5,"100mM MOPS (pH 6.5), 16% PEG 3350, 300mM sodium sulfate, VAPOR DIFFUSION, SITTING DROP, temperature 294K",294,"10.1038/nature05363",,"2I7T",52.53,"2.1","2.1","Structure of human CPSF-73","MSAIPAEESDQLLIRPLGAGQEVGRSCIILEFKGRKIMLDCGIHPGLEGMDALPYIDLIDPAEIDLLLISHFHLDHCGALPWFLQKTSFKGRTFMTHATKAIYRWLLSDYVKVSNISADDMLYTETDLEESMDKIETINFHEVKEVAGIKFWCYHAGHVLGAAMFMIEIAGVKLLYTGDFSRQEDRHLMAAEIPNIKPDILIIESTYGTHIHEKREEREARFCNTVHDIVNRGGRGLIPVFALGRAQELLLILDEYWQNHPELHDIPIYYASSLAKKCMAVYQTYVNAMNDKIRKQININNPFVFKHISNLKSMDHFDDIGPSVVMASPGMMQSGLSRELFESWCTDKRNGVIIAGYCVEGTLAKHIMSEPEEITTMSGQKLPLKMSVDYISFSAHTDYQQTSEFIRALKPPHVILVHGEQNEMARLKAALIREYEDNDEVHIEVHNPRNTEAVTLNFR","Homo sapiens","CPSF3, CPSF73","Cleavage and polyadenylation specificity factor 73 kDa subunit","1","2I7T"
"2I7V",,"X-RAY DIFFRACTION",2.44,49.6,"VAPOR DIFFUSION, SITTING DROP",6.5,"100mM MOPS (pH 6.5), 300mM sodium sulfate, 16% PEG 3350, 0.5mM Zinc Chloride, VAPOR DIFFUSION, SITTING DROP, temperature 294K",294,"10.1038/nature05363",,"2I7V",52.66,"2.1","2.1","Structure of Human CPSF-73","MSAIPAEESDQLLIRPLGAGQEVGRSCIILEFKGRKIMLDCGIHPGLEGMDALPYIDLIDPAEIDLLLISHFHLDHCGALPWFLQKTSFKGRTFMTHATKAIYRWLLSDYVKVSNISADDMLYTETDLEESMDKIETINFHEVKEVAGIKFWCYHAGHVLGAAMFMIEIAGVKLLYTGDFSRQEDRHLMAAEIPNIKPDILIIESTYGTHIHEKREEREARFCNTVHDIVNRGGRGLIPVFALGRAQELLLILDEYWQNHPELHDIPIYYASSLAKKCMAVYQTYVNAMNDKIRKQININNPFVFKHISNLKSMDHFDDIGPSVVMASPGMMQSGLSRELFESWCTDKRNGVIIAGYCVEGTLAKHIMSEPEEITTMSGQKLPLKMSVDYISFSAHTDYQQTSEFIRALKPPHVILVHGEQNEMARLKAALIREYEDNDEVHIEVHNPRNTEAVTLNFR","Homo sapiens","CPSF3, CPSF73","Cleavage and polyadenylation specificity factor 73 kDa subunit","1","2I7V"
"2I83",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M608425200",,"2I83",17.73,,,"hyaluronan-binding domain of CD44 in its ligand-bound form","MAQIDLNITCRFAGVFHVEKNGRYSISRTEAADLCKAFNSTLPTMAQMEKALSIGFETCRYGFIEGHVVIPRIHPNSICAANNTGVYILTSNTSQYDTYCFNASAPPEEDCTSVTDLPNAFDGPITITIVNRDGTRYVQKGEYRTNPEDIYPSNPTDDDV","Homo sapiens","CD44, LHR, MDU2, MDU3, MIC4","CD44 antigen","1","2I83"
"2I85",,"SOLUTION NMR",,,,,,,,,"2I85",16.2,,,"NMR solution structure of Human ephrinB2 ectodomain","SKSIVLEPIYWNSSNSKFLPGQGLVLYPQIGDKLDIICPKVDSKTVGQYEYYKVYMVDKDQADRCTIKKENTPLLNCAKPDQDIKFTIKFQEFSPNLWGLEFQKNKDYYIISTSNGSLEGLDNQEGGVCQTRAMKILMKVGQ","Homo sapiens","EFNB2, EPLG5, HTKL, LERK5","Ephrin-B2","1","2I85"
"2I8N",,"SOLUTION NMR",,,,,,,,,"2I8N",13.52,,,"Solution structure of the second bromodomain of Brd4","EQLKCCSGILKEMFAKKHAAYAWPFYKPVDVEALGLHDYCDIIKHPMDMSTIKSKLEAREYRDAQEFGADVRLMFSNCYKYNPPDHEVVAMARKLQDVFEMRFAKMLQHHHHHH","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","2I8N"
"2I96",,"SOLUTION NMR",,,,,,,,,"2I96",12.91,,,"Solution structure of the oxidized microsomal human cytochrome b5","MAEQSDEAVKYYTLEEIQKHNHSKSTWLILHHKVYDLTKFLEEHPGGEEVLREQAGGDATENFEDVGHSTDAREMSKTFIIGELHPDDRPKLNKPPETLITTIDSSSS","Homo sapiens","CYB5A, CYB5","Cytochrome b5","1","2I96"
"2I99",,"X-RAY DIFFRACTION",2.43,49.39,"VAPOR DIFFUSION",6.5,"0.2M NH4Ac, 20% PEG 3350, pH 6.5, VAPOR DIFFUSION, temperature 277K",277,"10.1110/ps.062556907",,"2I99",68.59,"2.6","2.6","Crystal structure of human Mu_crystallin at 2.6 Angstrom","SRVPAFLSAAEVEEHLRSSSLLIPPLETALANFSSGPEGGVMQPVRTVVPVTKHRGYLGVMPAYSAAEDALTTKLVTFYEDRGITSVVPSHQATVLLFEPSNGTLLAVMDGNVITAKRTAAVSAIATKFLKPPSSEVLCILGAGVQAYSHYEIFTEQFSFKEVRIWNRTKENAEKFADTVQGEVRVCSSVQEAVAGADVIITVTLATEPILFGEWVKPGAHINAVGASRPDWRELDDELMKEAVLYVDSQEAALKESGDVLLSGAEIFAELGEVIKGVKPAHCEKTTVFKSLGMAVEDTVAAKLIYDSWSSG","Homo sapiens","CRYM, THBP","Mu-crystallin homolog","1","2I99"
"2I9A",,"X-RAY DIFFRACTION",2.85,56.87,"VAPOR DIFFUSION, HANGING DROP",10.5,"1.2 M sodium dihydrogen phosphate, 0.8 M potassium hydrogen phosphate, 200 mM lithium sulfate, 100 mM CHES, pH 10.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.jmb.2006.08.063",,"2I9A",65.97,"1.9","1.9","Crystal structure of the free aminoterminal fragment of urokinase type plasminogen activator (ATF)","RSSNELHQVPSNCDCLNGGTCVSNKYFSNIHWCNCPKKFGGQHCEIDKSKTCYEGNGHFYRGKASTDTMGRPCLPWNSATVLQQTYHAHRSDALQLGLGKHNYCRNPDNRRRPWCYVQVGLKPLVQECMVHDCADGKKPSSPPEE","Homo sapiens","PLAU","Urokinase-type plasminogen activator","1","2I9A"
"2I9G",,"X-RAY DIFFRACTION",2.37,48,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1M HEPES, pH 7.50, 20% PEG 3000, 0.2M Sodium Chloride, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1073/pnas.0605069103",,"2I9G",48.09,"2.1","2.1","DNA Polymerase Beta with a Benzo[c]phenanthrene diol epoxide adducted guanine base","GTCGG",,,"5'-D(P*GP*TP*CP*GP*G)-3'","1","2I9G"
,,,,,,,,,,,,,,,,"GCTGATGCGC",,,"5'-D(*GP*CP*TP*GP*AP*TP*GP*CP*GP*C)-3'","2","2I9G"
,,,,,,,,,,,,,,,,"CCGACGGCGCATCAGC",,,"5'-D(*CP*CP*GP*AP*CP*GP*GP*CP*GP*CP*AP*TP*CP*AP*GP*C)-3'","3","2I9G"
,,,,,,,,,,,,,,,,"MSKRKAPQETLNGGITDMLTELANFEKNVSQAIHKYNAYRKAASVIAKYPHKIKSGAEAKKLPGVGTKIAEKIDEFLATGKLRKLEKIRQDDTSSSINFLTRVSGIGPSAARKFVDEGIKTLEDLRKNEDKLNHHQRIGLKYFGDFEKRIPREEMLQMQDIVLNEVKKVDSEYIATVCGSFRRGAESSGDMDVLLTHPSFTSESTKQPKLLHQVVEQLQKVHFITDTLSKGETKFMGVCQLPSKNDEKEYPHRRIDIRLIPKDQYYCGVLYFTGSDIFNKNMRAHALEKGFTINEYTIRPLGVTGVAGEPLPVDSEKDIFDYIQWKYREPKDRSE","Homo sapiens","POLB","DNA polymerase beta","4","2I9G"
"2I9P",,"X-RAY DIFFRACTION",2.07,40.68,"VAPOR DIFFUSION, SITTING DROP",6.5,"25% PEG 3350, 0.2 M NaCl, 0.1 M Bis-Tris, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,,,"2I9P",138.12,"2.55","2.55","Crystal structure of human hydroxyisobutyrate dehydrogenase complexed with NAD+","MHHHHHHSSGVDLGTENLYFQSMPVGFIGLGNMGNPMAKNLMKHGYPLIIYDVFPDACKEFQDAGEQVVSSPADVAEKADRIITMLPTSINAIEAYSGANGILKKVKKGSLLIDSSTIDPAVSKELAKEVEKMGAVFMDAPVSGGVGAARSGNLTFMVGGVEDEFAAAQELLGCMGSNVVYCGAVGTGQAAKICNNMLLAISMIGTAEAMNLGIRLGLDPKLLAKILNMSSGRCWSSDTYNPVPGVMDGVPSANNYQGGFGTTLMAKDLGLAQDSATSTKSPILLGSLAHQIYRMMCAKGYSKKDFSSVFQFLREEETF","Homo sapiens","HIBADH","3-hydroxyisobutyrate dehydrogenase","1","2I9P"
"2IAG",,"X-RAY DIFFRACTION",2.39,48.45,"VAPOR DIFFUSION, HANGING DROP",8,"The native recombinant PGIS (25 mg/ml in the buffer containing 20 mM Tris, pH 8.0 and 150 mM NaCl) was 
found to crystallize spontaneously into needle clusters in the Eppendorf tube when stored at 4 C for 
about a week. A combination of microseeding technique and the hanging-drop vapor-diffusion method was 
then used to improve crystal quality. Specifically, seed stock was prepared by crushing these initial 
PGIS needle clusters with the Seed Bead Kit (Hampton Research). Following four 10-fold serial dilutions 
of the seed stock using the gel filtration buffer, 1 micro-l of diluted seeds was added into a 10 
micro-l drop of freshly concentrated PGIS sample, and equilibrated at 4 C against 450 micro-l of the 
gel filtration buffer. High quality single crystals of PGIS were most often obtained using 100- or 
1000-fold diluted seed stock, and reached suitable size (~ 0.05,0.05 ~ 0.1 mm3) within one week., 
VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.jmb.2006.09.039",,"2IAG",111.97,"2.15","2.15","Crystal structure of human prostacyclin synthase","RTRRPGEPPLDLGSIPWLGYALDFGKDAASFLTRMKEKHGDIFTILVGGRYVTVLLDPHSYDAVVWEPRTRLDFHAYAIFLMERIFDVQLPHYSPSDEKARMKLTLLHRELQALTEAMYTNLHAVLLGDATEAGSGWHEMGLLDFSYSFLLRAGYLTLYGIEALPRTHESQAQDRVHSADVFHTFRQLDRLLPKLARGSLSVGDKDHMCSVKSRLWKLLSPARLARRAHRSKWLESYLLHLEEMGVSEEMQARALVLQLWATQGNMGPAAFWLLLFLLKNPEALAAVRGELESILWQAEQPVSQTTTLPQKVLDSTPVLDSVLSESLRLTAAPFITREVVVDLAMPMADGREFNLRRGDRLLLFPFLSPQRDPEIYTDPEVFKYNRFLNPDGSEKKDFYKDGKRLKNYNMPWGAGHNHCLGRSYAVNSIKQFVFLVLVHLDLELINADVEIPEFDLSRYGFGLMQPEHDVPVRYRIRPHHHH","Homo sapiens","PTGIS, CYP8, CYP8A1","Prostacyclin synthase","1","2IAG"
"2IB7",,"X-RAY DIFFRACTION",2.39,48.65,"VAPOR DIFFUSION, HANGING DROP",6.5,"18% PEG 5000 monomethylether, 0.1M MES, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277.0K",277,"10.1021/bi6026192",,"2IB7",167.52,"2.05","2.05","Crystallographic and kinetic studies of human mitochondrial acetoacetyl-CoA thiolase (T2): the importance of potassium and chloride for its structure and function","MASKPTLKEVVIVSATRTPIGSFLGSLSLLPATKLGSIAIQGAIEKAGIPKEEVKEAYMGNVLQGGEGQAPTRQAVLGAGLPISTPCTTINKVCASGMKAIMMASQSLMCGHQDVMVAGGMESMSNVPYVMNRGSTPYGGVKLEDLIVKDGLTDVYNKIHMGSCAENTAKKLNIARNEQDAYAINSYTRSKAAWEAGKFGNEVIPVTVTVKGQPDVVVKEDEEYKRVDFSKVPKLKTVFQKENGTVTAANASTLNDGAAALVLMTADAAKRLNVTPLARIVAFADAAVEPIDFPIAPVYAASMVLKDVGLKKEDIAMWEVNEAFSLVVLANIKMLEIDPQKVNINGGAVSLGHPIGMSGARIVGHLTHALKQGEYGLASICNGGGGASAMLIQKL","Homo sapiens","ACAT1, ACAT, MAT","Acetyl-CoA acetyltransferase","1","2IB7"
"2IB8",,"X-RAY DIFFRACTION",2.43,49.51,"VAPOR DIFFUSION, HANGING DROP",6.5,"18% PEG 5000 monomethylether, 0.1M MES, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277.0K",277,"10.1021/bi6026192",,"2IB8",167.67,"1.85","1.85","Crystallographic and kinetic studies of human mitochondrial acetoacetyl-CoA thiolase (T2): the importance of potassium and chloride for its structure and function","MASKPTLKEVVIVSATRTPIGSFLGSLSLLPATKLGSIAIQGAIEKAGIPKEEVKEAYMGNVLQGGEGQAPTRQAVLGAGLPISTPCTTINKVCASGMKAIMMASQSLMCGHQDVMVAGGMESMSNVPYVMNRGSTPYGGVKLEDLIVKDGLTDVYNKIHMGSCAENTAKKLNIARNEQDAYAINSYTRSKAAWEAGKFGNEVIPVTVTVKGQPDVVVKEDEEYKRVDFSKVPKLKTVFQKENGTVTAANASTLNDGAAALVLMTADAAKRLNVTPLARIVAFADAAVEPIDFPIAPVYAASMVLKDVGLKKEDIAMWEVNEAFSLVVLANIKMLEIDPQKVNINGGAVSLGHPIGMSGARIVGHLTHALKQGEYGLASICNGGGGASAMLIQKL","Homo sapiens","ACAT1, ACAT, MAT","Acetyl-CoA acetyltransferase","1","2IB8"
"2IB9",,"X-RAY DIFFRACTION",2.44,49.71,"VAPOR DIFFUSION, HANGING DROP",6.5,"18% PEG 5000 monomethylether, 0.1M MES, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277.0K",277,"10.1021/bi6026192",,"2IB9",167.67,"2.05","2.05","Crystallographic and kinetic studies of human mitochondrial acetoacetyl-CoA thiolase (T2): the importance of potassium and chloride for its structure and function","MASKPTLKEVVIVSATRTPIGSFLGSLSLLPATKLGSIAIQGAIEKAGIPKEEVKEAYMGNVLQGGEGQAPTRQAVLGAGLPISTPCTTINKVCASGMKAIMMASQSLMCGHQDVMVAGGMESMSNVPYVMNRGSTPYGGVKLEDLIVKDGLTDVYNKIHMGSCAENTAKKLNIARNEQDAYAINSYTRSKAAWEAGKFGNEVIPVTVTVKGQPDVVVKEDEEYKRVDFSKVPKLKTVFQKENGTVTAANASTLNDGAAALVLMTADAAKRLNVTPLARIVAFADAAVEPIDFPIAPVYAASMVLKDVGLKKEDIAMWEVNEAFSLVVLANIKMLEIDPQKVNINGGAVSLGHPIGMSGARIVGHLTHALKQGEYGLASICNGGGGASAMLIQKL","Homo sapiens","ACAT1, ACAT, MAT","Acetyl-CoA acetyltransferase","1","2IB9"
"2IBN",,"X-RAY DIFFRACTION",2.8,56.12,"VAPOR DIFFUSION, HANGING DROP",7.8,"100 mM Tris pH 7.8, 1.8 M Ammonium sulphate, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1074/jbc.M800348200",,"2IBN",60.38,"1.5","1.5","Crystal structure of Human myo-Inositol Oxygenase (MIOX)","SMDRVFTTYKLMHTHQTVDFVRSKHAQFGGFSYKKMTVMEAVDLLDGLVDESDPDVDFPNSFHAFQTAEGIRKAHPDKDWFHLVGLLHDLGKVLALFGEPQWAVVGDTFPVGCRPQASVVFCDSTFQDNPDLQDPRYSTELGMYQPHCGLDRVLMSWGHDEYMYQVMKFNKFSLPPEAFYMIRFHSFYPWHTGRDYQQLCSQQDLAMLPWVREFNKFDLYTKCPDLPDVDKLRPYYQGLIDKYCPGILSW","Homo sapiens","MIOX, ALDRL6, KSP32, RSOR","Inositol oxygenase","1","2IBN"
"2IBU",,"X-RAY DIFFRACTION",2.39,48.57,"VAPOR DIFFUSION, HANGING DROP",6.5,"18% PEG 5000 monomethylether, 0.1M MES, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277.0K",277,"10.1021/bi6026192",,"2IBU",169.5,"1.9","1.9","Crystallographic and kinetic studies of human mitochondrial acetoacetyl-CoA thiolase (T2): the importance of potassium and chloride for its structure and function","MASKPTLKEVVIVSATRTPIGSFLGSLSLLPATKLGSIAIQGAIEKAGIPKEEVKEAYMGNVLQGGEGQAPTRQAVLGAGLPISTPCTTINKVCASGMKAIMMASQSLMCGHQDVMVAGGMESMSNVPYVMNRGSTPYGGVKLEDLIVKDGLTDVYNKIHMGSCAENTAKKLNIARNEQDAYAINSYTRSKAAWEAGKFGNEVIPVTVTVKGQPDVVVKEDEEYKRVDFSKVPKLKTVFQKENGTVTAANASTLNDGAAALVLMTADAAKRLNVTPLARIVAFADAAVEPIDFPIAPVYAASMVLKDVGLKKEDIAMWEVNEAFSLVVLANIKMLEIDPQKVNINGGAVSLGHPIGMSGARIVGHLTHALKQGEYGLASICNGGGGASAMLIQKL","Homo sapiens","ACAT1, ACAT, MAT","Acetyl-CoA acetyltransferase","1","2IBU"
"2IBW",,"X-RAY DIFFRACTION",2.45,49.88,"VAPOR DIFFUSION, HANGING DROP",6.5,"18% PEG 5000 monomethylether, 0.1M MES, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277.0K",277,"10.1021/bi6026192",,"2IBW",169.85,"1.9","1.9","Crystallographic and kinetic studies of human mitochondrial acetoacetyl-CoA thiolase (T2): the importance of potassium and chloride for its structure and function","MASKPTLKEVVIVSATRTPIGSFLGSLSLLPATKLGSIAIQGAIEKAGIPKEEVKEAYMGNVLQGGEGQAPTRQAVLGAGLPISTPCTTINKVCASGMKAIMMASQSLMCGHQDVMVAGGMESMSNVPYVMNRGSTPYGGVKLEDLIVKDGLTDVYNKIHMGSCAENTAKKLNIARNEQDAYAINSYTRSKAAWEAGKFGNEVIPVTVTVKGQPDVVVKEDEEYKRVDFSKVPKLKTVFQKENGTVTAANASTLNDGAAALVLMTADAAKRLNVTPLARIVAFADAAVEPIDFPIAPVYAASMVLKDVGLKKEDIAMWEVNEAFSLVVLANIKMLEIDPQKVNINGGAVSLGHPIGMSGARIVGHLTHALKQGEYGLASICNGGGGASAMLIQKL","Homo sapiens","ACAT1, ACAT, MAT","Acetyl-CoA acetyltransferase","1","2IBW"
"2IBY",,"X-RAY DIFFRACTION",2.4,48.78,"VAPOR DIFFUSION, HANGING DROP",6.5,"18% PEG 5000 monomethylether, 0.1M MES, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277.0K",277,"10.1021/bi6026192",,"2IBY",169.94,"1.85","1.85","Crystallographic and kinetic studies of human mitochondrial acetoacetyl-CoA thiolase (T2): the importance of potassium and chloride for its structure and function","MASKPTLKEVVIVSATRTPIGSFLGSLSLLPATKLGSIAIQGAIEKAGIPKEEVKEAYMGNVLQGGEGQAPTRQAVLGAGLPISTPCTTINKVCASGMKAIMMASQSLMCGHQDVMVAGGMESMSNVPYVMNRGSTPYGGVKLEDLIVKDGLTDVYNKIHMGSCAENTAKKLNIARNEQDAYAINSYTRSKAAWEAGKFGNEVIPVTVTVKGQPDVVVKEDEEYKRVDFSKVPKLKTVFQKENGTVTAANASTLNDGAAALVLMTADAAKRLNVTPLARIVAFADAAVEPIDFPIAPVYAASMVLKDVGLKKEDIAMWEVNEAFSLVVLANIKMLEIDPQKVNINGGAVSLGHPIGMSGARIVGHLTHALKQGEYGLASICNGGGGASAMLIQKL","Homo sapiens","ACAT1, ACAT, MAT","Acetyl-CoA acetyltransferase","1","2IBY"
"2IC1",,"X-RAY DIFFRACTION",3.63,66.14,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1 M Sodium cacodylate, 0.2 M Magnesium chloride, 17.6% PEG 8000, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1074/jbc.M609337200",,"2IC1",23.71,"2.7","2.7","Crystal Structure of Human Cysteine Dioxygenase in Complex with Substrate Cysteine","GPLGSMEQTEVLKPRTLADLIRILHQLFAGDEVNVEEVQAIMEAYESDPTEWAMYAKFDQYRYTRNLVDQGNGKFNLMILCWGEGHGSSIHDHTNSHCFLKMLQGNLKETLFAWPDKKSNEMVKKSERVLRENQCAYINDSIGLHRVENISHTEPAVSLHLYSPPFDTCHAFDQRTGHKNKVTMTFHSKFGIRTPNATSGSLENN","Homo sapiens","CDO1","Cysteine dioxygenase type 1","1","2IC1"
"2IC4",,"SOLUTION SCATTERING",,,,7.3,"SOLUTION, pH 7.3, temperature 288K",288,"10.1016/j.jmb.2007.02.038",,"2IC4",21.14,,,"Solution structure of the His402 allotype of the Factor H SCR6-SCR7-SCR8 fragment","GTLKPCDYPDIKHGGLYHENMRRPYFPVAVGKYYSYYCDEHFETPSGSYWDHIHCTQDGWSPAVPCLRKCYFPYLENGYNQNYGRKFVQGKSIDVACHPGYALPKAQTTVTCMENGWSPTPRCIRVKTCSKSSIDIENGFISESQYTYALKEKAKYQCKLGYVTADGETSGSITCGKDGWSAQPTCI","Homo sapiens","CFH, HF, HF1, HF2","Complement factor H","1","2IC4"
"2IC5",,"X-RAY DIFFRACTION",2.31,46.81,,6.5,"0.1 M BIS-TRIS, 20% MPEG 5K , pH 6.5, temperature 293K",293,,,"2IC5",41.28,"1.9","1.9","Crystal structure of human RAC3 grown in the presence of Gpp(NH)p.","SMQAIKCVVVGDGAVGKTCLLISYTTNAFPGEYIPTVFDNYSANVMVDGKPVNLGLWDTAGQEDYDRLRPLSYPQTDVFLICFSLVSPASFENVRAKWYPEVRHHCPHTPILLVGTKLDLRDDKDTIERLRDKKLAPITYPQGLAMAREIGSVKYLECSALTQRGLKTVFDEAIRAVLGG","Homo sapiens","RAC3","Ras-related C3 botulinum toxin substrate 3","1","2IC5"
"2ICA",,"X-RAY DIFFRACTION",2.01,38.94,,8.9,"80% (w/v) sodium citrate, 5% (v/v) glycerol, measured pH 8.9, vapor diffusion, hanging drop, temperature 293K",293,"10.1021/jm0610806","2IC","2ICA",21.49,"1.56","1.56","CD11a (LFA1) I-domain complexed with BMS-587101 aka 5-[(5S, 9R)-9-(4-cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro [4.4]non-7-yl]methyl]-3-thiophenecarboxylicacid","GSHMNVDLVFLFDGSMSLQPDEFQKILDFMKDVMKKLSNTSYQFAAVQFSTSYKTEFDFSDYVKRKDPDALLKHVKHMLLLTNTFGAINYVATEVFREELGARPDATKVLIIITDGEATDSGNIDAAKDIIRYIIGIGKHFQTKESQETLHKFASKPASEFVKILDTFEKLKDLFTELQKKIY","Homo sapiens","ITGAL, CD11A","Integrin alpha-L","1","2ICA"
"2ICC",,"X-RAY DIFFRACTION",1.761057,30.1556,"EVAPORATION",6.4,"pH 6.4, EVAPORATION, temperature 298K",298,"10.1038/nature05263",,"2ICC",13.5,"1.2","1.2","Extracellular Domain of CRIg","GRPILEVPESVTGPWKGDVNLPCTYDPLQGYTQVLVKWLVQRGSDPVTIFLRDSSGDHIQQAKYQGRLHVSHKVPGDVSLQLSTLEMDDRSHYTCEVTWQTPDGNQVVRDKITELRVQK","Homo sapiens","VSIG4, CRIg, Z39IG, UNQ317/PRO362","V-set and immunoglobulin domain-containing protein 4","1","2ICC"
"2ICJ",,"X-RAY DIFFRACTION",2.1,41.33,,,,,"10.1016/j.jmb.2006.12.055",,"2ICJ",27.02,"1.7","1.7","The crystal structure of human isopentenyl diphophate isomerase","GPLGSMMPEINTNHLDKQQVQLLAEMCILIDENDNKIGAETKKNCHLNENIEKGLLHRAFSVFLFNTENKLLLQQRSDAKITFPGCFTNTCCSHPLSNPAELEESDALGVRRAAQRRLKAELGIPLEEVPPEEINYLTRIHYKAQSDGIWGEHEIDYILLVRKNVTLNPDPNEIKSYCYVSKEELKELLKKAASGEIKITPWFKIIAATFLFKWWDNLNHLNQFVDHEKIYRM","Homo sapiens","IDI1","Isopentenyl-diphosphate delta isomerase","1","2ICJ"
"2ICK",,"X-RAY DIFFRACTION",2.1,41.41,,,,,"10.1016/j.jmb.2006.12.055",,"2ICK",27.2,"1.93","1.93","Human isopentenyl diphophate isomerase complexed with substrate analog","GPLGSMMPEINTNHLDKQQVQLLAEMCILIDENDNKIGAETKKNCHLNENIEKGLLHRAFSVFLFNTENKLLLQQRSDAKITFPGCFTNTCCSHPLSNPAELEESDALGVRRAAQRRLKAELGIPLEEVPPEEINYLTRIHYKAQSDGIWGEHEIDYILLVRKNVTLNPDPNEIKSYCYVSKEELKELLKKAASGEIKITPWFKIIAATFLFKWWDNLNHLNQFVDHEKIYRM","Homo sapiens","IDI1","Isopentenyl-diphosphate delta isomerase","1","2ICK"
"2ID5",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, HANGING DROP",5,"1.4 M Am Sulfate, O.1 M Sodium Citrate, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 291.0K",291,"10.1074/jbc.M607314200",,"2ID5",227.59,"2.698","2.698","Crystal Structure of the Lingo-1 Ectodomain","TGCPPRCECSAQDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACDCRLLWVFRRRWRLNFNRQQPTCATPEFVQGKEFKDFPDVLLPNYFTCRRARIRDRKAQQVFVDEGHTVQFVCRADGDPPPAILWLSPRKHLVSAKSNGRLTVFPDGTLEVRYAQVQDNGTYLCIAANAGGNDSMPAHLHVRS","Homo sapiens","LRRN6A, LINGO1, LERN1, UNQ201/PRO227","Leucine rich repeat neuronal 6A","1","2ID5"
"2IDH",,"X-RAY DIFFRACTION",2.78,55.78,"VAPOR DIFFUSION, SITTING DROP",7.5,"2.2M Ammonium Sulfate, 0.1M hepes 7.5, 2% PEG400, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.jmb.2007.06.064",,"2IDH",35.11,"2.28","2.28","Crystal Structure of human FE65 WW domain","GSDLPAGWMRVQDTSGTYYWHIPTGTTQWEPPGRASPS","Homo sapiens","APBB1, FE65, RIR","Amyloid beta A4 protein-binding family B member 1","1","2IDH"
"2IDX",,"X-RAY DIFFRACTION",3.17,61.14,"VAPOR DIFFUSION, SITTING DROP",,"20% PEG 3350, 0.2 M MgSO4, 10% glycerol, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1021/bi061396f",,"2IDX",66.6,"2.5","2.5","Structure of Human ATP:Cobalamin adenosyltransferase bound to ATP.","MPKIYTKTGDKGFSSTFTGERRPKDDQVFEAVGTTDELSSAIGFALELVTEKGHTFAEELQKIQCTLQDVGSALATPCSSAREAHLKYTTFKAGPILELEQWIDKYTSQLPPLTAFILPSGGKISSALHFCRAVCRRAERRVVPLVQMGETDANVAKFLNRLSDYLFTLARYAAMKEGNQEKIYMKNDPSAESEGL","Homo sapiens","MMAB","Cob(I)yrinic acid a,c-diamide adenosyltransferase","1","2IDX"
"2IEH",,"X-RAY DIFFRACTION",2.7,54.39,"VAPOR DIFFUSION, HANGING DROP",5.6,"20%PEG4000, 0.2M K2HPO4, 0.1M MES, pH 5.6, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1074/jbc.M608883200","MOY","2IEH",83.7,"2.7","2.7","Crystal structure of human kinesin Eg5 in complex with (R)-mon97, a new monastrol-based inhibitor that binds as (R)-enantiomer","ASQPNSSAKKKEEKGKNIQVVVRCRPFNLAERKASAHSIVECDPVRKEVSVRTGGLADKSSRKTYTFDMVFGASTKQIDVYRSVVCPILDEVIMGYNCTIFAYGQTGTGKTFTMEGERSPNEEYTWEEDPLAGIIPRTLHQIFEKLTDNGTEFSVKVSLLEIYNEELFDLLNPSSDVSERLQMFDDPRNKRGVIIKGLEEITVHNKDEVYQILEKGAAKRTTAATLMNAYSSRSHSVFSVTIHMKETTIDGEELVKIGKLNLVDLAGSENIGRSGAVDKRAREAGNINQSLLTLGRVITALVERTPHVPYRESKLTRILQDSLGGRTRTSIIATISPASLNLEETLSTLEYAHRAKNILNKPEVNQK","Homo sapiens","KIF11, EG5, KNSL1, TRIP5","Kinesin-like protein KIF11","1","2IEH"
"2IF1",,"SOLUTION NMR",,,,,,,"10.1093/emboj/18.9.2631",,"2IF1",14.33,,,"HUMAN TRANSLATION INITIATION FACTOR EIF1, NMR, 29 STRUCTURES","MRGSHHHHHHTDPMSAIQNLHSFDPFADASKGDDLLPAGTEDYIHIRIQQRNGRKTLTTVQGIADDYDKKKLVKAFKKKFACNGTVIEHPEYGEVIQLQGDQRKNICQFLVEIGLAKDDQLKVHGF","Homo sapiens","EIF1, SUI1","EIF1","1","2IF1"
"2IF5",,"X-RAY DIFFRACTION",3.4,63.87,"VAPOR DIFFUSION, SITTING DROP",7.5,"Protein at 24 mg/ml in 25 mM Tris, 150 mM NaCl, 2mM DTT, 0.18 M Calcium acetate hydrate, 18% w/v Polyethylene glycol 3350, 0.01 M Praseodymium (III) Acetate, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 290K",290,"10.1016/j.bbrc.2006.09.167",,"2IF5",13.36,"2","2","Structure of the POZ domain of human LRF, a master regulator of oncogenesis","IGIPFPDHSSDILSGLNEQRTQGLLCDVVILVEGREFPTHRSVLAACSQYFKKLFTSGAVVDQQNVYEIDFVSAEALTALMDFAYTATLTVSTANVGDILSAARLLEIPAVSHVCADLLD","Homo sapiens","ZBTB7A, FBI1, LRF, ZBTB7, ZNF857A","Zinc finger and BTB domain-containing protein 7A","1","2IF5"
"2IF7",,"X-RAY DIFFRACTION",4.13,70.25,"VAPOR DIFFUSION, SITTING DROP",7.4,"0.4-0.5 M CaCl2, 0.1 M HEPES pH 7.4,  1.0 mM Pt(NH3)2Cl2, 4% PEG-400, Vapor diffusion, Sitting drop, temperature 277K",277,"10.1016/j.immuni.2006.06.020",,"2IF7",86.86,"3","3","Crystal Structure of NTB-A","MSLTPLMVNGILGESVTLPLEFPAGEKVNFITWLFNETSLAFIVPHETKSPEIHVTNPKQGKRLNFTQSYSLQLSNLKMEDTGSYRAQISTKTSAKLSSYTLRILRQLRNIQVTNHSQLFQNMTCELHLTCSVEDADDNVSFRWEALGNTLSSQPNLTVSWDPRISSEQDYTCIAENAVSNLSFSVSAQKLCE","Homo sapiens","SLAMF6, KALI, UNQ6123/PRO20080","SLAM family member 6","1","2IF7"
"2IFD",,"X-RAY DIFFRACTION",3.24,62.01,"VAPOR DIFFUSION, HANGING DROP",7.5,"DTT, AMMONIUM SULFATE, TRIS, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/bi061257y",,"2IFD",20.8,"2","2","Crystal structure of a remote binding site mutant, R492L, of CDC25B Phosphatase catalytic domain","MELIGDYSKAFLLQTVDGKHQDLKYISPETMVALLTGKFSNIVDKFVIVDCRYPYEYEGGHIKTAVNLPLERDAESFLLKSPIAPCSLDKRVILIFHCEFSSERGPRMCRFIRERDLAVNDYPSLYYPEMYILKGGYKEFFPQHPNFCEPQDYRPMNHEAFKDELKTFRLKTRSW","Homo sapiens","CDC25B, CDC25HU2","M-phase inducer phosphatase 2","1","2IFD"
"2IFQ",,"X-RAY DIFFRACTION",1.8,31.63,"VAPOR DIFFUSION, HANGING DROP",7,"32% PEG 4000, 50 mM sodium phosphate, ethanol, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/bi061878r",,"2IFQ",35.49,"1.2","1.2","Crystal structure of S-nitroso thioredoxin","MVKQIESKTAFQEALDAAGDKLVVVDFSATWCGPCKMIKPFFHSLSEKYSNVIFLEVDVDDCQDVASECEVKCMPTFQFFKKGQKVGEFSGANKEKLEATINELV","Homo sapiens","TXN, TRDX, TRX, TRX1","Thioredoxin","1","2IFQ"
,,,,,,,,,,,,,,,,"MVKQIESKTAFQEALDAAGDKLVVVDFSATWCGPCKMIKPFFHSLSEKYSNVIFLEVDVDDCQDVASECEVKCMPTFQFFKKGQKVGEFSGANKEKLEATINELV","Homo sapiens","TXN, TRDX, TRX, TRX1","Thioredoxin","2","2IFQ"
"2IFV",,"X-RAY DIFFRACTION",3.17,61.17,"VAPOR DIFFUSION, HANGING DROP",7.5,"DTT, AMMONIUM SULFATE, TRIS, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/bi061257y",,"2IFV",20.76,"1.6","1.6","Crystal structure of an active site mutant, C473D, of CDC25B phosphatase catalytic domain","MELIGDYSKAFLLQTVDGKHQDLKYISPETMVALLTGKFSNIVDKFVIVDCRYPYEYEGGHIKTAVNLPLERDAESFLLKSPIAPCSLDKRVILIFHDEFSSERGPRMCRFIRERDRAVNDYPSLYYPEMYILKGGYKEFFPQHPNFCEPQDYRPMNHEAFKDELKTFRLKTRSW","Homo sapiens","CDC25B, CDC25HU2","M-phase inducer phosphatase 2","1","2IFV"
"2IG0",,"X-RAY DIFFRACTION",2.21,44.29,"VAPOR DIFFUSION, HANGING DROP",7,"2% PEG 400, 0.1M HEPES/NA, 2M AMMONIUM SULFATE, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.cell.2006.10.043",,"2IG0",15.4,"1.7","1.7","Structure of 53BP1/methylated histone peptide complex","GHMNSFVGLRVVAKWSSNGYFYSGKITRDVGAGKYKLLFDDGYECDVLGKDILLCDPIPLDTEVTALSEDEYFSAGVVKGHRKESGELYYSIEKEGQRKWYKRMAVILSLEQGNRLREQYGLG","Homo sapiens","TP53BP1","Tumor suppressor p53-binding protein 1","1","2IG0"
,,,,,,,,,,,,,,,,"KRHRKVLRDN",,,"Dimethylated Histone H4-K20 peptide","2","2IG0"
"2IG7",,"X-RAY DIFFRACTION",2.9,57.9,"VAPOR DIFFUSION, SITTING DROP",7,"18% PEG3350, 0.2M ammonium dihydrogen phosphate, 0.1M HEPES, pH 7.0, vapor diffusion, sitting drop, temperature 291K",291,,,"2IG7",93.56,"1.8","1.8","Crystal structure of Human Choline Kinase B","MGSSHHHHHHSSGLVPRGSVGGCLAKDGLQQSKCPDTTPKRRRASSLSRDAERRAYQWCREYLGGAWRRVQPEELRVYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPEGRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSYNYRGFDIGNHFCEWVYDYTHEEWPFYKARPTDYPTQEQQLHFIRHYLAEAKKGETLSQEEQRKLEEDLLVEVSRYALASHFFWGLWSILQASMSTIEFGYLDYAQSRFQFYFQQKGQLTSVHSSS","Homo sapiens","CHKB, CHETK, CHKL","Choline/ethanolamine kinase","1","2IG7"
,,,2.9,57.9
"2IGP",,"X-RAY DIFFRACTION",2.25,45.42,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1 M cacodylate, pH 6.5, 22-30% PEG 8K, 0.2 M (NH4)2SO4, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1038/nsmb1186",,"2IGP",13.96,"1.8","1.8","Crystal Structure of Hec1 CH domain","GSHMKDPRPLNDKAFIQQCIRQLCEFLTENGYAHNVSMKSLQAPSVKDFLKIFTFLYGFLCPSYELPDTKFEEEVPRIFKDLGYPFALSKSSMYTVGAPHTWPHIVAALVWLIDCIKIHT","Homo sapiens","HEC1, NDC80, HEC, KNTC2","Retinoblastoma-associated protein HEC","1","2IGP"
"2IGQ",,"X-RAY DIFFRACTION",2.78,55.7,"VAPOR DIFFUSION, HANGING DROP",7,"20% PEG 4K, 10% Isoproponol, 0.1M Hepes 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 300K",300,"10.1371/journal.pone.0008570","SAH","2IGQ",66.95,"2","2","Human euchromatic histone methyltransferase 1","NSQVWSALQMSKALQDSAPDRPSPVERIVSRDIARGYERIPIPCVNAVDSEPCPSNYKYVSQNCVTSPMNIDRNITHLQYCVCIDDCSSSNCMCGQLSMRCWYDKDGRLLPEFNMAEPPLIFECNHACSCWRNCRNRVVQNGLRARLQLYRTRDMGWGVRSLQDIPPGTFVCEYVGELISDSEADVREEDSYLFDLDNKDGEVYCIDARFYGNVSRFINHHCEPNLVPVRVFMAHQDLRFPRIAFFSTRLIEAGEQLGFDYGERFWDIKGKLFSCRCGSPKCRHS","Homo sapiens","EHMT1, EUHMTASE1, KIAA1876, GLP, KMT1D","euchromatic histone methyltransferase 1","1","2IGQ"
"2IHC",,"X-RAY DIFFRACTION",2.37,48.07,"VAPOR DIFFUSION, SITTING DROP",8.5,"20 % PEG3350, 200 mM MgCl2, 0.1M Tris buffer, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,,,"2IHC",56.23,"2.44","2.44","Crystal structure of the bric-a-brac (BTB) domain of human BACH1","SMSVFAYESSVHSTNVLLSLNDQRKKDVLCDVTIFVEGQRFRAHRSVLAACSSYFHSRIVGQADGELNITLPEEVTVKGFEPLIQFAYTAKLILSKENVDEVCKCVEFLSVHNIEESCFQFLKF","Homo sapiens","BACH1","Transcription regulator protein BACH1","1","2IHC"
"2IHD",,"X-RAY DIFFRACTION",2.28,46.01,"VAPOR DIFFUSION, SITTING DROP",,"0.20M NaI;  20.0% PEG 3350;  10.0% Ethylene Glycol, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1073/pnas.0801508105",,"2IHD",18.27,"1.7","1.7","Crystal structure of Human Regulator of G-protein signaling 8, RGS8","MHHHHHHSSGVDLGTENLYFQSMLKRLSTEEATRWADSFDVLLSHKYGVAAFRAFLKTEFSEENLEFWLACEEFKKTRSTAKLVSKAHRIFEEFVDVQAPREVNIDFQTREATRKNLQEPSLTCFDQAQGKVHSLMEKDSYPRFLRSKMYLDLLS","Homo sapiens","RGS8","Regulator of G-protein signaling 8","1","2IHD"
"2II0",,"X-RAY DIFFRACTION",2.73,54.87,"VAPOR DIFFUSION, HANGING DROP",7.5,"20% PEG3350, 0.2M ammonium chloride, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1073/pnas.0608127103",,"2II0",57.38,"2.02","2.02","Crystal Structure of catalytic domain of Son of sevenless (Rem-Cdc25) in the absence of Ras","GAMAEEQMRLPSADVYRFAEPDSEENIIFEENMQPKAGIPIIKAGTVIKLIERLTYHMYADPNFVRTFLTTYRSFCKPQELLSLIIERFEIPEPEPTEADRIAIENGDQPLSAELKRFRKEYIQPVQLRVLNVCRHWVEHHFYDFERDAYLLQRMEEFIGTVRGKAMKKWVESITKIIQRKKIARDNGPGHNITFQSSPPTVEWHISRPGHIETFDLLTLHPIEIARQLTLLESDLYRAVQPSELVGSVWTKEDKEINSPNLLKMIRHTTNLTLWFEKCIVETENLEERVAVVSRIIEILQVFQELNNFNGVLEVVSAMNSSPVYRLDHTFEQIPSRQKKILEEAHELSEDHYKKYLAKLRSINPPCVPFFGIYLTNILKTEEGNPEVLKRHGKELINFSKRRKVAEITGEIQQYQNQPYCLRVESDIKRFFENLNPMGNSMEKEFTDYLFNKSLEIEPRNPKPLPRFPKKYSYPLKSPGVRPSNPRPGT","Homo sapiens","SOS1","Son of sevenless homolog 1","1","2II0"
"2IIK",,"X-RAY DIFFRACTION",2.16,42.94,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.2M Amonium Sulphate, 0.1M Hepes, 25% PEG3350., pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,,,"2IIK",87.94,"2.55","2.55","Crystal Structure of human peroxisomal acetyl-CoA acyl transferase 1 (ACAA1)","MHHHHHHSSGVDLGTENLYFQSMAPQASAADVVVVHGRRTAICRAGRGGFKDTTPDELLSAVMTAVLKDVNLRPEQLGDICVGNVLQPGAGAIMARIAQFLSDIPETVPLSTVNRQCSSGLQAVASIAGGIRNGSYDIGMACGVESMSLADRGNPGNITSRLMEKEKARDCLIPMGITSENVAERFGISREKQDTFALASQQKAARAQSKGCFQAEIVPVTTTVHDDKGTKRSITVTQDEGIRPSTTMEGLAKLKPAFKKDGSTTAGNSSQVSDGAAAILLARRSKAEELGLPILGVLRSYAVVGVPPDIMGIGPAYAIPVALQKAGLTVSDVDIFEINEAFASQAAYCVEKLRLPPEKVNPLGGAVALGHPLGCTGARQVITLLNELKRRGKRAYGVVSMCIGTGMGAAAVFEYPGN","Homo sapiens","ACAA1, ACAA, PTHIO","3-ketoacyl-CoA thiolase, peroxisomal","1","2IIK"
"2IIM",,"X-RAY DIFFRACTION",2.46,49.92,"VAPOR DIFFUSION, HANGING DROP",7.5,"1 uL of protein solution (protein concentration 15 mg/mL, 20 mM Tris-HCl (pH 7.5) buffer) and 1 uL reservoir solution containing 28% PEG 400, 0.1 M HEPES buffer (pH 7.5) and 0.2 M. no addtional cryoprotectant was needed, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.jmb.2006.10.058",,"2IIM",7.19,"1","1","SH3 Domain of Human Lck","GSPLQDNLVIALHSYEPSHDGDLGFEKGEQLRILEQSGEWWKAQSLTTGQEGFIPFNFVAKA","Homo sapiens","LCK","Proto-oncogene tyrosine-protein kinase LCK","1","2IIM"
"2IIP",,"X-RAY DIFFRACTION",2.22,44.67,"VAPOR DIFFUSION, HANGING DROP",7,"PEG, pH 7, VAPOR DIFFUSION, HANGING DROP, temperature 300K",300,,,"2IIP",127.4,"2.05","2.05","Human Nicotinamide N-methyltransferase","MGSSHHHHHHSSGLVPRGSMESGFTSKDTYLSHFNPRDYLEKYYKFGSRHSAESQILKHLLKNLFKIFCLDGVKGDLLIDIGSGPTIYQLLSACESFKEIVVTDYSDQNLQELEKWLKAAPAAFDWSPVVTYVCDLEGNRVKGPEKEEKLRQAVKQVLKCDVTQSQPLGAVPLPPADCVLSTLCLDAACPDLPTYCRALRNLGSLLKPGGFLVIMDALKSSYYMIGEQKFSSLPLGREAVEAAVKEAGYTIEWFEVISQSYSSTMANNEGLFSLVARKLSRPL","Homo sapiens","NNMT","Nicotinamide N-methyltransferase","1","2IIP"
"2IIT",,"X-RAY DIFFRACTION",3,58.95,"VAPOR DIFFUSION, HANGING DROP",8,"PEG 4000, SODIUM ACETATE, TRIS, pH 8.00, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.bmcl.2006.09.099","872","2IIT",174.95,"2.35","2.35","Human dipeptidyl peptidase 4 in complex with a diazepan-2-one inhibitor","TRKTYTLTDYLKNTYRLKLYSLRWISDHEYLYKQENNILVFNAEYGNSSVFLENSTFDEFGHSINDYSISPDGQFILLEYNYVKQWRHSYTASYDIYDLNKRQLITEERIPNNTQWVTWSPVGHKLAYVWNNDIYVKIEPNLPSYRITWTGKEDIIYNGITDWVYEEEVFSAYSALWWSPNGTFLAYAQFNDTEVPLIEYSFYSDESLQYPKTVRVPYPKAGAVNPTVKFFVVNTDSLSSVTNATSIQITAPASMLIGDHYLCDVTWATQERISLQWLRRIQNYSVMDICDYDESSGRWNCLVARQHIEMSTTGWVGRFRPSEPHFTLDGNSFYKIISNEEGYRHICYFQIDKKDCTFITKGTWEVIGIEALTSDYLYYISNEYKGMPGGRNLYKIQLSDYTKVTCLSCELNPERCQYYSVSFSKEAKYYQLRCSGPGLPLYTLHSSVNDKGLRVLEDNSALDKMLQNVQMPSKKLDFIILNETKFWYQMILPPHFDKSKKYPLLLDVYAGPCSQKADTVFRLNWATYLASTENIIVASFDGRGSGYQGDKIMHAINRRLGTFEVEDQIEAARQFSKMGFVDNKRIAIWGWSYGGYVTSMVLGSGSGVFKCGIAVAPVSRWEYYDSVYTERYMGLPTPEDNLDHYRNSTVMSRAENFKQVEYLLIHGTADDNVHFQQSAQISKALVDVGVDFQAMWYTDEDHGIASSTAHQHIYTHMSHFIKQCFSLP","Homo sapiens","DPP4, ADCP2, CD26","Dipeptidyl peptidase 4 soluble form","1","2IIT"
"2IIV",,"X-RAY DIFFRACTION",3.01,59.14,"VAPOR DIFFUSION, HANGING DROP",8,"PEG 4000, SODIUM ACETATE, TRIS, pH 8.00, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.bmcl.2006.09.099","565","2IIV",174.57,"2.15","2.15","Human dipeptidyl peptidase 4 in complex with a diazepan-2-one inhibitor","TRKTYTLTDYLKNTYRLKLYSLRWISDHEYLYKQENNILVFNAEYGNSSVFLENSTFDEFGHSINDYSISPDGQFILLEYNYVKQWRHSYTASYDIYDLNKRQLITEERIPNNTQWVTWSPVGHKLAYVWNNDIYVKIEPNLPSYRITWTGKEDIIYNGITDWVYEEEVFSAYSALWWSPNGTFLAYAQFNDTEVPLIEYSFYSDESLQYPKTVRVPYPKAGAVNPTVKFFVVNTDSLSSVTNATSIQITAPASMLIGDHYLCDVTWATQERISLQWLRRIQNYSVMDICDYDESSGRWNCLVARQHIEMSTTGWVGRFRPSEPHFTLDGNSFYKIISNEEGYRHICYFQIDKKDCTFITKGTWEVIGIEALTSDYLYYISNEYKGMPGGRNLYKIQLSDYTKVTCLSCELNPERCQYYSVSFSKEAKYYQLRCSGPGLPLYTLHSSVNDKGLRVLEDNSALDKMLQNVQMPSKKLDFIILNETKFWYQMILPPHFDKSKKYPLLLDVYAGPCSQKADTVFRLNWATYLASTENIIVASFDGRGSGYQGDKIMHAINRRLGTFEVEDQIEAARQFSKMGFVDNKRIAIWGWSYGGYVTSMVLGSGSGVFKCGIAVAPVSRWEYYDSVYTERYMGLPTPEDNLDHYRNSTVMSRAENFKQVEYLLIHGTADDNVHFQQSAQISKALVDVGVDFQAMWYTDEDHGIASSTAHQHIYTHMSHFIKQCFSLP","Homo sapiens","DPP4, ADCP2, CD26","Dipeptidyl peptidase 4 soluble form","1","2IIV"
"2IIY",,"X-RAY DIFFRACTION",1.9,35.18,"VAPOR DIFFUSION, HANGING DROP",7,"32% PEG 1500, 50 mM sodium phosphate, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/bi061878r",,"2IIY",11.81,"1.7","1.7","Crystal structure of S-nitroso thioredoxin","MVKQIESKTAFQEALDAAGDKLVVVDFSATWCGPCKMIKPFFHSLSEKYSNVIFLEVDVDDCQDVASECEVKCMPTFQFFKKGQKVGEFSGANKEKLEATINELV","Homo sapiens","TXN, TRDX, TRX, TRX1","Thioredoxin","1","2IIY"
"2IJA",,"X-RAY DIFFRACTION",2.2,42.8,"VAPOR DIFFUSION, HANGING DROP",7.8,"26% peg-4000, 0.2M sodium acetate, 0.1M Tris, pH 7.8, vapor diffusion, hanging drop, temperature 291K",291,,,"2IJA",34.5,"1.701","1.701","Human N-acetyltransferase 1 F125S mutant","GSGSGSDIEAYLERIGYKKSRNKLDLETLTDILQHQIRAVPFENLNIHCGDAMDLGLEAIFDQVVRRNRGGWCLQVNHLLYWALTTIGFETTMLGGYVYSTPAKKYSTGMIHLLLQVTIDGRNYIVDAGSGRSYQMWQPLELISGKDQPQVPCVFRLTEENGFWYLDQIRREQYIPNEEFLHSDLLEDSKYRKIYSFTLKPRTIEDFESMNTYLQTSPSSVFTSKSFCSLQTPDGVHCLVGFTLTHRRFNYKDNTDLIEFKTLSEEEIEKVLKNIFNISLQRKLVPKHGDRFFTI","Homo sapiens","NAT1, AAC1","Arylamine N-acetyltransferase 1","1","2IJA"
"2IJM",,"X-RAY DIFFRACTION",2.32,46.89,"VAPOR DIFFUSION, HANGING DROP",7.5,"30% (v/v) PEG-600, 10% glycerol, 0.1M HEPES pH 7.5, 0.05M Li2SO4, VAPOR DIFFUSION, HANGING DROP, temperature 278K",278,,,"2IJM",65.4,"2.187","2.187","Crystal Structure of Focal Adhesion Kinase Domain with 2 molecules in the Asymmetric Unit Complexed with ADP and ATP","GASTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKAQQEE","Homo sapiens","PTK2, FAK, FAK1","Focal Adhesion Kinase 1","1","2IJM"
"2IKG",,"X-RAY DIFFRACTION",2.15,42.7,"VAPOR DIFFUSION, HANGING DROP",5,"20% PEG 6000, 120mM ammonium citrate, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.jmb.2006.12.004","BTO","2IKG",36.92,"1.43","1.43","Aldose reductase complexed with nitrophenyl-oxadiazol type inhibitor at 1.43 A","MASRILLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGKEFFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAKHNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVCALLSCTSHKDYPFHEEF","Homo sapiens","hALR2, AKR1B1, ALDR1, ALR2","Aldose reductase","1","2IKG"
"2IKH",,"X-RAY DIFFRACTION",2.16,43.1,"VAPOR DIFFUSION, HANGING DROP",5,"20% PEG 6000, 120mM ammonium citrate, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.jmb.2006.12.004","LIT","2IKH",36.91,"1.55","1.55","Human aldose reductase complexed with nitrofuryl-oxadiazol inhibitor at 1.55 A","MASRILLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGKEFFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAKHNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVCALLSCTSHKDYPFHEEF","Homo sapiens","hALR2, AKR1B1, ALDR1, ALR2","Aldose reductase","1","2IKH"
"2IKI",,"X-RAY DIFFRACTION",2.16,43,"VAPOR DIFFUSION, HANGING DROP",5,"20% PEG 6000, 120mM ammonium citrate, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.jmb.2006.12.004","388","2IKI",37.06,"1.47","1.47","Human aldose reductase complexed with halogenated IDD-type inhibitor","MASRILLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGKEFFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAKHNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVCALLSCTSHKDYPFHEEF","Homo sapiens","hALR2, AKR1B1, ALDR1, ALR2","Aldose reductase","1","2IKI"
"2IKJ",,"X-RAY DIFFRACTION",2.16,43.1,"VAPOR DIFFUSION, HANGING DROP",5,"20% PEG 6000, 120mM ammonium citrate buffer, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.jmb.2006.12.004","393","2IKJ",37.01,"1.55","1.55","Human aldose reductase complexed with nitro-substituted IDD-type inhibitor","MASRILLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGKEFFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAKHNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVCALLSCTSHKDYPFHEEF","Homo sapiens","hALR2, AKR1B1, ALDR1, ALR2","Aldose reductase","1","2IKJ"
"2IKO",,"X-RAY DIFFRACTION",3.13,60.64,"VAPOR DIFFUSION, HANGING DROP",4.5,"10-20% PEG 3350, 50 mM sodium citrate pH 4.5, 0.6 M NaCl. Renin concentration 8-12 mg/mL., VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.ab.2006.10.017","7IG","2IKO",74.89,"1.9","1.9","Crystal Structure of Human Renin Complexed with Inhibitor","LTLGNTTSSVILTNYMDTQYYGEIGIGTPPQTFKVVFDTGSSNVWVPSSKCSRLYTACVYHKLFDASDSSSYKHNGTELTLRYSTGTVSGFLSQDIITVGGITVTQMFGEVTEMPALPFMLAEFDGVVGMGFIEQAIGRVTPIFDNIISQGVLKEDVFSFYYNRDSENSQSLGGQIVLGGSDPQHYEGNFHYINLIKTGVWQIQMKGVSVGSSTLLCEDGCLALVDTGASYISGSTSSIEKLMEALGAKKRLFDYVVKCNEGPTLPDISFHLGGKEYTLTSADYVFQESYSSKKLCTLAIHAMDIPPPTGPTWALGATFIRKFYTEFDRRNNRIGFALAR","Homo sapiens","REN","Renin","1","2IKO"
"2IKU",,"X-RAY DIFFRACTION",3.14,60.88,"VAPOR DIFFUSION, HANGING DROP",4.5,"10-20% PEG 3350, 50 mM sodium citrate pH 4.5, 0.6 M NaCl., VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.ab.2006.10.017","LIY","2IKU",75.37,"2.6","2.6","Crystal Structure of Human Renin Complexed with Inhibitors","LTLGNTTSSVILTNYMDTQYYGEIGIGTPPQTFKVVFDTGSSNVWVPSSKCSRLYTACVYHKLFDASDSSSYKHNGTELTLRYSTGTVSGFLSQDIITVGGITVTQMFGEVTEMPALPFMLAEFDGVVGMGFIEQAIGRVTPIFDNIISQGVLKEDVFSFYYNRDSENSQSLGGQIVLGGSDPQHYEGNFHYINLIKTGVWQIQMKGVSVGSSTLLCEDGCLALVDTGASYISGSTSSIEKLMEALGAKKRLFDYVVKCNEGPTLPDISFHLGGKEYTLTSADYVFQESYSSKKLCTLAIHAMDIPPPTGPTWALGATFIRKFYTEFDRRNNRIGFALAR","Homo sapiens","REN","Renin","1","2IKU"
"2IL1",,"X-RAY DIFFRACTION",2.5,51.1,"VAPOR DIFFUSION, SITTING DROP",5,"22% PEG4000, 0.2M calcium acetate, 0.1M sodium cacodylate, pH 5.0, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,,,"2IL1",22.44,"2.1","2.1","Crystal structure of a predicted human GTPase in complex with GDP","MGSSHHHHHHSSGLVPRGSPRPADFKLQVIIIGSRGVGKTSLMERFTDDTFCEACKSTVGVDFKIKTVELRGKKIRLQIWDTAGQERFNSITSAYYRSAKGIILVYDITKKETFDDLPKWMKMIDKYASEDAELLLVGNKLDCETDREITRQQGEKFAQQITGMRFCEASAKDNFNVDEIFLKLVDDILKKM","Homo sapiens","RAB12","Rab12","1","2IL1"
"2IL2",,"X-RAY DIFFRACTION",3.17,61.18,"VAPOR DIFFUSION, HANGING DROP",4.5,"10-20 % PEG 3350, 50 mM sodium citrate pH 4.5, 0.6 M NaCl., VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.ab.2006.10.017","LIX","2IL2",75.96,"2.24","2.24","Crystal Structure of Human Renin Complexed with Inhibitor","LTLGNTTSSVILTNYMDTQYYGEIGIGTPPQTFKVVFDTGSSNVWVPSSKCSRLYTACVYHKLFDASDSSSYKHNGTELTLRYSTGTVSGFLSQDIITVGGITVTQMFGEVTEMPALPFMLAEFDGVVGMGFIEQAIGRVTPIFDNIISQGVLKEDVFSFYYNRDSENSQSLGGQIVLGGSDPQHYEGNFHYINLIKTGVWQIQMKGVSVGSSTLLCEDGCLALVDTGASYISGSTSSIEKLMEALGAKKRLFDYVVKCNEGPTLPDISFHLGGKEYTLTSADYVFQESYSSKKLCTLAIHAMDIPPPTGPTWALGATFIRKFYTEFDRRNNRIGFALAR","Homo sapiens","REN","Renin","1","2IL2"
"2IL6",,"SOLUTION NMR",,,,,,,"10.1006/jmbi.1997.0933",,"2IL6",21.01,,,"HUMAN INTERLEUKIN-6, NMR, 32 STRUCTURES","APVPPGEDSKDVAAPHRQPLTSSERIDKQIRYILDGISALRKETCNKSNMCESSKEALAENNLNLPKMAEKDGCFQSGFNEETCLVKIITGLLEFEVYLEYLQNRFESSEEQARAVQMSTKVLIQFLQKKAKNLDAITTPDPTTNASLLTKLQAQNQWLQDMTTHLILRSFKEFLQSSLRALRQM","Homo sapiens","IL6, IFNB2","INTERLEUKIN-6","1","2IL6"
"2IL8",,"SOLUTION NMR",,,,,,,"10.1021/bi00459a004",,"2IL8",16.8,,,"THREE-DIMENSIONAL STRUCTURE OF INTERLEUKIN 8 IN SOLUTION","SAKELRCQCIKTYSKPFHPKFIKELRVIESGPHCANTEIIVKLSDGRELCLDPKENWVQRVVEKFLKRAENS","Homo sapiens","POTENTIAL, CXCL8, IL8","INTERLEUKIN-8","1","2IL8"
"2ILA",,"X-RAY DIFFRACTION",2.14,42.47,,,,,"10.1021/bi00463a009",,"2ILA",17.62,"2.3","2.3","STRUCTURE OF INTERLEUKIN 1ALPHA AT 2.7-ANGSTROMS RESOLUTION","SFLSNVKYNFMRIIKYEFILNDALNQSIIRANAQYLTAAALHNLDEAVKFDMGAYKSSKDDAKITVILRISKTQLYVTAQDEDQPVLLKEMPEIPKTITGSETNLLFFWETHGTKNYFTSVAHPNLFIATKQDYWVCLAGGPPSITDFQILENQA","Homo sapiens","IL1A, IL1F1","INTERLEUKIN-1 ALPHA","1","2ILA"
"2ILI",,"X-RAY DIFFRACTION",2.09,41.08,"VAPOR DIFFUSION, HANGING DROP",7.8,"100 mM tris-Cl, 1.15 M sodium citrate, pH 7.8, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/bi062066y",,"2ILI",29.22,"1.05","1.05","Refine atomic structure of human carbonic anhydrase II","SHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","2ILI"
"2ILK",,"X-RAY DIFFRACTION",2.64,53.32,,6.5,"pH 6.5",,"10.1002/pro.5560051001",,"2ILK",18.96,"1.6","1.6","CRYSTAL STRUCTURE OF HUMAN INTERLEUKIN-10 AT 1.6 ANGSTROMS RESOLUTION","SPGQGTQSENSCTHFPGNLPNMLRDLRDAFSRVKTFFQMKDQLDNLLLKESLLEDFKGYLGCQALSEMIQFYLEEVMPQAENQDPDIKAHVNSLGENLKTLRLRLRRCHRFLPCENKSKAVEQVKNAFNKLQEKGIYKAMSEFDIFINYIEAYMTMKIRN","Homo sapiens","IL10","INTERLEUKIN-10","1","2ILK"
"2ILL",,"X-RAY DIFFRACTION",3.69,66.67,,,,,"10.1107/S0907444906055624",,"2ILL",21.71,"2.2","2.2","Anomalous substructure of Titin-A168169","MAPHFKEELRNLNVRYQSNATLVCKVTGHPKPIVKWYRQGKEIIADGLKYRIQEFKGGYHQLIIASVTDDDATVYQVRATNQGGSVSGTASLEVEVPAKIHLPKTLEGMGAVHALRGEVVSIKIPFSGKPDPVITWQKGQDLIDNNGHYQVIVTRSFTSLVFPNGVERKDAGFYVVCAKNRFGIDQKTVELDVAD","Homo sapiens","TTN","Titin","1","2ILL"
"2ILM",,"X-RAY DIFFRACTION",3.08,63,"VAPOR DIFFUSION, HANGING DROP",7.5,"1.6M AMMONIUM SULPHATE, 6% PEG400, 0.1M HEPES PH7.5 ARGON ATMOSPHERE, 14MG/ML PROTEIN WITH 1MM FE(II)SO4, 1MM ALPHA-KETOGLUTARATE, 1MM HIF-1ALPHA PEPTIDE, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298.0K, pH 7.50",,"10.1074/jbc.M804999200",,"2ILM",45.52,"2.3","2.3","Factor Inhibiting HIF-1 Alpha D201A Mutant in Complex with FE(II), Alpha-Ketoglutarate and HIF-1 Alpha 35mer","MAATAAEAVASGSGEPREEAGALGPAWDESQLRSYSFPTRPIPRLSQSDPRAEELIENEEPVVLTDTNLVYPALKWDLEYLQENIGNGDFSVYSASTHKFLYYDEKKMANFQNFKPRSNREEMKFHEFVEKLQDIQQRGGEERLYLQQTLNDTVGRKIVMDFLGFNWNWINKQQGKRGWGQLTSNLLLIGMEGNVTPAHYAEQQNFFAQIKGYKRCILFPPDQFECLYPYPVHHPCDRQSQVDFDNPDYERFPNFQNVVGYETVVGPGDVLYIPMYWWHHIESLLNGGITITVNFWYKGAPTPKRIEYPLKAHQKVAIMRNIEKMLGEALGNPQEVGPLLNTMIKGRYN","Homo sapiens","HIF1AN, FIH1","Hypoxia-inducible factor 1 alpha inhibitor","1","2ILM"
,,,,,,,,,,,,,,,,"SMDESGLPQLTSYDCEVNAPIQGSRNLLQGEELLRALDQVN",,,"Hypoxia-inducible factor 1 alpha","2","2ILM"
"2ILR",,"X-RAY DIFFRACTION",2.13,42.8,"VAPOR DIFFUSION, HANGING DROP",8,"0.085M TrisCl, 0.170M Sodium Acetate, 25.5% PEG 4000, 15% glycerol, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1093/nar/gkm033",,"2ILR",28.99,"2","2","Crystal structure of human Fanconi Anemia protein E C-terminal domain","GLAESLELPKAIQDQLPRLQQLLKTLEEGLEGLEDAPPVELQLLHECSPSQMDLLCAQLQLPQLSDLGLLRLCTWLLALSPDLSLSNATVLTRSLFLGRILSLTSSASRLLTTALTSFAAKYTYPVCSALLDPVLQAPGTGPAQTELLCCLVKMESLEPDAQVLMLGQILELPWKEETFLVLQSLLERQVEMTPEKFSVLMEKLCKKGLAATTSMAYAKLMLTVMTKYQANITETQRLGLAMALEPNTTFLRKSLKAALKHLGP","Homo sapiens","FANCE, FACE","Fanconi anemia group E protein","1","2ILR"
"2ILT",,"X-RAY DIFFRACTION",2.6,52.75,"VAPOR DIFFUSION, HANGING DROP",,"VAPOR DIFFUSION, HANGING DROP",,"10.1016/j.bmcl.2006.10.008","NN1","2ILT",31.72,"2.3","2.3","Human 11-beta-Hydroxysteroid Dehydrogenase (HSD1) with NADP and Adamantane Sulfone Inhibitor","QHQHQHQHQHQQPNEEFRPEMLQGKKVIVTGASKGIGREMAYHLAKMGAHVVVTARSKETLQKVVSHCLELGAASAHYIAGTMEDMTFAEQFVAQAGKLMGGLDMLILNHITNTSLNLFHDDIHHVRKSMEVNFLSYVVLTVAALPMLKQSNGSIVVVSSLAGKVAYPMVAAYSASKFALDGFFSSIRKEYSVSRVNVSITLCVLGLIDTETAMKAVSGIVHMQAAPKEECALEIIKGGALRQEEVYYDSSLWTTLLIRNPSRKILEFLYSTSYN","Homo sapiens","HSD11B1, HSD11, HSD11L, SDR26C1","Corticosteroid 11-beta-dehydrogenase isozyme 1","1","2ILT"
"2IMG",,"X-RAY DIFFRACTION",2.05,40,"VAPOR DIFFUSION, SITTING DROP",7,"0.1M DL Malic acid, 20% PEG 3350, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1074/jbc.M708945200",,"2IMG",16.86,"1.93","1.93","Crystal structure of dual specificity protein phosphatase 23 from Homo sapiens in complex with ligand malate ion","SLGVQPPNFSWVLPGRLAGLALPRLPAHYQFLLDLGVRHLVSLTERGPPHSDSCPGLTLHRLRIPDFCPPAPDQIDRFVQIVDEANARGEAVGVHCALGFGRTGTMLACYLVKERGLAAGDAIAEIRRLRPGSIETYEQEKAVFQFYQRTK","Homo sapiens","DUSP23, LDP3, VHZ","Dual specificity protein phosphatase 23","1","2IMG"
"2IMS",,"X-RAY DIFFRACTION",2.11,41.57,"VAPOR DIFFUSION, HANGING DROP",4.6,"PEG 3350 15-30% and 1-50 mM zinc acetate, pH 4.6, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.molcel.2006.10.014",,"2IMS",19.43,"1.48","1.48","The X-ray Structure of a Bak Homodimer Reveals an Inhibitory Zinc Binding Site","EPALPSASEEQVAQDTEEVFRSYVFYRHQQEQEAEGVAAPADPEMVTLPLQPSSTMGQVGRQLAIIGDDINRRYDSEFQTMLQHLQPTAENAYEYFTKIATSLFESGINWGRVVALLGFGYRLALHVYQHGLTGFLGQVTRFVVDFMLHHCIARWIAQRGGWVAALNLGNG","Homo sapiens","BAK1, BAK, BCL2L7, CDN1","Apoptosis regulator BAK","1","2IMS"
"2IMT",,"X-RAY DIFFRACTION",2.11,41.67,"VAPOR DIFFUSION, HANGING DROP",4.6,"PEG 3350 15-30% and 0.2 M ammonium fluoride, pH 4.6, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.molcel.2006.10.014",,"2IMT",19.24,"1.49","1.49","The X-ray Structure of a Bak Homodimer Reveals an Inhibitory Zinc Binding Site","EPALPSASEEQVAQDTEEVFRSYVFYRHQQEQEAEGVAAPADPEMVTLPLQPSSTMGQVGRQLAIIGDDINRRYDSEFQTMLQHLQPTAENAYEYFTKIATSLFESGINWGRVVALLGFGYRLALHVYQHGLTGFLGQVTRFVVDFMLHHCIARWIAQRGGWVAALNLGNG","Homo sapiens","BAK1, BAK, BCL2L7, CDN1","Apoptosis regulator BAK","1","2IMT"
"2IN6",,"X-RAY DIFFRACTION",2.93,58.03,"VAPOR DIFFUSION, HANGING DROP",7.5,"HEPES, sodium chloride, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.ejmech.2007.07.016","839","2IN6",32.77,"1.9","1.9","Wee1 kinase complex with inhibitor PD311839","AEMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASRK","Homo sapiens","WEE1","Wee1-like protein kinase","1","2IN6"
"2INE",,"X-RAY DIFFRACTION",2.15,42.67,"VAPOR DIFFUSION, HANGING DROP",5,"20 % PEG 6000, 50 mM Citrate, subsequent glutaraldehyde x-link, ligand soak, pH 5.00, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.bioorg.2006.09.004","PAC","2INE",36.65,"1.9","1.9","Crystal Structure of Aldose Reductase complexed with Phenylacetic Acid","ASRLLLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGKEFFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAKHNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVCALLSCTSHKDYPFHEEF","Homo sapiens","AKR1B1, ALDR1, ALR2","Aldose reductase","1","2INE"
"2ING",,"X-RAY DIFFRACTION",4.67,73.69,"VAPOR DIFFUSION, SITTING DROP",6.7,"1.4M Ammonium sulfate, 20mM Cobalt chloride, 100mM 2-(N-Morpholino) ethanesulfonic acid, pH 6.7, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1038/ejhg.2008.13",,"2ING",24.59,"3.6","3.6","X-ray Structure of the BRCA1 BRCT mutant M1775K","GPRMSMVVSGLTPEEFMLVYKFARKHHITLTNLITEETTHVVMKTDAEFVCERTLKYFLGIAGGKWVVSYFWVTQSIKERKMLNEHDFEVRGDVVNGRNHQGPKRARESQDRKIFRGLEICCYGPFTNKPTDQLEWMVQLCGASVVKELSSFTLGTGVHPIVVVQPDAWTEDNGFHAIGQMCEAPVVTREWVLDSVALYQCQELDTYLIPQIP","Homo sapiens","BRCA1, RNF53","Breast cancer type 1 susceptibility protein","1","2ING"
"2INT",,"X-RAY DIFFRACTION",3.25,62.11,,,,,"10.2210/pdb2int/pdb",,"2INT",14.99,"2.35","2.35","CRYSTAL STRUCTURE OF RECOMBINANT HUMAN INTERLEUKIN-4","HKCDITLQEIIKTLNSLTEQKTLCTELTVTDIFAASKNTTEKETFCRAATVLRQFYSHHEKDTRCLGATAQQFHRHKQLIRFLKRLDRNLWGLAGLNSCPVKEANQSTLENFLERLKTIMREKYSKCSS","Homo sapiens","IL4","INTERLEUKIN-4","1","2INT"
"2INZ",,"X-RAY DIFFRACTION",2.15,42.9,,5,"20 % PEG 6000, 50 mM Citrate,  
subsequent glutaraldehyde x-link, ligand soak, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K, pH 5.00",277,"10.1016/j.bioorg.2006.09.004","OHP","2INZ",36.66,"1.95","1.95","Crystal Structure of Aldose Reductase complexed with 2-Hydroxyphenylacetic Acid","ASRLLLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGKEFFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAKHNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVCALLSCTSHKDYPFHEEF","Homo sapiens","AKR1B1, ALDR1, ALR2","Aldose reductase","1","2INZ"
"2IO6",,"X-RAY DIFFRACTION",2.98,58.73,"VAPOR DIFFUSION, HANGING DROP",7.5,"HEPES, sodium chloride, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.ejmech.2007.07.016","330","2IO6",32.79,"2.2","2.2","Wee1 kinase complexed with inhibitor PD330961","AEMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASRK","Homo sapiens","WEE1","Wee1-like protein kinase","1","2IO6"
"2IOG",,"X-RAY DIFFRACTION",2.41,48.93,,7.1,"2-10% PEG 3350, 0.02-0.20M MGCL2, IMIDAZOLE, VAPOR DIFFUSION, HANGING DROP, PH 7.10, temperature 297K",297,"10.1016/j.bmcl.2007.01.054","IOG","2IOG",28.66,"1.6","1.6","Human estrogen receptor alpha ligand-binding domain in complex with compound 11F","SLTADQMVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLECAWLEILMIGLVWRSMEHPGKLLFAPNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGMEHLYSMKCKNVVPLYDLLLEMLDAHRLHAPTS","Homo sapiens","ESR1, ESR, NR3A1","Estrogen receptor","1","2IOG"
"2IOK",,"X-RAY DIFFRACTION",2.41,48.88,,,,,"10.1016/j.bmcl.2007.01.054","IOK","2IOK",58.75,"2.4","2.4","Human estrogen receptor alpha ligand-binding domain in complex with compound 1D","SKKNSLALSLTADQMVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLECAWLEILMIGLVWRSMEHPGKLLFAPNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGMEHLYSMKCKNVVPLYDLLLEMLDAHRLHAPTS","Homo sapiens","ESR1, ESR, NR3A1","Estrogen receptor","1","2IOK"
"2IPJ",,"X-RAY DIFFRACTION",2.82,56.38,"hanging drop",5.6,"PEG-4000 22%, 0.1M NaCitrate, pH 5.6, hanging drop, temperature 277K",277,"10.1016/j.jmb.2007.03.058",,"2IPJ",75.92,"1.8","1.8","Crystal structure of h3alpha-hydroxysteroid dehydrogenase type 3 mutant Y24A in complex with NADP+ and epi-testosterone","SKYQCVKLNDGHFMPVLGFGTAAPAEVPKSKALEAVKLAIEAGFHHIDSAHVYNNEEQVGLAIRSKIADGSVKREDIFYTSKLWSNSHRPELVRPALERSLKNLQLDYVDLYLIHFPVSVKPGEEVIPKDENGKILFDTVDLCATWEAMEKCKDAGLAKSIGVSNFNHRLLEMILNKPGLKYKPVCNQVECHPYFNQRKLLDFCKSKDIVLVAYSALGSHREEPWVDPNSPVLLEDPVLCALAKKHKRTPALIALRYQLQRGVVVLAKSYNEQRIRQNVQVFEFQLTSEEMKAIDGLNRNVRYLTLDIFAGPPNYPFSDEY","Homo sapiens","AKR1C2, DDH2","Aldo-keto reductase family 1 member C2","1","2IPJ"
"2IPP",,"X-RAY DIFFRACTION",2.28,45.96,"VAPOR DIFFUSION, HANGING DROP",4,"pH 4.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"2IPP",27.76,"2.15","2.15","Crystal Structure of the tetragonal form of human liver cathepsin B","LPASFDAREQWPQCPTIKEIRDQGSCGSCWAFGAVEAISDRICIHTN","Homo sapiens","CTSB, CPSB","Cathepsin B","1","2IPP"
,,,,,,,,,,,,,,,,"VSVEVSAEDLLTCCGSMCGDGCNGGYPAEAWNFWTRKGLVSGGLYESHVGCRPYSIPPCEHHVNGSRPPCTGEGDTPKCSKICEPGYSPTYKQDKHYGYNSYSVSNSEKDIMAEIYKNGPVEGAFSVYSDFLLYKSGVYQHVTGEMMGGHAIRILGWGVENGTPYWLVANSWNTDWGDNGFFKILRGQDHCGIESEVVAGIPRTD","Homo sapiens","CTSB, CPSB","Cathepsin B","2","2IPP"
"2IPW",,"X-RAY DIFFRACTION",2.14,42.6,"VAPOR DIFFUSION, HANGING DROP",5,"20 % PEG 6000, 50 mM Citrate, subsequent glutaraldehyde x-link, ligand soak, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.bioorg.2006.09.004","2CL","2IPW",36.66,"2","2","Crystal Structure of C298A W219Y Aldose Reductase complexed with Dichlorophenylacetic acid","ASRLLLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGKEFFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPYAKPEDPSLLEDPRIKAIAAKHNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVAALLSCTSHKDYPFHEEF","Homo sapiens","AKR1B1, ALDR1, ALR2","Aldose reductase","1","2IPW"
"2IPX",,"X-RAY DIFFRACTION",2.13,42.24,"VAPOR DIFFUSION, HANGING DROP",7,"20% PEG3350, 0.2 M CaCl2, pH 7, VAPOR DIFFUSION, HANGING DROP, temperature 300K",300,,,"2IPX",26.36,"1.82","1.82","Human Fibrillarin","GKNVMVEPHRHEGVFICRGKEDALVTKNLVPGESVYGEKRVSISEGDDKIEYRAWNPFRSKLAAAILGGVDQIHIKPGAKVLYLGAASGTTVSHVSDIVGPDGLVYAVEFSHRSGRDLINLAKKRTNIIPVIEDARHPHKYRMLIAMVDVIFADVAQPDQTRIVALNAHTFLRNGGHFVISIKANCIDSTASAEAVFASEVKKMQQENMKPQEQLTLEPYERDHAVVVGVYRP","Homo sapiens","FBL, FIB1, FLRN","rRNA 2'-O-methyltransferase fibrillarin","1","2IPX"
"2IQ0",,"X-RAY DIFFRACTION",2.15,42.8,"VAPOR DIFFUSION, HANGING DROP",5,"20 % PEG 6000, 50 mM Citrate, subsequent glutaraldehyde x-linking, ligand soaking, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.bioorg.2006.09.004","6NA","2IQ0",36.63,"1.95","1.95","Crystal Structure of Aldose Reductase complexed with Hexanoic Acid","ASRLLLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGKEFFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAKHNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVCALLSCTSHKDYPFHEEF","Homo sapiens","AKR1B1, ALDR1, ALR2","Aldose reductase","1","2IQ0"
"2IQ1",,"X-RAY DIFFRACTION",2.64,53.46,"VAPOR DIFFUSION",8,"100mM Hepes pH 8, 18% PEG 10K, VAPOR DIFFUSION, temperature 294K",294,"10.1007/s10969-007-9036-1",,"2IQ1",30.22,"2.25","2.25","Crystal structure of human PPM1K","MSLKISLENVGCASQIGKRKENEDRFDFAQLTDEVLYFAVYDGHGGPAAADFCHTHMEKCIMDLLPKEKNLETLLTLAFLEIDKAFSSHARLSADATLLTSGTTATVALLRDGIELVVASVGDSRAILCRKGKPMKLTIDHTPERKDEKERIKKCGGFVAWNSLGQPHVNGRLAMTRSIGDLDLKTSGVIAEPETKRIKLHHADDSFLVLTTDGINFMVNSQEICDFVNQCHDPNEAAHAVTEQAIQYGTEDNSTAVVVPFGAWGKEGHHHHHH","Homo sapiens","DKFZp761G058, PPM1K, PP2CM","Protein phosphatase 2C kappa, PPM1K","1","2IQ1"
"2IQC",,"X-RAY DIFFRACTION",2.75,55.31,"VAPOR DIFFUSION, HANGING DROP",7,"100 mM Bis/Tris, 200 mM Lithium sulfate, 20-25% PEG 3350, 10% Ethylene glycol, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 294K",294,"10.1074/jbc.M608356200",,"2IQC",23.55,"2.4","2.4","Crystal structure of Human FancF Protein that Functions in the Assembly of a DNA Damage Signaling Complex","GPMADIGSNLQEDSLMKTQAELLLERLQEVGKAEAERPARFLSSLWERLPQNNFLKVIAVALLQPPLSRRPQEELEPGIHKSPGEGSQVLVHWLLGNSEVFAAFCRALPAGLLTLVTSRHPALSPVYLGLLTDWGQRLHYDLQKGIWVGTESQDVPWEELHNRFQSLCQAPPPLKDKVLTALETCKAQDGDFEVPGLSIWTDLLLALRSG","Homo sapiens","FANCF","Fanconi anemia group F protein","1","2IQC"
"2IQD",,"X-RAY DIFFRACTION",2.15,42.89,"VAPOR DIFFUSION, HANGING DROP",5,"20 % PEG 6000, 50 mM Citrate, subsequent glutaraldehyde x-linking, ligand soaking, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.bioorg.2006.09.004","LPA","2IQD",36.72,"2","2","Crystal Structure of Aldose Reductase complexed with Lipoic Acid","ASRLLLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGKEFFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAKHNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVCALLSCTSHKDYPFHEEF","Homo sapiens","AKR1B1, ALDR1, ALR2","Aldose reductase","1","2IQD"
"2IQG",,"X-RAY DIFFRACTION",2.13,42.12,"VAPOR DIFFUSION, HANGING DROP",,"14-26 % PEG 750MME, SODIUM ACETATE, pH 4.6-5.2, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm061242y","F2I","2IQG",46.12,"1.7","1.7","Crystal Structure of Hydroxyethyl Secondary Amine-based Peptidomimetic Inhibitor of Human Beta-Secretase (BACE)","MRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDESRSHHHHHH","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","2IQG"
"2IQJ",,"X-RAY DIFFRACTION",2.1,40.7,"VAPOR DIFFUSION, SITTING DROP",6.5,"25% PEG-3350, 0.2M Ammonium acetate, 0.1M Bis-Tris, pH 6.5, vapor diffusion, sitting drop, temperature 291K",291,,,"2IQJ",31.19,"1.9","1.9","Crystal structure of the GAP domain of SMAP1L (LOC64744) stromal membrane-associated protein 1-like","GSMTGKSVKDVDRYQAVLANLLLEEDNKFCADCQSKGPRWASWNIGVFICIRCAGIHRNLGVHISRVKSVNLDQWTQEQIQCMQEMGNGKANRLYEAYLPETFRRPQIDPAVEGFIRDKYEKKKYMDRSLDINA","Homo sapiens","SMAP1L, SMAP2","Stromal membrane-associated protein 1-like","1","2IQJ"
"2IRT",,"X-RAY DIFFRACTION",2.19,43.76,,,,,"10.1107/S0907444993009394",,"2IRT",34.29,"3.2","3.2","INITIAL CRYSTALLOGRAPHIC ANALYSES OF A RECOMBINANT INTERLEUKIN-1 RECEPTOR ANTAGONIST PROTEIN","RPSGRKSSKMQAFRIWDVNQKTFYLRNNQLVAGYLQGPNVNLEEKIDVVPIEPHALFLGIHGGKMCLSCVKSGDETRLQLEAVNITDLSENRKQDKRFAFIRSDSGPTTSFESAACPGWFLCTAMEADQPVSLTNMPDEGVMVTKFYFQEDE","Homo sapiens","IL1RN, IL1F3, IL1RA","INTERLEUKIN-1 RECEPTOR ANTAGONIST","1","2IRT"
"2IRW",,"X-RAY DIFFRACTION",3.93,68.74,"VAPOR DIFFUSION",,"VAPOR DIFFUSION",,"10.1016/j.bmcl.2006.10.074",,"2IRW",241.37,"3.1","3.1","Human 11-beta-Hydroxysteroid Dehydrogenase (HSD1) with NADP and Adamantane Ether Inhibitor","EFRPEMLQGKKVIVTGASKGIGREMAYHLAKMGAHVVVTARSKETLQKVVSHCLELGAASAHYIAGTMEDMTFAEQFVAQAGKLMGGLDMLILNHITNTSLNLFHDDIHHVRKSMEVNFLSYVVLTVAALPMLKQSNGSIVVVSSLAGKVAYPMVAAYSASKFALDGFFSSIRKEYSVSRVNVSITLCVLGLIDTETAMKAVSGIVHMQAAPKEECALEIIKGGALRQEEVYYDSSLWTTLLIRNPSRKILEFLYSTSYNMDRF","Homo sapiens","HSD11B1, HSD11, HSD11L, SDR26C1","Corticosteroid 11-beta-dehydrogenase isozyme 1","1","2IRW"
"2IRZ",,"X-RAY DIFFRACTION",2.83,56.49,"VAPOR DIFFUSION, SITTING DROP",7.5,"1.5M Lithium sulfate, 0.1M HEPES buffer, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1021/jm061046r","I02","2IRZ",45.67,"1.8","1.8","Crystal structure of human Beta-secretase complexed with inhibitor","MLPRETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGAWAGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYN","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","2IRZ"
"2IS0",,"X-RAY DIFFRACTION",2.83,56.49,,7.5,"1.5M Lithium sulfate, 0.1M HEPES buffer, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K, pH 7.50",298,"10.1021/jm061046r","I03","2IS0",45.68,"2.2","2.2","Crystal structure of human Beta-secretase complexed with inhibitor","MLPRETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGAWAGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYN","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","2IS0"
"2IS7",,"X-RAY DIFFRACTION",2.16,43.05,"VAPOR DIFFUSION, HANGING DROP",5,"20 % PEG 6000, 50 mM Citrate, subsequent glutaraldehyde x-link, ligand soak, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.bioorg.2006.09.004","2CL","2IS7",36.72,"1.7","1.7","Crystal Structure of Aldose Reductase complexed with Dichlorophenylacetic acid","ASRLLLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGKEFFPLDESNGVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAKHDKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVCALLSCTSHKDYPFHEEF","Homo sapiens","AKR1B1, ALDR1, ALR2","Aldose reductase","1","2IS7"
"2ISF",,"X-RAY DIFFRACTION",2.16,42.98,"VAPOR DIFFUSION, HANGING DROP",5,"20 % PEG 6000, 50 mM Citrate, subsequent glutaraldehyde x-link, ligand soak, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.bioorg.2006.09.004","PAC","2ISF",36.59,"2","2","Crystal Structure of C298A W219Y Aldose Reductase complexed with Phenylacetic Acid","ASRLLLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGKEFFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPYAKPEDPSLLEDPRIKAIAAKHNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVAALLSCTSHKDYPFHEEF","Homo sapiens","AKR1B1, ALDR1, ALR2","Aldose reductase","1","2ISF"
"2ISI",,"X-RAY DIFFRACTION",2.91,57.78,"VAPOR DIFFUSION",7.5,"0.1M hepes, 70% MPD, pH 7.5, VAPOR DIFFUSION, temperature 277K",277,,,"2ISI",106.69,"2.76","2.76","Crystal structure of Ape1 from Homo sapiens in a new crystal form complexed with a ligand","PKRGKKGAVAEDGDELRTEPEAKKSKTAAKKNDKEAAGEGPALYEDPPDQKTSPSGKPATLKICSWNVDGLRAWIKKKGLDWVKEEAPDILCLQETKCSENKLPAELQELPGLSHQYWSAPSDKEGYSGVGLLSRQCPLKVSYGIGDEEHDQEGRVIVAEFDSFVLVTAYVPNAGRGLVRLEYRQRWDEAFRKFLKGLASRKPLVLCGDLNVAHEEIDLRNPKGNKKNAGFTPQERQGFGELLQAVPLADSFRHLYPNTPYAYTFWTYMMNARSKNVGWRLDYFLLSHSLLPALCDSKIRSKALGSDHCPITLYLAL","Homo sapiens","APEX1, APE, APE1, APEX, APX, HAP1, REF1","DNA-(apurinic or apyrimidinic site) lyase","1","2ISI"
"2ISO",,"X-RAY DIFFRACTION",2.24,45,"VAPOR DIFFUSION, SITTING DROP",7.5,"50 mM Imidazole, pH 7.5, 350 mM Sodium Acetate, 16% PEG3350, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1021/bi061517b","GFF","2ISO",48.43,"2.1","2.1","Ternary complex of DNA Polymerase beta with a dideoxy terminated primer and 2'-deoxyguanosine 5'-beta, gamma-difluoromethylene triphosphate","CCGACCGCGCATCAGC",,,"5'-D(*CP*CP*GP*AP*CP*CP*GP*CP*GP*CP*AP*TP*CP*AP*GP*C)-3'","1","2ISO"
,,,,,,,,,,,,,,,,"GCTGATGCGC",,,"5'-D(*GP*CP*TP*GP*AP*TP*GP*CP*GP*(DOC))-3'","2","2ISO"
,,,,,,,,,,,,,,,,"GTCGG",,,"5'-D(P*GP*TP*CP*GP*G)-3'","3","2ISO"
,,,,,,,,,,,,,,,,"MSKRKAPQETLNGGITDMLTELANFEKNVSQAIHKYNAYRKAASVIAKYPHKIKSGAEAKKLPGVGTKIAEKIDEFLATGKLRKLEKIRQDDTSSSINFLTRVSGIGPSAARKFVDEGIKTLEDLRKNEDKLNHHQRIGLKYFGDFEKRIPREEMLQMQDIVLNEVKKVDSEYIATVCGSFRRGAESSGDMDVLLTHPSFTSESTKQPKLLHQVVEQLQKVHFITDTLSKGETKFMGVCQLPSKNDEKEYPHRRIDIRLIPKDQYYCGVLYFTGSDIFNKNMRAHALEKGFTINEYTIRPLGVTGVAGEPLPVDSEKDIFDYIQWKYREPKDRSE","Homo sapiens","POLB","Polymerase (DNA directed), beta","4","2ISO"
"2ISP",,"X-RAY DIFFRACTION",2.24,45.06,"VAPOR DIFFUSION, SITTING DROP",7.5,"50 mM Imidazole, pH 7.5, 350 mM Sodium Acetate, 16% PEG3350, pH 7.50, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1021/bi061517b","GGH","2ISP",48.43,"2.2","2.2","Ternary complex of DNA Polymerase beta with a dideoxy terminated primer and 2'-deoxyguanosine 5'-beta, gamma-methylene triphosphate","CCGACCGCGCATCAGC",,,"5'-D(*CP*CP*GP*AP*CP*CP*GP*CP*GP*CP*AP*TP*CP*AP*GP*C)-3'","1","2ISP"
,,,,,,,,,,,,,,,,"GCTGATGCGC",,,"5'-D(*GP*CP*TP*GP*AP*TP*GP*CP*GP*(DOC))-3'","2","2ISP"
,,,,,,,,,,,,,,,,"GTCGG",,,"5'-D(P*GP*TP*CP*GP*G)-3'","3","2ISP"
,,,,,,,,,,,,,,,,"MSKRKAPQETLNGGITDMLTELANFEKNVSQAIHKYNAYRKAASVIAKYPHKIKSGAEAKKLPGVGTKIAEKIDEFLATGKLRKLEKIRQDDTSSSINFLTRVSGIGPSAARKFVDEGIKTLEDLRKNEDKLNHHQRIGLKYFGDFEKRIPREEMLQMQDIVLNEVKKVDSEYIATVCGSFRRGAESSGDMDVLLTHPSFTSESTKQPKLLHQVVEQLQKVHFITDTLSKGETKFMGVCQLPSKNDEKEYPHRRIDIRLIPKDQYYCGVLYFTGSDIFNKNMRAHALEKGFTINEYTIRPLGVTGVAGEPLPVDSEKDIFDYIQWKYREPKDRSE","Homo sapiens","POLB","Polymerase (DNA directed), beta","4","2ISP"
"2IT4",,"X-RAY DIFFRACTION",2.3,46.62,"VAPOR DIFFUSION, HANGING DROP",9,"100mM Tris.HCl buffer pH 9.0, 25% (w/v) PEG 4000, LiCl4 0.4 M, 10% ethylene glycol , VAPOR DIFFUSION, HANGING DROP,
temperature 22K",295,"10.1016/j.bmcl.2007.01.113","PPF","2IT4",57.07,"2","2","X ray structure of the complex between Carbonic Anhydrase I and the phosphonate antiviral drug foscarnet","WGYDDKNGPEQWSKLYPIANGNNQSPVDIKTSETKHDTSLKPISVSYNPATAKEIINVGHSFHVNFEDNDNRSVLKGGPFSDSYRLFQFHFHWGSTNEHGSEHTVDGVKYSAELHVAHWNSAKYSSLAEAASKADGLAVIGVLMKVGEANPKLQKVLDALQAIKTKGKRAPFTNFDPSTLLPSSLDFWTYPGSLTHPPLYESVTWIICKESISVSSEQLAQFRSLLSNVEGDNAVPMQHNNRPTQPLKGRTVRASF","Homo sapiens","CA1","Carbonic anhydrase 1","1","2IT4"
"2IT5",,"X-RAY DIFFRACTION",2.58,52.4,"VAPOR DIFFUSION, HANGING DROP",7,"protein solution contained 5 mg ml-1 protein, 5 mM CaCl2, 50 mM Man6, reservoir solution contained 30% (w/v) polyethylene glycol 3000, 0.2 M NaCl, 0.1 M Tris, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 294K",294,"10.1074/jbc.M609689200",,"2IT5",16.76,"2.4","2.4","Crystal Structure of DCSIGN-CRD with man6","ERLCHPCPWEWTFFQGNCYFMSNSQRNWHDSITACKEVGAQLVVIKSAEEQNFLQLQSSRSNRFTWMGLSDLNQEGTWQWVDGSPLLPSFKQYWNRGEPNNVGEEDCAEFSGNGWNDDKCNLAKFWICKKSAASCSRDE","Homo sapiens","CD209, CLEC4L","CD209 antigen, DCSIGN-CRD","1","2IT5"
"2IT6",,"X-RAY DIFFRACTION",2.32,46.95,"VAPOR DIFFUSION, HANGING DROP",7,"Protein solution contained 10 mg ml-1 protein, 5 mM CaCl2, 25 mM Man2, reservoir solution  
contained 30% (w/v) polyethylene glycol 3000, 0.2 M NaCl, 0.1 M Tris, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 294K",294,"10.1074/jbc.M609689200",,"2IT6",18.21,"1.95","1.95","Crystal Structure of DCSIGN-CRD with man2","ERLCHPCPWEWTFFQGNCYFMSNSQRNWHDSITACKEVGAQLVVIKSAEEQNFLQLQSSRSNRFTWMGLSDLNQEGTWQWVDGSPLLPSFKQYWNRGEPNNVGEEDCAEFSGNGWNDDKCNLAKFWICKKSAASCSRDEEQFLSPAPATPNPPPA","Homo sapiens","CD209, CLEC4L","CD209 antigen","1","2IT6"
"2ITK",,"X-RAY DIFFRACTION",2.82,56.37,"VAPOR DIFFUSION, HANGING DROP",7.5,"2M Ammonium Sulfate, 1% PEG400, 100mM HEPES, pH 7.5, VAPOR DIFFUSION, HANGING DROP",,"10.1021/cb7000044",,"2ITK",19.69,"1.45","1.45","human Pin1 bound to D-PEPTIDE","GSHGMADEEKLPPGWEKAMSRSSGRVYYFNHITNASQWERPSGNSSSGGKNGQGEPARVRCSHLLVKHSQSRRPSSWRQEKITRTKEEALELINGYIQKIKSGEEDFESLASQFSDCSSAKARGDLGAFSRGQMQKPFEDASFALRTGEMSGPVFTDSGIHIILRTE","Homo sapiens","PIN1","Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1","1","2ITK"
,,,,,,,,,,,,,,,,"XFTXAQX",,,"D-Peptide","2","2ITK"
"2ITN",,"X-RAY DIFFRACTION",3.4,64,,7.5,"1.2M KNA TARTRATE, 0.1M HEPES 7.5",,"10.1016/j.ccr.2006.12.017",,"2ITN",37.86,"2.47","2.47","Crystal structure of EGFR kinase domain G719S mutation in complex with AMP-PNP","GEAPNQALLRILKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","EPIDERMAL GROWTH FACTOR RECEPTOR","1","2ITN"
"2ITO",,"X-RAY DIFFRACTION",3.4,64,,7.5,"1.2M KNA TARTRATE, 0.1M HEPES 7.5",,"10.1016/j.ccr.2006.12.017","IRE","2ITO",37.78,"3.25","3.25","Crystal structure of EGFR kinase domain G719S mutation in complex with Iressa","GEAPNQALLRILKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","EPIDERMAL GROWTH FACTOR RECEPTOR","1","2ITO"
"2ITP",,"X-RAY DIFFRACTION",3.4,64,,7.5,"1.2M KNA TARTRATE, 0.1M HEPES 7.5",,"10.1016/j.ccr.2006.12.017","AEE","2ITP",37.77,"2.74","2.74","Crystal structure of EGFR kinase domain G719S mutation in complex with AEE788","GEAPNQALLRILKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","EPIDERMAL GROWTH FACTOR RECEPTOR PRECURSOR","1","2ITP"
"2ITQ",,"X-RAY DIFFRACTION",3.4,64,,7.5,"1.2M KNA TARTRATE, 0.1M HEPES 7.5",,"10.1016/j.ccr.2006.12.017",,"2ITQ",37.8,"2.68","2.68","Crystal structure of EGFR kinase domain G719S mutation in complex with AFN941","GEAPNQALLRILKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","EPIDERMAL GROWTH FACTOR RECEPTOR","1","2ITQ"
"2ITT",,"X-RAY DIFFRACTION",3.4,64,,7.5,"40% PEG400, 0.15M NACL, 0.1M HEPES 8.0, pH 7.5",,"10.1016/j.ccr.2006.12.017","AEE","2ITT",37.79,"2.73","2.73","Crystal structure of EGFR kinase domain L858R mutation in complex with AEE788","GEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","EPIDERMAL GROWTH FACTOR RECEPTOR","1","2ITT"
"2ITU",,"X-RAY DIFFRACTION",3.4,64,,7.5,"40% PEG400, 0.15M NACL, 0.1M HEPES 8.0, pH 7.50",,"10.1016/j.ccr.2006.12.017",,"2ITU",37.82,"2.8","2.8","Crystal structure of EGFR kinase domain L858R mutation in complex with AFN941","GEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","EPIDERMAL GROWTH FACTOR RECEPTOR","1","2ITU"
"2ITV",,"X-RAY DIFFRACTION",3.4,64,,7.5,"40% PEG400, 0.15M NACL, 0.1M HEPES 7.5, pH 7.50",,"10.1016/j.ccr.2006.12.017",,"2ITV",37.85,"2.47","2.47","Crystal structure of EGFR kinase domain L858R mutation in complex with AMP-PNP","GEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","EPIDERMAL GROWTH FACTOR RECEPTOR","1","2ITV"
"2ITW",,"X-RAY DIFFRACTION",3.4,64,,7.5,"1.2M KNA TARTRATE, 0.1M HEPES 7.5, pH 7.50",,"10.1016/j.ccr.2006.12.017",,"2ITW",37.77,"2.88","2.88","Crystal structure of EGFR kinase domain in complex with AFN941","GEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","EPIDERMAL GROWTH FACTOR RECEPTOR","1","2ITW"
"2ITX",,"X-RAY DIFFRACTION",3.4,64,,7.5,"1.2M KNA TARTRATE, 0.1M HEPES 7.5, pH 7.50",,"10.1016/j.ccr.2006.12.017",,"2ITX",37.81,"2.98","2.98","Crystal structure of EGFR kinase domain in complex with AMP-PNP","GEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","EPIDERMAL GROWTH FACTOR RECEPTOR","1","2ITX"
"2ITY",,"X-RAY DIFFRACTION",3.4,64,,7.5,"1.2M KNA TARTRATE, 0.1M HEPES 7.5, pH 7.50",,"10.1016/j.ccr.2006.12.017","IRE","2ITY",37.75,"3.42","3.42","Crystal structure of EGFR kinase domain in complex with Iressa","GEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","EPIDERMAL GROWTH FACTOR RECEPTOR","1","2ITY"
"2ITZ",,"X-RAY DIFFRACTION",3.4,64,,7.5,"40% PEG400, 0.15M NACL, 0.1M HEPES PH7.5, pH 7.50",,"10.1016/j.ccr.2006.12.017","IRE","2ITZ",37.83,"2.8","2.8","Crystal structure of EGFR kinase domain L858R mutation in complex with Iressa","GEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","EPIDERMAL GROWTH FACTOR RECEPTOR","1","2ITZ"
"2IU1",,"X-RAY DIFFRACTION",1.89,34.81,,8.5,"0.2 M MGCL2, 0.1 M TRIS PH 8.5, 25% PEG 3350, 20 DEG C",293,"10.1016/j.jmb.2006.05.021",,"2IU1",24.44,"1.8","1.8","Crystal structure of eIF5 C-terminal domain","LERTIEERVNILFDFVKKKKEEGVIDSSDKEIVAEAERLDVKAMGPLVLTEVLFNEKIREQIKKYRRHFLRFCHNNKKAQRYLLHGLECVVAMHQAQLISKIPHILKEMYDADLLEEEVIISWSEKASKKYVSKELAKEIRVKAEPFIKWLKEAEEESSGGEEEDEDENIEVVYSKLESVPKVETVKSDNKDDDIDIDAILEHHHHHH","Homo sapiens","EIF5","EUKARYOTIC TRANSLATION INITIATION FACTOR 5","1","2IU1"
"2IU2",,"X-RAY DIFFRACTION",2.83,56.5,"VAPOR DIFFUSION, HANGING DROP",8.5,"HANGING DROP. RESERVOIR : MPD 5.2%, CACL2 3.9 MM, TRIS 50 MM PH 8.5. DROP: 1UL PROTEIN (24 MG/ML) AND 1 UL RESERVOIR",,"10.1016/j.jmb.2006.10.010",,"2IU2",21.71,"1.8","1.8","Recombinant human H ferritin, K86Q, E27D and E107D mutant, soaked with Zn ions","MTTASTSQVRQNYHQDSEAAINRQINLDLYASYVYLSMSYYFDRDDVALKNFAKYFLHQSHEEREHAEKLMKLQNQRGGRIFLQDIQKPDCDDWESGLNAMECALHLDKNVNQSLLELHKLATDKNDPHLCDFIETHYLNEQVKAIKELGDHVTNLRKMGAPESGLAEYLFDKHTLGDSDNES","Homo sapiens","FTH1, FTH, FTHL6, OK/SW-cl.84, PIG15","FERRITIN HEAVY CHAIN","1","2IU2"
"2IUG",,"X-RAY DIFFRACTION",3.4,64,,,"20% PEG4000, 50MM MGCL2, 50MM TRIS PH7.5",,"10.1038/nsb0496-364",,"2IUG",13.94,"1.89","1.89","Crystal structure of the PI3-kinase p85 N-terminal SH2 domain","GMNNNMSLQNAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKED","Homo sapiens","PIK3R1, GRB1","PHOSPHATIDYLINOSITOL 3-KINASE REGULATORY ALPHA SUBUNIT","1","2IUG"
"2IUL",,"X-RAY DIFFRACTION",2.22,44.06,,4.7,"0.1M SODIUM ACETATE PH4.7 15%, PEG 4000, 10UM ZINC SULPHATE, pH 4.70",,"10.1021/bi061146z",,"2IUL",69.72,"2.01","2.01","Human tACE g13 mutant","LVTDEAEASKFVEEYDRTSQVVWNEYAEANWNYNTNITTETSKILLQKNMQIAQHTLKYGTQARKFDVNQLQNTTIKRIIKKVQDLERAALPAQELEEYNKILLDMETTYSVATVCHPQGSCLQLEPDLTNVMATSRKYEDLLWAWEGWRDKAGRAILQFYPKYVELINQAARLNGYVDAGDSWRSMYETPSLEQDLERLFQELQPLYLNLHAYVRRALHRHYGAQHINLEGPIPAHLLGNMWAQTWSNIYDLVVPFPSAPSMDTTEAMLKQGWTPRRMFKEADDFFTSLGLLPVPPEFWQKSMLEKPTDGREVVCHASAWDFYNGKDFRIKQCTTVNLEDLVVAHHEMGHIQYFMQYKDLPVALREGANPGFHEAIGDVLALSVSTPKHLHSLNLLSSEGGSDEHDINFLMKMALDKIAFIPFSYLVDQWRWRVFDGSITKENYNQEWWSLRLKYQGLCPPVPRTQGDFDPGAKFHIPSSVPYIRYFVSFIIQFQFHEALCQAAGHTGPLHKCDIYQSKEAGQRLATAMKLGFSRPWPEAMQLITGQPQMSASAMLSYFKPLLDWLRTENELHGEKLGWPQYNWTPNSAR","Homo sapiens","ACE, DCP, DCP1","ANGIOTENSIN-CONVERTING ENZYME","1","2IUL"
"2IUW",,"X-RAY DIFFRACTION",2.61,53,,5.5,"0.1 M BIS-TRIS PH 5.5, 0.1 M (NH4)2SO4, 4-9 % PEG 8000/10000",,"10.1038/sj.emboj.7601219",,"2IUW",28.38,"1.5","1.5","Crystal structure of human ABH3 in complex with iron ion and 2- oxoglutarate","MGSSHHHHHHSSGLVPRGSHMRVIDREGVYEISLSPTGVSRVCLYPGFVDVKEADWILEQLCQDVPWKQRTGIREDITYQQPRLTAWYGELPYTYSRITMEPNPHWHPVLRTLKNRIEENTGHTFNSLLCNLYRNEKDSVDWHSDDEPSLGRCPIIASLSFGATRTFEMRKKPPPEENGDYTYVERVKIPLDHGTLLIMEGATQADWQHRVPKEYHSREPRVNLTFRTVYPDPRGAPW","Homo sapiens","ALKBH3, ABH3, DEPC1","ALKYLATED REPAIR PROTEIN ALKB HOMOLOG 3","1","2IUW"
"2IUX",,"X-RAY DIFFRACTION",2.4,48.32,,4.7,"0.1M SODIUM ACETATE PH4.7 15% PEG 4000, 10UM ZINC SULPHATE, pH 4.70",,"10.1021/bi061146z",,"2IUX",69.1,"2.8","2.8","Human tACE mutant g1234","LVTDEAEASKFVEEYDRTSQVVWNEYAEANWNYNTNITTETSKILLQKNMQIANHTLKYGTQARKFDVNQLQNTTIKRIIKKVQDLERAALPAQELEEYNKILLDMETTYSVATVCHPNGSCLQLEPDLTNVMATSRKYEDLLWAWEGWRDKAGRAILQFYPKYVELINQAARLNGYVDAGDSWRSMYETPSLEQDLERLFQELQPLYLNLHAYVRRALHRHYGAQHINLEGPIPAHLLGNMWAQTWSNIYDLVVPFPSAPSMDTTEAMLKQGWTPRRMFKEADDFFTSLGLLPVPPEFWQKSMLEKPTDGREVVCHASAWDFYNGKDFRIKQCTTVNLEDLVVAHHEMGHIQYFMQYKDLPVALREGANPGFHEAIGDVLALSVSTPKHLHSLNLLSSEGGSDEHDINFLMKMALDKIAFIPFSYLVDQWRWRVFDGSITKENYNQEWWSLRLKYQGLCPPVPRTQGDFDPGAKFHIPSSVPYIRYFVSFIIQFQFHEALCQAAGHTGPLHKCDIYQSKEAGQRLATAMKLGFSRPWPEAMQLITGQPQMSASAMLSYFKPLLDWLRTENELHGEKLGWPQYNWTPNSAR","Homo sapiens","ACE, DCP, DCP1","ANGIOTENSIN-CONVERTING ENZYME","1","2IUX"
"2IV4",,"SOLUTION NMR",,,,,,,,,"2IV4",1.75,,,"hPrP180-195 structure","VNITIKQHTVTTTTKG","Homo sapiens","PRNP, ALTPRP, PRIP, PRP","MAJOR PRION PROTEIN","1","2IV4"
"2IV5",,"SOLUTION NMR",,,,,,,,,"2IV5",2.58,,,"hPrP-173-195 solution structure","NNFVHDCVNITIKQHTVTTTTKG","Homo sapiens","PRNP, ALTPRP, PRIP, PRP","MAJOR PRION PROTEIN","1","2IV5"
"2IV6",,"SOLUTION NMR",,,,,,,,,"2IV6",2.57,,,"hPrP-173-195-D178N solution structure","NNFVHNCVNITIKQHTVTTTTKG","Homo sapiens","PRNP, ALTPRP, PRIP, PRP","MAJOR PRION PROTEIN","1","2IV6"
"2IVS",,"X-RAY DIFFRACTION",2.22,47.7,"VAPOR DIFFUSION, SITTING DROP",,"PROTEIN 3 MG/ML IN 20 MM TRIS-HCL PH 8.0, 10MM NACL, 1MM DTT RESERVOIR 2.0 M SODIUM FORMATE, 0.1M SODIUM CITRATE PH 5.5 VAPOUR DIFFUSION, SITTING DROP,295 K",295,"10.1074/jbc.M605604200",,"2IVS",72.35,"2","2","Crystal structure of non-phosphorylated RET tyrosine kinase domain","GPLSLSVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVKRR","Homo sapiens","RET, CDHF12, CDHR16, PTC, RET51","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE RECEPTOR RET","1","2IVS"
"2IVT",,"X-RAY DIFFRACTION",2.76,57.7,"VAPOR DIFFUSION, SITTING DROP",,"PROTEIN 3 MG/ML IN 20 MM TRIS-HCL PH 8.0, 100MM NACL, 1MM DTT RESERVOIR 2.0 M SODIUM FORMATE, 0.1M SODIUM CITRATE PH 5.5,2.5MM ATP 5MM MAGNESIUM CHLORIDE VAPOUR DIFFUSION, SITTING DROP, 295 K",295,"10.1074/jbc.M605604200",,"2IVT",36.23,"2.6","2.6","Crystal structure of phosphorylated RET tyrosine kinase domain","GPLSLSVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVKRR","Homo sapiens","RET, CDHF12, CDHR16, PTC, RET51","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE RECEPTOR RET PRECURSOR","1","2IVT"
"2IVU",,"X-RAY DIFFRACTION",2.75,57.9,"VAPOR DIFFUSION, SITTING DROP",,"PROTEIN 3 MG/ML IN 20 MM TRIS-HCL PH 8.0, 100MM NACL, 1MM DTT, 1MM EDTA, 1MM SODIUM VANADATE RESERVOIR 2.2 M SODIUM FORMATE, 0.1M SODIUM ACETATE PH 4.5 VAPOUR DIFFUSION, SITTING DROP, 289 K",289,"10.1074/jbc.M605604200","ZD6","2IVU",36.36,"2.5","2.5","Crystal structure of phosphorylated RET tyrosine kinase domain complexed with the inhibitor ZD6474","GPLSLSVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVKRR","Homo sapiens","RET, CDHF12, CDHR16, PTC, RET51","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE RECEPTOR RET PRECURSOR","1","2IVU"
"2IVV",,"X-RAY DIFFRACTION",2.74,57.6,"VAPOR DIFFUSION, SITTING DROP",,"PROTEIN 1.5 MG/ML IN 20 MM TRIS-HCL PH 8.0, 100MM NACL, 1MM DTT, 1MM EDTA, 1MM SODIUM VANADATE RESERVOIR 2.8 M SODIUM FORMATE, 0.1 M SODIUM CITRATE PH 4.5, 0.2M LITHIUM CHLORIDE VAPOUR DIFFUSION, SITTING DROP, 289 K",289,"10.1074/jbc.M605604200","PP1","2IVV",36.12,"2.25","2.25","Crystal structure of phosphorylated RET tyrosine kinase domain complexed with the inhibitor PP1","GPLSLSVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMSLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVKRR","Homo sapiens","RET, CDHF12, CDHR16, PTC, RET51","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE RECEPTOR RET PRECURSOR","1","2IVV"
"2IVX",,"X-RAY DIFFRACTION",2.79,55,"VAPOR DIFFUSION, SITTING DROP",,"0.2M NA-FORMATE, 0.1M BIS-TRIS-PROPANE PH 8.5, 20%PEG3350, 10% ETHYLENE GLYCOL, 150 NL SITTING DROP",,"10.1038/emboj.2008.121",,"2IVX",60.02,"1.8","1.8","Crystal structure of human cyclin T2 at 1.8 A resolution","ASSRWFFTREQLENTPSRRCGVEADKELSCRQQAANLIQEMGQRLNVSQLTINTAIVYMHRFYMHHSFTKFNKNIISSTALFLAAKVEEQARKLEHVIKVAHACLHPLEPLLDTKCDAYLQQTRELVILETIMLQTLGFEITIEHPHTDVVKCTQLVRASKDLAQTSYFMATNSLHLTTFCLQYKPTVIACVCIHLACKWSNWEIPVSTDGKHWWEYVDPTVTLELLDELTHEFLQILEKTPNRLKKIRNWRANQAA","Homo sapiens","CCNT2","CYCLIN-T2","1","2IVX"
"2IW2",,"X-RAY DIFFRACTION",2.9,56.5,,8.5,"0.7M NA-CITRATE, 0.01M NA-BORATE PH 8.5",,,,"2IW2",109.44,"1.82","1.82","Crystal structure of human Prolidase","GSAAATGPSFWLGNETLKVPLALFALNRQRLCERLRKNPAVQAGSIVVLQGGEETQRYCTDTGVLFRQESFFHWAFGVTEPGCYGVIDVDTGKSTLFVPRLPASHATWMGKIHSKEHFKEKYAVDDVQYVDEIASVLTSQKPSVLLTLRGVNTDSGSVCREASFDGISKFEVNNTILHPEIVECRVFKTDMELEVLRYTNKISSEAHREVMKAVKVGMKEYELESLFEHYCYSRGGMRHSSYTCICGSGENSAVLHYGHAGAPNDRTIQNGDMCLFDMGGEYYCFASDITCSFPANGKFTADQKAVYEAVLRSSRAVMGAMKPGVWWPDMHRLADRIHLEELAHMGILSGSVDAMVQAHLGAVFMPHGLGHFLGIDVHDVGGYPEGVERIDEPGLRSLRTARHLQPGMVLTVEPGIYFIDHLLDEALADPARASFFNREVLQRFRGFGGVRIEEDVVVTDSGIELLTCVPRTVEEIEACMAGCDKAFTPFSGPK","Homo sapiens","PEPD, PRD","XAA-PRO DIPEPTIDASE","1","2IW2"
"2IWI",,"X-RAY DIFFRACTION",2.63,53.18,"VAPOR DIFFUSION, SITTING DROP",,"1.5 UL SITTING DROPS, 1.6 M SODIUM-POTASSIUM PHOSPHATE, 0.1 M HEPES PH 7.5",,"10.1371/journal.pone.0007112",,"2IWI",69.59,"2.8","2.8","CRYSTAL STRUCTURE OF THE HUMAN PIM2 IN COMPLEX WITH A RUTHENIUM ORGANOMETALLIC LIGAND RU1","SMLTKPLQGPPAPPGTPTPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVPLNPSKGGPAPLAWSLLP","Homo sapiens","PIM2","SERINE/THREONINE-PROTEIN KINASE PIM-2","1","2IWI"
"2IWL",,"X-RAY DIFFRACTION",2.05,40,,5.6,"1.7 M LI2SO4, 0.05 M MES PH 5.6",,"10.1074/jbc.M607079200",,"2IWL",16.75,"2.6","2.6","Structure of the PX Domain of Phosphoinositide 3-Kinase-C2alpha","DEPILSFSPKTYSFRQDGRIKEVSVFTYHKKYNPDKHYIYVVRILREGQIEPSFVFRTFDEFQELHNKLSIIFPLWKLPGFPNRMVLGRTHIKDVAAKRKIELNSYLQSLMNASTDVAECDLVCTFFHPLLRDEKAEGIA","Homo sapiens","PIK3C2A","PHOSPHATIDYLINOSITOL-4-PHOSPHATE 3-KINASE C2 DOMAIN-CONTAINING ALPHA POLYPEPTIDE","1","2IWL"
"2IWN",,"X-RAY DIFFRACTION",2.22,44.5,,4.5,"30% PEG 10K, 0.2M LI2SO4, 0.1M ACETATE PH4.5",,"10.1110/ps.062657507",,"2IWN",10.47,"1.35","1.35","3rd PDZ domain of Multiple PDZ Domain Protein MPDZ (CASP Target)","SMSETFDVELTKNVQGLGITIAGYIGDKKLEPSGIFVKSITKSSAVEHDGRIQIGDQIIAVDGTNLQGFTNQQAVEVLRHTGQTVLLTLMRRGETSV","Homo sapiens","MPDZ, MUPP1","MULTIPLE PDZ DOMAIN PROTEIN","1","2IWN"
"2IWO",,"X-RAY DIFFRACTION",1.85,33.6,,7.5,"2M (NH4)2SO4, pH 7.50",,"10.1110/ps.062657507",,"2IWO",25.1,"1.7","1.7","12th PDZ domain of Multiple PDZ Domain Protein MPDZ (CASP Target)","MHHHHHHSSGVDLGTENLYFQSMGLRTVEMKKGPTDSLGISIAGGVGSPLGDVPIFIAMMHPTGVAAQTQKLRVGDRIVTICGTSTEGMTHTQAVNLLKNASGSIEMQVVAGGDVSETSV","Homo sapiens","MPDZ, MUPP1","MULTIPLE PDZ DOMAIN PROTEIN","1","2IWO"
"2IWP",,"X-RAY DIFFRACTION",2.46,50.1,,4.5,"50% PEG 300, 0.2M LI2SO4, 0.1M ACETATE PH 4.5",,"10.1110/ps.062657507",,"2IWP",25.1,"2.15","2.15","12th PDZ domain of Multiple PDZ Domain Protein MPDZ (CASP Target)","MHHHHHHSSGVDLGTENLYFQSMGLRTVEMKKGPTDSLGISIAGGVGSPLGDVPIFIAMMHPTGVAAQTQKLRVGDRIVTICGTSTEGMTHTQAVNLLKNASGSIEMQVVAGGDVSETSV","Homo sapiens","MPDZ, MUPP1","MULTIPLE PDZ DOMAIN PROTEIN","1","2IWP"
"2IWQ",,"X-RAY DIFFRACTION",1.75,29.6,,8.5,"0.2M NAF, 0.1M BISTRIS PROPANE PH8.5, 20% PEG3350, 10% ETHYLENE GLYCOL",,"10.1110/ps.062657507",,"2IWQ",13.61,"1.8","1.8","7th PDZ domain of Multiple PDZ Domain Protein MPDZ","MHHHHHHSSGVDLGTENLYFQSMQPRRVELWREPSKSLGISIVGGRGMGSRLSNGEVMRGIFIKHVLEDSPAGKNGTLKPGDRIVEVDGMDLRDASHEQAVEAIRKAGNPVVFMVQSIISTRL","Homo sapiens","MPDZ, MUPP1","MULTIPLE PDZ DOMAIN PROTEIN","1","2IWQ"
"2IWR",,"X-RAY DIFFRACTION",1.94,36.7,,6,"0.1M PCB PH6.0, 30% PEG 1000",,"10.1042/BJ20060555",,"2IWR",19.85,"1.5","1.5","Gtpase Like Domain Of Centaurin Gamma 1 (Human)","SMRSIPELRLGVLGDARSGKSSLIHRFLTGSYQVLEKTESEQYKKEMLVDGQTHLVLIREEAGAPDAKFSGWADAVIFVFSLEDENSFQAVSRLHGQLSSLRGEGRGGLALALVGTQDRISASSPRVVGDARARALCADMKRCSYYETCATYGLNVDRVFQEVAQKVVTLRKQQQLLA","Homo sapiens","AGAP2, CENTG1, KIAA0167","CENTAURIN GAMMA 1","1","2IWR"
"2IWY",,"X-RAY DIFFRACTION",2.19,43.8,,7.8,"24% PEG-3350, 0.2 M NH4CL, pH 7.80",,"10.1110/ps.062473707",,"2IWY",92.92,"2.06","2.06","Human mitochondrial beta-ketoacyl ACP synthase","MRGSHHHHHHGSIEGRSRLHRRVVITGIGLVTPLGVGTHLVWDRLIGGESGIVSLVGEEYKSIPCSVAAYVPRGSDEGQFNEQNFVSKSDIKSMSSPTIMAIGAAELAMKDSGWHPQSEADQVATGVAIGMGMIPLEVVSETALNFQTKGYNKVSPFFVPKILVNMAAGQVSIRYKLKGPNHAVSTACTTGAHAVGDSFRFIAHGDADVMVAGGTDSCISPLSLAGFSRARALSTNSDPKLACRPFHPKRDGFVMGEGAAVLVLEEYEHAVQRRARIYAEVLGYGLSGDAGHITAPDPEGEGALRCMAAALKDAGVQPEEISYINAHATSTPLGDAAENKAIKHLFKDHAYALAVSSTKGATGHLLGAAGAVEAAFTTLACYYQKLPPTLNLDCSEPEFDLNYVPLKAQEWKTEKRFIGLTNSFGFGGTNATLCIAGL","Homo sapiens","OXSM","3-OXOACYL-[ACYL-CARRIER-PROTEIN] SYNTHASE","1","2IWY"
"2IWZ",,"X-RAY DIFFRACTION",2.19,43.8,,7.8,"24% PEG3350, 0.2M NH4CL, pH 7.80",,"10.1110/ps.062473707",,"2IWZ",93.15,"1.65","1.65","Human mitochondrial beta-ketoacyl ACP synthase complexed with hexanoic acid","MRGSHHHHHHGSIEGRSRLHRRVVITGIGLVTPLGVGTHLVWDRLIGGESGIVSLVGEEYKSIPCSVAAYVPRGSDEGQFNEQNFVSKSDIKSMSSPTIMAIGAAELAMKDSGWHPQSEADQVATGVAIGMGMIPLEVVSETALNFQTKGYNKVSPFFVPKILVNMAAGQVSIRYKLKGPNHAVSTACTTGAHAVGDSFRFIAHGDADVMVAGGTDSCISPLSLAGFSRARALSTNSDPKLACRPFHPKRDGFVMGEGAAVLVLEEYEHAVQRRARIYAEVLGYGLSGDAGHITAPDPEGEGALRCMAAALKDAGVQPEEISYINAHATSTPLGDAAENKAIKHLFKDHAYALAVSSTKGATGHLLGAAGAVEAAFTTLACYYQKLPPTLNLDCSEPEFDLNYVPLKAQEWKTEKRFIGLTNSFGFGGTNATLCIAGL","Homo sapiens","OXSM","3-OXOACYL-[ACYL-CARRIER-PROTEIN] SYNTHASE","1","2IWZ"
"2IXM",,"X-RAY DIFFRACTION",2.16,39.5,"VAPOR DIFFUSION, HANGING DROP",7,"PTPA CRYSTALS WERE GROWN USING THE HANGING DROP METHOD AT 20C. 1UL OF PROTEIN (20 MG/ML) WAS MIXED WITH 1 UL OF PRECIPITANT (23% TO 28% PEG 4000, 0.2 M LITHIUM SULFATE, 0.1 M TRIS PH 7.0-8.5 AND 5 MM DTT) WERE EQUILIBRATED AGAINST 0.5 ML OF PRECIPITANT. LARGE PLATE CRYSTALS APPEARED IN 2 TO 3 DAYS. FOR CRYOPROTECTION 5% MPD WAS ADDED TO THE PRECIPITANT SOLUTION.",293,"10.1016/j.molcel.2006.07.008",,"2IXM",34.8,"1.5","1.5","Structure of human PTPA","TQNFIIPKKEIHTVPDMGKWKRSQAYADYIGFILTLNEGVKGKKLTFEYRVSEAIEKLLALLNTLDRWIDETPPVDQPSRFGNKAYRTWYAKLDEEAENLVATVVPTHLAAAVPEVAVYLKESVGNSTRIDYGTGHEAAFAAFLCCLCKIGVLRVDDQIAIVFKVFNRYLEVMRKLQKTYRMEPAGSQGVWGLDDFQFLPFIWGSSQLIDHPYLEPRHFVDEKAVNENHKDYMFLECILFITEMKTGPFAEHSNQLWNISAVPSWSKVNQGLIRMYKAECLEKFPVIQHFKFGSLLPIHPVTS","Homo sapiens","PTPA, PPP2R4","SERINE/THREONINE-PROTEIN PHOSPHATASE 2A REGULATORY SUBUNIT B'","1","2IXM"
"2IYC",,"X-RAY DIFFRACTION",2.77,55.22,,,,,,,"2IYC",53.86,"2.45","2.45","SENP1 native structure","EFPEITEEMEKEIKNVFRNGNQDEVLSEAFRLTITRKDIQTLNHLNWLNDEIINFYMNMLMERSKEKGLPSVHAFNTFFFTKLKTAGYQAVKRWTKKVDVFSVDILLVPIHLGVHWCLAVVDFRKKNITYYDSMGGINNEACRILLQYLKQESIDKKRKEFDTNGWQLFSKKSQEIPQQMNGSDCGMFACKYADCITKDRPINFTQQHMPYFRKRMVWEILHRKLL","Homo sapiens","SENP1","SENTRIN-SPECIFIC PROTEASE 1","1","2IYC"
"2IYK",,"X-RAY DIFFRACTION",2.37,48.2,,6.5,"30% PENTAERYTHRITOL ETHOXYLATE (15/4EO/OH) (V/V), 50 MM AMMONIUM SULPHATE,50 MM BIS-TRIS PH 6.5",,"10.1261/rna.177606",,"2IYK",36.82,"2.95","2.95","Crystal structure of the UPF2-interacting domain of nonsense mediated mRNA decay factor UPF1","GAMGTKDLPIHACSYCGIHDPACVVYCNTSKKWFCNGRGNTSGSHIVNHLVRAKCKEVTLHKDGPLGETVLECYNCGCRNVFLLGFIPAKADSVVVLLCRQPCASQSSLKDINWDSSQWQPLIQDRCFLSWLVKIPSEQEQLRARQITAQQINKLEELWKEN","Homo sapiens","UPF1, KIAA0221, RENT1","REGULATOR OF NONSENSE TRANSCRIPTS 1","1","2IYK"
"2IZ3",,"SOLUTION NMR",,,,,,,"10.1016/j.jmb.2006.07.029",,"2IZ3",10.96,,,"Solution structure of human beta-microseminoprotein","GGGSCYFIPNEGVPGDSTRKCMDLKGNKHPINSEWQTDNCETCTCYETEISCCTLVSTPVGYDKDNCQRIFKKEDCKYIVVEKKDPKKTCSVSEWII","Homo sapiens","MSMB, PRSP","BETA-MICROSEMINOPROTEIN","1","2IZ3"
"2IZR",,"X-RAY DIFFRACTION",2.5,51,,7,"10% PEG10K, 0.20 M MGCL2, 0.1 M TRIS PH=7.0, pH 7.00",,,,"2IZR",39.18,"1.3","1.3","Structure of casein kinase gamma 3 in complex with inhibitor","SMGVLMVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEVLCENFPEMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDWIGKQLPTPVGAVQQDPALSSNREAHQHRDKMQQSKNQ","Homo sapiens","CSNK1G3","CASEIN KINASE I ISOFORM GAMMA-3","1","2IZR"
"2IZS",,"X-RAY DIFFRACTION",2.5,51,,7,"10% PEG10K, 0.20 M MGCL2, 0.10 M TRIS PH=7.0, pH 7.00",,,,"2IZS",39.1,"1.95","1.95","Structure of casein kinase gamma 3 in complex with inhibitor","SMGVLMVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEVLCENFPEMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDWIGKQLPTPVGAVQQDPALSSNREAHQHRDKMQQSKNQ","Homo sapiens","CSNK1G3","CASEIN KINASE I ISOFORM GAMMA-3","1","2IZS"
"2IZT",,"X-RAY DIFFRACTION",2.5,51,,8,"0.05 M CACL2, 20% PEG6000, 10% ETHYLENE GLYCOL, 0.10 M TRIS PH=8.0, pH 8.00",,,,"2IZT",39.01,"2","2","Structure of casein kinase gamma 3 in complex with inhibitor","SMGVLMVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEVLCENFPEMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDWIGKQLPTPVGAVQQDPALSSNREAHQHRDKMQQSKNQ","Homo sapiens","CSNK1G3","CASEIN KINASE I ISOFORM GAMMA-3","1","2IZT"
"2IZU",,"X-RAY DIFFRACTION",2.5,51,,,"20% PEG3350, 0.20 M NAFORMATE",,,,"2IZU",39.1,"1.85","1.85","Structure of casein kinase gamma 3 in complex with inhibitor","SMGVLMVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEVLCENFPEMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDWIGKQLPTPVGAVQQDPALSSNREAHQHRDKMQQSKNQ","Homo sapiens","CSNK1G3","CASEIN KINASE I ISOFORM GAMMA-3","1","2IZU"
"2IZZ",,"X-RAY DIFFRACTION",2.43,49.5,,7.5,"20% PEG3350, 10% ETHYLENE GLYCOL 0.2M NA2SO4, 0.1M BIS-TRIS PROPANE PH7.5, pH 7.50",,,,"2IZZ",173.97,"1.95","1.95","Crystal structure of human pyrroline-5-carboxylate reductase","MHHHHHHSSGVDLGTENLYFQSMSVGFIGAGQLAFALAKGFTAAGVLAAHKIMASSPDMDLATVSALRKMGVKLTPHNKETVQHSDVLFLAVKPHIIPFILDEIGADIEDRHIVVSCAAGVTISSIEKKLSAFRPAPRVIRCMTNTPVVVREGATVYATGTHAQVEDGRLMEQLLSSVGFCTEVEEDLIDAVTGLSGSGPAYAFTALDALADGGVKMGLPRRLAVRLGAQALLGAAKMLLHSEQHPGQLKDNVSSPGGATIHALHVLESGGFRSLLINAVEASCIRTRELQSMADQEQVSPAAIKKTILDKVKLDSPAGTAL","Homo sapiens","PYCR1","PYRROLINE-5-CARBOXYLATE REDUCTASE 1","1","2IZZ"
"2J05",,"X-RAY DIFFRACTION",1.92,36.1,,9,"100 MM KNO3, 100 MM TAPS, PH 9 AND 40% PEG 8000",,"10.1016/j.bbrc.2006.12.044",,"2J05",15.53,"1.5","1.5","Crystal structure of the RasGAP SH3 domain at 1.5 Angstrom resolution","GSHMRRRVRAILPYTKVPDTDEISFLKGDMFIVHNELEDGWMWVTNLRTDEQGLIVEDLVEEVGR","Homo sapiens","RASA1, GAP, RASA","RAS GTPASE-ACTIVATING PROTEIN 1","1","2J05"
"2J06",,"X-RAY DIFFRACTION",2.16,43,,9,"90 MM KNO3, 15.5% GLYCEROL, 90 MM TAPS, PH 9 AND 45.5% PEG8000",,"10.1016/j.bbrc.2006.12.044",,"2J06",15.53,"1.8","1.8","Crystal structure of the RasGAP SH3 domain at 1.8 Angstrom resolution","GSHMRRRVRAILPYTKVPDTDEISFLKGDMFIVHNELEDGWMWVTNLRTDEQGLIVEDLVEEVGR","Homo sapiens","RASA1, GAP, RASA","RAS GTPASE-ACTIVATING PROTEIN 1","1","2J06"
"2J0D",,"X-RAY DIFFRACTION",2.7,53,"VAPOR DIFFUSION, HANGING DROP",7.5,"HANGING DROP CRYSTALLISATION USING 1:1 RATIO OF PROTEIN AT 20-27 MG/ML AGAINST 0.1 M HEPES PH 7-7.5, 0.2 M LITHIUM SULFATE,0.8-1.0 M LITHIUM CHLORIDE AND 30% PEG4000",,"10.1073/pnas.0603236103","ERY","2J0D",112.93,"2.75","2.75","Crystal structure of human P450 3A4 in complex with erythromycin","MAYGTHSHGLFKKLGIPGPTPLPFLGNILSYHKGFCMFDMECHKKYGKVWGFYDGQQPVLAITDPDMIKTVLVKECYSVFTNRRPFGPVGFMKSAISIAEDEEWKRLRSLLSPTFTSGKLKEMVPIIAQYGDVLVRNLRREAETGKPVTLKDVFGAYSMDVITSTSFGVNIDSLNNPQDPFVENTKKLLRFDFLDPFFLSITVFPFLIPILEVLNICVFPREVTNFLRKSVKRMKESRLEDTQKHRVDFLQLMIDSQNSKETESHKALSDLELVAQSIIFIFAGYETTSSVLSFIMYELATHPDVQQKLQEEIDAVLPNKAPPTYDTVLQMEYLDMVVNETLRLFPIAMRLERVCKKDVEINGMFIPKGVVVMIPSYALHRDPKYWTEPEKFLPERFSKKNKDNIDPYIYTPFGSGPRNCIGMRFALMNMKLALIRVLQNFSFKPCKETQIPLKLSLGGLLQPEKPVVLKVESRDGTVSGAHHHH","Homo sapiens","CYP3A4, CYP3A3","CYTOCHROME P450 3A4","1","2J0D"
"2J0F",,"X-RAY DIFFRACTION",2.04,39.26,,7,"20% GLYCEROL, 20% PEG3350, pH 7.00",,"10.1042/BJ20060513",,"2J0F",200.5,"2.31","2.31","Structural basis for non-competitive product inhibition in human thymidine phosphorylase: implication for drug design","MAALMTPGTGAPPAPGDFSGEGSQGLPDPSPEPKQLPELIRMKRDGGRLSEADIRGFVAAVVNGSAQGAQIGAMLMAIRLRGMDLEETSVLTQALAQSGQQLEWPEAWRQQLVDKHSTGGVGDKVSLVLAPALAACGCKVPMISGRGLGHTGGTLDKLESIPGFNVIQSPEQMQVLLDQAGCCIVGQSEQLVPADGILYAARDVTATVDSLPLITASILSKKLVEGLSALVVDVKFGAGAVFPNQEQARELAKTLVGVGASLGLRVAAALTAMDKPLGRCVGHALEVEEALLCMDGAGPPDLRDLVTTLGGALLWLSGHAGTQAQGAARVAAALDDGSALGRFERMLAAQGVDPGLARALCSGSPAERRQLLPRAREQEELLAPADGTVELVRALPLALVLHELGAGRSRAGEPLRLGVGAELLVDVGQRLRRGTPWLRVHRDGPALSGPQSRALQEALVLSDRAPFAAPLPFAELVLPPQQ","Homo sapiens","TYMP, ECGF1","THYMIDINE PHOSPHORYLASE","1","2J0F"
"2J0G",,"X-RAY DIFFRACTION",2.55,51.47,,,,,"10.1038/sj.emboj.7601500",,"2J0G",151.31,"2.85","2.85","L-ficolin complexed to N-acetyl-mannosamine","NPCLTGPRTCKDLLDRGHFLSGWHTIYLPDCRPLTVLCDMDTDGGGWTVFQRRVDGSVDFYRDWATYKQGFGSRLGEFWLGNDNIHALTAQGTSELRTDLVDFEDNYQFAKYRSFKVADEAEKYNLVLGAFVEGSAGDSLTFHNNQSFSTKDQDNDLNTGNCAVMFQGAWWYKNCHTSNLNGRYLRGTHGSFANGINWKSGKGYNYSYKVSEMKVRPA","Homo sapiens","FCN2, FCNL","FICOLIN-2","1","2J0G"
"2J0H",,"X-RAY DIFFRACTION",2.57,51.74,,,,,"10.1038/sj.emboj.7601500",,"2J0H",150.36,"2.85","2.85","L-ficolin complexed to acetyl-choline","NPCLTGPRTCKDLLDRGHFLSGWHTIYLPDCRPLTVLCDMDTDGGGWTVFQRRVDGSVDFYRDWATYKQGFGSRLGEFWLGNDNIHALTAQGTSELRTDLVDFEDNYQFAKYRSFKVADEAEKYNLVLGAFVEGSAGDSLTFHNNQSFSTKDQDNDLNTGNCAVMFQGAWWYKNCHTSNLNGRYLRGTHGSFANGINWKSGKGYNYSYKVSEMKVRPA","Homo sapiens","FCN2, FCNL","FICOLIN-2","1","2J0H"
"2J0I",,"X-RAY DIFFRACTION",2.67,53.9,"VAPOR DIFFUSION, SITTING DROP",,"150 UL SITTING DROPS, 4DEG, 0.2M K3(CIT), 0.1M BIS-TRIS PROPANE PH 6.5, 20% PEG3350, 10% ETHYLENE GLYCOL",277,,,"2J0I",34.48,"1.6","1.6","CRYSTAL STRUCTURE OF THE HUMAN P21-ACTIVATED KINASE 4","GSSPQREPQRVSHEQFRAALQLVVDPGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPASIVPLMRQNRTR","Homo sapiens","PAK4, KIAA1142","SERINE/THREONINE-PROTEIN KINASE PAK 4","1","2J0I"
"2J0Y",,"X-RAY DIFFRACTION",2.52,50.8,,,,,"10.1038/sj.emboj.7601500",,"2J0Y",151.8,"2.35","2.35","L-ficolin complexed to b-1,3-D-glucan","NPCLTGPRTCKDLLDRGHFLSGWHTIYLPDCRPLTVLCDMDTDGGGWTVFQRRVDGSVDFYRDWATYKQGFGSRLGEFWLGNDNIHALTAQGTSELRTDLVDFEDNYQFAKYRSFKVADEAEKYNLVLGAFVEGSAGDSLTFHNNQSFSTKDQDNDLNTGNCAVMFQGAWWYKNCHTSNLNGRYLRGTHGSFANGINWKSGKGYNYSYKVSEMKVRPA","Homo sapiens","FCN2, FCNL","FICOLIN-2","1","2J0Y"
"2J0Z",,"SOLUTION NMR",,,,,,,"10.1002/prot.21854",,"2J0Z",15.06,,,"p53 tetramerization domain wild type","EYFTLQIRGRERFEMFRELNEALELKDAQAG","Homo sapiens","TP53, P53","CELLULAR TUMOR ANTIGEN P53","1","2J0Z"
"2J10",,"SOLUTION NMR",,,,,,,"10.1002/prot.21854",,"2J10",15.25,,,"p53 tetramerization domain mutant T329F Q331K","EYFFLKIRGRERFEMFRELNEALELKDAQAG","Homo sapiens","TP53, P53","CELLULAR TUMOR ANTIGEN P53","1","2J10"
"2J11",,"SOLUTION NMR",,,,,,,"10.1002/prot.21854",,"2J11",14.3,,,"p53 tetramerization domain mutant Y327S T329G Q331G","ESFGLGIRGRERFEMFRELNEALELKDAQAG","Homo sapiens","TP53, P53","CELLULAR TUMOR ANTIGEN P53","1","2J11"
"2J14",,"X-RAY DIFFRACTION",2.6,52.61,,,,,"10.1016/j.bmcl.2006.08.052","GNI","2J14",66.38,"2.8","2.8","3,4,5-Trisubstituted Isoxazoles as Novel PPARdelta Agonists: Part2","MGHHHHHHGSQYNPQVADLKAFSKHIYNAYLKNFNMTKKKARSILTGKASHTAPFVIHDIETLWQAEKGLVWKQLVNGLPPYKEISVHVFYRCQCTTVETVRELTEFAKSIPSFSSLFLNDQVTLLKYGVHEAIFAMLASIVNKDGLLVANGSGFVTREFLRSLRKPFSDIIEPKFEFAVKFNALELDDSDLALFIAAIILCGDRPGLMNVPRVEAIQDTILRALEFHLQANHPDAQYLFPKLLQKMADLRQLVTEHAQMMQRIKKTETETSLHPLLQEIYKDMY","Homo sapiens","PPARD, NR1C2, PPARB","PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR DELTA","1","2J14"
"2J1D",,"X-RAY DIFFRACTION",4.19,70.42,,6.2,"pH 6.20",,"10.1016/j.jmb.2007.04.002",,"2J1D",56.19,"2.25","2.25","Crystallization of hDaam1 C-terminal Fragment","LALKKKSIPQPTNALKSFNWSKLPENKLEGTVWTEIDDTKVFKILDLEDLERTFSAYQRQQDFFVNSNSKQKEADAIDDTLSSKLKVKELSVIDGRRAQNCNILLSRLKLSNDEIKRAILTMDEQEDLPKDMLEQLLKFVPEKSDIDLLEEHKHELDRMAKADRFLFEMSRINHYQQRLQSLYFKKKFAERVAEVKPKVEAIRSGSEEVFRSGALKQLLEVVLAFGNYMNKGQRGNAYGFKISSLNKIADTKSSIDKNITLLHYLITIVENKYPSVLNLNEELRDIPQAAKVNMTELDKEISTLRSGLKAVETELEYQKSQPPQPGDKFVSVVSQFITVASFSFSDVEDLLAEAKDLFTKAVKHFGEEAGKIQPDEFFGIFDQFLQAVSEAKQENENMRKKKEEEERRARMEAQLKEQRERERKMRKAKENSEESGEFDDLVSALRSGEVFDKDLSKLKRNRKRITNQMTDSSRERPITKLNF","Homo sapiens","DAAM1, KIAA0666","DISHEVELED-ASSOCIATED ACTIVATOR OF MORPHOGENESIS 1","1","2J1D"
"2J1G",,"X-RAY DIFFRACTION",2.54,51.27,,,,,"10.1038/sj.emboj.7601500",,"2J1G",151.65,"1.95","1.95","L-ficolin complexed to N-acetyl-cystein","NPCLTGPRTCKDLLDRGHFLSGWHTIYLPDCRPLTVLCDMDTDGGGWTVFQRRVDGSVDFYRDWATYKQGFGSRLGEFWLGNDNIHALTAQGTSELRTDLVDFEDNYQFAKYRSFKVADEAEKYNLVLGAFVEGSAGDSLTFHNNQSFSTKDQDNDLNTGNCAVMFQGAWWYKNCHTSNLNGRYLRGTHGSFANGINWKSGKGYNYSYKVSEMKVRPA","Homo sapiens","FCN2, FCNL","FICOLIN-2","1","2J1G"
"2J1L",,"X-RAY DIFFRACTION",2.79,56,,6,"19% PEG6K, 0.4M NH4CL, 15% ETG, 0.05M MES PH6.0, pH 6.00",,,,"2J1L",24.48,"2.5","2.5","Crystal Structure of Human Rho-related GTP-binding protein RhoD","MHHHHHHSSGVDLGTENLYFQSMAGEEAPPGVRSVKVVLVGDGGCGKTSLLMVFADGAFPESYTPTVFERYMVNLQVKGKPVHLHIWDTAGQDDYDRLRPLFYPDASVLLLCFDVTSPNSFDNIFNRWYPEVNHFCKKVPIIVVGCKTDLRKDKSLVNKLRRNGLEPVTYHRGQEMARSVGAVAYLECSARLHDNVHAVFQEAAEVALSSRGRN","Homo sapiens","RHOD, ARHD","RHO-RELATED GTP-BINDING PROTEIN RHOD","1","2J1L"
"2J1W",,"X-RAY DIFFRACTION",2.47,49.83,,,,,"10.1073/pnas.0607286103",,"2J1W",49.26,"1.8","1.8","Human p53 core domain mutant M133L-V143A-V203A-N239Y-N268D","SSSVPSQKTYQGSYGFRLGFLHSGTAKSVTCTYSPALNKLFCQLAKTCPAQLWVDSTPPPGTRVRAMAIYKQSQHMTEVVRRCPHHERCSDSDGLAPPQHLIRVEGNLRAEYLDDRNTFRHSVVVPYEPPEVGSDCTTIHYNYMCYSSCMGGMNRRPILTIITLEDSSGNLLGRDSFEVRVCACPGRDRRTEEENLRKKGEPHHELPPGSTKRALPNNT","Homo sapiens","TP53, P53","CELLULAR TUMOR ANTIGEN P53","1","2J1W"
"2J1X",,"X-RAY DIFFRACTION",2.46,49.59,,,,,"10.1073/pnas.0607286103",,"2J1X",49.19,"1.65","1.65","Human p53 core domain mutant M133L-V203A-Y220C-N239Y-N268D","SSSVPSQKTYQGSYGFRLGFLHSGTAKSVTCTYSPALNKLFCQLAKTCPVQLWVDSTPPPGTRVRAMAIYKQSQHMTEVVRRCPHHERCSDSDGLAPPQHLIRVEGNLRAEYLDDRNTFRHSVVVPCEPPEVGSDCTTIHYNYMCYSSCMGGMNRRPILTIITLEDSSGNLLGRDSFEVRVCACPGRDRRTEEENLRKKGEPHHELPPGSTKRALPNNT","Homo sapiens","TP53, P53","CELLULAR TUMOR ANTIGEN P53","1","2J1X"
"2J1Y",,"X-RAY DIFFRACTION",2.22,44.1,,,,,"10.1073/pnas.0607286103",,"2J1Y",90.58,"1.69","1.69","Human p53 core domain mutant M133L-V203A-N239Y-G245S-N268D","SSSVPSQKTYQGSYGFRLGFLHSGTAKSVTCTYSPALNKLFCQLAKTCPVQLWVDSTPPPGTRVRAMAIYKQSQHMTEVVRRCPHHERCSDSDGLAPPQHLIRVEGNLRAEYLDDRNTFRHSVVVPYEPPEVGSDCTTIHYNYMCYSSCMGSMNRRPILTIITLEDSSGNLLGRDSFEVRVCACPGRDRRTEEENLRKKG","Homo sapiens","TP53, P53","CELLULAR TUMOR ANTIGEN P53","1","2J1Y"
"2J1Z",,"X-RAY DIFFRACTION",2.47,49.87,,,,,"10.1073/pnas.0607286103",,"2J1Z",49.24,"1.8","1.8","Human p53 core domain mutant M133L-V203A-N239Y-N268D-F270L","SSSVPSQKTYQGSYGFRLGFLHSGTAKSVTCTYSPALNKLFCQLAKTCPVQLWVDSTPPPGTRVRAMAIYKQSQHMTEVVRRCPHHERCSDSDGLAPPQHLIRVEGNLRAEYLDDRNTFRHSVVVPYEPPEVGSDCTTIHYNYMCYSSCMGGMNRRPILTIITLEDSSGNLLGRDSLEVRVCACPGRDRRTEEENLRKKGEPHHELPPGSTKRALPNNT","Homo sapiens","TP53, P53","CELLULAR TUMOR ANTIGEN P53","1","2J1Z"
"2J20",,"X-RAY DIFFRACTION",2.49,50.23,,,,,"10.1073/pnas.0607286103",,"2J20",49.4,"1.8","1.8","Human p53 core domain mutant M133L-V203A-N239Y-N268D-R273C","SSSVPSQKTYQGSYGFRLGFLHSGTAKSVTCTYSPALNKLFCQLAKTCPVQLWVDSTPPPGTRVRAMAIYKQSQHMTEVVRRCPHHERCSDSDGLAPPQHLIRVEGNLRAEYLDDRNTFRHSVVVPYEPPEVGSDCTTIHYNYMCYSSCMGGMNRRPILTIITLEDSSGNLLGRDSFEVCVCACPGRDRRTEEENLRKKGEPHHELPPGSTKRALPNNT","Homo sapiens","TP53, P53","CELLULAR TUMOR ANTIGEN P53","1","2J20"
"2J21",,"X-RAY DIFFRACTION",2.58,51.96,,,,,"10.1073/pnas.0607286103",,"2J21",49.37,"1.6","1.6","Human p53 core domain mutant M133L-V203A-N239Y-N268D-R282W","SSSVPSQKTYQGSYGFRLGFLHSGTAKSVTCTYSPALNKLFCQLAKTCPVQLWVDSTPPPGTRVRAMAIYKQSQHMTEVVRRCPHHERCSDSDGLAPPQHLIRVEGNLRAEYLDDRNTFRHSVVVPYEPPEVGSDCTTIHYNYMCYSSCMGGMNRRPILTIITLEDSSGNLLGRDSFEVRVCACPGRDWRTEEENLRKKGEPHHELPPGSTKRALPNNT","Homo sapiens","TP53, P53","CELLULAR TUMOR ANTIGEN P53","1","2J21"
"2J25",,"X-RAY DIFFRACTION",2.8,56,,5.5,"1M BIS-TRIS PH 5.5, 2M (NH4)2SO4",,"10.1107/S0907444906038303",,"2J25",115.48,"2.9","2.9","Partially deglycosylated glucoceramidase","ARPCIPKSFGYSSVVCVCNATYCDSFDPPTFPALGTFSRYESTRSGRRMELSMGPIQANHTGTGLLLTLQPEQKFQKVKGFGGAMTDAAALNILALSPPAQNLLLKSYFSEEGIGYNIIRVPMASCDFSIRTYTYADTPDDFQLHNFSLPEEDTKLKIPLIHRALQLAQRPVSLLASPWTSPTWLKTNGAVNGKGSLKGQPGDIYHQTWARYFVKFLDAYAEHKLQFWAVTAENEPSAGLLSGYPFQCLGFTPEHQRDFIARDLGPTLANSTHHNVRLLMLDDQRLLLPHWAKVVLTDPEAAKYVHGIAVHWYLDFLAPAKATLGETHRLFPNTMLFASEACVGSKFWEQSVRLGSWDRGMQYSHSIITNLLYHVVGWTDWNLALNPEGGPNWVRNFVDSPIIVDITKDTFYKQPMFYHLGHFSKFIPEGSQRVGLVASQKNDLDAVALMHPDGSAVVVVLNRSSKDVPLTIKDPAVGFLETISPGYSIHTYLWHRQ","Homo sapiens","GBA, GC, GLUC","GLUCOSYLCERAMIDASE","1","2J25"
"2J2C",,"X-RAY DIFFRACTION",3.17,61.17,,,"1.8 M MG2SO4 0.1 M TRIS PH 8.5",,"10.1074/jbc.M700917200",,"2J2C",64.78,"2.2","2.2","Crystal structure of Human Cytosolic 5'-Nucleotidase II (NT5C2, cN-II)","MGSSHHHHHHSSGLVPRGSMSTSWSDRLQNAADMPANMDKHALKKYRREAYHRVFVNRSLAMEKIKCFGFDMDYTLAVYKSPEYESLGFELTVERLVSIGYPQELLSFAYDSTFPTRGLVFDTLYGNLLKVDAYGNLLVCAHGFNFIRGPETREQYPNKFIQRDDTERFYILNTLFNLPETYLLACLVDFFTNCPRYTSCETGFKDGDLFMSYRSMFQDVRDAVDWVHYKGSLKEKTVENLEKYVVKDGKLPLLLSRMKEVGKVFLATNSDYKYTDKIMTYLFDFPHGPKPGSSHRPWQSYFDLILVDARKPLFFGEGTVLRQVDTKTGKLKIGTYTGPLQHGIVYSGGSSDTICDLLGAKGKDILYIGDHIFGDILKSKKRQGWRTFLVIPELAQELHVWTDKSSLFEELQSLDIFLAELYKHLDSSSNERPDISSIQRRIKKVTHDMDMCYGMMGSLFRSGSRQTLFASQVMRYADLYAASFINLLYYPFSYLFRAAHVLMPHESTVEHTHVDINEMESPLATRNRTSVDFKDTDYKRHQLTRSISEIKPPNL","Homo sapiens","NT5C2, NT5B, NT5CP, PNT5","CYTOSOLIC PURINE 5'-NUCLEOTIDASE","1","2J2C"
"2J2I",,"X-RAY DIFFRACTION",3.7,67,"VAPOR DIFFUSION, SITTING DROP",,"0.2 M NA2SO4, 0.1 M BIS-TRIS-PROPANE PH 7.5, 20% PEG3350, 10% ETHYLENE-GLYCOL, 0.5% DMSO, SITTING DROP, VAPOR DIFFUSION, 277 K",277,"10.1073/pnas.0708800104","LY4","2J2I",36.07,"1.9","1.9","Crystal Structure of the humab PIM1 in complex with LY333531","MLLSKINSLAHLRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPS","Homo sapiens","PIM1","PROTO-ONCOGENE SERINE/THREONINE-PROTEIN KINASE PIM-1","1","2J2I"
"2J2P",,"X-RAY DIFFRACTION",2.53,50.99,,,,,"10.1038/sj.emboj.7601500",,"2J2P",151.77,"2.8","2.8","L-ficolin complexed to N-acetyl-cystein (150mM)","NPCLTGPRTCKDLLDRGHFLSGWHTIYLPDCRPLTVLCDMDTDGGGWTVFQRRVDGSVDFYRDWATYKQGFGSRLGEFWLGNDNIHALTAQGTSELRTDLVDFEDNYQFAKYRSFKVADEAEKYNLVLGAFVEGSAGDSLTFHNNQSFSTKDQDNDLNTGNCAVMFQGAWWYKNCHTSNLNGRYLRGTHGSFANGINWKSGKGYNYSYKVSEMKVRPA","Homo sapiens","FCN2, FCNL","FICOLIN-2","1","2J2P"
"2J2S",,"SOLUTION NMR",,,,,,,"10.1038/sj.emboj.7601340",,"2J2S",8.2,,,"Solution structure of the nonmethyl-CpG-binding CXXC domain of the leukaemia-associated MLL histone methyltransferase","GGSVKKGRRSRRCGQCPGCQVPEDCGVCTNCLDKPKFGGRNIKKQCCKMRKCQNLQWMPSKAYLQKQAKAVK","Homo sapiens","KMT2A, ALL1, CXXC7, HRX, HTRX, MLL, MLL1, TRX1","ZINC FINGER PROTEIN HRX","1","2J2S"
"2J2U",,"X-RAY DIFFRACTION",2.39,48.15,,5.85,"18% PEG6K, 50MM MES PH 5.85, 5MM CACL2, 50MM NACL",,"10.1016/j.bmcl.2006.08.092","GSQ","2J2U",44.22,"1.9","1.9","CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX","IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTRGLPKAKSHAPEVITSSPLK","Homo sapiens","F10","COAGULATION FACTOR X HEAVY CHAIN","1","2J2U"
,,,,,,,,,,,,,,,,"EEMKKGHLERECMEETCSYEEAREVFEDSDKTNEFWNKYKDGDQCETSPCQNQGKCKDGLGEYTCTCLEGFEGKNCELFTRKLCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACIPTGPYPCGKQTLER","Homo sapiens","F10","COAGULATION FACTOR X LIGHT CHAIN","2","2J2U"
"2J34",,"X-RAY DIFFRACTION",2.42,48.72,,5.85,"18% PEG6K, 50MM MES PH 5.85, 5MM CACL2, 50MM NACL",,"10.1016/j.bmcl.2006.08.092","GS6","2J34",44.27,"2.01","2.01","CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX","IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTRGLPKAKSHAPEVITSSPLK","Homo sapiens","F10","ACTIVATED FACTOR XA HEAVY CHAIN","1","2J34"
,,,,,,,,,,,,,,,,"EEMKKGHLERECMEETCSYEEAREVFEDSDKTNEFWNKYKDGDQCETSPCQNQGKCKDGLGEYTCTCLEGFEGKNCELFTRKLCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACIPTGPYPCGKQTLER","Homo sapiens","F10","FACTOR X LIGHT CHAIN","2","2J34"
"2J38",,"X-RAY DIFFRACTION",2.37,47.73,,5.85,"16% PEG6K, 50MM MES PH5.85, 5MM CACL2, 50MM NACL",,"10.1016/j.bmcl.2006.08.092","GS5","2J38",44.27,"2.1","2.1","CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX","IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTRGLPKAKSHAPEVITSSPLK","Homo sapiens","F10","ACTIVATED FACTOR XA HEAVY CHAIN","1","2J38"
,,,,,,,,,,,,,,,,"EEMKKGHLERECMEETCSYEEAREVFEDSDKTNEFWNKYKDGDQCETSPCQNQGKCKDGLGEYTCTCLEGFEGKNCELFTRKLCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACIPTGPYPCGKQTLER","Homo sapiens","F10","FACTOR X LIGHT CHAIN","2","2J38"
"2J3F",,"X-RAY DIFFRACTION",2.58,52.26,,,,,"10.1038/sj.emboj.7601500",,"2J3F",152.51,"2.8","2.8","L-ficolin complexed to N-acetyl-D-galactosamine","PQPCLTGPRTCKDLLDRGHFLSGWHTIYLPDCRPLTVLCDMDTDGGGWTVFQRRVDGSVDFYRDWATYKQGFGSRLGEFWLGNDNIHALTAQGTSELRTDLVDFEDNYQFAKYRSFKVADEAEKYNLVLGAFVEGSAGDSLTFHNNQSFSTKDQDNDLNTGNCAVMFQGAWWYKNCHTSNLNGRYLRGTHGSFANGINWKSGKGYNYSYKVSEMKVRPA","Homo sapiens","FCN2, FCNL","FICOLIN-2","1","2J3F"
,,,,,,,,,,,,,,,,"PQPCLTGPRTCKDLLDRGHFLSGWHTIYLPDCRPLTVLCDMDTDGGGWTVFQRRVDGSVDFYRDWATYKQGFGSRLGEFWLGNDNIHALTAQGTSELRTDLVDFEDNYQFAKYRSFKVADEAEKYNLVLGAFVEGSAGDSLTFHNNQSFSTKDQDNDLNNGNCAVMFQGAWWYKNCHTSNLNGRYLRGTHGSFANGINWKSGKGYNYSYKVSEMKVRPA","Homo sapiens","FCN2, FCNL","FICOLIN-2","2","2J3F"
"2J3G",,"X-RAY DIFFRACTION",2.67,53.54,,,,,"10.1038/sj.emboj.7601500",,"2J3G",150.42,"2.5","2.5","L-ficolin","NPCLTGPRTCKDLLDRGHFLSGWHTIYLPDCRPLTVLCDMDTDGGGWTVFQRRVDGSVDFYRDWATYKQGFGSRLGEFWLGNDNIHALTAQGTSELRTDLVDFEDNYQFAKYRSFKVADEAEKYNLVLGAFVEGSAGDSLTFHNNQSFSTKDQDNDLNTGNCAVMFQGAWWYKNCHTSNLNGRYLRGTHGSFANGINWKSGKGYNYSYKVSEMKVRPA","Homo sapiens","FCN2, FCNL","FICOLIN-2","1","2J3G"
"2J3N",,"X-RAY DIFFRACTION",3.1,58,,,,,"10.1016/j.jmb.2007.04.044",,"2J3N",351.42,"2.8","2.8","X-ray structure of human thioredoxin reductase 1","MGSSHHHHHHSSGLVPRGSHMNGPEDLPKSYDYDLIIIGGGSGGLAAAKEAAQYGKKVMVLDFVTPTPLGTRWGLGGTCVNVGCIPKKLMHQAALLGQALQDSRNYGWKVEETVKHDWDRMIEAVQNHIGSLNWGYRVALREKKVVYENAYGQFIGPHRIKATNNKGKEKIYSAERFLIATGERPRYLGIPGDKEYCISSDDLFSLPYCPGKTLVVGASYVALECAGFLAGIGLDVTVMVRSILLRGFDQDMANKIGEHMEEHGIKFIRQFVPIKVEQIEAGTPGRLRVVAQSTNSEEIIEGEYNTVMLAIGRDACTRKIGLETVGVKINEKTGKIPVTDEEQTNVPYIYAIGDILEDKVELTPVAIQAGRLLAQRLYAGSTVKCDYENVPTTVFTPLEYGACGLSEEKAVEKFGEENIEVYHSYFWPLEWTIPSRDNNKCYAKIICNTKDNERVVGFHVLGPNAGEVTQGFAAALKCGLTKKQLDSTIGIHPVCAEVFTTLSVTKRSGASILQAGCCG","Homo sapiens","TXNRD1, GRIM12, KDRF","THIOREDOXIN REDUCTASE 1","1","2J3N"
"2J3O",,"X-RAY DIFFRACTION",3.38,63.29,,,,,"10.1038/sj.emboj.7601500",,"2J3O",151.17,"2.65","2.65","L-ficolin complexed to N-acetyl-D-glucosamine","PQPCLTGPRTCKDLLDRGHFLSGWHTIYLPDCRPLTVLCDMDTDGGGWTVFQRRVDGSVDFYRDWATYKQGFGSRLGEFWLGNDNIHALTAQGTSELRTDLVDFEDNYQFAKYRSFKVADEAEKYNLVLGAFVEGSAGDSLTFHNNQSFSTKDQDNDLNTGNCAVMFQGAWWYKNCHTSNLNGRYLRGTHGSFANGINWKSGKGYNYSYKVSEMKVRPA","Homo sapiens","FCN2, FCNL","FICOLIN-2","1","2J3O"
"2J3S",,"X-RAY DIFFRACTION",2.7,54,,6.1,"PROTEIN WAS CRYSTALLIZED FROM 1.6M AMMONIUM SULPHATE, 0.1M CITRIC ACID PH 6.1, 10% DIOXANE.",,"10.1038/sj.emboj.7601827",,"2J3S",61.8,"2.5","2.5","Crystal structure of the human filamin A Ig domains 19 to 21","GAMGDASRVRVSGQGLHEGHTFEPAEFIIDTRDAGYGGLSLSIEGPSKVDINTEDLEDGTCRVTYCPTEPGNYIINIKFADQHVPGSPFSVKVTGEGRVKESITRRRRAPSVANVGSHCDLSLKIPEISIQDMTAQVTSPSGKTHEAEIVEGENHTYCIRFVPAEMGTHTVSVKYKGQHVPGSPFQFTVGPLGEGGAHKVRAGGPGLERAEAGVPAEFSIWTREAGAGGLAIAVEGPSKAEISFEDRKDGSCGVAYVVQEPGDYEVSVKFNEEHIPDSPFVVPVASPS","Homo sapiens","FLNA, FLN, FLN1","FILAMIN-A","1","2J3S"
"2J3U",,"X-RAY DIFFRACTION",2.41,48.59,,,,,"10.1038/sj.emboj.7601500",,"2J3U",153.62,"2.15","2.15","L-ficolin complexed to galactose","NPCLTGPRTCKDLLDRGHFLSGWHTIYLPDCRPLTVLCDMDTDGGGWTVFQRRVDGSVDFYRDWATYKQGFGSRLGEFWLGNDNIHALTAQGTSELRTDLVDFEDNYQFAKYRSFKVADEAEKYNLVLGAFVEGSAGDSLTFHNNQSFSTKDQDNDLNTGNCAVMFQGAWWYKNCHTSNLNGRYLRGTHGSFANGINWKSGKGYNYSYKVSEMKVRPA","Homo sapiens","FCN2, FCNL","FICOLIN-2","1","2J3U"
"2J4A",,"X-RAY DIFFRACTION",2.37,47.8,,,"0.45 M AMMONIUMSULFATE, 100 MMTRIS PH8.0, 100MM NDSB",,"10.1021/jm060521i","OEF","2J4A",29.01,"2.2","2.2","Human Thyroid hormone receptor beta ligand binding domain in complex with KB131084","GHKPEPTDEEWELIKTVTEAHVATNAQGSHWKQKRKFLPEDIGQAPIVNAPEGGKVDLEAFSHFTKIITPAITRVVDFAKKLPMFCELPCEDQIILLKGCCMEIMSLRAAVRYDPESETLTLSGEMAVTRGQLKNGGLGVVSDAIFDLGMSLSSFNLDDTEVALLQAVLLMSSDRPGLACVERIEKYQDSFLLAFEHYINYRKHHVTHFWPKLLMKVTDLRMIGACHASRFLHMKVECPTELFPPLFLEVFED","Homo sapiens","THRB, ERBA2, NR1A2, THR1","THYROID HORMONE RECEPTOR BETA-1","1","2J4A"
"2J4C",,"X-RAY DIFFRACTION",2.82,55.99,"VAPOR DIFFUSION, HANGING DROP",6.5,"AMMONIUM SULFATE, 2-(N-MORPHOLINO)-ETHANESULFONIC ACID, PH 6.5, VAPOR DIFFUSION, HANGING DROP,TEMPERATURE 298.0K",298,"10.1111/j.1742-4658.2007.05732.x",,"2J4C",63.15,"2.75","2.75","Structure of human Butyrylcholinesterase in complex with 10mM HgCl2","EDDIIIATKNGKVRGMQLTVFGGTVTAFLGIPYAQPPLGRLRFKKPQSLTKWSDIWNATKYANSCCQNIDQSFPGFHGSEMWNPNTDLSEDCLYLNVWIPAPKPKNATVLIWIYGGGFQTGTSSLHVYDGKFLARVERVIVVSMNYRVGALGFLALPGNPEAPGNMGLFDQQLALQWVQKNIAAFGGNPKSVTLFGESAGAASVSLHLLSPGSHSLFTRAILQSGSFNAPWAVTSLYEARNRTLNLAKLTGCSRENETEIIKCLRNKDPQEILLNEAFVVPYGTPLSVNFGPTVDGDFLTDMPDILLELGQFKKTQILVGVNKDEGTAFLVYGAPGFSKDNNSIITRKEFQEGLKIFFPGVSEFGKESILFHYTDWVDDQRPENYREALGDVVGDYNFICPALEFTKKFSEWGNNAFFYYFEHRSSKLPWPEWMGVMHGYEIEFVFGLPLERRDQYTKAEEILSRSIVKRWANFAKYGNPQETQNASTSWPVFKSTEQKYLTLNTESTRIMTKLRAQQCRFWTSFFPKV","Homo sapiens","BCHE, CHE1","CHOLINESTERASE","1","2J4C"
"2J4E",,"X-RAY DIFFRACTION",3.01,58.81,,,"0.2 M POTASSIUM CHLORIDE, 31 % (W/V) PEG 3350, AND THE PROTEIN WAS ADDED FROM A 50 MG/ML STOCK SOLUTION CONTAINING 10MM ITP AND 20 MM HEPES PH 7.5.",,"10.1074/jbc.M609838200",,"2J4E",177.18,"2.8","2.8","THE ITP COMPLEX OF HUMAN INOSINE TRIPHOSPHATASE","GSMAASLVGKKIVFVTGNAKKLEEVVQILGDKFPCTLVAQKIDLPEYQGEPDEISIQKCQEAVRQVQGPVLVEDTCLCFNALGGLPGPYIKWFLEKLKPEGLHQLLAGFEDKSAYALCTFALSTGDPSQPVRLFRGRTSGRIVAPRGCQDFGWDPCFQPDGYEQTYAEMPKAEKNAVSHRFRALLELQEYFGSLAA","Homo sapiens","ITPA, C20orf37, My049, OK/SW-cl.9","INOSINE TRIPHOSPHATE PYROPHOSPHATASE","1","2J4E"
"2J4I",,"X-RAY DIFFRACTION",2.35,47.32,,5.85,"18% PEG6K, 50MM MES PH 5.85, 5MM CACL2, 50MM NACL",,"10.1016/j.bmcl.2006.09.001","GSJ","2J4I",44.36,"1.8","1.8","CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX","IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTRGLPKAKSHAPEVITSSPLK","Homo sapiens","F10","COAGULATION FACTOR X","1","2J4I"
,,,,,,,,,,,,,,,,"EEMKKGHLERECMEETCSYEEAREVFEDSDKTNEFWNKYKDGDQCETSPCQNQGKCKDGLGEYTCTCLEGFEGKNCELFTRKLCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACIPTGPYPCGKQTLER","Homo sapiens","F10","COAGULATION FACTOR X","2","2J4I"
"2J4O",,"X-RAY DIFFRACTION",4.4,72,"VAPOR DIFFUSION",,"TAB1, WAS CONCENTRATED TO 14.1 MG/ML, AND CRYSTALLISED BY VAPOUR DIFFUSION. 1 MICROL OF PROTEIN WAS MIXED WITH 1 MICROL OF MOTHER LIQUOR (100 MM HEPES PH 7.5, 1.5 M LI2SO4) AND 0.25 MICROL 100 MM BACL2. HEXAGONALLY-SHAPED CRYSTALS APPEARED WITHIN THREE DAYS.",,"10.1042/BJ20061077",,"2J4O",43.73,"2.25","2.25","Structure of TAB1","MAAQRRSLLQSEQQPSWTDDLPLCHLSGVGSASNRSYSADGKGTESHPPEDSWLKFRSENNCFLYGVFNGYDGNRVTNFVAQRLSAELLLGQLNAEHAEADVRRVLLQAFDVVERSFLESIDDALAEKASLQSQLPEGVPQHQLPPQYQKILERLKTLEREISGGAMAVVAVLLNNKLYVANVGTNRALLCKSTVDGLQVTQLNVDHTTENEDELFRLSQLGLDAGKIKQVGIICGQESTRRIGDYKVKYGYTDIDLLSAAKSKPIIAEPEIHGAQPLDGVTGFLVLMSEGLYKALEAAHGPGQANQEIAAMIDTEFAKQTSLDAVAQAVVDRVKRIHSDTFASGGERARFCPRHEDMTLLVRNFGYPLGEMSQPTPSPAPAAGGRVYPVSVPYSSAQSTS","Homo sapiens","TAB1, MAP3K7IP1","MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 7-INTERACTING PROTEIN 1","1","2J4O"
"2J4Z",,"X-RAY DIFFRACTION",2.5,0.36,,6.5,"30% PEG 5000MME, 0.2M SODIUM ACETATE 0.1M SODIUM CACODYLATE PH 6.5, 2MM DTT",,"10.1021/jm060897w","626","2J4Z",71.68,"2","2","Structure of Aurora-2 in complex with PHA-680626","GPQPLPSAPENNPEEELASKQKNEESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESASKQS","Homo sapiens","AURKA, AIK, AIRK1, ARK1, AURA, AYK1, BTAK, IAK1, STK15, STK6","SERINE THREONINE-PROTEIN KINASE 6","1","2J4Z"
"2J50",,"X-RAY DIFFRACTION",2.5,40,,4.6,"20% PEG 2000MME, 0.2M LITHIUM SULPHATE, 0.1M SODIUM ACETATE PH 4.6, 2% ISOPROPANOL, 2MM DTT",,"10.1021/jm060897w","627","2J50",65.88,"3","3","Structure of Aurora-2 in complex with PHA-739358","GPRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESASKQS","Homo sapiens","AURKA, AIK, AIRK1, ARK1, AURA, AYK1, BTAK, IAK1, STK15, STK6","SERINE/THREONINE-PROTEIN KINASE 6","1","2J50"
"2J51",,"X-RAY DIFFRACTION",3.53,65,,6.5,"16% PEG3350, 0.15M KSCN, 10% ETG, 0.1M BTP PH6.5, pH 6.50",,"10.1038/emboj.2008.8",,"2J51",37.89,"2.1","2.1","Crystal structure of Human STE20-like kinase bound to 5-Amino-3-((4-(aminosulfonyl)phenyl)amino) -N-(2,6-difluorophenyl)-1H-1,2,4-triazole- 1-carbothioamide","MHHHHHHSSGVDLGTENLYFQSMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPIRELIAEAKAEVTEEVEDGKE","Homo sapiens","SLK, KIAA0204, STK2","STE20-LIKE SERINE/THREONINE-PROTEIN KINASE","1","2J51"
"2J5D",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M701745200",,"2J5D",9.85,,,"NMR structure of BNIP3 transmembrane domain in lipid bicelles","RNTSVMKKGGIFSAEFLKVFLPSLLLSHLLAIGLGIYIGRRLTTS","Homo sapiens","BNIP3, NIP3","BCL2/ADENOVIRUS E1B 19 KDA PROTEIN-INTERACTING PROTEIN 3","1","2J5D"
"2J5E",,"X-RAY DIFFRACTION",3.4,64,,7.5,"1.2M NAK TARTRATE, 0.1M HEPES PH 7.5",,"10.1038/nchembio866",,"2J5E",37.63,"3.1","3.1","Crystal structure of EGFR kinase domain in complex with an irreversible inhibitor 13-jab","GEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","EPIDERMAL GROWTH FACTOR RECEPTOR","1","2J5E"
"2J5F",,"X-RAY DIFFRACTION",3.4,64,,7.5,"1.2M NAK TARTRATE, 0.1M HEPES PH 7.5",,"10.1038/nchembio866","DJK","2J5F",37.67,"3","3","Crystal structure of EGFR kinase domain in complex with an irreversible inhibitor 34-jab","GEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","EPIDERMAL GROWTH FACTOR RECEPTOR","1","2J5F"
"2J5W",,"X-RAY DIFFRACTION",4.27,71.2,,4.5,"PH 4.5",,"10.1107/S090744490604947X",,"2J5W",123.57,"2.8","2.8","Ceruloplasmin revisited: structural and functional roles of various metal cation binding sites","MKILILGIFLFLCSTPAWAKEKHYYIGIIETTWDYASDHGEKKLISVDTEHSNIYLQNGPDRIGRLYKKALYLQYTDETFRTTIEKPVWLGFLGPIIKAETGDKVYVHLKNLASRPYTFHSHGITYYKEHEGAIYPDNTTDFQRADDKVYPGEQYTYMLLATEEQSPGEGDGNCVTRIYHSHIDAPKDIASGLIGPLIICKKDSLDKEKEKHIDREFVVMFSVVDENFSWYLEDNIKTYCSEPEKVDKDNEDFQQSNRMYSVNGYTFGSLSGLSMCAEDRVKWYLFGMGNEVDVHAAFFHGQALTNKNYRIDTINLFPATLFDAYMVAQNPGEWMLSCQNLNHLKAGLQAFFQVQECNKSSSKDNIRGKHVRHYYIAAEEIIWNYAPSGIDIFTKENLTAPGSDSAVFFEQGTTRIGGSYKKLVYREYTDASFTNRKERGPEEEHLGILGPVIWAEVGDTIRVTFHNKGAYPLSIEPIGVRFNKNNEGTYYSPNYNPQSRSVPPSASHVAPTETFTYEWTVPKEVGPTNADPVCLAKMYYSAVDPTKDIFTGLIGPMKICKKGSLHANGRQKDVDKEFYLFPTVFDENESLLLEDNIRMFTTAPDQVDKEDEDFQESNKMHSMNGFMYGNQPGLTMCKGDSVVWYLFSAGNEADVHGIYFSGNTYLWRGERRDTANLFPQTSLTLHMWPDTEGTFNVECLTTDHYTGGMKQKYTVNQCRRQSEDSTFYLGERTYYIAAVEVEWDYSPQREWEKELHHLQEQNVSNAFLDKGEFYIGSKYKKVVYRQYTDSTFRVPVERKAEEEHLGILGPQLHADVGDKVKIIFKNMATRPYSIHAHGVQTESSTVTPTLPGETLTYVWKIPERSGAGTEDSACIPWAYYSTVDQVKDLYSGLIGPLIVCRRPYLKVFNPRRKLEFALLFLVFDENESWYLDDNIKTYSDHPEKVNKDDEEFIESNKMHAINGRMFGNLQGLTMHVGDEVNWYLMGMGNEIDLHTVHFHGHSFQYKHRGVYSSDVFDIFPGTYQTLEMFPRTPGIWLLHCHVTDHIHAGMETTYTVLQNEDTKSG","Homo sapiens","CP","CERULOPLASMIN","1","2J5W"
"2J5X",,"X-RAY DIFFRACTION",2.28,45.69,,4.6,"pH 4.60",,"10.1093/embo-reports/kve043",,"2J5X",41.35,"2.8","2.8","STRUCTURE OF THE SMALL G PROTEIN ARF6 IN COMPLEX WITH GTPGAMMAS","MGKVLSKIFGNKEMRILMLGLDAAGKTTILYKLKLGQSVTTIPTVGFNVETVTYKNVKFNVWDVGGQDKIRPLWRHYYTGTQGLIFVVDCADRDRIDEARQELHRIINDREMRDAIILIFANKQDLPDAMKPHEIQEKLGLTRIRDRNWYVQPSCATSGDGLYEGLTWLTSNYKS","Homo sapiens","ARF6","ADP-RIBOSYLATION FACTOR 6","1","2J5X"
"2J5Z",,"X-RAY DIFFRACTION",2.07,40,,,,,"10.1038/sj.emboj.7601500",,"2J5Z",75.7,"1.73","1.73","H-ficolin complexed to galactose","DLVNLLRCQEGPRNCRELLSQGATLSGWYHLCLPEGRALPVFCDMDTEGGGWLVFQRRQDGSVDFFRSWSSYRAGFGNQESEFWLGNENLHQLTLQGNWELRVELEDFNGNRTFAHYATFRLLGEVDHYQLALGKFSEGTAGDSLSLHSGRPFTTYDADHDSSNSNCAVIVHGAWWYASCYRSNLNGRYAVSEAAAHKYGIDWASGRGVGHPYRRVRMMLR","Homo sapiens","FCN3, FCNH, HAKA1","FICOLIN-3","1","2J5Z"
"2J60",,"X-RAY DIFFRACTION",2.14,42.09,,,,,"10.1038/sj.emboj.7601500",,"2J60",75.82,"1.8","1.8","H-ficolin complexed to D-fucose","DLVNLLRCQEGPRNCRELLSQGATLSGWYHLCLPEGRALPVFCDMDTEGGGWLVFQRRQDGSVDFFRSWSSYRAGFGNQESEFWLGNENLHQLTLQGNWELRVELEDFNGNRTFAHYATFRLLGEVDHYQLALGKFSEGTAGDSLSLHSGRPFTTYDADHDSSNSNCAVIVHGAWWYASCYRSNLNGRYAVSEAAAHKYGIDWASGRGVGHPYRRVRMMLR","Homo sapiens","FCN3, FCNH, HAKA1","FICOLIN-3","1","2J60"
"2J61",,"X-RAY DIFFRACTION",3.16,60.8,,,,,"10.1038/sj.emboj.7601500",,"2J61",49.79,"2.7","2.7","L-ficolin complexed to N-acetylglucosamine (forme C)","NPCLTGPRTCKDLLDRGHFLSGWHTIYLPDCRPLTVLCDMDTDGGGWTVFQRRVDGSVDFYRDWATYKQGFGSRLGEFWLGNDNIHALTAQGTSELRTDLVDFEDNYQFAKYRSFRVADEAEKYNLVLGAFVEGSAGDSLTFHNNQSFSTKDQDNDLNTGNCAVMFQGAWWYKNCHTSNLNGRYLRGTHGSFANGINWKSGKGYNYSYKVSEMKVRPA","Homo sapiens","FCN2, FCNL","FICOLIN-2","1","2J61"
,,,,,,,,,,,,,,,,"NPCLTGPRTCKDLLDRGHFLSGWHTIYLPDCRPLTVLCDMDTDGGGWTVFQRRVDGSVDFYRDWATYKQGFGSRLGEFWLGNDNIHALTAQGTSELRTDLVDFEDNYQFAKYRSFKVADEAEKYNLVLGAFVEGSAGDSLTFHNNQSFSTKDQDNDLNTGNCAVMFQGAWWYKNCHTSNLNGRYLRGTHGSFANGINWKSGKGYNYSYKVSEMKVRPA","Homo sapiens","FCN2, FCNL","FICOLIN-2","2","2J61"
"2J64",,"X-RAY DIFFRACTION",2.24,44.75,,,,,"10.1038/sj.emboj.7601500",,"2J64",75.46,"2.2","2.2","H-ficolin","DLVNLLRCQEGPRNCRELLSQGATLSGWYHLCLPEGRALPVFCDMDTEGGGWLVFQRRQDGSVDFFRSWSSYRAGFGNQESEFWLGNENLHQLTLQGNWELRVELEDFNGNRTFAHYATFRLLGEVDHYQLALGKFSEGTAGDSLSLHSGRPFTTYDADHDSSNSNCAVIVHGAWWYASCYRSNLNGRYAVSEAAAHKYGIDWASGRGVGHPYRRVRMMLR","Homo sapiens","FCN3, FCNH, HAKA1","FICOLIN-3","1","2J64"
"2J67",,"X-RAY DIFFRACTION",2.89,57.16,,,"0.2 M NASCN, 11% PEG 3350",,"10.1074/jbc.C800001200",,"2J67",42.58,"2.2","2.2","The TIR domain of human Toll-Like Receptor 10 (TLR10)","MHHHHHHSSGVDLGTENLYFQSMKTTQEQLKRNVRFHAFISYSEHDSLWVKNELIPNLEKEDGSILICLYESYFDPGKSISENIVSFIEKSYKSIFVLSPNFVQNEWCHYEFYFAHHNLFHENSDHIILILLEPIPFYCIPTRYHKLKALLEKKAYLEWPKDRRKCGLFWANLRAAIN","Homo sapiens","TLR10, UNQ315/PRO358","TOLL LIKE RECEPTOR 10","1","2J67"
"2J6K",,"X-RAY DIFFRACTION",3.3,63,,6.1,"0.1 M SODIUM CITRATE PH 6.1, 25% PEG 4000, 20% ISOPROPANOL",,"10.1074/jbc.M606411200",,"2J6K",88.99,"2.77","2.77","N-TERMINAL SH3 DOMAIN OF CMS (CD2AP HUMAN HOMOLOG)","MVDYIVEYDYDAVHDDELTIRVGEIIRNVKKLQEEGWLEGELNGRRGMFPDNFVKEIKRETE","Homo sapiens","CD2AP","CD2-ASSOCIATED PROTEIN","1","2J6K"
"2J6L",,"X-RAY DIFFRACTION",2.22,44.6,,6.6,"0.1 M BTPROP PH 6.6, 0.20 M NABR, 23% PEG3350, 10% ETHYLENE GLYCOLE",,"10.1074/jbc.M109.077925",,"2J6L",440.06,"1.3","1.3","Structure of aminoadipate-semialdehyde dehydrogenase","SMSTLLINQPQYAWLKELGLREENEGVYNGSWGGRGEVITTYCPANNEPIARVRQASVADYEETVKKAREAWKIWADIPAPKRGEIVRQIGDALREKIQVLGSLVSLEMGKILVEGVGEVQEYVDICDYAVGLSRMIGGPILPSERSGHALIEQWNPVGLVGIITAFNFPVAVYGWNNAIAMICGNVCLWKGAPTTSLISVAVTKIIAKVLEDNKLPGAICSLTCGGADIGTAMAKDERVNLLSFTGSTQVGKQVGLMVQERFGRSLLELGGNNAIIAFEDADLSLVVPSALFAAVGTAGQRCTTARRLFIHESIHDEVVNRLKKAYAQIRVGNPWDPNVLYGPLHTKQAVSMFLGAVEEAKKEGGTVVYGGKVMDRPGNYVEPTIVTGLGHDASIAHTETFAPILYVFKFQNEEEVFAWNNEVKQGLSSSIFTKDLGRIFRWLGPKGSDCGIVNVNIPTSGAEIGGAFGGEKHTGGGRESGSDAWKQYMRRSTCTINYS","Homo sapiens","ALDH7A1, ATQ1","ALDEHYDE DEHYDROGENASE FAMILY 7 MEMBER A1","1","2J6L"
"2J6M",,"X-RAY DIFFRACTION",3.4,64,,7.5,"1.2M NAK TARTRATE, 0.1M HEPES 7.5, pH 7.50",,"10.1016/j.ccr.2006.12.017","AEE","2J6M",37.74,"3.1","3.1","Crystal structure of EGFR kinase domain in complex with AEE788","GEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","EPIDERMAL GROWTH FACTOR RECEPTOR","1","2J6M"
"2J76",,"SOLUTION NMR",,,,,,,"10.1021/bi034506g",,"2J76",11.46,,,"Solution structure and RNA interactions of the RNA recognition motif from eukaryotic translation initiation factor 4B","MRGSHHHHHHRSRLPKSPPYTAFLGNLPYDVTEESIKEFFRGLNISAVRLPREPSNPERLKGFGYAEFEDLDSLLSALSLNEESLGNRRIRVDVADQAQD","Homo sapiens","EIF4B","EUKARYOTIC TRANSLATION INITIATION FACTOR 4B","1","2J76"
"2J7T",,"X-RAY DIFFRACTION",2.71,54.6,,6.5,"45% PEG300, 0.24M CALCIUM ACETATE, 0.1M SODIUM CACODYLATE PH6.5, pH 6.50",,"10.1038/emboj.2008.8",,"2J7T",35.21,"2","2","Crystal structure of human serine threonine kinase-10 bound to SU11274","SMRKSREYEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNKALRELVAEAKAEVMEE","Homo sapiens","STK10, LOK","SERINE/THREONINE-PROTEIN KINASE 10","1","2J7T"
"2J7Z",,"X-RAY DIFFRACTION",2.24,45.08,,,,,"10.1002/prot.21350",,"2J7Z",15.96,"1.95","1.95","Crystal Structure of recombinant Human Stromal Cell-Derived Factor- 1alpha","KPVSLSYRCPCRFFESHVARANVKHLKILNTPNCALQIVARLKNNNRQVCIDPKLKWIQEYLEKALNK","Homo sapiens","CXCL12, SDF1, SDF1A, SDF1B","STROMAL CELL-DERIVED FACTOR 1 ALPHA","1","2J7Z"
"2J8B",,"X-RAY DIFFRACTION",1.84,33,,,"28 % PEG 4000 0.25M AMMONIUM SULPHATE",,"10.1107/S1744309107033477",,"2J8B",9.16,"1.15","1.15","High resolution structure of human CD59","MLQCYNCPNPTADCKTAVNCSSDFDACLITKAGLQVYNKCWKFEHCNFNDVTTRLRENELTYYCCKKDLCNFNEQLENG","Homo sapiens","CD59, MIC11, MIN1, MIN2, MIN3, MSK21","CD59 GLYCOPROTEIN","1","2J8B"
"2J8H",,"X-RAY DIFFRACTION",3.3,62,,9,"AMMONIUM SULFATE, BICINE, pH 9",,"10.1016/j.jmb.2007.05.055",,"2J8H",21.86,"1.99","1.99","Structure of the immunoglobulin tandem repeat A168-A169 of titin","GAMAPHFKEELRNLNVRYQSNATLVCKVTGHPKPIVKWYRQGKEIIADGLKYRIQEFKGGYHQLIIASVTDDDATVYQVRATNQGGSVSGTASLEVEVPAKIHLPKTLEGMGAVHALRGEVVSIKIPFSGKPDPVITWQKGQDLIDNNGHYQVIVTRSFTSLVFPNGVERKDAGFYVVCAKNRFGIDQKTVELDVAD","Homo sapiens","TTN","TITIN","1","2J8H"
"2J8J",,"SOLUTION NMR",,,,,,,"10.1073/pnas.0703080104",,"2J8J",19.92,,,"Solution Structure of the A4 Domain of Blood Coagulation Factor XI","FCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNE","Homo sapiens","F11","COAGULATION FACTOR XI","1","2J8J"
"2J8L",,"SOLUTION NMR",,,,,,,"10.1073/pnas.0703080104",,"2J8L",19.92,,,"FXI Apple 4 domain loop-out conformation","FCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNE","Homo sapiens","F11","COAGULATION FACTOR XI","1","2J8L"
"2J8O",,"X-RAY DIFFRACTION",3.6,66,,9,"AMMONIUM SULFATE, BICINE, pH 9",,"10.1016/j.jmb.2007.05.055",,"2J8O",43.72,"2.49","2.49","Structure of the immunoglobulin tandem repeat of titin A168-A169","GAMAPHFKEELRNLNVRYQSNATLVCKVTGHPKPIVKWYRQGKEIIADGLKYRIQEFKGGYHQLIIASVTDDDATVYQVRATNQGGSVSGTASLEVEVPAKIHLPKTLEGMGAVHALRGEVVSIKIPFSGKPDPVITWQKGQDLIDNNGHYQVIVTRSFTSLVFPNGVERKDAGFYVVCAKNRFGIDQKTVELDVAD","Homo sapiens","TTN","TITIN","1","2J8O"
"2J8P",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M609981200",,"2J8P",5.5,,,"NMR structure of C-terminal domain of human CstF-64","HMTPQDHEKAALIMQVLQLTADQIAMLPPEQRQSILILKEQIQKSTGAP","Homo sapiens","CSTF2","CLEAVAGE STIMULATION FACTOR 64 KDA SUBUNIT","1","2J8P"
"2J8Q",,"X-RAY DIFFRACTION",2.72,54.48,,,"17%(W/V)PEG3350, 0.2M AMSO4, 0.1M BIS TRIS PH 5.2.MIX 1:1UL DROPS OF 9MG/ML PROTEIN WITH WELL SOLUTION IN RT THEN MOVE TO CR.",,"10.1002/prot.22198",,"2J8Q",53.03,"2.3","2.3","Crystal structure of human cleavage and polyadenylation specificity factor 5 (CPSF5) in complex with a sulphate ion.","MHHHHHHSSGVDLGTENLYFQSMYIQQTKPLTLERTINLYPLTNYTFGTKEPLYEKDSSVAARFQRMREEFDKIGMRRTVEGVLIVHEHRLPHVLLLQLGTTFFKLPGGELNPGEDEVEGLKRLMTEILGRQDGVLQDWVIDDCIGNWWRPNFEPPQYPYIPAHITKPKEHKKLFLVQLQEKALFAVPKNYKLVAAPLFELYDNAPGYGPIISSLPQLLSRFNFIYN","Homo sapiens","NUDT21, CFIM25, CPSF25, CPSF5","CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR 5","1","2J8Q"
"2J8T",,"X-RAY DIFFRACTION",1.56,20.69,,5,"AS DESCRIBED IN LAMOUR ET AL. (1999) ACTA CRYSTALL. SECTION D 55: 721-723, pH 5.00",,"10.1107/S0907444907011997",,"2J8T",37.02,"0.82","0.82","Human aldose reductase in complex with NADP and citrate at 0.82 angstrom","MASRILLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGKEFFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAKHNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVCALLSCTSHKDYPFHEEF","Homo sapiens","AKR1B1, ALDR1, ALR2","ALDO-KETO REDUCTASE FAMILY 1, MEMBER B1","1","2J8T"
"2J8Z",,"X-RAY DIFFRACTION",2.28,46,,4,"0.22M LITHIUM SULPHATE, 0.1M SODIUM ACETATE PH4.0, 45% PEG300, pH 4.00",,"10.1074/jbc.M109.001800",,"2J8Z",38.87,"2.5","2.5","Crystal Structure of human P53 inducible oxidoreductase (TP53I3,PIG3)","MHHHHHHSSGVDLGTENLYFQSMLAVHFDKPGGPENLYVKEVAKPSPGEGEVLLKVAASALNRADLMQRQGQYDPPPGASNILGLEASGHVAELGPGCQGHWKIGDTAMALLPGGGQAQYVTVPEGLLMPIPEGLTLTQAAAIPEAWLTAFQLLHLVGNVQAGDYVLIHAGLSGVGTAAIQLTRMAGAIPLVTAGSQKKLQMAEKLGAAAGFNYKKEDFSEATLKFTKGAGVNLILDCIGGSYWEKNVNCLALDGRWVLYGLMGGGDINGPLFSKLLFKRGSLITSLLRSRDNKYKQMLVNAFTEQILPHFSTEGPQRLLPVLDRIYPVTEIQEAHKYMEANKNIGKIVLELPQ","Homo sapiens","TP53I3, PIG3","QUINONE OXIDOREDUCTASE","1","2J8Z"
"2J90",,"X-RAY DIFFRACTION",2.47,50.3,,8,"30% PEG 1000 0.1M SPG BUFFER PH 8.0",,"10.1038/emboj.2008.8",,"2J90",71.32,"2","2","Crystal structure of human ZIP kinase in complex with a tetracyclic pyridone inhibitor (Pyridone 6)","MHHHHHHSSGVDLGTENLYFQSMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNVRGEDSG","Homo sapiens","DAPK3, ZIPK","DEATH-ASSOCIATED PROTEIN KINASE 3","1","2J90"
"2J91",,"X-RAY DIFFRACTION",2.08,41,,,,,,,"2J91",230.78,"1.8","1.8","Crystal structure of Human Adenylosuccinate Lyase in complex with AMP","MHHHHHHSSGVDLGTENLYFQSMAAGGDHGSPDSYRSPLASRYASPEMCFVFSDRYKFRTWRQLWLWLAEAEQTLGLPITDEQIREMKSNLENIDFKMAAEEEKRLRHDVMAHVHTFGHCCPKAAGIIHLGATSCYVGDNTDLIILRNALDLLLPKLARVISRLADFAKERASLPTLGFTHFQPAQLTTVGKRCCLWIQDLCMDLQNLKRVRDDLRFRGVKGTTGTQASFLQLFEGDDHKVEQLDKMVTEKAGFKRAFIITGQTYTRKVDIEVLSVLASLGASVHKICTDIRLLANLKEMEEPFEKQQIGSSAMPYKRNPMRSERCCSLARHLMTLVMDPLQTASVQWFERTLDDSANRRICLAEAFLTADTILNTLQNISEGLVVYPKVIERRIRQELPFMATENIIMAMVKAGGSRQDCHEKIRVLSQQAASVVKQEGGDNDLIERIQVDAYFSPIHSQLDHLLDPSSFTGRASQQVQRFLEEEVYPLLKPYESVMKVKAE","Homo sapiens","ADSL, AMPS","ADENYLOSUCCINATE LYASE","1","2J91"
"2J94",,"X-RAY DIFFRACTION",2.39,33.72,,6.75,"18% PEG6K, 50MM MES PH 5.85, 5MM CACL2, 50MM NACL",,"10.1021/jm060870c","G15","2J94",44.29,"2.1","2.1","CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX","EEMKKGHLERECMEETCSYEEAREVFEDSDKTNEFWNKYKDGDQCETSPCQNQGKCKDGLGEYTCTCLEGFEGKNCELFTRKLCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACIPTGPYPCGKQTLER","Homo sapiens","F10","COAGULATION FACTOR X","2","2J94"
,,,,,,,,,,,,,,,,"IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTRGLPKAKSHAPEVITSSPLK","Homo sapiens","F10","COAGULATION FACTOR X","1","2J94"
"2J95",,"X-RAY DIFFRACTION",2.45,35.53,,5.85,"18% PEG 6K, 100MM MES PH5.75, 10MM CACL2, pH 5.85",,"10.1021/jm060870c","GSX","2J95",44.31,"2.01","2.01","CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX","IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTRGLPKAKSHAPEVITSSPLK","Homo sapiens","F10","ACTIVATED FACTOR XA HEAVY CHAIN","1","2J95"
,,,,,,,,,,,,,,,,"EEMKKGHLERECMEETCSYEEAREVFEDSDKTNEFWNKYKDGDQCETSPCQNQGKCKDGLGEYTCTCLEGFEGKNCELFTRKLCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACIPTGPYPCGKQTLER","Homo sapiens","F10","ACTIVATED FACTOR XA LIGHT CHAIN","2","2J95"
"2J9H",,"X-RAY DIFFRACTION",2.24,44.62,"VAPOR DIFFUSION, SITTING DROP",7.4,"SITTING DROP VAPOUR TECHNIQUE, 1 MICROLITRE OF PROTEIN AT 10 MG/ML IN 20 MM TRIS-HCL, PH 8.0 CONTAINING 5MM S-HEXYLGLUTATHIONE WAS MIXED WITH 1 MICROLITRE OF RESERVOIR SOLUTION, COMPOSED OF 1.5M AMMONIUM SULFATE AND 100MM SODIUM CITRATE",,"10.1016/j.jmb.2007.12.013","GTX","2J9H",47.09,"2.4","2.4","Crystal structure of human glutathione-S-transferase P1-1 cys-free mutant in complex with S-hexylglutathione at 2.4 A resolution","PPYTVVYFPVRGRSAALRMLLADQGQSWKEEVVTVETWQEGSLKASALYGQLPKFQDGDLTLYQSNTILRHLGRTLGLYGKDQQEAALVDMVNDGVEDLRAKYISLIYTNYEAGKDDYVKALPGQLKPFETLLSQNQGGKTFIVGDQISFADYNLLDLLLIHEVLAPGSLDAFPLLSAYVGRLSARPKLKAFLASPEYVNLPINGNGKQ","Homo sapiens","GSTP1, FAEES3, GST3","GLUTATHIONE S-TRANSFERASE P","1","2J9H"
"2J9L",,"X-RAY DIFFRACTION",2.8,56.2,,,"200 MM (NH4)2SO4, 10 MM TRIS HCL (PH 7.4), 18% PEG 4000",,"10.1038/nsmb1188","ATP","2J9L",129.86,"2.3","2.3","Cytoplasmic Domain of the Human Chloride Transporter ClC-5 in complex with ATP","MEAKEEFAHKTLAMDVMKPRRNDPLLTVLTQDSMTVEDVETIISETTYSGFPVVVSRESQRLVGFVLRRDLIISIENARKKQDGVVSTSIIYFTEHSPPLPPYTPPTLKLRNILDLSPFTVTDLTPMEIVVDIFRKLGLRQCLVTHNGRLLGIITKKDVLKHIAQMANQDPDSILFNEFLEVLFQ","Homo sapiens","CLCN5, CLCK2","CHLORIDE CHANNEL PROTEIN 5","1","2J9L"
"2J9M",,"X-RAY DIFFRACTION",2.07,40.1,,7.8,"pH 7.8",,"10.1002/cmdc.200600199","PY8","2J9M",34.36,"2.5","2.5","Crystal Structure of CDK2 in complex with Macrocyclic Aminopyrimidine","MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","CELL DIVISION PROTEIN KINASE 2","1","2J9M"
"2J9Q",,"X-RAY DIFFRACTION",2.35,39.53,,8.75,"23% (W/V) PEG 3350, 100 MM TRIS-HCL (PH 8.75) AND 10 MM SRCL2",,"10.1186/1472-6807-7-24",,"2J9Q",72.43,"2.65","2.65","A novel conformation for the TPR domain of pex5p","GMGLTSATYDKGYQFEEENPLRDHPQPFEEGLRRLQEGDLPNAVLLFEAAVQQDPKHMEAWQYLGTTQAENEQELLAISALRRCLELKPDNQTALMALAVSFTNESLQRQACEILRDWLRYTPAYAHLVTPAEEGAGGAGLGPSKRILGSLLSDSLFLEVKELFLAAVRLDPTSIDPDVQCGLGVLFNLSGEYDKAVDCFTAALSVRPNDYLLWNKLGATLANGNQSEEAVAAYRRALELQPGYIRSRYNLGISCINLGAHREAVEHFLEALNMQRKSRGPRGEGGAMSENIWSTLRLALSMLGQSDAYGAADARDLSTLLTMFGLPQ","Homo sapiens","PEX5, PXR1","PEROXISOMAL TARGETING SIGNAL 1 RECEPTOR","1","2J9Q"
"2JA3",,"X-RAY DIFFRACTION",3.19,61.47,,,"200 MM (NH4)2SO4, 10 MM TRIS HCL (PH 7.4) AND 18 % PEG 4000",,"10.1038/nsmb1188","ADP","2JA3",129.02,"3.05","3.05","Cytoplasmic Domain of the Human Chloride Transporter ClC-5 in complex with ADP","MEAKEEFAHKTLAMDVMKPRRNDPLLTVLTQDSMTVEDVETIISETTYSGFPVVVSRESQRLVGFVLRRDLIISIENARKKQDGVVSTSIIYFTEHSPPLPPYTPPTLKLRNILDLSPFTVTDLTPMEIVVDIFRKLGLRQCLVTHNGRLLGIITKKDVLKHIAQMANQDPDSILFNEFLEVLFQ","Homo sapiens","CLCN5, CLCK2","CHLORIDE CHANNEL PROTEIN 5","1","2JA3"
"2JA4",,"X-RAY DIFFRACTION",3.7,67.4,,7.4,"15-25% PEG 8000, 100 MM NAAC PH 4.4, 200 MM LI2SO4",,"10.1074/jbc.M611699200",,"2JA4",11.32,"2.21","2.21","Crystal structure of CD5 domain III reveals the fold of a group B scavenger cysteine-rich receptor","AFQPKVQSRLVGGSSICEGTVEVRQGAQWAALCDSSSARSSLRWEEVCREQQCGSVNSYRVLDAGDPTSRGLFCPHQKLSQCHELWERNSYCKKVFVTCQD","Homo sapiens","CD5, LEU1","T-CELL SURFACE GLYCOPROTEIN CD5","1","2JA4"
"2JAI",,"X-RAY DIFFRACTION",2.42,50,"MICROBATCH",,"PROTEIN: 20MG/ML IN 20MM TRIS-HCL PH 8.0, 150MM NACL, 1MM DTT PRECIPITANT: 50MM TRIS-HCL PH 8.5, 150-300MM SODIUM ACETATE, 20-30% W/V PEG4000, 1MM DTT CO-CRYSTALLISED WITH 10MM LIGAND IN PRECIPITATING SOLUTION EXPT:SITTING DROPS UNDER MINERAL OIL AT 16DEG C",289,"10.1038/nm1543","CIR","2JAI",63.99,"2.3","2.3","DDAH1 complexed with citrulline","GPLGMAGLGHPAAFGRATHAVVRALPESLGQHALRSAKGEEVDVARAERQHQLYVGVLGSKLGLQVVELPADESLPDCVFVEDVAVVCEETALITRPGAPSRRKEVDMMKEALEKLQLNIVEMKDENATLDGGDVLFTGREFFVGLSKRTNQRGAEILADTFKDYAVSTVPVADGLHLKSFCSMAGPNLIAIGSSESAQKALKIMQQMSDHRYDKLTVPDDIAANCIYLNIPNKGHVLLHRTPEEYPESAKVYEKLKDHMLIPVSMSELEKVDGLLTCCSVLINKKVDS","Homo sapiens","DDAH1, DDAH","NG, NG-DIMETHYLARGININE DIMETHYLAMINOHYDROLASE 1","1","2JAI"
"2JAJ",,"X-RAY DIFFRACTION",2.46,49,"MICROBATCH",,"PROTEIN: 20MG/ML IN 20MM TRIS-HCL PH 8.0, 150MM NACL, 1MM DTT. PRECIPITANT: 50MM TRIS-HCL PH 8.5, 150-300MM SODIUM ACETATE, 20-30% W/V PEG4000, 1MM DTT CO-CRYSTALLISED WITH 10MM LIGAND IN PRECIPITATING SOLUTION EXPT:SITTING DROPS UNDER MINERAL OIL AT 16DEG C",289,"10.1038/nm1543","D20","2JAJ",63.44,"2","2","DDAH1 complexed with L-257","GPLGMAGLGHPAAFGRATHAVVRALPESLGQHALRSAKGEEVDVARAERQHQLYVGVLGSKLGLQVVELPADESLPDCVFVEDVAVVCEETALITRPGAPSRRKEVDMMKEALEKLQLNIVEMKDENATLDGGDVLFTGREFFVGLSKRTNQRGAEILADTFKDYAVSTVPVADGLHLKSFCSMAGPNLIAIGSSESAQKALKIMQQMSDHRYDKLTVPDDIAANCIYLNIPNKGHVLLHRTPEEYPESAKVYEKLKDHMLIPVSMSELEKVDGLLTCCSVLINKKVDS","Homo sapiens","DDAH1, DDAH","NG, NG-DIMETHYLARGININE DIMETHYLAMINOHYDROLASE 1","1","2JAJ"
"2JAK",,"X-RAY DIFFRACTION",2.9,57.6,,,"29% MPD 0.1M TRIS, PH 8.0 20MM L-PROLINE",,"10.1002/prot.22150",,"2JAK",45.86,"2.6","2.6","Human PP2A regulatory subunit B56g","MHHHHHHSSGVDLGTENLYFQSMVVDAANSNGPFQPVVLLHIRDVPPADQEKLFIQKLRQCCVLFDFVSDPLSDLKWKEVKRAALSEMVEYITHNRNVITEPIYPEVVHMFAVNMFRTLPPSSNPTGAEFDPEEDEPTLEAAWPHLQLVYEFFLRFLESPDFQPNIAKKYIDQKFVLQLLELFDSEDPRERDFLKTTLHRIYGKFLGLRAYIRKQINNIFYRFIYETEHHNGIAELLEILGSIINGFALPLKEEHKIFLLKVLLPLHKVKSLSVYHPQLAYCVVQFLEKDSTLTEPVVMALLKYWPKTHSPKEVMFLNELEEILDVIEPSEFVKIMEPLFRQLAKCVSSPHFQVAERALYYWNNEYIMSLISDNAAKILPIMFPSLYRNSKT","Homo sapiens","PPP2R5C, KIAA0044","SERINE/THREONINE-PROTEIN PHOSPHATASE 2A 56 KDA REGULATORY SUBUNIT GAMMA ISOFORM","1","2JAK"
"2JAU",,"X-RAY DIFFRACTION",3.2,61.6,"VAPOR DIFFUSION, HANGING DROP",4.5,"20% PEG8000, 0.050 M POTASSIUM DIHYDROGEN PHOSPHATE, PH 4.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K",293,"10.1021/bi7014794",,"2JAU",23.33,"1.8","1.8","Crystal structure of D41N variant of human mitochondrial 5'(3')- deoxyribonucleotidase (mdN) in complex with 3'-azidothymidine 5'- monophosphate","GGRALRVLVNMDGVLADFEGGFLRKFRARFPDQPFIALEDRRGFWVSEQYGRLRPGLSEKAISIWESKNFFFELEPLPGAVEAVKEMASLQNTDVFICTSPIKMFKYCPYEKYAWVEKYFGPDFLEQIVLTRDKTVVSADLLIDDRPDITGAEPTPSWEHVLFTACHNQHLQLQPPRRRLHSWADDWKAILDSKRPC","Homo sapiens","NT5M, DNT2","5'(3')-DEOXYRIBONUCLEOTIDASE","1","2JAU"
"2JAV",,"X-RAY DIFFRACTION",2.39,48.52,"VAPOR DIFFUSION, SITTING DROP",,"10% PEG6000, 200 MM MGCL2. SITTING DROPS, 150NL AND 50NL PROTEIN AND RESERVOIR MIX.",,"10.1074/jbc.M609721200","5Z5","2JAV",32.96,"2.2","2.2","Human Kinase with pyrrole-indolinone ligand","MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHHHHHH","Homo sapiens","NEK2, NEK2A, NLK1","SERINE/THREONINE-PROTEIN KINASE NEK2","1","2JAV"
"2JAW",,"X-RAY DIFFRACTION",3.2,61.6,"VAPOR DIFFUSION, HANGING DROP",4.5,"20% PEG8000, 0.050 M POTASSIUM DIHYDROGEN PHOSPHATE, PH 4.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K",293,"10.1021/bi7014794",,"2JAW",23.3,"1.95","1.95","Crystal structure of D41N variant of human mitochondrial 5'(3')- deoxyribonucleotidase (mdN) in complex with 5-bromovinyldeoxyuridine 5'-monophosphate","GGRALRVLVNMDGVLADFEGGFLRKFRARFPDQPFIALEDRRGFWVSEQYGRLRPGLSEKAISIWESKNFFFELEPLPGAVEAVKEMASLQNTDVFICTSPIKMFKYCPYEKYAWVEKYFGPDFLEQIVLTRDKTVVSADLLIDDRPDITGAEPTPSWEHVLFTACHNQHLQLQPPRRRLHSWADDWKAILDSKRPC","Homo sapiens","NT5M, DNT2","5'(3')-DEOXYRIBONUCLEOTIDASE","1","2JAW"
"2JBH",,"X-RAY DIFFRACTION",2.8,56.4,,6.1,"100 MM SODIUM CACODYLATE PH 6.1, 200 MM CALCIUM ACETATE, 34% PEG 300",,"10.1111/j.1742-4658.2010.07897.x",,"2JBH",52.7,"1.7","1.7","Human phosphoribosyl transferase domain containing 1","MAGSSEEAPDYGRGVVIMDDWPGYDLNLFTYPQHYYGDLEYVLIPHGIIVDRIERLAKDIMKDIGYSDIMVLCVLKGGYKFCADLVEHLKNISRNSDRFVSMKVDFIRLKSYRNDQSMGEMQIIGGDDLSTLAGKNVLIVEDVVGTGRTMKALLSNIEKYKPNMIKVASLLVKRTSRSDGFRPDYAGFEIPNLFVVGYALDYNEYFRDLNHICVINEHGKEKYRV","Homo sapiens","PRTFDC1, HHGP","PHOSPHORIBOSYLTRANSFERASE DOMAIN-CONTAINING PROTEIN 1","1","2JBH"
"2JBJ",,"X-RAY DIFFRACTION",3.18,61.02,,,"20 MM HEPES PH 7.25, 200 MM NACL, 5% (W/V) PEG 400 AND 15% (W/V) PEG 1500.",,"10.1107/S090744490700902X","G88","2JBJ",82.73,"2.19","2.19","membrane-bound glutamate carboxypeptidase II (GCPII) in complex with 2-PMPA (2-phosphonoMethyl-pentanedioic acid)","KSSNEATNITPKHNMKAFLDELKAENIKKFLYNFTQIPHLAGTEQNFQLAKQIQSQWKEFGLDSVELAHYDVLLSYPNKTHPNYISIINEDGNEIFNTSLFEPPPPGYENVSDIVPPFSAFSPQGMPEGDLVYVNYARTEDFFKLERDMKINCSGKIVIARYGKVFRGNKVKNAQLAGAKGVILYSDPADYFAPGVKSYPDGWNLPGGGVQRGNILNLNGAGDPLTPGYPANEYAYRRGIAEAVGLPSIPVHPIGYYDAQKLLEKMGGSAPPDSSWRGSLKVPYNVGPGFTGNFSTQKVKMHIHSTNEVTRIYNVIGTLRGAVEPDRYVILGGHRDSWVFGGIDPQSGAAVVHEIVRSFGTLKKEGWRPRRTILFASWDAEEFGLLGSTEWAEENSRLLQERGVAYINADSSIEGNYTLRVDCTPLMYSLVHNLTKELKSPDEGFEGKSLYESWTKKSPSPEFSGMPRISKLGSGNDFEVFFQRLGIASGRARYTKNWETNKFSGYPLYHSVYETYELVEKFYDPMFKYHLTVAQVRGGMVFELANSIVLPFDCRDYAVVLRKYADKIYSISMKHPQEMKTYSVSFDSLFSAVKNFTEIASKFSERLQDFDKSNPIVLRMMNDQLMFLERAFIDPLGLPDRPFYRHVIYAPSSHNKYAGESFPGIYDALFDIESKVDPSKAWGEVKRQIYVAAFTVQAAAETLSEVA","Homo sapiens","FOLH1, FOLH, NAALAD1, PSM, PSMA, GIG27","GLUTAMATE CARBOXYPEPTIDASE 2","1","2JBJ"
"2JBK",,"X-RAY DIFFRACTION",3.48,64.42,,7,"20 MM HEPES PH 7.25, 200 MM NACL, 5% (W/V) PEG 400 AND 15% (W/V) PEG 1500.",,"10.1107/S090744490700902X","QUS","2JBK",82.7,"2.99","2.99","membrane-bound glutamate carboxypeptidase II (GCPII) in complex with quisqualic acid (quisqualate, alpha-amino-3,5-dioxo-1,2,4- oxadiazolidine-2-propanoic acid)","KSSNEATNITPKHNMKAFLDELKAENIKKFLYNFTQIPHLAGTEQNFQLAKQIQSQWKEFGLDSVELAHYDVLLSYPNKTHPNYISIINEDGNEIFNTSLFEPPPPGYENVSDIVPPFSAFSPQGMPEGDLVYVNYARTEDFFKLERDMKINCSGKIVIARYGKVFRGNKVKNAQLAGAKGVILYSDPADYFAPGVKSYPDGWNLPGGGVQRGNILNLNGAGDPLTPGYPANEYAYRRGIAEAVGLPSIPVHPIGYYDAQKLLEKMGGSAPPDSSWRGSLKVPYNVGPGFTGNFSTQKVKMHIHSTNEVTRIYNVIGTLRGAVEPDRYVILGGHRDSWVFGGIDPQSGAAVVHEIVRSFGTLKKEGWRPRRTILFASWDAEEFGLLGSTEWAEENSRLLQERGVAYINADSSIEGNYTLRVDCTPLMYSLVHNLTKELKSPDEGFEGKSLYESWTKKSPSPEFSGMPRISKLGSGNDFEVFFQRLGIASGRARYTKNWETNKFSGYPLYHSVYETYELVEKFYDPMFKYHLTVAQVRGGMVFELANSIVLPFDCRDYAVVLRKYADKIYSISMKHPQEMKTYSVSFDSLFSAVKNFTEIASKFSERLQDFDKSNPIVLRMMNDQLMFLERAFIDPLGLPDRPFYRHVIYAPSSHNKYAGESFPGIYDALFDIESKVDPSKAWGEVKRQIYVAAFTVQAAAETLSEVA","Homo sapiens","FOLH1, FOLH, NAALAD1, PSM, PSMA, GIG27","GLUTAMATE CARBOXYPEPTIDASE 2","1","2JBK"
"2JBM",,"X-RAY DIFFRACTION",2.45,49.41,,,,,"10.1016/j.jmb.2007.08.043",,"2JBM",373.48,"2","2","QPRTASE STRUCTURE FROM HUMAN","GAMDAEGLALLLPPVTLAALVDSWLREDCPGLNYAALVSGAGPSQAALWAKSPGVLAGQPFFDAIFTQLNCQVSWFLPEGSKLVPVARVAEVRGPAHCLLLGERVALNTLARCSGIASAAAAAVEAARGAGWTGHVAGTRKTTPGFRLVEKYGLLVGGAASHRYDLGGLVMVKDNHVVAAGGVEKAVRAARQAADFALKVEVECSSLQEAVQAAEAGADLVLLDNFKPEELHPTATVLKAQFPSVAVEASGGITLDNLPQFCGPHIDVISMGMLTQAAPALDFSLKLFAKEVAPVPKIH","Homo sapiens","QPRT","NICOTINATE-NUCLEOTIDE PYROPHOSPHORYLASE","1","2JBM"
"2JBO",,"X-RAY DIFFRACTION",4.5,72.9,,4.5,"1.5-1.6M SODIUM POTASSIUM PHOSPHATE PH 4.5, 0.014M DEOXY-BIGCHAP. THE INHIBITOR WAS SOAKED INTO CRYSTALS GROWN INITIALLY FROM MK2-ADP",,"10.1016/j.jmb.2007.03.004","P4O","2JBO",38.1,"3.1","3.1","Protein kinase MK2 in complex with an inhibitor (crystal form-1, soaking)","GSQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMR","Homo sapiens","MAPKAPK2","MAP KINASE-ACTIVATED PROTEIN KINASE 2","1","2JBO"
"2JBP",,"X-RAY DIFFRACTION",3,59.1,,7.5,"1.8-2.0M SODIUM POTTASIUM PHOSPHATE PH 7.5, 0.0003M INHIBITOR",,"10.1016/j.jmb.2007.03.004","P4O","2JBP",455.73,"3.31","3.31","Protein kinase MK2 in complex with an inhibitor (crystal form-2, co- crystallization)","GSQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMR","Homo sapiens","MAPKAPK2","MAP KINASE-ACTIVATED PROTEIN KINASE 2","1","2JBP"
"2JC2",,"X-RAY DIFFRACTION",2.51,50.52,,5.7,"AMMONIUM SULFATE 1.0M, PH 5.7, 12% V/V DIOXANE",,"10.1096/fj.07-8988com",,"2JC2",87.22,"2.5","2.5","The crystal structure of the natural F112L human sorcin mutant","MAYPGHPGAGGGYYPGGYGGAPGGPAFPGQTQDPLYGYFAAVAGQDGQIDADELQRCLTQSGIAGGYKPFNLETCRLMVSMLDRDMSGTMGFNEFKELWAVLNGWRQHFISLDTDRSGTVDPQELQKALTTMGFRLSPQAVNSIAKRYSTNGKITFDDYIACCVKLRALTDSFRRRDTAQQGVVNFPYDDFIQCVMSV","Homo sapiens","SRI","SORCIN","1","2JC2"
"2JC6",,"X-RAY DIFFRACTION",2.59,52,,,"0.1M CITRATE PH 5.6, 20% ISOPROPANOL, 20% PEG 4K.",,,,"2JC6",76.38,"2.3","2.3","Crystal structure of human calmodulin-dependent protein kinase 1D","SMARENGESSSSWKKQAEDIKKIFEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLDAVYYLHRMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDSKLFEQILKAEYEFDSPYWDDISDSAKDFIRNLMEKDPNKRYTCEQAARHPWIAGDTALNKNIHESVSAQIRKNFAKSKWRQAFNATAVVRHMRKLHLGSSLDSSNA","Homo sapiens","CAMK1D, CAMKID","CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 1D","1","2JC6"
"2JC9",,"X-RAY DIFFRACTION",3.16,61.13,,8.5,"1.8 M MAGNESIUM SULFATE, 0.1 M TRIS PH 8.5",,"10.1074/jbc.M700917200",,"2JC9",65.31,"1.5","1.5","Crystal structure of Human Cytosolic 5'-Nucleotidase II in complex with adenosine","MGSSHHHHHHSSGLVPRGSMSTSWSDRLQNAADMPANMDKHALKKYRREAYHRVFVNRSLAMEKIKCFGFDMDYTLAVYKSPEYESLGFELTVERLVSIGYPQELLSFAYDSTFPTRGLVFDTLYGNLLKVDAYGNLLVCAHGFNFIRGPETREQYPNKFIQRDDTERFYILNTLFNLPETYLLACLVDFFTNCPRYTSCETGFKDGDLFMSYRSMFQDVRDAVDWVHYKGSLKEKTVENLEKYVVKDGKLPLLLSRMKEVGKVFLATNSDYKYTDKIMTYLFDFPHGPKPGSSHRPWQSYFDLILVDARKPLFFGEGTVLRQVDTKTGKLKIGTYTGPLQHGIVYSGGSSDTICDLLGAKGKDILYIGDHIFGDILKSKKRQGWRTFLVIPELAQELHVWTDKSSLFEELQSLDIFLAELYKHLDSSSNERPDISSIQRRIKKVTHDMDMCYGMMGSLFRSGSRQTLFASQVMRYADLYAASFINLLYYPFSYLFRAAHVLMPHESTVEHTHVDINEMESPLATRNRTSVDFKDTDYKRHQLTRSISEIKPPNL","Homo sapiens","NT5C2, NT5B, NT5CP, PNT5","CYTOSOLIC PURINE 5'-NUCLEOTIDASE","1","2JC9"
"2JCM",,"X-RAY DIFFRACTION",3.16,61.13,,8.5,"1.8 M MAGNESIUM SULFATE, 0.1 M TRIS PH 8.5",,"10.1074/jbc.M700917200",,"2JCM",64.37,"2.15","2.15","Crystal structure of Human Cytosolic 5'-Nucleotidase II in complex with beryllium trifluoride","MGSSHHHHHHSSGLVPRGSMSTSWSDRLQNAADMPANMDKHALKKYRREAYHRVFVNRSLAMEKIKCFGFDMDYTLAVYKSPEYESLGFELTVERLVSIGYPQELLSFAYDSTFPTRGLVFDTLYGNLLKVDAYGNLLVCAHGFNFIRGPETREQYPNKFIQRDDTERFYILNTLFNLPETYLLACLVDFFTNCPRYTSCETGFKDGDLFMSYRSMFQDVRDAVDWVHYKGSLKEKTVENLEKYVVKDGKLPLLLSRMKEVGKVFLATNSDYKYTDKIMTYLFDFPHGPKPGSSHRPWQSYFDLILVDARKPLFFGEGTVLRQVDTKTGKLKIGTYTGPLQHGIVYSGGSSDTICDLLGAKGKDILYIGDHIFGDILKSKKRQGWRTFLVIPELAQELHVWTDKSSLFEELQSLDIFLAELYKHLDSSSNERPDISSIQRRIKKVTHDMDMCYGMMGSLFRSGSRQTLFASQVMRYADLYAASFINLLYYPFSYLFRAAHVLMPHESTVEHTHVDINEMESPLATRNRTSVDFKDTDYKRHQLTRSISEIKPPNL","Homo sapiens","NT5C2, NT5B, NT5CP, PNT5","CYTOSOLIC PURINE 5'-NUCLEOTIDASE","1","2JCM"
"2JCN",,"X-RAY DIFFRACTION",2.04,39.2,,7.5,"22% PEG3350, 20% GLYCEROL, 0.2M SODIUM SULPHATE, 2MM TCEP, 0.3M NACL, 20 MM HEPES PH7.5, pH 7.50",,,,"2JCN",19.42,"1.8","1.8","The crystal structure of BAK1 - a mitochondrial apoptosis regulator","SMSASEEQVAQDTEEVFRSYVFYRHQQEQEAEGVAAPADPEMVTLPLQPSSTMGQVGRQLAIIGDDINRRYDSEFQTMLQHLQPTAENAYEYFTKIATSLFESGINWGRVVALLGFGYRLALHVYQHGLTGFLGQVTRFVVDFMLHHCIARWIAQRGGWVAALNLGNGPILN","Homo sapiens","BAK1, BAK, BCL2L7, CDN1","BCL-2 HOMOLOGOUS ANTAGONIST/KILLER","1","2JCN"
"2JDF",,"X-RAY DIFFRACTION",1.88,39.9,,,,,"10.1016/j.jmb.2007.06.045",,"2JDF",21.87,"1.7","1.7","Human gamma-B crystallin","GKITFYEDRAFQGRSYECTTDCPNLQPYFSRCNSIRVESGCWMIYERPNYQGHQYFLRRGEYPDYQQWMGLSDSIRSCCLIPPHSGAYRMKIYDRDELRGQMSELTDDCLSVQDRFHLTEIHSLNVLEGSWILYEMPNYRGRQYLLRPGEYRRFLDWGAPNAKVGSLRRVMDLYLEHHHHHH","Homo sapiens","CRYGB, CRYG2","GAMMA CRYSTALLIN B","1","2JDF"
"2JDG",,"X-RAY DIFFRACTION",1.89,34.33,,,,,"10.1016/j.jmb.2007.06.045",,"2JDG",21.82,"2","2","Affilin based on HUMAN GAMMA-B CRYSTALLIN","MGSIIFLEDRAFQGRIYGCTTDCPNLQPYFSRCNSIVVQSGCWMIYERPNYQGHQYFLRRGEYPDYQQWMGLSDSIRSCCLIPPHSGAYRMKIYDRDELRGQMSELTDDCLSVQDRFHLTEIHSLNVLEGSWILYEMPNYRGRQYLLRPGEYRRFLDWGAPNAKVGSLRRVMDLYLEHHHHHH","Homo sapiens","CRYGB, CRYG2","GAMMA CRYSTALLIN B","1","2JDG"
"2JDW",,"X-RAY DIFFRACTION",3.8,65,,7,"1 PART OF AT38H (13-16 MG/ML) 2 PARTS OF PRECIPITANT (3% PEG 6000, 40 MM HEPES, 1MM GLUTATHIONE, PH7.0), SEVERAL DAYS AT ROOM TEMPERATURE, MACRO SEEDING.",,"10.1093/emboj/16.12.3373",,"2JDW",48.52,"2.1","2.1","CRYSTAL STRUCTURE AND MECHANISM OF L-ARGININE: GLYCINE AMIDINOTRANSFERASE: A MITOCHONDRIAL ENZYME INVOLVED IN CREATINE BIOSYNTHESIS","MLRVRCLRGGSRGAEAVHYIGSRLGRTLTGWVQRTFQSTQAATASSRNSCAADDKATEPLPKDCPVSSYNEWDPLEEVIVGRAENACVPPFTIEVKANTYEKYWPFYQKQGGHYFPKDHLKKAVAEIEEMCNILKTEGVTVRRPDPIDWSLKYKTPDFESTGLYSAMPRDILIVVGNEIIEAPMAWRSRFFEYRAYRSIIKDYFHRGAKWTTAPKPTMADELYNQDYPIHSVEDRHKLAAQGKFVTTEFEPCFDAADFIRAGRDIFAQRSQVTNYLGIEWMRRHLAPDYRVHIISFKDPNPMHIDATFNIIGPGIVLSNPDRPCHQIDLFKKAGWTIITPPTPIIPDDHPLWMSSKWLSMNVLMLDEKRVMVDANEVPIQKMFEKLGITTIKVNIRNANSLGGGFHCWTCDVRRRGTLQSYLD","Homo sapiens","AT38H, GATM, AGAT","L-ARGININE\:GLYCINE AMIDINOTRANSFERASE","1","2JDW"
"2JDX",,"X-RAY DIFFRACTION",3.83,68,,7,"pH 7.0",,"10.1074/jbc.274.5.3026",,"2JDX",44.21,"2.9","2.9","CRYSTAL STRUCTURE OF HUMAN L-ARGININE:GLYCINE AMIDINOTRANSFERASE, DELETIONMUTANT ATDELTAM302","STQAATASSRNSCAADDKATEPLPKDCPVSSYNEWDPLEEVIVGRAENACVPPFTIEVKANTYEKYWPFYQKQGGHYFPKDHLKKAVAEIEEMCNILKTEGVTVRRPDPIDWSLKYKTPDFESTGLYSAMPRDILIVVGNEIIEAPMAWRSRFFEYRAYRSIIKDYFHRGAKWTTAPKPTMADELYNQDYPIHSVEDRHKLAAQGKFVTTEFEPCFDAADFIRAGRDIFAQRSQVTNYLGIEWMRRHLAPDYRVHIISFKDPNPHIDATFNIIGPGIVLSNPDRPCHQIDLFKKAGWTIITPPTPIIPDDHPLWMSSKWLSMNVLMLDEKRVMVDANEVPIQKMFEKLGITTIKVNIRNANSLGGGFHCWTCDVRRRGTLQSYLD","Homo sapiens","AT38H, GATM, AGAT","PROTEIN (L-ARGININE:GLYCINE AMIDINOTRANSFERASE)","1","2JDX"
"2JE0",,"X-RAY DIFFRACTION",3.03,59.14,,5.5,"pH 5.50",,"10.1110/ps.072803507",,"2JE0",102.9,"2.4","2.4","Crystal Structure of pp32","MEMGRRIHLELRNRTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSIANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD","Homo sapiens","ANP32A, C15orf1, LANP, MAPM, PHAP1","ACIDIC LEUCINE-RICH NUCLEAR PHOSPHOPROTEIN 32 FAMILY MEMBER A","1","2JE0"
"2JE1",,"X-RAY DIFFRACTION",3.17,60.94,,5.5,"pH 5.50",,"10.1110/ps.072803507",,"2JE1",68.01,"2.69","2.69","The crystal Structure of the tumor supressor protein pp32 (Anp32a) :structural insights into the Anp32 family of proteins","MEMGRRIHLELRNRTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSIANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD","Homo sapiens","ANP32A, C15orf1, LANP, MAPM, PHAP1","ACIDIC LEUCINE-RICH NUCLEAR PHOSPHOPROTEIN 32 FAMILY MEMBER A","1","2JE1"
"2JED",,"X-RAY DIFFRACTION",3.14,56,"VAPOR DIFFUSION",6.5,"VAPOR DIFFUSION AT 4C PROTEIN SOLUTION: 10MG/ML PROTEIN IN 0.2M NACL, 0.05M IMIDAZOLE, 0.001M NAF, 0.05M TCEP, PH = 8.0 RESERVOIR SOLUTION: 0.1 M NA-CACODYLATE PH = 6.5 24% MPD (V/V) 4% PEG8000 (W/V) DROP: 1:1 SMALL ORGANIC MOLECULES LIKE 2,5-HEXANEDIOL AND SULFOBETAINE-195 HAVE A POSITIVE EFFECT ON THE CRYSTAL GROWTH",277,,,"2JED",84.67,"2.32","2.32","The crystal structure of the kinase domain of the protein kinase C theta in complex with NVP-XAA228 at 2.32A resolution.","EPELNKERPSLQIKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEELERKEIDPPFRPKVKSPFDCSNFDKEFLNEKPRLSFADRALINSMDQNMFRNFSFMNPGMERLISHHHHHH","Homo sapiens","PRKCQ, PRKCT","PROTEIN KINASE C THETA","1","2JED"
"2JEO",,"X-RAY DIFFRACTION",2.6,53,,,"0.8-1.0 M SUCCINIC ACID PH 6.7-7.3",,,,"2JEO",28.24,"2.5","2.5","Crystal structure of human uridine-cytidine kinase 1","MHHHHHHSSGVDLGTENLYFQSMRPFLIGVSGGTASGKSTVCEKIMELLGQNEVEQRQRKVVILSQDRFYKVLTAEQKAKALKGQYNFDHPDAFDNDLMHRTLKNIVEGKTVEVPTYDFVTHSRLPETTVVYPADVVLFEGILVFYSQEIRDMFHLRLFVDTDSDVRLSRRVLRDVRRGRDLEQILTQYTTFVKPAFEEFCLPTKKYADVIIPRGVDNMVAINLIVQHIQDILNGDICKWHRGGS","Homo sapiens","UCK1, URK1","URIDINE-CYTIDINE KINASE 1","1","2JEO"
"2JEV",,"X-RAY DIFFRACTION",2.61,52.9,"VAPOR DIFFUSION, HANGING DROP",7.5,"PROTEIN AT 15MG/ML IN 20 MM TRIS PH 8.0 CONTAINING 1 MM DTT, 0.1 MM EDTA, 4MM N1-ACETYLSPERMINE-S-COA. CRYSTALLIZED BY HANGING DROP VAPOUR DIFFUSION WITH 3-4 M NACL, 200 MM K/NA TARTRATE, 100 MM TRIS-HCL PH 7-8, 50 MM MGCL2",,"10.1021/bi700256z","NHQ","2JEV",42.68,"2.3","2.3","Crystal structure of human spermine,spermidine acetyltransferase in complex with a bisubstrate analog (N1-acetylspermine-S-CoA).","GSHMAKFVIRPATAADCSDILRLIKELAKYEYMEEQVILTEKDLLEDGFGEHPFYHCLVAEVPKEHWTPEGHSIVGFAMYYFTYDPWIGKLLYLEDFFVMSDYRGFGIGSEILKNLSQVAMRCRCSSMHFLVAEWNEPSINFYKRRGASDLSSEEGWRLFKIDKEYLLKMATEE","Homo sapiens","SAT1, SAT","DIAMINE ACETYLTRANSFERASE 1","1","2JEV"
"2JF5",,"X-RAY DIFFRACTION",2.83,56,,7.5,"12 % (W/V) PEG 3350, 5 MM NICKEL CHLORIDE, 5 MM COBALT CHLORIDE, 5 MM CADMIUM CHLORIDE, 5 MM MAGNESIUM CHLORIDE, 0.1 M HEPES [PH 7.5]",,"10.1038/embor.2009.55",,"2JF5",17.56,"1.95","1.95","crystal structure of Lys63-linked di-ubiquitin","MQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGG","Homo sapiens","UBC","UBIQUITIN","1","2JF5"
"2JFD",,"X-RAY DIFFRACTION",2.7,55,,8.5,"20% PEG10K, 0.04 M NAKPO4, 25% GLYCEROL, pH 8.50",,"10.1016/j.chembiol.2009.04.011",,"2JFD",186.95,"2.81","2.81","Structure of the MAT domain of human FAS","MHHHHHHSSGVDLGTENLYFQSMRLLRASGRTPEAVQKLLEQGLRHSQDLAFLSMLNDIAAVPATAMPFRGYAVLGGERGGPEVQQVPAGERPLWFICSGMGTQWRGMGLSLMRLDRFRDSILRSDEAVKPFGLKVSQLLLSTDESTFDDIVHSFVSLTAIQIGLIDLLSCMGLRPDGIVGHSLGEVACGYADGCLSQEEAVLAAYWRGQCIKEAHLPPGAMAAVGLSWEECKQRCPPGVVPACHNSKDTVTISGPQAPVFEFVEQLRKEGVFAKEVRTGGMAFHSYFMEAIAPPLLQELKKVIREPKPRSARWLSTSIPEAQWHSSLARTSSAEYNVNNLVSPVLFQEALWHVPEHAVVLEIAPHALLQAVLKRGLKPSCTIIPLMKKDHRDNLEFFLAGIGRLHLSGIDANPNALFPPVEFPA","Homo sapiens","FASN, FAS","FATTY ACID SYNTHASE","1","2JFD"
"2JFE",,"X-RAY DIFFRACTION",2.82,56.38,,6.5,"CRYSTALS GREW WITHIN SEVERAL DAYS IN THE CRYSTALLIZATION TRIAL CONTAINING 0.2 M AMMONIUM SULPHATE, MES BUFFER AT PH 6.5 AND 30 % (W/V) POLYETHYLENEGLYCOL-MONOMETHYLETHER (PEG-MME) 5500",,"10.1016/j.jmb.2007.05.034",,"2JFE",54.16,"2.7","2.7","The crystal structure of human cytosolic beta-glucosidase","MAFPAGFGWAAATAAYQVEGGWDADGKGPCVWDTFTHQGGERVFKNQTGDVACGSYTLWEEDLKCIKQLGLTHYRFSLSWSRLLPDGTTGFINQKGIDYYNKIIDDLLKNGVTPIVTLYHFDLPQTLEDQGGWLSEAIIESFDKYAQFCFSTFGDRVKQWITINEANVLSVMSYDLGMFPPGIPHFGTGGYQAAHNLIKAHARSWHSYDSLFRKKQKGMVSLSLFAVWLEPADPNSVSDQEAAKRAITFHLDLFAKPIFIDGDYPEVVKSQIASMSQKQGYPSSRLPEFTEEEKKMIKGTADFFAVQYYTTRLIKYQENKKGELGILQDAEIEFFPDPSWINVDWIYVVPWGVCKLLKYIKDTYNNPVIYITENGFPQSDPAPLDDTQRWEYFRQTFQELFKAIQLDKVNLQVYCAWSLLDNFEWNQGYSSRFGLFHVDFEDPARPRVPYTSAKEYAKIIRNNGLEAHL","Homo sapiens","GBA3, CBG, CBGL1","CYTOSOLIC BETA-GLUCOSIDASE","1","2JFE"
"2JFK",,"X-RAY DIFFRACTION",2.7,55,,8.5,"16% PEG10K 0.16M MGCL2 0.08 M TRIS PH=8.5, pH 8.50",,,,"2JFK",193.65,"2.4","2.4","Structure of the MAT domain of human FAS with malonyl-CoA","MHHHHHHSSGVDLGTENLYFQSMRLLRASGRTPEAVQKLLEQGLRHSQDLAFLSMLNDIAAVPATAMPFRGYAVLGGERGGPEVQQVPAGERPLWFICSGMGTQWRGMGLSLMRLDRFRDSILRSDEAVKPFGLKVSQLLLSTDESTFDDIVHSFVSLTAIQIGLIDLLSCMGLRPDGIVGHSLGEVACGYADGCLSQEEAVLAAYWRGQCIKEAHLPPGAMAAVGLSWEECKQRCPPGVVPACHNSKDTVTISGPQAPVFEFVEQLRKEGVFAKEVRTGGMAFHSYFMEAIAPPLLQELKKVIREPKPRSARWLSTSIPEAQWHSSLARTSSAEYNVNNLVSPVLFQEALWHVPEHAVVLEIAPHALLQAVLKRGLKPSCTIIPLMKKDHRDNLEFFLAGIGRLHLSGIDANPNALFPPVEFPAPRGTPLIS","Homo sapiens","FASN, FAS","FATTY ACID SYNTHASE","1","2JFK"
"2JFL",,"X-RAY DIFFRACTION",3.53,65.1,,6.5,"18% PEG3350,10% ETHYLENE GLYCOL, 0.15 KSCN, 0.1M BISTRIS PROPANE PH6.5, pH 6.50",,"10.1038/emboj.2008.8",,"2JFL",38.15,"2.2","2.2","CRYSTAL STRUCTURE OF HUMAN STE20-LIKE KINASE (DIPHOSPHORYLATED FORM) BOUND TO 5- AMINO-3-((4-(AMINOSULFONYL)PHENYL)AMINO)-N-(2,6- DIFLUOROPHENYL)-1H-1,2,4-TRIAZOLE-1-CARBOTHIOAMIDE","MHHHHHHSSGVDLGTENLYFQSMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPIRELIAEAKAEVTEEVEDGKE","Homo sapiens","SLK, KIAA0204, STK2","STE20-LIKE SERINE/THREONINE-PROTEIN KINASE","1","2JFL"
"2JFM",,"X-RAY DIFFRACTION",3.53,65.1,,7.5,"20% PEG3350,10% ETHYLENE GLYCOL, 0.2 KSCN, 0.1M BISTRIS PROPANE PH7.5, pH 7.50",,"10.1038/emboj.2008.8",,"2JFM",37.37,"2.85","2.85","CRYSTAL STRUCTURE OF HUMAN STE20-LIKE KINASE (UNLIGANDED FORM)","MHHHHHHSSGVDLGTENLYFQSMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPIRELIAEAKAEVTEEVEDGKE","Homo sapiens","SLK, KIAA0204, STK2","STE20-LIKE SERINE-THREONINE KINASE","1","2JFM"
"2JG4",,"X-RAY DIFFRACTION",3.8,67,"VAPOR DIFFUSION, HANGING DROP",7,"10% PEGMME 5000, 0.1M HEPES, 10%, DIAOXANE, 5% TACSIMATE, PH 7.0, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K",298,"10.1074/jbc.M701590200",,"2JG4",229.88,"2.8","2.8","Substrate-free IDE structure in its closed conformation","MHHHHHHAAGIPMNNPAIKRIGNHITKSPEDKREYRGLELANGIKVLLISDPTTDKSSAALDVHIGSLSDPPNIAGLSHFCEHMLFLGTKKYPKENEYSQFLSEHAGSSNAFTSGEHTNYYFDVSHEHLEGALDRFAQFFLCPLFDESCKDREVNAVDSEHEKNVMNDAWRLFQLEKATGNPKHPFSKFGTGNKYTLETRPNQEGIDVRQELLKFHSAYYSSNLMAVCVLGRESLDDLTNLVVKLFSEVENKNVPLPEFPEHPFQEEHLKQLYKIVPIKDIRNLYVTFPIPDLQKYYKSNPGHYLGHLIGHEGPGSLLSELKSKGWVNTLVGGQKEGARGFMFFIINVDLTEEGLLHVEDIILHMFQYIQKLRAEGPQEWVFQECKDLNAVAFRFKDKERPRGYTSKIAGILHYYPLEEVLTAEYLLEEFRPDLIEMVLDKLRPENVRVAIVSKSFEGKTDRTEEWYGTQYKQEAIPDEVIKKWQNADLNGKFKLPTKNEFIPTNFEILPLEKEATPYPALIKDTAMSKLWFKQDDKFFLPKACLNFEFFSPFAYVDPLHCNMAYLYLELLKDSLNEYAYAAELAGLSYDLQNTIYGMYLSVKGYNDKQPILLKKIIEKMATFEIDEKRFEIIKEAYMRSLNNFRAEQPHQHAMYYLRLLMTEVAWTKDELKEALDDVTLPRLKAFIPQLLSRLHIEALLHGNITKQAALGIMQMVEDTLIEHAHTKPLLPSQLVRYREVQLPDRGWFVYQQRNEVHNNCGIEIYYQTDMQSTSENMFLELFCQIISEPCFNTLRTKEQLGFIVFSGPRRANGIQGLRFIIQSEKPPHYLESRVEAFLITMEKSIEDMTEEAFQKHIQALAIRRLDKPKKLSAECAKYWGEIISQQYNFDRDNTEVAYLKTLTKEDIIKFYKEMLAVDAPRRHKVSVHVLAREMDSCPVVGEFPCQNDINLSQAPALPQPEVIQNMTEFKRGLPLFPLVKPHINFMAAKL","Homo sapiens","IDE","INSULIN DEGRADING ENZYME","1","2JG4"
"2JGA",,"X-RAY DIFFRACTION",2.6,53,,,"24% PEG1500 AND 20% GLYCEROL",,"10.1074/jbc.M700917200",,"2JGA",33.35,"3.01","3.01","Crystal structure of human cytosolic 5'-nucleotidase III in complex with phosphate and magnesium","MGSSHHHHHHSSGLVPRGSNPTRVEEIICGLIKGGAAKLQIITDFDMTLSRFSYKGKRCPTCHNIIDNCKLVTDECRRKLLQLKEKYYAIEVDPVLTVEEKYPYMVEWYTKSHGLLVQQALPKAKLKEIVAESDVMLKEGYENFFDKLQQHSIPVFIFSAGIGDVLEEVIRQAGVYHPNVKVVSNFMDFDETGVLKGFKGELIHVFNKHDGALRNTEYFNQLKDNSNIILLGDSQGDLRMADGVANVEHILKIGYLNDRVDELLEKYMDSYDIVLVQDESLEVANSILQKIL","Homo sapiens","NT5C3A, NT5C3, P5N1, UMPH1, HSPC233","CYTOSOLIC 5'-NUCLEOTIDASE III","1","2JGA"
"2JGN",,"X-RAY DIFFRACTION",2.04,34,,,"RESERVOIR: 2M (NH4)2SO4, 0.1M IMIDAZOLE PH 6.4 PLUS 5MM SPERMINE TETRA-HCL PROTEIN: 10MM HEPES, 500MM (NH4)2SO4, PH 8.0.",,"10.1107/S1744309107006434",,"2JGN",63.52,"1.91","1.91","DDX3 helicase domain","MHHHHHHENLYFQGSTSENITQKVVWVEESDKRSFLLDLLNATGKDSLTLVFVETKKGADSLEDFLYHEGYACTSIHGDRSQRDREEALHQFRSGKSPILVATAVAARGLDISNVKHVINFDLPSDIEEYVHRIGRTGRVGNLGLATSFFNERNINITKDLLDLLVEAKQEVPSWLENMAYEHHY","Homo sapiens","DDX3X, DBX, DDX3","ATP-DEPENDENT RNA HELICASE DDX3X","1","2JGN"
"2JGW",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M609636200",,"2JGW",6.99,,,"Structure of CCP module 7 of complement factor H - The AMD at risk varient (402H)","LRKCYFPYLENGYNQNHGRKFVQGKSIDVACHPGYALPKAQTTVTCMENGWSPTPRCIRVK","Homo sapiens","CFH, HF, HF1, HF2","COMPLEMENT FACTOR H","1","2JGW"
"2JGX",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M609636200",,"2JGX",7.01,,,"Structure of CCP module 7 of complement factor H - The AMD Not at risk varient (402Y)","LRKCYFPYLENGYNQNYGRKFVQGKSIDVACHPGYALPKAQTTVTCMENGWSPTPRCIRVK","Homo sapiens","CFH, HF, HF1, HF2","COMPLEMENT FACTOR H","1","2JGX"
"2JGY",,"X-RAY DIFFRACTION",2.9,58,,7.5,"pH 7.50",,,,"2JGY",61.26,"1.95","1.95","The crystal structure of human orotidine-5'-decarboxylase domain of human uridine monophosphate synthetase (UMPS)","MHHHHHHSSGVDLGTENLYFQSMELSFGARAELPRIHPVASKLLRLMQKKETNLCLSADVSLARELLQLADALGPSICMLKTHVDILNDFTLDVMKELITLAKCHEFLIFEDRKFADIGNTVKKQYEGGIFKIASWADLVNAHVVPGSGVVKGLQEVGLPLHRGCLLIAEMSSTGSLATGDYTRAAVRMAEEHSEFVVGFISGSRVSMKPEFLHLTPGVQLEAGGDNLGQQYNSPQEVIGKRGSDIIIVGRGIISAADRLEAAEMYRKAAWEAYLSRLG","Homo sapiens","UMPS, OK/SW-cl.21","UMP SYNTHASE","1","2JGY"
"2JHH",,"X-RAY DIFFRACTION",2.07,40.06,"VAPOR DIFFUSION, HANGING DROP",5.6,"pH 5.6",293,"10.1074/jbc.M705741200",,"2JHH",48.83,"1.7","1.7","Structure of globular heads of M-ficolin at acidic pH","QSCATGPRNCKDLLDRGYFLSGWHTIYLPDCRPLTVLCDMDTDGGGWTVFQRRMDGSVDFYRDWAAYKQGFGSQLGEFWLGNDNIHALTAQGSSELRTDLVDFEGNHQFAKYKSFKVADEAEKYKLVLGAFVGGSAGNSLTGHNNNFFSTKDQDNDVSSSNCAEKFQGAWWYADCHASNLNGLYLMGPHESYANGINWSAAKGYKYSYKVSEMKVRPA","Homo sapiens","FCN1, FCNM","FICOLIN-1","1","2JHH"
"2JHI",,"X-RAY DIFFRACTION",2.47,49.88,,7,"pH 7",,"10.1074/jbc.M705741200",,"2JHI",24.61,"1.8","1.8","Structure of globular heads of M-ficolin complexed with N-acetyl-D- galactosamine","QSCATGPRNCKDLLDRGHFLSGWHTIYLPDCRPLTVLCDMDTDGGGWTVFQRRMDGSVDFYRDWAAYKQGFGSQLGEFWLGNDNIHALTAQGSSELRTDLVDFEGNHQFAKYKSFKVADEAEKYKLVLGAFVGGSAGNSLTGHNNNFFSTKDQDNDVSSSNCAEKFQGAWWYADCHASNLNGLYLMGPHESYANGINWSAAKGYKYSYKVSEMKVRPA","Homo sapiens","FCN1, FCNM","FICOLIN-1","1","2JHI"
"2JHK",,"X-RAY DIFFRACTION",2.41,54.4,,7,"pH 7",,"10.1074/jbc.M705741200",,"2JHK",24.61,"1.75","1.75","Structure of globular heads of M-ficolin complexed with N-acetyl-D- glucosamine","QSCATGPRNCKDLLDRGHFLSGWHTIYLPDCRPLTVLCDMDTDGGGWTVFQRRMDGSVDFYRDWAAYKQGFGSQLGEFWLGNDNIHALTAQGSSELRTDLVDFEGNHQFAKYKSFKVADEAEKYKLVLGAFVGGSAGNSLTGHNNNFFSTKDQDNDVSSSNCAEKFQGAWWYADCHASNLNGLYLMGPHESYANGINWSAAKGYKYSYKVSEMKVRPA","Homo sapiens","FCN1, FCNM","FICOLIN-1","1","2JHK"
"2JHL",,"X-RAY DIFFRACTION",2.39,48.03,,7,"pH 7",,"10.1074/jbc.M705741200",,"2JHL",24.73,"1.75","1.75","Structure of globular heads of M-ficolin complexed with sialic acid","QSCATGPRNCKDLLDRGYFLSGWHTIYLPDCRPLTVLCDMDTDGGGWTVFQRRMDGSVDFYRDWAAYKQGFGSQLGEFWLGNDNIHALTAQGSSELRTDLVDFEGNHQFAKYKSFKVADEAEKYKLVLGAFVGGSAGNSLTGHNNNFFSTKDQDNDVSSSNCAEKFQGAWWYADCHASNLNGLYLMGPHESYANGINWSAAKGYKYSYKVSEMKVRPA","Homo sapiens","FCN1, FCNM","FICOLIN-1","1","2JHL"
"2JHM",,"X-RAY DIFFRACTION",2.27,53.96,,7,"pH 7",,"10.1074/jbc.M705741200",,"2JHM",24.71,"1.52","1.52","Structure of globular heads of M-ficolin at neutral pH","QSCATGPRNCKDLLDRGYFLSGWHTIYLPDCRPLTVLCDMDTDGGGWTVFQRRMDGSVDFYRDWAAYKQGFGSQLGEFWLGNDNIHALTAQGSSELRTDLVDFEGNHQFAKYKSFKVADEAEKYKLVLGAFVGGSAGNSLTGHNNNFFSTKDQDNDVSSSNCAEKFQGAWWYADCHASNLNGLYLMGPHESYANGINWSAAKGYKYSYKVSEMKVRPA","Homo sapiens","FCN1, FCNM","FICOLIN-1","1","2JHM"
"2JHS",,"X-RAY DIFFRACTION",5,75,,7.5,"1.4 M SODIUM CITRATE, 100 MM HEPES PH 7.5",,"10.1107/S0907444907010931",,"2JHS",16.01,"1.95","1.95","CRYSTAL STRUCTURE OF RHOGDI K135H,K138H,K141H MUTANT","AMVPNVVVTGLTLVCSSAPGPLELDLTGDLESFKKQSFVLKEGVEYRIKISFRVNREIVSGMKYIQHTYRHGVHIDHTDYMVGSYGPRAEEYEFLTPVEEAPKGMLARGSYSIKSRFTDDDKTDHLSWEWNLTIKKDW","Homo sapiens","ARHGDIA, GDIA1","RHO GDP-DISSOCIATION INHIBITOR 1","1","2JHS"
"2JHT",,"X-RAY DIFFRACTION",2.54,51.5,,8.5,"35% PEG 4000 0.2 M LITHIUM SULFATE 0.1M TRIS PH 8.5",,"10.1107/S0907444907010931",,"2JHT",63.05,"1.88","1.88","CRYSTAL STRUCTURE OF RHOGDI K135T,K138T,K141T MUTANT","AMVPNVVVTGLTLVCSSAPGPLELDLTGDLESFKKQSFVLKEGVEYRIKISFRVNREIVSGMKYIQHTYRTGVTIDTTDYMVGSYGPRAEEYEFLTPVEEAPKGMLARGSYSIKSRFTDDDKTDHLSWEWNLTIKKDW","Homo sapiens","ARHGDIA, GDIA1","RHO GDP-DISSOCIATION INHIBITOR 1","1","2JHT"
"2JHU",,"X-RAY DIFFRACTION",4.45,72.39,,6.5,"2.0 M AMMONIUM SULFATE 0.2 M SODIUM CHLORIDE 0.1 M SODIUM CACODYLATE PH 6.5",,"10.1107/S0907444907010931",,"2JHU",31.65,"1.65","1.65","CRYSTAL STRUCTURE OF RHOGDI E154A,E155A MUTANT","AMVPNVVVTGLTLVCSSAPGPLELDLTGDLESFKKQSFVLKEGVEYRIKISFRVNREIVSGMKYIQHTYRKGVKIDKTDYMVGSYGPRAAAYEFLTPVEEAPKGMLARGSYSIKSRFTDDDKTDHLSWEWNLTIKKDW","Homo sapiens","ARHGDIA, GDIA1","RHO GDP-DISSOCIATION INHIBITOR 1","1","2JHU"
"2JHV",,"X-RAY DIFFRACTION",4.45,72.38,,6.5,"2.0 M AMMONIUM SULFATE 0.2 M SODIUM CHLORIDE 0.1 M SODIUM CACODYLATE PH 6.5",,"10.1107/S0907444907010931",,"2JHV",94.08,"2.07","2.07","CRYSTAL STRUCTURE OF RHOGDI E154A,E155A MUTANT","AMVPNVVVTGLTLVCSSAPGPLELDLTGDLESFKKQSFVLKEGVEYRIKISFRVNREIVSGMKYIQHTYRKGVKIDKTDYMVGSYGPRAAAYEFLTPVEEAPKGMLARGSYSIKSRFTDDDKTDHLSWEWNLTIKKDW","Homo sapiens","ARHGDIA, GDIA1","RHO GDP-DISSOCIATION INHIBITOR 1","1","2JHV"
"2JHW",,"X-RAY DIFFRACTION",4.46,72.4,,8,"2M AMMONIUM SULFATE, pH 8.00",,"10.1107/S0907444907010931",,"2JHW",31.84,"2.5","2.5","CRYSTAL STRUCTURE OF RHOGDI E155A, E157A MUTANT","AMVPNVVVTGLTLVCSSAPGPLELDLTGDLESFKKQSFVLKEGVEYRIKISFRVNREIVSGMKYIQHTYRKGVKIDKTDYMVGSYGPRAEAYAFLTPVEEAPKGMLARGSYSIKSRFTDDDKTDHLSWEWNLTIKKDW","Homo sapiens","ARHGDIA, GDIA1","RHO GDP-DISSOCIATION INHIBITOR 1","1","2JHW"
"2JHX",,"X-RAY DIFFRACTION",4.42,72.2,,7.5,"1.4 M SODIUM CITRATE 0.1 M HEPES PH 7.5",,"10.1107/S0907444907010931",,"2JHX",31.63,"1.6","1.6","CRYSTAL STRUCTURE OF RHOGDI E155H, E157H MUTANT","AMVPNVVVTGLTLVCSSAPGPLELDLTGDLESFKKQSFVLKEGVEYRIKISFRVNREIVSGMKYIQHTYRKGVKIDKTDYMVGSYGPRAEHYHFLTPVEEAPKGMLARGSYSIKSRFTDDDKTDHLSWEWNLTIKKDW","Homo sapiens","ARHGDIA, GDIA1","RHO GDP-DISSOCIATION INHIBITOR 1","1","2JHX"
"2JHY",,"X-RAY DIFFRACTION",4.98,75.3,,7.5,"1.4 M SODIUM CITRATE 0.1 M HEPES PH 7.5",,"10.1107/S0907444907010931",,"2JHY",15.81,"1.9","1.9","CRYSTAL STRUCTURE OF RHOGDI E155H, E157H MUTANT","AMVPNVVVTGLTLVCSSAPGPLELDLTGDLESFKKQSFVLKEGVEYRIKISFRVNREIVSGMKYIQHTYRKGVKIDKTDYMVGSYGPRAEHYHFLTPVEEAPKGMLARGSYSIKSRFTDDDKTDHLSWEWNLTIKKDW","Homo sapiens","ARHGDIA, GDIA1","RHO GDP-DISSOCIATION INHIBITOR 1","1","2JHY"
"2JHZ",,"X-RAY DIFFRACTION",4.47,72.5,,7.5,"1.4 M SODIUM CITRATE 0.1 M HEPES PH 7.5",,"10.1107/S0907444907010931",,"2JHZ",31.42,"2.2","2.2","CRYSTAL STRUCTURE OF RHOGDI E155S, E157S MUTANT","AMVPNVVVTGLTLVCSSAPGPLELDLTGDLESFKKQSFVLKEGVEYRIKISFRVNREIVSGMKYIQHTYRKGVKIDKTDYMVGSYGPRAESYSFLTPVEEAPKGMLARGSYSIKSRFTDDDKTDHLSWEWNLTIKKDW","Homo sapiens","ARHGDIA, GDIA1","RHO GDP-DISSOCIATION INHIBITOR 1","1","2JHZ"
"2JI0",,"X-RAY DIFFRACTION",2.2,43.3,,7.5,"32% PEG 8000, 0.22M AMMONIUM SULFATE, 0.1 M SODIUM CACODYLATE PH6.5, pH 7.50",,"10.1107/S0907444907010931",,"2JI0",15.96,"2.1","2.1","CRYSTAL STRUCTURE OF RHOGDI K138Y, K141Y MUTANT","AMVPNVVVTGLTLVCSSAPGPLELDLTGDLESFKKQSFVLKEGVEYRIKISFRVNREIVSGMKYIQHTYRKGVYIDYTDYMVGSYGPRAEEYEFLTPVEEAPKGMLARGSYSIKSRFTDDDKTDHLSWEWNLTIKKDW","Homo sapiens","ARHGDIA, GDIA1","RHO GDP-DISSOCIATION INHIBITOR 1","1","2JI0"
"2JI4",,"X-RAY DIFFRACTION",3.03,48.47,,,,,,,"2JI4",42.23,"2.55","2.55","Human phosphoribosylpyrophosphate synthetase - associated protein 41 (PAP41)","MHHHHHHSSGVDLGTENLYFQSMNITKGGLVLFSANSNSSCMELSKKIAERLGVEMGKVQVYQEPNRETRVQIQESVRGKDVFIIQTVSKDVNTTIMELLIMVYACKTSCAKSIIGVIPYFPYSKQCKMRKRGSIVSKLLASMMCKAGLTHLITMDLHQKEIQGFFNIPVDNLRASPFLLQYIQEEIPDYRNAVIVAKSPASAKRAQSFAERLRLGIAVIHGEAQDAESDLVDGRHSPPMVRSVAAIHPSLEIPMLIPKEKPPITVVGDVGGRIAIIVDDIIDDVDSFLAAAETLKERGAYKIFVMATHGLLSSDAPRRIEESAIDEVVVTNTIPHEVQKLQCPKIKTVDISMILSEAIRRIHNGESMSYLFRNIGLDD","Homo sapiens","PRPSAP2","PHOSPHORIBOSYL PYROPHOSPHATE SYNTHETASE-ASSOCIATED PROTEIN 2","1","2JI4"
"2JID",,"X-RAY DIFFRACTION",2.71,54.64,,,,,"10.1016/j.bmcl.2007.03.072",,"2JID",172.84,"2.8","2.8","Human Dipeptidyl peptidase IV in complex with 1-(3,4-Dimethoxy-phenyl) -3-m-tolyl-piperidine-4-ylamine","GTDDATADSRKTYTLTDYLKNTYRLKLYSLRWISDHEYLYKQENNILVFNAEYGNSSVFLENSTFDEFGHSINDYSISPDGQFILLEYNYVKQWRHSYTASYDIYDLNKRQLITEERIPNNTQWVTWSPVGHKLAYVWNNDIYVKIEPNLPSYRITWTGKEDIIYNGITDWVYEEEVFSAYSALWWSPNGTFLAYAQFNDTEVPLIEYSFYSDESLQYPKTVRVPYPKAGAVNPTVKFFVVNTDSLSSVTNATSIQITAPASMLIGDHYLCDVTWATQERISLQWLRRIQNYSVMDICDYDESSGRWNCLVARQHIEMSTTGWVGRFRPSEPHFTLDGNSFYKIISNEEGYRHICYFQIDKKDCTFITKGTWEVIGIEALTSDYLYYISNEYKGMPGGRNLYKIQLSDYTKVTCLSCELNPERCQYYSVSFSKEAKYYQLRCSGPGLPLYTLHSSVNDKGLRVLEDNSALDKMLQNVQMPSKKLDFIILNETKFWYQMILPPHFDKSKKYPLLLDVYAGPCSQKADTVFRLNWATYLASTENIIVASFDGRGSGYQGDKIMHAINRRLGTFEVEDQIEAARQFSKMGFVDNKRIAIWGWSYGGYVTSMVLGSGSGVFKCGIAVAPVSRWEYYDSVYTERYMGLPTPEDNLDHYRNSTVMSRAENFKQVEYLLIHGTADDNVHFQQSAQISKALVDVGVDFQAMWYTDEDHGIASSTAHQHIYTHMSHFIKQCFSLP","Homo sapiens","DPP4, ADCP2, CD26","DIPEPTIDYL PEPTIDASE 4","1","2JID"
"2JIF",,"X-RAY DIFFRACTION",3.7,66.7,,6.3,"30% PEG6000, 0.15M AMMONIUM CHLORIDE PH6.3, 10% ETHYLENE GLYCOL, pH 6.30",,,,"2JIF",185.03,"2","2","Structure of human short-branched chain acyl-CoA dehydrogenase (ACADSB)","MHHHHHHSSGVDLGTENLYFQSMAPLQTFTDEEMMIKSSVKKFAQEQIAPLVSTMDENSKMEKSVIQGLFQQGLMGIEVDPEYGGTGASFLSTVLVIEELAKVDASVAVFCEIQNTLINTLIRKHGTEEQKATYLPQLTTEKVGSFCLSEAGAGSDSFALKTRADKEGDYYVLNGSKMWISSAEHAGLFLVMANVDPTIGYKGITSFLVDRDTPGLHIGKPENKLGLRASSTCPLTFENVKVPEANILGQIGHGYKYAIGSLNEGRIGIAAQMLGLAQGCFDYTIPYIKERIQFGKRLFDFQGLQHQVAHVATQLEAARLLTYNAARLLEAGKPFIKEASMAKYYASEIAGQTTSKCIEWMGGVGYTKDYPVEKYFRDAKIGTIYEGASNIQLNTIAKHIDAEY","Homo sapiens","ACADSB","SHORT/BRANCHED CHAIN SPECIFIC ACYL-COA DEHYDROGENASE","1","2JIF"
"2JIH",,"X-RAY DIFFRACTION",2.88,57,,7,"0.2-0.6M SODIUM ACETATE, 0.05M CADMIUM SULPHATE, 0.1M HEPES PH 7.0, 12-22% GLYCEROL",,"10.1016/j.jmb.2007.07.047",,"2JIH",68.26,"2.1","2.1","Crystal Structure of Human ADAMTS-1 catalytic Domain and Cysteine- Rich Domain (complex-form)","FVSSHRYVETMLVADQSMAEFHGSGLKHYLLTLFSVAARLYKHPSIRNSVSLVVVKILVIHDEQKGPEVTSNAALTLRNFCNWQKQHNPPSDRDAEHYDTAILFTRQDLCGSQTCDTLGMADVGTVCDPSRSCSVIEDDGLQAAFTTAHELGHVFNMPHDDAKQCASLNGVNQDSHMMASMLSNLDHSQPWSPCSAYMITSFLDNGHGECLMDKPQNPIQLPGDLPGTSYDANRQCQFTFGEDSKHCPDAASTCSTLWCTGTSGGVLVCQTKHFPWADGTSCGEGKWCINGKCVNKLVPR","Homo sapiens","ADAMTS1, KIAA1346, METH1","ADAMTS-1","1","2JIH"
"2JII",,"X-RAY DIFFRACTION",2.9,57,,7.5,"0.1 M HEPES PH=7.5 2.0 M AMMONIUMFORMATE, pH 7.50",,"10.1016/j.str.2008.10.018",,"2JII",80.11,"2","2","Structure of vaccinia related kinase 3","MHHHHHHSSGVDLGTENLYFQSMTTSLEALPTGTVLTDKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVSPYDPIGLPMVP","Homo sapiens","VRK3","SERINE/THREONINE-PROTEIN KINASE VRK3 MOLECULE: VACCINIA RELATED KINASE 3","1","2JII"
"2JIK",,"X-RAY DIFFRACTION",1.88,34.75,,4,"20% PEG6K, 1M LITHIUM CHLORIDE, 0.1M CITRATE PH4.0, pH 4.00",,,,"2JIK",22.07,"1.35","1.35","Crystal structure of PDZ domain of Synaptojanin-2 binding protein","SMDYLVTEEEINLTRGPSGLGFNIVGGTDQQYVSNDSGIYVSRIKENGAAALDGRLQEGDKILSVNGQDLKNLLHQDAVDLFRNAGYAVSLRVQHRLESSI","Homo sapiens","SYNJ2BP, OMP25","SYNAPTOJANIN-2 BINDING PROTEIN","1","2JIK"
"2JIL",,"X-RAY DIFFRACTION",1.98,38,,7.5,"20% PEG3350, 0.20M POTASSIUM THIOCYANATE, 10% ETHYLENE GLYCOL, 0.1M BIS TRIS PROPANE PH 7.5",,,,"2JIL",21.16,"1.5","1.5","Crystal structure of 2nd PDZ domain of glutamate receptor interacting protein-1 (GRIP1)","SMRTVEVTLHKEGNTFGFVIRGGAHDDRNKSRPVVITSVRPGGPADREGTIKPGDRLLSVDGIRLLGTTHAEAMSILKQCGQEAALLIEYDVSETAV","Homo sapiens","GRIP1","GLUTAMATE RECEPTOR INTERACTING PROTEIN-1","1","2JIL"
"2JIN",,"X-RAY DIFFRACTION",2.02,39.23,,4.5,"30% PEG10K, 0.20M LITHIUM SULPHATE, 0.1M ACETATE PH 4.5",,,,"2JIN",11.3,"1.5","1.5","Crystal structure of PDZ domain of Synaptojanin-2 binding protein","SMRVDYLVTEEEINLTRGPSGLGFNIVGGTDQQYVSNDSGIYVSRIKENGAAALDGRLQEGDKILSVNGQDLKNLLHQDAVDLFRNAGYAVSLRVQHRESSI","Homo sapiens","SYNJ2BP, OMP25","SYNAPTOJANIN-2 BINDING PROTEIN","1","2JIN"
"2JIS",,"X-RAY DIFFRACTION",2.19,43.38,,,,,,,"2JIS",115.92,"1.6","1.6","Human cysteine sulfinic acid decarboxylase (CSAD) in complex with PLP.","MHHHHHHSSGVDLGTENLYFQSMADSEALPSLAGDPVAVEALLRAVFGVVVDEAIQKGTSVSQKVCEWKEPEELKQLLDLELRSQGESQKQILERCRAVIRYSVKTGHPRFFNQLFSGLDPHALAGRIITESLNTSQYTYEIAPVFVLMEEEVLRKLRALVGWSSGDGIFCPGGSISNMYAVNLARYQRYPDCKQRGLRTLPPLALFTSKECHYSIQKGAAFLGLGTDSVRVVKADERGKMVPEDLERQIGMAEAEGAVPFLVSATSGTTVLGAFDPLEAIADVCQRHGLWLHVDAAWGGSVLLSQTHRHLLDGIQRADSVAWNPHKLLAAGLQCSALLLQDTSNLLKRCHGSQASYLFQQDKFYDVALDTGDKVVQCGRRVDCLKLWLMWKAQGDQGLERRIDQAFVLARYLVEEMKKREGFELVMEPEFVNVCFWFVPPSLRGKQESPDYHERLSKVAPVLKERMVKEGSMMIGYQPHGTRGNFFRVVVANSALTCADMDFLLNELERLGQDL","Homo sapiens","CSAD, CSD","CYSTEINE SULFINIC ACID DECARBOXYLASE","1","2JIS"
"2JIT",,"X-RAY DIFFRACTION",2.4,48,,7.5,"0.1M HEPES 7.5, 0.3M NACL, 21% PEG6K, 5MM TCEP",,"10.1073/pnas.0709662105",,"2JIT",74.67,"3.1","3.1","Crystal structure of EGFR kinase domain T790M mutation","GEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","EPIDERMAL GROWTH FACTOR RECEPTOR","1","2JIT"
"2JIU",,"X-RAY DIFFRACTION",2.4,48,,7.5,"0.1M HEPES 7.5, 0.3M NACL, 21% PEG6K, 5MM TCEP",,"10.1073/pnas.0709662105","AEE","2JIU",75.28,"3.05","3.05","Crystal structure of EGFR kinase domain T790M mutation in complex with AEE788","SGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","EPIDERMAL GROWTH FACTOR RECEPTOR","1","2JIU"
"2JIV",,"X-RAY DIFFRACTION",2.58,52.3,,7.5,"0.1M HEPES PH7.0, 0.2M LI2SO4, 28% PEG3350, 5MM TCEP, pH 7.5",,"10.1073/pnas.0709662105",,"2JIV",76.03,"3.5","3.5","Crystal structure of EGFR kinase domain T790M mutation in compex with HKI-272","SGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","EPIDERMAL GROWTH FACTOR RECEPTOR","1","2JIV"
"2JJ3",,"X-RAY DIFFRACTION",2.84,50.21,,8,"2M NACL, 9% PEG 6,000, 100MM TRIS PH 8.0",,"10.1016/j.bmcl.2007.07.009","JJ3","2JJ3",59.11,"2.28","2.28","Estrogen receptor beta ligand binding domain in complex with a Benzopyran agonist","MHHHHHHRELLLDALSPEQLVLTLLEAEPPHVLISRPSAPFTEASMMMSLTKLADKELVHMISWAKKIPGFVELSLFDQVRLLESCWMEVLMMGLMWRSIDHPGKLIFAPDLVLDRDEGKCVEGILEIFDMLLATTSRFRELKLQHKEYLCVKAMILLNSSMYPLVTATQDADSSRKLAHLLNAVTDALVWVIAKSGISSQQQSMRLANLLMLLSHVRHASNKGMEHLLNMKCKNVVPVYDLLLEMLNAHVLRGCKS","Homo sapiens","ESR2, ESTRB, NR3A2","ESTROGEN RECEPTOR BETA","1","2JJ3"
"2JJ6",,"X-RAY DIFFRACTION",2.43,48.9,,,"TRIS/HCL, PH8.0, 14% PEG6000",,"10.1002/prot.22078",,"2JJ6",30.12,"2","2","Crystal structure of the putative carbohydrate recognition domain of the human galectin-related protein","VPFCGHIKGGMRPGKKVLVMGIVDLNPESFAISLTCGDSEDPPADVAIELKAVFTDRQLLRNSCISGERGEEQSAIPYFPFIPDQPFRVEILCEHPRFRVFVDGHQLFDFYHRIQTLSAIDTIKINGDLQITKL","Homo sapiens","LGALSL, GRP, HSPC159","GALECTIN-RELATED PROTEIN","1","2JJ6"
"2JJC",,"X-RAY DIFFRACTION",2.96,59,,6.8,"0.1M SODIUM CACODYLATE PH 6.8 0.2M MAGNESIUM CHLORIDE 20%(W/V) MPEG 2000",,"10.1021/jm8000373","LGA","2JJC",24.58,"1.95","1.95","Hsp90 alpha ATPase domain with bound small molecule fragment","GSHMDQPMEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","HEAT SHOCK PROTEIN HSP 90-ALPHA","1","2JJC"
"2JJD",,"X-RAY DIFFRACTION",5.13,75.84,,6.5,"1.60 M MGSO4, 0.1 M MES PH 6.5",,"10.1016/j.cell.2008.11.038",,"2JJD",418.03,"3.2","3.2","Protein Tyrosine Phosphatase, Receptor Type, E isoform","MSGPKKYFPIPVEHLEEEIRIRSADDCKQFREEFNSLPSGHIQGTFELANKEENREKNRYPNILPNDHSRVILSQLDGIPCSDYINASYIDGYKEKNKFIAAQGPKQETVNDFWRMVWEQKSATIVMLTNLKERKEEKCHQYWPDQGCWTYGNIRVCVEDCVVLVDYTIRKFCIQPQLPDGCKAPRLVSQLHFTSWPDFGVPFTPIGMLKFLKKVKTLNPVHAGPIVVHCSAGVGRTGTFIVIDAMMAMMHAEQKVDVFEFVSRIRNQRPQMVQTDMQYTFIYQALLEYYLYGDTELDVSSLEKHLQTMHGTTTHFDKIGLEEEFRKLTNVRIMKENMRTGNLPANMKKARVIQIIPYDFNRVILSMKRGQEYTDYINASFIDGYRQKDYFIATQGPLAHTVEDFWRMIWEWKSHTIVMLTEVQEREQDKCYQYWPTEGSVTHGEITIEIKNDTLSEAISIRDFLVTLNQPQARQGEQVRVVRQFHFHGWPEIGIPAEGKGMIDLIAAVQKQQQQTGNHPITVHCSAGAGRTGTFIALSNILERVKAEGLLDVFQAVKSLRLQRPHMVQTLEQYEFCYKVVQDFIDIFSDYAAHHHHHH","Homo sapiens","PTPRE","RECEPTOR-TYPE TYROSINE-PROTEIN PHOSPHATASE EPSILON","1","2JJD"
"2JJK",,"X-RAY DIFFRACTION",2.53,51.08,,,"RESERVOIR = 0.1M HEPES PH7.0, 0.1M AMMONIUM ACETATE, 12% PEG 3350",,"10.1016/j.bmcl.2008.06.103","R15","2JJK",148.57,"2","2","FRUCTOSE-1,6-BISPHOSPHATASE(D-FRUCTOSE-1,6-BISPHOSPHATE -1- PHOSPHOHYDROLASE) (E.C.3.1.3.11) COMPLEXED WITH A DUAL BINDING AMP SITE INHIBITOR","MADQAPFDTDVNTLTRFVMEEGRKARGTGELTQLLNSLCTAVKAISSAVRKAGIAHLYGIAGSTNVTGDQVKKLDVLSNDLVMNMLKSSFATCVLVSEEDKHAIIVEPEKRGKYVVCFDPLDGSSNIDCLVSVGTIFGIYRKKSTDEPSEKDALQPGRNLVAAGYALYGSATMLVLAMDCGVNCFMLDPAIGEFILVDKDVKIKKKGKIYSLNEGYAKDFDPAVTEYIQRKKFPPDNSAPYGARYVGSMVADVHRTLVYGGIFLYPANKKSPNGKLRLLYECNPMAYVMEKAGGMATTGKEAVLDVIPTDIHQRAPVILGSPDDVLEFLKVYEKHSAQ","Homo sapiens","FBP1, FBP","FRUCTOSE-1,6-BISPHOSPHATASE 1","1","2JJK"
"2JJU",,"X-RAY DIFFRACTION",2.2,43.5,,7,"400 NL 25 MG/ML SIRP BETA PLUS 50 NL RESERVOIR (2.5 M AMMONIUM SULPHATE, 0.1 M BIS-TRIS PROPANE PH 7.0) EQUILIBRATED AGAINST 95 UL OF RESERVOIR AT 20.5 C.",,"10.1016/j.molcel.2008.05.026",,"2JJU",28.16,"1.19","1.19","Structure of human signal regulatory protein (sirp) beta","EDELQVIQPEKSVSVAAGESATLRCAMTSLIPVGPIMWFRGAGAGRELIYNQKEGHFPRVTTVSELTKRNNLDFSISISNITPADAGTYYCVKFRKGSPDDVEFKSGAGTELSVRAKPSTRHHHHHH","Homo sapiens","SIRPB1","SIGNAL REGULATORY PROTEIN BETA-1","1","2JJU"
"2JJV",,"X-RAY DIFFRACTION",1.94,36.5,,6,"300 NL 25 MG/ML SIRP BETA PLUS 100 NL RESERVOIR (3.2 M AMMONIUM SULPHATE, 0.1 M MES PH 6.0) EQUILIBRATED AGAINST 95 UL OF RESERVOIR AT 20.5 C.",,"10.1016/j.molcel.2008.05.026",,"2JJV",28.64,"1.8","1.8","Structure of human signal regulatory protein (sirp) beta(2)","EEELQVIQPDKSISVAAGESATLHCTVTSLIPVGPIQWFRGAGPGRELIYNQKEGHFPRVTTVSDLTKRNNMDFSIRISNITPADAGTYYCVKFRKGSPDHVEFKSGAGTELSVRAKPSTRHHHHHH","Homo sapiens","SIRPB1","SIGNAL-REGULATORY PROTEIN BETA 1.","1","2JJV"
"2JJW",,"X-RAY DIFFRACTION",2.32,47.1,,6.5,"300 NL 11.5 MG/ML SIRP GAMMA PLUS 50 NL RESERVOIR (2.0 M AMMONIUM SULPHATE, 0.1 M BIS-TRIS PH 6.5) EQUILIBRATED AGAINST 95 UL OF RESERVOIR AT 20.5 C.",,"10.1016/j.molcel.2008.05.026",,"2JJW",14.21,"1.7","1.7","Structure of human signal regulatory protein (sirp) gamma","EEELQMIQPEKLLLVTVGKTATLHCTVTSLLPVGPVLWFRGVGPGRELIYNQKEGHFPRVTTVSDLTKRNNMDFSIRISSITPADVGTYYCVKFRKGSPENVEFKSGPGTEMALGAKPSTRHHHHHH","Homo sapiens","SIRPG, SIRPB2","SIGNAL REGULATORY PROTEIN GAMMA","1","2JJW"
"2JJZ",,"X-RAY DIFFRACTION",3.36,50.94,,,,,"10.1111/j.1742-4658.2008.06605.x",,"2JJZ",68.84,"2.15","2.15","Crystal Structure of Human Iba2, orthorhombic crystal form","MSGELSNRFQGGKAFGILKARQERRLAEINREFLCDQKYSDEENLPEKLTAFKEKYMEFDLNNEGEIDLMSLKRMMEKLGVPKTHLEMKKMISEVTGGVSDTISYRDFVNMMLGKRSAVLKLVMMFEGKANESSPKPVGPPPERDIASLP","Homo sapiens","AIF1L, C9orf58, IBA2, UNQ672/PRO1306","IONIZED CALCIUM-BINDING ADAPTER MOLECULE 2","1","2JJZ"
,,,,,,,,,,,,,,,,"MSGELSNRFQGGKAFGLLKARQERRLAEINREFLCDQKYSDEENLPEKLTAFKEKYMEFDLNNEGEIDLMSLKRMMEKLGVPKTHLEMKKMISEVTGGVSDTISYRDFVNMMLGKRSAVLKLVMMFEGKANESSPKPVGPPPERDIASLP","Homo sapiens","AIF1L, C9orf58, IBA2, UNQ672/PRO1306","IONIZED CALCIUM-BINDING ADAPTER MOLECULE 2","2","2JJZ"
"2JK2",,"X-RAY DIFFRACTION",2.21,44,,8.5,"100 MM TRIS PH 8.5, 20% PEG MME2000, 10 MM NICL2",,"10.1074/jbc.M802145200",,"2JK2",53.43,"1.7","1.7","STRUCTURAL BASIS OF HUMAN TRIOSEPHOSPHATE ISOMERASE DEFICIENCY. CRYSTAL STRUCTURE OF THE WILD TYPE ENZYME.","GSAPSRKFFVGGNWKMNGRKQSLGELIGTLNAAKVPADTEVVCAPPTAYIDFARQKLDPKIAVAAQNCYKVTNGAFTGEISPGMIKDCGATWVVLGHSERRHVFGESDELIGQKVAHALAEGLGVIACIGEKLDEREAGITEKVVFEQTKVIADNVKDWSKVVLAYEPVWAIGTGKTATPQQAQEVHEKLRGWLKSNVSDAVAQSTRIIYGGSVTGATCKELASQPDVDGFLVGGASLKPEFVDIINAKQ","Homo sapiens","TPI1, TPI","TRIOSEPHOSPHATE ISOMERASE","1","2JK2"
"2JK4",,"X-RAY DIFFRACTION",4.5,73,,,"0.2 M MAGNESIUM CHLORIDE HEXAHYDRATE, 0.1 M HEPES SODIUM PH 7.5, 30% V/V POLYETHYLENE GLYCOL 400",,"10.1073/pnas.0808115105",,"2JK4",32.18,"4.1","4.1","Structure of the human voltage-dependent anion channel","MRGSAVPPTYADLGKSARDVFTKGYGFGLIKLDLKTKSENGLEFTSSGSANTETTKVTGSLETKYRWTEYGLTFTEKWNTDNTLGTEITVEDQLARGLKLTFDSSFSPNTGKKNAKIKTGYKREHINLGCDMDFDIAGPSIRGALVLGYEGWLAGYQMNFETAKSRVTQSNFAVGYKTDEFQLHTNVNDGTEFGGSIYQKVNKKLETAVNLAWTAGNSNTRFGIAAKYQIDPDACFSAKVNNSSLIGLGYTQTLKPGIKLTLSALLDGKNVNAGGHKLGLGLEFQARSHHHHHH","Homo sapiens","VDAC1, VDAC","VOLTAGE-DEPENDENT ANION-SELECTIVE CHANNEL PROTEIN 1","1","2JK4"
"2JK7",,"X-RAY DIFFRACTION",3.6,66,,7.5,"20% POLYETHYLENE GLYCOL 8000 0.2M MGCL2 0.1M TRIS, PH 8.5",,"10.1021/jm8006849","BI6","2JK7",13.85,"2.82","2.82","XIAP BIR3 bound to a Smac Mimetic","SDAVSSDRNFPNSTNLPRNPSMADYEARIFTFGTWIYSVNKEQLARAGFYALGEGDKVKCFHCGGGLTDWKPSEDPWEQHAKWYPGCKYLLEQKGQEYINNIHLTHSLEECLVRTT","Homo sapiens","XIAP, API3, BIRC4, IAP3","BACULOVIRAL IAP REPEAT-CONTAINING PROTEIN 4","1","2JK7"
"2JKH",,"X-RAY DIFFRACTION",2.12,42,,,,,"10.1002/anie.200804695","BI7","2JKH",33.76,"1.25","1.25","Factor Xa - cation inhibitor complex","IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGEQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTRGLPKAK","Homo sapiens","F10","ACTIVATED FACTOR XA HEAVY CHAIN","1","2JKH"
,,,,,,,,,,,,,,,,"RKLCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACIPTGPYPCGKQTLERR","Homo sapiens","F10","FACTOR X LIGHT CHAIN","2","2JKH"
"2JKU",,"X-RAY DIFFRACTION",3.57,65.53,,,"20% PEG 3350, 0.20M NA FORMATE",,"10.1021/bi901612y",,"2JKU",10.33,"1.5","1.5","Crystal structure of the N-terminal region of the biotin acceptor domain of human propionyl-CoA carboxylase","MHHHHHHSSGVDLGTENLYFQSMTSSVLRSPMPGVVVAVSVKPGDAVAEGQEICVIEAMKMQNSMTAGKTGTVKSVHCQAGDTVGEGDLLVELE","Homo sapiens","PCCA","PROPIONYL-COA CARBOXYLASE ALPHA CHAIN, MITOCHONDRIAL","1","2JKU"
"2JKV",,"X-RAY DIFFRACTION",2.93,58,,,"0.20M NA2SO4, 20.0% PEG 3350, 10.0% ETGLY",,,,"2JKV",339.84,"2.532","2.532","Structure of human Phosphogluconate Dehydrogenase in complex with NADPH at 2.53A","MHHHHHHSSGVDLGTENLYFQSMAQADIALIGLAVMGQNLILNMNDHGFVVCAFNRTVSKVDDFLANEAKGTKVVGAQSLKEMVSKLKKPRRIILLVKAGQAVDDFIEKLVPLLDTGDIIIDGGNSEYRDTTRRCRDLKAKGILFVGSGVSGGEEGARYGPSLMPGGNKEAWPHIKTIFQGIAAKVGTGEPCCDWVGDEGAGHFVKMVHNGIEYGDMQLICEAYHLMKDVLGMAQDEMAQAFEDWNKTELDSFLIEITANILKFQDTDGKHLLPKIRDSAGQKGTGKWTAISALEYGVPVTLIGEAVFARCLSSLKDERIQASKKLKGPQKFQFDGDKKSFLEDIRKALYASKIISYAQGFMLLRQAATEFGWTLNYGGIALMWRGGCIIRSVFLGKIKDAFDRNPELQNLLLDDFFKSAVENCQDSWRRAVSTGVQAGIPMPCFTTALSFYDGYRHEMLPASLIQAQRDYFGAHTYELLAKPGQFIHTNWTGHGGTVSSSSYNA","Homo sapiens","PGD, PGDH","6-PHOSPHOGLUCONATE DEHYDROGENASE, DECARBOXYLATING","1","2JKV"
"2JLL",,"X-RAY DIFFRACTION",2.48,50.39,,6.5,"0.1M HEPES PH6.5, 14% PEG10000, 0.2M CALCIUM ACETATE",,"10.1016/j.str.2010.12.014",,"2JLL",44.71,"2.3","2.3","Crystal structure of NCAM2 IgIV-FN3II","QPHIIQLKNETTYENGQVTLVCDAEGEPIPEITWKRAVDGFTFTEGDKSLDGRIEVKGQHGSSSLHIKDVKLSDSGRYDCEAASRIGGHQKSMYLDIEYAPKFISNQTIYYSWEGNPINISCDVKSNPPASIHWRRDKLVLPAKNTTNLKTYSTGRKMILEIAPTSDNDFGRYNCTATNHIGTRFQEYILALADVPSSPYGVKIIELSQTTAKVSFNKPDSHGGVPIHHYQVDVKEVASEIWKIVRSHGVQTMVVLNNLEPNTTYEIRVAAVNGKGQGDYSKIEIFQTLPVREPSPPSIHGQPSSGKSFKLSITKQDDGGAPILEYIVKYRSKDKEDQWLEKKVQGNKDHIILEHLQWTMGYEVQITAANRLGYSEPTVYEFSMPPKPN","Homo sapiens","NCAM2, NCAM21","NEURAL CELL ADHESION MOLECULE 2","1","2JLL"
"2JLP",,"X-RAY DIFFRACTION",1.93,36.2,,7.5,"PEG3350, THIOCYANATE, BIS-TRIS PROPANE PH 7.5",,"10.1016/j.jmb.2009.03.026",,"2JLP",97.42,"1.7","1.7","Crystal structure of human extracellular copper-zinc superoxide dismutase.","WTGEDSAEPNSDSAEWIRDMYAKVTEIWQEVMQRRDDDGTLHAACQVQPSATLDAAQPRVTGVVLFRQLAPRAKLDAFFALEGFPTEPNSSSRAIHVHQFGDLSQGCESTGPHYNPLAVPHPQHPGDFGNFAVRDGSLWRYRAGLAASLAGPHSIVGRAVVVHAGEDDLGRGGNQASVENGNAGRRLACCVVGVCGPGLWERQAREHSERKKRRRESECKAA","Homo sapiens","SOD3","EXTRACELLULAR SUPEROXIDE DISMUTASE (CU-ZN)","1","2JLP"
"2JM1",,"SOLUTION NMR",,,,,,,"10.1073/pnas.0704057104",,"2JM1",16.41,,,"Structures and chemical shift assignments for the ADD domain of the ATRX protein","GAMKRGEDGLHGIVSCTACGQQVNHFQKDSIYRHPSLQVLICKNCFKYYMSDDISRDSDGMDEQCRWCAEGGNLICCDFCHNAFCKKCILRNLGRKELSTIMDENNQWYCYICHPEPLLDLVTACNSVFENLEQLLQQNKK","Homo sapiens","ATRX, RAD54L, XH2","Transcriptional regulator ATRX","1","2JM1"
"2JM2",,"SOLUTION NMR",,,,,,,"10.1021/bi0619876",,"2JM2",4.37,,,"Structure of the N-terminal subdomain of insulin-like growth factor (IGF) binding protein-6 and its interactions with IGFs","ALARCPGCGQGVQAGCPGGCVEEEDGGSPAEGCAEAEGCLRREGQ","Homo sapiens","IGFBP6, IBP6","Insulin-like growth factor-binding protein 6","1","2JM2"
"2JM4",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M609526200",,"2JM4",4.58,,,"The solution NMR structure of the relaxin (RXFP1) receptor LDLa module.","GSQDVKCSLGYFPCGNITKCLPQLLHCNGVDDCGNQADEDNCG","Homo sapiens","RXFP1, LGR7","Relaxin receptor 1","1","2JM4"
"2JM5",,"SOLUTION NMR",,,,,,,"10.1073/pnas.0801508105",,"2JM5",17.79,,,"Solution Structure of the RGS domain from human RGS18","SMVSPEEAVKWGESFDKLLSHRDGLEAFTRFLKTEFSEENIEFWIACEDFKKSKGPQQIHLKAKAIYEKFIQTDAPKEVNLDFHTKEVITNSITQPTLHSFDAAQSRVYQLMEQDSYTRFLKSDIYLDLMEGRPQRPTNLRRRSRSFTCNE","Homo sapiens","RGS18, RGS13","Regulator of G-protein signaling 18","1","2JM5"
"2JMD",,"SOLUTION NMR",,,,,,,"10.1110/ps.062358007",,"2JMD",7.15,,,"Solution Structure of the Ring Domain of Human TRAF6","GPLGSKYECPICLMALREAVQTPCGHRFCKACIIKSIRDAGHKCPVDNEILLENQLFPDNFAK","Homo sapiens","TRAF6, RNF85","TNF receptor-associated factor 6","1","2JMD"
"2JMN",,"SOLUTION NMR",,,,,,,"10.1006/jmbi.1996.0648",,"2JMN",5.79,,,"NMR structure of human insulin mutant His-B10-Asp, Pro-B28-Lys, Lys-B29-Pro, 20 structures","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","Insulin A chain","1","2JMN"
,,,,,,,,,,,,,,,,"FVNQHLCGSDLVEALYLVCGERGFFYTKPT","Homo sapiens","INS","Insulin B chain","2","2JMN"
"2JMO",,"SOLUTION NMR",,,,,,,"10.1073/pnas.0610548104",,"2JMO",8.75,,,"IBR domain of Human Parkin","GHMGEEQYNRYQQYGAEECVLQMGGVLCPRPGCGAGLLPEPDQRKVTCEGGNGLGCGFAFCRECKEAYHEGECSAVFEAS","Homo sapiens","PARK2, PRKN","Parkin","1","2JMO"
"2JN5",,"SOLUTION NMR",,,,,,,"10.1096/fj.09-133082",,"2JN5",1.36,,,"Solution Structure of a Dodecapeptide from Alpha-Synuclein Bound with Synphilin-1","MDVFMKGLSKAK","Homo sapiens","SNCA, NACP, PARK1","Alpha-synuclein","1","2JN5"
"2JNB",,"SOLUTION NMR",,,,,,,"10.1021/bi701254q",,"2JNB",16.03,,,"Solution Structure of RNA-binding protein 15.5K","MGHHHHHHSSGIEEGRMTEADVNPKAYPLADAHLTKKLLDLVQQSCNYKQLRKGANEATKTLNRGISEFIVMAADAEPLEIILHLPLLCEDKNVPYVFVRSKQALGRACGVSRPVIACSVTIKEGSQLKQQIQSIQQSIERLLV","Homo sapiens","NHP2L1, SNU13","NHP2-like protein 1","1","2JNB"
"2JNG",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M611297200",,"2JNG",12.01,,,"Solution structure of the CUL7-CPH domain from Homo Sapiens; Northeast Structural Genomics Consortium target HT1.","GSHMRSEFASGNTYALYVRDTLQPGMRVRMLDDYEEISAGDEGEFRQSNNGVPPVQVFWESTGRTYWVHWHMLEILGFEEDIEDMVEADEYQGAVASRVLGRALP","Homo sapiens","CUL7, KIAA0076","Cullin-7","1","2JNG"
"2JNH",,"SOLUTION NMR",,,,,,,"10.1110/ps.036384.108",,"2JNH",5.11,,,"Solution Structure of the UBA Domain from Cbl-b","EAALENVDAKIAKLMGEGYAFEEVKRALEIAQNNVEVARSILREFA","Homo sapiens","CBLB, RNF56, Nbla00127","E3 ubiquitin-protein ligase CBL-B","1","2JNH"
"2JNJ",,"SOLUTION NMR",,,,,,,"10.1016/j.jmb.2007.02.020",,"2JNJ",16.69,,,"Solution structure of the p8 TFIIH subunit","GSHMVNVLKGVLIECDPAMKQFLLYLDESNALGKKFIIQDIDDTHVFVIAELVNVLQERVGELMDQNAFSLTQK","Homo sapiens","GTF2H5, TTDA, C6orf175","TFIIH basal transcription factor complex TTD-A subunit","1","2JNJ"
"2JNP",,"SOLUTION NMR",,,,,,,"10.1007/s00775-007-0288-9","NGH","2JNP",18.57,,,"Solution structure of matrix metalloproteinase 3 (MMP-3) in the presence of N-isobutyl-N-[4-methoxyphenylsulfonyl]glycyl hydroxamic acid (NNGH)","GIPKWRKTHLTYRIVNYTPDLPKDAVDSAVEKALKVWEEVTPLTFSRLYEGEADIMISFAVREHGDFYPFDGPGNVLAHAYAPGPGINGDAHFDDDEQWTKDTTGTNLFLVAAHEIGHSLGLFHSANTEALMYPLYHSLTDLTRFRLSQDDINGIQSLYGP","Homo sapiens","MMP3, STMY1","Matrix metalloproteinase-3","1","2JNP"
"2JNU",,"SOLUTION NMR",,,,,,,"10.1073/pnas.0801508105",,"2JNU",17.72,,,"Solution structure of the RGS domain of human RGS14","SMTEEQPVASWALSFERLLQDPLGLAYFTEFLKKEFSAENVTFWKACERFQQIPASDTQQLAQEARNIYQEFLSSQALSPVNIDRQAWLGEEVLAEPRPDMFRAQQLQIFNLMKFDSYARFVKSPLYRECLLAEAEGRPLREPGSSRLGSPDAT","Homo sapiens","RGS14","Regulator of G-protein signaling 14","1","2JNU"
"2JNW",,"SOLUTION NMR",,,,,,,"10.1038/sj.emboj.7601894",,"2JNW",16.64,,,"Solution structure of a ERCC1-XPA heterodimer","MGSSHHHHHHSQDPAKSNSIIVSPRQRGNPVLKFVRNVPWEFGDVIPDYVLGQSTCALFLSLRYHNLHPDYIHGRLQSLGKNFALRVLLVQVDVKDPQQALKELAKMCILADCTLILAWSPEEAGRYLETYKA","Homo sapiens","ERCC1","DNA excision repair protein ERCC-1","1","2JNW"
,,,,,,,,,,,,,,,,"KIIDTGGGFILEEE",,,"DNA-repair protein complementing XP-A cells","2","2JNW"
"2JO1",,"SOLUTION NMR",,,,,,,"10.1021/bi700391b",,"2JO1",8.4,,,"Structure of the Na,K-ATPase regulatory protein FXYD1 in micelles","ESPKEHDPFTYDYQSLQIGGLVIAGILFILGILIVLSRRCRCKFNQQQRTGEPDEEEGTFRSSIRRLSTRRR","Homo sapiens","FXYD1, PLM","Phospholemman","1","2JO1"
"2JO8",,"SOLUTION NMR",,,,,,,"10.1073/pnas.0610716104",,"2JO8",12.24,,,"Solution structure of C-terminal domain of human mammalian sterile 20-like kinase 1 (MST1)","GSDYEFLKSWTVEDLQKRLLALDPMMEQEIEEIRQKYQSKRQPILDAIEAK","Homo sapiens","STK4, MST1, KRS2","Serine/threonine-protein kinase 4","1","2JO8"
"2JOG",,"SOLUTION NMR",,,,,,,"10.1016/j.str.2007.03.015",,"2JOG",39.59,,,"Structure of the calcineurin-NFAT complex","VPFPPSHRLTAKEVFDNDGKPRVDILKAHLMKEGRLEESVALRIITEGASILRQEKNLLDIDAPVTVCGDIHGQFFDLMKLFEVGGSPANTRYLFLGDYVDRGYFSIECVLYLWALKILYPKTLFLLRGNHECRHLTEYFTFKQECKIKYSERVYDACMDAFDCLPLAALMNQQFLCVHGGLSPEINTLDDIRKLDRFKEPPAYGPMCDILWSDPLEDFGNEKTQEHFTHNTVRGCSYFYSYPAVCEFLQHNNLLSILRAHEAQDAGYRMYRKSQTTGFPSLITIFSAPNYLDVYNNKAAVLKYENNVMNIRQFNCSPHPYWLPNFM","Homo sapiens","PPP3CA, CALNA, CNA","Calmodulin-dependent calcineurin A subunit alpha isoform","1","2JOG"
,,,,,,,,,,,,,,,,"GPHPVIVITGPHEELE",,,"NFAT","2","2JOG"
"2JOP",,"SOLUTION NMR",,,,,,,"10.1016/j.jmb.2008.02.006",,"2JOP",14.79,,,"Solution structure of the N-terminal extracellular domain of the lymphocyte receptor CD5 (CD5 domain 1)","MGSSHHHHHHSSGLVPRGSHMRLSWYDPDFQARLTRSNSKCQGQLEVYLKDGWHMVCSQSWGRSSKQWEDPSQASKVCQRLNCGDPLSLGPFLKTYTPQSSIICYGQLGSFSNCSHSRNDMCHSLGLTCLE","Homo sapiens","CD5, LEU1","T-cell surface glycoprotein CD5","1","2JOP"
"2JOX",,"SOLUTION NMR",,,,,,,"10.1016/j.jmb.2007.06.021",,"2JOX",12.36,,,"Embryonic Neural Inducing Factor Churchill is not a DNA-Binding Zinc Finger Protein: Solution Structure Reveals a Solvent-Exposed beta-Sheet and Zinc Binuclear Cluster","CGDCVEKEYPNRGNTCLENGSFLLNFTGCAVCSKRDFMLITNKSLKEEDGEEIVTYDHLCKNCHHVIARHEYTFSIMDEFQEYTMLCLLCGKAEDTISILPDDPRQ","Homo sapiens","CHURC1, C14orf52, CHCH, My015","Churchill protein","1","2JOX"
"2JP0",,"SOLUTION NMR",,,,,,,"10.1016/j.jmb.2008.02.006",,"2JP0",14.76,,,"Solution structure of the N-terminal extraceullular domain of the lymphocyte receptor CD5 calculated using inferential structure determination (ISD)","MGGSHHHHHHSSGLVPRGSHMRLSWYDPDFQARLTRSNSKCQGQLEVYLKDGWHMVCSQSWGRSSKQWEDPSQASKVCQRLNCGDPLSLGPFLKTYTPQSSIICYGQLGSFSNCSHSRNDMCHSLGLTCLE","Homo sapiens","CD5, LEU1","T-cell surface glycoprotein CD5","1","2JP0"
"2JP1",,"SOLUTION NMR",,,,,,,"10.1073/pnas.0709518105",,"2JP1",20.57,,,"Solution structure of the alternative conformation of XCL1/Lymphotactin","VGSEVSDKRTCVSLTTQRLPVSRIKTYTITEGSLRAVIFITKRGLKVCADPQATWVRDVVRSMDRKSNTRNNMIQTKPTGTQQSTNTAVTLTG","Homo sapiens","XCL1, LTN, SCYC1","Lymphotactin","1","2JP1"
"2JP2",,"SOLUTION NMR",,,,,,,"10.1023/B:JNMR.0000032526.17586.8c",,"2JP2",14.22,,,"Solution structure and resonance assignment of the N-terminal EVH1 domain from the human Spred2 protein (Sprouty-related protein with EVH1 domain isoform 2)","GSMTEETHPDDDSYIVRVKAVVMTRDDSSGGWFPQEGGGISRVGVCKVMHPEGNGRSGFLIHGERQKDKLVVLECYVRKDLVYTKANPTFHHWKVDNRKFGLTFQSPADARAFDRGVRKAIEDLIE","Homo sapiens","SPRED2","Sprouty-related, EVH1 domain-containing protein 2","1","2JP2"
"2JPD",,"SOLUTION NMR",,,,,,,"10.1093/nar/gkm503",,"2JPD",15.46,,,"Solution structure of the ERCC1 central domain","MAKSNSIIVSPRQRGNPVLKFVRNVPWEFGDVIPDYVLGQSTCALFLSLRYHNLHPDYIHGRLQSLGKNFALRVLLVQVDVKDPQQALKELAKMCILADCTLILAWSPEEAGRYLETYKAYEQKPGGLEHHHHHH","Homo sapiens","ERCC1","DNA excision repair protein ERCC-1","1","2JPD"
"2JPH",,"SOLUTION NMR",,,,,,,"10.1016/j.str.2007.12.012",,"2JPH",13.59,,,"NMR solution structure of the Rho GTPase binding domain of human plexin-b1","MKKDVEYRPLTLNALLAVGPGAGEAQGVPVKVLDCDTISQAKEKMLDQLYKGVPLTQRPDPRTLDVEWRSGVAGHLILSDEDVTSEVQGLFRRLNTLQHYKVPDGATVALVPCLTKHVLRENQ","Homo sapiens","PLXNB1, KIAA0407, SEP, PLXN5","Plexin-B1","1","2JPH"
"2JQ3",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M800756200",,"2JQ3",8.77,,,"Structure and Dynamics of Human Apolipoprotein C-III","SEAEDASLLSFMQGYMKHATKTAKDALSSVQESQVAQQARGWVTDGFSSLKDYWSTVKDKFSEFWDLDPEVRPTSAVAA","Homo sapiens","APOC3","Apolipoprotein C-III","1","2JQ3"
"2JQ6",,"SOLUTION NMR",,,,,,,"10.1007/s10858-007-9196-0",,"2JQ6",15.03,,,"Structure of EH-domain of EHD1","GPLGSESLMPSQVVKGGAFDGTMNGPFGHGYGEGAGEGIDDVEWVVGKDKPTYDEIFYTLSPVNGKITGANAKKEMVKSKLPNTVLGKIWKLADVDKDGLLDDEEFALANHLIKVKLEGHELPADLPPHLVPPSKRRHE","Homo sapiens","EHD1, PAST, PAST1, CDABP0131","EH domain-containing protein 1","1","2JQ6"
"2JQ8",,"SOLUTION NMR",,,,,,,"10.1110/ps.072949607",,"2JQ8",6.17,,,"Solution structure of the Somatomedin B domain from vitronectin produced in Pichia pastoris","DQESCKGRCTEGFNVDKKCQCDELCSYYQSCCTDYTAECKPQVTRGDHHHHHH","Homo sapiens","VTN","Vitronectin","1","2JQ8"
"2JQH",,"SOLUTION NMR",,,,,,,"10.1038/nature06172",,"2JQH",10.19,,,"VPS4B MIT","GHMMSSTSPNLQKAIDLASKAAQEDKAGNYEEALQLYQHAVQYFLHVVKYEAQGDKAKQSIRAKCTEYLDRAEKLKEYLKNKEKKAQKP","Homo sapiens","VPS4B, SKD1, VPS42, MIG1","Vacuolar protein sorting-associating protein 4B","1","2JQH"
"2JQZ",,"SOLUTION NMR",,,,,,,"10.1016/j.cell.2007.06.050",,"2JQZ",14.7,,,"Solution Structure of the C2 domain of human Smurf2","GPVKLRLTVLCAKNLVKKDFFRLPDPFAKVVVDGSGQCHSTDTVKNTLDPKWNQHYDLYIGKSDSVTISVWNHKKIHKKQGAGFLGCVRLLSNAINRLKDTGYQRLDLCKLGPNDNDTVRGQIVVSLQSRD","Homo sapiens","SMURF2","E3 ubiquitin-protein ligase SMURF2","1","2JQZ"
"2JR7",,"SOLUTION NMR",,,,,,,"10.1002/prot.21915",,"2JR7",10.26,,,"Solution structure of human DESR1","MAVFHDEVEIEDFQYDEDSETYFYPCPCGDNFSITKEDLENGEDVATCPSCSLIIKVIYDKDQFVSGETVPAPSANKELVKLEHHHHHH","Homo sapiens","DPH3, DESR1, ZCSL2","DPH3 homolog","1","2JR7"
"2JRF",,"SOLUTION NMR",,,,,,,,,"2JRF",20.07,,,"Solution NMR structure of Tubulin polymerization-promoting protein family member 3 from Homo sapiens. Northeast Structural Genomics target HR387.","MAASTDIAGLEESFRKFAIHGDPKASGQEMNGKNWAKLCKDCKVADGKSVTGTDVDIVFSKVKGKSARVINYEEFKKALEELATKRFKGKSKEEAFDAICQLVAGKEPANVGVTKAKTGGAVDRLTDTSRYTGSHKERFDESGKGKGIAGRQDILDDSGYVSAYKNAGTYDAKVKKLEHHHHHH","Homo sapiens","TPPP3, CGI-38","Tubulin polymerization-promoting protein family member 3","1","2JRF"
"2JRH",,"SOLUTION NMR",,,,,,,"10.1021/bi701341n",,"2JRH",11.19,,,"Solution structure of human MEKK3 PB1 domain cis isomer","MQSDVRIKFEHNGERRIIAFSRPVKYEDVEHKVTTVFGQPLDLHYMNNELSILLKNQDDLDKAIDILDRSSSMKSLRILLLSQDRNLEHHHHHH","Homo sapiens","MAP3K3, MAPKKK3, MEKK3","Mitogen-activated protein kinase kinase kinase 3","1","2JRH"
"2JRJ",,"SOLUTION NMR",,,,,,,"10.1038/nsmb.1521",,"2JRJ",6.13,,,"Solution structure of the human Pirh2 RING-H2 domain. Northeast Structural Genomics Consortium Target HT2B","ENVSQQNCPICLEDIHTSRVVAHVLPCGHLLHRTCYEEMLKEGYRCPLCMHS","Homo sapiens","RCHY1, ARNIP, CHIMP, PIRH2, RNF199, ZNF363","Ring finger and CHY zinc finger domain containing protein 1","1","2JRJ"
"2JRS",,"SOLUTION NMR",,,,,,,,,"2JRS",12.06,,,"Solution NMR Structure of CAPER RRM2 Domain. Northeast Structural Genomics Target HR4730A","MGHHHHHHSHMAAAMANNLQKGSAGPMRLYVGSLHFNITEDMLRGIFEPFGRIESIQLMMDSETGRSKGYGFITFSDSECAKKALEQLNGFELAGRPMKVGHVTERTD","Homo sapiens","RBM39, HCC1, RNPC2","RNA-binding protein 39","1","2JRS"
"2JRZ",,"SOLUTION NMR",,,,,,,"10.1007/s12104-007-9071-7",,"2JRZ",13.75,,,"Solution structure of the Bright/ARID domain from the human JARID1C protein.","SMNELEAQTRVKLNYLDQIAKFWEIQGSSLKIPNVERRILDLYSLSKIVVEEGGYEAICKDRRWARVAQRLNYPPGKNIGSLLRSHYERIVYPYEMYQSGANLVCNTRPFDNEEKDK","Homo sapiens","JARID1C, DXS1272E, SMCX, XE169, KDM5C","Histone demethylase JARID1C","1","2JRZ"
"2JS0",,"SOLUTION NMR",,,,,,,"10.1021/bi701549a",,"2JS0",6.99,,,"Solution structure of second SH3 domain of adaptor Nck","GSLNMPAYVKFNYMAEREDELSLIKGTKVIVMEKCSDGWWRGSYNGQVGWFPSNYVTEEGD","Homo sapiens","NCK1, NCK","Cytoplasmic protein NCK1","1","2JS0"
"2JS2",,"SOLUTION NMR",,,,,,,"10.1021/bi701549a",,"2JS2",7.46,,,"Solution structure of first SH3 domain of adaptor Nck","GSMAEEVVVVAKFDYVAQQEQELDIKKNERLWLLDDSKSWWRVRNSMNKTGFVPSNYVERKNS","Homo sapiens","NCK1, NCK","Cytoplasmic protein NCK1","1","2JS2"
"2JS7",,"SOLUTION NMR",,,,,,,,,"2JS7",18.76,,,"Solution NMR structure of human myeloid differentiation primary response (MyD88). Northeast Structural Genomics target HR2869A","MGITTLDDPLGHMPERFDAFICYCPSDIQFVQEMIRQLEQTNYRLKLCVSDRDVLPGTCVWSIASELIEKRCRRMVVVVSDDYLQSKECDFQTKFALSLSPGAHQKRLIPIKYKAMKKEFPSILRFITVCDYTNPCTKSWFWTRLAKALSLPLEHHHHHH","Homo sapiens","MYD88","Myeloid differentiation primary response protein MyD88","1","2JS7"
"2JSD",,"SOLUTION NMR",,,,,,,"10.1016/j.febslet.2007.08.069","NGH","2JSD",18.02,,,"Solution structure of MMP20 complexed with NNGH","GEPKWKKNTLTYRISKYTPSMSSVEVDKAVEMALQAWSSAVPLSFVRINSGEADIMISFENGDHGDSYPFDGPRGTLAHAFAPGEGLGGDTHFDNAEKWTMGTNGFNLFTVAAHEFGHALGLAHSTDPSALMYPTYKYKNPYGFHLPKDDVKGIQALYGP","Homo sapiens","MMP20","Matrix metalloproteinase-20","1","2JSD"
"2JSN",,"SOLUTION NMR",,,,,,,"10.2174/092986609787316342",,"2JSN",10.82,,,"Solution structure of the atypical PDZ-like domain of synbindin","MGHHHHHHLDSYAPRAEAEKTFSYPLDLLLKLHDERVLVAFGQRDGIRVGHAVLAINGMDVNGRYTADGKEVLEYLGNPANYPVSIRFGRPRLTSN","Homo sapiens","TRAPPC4, SBDN, CGI-104, HSPC172, PTD009","Trafficking protein particle complex subunit 4","1","2JSN"
"2JT0",,"SOLUTION NMR",,,,,,,"10.1110/ps.051595805",,"2JT0",18.43,,,"Solution structure of F104W cardiac troponin C","MDDIYKAAVEQLTEEQKNEFKAAFDIFVLGAEDGSISTKELGKVMRMLGQNPTPEELQEMIDEVDEDGSGTVDFDEFLVMMVRSMKDDSKGKSEEELSDLFRMWDKNADGYIDLDELKIMLQATGETITEDDIEELMKDGDKNNDGRIDYDEFLEFMKGVE","Homo sapiens","TNNC1, TNNC","Troponin C, slow skeletal and cardiac muscles","1","2JT0"
"2JT3",,"SOLUTION NMR",,,,,,,"10.1110/ps.051595805",,"2JT3",18.43,,,"Solution Structure of F153W cardiac troponin C","MDDIYKAAVEQLTEEQKNEFKAAFDIFVLGAEDGSISTKELGKVMRMLGQNPTPEELQEMIDEVDEDGSGTVDFDEFLVMMVRSMKDDSKGKSEEELSDLFRMFDKNADGYIDLDELKIMLQATGETITEDDIEELMKDGDKNNDGRIDYDEWLEFMKGVE","Homo sapiens","TNNC1, TNNC","Troponin C","1","2JT3"
"2JT5",,"SOLUTION NMR",,,,,,,"10.1007/s00775-007-0288-9","JT5","2JT5",18.6,,,"solution structure of matrix metalloproteinase 3 (MMP-3) in the presence of n-hydroxy-2-[n-(2-hydroxyethyl)biphenyl-4-sulfonamide] hydroxamic acid (MLC88)","GIPKWRKTHLTYRIVNYTPDLPKDAVDSAVEKALKVWEEVTPLTFSRLYEGEADIMISFAVREHGDFYPFDGPGNVLAHAYAPGPGINGDAHFDDDEQWTKDTTGTNLFLVAAHEIGHSLGLFHSANTEALMYPLYHSLTDLTRFRLSQDDINGIQSLYGP","Homo sapiens","MMP3, STMY1","Stromelysin-1","1","2JT5"
"2JT6",,"SOLUTION NMR",,,,,,,"10.1007/s00775-007-0288-9","JT6","2JT6",18.54,,,"Solution structure of matrix metalloproteinase 3 (MMP-3) in the presence of 3-4'-cyanobyphenyl-4-yloxy)-n-hdydroxypropionamide (MMP-3 inhibitor VII)","GIPKWRKTHLTYRIVNYTPDLPKDAVDSAVEKALKVWEEVTPLTFSRLYEGEADIMISFAVREHGDFYPFDGPGNVLAHAYAPGPGINGDAHFDDDEQWTKDTTGTNLFLVAAHEIGHSLGLFHSANTEALMYPLYHSLTDLTRFRLSQDDINGIQSLYGP","Homo sapiens","MMP3, STMY1","Stromelysin-1","1","2JT6"
"2JT8",,"SOLUTION NMR",,,,,,,"10.1110/ps.051595805",,"2JT8",18.44,,,"Solution structure of the F153-to-5-flurotryptophan mutant of human cardiac troponin C","MDDIYKAAVEQLTEEQKNEFKAAFDIFVLGAEDGSISTKELGKVMRMLGQNPTPEELQEMIDEVDEDGSGTVDFDEFLVMMVRSMKDDSKGKSEEELSDLFRMFDKNADGYIDLDELKIMLQATGETITEDDIEELMKDGDKNNDGRIDYDEWLEFMKGVE","Homo sapiens","TNNC1, TNNC","Troponin C, slow skeletal and cardiac muscles","1","2JT8"
"2JTF",,"SOLUTION NMR",,,,,,,,,"2JTF",10.06,,,"Solution Structure of the PHF20L1 MBT domain","GSRRASVGSMSKKPPNRPGITFEIGARLEALDYLQKWYPSRIEKIDYEEGKMLVHFERWSHRYDEWIYWDSNRLRPLERPALR","Homo sapiens","PHF20L1, CGI-72","PHD finger protein 20-like 1","1","2JTF"
"2JTG",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M707537200",,"2JTG",10.29,,,"Solution structure of the THAP-zinc finger of THAP1","MVQSCSAYGCKNRYDKDKPVSFHKFPLTRPSLCKEWEAAVRRKNFKPTKYSSICSEHFTPDCFKRECNNKLLKENAVPTIFLELVPR","Homo sapiens","THAP1","THAP domain-containing protein 1","1","2JTG"
"2JTX",,"SOLUTION NMR",,,,,,,"10.1073/pnas.0707892105",,"2JTX",11.49,,,"NMR structure of the TFIIE-alpha carboxyl terminus","GSMAGSVGAAAPVTAANGDDSESETSESDDDSPPRPAAVAVHKREEDEEEDDEFEEVADDPIVMVAGRPFSYSEVSQRPELVAQMTPEEKEAYIAMGQRMFEDLFE","Homo sapiens","GTF2E1, TF2E1","Transcription initiation factor IIE subunit alpha","1","2JTX"
"2JTZ",,"SOLUTION NMR",,,,,,,"10.1110/ps.051595805",,"2JTZ",18.44,,,"Solution structure and chemical shift assignments of the F104-to-5-flurotryptophan mutant of cardiac troponin C","MDDIYKAAVEQLTEEQKNEFKAAFDIFVLGAEDGSISTKELGKVMRMLGQNPTPEELQEMIDEVDEDGSGTVDFDEFLVMMVRSMKDDSKGKSEEELSDLFRMWDKNADGYIDLDELKIMLQATGETITEDDIEELMKDGDKNNDGRIDYDEFLEFMKGVE","Homo sapiens","TNNC1, TNNC","Troponin C, slow skeletal and cardiac muscles","1","2JTZ"
"2JUF",,"SOLUTION NMR",,,,,,,,,"2JUF",11.62,,,"NMR solution structure of PARC CPH Domain. NESG Target HR3443B/SGC-Toronto","GSHMRSEFSSRGGYGEYVQQTLQPGMRVRMLDDYEEISAGDEGEFRQSNNGIPPVQVFWQSTGRTYWVHWHMLEILGPEEATEDKASAAVEKGAGATVLGTAFPS","Homo sapiens","PARC, H7AP1, KIAA0708, CUL9","p53-associated parkin-like cytoplasmic protein","1","2JUF"
"2JUJ",,"SOLUTION NMR",,,,,,,"10.1110/ps.036384.108",,"2JUJ",6.11,,,"Solution Structure of the UBA domain from c-Cbl","ATASPQLSSEIENLMSQGYSYQDIQKALVIAQNNIEMAKNILREFVSISSPAHVAT","Homo sapiens","CBL, CBL2, RNF55","E3 ubiquitin-protein ligase CBL","1","2JUJ"
"2JUN",,"SOLUTION NMR",,,,,,,"10.1021/bi7018496",,"2JUN",11.68,,,"Structure of the MID1 tandem B-boxes reveals an interaction reminiscent of intermolecular RING heterodimers","AEKVLCQFCDQDPAQDAVKTCVTCEVSYCDECLKATHPNKKPFTGHRLIEPIPDSHIRGLMCLEHEDEKVNMYCVTDDQLICALCKLVGRHRDHQVAALSE","Homo sapiens","MID1, FXY, RNF59, TRIM18, XPRF","Midline-1","1","2JUN"
"2JV0",,"SOLUTION NMR",,,,,,,"10.1016/j.bbrc.2007.12.034",,"2JV0",18.52,,,"SET domain of RIZ1 tumor suppressor (PRDM2)","GSMDQNTTEPVAATETLAEVPEHVLRGLPEEVRLFPSAVDKTRIGVWATKPILKGKKFGPFVGDKKKRSQVKNNVYMWEVYYPNLGWMCIDATDPEKGNWLRYVNWACSGEEQNLFPLEINRAIYYKTLKPIAPGEELLVWYDGEDNPEIAAAIEEERASARS","Homo sapiens","PRDM2, RIZ, KMT8","PR domain zinc finger protein 2","1","2JV0"
"2JV1",,"SOLUTION NMR",,,,,,,"10.1007/s10858-007-9206-2",,"2JV1",5.82,,,"NMR structure of human insulin monomer in 35% CD3CN zinc free, 50 structures","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","Insulin","1","2JV1"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFYTPKT","Homo sapiens","INS","Insulin","2","2JV1"
"2JV5",,"SOLUTION NMR",,,,,,,,,"2JV5",6.19,,,"Nogo54","RIYKGVIQAIQKSDEGHPFRAYLESEVAISEELVQKYSNSALGHVNCTIKELRR","Homo sapiens","RTN4, KIAA0886, NOGO, My043, SP1507","Reticulon-4","1","2JV5"
"2JVN",,"SOLUTION NMR",,,,,,,"10.1021/bi800018a",,"2JVN",14.56,,,"Domain C of human PARP-1","KLEKALKAQNDLIWNIKDELKKVCSTNDLKELLIFNKQQVPSGESAILDRVADGMVFGALLPCEECSGQLVFKSDAYYCTGDVTAWTKCMVKTQTPNRKEWVTPKEFREISYLKKLKVKKQDRIFP","Homo sapiens","PARP1, ADPRT, PPOL","Poly [ADP-ribose] polymerase 1","1","2JVN"
"2JVZ",,"SOLUTION NMR",,,,,,,,,"2JVZ",17.76,,,"Solution NMR Structure of the Second and Third KH Domains of KSRP","GTVQEIMIPAGKAGLVIGKGGETIKQLQERAGVKMILIQDGSQNTNVDKPLRIIGDPYKVQQACEMVMDILRERDQGGFGDRNEYGSRIGGGIDVPVPRHSVGVVIGRSGEMIKKIQNDAGVRIQFKQDDGTGPEKIAHIMGPPDRCEHAARIINDLLQSLRSG","Homo sapiens","KHSRP, FUBP2","Far upstream element-binding protein 2","1","2JVZ"
"2JW2",,"SOLUTION NMR",,,,,,,,,"2JW2",9.34,,,"Validation of inter-helical orientation of the steril-alpha-motif of human deleted in liver cancer 2 by residual dipolar couplings","MHHHHHHSSGLVPRGSQEIEAKEACDWLRAAGFPQYAQLYEDSQFPINIVAVKNDHDFLEKDLVEPLCRRLNTLNKCASMK","Homo sapiens","DLC2, STARD13, GT650","StAR-related lipid transfer protein 13","1","2JW2"
"2JW4",,"SOLUTION NMR",,,,,,,"10.1016/j.bbapap.2008.09.016",,"2JW4",8.29,,,"NMR solution structure of the N-terminal SH3 domain of human Nckalpha","GSTMAEEVVVVAKFDYVAQQEQELDIKKNERLWLLDDSKSWWRVRNSMNKTGFVPSNYVERKNSARAAANSS","Homo sapiens","NCK1, NCK","Cytoplasmic protein NCK1","1","2JW4"
"2JW5",,"SOLUTION NMR",,,,,,,,,"2JW5",11.64,,,"Polymerase Lambda BRCT domain","GSNSGEEAEEWLSSLRAHVVRTGIGRARAELFEKQIVQHGGQLCPAQGPGVTHIVVDEGMDYERALRLLRLPQLPPGAQLVKSAWLSLCLQERRLVDVAGFSIFIP","Homo sapiens","POLL","DNA polymerase lambda","1","2JW5"
"2JW6",,"SOLUTION NMR",,,,,,,"10.1016/j.jmb.2008.01.071",,"2JW6",6.01,,,"Solution structure of the DEAF1 MYND domain","GAMDAERKEQSCVNCGREAMSECTGCHKVNYCSTFCQRKDWKDHQHICGQSA","Homo sapiens","DEAF1, SPN, ZMYND5","Deformed epidermal autoregulatory factor 1 homolog","1","2JW6"
"2JWA",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M709202200",,"2JWA",9.47,,,"ErbB2 transmembrane segment dimer spatial structure","GCPAEQRASPLTSIISAVVGILLVVVLGVVFGILIKRRQQKIRK","Homo sapiens","ERBB2, HER2, NEU, NGL, MLN19","Receptor tyrosine-protein kinase erbB-2","1","2JWA"
"2JWE",,"SOLUTION NMR",,,,,,,"10.1002/prot.22955",,"2JWE",20.06,,,"Solution structure of the second PDZ domain from human zonula occludens-1: A dimeric form with 3D domain swapping","TKVTLVKSRKNEEYGLRLASHIFVKEISQDSLAARDGNIQEGDVVLKINGTVTENMSLTDAKTLIERSKGKLKMVVQRDELEHHHHHH","Homo sapiens","TJP1, ZO1","Tight junction protein ZO-1","1","2JWE"
"2JX2",,"SOLUTION NMR",,,,,,,"10.1021/bi702429m",,"2JX2",13.38,,,"Solution conformation of RNA-bound NELF-E RRM","MGSSHHHHHHSSGLVPRGSHMGPFRRSDSFPERRAPRKGNTLYVYGEDMTPTLLRGAFSPFGNIIDLSMDPPRNCAFVTYEKMESADQAVAELNGTQVESVQLKVNIARKQPMLDAATGKS","Homo sapiens","RDBP, NELFE, RD","Negative elongation factor E","1","2JX2"
"2JX3",,"SOLUTION NMR",,,,,,,"10.1110/ps.073244108",,"2JX3",15.1,,,"NMR solution structure of the N-terminal domain of DEK","FTIAQGKGQKLCEIERIHFFLSKKKTDELRNLHKLLYNRPGTVSSLKKNVGQFSGFPFEKGSVQYKKKEEMLKKFRNAMLKSICEVLDLERSGVNSELVKRILNFLMHPKPSGKPLPKSKKTCSKGSKKER","Homo sapiens","DEK","Protein DEK","1","2JX3"
"2JX8",,"SOLUTION NMR",,,,,,,,,"2JX8",6.15,,,"Solution structure of hPCIF1 WW domain","GPLGSLPEELVHAGWEKCWSRRENRPYYFNRFTNQSLWEMPVLGQHDVISDP","Homo sapiens","PCIF1, C20orf67, CAPAM, PPP1R121","Phosphorylated CTD-interacting factor 1","1","2JX8"
"2JXB",,"SOLUTION NMR",,,,,,,"10.1016/j.jmb.2008.05.037",,"2JXB",10.27,,,"Structure of CD3epsilon-Nck2 first SH3 domain complex","HMKERPPPVPNPDYNSLKKGSLVKNLHMTEEVIVIAKWDYTAQQDQELDIKKNERLWLLDDSKTWWRVRNAANRTGYVPSNYVERK","Homo sapiens","CD3E, NCK2, GRB4","T-cell surface glycoprotein CD3 epsilon chain, Cytoplasmic protein NCK2","1","2JXB"
"2JXD",,"SOLUTION NMR",,,,,,,"10.1002/prot.22432",,"2JXD",7.02,,,"NMR structure of human Serine protease inhibitor Kazal type II (SPINK2)","PQFGLFSKYRTPNCSQYRLPGCPRHFNPVCGSDMSTYANECTLCMKIREGGHNIKIIRNGPC","Homo sapiens","SPINK2","Serine protease inhibitor Kazal-type 2","1","2JXD"
"2JXJ",,"SOLUTION NMR",,,,,,,"10.1038/nsmb.1400",,"2JXJ",10.84,,,"NMR structure of the ARID domain from the histone H3K4 demethylase RBP2","GPLGSRVRLDFLDQLAKFWELQGSTLKIPVVERKILDLYALSKIVASKGGFEMVTKEKKWSKVGSRLGYLPGKGTGSLLKSHYERILYPYELFQSG","Homo sapiens","JARID1A, RBBP2, RBP2, KDM5A","Histone demethylase JARID1A","1","2JXJ"
"2JXL",,"SOLUTION NMR",,,,,,,"10.1021/bi702056g",,"2JXL",10.12,,,"Solution structure of cardiac N-domain troponin C mutant F77W-V82A","MDDIYKAAVEQLTEEQKNEFKAAFDIFVLGAEDGCISTKELGKVMRMLGQNPTPEELQEMIDEVDEDGSGTVDFDEWLVMMARCMKDDS","Homo sapiens","TNNC1, TNNC","Troponin C, slow skeletal and cardiac muscles","1","2JXL"
"2JXO",,"SOLUTION NMR",,,,,,,"10.1016/j.str.2009.03.009",,"2JXO",10.73,,,"Structure of the second PDZ domain of NHERF-1","GIDPFTMLRPRLCTMKKGPSGYGFNLHSDKSKPGQFIRSVDPDSPAEASGLRAQDRIVEVNGVCMEGKQHGDVVSAIRAGGDETKLLVVDRETDEFFK","Homo sapiens","SLC9A3R1, NHERF, NHERF1","Ezrin-radixin-moesin-binding phosphoprotein 50","1","2JXO"
"2JXW",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M109.024828",,"2JXW",8.69,,,"Solution Structure of the Tandem WW Domains of FBP21","DPSKGRWVEGITSEGYHYYYDLISGASQWEKPEGFQGDLKKTAVKTVWVEGLSEDGFTYYYNTETGESRWEKPDD","Homo sapiens","WBP4, FBP21, FNBP21","WW domain-binding protein 4","1","2JXW"
"2JXX",,"SOLUTION NMR",,,,,,,,,"2JXX",10.77,,,"NMR solution structure of Ubiquitin-like domain of NFATC2IP. Northeast Structural Genomics Consortium target HR5627","MGSSHHHHHHSSGLVPRGSTETSQQLQLRVQGKEKHQTLEVSLSRDSPLKTLMSHYEEAMGLSGRKLSFFFDGTKLSGRELPADLGMESGDLIEVWG","Homo sapiens","NFATC2IP, NIP45","NFATC2-interacting protein","1","2JXX"
"2JXY",,"SOLUTION NMR",,,,,,,"10.1021/ja710491y",,"2JXY",23.24,,,"Solution structure of the hemopexin-like domain of MMP12","MEPALCDPNLSFDAVTTVGNKIFFFKDRFFWLKVSERPKTSVNLISSLWPTLPSGIEAAYEIEARNQVFLFKDDKYWLISNLRPEPNYPKSIHSFGFPNFVKKIDAAVFNPRFYRTYFFVDNQYWRYDERRQMMDPGYPKLITKNFQGIGPKIDAVFYSKNKYYYFFQGSNQFEYDFLLQRITKTLKSNSWFGC","Homo sapiens","MMP12, HME","Macrophage metalloelastase","1","2JXY"
"2JY5",,"SOLUTION NMR",,,,,,,"10.1016/j.jmb.2007.12.029",,"2JY5",5.63,,,"NMR structure of Ubiquilin 1 UBA domain","GSPEFQNPEVRFQQQLEQLSAMGFLNREANLQALIATGGDINAAIERLLGSS","Homo sapiens","UBQLN1, DA41, PLIC1","Ubiquilin-1","1","2JY5"
"2JY7",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M704973200",,"2JY7",5.74,,,"NMR structure of the ubiquitin associated (UBA) domain of p62 (SQSTM1). RDC refined","GSPPEADPRLIESLSQMLSMGFSDEGGWLTRLLQTKNYDIGAALDTIQYSKH","Homo sapiens","SQSTM1, ORCA, OSIL","Ubiquitin-binding protein p62","1","2JY7"
"2JY8",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M704973200",,"2JY8",5.74,,,"NMR structure of the ubiquitin associated (UBA) domain of p62 (SQSTM1) in complex with ubiquitin. RDC refined","GSPPEADPRLIESLSQMLSMGFSDEGGWLTRLLQTKNYDIGAALDTIQYSKH","Homo sapiens","SQSTM1, ORCA, OSIL","Ubiquitin-binding protein p62","1","2JY8"
"2JYE",,"SOLUTION NMR",,,,,,,"10.1110/ps.073295308",,"2JYE",7.92,,,"Human Granulin A","AMDVKCDMEVSCPDGYTCCRLQSGAWGCCPFTQAVCCEDHIHCCPAGFTCDTQKGTCEQKLAAALEHHHHHH","Homo sapiens","GRN","Granulin A","1","2JYE"
"2JYI",,"SOLUTION NMR",,,,,,,,,"2JYI",6.66,,,"Solution structure of MLL CXXC domain","KKGRRSRRCGQCPGCQVPEDCGVCTNCLDKPKFGGRNIKKQCCKMRKCQNLQWMPSK","Homo sapiens","MLL, ALL1, HRX, HTRX, TRX1, KMT2A, CXXC7, MLL1","Zinc finger protein HRX","1","2JYI"
"2JYT",,"SOLUTION NMR",,,,,,,"10.1110/ps.073295308",,"2JYT",7.4,,,"Human Granulin C, isomer 1","AMVPCDNVSSCPSSDTCCQLTSGEWGCCPIPEAVCCSDHQHCCPQGYTCVAEGQCQKLAAALEHHHHHH","Homo sapiens","GRN","Granulin-5","1","2JYT"
"2JYU",,"SOLUTION NMR",,,,,,,"10.1110/ps.073295308",,"2JYU",7.4,,,"Human Granulin C, isomer 2","AMVPCDNVSSCPSSDTCCQLTSGEWGCCPIPEAVCCSDHQHCCPQGYTCVAEGQCQKLAAALEHHHHHH","Homo sapiens","GRN","Granulin-5","1","2JYU"
"2JYV",,"SOLUTION NMR",,,,,,,"10.1110/ps.073295308",,"2JYV",7.98,,,"Human Granulin F","AMAIQCPDSQFECPDFSTCCVMVDGSWGCCPMPQASCCEDRVHCCPHGAFCDLVHTRCIKLAAALEHHHHHH","Homo sapiens","GRN","Granulin-2","1","2JYV"
"2JYW",,"SOLUTION NMR",,,,,,,"10.1038/nature06638",,"2JYW",22.78,,,"Solution structure of C-terminal domain of APOBEC3G","GPLGSPEFDPPTFTFNFNNEPWVRGRHETYLCYEVERMHNDTWVKLNQRRGFLANQAPHKHGFLEGRHAELCFLDVIPFWKLDLDQDYRVTCFTSWSPCFSCAQEMAKFISKNKHVSLCIKTARIYDDQGRAQEGLRTLAEAGAKISIMTYSEFKHCWDTFVDHQGAPFQPWDGLDEHSQDLSGRLRAILQNQEN","Homo sapiens","APOBEC3G, MDS019","DNA dC->dU-editing enzyme APOBEC-3G","1","2JYW"
"2JZX",,"SOLUTION NMR",,,,,,,,,"2JZX",17.06,,,"PCBP2 KH1-KH2 domains","KNVTLTIRLLMHGKEVGSIIGKKGESVKKMREESGARINISEGNCPERIITLAGPTNAIFKAFAMIIDKLEEDISSSMTNSTAASRPPVTLRLVVPASQCGSLIGKGGCKIKEIRESTGAQVQVAGDMLPNSTERAITIAGIPQSIIECVKQICVVMLET","Homo sapiens","PCBP2","Poly(rC)-binding protein 2","1","2JZX"
"2JZZ",,"SOLID-STATE NMR",,,,,,,"10.1021/ja078039s",,"2JZZ",8.58,,,"Solid-State NMR Structure of Microcrystalline Ubiquitin","MQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGG","Homo sapiens","UBC","Ubiquitin","1","2JZZ"
"2K01",,"SOLUTION NMR",,,,,,,"10.1126/scisignal.1160755",,"2K01",16.38,,,"Structure of a locked SDF1 dimer","GMKPVSLSYRCPCRFFESHVARANVKHLKILNTPNCACQIVARLKNNNRQVCIDPKLKWIQEYLEKCLNK","Homo sapiens","CXCL12, SDF1, SDF1A, SDF1B","Stromal cell-derived factor 1","1","2K01"
"2K07",,"SOLUTION NMR",,,,,,,"10.1007/s10969-008-9054-7",,"2K07",20.56,,,"Solution NMR structure of human E2-like ubiquitin-fold modifier conjugating enzyme 1 (UFC1). Northeast Structural Genomics Consortium target HR41","MADEATRRVVSEIPVLKTNAGPRDRELWVQRLKEEYQSLIRYVENNKNADNDWFRLESNKEGTRWFGKCWYIHDLLKYEFDIEFDIPITYPTTAPEIAVPELDGKTAKMYRGGKICLTDHFKPLWARNVPKFGLAHLMALGLGPWLAVEIPDLIQKGVIQHKEKCNQLEHHHHHH","Homo sapiens","UFC1, CGI-126, HSPC155","Ufm1-conjugating enzyme 1","1","2K07"
"2K0B",,"SOLUTION NMR",,,,,,,"10.1002/prot.21692",,"2K0B",5.74,,,"NMR structure of the UBA domain of p62 (SQSTM1)","GSPPEADPRLIESLSQMLSMGFSDEGGWLTRLLQTKNYDIGAALDTIQYSKH","Homo sapiens","SQSTM1, ORCA, OSIL","Sequestosome-1","1","2K0B"
"2K0E",,"SOLUTION NMR",,,,,,,"10.1016/j.str.2008.02.017",,"2K0E",16.88,,,"A Coupled Equilibrium Shift Mechanism in Calmodulin-Mediated Signal Transduction","ADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTIDFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADIDGDGQVNYEEFVQMMTAK","Homo sapiens","CALM1, CALM, CAM, CAM1","Calmodulin","1","2K0E"
"2K0F",,"SOLUTION NMR",,,,,,,"10.1016/j.str.2008.02.017",,"2K0F",19.1,,,"Calmodulin complexed with calmodulin-binding peptide from smooth muscle myosin light chain kinase","ADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTIDFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADIDGDGQVNYEEFVQMMTAK","Homo sapiens","CALM1, CALM, CAM, CAM1","calmodulin","1","2K0F"
,,,,,,,,,,,,,,,,"RRKWQKTGHAVRAIGRLSS",,,"19-mer peptide from Myosin light chain kinase","2","2K0F"
"2K0J",,"SOLUTION NMR",,,,,,,"10.1021/ja8080764",,"2K0J",16.98,,,"Solution structure of CaM complexed to DRP1p","ADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGDGTIDFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADIDGDGQVNYEEFVQMMTAK","Homo sapiens","CALM1, CALM, CAM, CAM1","calmodulin","1","2K0J"
"2K11",,"SOLUTION NMR",,,,,,,"10.1016/j.jmb.2008.04.042",,"2K11",14.5,,,"Solution structure of human pancreatic ribonuclease","KESRAKKFQRQHMDSDSSPSSSSTYCNQMMRRRNMTQGRCKPVNTFVHEPLVDVQNVCFQEKVTCKNGQGNCYKSNSSMHITDCRLTNGSRYPNCAYRTSPKERHIIVACEGSPYVPVHFDASVEDS","Homo sapiens","RNASE1, RIB1, RNS1","Pancreatic Ribonuclease","1","2K11"
"2K18",,"SOLUTION NMR",,,,,,,"10.1111/j.1742-4658.2009.06884.x",,"2K18",25.56,,,"Solution structure of bb' domains of human protein disulfide isomerase","GPLGSPAATTLPDGAAAESLVESSEVAVIGFFKDVESDSAKQFLQAAEAIDDIPFGITSNSDVFSKYQLDKDGVVLFKKFDEGRNNFEGEVTKENLLDFIKHNQLPLVIEFTEQTAPKIFGGEIKTHILLFLPKSVSDYDGKLSNFKTAAESFKGKILFIFIDSDHTDNQRILEFFGLKKEECPAVRLITLEEEMTKYKPESEELTAERITEFCHRFLEGKIKPHLMS","Homo sapiens","P4HB, ERBA2L, PDI, PDIA1, PO4DB","Protein disulfide-isomerase","1","2K18"
"2K1A",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M801748200",,"2K1A",4.75,,,"Bicelle-embedded integrin alpha(IIB) transmembrane segment","GALEERAIPIWWVLVGVLGGLLLLTILVLAMWKVGFFKRNRP","Homo sapiens","ITGA2B, GP2B, ITGAB","Integrin alpha-IIb","1","2K1A"
"2K1B",,"SOLUTION NMR",,,,,,,,,"2K1B",8.96,,,"Solution NMR structure of the chromo domain of the chromobox protein homolog 7","MHHHHHHSSGRENLYFQGEQVFAVESIRKKRVRKGKVEYLVKWKGWPPKYSTWEPEEHILDPRLVMAYEEKEE","Homo sapiens","CBX7","Chromobox protein homolog 7","1","2K1B"
"2K1D",,"SOLUTION NMR",,,,,,,,,"2K1D",16.49,,,"NMR Studies of a Pathogenic Mutant (D178N) of the Human Prion Protein","GSDPGQGGGTHSQWNKPSKPKTNMKHMAGAAAAGAVVGGLGGYVLGSAMSRPIIHFGSDYEDRYYRENMHRYPNQVYYRPMDEYSNQNNFVHNCVNITIKQHTVTTTTKGENFTETDVKMMERVVEQMCITQYERESQAYYQRGSS","Homo sapiens","PRNP, PRIP, PRP, ALTPRP","Major prion protein","1","2K1D"
"2K1J",,"SOLUTION NMR",,,,,,,"10.1016/j.febslet.2006.11.055",,"2K1J",7.46,,,"Plan homeodomain finger of tumour supressor ING4","MDMPVDPNEPTYCLCHQVSYGEMIGCDNPDCSIEWFHFACVGLTTKPRGKWFCPRCSQERKKK","Homo sapiens","ING4, My036","Inhibitor of growth protein 4","1","2K1J"
"2K1K",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M803089200",,"2K1K",7.79,,,"NMR structures of dimeric transmembrane domain of the receptor tyrosine kinase EphA1 in lipid bicelles at pH 4.3","SPPVSRGLTGGEIVAVIFGLLLGAALLLGILVFRSRRA","Homo sapiens","EPHA1, EPH, EPHT, EPHT1","Ephrin type-A receptor 1","1","2K1K"
"2K1L",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M803089200",,"2K1L",7.79,,,"NMR structures of dimeric transmembrane domain of the receptor tyrosine kinase EphA1 in lipid bicelles at pH 6.3","SPPVSRGLTGGEIVAVIFGLLLGAALLLGILVFRSRRA","Homo sapiens","EPHA1, EPH, EPHT, EPHT1","Ephrin type-A receptor 1","1","2K1L"
"2K1M",,"SOLUTION NMR",,,,,,,,,"2K1M",10.05,,,"3D NMR structure of domain cC0 of cardiac myosin binding protein C (MyBPC)","PEPGKKPVSAFSKKPRSVEVAAGSPAVFEAETERAGVKVRWQRGGSDISASNKYGLATEGTRHTLTVREVGPADQGSYAVIAGSSKVKFDLKVIE","Homo sapiens","MYBPC3","Myosin-binding protein C, cardiac-type","1","2K1M"
"2K1P",,"SOLUTION NMR",,,,,,,,,"2K1P",3.82,,,"Solution structure of the second zinc finger domain of ZRANB2/ZNF265","GSSANDWQCKTCSNVNWARRSECNMCNTPKYAK","Homo sapiens","ZRANB2, ZIS, ZNF265","Zinc finger Ran-binding domain-containing protein 2","1","2K1P"
"2K21",,"SOLUTION NMR",,,,,,,"10.1021/bi800875q",,"2K21",15.71,,,"NMR structure of human KCNE1 in LMPG micelles at pH 6.0 and 40 degree C","MGHHHHHHGMILSNTTAVTPFLTKLWQETVQQGGNMSGLARRSPRSGDGKLEALYVLMVLGFFGFFTLGIMLSYIRSKKLEHSNDPFNVYIESDAWQEKDKAYVQARVLESYKSCYVVENHLAIEQPNTHLPETKPSP","Homo sapiens","KCNE1","Potassium voltage-gated channel subfamily E member","1","2K21"
"2K25",,"SOLUTION NMR",,,,,,,,,"2K25",11.54,,,"Automated NMR Structure of the UBB by FAPSY","GSLVPRGSMQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSEYNIQKESTLHLVLRLRGYADLREDPDRQDHHPGSGAQ","Homo sapiens","TA0895, UBC","UBB","1","2K25"
"2K27",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M805717200",,"2K27",17.45,,,"Solution structure of Human Pax8 Paired Box Domain","MPHNSIRSGHGGLNQLGGAFVNGRPLPEVVRQRIVDLAHQGVRPCDISRQLRVSHGCVSKILGRYYETGSIRPGVIGGSKPKVATPKVVEKIGDYKRQNPTMFAWEIRDRLLAEGVCDNDTVPSVSSINRIIRTKVQQPFNLPMDSGAPGGGSHHHHHH","Homo sapiens","PAX8","Paired box protein Pax-8","1","2K27"
"2K28",,"SOLUTION NMR",,,,,,,,,"2K28",7.35,,,"Solution NMR structure of the chromo domain of the chromobox protein homolog 4","GSEHVFAVESIEKKRIRKGRVEYLVKWRGWSPKYNTWEPEENILDPRLLIAFQNRERQEQ","Homo sapiens","CBX4","E3 SUMO-protein ligase CBX4","1","2K28"
"2K2C",,"SOLUTION NMR",,,,,,,"10.1038/nsmb.1521",,"2K2C",16.3,,,"Solution NMR structure of N-terminal domain of human pirh2. Northeast Structural Genomics Consortium (NESG) target HT2A","MAATAREDGATGEERGQRGCEHYDRGCLLKAPCCDKLYTCRLCHDNNEDHQLDRFKVKEVQCINCEKIQHAQQTCEECSTLFGEYYCDICHLFDKDKKQYHCENCGICRIGPKEDFFHCLKCNLCLAMNLQGRHKCI","Homo sapiens","RCHY1, ARNIP, CHIMP, PIRH2, RNF199, ZNF363","RING finger and CHY zinc finger domain-containing protein 1","1","2K2C"
"2K2D",,"SOLUTION NMR",,,,,,,"10.1038/nsmb.1521",,"2K2D",9.1,,,"Solution NMR structure of C-terminal domain of human pirh2. Northeast Structural Genomics Consortium (NESG) target HT2C","GSHMMHSALDMTRYWRQLDDEVAQTPMPSEYQNMTVDILCNDCNGRSTVQFHILGMKCKICESYNTAQAGGRRISLDQQ","Homo sapiens","RCHY1, ARNIP, CHIMP, PIRH2, RNF199, ZNF363","RING finger and CHY zinc finger domain-containing protein 1","1","2K2D"
"2K2G",,"SOLUTION NMR",,,,,,,"10.1007/s10858-008-9236-4","DSV","2K2G",18.86,,,"Solution structure of the wild-type catalytic domain of human matrix metalloproteinase 12 (MMP-12) in complex with a tight-binding inhibitor","MFREMPGGPVWRKHYITYRINNYTPDMNREDVDYAIRKAFQVWSNVTPLKFSKINTGMADILVVFARGAHGDFHAFDGKGGILAHAFGPGSGIGGDAHFDEDEFWTTHSGGTNLFLTAVHEIGHSLGLGHSSDPKAVMFPTYKYVDINTFRLSADDIRGIQSLYG","Homo sapiens","MMP12, HME","Macrophage metalloelastase","1","2K2G"
"2K2J",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M803316200",,"2K2J",14.25,,,"NMR solution structure of the split PH domain from Phospholipase C gamma 2","GGGSGGSKKDEHKQQGELYMWDSIDQKWTRHYCAIADAKLSFSDDIEQTMEEDNPLGSLCRGILDLNTYNVVKAPQGKNQKSFVFILEPKQQGDPPVEFATDRVEELFEWFQSIREITWKIDTK","Homo sapiens","PLCG2","1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-2","1","2K2J"
"2K2M",,"SOLUTION NMR",,,,,,,"10.1016/j.jmb.2008.07.008",,"2K2M",7.64,,,"Structural Basis of PxxDY Motif Recognition in SH3 Binding","GPLGSGALKWVLCNYDFQARNSSELSVKQRDVLEVLDDSRKWWKVRDPAGQEGYVPYNILTPYPAAAS","Homo sapiens","EPS8L1, DRC3, EPS8R1, PP10566","Eps8-like protein 1","1","2K2M"
"2K2O",,"SOLUTION NMR",,,,,,,"10.1016/j.jmb.2008.04.046",,"2K2O",14.2,,,"Solution Structure of the inner DysF domain of human myoferlin","IDPFTADAGHTEFTDEVYQNESRYPGGDWKPAEDTYTDANGDKAASPSELTCPPGWEWEDDAWSYDINRAVDEKGWEYGITIPPDHKPKSWVAAEKMYHTHRRRRLVRKRKKDLTQTASSTAR","Homo sapiens","FER1L3, KIAA1207, MYOF","Myoferlin","1","2K2O"
"2K2R",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M801270200",,"2K2R",16.1,,,"The NMR structure of alpha-parvin CH2/paxillin LD1 complex","RHERDAFDTLFDHAPDKLNVVKKTLITFVNKHLNKLNLEVTELETQFADGVYLVLLMGLLEGYFVPLHSFFLTPDSFEQKVLNVSFAFELMQDGGLEKPKPRPEDIVNCDLKSTLRVLYNLFTKYRNVE","Homo sapiens","PARVA, MXRA2","Alpha-parvin","1","2K2R"
,,,,,,,,,,,,,,,,"DLDALLADLE",,,"Paxillin","2","2K2R"
"2K3G",,"SOLUTION NMR",,,,,,,"10.1021/bi801059j",,"2K3G",11.28,,,"NMR structure analysis of a BMP receptor","GPEDTLPFLKCYCSGHCPDDAINNTCITNGHCFAIIEEDDQGETTLASGCMKYEGSDFQCKDSPKAQLRRTIECCRTNLCNQYLQPTLPPVVIGPFFDGSIR","Homo sapiens","BMPR1A, ACVRLK3, ALK3","Bone morphogenetic protein receptor type-1A","1","2K3G"
"2K3J",,"SOLUTION NMR",,,,,,,"10.1038/nsmb.1553",,"2K3J",16.4,,,"The solution structure of human Mia40","GSFTMSYCRQEGKDRIIFVTKEDHETPSSAELVADDPNDPYEEHGLILPNGNINWNCPCLGGMASGPCGEQFKSAFSCFHYSTEEIKGSDCVDQFRAMQECMQKYPDLYPQEDEDEEEEREKKPAEQAEETAPIEATATKEEEGSS","Homo sapiens","CHCHD4, MIA40","Mitochondrial intermembrane space import and assembly protein 40","1","2K3J"
"2K3T",,"SOLUTION NMR",,,,,,,"10.1371/journal.pone.0004928",,"2K3T",9.99,,,"Solution Structure of IG-Like Domain 23 from Human Filamin A","GAMGDPGLVSAYGAGLEGGVTGNPAEFVVNTSNAGAGALSVTIDGPSKVKMDCQECPEGYRVTYTPMAPGSYLISIKYGGPYHIGGSPFKAKVTGPRLV","Homo sapiens","FLNA, FLN, FLN1","Filamin-A","1","2K3T"
"2K40",,"SOLUTION NMR",,,,,,,,,"2K40",8.13,,,"NMR structure of HESX-1 homeodomain double mutant R31L/E42L","GRRPRTAFTQNQIEVLENVFRVNCYPGIDILEDLAQKLNLELDRIQIWFQNRRAKLKRSHRESQFLM","Homo sapiens","HESX1, HANF","Homeobox expressed in ES cells 1","1","2K40"
"2K43",,"SOLUTION NMR",,,,,,,,,"2K43",15.12,,,"Acidic fibroblast growth factor solution structure in the FGF-1-C2A binary complex: key component in the fibroblast growthfactor non-classical pathway","YKKPKLLYCSNGGHFLRILPDGTVDGTRDRSDQHIQLQLSAESVGEVYIKSTETGQYLAMDTDGLLYGSQTPNEECLFLERLEENHYNTYISKKHAEKNWFVGLKKNGSCKRGPRTHYGQKAILFLPLPVSSD","Homo sapiens","FGF1, FGFA","Heparin-binding growth factor 1","1","2K43"
"2K45",,"SOLUTION NMR",,,,,,,,,"2K45",14.78,,,"C2A domain of synaptototagmin I solution structure in the FGF-1-C2A binary complex: key component in the fibroblast growthfactor non-classical pathway","EKLGKLQYSLDYDFQNNQLLVGIIQAAELPALDMGGTSDPYVKVFLLPDKKKKFETKVHRKTLNPVFNEQFTFKVPYSELGGKTLVMAVYDFDRFSKHDIIGEFKVPMNTVDFGHVTEEWRDLQSAEK","Homo sapiens","SYT1, SVP65, SYT","Synaptotagmin-1","1","2K45"
"2K4D",,"SOLUTION NMR",,,,,,,"10.1016/j.jmb.2008.10.044",,"2K4D",9.52,,,"E2-c-Cbl recognition is necessary but not sufficient for ubiquitination activity","GSLQDHIKVTQEQYELYCEMGSTFQLCKICAENDKDVKIEPCGHLMCTSCLTSWQESEGQGCPFCRCEIKGTEPIVVDPFDPR","Homo sapiens","CBL, CBL2, RNF55","E3 ubiquitin-protein ligase CBL","1","2K4D"
"2K4P",,"SOLUTION NMR",,,,,,,"10.1021/bi801713f",,"2K4P",9.55,,,"Solution Structure of Ship2-Sam","MGSSHHHHHHSSGLVPRGSHMSGLGEAGMSAWLRAIGLERYEEGLVHNGWDDLEFLSDITEEDLEEAGVQDPAHKRLLLDTLQLSK","Homo sapiens","INPPL1, SHIP2","Phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase 2","1","2K4P"
"2K4T",,"SOLUTION NMR",,,,,,,"10.1126/science.1161302",,"2K4T",31.88,,,"Solution structure of human VDAC-1 in LDAO micelles","MAVPPTYADLGKSARDVFTKGYGFGLIKLDLKTKSENGLEFTSSGSANTETTKVTGSLETKYRWTEYGLTFTEKWNTDNTLGTEITVEDQLARGLKLTFDSSFSPNTGKKNAKIKTGYKREHINLGCDMDFDIAGPSIRGALVLGYEGWLAGYQMNFETAKSRVTQSNFAVGYKTDEFQLHTNVNDGTEFGGSIYQKVNKKLETAVNLAWTAGNSNTRFGIAAKYQIDPDACFSAKVNNSSLIGLGYTQTLKPGIKLTLSALLDGKNVNAGGHKLGLGLEFQALEHHHHHH","Homo sapiens","VDAC1, VDAC","Voltage-dependent anion-selective channel protein 1","1","2K4T"
"2K60",,"SOLUTION NMR",,,,,,,"10.1016/j.cell.2008.08.006",,"2K60",17.42,,,"NMR structure of calcium-loaded STIM1 EF-SAM","GSHMASSEDEKLSFEAVRNIHKLMDDDANGDVDVEESDEFLREDLNYHDPTVKHSTFHGEDKLISVEDLWKAWKSSEVYNWTVDEVVQWLITYVELPQYEETFRKLQLSGHAMPRLAVTNTTMTGTVLKMTDRSHRQKLQLKALDTVLFG","Homo sapiens","STIM1, GOK","PROTEIN (Stromal interaction molecule 1)","1","2K60"
"2K61",,"SOLUTION NMR",,,,,,,"10.1021/ja8080764",,"2K61",17,,,"Solution structure of CaM complexed to DAPk peptide","ADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGDGTIDFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADIDGDGQVNYEEFVQMMTAK","Homo sapiens","CALM1, CALM, CAM, CAM1, CALM2, CAM2, CAMB, CALM3, CALML2, CAM3, CAMC, CAMIII","Calmodulin","1","2K61"
"2K6B",,"SOLUTION NMR",,,,,,,"10.1016/j.abb.2009.03.018",,"2K6B",12.69,,,"Solution structure of 1-112 fragment of human programmed cell death 5 protein","GSADEELEALRRQRLAELQAKHGDPGDAAQQEAKHREAEMRNSILAQVLDQSARARLSNLALVKPEKTKAVENYLIQMARYGQLSEKVSEQGLIEILKKVSQQTEKTTTVKFN","Homo sapiens","PDCD5, TFAR19","Programmed cell death protein 5","1","2K6B"
"2K6G",,"SOLUTION NMR",,,,,,,,,"2K6G",12,,,"Solution structure of the DNA binding BRCT domain from the large subunit of human Replication Factor C","KRTNYQAYRSYLNREGPKALGSKEIPKGAENCLEGLIFVITGVLESIERDEAKSLIERYGGKVTGNVSKKTNYLVMGRDSGQSKSDKAAALGTKIIDEDGLLNLIRNLE","Homo sapiens","RFC1, RFC140","Replication factor C subunit 1","1","2K6G"
"2K6M",,"SOLUTION NMR",,,,,,,"10.1016/j.jmb.2009.08.018",,"2K6M",7.71,,,"Solution Structure of Human Supervillin Headpiece","MLAKLCKTIYPLADLLARPLPEGVDPLKLEIYLTDEDFEFALDMTRDEYNALPAWKQVNLKKAKGLF","Homo sapiens","SVIL","Supervillin","1","2K6M"
"2K6N",,"SOLUTION NMR",,,,,,,"10.1016/j.jmb.2009.08.018",,"2K6N",7.71,,,"Solution Structure of Human Supervillin Headpiece, Minimized Average","MLAKLCKTIYPLADLLARPLPEGVDPLKLEIYLTDEDFEFALDMTRDEYNALPAWKQVNLKKAKGLF","Homo sapiens","SVIL","Supervillin","1","2K6N"
"2K6O",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M805533200",,"2K6O",4.5,,,"Human LL-37 Structure","LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES","Homo sapiens","CAMP, CAP18, FALL39, HSD26","Cathelicidin antimicrobial peptide","1","2K6O"
"2K6S",,"SOLUTION NMR",,,,,,,"10.1021/bi8020197",,"2K6S",10.01,,,"Structure of Rab11-FIP2 C-terminal Coiled-coil Domain","GSLTYEEVLQELVKHKELLRRKDTHIRELEDYIDNLLVRVM","Homo sapiens","RAB11FIP2, KIAA0941","Rab11fip2 protein","1","2K6S"
"2K7B",,"SOLUTION NMR",,,,,,,,,"2K7B",8.98,,,"NMR structure of Mg2+-bound CaBP1 N-domain","DRSLRPEEIEELREAFREFDKDKDGYINCRDLGNCMRTMGYMPTEMELIELSQQINMNLGGHVDFDDFVELMGPKL","Homo sapiens","CABP1","Calcium-binding protein 1","1","2K7B"
"2K7C",,"SOLUTION NMR",,,,,,,,,"2K7C",8.34,,,"NMR Structure of Mg2+-bound CaBP1 C-domain","ADMIGVKELRDAFREFDTNGDGEISTSELREAMRKLLGHQVGHRDIEEIIRDVDLNGDGRVDFEEFVRMMSR","Homo sapiens","CABP1","Calcium-binding protein 1","1","2K7C"
"2K7D",,"SOLUTION NMR",,,,,,,,,"2K7D",8.42,,,"NMR Structure of Ca2+-bound CaBP1 C-domain","ADMIGVKELRDAFREFDTNGDGEISTSELREAMRKLLGHQVGHRDIEEIIRDVDLNGDGRVDFEEFVRMMSR","Homo sapiens","CABP1","Calcium-binding protein 1","1","2K7D"
"2K7F",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M109.054106",,"2K7F",19.31,,,"HADDOCK calculated model of the complex between the BRCT region of RFC p140 and dsDNA","KRTNYQAYRSYLNREGPKALGSKEIPKGAENCLEGLIFVITGVLESIERDEAKSLIERYGGKVTGNVSKKTNYLVMGRDSGQSKSDKAAALGTKIIDEDGLLNLIRNLE","Homo sapiens","RFC1, RFC140","Replication factor C subunit 1","1","2K7F"
,,,,,,,,,,,,,,,,"CGACCTCGAGATCA",,,"5'-D(P*DCP*DGP*DAP*DCP*DCP*DTP*DCP*DGP*DAP*DGP*DAP*DTP*DCP*DA)-3'","2","2K7F"
,,,,,,,,,,,,,,,,"CTCGAGGTCG",,,"5'-D(P*DCP*DTP*DCP*DGP*DAP*DGP*DGP*DTP*DCP*DG)-3'","3","2K7F"
"2K7J",,"SOLUTION NMR",,,,,,,"10.1073/pnas.0808220106",,"2K7J",11.21,,,"Human Acylphosphatase(AcPh) surface charge-optimized","GAEGNTLISVDYEIFGKVQGVFFRKHTQAEGKKLGLVGWVQNTDRGTVQGKLQGPISKVREMQKWLETRGSPESHIDKANFKNEKVILKLDYSDFQIVK","Homo sapiens","ACYP1, ACYPE","Acylphosphatase-1","1","2K7J"
"2K7K",,"SOLUTION NMR",,,,,,,"10.1073/pnas.0808220106",,"2K7K",11.2,,,"Human Acylphosphatase (AcPh) common type","GAEGNTLISVDYEIFGKVQGVFFRKHTQAEGKKLGLVGWVQNTDRGTVQGQLQGPISKVRHMQEWLETRGSPKSHIDKANFNNEKVILKLDYSDFQIVK","Homo sapiens","ACYP1, ACYPE","Acylphosphatase-1","1","2K7K"
"2K7L",,"SOLUTION NMR",,,,,,,"10.1021/bi801549m",,"2K7L",10.3,,,"NMR structure of a complex formed by the C-terminal domain of human RAP74 and a phosphorylated peptide from the central domain of the FCP1","EDTDEDDHLIYLEEILVRV",,,"centFCP1-T584PO4 peptide","1","2K7L"
,,,,,,,,,,,,,,,,"DVQVTEDAVRRYLTRKPMTTKDLLKKFQTKKTGLSSEQTVNVLAQILKRLNPERKMINDKMHFSLKE","Homo sapiens","GTF2F1, RAP74","General transcription factor IIF subunit 1","2","2K7L"
"2K7N",,"SOLUTION NMR",,,,,,,,,"2K7N",21.53,,,"Solution structure of the PPIL1 bound to a fragment of SKIP","MAAIPPDSWQPPNVYLETSMGIIVLELYWKHAPKTCKNFAELARRGYYNGTKFHRIIKDFMIQGGDPTGTGRGGASIYGKQFEDELHPDLKFTGAGILAMANAGPDTNGSQFFVTLAPTQWLDGKHTIFGRVCQGIGMVNRVGMVETNSQDRPVDDVKIIKAYPSGGGGSGGGSGGGSGGGSGDGGAFPEIHVAQYPLDMGRK","Homo sapiens","PPIL1, CYPL1, CGI-124, UNQ2425/PRO4984","Peptidyl-prolyl cis-trans isomerase-like 1","1","2K7N"
"2K7P",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M109.019661",,"2K7P",20.01,,,"Filamin A Ig-like domains 16-17","GAMAPERPLVGVNGLDVTSLRPFDLVIPFTIKKGEITGEVRMPSGKVAQPTITDNKDGTVTVRYAPSEAGLHEMDIRYDNMHIPGSPLQFYVDYVNCGHVTAYGPGLTHGVVNKPATFTVNTKDAGEGGLSLAIEGPSKAEISCTDNQDGTCSVSYLPVLPGDYSILVKYNEQHVPGSPFTARVTGDD","Homo sapiens","FLNA, FLN, FLN1","Filamin-A","1","2K7P"
"2K7Q",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M109.019661",,"2K7Q",20.41,,,"Filamin A Ig-like domains 18-19","GAMGDDSMRMSHLKVGSAADIPINISETDLSLLTATVVPPSGREEPCLLKRLRNGHVGISFVPKETGEHLVHVKKNGQHVASSPIPVVISQSEIGDASRVRVSGQGLHEGHTFEPAEFIIDTRDAGYGGLSLSIEGPSKVDINTEDLEDGTCRVTYCPTEPGNYIINIKFADQHVPGSPFSVKVTGEGRVK","Homo sapiens","FLNA, FLN, FLN1","Filamin-A","1","2K7Q"
"2K7S",,"SOLUTION NMR",,,,,,,"10.1073/pnas.0808270106",,"2K7S",13.8,,,"Human ARNT C-Terminal PAS Domain, 3 Residue IB slip","GAMDNVCQPTEFISRHNIEGIFTFVDHRCVATVGYQPQELLGKNIVEFCHPEDQQLLRDSFQQVVKLKGQVLSVMFRFRSKNQEWLWMRTSSQTAQNPYSDEIETIICTNTNVKNSSQE","Homo sapiens","ARNT, BHLHE2","Aryl hydrocarbon receptor nuclear translocator","1","2K7S"
"2K7W",,"SOLUTION NMR",,,,,,,"10.1038/nature07396",,"2K7W",23.66,,,"BAX Activation is Initiated at a Novel Interaction Site","MDGSGEQPRGGGPTSSEQIMKTGALLLQGFIQDRAGRMGGEAPELALDPVPQDASTKKLSECLKRIGDELDSNMELQRMIAAVDTDSPREVFFRVAADMFSDGNFNWGRVVALFYFASKLVLKALCTKVPELIRTIMGWTLDFLRERLLGWIQDQGGWDGLLSYFGTPTWQTVTIFVAGVLTASLTIWKKMG","Homo sapiens","BAX, BCL2L4","Apoptosis regulator BAX","1","2K7W"
,,,,,,,,,,,,,,,,"EIWIAQELRRIGDEFNAYYA",,,"Bcl-2-like protein 11","2","2K7W"
"2K7Z",,"SOLUTION NMR",,,,,,,"10.1016/j.str.2008.12.019",,"2K7Z",30.35,,,"Solution Structure of the Catalytic Domain of Procaspase-8","MRGSESQTLDKVYQMKSKPRGYCLIINNHNFAKAREKVPKLHSIRDRNGTHLDAGALTTTFEELHFEIKPHDDCTVEQIYEILKIYQLMDHSNMDCFICCILSHGDKGIIYGTDGQEAPIYELTSQFTGLKCPSLAGKPKVFFIQAAQGDNYQKGIPVETDSEEQPYLEMDLSSPQTRYIPDEADFLLGMATVNNCVSYRNPAEGTWYIQSLCQSLRERCPRGDDILTILTEVNYEVSNKDDKKNMGKQMPQPTFTLRKKLVFPSD","Homo sapiens","CASP8, MCH5","Caspase-8","1","2K7Z"
"2K85",,"SOLUTION NMR",,,,,,,"10.1016/j.jmb.2009.04.035",,"2K85",8.17,,,"p190-A RhoGAP FF1 domain","GAMGSQQIATAKDKYEWLVSRIVKNHNENWLSVSRKMQASPEYQDYVYLEGTQKAKKLFLQHIHRLKHE","Homo sapiens","GRLF1, GRF1, KIAA1722, ARHGAP35, P190A, p190ARHOGAP","Glucocorticoid receptor DNA-binding factor 1","1","2K85"
"2K86",,"SOLUTION NMR",,,,,,,"10.1016/j.jmb.2008.09.025",,"2K86",11.71,,,"Solution Structure of FOXO3a Forkhead domain","GSSSRRNAWGNLSYADLITRAIESSPDKRLTLSQIYEWMVRCVPYFKDKGDSNSSAGWKNSIRHNLSLHSRFMRVQNEGTGKSSWWIINPDGGKSGKAPRRRA","Homo sapiens","FOXO3, FKHRL1, FOXO3A","Forkhead box protein O3","1","2K86"
"2K89",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M109.009126",,"2K89",9.03,,,"Solution structure of a novel Ubiquitin-binding domain from Human PLAA (PFUC, Gly76-Pro77 cis isomer)","ANQQTSGKVLYEGKEFDYVFSIDVNEGGPSYKLPYNTSDDPWLTAYNFLQKNDLNPMFLDQVAKFIIDNTKGQMLGLGNP","Homo sapiens","PLAA, PLAP","Phospholipase A-2-activating protein","1","2K89"
"2K8A",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M109.009126",,"2K8A",9.03,,,"Solution structure of a novel Ubiquitin-binding domain from Human PLAA (PFUC, Gly76-Pro77 trans isomer)","ANQQTSGKVLYEGKEFDYVFSIDVNEGGPSYKLPYNTSDDPWLTAYNFLQKNDLNPMFLDQVAKFIIDNTKGQMLGLGNP","Homo sapiens","PLAA, PLAP","Phospholipase A-2-activating protein","1","2K8A"
"2K8G",,"SOLUTION NMR",,,,,,,,,"2K8G",10.63,,,"Solution structure of RRM2 domain of PABP1","GADPSLRKSGVGNIFIKNLDKSIDNKALYDTFSAFGNILSCKVVCDENGSKGYGFVHFETQEAAERAIEKMNGMLLNDRKVFVGRFKSRKEREAE","Homo sapiens","PABPC1, PAB1, PABP1, PABPC2, PABP","Polyadenylate-binding protein 1","1","2K8G"
"2K8O",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M807236200",,"2K8O",6.26,,,"Solution structure of integrin Alpha L","LKVGFFKRNLKEKIEAGRGVPNGIPAEDSEQLASGQEAGDPGCLKPLHEKDSESGGGKDG","Homo sapiens","ITGAL, CD11A","Integrin alpha-L","1","2K8O"
"2K8P",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M807994200",,"2K8P",21.43,,,"Characterisation of the structural features and interactions of sclerostin: molecular insight into a key regulator of Wnt-mediated bone formation","GWQAFKNDATEIIPELGEYPEPPPELENNKTMNRAENGGRPPHHPFETKDVSEYSCRELHFTRYVTDGPCRSAKPVTELVCSGQCGPARLLPNAIGRGKWWRPSGPDFRCIPDRYRAQRVQLLCPGGEAPRARKVRLVASCKCKRLTRFHNQSELKDFGTEAARPQKGRKPRPRARSAKANQAELENAY","Homo sapiens","SOST, UNQ2976/PRO7455/PRO7476","Sclerostin","1","2K8P"
"2K8R",,"SOLUTION NMR",,,,,,,,,"2K8R",15.78,,,"Solution structure of human acidic fibroblast growth factor in complex with anti-angiogenic drug inositol hexaphosphate (IP6)","YKKPKLLYCSNGGHFLRILPDGTVDGTRDRSDQHIQLQLSAESVGEVYIKSTETGQYLAMDTDGLLYGSQTPNEECLFLERLEENHYNTYISKKHAEKNWFVGLKKNGSCKRGPRTHYGQKAILFLPLPVSSD","Homo sapiens","hFGF-1, FGF1, FGFA","Heparin-binding growth factor 1","1","2K8R"
"2K8V",,"SOLUTION NMR",,,,,,,"10.1021/bi9003342",,"2K8V",17.8,,,"Solution structure of Oxidised ERp18","MHHHHHHMSDGHNGLGKGFGDHIHWRTLEDGKKEAAASGLPLMVIIHKSWCGACKALKPKFAESTEISELSHNFVMVNLEDEEEPKDEDFSPDGGYIPRILFLDPSGKVHPEIINENGNPSYKYFYVSAEQVVQGMKEAQERLTGDAFRKKHLEDEL","Homo sapiens","TXNDC12, TLP19, UNQ713/PRO1376","Thioredoxin domain-containing protein 12","1","2K8V"
"2K91",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M900085200",,"2K91",5.72,,,"Enhancing the activity of insulin by stereospecific unfolding","FVNQHLCGSDLVEALYLVCGERGAFYTKPT","Homo sapiens","INS","Insulin","2","2K91"
,,,,,,,,,,,,,,,,"GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","Insulin","1","2K91"
"2K9A",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M806167200",,"2K9A",16.16,,,"The Solution Structure of the Arl2 Effector, BART","HMDALEGESFALSFSSASDAEFDAVVGYLEDIIMDDEFQLLQRNFMDKYYLEFEDTEENKLIYTPIFNEYISLVEKYIEEQLLQRIPEFNMAAFTTTLQHHKDEVAGDIFDMLLTFTDFLAFKEMFLDYRAEKEGRG","Homo sapiens","ARL2BP, BART, BART1","ADP-ribosylation factor-like protein 2-binding protein","1","2K9A"
"2K9C",,"SOLUTION NMR",,,,,,,"10.1073/pnas.0708460105",,"2K9C",16.82,,,"Paramagnetic shifts in solid-state NMR of Proteins to elicit structural information","HYITYRINNYTPDMNREDVDYAIRKAFQVWSNVTPLKFSKINTGMADILVVFARGAHGDDHAFDGKGGILAHAFGPGSGIGGDAHFDEDEFWTTHSGGTNLFLTAVHEIGHSLGLGHSSDPKAVMFPTYKYVDINTFRLSADDIRGIQSLYG","Homo sapiens","MMP12, HME","Macrophage metalloelastase","1","2K9C"
"2K9G",,"SOLUTION NMR",,,,,,,,,"2K9G",8.48,,,"Solution structure of the third SH3 domain of the Cin85 adapter protein","SMDSRTKSKDYCKVIFPYEAQNDDELTIKEGDIVTLINKDCIDVGWWEGELNGRRGVFPDNFVKLLPPDFEKE","Homo sapiens","CIN85, SH3KBP1","SH3 domain-containing kinase-binding protein 1","1","2K9G"
"2K9R",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M900085200",,"2K9R",5.72,,,"Enhancing the activity of insulin by stereospecific unfolding","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","Insulin","1","2K9R"
,,,,,,,,,,,,,,,,"FVNQHLCGSDLVEALYLVCGERGAFYTKPT","Homo sapiens","INS","Insulin","2","2K9R"
"2K9U",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M807719200",,"2K9U",15.1,,,"Solution NMR structure of the Filamin-migfilin complex","GIPEFFQFTVGPLGEGGAHKVRAGGTGLERGVAGVPAEFSIWTREAGAGGLSIAVEGPSKAEIAFEDRKDGSCGVSYVVQEPGDYEVSIKFNDEHIPDSPFVVPVASLSDDARRLTVTS","Homo sapiens","FLNC, ABPL, FLN2","Gamma filamin","1","2K9U"
,,,,,,,,,,,,,,,,"MASKPEKRVASSVFITLAPPRRDV",,,"Filamin-binding LIM protein 1","2","2K9U"
"2K9Y",,"SOLUTION NMR",,,,,,,"10.1016/j.bpj.2009.11.008",,"2K9Y",8.57,,,"EphA2 dimeric structure in the lipidic bicelle at pH 5.0","EFQTLSPEGSGNLAVIGGVAVGVVLLLVLAGVGFFIHRRRK","Homo sapiens","EPHA2, ECK","Ephrin type-A receptor 2","1","2K9Y"
"2KA1",,"SOLUTION NMR",,,,,,,"10.1021/bi802245u",,"2KA1",7.58,,,"Solution NMR structure of BNIP3 transmembrane peptide dimer in detergent micelles","GGIFSAEFLKVFLPSLLLSHLLAIGLGIYIGRRLT","Homo sapiens","BNIP3, NIP3","BCL2/adenovirus E1B 19 kDa protein-interacting protein 3","1","2KA1"
"2KA2",,"SOLUTION NMR",,,,,,,"10.1021/bi802245u",,"2KA2",7.58,,,"Solution NMR structure of BNIP3 transmembrane peptide dimer in detergent micelles with His173-Ser172 intermonomer hydrogen bond restraints","GGIFSAEFLKVFLPSLLLSHLLAIGLGIYIGRRLT","Homo sapiens","BNIP3, NIP3","BCL2/adenovirus E1B 19 kDa protein-interacting protein 3","1","2KA2"
"2KA3",,"SOLUTION NMR",,,,,,,"10.1007/s10858-008-9290-y",,"2KA3",51.68,,,"Structure of EMILIN-1 C1Q-like domain","MRGSHHHHHHGSPVPQVAFSAALSLPRSEPGTVPFDRVLLNDGGYYDPETGVFTAPLAGRYLLSAVLTGHRHEKVEAVLSRSNQGVARVDSGGYEPEGLENKPVAESQPSPGTLGVFSLILPLQAGDTVCVDLVMGQLAHSEEPLTIFSGALLYGDPELEHA","Homo sapiens","EM1, EMILIN1, EMI","EMILIN-1","1","2KA3"
"2KAP",,"SOLUTION NMR",,,,,,,"10.1021/bi9000936",,"2KAP",7.1,,,"Solution structure of DLC1-SAM","KEACDWLRATGFPQYAQLYEDFLFPIDISLVKREHDFLDRDAIEALCRRLNTLNKCAVMK","Homo sapiens","DLC1, ARHGAP7, KIAA1723, STARD12","Rho GTPase-activating protein 7","1","2KAP"
"2KAV",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M807401200",,"2KAV",14.59,,,"Solution structure of the human Voltage-gated Sodium Channel, brain isoform (Nav1.2)","MGSSHHHHHHSSGLVPRGSHMASENFSVATEESAEPLSEDDFEMFYEVWEKFDPDATQFIEFAKLSDFADALDPPLLIAKPNKVQLIAMDLPMVSGDRIHCLDILFAFTKRVLGESGEMDALRIQMEER","Homo sapiens","NAC2, SCN2A, SCN2A1, SCN2A2","Sodium channel protein type 2 subunit alpha","1","2KAV"
"2KAX",,"SOLUTION NMR",,,,,,,"10.1007/s00775-009-0553-1",,"2KAX",21.52,,,"Solution structure and dynamics of S100A5 in the apo and Ca2+ -bound states","METPLEKALTTMVTTFHKYSGREGSKLTLSRKELKELIKKELCLGEMKESSIDDLMKSLDKNSDQEIDFKEYSVFLTMLCMAYNDFFLEDNK","Homo sapiens","S100A5, S100D","Protein S100-A5","1","2KAX"
"2KAY",,"SOLUTION NMR",,,,,,,"10.1007/s00775-009-0553-1",,"2KAY",21.68,,,"Solution structure and dynamics of S100A5 in the Ca2+ -bound states","METPLEKALTTMVTTFHKYSGREGSKLTLSRKELKELIKKELCLGEMKESSIDDLMKSLDKNSDQEIDFKEYSVFLTMLCMAYNDFFLEDNK","Homo sapiens","S100A5, S100D","Protein S100-A5","1","2KAY"
"2KB0",,"SOLUTION NMR",,,,,,,,,"2KB0",19.74,,,"Cdc42(T35A)","MQTIKCVVVGDGAVGKTCLLISYTTNKFPSEYVPAVFDNYAVTVMIGGEPYTLGLFDTAGQEDYDRLRPLSYPQTDVFLVCFSVVSPSSFENVKEKWVPEITHHCPKTPFLLVGTQIDLRDDPSTIEKLAKNKQKPITPETAEKLARDLKAVKYVECSALTQKGLKNVFDEAILAALE","Homo sapiens","CDC42","Cell division control protein 42 homolog","1","2KB0"
"2KB5",,"SOLUTION NMR",,,,,,,"10.1002/bip.21152",,"2KB5",15.6,,,"Solution NMR Structure of Eosinophil Cationic Protein/RNase 3","RPPQFTRAQWFAIQHISLNPPRCTIAMRAINNYRWRCKNQNTFLRTTFANVVNVCGNQSIRCPHNRTLNNCHRSRFRVPLLHCDLINPGAQNISNCRYADRPGRRFYVVACDNRDPRDSPRYPVVPVHLDTTI","Homo sapiens","RNASE3, ECP, RNS3","Eosinophil cationic protein","1","2KB5"
"2KB8",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M809085200",,"2KB8",3.91,,,"The dynamic alpha-helix structure of micelle-bound human amylin.","KCNTATCATQRLANFLVHSSNNFGAILSSTNVGSNTY","Homo sapiens","IAPP","Islet amyloid polypeptide","1","2KB8"
"2KBG",,"SOLUTION NMR",,,,,,,,,"2KBG",13.12,,,"Solution structure of the second Fibronectin type-III module of NCAM2","EAEASMREPSPPSIHGQPSSGKSFKLSITKQDDGGAPILEYIVKYRSKDKEDQWLEKKVQGNKDHIILEHLQWTMGYEVQITAANRLGYSEPTVYEFSMPPKPNIIKDHHHHHH","Homo sapiens","NCAM2, NCAM21","Neural cell adhesion molecule 2","1","2KBG"
"2KBI",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M807747200",,"2KBI",10.99,,,"Solution NMR structure of the C-terminal EF-hand domain of human cardiac sodium channel NaV1.5","GPGSENFSVATEESTEPLSEDDFDMFYEIWEKFDPEATQFIEYSVLSDFADALSEPLRIAKPNQISLINMDLPMVSGDRIHCMDILFAFTKRVLGES","Homo sapiens","SCN5A","Sodium channel protein type 5 subunit alpha","1","2KBI"
"2KBO",,"SOLUTION NMR",,,,,,,"10.1038/emboj.2008.290",,"2KBO",22.99,,,"Structure, interaction, and real-time monitoring of the enzymatic reaction of wild type APOBEC3G","HMLRHSMDPPTFTFNFNNEPWVRGRHETYLCYEVERMHNDTWVLLNQRRGFLCNQAPHKHGFLEGRHAELCFLDVIPFWKLDLDQDYRVTCFTSWSPCFSCAQEMAKFISKNKHVSLCIFTARIYDDQGRCQEGLRTLAEAGAKISIMTYSEFKHCWDTFVDHQGCPFQPWDGLDEHSQDLSGRLRAILQNQEN","Homo sapiens","MDS019, APOBEC3G","DNA dC->dU-editing enzyme APOBEC-3G","1","2KBO"
"2KBQ",,"SOLUTION NMR",,,,,,,"10.1073/pnas.0901819106",,"2KBQ",9.57,,,"Solution structure of harmonin N terminal domain","MDRKVAREFRHKVDFLIENDAEKDYLYDVLRMYHQTMDVAVLVGDLKLVINEPSRLPLFDAIRPLIPLKHQVEYDQLTPR","Homo sapiens","HARMONIN, USH1C, AIE75","Harmonin","1","2KBQ"
"2KBV",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M809201200",,"2KBV",2.89,,,"Structural and functional analysis of TM XI of the NHE1 isoform of thE NA+/H+ exchanger","XKDQFIIAYGGLRGAIAFSLGYLLDKKX","Homo sapiens","SLC9A1, APNH1, NHE1","Sodium/hydrogen exchanger 1","1","2KBV"
"2KBY",,"SOLUTION NMR",,,,,,,"10.1038/cdd.2009.139",,"2KBY",24.14,,,"The Tetramerization Domain of Human p73","GSDEDTYYLQVRGRENFEILMKLKESLELMELVPQPLVDSYRQQQQLLQR","Homo sapiens","P73, TP73","Tumor protein p73","1","2KBY"
"2KC3",,"SOLUTION NMR",,,,,,,,,"2KC3",21.35,,,"NMR solution structure of complete receptor binding domain of human apolipoprotein E","MKVEQAVETEPEPELRQQTEWQSGQRWELALGRFWDYLRWVQTLSEQVQEELLSSQVTQELRALMDETMKELKAYKSELEEQLTPVAEETRARLSKELQAAQARLGADMEDVCGRLVQYRGEVQAMLGQSTEELRVRLASHLRKLRKRLLRDADDLQKRLAVYQAGAREGAERGLSAIRERLGP","Homo sapiens","APOE","Apolipoprotein E","1","2KC3"
"2KCC",,"SOLUTION NMR",,,,,,,"10.1002/prot.21952",,"2KCC",9.42,,,"Solution Structure of biotinoyl domain from human acetyl-CoA carboxylase 2","MENDPTVLRSPSAGKLTQYTVEDGGHVEAGSSYAEMEVMKMIMTLNVQERGRVKYIKRPGAVLEAGCVVARLELDDLEHHHHHH","Homo sapiens","ACACB, ACC2, ACCB","Acetyl-CoA carboxylase 2","1","2KCC"
"2KCF",,"SOLUTION NMR",,,,,,,"10.1002/bip.10020",,"2KCF",4.17,,,"The NMR solution structure of the isolated Apo Pin1 WW domain","GSKLPPGWEKRMSRSSGRVYYFNHITNASQWERPSG","Homo sapiens","PIN1","Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1","1","2KCF"
"2KCJ",,"SOLUTION NMR",,,,,,,"10.1038/embor.2010.28",,"2KCJ",12.22,,,"solution structure of FAPP1 PH domain","GPLGSPEFMEGVLYKWTNYLTGWQPRWFVLDNGILSYYDSQDDVCKGSKGSIKMAVCEIKVHSADNTRMELIIPGEQHFYMKAVNAAERQRWLVALGSSKASLTDTRT","Homo sapiens","PLEKHA3, FAPP1","Pleckstrin homology domain-containing family A member 3","1","2KCJ"
"2KCX",,"SOLUTION NMR",,,,,,,,,"2KCX",7.98,,,"Solution NMR Structure of Kazal-1 Domain of Human Follistatin-related protein 3 (FSTL-3). Northeast Structural Genomics Target HR6186A.","SDSCDGVECGPGKACRMLGGRPRCECAPDCSGLPARLQVCGSDGATYRDECELRAARCRGHPDLSVMYRGRCRK","Homo sapiens","FSTL3, FLRG, UNQ674/PRO1308","Follistatin-related protein 3","1","2KCX"
"2KDB",,"SOLUTION NMR",,,,,,,,,"2KDB",11.57,,,"Solution Structure of human ubiquitin-like domain of Herpud2_9_85, Northeast Structural Genomics Consortium (NESG) target HT53A","MGSSHHHHHHSSGRENLYFQGHPVTLIIKAPNQKYSDQTISCFLNWTVGKLKTHLSNVYPSKPLTKDQRLVYSGRLLPDHLQLKDILRKQDEYHMVHLV","Homo sapiens","HERPUD2","Homocysteine-responsive endoplasmic reticulum-resident ubiquitin-like domain member 2 protein","1","2KDB"
"2KDD",,"SOLUTION NMR",,,,,,,"10.1021/bi900530v",,"2KDD",16.16,,,"Solution structure of the conserved C-terminal dimerization domain of Borealin","GSAGERIYNISGNGSPLADSKEIFLTVPVGGGESLRLLASDLQRHSIAQLDPEALGNIKKLSNRLAQICSSIRTHK","Homo sapiens","CDCA8, PESCRG3","Borealin","1","2KDD"
"2KDG",,"SOLUTION NMR",,,,,,,"10.1007/s10858-009-9320-4",,"2KDG",10.97,,,"Solution Structure of the 1st Ig domain of Myotilin","GAMGPPRFIQVPENMSIDEGRFCRMDFKVSGLPAPDVSWYLNGRTVQSDDLHKMIVSEKGLHSLIFEVVRASDAGAYACVAKNRAGEATFTVQLDVLAKE","Homo sapiens","MYOT, TTID","Myotilin","1","2KDG"
"2KDH",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M109.021352","KDH","2KDH",8.91,,,"The Solution Structure of Human Cardiac Troponin C in complex with the Green Tea Polyphenol; (-)-epigallocatechin-3-gallate","MGKSEEELSDLFRMFDKNADGYIDLDELKIMLQATGETITEDDIEELMKDGDKNNDGRIDYDEFLEFMKGVE","Homo sapiens","TNNC1, TNNC","Troponin C, slow skeletal and cardiac muscles","1","2KDH"
"2KDK",,"SOLUTION NMR",,,,,,,,,"2KDK",13.87,,,"Structure of human circadian clock protein BMAL2 C-terminal PAS domain","GHMNSGEINVKPTEFITRFAVNGKFVYVDQRATAILGYLPQELLGTSCYEYFHQDDHNNLTDKHKAVLQSKEKILTDSYKFRAKDGSFVTLKSQWFSFTNPDTKELEYIVSVNTLVLGHSE","Homo sapiens","ARNTL2, BMAL2, CLIF, MOP9, BHLHE6, PASD9","Aryl hydrocarbon receptor nuclear translocator-like protein 2","1","2KDK"
"2KDO",,"SOLUTION NMR",,,,,,,"10.1016/j.jmb.2009.12.039",,"2KDO",29.01,,,"Structure of the human Shwachman-Bodian-Diamond syndrome protein, SBDS","GHMSIFTPTNQIRLTNVAVVRMKRAGKRFEIACYKNKVVGWRSGVEKDLDEVLQTHSVFVNVSKGQVAKKEDLISAFGTDDQTEICKQILTKGEVQVSDKERHTQLEQMFRDIATIVADKCVNPETKRPYTVILIERAMKDIHYSVKTNKSTKQQALEVIKQLKEKMKIERAHMRLRFILPVNEGKKLKEKLKPLIKVIESEDYGQQLEIVCLIDPGCFREIDELIKKETKGKGSLEVLNLKDVEEGDEKFE","Homo sapiens","SBDS, CGI-97","Ribosome maturation protein SBDS","1","2KDO"
"2KDP",,"SOLUTION NMR",,,,,,,"10.1093/nar/gkp051",,"2KDP",8.19,,,"Solution Structure of the SAP30 zinc finger motif","SNAGQLCCLREDGERCGRAAGNASFSKRIQKSISQKKVKIELDKSARHLYICDYHKNLIQSVRNRRKRKGS","Homo sapiens","SAP30","Histone deacetylase complex subunit SAP30","1","2KDP"
"2KE1",,"SOLUTION NMR",,,,,,,"10.1093/nar/gkp166",,"2KE1",8.43,,,"Molecular Basis of non-modified histone H3 tail Recognition by the First PHD Finger of Autoimmune Regulator","GAMAQKNEDECAVCRDGGELICCDGCPRAFHLACLSPPLREIPSGTWRCSSCLQATVQEVQPRAEE","Homo sapiens","AIRE, APECED","Autoimmune regulator","1","2KE1"
,,,,,,,,,,,,,,,,"ARTKQTARKS",,,"H3K4me0","2","2KE1"
"2KE4",,"SOLUTION NMR",,,,,,,"10.1007/s10858-009-9317-z",,"2KE4",11.53,,,"The NMR structure of the TC10 and Cdc42 interacting domain of CIP4","GPHMTEDFSHLPPEQQRKRLQQQLEERSRELQKEVDQREALKKMKDVYEKTPQMGDPASLEPQIAETLSNIERLKLEVQKYEAWLAEAESRVLSNRGD","Homo sapiens","TRIP10, CIP4, STOT, STP","Cdc42-interacting protein 4","1","2KE4"
"2KE5",,"SOLUTION NMR",,,,,,,"10.1021/bi802129d",,"2KE5",20.45,,,"Solution structure and dynamics of the small GTPase Ralb in its active conformation: significance for effector protein binding","LALHKVIMVGSGGVGKSALTLQFMYDEFVEDYEPTKADSYRKKVVLDGEEVQIDILDTAGLEDYAAIRDNYFRSGEGFLLVFSITEHESFTATAEFREQILRVKAEEDKIPLLVVGNKSDLEERRQVPVEEARSKAEEWGVQYVETSAKTRANVDKVFFDLMREIRTKKMSENK","Homo sapiens","RALB","Ras-related protein Ral-B","1","2KE5"
"2KE7",,"SOLUTION NMR",,,,,,,,,"2KE7",11.5,,,"NMR structure of the first SAM domain from AIDA1","GSDITSLYKKAGSEMNGPRCPVQTVGQWLESIGLPQYENHLMANGFDNVQFMGSNVMEDQDLLEIGILNSGHRQRILQAIQLLPKMRPIGHDGYHPTSVAEWL","Homo sapiens","ANKS1B","Ankyrin repeat and sterile alpha motif domain-containing protein 1B","1","2KE7"
"2KE9",,"SOLUTION NMR",,,,,,,,,"2KE9",9.34,,,"NMR solution structure of the CASKIN SH3 domain","GSSHHHHHHSSGLVPRGSLKVRALKDFWNLHDPTALNVRAGDVITVLEQHPDGRWKGHIHESQRGTDRIGYFPPGIVEVVSKR","Homo sapiens","CASKIN2, KIAA1139","Caskin-2","1","2KE9"
"2KEB",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M110.116830",,"2KEB",11.15,,,"NMR solution structure of the N-terminal domain of the DNA polymerase alpha p68 subunit","MGSSHHHHHHGSSLEVLFQGPGSMSASAQQLAEELQIFGLDCEEALIEKLVELCVQYGQNEEGMVGELIAFCTSTHKVGLTSEILNSFEHEFLSKRLSKAR","Homo sapiens","POLA2","DNA polymerase subunit alpha B","1","2KEB"
"2KEC",,"SOLUTION NMR",,,,,,,"10.1002/pro.167",,"2KEC",8.17,,,"Structure of SDF-1/CXCL12","GMKPVSLSYRCPCRFFESHVARANVKHLKILNTPNCALQIVARLKNNNRQVCIDPKLKWIQEYLEKALNK","Homo sapiens","CXCL12, SDF1, SDF1A, SDF1B","Stromal cell-derived factor 1-alpha","1","2KEC"
"2KED",,"SOLUTION NMR",,,,,,,"10.1002/pro.167",,"2KED",8.17,,,"Structure of SDF-1/CXCL12","GMKPVSLSYRCPCRFFESHVARANVKHLKILNTPNCALQIVARLKNNNRQVCIDPKLKWIQEYLEKALNK","Homo sapiens","CXCL12, SDF1, SDF1A, SDF1B","Stromal cell-derived factor 1-alpha","1","2KED"
"2KEE",,"SOLUTION NMR",,,,,,,"10.1002/pro.167",,"2KEE",8.12,,,"Structure of SDF-1/CXCL12","GSKPVSLSYRCPCRFFESHVARANVKHLKILNTPNCALQIVARLKNNNRQVCIDPKLKWIQEYLEKALNK","Homo sapiens","CXCL12, SDF1, SDF1A, SDF1B","Stromal cell-derived factor 1-alpha","1","2KEE"
"2KEF",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M109.017764",,"2KEF",2.8,,,"Solution NMR structures of human hepcidin at 325K","DTHFPICIFCCGCCHRSKCGMCCKT","Homo sapiens","HAMP, HEPC, LEAP1, UNQ487/PRO1003","Hepcidin","1","2KEF"
"2KEM",,"SOLUTION NMR",,,,,,,"10.1016/j.jmb.2009.04.031",,"2KEM",23.58,,,"Extended structure of citidine deaminase domain of APOBEC3G","GPLGSPGFEILRHSMDPPTFTFNFNNEPWVRGRHETYLCYEVERMHNDTWVKLNQRRGFLANQAPHKHGFLEGRHAELCFLDVIPFWKLDLDQDYRVTCFTSWSPCFSCAQEMAKFISKNKHVSLCIKTARIYDDQGRAQEGLRTLAEAGAKISIMTYSEFKHCWDTFVDHQGAPFQPWDGLDEHSQDLSGRLRAILQNQEN","Homo sapiens","APOBEC3G, MDS019","DNA dC->dU-editing enzyme APOBEC-3G","1","2KEM"
"2KEO",,"SOLUTION NMR",,,,,,,,,"2KEO",12.65,,,"Solution NMR structure of human protein HS00059, cytochrome-b5-like domain of the HERC2 E3 ligase. Northeast structural genomics consortium (NESG) target ht98a","MHHHHHHSSGRENLYFQGNNEKVTLVRIADLENHNNDGGFWTVIDGKVYDIKDFQTQSLTENSILAQFAGEDPVVALEAALQFEDTRESMHAFCVGQYLEPDQEGVTIPDLG","Homo sapiens","HERC2","Probable E3 ubiquitin-protein ligase HERC2","1","2KEO"
"2KES",,"SOLUTION NMR",,,,,,,"10.1096/fj.09-133082",,"2KES",5.37,,,"Solution Structure of the Coiled-coil Domain of Synphilin-1","GSVETCMSLASQVVKLTKQLKEQTVERVTLQNQLQQFLEAQKSEGKSL","Homo sapiens","SNCAIP","Synphilin-1","1","2KES"
"2KFB",,"SOLUTION NMR",,,,,,,"10.1021/bi802292q",,"2KFB",21.86,,,"The structure of the cataract causing P23T mutant of human gamma-D crystallin","MKHHHHHHQGKITLYEDRGFQGRHYECSSDHTNLQPYLSRCNSARVDSGCWMLYEQPNYSGLQYFLRRGDYADHQQWMGLSDSVRSCRLIPHSGSHRIRLYEREDYRGQMIEFTEDCSCLQDRFRFNEIHSLNVLEGSWVLYELSNYRGRQYLLMPGDYRRYQDWGATNARVGSLRRVIDFS","Homo sapiens","CRYGD, CRYG4","Gamma-crystallin D","1","2KFB"
"2KFF",,"SOLUTION NMR",,,,,,,"10.1002/pro.258",,"2KFF",13.11,,,"Structure of the C-terminal domain of EHD1 with FNYESTNPFTAK","GPLGSDDVEWVVGKDKPTYDEIFYTLSPVNGKITGANAKKEMVKSKLPNTVLGKIWKLADVDKDGLLDDEEFALANHLIKVKLEGHELPADLPPHLVPPSKRRHE","Homo sapiens","EHD1, PAST, PAST1, CDABP0131","EH domain-containing protein 1","1","2KFF"
,,,,,,,,,,,,,,,,"FNYESTNPFTAK",,,"Rab11-FIP2 NPF peptide FNYESTNPFTAK","2","2KFF"
"2KFG",,"SOLUTION NMR",,,,,,,"10.1002/pro.258",,"2KFG",13.11,,,"Structure of the C-terminal domain of EHD1 in complex with FNYESTDPFTAK","GPLGSDDVEWVVGKDKPTYDEIFYTLSPVNGKITGANAKKEMVKSKLPNTVLGKIWKLADVDKDGLLDDEEFALANHLIKVKLEGHELPADLPPHLVPPSKRRHE","Homo sapiens","EHD1, PAST, PAST1, CDABP0131","EH domain-containing protein 1","1","2KFG"
,,,,,,,,,,,,,,,,"FNYESTDPFTAK",,,"Rab11-FIP2 DPF peptide FNYESTDPFTAK","2","2KFG"
"2KFH",,"SOLUTION NMR",,,,,,,"10.1002/pro.258",,"2KFH",13.06,,,"Structure of the C-terminal domain of EHD1 with FNYESTGPFTAK","GPLGSDDVEWVVGKDKPTYDEIFYTLSPVNGKITGANAKKEMVKSKLPNTVLGKIWKLADVDKDGLLDDEEFALANHLIKVKLEGHELPADLPPHLVPPSKRRHE","Homo sapiens","EHD1, PAST, PAST1, CDABP0131","EH domain-containing protein 1","1","2KFH"
,,,,,,,,,,,,,,,,"FNYESTGPFTAK",,,"Rab11-FIP2 GPF peptide FNYESTGPFTAK","2","2KFH"
"2KFT",,"SOLUTION NMR",,,,,,,"10.1016/j.str.2009.02.017",,"2KFT",8.44,,,"NMR Solution structure of the first PHD finger domain of human Autoimmune Regulator (AIRE) in complex with Histone H3(1-20Cys) Peptide","GSKNEDECAVCRDGGELICCDGCPRAFHLACLSPPLREIPSGTWRCSSCLQATVQE","Homo sapiens","AIRE, APECED","Autoimmune regulator","1","2KFT"
,,,,,,,,,,,,,,,,"ARTKQTARKSTGGKAPRKQLC",,,"Histone H3","2","2KFT"
"2KFV",,"SOLUTION NMR",,,,,,,,,"2KFV",10.45,,,"Structure of the amino-terminal domain of human FK506-binding protein 3 / Northeast Structural Genomics Consortium Target HT99A","MGSSHHHHHHSSGLVPRGSMAAAVPQRAWTVEQLRSEQLPKKDIIKFLQEHGSDSFLAEHKLLGNIKNVAKTANKDHLVTAYNHLFETKRFK","Homo sapiens","FKBP25, FKBP3","FK506-binding protein 3","1","2KFV"
"2KFX",,"SOLUTION NMR",,,,,,,"10.1021/bi9001826","WW7","2KFX",10.42,,,"Structure of the N-terminal domain of human cardiac troponin C bound to calcium ion and to the inhibitor W7","MDDIYKAAVEQLTEEQKNEFKAAFDIFVLGAEDGSISTKELGKVMRMLGQNPTPEELQEMIDEVDEDGSGTVDFDEFLVMMVRSMKDDS","Homo sapiens","TNNC1, TNNC","Troponin C, slow skeletal and cardiac muscles","1","2KFX"
"2KFY",,"SOLUTION NMR",,,,,,,"10.1038/nsmb.1814",,"2KFY",16.98,,,"NMR structure of the first qRRM of hnRNP F in complex with AGGGAU G-tract RNA","MGSSHHHHHHSSGLVPRGSHMASMTGGQQMGRGSMMLGPEGGEGFVVKLRGLPWSCSVEDVQNFLSDCTIHDGAAGVHFIYTREGRQSGEAFVELGSEDDVKMALKKDRESMGHRYIEVFKSHRTEMDWVLKHSGP","Homo sapiens","HNRNPF, HNRPF","Heterogeneous nuclear ribonucleoprotein F","1","2KFY"
,,,,,,,,,,,,,,,,"AGGGAU",,,"5'-R(*AP*GP*GP*GP*AP*U)-3'","2","2KFY"
"2KG0",,"SOLUTION NMR",,,,,,,"10.1038/nsmb.1814",,"2KG0",15.74,,,"Structure of the second qRRM domain of hnRNP F in complex with a AGGGAU G-tract RNA","MGSSHHHHHHSSGLVPRGSHMASMTGGQQMGRGSNSADSANDGFVRLRGLPFGCTKEEIVQFFSGLEIVPNGITLPVDPEGKITGEAFVQFASQELAEKALGKHKERIGHRYIEVFKSSQEEVRSY","Homo sapiens","HNRNPF, HNRPF","Heterogeneous nuclear ribonucleoprotein F","1","2KG0"
,,,,,,,,,,,,,,,,"AGGGAU",,,"5'-R(*AP*GP*GP*GP*AP*U)-3'","2","2KG0"
"2KG1",,"SOLUTION NMR",,,,,,,"10.1038/nsmb.1814",,"2KG1",17.02,,,"Structure of the third qRRM domain of hnRNP F in complex with a AGGGAU G-tract RNA","MGSSHHHHHHSSGLVPRGSHMASMTGGQQMGRGSGDSEFTVQSTTGHCVHMRGLPYKATENDIYNFFSPLNPVRVHIEIGPDGRVTGEADVEFATHEEAVAAMSKDRANMQHRYIELFLNSTTGASNGAYSSQVMQGMG","Homo sapiens","HNRNPF, HNRPF","Heterogeneous nuclear ribonucleoprotein F","1","2KG1"
,,,,,,,,,,,,,,,,"AGGGAU",,,"5'-R(*AP*GP*GP*GP*AP*U)-3'","2","2KG1"
"2KG2",,"SOLUTION NMR",,,,,,,"10.1007/s10858-009-9361-8",,"2KG2",13.68,,,"Solution structure of a PDZ protein","GSYIPGQPVTAVVQRVEIHKLRQGENLILGFSIGGGIDQDPSQNPFSEDKTDKGIYVTRVSEGGPAEIAGLQIGDKIMQVNGWDMTMVTHDQARKRLTKRSEEVVRLLVTRQSLQKAVQQSMLS","Homo sapiens","TAX1BP3, TIP1","Tax1-binding protein 3","1","2KG2"
"2KG4",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M109.069344",,"2KG4",18.35,,,"Three-dimensional structure of human Gadd45alpha in solution by NMR","MTLEEFSAGEQKTERMDKVGDALEEVLSKALSQRTITVGVYEAAKLLNVDPDNVVLCLLAADEDDDRDVALQIHFTLIQAFCCENDINILRVSNPGRLAELLLLETDAGPAASEGAEQPPDLHCVLVTNPHSSQWKDPALSQLICFCRESRYMDQWVPVINLPER","Homo sapiens","GADD45A, DDIT1, GADD45","Growth arrest and DNA-damage-inducible protein GADD45 alpha","1","2KG4"
"2KG5",,"SOLUTION NMR",,,,,,,"10.1186/1472-6807-9-59",,"2KG5",10.86,,,"NMR Solution structure of ARAP3-SAM","MGSSHHHHHHSSGLVPRGSHMAAPQDLDIAVWLATVHLEQYADTFRRHGLATAGAARGLGHEELKQLGISATGHRKRILRLLQTGTEEGSLDPKSDSAME","Homo sapiens","ARAP3, CENTD3","Arf-GAP, Rho-GAP domain, ANK repeat and PH domain-containing protein 3","1","2KG5"
"2KGB",,"SOLUTION NMR",,,,,,,"10.1002/pro.121",,"2KGB",12.37,,,"NMR solution of the regulatory domain cardiac F77W-Troponin C in complex with the cardiac Troponin I 144-163 switch peptide","MDDIYKAAVEQLTEEQKNEFKAAFDIFVLGAEDGCISTKELGKVMRMLGQNPTPEELQEMIDEVDEDGSGTVDFDEWLVMMVRCMKDDS","Homo sapiens","TNNC1, TNNC","Troponin C, slow skeletal and cardiac muscles","1","2KGB"
,,,,,,,,,,,,,,,,"RRVRISADAMMQALLGARAK",,,"Troponin I, cardiac muscle","2","2KGB"
"2KGG",,"SOLUTION NMR",,,,,,,"10.1038/nature08036",,"2KGG",5.93,,,"Solution Structure of JARID1A C-terminal PHD finger","SVCAAQNCQRPCKDKVDWVQCDGGCDEWFHQVCVGVSPEMAENEDYICINCA","Homo sapiens","JARID1A, RBBP2, RBP2, KDM5A","Histone demethylase JARID1A","1","2KGG"
"2KGI",,"SOLUTION NMR",,,,,,,"10.1038/nature08036",,"2KGI",7.04,,,"Solution structure of JARID1A C-terminal PHD finger in complex with H3(1-9)K4me3","SVCAAQNCQRPCKDKVDWVQCDGGCDEWFHQVCVGVSPEMAENEDYICINCA","Homo sapiens","JARID1A, RBBP2, RBP2, KDM5A","Histone demethylase JARID1A","1","2KGI"
,,,,,,,,,,,,,,,,"ARTKQTARK",,,"H3(1-9)K4me3","2","2KGI"
"2KGR",,"SOLUTION NMR",,,,,,,,,"2KGR",12.61,,,"Solution structure of protein ITSN1 from Homo sapiens. Northeast Structural Genomics Consortium target HR5524A","PPVAEWAVPQSSRLKYRQLFNSHDKTMSGHLTGPQARTILMQSSLPQAQLASIWNLSDIDQDGKLTAEEFILAMHLIDVAMSGQPLPPVLPPEYIPPSFRRVRLEHHHHHH","Homo sapiens","ITSN1, ITSN, SH3D1A","Intersectin-1","1","2KGR"
"2KGT",,"SOLUTION NMR",,,,,,,,,"2KGT",8.33,,,"Solution structure of SH3 domain of PTK6","MVSRDQAHLGPKYVGLWDFKSRTDEELSFRAGDVFHVARKEEQWWWATLLDEAGGAVAQGYVPHNYLAERET","Homo sapiens","PTK6, BRK","Tyrosine-protein kinase 6","1","2KGT"
"2KHN",,"SOLUTION NMR",,,,,,,,,"2KHN",13.61,,,"NMR solution structure of the EH 1 domain from human intersectin-1 protein. Northeast Structural Genomics Consortium target HR3646E.","MGHHHHHHSHMAQFPTPFGGSLDTWAITVEERAKHDQQFHSLKPISGFITGDQARNFFFQSGLPQPVLAQIWALADMNNDGRMDQVEFSIAMKLIKLKLQGYQLPSALPPVMKQQPVAISS","Homo sapiens","ITSN1, ITSN, SH3D1A","Intersectin-1","1","2KHN"
"2KHT",,"SOLID-STATE NMR",,,,,,,"10.1016/j.jmb.2010.01.030",,"2KHT",3.45,,,"NMR Structure of human alpha defensin HNP-1","ACYCRIPACIAGERRYGTCIYQGRLWAFCC","Homo sapiens","DEF1, DEFA1, DEFA2, MRS, DEFA1B","Neutrophil defensin 1","1","2KHT"
"2KHX",,"SOLUTION NMR",,,,,,,"10.1186/1758-907X-1-2",,"2KHX",9.59,,,"Drosha double-stranded RNA binding motif","NDPKSQLQQCCLTLRTEGKEPDIPLYKTLQTVGPSHARTYTVAVYFKGERIGCGKGPSIQQAEMGAAMDALEKYNFPQMHHHHHH","Homo sapiens","RNASEN, RN3, RNASE3L, DROSHA","Ribonuclease 3","1","2KHX"
"2KIE",,"SOLUTION NMR",,,,,,,"10.1038/emboj.2009.155",,"2KIE",13.87,,,"A PH domain within OCRL bridges clathrin mediated membrane trafficking to phosphoinositide metabolis","GPLGSMEPPLPVGAQPLATVEGMEMKGPLREPCALTLAQRNGQYELIIQLHEKEQHVQDIIPINSHFRCVQEAEETLLIDIASNSGCKIRVQGDWIRERRFEIPDEEHCLKFLSAVLAAQKAQS","Homo sapiens","OCRL, INPP5F, OCRL1","Inositol polyphosphate 5-phosphatase OCRL-1","1","2KIE"
"2KIJ",,"SOLUTION NMR",,,,,,,"10.1021/bi901003k",,"2KIJ",12.97,,,"Solution structure of the Actuator domain of the copper-transporting ATPase ATP7A","GSFTMSEALAKLISLQATEATIVTLDSDNILLSEEQVDVELVQRGDIIKVVPGGKFPVDGRVIEGHSMVDESLITGEAMPVAKKPGSTVIAGSINQNGSLLICATHVGADTTLSQIVKLVEEAQ","Homo sapiens","ATP7A, MC1, MNK","Copper-transporting ATPase 1","1","2KIJ"
"2KIQ",,"SOLUTION NMR",,,,,,,"10.1007/s10858-009-9366-3",,"2KIQ",7.32,,,"Solution structure of the FF Domain 2 of human transcription elongation factor CA150","SHMKIMQAKEDFKKMMEEAKFNPRATFSEFAAKHAKDSRFKAIEKMKDREALFNEFVAAARK","Homo sapiens","TCERG1, CA150, TAF2S","Transcription elongation regulator 1","1","2KIQ"
"2KIS",,"SOLUTION NMR",,,,,,,"10.1016/j.jmb.2009.08.049",,"2KIS",8.58,,,"Solution structure of CA150 FF1 domain and FF1-FF2 interdomain linker","GAMGSLEARMKQFKDMLLERGVSAFSTWEKELHKIVFDPRYLLLNPKERKQVFDQYVKTRAEEERREKKNK","Homo sapiens","CA150, TAF2S, TCERG-1, TCERG1","Transcription elongation regulator 1","1","2KIS"
"2KIU",,"SOLUTION NMR",,,,,,,"10.1002/pro.626",,"2KIU",10.54,,,"Solution structure and backbone dynamics of the DNA-binding domain of FOXP1: Insight into its domain swapping","AEVRPPFTYASLIRQAILESPEKQLTLNEIYNWFTRMFPYFRRNAATWKNAVRHNLSLHKYFVRVENVKGAVWTVDEVEFQKRRPQK","Homo sapiens","3p14.1, FOXP1, HSPC215","Forkhead box protein P1","1","2KIU"
"2KIV",,"SOLUTION NMR",,,,,,,"10.1016/j.jmb.2009.08.004",,"2KIV",16.67,,,"AIDA-1 SAM domain tandem","MHHHHHHLVPRGSVQTVGQWLESIGLPQYENHLMANGFDNVQAMGSNVMEDQDLLEIGILNSGHRQRILQAIQLLPKMRPIGHDGAHPTSVAEWLDSIELGDYTKAFLINGYTSMDLLKKIAEVELINVLKINLIGHRKRILASLGDR","Homo sapiens","AIDA-1b, ANKS1B","Ankyrin repeat and sterile alpha motif domain-containing protein 1B","1","2KIV"
"2KIZ",,"SOLUTION NMR",,,,,,,"10.1002/prot.24048",,"2KIZ",8.09,,,"Solution structure of Arkadia RING-H2 finger domain","MKQDGEEGTEEDTEEKCTICLSILEEGEDVRRLPCMHLFHQVCVDQWLITNKKCPICRVDIEAQLPSES","Homo sapiens","RNF111","E3 ubiquitin-protein ligase Arkadia","1","2KIZ"
"2KJD",,"SOLUTION NMR",,,,,,,,,"2KJD",14.1,,,"Solution structure of extended PDZ2 domain from NHERF1 (150-270)","GIDPFTMLRPRLCTMKKGPSGYGFNLHSDKSKPGQFIRSVDPDSPAEASGLRAQDRIVEVNGVCMEGKQHGDVVSAIRAGGDETKLLVVDRETDEFFKKCRVIPSQEHLNGPLPVPFTNGEIQKENSR","Homo sapiens","SLC9A3R1, NHERF, NHERF1","Sodium/hydrogen exchange regulatory cofactor NHE-RF1","1","2KJD"
"2KJJ",,"SOLUTION NMR",,,,,,,,,"2KJJ",5.82,,,"Dynamics of insulin probed by 1H-NMR amide proton exchange anomalous flexibility of the receptor-binding surface","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","Insulin","1","2KJJ"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFYTKPT","Homo sapiens","INS","Insulin","2","2KJJ"
"2KJM",,"SOLUTION NMR",,,,,,,"10.1021/bi2018255",,"2KJM",3.67,,,"Solution structure of SLBP RNA binding domain fragment","ETDESVLMRRQKQINYGKNTIAYDRYIKEV","Homo sapiens","SLBP, HBP","Histone RNA hairpin-binding protein","1","2KJM"
"2KJU",,"SOLUTION NMR",,,,,,,,,"2KJU",5.79,,,"NMR structure of human insulin mutant glu-b21-d-glu, his-b10 asp pro-b28-lys, lys-b29-pro, 20 structures","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","Insulin","1","2KJU"
,,,,,,,,,,,,,,,,"FVNQHLCGSDLVEALYLVCGERGFFYTKPT","Homo sapiens","INS","Insulin","2","2KJU"
"2KJX",,"SOLUTION NMR",,,,,,,"10.1016/j.jmb.2011.10.048",,"2KJX",7.3,,,"Solution structure of the extracellular domain of JTB","GSGMKEFPCWLVEEFVVAEECSPCSNFRAKTTPECGPTGYVEKITCSSSKRNEFKSCRSALMEQR","Homo sapiens","JTB, HSPC222","Jumping translocation breakpoint protein","1","2KJX"
"2KJY",,"SOLUTION NMR",,,,,,,"10.1002/prot.22529",,"2KJY",6.96,,,"MYPT1(658-714)","GPMSTTEVRERRRSYLTPVRDEESESQRKARSRQARQSRRSTQGVTLTDLQEAEKTIGRS","Homo sapiens","PPP1R12A, MBS, MYPT1","Protein phosphatase 1 regulatory subunit 12A","1","2KJY"
"2KK0",,"SOLUTION NMR",,,,,,,"10.1002/prot.22718",,"2KK0",17.16,,,"Solution structure of dead ringer-like protein 1 (at-rich interactive domain-containing protein 3a) from homo sapiens, northeast structural genomics consortium (NESG) target hr4394c","MGHHHHHHSHMPDHGDWTYEEQFKQLYELDGDPKRKEFLDDLFSFMQKRGTPVNRIPIMAKQVLDLFMLYVLVTEKGGLVEVINKKLWREITKGLNLPTSITSAAFTLRTQYMKYLYPYECEKRGLSNPNELQAAIDSNRREGRR","Homo sapiens","ARID3A, DRIL1, DRIL3, DRX, E2FBP1","AT-rich interactive domain-containing protein 3A","1","2KK0"
"2KK1",,"SOLUTION NMR",,,,,,,"10.1002/prot.22656",,"2KK1",14.56,,,"Solution structure of C-terminal Domain of Tyrosine-protein kinase ABL2 from Homo sapiens, Northeast Structural Genomics Consortium (NESG) target HR5537A","MGHHHHHHSHMANGAAGTKVALRKTKQAAEKISADKISKEALLECADLLSSALTEPVPNSQLVDTGHQLLDYCSGYVDCIPQTRNKFAFREAVSKLELSLQELQVSSAAAGVPGTNPVLNNLLSCVQEISDVVQR","Homo sapiens","ABL2, ABLL, ARG","Tyrosine-protein kinase ABL2","1","2KK1"
"2KK6",,"SOLUTION NMR",,,,,,,,,"2KK6",13.65,,,"Solution structure of sh2 domain of proto-oncogene tyrosine-protein kinase fer from homo sapiens, northeast structural genomics consortium (nesg) target hr3461d","MGHHHHHHSHMKPLAEQDWYHGAIPRIEAQELLKKQGDFLVRESHGKPGEYVLSVYSDGQRRHFIIQYVDNMYRFEGTGFSNIPQLIDHHYTTKQVITKKSGVVLLNPIPKDKKWI","Homo sapiens","FER, TYK3","Proto-oncogene tyrosine-protein kinase FER","1","2KK6"
"2KKF",,"SOLUTION NMR",,,,,,,"10.1038/nsmb.1714",,"2KKF",14.14,,,"Solution structure of MLL CXXC domain in complex with palindromic CPG DNA","GSKKGRRSRRCGQCPGCQVPEDCGVCTNCLDKPKFGGRNIKKQCCKMRKCQNLQWMPSK","Homo sapiens","ALL1, CXXC7, HRX, HTRX, KMT2A, MLL, TRX1, MLL1","Histone-lysine N-methyltransferase HRX","1","2KKF"
,,,,,,,,,,,,,,,,"CCCTGCGCAGGG",,,"5'-D(*CP*CP*CP*TP*GP*CP*GP*CP*AP*GP*GP*G)-3'","2","2KKF"
"2KKI",,"SOLUTION NMR",,,,,,,"10.1007/s12104-010-9207-z",,"2KKI",17.23,,,"Solution structure of human Interleukin 1a","NVKYNFMRIIKYEFILNDALNQSIIRANDQYLTAAALHNLDEAVKFDMGAYKSSKDDAKITVILRISKTQLYVTAQDEDQPVLLKEMPEIPKTITGSETNLLFFWETHGTKNYFTSVAHPNLFIATKQDYWVCLAGGPPSITDFQILENQA","Homo sapiens","IL1A, IL1F1","Interleukin-1 alpha","1","2KKI"
"2KKQ",,"SOLUTION NMR",,,,,,,,,"2KKQ",13.34,,,"Solution NMR Structure of the Ig-like C2-type 2 Domain of Human Myotilin. Northeast Structural Genomics Target HR3158.","MGHHHHHHSHEHKRAPMFIYKPQSKKVLEGDSVKLECQISAIPPPKLFWKRNNEMVQFNTDRISLYQDNTGRVTLLIKDVNKKDAGWYTVSAVNEAGVTTCNTRLDVTARPNQTLP","Homo sapiens","MYOT, TTID","Myotilin","1","2KKQ"
"2KKR",,"SOLUTION NMR",,,,,,,,,"2KKR",8.83,,,"Solution structure of SCA7 zinc finger domain from human ataxin-7 protein","GSKFLNKRLSEREFDPDIHCGVIDLDTKKPCTRSLTCKTHSLTQRRAVQGRRKRFDVLLAEHKNKTREKELIRH","Homo sapiens","ATXN7, SCA7","Ataxin-7","1","2KKR"
"2KKT",,"SOLUTION NMR",,,,,,,,,"2KKT",9.56,,,"Solution structure of the SCA7 domain of human Ataxin-7-L3 protein","GSHMGPEELRSLLTTQCGVISEHTKKMCTRSLRCPQHTDEQRRTVRVYFLGPSAVLPEVESSLDNDSFDMTDSQALISRLQWDG","Homo sapiens","ATXN7L3","Ataxin-7-like protein 3","1","2KKT"
"2KKW",,"SOLUTION NMR, EPR",,,,,,,"10.1021/ja100646t",,"2KKW",14.48,,,"SLAS-micelle bound alpha-synuclein","MDVFMKGLSKAKEGVVAAAEKTKQGVAEAAGKTKEGVLYVGSKTKEGVVHGVATVAEKTKEQVTNVGGAVVTGVTAVAQKTVEGAGSIAAATGFVKKDQLGKNEEGAPQEGILEDMPVDPDNEAYEMPSEEGYQDYEPEA","Homo sapiens","SNCA, NACP, PARK1","Alpha-synuclein","1","2KKW"
"2KL7",,"SOLUTION NMR",,,,,,,,,"2KL7",7.58,,,"Solution NMR Structure of the EGF-like 1 Domain of Human Fibulin-4. Northeast Structural Genomics Target HR6275","SDVNECLTIPEACKGEMKCINHYGGYLCLPRSAAVINDLHGEGPPPPVPPAQHPNPCPPGYEPDDQDSCVD","Homo sapiens","EFEMP2, FBLN4, UNQ200/PRO226","Fibulin-4","1","2KL7"
"2KLC",,"SOLUTION NMR",,,,,,,,,"2KLC",11.62,,,"NMR solution structure of human ubiquitin-like domain of ubiquilin 1, Northeast Structural Genomics Consortium (NESG) target HT5A","MGSSHHHHHHSSGRENLYFQGHPKIMKVTVKTPKEKEEFAVPENSSVQQFKEEISKRFKSHTDQLVLIFAGKILKDQDTLSQHGIHDGLTVHLVIKTQNRP","Homo sapiens","DA41, PLIC1, UBQLN1","Ubiquilin-1","1","2KLC"
"2KLD",,"SOLUTION NMR",,,,,,,"10.1007/s12104-009-9160-x",,"2KLD",14.02,,,"Solution Structure of the Calcium Binding Domain of the C-terminal Cytosolic Domain of Polycystin-2","GSTAIGINDTYSEVKSDLAQQKAEMELSDLIRKGYHKALVKLKLKKNTVDDISESLRQGGGKLNFDELRQDLKGKGHTDAEIEAIFTKYDQDGDQELTEHEHQQMRDDLEKEREDLDLDHSSL","Homo sapiens","PKD2, TRPP2","Polycystin-2","1","2KLD"
"2KLE",,"SOLUTION NMR",,,,,,,"10.1007/s12104-009-9160-x",,"2KLE",14.02,,,"ISIC Refined Solution Structure of the Calcium Binding Domain of the C-terminal Cytosolic Domain of Polycystin-2","GSTAIGINDTYSEVKSDLAQQKAEMELSDLIRKGYHKALVKLKLKKNTVDDISESLRQGGGKLNFDELRQDLKGKGHTDAEIEAIFTKYDQDGDQELTEHEHQQMRDDLEKEREDLDLDHSSL","Homo sapiens","PKD2, TRPP2","Polycystin-2","1","2KLE"
"2KLG",,"SOLUTION NMR",,,,,,,"10.1002/anie.200902561",,"2KLG",8.58,,,"PERE NMR structure of ubiquitin","MQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGG","Homo sapiens","UBC","Ubiquitin","1","2KLG"
"2KLJ",,"SOLUTION SCATTERING, SOLUTION NMR",,,,,,,"10.1021/ja902528f",,"2KLJ",20.77,,,"Solution Structure of gammaD-Crystallin with RDC and SAXS","QGKITLYEDRGFQGRHYECSSDHTNLQPYLSRCNSARVDSGCWMLYEQPNYSGLQYFLRRGDYADHQQWMGLSDSVRSCRLIPHSGSHRIRLYEREDYRGQMIEFTEDCSCLQDRFRFNEIHSLNVLEGSWVLYELSNYRGRQYLLMPGDYRRYQDWGATNARVGSLRRVIDFS","Homo sapiens","CRYGD, CRYG4","Gamma-crystallin D","1","2KLJ"
"2KLL",,"SOLUTION NMR",,,,,,,"10.1016/j.str.2009.08.009",,"2KLL",18.16,,,"Solution structure of human interleukin-33","GSSITGISPITEYLASLSTYNDQSITFALEDESYEIYVEDLKKDEKKDKVLLSYYESQHPSNESGDGVDGKMLMVTLSPTKDFWLHANNKEHSVELHKCEKPLPDQAFFVLHNMHSNCVSFECKTDPGVFIGVKDNHLALIKVDSSENLCTENILFKLSET","Homo sapiens","IL33, C9orf26, IL1F11, NFHEV","Interleukin-33","1","2KLL"
"2KLQ",,"SOLUTION NMR",,,,,,,"10.1074/jbc.C109.094599",,"2KLQ",13.3,,,"The solution structure of CBD of human MCM6","APKASLRLGFSEYSRISNLIVLHLRKVEEEEDESALKRSELVNWYLKEIESEIDSEEELINKKRIIEKVIHRLTHYDHVLIELTQAGLKGSTEGSESYEEDPYLVVNPNYLLED","Homo sapiens","MCM6","DNA replication licensing factor MCM6","1","2KLQ"
"2KLR",,"SOLID-STATE NMR",,,,,,,"10.1038/nsmb.1891",,"2KLR",40.38,,,"Solid-state NMR structure of the alpha-crystallin domain in alphaB-crystallin oligomers","MDIAIHHPWIRRPFFPFHSPSRLFDQFFGEHLLESDLFPTSTSLSPFYLRPPSFLRAPSWFDTGLSEMRLEKDRFSVNLDVKHFSPEELKVKVLGDVIEVHGKHEERQDEHGFISREFHRKYRIPADVDPLTITSSLSSDGVLTVNGPRKQVSGPERTIPITREEKPAVTAAPKK","Homo sapiens","CRYAB, CRYA2, HSPB5","Alpha-crystallin B chain","1","2KLR"
"2KLU",,"SOLUTION NMR",,,,,,,"10.1016/j.bbamem.2009.09.010",,"2KLU",7.87,,,"NMR structure of the transmembrane and cytoplasmic domains of human CD4","GPLVPRGSMALIVLGGVAGLLLFIGLGIFFSVRSRHRRRQAERMSQIKRLLSEKKTSQSPHRFQKTHSPI","Homo sapiens","CD4","T-cell surface glycoprotein CD4","1","2KLU"
"2KLY",,"SOLUTION NMR",,,,,,,"10.1002/prot.22648",,"2KLY",18.78,,,"Solution structure of human ubiquitin conjugating enzyme Ube2g2","GHMAGTALKRLMAEYKQLTLNPPEGIVAGPMNEENFFEWEALIMGPEDTCFEFGVFPAILSFPLDYPLSPPKMRFTCEMFHPNIYPDGRVCISILHAPGDDPMGYESSAERWSPVQSVEKILLSVVSMLAEPNDESGANVDASKMWRDDREQFYKIAKQIVQKSLGL","Homo sapiens","UBE2G2, UBC7","Ubiquitin-conjugating enzyme E2 G2","1","2KLY"
"2KLZ",,"SOLUTION NMR",,,,,,,,,"2KLZ",6.1,,,"Solution Structure of the Tandem UIM Domain of Ataxin-3 Complexed with Ubiquitin","GSLDEDEEDLQRALALSRQEIDMEDEEADLRRAIQLSMQGSSRNLEHHHHHH","Homo sapiens","ATXN3, ATX3, MJD, MJD1, SCA3","Ataxin-3","1","2KLZ"
"2KM2",,"SOLUTION NMR",,,,,,,"10.1016/j.jmb.2010.02.033",,"2KM2",29.2,,,"Galectin-1 dimer","ACGLVASNLNLKPGECLRVRGEVAPDAKSFVLNLGKDSNNLCLHFNPRFNAHGDANTIVCNSKDGGAWGTEQREAVFPFQPGSVAEVCITFDQANLTVKLPDGYEFKFPNRLNLEAINYMAADGDFKIKCVAFD","Homo sapiens","LGALS1","Galectin-1","1","2KM2"
"2KM6",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M110.113191",,"2KM6",12.36,,,"NMR structure of the NLRP7 Pyrin domain","GHMTSPQLEWTLQTLLEQLNEDELKSFKSLLWAFPLEDVLQKTPWSEVEEADGKKLAEILVNTSSENWIRNATVNILEEMNLTELCKMAKAEMMEDGQLEHHHHHH","Homo sapiens","NLRP7, NALP7, NOD12, PYPAF3","NACHT, LRR and PYD domains-containing protein 7","1","2KM6"
"2KMS",,"SOLUTION NMR",,,,,,,"10.1016/j.jmb.2009.10.010",,"2KMS",13.26,,,"Combined high- and low-resolution techniques reveal compact structure in central portion of factor H despite long inter-modular linkers","TCGDIPELEHGWAQLSSPPYYYGDSVEFNCSESFTMIGHRSITCIHGVWTQLPQCVAIDKLKKCKSSNLIILEEHLKNKKEFDHNSNIRYRCRGKEGWIHTVCINGRWDPEVNCS","Homo sapiens","CFH, HF, HF1, HF2","Complement factor H","1","2KMS"
"2KMU",,"SOLUTION NMR",,,,,,,"10.1093/nar/gks591",,"2KMU",6.85,,,"RecQL4 Amino-terminal Domain","GSMERLRDVRERLQAWERAFRRQRGRRPSQDDVEAAPEETRALYREYRTLKRTTGQ","Homo sapiens","RECQL4, RECQ4","ATP-dependent DNA helicase Q4","1","2KMU"
"2KMV",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M109.054262",,"2KMV",20.27,,,"Solution structure of the nucleotide binding domain of the human Menkes protein in the ATP-free form","SFTMHGTPVVNQVKVLTESNRISHHKILAIVGTAESNSEHPLGTAITKYCKQELDTETLGTCIDFQVVPGCGISCKVTNIEGLLHKNNWNIEDNNIKNASLVQIDASNEQSSTSSSMIIDAQISNALNAQQYKVLIGNREWMIRNGLVINNDVNDFMTEHERKGRTAVLVAVDDELCGLIAIADT","Homo sapiens","ATP7A, MC1, MNK","Copper-transporting ATPase 1","1","2KMV"
"2KMX",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M109.054262","ATP","2KMX",20.78,,,"Solution structure of the nucleotide binding domain of the human Menkes protein in the ATP-bound form","SFTMHGTPVVNQVKVLTESNRISHHKILAIVGTAESNSEHPLGTAITKYCKQELDTETLGTCIDFQVVPGCGISCKVTNIEGLLHKNNWNIEDNNIKNASLVQIDASNEQSSTSSSMIIDAQISNALNAQQYKVLIGNREWMIRNGLVINNDVNDFMTEHERKGRTAVLVAVDDELCGLIAIADT","Homo sapiens","ATP7A, MC1, MNK","Copper-transporting ATPase 1","1","2KMX"
"2KMZ",,"SOLUTION NMR",,,,,,,"10.1111/febs.12206",,"2KMZ",5.62,,,"NMR Structure of hFn14","EQAPGTAPCSRGSSWSADLDKCMDCASCRARPHSDFCLGCAAAPPAPFRLLWP","Homo sapiens","FN14, TNFRSF12A","Tumor necrosis factor receptor superfamily member 12A","1","2KMZ"
"2KN1",,"SOLUTION NMR",,,,,,,"10.1111/febs.12206",,"2KN1",5.6,,,"Solution NMR Structure of BCMA","LQMAGQCSQNEYFDSLLHACIPCQLRCSSNTPPLTCQRYCNASVTNSVKCX","Homo sapiens","TNFRSF17, BCM, BCMA","Tumor necrosis factor receptor superfamily member 17","1","2KN1"
"2KN5",,"SOLUTION NMR",,,,,,,"10.1371/journal.pcbi.1000393",,"2KN5",8.58,,,"A Correspondence Between Solution-State Dynamics of an Individual Protein and the Sequence and Conformational Diversity of its Family","MQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGG","Homo sapiens","RPS27A, UBA80, UBCEP1, UBA52, UBCEP2, UBB, UBC","Ubiquitin","1","2KN5"
"2KN6",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M109.024273",,"2KN6",23.82,,,"Structure of full-length human ASC (Apoptosis-associated speck-like protein containing a CARD)","MGSSHHHHHHSSGLVPRGSHMGRARDAILDALENLTAEELKKFKLKLLSVPLREGYGRIPRGALLSMDALDLTDKLVSFYLETYGAELTANVLRDMGLQEMAGQLQAATHQGSGAAPAGIQAPPQSAAKPGLHFIDQHRAALIARVTNVEWLLDALYGKVLTDEQYQAVRAEPTNPSKMRKLFSFTPAWNWTCKDLLLQALRESQSYLVEDLERS","Homo sapiens","ASC, CARD5, PYCARD, TMS1","Apoptosis-associated speck-like protein containing a CARD","1","2KN6"
"2KN7",,"SOLUTION NMR",,,,,,,"10.1016/j.str.2012.02.009",,"2KN7",21.02,,,"Structure of the XPF-single strand DNA complex","EKYNPGPQDFLLKMPGVNAKNCRSLMHHVKNIAELAALSQDELTSILGNAANAKQLYDFIHTSFAEV","Homo sapiens","XPF, ERCC4, ERCC11","DNA repair endonuclease XPF","1","2KN7"
,,,,,,,,,,,,,,,,"CAGTGGCTGA",,,"DNA (5'-D(*CP*AP*GP*TP*GP*GP*CP*TP*GP*A)-3')","2","2KN7"
"2KN8",,"SOLUTION NMR",,,,,,,"10.1002/prot.22669",,"2KN8",7.92,,,"NMR structure of the C-terminal domain of pUL89","DQNHIEQPFYLMGRDKALAVEQFISRFNSGYIKASQELVSYTIKLSHDPIEYLLEQIQNLHRVTLAEG","Homo sapiens",,"DNA cleavage and packaging protein large subunit, UL89","1","2KN8"
"2KNA",,"SOLUTION NMR",,,,,,,"10.1007/s12104-009-9197-x",,"2KNA",11.87,,,"Solution structure of UBA domain of XIAP","GSAMADIGSEFEKTPSLTRRIDDTIFQNPMVQEAIRMGFSFKDIKKIMEEKIQISGSNYKSLEVLVADLVNAQKDSMQDESSQTSLQKEISTEEQLRRLQEEKL","Homo sapiens","XIAP, API3, BIRC4, IAP3","Baculoviral IAP repeat-containing protein 4","1","2KNA"
"2KNF",,"SOLUTION NMR",,,,,,,"10.1021/bi901433n",,"2KNF",9.57,,,"Solution structure and functional characterization of human plasminogen kringle 5","SNADCMFGNGKGYRGKRVTTVTGTPCQDWAAQEPHRHSIFTPETNPRAGLEKNYCRNPDGDVGGPWCYTTNPRKLYDYCDVPQCAA","Homo sapiens","PLG","Plasminogen","1","2KNF"
"2KNO",,"SOLUTION NMR",,,,,,,,,"2KNO",14.4,,,"NMR Solution Structure of SH2 Domain of the Human Tensin Like C1 Domain Containing Phosphatase (TENC1)","MHHHHHHSSGLVPRGSDTSKFWYKPHLSRDQAIALLKDKDPGAFLIRDSHSFQGAYGLALKVATPPPSAQPWKGDPVEQLVRHFLIETGPKGVKIKGCPSEPYFGSLSALVSQHSISPISLPCCLRIPSKD","Homo sapiens","KIAA1075, TENC1, tensin like C1 domain containing phosphatase, TNS2","Tensin-like C1 domain-containing phosphatase","1","2KNO"
"2KNT",,"X-RAY DIFFRACTION",1.99,39,,3.3,"0.2M LI2SO4, 0.1M CITRIC ACID, 0.074M NA2HPO4, 1.6M (NH4)2SO4, 10MG/ML, PH3.3",,"10.1107/s0907444997010846",,"2KNT",6.73,"1.2","1.2","THE 1.2 ANGSTROM STRUCTURE OF KUNITZ TYPE DOMAIN C5","ETDICKLPKDEGTCRDFILKWYYDPNTKSCARFWYGGCGGNENKFGSQKECEKVCAPV","Homo sapiens","COL6A3","COLLAGEN","1","2KNT"
"2KNV",,"SOLUTION NMR",,,,,,,"10.1016/j.jmb.2009.11.032",,"2KNV",11.49,,,"NMR dimer structure of the UBA domain of p62 (SQSTM1)","GSPPEADPRLIESLSQMLSMGFSDEGGWLTRLLQTKNYDIGAALDTIQYSKH","Homo sapiens","SQSTM1, ORCA, OSIL","Sequestosome-1","1","2KNV"
"2KNX",,"SOLUTION NMR",,,,,,,"10.1016/j.jmb.2010.03.022",,"2KNX",5.14,,,"Solution Structure of complement repeat CR17 from LRP-1","GSEGKTCGPSSFSCPGTHVCVPERWLCDGDKDCADGADESIAAGCLYNST","Homo sapiens","LRP1, A2MR, APR","Prolow-density lipoprotein receptor-related protein 1","1","2KNX"
"2KNY",,"SOLUTION NMR",,,,,,,"10.1016/j.jmb.2010.03.022",,"2KNY",8.44,,,"Fusion construct of CR17 from LRP-1 and ApoE residues 130-149","GSKLEGKTCGPSSFSCPGTHVCVPERWLCDGDKDCADGADESIAAGCLYNSTGSGSGSGSTEELRVRLASHLRKLRKRLL","Homo sapiens","LRP1, A2MR, APR, APOE","LRP-1, linker, Apo-E","1","2KNY"
"2KO0",,"SOLUTION NMR",,,,,,,"10.1093/nar/gkq053",,"2KO0",20.05,,,"Solution structure of the THAP zinc finger of THAP1 in complex with its DNA target","MVQSCSAYGCKNRYDKDKPVSFHKFPLTRPSLCKEWEAAVRRKNFKPTKYSSICSEHFTPDSFKRESNNKLLKENAVPTIFLELVPR","Homo sapiens","THAP1","THAP domain-containing protein 1","1","2KO0"
,,,,,,,,,,,,,,,,"GCTTGTGTGGGCAGCG",,,"RRM1","2","2KO0"
,,,,,,,,,,,,,,,,"CGCTGCCCACACAAGC",,,"ZINC ION","3","2KO0"
"2KO3",,"SOLUTION NMR",,,,,,,"10.1016/j.febslet.2009.09.034",,"2KO3",8.57,,,"Nedd8 solution structure","MLIKVKTLTGKEIEIDIEPTDKVERIKERVEEKEGIPPQQQRLIYSGKQMNDEKTAADYKILGGSVLHLVLALRGG","Homo sapiens","NEDD8","NEDD8","1","2KO3"
"2KOE",,"SOLUTION NMR",,,,,,,"10.1016/j.bbrc.2009.09.053",,"2KOE",4.52,,,"Human cannabinoid receptor 1 - helix 7/8 peptide","TVFAFASMLCLLNSTVNPIIYALRSKDLRHAFRSMFPSAE","Homo sapiens","CNR1, CNR","human cannabinoid receptor 1 - helix 7/8 peptide","1","2KOE"
"2KOL",,"SOLUTION NMR",,,,,,,,,"2KOL",8,,,"Solution structure of human SDF1-alpha H25R","KPVSLSYRCPCRFFESHVARANVKRLKILNTPNCALQIVARLKNNNRQVCIDPKLKWIQEYLEKALNK","Homo sapiens","CXCL12, SDF1, SDF1A, SDF1B","Stromal cell-derived factor 1","1","2KOL"
"2KOM",,"SOLUTION NMR",,,,,,,"10.1002/pro.335",,"2KOM",13.39,,,"Solution structure of humar Par-3b PDZ2 (residues 451-549)","MRGSHHHHHHHHGSENLYFQGSYNTKKIGKRLNIQLKKGTEGLGFSITSRDVTIGGSAPIYVKNILPRGAAIQDGRLKAGDRLIEVNGVDLVGKSQEEVVSLLRSTKMEGTVSLLVFRQED","Homo sapiens","PARD3, PAR3, PAR3A","Partitioning defective 3 homolog","1","2KOM"
"2KOT",,"SOLUTION NMR",,,,,,,"10.1021/bi9019077",,"2KOT",23.58,,,"Solution structure of S100A13 with a drug amlexanox","MAAEPLTELEESIETVVTTFFTFARQEGRKDSLSVNEFKELVTQQLPHLLKDVGSLDEKMKSLDVNQDSELKFNEYWRLIGELAKEIRKKKDLKIRKK","Homo sapiens","S100A13","Protein S100-A13","1","2KOT"
"2KOX",,"SOLUTION NMR",,,,,,,"10.1021/ja200461n",,"2KOX",8.58,,,"NMR residual dipolar couplings identify long range correlated motions in the backbone of the protein ubiquitin","MQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGG","Homo sapiens","UBA52, UBCEP2","Ubiquitin","1","2KOX"
"2KOY",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M110.198101",,"2KOY",14.75,,,"Structure of the E1064A mutant of the N-domain of Wilson Disease Associated Protein","AGHMVPRVMRVLLLGDVATLPLRKVLAVVGTAAASSEHPLGVAVTKYCKEELGTETLGYCTDFQAVPGCGIGCKVSNVEGILAAVPQTFSVLIGNREWLRRNGLTISSDVSDAMTDHEMKGQTAILVAIDGVLCGMIAIAD","Homo sapiens","ATP7B, PWD, WC1, WND","Copper-transporting ATPase 2","1","2KOY"
"2KPE",,"SOLUTION NMR",,,,,,,,,"2KPE",6.32,,,"Refined structure of Glycophorin A transmembrane segment dimer in DPC micelles","EPEITLIIFGVMAGVIGTILLISYGIRRL","Homo sapiens","GYPA, GPA","Glycophorin-A","1","2KPE"
"2KPF",,"SOLUTION NMR",,,,,,,,,"2KPF",8.48,,,"Spatial structure of the dimeric transmembrane domain of glycophorin A in bicelles soluton","RVQLAHHFSEPEITLIIFGVMAGVIGTILLISYGIRRL","Homo sapiens","GYPA, GPA","Glycophorin-A","1","2KPF"
"2KPK",,"SOLUTION NMR",,,,,,,"10.1016/j.jmb.2011.01.015",,"2KPK",13.87,,,"MAGI-1 PDZ1","GAMGKPFFTRNPSELKGKFIHTKLRKSSRGFGFTVVGGDEPDEFLQIKSLVLDGPAALDGKMETGDVIVSVNDTCVLGHTHAQVVKIFQSIPIGASVDLELCRGYPLPFDPDDPNTSLVTSVAILDKEP","Homo sapiens","MAGI1, BAIAP1, BAP1, TNRC19, AIP3","Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1","1","2KPK"
"2KPW",,"SOLUTION NMR",,,,,,,,,"2KPW",13.67,,,"NMR solution structure of Lamin-B1 protein from Homo sapiens: Northeast Structural Genomics Consortium MEGA target, HR5546A (439-549)","MGHHHHHHSHMTGNVCIEEIDVDGKFIRLKNTSEQDQPMGGWEMIRKIGDTSVSYKYTSRYVLKAGQTVTIWAANAGVTASPPTDLIWKNQNSWGTGEDVKVILKNSQGEEVAQRSTVFKTT","Homo sapiens","LMN2, LMNB, LMNB1","Lamin-B1","1","2KPW"
"2KQ6",,"SOLUTION NMR",,,,,,,"10.1073/pnas.0912295107",,"2KQ6",9.01,,,"The structure of the EF-hand domain of polycystin-2 suggests a mechanism for Ca2+-dependent regulation of polycystin-2 channel activity","NTVDDISESLRQGGGKLNFDELRQDLKGKGHTDAEIEAIFTKYDQDGDQELTEHEHQQMRDDLEKEREDLDLDHSSLP","Homo sapiens","PKD2, TRPP2","Polycystin-2","1","2KQ6"
"2KQB",,"SOLUTION NMR",,,,,,,"10.1038/nsmb.1747",,"2KQB",10.12,,,"First PBZ domain of human APLF protein","GPLGSGSEGNKVKRTSCMYGANCYRKNPVHFQHFSHPGDSDYGGVQIVGQDETDDRPECPYGPSCYRKNPQHKIEYRHNTLPVRNVLDE","Homo sapiens","APLF, C2orf13, PALF, XIP1","Aprataxin and PNK-like factor","1","2KQB"
"2KQC",,"SOLUTION NMR",,,,,,,"10.1038/nsmb.1747",,"2KQC",10.12,,,"Second PBZ domain of human APLF protein","GPLGSGSEGNKVKRTSCMYGANCYRKNPVHFQHFSHPGDSDYGGVQIVGQDETDDRPECPYGPSCYRKNPQHKIEYRHNTLPVRNVLDE","Homo sapiens","APLF, C2orf13, PALF, XIP1","Aprataxin and PNK-like factor","1","2KQC"
"2KQD",,"SOLUTION NMR",,,,,,,"10.1038/nsmb.1747",,"2KQD",10.54,,,"First PBZ domain of human APLF protein in complex with ribofuranosyladenosine","GPLGSGSEGNKVKRTSCMYGANCYRKNPVHFQHFSHPGDSDYGGVQIVGQDETDDRPECPYGPSCYRKNPQHKIEYRHNTLPVRNVLDE","Homo sapiens","APLF, C2orf13, PALF, XIP1","Aprataxin and PNK-like factor","1","2KQD"
"2KQE",,"SOLUTION NMR",,,,,,,"10.1038/nsmb.1747",,"2KQE",10.54,,,"Second PBZ domain of human APLF protein in complex with ribofuranosyladenosine","GPLGSGSEGNKVKRTSCMYGANCYRKNPVHFQHFSHPGDSDYGGVQIVGQDETDDRPECPYGPSCYRKNPQHKIEYRHNTLPVRNVLDE","Homo sapiens","APLF, C2orf13, PALF, XIP1","Aprataxin and PNK-like factor","1","2KQE"
"2KQF",,"SOLUTION NMR",,,,,,,,,"2KQF",11.93,,,"Solution structure of MAST205-PDZ complexed with the C-terminus of a rabies virus G protein","GGSMRPPIIIHRAGKKYGFTLRAIRVYMGDSDVYTVHHMVWHVEDGGPASEAGLRQGDLITHVNGEPVHGLVHTEVVELILKSGNKVAISTTPLEN","Homo sapiens","MAST205, MAST2, KIAA0807","Microtubule-associated serine/threonine-protein kinase 2","1","2KQF"
,,,,,,,,,,,,,,,,"SWESHKSGGETRL",,,"C-terminal motif from Glycoprotein","2","2KQF"
"2KQM",,"SOLUTION NMR",,,,,,,"10.1016/j.str.2010.02.012",,"2KQM",24.21,,,"Solution structure of the KI O18/O8 Y87H immunoglobulin light chain variable domain","STDIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYHCQQYDNLPYTFGQGTKLEIKR","Homo sapiens",,"Ig kappa chain V-I region AU","1","2KQM"
"2KQN",,"SOLUTION NMR",,,,,,,"10.1016/j.str.2010.02.012",,"2KQN",24.31,,,"Solution structure of the AL-09 H87Y immunoglobulin light chain variable domain","STDIQMTQSPSSLSASVGDRVTITCQASQDINNYLIWYQQKPGQAPKLLIYDASTLETGVPSRFSGSGSGTEFTFTISSLQPEDLATYYCQQYDNLPYTFGQGTKLEIKR","Homo sapiens",,"Ig kappa chain V-I region AU","1","2KQN"
"2KQP",,"SOLUTION NMR",,,,,,,"10.1074/jbc.C109.084921",,"2KQP",9.38,,,"NMR Structure of Proinsulin","FVNQHLCGSDLVEALYLVCGERGFFYTKPTRREAEDLQVGQVELGGGPGAGSLQPLALEGSLQKRGIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","Insulin","1","2KQP"
"2KQQ",,"SOLUTION NMR",,,,,,,,,"2KQQ",5.81,,,"NMR structure of human insulin mutant gly-b8-d-ala, his-b10-asp, pro-b28-lys, lys-b29-pro, 20 structures","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","Insulin B chain","1","2KQQ"
,,,,,,,,,,,,,,,,"FVNQHLCASDLVEALYLVCGERGFFYTKPT","Homo sapiens","INS","Insulin A chain","2","2KQQ"
"2KQZ",,"SOLUTION NMR",,,,,,,"10.1016/j.molcel.2010.04.019",,"2KQZ",16.28,,,"Solution structure of the Rpn13 DEUBAD domain","STAASPTQPIQLSDLQSILATMNVPAGPAGGQQVDLASVLTPEIMAPILANADVQERLLPYLPSGESLPQTADEIQNTLTSPQFQQALGMFSAALASGQLGPLMCQFGLPAEAVEAANKGDVEAFAKAMQNNAKPEQKEGDTKDKKDEEEDMSLD","Homo sapiens","ADRM1, GP110","Proteasomal ubiquitin receptor ADRM1","1","2KQZ"
"2KR0",,"SOLUTION NMR",,,,,,,"10.1016/j.molcel.2010.04.019",,"2KR0",42.49,,,"Solution structure of the proteasome ubiquitin receptor Rpn13","GPGSMTTSGALFPSLVPGSRGASNKYLVEFRAGKMSLKGTTVTPDKRKGLVYIQQTDDSLIHFCWKDRTSGNVEDDLIIFPDDCEFKRVPQCPSGRVYVLKFKAGSKRLFFWMQEPKTDQDEEHCRKVNEYLNNPPMPGALGASGSSGHELSALGGEGGLQSLLGNMSHSQLMQLIGPAGLGGLGGLGALTGPGLASLLGSSGPPGSSSSSSSRSQSAAVTPSSTTSSTRATPAPSAPAAASATSPSPAPSSGNGASTAASPTQPIQLSDLQSILATMNVPAGPAGGQQVDLASVLTPEIMAPILANADVQERLLPYLPSGESLPQTADEIQNTLTSPQFQQALGMFSAALASGQLGPLMCQFGLPAEAVEAANKGDVEAFAKAMQNNAKPEQKEGDTKDKKDEEEDMSLD","Homo sapiens","ADRM1, GP110","Proteasomal ubiquitin receptor ADRM1","1","2KR0"
"2KR1",,"SOLUTION NMR",,,,,,,"10.1007/s10858-011-9552-y",,"2KR1",9.48,,,"Solution NMR structure of zinc binding N-terminal domain of ubiquitin-protein ligase E3A from Homo Sapiens. Northeast Structural Genomics Consortium (NESG) target HR3662","MHHHHHHSSGRENLYFQGMKRAAAKHLIERYYHQLTEGCGNEACTNEFCASCPTFLRMDNNAAAIKALELYKINAKLCDPHP","Homo sapiens","UBE3A, hCG_18679, E6AP, EPVE6AP, HPVE6A","Ubiquitin protein ligase E3A","1","2KR1"
"2KR6",,"SOLUTION NMR",,,,,,,,,"2KR6",19.45,,,"Solution structure of presenilin-1 CTF subunit","MVWLVNMAEGDPEAQRRVSKNSKYNAESTERESQDTVAENDDGGFSEEWEAQRDSHLGPHRSTPESRAAVQELSSSILAGEDPEERGVKLGLGDFIFYSVLVGKASATASGDWNTTIACFVAILIGLCLTLLLLAIFKKALPALPISITFGLVFYFATDYLVQPFMDQLAFHQFYI","Homo sapiens","AD3, PS1, PSEN1, PSNL1","Presenilin-1","1","2KR6"
"2KRE",,"SOLUTION NMR",,,,,,,"10.1016/j.str.2010.04.017",,"2KRE",11.55,,,"Solution structure of E4B/UFD2A U-Box domain","GSHKFAEKVEEIVAKNARAEIDYSDAPDEFRDPLMDTLMTDPVRLPSGTIMDRSIILRHLLNSPTDPFNRQTLTESMLEPVPELKEQIQAWMREKQNSDH","Homo sapiens","HDNB1, KIAA0684, UBE4B, UFD2","Ubiquitin conjugation factor E4 B","1","2KRE"
"2KRG",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M109.074005",,"2KRG",23.67,,,"Solution Structure of human sodium/ hydrogen exchange regulatory factor 1(150-358)","GIDPFTMLRPRLCTMKKGPSGYGFNLHSDKSKPGQFIRSVDPDSPAEASGLRAQDRIVEVNGVCMEGKQHGDVVSAIRAGGDETKLLVVDRETDEFFKKCRVIPSQEHLNGPLPVPFTNGEIQKENSREALAEAALESPRPALVRSASSDTSEELNSQDSPPKQDSTAPSSTSSSDPILDFNISLAMAKERAHQKRSSKRAPQMDWSKKNELFSNL","Homo sapiens","SLC9A3R1, NHERF, NHERF1","Na(+)/H(+) exchange regulatory cofactor NHE-RF1","1","2KRG"
"2KRJ",,"SOLID-STATE NMR",,,,,,,"10.1021/ja906426p",,"2KRJ",16.82,,,"High-Resolution Solid-State NMR Structure of a 17.6 kDa Protein","HYITYRINNYTPDMNREDVDYAIRKAFQVWSNVTPLKFSKINTGMADILVVFARGAHGDDHAFDGKGGILAHAFGPGSGIGGDAHFDEDEFWTTHSGGTNLFLTAVHEIGHSLGLGHSSDPKAVMFPTYKYVDINTFRLSADDIRGIQSLYG","Homo sapiens","MMP12, HME","Macrophage metalloelastase","1","2KRJ"
"2KRK",,"SOLUTION NMR",,,,,,,,,"2KRK",9.8,,,"Solution NMR Structure of 26S protease regulatory subunit 8 from H.sapiens, Northeast Structural Genomics Consortium Target Target HR3102A","MGHHHHHHSHPNEEARLDILKIHSRKMNLTRGINLRKIAELMPGASGAEVKGVCTEAGMYALRERRVHVTQEDFEMAVAKVMQKDS","Homo sapiens","PSMC5, SUG1","26S protease regulatory subunit 8","1","2KRK"
"2KRR",,"SOLUTION NMR",,,,,,,"10.1007/s10858-010-9412-1",,"2KRR",20.21,,,"Solution structure of the RBD1,2 domains from human nucleolin","GTEPTTAFNLFVGNLNFNKSAPELKTGISDVFAKNDLAVVDVRIGMTRKFGYVDFESAEDLEKALELTGLKVFGNEIKLEKPKGKDSKKERDARTLLAKNLPYKVTQDELKEVFEDAAEIRLVSKDGKSKGIAYIEFKTEADAEKTFEEKQGTEIDGRSISLYYTGEPKGEGLEHHHHHH","Homo sapiens","NCL","Nucleolin","1","2KRR"
"2KS9",,"SOLUTION NMR",,,,,,,"10.1016/j.bbamem.2010.09.023",,"2KS9",43.03,,,"Solution conformation of substance P in water complexed with NK1R","MDNVLPVDSDLSPNISTNTSEPNQFVQPAWQIVLWAAAYTVIVVTSVVGNVVVMWIILAHKRMRTVTNYFLVNLAFAEASMAAFNTVVNFTYAVHNEWYYGLFYCKFHNFFPIAAVFASIYSMTAVAFDRYMAIIHPLQPRLSATATKVVICVIWVLALLLAFPQGYYSTTETMPSRVVCMIEWPEHPNKIYEKVYHICVTVLIYFLPLLVIGYAYTVVGITLWASEIPGDSSDRYHEQVSAKRKVVKMMIVVVCTFAICWLPFHIFFLLPYINPDLYLKKFIQQVYLAIMWLAMSSTMYNPIIYCCLNDRFRLGFKHAFRCCPFISAGDYEGLEMKSTRYLQTQGSVYKVSRLETTISTVVGA","Homo sapiens","TACR1, NK1R, TAC1R","Substance-P receptor","1","2KS9"
,,,,,,,,,,,,,,,,"RPKPQQFFGLM",,,"Substance P","2","2KS9"
"2KSA",,"SOLUTION NMR",,,,,,,"10.1016/j.bbamem.2010.09.023",,"2KSA",43.03,,,"Substance P in DMPC/CHAPS isotropic q=0.25 bicelles as a ligand for NK1R","MDNVLPVDSDLSPNISTNTSEPNQFVQPAWQIVLWAAAYTVIVVTSVVGNVVVMWIILAHKRMRTVTNYFLVNLAFAEASMAAFNTVVNFTYAVHNEWYYGLFYCKFHNFFPIAAVFASIYSMTAVAFDRYMAIIHPLQPRLSATATKVVICVIWVLALLLAFPQGYYSTTETMPSRVVCMIEWPEHPNKIYEKVYHICVTVLIYFLPLLVIGYAYTVVGITLWASEIPGDSSDRYHEQVSAKRKVVKMMIVVVCTFAICWLPFHIFFLLPYINPDLYLKKFIQQVYLAIMWLAMSSTMYNPIIYCCLNDRFRLGFKHAFRCCPFISAGDYEGLEMKSTRYLQTQGSVYKVSRLETTISTVVGA","Homo sapiens","TACR1, NK1R, TAC1R","Substance-P receptor","1","2KSA"
,,,,,,,,,,,,,,,,"RPKPQQFFGLM",,,"Substance P","2","2KSA"
"2KSB",,"SOLUTION NMR",,,,,,,"10.1016/j.bbamem.2010.09.023",,"2KSB",43.03,,,"Substance P in isotropic q=0.25 DMPC/CHAPS/GM1 bicelles as a ligand for NK1R","MDNVLPVDSDLSPNISTNTSEPNQFVQPAWQIVLWAAAYTVIVVTSVVGNVVVMWIILAHKRMRTVTNYFLVNLAFAEASMAAFNTVVNFTYAVHNEWYYGLFYCKFHNFFPIAAVFASIYSMTAVAFDRYMAIIHPLQPRLSATATKVVICVIWVLALLLAFPQGYYSTTETMPSRVVCMIEWPEHPNKIYEKVYHICVTVLIYFLPLLVIGYAYTVVGITLWASEIPGDSSDRYHEQVSAKRKVVKMMIVVVCTFAICWLPFHIFFLLPYINPDLYLKKFIQQVYLAIMWLAMSSTMYNPIIYCCLNDRFRLGFKHAFRCCPFISAGDYEGLEMKSTRYLQTQGSVYKVSRLETTISTVVGA","Homo sapiens","TACR1, NK1R, TAC1R","Substance-P receptor","1","2KSB"
,,,,,,,,,,,,,,,,"RPKPQQFFGLM",,,"Substance P","2","2KSB"
"2KSG",,"SOLUTION NMR",,,,,,,,,"2KSG",4.83,,,"Solution structure of dermcidin-1L, a human antibiotic peptide","SSLLEKGLDGAKKAVGGLGKLGKDAVEDLESVGKGAVHDVKDVLDSVL","Homo sapiens","DCD, AIDD, DSEP","Dermcidin","1","2KSG"
"2KSN",,"SOLUTION NMR",,,,,,,"10.1002/pro.386",,"2KSN",15.59,,,"Solution Structure of the N-terminal Domain of DC-UbP/UBTD2","MSLNENSEGTGVALGRNQPLKKEKPKWKSDYPMTDGQLRSKRDEFWDTAPAFEGRKEIWDALKAAAHAFESNDHELAQAIIDGANITLPHGALTECYDELGNRYQLPVYCLAPPINMIEEKSDIETLDILEHHHHHH","Homo sapiens","UBTD2, DCUBP, SB72","Ubiquitin domain-containing protein 2","1","2KSN"
"2KSP",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M109.045666",,"2KSP",13.55,,,"Mechanism for the selective interaction of C-terminal EH-domain proteins with specific NPF-containing partners","GPLGSDDVEWVVGKDKPTYDEIFYTLSPVNGKITGANAKKEMVKSKLPNTVLGKIWKLADVDKDGLLDDEEFALANHLIKVKLEGHELPADLPPHLVPPSKRRHE","Homo sapiens","EHD1, PAST, PAST1, CDABP0131","EH domain-containing protein 1","1","2KSP"
,,,,,,,,,,,,,,,,"LESKPYNPFEEEEED",,,"MICAL L1 like peptide","2","2KSP"
"2KSR",,"SOLUTION NMR",,,,,,,"10.1016/j.bbamem.2010.04.014",,"2KSR",18.47,,,"NMR structures of TM domain of the n-Acetylcholine receptor b2 subunit","MHHHHHHSTSVDLGTENLYFQSNARRKPLFYTINLIIPCVLITSLAILVFYLPSDCGEKMTLCISVLLALTVFLLLISKIVPPTSLDVPLVGKYLMFTMVLVTFSIVTSVCVLNVHHRSPTTHTPRGGGGYVAMVIDRLFLWIFVFVCVFGTIGMFLQPLFQNY","Homo sapiens","CHRNB2","Neuronal acetylcholine receptor subunit beta-2","1","2KSR"
"2KT0",,"SOLUTION NMR",,,,,,,,,"2KT0",10.07,,,"Solution structure of human stem cell transcription factor Nanog homeodomain fragment","SKQPTSAENSVAKKEDKVPVKKQKTRTVFSSTQLCVLNDRFQRQKYLSLQQMQELSNILNLSYKQVKTWFQNQRMKSKRWQKNN","Homo sapiens","NANOG","Homeobox protein NANOG","1","2KT0"
"2KT1",,"SOLUTION NMR",,,,,,,,,"2KT1",9.96,,,"Solution NMR Structure of the SH3 Domain from the p85beta subunit of Phosphatidylinositol 3-kinase from H.sapiens, Northeast Structural Genomics Consortium Target HR5531E","MAGPEGFQYRALYPFRRERPEDLELLPGDVLVVSRAALQALGVAEGGERCPQSVGWMPGLNERTRQRGDFPGTYVEFLGPLEHHHHHH","Homo sapiens","PIK3R2","Phosphatidylinositol 3-kinase regulatory subunit beta","1","2KT1"
"2KTB",,"SOLUTION NMR",,,,,,,"10.1038/cr.2010.43",,"2KTB",15.91,,,"Solution Structure of the Second Bromodomain of Human Polybromo in complex with an acetylated peptide from Histone 3","ARTKQTARKSTGGKAPRKQL",,,"H3_Peptide","1","2KTB"
,,,,,,,,,,,,,,,,"STEGSSPAYLKEILEQLLEAIVVATNPSGRLISELFQKLPSKVQYPDYYAIIKEPIDLKTIAQRIQNGSYKSIHAMAKDIDLLAKNAKTYNEPGSQVFKDANSIKKIFYMKKAEIEHHEMA","Homo sapiens","PB1, PBRM1, BAF180","Protein polybromo-1","2","2KTB"
"2KTU",,"SOLUTION NMR",,,,,,,"10.1007/s12104-007-9050-z",,"2KTU",19.85,,,"Human eRF1 C-domain, ""closed"" conformer","SNVKFIQEKKLIGRYFDEISQDTGKYCFGVEDTLKALEMGAVEILIVYENLDIMRYVLHCQGTEEEKILYLTPEQEKDKSHFTDKETGQEHELIESMPLLEWFANNYKKFGATLEIVTDKSQEGSQFVKGFGGIGGILRYRVDFQGMEYQGGDDEFFDLDDYLEHHHHHH","Homo sapiens","ETF1, ERF1, RF1, SUP45L1","Eukaryotic peptide chain release factor subunit 1","1","2KTU"
"2KTV",,"SOLUTION NMR",,,,,,,"10.1111/j.1742-464X.2010.07672.x",,"2KTV",19.85,,,"Human eRF1 C-domain, ""open"" conformer","SNVKFIQEKKLIGRYFDEISQDTGKYCFGVEDTLKALEMGAVEILIVYENLDIMRYVLHCQGTEEEKILYLTPEQEKDKSHFTDKETGQEHELIESMPLLEWFANNYKKFGATLEIVTDKSQEGSQFVKGFGGIGGILRYRVDFQGMEYQGGDDEFFDLDDYLEHHHHHH","Homo sapiens","ETF1, ERF1, RF1, SUP45L1","Eukaryotic peptide chain release factor subunit 1","1","2KTV"
"2KTY",,"SOLUTION NMR",,,,,,,,,"2KTY",42.36,,,"Solution Structure of human Vaccinia Related Kinase-1","MPRVKAAQAGRQSSAKRHLAEQFAVGEIITDMAKKEWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKEYKEDPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFPEKNKPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLDLSVVENGGLKAKTITKKRKKLEHHHHHH","Homo sapiens","VRK1","Serine/threonine-protein kinase VRK1","1","2KTY"
"2KU3",,"SOLUTION NMR",,,,,,,,,"2KU3",8.25,,,"Solution structure of BRD1 PHD1 finger","MGHHHHHHMQSLIDEDAVCSICMDGESQNSNVILFCDMCNLAVHQECYGVPYIPEGQWLCRHCLQSRARPA","Homo sapiens","BRD1, BRL, BRPF2","Bromodomain-containing protein 1","1","2KU3"
"2KU7",,"SOLUTION NMR",,,,,,,"10.1016/j.cell.2010.05.016",,"2KU7",15.26,,,"Solution structure of MLL1 PHD3-Cyp33 RRM chimeric protein","SMMQCGKCDRWVHSKCENLSDEMYEILSNLPESVAYTCVNCTERHVDGGSGGSGGSGGSATTKRVLYVGGLAEEVDDKVLHAAFIPFGDITDIQIPLDYETEKHRGFAFVEFELAEDAAAAIDNMNESELFGRTIRVNLA","Homo sapiens","KMT2A, ALL1, CXXC7, HRX, HTRX, MLL, MLL1, TRX1, PPIE, CYP33","MLL1 PHD3-Cyp33 RRM chimeric protein","1","2KU7"
"2KUG",,"SOLUTION NMR",,,,,,,,,"2KUG",8.73,,,"Halothane binds to druggable sites in calcium-calmodulin: Solution Structure of halothane-CaM N-terminal domain","ADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTIDFPEFLTMMARKM","Homo sapiens","CALM, CALM1, CALM2, CALM3, CALML2, CAM, CAM1, CAM2, CAM3, CAMB, CAMC, CAMIII","Calmodulin","1","2KUG"
"2KUH",,"SOLUTION NMR",,,,,,,,,"2KUH",8.02,,,"Halothane binds to druggable sites in calcium-calmodulin: Solution structure of halothane-CaM C-terminal domain","EEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADIDGDGQVNYEEFVQMMTAK","Homo sapiens","CALM1, CALM, CAM, CAM1, CALM2, CAM2, CAMB, CALM3, CALML2, CAM3, CAMC, CAMIII","Calmodulin","1","2KUH"
"2KUL",,"SOLUTION NMR",,,,,,,,,"2KUL",42.36,,,"Solution structure of human vaccinia related kinase 1(VRK1)","MPRVKAAQAGRQSSAKRHLAEQFAVGEIITDMAKKEWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKEYKEDPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFPEKNKPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLDLSVVENGGLKAKTITKKRKKLEHHHHHH","Homo sapiens","VRK1","Serine/threonine-protein kinase VRK1","1","2KUL"
"2KUM",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M109.091108",,"2KUM",10.17,,,"Solution structure of the human chemokine CCL27","FLLPPSTACCTQLYRKPLSDKLLRKVIQVELQEADGDCHLQAFVLHLAQRSICIHPQNPSLSQWFEHQERKLHGTLPKLNFGMLRKMG","Homo sapiens","ALP, CCL27, CTACK, CTAK, ESKINE, ILC, PESKY, SCYA27","C-C motif chemokine 27","1","2KUM"
"2KUN",,"SOLUTION NMR",,,,,,,"10.1371/journal.pone.0011715",,"2KUN",16.97,,,"Three dimensional structure of HuPrP(90-231 M129 Q212P)","GQGGGTHSQWNKPSKPKTNMKHMAGAAAAGAVVGGLGGYMLGSAMSRPIIHFGSDYEDRYYRENMHRYPNQVYYRPMDEYSNQNNFVHDCVNITIKQHTVTTTTKGENFTETDVKMMERVVEPMCITQYERESQAYYQRGSSHHHHHH","Homo sapiens","PRNP, PRIP, PRP, ALTPRP","Major prion protein","1","2KUN"
"2KUO",,"SOLUTION NMR",,,,,,,,,"2KUO",10.4,,,"Structure and identification of ADP-ribose recognition motifs of APLF and role in the DNA damage response","GSKATDSVLQGSEGNKVKRTSCMYGANCYRKNPVHFQHFSHPGDSDYGGVQIVGQDETDDRPECPYGPSCYRKNPQHKIEYRHNTLPVRNV","Homo sapiens","APLF, APLF(C2orf13), C2orf13, PALF, XIP1","Aprataxin and PNK-like factor","1","2KUO"
"2KUP",,"SOLUTION NMR",,,,,,,"10.1007/s10969-010-9091-x",,"2KUP",18.68,,,"Solution structure of the complex of the PTB domain of SNT-2 and 19-residue peptide (aa 1571-1589) of HALK","GSSGSSGLNRDSVPDNHPTKFKVTNVDDEGVELGSGVMELTQSELVLHLHRREAVRWPYLCLRRYGYDSNLFSFESGRRCQTGQGIFAFKCSRAEEIFNLLQDLMQCNSINVMEEPVIITRNSHPAELDLPRAPQPPNALGYTVSS","Homo sapiens","FRS3","Fibroblast growth factor receptor substrate 3","1","2KUP"
,,,,,,,,,,,,,,,,"LFRLRHFPCGNVNYGYQQQ",,,"19-residue peptide from ALK tyrosine kinase receptor","2","2KUP"
"2KV2",,"SOLUTION NMR",,,,,,,"10.1093/nar/gkq586",,"2KV2",9.59,,,"Solution Structure of the human BLM HRDC domain","QREEMVKKCLGELTEVCKSLGKVFGVHYFNIFNTVTLKKLAESLSSDPEVLLQIDGVTEDKLEKYGAEVISVLQKYSEWTSPAED","Homo sapiens","BLM, RECQ2, RECQL3","Bloom syndrome protein","1","2KV2"
"2KV3",,"SOLUTION NMR",,,,,,,"10.1016/j.jmb.2010.07.061",,"2KV3",15.33,,,"Human Regenerating Gene Type IV (REG IV) PROTEIN, P91S mutant","QSCAPGWFYHKSNCYGYFRKLRNWSDAELECQSYGNGAHLASILSLKEASTIAEYISGYQRSQSIWIGLHDPQKRQQWQWIDGAMYLYRSWSGKSMGGNKHCAEMSSNNNFLTWSSNECNKRQHFLCKYRP","Homo sapiens","REG4, GISP, RELP","Regenerating islet-derived protein 4","1","2KV3"
"2KV4",,"SOLUTION NMR",,,,,,,"10.1016/j.bbrc.2010.10.089",,"2KV4",6.23,,,"EGF","NSDSECPLSHDGYCLHDGVCMYIEALDKYACNCVVGYIGERCQYRDLKWWELR","Homo sapiens","EGF","Epidermal growth factor","1","2KV4"
"2KV8",,"SOLUTION NMR",,,,,,,,,"2KV8",8.66,,,"Solution structure ofRGS12 PDZ domain","PRVRSVEVARGRAGYGFTLSGQAPCVLSCVMRGSPADFVGLRAGDQILAVNEINVKKASHEDVVKLIGKCSGVLHMVIAEGVG","Homo sapiens","RGS12","Regulator of G-protein signaling 12","1","2KV8"
"2KV9",,"SOLUTION NMR",,,,,,,"10.1073/pnas.1015545107",,"2KV9",8.72,,,"Integrin beta3 subunit in a disulfide linked alphaIIb-beta3 cytosolic domain","MGSSHHHHHHSSGLVPRGSHMSPECLIWKLLITIHDRKEFAKFEEERARAKWDTANNPLYKEATSTFTNITYRGT","Homo sapiens","ITGB3, GP3A","Integrin beta-3","1","2KV9"
"2KVD",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M110.146738",,"2KVD",18.34,,,"Mesencephalic astrocyte-derived neurotrophic factor (MANF)","GSLRPGDCEVCISYLGRFYQDLKDRDVTFSPATIENELIKFCREARGKENRLCYYIGATDDAATKIINEVSKPLAHHIPVEKICEKLKKKDSQICELKYDKQIDLSTVDLKKLRVKELKKILDDWGETCKGCAEKSDYIRKINELMPKYAPKAASARTDL","Homo sapiens","mesencephalic astrocyte-derived neurotrophic factor, MANF, ARMET, ARP","Mesencephalic astrocyte-derived neurotrophic factor","1","2KVD"
"2KVE",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M110.146738",,"2KVE",7.48,,,"C-terminal domain of mesencephalic astrocyte-derived neurotrophic factor (MANF)","MGKYDKQIDLSTVDLKKLRVKELKKILDDWGETCKGCAEKSDYIRKINELMPKYAPKAASARTDL","Homo sapiens","MANF, ARMET, ARP","Mesencephalic astrocyte-derived neurotrophic factor","1","2KVE"
"2KVR",,"SOLUTION NMR",,,,,,,,,"2KVR",15.18,,,"Solution NMR structure of human ubiquitin specific protease Usp7 UBL domain (residues 537-664). NESG target hr4395c/ SGC-Toronto","GSPQQLVERLQEEKRIEAQKRKERQEAHLYMQVQIVAEDQFCGHQGNDMYDEEKVKYTVFKVLKNSSLAEFVQSLSQTMGFPQDQIRLWPMQARSNGTKRPAMLDNEADGNKTMIELSDNENPWTIFLET","Homo sapiens","USP7, HAUSP","Ubiquitin carboxyl-terminal hydrolase 7","1","2KVR"
"2KVU",,"SOLUTION NMR",,,,,,,,,"2KVU",8.16,,,"Solution NMR Structure of SAP domain of MKL/myocardin-like protein 1 from H.sapiens, Northeast Structural Genomics Consortium Target Target HR4547E","MGHHHHHHSHMSTPLTGKPGALPANLDDMKVAELKQELKLRSLPVSGTKTELIERLRAYQDQISPVPGAPKAPAA","Homo sapiens","KIAA1438, MAL, MKL1, MRTFA","MKL/myocardin-like protein 1","1","2KVU"
"2KW1",,"SOLUTION NMR",,,,,,,,,"2KW1",10.08,,,"Solution structure of CTD","EDRSKTTNTWVLHMDGENFRIVLEKDAMDVWCNGKKLETAGEFVDDGTETHFSIGNHDCYIKAVSSGKRKEGIIHTLIVDNREIPEIAS","Homo sapiens","FAIM, FAIM1","Fas apoptotic inhibitory molecule 1","1","2KW1"
"2KW6",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M112.343863",,"2KW6",14.88,,,"Solution NMR Structure of Cyclin-dependent kinase 2-associated protein 1 (CDK2-associated protein 1; oral cancer suppressor Deleted in oral cancer 1, DOC-1) from H.sapiens, Northeast Structural Genomics Consortium Target Target HR3057H","MGHHHHHHSHSKYAELLAIIEELGKEIRPTYAGSKSAMERLKRGIIHARGLVRECLAETERNARS","Homo sapiens","CDK2AP1, CDKAP1, DOC1","Cyclin-dependent kinase 2-associated protein 1","1","2KW6"
"2KW9",,"SOLUTION NMR",,,,,,,,,"2KW9",8.16,,,"Solution NMR Structure of SAP domain of MKL/myocardin-like protein 1 from H.sapiens, Northeast Structural Genomics Consortium Target HR4547E","MGHHHHHHSHMSTPLTGKPGALPANLDDMKVAELKQELKLRSLPVSGTKTELIERLRAYQDQISPVPGAPKAPAA","Homo sapiens","KIAA1438, MAL, MKL1, MRTFA","MKL/myocardin-like protein 1","1","2KW9"
"2KWH",,"SOLUTION NMR",,,,,,,"10.1016/j.str.2010.05.013",,"2KWH",6.6,,,"Ral binding domain of RLIP76 (RalBP1)","GSETQAGIKEEIRRQEFLLNSLHRDLQGGIKDLSKEERLWEVQRILTALKRKLREA","Homo sapiens","RALBP1, RLIP1, RLIP76, RLIP","RalA-binding protein 1","1","2KWH"
"2KWJ",,"SOLUTION NMR",,,,,,,"10.1038/nature09139",,"2KWJ",15.24,,,"Solution structures of the double PHD fingers of human transcriptional protein DPF3 bound to a histone peptide containing acetylation at lysine 14","ARTKQTARKSTGGKAPRKQL",,,"Histone peptide","1","2KWJ"
,,,,,,,,,,,,,,,,"GSYCDFCLGGSNMNKKSGRPEELVSCADCGRSGHPTCLQFTLNMTEAVKTYKWQCIECKSCILCGTSENDDQLLFCDDCDRGYHMYCLNPPVAEPPEGSWSCHLCWELLKEKAS","Homo sapiens","DPF3, BAF45C, CERD4","Zinc finger protein DPF3","2","2KWJ"
"2KWK",,"SOLUTION NMR",,,,,,,"10.1038/nature09139",,"2KWK",15.2,,,"Solution structures of the double PHD fingers of human transcriptional protein DPF3b bound to a H3 peptide wild type","ARTKQTARKSTGGKAPRKQL",,,"Histone peptide","1","2KWK"
,,,,,,,,,,,,,,,,"GSYCDFCLGGSNMNKKSGRPEELVSCADCGRSGHPTCLQFTLNMTEAVKTYKWQCIECKSCILCGTSENDDQLLFCDDCDRGYHMYCLNPPVAEPPEGSWSCHLCWELLKEKAS","Homo sapiens","DPF3, BAF45C, CERD4","Zinc finger protein DPF3","2","2KWK"
"2KWN",,"SOLUTION NMR",,,,,,,"10.1038/nature09139",,"2KWN",14.69,,,"Solution structure of the double PHD (plant homeodomain) fingers of human transcriptional protein DPF3b bound to a histone H4 peptide containing acetylation at Lysine 16","GLGKGGAKRHRKVLR",,,"Histone peptide","1","2KWN"
,,,,,,,,,,,,,,,,"GSYCDFCLGGSNMNKKSGRPEELVSCADCGRSGHPTCLQFTLNMTEAVKTYKWQCIECKSCILCGTSENDDQLLFCDDCDRGYHMYCLNPPVAEPPEGSWSCHLCWELLKEKAS","Homo sapiens","DPF3, BAF45C, CERD4","Zinc finger protein DPF3","2","2KWN"
"2KWO",,"SOLUTION NMR",,,,,,,"10.1038/nature09139",,"2KWO",15.05,,,"Solution structure of the double PHD (plant homeodomain) fingers of human transcriptional protein DPF3b bound to a histone H4 peptide containing N-terminal acetylation at Serine 1","SGRGKGGKGLGKGGAKRHRK",,,"Histone peptide","1","2KWO"
,,,,,,,,,,,,,,,,"GSYCDFCLGGSNMNKKSGRPEELVSCADCGRSGHPTCLQFTLNMTEAVKTYKWQCIECKSCILCGTSENDDQLLFCDDCDRGYHMYCLNPPVAEPPEGSWSCHLCWELLKEKAS","Homo sapiens","DPF3, BAF45C, CERD4","Zinc finger protein DPF3","2","2KWO"
"2KX0",,"SOLUTION NMR",,,,,,,,,"2KX0",11.54,,,"the solution structure of UBB+1, frameshift mutant of ubiquitin B","GSLVPRGSMQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSEYNIQKESTLHLVLRLRGYADLREDPDRQDHHPGSGAQ","Homo sapiens","UBC","ubiquitin B","1","2KX0"
"2KX3",,"SOLUTION NMR",,,,,,,,,"2KX3",9.02,,,"The solution structure of the mutant of UBL domain of UBLCP1, I5M","MALPMIVKWGGQEYSVTTLSEDDTVLDLKQFLKTLTGVLPERQKLLGLKVKGKPAENDVKLGALKLKPNTKIMMMGTREES","Homo sapiens","UBLCP1","Ubiquitin-like domain-containing CTD phosphatase 1","1","2KX3"
"2KX8",,"SOLUTION NMR",,,,,,,"10.1016/j.jmb.2010.08.042","ARG","2KX8",13.62,,,"NMR structure of stem-loop 4 from the human 7SK snRNA in complex with arginine","GGGAAAUGAGGCGCUGCAUGUGGCAGUCUGCCUUUCUUUCCC","Homo sapiens",,"7SK","1","2KX8"
"2KXF",,"SOLUTION NMR",,,,,,,"10.1038/nsmb.1883",,"2KXF",21.93,,,"Solution structure of the first two RRM domains of FBP-interacting repressor (FIR)","GAMAQRQRALAIMCRVYVGSIYYELGEDTIRQAFAPFGPIKSIDMSWDSVTMKHKGFAFVEYEVPEAAQLALEQMNSVMLGGRNIKVGRPSNIGQAQPIIDQLAEEARAFNRIYVASVHQDLSDDDIKSVFEAFGKIKSCTLARDPTTGKHKGYGFIEYEKAQSSQDAVSSMNLFDLGGQYLRVGKAVTPPMPLLTPAT","Homo sapiens","PUF60, FIR, ROBPI, SIAHBP1","Poly(U)-binding-splicing factor PUF60","1","2KXF"
"2KXJ",,"SOLUTION NMR",,,,,,,,,"2KXJ",10.11,,,"Solution structure of UBX domain of human UBXD2 protein","MGHHHHHHMSTVARIQFRLPDGSSFTNQFPSDAPLEEARQFAAQTVGNTYGNFSLATMFPRREFTKEDYKKKLLDLELAPSASVVLLPAG","Homo sapiens","UBXN4, KIAA0242, UBXD2, UBXDC1","UBX domain-containing protein 4","1","2KXJ"
"2KXK",,"SOLUTION NMR",,,,,,,,,"2KXK",6.16,,,"Human Insulin Mutant A22Gly-B31Lys-B32Arg","GIVEQCCTSICSLYQLENYCNG","Homo sapiens","INS","Insulin A chain","1","2KXK"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFYTPKTKR","Homo sapiens","INS","Insulin B chain","2","2KXK"
"2KXN",,"SOLUTION NMR",,,,,,,"10.1038/nsmb.2001",,"2KXN",16.42,,,"NMR structure of human Tra2beta1 RRM in complex with AAGAAC RNA","AAGAAC",,,"5'-R(*AP*AP*GP*AP*AP*C)-3'","1","2KXN"
,,,,,,,,,,,,,,,,"MGSSHHHHHHSSGLVPRGSHMASMTGGQQMGRGSRHVGNRANPDPNCCLGVFGLSLYTTERDLREVFSKYGPIADVSIVYDQQSRRSRGFAFVYFENVDDAKEAKERANGMELDGRRIRVDFSITKRPH","Homo sapiens","TRA2B, SFRS10","Transformer-2 protein homolog beta","2","2KXN"
"2KXR",,"SOLUTION NMR",,,,,,,"10.1038/emboj.2010.353",,"2KXR",12.69,,,"ZO1 ZU5 domain MC/AA mutation","TVVATARGIFNSNGGVLSSIETGVSIIIPQGAIPEGVEQEIYFKVCRDNSILPPLDKEKGETLLSPLVAAGPHGLKFLKPVELRLPHCDPKTWQNKCLPGDPNYLVGANCVSVLIDHF","Homo sapiens","TJP1, ZO1","Tight junction protein ZO-1","1","2KXR"
"2KY5",,"SOLUTION NMR",,,,,,,"10.1182/blood-2010-11-317867",,"2KY5",5.99,,,"Solution structure of the PECAM-1 cytoplasmic tail with DPC","GSSDVQYTEVQVSSAESHKDLGKKDTETVYSEVRKAVPDAVESRYSRTEGSLDGT","Homo sapiens","PECAM-1, PECAM1","Platelet endothelial cell adhesion molecule","1","2KY5"
"2KY6",,"SOLUTION NMR",,,,,,,"10.1038/nsmb.1999",,"2KY6",18.98,,,"Structure of ARC92VBD/MED25ACID","GEFGQQSVSNKLLAWSGVLEWQEKPKPASVDANTKLTRSLPCQVYVNHGENLKTEQWPQKLIMQLIPQQLLTTLGPLFRNSRMVQFHFTNKDLESLKGLYRIMGNGFAGCVHFPHTAPCEVRVLMLLYSSKKKIFMGLIPYDQSGFVNGIRQVITNHKQVQQQKLE","Homo sapiens","MED25, ACID1, ARC92, PTOV2, TCBAP0758","Mediator of RNA polymerase II transcription subunit 25","1","2KY6"
"2KYK",,"SOLUTION NMR",,,,,,,,,"2KYK",4.67,,,"The sandwich region between two LMP2A PY motif regulates the interaction between AIP4WW2domain and PY motif","GRAMGPLPPGWERRVDNMGRIYYVDHFTRTTTWQRPTLE","Homo sapiens","ITCH","E3 ubiquitin-protein ligase Itchy homolog","1","2KYK"
"2KYL",,"SOLUTION NMR",,,,,,,,,"2KYL",12.01,,,"Solution structure of MAST2-PDZ complexed with the C-terminus of PTEN","GGSMRPPIIIHRAGKKYGFTLRAIRVYMGDSDVYTVHHMVWHVEDGGPASEAGLRQGDLITHVNGEPVHGLVHTEVVELILKSGNKVAISTTPLEN","Homo sapiens","MAST2, KIAA0807, MAST205","Microtubule-associated serine/threonine-protein kinase 2","1","2KYL"
,,,,,,,,,,,,,,,,"PFDEDQHTQITKV",,,"C-terminus of Phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN","2","2KYL"
"2KYT",,"SOLUTION NMR",,,,,,,"10.1016/j.febslet.2010.09.015",,"2KYT",13.97,,,"Solution structure of the H-REV107 N-terminal domain","MRAPIPEPKPGDLIEIFRPFYRHWAIYVGDGYVVHLAPPSEVAGAGAASVMSALTDKAIVKKELLYDVAGSDKYQVNNKHDDKYSPLPCSKIIQRAEELVGQEVLYKLTSENCEHFVNELRYGVA","Homo sapiens","PLA2G16, HRASLS3, HREV107, PLAAT3","Group XVI phospholipase A2","1","2KYT"
"2KYU",,"SOLUTION NMR",,,,,,,"10.1021/bi1009387",,"2KYU",7.85,,,"The solution structure of the PHD3 finger of MLL","GSAKGNFCPLCDKCYDDDDYESKMMQCGKCDRWVHSKCENLSDEMYEILSNLPESVAYTCVNCTERH","Homo sapiens","MLL, ALL1, CXXC7, HRX, HTRX, KMT2A, MLL1, TRX1","Histone-lysine N-methyltransferase MLL","1","2KYU"
"2KYX",,"SOLUTION NMR",,,,,,,"10.1021/bi1009387",,"2KYX",9.21,,,"Solution structure of the RRM domain of CYP33","GSTTKRVLYVGGLAEEVDDKVLHAAFIPFGDITDIQIPLDYETEKHRGFAFVEFELAEDAAAAIDNMNESELFGRTIRVNLAK","Homo sapiens","PPIE, CYP33","Peptidyl-prolyl cis-trans isomerase E","1","2KYX"
"2KZ3",,"SOLUTION NMR",,,,,,,"10.1016/j.biocel.2010.11.014",,"2KZ3",9.07,,,"Backbone 1H, 13C, and 15N Chemical Shift Assignments for human Rad51D from 1 to 83","MGVLRVGLCPGLTEEMIQLLRSHRIKTVVDLVSADLEEVAQKCGLSYKALVALRRVLLAQFSAFPVNGADLYEELKTSTAILS","Homo sapiens","RAD51D, RAD51L3","Putative uncharacterized protein RAD51L3","1","2KZ3"
"2KZ5",,"SOLUTION NMR",,,,,,,,,"2KZ5",10.57,,,"Solution NMR Structure of Transcription factor NF-E2 subunit's DNA binding domain from Homo sapiens, Northeast Structural Genomics Consortium Target HR4653B","MGHHHHHHSHMAKPTARGEAGSRDERRALAMKIPFPTDKIVNLPVDDFNELLARYPLTESQLALVRDIRRRGKNKVAAQNYRKRKLETIVQ","Homo sapiens","NFE2","Transcription factor NF-E2 45 kDa subunit","1","2KZ5"
"2KZA",,"SOLUTION NMR",,,,,,,"10.1016/j.jmb.2010.08.054",,"2KZA",5.77,,,"Solution structure of ASIP(80-132, P103A, P105A, Q115Y, S124Y)","KKVVRPRTPLSAPCVATRNSCKPAAAACCDPCASCYCRFFRSACYCRVLSLNC","Homo sapiens","ASIP, AGTI, AGTIL, ASP","Agouti-signaling protein","1","2KZA"
"2KZG",,"SOLUTION NMR",,,,,,,"10.1126/science.1191723",,"2KZG",8.25,,,"A Transient and Low Populated Protein Folding Intermediate at Atomic Resolution","GSQPAKKTYTWNTKEEAKQAFKELLKEKRVPSNASWEQAMKMIINDPRYSALAKLSEKKQAFNAYKVQTEK","Homo sapiens","HYPA, FBP11, PRPF40A, FLAF1, FNBP3, HIP10, HSPC225","Pre-mRNA-processing factor 40 homolog A","1","2KZG"
"2KZS",,"SOLUTION NMR",,,,,,,"10.1016/j.str.2010.09.016",,"2KZS",10.95,,,"DAXX helical bundle (DHB) domain","GSHMGKKCYKLENEKLFEEFLELCKMQTADHPEVVPFLYNRQQRAHSLFLASAEFCNILSRVLSRARSRPAKLYVYINELCTVLKAHSAKKKLN","Homo sapiens","DAXX, DADB-159G18.9-007, DAMC-227D19.15-007, DAQB-126H3.2-007, XXbac-BCX165D10.3-007, XXbac-BPG185D15.6-007, BING2, DAP6","Death-associated protein 6","1","2KZS"
"2L03",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M110.189100",,"2L03",8.42,,,"Spatial structure of water-soluble Lynx1","MLDCHVCAYNGDNCFNPMRCPAMVAYCMTTRTYYTPTRMKVSKSCVPRCFETVYDGYSKHASTTSCCQYDLCNG","Homo sapiens","LYNX1","Ly-6/neurotoxin-like protein 1","1","2L03"
"2L05",,"SOLUTION NMR",,,,,,,,,"2L05",10.88,,,"Solution NMR Structure of the Ras-binding domain of Serine/threonine-protein kinase B-raf from Homo sapiens, Northeast Structural Genomics Consortium Target HR4694F","MGHHHHHHSHMPKSPQKPIVRVFLPNKQRTVVPARCGVTVRDSLKKALMMRGLIPECCAVYRIQDGEKKPIGWDTDISWLTGEELHVEVLENVPL","Homo sapiens","BRAF, BRAF1, RAFB1","Serine/threonine-protein kinase B-raf","1","2L05"
"2L08",,"SOLUTION NMR",,,,,,,,,"2L08",11.6,,,"Solution NMR Structure of Nonsense mRNA reducing factor 3A from H. Sapiens, Northeast Structural Genomics Consortium Target HR4714B","MGHHHHHHSHMVVIRRLPPGLTKEQLEEQLRPLPAHDYFEFFAADLSLYPHLYSRAYINFRNPDDILLFRDRFDGYIFLDSKGLEYPAVVEFAPFQK","Homo sapiens","UPF3A, RENT3A, UPF3","Regulator of nonsense transcripts 3A","1","2L08"
"2L0A",,"SOLUTION NMR",,,,,,,,,"2L0A",8.33,,,"Solution NMR Structure of Signal transducing adapter molecule 1 STAM-1 from Homo sapiens, Northeast Structural Genomics Consortium Target HR4479E","MGHHHHHHSHMNHQHEARKVRAIYDFEAAEDNELTFKAGEIITVLDDSDPNWWKGETHQGIGLFPSNFVTAD","Homo sapiens","STAM, STAM1","Signal transducing adapter molecule 1","1","2L0A"
"2L0B",,"SOLUTION NMR",,,,,,,,,"2L0B",10.24,,,"Solution NMR structure of zinc finger domain of E3 ubiquitin-protein ligase praja-1 from Homo sapiens, Northeast Structural Genomics Consortium (NESG) target HR4710B","MGHHHHHHSHMVANPPASKESIDALPEILVTEDHGAVGQEMCCPICCSEYVKGDVATELPCHHYFHKPCVSIWLQKSGTCPVCRCMFPPPL","Homo sapiens","PJA1, RNF70","E3 ubiquitin-protein ligase Praja-1","1","2L0B"
"2L0E",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M110.161471",,"2L0E",3.47,,,"Structural and functional analysis of tm vi of the nhe1 isoform of the na+/h+ exchanger","XKKKDNLLFGSIISAVDPVAVLAVFEEIHKKKX","Homo sapiens","SLC9A1, APNH1, NHE1","Sodium/hydrogen exchanger 1","1","2L0E"
"2L0G",,"SOLUTION NMR",,,,,,,"10.1021/bi101303t",,"2L0G",3.74,,,"Solution NMR structure of ubiquitin-binding motif (UBM2) of human polymerase iota","GHMFPSDIDPQVFYELPEAVQKELLAEWKRTG","Homo sapiens","POLI, RAD30B","DNA polymerase iota","1","2L0G"
"2L0P",,"SOLUTION NMR",,,,,,,"10.1016/j.jsb.2011.01.011",,"2L0P",21.11,,,"Solution structure of human apo-S100A1 protein by NMR spectroscopy","MGSELETAMETLINVFHAHSGKEGDKYKLSKKELKELLQTELSGFLDAQKDVDAVDKVMKELDENGDGEVDFQEYVVLVAALTVACNNFFWENS","Homo sapiens","S100A1, RP1-178F15.1-003, hCG_15470, S100A","S100 calcium binding protein A1","1","2L0P"
"2L0S",,"SOLUTION NMR",,,,,,,"10.1021/bi100687f",,"2L0S",9.53,,,"Solution Structure of Human Plasminogen Kringle 3","TYQCLKGTGENYRGNVAVTVSGHTCQHWSAQTPHTHNRTPENFPSKNLDENYCRNPDGKRAPWCHTTNSQVRWEYCKIPSCDS","Homo sapiens","PLG","Plasminogen","1","2L0S"
"2L0W",,"SOLUTION NMR",,,,,,,"10.1371/journal.pone.0016191",,"2L0W",15.5,,,"Solution NMR structure of the N-terminal PAS domain of HERG potassium channel","GGSMPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEK","Homo sapiens","KCNH2, hCG_18699, ERG, ERG1, HERG","Potassium voltage-gated channel, subfamily H (Eag-related), member 2, isoform CRA_b","1","2L0W"
"2L1C",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M110.159087",,"2L1C",26.45,,,"Shc-PTB:biphosphorylated integrin beta3 cytoplasmic tail complex (1:1)","GSSHHHHHHSSGLVPRGSHMGQLGGEEWTRHGSFVNKPTRGWLHPNDKVMGPGVSYLVRYMGCVEVLQSMRALDFNTRTQVTREAISLVCEAVPGAKGATRRRKPCSRPLSSILGRSNLKFAGMPITLTVSTSSLNLMAADCKQIIANHHMQSISFASGGDPDTAEYVAYVAKDPVNQRACHILECPEGLAQDVISTIGQAFELRFKQYLR","Homo sapiens","SHC1, hCG_1997126, SHC, SHCA","SHC (Src homology 2 domain containing) transforming protein 1, isoform CRA_d","1","2L1C"
,,,,,,,,,,,,,,,,"RAKWDTANNPLYKEATSTFTNITYRGT",,,"Integrin beta-3","2","2L1C"
"2L1G",,"SOLUTION NMR",,,,,,,,,"2L1G",20.05,,,"RDC refined solution structure of the THAP zinc finger of THAP1 in complex with its 16bp RRM1 DNA target","MVQSCSAYGCKNRYDKDKPVSFHKFPLTRPSLCKEWEAAVRRKNFKPTKYSSICSEHFTPDSFKRESNNKLLKENAVPTIFLELVPR","Homo sapiens","THAP1","THAP domain-containing protein 1","1","2L1G"
,,,,,,,,,,,,,,,,"GCTTGTGTGGGCAGCG",,,"DNA (5'-D(*GP*CP*TP*TP*GP*TP*GP*TP*GP*GP*GP*CP*AP*GP*CP*G)-3')","2","2L1G"
,,,,,,,,,,,,,,,,"CGCTGCCCACACAAGC",,,"DNA (5'-D(P*CP*GP*CP*TP*GP*CP*CP*CP*AP*CP*AP*CP*AP*AP*GP*C)-3')","3","2L1G"
"2L1J",,"SOLUTION NMR",,,,,,,"10.1016/j.jmb.2010.08.054",,"2L1J",3.68,,,"1H assignments for ASIP(93-126, P103A, P105A, P111A, Q115Y, S124Y)","CVATRNSCKPAAAACCDPAASCYCRFFRSACYCR","Homo sapiens","ASIP, AGTI, AGTIL, ASP","Agouti-signaling protein","1","2L1J"
"2L1M",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M110.199364",,"2L1M",17.25,,,"Solution structure of the eag domain of the hERG (Kv11.1) K+ channel","MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKENLYFQSLEHHHHHH","Homo sapiens","KCNH2, ERG, ERG1, HERG","Potassium voltage-gated channel subfamily H member 2","1","2L1M"
"2L1P",,"SOLUTION NMR",,,,,,,,,"2L1P",9.7,,,"NMR solution structure of the N-terminal domain of DNA-binding protein SATB1 from Homo sapiens: Northeast Structural Genomics Target HR4435B(179-250)","MGHHHHHHSHMLPPEQWSHTTVRNALKDLLKDMNQSSLAKECPLSQSMISSIVNSTYYANVSAAKCQEFGRWYKHFKKTKDMM","Homo sapiens","SATB1","DNA-binding protein SATB1","1","2L1P"
"2L1Q",,"SOLUTION NMR",,,,,,,"10.1002/cbic.201000400",,"2L1Q",4.59,,,"Solution structure of human Liver Expressed Antimicrobial Peptide 2","MTPFWRGVSLRPIGASCRDDSECITRLCRKRRCSLSVAQE","Homo sapiens","LEAP2","Liver-expressed antimicrobial peptide 2","1","2L1Q"
"2L1X",,"SOLUTION NMR",,,,,,,,,"2L1X",4.67,,,"The Solution Structure Of Human Parathyroid Hormone-Related Protein","PPSVSEIQLMHNRGKHLNSMERVEWLRKKLQDVHNFPPD","Homo sapiens","PTH","Parathyroid hormone","1","2L1X"
"2L1Y",,"SOLUTION NMR",,,,,,,,,"2L1Y",5.85,,,"NMR Structure of human insulin mutant GLY-B20-D-ALA, GLY-B23-D-ALA PRO-B28-LYS, LYS-B29-PRO, 20 Structures","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","Insulin A chain","1","2L1Y"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCAERAFFYTKPT","Homo sapiens","INS","Insulin B chain","2","2L1Y"
"2L1Z",,"SOLUTION NMR",,,,,,,,,"2L1Z",5.85,,,"NMR Structure of human insulin mutant GLY-B20-D-ALA, GLY-B23-D-ALA PRO-B28-LYS, LYS-B29-PRO, 20 Structures","GLLEQCCHSICSLYQLENYCN","Homo sapiens","INS","Insulin A chain","1","2L1Z"
,,,,,,,,,,,,,,,,"FVNQHLCGSDLVEALYLVCGERGFFYTKPT","Homo sapiens","INS","Insulin B chain","2","2L1Z"
"2L23",,"SOLUTION NMR",,,,,,,"10.1016/j.jsb.2010.10.011",,"2L23",19.22,,,"NMR structure of the ACID (ACtivator Interacting Domain) of the human mediator Med25 protein","MGQQSVSNKLLAWSGVLEWQEKPKPASVDANTKLTRSLPCQVYVNHGENLKTEQWPQKLIMQLIPQQLLTTLGPLFRNSRMVQFHFTNKDLESLKGLYRIMGNGFAGCVHFPHTAPCEVRVLMLLYSSKKKIFMGLIPYDQSGFVNGIRQVITNHKQVQLEHHHHHH","Homo sapiens","ACID1, ARC92, MED25, PTOV2, TCBAP0758","Mediator of RNA polymerase II transcription subunit 25","1","2L23"
"2L27",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M110.121897",,"2L27",13.56,,,"NMR Structure of the ECD1 of CRF-R1 in complex with a peptide agonist","LQDQHCESLSLASNISGLQCNASVDLIGTCWPRSPAGQLVVRPCPAFFYGVRYNTTNNGYRECLANGSWAARVNYSECQEILNE","Homo sapiens","CRHR1, CRFR, CRFR1, CRHR","Corticotropin-releasing factor receptor 1","1","2L27"
,,,,,,,,,,,,,,,,"PPISLDLTFNLLREVLEIAKAEQEAEEAAKNRLLLEEA",,,"peptide agonist","2","2L27"
"2L2A",,"SOLUTION NMR",,,,,,,"10.1126/science.1228633",,"2L2A",15.43,,,"Mutated Domain 11 of the Cytoplasmic region of the Cation-independent mannose-6-phosphate receptor","MKSNEHDDCQVTNPSTGHLFDLSSLSGRAGFTAAYSKSGVVYMSICGENENCPPGVGACFGQTRISVGKANKRLRYVDQVLQLVYKDGSPCPSKSGLSYKSVISFVCRPEAGPTNRPMLISLDKQTCTLFFSWHTPLACEPE","Homo sapiens","IGF2R, MPRI","Insulin-like growth factor 2 receptor variant","1","2L2A"
"2L2D",,"SOLUTION NMR",,,,,,,,,"2L2D",8.05,,,"Solution NMR Structure of human UBA-like domain of OTUD7A_11_83, NESG target HT6304A/OCSP target OTUD7A_11_83/SGC-Toronto","SAECWAALLHDPMTLDMDAVLSDFVRSTGAEPGLARDLLEGKNWDLTAALSDYEQLRQVHTANLPHVFNEGRG","Homo sapiens","OTUD7A, C15orf16, CEZANNE2, OTUD7","OTU domain-containing protein 7A","1","2L2D"
"2L2J",,"SOLUTION NMR",,,,,,,"10.1016/j.cell.2010.09.026",,"2L2J",13.47,,,"Solution NMR structure of the lower part of the R/G stem loop RNA","GGUAAGGUGGGUGGAAUCCUUCGGGAUCCCACCUACCCUGCC","Homo sapiens",,"RNA (42-MER)","1","2L2J"
"2L2O",,"SOLUTION NMR",,,,,,,"10.1002/pro.548",,"2L2O",10.13,,,"Solution structure of human HSPC280 protein","MNVDHEVNLLVEEIHRLGSKNADGKLSVKFGVLFRDDKSANLFEALVGTLKAAKRRKIVTYPGELLLQGVHDDVDIILLQDLEHHHHHH","Homo sapiens","C6orf115, ABRACL, HSPC280, PRO2013","UPF0727 protein C6orf115","1","2L2O"
"2L2T",,"SOLUTION NMR",,,,,,,"10.1016/j.bbamem.2012.05.001",,"2L2T",9.54,,,"Solution NMR structure of the ErbB4 dimeric membrane domain","STLPQHARTPLIAAGVIGGLFILVIVGLTFAVYVRRKSIKKKRA","Homo sapiens","ERBB4, HER4","Receptor tyrosine-protein kinase erbB-4","1","2L2T"
"2L30",,"SOLUTION NMR",,,,,,,"10.1016/j.jmb.2011.01.034",,"2L30",12.2,,,"Human PARP-1 zinc finger 1","MAESSDKLYRVEYAKSGRASCKKCSESIPKDSLRMAIMVQSPMFDGKVPHWYHFSCFWKVGHSIRHPDVEVDGFSELRWDDQQKVKKTAEAGGVTGKGQDGIGSKAEK","Homo sapiens","PARP1, ADPRT, PPOL","Poly [ADP-ribose] polymerase 1","1","2L30"
"2L31",,"SOLUTION NMR",,,,,,,"10.1016/j.jmb.2011.01.034",,"2L31",12.66,,,"Human PARP-1 zinc finger 2","GSKAEKTLGDFAAEYAKSNRSTCKGCMEKIEKGQVRLSKKMVDPEKPQLGMIDRWYHPGCFVKNREELGFRPEYSASQLKGFSLLATEDKEALKKQLPGVKSEGKRKGDEVD","Homo sapiens","PARP1, ADPRT, PPOL","Poly [ADP-ribose] polymerase 1","1","2L31"
"2L33",,"SOLUTION NMR",,,,,,,,,"2L33",10.19,,,"Solution NMR Structure of DRBM 2 domain of Interleukin enhancer-binding factor 3 from Homo sapiens, Northeast Structural Genomics Consortium Target HR4527E","MGHHHHHHSHMLTKHGKNPVMELNEKRRGLKYELISETGGSHDKRFVMEVEVDGQKFQGAGSNKKVAKAYAALAALEKLFPDTPLALDANK","Homo sapiens","ILF3, DRBF, MPHOSPH4, NF90","Interleukin enhancer-binding factor 3","1","2L33"
"2L34",,"SOLUTION NMR",,,,,,,"10.1038/ni.1943",,"2L34",6.66,,,"Structure of the DAP12 transmembrane homodimer","CSTVSPGVLAGIVVGDLVLTVLIALAVYFLGRL","Homo sapiens","TYROBP, DAP12, KARAP","TYRO protein tyrosine kinase-binding protein","1","2L34"
"2L3D",,"SOLUTION NMR",,,,,,,,,"2L3D",11.77,,,"The solution structure of the short form SWIRM domain of LSD1","GSVEGAAFQSRLPHDRMTSQEAACFPDIISGPQQTQKVFLFIRNRTLQLWLDNPKIQLTFEATLQQLEAPYNSDTVLVHRVHSYLERHGLINFGIYKRIKPL","Homo sapiens","KDM1A, AOF2, KDM1, KIAA0601, LSD1","Lysine-specific histone demethylase 1A","1","2L3D"
"2L3G",,"SOLUTION NMR",,,,,,,,,"2L3G",14.07,,,"Solution NMR Structure of CH domain of Rho guanine nucleotide exchange factor 7 from Homo sapiens, Northeast Structural Genomics Consortium Target HR4495E","MGHHHHHHSHMNSAEQTVTWLITLGVLESPKKTISDPEGFLQASLKDGVVLCRLLERLLPGTIEKVYPEPRSESECLSNIREFLRGCGASLRLETFDANDLYQGQNFNKVLSSLVTLNKVTADIGL","Homo sapiens","ARHGEF7, COOL1, KIAA0142, P85SPR, PAK3BP, PIXB, Nbla10314","Rho guanine nucleotide exchange factor 7","1","2L3G"
"2L3H",,"SOLUTION NMR",,,,,,,"10.1021/ja908170s",,"2L3H",4.56,,,"NMR Structure in a Membrane Environment Reveals Putative Amyloidogenic Regions of the SEVI Precursor Peptide PAP248-286","GIHKQKEKSRLQGGVLVNEILNHMKRATQIPSYKKLIMY","Homo sapiens","ACP3, ACPP","Prostatic acid phosphatase","1","2L3H"
"2L3L",,"SOLUTION NMR",,,,,,,,,"2L3L",13.17,,,"The solution structure of the N-terminal domain of human Tubulin Binding Cofactor C reveals a platform for the interaction with ab-tubulin","MPERLQRREQERQLEVERRKQKRQNQEVEKENSHFFVATFARERAAVEELLERAESVERLEEAASRLQGLQKLINDSVFFLAAYDLRQGQEALARLQAALAERRRGLQPKK","Homo sapiens","TBCC","Tubulin-specific chaperone C","1","2L3L"
"2L3X",,"SOLUTION NMR",,,,,,,,,"2L3X",8.21,,,"villin head piece domain of human ABLIM2","QYKIYPYDSLIVTNRIRVKLPKDVDRTRLERHLSPEEFQEVFGMSIEEFDRLALWKRNDLKKKALLF","Homo sapiens","ABLIM2, KIAA1808","ABLIM2 protein","1","2L3X"
"2L3Z",,"SOLID-STATE NMR",,,,,,,"10.1002/cphc.201100062",,"2L3Z",8.58,,,"Proton-Detected 4D DREAM Solid-State NMR Structure of Ubiquitin","MQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGG","Homo sapiens","UBC","Ubiquitin","1","2L3Z"
"2L4C",,"SOLUTION NMR",,,,,,,,,"2L4C",13.81,,,"Solution Structure of the b domain of Human ERp27","MHHHHHHMEVEKSSDGPGAAQEPTWLTDVPAAMEFIAATEVAVIGFFQDLEIPAVPILHSMVQKFPGVSFGISTDSEVLTHYNITGNTICLFRLVDNEQLNLEDEDIESIDATKLSRFIEINSL","Homo sapiens","ERP27, C12orf46, UNQ781/PRO1575","Endoplasmic reticulum resident protein 27","1","2L4C"
"2L4H",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M110.179028",,"2L4H",24.59,,,"The Solution Structure of Calcium Bound CIB1","MGHHHHHHHHHHSSGHIDDDDKHMGGSGSRLSKELLAEYQDLTFLTKQEILLAHRRFCELLPQEQRSVESSLRAQVPFEQILSLPELKANPFKERICRVFSTSPAKDSLSFEDFLDLLSVFSDTATPDIKSHYAFRIFDFDDDGTLNREDLSRLVNCLTGEGEDTRLSASEMKQLIDNILEESDIDRDGTINLSEFQHVISRSPDFASSFKIVL","Homo sapiens","CIB1, CIB, KIP, PRKDCIP","Calcium and integrin-binding protein 1","1","2L4H"
"2L4I",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M110.179028",,"2L4I",24.53,,,"The Solution Structure of Magnesium bound CIB1","MGHHHHHHHHHHSSGHIDDDDKHMGGSGSRLSKELLAEYQDLTFLTKQEILLAHRRFCELLPQEQRSVESSLRAQVPFEQILSLPELKANPFKERICRVFSTSPAKDSLSFEDFLDLLSVFSDTATPDIKSHYAFRIFDFDDDGTLNREDLSRLVNCLTGEGEDTRLSASEMKQLIDNILEESDIDRDGTINLSEFQHVISRSPDFASSFKIVL","Homo sapiens","CIB1, CIB, KIP, PRKDCIP","Calcium and integrin-binding protein 1","1","2L4I"
"2L4M",,"SOLUTION NMR",,,,,,,,,"2L4M",8.23,,,"Solution structure of the Zbeta domain of human DAI and its binding modes to B- and Z-DNA","SHMASPQFSQQREEDIYRFLKDNGPQRALVIAQALGMRTAKDVNRDLYRMKSRHLLDMDEQSKAWTIYR","Homo sapiens","ZBP1, C20orf183, DLM1","Uncharacterized protein","1","2L4M"
"2L4N",,"SOLUTION NMR",,,,,,,"10.1021/bi201601k",,"2L4N",12.52,,,"Solution Structure of the Chemokine CCL21","SDGGAQDCCLKYSQRKIPAKVVRSYRKQEPSLGCSIPAILFLPRKRSQAELCADPKELWVQQLMQHLDKTPSPQKPAQGCRKDRGASKTGKKGKGSKGCKRTERSQTPKGPKL","Homo sapiens","CCL21, RP11-195F19.22-001, SCYA21, UNQ784/PRO1600","C-C motif chemokine 21","1","2L4N"
"2L4R",,"SOLUTION NMR",,,,,,,"10.1016/j.bbrc.2010.10.132",,"2L4R",15.3,,,"NMR solution structure of the N-terminal PAS domain of hERG","MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEK","Homo sapiens","KCNH2, ERG, ERG1, HERG","Potassium voltage-gated channel subfamily H member 2","1","2L4R"
"2L4S",,"SOLUTION NMR",,,,,,,"10.1021/bi102055y",,"2L4S",13.75,,,"Promiscuous Binding at the Crossroads of Numerous Cancer Pathways: Insight from the Binding of GIP with Glutaminase L","MSYIPGQPVTAVVQRVEIHKLRQGENLILGFSIGGGIDQDPSQNPFSEDKTDKGIYVTRVSEGGPAEIAGLQIGDKIMQVNGWDMTMVTHDQARKRLTKRSEEVVRLLVTRQSLQKAVQQSMLS","Homo sapiens","TAX1BP3, TIP1","Tax1-binding protein 3","1","2L4S"
"2L4T",,"SOLUTION NMR",,,,,,,"10.1021/bi102055y",,"2L4T",14.7,,,"GIP/Glutaminase L peptide complex","MSYIPGQPVTAVVQRVEIHKLRQGENLILGFSIGGGIDQDPSQNPFSEDKTDKGIYVTRVSEGGPAEIAGLQIGDKIMQVNGWDMTMVTHDQARKRLTKRSEEVVRLLVTRQSLQKAVQQSMLS","Homo sapiens","TAX1BP3, TIP1","Tax1-binding protein 3","1","2L4T"
,,,,,,,,,,,,,,,,"KENLESMV",,,"Glutaminase L peptide","2","2L4T"
"2L50",,"SOLUTION NMR",,,,,,,"10.1007/s00775-010-0721-3",,"2L50",23.37,,,"Solution structure of apo S100A16","SDCYTELEKAVIVLVENFYKYVSKYSLVKNKISKSSFREMLQKELNHMLSDTGNRKAADKLIQNLDANHDGRISFDEYWTLIGGITGPIAKLIHEQEQQSSS","Homo sapiens","S100A16, S100F, AAG13","Protein S100-A16","1","2L50"
"2L51",,"SOLUTION NMR",,,,,,,"10.1007/s00775-010-0721-3",,"2L51",23.53,,,"Solution structure of calcium bound S100A16","SDCYTELEKAVIVLVENFYKYVSKYSLVKNKISKSSFREMLQKELNHMLSDTGNRKAADKLIQNLDANHDGRISFDEYWTLIGGITGPIAKLIHEQEQQSSS","Homo sapiens","S100A16, S100F, AAG13","Protein S100-A16","1","2L51"
"2L54",,"SOLUTION NMR",,,,,,,"10.1038/nsmb.1962",,"2L54",6.94,,,"Solution structure of the Zalpha domain mutant of ADAR1 (N43A,Y47A)","YQDQEQRILKFLEELGEGKATTAHDLSGKLGTPKKEIARVLASLAKKGKLQKEAGTPPLWKIA","Homo sapiens","ADAR, ADAR1, DSRAD, G1P1, IFI4","Double-stranded RNA-specific adenosine deaminase","1","2L54"
"2L5C",,"SOLUTION NMR",,,,,,,"10.1002/prot.23003",,"2L5C",15.67,,,"Solution structures of human PIWI-like 1 PAZ domain","CTDVSHKVLRSETVLDFMFNFYHQTEEHKFQEQVSKELIGLVVLTKYNNKTYRVDDIDWDQNPKSTFKKADGSEVSFLEYYRKQYNQEITDLKQPVLVSQPKRRRGPGGTLPGPAMLIPELCYLTGLTDKMRND","Homo sapiens","PIWIL1, HIWI","Piwi-like protein 1","1","2L5C"
"2L5F",,"SOLUTION NMR",,,,,,,,,"2L5F",10.55,,,"Solution structure of the tandem WW domains from HYPA/FBP11","GSDVAAGTASGAKSMWTEHKSPDGRTYYYNTETKQSTWEKPDDLKTPAEQLLSKCPWKEYKSDSGKTYYYNSQTKESRWAKPKELEDLEGLE","Homo sapiens","PRPF40A, FBP11, FLAF1, FNBP3, HIP10, HYPA, HSPC225","Pre-mRNA-processing factor 40 homolog A","1","2L5F"
"2L5I",,"SOLUTION NMR",,,,,,,"10.1371/journal.pone.0005273",,"2L5I",2.57,,,"structure of the spliceosomal phosphopeptide P140 (non-phosphorylated form)","RIHMVYSKRSGKPRGYAFIEY","Homo sapiens","SNRNP70, RNPU1Z, RPU1, SNRP70, U1AP1","U1 small nuclear ribonucleoprotein 70 kDa","1","2L5I"
"2L5J",,"SOLUTION NMR",,,,,,,"10.1371/journal.pone.0005273",,"2L5J",2.64,,,"structure of the spliceosomal phosphopeptide P140 (phosphorylated form)","RIHMVYSKRSGKPRGYAFIEY","Homo sapiens","SNRNP70, RNPU1Z, RPU1, SNRP70, U1AP1","U1 small nuclear ribonucleoprotein 70 kDa","1","2L5J"
"2L5S",,"SOLUTION NMR",,,,,,,"10.1016/j.jmb.2011.07.046",,"2L5S",9.47,,,"Solution structure of the extracellular domain of the TGF-beta type I receptor","GSATALQCFCHLCTKDNFTCVTDGLCFVSVTETTDKVIHNSMCIAEIDLIPRDRPFVCAPSSKTGSVTTTYCCNQDHCNKIELPTTVX","Homo sapiens","TGFBR1, ALK5, SKR4","TGF-beta receptor type-1","1","2L5S"
"2L5U",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M110.208207",,"2L5U",6.98,,,"Structure of the first PHD finger (PHD1) from CHD4 (Mi2b)","GPLGSYETDHQDYCEVCQQGGEIILCDTCPRAYHMVCLDPDMEKAPEGKWSCPHCEKEGIQ","Homo sapiens","CHD4","Chromodomain-helicase-DNA-binding protein 4","1","2L5U"
"2L5V",,"SOLUTION NMR",,,,,,,,,"2L5V",15.8,,,"Solution structure of the C-terminal domain of hRpn13","GSQPIQLSDLQSILATMNVPAGPAGGQQVDLASVLTPEIMAPILANADVQERLLPYLPSGESLPQTADEIQNTLTSPQFQQALGMFSAALASGQLGPLMCQFGLPAEAVEAANKGDVEAFAKAMQNNAKPEQKEGDTKDKKDEEEDMSLD","Homo sapiens","ADRM1, GP110","Proteasomal ubiquitin receptor ADRM1","1","2L5V"
"2L5Y",,"SOLUTION NMR",,,,,,,"10.1073/pnas.1015125108",,"2L5Y",17.87,,,"NMR structure of calcium-loaded STIM2 EF-SAM.","GSHMASTEEDRFSLEALQTIHKQMDDDKDGGIEVEESDEFIREDMKYKDATNKHSHLHREDKHITIEDLWKRWKTSEVHNWTLEDTLQWLIEFVELPQYEKNFRDNNVKGTTLPRIAVHEPSFMISQLKISDRSHRQKLQLKALDVVLFG","Homo sapiens","KIAA1482, STIM2","Stromal interaction molecule 2","1","2L5Y"
"2L63",,"SOLUTION NMR",,,,,,,"10.1016/j.febslet.2010.12.011",,"2L63",3.77,,,"NMR solution structure of GLP-2 in 2,2,2 trifluroethanol","HADGSFSDEMNTILDNLAARDFINWLIQTKITD","Homo sapiens","GCG","Glucagon-like peptide 2","1","2L63"
"2L64",,"SOLUTION NMR",,,,,,,"10.1016/j.febslet.2010.12.011",,"2L64",3.77,,,"NMR Solution structure of GLP-2 in DHPC micelles","HADGSFSDEMNTILDNLAARDFINWLIQTKITD","Homo sapiens","GCG","Glucagon-like peptide 2","1","2L64"
"2L67",,"SOLUTION NMR",,,,,,,"10.1016/j.bpj.2012.04.039",,"2L67",14.1,,,"Solution Structure of Human Apo L-FABP","SFSGKYQLQSQENFEAFMKAIGLPEELIQKGKDIKGVSEIVQNGKHFKFTITAGSKVIQNEFTVGEECELETMTGEKVKTVVQLEGDNKLVTTFKNIKSVTELNGDIITNTMTLGDIVFKRISKRI","Homo sapiens","FABP1, FABPL","Fatty acid-binding protein, liver","1","2L67"
"2L68",,"SOLUTION NMR",,,,,,,"10.1016/j.bpj.2012.04.039",,"2L68",14.1,,,"Solution Structure of Human Holo L-FABP","SFSGKYQLQSQENFEAFMKAIGLPEELIQKGKDIKGVSEIVQNGKHFKFTITAGSKVIQNEFTVGEECELETMTGEKVKTVVQLEGDNKLVTTFKNIKSVTELNGDIITNTMTLGDIVFKRISKRI","Homo sapiens","FABP1, FABPL","Fatty acid-binding protein, liver","1","2L68"
"2L6A",,"SOLUTION NMR",,,,,,,"10.1016/j.jmb.2011.09.024",,"2L6A",11.72,,,"Three-dimensional structure of the N-terminal effector PYRIN domain of NLRP12","GHMLRTAGRDGLCRLSTYLEELEAVELKKFKLYLGTATELGEGKIPWGSMEKAGPLEMAQLLITHFGPEEAWRLALSTFERINRKDLWERGQREDLVRDTVE","Homo sapiens","NLRP12, NALP12, PYPAF7, RNO","NACHT, LRR and PYD domains-containing protein 12","1","2L6A"
"2L6K",,"SOLUTION NMR",,,,,,,"10.1371/journal.pone.0021965",,"2L6K",13.69,,,"Solution Structure of a Nonphosphorylated Peptide Recognizing Domain","MDTSKFWYKPHLSRDQAIALLKDKDPGAFLIRDSHSFQGAYGLALKVATPPPSAQPWKGDPVEQLVRHFLIETGPKGVKIKGCPSEPYFGSLSALVSQHSISPISLPCCLRIPSKLEHHHHHH","Homo sapiens","TNS2, KIAA1075, TENC1","Tensin-like C1 domain-containing phosphatase","1","2L6K"
"2L6L",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M112.339655",,"2L6L",18.05,,,"Solution structure of human J-protein co-chaperone, Dph4","MMAVEQMPKKDWYSILGADPSANISDLKQKYQKLILMYHPDKQSTDVPAGTVEECVQKFIEIDQAWKILGNEETKREYDLQRCEDDLRNVGPVDAQVYLEEMSWNEGDHSFYLSCRCGGKYSVSKDEAEEVSLISCDTCSLIIELLHYNHHHHHH","Homo sapiens","DNAJC24, DPH4, ZCSL3","DnaJ homolog subfamily C member 24","1","2L6L"
"2L6U",,"SOLUTION NMR",,,,,,,"10.1007/s10969-011-9115-1",,"2L6U",18.64,,,"Solution NMR Structure of Med25(391-543) Comprising the Activator-Interacting Domain (ACID) of Human Mediator Subuniti 25. Northeast Structural Genomics Consortium Target HR6188A","MGHHHHHHSHGQQSVSNKLLAWSGVLEWQEKPKPASVDANTKLTRSLPCQVYVNHGENLKTEQWPQKLIMQLIPQQLLTTLGPLFRNSRMVQFHFTNKDLESLKGLYRIMGNGFAGCVHFPHTAPCEVRVLMLLYSSKKKIFMGLIPYDQSGFVNGIRQVITN","Homo sapiens","MED25, ACID1, ARC92, PTOV2, TCBAP0758","Mediator complex subunit MED25","1","2L6U"
"2L6W",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M111.325555",,"2L6W",8.84,,,"PDGFR beta-TM","GHSLPFKVVVISAILALVVLTIISLIILIMLWQKKPRYE","Homo sapiens","PDGFRB, PDGFR, PDGFR1","Beta-type platelet-derived growth factor receptor","1","2L6W"
"2L70",,"SOLUTION NMR",,,,,,,"10.1016/j.bbapap.2011.04.002",,"2L70",4.99,,,"NMR solution structure of GIP in micellular media","YAEGTFISDYSIAMDKIHQQDFVNWLLAQKGKKNDWKHNITQ","Homo sapiens","GIP","Gastric inhibitory polypeptide","1","2L70"
"2L71",,"SOLUTION NMR",,,,,,,"10.1016/j.bbapap.2011.04.002",,"2L71",4.99,,,"NMR solution structure of GIP in Bicellular media","YAEGTFISDYSIAMDKIHQQDFVNWLLAQKGKKNDWKHNITQ","Homo sapiens","GIP","Gastric inhibitory polypeptide","1","2L71"
"2L73",,"SOLUTION NMR",,,,,,,,,"2L73",16.6,,,"Structure of the NOXO1b PX domain","GPLGSMAGPRYPVSVQGAALVQIKRLQTFAFSVRWSDGSDTFVRRSWDEFRQLKKTLKETFPVEAGLLRRSDRVLPKLLDAPLLGRVGRTSRGLARLQLLETYSRRLLATAERVARSPTITGFFAPQPLDLEPALPPGSRVILPTPEEQ","Homo sapiens","NOXO1, P41NOX, SH3PXD5","NADPH oxidase organizer 1","1","2L73"
"2L76",,"SOLUTION NMR",,,,,,,,,"2L76",10.4,,,"Solution NMR structure of human NFATC2IP ubiquitin-like domain, NFATC2IP_244_338, NESG target HT65A/OCSP target hs00387_244_338/SGC-toronto","QGQEDEVVLVEGPTLPETPRLFPLKIRCRADLVRLPLRMSEPLQSVVDHMATHLGVSPSRILLLFGETELSPTATPRTLKLGVADIIDCVVLTSS","Homo sapiens","NFATC2IP, NIP45","NFATC2-interacting protein","1","2L76"
"2L77",,"SOLUTION NMR",,,,,,,,,"2L77",4.56,,,"Solution NMR structure of PAP248-286 in 50% TFE","GIHKQKEKSRLQGGVLVNEILNHMKRATQIPSYKKLIMY","Homo sapiens","ACP3, ACPP","Prostatic acid phosphatase","1","2L77"
"2L79",,"SOLUTION NMR",,,,,,,,,"2L79",4.56,,,"Solution NMR structure of PAP248-286 in 30% TFE","GIHKQKEKSRLQGGVLVNEILNHMKRATQIPSYKKLIMY","Homo sapiens","ACP3, ACPP","Prostatic acid phosphatase","1","2L79"
"2L7B",,"SOLUTION NMR",,,,,,,"10.1073/pnas.1106420108",,"2L7B",35.3,,,"NMR Structure of full length apoE3","HHHHHHHHKVEQAVETEPEPELRQQTEWQSGQRWELALGRFWDYLRWVQTLSEQVQEELLSSQVTQELRALMDETMKELKAYKSELEEQLTPVAEETRARLSKELQAAQARLGADMEDVCGRLVQYRGEVQAMLGQSTEELRVRLASHLRKLRKRLLRDADDLQKRLAVYQAGAREGAERGLSAIRERLGPLVEQGRVRAATVGSLAGQPLQERAQAWGERLRARMEEMGSRTRDRLDEVKEQVAEVRAKLEEQAQQIRLQAEAAQARLKSRFEPLAEDMQRQWAGQVEKVQAAEGTSAAPVPSDNH","Homo sapiens","APOE","Apolipoprotein E","1","2L7B"
"2L7F",,"SOLUTION NMR",,,,,,,,,"2L7F",8.49,,,"Solution Structure of the Pitx2 Homeodomain","GSQRRQRTHFTSQQLQELEATFQRNRYPDMSTREEIAVWTNLTEARVRVWFKNRRAKWRKREEFIVTD","Homo sapiens","PITX2, ARP1, RGS, RIEG, RIEG1","Pituitary homeobox 2","1","2L7F"
"2L7M",,"SOLUTION NMR",,,,,,,,,"2L7M",8.47,,,"Solution Structure of the Pitx2 Homeodomain R24H mutant","GSQRRQRTHFTSQQLQELEATFQRNHYPDMSTREEIAVWTNLTEARVRVWFKNRRAKWRKREEFIVTD","Homo sapiens","PITX2, ARP1, RGS, RIEG, RIEG1","Pituitary homeobox 2","1","2L7M"
"2L7R",,"SOLUTION NMR",,,,,,,,,"2L7R",9.8,,,"Solution NMR structure of N-terminal Ubiquitin-like domain of FUBI, a ribosomal protein S30 precursor from Homo sapiens. NorthEast Structural Genomics consortium (NESG) target HR6166","MGSSHHHHHHSSGLVPRGSMQLFVRAQELHTFEVTGQETVAQIKAHVASLEGIAPEDQVVLLAGAPLEDEATLGQCGVEALTTLEVAGRMLGG","Homo sapiens","FAU","Ubiquitin-like protein FUBI","1","2L7R"
"2L7S",,"SOLUTION NMR",,,,,,,"10.1002/bip.21700",,"2L7S",6.04,,,"Determination of the three-dimensional structure of adrenomedullin, a first step towards the analysis of its interactions with receptors and small molecules","YRQSMNNFQGLRSFGCRFGTCTVQKLAHQIYQFTDKDKDNVAPRSKISPQGYX","Homo sapiens","ADM, AM","Adrenomedullin","1","2L7S"
"2L7T",,"SOLUTION NMR",,,,,,,"10.1126/science.1198848",,"2L7T",1.32,,,"Solution structure of the MFS-bound Sans CEN2 peptide","EELPWDELDLG","Homo sapiens","USH1G, SANS","MFS-bound Sans CEN2 peptide","1","2L7T"
"2L7W",,"SOLUTION NMR",,,,,,,,,"2L7W",21.09,,,"Solution structure of the human Raf-1 kinase inhibitor protein","MPVDLSKWSGPLSLQEVDEQPQHPLHVTYAGAAVDELGKVLTPTQVKNRPTSISWDGLDSGKLYTLVLTDPDAPSRKDPKYREWHHFLVVNMKGNDISSGTVLSDYVGSGPPKGTGLHRYVWLVYEQDRPLKCDEPILSNRSGDHRGKFKVASFRKKYELRAPVAGTCYQAEWDDYVPKLYEQLSGK","Homo sapiens","RKIP, PEBP1, PBP, PEBP","Phosphatidylethanolamine-binding protein 1","1","2L7W"
"2L7Z",,"SOLUTION NMR",,,,,,,"10.1371/journal.pone.0023069",,"2L7Z",8.89,,,"NMR Structure of A13 homedomain","MSHMLEGRKKRVPYTKVQLKELEREYATNKFITKDKRRRISATTNLSERQVTIWFQNRRVKEKKVINKLKTTS","Homo sapiens","HOXA13, HOX1J","Homeobox protein Hox-A13","1","2L7Z"
"2L80",,"SOLUTION NMR",,,,,,,,,"2L80",12.91,,,"Solution Structure of the Zinc Finger Domain of USP13","GSVSKYANNLTQLDNGVRIPPSGWKCARCDLRENLWLNLTDGSVLCGKWFFDSSGGNGHALEHYRDMGYPLAVKLGTITPDGADVYSFQEEEPVLDPHLAKHLAHFGIDMLHMHGT","Homo sapiens","USP13, ISOT3","Ubiquitin carboxyl-terminal hydrolase 13","1","2L80"
"2L81",,"SOLUTION NMR",,,,,,,,,"2L81",20.24,,,"Solution NMR Structure of the serine-rich domain of hEF1 (Enhancer of filamentation 1) from Homo sapiens, Northeast Structural Genomics Consortium Target HR5554A","MGHHHHHHSHMDKRLFLDPDTAIERLQRLQQALEMGVSSLMALVTTDWRCYGYMERHINEIRTAVDKVELFLKEYLHFVKGAVANAACLPELILHNKMKRELQRVEDSHQILSQTSHDLNECSWSLNILAINKPQNKCDDLDRFVMVAKTVPDDAKQLTTTINTNAEALFRPGPGS","Homo sapiens","NEDD9, CASL, CASS2","Enhancer of filamentation 1","1","2L81"
"2L84",,"SOLUTION NMR",,,,,,,"10.1016/j.chembiol.2010.12.021","J28","2L84",14.75,,,"Solution NMR structures of CBP bromodomain with small molecule j28","GSHMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG","Homo sapiens","CREBBP, CBP","CREB-binding protein","1","2L84"
"2L85",,"SOLUTION NMR",,,,,,,"10.1016/j.chembiol.2010.12.021",,"2L85",14.7,,,"Solution NMR structures of CBP bromodomain with small molecule of HBS","GSHMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG","Homo sapiens","CREBBP, CBP","CREB-binding protein","1","2L85"
"2L86",,"SOLUTION NMR",,,,,,,"10.1016/j.bbamem.2011.06.012",,"2L86",3.91,,,"Solution NMR structure of human amylin in SDS micelles at pH 7.3","KCNTATCATQRLANFLVHSSNNFGAILSSTNVGSNTYX","Homo sapiens","IAPP","Islet amyloid polypeptide","1","2L86"
"2L87",,"SOLUTION NMR",,,,,,,"10.1016/j.jmb.2011.04.023",,"2L87",3.36,,,"The 27-residue N-terminus CCR5-peptide in a ternary complex with HIV-1 gp120 and a CD4-mimic peptide","MDYQVSSPIYDINYYTSEPAQKINVKQ","Homo sapiens","CCR5, CMKBR5","C-C chemokine receptor type 5","1","2L87"
"2L8E",,"SOLUTION NMR",,,,,,,,,"2L8E",5.56,,,"Solution NMR structure of FCS domain of Human Polyhomeotic Homolog 1 (HPH1)","GTRGVDSPSAELDKKANLLKCEYCGKYAPAEQFRGSKRFCSMTCAKRYN","Homo sapiens","PHC1, EDR1, PH1","Polyhomeotic-like protein 1","1","2L8E"
"2L8R",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M111.276238","APR","2L8R",17.46,,,"Solution structure of human protein C6orf130 in complex with ADP-ribose","GSSLNEDPEGSRITYVKGDLFACPKTDSLAHCISEDCRMGAGIAVLFKKKFGGVQELLNQQKKSGEVAVLKRDGRYIYYLITKKRASHKPTYENLQKSLEAMKSHCLKNGVTDLSMPRIGCGLDRLQWENVSAMIEEVFEATDIKITVYTL","Homo sapiens","C6orf130, OARD1, TARG1","Uncharacterized protein C6orf130","1","2L8R"
"2L8S",,"SOLUTION NMR",,,,,,,"10.1371/journal.pone.0062954",,"2L8S",6.34,,,"Solution NMR Structure of Transmembrane and Cytosolic Regions of Integrin Alpha1 in Detergent Micelles","MGLPGRVPLWVILLSAFAGLLLLMLLILALWKIGFFKRPLKKKMEKLEHHHHHH","Homo sapiens","ITGA1","Integrin alpha-1","1","2L8S"
"2L91",,"SOLUTION NMR",,,,,,,"10.1038/nature10697",,"2L91",4.68,,,"Structure of the Integrin beta3 (A711P,K716A) Transmembrane Segment","PESPKGPDILVVLLSVMGAILLIGLAPLLIWALLITIHDRKEF","Homo sapiens","ITGB3, GP3A","Integrin beta-3","1","2L91"
"2L98",,"SOLUTION NMR",,,,,,,"10.1021/bi101985j","STL","2L98",8.68,,,"Structure of trans-Resveratrol in complex with the cardiac regulatory protein Troponin C","MGKSEEELSDLFRMFDKNADGYIDLDELKIMLQATGETITEDDIEELMKDGDKNNDGRIDYDEFLEFMKGVE","Homo sapiens","TNNC, TNNC1","Troponin C, slow skeletal and cardiac muscles","1","2L98"
"2L9H",,"SOLUTION NMR, SOLUTION SCATTERING",,,,,,,"10.1016/j.str.2011.06.001",,"2L9H",31.45,,,"Oligomeric Structure of the Chemokine CCL5/RANTES from NMR, MS, and SAXS Data","SPYSSDTTPCCFAYIARPLPRAHIKEYFYTSGKCSNPAVVFVTRKNRQVCANPEKKWVREYINSLEMS","Homo sapiens","CCL5, D17S136E, SCYA5","C-C motif chemokine 5","1","2L9H"
"2L9I",,"SOLUTION NMR",,,,,,,"10.1016/j.bbrc.2011.11.041",,"2L9I",3.1,,,"NMR structure of thymosin alpha-1","XSDAAVDTSSEITTKDLKEKKEVVEEAEN","Homo sapiens","PTMA, TMSA","Thymosin alpha-1","1","2L9I"
"2L9M",,"SOLUTION NMR",,,,,,,"10.1016/j.molcel.2011.04.008",,"2L9M",15.15,,,"Structure of cIAP1 CARD","GSHMLNAEDEKREEEKEKQAEEMASDDLSLIRKNRMALFQQLTCVLPILDNLLKANVINKQEHDIIKQKTQIPLQARELIDTILVKGNAAANIFKNCLKEIDSTLYKNLFVDKNMKYIPTEDVSGLSLEEQL","Homo sapiens","API1, BIRC2, IAP2, MIHB, RNF48","Baculoviral IAP repeat-containing protein 2","1","2L9M"
"2L9N",,"SOLUTION NMR",,,,,,,"10.1101/gad.623011",,"2L9N",28.96,,,"Structure of the human Shwachman-Bodian-Diamond syndrome (SBDS) protein","GSMSIFTPTNQIRLTNVAVVRMKRAGKRFEIACYKNKVVGWRSGVEKDLDEVLQTHSVFVNVSKGQVAKKEDLISAFGTDDQTEICKQILTKGEVQVSDKERHTQLEQMFRDIATIVADKCVNPETKRPYTVILIERAMKDIHYSVKTNKSTKQQALEVIKQLKEKMKIERAHMRLRFILPVNEGKKLKEKLKPLIKVIESEDYGQQLEIVCLIDPGCFREIDELIKKETKGKGSLEVLNLKDVEEGDEKFE","Homo sapiens","CGI-97, SBDS","Ribosome maturation protein SBDS","1","2L9N"
"2L9R",,"SOLUTION NMR",,,,,,,,,"2L9R",8.37,,,"Solution NMR Structure of Homeobox domain of Homeobox protein Nkx-3.1 from homo sapiens, Northeast Structural Genomics Consortium Target HR6470A","MGHHHHHHSHMSHTQVIELERKFSHQKYLSAPERAHLAKNLKLTETQVKIWFQNRRYKTKRKQLSSELG","Homo sapiens","NKX3-1, NKX3.1, NKX3A","Homeobox protein Nkx-3.1","1","2L9R"
"2L9U",,"SOLUTION NMR",,,,,,,"10.1016/j.bbamem.2011.04.017",,"2L9U",9.41,,,"Spatial structure of dimeric ErbB3 transmembrane domain","MGRTHLTMALTVIAGLVVIFMMLGGTFLYWRGRRHHHHHH","Homo sapiens","ERBB3, HER3","Receptor tyrosine-protein kinase erbB-3","1","2L9U"
"2L9V",,"SOLUTION NMR",,,,,,,"10.1021/ja203686t",,"2L9V",8.15,,,"NMR structure of the FF domain L24A mutant's folding transition state","SQPAKKTYTWNTKEEAKQAFKEALKEKRVPSNASWEQAMKMIINDPRYSALAKLSEKKQAFNAYKVQTEK","Homo sapiens","FBP11, FLAF1, FNBP3, HIP10, HSPC225, HYPA, PRPF40A","Pre-mRNA-processing factor 40 homolog A","1","2L9V"
"2L9Z",,"SOLUTION NMR",,,,,,,"10.1002/prot.23057",,"2L9Z",4.38,,,"Zinc knuckle in PRDM4","GSKENMATLFTIWCTLCDRAYPSDCPEHGPVTFVPDTPI","Homo sapiens","PRDM4, PFM1","PR domain zinc finger protein 4","1","2L9Z"
"2LA5",,"SOLUTION NMR",,,,,,,"10.1038/nsmb.2064",,"2LA5",13.56,,,"RNA Duplex-Quadruplex Junction Complex with FMRP RGG peptide","GCUGCGGUGUGGAAGGAGUGGCUGGGUUGCGCAGCG",,,"RNA (36-MER)","1","2LA5"
,,,,,,,,,,,,,,,,"GPRRGDGRRRGGGGRGQ","Homo sapiens","FMR1","Fragile X mental retardation 1 protein","2","2LA5"
"2LA6",,"SOLUTION NMR",,,,,,,,,"2LA6",10.97,,,"Solution NMR Structure of RRM domain of RNA-binding protein FUS from homo sapiens, Northeast Structural Genomics Consortium Target HR6430A","MGHHHHHHSHSDNNTIFVQGLGENVTIESVADYFKQIGIIKTNKKTGQPMINLYTDRETGKLKGEATVSFDDPPSAKAAIDWFDGKEFSGNPIKVSFAT","Homo sapiens","FUS, TLS","RNA-binding protein FUS","1","2LA6"
"2LAH",,"SOLUTION NMR",,,,,,,,,"2LAH",19.21,,,"Solution NMR Structure of Mitotic checkpoint serine/threonine-protein kinase BUB1 N-terminal domain from Homo sapiens, Northeast Structural Genomics Consortium Target HR5460A (Methods Development)","MGHHHHHHSHMDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTET","Homo sapiens","BUB1, BUB1L","Mitotic checkpoint serine/threonine-protein kinase BUB1","1","2LAH"
"2LAN",,"SOLUTION NMR",,,,,,,,,"2LAN",19.5,,,"NMR structure of Ca2+-bound CaBP1 N-domain with RDC","MGNCVKYPLRNLSRKDRSLRPEEIEELREAFREFDKDKDGYINCRDLGNCMRTMGYMPTEMELIELSQQINMNLGGHVDFDDFVELMGPKLLAETADMIGVKELRDAFREFDTNGDGEISTSELREAMRKLLGHQVGHRDIEEIIRDVDLNGDGRVDFEEFVRMMSR","Homo sapiens","CABP1","Calcium-binding protein 1","1","2LAN"
"2LAP",,"SOLUTION NMR",,,,,,,,,"2LAP",19.54,,,"NMR structure of Ca2+-bound CaBP1 C-domain with RDC","MGNCVKYPLRNLSRKDRSLRPEEIEELREAFREFDKDKDGYINCRDLGNCMRTMGYMPTEMELIELSQQINMNLGGHVDFDDFVELMGPKLLAETADMIGVKELRDAFREFDTNGDGEISTSELREAMRKLLGHQVGHRDIEEIIRDVDLNGDGRVDFEEFVRMMSR","Homo sapiens","CABP1","Calcium-binding protein 1","1","2LAP"
"2LAT",,"SOLUTION NMR",,,,,,,"10.1016/j.bbrc.2011.05.050",,"2LAT",4.2,,,"Solution structure of a Human minimembrane protein OST4","MITDVQLAIFANMLGVSLFLLVVLYHYVAVNNPKKQE","Homo sapiens","OST4","Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 4","1","2LAT"
"2LAU",,"SOLUTION NMR",,,,,,,,,"2LAU",9.19,,,"Solution structure of the THAP-zinc finger domain 1-81 from the cell growth suppressor human THAP11 protein","GSPGFTCCVPGCYNNSHRDKALHFYTFPKDAELRRLWLKNVSRAGVSGCFSTFQPTTGHRLCSVHFQGGRKTYTVRVPTIF","Homo sapiens","THAP11, HRIHFB2206","THAP domain-containing protein 11","1","2LAU"
"2LAV",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M110.200162",,"2LAV",41.42,,,"NMR solution structure of human Vaccinia-Related Kinase 1","MPRVKAAQAGRQSSAKRHLAEQFAVGEIITDMAKKEWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKEYKEDPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFPEKNKPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLDLSVVENGGLKAKTITKKRKKE","Homo sapiens","VRK1","Vaccinia-related kinase 1","1","2LAV"
"2LBC",,"SOLUTION NMR",,,,,,,"10.1371/journal.pone.0029362",,"2LBC",13.77,,,"solution structure of tandem UBA of USP13","DIDESSVMQLAEMGFPLEACRKAVYFTGNMGAEVAFNWIIVHMEEPDFAEPLTMPGYGGAASAGASVFGASGLDNQPPEEIVAIITSMGFQRNQAIQALRATNNNLERALDWIFSHPEFEEDSDFV","Homo sapiens","USP13, ISOT3","Ubiquitin carboxyl-terminal hydrolase 13","1","2LBC"
"2LBD",,"X-RAY DIFFRACTION",2.36,33,"VAPOR DIFFUSION, HANGING DROP",7,"VAPOR DIFFUSION METHOD, HANGING DROP TECHNIQUE 5UL PROTEIN SOLUTION + 5UL RESERVOIR AGAINST 500UL RESERVOIR, pH 7.0, vapor diffusion - hanging drop",,"10.1038/378681a0","REA","2LBD",30.49,"2.06","2.06","LIGAND-BINDING DOMAIN OF THE HUMAN RETINOIC ACID RECEPTOR GAMMA BOUND TO ALL-TRANS RETINOIC ACID","MGSSHHHHHHSSGLVPRGSHMDSYELSPQLEELITKVSKAHQETFPSLCQLGKYTTNSSADHRVQLDLGLWDKFSELATKCIIKIVEFAKRLPGFTGLSIADQITLLKAACLDILMLRICTRYTPEQDTMTFSDGLTLNRTQMHNAGFGPLTDLVFAFAGQLLPLEMDDTETGLLSAICLICGDRMDLEEPEKVDKLQEPLLEALRLYARRRRPSQPYMFPRMLMKITDLRGISTKGAERAITLKMEIPGPMPPLIREMLENPEMFE","Homo sapiens","HUMAN RAR GAMMA A CDNA (NUCLEOTIDES 946 - 1683), RARG, NR1B3","RETINOIC ACID RECEPTOR GAMMA","1","2LBD"
"2LBG",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M111.279364",,"2LBG",2.49,,,"Structure of the CHR of the Prion protein in DPC Micelles","KHMAGAAAAGAVVGGLGGYMLGSAMSR","Homo sapiens","PRNP, PRIP, PRP, ALTPRP","Major prion protein","1","2LBG"
"2LC3",,"SOLUTION NMR",,,,,,,,,"2LC3",10.08,,,"Solution NMR structure of a helical bundle domain from human E3 ligase HECTD1. Northeast structural genomics consortium (NESG) target HT6305A","MKDSDKEKENGKMGCWSIEHVEQYLGTDELPKNDLITYLQKNADAAFLRHWKLTGTNKSIRKNRNCSQLIAAYKDFCEHGTKSGLNQG","Homo sapiens","HECTD1, KIAA1131","E3 ubiquitin-protein ligase HECTD1","1","2LC3"
"2LCC",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M111.299149",,"2LCC",9.08,,,"Solution structure of RBBP1 chromobarrel domain","EDMEPCLTGTKVKVKYGRGKTQKIYEASIKSTEIDDGEVLYLVHYYGWNVRYDEWVKADRIIWPLDKGLEHHHHHH","Homo sapiens","ARID4A, RBBP1, RBP1","AT-rich interactive domain-containing protein 4A","1","2LCC"
"2LCE",,"SOLUTION NMR",,,,,,,,,"2LCE",8.77,,,"Chemical shift assignment of Hr4436B from Homo Sapiens, Northeast Structural Genomics Consortium","MGHHHHHHSHMTHSDKPYKCDRCQASFRYKGNLASHKTVHTGEKPYRCNICGAQFNRPANLKTHTRIHSGEKPY","Homo sapiens","BCL6, BCL5, LAZ3, ZBTB27, ZNF51","B-cell lymphoma 6 protein","1","2LCE"
"2LCF",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M111.227074",,"2LCF",19.93,,,"Solution structure of GppNHp-bound H-RasT35S mutant protein","GPLGSDMTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPSIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHQYREQIKRVKDSDDVPMVLVGNKCDLAARTVESRQAQDLARSYGIPYIETSAKTRQGVEDAFYTLVREIRQH","Homo sapiens","HRAS, HRAS1","GTPase HRas","1","2LCF"
"2LCM",,"SOLUTION NMR",,,,,,,,,"2LCM",3.35,,,"NMR structure of S3-4 peptide","KDINTIKSLRVLRVLRPLKTIKRLPKLK","Homo sapiens","CACNA1B, CACH5, CACNL1A5","Voltage-dependent N-type calcium channel subunit alpha-1B","1","2LCM"
"2LCP",,"SOLUTION NMR",,,,,,,"10.1016/j.jmb.2011.12.049",,"2LCP",22.02,,,"NMR structure of calcium loaded, un-myristoylated human NCS-1","MGKSNSKLKPEVVEELTRKTYFTEKEVQQWYKGFIKDCPSGQLDAAGFQKIYKQFFPFGDPTKFATFVFNVFDENKDGRIEFSEFIQALSVTSRGTLDEKLRWAFKLYDLDNDGYITRNEMLDIVDAIYQMVGNTVELPEEENTPEKRVDRIFAMMDKNADGKLTLQEFQEGSKADPSIVQALSLYDGLV","Homo sapiens","NCS1, FLUP, FREQ","Neuronal calcium sensor 1","1","2LCP"
"2LCR",,"SOLUTION NMR",,,,,,,"10.1021/bi300942x",,"2LCR",11.15,,,"NMR Structure of Alk1 extracellular domain","MTQGDPVKPSRGPLVTCTCESPHCKGPTCRGAWCTVVLVREEGRHPQEHRGCGNLHRELCRGRPTEFVNHYCCDSHLCNHNVSLVLEATQPPSEQPGTDGQ","Homo sapiens","ACVRL1, ACVRLK1, ALK1","Activin receptor-like kinase 1","1","2LCR"
"2LCW",,"SOLUTION NMR",,,,,,,,,"2LCW",12.82,,,"solution structure of FUS/TLS RRM domain","EQDNSDNNTIFVQGLGENVTIESVADYFKQIGIIKTNKKTGQPMINLYTDRETGKLKGEATVSFDDPPSAKAAIDWFDGKEFSGNPIKVSFATRRADFNRGGGNGRGGLEHHHHHH","Homo sapiens","FUS, TLS","RNA-binding protein FUS","1","2LCW"
"2LCX",,"SOLUTION NMR",,,,,,,"10.1016/j.bbamem.2012.05.001",,"2LCX",9.54,,,"Spatial Structure of the ErbB4 dimeric TM domain","STLPQHARTPLIAAGVIGGLFILVIVGLTFAVYVRRKSIKKKRA","Homo sapiens","ERBB4, HER4","Receptor tyrosine-protein kinase erbB-4","1","2LCX"
"2LD0",,"SOLUTION NMR",,,,,,,"10.1016/j.bpj.2013.06.030",,"2LD0",1.98,,,"Solution structure of the N-terminal domain of huntingtin (htt17) in 50 % TFE","MATLEKLMKAFESLKSFX","Homo sapiens","HTT, HD, IT15","Huntingtin","1","2LD0"
"2LD1",,"SOLUTION NMR",,,,,,,"10.1073/pnas.0704057104",,"2LD1",16.47,,,"Structures and chemical shift assignments for the ADD domain of the ATRX protein","GAMADKRGDGLHGIVSCTACGQQVNHFQKDSIYRHPSLQVLICKNCFKYYMSDDISRDSDGMDEQCRWCAEGGNLICCDFCHNAFCKKCILRNLGRKELSTIMDENNQWYCYICHPEPLLDLVTACNSVFENLEQLLQQNKK","Homo sapiens","ATRX, RAD54L, XH2","Transcriptional regulator ATRX","1","2LD1"
"2LD2",,"SOLUTION NMR",,,,,,,"10.1016/j.bpj.2013.06.030",,"2LD2",1.98,,,"Solution structure of the N-terminal domain of huntingtin (htt17) in presence of DPC micelles","MATLEKLMKAFESLKSFX","Homo sapiens","HTT, HD, IT15","Huntingtin","1","2LD2"
"2LD4",,"SOLUTION NMR",,,,,,,"10.1016/j.chembiol.2011.03.015",,"2LD4",18.93,,,"Solution structure of the N-terminal domain of human anamorsin","GSFTMADFGISAGQFVAVVWDKSSPVEALKGLVDKLQALTGNEGRVSVENIKQLLQSAHKESSFDIILSGLVPGSTTLHSAEILAEIARILRPGGCLFLKEPVETAVDNNSKVKTASKLCSALTLSGLVEVKELQREPLTPEEVQSVREHLGHESDNLLFVQITGKKPNFEVGSSR","Homo sapiens","CIAPIN1, CUA001, PRO0915","Anamorsin","1","2LD4"
"2LD9",,"SOLUTION NMR",,,,,,,,,"2LD9",8.63,,,"Backbone Structure of Ubiquitin determined using Backbone amide NOEs and Backbone N-H and N-C RDCs","GMQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGG","Homo sapiens","UBC","Ubiquitin","1","2LD9"
"2LDM",,"SOLUTION NMR",,,,,,,"10.1038/nsmb.2353",,"2LDM",9.07,,,"Solution structure of human PHF20 Tudor2 domain bound to a p53 segment containing a dimethyllysine analog p53K370me2","GHMSSEFQINEQVLASWSDSRFYPAKVTAVNKDGTYTVKFYDGVVQTVKHIHVKAFSKDQNIVGNARGSRAHSSHLKSKKG","Homo sapiens",,"Uncharacterized protein","1","2LDM"
"2LDR",,"SOLUTION NMR",,,,,,,"10.1073/pnas.1110712108",,"2LDR",9.4,,,"Solution structure of Helix-RING domain of Cbl-b in the Tyr363 phosphorylated form","GPHMGSDHIKVTQEQYELYCEMGSTFQLCKICAENDKDVKIEPCGHLMCTSCLTAWQESDGQGCPFCRCEIKGTEPIIVDPF","Homo sapiens","CBLB, RNF56, Nbla00127","E3 ubiquitin-protein ligase CBL-B","1","2LDR"
"2LDU",,"SOLUTION NMR",,,,,,,,,"2LDU",14.4,,,"Solution NMR Structure of Heat shock factor protein 1 DNA binding domain from homo sapiens, Northeast Structural Genomics Consortium Target HR3023C","MGHHHHHHSHMAGPSNVPAFLTKLWTLVSDPDTDALICWSPSGNSFHVFDQGQFAKEVLPKYFKHNNMASFVRQLNMYGFRKVVHIEQGGLVKPERDDTEFQHPCFLRGQEQLLENIKRKVTSVS","Homo sapiens","HSF1, HSF1_HUMAN, HSTF1","Heat shock factor protein 1","1","2LDU"
"2LDY",,"SOLUTION NMR",,,,,,,"10.1038/nsmb.2097",,"2LDY",21.52,,,"Solution structure of the RMM-CTD domains of human LINE-1 ORF1p","MGNLRLIGVPESDVENGTKLENTLQDIIQENFPNLARQANVQIQEIQRTPQRYSSRRATPRHIIVRFTKVEMKEKMLRAAREKGRVTLKGKPIRLTVDLSAETLQARREWGPIFNILKEKNFQPRISYPAKLSFISEGEIKYFIDKQMLRDFVTTRPALKELLKEALNMERNNRYQHHHHHH","Homo sapiens","L1RE1, LRE1","ORF1 codes for a 40 kDa product","1","2LDY"
"2LE3",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M111.306951",,"2LE3",4.8,,,"N-terminal regulatory segment of carnitine palmitoyltransferase 1A","MAEAHQAVAFQFTVTPDGIDLRLSHEALRQIYLSGLHSWKKK","Homo sapiens","CPT1A, CPT1","Carnitine O-palmitoyltransferase 1, liver isoform","1","2LE3"
"2LE4",,"SOLUTION NMR",,,,,,,,,"2LE4",9.92,,,"Solution structure of the HMG box DNA-binding domain of human stem cell transcription factor Sox2","SDRVKRPMNAFMVWSRGQRRKMAQENPKMHNSEISKRLGAEWKLLSETEKRPFIDEAKRLRALHMKEHPDYKYRPRRKTKT","Homo sapiens","SOX2","Transcription factor SOX-2","1","2LE4"
"2LE7",,"SOLUTION NMR",,,,,,,"10.1371/journal.pone.0031640",,"2LE7",2.33,,,"Solution nmr structure of the S4S5 linker of herg potassium channel","LVRVARKLDRYSEYGAAVLF","Homo sapiens","KCNH2, ERG, ERG1, HERG","Potassium voltage-gated channel subfamily H member 2","1","2LE7"
"2LEA",,"SOLUTION NMR",,,,,,,"10.1038/emboj.2011.367",,"2LEA",15.26,,,"Solution structure of human SRSF2 (SC35) RRM","MGSSHHHHHHSSGLVPRGSHMASMTGGQQMGRGSMSYGRPPPDVEGMTSLKVDNLTYRTSPDTLRRVFEKYGRVGDVYIPRDRYTKESRGFAFVRFHDKRDAEDAMDAMDGAVLDGRELRVQMARYGRPPDSHHS","Homo sapiens","SFRS2, SRSF2","Serine/arginine-rich splicing factor 2","1","2LEA"
"2LEB",,"SOLUTION NMR",,,,,,,"10.1038/emboj.2011.367",,"2LEB",17.11,,,"Solution structure of human SRSF2 (SC35) RRM in complex with 5'-UCCAGU-3'","MGSSHHHHHHSSGLVPRGSHMASMTGGQQMGRGSMSYGRPPPDVEGMTSLKVDNLTYRTSPDTLRRVFEKYGRVGDVYIPRDRYTKESRGFAFVRFHDKRDAEDAMDAMDGAVLDGRELRVQMARYGRPPDSHHS","Homo sapiens","SFRS2, SRSF2","Serine/arginine-rich splicing factor 2","1","2LEB"
,,,,,,,,,,,,,,,,"UCCAGU",,,"RNA (5'-R(*UP*CP*CP*AP*GP*U)-3')","2","2LEB"
"2LEC",,"SOLUTION NMR",,,,,,,"10.1038/emboj.2011.367",,"2LEC",17.19,,,"Solution structure of human SRSF2 (SC35) RRM in complex with 5'-UGGAGU-3'","MGSSHHHHHHSSGLVPRGSHMASMTGGQQMGRGSMSYGRPPPDVEGMTSLKVDNLTYRTSPDTLRRVFEKYGRVGDVYIPRDRYTKESRGFAFVRFHDKRDAEDAMDAMDGAVLDGRELRVQMARYGRPPDSHHS","Homo sapiens","SFRS2, SRSF2","Serine/arginine-rich splicing factor 2","1","2LEC"
,,,,,,,,,,,,,,,,"UGGAGU",,,"RNA (5'-R(*UP*GP*GP*AP*GP*U)-3')","2","2LEC"
"2LEJ",,"SOLUTION NMR",,,,,,,"10.1016/j.jmb.2011.07.067",,"2LEJ",16.65,,,"human prion protein mutant HuPrP(90-231, M129, V210I)","GAMDPGQGGGTHSQWNKPSKPKTNMKHMAGAAAAGAVVGGLGGYMLGSAMSRPIIHFGSDYEDRYYRENMHRYPNQVYYRPMDEYSNQNNFVHDCVNITIKQHTVTTTTKGENFTETDVKMMERVIEQMCITQYERESQAYYQRGSS","Homo sapiens","PRNP, PRIP, PRP, ALTPRP","Major prion protein","1","2LEJ"
"2LEN",,"SOLUTION NMR",,,,,,,,,"2LEN",26,,,"Solution structure of UCHL1 S18Y variant","MQLKPMEINPEMLNKVLYRLGVAGQWRFVDVLGLEEESLGSVPAPACALLLLFPLTAQHENFRKKQIEELKGQEVSPKVYFMKQTIGNSCGTIGLIHAVANNQDKLGFEDGSVLKQFLSETEKMSPEDRAKCFEKNEAIQAAHDAVAQEGQCRVDDKVNFHFILFNNVDGHLYELDGRMPFPVNHGASSEDTLLKDAAKVCREFTEREQGEVRFSAVALCKAALEHHHHHH","Homo sapiens","UCHL1","Ubiquitin carboxyl-terminal hydrolase isozyme L1","1","2LEN"
"2LEO",,"SOLUTION NMR",,,,,,,"10.1007/s10858-012-9622-9",,"2LEO",7.21,,,"Solution structure of esophageal cancer-related gene 2","SEAASLSPKKVDCSIYKKYPVVAIPCPITYLPVCGSDYITYGNECHLCTESLKSNGRVQFLHDGSC","Homo sapiens","SPINK7, ECG2, UNQ745/PRO1474","Serine protease inhibitor Kazal-type 7","1","2LEO"
"2LFE",,"SOLUTION NMR",,,,,,,,,"2LFE",15.95,,,"Solution NMR structure of N-terminal domain of human E3 ubiquitin-protein ligase HECW2, Northeast structural genomics consortium (NESG) target ht6306A","MHHHHHHSSQRENLYFQGLQRANSDTDLVTSESRSSLTASMYEYTLGQAQNLIIFWDIKEEVDPSDWIGLYHIDENSPANFWDSKNRGVTGTQKGQIVWRIEPGPYFMEPEIKICFKYYHGISGALRATTPCITVKNP","Homo sapiens","HECW2, KIAA1301, NEDL2","E3 ubiquitin-protein ligase HECW2","1","2LFE"
"2LFG",,"SOLUTION NMR",,,,,,,"10.1016/j.str.2011.12.010",,"2LFG",13.34,,,"Solution structure of the human prolactin receptor ecd domain d2","MYIVQPDPPLELAVEVKQPEDRKPYLWIKWSPPTLIDLKTGWFTLLYEIRLKPEKAAEWEIHFAGQQTEFKILSLHPGQKYLVQVRCKPDHGYWSAWSPATFIQIPSDFTMND","Homo sapiens","PRLR","Prolactin receptor","1","2LFG"
"2LFH",,"SOLUTION NMR",,,,,,,,,"2LFH",15.28,,,"Solution NMR Structure of the Helix-loop-Helix Domain of Human ID3 Protein, Northeast Structural Genomics Consortium Target HR3111A","MGHHHHHHSHMGGGKGPAAEEPLSLLDDMNHCYSRLRELVPGVPRGTQLSQVEILQRVIDYILDLQVV","Homo sapiens","1R21, BHLHB25, HEIR1, ID3","DNA-binding protein inhibitor ID-3","1","2LFH"
"2LFM",,"SOLUTION NMR",,,,,,,"10.1016/j.bbrc.2011.06.133",,"2LFM",4.34,,,"A partially folded structure of amyloid-beta(1 40) in an aqueous environment","DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVV","Homo sapiens","APP, A4, AD1","Beta-amyloid protein 40","1","2LFM"
"2LFT",,"SOLUTION NMR",,,,,,,"10.1042/BJ20111940",,"2LFT",16.17,,,"Human prion protein with E219K protective polymorphism","GQGGGTHSQWNKPSKPKTNMKHMAGAAAAGAVVGGLGGYMLGSAMSRPIIHFGSDYEDRYYRENMHRYPNQVYYRPMDEYSNQNNFVHDCVNITIKQHTVTTTTKGENFTETDVKMMERVVEQMCITQYKRESQAYYQRGSS","Homo sapiens","PRNP, PRIP, PRP, ALTPRP","Major prion protein","1","2LFT"
"2LG1",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M114.561787",,"2LG1",21.06,,,"Solution structure of the human AKAP13 PH domain and stabilizing DH helix","SMTKDNEVEQEDLAQSLSLVKDVIGAVDSKVASYEKKVRLNEIYTKTDSKSIMRMKSGQMFAKEDLKRKKLVRDGSVFLKNAAGRLKEVQAVLLTDILVFLQEKDQKYIFASLDQKSTVISLKKLIVREVAHEEKGLFLISMGMTDPEMVEVHASSKEERNSWIQIIQDTINTLNRDEDEGIPSE","Homo sapiens","AKAP13, BRX, HT31, LBC","A-kinase anchor protein 13","1","2LG1"
"2LGB",,"SOLUTION NMR",,,,,,,"10.1007/s10858-012-9612-y",,"2LGB",6.03,,,"Modified A22Gly-B31Arg Human Insulin","GIVEQCCTSICSLYQLENYCNG","Homo sapiens","INS","Insulin A chain","1","2LGB"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFYTPKTR","Homo sapiens","INS","Insulin B chain","2","2LGB"
"2LGC",,"SOLUTION NMR",,,,,,,"10.1002/anie.201105241",,"2LGC",41.21,,,"Joint NMR and X-ray refinement reveals the structure of a novel dibenzo[a,d]cycloheptenone inhibitor/p38 MAP kinase complex in solution","SHMLEMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLD","Homo sapiens","MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2, SAPK2A","Mitogen-activated protein kinase 14","1","2LGC"
"2LGD",,"SOLUTION NMR",,,,,,,,,"2LGD",9.14,,,"The high resolution structure of ubiquitin like domain of UBLCP1","GSMALPIIVKWGGQEYSVTTLSEDDTVLDLKQFLKTLTGVLPERQKLLGLKVKGKPAENDVKLGALKLKPNTKIMMMGTREES","Homo sapiens","UBLCP1","Ubiquitin-like domain-containing CTD phosphatase 1","1","2LGD"
"2LGG",,"SOLUTION NMR",,,,,,,"10.1038/cr.2011.123",,"2LGG",9.35,,,"Structure of PHD domain of UHRF1 in complex with H3 peptide","SGPSCKHCKDDVNRLCRVCACHLCGGRQDPDKQLMCDECDMAFHIYCLDPPLSSVPSEDEWYCPECRND","Homo sapiens","UHRF1, ICBP90, NP95, RNF106","E3 ubiquitin-protein ligase UHRF1","1","2LGG"
,,,,,,,,,,,,,,,,"ARTKQTARKSTG",,,"histone H3 peptide","2","2LGG"
"2LGK",,"SOLUTION NMR",,,,,,,"10.1038/cr.2011.123",,"2LGK",9.4,,,"NMR Structure of UHRF1 PHD domains in a complex with histone H3 peptide","SGPSCKHCKDDVNRLCRVCACHLCGGRQDPDKQLMCDECDMAFHIYCLDPPLSSVPSEDEWYCPECRND","Homo sapiens","UHRF1, ICBP90, NP95, RNF106","E3 ubiquitin-protein ligase UHRF1","1","2LGK"
,,,,,,,,,,,,,,,,"ARTKQTARKSTG",,,"histone H3 peptide","2","2LGK"
"2LGL",,"SOLUTION NMR",,,,,,,"10.1038/cr.2011.123",,"2LGL",8.05,,,"NMR structure of the UHRF1 PHD domain","SGPSCKHCKDDVNRLCRVCACHLCGGRQDPDKQLMCDECDMAFHIYCLDPPLSSVPSEDEWYCPECRND","Homo sapiens","UHRF1, ICBP90, NP95, RNF106","E3 ubiquitin-protein ligase UHRF1","1","2LGL"
"2LGP",,"SOLUTION NMR",,,,,,,"10.1021/bi2014486",,"2LGP",10.25,,,"Solution structure of LA45 from LDLR","GSPVLTCGPASFQCNSSTCIPQLWACDNDPDCEDGSDEWPQRCRGLYVFQGDSSPCSAFEFHCLSGECIHSSWRCDGGPDCKDKSDEENCAVAT","Homo sapiens","LDLR","Low-density lipoprotein receptor","1","2LGP"
"2LGQ",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M111.246223",,"2LGQ",7.29,,,"Human C30S/C59S-Cox17 mutant","GSFTMPGLVDSNPAPPESQEKKPLKPCCASPETKKARDACIIEKGEEHCGHLIEAHKESMRALGFKI","Homo sapiens","COX17","Cytochrome c oxidase copper chaperone","1","2LGQ"
"2LGR",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M111.276238",,"2LGR",18.05,,,"Solution structure of human protein C6orf130, a putative macro domain","GHHHHHHLEASSLNEDPEGSRITYVKGDLFACPKTDSLAHCISEDCRMGAGIAVLFKKKFGGVQELLNQQKKSGEVAVLKRDGRYIYYLITKKRASHKPTYENLQKSLEAMKSHCLKNGVTDLSMPRIGCGLDRLQWENVSAMIEEVFEATDIKITVYTL","Homo sapiens","BC011709.2, C6orf130, OARD1, TARG1","Uncharacterized protein C6orf130","1","2LGR"
"2LGT",,"SOLUTION NMR",,,,,,,"10.1093/nar/gks192",,"2LGT",16.08,,,"Backbone 1H, 13C, and 15N Chemical Shift Assignments for QFM(Y)F","MADDPSAADRNVEIWKIKKLIKSLEAARGNGTSMISLIIPPKDQISRVAKMLADEFGTASNIKSRVNRLSVLGAITSVQQRLKLYNKVPPNGLVVYCGTIVTEEGKEKKVNIDFEPFKPINQFMYFCDNKFHTEALTALLSDLE","Homo sapiens","ETF1, ERF1, RF1, SUP45L1","Eukaryotic peptide chain release factor subunit 1","1","2LGT"
"2LGV",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M112.353748",,"2LGV",11.37,,,"Rbx1","GGGGTNSGAGKKRFEVKKSNASAQSAWDIVVDNCAICRNHIMDLCIECQANQASATSEECTVAWGVCNHAFHFHCISRWLKTRQVCPLDNREWEFQKYGH","Homo sapiens","RBX1, RNF75, ROC1","E3 ubiquitin-protein ligase RBX1","1","2LGV"
"2LGW",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M111.294728",,"2LGW",11.3,,,"Solution Structure of the J Domain of HSJ1a","MASYYEILDVPRSASADDIKKAYRRKALQWHPDKNPDNKEFAEKKFKEVAEAYEVLSDKHKREIYDRYGREGLTGTGTGPSRAEAGSGGPGLEHHHHHH","Homo sapiens","DNAJB2, HSJ1, HSPF3","DnaJ homolog subfamily B member 2","1","2LGW"
"2LGX",,"SOLUTION NMR",,,,,,,"10.1016/j.str.2011.08.012",,"2LGX",12.99,,,"NMR structure for Kindle-2 N-terminus","GAMPDEFMALDGIRMPDGCYADGTWELSVHVTDVNRDVTLRVTGEVHIGGVMLKLVEKLDVKKDWSDHALWWEKKRTWLLKTHWTLDKYGIQADAKLQFTPQHKLLRLQLPN","Homo sapiens","FERMT2, KIND2, MIG2, PLEKHC1","Fermitin family homolog 2","1","2LGX"
"2LGY",,"SOLUTION NMR",,,,,,,"10.1002/pro.2080",,"2LGY",10.35,,,"Ubiquitin-like domain from HOIL-1","MPTQDIRLWVSVEDAQMHTVTIWLTVRPDMTVASLKDMVFLDYGFPPVLQQWVIGQRLARDQETLHSHGVRQNGDSAYLYLLSARNTSLN","Homo sapiens","RBCK1, C20orf18, RNF54, UBCE7IP3, XAP3, XAP4","RanBP-type and C3HC4-type zinc finger-containing protein 1","1","2LGY"
"2LHA",,"SOLUTION NMR",,,,,,,"10.1021/bi300005w","IHP","2LHA",18.01,,,"Solution structure of C2B with IP6","QEKLGDICFSLRYVPTAGKLTVVILEAKNLKKMDVGGLSDPYVKIHLMQNGKRLKKKKTTIKKNTLNPYYNESFSFEVPFEQIQKVQVVVTVLDYDKIGKNDAIGKVFVGYNSTGAELRHWSDMLANPRRPIAQWHTLQVEEEVDAMLAVKK","Homo sapiens","SYT1, SVP65, SYT","Synaptotagmin-1","1","2LHA"
"2LHL",,"SOLUTION NMR",,,,,,,,,"2LHL",20.85,,,"Chemical Shift Assignments and solution structure of human apo-S100A1 E32Q mutant","GSELETAMETLINVFHAHSGKEGDKYKLSKKQLKELLQTELSGFLDAQKDVDAVDKVMKELDENGDGEVDFQEYVVLVAALTVACNNFFWENS","Homo sapiens","S100A1, S100A","Protein S100-A1","1","2LHL"
"2LHM",,"X-RAY DIFFRACTION",1.98,37.93,,,,,,,"2LHM",14.75,"1.8","1.8","CRYSTAL STRUCTURES OF THE APO-AND HOLOMUTANT HUMAN LYSOZYMES WITH AN INTRODUCED CA2+ BINDING SITE","KVFERCELARTLKRLGMDGYRGISLANWMCLAKWESGYNTRATNYNAGDRSTDYGIFQINSRYWCNDGKTPGAVNACHLSCSALLDDNIADDVACAKRVVRDPQGIRAWVAWRNRCQNRDVRQYVQGCGV","Homo sapiens","LYZ, LZM","HUMAN LYSOZYME","1","2LHM"
"2LI8",,"SOLUTION NMR",,,,,,,"10.1038/nsmb.2202",,"2LI8",10.45,,,"The solution structure of the Lin28-ZnF domains bound to AGGAGAU of pre-let-7 miRNA","SSGLVPRGSHMPKGKSMQKRRSKGDRCYNCGGLDHHAKECKLPPQPKKCHFCQSISHMVASCPLKAQQGPSAQG","Homo sapiens","CSDD1, Lin-28a, LIN28, LIN28A, ZCCHC1","Protein lin-28 homolog A","1","2LI8"
,,,,,,,,,,,,,,,,"AGGAGAU",,,"RNA (5'-R(*AP*GP*GP*AP*GP*AP*U)-3')","2","2LI8"
"2LJ0",,"SOLUTION NMR",,,,,,,,,"2LJ0",7.58,,,"The third SH3 domain of R85FL","QTSQDLFSYQALYSYIPQNDDELELRDGDIVDVMEKCDDGWFVGTSRRTKQFGTFPGNYVKPLYL","Homo sapiens","SORBS1, KIAA0894, KIAA1296, SH3D5","Sorbin and SH3 domain-containing protein 1","1","2LJ0"
"2LJ1",,"SOLUTION NMR",,,,,,,,,"2LJ1",7.47,,,"The third SH3 domain of R85FL with ataxin-7 PRR","QTSQDLFSYQALYSYIPQNDDELELRDGDIVDVMEKCDDGWFVGTSRRTKQFGTFPGNYVKPLY","Homo sapiens","SORBS1, KIAA0894, KIAA1296, SH3D5","Sorbin and SH3 domain-containing protein 1","1","2LJ1"
"2LJ5",,"SOLUTION NMR",,,,,,,"10.1007/s10858-012-9644-3",,"2LJ5",8.58,,,"Description of the Structural fluctuations of proteins from structure-based calculations of Residual dipolar couplings","MQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGG","Homo sapiens","UBA52, UBCEP2, RPS27A, UBA80, UBCEP1, UBB, UBC","Ubiquitin","1","2LJ5"
"2LJD",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M111.231951",,"2LJD",7.84,,,"monophosphorylated (747pY) beta3 integrin cytoplasmic tail under membrane mimetic conditions","GSSHHHHHHSSGLVPRGSHMKLLITIHDRKEFAKFEEERARAKWDTANNPLYKEATSTFTNITYRGT","Homo sapiens","ITGB3, GP3A","Integrin beta-3","1","2LJD"
"2LJE",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M111.231951",,"2LJE",7.92,,,"Biphosphorylated (747pY, 759pY) beta3 integrin cytoplasmic tail under membrane mimetic conditions","GSSHHHHHHSSGLVPRGSHMKLLITIHDRKEFAKFEEERARAKWDTANNPLYKEATSTFTNITYRGT","Homo sapiens","ITGB3, GP3A","Integrin beta-3","1","2LJE"
"2LJF",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M111.231951",,"2LJF",7.84,,,"Monophosphorylated (747pY) beta3 integrin cytoplasmic tail under aqueous conditions","GSSHHHHHHSSGLVPRGSHMKLLITIHDRKEFAKFEEERARAKWDTANNPLYKEATSTFTNITYRGT","Homo sapiens","ITGB3, GP3A","Integrin beta-3","1","2LJF"
"2LJK",,"SOLUTION NMR",,,,,,,,,"2LJK",12.56,,,"Solution structure of the oncogenic-potential MIEN1 protein","GSMSGEPGQTSVAPPPEEVEPGSGVRIVVEYCEPCGFEATYLELASAVKEQYPGIEIESRLGGTGAFEIEINGQLVFSKLENGGFPYEKDLIEAIRRASNGETLEKITNSRPPCVIL","Homo sapiens","C17orf37, MIEN1, XTP4, RDX12","Protein C17orf37","1","2LJK"
"2LJR",,"X-RAY DIFFRACTION",2.76,55.48,,,,,"10.1016/s0969-2126(98)00034-3",,"2LJR",55.08,"3.2","3.2","GLUTATHIONE TRANSFERASE APO-FORM FROM HUMAN","MGLELFLDLVSQPSRAVYIFAKKNGIPLELRTVDLVKGQHKSKEFLQINSLGKLPTLKDGDFILTESSAILIYLSCKYQTPDHWYPSDLQARARVHEYLGWHADCIRGTFGIPLWVQVLGPLIGVQVPEEKVERNRTAMDQALQWLEDKFLGDRPFLAGQQVTLADLMALEELMQPVALGYELFEGRPRLAAWRGRVEAFLGAELCQEAHSIILSILEQAAKKTLPTPSPEAYQAMLLRIARIP","Homo sapiens","GSTT2B, GSTT2","GLUTATHIONE S-TRANSFERASE","1","2LJR"
"2LK0",,"SOLUTION NMR",,,,,,,"10.1002/cbic.201100582",,"2LK0",3.8,,,"Solution structure and binding studies of the RanBP2-type zinc finger of RBM5","XKFEDWLCNKCCLNNFRKRLKCFRCGADKFDX","Homo sapiens","RBM5, H37, LUCA15","RNA-binding protein 5","1","2LK0"
"2LK1",,"SOLUTION NMR",,,,,,,"10.1002/cbic.201100582","AQN","2LK1",4.09,,,"Solution structure and binding studies of the RanBP2-type zinc finger of RBM5","XKFEDWLCNKCCLNNFRKRLKCFRCGADKFDX","Homo sapiens","RBM5, H37, LUCA15","RNA-binding protein 5","1","2LK1"
"2LK2",,"SOLUTION NMR",,,,,,,,,"2LK2",10.69,,,"Solution NMR structure of homeobox domain (171-248) of human homeobox protein TGIF1, Northeast Structural Genomics Consortium Target HR4411B","MGHHHHHHSHMLPKESVQILRDWLYEHRYNAYPSEQEKALLSQQTHLSTLQVCNWFINARRRLLPDMLRKDGKDPNQFTISRRGAKISE","Homo sapiens","TGIF1, TGIF","Homeobox protein TGIF1","1","2LK2"
"2LK4",,"SOLUTION NMR",,,,,,,"10.1016/j.jmb.2014.08.014",,"2LK4",14.82,,,"Structural and mechanistic insights into the interaction between PAT Pyk2 and Paxillin LD motif","ANLDRTDDLVYLNVMELVRAVLELKNELSQLPPEGYVVVVKNVGLTLRKLIGSVDDLLPSLPSSSRTEIEGTQKLLNKDLAELINKMRLAQQNAVTSLSEEAKRQMLTASHTLAVDAKNLLDAVDQAKVLANLAH","Homo sapiens","PTK2B, FAK2, PYK2, RAFTK","Protein-tyrosine kinase 2-beta","1","2LK4"
"2LK9",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M111.296772",,"2LK9",3.92,,,"Structure of BST-2/Tetherin Transmembrane Domain","KRSKLLLGIGILVLLIIVILGVPLIIFTIKKKKKK","Homo sapiens","BST2","Bone marrow stromal antigen 2","1","2LK9"
"2LKE",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M111.280164",,"2LKE",2.7,,,"Structures and Interaction Analyses of the Integrin Alpha-M Beta-2 Cytoplasmic Tails","KLGFFKRQYKDMMSEGGPPGAEPQ","Homo sapiens","ITGAM, CD11B, CR3A","Integrin alpha-M","1","2LKE"
"2LKJ",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M111.280164",,"2LKJ",2.78,,,"Structures and Interaction Analyses of the Integrin Alpha-M Beta-2 Cytoplasmic Tails","KLGFFKRQYKDMMSEGGPPGAEPQ","Homo sapiens","ITGAM, CD11B, CR3A","Integrin alpha-M","1","2LKJ"
"2LKK",,"SOLUTION NMR",,,,,,,"10.1016/j.bpj.2012.04.039","OLA","2LKK",14.66,,,"Human L-FABP in complex with oleate","SFSGKYQLQSQENFEAFMKAIGLPEELIQKGKDIKGVSEIVQNGKHFKFTITAGSKVIQNEFTVGEECELETMTGEKVKTVVQLEGDNKLVTTFKNIKSVTELNGDIITNTMTLGDIVFKRISKRI","Homo sapiens","FABP1, FABPL","Fatty acid-binding protein, liver","1","2LKK"
"2LKN",,"SOLUTION NMR",,,,,,,"10.1021/bi301649m",,"2LKN",18.68,,,"Solution structure of the PPIase domain of human aryl-hydrocarbon receptor-interacting protein (AIP)","ADIIARLREDGIQKRVIQEGRGELPDFQDGTKATFHYRTLHSDDEGTVLDDSRARGKPMELIIGKKFKLPVWETIVCTMREGEIAQFLCDIKHVVLYPLVAKSLRNIAVGKDPLEGQRHCCGVAQMREHSSLGHADLDALQQNPQPLIFHMEMLKVESPGTYQQD","Homo sapiens","AIP, XAP2","AH receptor-interacting protein","1","2LKN"
"2LKO",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M111.295352","4IP","2LKO",16.22,,,"Structural Basis of Phosphoinositide Binding to Kindlin-2 Pleckstrin Homology Domain in Regulating Integrin Activation","GSHMGDITSIPELADYIKVFKPKKLTLKGYKQYWCTFKDTSISCYKSKEESSGTPAHQMNLRGCEVTPDVNISGQKFNIKLLIPVAEGMNEIWLRCDNEKQYAHWMAACRLASKGKTMADSSYNLEVQNILSFLKMQH","Homo sapiens","FERMT2, KIND2, MIG2, PLEKHC1","Fermitin family homolog 2","1","2LKO"
"2LKQ",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M112.395152",,"2LKQ",2.86,,,"NMR structure of the lambda 5 22-45 peptide","SRSSLRSRWGRFLLQRGSWTGPRC","Homo sapiens","IGLL1, IGL1","Immunoglobulin lambda-like polypeptide 1","1","2LKQ"
"2LKS",,"SOLUTION NMR",,,,,,,"10.1021/jp209974f",,"2LKS",5.78,,,"Ff11-60","GNTKEEAKQAFKELLKEKRVPSNASWEQAMKMIINDPRYSALAKLSEKKQ","Homo sapiens","FBP11, FLAF1, FNBP3, HIP10, HSPC225, HYPA, Hypa/FBP11, PRPF40A","Pre-mRNA-processing factor 40 homolog A","1","2LKS"
"2LKT",,"SOLUTION NMR",,,,,,,"10.1007/s12104-012-9357-2",,"2LKT",14.05,,,"Solution structure of N-terminal domain of human TIG3 in 2 M UREA","MASPHQEPKPGDLIEIFRLGYEHWALYIGDGYVIHLAPPSEYPGAGSSSVFSVLSNSAEVKRERLEDVVGGCCYRVNNSLDHEYQPRPVEVIISSAKEMVGQKMKYSIVSRNCEHFVTQLRYGKS","Homo sapiens","TIG3, PLAAT4, RARRES3, RIG1","Retinoic acid receptor responder protein 3","1","2LKT"
"2LKX",,"SOLUTION NMR",,,,,,,"10.1021/bi0473253","DNA","2LKX",16.43,,,"NMR structure of the homeodomain of Pitx2 in complex with a TAATCC DNA binding site","GSQRRQRTHFTSQQLQELEATFQRNRYPDMSTREEIAVWTNLTEARVRVWFKNRRAKWRKREEFIVTD","Homo sapiens","PITX3, PTX3, PITX2, ARP1, RGS, RIEG, RIEG1","Pituitary homeobox 3","1","2LKX"
,,,,,,,,,,,,,,,,"CGGGGATTAGAGC",,,"DNA (5'-D(*CP*GP*GP*GP*GP*AP*TP*TP*AP*GP*AP*GP*C)-3')","3","2LKX"
,,,,,,,,,,,,,,,,"GCTCTAATCCCCG",,,"DNA (5'-D(*GP*CP*TP*CP*TP*AP*AP*TP*CP*CP*CP*CP*G)-3')","2","2LKX"
"2LKZ",,"SOLUTION NMR",,,,,,,"10.1021/bi300539t",,"2LKZ",10.52,,,"Solution structure of the second RRM domain of RBM5","MGHHHHHHMDTIILRNIAPHTVVDSIMTALSPYASLAVNNIRLIKDKQTQQNRGFAFVQLSSAMDASQLLQILQSLHPPLKIDGKTIGVDFAKSA","Homo sapiens","RBM5, H37, LUCA15","RNA-binding protein 5","1","2LKZ"
"2LL2",,"SOLUTION NMR",,,,,,,"10.1021/bi201806j",,"2LL2",2.72,,,"Structure of the Cx43 C-terminal domain bound to tubulin","KGVKDRVKGKSDPYHATSGALSPAKD","Homo sapiens","GJA1, GJAL","Gap junction alpha-1 protein","1","2LL2"
"2LLH",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M112.371013",,"2LLH",8.51,,,"NMR structure of Npm1_c70","GSHMQESFKKQEKTPKTPKGPSSVEDIKAKMQASIEKGGSLPKVEAKFINYVKNCFRMTDQEAIQDLWQWRKSL","Homo sapiens","NPM1, NPM","Nucleophosmin","1","2LLH"
"2LLK",,"SOLUTION NMR",,,,,,,,,"2LLK",8.38,,,"Solution NMR structure of the N-terminal myb-like 1 domain of the human cyclin-D-binding transcription factor 1 (hDMP1), Northeast Structural Genomics Consortium (NESG) target ID hr8011a","MHHHHHHSSGRENLYFQGDRNHVGKYTPEEIEKLKELRIKHGNDWATIGAALGRSASSVKDRCRLMKDTCNTG","Homo sapiens","DMTF1, DMP1","Cyclin-D-binding Myb-like transcription factor 1","1","2LLK"
"2LLL",,"SOLUTION NMR",,,,,,,,,"2LLL",15.48,,,"Solution NMR structure of C-terminal globular domain of human Lamin-B2, Northeast Structural Genomics Consortium target HR8546A","MHHHHHHSSGRENLYFQGSASGSVSIEEIDLEGKFVQLKNNSDKDQSLGNWRIKRQVLEGEEIAYKFTPKYILRAGQMVTVWAAGAGVAHSPPSTLVWKGQSSWGTGESFRTVLVNADGEEVAMRTVKKSSVMRENENG","Homo sapiens","LMNB2, LMN2","Lamin-B2","1","2LLL"
"2LLM",,"SOLUTION NMR",,,,,,,,,"2LLM",4.45,,,"Structure of amyloid precursor protein's transmembrane domain","GSQKLVFFAEDVGSNKGAIIGLMVGGVVIATVIVITLVMLKKK","Homo sapiens","APP, A4, AD1","Amyloid beta A4 protein","1","2LLM"
"2LLP",,"SOLUTION NMR",,,,,,,"10.1021/ja208338j",,"2LLP",4.97,,,"Solution structure of a THP type 1 alpha 1 collagen fragment (772-786)","PPGPQGIAGQRGVVGLPG","Homo sapiens","COL1A1","Collagen alpha-1(I) chain","1","2LLP"
"2LLS",,"SOLUTION NMR",,,,,,,,,"2LLS",20.91,,,"solution structure of human apo-S100A1 C85M","GSELETAMETLINVFHAHSGKEGDKYKLSKKELKELLQTELSGFLDAQKDVDAVDKVMKELDENGDGEVDFQEYVVLVAALTVAMNNFFWENS","Homo sapiens","S100A1, S100A","Protein S100-A1","1","2LLS"
"2LLT",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M112.418392",,"2LLT",20.91,,,"Post-translational S-nitrosylation is an endogenous factor fine-tuning human S100A1 protein properties","GSELETAMETLINVFHAHSGKEGDKYKLSKKELKELLQTELSGFLDAQKDVDAVDKVMKELDENGDGEVDFQEYVVLVAALTVACNNFFWENS","Homo sapiens","S100A1, S100A","Protein S100-A1","1","2LLT"
"2LLU",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M112.418392",,"2LLU",20.85,,,"Post-translational S-nitrosylation is an endogenous factor fine-tuning human S100A1 protein properties","GSELETAMETLINVFHAHSGKEGDKYKLSKKELKELLQTELSGFLDAQKDVDAVDKVMKELDENGDGEVDFQEYVVLVAALTVACNNFFWENS","Homo sapiens","S100A1, S100A","Protein S100-A1","1","2LLU"
"2LLX",,"SOLUTION NMR",,,,,,,"10.1002/pro.2067",,"2LLX",16.77,,,"Solution structure of the N-terminal domain of human polypeptide chain release factor eRF1","MADDPSAADRNVEIWKIKKLIKSLEAARGNGTSMISLIIPPKDQISRVAKMLADEFGTASNIKSRVNRLSVLGAITSVQQRLKLYNKVPPNGLVVYCGTIVTEEGKEKKVNIDFEPFKPINTSLYLCDNKFHTEALTALLSDLEHHHHHH","Homo sapiens","ETF1, ERF1, RF1, SUP45L1","Eukaryotic peptide chain release factor subunit 1","1","2LLX"
"2LLY",,"SOLUTION NMR",,,,,,,"10.1016/j.bbamem.2012.02.008",,"2LLY",15.02,,,"NMR structures of the transmembrane domains of the nAChR a4 subunit","SNAEELPLFYTINLIIPCLLISCLTVLVFYLPSECGEKITLCISVLLSLTVFLLLITEIIPSTSSVSPSIGEYLLFTMIFVTLSIVITVFVLNVHHRSPETHTGGGGGIDRIFLWMFIIVCLLGTVGLFLPPWLAGE","Homo sapiens","CHRNA4, NACRA4","Neuronal acetylcholine receptor subunit alpha-4","1","2LLY"
"2LM0",,"SOLUTION NMR",,,,,,,"10.1016/j.str.2012.11.011",,"2LM0",14.34,,,"Solution structure of the AF4-AF9 complex","TRLPLPLRDTKLLSPLRDTPPPQSLMVKITLDLLSRIPQPPGKPMGSDKQIKNGECDKAYLDELVELHRRLMTLRERHILQQIVNLIEETGHFHITNTTFDFDLCSLDKTTVRKLQSYLETSGTS","Homo sapiens","AFF1, AF4, FEL, MLLT2, PBM1, MLLT3, AF9, YEATS3","AF4/FMR2 family member 1/Protein AF-9 chimera","1","2LM0"
"2LM2",,"SOLUTION NMR",,,,,,,"10.1016/j.bbamem.2012.02.008",,"2LM2",15.09,,,"NMR structures of the transmembrane domains of the AChR b2 subunit","SNAEEEPLFYTINLIIPCVLITSLAILVFYLPSDCGEKMTLCISVLLALTVFLLLISKIVPPTSSDSPSVGEYLMFTMVLVTFSIVTSVCVLNVHHRSPETHTGGGGGIDRLFLWIFVFVCVFGTIGMFLQPLFQEE","Homo sapiens","CHRNB2","Neuronal acetylcholine receptor subunit beta-2","1","2LM2"
"2LM5",,"SOLUTION NMR",,,,,,,"10.1021/ja2111306",,"2LM5",24.59,,,"Solution structure of Ca2+-CIB1 in complex with the cytoplasmic domain of the integrin aIIb subunit","MGHHHHHHHHHHSSGHIDDDDKHMGGSGSRLSKELLAEYQDLTFLTKQEILLAHRRFCELLPQEQRSVESSLRAQVPFEQILSLPELKANPFKERICRVFSTSPAKDSLSFEDFLDLLSVFSDTATPDIKSHYAFRIFDFDDDGTLNREDLSRLVNCLTGEGEDTRLSASEMKQLIDNILEESDIDRDGTINLSEFQHVISRSPDFASSFKIVL","Homo sapiens","CIB1, CIB, KIP, PRKDCIP","Calcium and integrin-binding protein 1","1","2LM5"
"2LMB",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M111.277731",,"2LMB",5.04,,,"Solution Structure of C-terminal RAGE (ctRAGE)","MWQRRQRRGEERKAPENQEEEEERAELNQSEEPEAGESSTGGP","Homo sapiens","AGER, RAGE","Advanced glycosylation end product-specific receptor","1","2LMB"
"2LMD",,"SOLUTION NMR",,,,,,,"10.1073/pnas.1203013109",,"2LMD",20.72,,,"Minimal Constraints Solution NMR Structure of Prospero Homeobox protein 1 from Homo sapiens, Northeast Structural Genomics Consortium Target HR4660B","MGHHHHHHSHMAMQEGLSPNHLKKAKLMFFYTRYPSSNMLKTYFSDVKFNRCITSQLIKWFSNFREFYYIQMEKYARQAINDGVTSTEELSITRDCELYRALNMHYNKANDFEVPERFLEVAQITLREFFNAIIAGKDVDPSWKKAIYKVICKLDSEVPEIFKSPNCLQELLHE","Homo sapiens","PROX1","Prospero homeobox protein 1","1","2LMD"
"2LMF",,"SOLUTION NMR",,,,,,,"10.1021/bi2016266",,"2LMF",2.83,,,"Solution structure of human LL-23 bound to membrane-mimetic micelles","LLGDFFRKSKEKIGKEFKRIVQR","Homo sapiens","CAMP, CAP18, FALL39, HSD26","Antibacterial protein LL-37","1","2LMF"
"2LMG",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M111.294728",,"2LMG",8.38,,,"Solution Structure of The C-terminal Domain (537-610) of Human Heat Shock Protein 70","GSAKNALESYAFNMKSAVEDEGLKGKISEADKKKVLDKCQEVISWLDANTLAEKDEFEHKRKELEQVCNPIISGL","Homo sapiens","HSPA1A, HSPA1, HSPA1B, HSP72, HSX70","Heat shock 70 kDa protein 1A/1B","1","2LMG"
"2LMI",,"SOLUTION NMR",,,,,,,,,"2LMI",12.44,,,"NMR structure of the protein BC040485 from Homo sapiens","GSKLEEEVDDVFLIRAQGLPWSCTMEDVLNFFSDCRIRNGENGIHFLLNRDGKRRGDALIEMESEQDVQKALEKHRMYMGQRYVEVYEINNEDVDALMKSLQVKSSP","Homo sapiens","GRSF1","G-rich sequence factor 1","1","2LMI"
"2LMJ",,"SOLUTION NMR",,,,,,,,,"2LMJ",7.66,,,"Itk-sh3","GPLGSPEETVVIALYDYQTNDPQELALRRNEEYCLLDSSEIHWWRVQDRNGHEGYVPSSYLVEKSP","Homo sapiens","ITK, EMT, LYK","Tyrosine-protein kinase ITK/TSK","1","2LMJ"
"2LMN",,"SOLID-STATE NMR",,,,,,,"10.1073/pnas.0806270105",,"2LMN",52.03,,,"Structural Model for a 40-Residue Beta-Amyloid Fibril with Two-Fold Symmetry, Positive Stagger","DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVV","Homo sapiens","APP, A4, AD1","Beta-amyloid protein 40","1","2LMN"
"2LMO",,"SOLID-STATE NMR",,,,,,,"10.1073/pnas.0806270105",,"2LMO",52.03,,,"Structural Model for a 40-Residue Beta-Amyloid Fibril with Two-Fold Symmetry, Negative Stagger","DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVV","Homo sapiens","APP, A4, AD1","Beta-amyloid protein 40","1","2LMO"
"2LMP",,"SOLID-STATE NMR",,,,,,,"10.1073/pnas.0806270105",,"2LMP",78.05,,,"Structural Model for a 40-residue Beta-Amyloid Fibril with Three-Fold Symmetry, Positive Stagger","DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVV","Homo sapiens","APP, A4, AD1","Beta-amyloid protein 40","1","2LMP"
"2LMQ",,"SOLID-STATE NMR",,,,,,,"10.1073/pnas.0806270105",,"2LMQ",78.05,,,"Structural Model for a 40-residue Beta-Amyloid Fibril with Three-Fold Symmetry, Negative Stagger","DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVV","Homo sapiens","APP, A4, AD1","Beta-amyloid protein 40","1","2LMQ"
"2LMR",,"SOLUTION NMR",,,,,,,"10.1021/bi300141h",,"2LMR",11.31,,,"Solution structure of the first sam domain of odin","MGSSHHHHHHSSGLVPRGSHMISGLRTLEQSVGEWLESIGLQQYESKLLLNGFDDVHFLGSNVMEEQDLRDIGISDPQHRRKLLQAARSLPKVKALGYDGN","Homo sapiens","ANKS1A, ANKS1, KIAA0229, ODIN","Ankyrin repeat and SAM domain-containing protein 1A","1","2LMR"
"2LMS",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M112.413252",,"2LMS",19.62,,,"A single GalNAc residue on Threonine-106 modifies the dynamics and the structure of Interferon alpha-2a around the glycosylation site","MCDLPQTHSLGSRRTLMLLAQMRKISLFSCLKDRHDFGFPQEEFGNQFQKAETIPVLHEMIQQIFNLFSTKDSSAAWDETLLDKFYTELYQQLNDLEACVIQGVGVTETPLMKEDSILAVRKYFQRITLYLKEKKYSPCAWEVVRAEIMRSFSLSTNLQESLRSKE","Homo sapiens","IFNA2, IFNA2A, IFNA2B, IFNA2C","Interferon alpha-2","1","2LMS"
"2LN0",,"SOLUTION NMR",,,,,,,"10.1101/gad.188359.112",,"2LN0",13.04,,,"Structure of MOZ","HMEPIPICSFCLGTKEQNREKKPEELISCADCGNSGHPSCLKFSPELTVRVKALRWQCIECKTCSSCRDQGKNADNMLFCDSCDRGFHMECCDPPLTRMPKGMWICQICRPR","Homo sapiens","KAT6A, MOZ, MYST3, RUNXBP2, ZNF220","Histone acetyltransferase KAT6A","1","2LN0"
"2LNA",,"SOLUTION NMR",,,,,,,"10.1016/j.febslet.2013.09.009",,"2LNA",11.49,,,"Solution NMR Structure of the mitochondrial inner membrane domain (residues 164-251), FtsH_ext, from the paraplegin-like protein AFG3L2 from Homo sapiens, Northeast Structural Genomics Consortium Target HR6741A","MGHHHHHHSHMKRSGREITWKDFVNNYLSKGVVDRLEVVNKRFVRVTFTPGKTPVDGQYVWFNIGSVDTFERNLETLQQELGIEGENRVPVVYIAESDG","Homo sapiens","AFG3L2","AFG3-like protein 2","1","2LNA"
"2LNB",,"SOLUTION NMR",,,,,,,,,"2LNB",9.04,,,"Solution NMR structure of N-terminal domain (6-74) of human ZBP1 protein, Northeast Structural Genomics Consortium Target HR8174A.","MGHHHHHHSHMADPGREGHLEQRILQVLTEAGSPVKLAQLVKECQAPKRELNQVLYRMKKELKVSLTSPATWCLGGTDPE","Homo sapiens","C20orf183, DLM1, ZBP1","Z-DNA-binding protein 1","1","2LNB"
"2LNE",,"SOLUTION NMR",,,,,,,"10.1016/j.bpc.2012.06.003",,"2LNE",1.69,,,"Neurotensin 40 structures in water pH 5.5 298 K. NMR data & structures","ELYENKPRRPYIL","Homo sapiens","NTS","Neurotensin","1","2LNE"
"2LNF",,"SOLUTION NMR",,,,,,,"10.1016/j.bpc.2012.06.003",,"2LNF",1.69,,,"Neurotensin 40 structures in DMPC/CHAPS(q=0.25) bicelle pH 5.5 & 298K. NMR data & Structures","ELYENKPRRPYIL","Homo sapiens","NTS","Neurotensin","1","2LNF"
"2LNG",,"SOLUTION NMR",,,,,,,"10.1016/j.bpc.2012.06.003",,"2LNG",1.69,,,"Neurotensin 40 structures in DMPC:CHAPS:GM1(q= 0.25) bicelle pH 5.5 & 298K. NMR data & Structures","ELYENKPRRPYIL","Homo sapiens","NTS","Neurotensin","1","2LNG"
"2LNI",,"SOLUTION NMR",,,,,,,,,"2LNI",15.37,,,"Solution NMR Structure of Stress-induced-phosphoprotein 1 STI1 from Homo sapiens, Northeast Structural Genomics Consortium Target HR4403E","MGHHHHHHSHMNPDLALMVKNKGNECFQKGDYPQAMKHYTEAIKRNPKDAKLYSNRAACYTKLLEFQLALKDCEECIQLEPTFIKGYTRKAAALEAMKDYTKAMDVYQKALDLDSSCKEAADGYQRCMMAQYN","Homo sapiens","STIP1","Stress-induced-phosphoprotein 1","1","2LNI"
"2LNL",,"SOLID-STATE NMR",,,,,,,"10.1038/nature11580",,"2LNL",35.16,,,"Structure of human CXCR1 in phospholipid bilayers","MPPADEDYSPCMLETETLNKYVVIIAYALVFLLSLLGNSLVMLVILYSRVGRSVTDVYLLNLALADLLFALTLPIWAASKVNGWIFGTFLCKVVSLLKEVNFYSGILLLACISVDRYLAIVHATRTLTQKRHLVKFVCLGCWGLSMNLSLPFFLFRQAYHPNNSSPVCYEVLGNDTAKWRMVLRILPHTFGFIVPLFVMLFCYGFTLRTLFKAHMGQKHRAMRVIFAVVLIFLLCWLPYNLVLLADTLMRTQVIQESCERRNNIGRALDATEILGFLHSCLNPIIYAFIGQNFRHGFLKILAMHGLVSK","Homo sapiens","CMKAR1, CXCR1, IL8RA","C-X-C chemokine receptor type 1","1","2LNL"
"2LNQ",,"SOLID-STATE NMR",,,,,,,"10.1073/pnas.1111305109",,"2LNQ",34.68,,,"40-residue D23N beta amyloid fibril","DAEFRHDSGYEVHHQKLVFFAENVGSNKGAIIGLMVGGVV","Homo sapiens","APP, A4, AD1","P3(40)","1","2LNQ"
"2LNS",,"SOLUTION NMR",,,,,,,"10.1016/j.jmb.2012.12.009",,"2LNS",32.38,,,"Solution structure of AGR2 residues 41-175","IDPFTPQTLSRGWGDQLIWTQTYEEALYKSKTSNKPLMIIHHLDECPHSQALKKVFAENKEIQKLAEQFVLLNLVYETTDKHLSPDGQYVPRIMFVDPSLTVRADITGRYSNRLYAYEPADTALLLDNMKKALKLLKTEL","Homo sapiens","AGR2, AG2, UNQ515/PRO1030","Anterior gradient protein 2 homolog","1","2LNS"
"2LNT",,"SOLUTION NMR",,,,,,,"10.1016/j.jmb.2012.12.009",,"2LNT",16.13,,,"Solution structure of E60A mutant AGR2","IDPFTPQTLSRGWGDQLIWTQTYEAALYKSKTSNKPLMIIHHLDECPHSQALKKVFAENKEIQKLAEQFVLLNLVYETTDKHLSPDGQYVPRIMFVDPSLTVRADITGRYSNRLYAYEPADTALLLDNMKKALKLLKTEL","Homo sapiens","AGR2, AG2, UNQ515/PRO1030","Anterior gradient protein 2 homolog","1","2LNT"
"2LNX",,"SOLUTION NMR",,,,,,,"10.1016/j.jsb.2012.06.011",,"2LNX",14.63,,,"Solution structure of Vav2 SH2 domain","MGHHHHHHMSRPPSREIDYTAYPWFAGNMERQQTDNLLKSHASGTYLIRERPAEAERFAISIKFNDEVKHIKVVEKDNWIHITEAKKFDSLLELVEYYQCHSLKESFKQLDTTLKYPYKSRE","Homo sapiens","VAV2","Guanine nucleotide exchange factor VAV2","1","2LNX"
"2LO1",,"SOLUTION NMR",,,,,,,,,"2LO1",8.22,,,"NMR structure of the protein BC008182, a DNAJ-like domain from Homo sapiens","GMVKETTYYDVLGVKPNATQEELKKAYRKLALKYHPDKNPNEGEKFKQISQAYEVLSDAKKRELYDKGGEQ","Homo sapiens","DNAJA1, DNAJ2, HDJ2, HSJ2, HSPF4","DnaJ homolog subfamily A member 1","1","2LO1"
"2LO4",,"SOLUTION NMR",,,,,,,,,"2LO4",5.63,,,"NMR Solution Structure of Optineurin Zinc-finger Domain","MGSSHHHHHHSSGLVPRGSHMASIPIHSCPKCGEVLPDIDTLQIHVMDCII","Homo sapiens","OPTN, FIP2, GLC1E, HIP7, HYPL, NRP","Optineurin","1","2LO4"
"2LOH",,"SOLUTION NMR",,,,,,,"10.1016/j.febslet.2012.04.062",,"2LOH",8.9,,,"Dimeric structure of transmembrane domain of amyloid precursor protein in micellar environment","GSQKLVFFAEDVGSNKGAIIGLMVGGVVIATVIVITLVMLKKK","Homo sapiens","APP, A4, AD1","P3(42)","1","2LOH"
"2LOM",,"SOLUTION NMR",,,,,,,"10.1038/nmeth.2033",,"2LOM",10.16,,,"Backbone structure of human membrane protein HIGD1A","MSTDTGVSLPSYEEDQGSKLIRKAKEAPFVPVGIAGFAAIVAYGLYKLKSRGNTKMSIHLIHMRVAAQGFVVGAMTVGMGYSMYREFWAKPKP","Homo sapiens","HIGD1A, HIG1, HSPC010","HIG1 domain family member 1A","1","2LOM"
"2LON",,"SOLUTION NMR",,,,,,,"10.1038/nmeth.2033",,"2LON",11.07,,,"Backbone structure of human membrane protein HIGD1B","MSANRRWWVPPDDEDCVSEKLLRKTRESPLVPIGLGGCLVVAAYRIYRLRSRGSTKMSIHLIHTRVAAQACAVGAIMLGAVYTMYSDYVKRMAQDAGEK","Homo sapiens","HIGD1B","HIG1 domain family member 1B","1","2LON"
"2LOO",,"SOLUTION NMR",,,,,,,"10.1038/nmeth.2033",,"2LOO",11.74,,,"Backbone structure of human membrane protein TMEM14A from NOE data","MTSLYKKVGMDLIGFGYAALVTFGSIFGYKRRGGVPSLIAGLFVGCLAGYGAYRVSNDKRDVKVSLFTAFFLATIMGVRFKRSKKIMPAGLVAGLSLMMILRLVLLLL","Homo sapiens","TMEM14A, C6orf73, PTD011","Transmembrane protein 14A","1","2LOO"
"2LOP",,"SOLUTION NMR",,,,,,,"10.1038/nmeth.2033",,"2LOP",11.74,,,"Backbone structure of human membrane protein TMEM14A","MTSLYKKVGMDLIGFGYAALVTFGSIFGYKRRGGVPSLIAGLFVGCLAGYGAYRVSNDKRDVKVSLFTAFFLATIMGVRFKRSKKIMPAGLVAGLSLMMILRLVLLLL","Homo sapiens","TMEM14A, C6orf73, PTD011","Transmembrane protein 14A","1","2LOP"
"2LOQ",,"SOLUTION NMR",,,,,,,"10.1038/nmeth.2033",,"2LOQ",10.56,,,"Backbone structure of human membrane protein FAM14B (Interferon alpha-inducible protein 27-like protein 1)","MTSLYKKVGMGKESGWDSGRAAVAAVVGGVVAVGTVLVALSAMGFTSVGIAASSIAAKMMSTAAIANGGGVAAGSLVAILQSVGAAGLSVTSKVIGGFAGTALGAWLGSPPSS","Homo sapiens","IFI27L1, FAM14B","Interferon alpha-inducible protein 27-like protein 1","1","2LOQ"
"2LOR",,"SOLUTION NMR",,,,,,,"10.1038/nmeth.2033",,"2LOR",11.89,,,"Backbone structure of human membrane protein TMEM141","MVNLGLSRVDDAVAAKHPGLGEYAACQSHAFMKGVFTFVTGTGMAFGLQMFIQRKFPYPLQWSLLVAVVAGSVVSYGVTRVESEKCNNLWLFLETGQLPKDRSTDQRS","Homo sapiens","TMEM141","Transmembrane protein 141","1","2LOR"
"2LOS",,"SOLUTION NMR",,,,,,,"10.1038/nmeth.2033",,"2LOS",12.61,,,"Backbone structure of human membrane protein TMEM14C","MTSLYKKVGMQDTSSVVPLHWFGFGYAALVASGGIIGYVKAGSVPSLAAGLLFGSLAGLGAYQLSQDPRNVWVFLATSGTLAGIMGMRFYHSGKFMPAGLIAGASLLMVAKVGVSMFNRPH","Homo sapiens","TMEM14C, C6orf53, HSPC194","Transmembrane protein 14C","1","2LOS"
"2LOT",,"SOLUTION NMR",,,,,,,"10.1021/acs.jpclett.7b00867",,"2LOT",7.31,,,"AR55 solubilised in SDS micelles","MEEGGDFDNYYGADNQSECEYTDWKSSGALIPAIYMLVFLLGTTGNGLVLWTVFRKKGHHHHHH","Homo sapiens","APLNR, AGTRL1, APJ","Apelin receptor","1","2LOT"
"2LOU",,"SOLUTION NMR",,,,,,,"10.1016/j.bbamem.2013.02.005",,"2LOU",7.31,,,"AR55 solubilised in DPC micelles","MEEGGDFDNYYGADNQSECEYTDWKSSGALIPAIYMLVFLLGTTGNGLVLWTVFRKKGHHHHHH","Homo sapiens","APLNR, AGTRL1, APJ","Apelin receptor","1","2LOU"
"2LOV",,"SOLUTION NMR",,,,,,,"10.1021/acs.jpclett.7b00867",,"2LOV",7.31,,,"AR55 solubilised in LPPG micelles","MEEGGDFDNYYGADNQSECEYTDWKSSGALIPAIYMLVFLLGTTGNGLVLWTVFRKKGHHHHHH","Homo sapiens","APLNR, AGTRL1, APJ","Apelin receptor","1","2LOV"
"2LOW",,"SOLUTION NMR",,,,,,,"10.1021/acs.jpclett.7b00867",,"2LOW",7.31,,,"Solution structure of AR55 in 50% HFIP","MEEGGDFDNYYGADNQSECEYTDWKSSGALIPAIYMLVFLLGTTGNGLVLWTVFRKKGHHHHHH","Homo sapiens","APLNR, AGTRL1, APJ","Apelin receptor","1","2LOW"
"2LP1",,"SOLUTION NMR",,,,,,,"10.1126/science.1219988",,"2LP1",13.8,,,"The solution NMR structure of the transmembrane C-terminal domain of the amyloid precursor protein (C99)","MDAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIATVIVITLVMLKKKQYTSIHHGVVEVDAAVTPEERHLSKMQQNGYENPTYKFFEQMQNQGRILQISITLAAALEHHHHHH","Homo sapiens","A4, AD1, APP","C99","1","2LP1"
"2LP2",,"SOLUTION NMR",,,,,,,"10.1021/bi3015407",,"2LP2",21.28,,,"Solution structure and dynamics of human S100A1 protein modified at cysteine 85 with homocysteine disulfide bond formation in calcium saturated form","GSELETAMETLINVFHAHSGKEGDKYKLSKKELKELLQTELSGFLDAQKDVDAVDKVMKELDENGDGEVDFQEYVVLVAALTVACNNFFWENS","Homo sapiens","S100A1, S100A","Protein S100-A1","1","2LP2"
"2LP3",,"SOLUTION NMR",,,,,,,"10.1021/bi3015407",,"2LP3",21.01,,,"Solution structure of S100A1 Ca2+","GSELETAMETLINVFHAHSGKEGDKYKLSKKELKELLQTELSGFLDAQKDVDAVDKVMKELDENGDGEVDFQEYVVLVAALTVACNNFFWENS","Homo sapiens","S100A1, S100A","Protein S100-A1","1","2LP3"
"2LPC",,"SOLUTION NMR",,,,,,,"10.1021/ja302390a",,"2LPC",21.46,,,"NMR STRUCTURE of Bcl-XL","MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERLEHHHHHHLEHHHHHH","Homo sapiens","BCL2L1, BCL2L, BCLX","Bcl-2-like protein 1","1","2LPC"
"2LPN",,"SOLUTION NMR",,,,,,,"10.1007/s12104-012-9388-8",,"2LPN",11.96,,,"Solution Structure of N-Terminal domain of human Conserved Dopamine Neurotrophic Factor (CDNF)","QEAGGRPGADCEVCKEFLNRFYKSLIDRGVNFSLDTIEKELISFCLDTKGKENRLCYYLGATKDAATKILSEVTRPMSVHMPAMKICEKLKKLDSQICELKYEKT","Homo sapiens","CDNF, ARMETL1","Cerebral dopamine neurotrophic factor","1","2LPN"
"2LQ6",,"SOLUTION NMR",,,,,,,"10.1016/j.jsb.2012.06.014",,"2LQ6",9.79,,,"Solution structure of BRD1 PHD2 finger","MGHHHHHHMNIPPARWKLTCYLCKQKGVGASIQCHKANCYTAFHVTCAQKAGLYMKMEPVKELTGGGTTFSVRKTAYCDVHTPPGST","Homo sapiens","BRD1, BRL, BRPF2","Bromodomain-containing protein 1","1","2LQ6"
"2LQ7",,"SOLUTION NMR",,,,,,,"10.1002/prot.24148",,"2LQ7",10.66,,,"E2 binding surface on Uba3 beta-grasp domain undergoes a conformational transition","GSQLPQNIQFSPSAKLQEVLDYLTNSASLQMKSPAITATLEGKNRTLYLQSVTSIEERTRPNLSKTLKELGLVDGQELAVADVTTPQTVLFKLHFTS","Homo sapiens","UBA3, UBE1C","NEDD8-activating enzyme E1 catalytic subunit","1","2LQ7"
"2LQ9",,"SOLUTION NMR",,,,,,,,,"2LQ9",7.35,,,"Solution structure of the K60A mutant of Atox1","MPKHEFSVDMTCGGCAEAVSRVLNKLGGVKYDIDLPNKKVCIESEHSMDTLLATLKKTGATVSYLGLE","Homo sapiens","ATOX1, HAH1","Copper transport protein ATOX1","1","2LQ9"
"2LQB",,"SOLUTION NMR",,,,,,,"10.1042/BJ20121656",,"2LQB",8.43,,,"Metal binding repeat 2 of the Wilson disease protein (ATP7B)","AGHMQEAVVKLRVEGMTCQSCVSSIEGKVRKLQGVVRVKVSLSNQEAVITYQPYLIQPEDLRDHVNDMGFEAAIKS","Homo sapiens","ATP7B, PWD, WC1, WND","Copper-transporting ATPase 2","1","2LQB"
"2LQL",,"SOLUTION NMR",,,,,,,"10.1016/j.jsb.2012.07.007",,"2LQL",12.69,,,"Solution structure of CHCH5","GSHMQAALEVTARYCGRELEQYGQCVAAKPESWQRDCHYLKMSIAQCTSSHPIIRQIRQACAQPFEAFEECLRQNEAAVGNCAEHMRRFLQCAEQVQPPRSPATVEAQPLPAS","Homo sapiens","C2orf9, CHCHD5","Coiled-coil-helix-coiled-coil-helix domain-containing protein 5","1","2LQL"
"2LQN",,"SOLUTION NMR",,,,,,,"10.1038/nchembio.954",,"2LQN",33.82,,,"Solution structure of CRKL","MSSARFDSSDRSAWYMGPVSRQEAQTRLQGQRHGMFLVRDSSTCPGDYVLSVSENSRVSHYIINSLPNRRFKIGDQEFDHLPALLEFYKIHYLDTTTLIEPAPRYPSPPMGSVSAPNLPTAEDNLEYVRTLYDFPGNDAEDLPFKKGEILVIIEKPEEQWWSARNKDGRVGMIPVPYVEKLVRSSPHGKHGNRNSNSYGIPEPAHAYAQPQTTTPLPAVSGSPGAAITPLPSTQNGPVFAKAIQKRVPCAYDKTALALEVGDIVKVTRMNINGQWEGEVNGRKGLFPFTHVKIFDPQNPDENE","Homo sapiens","CRKL","Crk-like protein","1","2LQN"
"2LQP",,"SOLUTION NMR",,,,,,,"10.3389/fnmol.2012.00038",,"2LQP",8.24,,,"NMR solution structure of the Ca2+-Calmodulin C-terminal domain in a complex with a peptide (NSCaTE) from the L-type Voltage-Gated Calcium Channel alpha1C subunit","DTDSEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADIDGDGQVNYEEFVQMMTAK","Homo sapiens","CALM1, CALM, CAM, CAM1, CALM2, CAM2, CAMB, CALM3, CALML2, CAM3, CAMC, CAMIII","Calmodulin","1","2LQP"
"2LQT",,"SOLUTION NMR",,,,,,,"10.1016/j.jsb.2012.07.007",,"2LQT",10.11,,,"Solution structure of CHCHD7","MPSVTQRLRDPDINPCLSESDASTRCLDENNYDRERCSTYFLRYKNCRRFWNSIVMQRRKNGVKPFMPTAAERDEILRAVGNMPY","Homo sapiens","CHCHD7","Coiled-coil-helix-coiled-coil-helix domain-containing protein 7","1","2LQT"
"2LQW",,"SOLUTION NMR",,,,,,,"10.1038/nchembio.954",,"2LQW",33.9,,,"Solution structure of phosphorylated CRKL","MSSARFDSSDRSAWYMGPVSRQEAQTRLQGQRHGMFLVRDSSTCPGDYVLSVSENSRVSHYIINSLPNRRFKIGDQEFDHLPALLEFYKIHYLDTTTLIEPAPRYPSPPMGSVSAPNLPTAEDNLEYVRTLYDFPGNDAEDLPFKKGEILVIIEKPEEQWWSARNKDGRVGMIPVPYVEKLVRSSPHGKHGNRNSNSYGIPEPAHAYAQPQTTTPLPAVSGSPGAAITPLPSTQNGPVFAKAIQKRVPCAYDKTALALEVGDIVKVTRMNINGQWEGEVNGRKGLFPFTHVKIFDPQNPDENE","Homo sapiens","CRKL","Crk-like protein","1","2LQW"
"2LR6",,"SOLUTION NMR",,,,,,,,,"2LR6",19.82,,,"NMR structure of a LINE-1 type transposase domain-containing protein 1 (L1TD1) from Homo sapiens","GVLMDEGAVLTLAADLSSATLDISKQWSNVFNILRENDFEPKFLCEVKLAFKCDGEIKTFSDLQSLRKFASQKSSMKELLKDVLPQKE","Homo sapiens","L1TD1, ECAT11","LINE-1 type transposase domain-containing protein 1","1","2LR6"
"2LR8",,"SOLUTION NMR",,,,,,,,,"2LR8",8.27,,,"Solution NMR Structure of CASP8-associated protein 2 from Homo sapiens, Northeast Structural Genomics Consortium (NESG) Target HR8150A","SHMKNVIKKKGEIIILWTRNDDRVILLECQKRGPSSKTFAYLAAKLDKNPNQVSERFQQLMKLFEKSKCR","Homo sapiens","CASP8AP2, FLASH, KIAA1315, RIP25","CASP8-associated protein 2","1","2LR8"
"2LRI",,"SOLUTION NMR",,,,,,,"10.1093/nar/gks933",,"2LRI",6.94,,,"NMR structure of the second PHD finger of AIRE (AIRE-PHD2)","GAMEGQQNLAPGARCGVCGDGTDVLRCTHCAAAFHWRCHFPAGTSRPGTGLRCRSCSGDVTPAPVE","Homo sapiens","AIRE, APECED","Autoimmune regulator","1","2LRI"
"2LRR",,"SOLUTION NMR",,,,,,,"10.1016/j.jmb.2012.09.010",,"2LRR",10.05,,,"Solution structure of the R3H domain from human Smubp-2 in complex with 2'-deoxyguanosine-5'-monophosphate","MGSLNGGSPEGVESQDGVDHFRAMIVEFMASKKMQLEFPPSLNSHDRLRVHQIAEEHGLRHDSSGEGKRRFITVSKRAGSHHHHHH","Homo sapiens","IGHMBP2, SMBP2, smubp-2, SMUBP2","DNA-binding protein SMUBP-2","1","2LRR"
"2LS2",,"SOLUTION NMR",,,,,,,,,"2LS2",2.68,,,"1H Chemical Shift Assignments for the first transmembrane domain from human copper transport 1","KNTAGEMAGAFVAVFLLAMFYEGLK","Homo sapiens","SLC31A1, COPT1, CTR1","High affinity copper uptake protein 1","1","2LS2"
"2LS3",,"SOLUTION NMR",,,,,,,,,"2LS3",3.54,,,"1H Chemical Shift Assignments for the secondary transmembrane domain from human copper transport 1","KHLLQTVLHIIQVVISYFLMLIFMTYNKK","Homo sapiens","SLC31A1, COPT1, CTR1","High affinity copper uptake protein 1","1","2LS3"
"2LS4",,"SOLUTION NMR",,,,,,,,,"2LS4",2.6,,,"1H Chemical Shift Assignments for the third transmembrane domain from the human copper transport 1","YNGYLCIAVAAGAGTGYFLFSWKK","Homo sapiens","SLC31A1, COPT1, CTR1","High affinity copper uptake protein 1","1","2LS4"
"2LS8",,"SOLUTION NMR",,,,,,,,,"2LS8",18.61,,,"Solution structure of human C-type lectin domain family 4 member D","MVCPIDWRAFQSNCYFPLTDNKTWAESERNCSGMGAHLMTISTEAEQNFIIQFLDRRLSYFLGLRDENAKGQWRWVDQTPFNPRRVFWHKNEPDNSQGENCVVLVYNQDKWAWNDVPCNFEASRICKIPGTTLNAENLYFQSHHHHHHWSHPQFEK","Homo sapiens","CLEC4D, CLECSF8, MCL","C-type lectin domain family 4 member D","1","2LS8"
"2LSB",,"SOLUTION NMR",,,,,,,"10.1042/BJ20111940",,"2LSB",16.17,,,"Solution-state NMR structure of the human prion protein","GQGGGTHSQWNKPSKPKTNMKHMAGAAAAGAVVGGLGGYMLGSAMSRPIIHFGSDYEDRYYRENMHRYPNQVYYRPMDEYSNQNNFVHDCVNITIKQHTVTTTTKGENFTETDVKMMERVVEQMCITQYERESQAYYQRGSS","Homo sapiens","PRNP, PRIP, PRP, ALTPRP","Major prion protein","1","2LSB"
"2LSO",,"SOLUTION NMR",,,,,,,,,"2LSO",9.4,,,"Solution NMR Structure of the Globular Domain of Human Histone H1x, Northeast Structural Genomics Consortium (NESG) Target HR7057A","SHMQPGKYSQLVVETIRRLGERNGSSLAKIYTEAKKVPWFDQQNGRTYLKYSIKALVQNDTLLQVKGTGANGSFKLNRKKLEG","Homo sapiens","H1FX, H1-10","Histone H1x","1","2LSO"
"2LSQ",,"SOLUTION NMR",,,,,,,,,"2LSQ",2.94,,,"Analog of the fragment 197-221 of beta-1 adrenoreceptor","NCWRAESDEARRCYNDPKCSDSVCK","Homo sapiens","ADRB1, ADRB1R, B1AR","ANALOG OF THE FRAGMENT 197-221 OF BETA-1 ADRENORECEPTOR","1","2LSQ"
"2LSW",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M112.385609",,"2LSW",4.41,,,"Structure, sulfatide-binding properties, and inhibition of platelet aggregation by a Disabled-2-derived peptide","GPLGSSKKEKKKGPEKTDEYLLARFKGDGVKYKAKLIGID","Homo sapiens","DAB2, DOC2","Disabled homolog 2","1","2LSW"
"2LSY",,"SOLUTION NMR",,,,,,,"10.1021/bi300566z",,"2LSY",11.01,,,"Structure of the C-terminal domain from human REV1","GNLAGAVEFNDVKTLLREWITTISDPMEEDILQVVKYCTDLIEEKDLEKLDLVIKYMKRLMQQSVESVWNMAFDFILDNVQVVLQQTYGSTLKVT","Homo sapiens","REV1, REV1L","DNA repair protein REV1","1","2LSY"
"2LT7",,"SOLUTION NMR",,,,,,,"10.1073/pnas.1213726109",,"2LT7",27.93,,,"Solution NMR structure of Kaiso zinc finger DNA binding domain in complex with Kaiso binding site DNA","ANKRMKVKHDDHYELIVDGRVYYICIVCKRSYVCLTSLRRHFNIHSWEKKYPCRYCEKVFPLAEYRTKHEIHHTGERRYQCLACGKSFINYQFMSSHIKSVHSQDPSGDSKLYRLHPCRSLQIRQYAYLSDRS","Homo sapiens","ZBTB33, KAISO, ZNF348","Transcriptional regulator Kaiso","1","2LT7"
,,,,,,,,,,,,,,,,"GTGCTTCCTGCCAATAACG",,,"DNA (5'-D(*GP*TP*GP*CP*TP*TP*CP*CP*TP*GP*CP*CP*AP*AP*TP*AP*AP*CP*G)-3')","2","2LT7"
,,,,,,,,,,,,,,,,"CGTTATTGGCAGGAAGCAC",,,"DNA (5'-D(*CP*GP*TP*TP*AP*TP*TP*GP*GP*CP*AP*GP*GP*AP*AP*GP*CP*AP*C)-3')","3","2LT7"
"2LTB",,"SOLUTION NMR",,,,,,,"10.1016/j.bbapap.2013.10.008",,"2LTB",14.48,,,"Wild-type FAS1-4","AGMGTVMDVLKGDNRFSMLVAAIQSAGLTETLNREGVYTVFAPTNEAFRALPPRERSRLLGDAKELANILKYHIGDEILVSGGIGALVRLKSLQGDKLEVSLKNNVVSVNKEPVAEPDIMATNGVVHVITNVLQP","Homo sapiens","TGFBI, BIGH3","Transforming growth factor-beta-induced protein ig-h3","1","2LTB"
"2LTC",,"SOLUTION NMR",,,,,,,"10.1016/j.bbapap.2013.10.008",,"2LTC",14.48,,,"Fas1-4, R555W","AGMGTVMDVLKGDNRFSMLVAAIQSAGLTETLNREGVYTVFAPTNEAFRALPPREWSRLLGDAKELANILKYHIGDEILVSGGIGALVRLKSLQGDKLEVSLKNNVVSVNKEPVAEPDIMATNGVVHVITNVLQA","Homo sapiens","TGFBI, BIGH3","Transforming growth factor-beta-induced protein ig-h3","1","2LTC"
"2LTM",,"SOLUTION NMR",,,,,,,,,"2LTM",12.2,,,"Solution NMR Structure of NFU1 Iron-Sulfur Cluster Scaffold Homolog from Homo sapiens, Northeast Structural Genomics Consortium (NESG) Target HR2876B","MGHHHHHHSHMFIQTQDTPNPNSLKFIPGKPVLETRTMDFPTPAAAFRSPLARQLFRIEGVKSVFFGPDSITVTKENEELDWNLLKPDIYATIMDFFASGLPLVTEE","Homo sapiens","CGI-33, HIRIP5, NFU1","NFU1 iron-sulfur cluster scaffold homolog, mitochondrial","1","2LTM"
"2LTP",,"SOLUTION NMR",,,,,,,,,"2LTP",10.78,,,"Solution structure of the SANT2 domain of the human nuclear receptor corepressor 2 (NCoR2), Northeast Structural Genomics Consortium (NESG) target ID HR4636E","MHHHHHHSSGRENLYFQGWTEEEMGTAKKGLLEHGRNWSAIARMVGSKTVSQCKNFYFNYKKRQNLDEILQQHKLKMEKERNARRKKKK","Homo sapiens","NCOR2, CTG26","Nuclear receptor corepressor 2","1","2LTP"
"2LTU",,"SOLUTION NMR",,,,,,,,,"2LTU",7.03,,,"Solution Structure of autoinhibitory domain of human AMP-activated protein kinase catalytic subunit","GPHMSYDANVIDDEAVKEVCEKFECTESEVMNSLYSGDPQDQLAVAYHLIIDNRRIMNQASE","Homo sapiens","PRKAA2, AMPK, AMPK2","5'-AMP-activated protein kinase catalytic subunit alpha-2","1","2LTU"
"2LU5",,"SOLID-STATE NMR",,,,,,,"10.1073/pnas.1204515109",,"2LU5",15.84,,,"Structure and chemical shifts of Cu(I),Zn(II) superoxide dismutase by solid-state NMR","ATKAVAVLKGDGPVQGIINFEQKESNGPVKVWGSIKGLTEGLHGFHVHEFGDNTAGCTSAGPHFNPLSRKHGGPKDEERHVGDLGNVTADKDGVADVSIEDSVISLSGDHSIIGRTLVVHEKADDLGKGGNEESTKTGNAGSRLACGVIGIAQ","Homo sapiens","SOD1","Superoxide dismutase [Cu-Zn]","1","2LU5"
"2LU7",,"SOLUTION NMR",,,,,,,,,"2LU7",9.11,,,"Solution NMR Structure of Ig like domain (1277-1357) of Obscurin-like protein 1 from Homo sapiens, Northeast Structural Genomics Consortium (NESG) Target HR8578D","SHMTRVRSTPGGDLELVVHLSGPGGPVRWYKDGERLASQGRVQLEQAGARQVLRVQGARSGDAGEYLCDAPQDSRIFLVSVEEP","Homo sapiens","KIAA0657, OBSL1","Obscurin-like protein 1","1","2LU7"
"2LUB",,"SOLUTION NMR",,,,,,,"10.1002/cbic.201200401",,"2LUB",11.89,,,"High resolution NMR solution structure of helix H1 of the human HAR1 RNA","GGGUGAAACGGAGGACUUCGGUCCUCAAGUUUCACCC","Homo sapiens",,"RNA (37-MER)","1","2LUB"
"2LUC",,"SOLUTION NMR",,,,,,,"10.1007/s10858-012-9661-2",,"2LUC",23.51,,,"Solution Structure of human S100 calcium-binding protein A11","MAKISSPTETERCIESLIAVFQKYAGKDGYNYTLSKTEFLSFMNTELAAFTKNQKDPGVLDRMMKKLDTNSDGQLDFSEFLNLIGGLAMACHDSFLKAVPSQKRT","Homo sapiens","S100A11, MLN70, S100C","Protein S100-A11","1","2LUC"
"2LUL",,"SOLUTION NMR",,,,,,,,,"2LUL",19.6,,,"Solution NMR Structure of PH Domain of Tyrosine-protein kinase Tec from Homo sapiens, Northeast Structural Genomics Consortium (NESG) Target HR3504C","MGHHHHHHSHMNFNTILEEILIKRSQQKKKTSPLNYKERLFVLTKSMLTYYEGRAEKKYRKGFIDVSKIKCVEIVKNDDGVIPCQNKYPFQVVHDANTLYIFAPSPQSRDLWVKKLKEEIKNNNNIMIKYHPKFWTDGSYQCCRQTEKLAPGCEKYNLFESSIR","Homo sapiens","PSCTK4, TEC","Tyrosine-protein kinase Tec","1","2LUL"
"2LUV",,"SOLUTION NMR",,,,,,,,,"2LUV",3.96,,,"Structure and Binding Interface of the Cytosolic Tails of aXb2 Integrin","KVGFFKRQYKEMMEEANGQIAPENGTQTPSPPSEK","Homo sapiens","ITGAX, CD11C","Integrin alpha-X","1","2LUV"
"2LUX",,"SOLUTION NMR",,,,,,,,,"2LUX",21.07,,,"Calcium saturated form of human C85M S100A1 mutant","GSELETAMETLINVFHAHSGKEGDKYKLSKKELKELLQTELSGFLDAQKDVDAVDKVMKELDENGDGEVDFQEYVVLVAALTVAMNNFFWENS","Homo sapiens","S100A1, S100A","Protein S100-A1","1","2LUX"
"2LV1",,"SOLUTION NMR",,,,,,,"10.1021/bi3009856",,"2LV1",16.65,,,"Solution-state NMR structure of prion protein mutant V210I at neutral pH","GAMDPGQGGGTHSQWNKPSKPKTNMKHMAGAAAAGAVVGGLGGYMLGSAMSRPIIHFGSDYEDRYYRENMHRYPNQVYYRPMDEYSNQNNFVHDCVNITIKQHTVTTTTKGENFTETDVKMMERVIEQMCITQYERESQAYYQRGSS","Homo sapiens","PRNP, PRIP, PRP, ALTPRP","Major prion protein","1","2LV1"
"2LV2",,"SOLUTION NMR",,,,,,,,,"2LV2",9.39,,,"Solution NMR structure of C2H2-type Zinc-fingers 4 and 5 from human Insulinoma-associated protein 1 (fragment 424-497), Northeast Structural Genomics Consortium Target HR7614B","MGHHHHHHSHMGDGEGAGVLGLSASAECHLCPVCGESFASKGAQERHLRLLHAAQVFPCKYCPATFYSSPGLTRHINKCHPSENR","Homo sapiens","IA1, INSM1","Insulinoma-associated protein 1","1","2LV2"
"2LV7",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M112.402289",,"2LV7",11.48,,,"Solution structure of Ca2+-bound CaBP7 N-terminal doman","MPFHPVTAALMYRGIYTVPNLLSEQRPVDIPEDELEEIREAFKVFDRDGNGFISKQELGTAMRSLGYMPNEVELEVIIQRLDMDGDGQVDFEEFVTLLGP","Homo sapiens","CABP7, CALN2","Calcium-binding protein 7","1","2LV7"
"2LV9",,"SOLUTION NMR",,,,,,,,,"2LV9",11.65,,,"Solution NMR structure of the PHD domain of human MLL5, Northeast structural genomics consortium target HR6512A","MHHHHHHSSGRENLYFQGSEDGSYGTDVTRCICGFTHDDGYMICCDKCSVWQHIDCMGIDRQHIPDTYLCERCQPRNLDKERAVLLQRRKRENMSDGD","Homo sapiens","MLL5, KMT2E","Histone-lysine N-methyltransferase MLL5","1","2LV9"
"2LVA",,"SOLUTION NMR",,,,,,,,,"2LVA",14.25,,,"NMR solution structure of the N-terminal domain of human USP28, Northeast structural genomics consortium target HT8470A","MHHHHHHSSGRENLYFQGQMLLNQLREITGIQDPSFLHEALKASNGDITQAVSLLTDERVKEPSQDTVATEPSEVEGSAANKEVLAKVIDLTHDNKDDLQAAIALSLLESPKIQADGRDLNRMHEATSA","Homo sapiens","USP28, KIAA1515","Ubiquitin carboxyl-terminal hydrolase 28","1","2LVA"
"2LVC",,"SOLUTION NMR",,,,,,,,,"2LVC",10.25,,,"Solution NMR Structure of Ig like domain (805-892) of Obscurin-like protein 1 from Homo sapiens, Northeast Structural Genomics Consortium (NESG) Target HR8578K","SHMPVHIVDPREHVFVHAITSECVMLACEVDREDAPVRWYKDGQEVEESDFVVLENEGPHRRLVLPATQPSDGGEFQCVAGDECAYFTVTI","Homo sapiens","KIAA0657, OBSL1","Obscurin-like protein 1","1","2LVC"
"2LVE",,"X-RAY DIFFRACTION",3.8,68,,5.6,"pH 5.6",,"10.1016/s0969-2126(98)00107-5",,"2LVE",12.65,"2.7","2.7","RECOMBINANT LEN","DIVMTQSPDSLAVSLGERATINCKSSQSVLYSSNSKNYLAWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYYSTPYSFGQGTKLEIKR","Homo sapiens","IGKV4-1","RLEN","1","2LVE"
"2LVN",,"SOLUTION NMR",,,,,,,"10.1016/j.str.2012.09.020",,"2LVN",5.97,,,"Structure of the gp78 CUE domain","SNSQLNAMAHQIQEMFPQVPYHLVLQDLQLTRSVEITTDNILEGRIQVPFPT","Homo sapiens","AMFR, RNF45","E3 ubiquitin-protein ligase AMFR","1","2LVN"
"2LVR",,"SOLUTION NMR",,,,,,,"10.1007/s10858-012-9670-1",,"2LVR",9.58,,,"Solution structure of Miz-1 zinc finger 8","MKPYVCIHCQRQFADPGALQRHVRIHTGEKPCQCVMCGKAFTQASSLIAHVRQHTGEKPYVCERCGKRFVQSSQLANHIRHHD","Homo sapiens","MIZ1, ZBTB17, ZHX1, ZNF151, ZNF60","Zinc finger and BTB domain-containing protein 17","1","2LVR"
"2LVT",,"SOLUTION NMR",,,,,,,"10.1007/s10858-012-9670-1",,"2LVT",9.58,,,"Solution structure of Miz-1 zinc finger 9","MKPYVCIHCQRQFADPGALQRHVRIHTGEKPCQCVMCGKAFTQASSLIAHVRQHTGEKPYVCERCGKRFVQSSQLANHIRHHD","Homo sapiens","MIZ1, ZBTB17, ZNF151, ZNF60","Zinc finger and BTB domain-containing protein 17","1","2LVT"
"2LVU",,"SOLUTION NMR",,,,,,,"10.1007/s10858-012-9670-1",,"2LVU",9.58,,,"Solution structure of Miz-1 zinc finger 10","MKPYVCIHCQRQFADPGALQRHVRIHTGEKPCQCVMCGKAFTQASSLIAHVRQHTGEKPYVCERCGKRFVQSSQLANHIRHHD","Homo sapiens","MIZ1, ZBTB17, ZNF151, ZNF60","Zinc finger and BTB domain-containing protein 17","1","2LVU"
"2LVZ",,"SOLUTION NMR",,,,,,,"10.1021/cb300386v",,"2LVZ",16.56,,,"Solution structure of a Eosinophil Cationic Protein-trisaccharide heparin mimetic complex","RPPQFTRAQWFAIQHISLNPPRCTIAMRAINNYRWRCKNQNTFLRTTFANVVNVCGNQSIRCPHNRTLNNCHRSRFRVPLLHCDLINPGAQNISNCRYADRPGRRFYVVACDNRDPRDSPRYPVVPVHLDTTI","Homo sapiens","RNASE3, ECP, RNS3","Eosinophil cationic protein","1","2LVZ"
"2LW4",,"SOLUTION NMR",,,,,,,,,"2LW4",12.74,,,"Solution NMR Structure of Human Transcription Elongation Factor A protein 2, Central Domain, Northeast Structural Genomics Consortium (NESG) Target HR8682B","SHMPVPVTCDAVRNKCREMLTAALQTDHDHVAIGADCERLSAQIEECIFRDVGNTDMKYKNRVRSRISNLKDAKNPDLRRNVLCGAITPQQIAVMTSEEMASDELKEIRKAMT","Homo sapiens","TCEA2","Transcription elongation factor A protein 2","1","2LW4"
"2LW7",,"SOLUTION NMR",,,,,,,,,"2LW7",19.21,,,"NMR solution structure of human HisRS splice variant","AERAALEELVKLQGERVRGLKQQKASAELIEEEVAKLLKLKAQLGPDESKQKFVLKTPKALEEKIRTTETQVLVASAQKKLLEERLKLVSELQDAGIKAELLYKKNPKLLNQLQYCEEAGIPLVAIIGEQELKDGVIKLRSVTSREEVDVRREDLVEEIKRRTGQPLSIS","Homo sapiens","HARS, HRS, HARS1","Histidine--tRNA ligase, cytoplasmic","1","2LW7"
"2LW8",,"SOLUTION NMR",,,,,,,,,"2LW8",20.99,,,"NMR solution structure of Eph receptor","GSNEVTLLDSRSVQGELGWIASPLEGGWEEVSIMDEKNTPIRTYQVCNVMEPSQNNWLRTDWITREGAQRVYIEIKFTLRDCNSLPGVMGTCKETFNLYYYESDNDKERFIRENQFVKIDTIAADESFTQVDIGDRIMKLNTEIRDVGPLSKKGFYLAFQDVGACIALVSVRVFYKKAPLTVR","Homo sapiens","EPHA4, HEK8, SEK, TYRO1","Ephrin type-A receptor 4","1","2LW8"
"2LW9",,"SOLUTION NMR",,,,,,,"10.1073/pnas.1208642109",,"2LW9",12.7,,,"NMR solution structure of Myo10 anti-CC","ENKQVEEILRLEKEIEDLQRMKEQQELSLTEASLQKLQERRDQELRRLEEE","Homo sapiens","MYO10, KIAA0799","Unconventionnal myosin-X","1","2LW9"
"2LWC",,"SOLUTION NMR",,,,,,,,,"2LWC",0.57,,,"Met-enkephalin in DPMC SUV","YGGFM","Homo sapiens","PENK","Met-enkephalin","1","2LWC"
"2LWD",,"SOLUTION NMR",,,,,,,"10.1016/j.str.2012.09.003",,"2LWD",11.78,,,"Solution structure of second CARD of human RIG-I","GSHMKKIEKLEEYRLLLKRLQPEFKTRIIPTDIISDLSECLINQECEEILQICSTKGMMAGAEKLVECLLRSDKENWPKTLKLALEKERNKFSELWIVEK","Homo sapiens","DDX58","Probable ATP-dependent RNA helicase DDX58","1","2LWD"
"2LWE",,"SOLUTION NMR",,,,,,,"10.1016/j.str.2012.09.003",,"2LWE",11.81,,,"Solution structure of mutant (T170E) second CARD of human RIG-I","GSHMKKIEKLEEYRLLLKRLQPEFKTRIIPTDIISDLSECLINQECEEILQICSTKGMMAGAEKLVECLLRSDKENWPKELKLALEKERNKFSELWIVEK","Homo sapiens","DDX58","Probable ATP-dependent RNA helicase DDX58","1","2LWE"
"2LWI",,"SOLUTION NMR",,,,,,,"10.1073/pnas.1217730110","KOB","2LWI",20.29,,,"Solution structure of H-RasT35S mutant protein in complex with Kobe2601","GPLGSDMTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPSIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHQYREQIKRVKDSDDVPMVLVGNKCDLAARTVESRQAQDLARSYGIPYIETSAKTRQGVEDAFYTLVREIRQH","Homo sapiens","HRAS, HRAS1","GTPase HRas","1","2LWI"
"2LWL",,"SOLUTION NMR",,,,,,,"10.1016/j.jmb.2013.08.001",,"2LWL",5.44,,,"Structural Basis for the Interaction of Human β-Defensin 6 and Its Putative Chemokine Receptor CCR2 and Breast Cancer Microvesicles","GSHMFFDEKCNKLKGTCKNNCGKNEELIALCQKSLKCCRTIQPSGSIID","Homo sapiens","DEFB106A, BD6, DEFB106, DEFB6, DEFB106B","Beta-defensin 106","1","2LWL"
"2LWZ",,"SOLUTION NMR",,,,,,,,,"2LWZ",6.38,,,"NMR Structures of Single-chain Insulin","FVNQHLCGSDLVEALYLVCGERGFFYTDPTGGGPRRGIVEQCCHSICSLYQLENYCN","Homo sapiens","INS","SINGLE-CHAIN INSULIN","1","2LWZ"
"2LX7",,"SOLUTION NMR",,,,,,,,,"2LX7",6.72,,,"Solution NMR structure of SH3 domain of growth arrest-specific protein 7 (GAS7) (fragment 1-60) from Homo sapiens, Northeast Structural Genomics Consortium (NESG) Target HR8574A","MSGARCRTLYPFSGERHGQGLRFAAGELITLLQVPDGGWWEGEKEDGLRGWFPASYVQLL","Homo sapiens","GAS7, KIAA0394","Growth arrest-specific protein 7","1","2LX7"
"2LXH",,"SOLUTION NMR",,,,,,,"10.1038/emboj.2013.174",,"2LXH",9.37,,,"NMR structure of the RING domain in ubiquitin ligase gp78","KNYLRVVGNMEARFAVATPEELAVNNDDCAICWDSMQAARKLPCGHLFHNSCLRSWLEQDTSCPTCRMSLNIADNNRVREE","Homo sapiens","AMFR, RNF45","E3 ubiquitin-protein ligase AMFR","1","2LXH"
"2LXI",,"SOLUTION NMR",,,,,,,,,"2LXI",10.48,,,"NMR structure of the N-terminal RNA Binding domain 1 (RRM1) of the protein RBM10 from Homo sapiens","SNIVMLRMLPQAATEDDIRGQLQSHGVQAREVRLMRNKSSGQSRGFAFVEFSHLQDATRWMEANQHSLNILGQKVSMHYSDPKPKINEDWL","Homo sapiens","RBM10, DXS8237E, GPATC9, GPATCH9, KIAA0122","RNA-binding protein 10","1","2LXI"
"2LXL",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M112.417899",,"2LXL",20.86,,,"Lip5(mit)2","MAALAPLPPLPAQFKSIQHHLRTAQEHDKRDPVVAYYCRLYAMQTGMKIDSKTPECRKFLSKLMDQLEALKKQLGDNEAITQEIVGCAHLENYALKMFLYADNEDRAGRFHKNMIKSFYTASLLIDVITVFGELTDENVKHRKYARWKATYIHNCLKNGETPQAGPVGIEEDNDIEENEDAGA","Homo sapiens","VTA1, C6orf55, HSPC228, My012","Vacuolar protein sorting-associated protein VTA1 homolog","1","2LXL"
"2LXU",,"SOLUTION NMR",,,,,,,,,"2LXU",12.17,,,"Solution NMR Structure of the eukaryotic RNA recognition motif, RRM1, from the heterogeneous nuclear ribonucleoprotein H from Homo sapiens, Northeast Structural Genomics Consortium (NESG) Target HR8614A","SHMGGEGFVVKVRGLPWSCSADEVQRFFSDCKIQNGAQGIRFIYTREGRPSGEAFVELESEDEVKLALKKDRETMGHRYVEVFKSNNVEMDWVLKHTGPNSPDTANDG","Homo sapiens","HNRNPH1, HNRPH, HNRPH1","Heterogeneous nuclear ribonucleoprotein H","1","2LXU"
"2LXW",,"SOLUTION NMR",,,,,,,,,"2LXW",6.27,,,"The solution structure of XIAP(RING)-binding domain of human XAF1","GSEFTSSPRGDKAAYDILRRCSQCGILLPLPILNQHQEKCRWLASSKGKQVRNFS","Homo sapiens","XAF1, BIRC4BP, XIAPAF1","XIAP-associated factor 1","1","2LXW"
"2LXZ",,"SOLUTION NMR",,,,,,,"10.1021/bi301255u",,"2LXZ",3.59,,,"Solution Structure of the Antimicrobial Peptide Human Defensin 5","ATCYCRTGRCATRESLSGVCEISGRLYRLCCR","Homo sapiens","DEFA5, DEF5","Defensin-5","1","2LXZ"
"2LY9",,"SOLUTION NMR",,,,,,,,,"2LY9",8.71,,,"Solution NMR Structure of Homeobox 2 Domain from Human ZHX1 repressor, Northeast Structural Genomics Consortium (NESG) Target HR7907F","SHMPDSFGIRAKKTKEQLAELKVSYLKNQFPHDSEIIRLMKITGLTKGEIKKWFSDTRYNQRNSKSNQCLHLNN","Homo sapiens","ZHX1","Zinc fingers and homeoboxes protein 1","1","2LY9"
"2LYH",,"SOLUTION NMR",,,,,,,"10.1093/nar/gkt354",,"2LYH",10.75,,,"Structure of Faap24 residues 141-215","MGSSHHHHHHSSHMLVPRGSLEPSKNPLLGKKRALLLSEPSLLRTVQQIPGVGKVKAPLLLQKFPSIQQLSNASIGELEQVVGQAVAQQIHAFFTQPR","Homo sapiens","C19orf40, FAAP24","Fanconi anemia-associated protein of 24 kDa","1","2LYH"
"2LYV",,"SOLUTION NMR",,,,,,,"10.1007/s10858-012-9696-4",,"2LYV",22.29,,,"Solution structure of the two RRM domains of hnRNP A1 (UP1) using segmental isotope labeling","GGSKSESPKEPEQLRKLFIGGLSFETTDESLRSHFEQWGTLTDCVVMRDPNTKRSRGFGFVTYATVEEVDAAMNARPHKVDGRVVEPKRAVSREDSQRPGAHLTVKKIFVGGIKEDTEEHHLRDYFEQYGKIEVIEIMTDRGSGKKRGFAFVTFDDHDSVDKIVIQKYHTVNGHNCEVRKALSKQEMASASSSQRGR","Homo sapiens","HNRNPA1, HNRPA1","Heterogeneous nuclear ribonucleoprotein A1","1","2LYV"
"2LZ1",,"SOLUTION NMR",,,,,,,,,"2LZ1",10.67,,,"Solution NMR Structure of the DNA-Binding Domain of Human NF-E2-Related Factor 2, Northeast Structural Genomics Consortium (NESG) Target HR3520O","MGHHHHHHSHMKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIV","Homo sapiens","NFE2L2, NRF2","Nuclear factor erythroid 2-related factor 2","1","2LZ1"
"2LZ3",,"SOLUTION NMR",,,,,,,"10.1038/ncomms4037",,"2LZ3",6.29,,,"Solution NMR structure of transmembrane domain of amyloid precursor protein WT","AMAKGAIIGLMVGGVVIATVIVITLVMLKKK","Homo sapiens","APP, A4, AD1","Amyloid beta A4 protein","1","2LZ3"
"2LZ4",,"SOLUTION NMR",,,,,,,"10.1038/ncomms4037",,"2LZ4",6.35,,,"Solution NMR structure of transmembrane domain of amyloid precursor protein V44M","AMAKGAIIGLMVGGVVIATMIVITLVMLKKK","Homo sapiens","APP, A4, AD1","Amyloid beta A4 protein","1","2LZ4"
"2LZG",,"SOLUTION NMR",,,,,,,"10.1021/ja305839b","13Q","2LZG",14.59,,,"NMR Structure of Mdm2 (6-125) with Pip-1","MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSEN","Homo sapiens","MDM2","E3 ubiquitin-protein ligase Mdm2","1","2LZG"
"2LZL",,"SOLUTION NMR",,,,,,,"10.1016/j.str.2013.08.026",,"2LZL",9.21,,,"FGFR3tm","LPAEEELVEADEAGSVYAGILSYGVGFFLFILVVAAVTLCRLR","Homo sapiens","FGFR3, JTK4","Fibroblast growth factor receptor 3","1","2LZL"
"2LZU",,"SOLUTION NMR",,,,,,,,,"2LZU",8.45,,,"Solution structure of LIMD2","RAQVKETCAACQKTVYPMERLVADKLIFHNSCFCCKHCHTKLSLGSYAALHGEFYCKPHFQQLFKSKGNYDE","Homo sapiens","LIMD2, SB143","LIM domain-containing protein 2","1","2LZU"
"2M03",,"SOLUTION NMR",,,,,,,"10.1038/nchembio.1166",,"2M03",20.8,,,"Solution structure of BCL-xL determined with selective isotope labelling of I,L,V sidechains","MSMAMSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERLEHHHHHH","Homo sapiens","BCL2-like 1, BCL2L, BCL2L1, BCLX","Bcl-2-like protein 1","1","2M03"
"2M09",,"SOLUTION NMR",,,,,,,"10.1093/nar/gks1097",,"2M09",13.82,,,"Structure, phosphorylation and U2AF65 binding of the Nterminal Domain of splicing factor 1 during 3 splice site Recognition","GAMEQKTVIPGMPTVIPPGLTREQERAYIVQLQIEDLTRKLRTGDLGIPPNPEDRSPSPEPIYNSEGKRLNTREFRTRKKLEEERHNLITEMVALNPDFKPPADYKPPATRVSDKVMIPQD","Homo sapiens","SF1, ZFM1, ZNF162","Splicing factor 1","1","2M09"
"2M0B",,"SOLUTION NMR",,,,,,,"10.1016/j.bbamem.2016.02.023",,"2M0B",9.47,,,"Homodimeric transmembrane domain of the human receptor tyrosine kinase ErbB1 (EGFR, HER1) in micelles","EGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKR","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","2M0B"
"2M0C",,"SOLUTION NMR",,,,,,,,,"2M0C",9.36,,,"Solution NMR Structure of Homeobox Domain of Human ALX4, Northeast Structural Genomics Consortium (NESG) Target HR4490C","SHMSNKGKKRRNRTTFTSYQLEELEKVFQKTHYPDVYAREQLAMRTDLTEARVQVWFQNRRAKWRKRERFGQMQQ","Homo sapiens","ALX4, KIAA1788","Homeobox protein aristaless-like 4","1","2M0C"
"2M0D",,"SOLUTION NMR",,,,,,,,,"2M0D",13.03,,,"Solution Structure of Miz-1 zinc finger 5","MKPYQCDYCGRSFSDPTSKMRHLETHDTDKEHKCPHCDKKFNQVGNLKAHLKIHIADGPLKCRECGKQFTTSGNLKRHLRIHSGEKPYVCIHCQRQFADPGALQRHVRIHTG","Homo sapiens","MIZ1, ZBTB17, ZNF151, ZNF60","Zinc finger and BTB domain-containing protein 17","1","2M0D"
"2M0E",,"SOLUTION NMR",,,,,,,,,"2M0E",13.03,,,"Solution Structure of Miz-1 zinc finger 6","MKPYQCDYCGRSFSDPTSKMRHLETHDTDKEHKCPHCDKKFNQVGNLKAHLKIHIADGPLKCRECGKQFTTSGNLKRHLRIHSGEKPYVCIHCQRQFADPGALQRHVRIHTG","Homo sapiens","MIZ1, ZBTB17, ZNF151, ZNF60","Zinc finger and BTB domain-containing protein 17","1","2M0E"
"2M0F",,"SOLUTION NMR",,,,,,,,,"2M0F",13.03,,,"Solution Structure of Miz-1 zinc finger 7","MKPYQCDYCGRSFSDPTSKMRHLETHDTDKEHKCPHCDKKFNQVGNLKAHLKIHIADGPLKCRECGKQFTTSGNLKRHLRIHSGEKPYVCIHCQRQFADPGALQRHVRIHTG","Homo sapiens","MIZ1, ZBTB17, ZNF151, ZNF60","Zinc finger and BTB domain-containing protein 17","1","2M0F"
"2M0H",,"SOLUTION NMR",,,,,,,,,"2M0H",2.54,,,"SP-B C-terminal (residues 59-80) peptide in methanol","DTLLGRMLPQLVCRLVLRCSMD","Homo sapiens","SFTPB, SFTP3","Pulmonary surfactant-associated protein B","1","2M0H"
"2M0O",,"SOLUTION NMR",,,,,,,"10.1016/j.molcel.2012.11.026",,"2M0O",10,,,"The solution structure of human PHF1 in complex with H3K36me3","SRLSRSGASSLWDPASPAPTSGPRPRLWEGQDVLARWTDGLLYLGTIKKVDSAREVCLVQFEDDSQFLVLWKDISPAAL","Homo sapiens","PHF1, PCL1","PHD finger protein 1","1","2M0O"
,,,,,,,,,,,,,,,,"ATGGVKKPHRY",,,"H3K36me3 peptide","2","2M0O"
"2M0P",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M112.434159",,"2M0P",5.91,,,"Solution structure of the tenth complement type repeat of human megalin","THAPASCLDTQYTCDNHQCISKNWVCDTDNDCGDGSDEKNCNSTETHHHHHH","Homo sapiens","LRP2","Low-density lipoprotein receptor-related protein 2","1","2M0P"
"2M0Q",,"SOLUTION NMR",,,,,,,"10.1038/srep04973",,"2M0Q",14.49,,,"Solution NMR analysis of intact KCNE2 in detergent micelles demonstrate a straight transmembrane helix","MSTLSNFTQTLEDVFRRIFITYMDNWRQNTTAEQEALQAKVDAENFYYVILYLMVMIGMFSFIIVAILVSTVKSKRREHSNDPYHQYIVEDWQEKYKSQILNLEESKATIHENIGAAGFKMSP","Homo sapiens","KCNE2","Potassium voltage-gated channel subfamily E member 2","1","2M0Q"
"2M0R",,"SOLUTION NMR",,,,,,,"10.1007/s00775-012-0963-3",,"2M0R",23.35,,,"Solution structure and dynamics of human S100A14","MGQCRSANAEDAQEFSDVERAIETLIKNFHQYSVEGGKETLTPSELRDLVTQQLPHLMPSNCGLEEKIANLGSCNDSKLEFRSFWELIGEAAKSVKLERPVRGH","Homo sapiens","S100A14, S100A15","Protein S100-A14","1","2M0R"
"2M0T",,"SOLUTION NMR",,,,,,,"10.1016/j.jmb.2013.04.001",,"2M0T",12.82,,,"Structural characterization of the extended PDZ1 domain from NHERF1","GIDPFTMLPRLCCLEKGPNGYGFHLHGEKGKLGQYIRLVEPGSPAEKAGLLAGDRLVEVNGENVEKETHQQVVSRIRAALNAVRLLVVDPETDEQLQKLGVQVREELLRAQEAPGQA","Homo sapiens","SLC9A3R1, NHERF, NHERF1","Na(+)/H(+) exchange regulatory cofactor NHE-RF1","1","2M0T"
"2M0U",,"SOLUTION NMR",,,,,,,"10.1016/j.jmb.2013.04.001",,"2M0U",13.46,,,"Complex structure of C-terminal CFTR peptide and extended PDZ1 domain from NHERF1","GIDPFTMLPRLCCLEKGPNGYGFHLHGEKGKLGQYIRLVEPGSPAEKAGLLAGDRLVEVNGENVEKETHQQVVSRIRAALNAVRLLVVDPETDEQLQKLGVQVREELLRAQEAPGQA","Homo sapiens","SLC9A3R1, NHERF, NHERF1","Na(+)/H(+) exchange regulatory cofactor NHE-RF1","1","2M0U"
,,,,,,,,,,,,,,,,"QDTRL",,,"C-terminal CFTR peptide","2","2M0U"
"2M0V",,"SOLUTION NMR",,,,,,,"10.1016/j.jmb.2013.04.001",,"2M0V",14.73,,,"Complex structure of C-terminal CFTR peptide and extended PDZ2 domain from NHERF1","GIDPFTMLRPRLCTMKKGPSGYGFNLHSDKSKPGQFIRSVDPDSPAEASGLRAQDRIVEVNGVCMEGKQHGDVVSAIRAGGDETKLLVVDRETDEFFKKCRVIPSQEHLNGPLPVPFTNGEIQKENSR","Homo sapiens","SLC9A3R1, NHERF, NHERF1","Na(+)/H(+) exchange regulatory cofactor NHE-RF1","1","2M0V"
,,,,,,,,,,,,,,,,"QDTRL",,,"C-terminal CFTR peptide","2","2M0V"
"2M0X",,"SOLUTION NMR",,,,,,,"10.1073/pnas.1302407110",,"2M0X",8.71,,,"Solution structure of U14Ub1, an engineered ubiquitin variant with increased affinity for USP14","GSMQIFVKGLTGKTTTLEVEPSDTIENVKAKIQDKTGLPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHIVWRLRGG","Homo sapiens",,"engineered ubiquitin variant","1","2M0X"
"2M0Z",,"SOLUTION NMR",,,,,,,"10.1073/pnas.1306323110",,"2M0Z",10.59,,,"cis form of a photoswitchable PDZ domain crosslinked with an azobenzene derivative","GPKPGDIFEVELAKNDNSLGICVTGGVNTSVRHGGIYVKAVIPQGAAESDGRIHKGDRVLAVNGVSLEGATHKQAVCTLRNTGQVVHLLLEKGQSPT","Homo sapiens","PTPN13, PNP1, PTP1E, PTPL1","Tyrosine-protein phosphatase non-receptor type 13","1","2M0Z"
"2M10",,"SOLUTION NMR",,,,,,,"10.1073/pnas.1306323110",,"2M10",10.59,,,"trans form of a photoswitchable PDZ domain crosslinked with an azobenzene derivative","GPKPGDIFEVELAKNDNSLGICVTGGVNTSVRHGGIYVKAVIPQGAAESDGRIHKGDRVLAVNGVSLEGATHKQAVCTLRNTGQVVHLLLEKGQSPT","Homo sapiens","PTPN13, PNP1, PTP1E, PTPL1","Tyrosine-protein phosphatase non-receptor type 13","1","2M10"
"2M13",,"SOLUTION NMR",,,,,,,"10.1016/j.jmb.2013.03.009",,"2M13",7.9,,,"The ZZ domain of cytoplasmic polyadenylation element binding protein 1 (CPEB1)","GPVQIDPYLEDSLCHICSSQPGPFFCRDQVCFKYFCRSCWHWRHSMEGLRHHSPLMRNQKNRDSS","Homo sapiens","CPEB, CPEB1","Cytoplasmic polyadenylation element-binding protein 1","1","2M13"
"2M16",,"SOLUTION NMR",,,,,,,"10.1093/nar/gkt074",,"2M16",11.03,,,"P75/LEDGF PWWP Domain","GPGSMTRDFKPGDLIFAKMKGYPHWPARVDEVPDGAVKPPTNKLPIFFFGTHETAFLGPKDIFPYSENKEKYGKPNKRKGFNEGLWEIDNNPKVKFS","Homo sapiens","DFS70, LEDGF, PSIP1, PSIP2","PC4 and SFRS1-interacting protein","1","2M16"
"2M17",,"SOLUTION NMR",,,,,,,"10.1371/journal.pone.0062981",,"2M17",9,,,"ubiquitin-like domain-containing C-terminal domain phosphatase (UBLCP1)","MALPIIVKWGGQEYSVTTLSEDDTVLDLKQFLKTLTGVLPERQKLLGLKVKGKPAENDVKLGALKLKPNTKIMMMGTREESX","Homo sapiens","UBLCP1","Ubiquitin-like domain-containing CTD phosphatase 1","1","2M17"
"2M1D",,"SOLUTION NMR",,,,,,,"10.1007/s10858-013-9713-2",,"2M1D",5.82,,,"Biosynthetic engineered B28K-B29P human insulin monomer structure in in water/acetonitrile solutions.","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","Insulin","1","2M1D"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFYTKPT","Homo sapiens","INS","Insulin","2","2M1D"
"2M1E",,"SOLUTION NMR",,,,,,,"10.1007/s10858-013-9713-2",,"2M1E",5.82,,,"Biosynthetic engineered B28K-B29P human insulin monomer structure in in water solutions.","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","Insulin","1","2M1E"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFYTKPT","Homo sapiens","INS","Insulin","2","2M1E"
"2M1L",,"SOLUTION NMR",,,,,,,,,"2M1L",15.29,,,"Solution NMR Structure of Cyclin-dependent kinase 2-associated protein 2 (CDK2AP2, DOC-1R) from Homo sapiens, Northeast Structural Genomics Consortium (NESG) Target HR8910C","SHMAMKPPGAQGSQSTYTDLLSVIEEMGKEIRPTYAGSKSAMERLKRGIIHARALVRECLAETERNART","Homo sapiens","CDK2AP2, DOC1R","Cyclin-dependent kinase 2-associated protein 2","1","2M1L"
"2M1R",,"SOLUTION NMR",,,,,,,"10.1093/carcin/bgq171",,"2M1R",7.46,,,"PHD domain of ING4 N214D mutant","MDMPVDPNEPTYCLCHQVSYGEMIGCDDPDCSIEWFHFACVGLTTKPRGKWFCPRCSQERKKK","Homo sapiens","ING4, My036","Inhibitor of growth protein 4","1","2M1R"
"2M1T",,"SOLUTION NMR",,,,,,,,,"2M1T",2.5,,,"SP-B C-terminal (residues 59-80) peptide in DPC micelles","DTLLGRILPQLVCRLVLRCSID","Homo sapiens","SFTPB, SFTP3","Pulmonary surfactant-associated protein B","1","2M1T"
"2M1W",,"SOLUTION NMR",,,,,,,"10.1073/pnas.1222811110",,"2M1W",19.39,,,"TICAM-2 TIR domain","GPLGSEEVFLKFVILHAEDDTDEALRVQNLLQDDFGIKPGIIFAEMPHGRQHLQNLDDAVNGSAWTILLLTENFLRDTWCNFQFYTSLMNSVNRQHKYNSVIPMRPLNNPLPRERTPFALQTINALEEESRGFPTQVERIFQESVYKTQQTIWKETRNMVQRQFIA","Homo sapiens","TICAM2, TIRAP3, TIRP, TRAM","TIR domain-containing adapter molecule 2","1","2M1W"
"2M1X",,"SOLUTION NMR",,,,,,,"10.1073/pnas.1222811110",,"2M1X",19.13,,,"TICAM-1 TIR domain structure","MESSSEQKFYNFVILHARADEHIALRVREKLEALGVPDGATFCEDFQVHGRGELSCLQDAIDHSAFIILLLTSNFDCRLSLHQVNQAMMSNLTRQGSPDCVIPFLPLESSPAQLSSDTASLLSGLVRLDEHSQIFARKVANTFKPHRLQARKAMWRKEQDLEHHHHHH","Homo sapiens","TICAM1, PRVTIRB, TRIF","TIR domain-containing adapter molecule 1","1","2M1X"
"2M20",,"SOLUTION NMR",,,,,,,"10.1016/j.cell.2012.12.032",,"2M20",13.56,,,"EGFR transmembrane - juxtamembrane (TM-JM) segment in bicelles: MD guided NMR refined structure.","KIPSIATGLVGALLLLLVVALGIGLFIRRRHIVRKRTLRRLLQERELVEPLTPSGEKLWS","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","2M20"
"2M27",,"SOLUTION NMR",,,,,,,"10.1093/nar/gkt784",,"2M27",6.92,,,"Major G-quadruplex structure formed in human VEGF promoter, a monomeric parallel-stranded quadruplex","CGGGGCGGGCCTTGGGCGGGGT","Homo sapiens",,"DNA_(5'-D(*CP*GP*GP*GP*GP*CP*GP*GP*GP*CP*CP*TP*TP*GP*GP*GP*CP*GP*GP*GP*GP*T)-3')_","1","2M27"
"2M2B",,"SOLUTION NMR",,,,,,,,,"2M2B",13.78,,,"NMR structure of the RRM2 domain of the protein RBM10 from Homo sapiens","QAQGVLASQALSQGSEPSSENANDTIILRNLNPHSTMDSILGALAPYAVLSSSNVRVIKDKQTQLNRGFAFIQLSTIEAAQLLQILQALHPPLTIDGKTINVEFAKGSKRDMASNEGSRISAASVASTAIA","Homo sapiens","RBM10, DXS8237E, GPATC9, GPATCH9, KIAA0122","RNA-binding protein 10","1","2M2B"
"2M2D",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M112.448126",,"2M2D",13.25,,,"Human programmed cell death 1 receptor","MPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDSRFRVTQLPNGRDFHMSVVRARRNDSGTYLCGAISLAPKAQIKESLRAELRVTERRAE","Homo sapiens","PDCD1, PD1","Programmed cell death protein 1","1","2M2D"
"2M2E",,"SOLUTION NMR",,,,,,,,,"2M2E",8.49,,,"Solution NMR structure of the SANT domain of human DNAJC2, Northeast structural genomics consortium target HR8254a","QGFTPWTTEEQKLLEQALKTYPVNTPERWKKIAEAVPGRTKKDCMKRYKELVEMVKAKKAAQEQVLNASRAKK","Homo sapiens","DNAJC2, MPHOSPH11, MPP11, ZRF1","DnaJ homolog subfamily C member 2","1","2M2E"
"2M2F",,"SOLUTION NMR",,,,,,,"10.1021/ja400340u",,"2M2F",9.91,,,"The membran-proximal domain of ADAM17","MGSSHHHHHHSSGLVPRGSHMDDDDKFCEREQQLESCACNETDNSCKVCCRDLSGRCVPYVDAEQKNLFLRKGKPCTVGFCDMNGKCE","Homo sapiens","ADAM17, CSVP, TACE","Disintegrin and metalloproteinase domain-containing protein 17","1","2M2F"
"2M2M",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M112.448050",,"2M2M",5.81,,,"Structure of [L-HisB24] insulin analogue at pH 1.9","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","Insulin A chain","1","2M2M"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGHFYTPKT","Homo sapiens","INS","Insulin B chain","2","2M2M"
"2M2N",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M112.448050",,"2M2N",5.81,,,"Structure of [L-HisB24] insulin analogue at pH 8.0","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","Insulin A chain","1","2M2N"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGHFYTPKT","Homo sapiens","INS","Insulin B chain","2","2M2N"
"2M2O",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M112.448050",,"2M2O",5.81,,,"Structure of [D-HisB24] insulin analogue at pH 1.9","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","Insulin A chain","1","2M2O"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGHFYTPKT","Homo sapiens","INS","Insulin B chain","2","2M2O"
"2M2P",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M112.448050",,"2M2P",5.81,,,"Structure of [D-HisB24] insulin analogue at pH 8.0","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","Insulin A chain","1","2M2P"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGHFYTPKT","Homo sapiens","INS","Insulin B chain","2","2M2P"
"2M32",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M113.480251",,"2M32",27.42,,,"Alpha-1 integrin I-domain in complex with GLOGEN triple helical peptide","STQLDIVIVLDGSNSIYPWDSVTAFLNDLLERMDIGPKQTQVGIVQYGENVTHEFNLNKYSSTEEVLVAAKKIVQRGGRQTMTALGIDTARKEAFTEARGARRGVKKVMVIVTDGESHDNHRLKKVIQDCEDENIQRFSIAILGSYNRGNLSTEKFVEEIKSIASEPTEKHFFNVSDELALVTIVKTLGERI","Homo sapiens","ITGA1","Integrin alpha-1","1","2M32"
,,,,,,,,,,,,,,,,"XGPPGPPGLPGENGPPGPPGPPX",,,"GLOGEN peptide","2","2M32"
"2M34",,"SOLUTION NMR",,,,,,,,,"2M34",8.35,,,"NMR Structure of the homeodomain transcription factor Gbx1 from Homo sapiens","SAPGGKSRRRRTAFTSEQLLELEKEFHCKKYLSLTERSQIAHALKLSEVQVKIWFQNRRAKWKRIKAGNVS","Homo sapiens","GBX1","Homeobox protein GBX-1","1","2M34"
"2M38",,"SOLUTION NMR",,,,,,,"10.1371/journal.pone.0065605",,"2M38",17.07,,,"PTB domain of AIDA1","STPVQAWQHHPEKLIAQSCDYKAAYLGSMLIKELRGTESTQDACAKMRANCQKSTEQMKKVPTIILSVSAKGVKFIDATNKNIIAEHEIRNISCAAQDPEDLSTFAYITKDLKSNHHYCHVFTAFDVNLAAEIILTLGQAFEVAYQLALQARK","Homo sapiens","ANKS1B","Ankyrin repeat and sterile alpha motif domain-containing protein 1B","1","2M38"
"2M3D",,"SOLUTION NMR",,,,,,,,,"2M3D",10.64,,,"NMR structure of the GUCT domain from human DEAD box polypeptide 21","GHISGATSVDQRSLINSNVGFVTMILQCSIEMPNISYAWKELKEQLGEEIDSKVKGMVFLKGKLGVCFDVPTASVTEIQEKWHDSRRWQLSVATE","Homo sapiens","DDX21","Nucleolar RNA helicase 2","1","2M3D"
"2M3E",,"SOLUTION NMR",,,,,,,,,"2M3E",5.72,,,"The Integrin Alpha L Transmembrane Domain in Bicelles: Structure and Interaction with Integrin Beta 2","SNADVVYEKQMLYLYVLSGIGGLLLLLLIFIVLYKVGFFKRNLKEKMEAG","Homo sapiens","ITGAL, CD11A","Integrin alpha-L","1","2M3E"
"2M3H",,"SOLUTION NMR",,,,,,,"10.1007/s10858-013-9726-x",,"2M3H",7.18,,,"Structure of Dido PHD domain","GSMDPNALYCICRQPHNNRFMICCDRCEEWFHGDCVGISEARGRLLERNGEDYICPNCTIL","Homo sapiens","DIDO1, C20orf158, DATF1, KIAA0333","Death-inducer obliterator 1","1","2M3H"
"2M3T",,"SOLUTION NMR",,,,,,,"10.1016/j.str.2013.09.017",,"2M3T",20.96,,,"Solution-state NMR structure of wild-type human gamma(S)-crystallin","GSKTGTKITFYEDKNFQGRRYDCDCDCADFHTYLSRCNSIKVEGGTWAVYERPNFAGYMYILPQGEYPEYQRWMGLNDRLSSCRAVHLPSGGQYKIQIFEKGDFSGQMYETTEDCPSIMEQFHMREIHSCKVLEGVWIFYELPNYRGRQYLLDKKEYRKPIDWGAASPAVQSFRRIVE","Homo sapiens","CRYGS, GRYG8, CRYG8","Beta-crystallin S","1","2M3T"
"2M3U",,"SOLUTION NMR",,,,,,,"10.1016/j.str.2013.09.017",,"2M3U",21,,,"Solution-state NMR structure of cataract-related human gamma(S)-crystallin point variant G18V","GSKTGTKITFYEDKNFQVRRYDCDCDCADFHTYLSRCNSIKVEGGTWAVYERPNFAGYMYILPQGEYPEYQRWMGLNDRLSSCRAVHLPSGGQYKIQIFEKGDFSGQMYETTEDCPSIMEQFHMREIHSCKVLEGVWIFYELPNYRGRQYLLDKKEYRKPIDWGAASPAVQSFRRIVE","Homo sapiens","CRYGS, GRYG8, CRYG8","Beta-crystallin S","1","2M3U"
"2M3W",,"SOLUTION NMR",,,,,,,,,"2M3W",20.85,,,"Protein structure determination from a set of 4D NOESY","GSELETAMETLINVFHAHSGKEGDKYKLSKKQLKELLQTELSGFLDAQKDVDAVDKVMKELDENGDGEVDFQEYVVLVAALTVACNNFFWENS","Homo sapiens","S100A1, S100A","Protein S100-A1","1","2M3W"
"2M4J",,"SOLID-STATE NMR",,,,,,,"10.1016/j.cell.2013.08.035",,"2M4J",39.02,,,"40-residue beta-amyloid fibril derived from Alzheimer's disease brain","DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVV","Homo sapiens","APP, A4, AD1","Amyloid beta A4 protein","1","2M4J"
"2M51",,"SOLUTION NMR",,,,,,,,,"2M51",7.27,,,"NMR structure of the SH3 domain of human RAS p21 protein activator (GTPase activating protein) 1","GRRRVRAILPYTKVPDTDEISFLKGDMFIVHNELEDGWMWVTNLRTDEQGLIVEDLVEEVGR","Homo sapiens","RASA1, RASA, GAP","Ras GTPase-activating protein 1","1","2M51"
"2M59",,"SOLUTION NMR",,,,,,,"10.1016/j.str.2014.05.010",,"2M59",8.26,,,"Spatial structure of dimeric VEGFR2 membrane domain in DPC micelles","EKTNLEIIILVGTAVIAMFFWLLLVIILRTVKRANGG","Homo sapiens","KDR, FLK1, VEGFR2","Vascular endothelial growth factor receptor 2","1","2M59"
"2M5H",,"SOLUTION NMR",,,,,,,"10.1007/s10858-013-9746-6",,"2M5H",16.25,,,"NMR structure note: solution structure of monomeric human FAM96A","MRQPRIMEEKALEVYDLIRTIRDPEKPNTLEELEVVSESCVEVQEINEEEYLVIIRFTPTVPHCSLATLIGLCLRVKLQRCLPFKHKLEIYISEGTHSTEEDINKQINDKERVAAAMENPNLREIVEQCVLEPDQLEHH","Homo sapiens","FAM96A, CIAO2A, CIA2A","MIP18 family protein FAM96A","1","2M5H"
"2M5I",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M113.503680",,"2M5I",15.24,,,"NMR structures of human apoptotic protein tBid in LPPG micelle","GNRSSHSRLGRIEADSESQEDIIRNIARHLAQVGDSMDRSIPPGLVNGLALQLRNTSRSEEDRNRDLATALEQLLQAYPRDMEKEKTMLVLALLLAKKVASHTPSLLRDVFHTTVNFINQNLRTYVRSLARNGMD","Homo sapiens","BID","BH3-interacting domain death agonist","1","2M5I"
"2M5N",,"SOLID-STATE NMR",,,,,,,"10.1073/pnas.1219476110",,"2M5N",19.17,,,"Atomic-resolution structure of a cross-beta protofilament","YTIAALLSPYS","Homo sapiens","TTR, PALB","Transthyretin","1","2M5N"
"2M5O",,"SOLUTION NMR",,,,,,,,,"2M5O",10.82,,,"Solution NMR Structure CTD domain of NFU1 Iron-Sulfur Cluster Scaffold Homolog from Homo sapiens, Northeast Structural Genomics Consortium (NESG) Target HR2876C","MGHHHHHHSHMGSEEDDGVVAMIKELLDTRIRPTVQEDGGDVIYKGFEDGIVQLKLQGSCTSCPSSIITLKNGIQNMLQFYIPEVEGVEQVMDDESD","Homo sapiens","CGI-33, HIRIP5, NFU1","NFU1 iron-sulfur cluster scaffold homolog, mitochondrial","1","2M5O"
"2M5P",,"SOLUTION NMR",,,,,,,,,"2M5P",4,,,"Solution structure of lipidated glucagon analog in water","HAQGTFTSDYSKKLDARRAQDFVQWLMNTX","Homo sapiens","GCG","Glucagon","1","2M5P"
"2M5Q",,"SOLUTION NMR",,,,,,,,,"2M5Q",4,,,"Solution structure of lipidated glucagon analog in d-TFE","HAQGTFTSDYSKKLDARRAQDFVQWLMNTX","Homo sapiens","GCG","Glucagon","1","2M5Q"
"2M5V",,"SOLUTION NMR",,,,,,,"10.1371/journal.pone.0067843",,"2M5V",11.58,,,"Three-dimensional structure of human NLRP10/PYNOD pyrin domain","GAMAMAKARKPREALLWALSDLEENDFKKLKFYLRDMTLSEGQPPLARGELEGLIPVDLAELLISKYGEKEAVKVVLKGLKVMNLLELVDQLSHICLHDYRE","Homo sapiens","NLRP10, NALP10, NOD8, PYNOD","NACHT, LRR and PYD domains-containing protein 10","1","2M5V"
"2M63",,"SOLUTION NMR",,,,,,,"10.1007/s10858-014-9819-1",,"2M63",17.4,,,"The protease-resistant N-terminal domain of TIR-domain containing adaptor molecule-1, TICAM-1","GPHMACTGPSLPSAFDILGAAGQDKLLYLKHKLKTPRPGCQGQDLLHAMVLLKLGQETEARISLEALKADAVARLVARQWAGVDSTEDPEEPPDVSWAVARLYHLLAEEKLCPASLRDVAYQEAVRTLSSRDDHRLGELQDEARNRCGWDIAGDPGSIR","Homo sapiens","TICAM1, PRVTIRB, TRIF","TIR domain-containing adapter molecule 1","1","2M63"
"2M65",,"SOLUTION NMR",,,,,,,"10.1038/ncomms2883",,"2M65",24.18,,,"NMR structure of human restriction factor APOBEC3A","MEASPASGPRHLMDPHIFTSNFNNGIGRHKTYLCYEVERLDNGTSVKMDQHRGFLHNQAKNLLCGFYGRHAELRFLDLVPSLQLDPAQIYRVTWFISWSPCFSWGCAGEVRAFLQENTHVRLRIFAARIYDYDPLYKEALQMLRDAGAQVSIMTYDEFKHCWDTFVDHQGCPFQPWDGLDEHSQALSGRLRAILQNQGNLEHHHHHH","Homo sapiens","APOBEC3A","Probable DNA dC->dU-editing enzyme APOBEC-3A","1","2M65"
"2M68",,"SOLUTION NMR",,,,,,,"10.1073/pnas.1513023113",,"2M68",15.43,,,"NMR solution structure ensemble of 3-4D mutant domain 11 IGF2R in complex with IGF2 (domain 11 structure only)","MKSNEHDDCQVTNPSTGHLFDLSSLSGRAGFTAAYAKGWGVYMSICGENENCPPGVGACFGQTRISVGKANKRLRYVDQVLQLVYKDGSPCPSKSGLSYKSVISFVCRPEAGPTNRPMLISLDKQTCTLFFSWHTPLACELA","Homo sapiens","Domain 11 IGF2R, IGF2R, MPRI","Insulin-like growth factor 2 receptor variant","1","2M68"
"2M6B",,"SOLUTION NMR",,,,,,,"10.1016/j.str.2013.07.014",,"2M6B",17.32,,,"Structure of full-length transmembrane domains of human glycine receptor alpha1 monomer subunit","MLERQLGYYLIQLYIPSLLIVILSWISFWINLDAAPARVGLGITTVLTLTTQSSGSRASLPKVSYVKAIDIWLAVCLLFVFSALLEYAAVNFVSRQREFGGGGFIQRAKKIDKISRIGFPLAFLIFNLFYWIIYKIVRREDEFEHHHHHH","Homo sapiens","GLRA1","Full-Length Transmembrane Domains of Human Glycine Receptor alpha1 Subunit","1","2M6B"
"2M6I",,"SOLUTION NMR",,,,,,,"10.1016/j.str.2013.07.014",,"2M6I",86.6,,,"Putative pentameric open-channel structure of full-length transmembrane domains of human glycine receptor alpha1 subunit","MLERQLGYYLIQLYIPSLLIVILSWISFWINLDAAPARVGLGITTVLTLTTQSSGSRASLPKVSYVKAIDIWLAVCLLFVFSALLEYAAVNFVSRQREFGGGGFIQRAKKIDKISRIGFPLAFLIFNLFYWIIYKIVRREDEFEHHHHHH","Homo sapiens","GLRA1","Full-Length Transmembrane Domains of Human Glycine Receptor alpha1 Subunit","1","2M6I"
"2M6N",,"SOLUTION NMR",,,,,,,"10.1038/nsmb.2593",,"2M6N",9.74,,,"3D solution structure of EMI1 (Early Mitotic Inhibitor 1)","GSEVAKTLKKNESLKACIRCNSPAKYDCYLQRATCKREGCGFDYCTKCLCNYHTTKDCSDGKLLKASCKIGPLPGTKKSKKNLRRL","Homo sapiens","FBXO5, EMI1, FBX5","F-box only protein 5","1","2M6N"
"2M6T",,"SOLUTION NMR",,,,,,,"10.1073/pnas.1513023113",,"2M6T",15.43,,,"NMR solution structure ensemble of 3-4D mutant domain 11 IGF2R","MKSNEHDDCQVTNPSTGHLFDLSSLSGRAGFTAAYAKGWGVYMSICGENENCPPGVGACFGQTRISVGKANKRLRYVDQVLQLVYKDGSPCPSKSGLSYKSVISFVCRPEAGPTNRPMLISLDKQTCTLFFSWHTPLACELA","Homo sapiens","IGF2R, MPRI","Insulin-like growth factor 2 receptor variant","1","2M6T"
"2M6Y",,"SOLUTION NMR",,,,,,,"10.1021/bi401329a",,"2M6Y",9.1,,,"The solution structure of the J-domain of human DnaJA1","MGHHHHHHSHMVKETTYYDVLGVKPNATQEELKKAYRKLALKYHPDKNPNEGEKFKQISQAYEVLSDAKKRELYDKG","Homo sapiens","DNAJA1, DNAJ2, HDJ2, HSJ2, HSPF4","DnaJ homolog subfamily A member 1","1","2M6Y"
"2M74",,"SOLUTION NMR",,,,,,,"10.1016/j.str.2013.08.004",,"2M74",14.12,,,"1H, 13C and 15N assignments of the four N-terminal domains of human fibrillin-1","SARGGGGHDALKGPNVCGSRYNAYCCPGWKTLPGGNQCIVPICRHSCGDGFCSRPNMCTCPSGQIAPSCGSRSIQHCNIRCMNGGSCSDDHCLCQKGYIGTHCGQPVCESGCLNGGRCVAPNRCACTYGFTGPQCE","Homo sapiens","FBN, FBN1","Fibrillin-1","1","2M74"
"2M76",,"SOLUTION NMR",,,,,,,"10.1002/bip.22396",,"2M76",5.71,,,"Structure of the Regulatory Domain of Human Brain Carnitine Palmitoyltransferase 1","MAEAHQAVGFRPSLTSDGAEVELSAPVLQEIYLSGLRSWKRHLSRFWNDF","Homo sapiens","CPT1C, CATL1","Carnitine O-palmitoyltransferase 1, brain isoform","1","2M76"
"2M7P",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M113.499640",,"2M7P",4.59,,,"RXFP1 utilises hydrophobic moieties on a signalling surface of the LDLa module to mediate receptor activation","GSQDVTCSLGYFPCGNITKCIPQFWRCDGQVDCDNGSDEQGC","Homo sapiens","RXFP1, LGR7, LDLR","Low-density lipoprotein receptor, Relaxin receptor 1","1","2M7P"
"2M7Q",,"SOLUTION NMR",,,,,,,"10.1016/j.jmb.2013.11.006",,"2M7Q",8.46,,,"Solution structure of TAX1BP1 UBZ1+2","GPHMDVHKKCPLCELMFPPNYDQSKFEEHVESHWKVCPMCSEQFPPDYDQQVFERHVQTHFDQNVLNFD","Homo sapiens","TAX1BP1, T6BP, PRO0105","Tax1-binding protein 1","1","2M7Q"
"2M7S",,"SOLUTION NMR",,,,,,,,,"2M7S",10.21,,,"NMR structure of RNA recognition motif 2 (RRM2) of Homo sapiens splicing factor, arginine/serine-rich 1","GAPRGRYGPPSRRSENRVVVSGLPPSGSWQDLKDHMREAGDVCYADVYRDGTGVVEFVRKEDMTYAVRKLDNTKFRSHEGETAYIRVKVD","Homo sapiens","SRSF1, ASF, SF2, SF2P33, SFRS1, OK/SW-cl.3","Serine/arginine-rich splicing factor 1","1","2M7S"
"2M85",,"SOLUTION NMR",,,,,,,"10.1007/s10858-013-9758-2",,"2M85",8.72,,,"PHD Domain from Human SHPRH","GSPNSRVDFNTSDYRFECICGELDQIDRKPRVQCLKCHLWQHAKCVNYDEKNLKIKPFYCPHCLVAMEPVSTR","Homo sapiens","SHPRH, KIAA2023","E3 ubiquitin-protein ligase SHPRH","1","2M85"
"2M8D",,"SOLUTION NMR",,,,,,,"10.1073/pnas.1303445110",,"2M8D",12.93,,,"Structure of SRSF1 RRM2 in complex with the RNA 5'-UGAAGGAC-3'","UGAAGGAC",,,"RNA (5'-R(*UP*GP*AP*AP*GP*GP*AP*C)-3')","1","2M8D"
,,,,,,,,,,,,,,,,"MAPRGRYGPPSRRSENRVVVSGLPPSGSWQDLKDHMREAGDVCYADVYRDGTGVVEFVRKEDMTYAVRKLDNTKFRSHEGETAYIRVKVDG","Homo sapiens","SRSF1, ASF, SF2, SF2P33, SFRS1, OK/SW-cl.3","Serine/arginine-rich splicing factor 1","2","2M8D"
"2M8H",,"SOLUTION NMR",,,,,,,,,"2M8H",11.47,,,"RRM domain of human RBM7","GSEFELRRQQALAEADRTLFVGNLETKVTEELLFELFHQAGPVIKVKIPKDKDGKPKQFAFVNFKHEVSVPYAMNLLNGIKLYGRPIKIQFRSGSSHAPQD","Homo sapiens","RBM7","RNA-binding protein 7","1","2M8H"
"2M8I",,"SOLUTION NMR",,,,,,,"10.1021/ja405244v",,"2M8I",5.04,,,"Structure of Pin1 WW domain","GLEHMADEEKLPPGWEKRMSRSSGRVYYFNHITNASQWERPSG","Homo sapiens","PIN1","Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1","1","2M8I"
"2M8J",,"SOLUTION NMR",,,,,,,"10.1021/ja405244v",,"2M8J",5.09,,,"Structure of Pin1 WW domain phospho-mimic S16E","GLEHMADEEKLPPGWEKRMERSSGRVYYFNHITNASQWERPSG","Homo sapiens","PIN1","Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1","1","2M8J"
"2M8T",,"SOLUTION NMR",,,,,,,"10.1016/j.celrep.2013.06.030",,"2M8T",16.56,,,"Solution NMR structure of the V209M variant of the human prion protein (residues 90-231)","GSDPGQGGGTHSQWNKPSKPKTNMKHMAGAAAAGAVVGGLGGYMLGSAMSRPIIHFGSDYEDRYYRENMHRYPNQVYYRPMDEYSNQNNFVHDCVNITIKQHTVTTTTKGENFTETDVKMMERMVEQMCITQYERESQAYYQRGSS","Homo sapiens","PRIP, PRNP, PRP, ALTPRP","Major prion protein","1","2M8T"
"2M96",,"SOLUTION NMR",,,,,,,,,"2M96",4.69,,,"Solution NMR structure of the RXFP2 LDLa module","GSMITPSCQKGYFPCGNLTKCLPRAFHCDGKDDCGNGADEENCG","Homo sapiens","RXFP2, GPR106, GREAT, LGR8","Relaxin receptor 2","1","2M96"
"2M9A",,"SOLUTION NMR",,,,,,,,,"2M9A",11.7,,,"Solution NMR Structure of E3 ubiquitin-protein ligase ZFP91 from Homo sapiens, Northeast Structural Genomics Consortium (NESG) Target HR7784A","MGHHHHHHSHMRDYICEYCARAFKSSHNLAVHRMIHTGEKPLQCEICGFTCRQKASLNWHMKKHDADSFYQFSCNICGKKFEKKDSVVAHKAKSHPEV","Homo sapiens","FKSG11, ZFP91, ZNF757","E3 ubiquitin-protein ligase ZFP91","1","2M9A"
"2M9E",,"SOLUTION NMR",,,,,,,"10.1021/ja4040472",,"2M9E",3.85,,,"NMR solution structure of Pin1 WW domain mutant 5-1","KLPPGWEKRMFANGTVYYFNHITNASQFERPSG","Homo sapiens","PIN1","Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1","1","2M9E"
"2M9F",,"SOLUTION NMR",,,,,,,"10.1021/ja4040472",,"2M9F",4.07,,,"NMR solution structure of Pin1 WW domain mutant 5-1g","KLPPGWEKRMFANGTVYYFNHITNASQFERPSG","Homo sapiens","PIN1","Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1","1","2M9F"
"2M9G",,"SOLUTION NMR",,,,,,,"10.1007/s10858-013-9781-3",,"2M9G",21.18,,,"Solution structure of calcium-bound human S100A12","MTKLEEHLEGIVNIFHQYSVRKGHFDTLSKGELKQLLTKELANTIKNIKDKAVIDEIFQGLDANQDEQVDFQEFISLVAIALKAAHYHTHKE","Homo sapiens","S100A12","Protein S100-A12","1","2M9G"
"2M9I",,"SOLUTION NMR",,,,,,,"10.1021/ja4040472",,"2M9I",4.02,,,"NMR solution structure of Pin1 WW domain variant 6-1","KLPPGWEKRMFRSNGTVYYFNHITNASQFERPSG","Homo sapiens","PIN1","Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1","1","2M9I"
"2M9J",,"SOLUTION NMR",,,,,,,"10.1021/ja4040472",,"2M9J",4.24,,,"NMR solution structure of Pin1 WW domain mutant 6-1g","KLPPGWEKRMFRSNGTVYYFNHITNASQFERPSG","Homo sapiens","PIN1","Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1","1","2M9J"
"2M9K",,"SOLUTION NMR",,,,,,,"10.1093/nar/gku692",,"2M9K",21,,,"RBPMS2-Nter","MEEEVRTLFVSGLPVDIKPRELYLLFRPFKGYEGSLIKLTARQPVGFVIFDSRAGAEAAKNALNGIRFDPENPQTLRLEFAKANTKMAKSKLE","Homo sapiens","RBPMS2","RNA-binding protein with multiple splicing 2","1","2M9K"
"2M9M",,"SOLUTION NMR",,,,,,,"10.1038/cr.2013.124",,"2M9M",16.75,,,"Solution Structure of ERCC4 domain of human FAAP24","MEKNPPDDTGPVHVPLGHIVANEKWRGSQLAQEMQGKIKLIFEDGLTPDFYLSNRCCILYVTEADLVAGNGYRKRLVRVRNSNNLKGIVVVEKTRMSEQYFPALQKFTVLDLGMVLLPVASQMEASCLVIQLVQEQTKELEHHHHHH","Homo sapiens","FAAP24, C19orf40","Fanconi anemia-associated protein of 24 kDa","1","2M9M"
"2M9N",,"SOLUTION NMR",,,,,,,"10.1038/cr.2013.124",,"2M9N",6.77,,,"Solution Structure of (HhH)2 domain of human FAAP24","GSSEPSLLRTVQQIPGVGKVKAPLLLQKFPSIQQLSNASIGELEQVVGQAVAQQIHAFFTQPR","Homo sapiens","FAAP24, C19orf40","Fanconi anemia-associated protein of 24 kDa","1","2M9N"
"2M9R",,"SOLUTION NMR",,,,,,,"10.1016/j.bbagen.2013.06.031",,"2M9R",5.57,,,"3D NMR structure of a complex between the amyloid beta peptide (1-40) and the polyphenol epsilon-viniferin glucoside","DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVV","Homo sapiens","APP, A4, AD1","Amyloid beta A4 protein","1","2M9R"
"2M9S",,"SOLUTION NMR",,,,,,,"10.1016/j.bbagen.2013.06.031",,"2M9S",5.57,,,"3D NMR structure of a complex between the amyloid beta peptide (1-40) and the polyphenol epsilon-viniferin glucoside","DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVV","Homo sapiens","APP, A4, AD1","Amyloid beta A4 protein","1","2M9S"
"2M9W",,"SOLUTION NMR",,,,,,,,,"2M9W",7.14,,,"Solution NMR Structure of Transcription Factor GATA-4 from Homo sapiens, Northeast Structural Genomics Consortium (NESG) Target HR4783B","SHMSASRRVGLSCANCQTTTTTLWRRNAEGEPVCNACGLYMKLHGVPRPLAMRKEGIQTRKRK","Homo sapiens","GATA4","Transcription factor GATA-4","1","2M9W"
"2M9X",,"SOLUTION NMR",,,,,,,,,"2M9X",13.04,,,"Solution NMR Structure of Microtubule-associated serine/threonine-protein kinase 1 from Homo sapiens, Northeast Structural Genomics Consortium (NESG) Target HR9151A","MGHHHHHHSHMPKATAQMEEKLRDFTRAYEPDSVLPLADGVLSFIHHQIIELARDCLTKSRDGLITTVYFYELQENLEKLLQDAYERSESLEVAFVTQLVKKLLIIISRPAR","Homo sapiens","KIAA0973, MAST1, SAST","Microtubule-associated serine/threonine-protein kinase 1","1","2M9X"
"2M9Y",,"SOLUTION NMR",,,,,,,"10.1371/journal.pone.0074047",,"2M9Y",8.57,,,"Solution Structure of the Catalytic Domain of HHARI","GSKKCDDDSETSNWIAANTKECPKCHVTIEKDGGSNHMVCRNQNCKAEFCWVCLGPWEPHGSAWYNCNRYNEDD","Homo sapiens","ARIH1, ARI, MOP6, UBCH7BP, HUSSY-27","E3 ubiquitin-protein ligase ARIH1","1","2M9Y"
"2MA2",,"SOLUTION NMR",,,,,,,"10.7554/eLife.00813",,"2MA2",9.22,,,"Solution structure of RasGRP2 EF hands bound to calcium","KLDQALVVEHIEKMVESVFRNFDVDGDGHISQEEFQIIRGNFPYLSAFGDLDQNQDGCISREEMVSYFLRSSSVLGGRMGF","Homo sapiens","RASGRP2, CDC25L, MCG7","RAS guanyl-releasing protein 2","1","2MA2"
"2MA5",,"SOLUTION NMR",,,,,,,,,"2MA5",6.97,,,"Solution NMR structure of PHD type Zinc finger domain of Lysine-specific demethylase 5B (PLU-1/JARID1B) from Homo sapiens, Northeast Structural Genomics Consortium (NESG) Target HR7375C","SHMCPAVSCLQPEGDEVDWVQCDGSCNQWFHQVCVGVSPEMAEKEDYICVRCTVKDAPSRK","Homo sapiens","JARID1B, KDM5B, PLU1, RBBP2H1","Lysine-specific demethylase 5B","1","2MA5"
"2MA6",,"SOLUTION NMR",,,,,,,,,"2MA6",7.01,,,"Solution NMR Structure of the RING finger domain from the Kip1 ubiquitination-promoting E3 complex protein 1 (KPC1/RNF123) from Homo sapiens, Northeast Structural Genomics Consortium (NESG) Target HR8700A","SHMPTSEEDLCPICYAHPISAVFQPCGHKSCKACINQHLMNNKDCFFCKTTIVSVEDWEKG","Homo sapiens","FP1477, KPC1, RNF123","E3 ubiquitin-protein ligase RNF123","1","2MA6"
"2MA7",,"SOLUTION NMR",,,,,,,,,"2MA7",8.34,,,"Solution NMR Structure of Zinc finger protein Eos from Homo sapiens, Northeast Structural Genomics Consortium (NESG) Target HR7992A","MGHHHHHHSHMPNGKLKCDVCGMVCIGPNVLMVHKRSHTGERPFHCNQCGASFTQKGNLLRHIKLHSGEKPFK","Homo sapiens","IKZF4, KIAA1782, ZNFN1A4","Zinc finger protein Eos","1","2MA7"
"2MAE",,"SOLUTION NMR",,,,,,,,,"2MAE",3.18,,,"Transmembrane-cytosolic part of Trop2 explored by NMR and Molecular Dynamics","TNRRKSGKYKKVEIKELGELRKEPSL","Homo sapiens","TACSTD2, GA733-1, M1S1, TROP2","Tumor-associated calcium signal transducer 2","1","2MAE"
"2MAJ",,"SOLUTION NMR",,,,,,,"10.1038/ncomms3963",,"2MAJ",19.41,,,"Solution Structure of the STIM1 CC1-CC2 homodimer.","GSHMASSRQKYAEEELEQVREALRKAEKELESHSSWYAPEALQKWLQLTHEVEVQYYNIKKQNAEKQLLVAKEGAEKIKKKR","Homo sapiens","STIM1, GOK","Stromal interaction molecule 1","1","2MAJ"
"2MAM",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M113.501940",,"2MAM",13.17,,,"Solution structure of the interdigitated double Tudor domain of RBBP1","ADEPAYLTVGTDVSAKYRGAFCEAKIKTVKRLVKVKVLLKQDNTTQLVQDDQVKGPLRVGAIVETRTSDGSFQEAIISKLTDASWYTVVFDDGDERTLRRTSLCLKGERHFAESETLD","Homo sapiens","ARID4A, RBBP1, RBP1","AT-rich interactive domain-containing protein 4A","1","2MAM"
"2MAW",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M113.508333",,"2MAW",14.58,,,"NMR structures of the alpha7 nAChR transmembrane domain.","SNAEEELYYGLNLLIPCVLISALALLVFLLPADSGEKISLGITVLLSLTVFMLLVAEIMPSTSDSSPSIAQYFASTMIIVGLSVVVTVIVLQYHHHDPDGGEGGGEGIDRLCLMAFSVFTIICTIGILMSAPNFVEE","Homo sapiens","CHRFAM7A, CHRNA7, NACHRA7","Neuronal acetylcholine receptor subunit alpha-7","1","2MAW"
"2MB0",,"SOLUTION NMR",,,,,,,"10.1093/nar/gku244",,"2MB0",12.3,,,"Solution structure of hnRNP G RRM in complex with the RNA 5'-AUCAAA-3'","MVEADRPGKLFIGGLNTETNEKALEAVFGKYGRIVEVLLMKDRETNKSRGFAFVTFESPADAKDAARDMNGKSLDGKAIKVEQATKPSFESGRRG","Homo sapiens","RBMX, HNRPG, RBMXP1","RNA-binding motif protein, X chromosome","1","2MB0"
,,,,,,,,,,,,,,,,"AUCAAA",,,"RNA_(5'-R(*AP*UP*CP*AP*AP*A)-3')","2","2MB0"
"2MB7",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M113.512236",,"2MB7",8.34,,,"Solution structure of MBD3 methylcytosine binding domain","GSMERKRWECPALPQGWEREEVPRRSGLSAGHRDVFYYSPSGKKFRSKPQLARYLGGSMDLSTFDFRTGKML","Homo sapiens","MBD3","Methyl-CpG-binding domain protein 3","1","2MB7"
"2MB9",,"SOLUTION NMR",,,,,,,"10.1016/j.molcel.2013.08.032",,"2MB9",13.85,,,"Human Bcl10 CARD","GSHMEPTAPSLTEEDLTEVKKDALENLRVYLCEKIIAERHFDHLRAKKILSREDTREISCRTSSRKRAGKLLDYLQENPKGLDTLVESIRREKTQNFLIQKITDEVLKLRNIKLEHLK","Homo sapiens","BCL10, CIPER, CLAP","B-cell lymphoma/leukemia 10","1","2MB9"
"2MBC",,"SOLUTION NMR",,,,,,,"10.1021/bi5003844",,"2MBC",18.27,,,"Solution Structure of human holo-PRL-3 in complex with vanadate","MARMNRPAPVEVSYKHMRFLITHNPTNATLSTFIEDLKKYGATTVVRVCEVTYDKTPLEKDGITVVDWPFDDGAPPPGKVVEDWLSLVKAKFCEAPGSCVAVHCVAGLGRAPVLVALALIESGMKYEDAIQFIRQKRRGAINSKQLTYLEKYRPKQRLRFKD","Homo sapiens","PTP4A3, PRL3","Protein tyrosine phosphatase type IVA 3","1","2MBC"
"2MBE",,"SOLUTION NMR",,,,,,,"10.1073/pnas.1403383111",,"2MBE",8.68,,,"Backbone 1H and 15N Chemical Shift Assignments for the first domain of FAT10","LCVHVRSEEWDLMTFDANPYDSVLKIKEHVRSKTKVPVQDQVLLLGSKILKPRRSLSSYGIDKEKTIHLTLKVVK","Homo sapiens","UBD, FAT10","Ubiquitin D","1","2MBE"
"2MBG",,"SOLUTION NMR",,,,,,,"10.1016/j.str.2013.09.007",,"2MBG",31.02,,,"Rlip76 (gap-gbd)","HMPNLKPIFGIPLADAVERTMMYDGIRLPAVFRECIDYVEKYGMKCEGIYRVSGIKSKVDELKAAYDREESTNLEDYEPNTVASLLKQYLRDLPENLLTKELMPRFEEACGRTTETEKVQEFQRLLKELPECNYLLISWLIVHMDHVIAKELETKMNIQNISIVLSPTVQISNRVLYVFFTHVQELFGNVVLKQVMKPLRWSNMATMPTLPETQAGIKEEIRRQEFLLNCLHRDLQGGIKDLSKEERLWEVQRILTALKRKLREA","Homo sapiens","RALBP1, RLIP1, RLIP76, RLIP","RalA-binding protein 1","1","2MBG"
"2MBO",,"SOLUTION NMR",,,,,,,"10.1016/j.str.2013.04.029",,"2MBO",17.15,,,"K11-linked Diubiquitin average solution structure at pH 6.8, 0 mM NaCl","MQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGG","Homo sapiens","UBC","Ubiquitin","1","2MBO"
"2MBQ",,"SOLUTION NMR",,,,,,,"10.1016/j.str.2013.04.029",,"2MBQ",17.15,,,"K11-linked Diubiquitin average solution structure at pH 6.8, 150 mM NaCl","MQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGG","Homo sapiens","UBC","Ubiquitin","1","2MBQ"
"2MC3",,"SOLUTION NMR",,,,,,,"10.1093/nar/gkt760",,"2MC3",12.01,,,"NMR solution structure of the winged-helix domain from MUS81 structure-specific endonuclease","GPTMGSGSYWPARHSGARVILLVLYREHLNPNGHHFLTKEELLQRCAQKSPRVAPGSAPPWPALRSLLHRNLVLRTHQPARYSLTPEGLELAQKLAESEGLSLLNVGIG","Homo sapiens","hCG_23303, MUS81","MUS81 endonuclease homolog (Yeast), isoform CRA_b","1","2MC3"
"2MCG",,"X-RAY DIFFRACTION",3.07,59.93,,,,,"10.1016/0022-2836(89)90135-6",,"2MCG",45.67,"2","2","THREE-DIMENSIONAL STRUCTURE OF A LIGHT CHAIN DIMER CRYSTALLIZED IN WATER. CONFORMATIONAL FLEXIBILITY OF A MOLECULE IN TWO CRYSTAL FORMS","QSALTQPPSASGSLGQSVTISCTGTSSDVGGYNYVSWYQQHAGKAPKVIIYEVNKRPSGVPDRFSGSKSGNTASLTVSGLQAEDEADYYCSSYEGSDNFVFGTGTKVTVLGQPKANPTVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADGSPVKAGVETTKPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS","Homo sapiens","IGLV2-8","IMMUNOGLOBULIN LAMBDA DIMER MCG (LIGHT CHAIN)","1","2MCG"
"2MCY",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M113.520346",,"2MCY",14.68,,,"CR1 Sushi domains 2 and 3","EAEAKSCRNPPDPVNGMVHVIKGIQFGSQIKYSCTKGYRLIGSSSATCIISGDTVIWDTETPICDRIPCGLPPTITNGDFISTNRENFHYGSVVTYRCNPGSGGRKVFELVGEPSIYCTSNDDQVGIWSGPAPQCI","Homo sapiens","CR1, C3BR","Complement receptor type 1","1","2MCY"
"2MCZ",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M113.520346",,"2MCZ",14.3,,,"CR1 Sushi domains 1 and 2","EAEAAGQCNAPEWLPFARPTQLTDEFEFPIGTYLNYECRPGYSGRPFSIICLKNSVWTGAKDRCRRKSCRNPPDPVNGMVHVIKGIQFGSQIKYSCTKGYRLIGSSSATCIISGDTVIWDQETPICDR","Homo sapiens","CR1, C3BR","Complement receptor type 1","1","2MCZ"
"2MD7",,"SOLUTION NMR",,,,,,,"10.1111/febs.12588",,"2MD7",6.57,,,"NMR structure of human Sp140 PHD finger trans conformer","GAMGMRNLDECEVCRDGGELFCCDTCSRVFHEDCHIPPVEAERTPWNCIFCRMKES","Homo sapiens","SP140, LYSP100","Nuclear body protein SP140","1","2MD7"
"2MD8",,"SOLUTION NMR",,,,,,,"10.1111/febs.12588",,"2MD8",6.57,,,"NMR structure of Sp140 PHD finger cis conformer","GAMGMRNLDECEVCRDGGELFCCDTCSRVFHEDCHIPPVEAERTPWNCIFCRMKES","Homo sapiens","SP140, LYSP100","Nuclear body protein SP140","1","2MD8"
"2MDC",,"SOLUTION NMR",,,,,,,"10.1016/j.str.2013.12.005",,"2MDC",5.54,,,"Solution structure of the WW domain of HYPB","GSKPKTIVLPPNWKTARDPEGKIYYYHVITRQTQWDPPTWESPGDDAS","Homo sapiens","HYPB, SETD2, HIF1, KIAA1732, KMT3A, SET2, HSPC069","Histone-lysine N-methyltransferase SETD2","1","2MDC"
"2MDF",,"SOLUTION NMR",,,,,,,"10.1021/bi500392y",,"2MDF",6.26,,,"NMR structure of a two-transmembrane segment TM VI-VII of NHE1","GSKKKDNLLFGSIISAVDPVAVLAVFEEIHINELLHILVFGESLLNDAVTVVLYKKK","Homo sapiens","SLC9A1, APNH1, NHE1","Sodium/hydrogen exchanger 1","1","2MDF"
"2MDG",,"SOLUTION NMR",,,,,,,,,"2MDG",6.47,,,"Solution NMR Structure of Zinc finger protein 423 from Homo sapiens, Northeast Structural Genomics Consortium (NESG) Target HR7298F","MGSHKCNVCSRTFFSENGLREHLQTHRGPAKHYMCPICGERFPSLLTLTEHKVTH","Homo sapiens","KIAA0760, NPHP14, OAZ, ZNF423","Zinc finger protein 423","1","2MDG"
"2MDI",,"SOLUTION NMR",,,,,,,"10.1016/j.str.2013.12.005",,"2MDI",6.19,,,"Solution structure of the PP2WW mutant (KPP2WW) of HYPB","GSDLPPPSPPAAATIVLPPNWKTARDPEGKIYYYHVITRQTQWDPPTWESPGDDAS","Homo sapiens","HYPB, SETD2, HIF1, KIAA1732, KMT3A, SET2, HSPC069","Histone-lysine N-methyltransferase SETD2","1","2MDI"
"2MDJ",,"SOLUTION NMR",,,,,,,"10.1016/j.str.2013.12.005",,"2MDJ",6.34,,,"Solution structure of WW domain with polyproline stretch (PP2WW) of HYPB","GSDLPPPSPPKPKTIVLPPNWKTARDPEGKIYYYHVITRQTQWDPPTWESPGDDAS","Homo sapiens","SETD2, HIF1, HYPB, KIAA1732, KMT3A, SET2, HSPC069","Histone-lysine N-methyltransferase SETD2","1","2MDJ"
"2MDK",,"SOLUTION NMR",,,,,,,,,"2MDK",14.21,,,"NMR Solution Structure of MSP-P56S Domain/VAPB in DPC","MAKVEQVLSLEPQHELKFRGPFTDVVTTNLKLGNPTDRNVCFKVKTTAPRRYCVRSNSGIIDAGASINVSVMLQPFDYDPNEKSKHKFMVQSMFAPTDTSDMEAVWKEAKPEDLMDSKLRCVFEL","Homo sapiens","VAPB, UNQ484/PRO983","Vesicle-associated membrane protein-associated protein B/C","1","2MDK"
"2MDR",,"SOLUTION NMR",,,,,,,"10.1073/pnas.1323698111",,"2MDR",12.49,,,"Solution structure of the third double-stranded RNA-binding domain (dsRBD3) of human adenosine-deaminase ADAR1","GSSHHHHHHSSGLVPRGSHMMPNKVRKIGELVRYLNTNPVGGLLEYARSHGFAAEFKLVDQSGPPHEPKFVYQAKVGGRWFPAVCAHSKKQGKQEAADAALRVLIGENEKAER","Homo sapiens","ADAR, ADAR1, DSRAD, G1P1, IFI4","Double-stranded RNA-specific adenosine deaminase","1","2MDR"
"2MDX",,"SOLUTION NMR",,,,,,,,,"2MDX",12.24,,,"Solution structure of the human wild type FAPP1-PH domain","GPLGSPEFMEGVLYKWTNYLTGWQPRWFVLDNGILSYYDSQDDVCKGSKGSIKMAVCEIKVHSADNTRMELIIPGEQHFYMKAVNAAERQRWLVALGSSKACLTDTRT","Homo sapiens","PLEKHA3, FAPP1","Pleckstrin homology domain-containing family A member 3","1","2MDX"
"2ME0",,"SOLUTION NMR",,,,,,,,,"2ME0",8.35,,,"NMR Structure of the homeodomain transcription factor Gbx1 from Homo sapiens solved in the presence of the DNA sequence CGACTAATTAGTCG","SAPGGKSRRRRTAFTSEQLLELEKEFHCKKYLSLTERSQIAHALKLSEVQVKIWFQNRRAKWKRIKAGNVS","Homo sapiens","GBX1","Homeobox protein GBX-1","1","2ME0"
"2ME6",,"SOLUTION NMR",,,,,,,,,"2ME6",16.91,,,"NMR Structure of the homeodomain transcription factor Gbx1 from Homo sapiens in complex with the DNA sequence CGACTAATTAGTCG","SAPGGKSRRRRTAFTSEQLLELEKEFHCKKYLSLTERSQIAHALKLSEVQVKIWFQNRRAKWKRIKAGNVS","Homo sapiens","GBX1","Homeobox protein GBX-1","1","2ME6"
,,,,,,,,,,,,,,,,"CGACTAATTAGTCG",,,"DNA (5'-D(*CP*GP*AP*CP*TP*AP*AP*TP*TP*AP*GP*TP*CP*G)-3')","2","2ME6"
"2ME8",,"SOLUTION NMR",,,,,,,"10.1038/nsmb.2829",,"2ME8",23.67,,,"Solution Structure of BCL-xL in its p53-bound conformation determined with selective isotope labelling of I,L,V sidechains","GHSMSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQER","Homo sapiens","BCL2L1, BCL2L, BCLX","Bcl-2-like protein 1","1","2ME8"
"2ME9",,"SOLUTION NMR",,,,,,,"10.1038/nsmb.2829",,"2ME9",23.67,,,"Solution structure of BCL-xL containing the alpha1-alpha2 disordered loop determined with selective isotope labelling of I,L,V sidechains","GHSMSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQER","Homo sapiens","BCL2L1, BCL2L, BCLX","Bcl-2-like protein 1","1","2ME9"
"2MEA",,"X-RAY DIFFRACTION",2.64,53.37,,4.5,"1.5M TO 1.8M NACL, 20MM ACETATE, PH 4.5",,"10.1093/protein/12.10.841",,"2MEA",29.51,"2.2","2.2","CHANGES IN CONFORMATIONAL STABILITY OF A SERIES OF MUTANT HUMAN LYSOZYMES AT CONSTANT POSITIONS","KVFERCELARTLKRLGMDGYRGISLANWMCLAKWESGYNTRATNYNAGDRSTDYGFFQINSRYWCNDGKTPGAVNACHLSCSALLQDNIADAVACAKRVVRDPQGIRAWVAWRNRCQNRDVRQYVQGCGV","Homo sapiens","LYZ, LZM","LYSOZYME","1","2MEA"
"2MEB",,"X-RAY DIFFRACTION",1.99,38.24,,4.5,"1.5M TO 1.8M NACL, 20MM ACETATE, PH 4.5",,"10.1093/protein/12.10.841",,"2MEB",14.74,"1.8","1.8","CHANGES IN CONFORMATIONAL STABILITY OF A SERIES OF MUTANT HUMAN LYSOZYMES AT CONSTANT POSITIONS","KVFERCELARTLKRLGMDGYRGISLANWMCLAKWESGYNTRATNYNAGDRSTDYGLFQINSRYWCNDGKTPGAVNACHLSCSALLQDNIADAVACAKRVVRDPQGIRAWVAWRNRCQNRDVRQYVQGCGV","Homo sapiens","LYZ, LZM","LYSOZYME","1","2MEB"
"2MEC",,"X-RAY DIFFRACTION",2.63,53.25,,4.5,"1.5M TO 1.8M NACL, 20MM ACETATE, PH 4.5",,"10.1093/protein/12.10.841",,"2MEC",29.48,"2.2","2.2","CHANGES IN CONFORMATIONAL STABILITY OF A SERIES OF MUTANT HUMAN LYSOZYMES AT CONSTANT POSITIONS","KVFERCELARTLKRLGMDGYRGISLANWMCLAKWESGYNTRATNYNAGDRSTDYGMFQINSRYWCNDGKTPGAVNACHLSCSALLQDNIADAVACAKRVVRDPQGIRAWVAWRNRCQNRDVRQYVQGCGV","Homo sapiens","LYZ, LZM","LYSOZYME","1","2MEC"
"2MED",,"X-RAY DIFFRACTION",1.99,38.18,,4.5,"1.5M TO 1.8M NACL, 20MM ACETATE, PH 4.5",,"10.1093/protein/12.10.841",,"2MED",14.78,"1.8","1.8","CONTRIBUTION OF HYDROPHOBIC EFFECT TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME","KVFERCELARTLKRLGMDGYRGISLANWMCLAKWESGYNTRATNYNAGDRSTDYGIFQFNSRYWCNDGKTPGAVNACHLSCSALLQDNIADAVACAKRVVRDPQGIRAWVAWRNRCQNRDVRQYVQGCGV","Homo sapiens","LYZ, LZM","LYSOZYME","1","2MED"
"2MEE",,"X-RAY DIFFRACTION",1.99,38.33,,4.5,"1.5M TO 1.8M NACL, 20MM ACETATE, PH 4.5",,"10.1093/protein/12.10.841",,"2MEE",14.74,"1.8","1.8","CONTRIBUTION OF HYDROPHOBIC EFFECT TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME","KVFERCELARTLKRLGMDGYRGISLANWMCLAKWESGYNTRATNYNAGDRSTDYGIFQLNSRYWCNDGKTPGAVNACHLSCSALLQDNIADAVACAKRVVRDPQGIRAWVAWRNRCQNRDVRQYVQGCGV","Homo sapiens","LYZ, LZM","LYSOZYME","1","2MEE"
"2MEF",,"X-RAY DIFFRACTION",1.99,38.18,,4.5,"1.5M TO 1.8M NACL, 20MM ACETATE, PH 4.5",,"10.1093/protein/12.10.841",,"2MEF",14.76,"1.8","1.8","CONTRIBUTION OF HYDROPHOBIC EFFECT TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME","KVFERCELARTLKRLGMDGYRGISLANWMCLAKWESGYNTRATNYNAGDRSTDYGIFQMNSRYWCNDGKTPGAVNACHLSCSALLQDNIADAVACAKRVVRDPQGIRAWVAWRNRCQNRDVRQYVQGCGV","Homo sapiens","LYZ, LZM","LYSOZYME","1","2MEF"
"2MEG",,"X-RAY DIFFRACTION",2,38.57,,4.5,"1.5M TO 1.8M NACL, 20MM ACETATE, PH 4.5",,"10.1093/protein/12.10.841",,"2MEG",14.72,"1.8","1.8","CHANGES IN CONFORMATIONAL STABILITY OF A SERIES OF MUTANT HUMAN LYSOZYMES AT CONSTANT POSITIONS.","KVFERCELARTLKRLGMDGYRGISLANWMCLAKWESGYNTRATNYNAGDRSTDYGIFQSNSRYWCNDGKTPGAVNACHLSCSALLQDNIADAVACAKRVVRDPQGIRAWVAWRNRCQNRDVRQYVQGCGV","Homo sapiens","LYZ, LZM","LYSOZYME","1","2MEG"
"2MEH",,"X-RAY DIFFRACTION",1.99,38.19,,4.5,"1.5M TO 1.8M NACL, 20MM ACETATE, PH 4.5",,"10.1093/protein/12.10.841",,"2MEH",14.73,"1.8","1.8","CONTRIBUTION OF HYDROPHOBIC EFFECT TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME","KVFERCELARTLKRLGMDGYRGISLANWMCLAKWESGYNTRATNYNAGDRSTDYGIFQTNSRYWCNDGKTPGAVNACHLSCSALLQDNIADAVACAKRVVRDPQGIRAWVAWRNRCQNRDVRQYVQGCGV","Homo sapiens","LYZ, LZM","LYSOZYME","1","2MEH"
"2MEI",,"X-RAY DIFFRACTION",1.99,38.11,,4.5,"1.5M TO 1.8M NACL, 20MM ACETATE, PH 4.5",,"10.1093/protein/12.10.841",,"2MEI",14.79,"1.8","1.8","CONTRIBUTION OF HYDROPHOBIC EFFECT TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME","KVFERCELARTLKRLGMDGYRGISLANWMCLAKWESGYNTRATNYNAGDRSTDYGIFQYNSRYWCNDGKTPGAVNACHLSCSALLQDNIADAVACAKRVVRDPQGIRAWVAWRNRCQNRDVRQYVQGCGV","Homo sapiens","LYZ, LZM","LYSOZYME","1","2MEI"
"2MEM",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M113.524009",,"2MEM",13.11,,,"Solution NMR structure of SLED domain of Scml2","GSHMMSTVCVYVNKHGNFGPHLDPKRIQQLPDHFGPGPVNVVLRRIVQACVDCALETKTVFGYLKPDNRGGEVITASFDGETHSIQLPPVNSASFALRFLENFCHSLQCDNLLSSQPFS","Homo sapiens","SCML2","Sex comb on midleg-like protein 2","1","2MEM"
"2MET",,"SOLUTION NMR",,,,,,,"10.1016/j.str.2014.05.010",,"2MET",12.48,,,"NMR spatial structure of the trimeric mutant TM domain of VEGFR2 receptor.","EKTNLEIIILEGTAVIAMFFWLLLVIILRTVKRANGG","Homo sapiens","KDR, FLK1, VEGFR2","Vascular endothelial growth factor receptor 2","1","2MET"
"2MEU",,"SOLUTION NMR",,,,,,,"10.1016/j.str.2014.05.010",,"2MEU",8.37,,,"NMR spatial structure of mutant dimeric TM domain of VEGFR2 receptor","EKTNLEIIILVETAVIAMEFWLLLVIILRTVKRANGG","Homo sapiens","KDR, FLK1, VEGFR2","Vascular endothelial growth factor receptor 2","1","2MEU"
"2MF9",,"SOLUTION NMR",,,,,,,"10.1038/srep02985",,"2MF9",16.91,,,"Solution structure of the N-terminal domain of human FKBP38 (FKBP38NTD)","MGQPPAEEAEQPGALAREFLAAMEPEPAPAPAPEEWLDILGNGLLRKKTLVPGPPGSSRPVKGQVVTVHLQTSLENGTRVQEEPELVFTLGDCDVIQALDLSVPLMDVGETAMVTADSKYCYGPQGSRSPYIPPHAALCLEVTLKTAVDLEHHHHHH","Homo sapiens","FKBP8, FKBP38","Peptidyl-prolyl cis-trans isomerase FKBP8","1","2MF9"
"2MFR",,"SOLUTION NMR",,,,,,,"10.1016/j.bbamem.2014.01.005",,"2MFR",6.72,,,"Solution structure of the transmembrane domain of the insulin receptor in micelles","MTYFYVTDYLDVPSNIAKIIIGPLIFVFLFSVVIGSIYLFLRKRQPDGPLEHHHHHH","Homo sapiens","INSR","Insulin receptor","1","2MFR"
"2MG0",,"SOLUTION NMR",,,,,,,,,"2MG0",1.08,,,"PAP262-270 in SDS micelles","XVLVNEILNHX","Homo sapiens","ACP3, ACPP","Peptide from Prostatic acid phosphatase","1","2MG0"
"2MG5",,"SOLUTION NMR",,,,,,,"10.1021/bi401466s",,"2MG5",18.51,,,"Solution Structure of Calmodulin bound to the target peptide of Endothelial Nitrogen Oxide Synthase phosphorylated at Thr495","ADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTIDFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADIDGDGQVNYEEFVQMMTAK","Homo sapiens","CALM1, CALM, CAM, CAM1, CALM2, CAM2, CAMB, CALM3, CALML2, CAM3, CAMC, CAMIII","Calmodulin","1","2MG5"
,,,,,,,,,,,,,,,,"TFKEVANAVKISASLM",,,"target peptide","2","2MG5"
"2MG9",,"SOLUTION NMR",,,,,,,"10.1016/j.chembiol.2013.11.014",,"2MG9",2.81,,,"Truncated EGF-A","GTNECLDNNGGCSHVCNDLKIGYECLX","Homo sapiens","LDLR","Low-density lipoprotein receptor","1","2MG9"
"2MGS",,"SOLUTION NMR",,,,,,,"10.1371/journal.pone.0093228",,"2MGS",16.74,,,"Solution structure of CXCL5","AGPAAAVLRELRCVCLQTTQGVHPKMISNLQVFAIGPQCSKVEVVASLKNGKEICLDPEAPFLKKVIQKILDGGNKEN","Homo sapiens","CXCL5, ENA78, SCYB5","C-X-C motif chemokine 5","1","2MGS"
"2MGT",,"SOLUTION NMR",,,,,,,"10.1038/srep21734",,"2MGT",4.07,,,"Zinc induced dimer of the metal binding domain 1-16 of human amyloid beta-peptide with Alzheimer's disease pathogenic English mutation H6R","XDAEFRRDSGYEVHHQKX","Homo sapiens","APP, A4, AD1","Amyloid beta A4 protein","1","2MGT"
"2MGW",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M114.555441",,"2MGW",5.92,,,"Solution Structure of the UBA Domain of Human NBR1","GPLGSSEDQTAALMAHLFEMGFCDRQLNLRLLKKHNYNILQVVTELLQLNNN","Homo sapiens","NBR1, 1A13B, KIAA0049, M17S2, MIG19","Next to BRCA1 gene 1 protein","1","2MGW"
"2MGX",,"SOLUTION NMR",,,,,,,"10.1016/j.jmb.2014.01.007",,"2MGX",14.77,,,"NMR structure of SRA1p C-terminal domain","GSEAVMEDVLRPLEQALEDCRGHTRKQVCDDISRRLALLQEQWAGGKLSIPVKKRMALLVQELSSHRWDAADDIHRSLMVDHVTEVSQWMVGVKRLIAEKRSLFSEEAANEEKSAATAEKNHTIPGFQQAS","Homo sapiens","SRA1, PP7684","Steroid receptor RNA activator 1","1","2MGX"
"2MH3",,"SOLUTION NMR",,,,,,,"10.1002/prot.24507",,"2MH3",16.46,,,"NMR structure of the basic helix-loop-helix region of the transcriptional repressor HES-1","MKPKTASEHRKSSKPIMEKRRRARINESLSQLKTLILDALKKDSSRHSKLEKADILEMTVKHLRNLQRAQ","Homo sapiens","HES1, BHLHB39, HL, HRY","Transcription factor HES-1","1","2MH3"
"2MH9",,"SOLUTION NMR",,,,,,,"10.1007/s10858-014-9812-8",,"2MH9",16.12,,,"Resonance assignment of RQC domain of human Bloom syndrome protein","CKTKDYKTRDVTDDVKSIVRFVQEHSSSQGMRNIKHVGPSGRFTMNMLVDIFLGSKSAKIQSGIFGKGSAYSRHNAERLFKKLILDKILDEDLYINANDQAIAYVMLGNKAQTVLNGNLKVDFMETENSSSVKKQKALVAKVSQ","Homo sapiens","BLM, RECQ2, RECQL3","Bloom syndrome protein","1","2MH9"
"2MHN",,"SOLUTION NMR",,,,,,,,,"2MHN",10.57,,,"NMR structure of the first RRM domain of the protein RBM39 from Homo sapiens","GHMNLTPEERDARTVFCMQLAARIRPRDLEEFFSTVGKVRDVRMISDRNSRRSKGIAYVEFVDVSSVPLAIGLTGQRVLGVPIIVQASQAEKNR","Homo sapiens","RBM39, HCC1, RNPC2","RNA-binding protein 39","1","2MHN"
"2MHP",,"SOLUTION NMR",,,,,,,"10.1182/blood-2013-07-517086",,"2MHP",11.35,,,"Solution structure of the major factor VIII binding region on von Willebrand factor","GAMGSCRPPMVKLVCPADNLRAEGLECTKTCQNYDLECMSMGCVSGCLCPPGMVRHENRCVALERCPCFHQGKEYAPGETVKIGCNTCVCRDRKWNCTDHVCD","Homo sapiens","VWF, F8VWF","von Willebrand factor","1","2MHP"
"2MHQ",,"SOLUTION NMR",,,,,,,"10.1182/blood-2013-07-517086",,"2MHQ",11.35,,,"Solution structure of the major factor VIII binding region on von Willebrand factor","GAMGSCRPPMVKLVCPADNLRAEGLECTKTCQNYDLECMSMGCVSGCLCPPGMVRHENRCVALERCPCFHQGKEYAPGETVKIGCNTCVCRDRKWNCTDHVCD","Homo sapiens","VWF, F8VWF","von Willebrand factor","1","2MHQ"
"2MHS",,"SOLUTION NMR",,,,,,,"10.1371/journal.pone.0096521",,"2MHS",18.87,,,"NMR Structure of human Mcl-1","MEDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESSIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGHHHHHH","Homo sapiens","MCL1, BCL2L3","Induced myeloid leukemia cell differentiation protein Mcl-1","1","2MHS"
"2MHU",,"SOLUTION NMR",,,,,,,"10.1016/0022-2836(90)90291-S",,"2MHU",3.38,,,"THE THREE-DIMENSIONAL STRUCTURE OF HUMAN [113CD7] METALLOTHIONEIN-2 IN SOLUTION DETERMINED BY NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY","MDPNCSCAAGDSCTCAGSCKCKECKCTSCK","Homo sapiens","MT2A, CES1, MT2","CD7 METALLOTHIONEIN-2","1","2MHU"
"2MI1",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M114.548354",,"2MI1",1.64,,,"Somatostatin-14 solution structure in 5% D-mannitol","AGCKNFFWKTFTSC","Homo sapiens","SST","Somatostatin-14","1","2MI1"
"2MI8",,"SOLUTION NMR",,,,,,,"10.1002/pro.2450",,"2MI8",8.77,,,"Solution structure of lysine-free (K0) ubiquitin","MQIFVRTLTGRTITLEVEPSDTIENVRARIQDREGIPPDQQRLIFAGRQLEDGRTLSDYNIQRESTLHLVLRLRGG","Homo sapiens","UBC","Ubiquitin","1","2MI8"
"2MIO",,"SOLUTION NMR",,,,,,,,,"2MIO",8.04,,,"Solution NMR Structure of SH3 Domain 1 of Rho GTPase-activating Protein 10 from Homo sapiens, Northeast Structural Genomics Consortium (NESG) Target HR9129A","MGHHHHHHSHMIRSRKARAVYPCEAEHSSELSFEIGAIFEDVQTSREPGWLEGTLNGKRGLIPQNYVKLL","Homo sapiens","ARHGAP10, GRAF2","Rho GTPase-activating protein 10","1","2MIO"
"2MIT",,"SOLUTION NMR",,,,,,,,,"2MIT",7.19,,,"Solution structure of oxidized dimeric form of human defensin 5","ATCYCRTGRCATRESLSGVCEISGRLYRLCCR","Homo sapiens","DEF5, DEFA5","Defensin-5","1","2MIT"
"2MIU",,"SOLUTION NMR",,,,,,,,,"2MIU",11.68,,,"Structure of FHL2 LIM adaptor and its Interaction with Ski","MTERFDCHHCNESLFGKKYILREESPYCVVCFETLFANTCEECGKPIGCDCKDLSYKDRHWHEACFHCSQCRNSLVDKPFAAKEDQLLCTDCYSNEYS","Homo sapiens","FHL2, DRAL, SLIM3","Four and a half LIM domains protein 2","1","2MIU"
"2MJ1",,"SOLUTION NMR",,,,,,,"10.1042/BSR20140094",,"2MJ1",1.85,,,"NMR structure of the soluble A beta 17-34 peptide","LVFFAEDVGSNKGAIIGL","Homo sapiens","APP, A4, AD1","Amyloid beta A4 protein","1","2MJ1"
"2MJ7",,"SOLUTION NMR",,,,,,,,,"2MJ7",16,,,"Solution NMR structure of beta-adaptin appendage domain of human adaptor protein complex 4 subunit beta, Northeast Structural Genomics Consortium (NESG) Target HR8998C","MGHHHHHHSHMQELPDSGALMLVPNRQLTADYFEKTWLSLKVAHQQVLPWRGEFHPDTLQMALQVVNIQTIAMSRAGSRPWKAYLSAQDDTGCLFLTELLLEPGNSEMQISVKQNEARTETLNSFISVLETVIGTIEEIKS","Homo sapiens","AP4B1","AP-4 complex subunit beta-1","1","2MJ7"
"2MJ8",,"SOLUTION NMR",,,,,,,"10.1016/j.chembiol.2020.05.007",,"2MJ8",7.7,,,"Solution structure of CDYL2 chromodomain","GASGDLYEVERIVDKRKNKKGKWEYLIRWKGYGSTEDTWEPEHHLLHCEEFIDEFNGLHMSKDK","Homo sapiens","CDYL2","Chromodomain Y-like protein 2","1","2MJ8"
"2MJB",,"SOLUTION NMR",,,,,,,"10.1021/ja4132642",,"2MJB",8.58,,,"Solution nmr structure of ubiquitin refined against dipolar couplings in 4 media","MQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGG","Homo sapiens","UBA52, UBCEP2, RPS27A, UBA80, UBCEP1, UBB, UBC","Ubiquitin-60S ribosomal protein L40","1","2MJB"
"2MJC",,"SOLUTION NMR",,,,,,,,,"2MJC",3.88,,,"Zn-binding domain of eukaryotic translation initiation factor 3, subunit G","PLGSKGQKIVSCRICKGDHWTTRCPYKDTLGPMQ","Homo sapiens","EIF3G, EIF3S4","Eukaryotic translation initiation factor 3 subunit G","1","2MJC"
"2MJI",,"SOLUTION NMR",,,,,,,"10.1021/cb5005178","KTR","2MJI",15.35,,,"HIFABP_Ketorolac_complex","AFDSTWKVDRSENYDKFMEKMGVNIVKRKLAAHDNLKLTITQEGNKFTVKESSAFRNIEVVFELGVTFNYNLADGTELRGTWSLEGNKLIGKFKRTDNGNELNTVREIIGDELVQTYVYEGVEAKRIFKKD","Homo sapiens","FABP2, FABPI","Fatty acid-binding protein, intestinal","1","2MJI"
"2MJN",,"SOLUTION NMR",,,,,,,"10.1093/nar/gku193",,"2MJN",20.57,,,"Structure, dynamics and RNA binding of the multi-domain splicing factor TIA-1","GAMANHFHVFVGDLSPEITTEDIKAAFAPFGRISDARVVKDMATGKSKGYGFVSFFNKWDAENAIQQMGGQWLGGRQIRTNWATRKPPAPKSTYESNTKQLSYDEVVNQSSPSNCTVYCGGVTSGLTEQLMRQTFSPFGQIMEIRVFPDKGYSFVRFNSHESAAHAIVSVNGTTIEGHVVKCYWGK","Homo sapiens","TIA1","Nucleolysin TIA-1 isoform p40","1","2MJN"
"2MJU",,"SOLUTION NMR",,,,,,,"10.7717/peerj.305",,"2MJU",22.92,,,"Solution structure of a C terminal fragment of the neuronal isoform of the polypyrimidine tract binding protein (nPTB)","GRVGMPGVSAGGNTVLLVSNLNEEMVTPQSLFTLFGVYGDVQRVKILYNKKDSALIQMADGNQSQLAMNHLNGQKMYGKIIRVTLSKHQTVQLPREGLDDQGLTKDFGNSPLHRFKKPGSKNFQNIFPPSATLHLSNIPPSVAEEDLRTLFANTGGTVKAFKFFQDHKMALLQMATVEEAIQALIDLHNYNLGENHHLRVSFSKSTI","Homo sapiens","PTBP2, NPTB, PTB, PTBLP","Polypyrimidine tract-binding protein 2","1","2MJU"
"2MK2",,"SOLUTION NMR",,,,,,,,,"2MK2",12.2,,,"Solution NMR structure of N-terminal domain (SH2 domain) of human Inositol polyphosphate phosphatase-like protein 1 (INPPL1) (fragment 20-117), Northeast Structural Genomics Consortium Target HR9134A","MGHHHHHHSHMSWYHRDLSRAAAEELLARAGRDGSFLVRDSESVAGAFALCVLYQKHVHTYRILPDGEDFLAVQTSQGVPVRRFQTLGELIGLYAQPNQGLVCALLLPV","Homo sapiens","INPPL1, SHIP2","Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2","1","2MK2"
"2MK7",,"SOLUTION NMR",,,,,,,"10.1093/glycob/cwaa112",,"2MK7",1.88,,,"Tetra-O-GalNAc glycosylated mucin sequence from alpha dystroglycan mucin domain","XPPTTTTKKPX","Homo sapiens","DAG1","Alpha-dystroglycan","1","2MK7"
"2MK9",,"SOLUTION NMR",,,,,,,"10.1016/j.febslet.2014.08.031",,"2MK9",8.18,,,"Spatial structure of the dimeric transmembrane domain of Toll-like receptor 3","MDSAPFELFFMINTSILLIFIFIVLLIHFEGWRI","Homo sapiens","TLR3","Toll-like receptor 3","1","2MK9"
"2MKA",,"SOLUTION NMR",,,,,,,"10.1016/j.febslet.2014.08.031",,"2MKA",12.27,,,"Spatial structure of the Toll-like receptor 3 transmembrane domain in the trimeric state","MDSAPFELFFMINTSILLIFIFIVLLIHFEGWRI","Homo sapiens","TLR3","Toll-like receptor 3","1","2MKA"
"2MKD",,"SOLUTION NMR",,,,,,,"10.1021/bi401675h",,"2MKD",7.1,,,"Human JAZ ZF3 Residues 168-227","STKVEALHQNREMIDPDKFCSLCHATFNDPVMAQQHYVGKKHRKQETKLKLMARYGRLAD","Homo sapiens","ZNF346, JAZ","Zinc finger protein 346","1","2MKD"
"2MKE",,"SOLUTION NMR",,,,,,,"10.1101/gad.241133.114",,"2MKE",7.52,,,"Solution structure of CPEB1 ZZ domain in the free state","IDPYLEDSLCHICSSQPGPFFCRDQVCFKYFCRSCWHWRHSMEGLRHHSPLMRNQKNRDSS","Homo sapiens","CPEB1, CPEB","Cytoplasmic polyadenylation element-binding protein 1","1","2MKE"
"2MKF",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M113.538280",,"2MKF",6.89,,,"Solution structure of the E81 deletion mutant of the tandem UIMs of RAP80","GPLGSRKIAQMTEEQFALALKMSEQEAREVNSQEEEEEELLRKAIAESLNSCRPSDASATRS","Homo sapiens","UIMC1, RAP80, RXRIP110","BRCA1-A complex subunit RAP80","1","2MKF"
"2MKG",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M113.538280",,"2MKG",7.02,,,"Solution structure of the tandem UIMs of RAP80","GPLGSRKIAQMTEEEQFALALKMSEQEAREVNSQEEEEEELLRKAIAESLNSCRPSDASATRS","Homo sapiens","UIMC1, RAP80, RXRIP110","BRCA1-A complex subunit RAP80","1","2MKG"
"2MKH",,"SOLUTION NMR",,,,,,,"10.1101/gad.241133.114",,"2MKH",24.38,,,"Solution structure of tandem RRM domains of cytoplasmic polyadenylation element binding protein 1 (CPEB1) in free state","MTWSGQLPPRNYKNPIYSCKVFLGGVPWDITEAGLVNTFRVFGSLSVEWPGKDGKHPRCPPKGYVYLVFELEKSVRSLLQACSHDPLSPDGLSEYYFKMSSRRMRCKEVQVIPWVLADSNFVRSPSQRLDPSRTVFVGALHGMLNAEALAAILNDLFGGVVYAGIDTDKHKYPIGSGRVTFNNQRSYLKAVSAAFVEIKTTKFTKKVQIDPYLEDSL","Homo sapiens","CPEB1, CPEB","Cytoplasmic polyadenylation element-binding protein 1","1","2MKH"
"2MKI",,"SOLUTION NMR",,,,,,,"10.1101/gad.241133.114",,"2MKI",24.33,,,"Solution structure of tandem RRM domains of cytoplasmic polyadenylation element binding protein 4 (CPEB4) in complex with RNA","SHQNGERVERYSRKVFVGGLPPDIDEDEITASFRRFGPLIVDWPHKAESKSYFPPKGYAFLLFQDESSVQALIDACIEEDGKLYLCVSSPTIKDKPVQIRPWNLSDSDFVMDGSQPLDPRKTIFVGGVPRPLRAVELAMIMDRLYGGVCYAGIDTDPELKYPKGAGRVAFSNQQSYIAAISARFVQLQHGEIDKRVEVKPYVL","Homo sapiens","CPEB4, KIAA1673","Cytoplasmic polyadenylation element-binding protein 4","1","2MKI"
,,,,,,,,,,,,,,,,"CUUUA",,,"RNA (5'-R(*CP*UP*UP*UP*A)-3')","2","2MKI"
"2MKJ",,"SOLUTION NMR",,,,,,,"10.1101/gad.241133.114",,"2MKJ",22.83,,,"Solution structure of tandem RRM domains of cytoplasmic polyadenylation element binding protein 4 (CPEB4) in free state","SHQNGERVERYSRKVFVGGLPPDIDEDEITASFRRFGPLIVDWPHKAESKSYFPPKGYAFLLFQDESSVQALIDACIEEDGKLYLCVSSPTIKDKPVQIRPWNLSDSDFVMDGSQPLDPRKTIFVGGVPRPLRAVELAMIMDRLYGGVCYAGIDTDPELKYPKGAGRVAFSNQQSYIAAISARFVQLQHGEIDKRVEVKPYVL","Homo sapiens","CPEB4, KIAA1673","Cytoplasmic polyadenylation element-binding protein 4","1","2MKJ"
"2MKK",,"SOLUTION NMR",,,,,,,"10.1101/gad.241133.114",,"2MKK",25.44,,,"Structural model of tandem RRM domains of cytoplasmic polyadenylation element binding protein 1 (CPEB1) in complex with RNA","MTWSGQLPPRNYKNPIYSCKVFLGGVPWDITEAGLVNTFRVFGSLSVEWPGKDGKHPRCPPKGYVYLVFELEKSVRSLLQACSHDPLSPDGLSEYYFKMSSRRMRCKEVQVIPWVLADSNFVRSPSQRLDPSRTVFVGALHGMLNAEALAAILNDLFGGVVYAGIDTDKHKYPIGSGRVTFNNQRSYLKAVSAAFVEIKTTKFTKKVQIDPYL","Homo sapiens","CPEB1, CPEB","Cytoplasmic polyadenylation element-binding protein 1","1","2MKK"
,,,,,,,,,,,,,,,,"UUUUA",,,"RNA (5'-R(*UP*UP*UP*UP*A)-3')","2","2MKK"
"2MKS",,"SOLUTION NMR",,,,,,,,,"2MKS",10.09,,,"NMR structure of the RRM domain of RBMX from homo sapiens","GHMVEADRPGKLFIGGLNTETNEKALEAVFGKYGRIVEVLLMKDRETNKSRGFAFVTFESPADAKDAARDMNGKSLDGKAIKVEQATKPSFE","Homo sapiens","RBMX, HNRPG, RBMXP1","RNA-binding motif protein, X chromosome","1","2MKS"
"2MKV",,"SOLUTION NMR",,,,,,,"10.1016/j.bbamem.2014.04.021",,"2MKV",7.33,,,"Structure of the NA,K-ATPASE regulatory protein FXYD2b in micelles","LDRWYLGGSPKGDVDPFYYDYETVRNGGLIFAGLAFIVGLLILLSRRFRSGGNKKRRQINEDEP","Homo sapiens","ATP1C, ATP1G1, FXYD2, FXYD2b","Sodium/potassium-transporting ATPase subunit gamma","1","2MKV"
"2MKW",,"SOLUTION NMR",,,,,,,"10.1016/j.bbrc.2014.12.044",,"2MKW",11.86,,,"Solution Structure of 6aJl2 and 6aJL2-R24G Amyloidogenics Light Chain Proteins","NFMLTQPHSVSESPGKTVTISCTGSSGSIASNYVQWYQQRPGSSPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDSSNHVVFGGGTKLTVL","Homo sapiens","V1-22","V1-22 protein","1","2MKW"
"2MKZ",,"SOLUTION NMR",,,,,,,"10.1007/s13238-014-0046-z",,"2MKZ",14.82,,,"solution structure of a protein C-terminal domain","SNAILATMNVPAGPAGGQQVDLASVLTPEIMAPILANADVQERLLPYLPSGESLPQTADEIQNTLTSPQFQQALGMFSAALASGQLGPLMCQFGLPAEAVEAANKGDVEAFAKAMQNNAKPEQKEGDTKDKKDEEEDMSLD","Homo sapiens","ADRM1, GP110","Proteasomal ubiquitin receptor ADRM1","1","2MKZ"
"2MLE",,"SOLUTION NMR",,,,,,,"10.1021/bi801165c",,"2MLE",8.45,,,"NMR structure of the C-domain of troponin C bound to the anchoring region of troponin I","MGKSEEELSDLFRMFDKNADGYIDLDELKIMLQATGETITEDDIEELMKDGDKNNDGRIDYDEFLEFMKGVE","Homo sapiens","TNNC1, TNNC","Troponin C, slow skeletal and cardiac muscles","1","2MLE"
"2MLF",,"SOLUTION NMR",,,,,,,"10.1021/bi801165c",,"2MLF",8.51,,,"NMR structure of the dilated cardiomyopathy mutation G159D in troponin C bound to the anchoring region of troponin I","MGKSEEELSDLFRMFDKNADGYIDLDELKIMLQATGETITEDDIEELMKDGDKNNDGRIDYDEFLEFMKDVE","Homo sapiens","TNNC1, TNNC","Troponin C, slow skeletal and cardiac muscles","1","2MLF"
"2MLO",,"SOLUTION NMR",,,,,,,"10.1111/febs.13096",,"2MLO",2.13,,,"Human CCR2 Membrane-Proximal C-Terminal Region (PRO-C) in a Membrane bound form","EKFRRYLSVFFRKHIT","Homo sapiens","CCR2, CMKBR2","MCP-1 receptor","1","2MLO"
"2MLQ",,"SOLUTION NMR",,,,,,,"10.1111/febs.13096",,"2MLQ",2.13,,,"Human CCR2 Membrane-Proximal C-Terminal Region (PRO-C) in a frount bound form","EKFRRYLSVFFRKHIT","Homo sapiens","CCR2, CMKBR2","MCP-1 receptor","1","2MLQ"
"2MLR",,"SOLUTION NMR",,,,,,,"10.1038/ncomms6552",,"2MLR",103.3,,,"Membrane Bilayer complex with Matrix Metalloproteinase-12 at its Alpha-face","FREMPGGPVWRKHYITYRINNYTPDMNREDVDYAIRKAFQVWSNVTPLKFSKINTGMADILVVFARGAHGDFHAFDGKGGILAHAFGPGSGIGGDAHFDEDEFWTTHSGGTNLFLTAVHAIGHSLGLGHSSDPKAVMFPTYKYVDINTFRLSADDIRGIQSLYG","Homo sapiens","MMP12, HME","Macrophage metalloelastase","1","2MLR"
"2MLS",,"SOLUTION NMR",,,,,,,"10.1038/ncomms6552",,"2MLS",103.3,,,"Membrane Bilayer complex with Matrix Metalloproteinase-12 at its Beta-face","FREMPGGPVWRKHYITYRINNYTPDMNREDVDYAIRKAFQVWSNVTPLKFSKINTGMADILVVFARGAHGDFHAFDGKGGILAHAFGPGSGIGGDAHFDEDEFWTTHSGGTNLFLTAVHAIGHSLGLGHSSDPKAVMFPTYKYVDINTFRLSADDIRGIQSLYG","Homo sapiens","MMP12, HME","Macrophage metalloelastase","1","2MLS"
"2MM3",,"SOLUTION NMR",,,,,,,"10.1111/febs.13610",,"2MM3",15.17,,,"Solution NMR structure of the ternary complex of human ileal bile acid-binding protein with glycocholate and glycochenodeoxycholate","AFTGKFEMESEKNYDEFMKLLGISSDVIEKARNFKIVTEVQQDGQDFTWSQHYSGGHTMTNKFTVGKESNIQTMGGKTFKATVQMEGGKLVVNFPNYHQTSEIVGDKLVEVSTIGGVTYERVSKRLA","Homo sapiens","FABP6, ILBP, ILLBP","Gastrotropin","1","2MM3"
"2MMC",,"SOLUTION NMR",,,,,,,,,"2MMC",24.46,,,"Nucleotide-free human ran gtpase","MAAQGEPQVQFKLVLVGDGGTGKTTFVKRHLTGEFEKKYVATLGVEVHPLVFHTNRGPIKFNVWDTAGQEKFGGLRDGYYIQAQCAIIMFDVTSRVTYKNVPNWHRDLVRVCENIPIVLCGNKVDIKDRKVKAKSIVFHRKKNLQYYDISAKSNYNFEKPFLWLARKLIGDPNLEFVAMPALAPPEVVMDPALAAQYEHDLEVAQTTALPDEDDDL","Homo sapiens","ARA24, OK/SW-cl.81, RAN, RAN GTPASE","GTP-binding nuclear protein Ran","1","2MMC"
"2MMG",,"SOLUTION NMR",,,,,,,"10.1073/pnas.1411098111",,"2MMG",24.46,,,"Structural Characterization of the Mengovirus Leader Protein Bound to Ran GTPase by Nuclear Magnetic Resonance","MAAQGEPQVQFKLVLVGDGGTGKTTFVKRHLTGEFEKKYVATLGVEVHPLVFHTNRGPIKFNVWDTAGQEKFGGLRDGYYIQAQCAIIMFDVTSRVTYKNVPNWHRDLVRVCENIPIVLCGNKVDIKDRKVKAKSIVFHRKKNLQYYDISAKSNYNFEKPFLWLARKLIGDPNLEFVAMPALAPPEVVMDPALAAQYEHDLEVAQTTALPDEDDDL","Homo sapiens","ARA24, OK/SW-cl.81, RAN, Ran GTPase","GTP-binding nuclear protein Ran","1","2MMG"
"2MMX",,"SOLUTION NMR",,,,,,,"10.1016/j.bbrc.2014.12.044",,"2MMX",11.96,,,"NMR study of 6aJL2","NFMLTQPHSVSESPGKTVTISCTRSSGSIASNYVQWYQQRPGSSPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDSSNHVVFGGGTKLTVL","Homo sapiens","V1-22","V1-22 protein","1","2MMX"
"2MMY",,"SOLUTION NMR",,,,,,,"10.1038/srep17298",,"2MMY",10.62,,,"Solution structure of the RNA recognition motif of human TAF15","GSHMSDNNTIFVQGLGEGVSTDQVGEFFKQIGIIKTNKKTGKPMINLYTDKDTGKPKGEATVSFDDPPSAKAAIDWFDGKEFHGNIIKVSFATRRPE","Homo sapiens","TAF15, RBP56, TAF2N","TATA-binding protein-associated factor 2N","1","2MMY"
"2MMZ",,"SOLUTION NMR",,,,,,,"10.1073/pnas.1400102111",,"2MMZ",13.17,,,"Solution structure of the apo form of human glutaredoxin 5","GSFTMGAGGGGSAEQLDALVKKDKVVVFLKGTPEQPQCGFSNAVVQILRLHGVRDYAAYNVLDDPELRQGIKDYSNWPTIPQVYLNGEFVGGCDILLQMHQNGDLVEELKKLGIHSALLDE","Homo sapiens","GLRX5, C14orf87","Glutaredoxin-related protein 5, mitochondrial","1","2MMZ"
"2MNG",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M114.572164",,"2MNG",14.99,,,"Apo Structure of human HCN4 CNBD solved by NMR","NSEEIINFNCRKLVASMPLFANADPNFVTSMLTKLRFEVFQPGDYIIREGTIGKKMYFIQHGVVSVLTKGNKETKLADGSYFGEICLLTRGRRTASVRADTYCRLYSLSVDNFNEVLEEYPMMRRAFETVA","Homo sapiens","HCN4","Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4","1","2MNG"
"2MNQ",,"SOLUTION NMR",,,,,,,"10.1517/14712598.2015.1009034",,"2MNQ",3.1,,,"1H, 13C, and 15N Chemical Shift Assignments for Thymosin alpha 1","XSDAAVDTSSEITTKDLKEKKEVVEEAEN","Homo sapiens","PTMA, TMSA","THYMOSIN ALPHA-1","1","2MNQ"
"2MNW",,"SOLUTION NMR",,,,,,,"10.1016/j.jmb.2014.12.012",,"2MNW",14.61,,,"Solution structure of the P22S mutant of N-terminal CS domain of human Shq1","GSTAIGMKETAAAKFERQHMDSPDLGTGGGSGDDDDKMLTPAFDLSQDPDFLTIAIRVSYARVSEFDVYFEGSDFKFYAKPYFLRLTLPGRIVENGSEQGSYDADKGIFTIRLPKETPGQHFEGLNMLTALLA","Homo sapiens","SHQ1","Protein SHQ1 homolog","1","2MNW"
"2MNY",,"SOLUTION NMR",,,,,,,"10.1007/s13238-014-0078-4",,"2MNY",6.26,,,"NMR Structure of KDM5B PHD1 finger","AVDLYVCLLCGSGNDEDRLLLCDGCDDSYHTFCLIPPLHDVPKGDWRCPKCLAQE","Homo sapiens","KDM5B, JARID1B, PLU1, RBBP2H1","Lysine-specific demethylase 5B","1","2MNY"
"2MNZ",,"SOLUTION NMR",,,,,,,"10.1007/s13238-014-0078-4",,"2MNZ",7.41,,,"NMR Structure of KDM5B PHD1 finger in complex with H3K4me0(1-10aa)","AVDLYVCLLCGSGNDEDRLLLCDGCDDSYHTFCLIPPLHDVPKGDWRCPKCLAQE","Homo sapiens","KDM5B, JARID1B, PLU1, RBBP2H1","Lysine-specific demethylase 5B","1","2MNZ"
,,,,,,,,,,,,,,,,"ARTKQTARKS",,,"H3K4me0","2","2MNZ"
"2MO5",,"SOLUTION NMR",,,,,,,,,"2MO5",16.67,,,"hIFABP-oleate complex","AHHHHHHVGTQAFDSTWKVDRSENYDKFMEKMGVNIVKRKLAAHDNLKLTITQEGNKFTVKESSAFRNIEVVFELGVTFNYNLADGTELRGTWSLEGNKLIGKFKRTDNGNELNTVREIIGDELVQTYVYEGVEAKRIFKKD","Homo sapiens","FABP2, FABPI","Fatty acid-binding protein, intestinal","1","2MO5"
"2MOC",,"SOLUTION NMR",,,,,,,,,"2MOC",1.19,,,"Membrane induced structure of novel human tachykinin Hemokinin-1 (hHK1)","TGKASQFFGLM","Homo sapiens","TAC4","Tachykinin-4","1","2MOC"
"2MOE",,"SOLUTION NMR",,,,,,,"10.1093/nar/gku782",,"2MOE",14.21,,,"Solution structure of MBD4 methyl-cytosine binding domain bound to methylated DNA","GSTECRKSVPCGWERVVKQRLFGKTAGRFDVYFISPQGLKFRSKSSLANYLHKNGETSLKPEDFDFTVLSK","Homo sapiens","MBD4, MED1","Methyl-CpG-binding domain protein 4","1","2MOE"
,,,,,,,,,,,,,,,,"GGATCGGCTC",,,"DNA (5'-D(*GP*GP*AP*TP*(5CM)P*GP*GP*CP*TP*C)-3')","2","2MOE"
,,,,,,,,,,,,,,,,"GAGCCGATCC",,,"DNA (5'-D(*GP*AP*GP*CP*(5CM)P*GP*AP*TP*CP*C)-3')","3","2MOE"
"2MOF",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M114.609446",,"2MOF",4.48,,,"Structural insights of TM domain of LAMP-2A in DPC micelles","SADDDNFLVPIAVGAALAGVLILVLLAYFIGLKHHHAGYEQF","Homo sapiens","LAMP2","Lysosome-associated membrane glycoprotein 2","1","2MOF"
"2MOM",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M114.609446",,"2MOM",13.45,,,"Structural insights of TM domain of LAMP-2A in DPC micelles","SADDDNFLVPIAVGAALAGVLILVLLAYFIGLKHHHAGYEQF","Homo sapiens","LAMP2","Lysosome-associated membrane glycoprotein 2","1","2MOM"
"2MOR",,"SOLUTION NMR",,,,,,,"10.1021/jp5021824",,"2MOR",8.58,,,"A tensor-free method for the structural and dynamical refinement of proteins using residual dipolar couplings","MQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGG","Homo sapiens","UBC","Ubiquitin","1","2MOR"
"2MOU",,"SOLUTION NMR",,,,,,,,,"2MOU",25.06,,,"Solution structure of StAR-related lipid transfer domain protein 6 (STARD6)","MDFKAIAQQTAQEVLGYNRDTSGWKVVKTSKKITVSSKASRKFHGNLYRVEGIIPESPAKLSDFLYQTGDRITWDKSLQVYNMVHRIDSDTFICHTITQSFAVGSISPRDFIDLVYIKRYEGNMNIISSKSVDFPEYPPSSNYIRGYNHPCGFVCSPMEENPAYSKLVMFVQTEMRGKLSPSIIEKTMPSNLVNFILNAKDGIKAHRTPSRRGFHHNSHS","Homo sapiens","NM_139171/NP_631910, STARD6","StAR-related lipid transfer protein 6","1","2MOU"
"2MOV",,"SOLUTION NMR",,,,,,,"10.1021/bi500046t",,"2MOV",11.8,,,"Receptor for Advanced Glycation End Products (RAGE) Specifically Recognizes Methylglyoxal Derived AGEs.","GSAQNITARIGEPLVLKCKGAPKKPPQRLEWKLNTGRTEAWKVLSPQGGGPWDSVARVLPNGSLFLPAVGIQDEGIFRCQAMNRNGKETKSNYRVRVYQIPGKPE","Homo sapiens","AGER, RAGE","Advanced glycosylation end product-specific receptor","1","2MOV"
"2MOX",,"SOLUTION NMR",,,,,,,"10.1016/j.jsb.2014.05.009",,"2MOX",16.66,,,"solution structure of tandem SH3 domain of Sorbin and SH3 domain-containing protein 1","QHMSGSEMRPARAKFDFKAQTLKELPLQKGDIVYIYKQIDQNWYEGEHHGRVGIFPRTYIELLPPAEKAQPKKLTPVQVLEYGEAIAKFNFNGDTQVEMSFRKGERITLLRQVDENWYEGRIPGTSRQGIFPITYVDVIKRPL","Homo sapiens","SORBS1, KIAA0894, KIAA1296, SH3D5","Sorbin and SH3 domain-containing protein 1","1","2MOX"
"2MP1",,"SOLUTION NMR",,,,,,,"10.1021/acs.biochem.5b00560",,"2MP1",8.81,,,"Solution structure of the human chemokine CCL19","GTNDAEDCCLSVTQKPIPGYIVRNFHYLLIKDGCRVPAVVFTTLRGRQLCAPPDQPWVERIIQRLQRTSAKMKRRSS","Homo sapiens","CCL19, ELC, MIP3B, SCYA19","C-C motif chemokine 19","1","2MP1"
"2MP3",,"SOLUTION NMR",,,,,,,"10.1016/j.bbamem.2014.10.002",,"2MP3",14.04,,,"Truncated L126Z-sod1 in DPC micelle","GHHHHHHATKAVCVLKGDGPVQGIINFEQKESNGPVKVWGSIKGLTEGLHGFHVHEFGDNTAGCTSAGPHFNPLSRKHGGPKDEERHVGDLGNVTADKDGVADVSIEDSVISLSGDHCIIGRTLVVHEKADD","Homo sapiens","SOD1","Superoxide dismutase [Cu-Zn]","1","2MP3"
"2MPC",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M114.553305",,"2MPC",11.83,,,"Solution structure of the pyrin domain of human Pyrin","MAKTPSDHLLSTLEELVPYDFEKFKFKLQNTSVQKEHSRIPRSQIQRARPVKMATLLVTYYGEEYAVQLTLQVLRAINQRLLAEELHRAAIQLEHHHHHH","Homo sapiens","MEFV, MEF, TRIM20","Pyrin","1","2MPC"
"2MPF",,"SOLUTION NMR",,,,,,,"10.1073/pnas.1410389111",,"2MPF",17.99,,,"Solution structure human HCN2 CNBD in the cAMP-unbound state","GPSSPMELNGPLREEIVNFNCRKLVASMPLFANADPNFVTAMLTKLKFEVFQPGDYIIREGTIGKKMYFIQHGVVSVLTKGNKEMKLSDGSYFGEICLLTRGRRTASVRADTYCRLYSLSVDNFNEVLEEYPMMRRAFETVAIDRLDRIGKKNSILLH","Homo sapiens","HCN2, BCNG2","Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2","1","2MPF"
"2MPG",,"SOLUTION NMR",,,,,,,"10.1021/bi500073z",,"2MPG",5.85,,,"Solution structure of the [AibB8,LysB28,ProB29]-insulin analogue","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","Insulin A chain","1","2MPG"
,,,,,,,,,,,,,,,,"FVNQHLCASHLVEALYLVCGERGFFYTKPT","Homo sapiens","INS","Insulin B chain","2","2MPG"
"2MPH",,"SOLUTION NMR",,,,,,,"10.1093/nar/gkw001",,"2MPH",25.22,,,"Solution Structure of human FK506 binding Protein 25","MAAAVPQRAWTVEQLRSEQLPKKDIIKFLQEHGSDSFLAEHKLLGNIKNVAKTANKDHLVTAYNHLFETKRFKGTESISKVSEQVKNVKLNEDKPKETKSEETLDEGPPKYTKSVLKKGDKTNFPKKGDVVHCWYTGTLQDGTVFDTNIQTSAKKKKNAKPLSFKVGVGKVIRGWDEALLTMSKGEKARLEIEPEWAYGKKGQPDAKIPPNAKLTFEVELVDID","Homo sapiens","FKBP3, FKBP25","Peptidyl-prolyl cis-trans isomerase FKBP3","1","2MPH"
"2MPI",,"SOLUTION NMR",,,,,,,"10.1073/pnas.1412897111",,"2MPI",5.7,,,"Solution structure of B24G insulin","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","insulin chain A","1","2MPI"
,,,,,,,,,,,,,,,,"FVNQHLCGSDLVEALYLVCGERGGFYTKPT","Homo sapiens","INS","insulin chain B","2","2MPI"
"2MPZ",,"SOLID-STATE NMR",,,,,,,"10.1016/j.str.2014.10.022",,"2MPZ",71.55,,,"Atomic model of the Abeta D23N ""Iowa"" mutant using solid-state NMR, EM and Rosetta modeling","QKLVFFAENVGSNKGAIIGLMVGGVV","Homo sapiens","APP, A4, AD1","Amyloid beta A4 protein","1","2MPZ"
"2MQ0",,"SOLUTION NMR",,,,,,,"10.1021/bi500784g",,"2MQ0",10.83,,,"NMR structure of the c3 domain of human cardiac myosin binding protein-c","GSHMPVLITRPLEDQLVMVGQRVEFECEVSEEGAQVKWLKDGVELTREETFKYRFKKDGQRHHLIINEAMLEDAGHYALCTSGGQALAELIVQEK","Homo sapiens","MYBPC3","Myosin-binding protein C, cardiac-type","1","2MQ0"
"2MQ3",,"SOLUTION NMR",,,,,,,"10.1021/bi500784g",,"2MQ3",10.86,,,"NMR structure of the c3 domain of human cardiac myosin binding protein-c with a hypertrophic cardiomyopathy-related mutation R502W.","GSHMPVLITRPLEDQLVMVGQRVEFECEVSEEGAQVKWLKDGVELTREETFKYWFKKDGQRHHLIINEAMLEDAGHYALCTSGGQALAELIVQEK","Homo sapiens","MYBPC3","Myosin-binding protein C, cardiac-type","1","2MQ3"
"2MQ6",,"SOLUTION NMR",,,,,,,,,"2MQ6",15.68,,,"Solution structure of Y125F mutant of eRF1 N-domain","MADDPSAADRNVEIWKIKKLIKSLEAARGNGTSMISLIIPPKDQISRVAKMLADEFGTASNIKSRVNRLSVLGAITSVQQRLKLYNKVPPNGLVVYCGTIVTEEGKEKKVNIDFEPFKPINTSLFLCDNKFHTEALTALLSD","Homo sapiens","ETF1, ERF1, RF1, SUP45L1","Eukaryotic peptide chain release factor subunit 1","1","2MQ6"
"2MQ9",,"SOLUTION NMR",,,,,,,,,"2MQ9",15.7,,,"Solution structure of E55Q mutant of eRF1 N-domain","MADDPSAADRNVEIWKIKKLIKSLEAARGNGTSMISLIIPPKDQISRVAKMLADQFGTASNIKSRVNRLSVLGAITSVQQRLKLYNKVPPNGLVVYCGTIVTEEGKEKKVNIDFEPFKPINTSLYLCDNKFHTEALTALLSD","Homo sapiens","ERF1, ETF1, RF1, SUP45L1","Eukaryotic peptide chain release factor subunit 1","1","2MQ9"
"2MQI",,"SOLUTION NMR",,,,,,,"10.1016/j.str.2016.08.016",,"2MQI",13.12,,,"human Fyn SH2 free state","NKVHHHHHHMEWYFGKLGRKDAERQLLSFGNPRGTFLIRESETTKGAYSLSIRDWDDMKGDHVKHYKIRKLDNGGYYITTRAQFETLQQLVQHYSERAAGLCCRLVVPCHK","Homo sapiens","FYN","Tyrosine-protein kinase Fyn","1","2MQI"
"2MQS",,"SOLUTION NMR",,,,,,,"10.1016/j.str.2014.11.021",,"2MQS",32.71,,,"Transient Collagen Triple Helix Binding to a Key Metalloproteinase in Invasion and Development: Spin Labels to Structure","PNICDGNFDTVAMLRGEMFVFKERWFWRVRNNQVMDGYPMPIGQFWRGLPASINTAYERKDGKFVFFKGDKHWVFDEASLEPGYPKHIKELGRGLPTDKIDAALFWMPNGKTYFFRGNKYYRFNEELRAVDSEYPKNIKVWEGIPESPRGSFMGSDEVFTYFYKGNKYWKFNNQKLKVEPGYPKSALRDWMGCPSG","Homo sapiens","MMP14","Matrix metalloproteinase-14","1","2MQS"
,,,,,,,,,,,,,,,,"GPPGPPGPPGPQGIAGQRGVVGLPGPPGPPGPPGPP",,,"THP_L_and_M_chain","2","2MQS"
,,,,,,,,,,,,,,,,"GPPGPPGPPGPQGIAGQRGVVGLPGPPGPPGPP",,,"THP_T_chain","3","2MQS"
"2MRD",,"SOLUTION NMR",,,,,,,"10.1007/s10858-015-9927-6",,"2MRD",23.36,,,"Solution structure of human Ca2+-loaded S100A4 cys-free mutant","MASPLEKALDVMVSTFHKYSGKEGDKFKLNKSELKELLTRELPSFLGKRTDEAAFQKLMSNLDSNRDNEVDFQEYSVFLSSIAMMSNEFFEGFPDKQPRKK","Homo sapiens","S100A4, CAPL, MTS1","Protein S100-A4","1","2MRD"
"2MRF",,"SOLUTION NMR",,,,,,,"10.1021/bi500823h",,"2MRF",3.69,,,"NMR structure of the ubiquitin-binding zinc finger (UBZ) domain from human Rad18","GSRQVTKVDCPVCGVNIPESHINKHLDSCLSRE","Homo sapiens","RAD18, RNF73","E3 ubiquitin-protein ligase RAD18","1","2MRF"
"2MRJ",,"SOLUTION NMR",,,,,,,"10.1016/j.str.2016.08.016",,"2MRJ",12.93,,,"Structure of Fyn protein SH2 bound","SSGLVPRGSHMEWYFGKLGRKDAERQLLSFGNPRGTFLIRESETTKGAYSLSIRDWDDMKGDHVKHYKIRKLDNGGYYITTRAQFETLQQLVQHYSERAAGLCCRLVVPCHK","Homo sapiens","FYN","Tyrosine-protein kinase Fyn","1","2MRJ"
"2MS4",,"SOLUTION NMR",,,,,,,"10.1038/nchembio.1981",,"2MS4",18.99,,,"Cyclophilin a complexed with a fragment of crk-ii","MVNPTVFFDIAVDGEPLGRVSFELFADKVPKTAENFRALSTGEKGFGYKGSCFHRIIPGFMCQGGDFTRHNGTGGKSIYGEKFEDENFILKHTGPGILSMANAGPNTNGSQFFICTAKTEWLDGKHVVFGKVKEGMNIVEAMERFGSRNGKTSKKITIADCGQLE","Homo sapiens","PPIA, CYPA","Peptidyl-prolyl cis-trans isomerase A","1","2MS4"
,,,,,,,,,,,,,,,,"PEPGPYAQP",,,"Peptide","2","2MS4"
"2MS7",,"SOLID-STATE NMR",,,,,,,"10.1073/pnas.1513119113",,"2MS7",248.16,,,"High-resolution solid-state NMR structure of the helical signal transduction filament MAVS CARD","GSMPFAEDKTYKYICRNFSNFCNVDVVEILPYLPCLTARDQDRLRATCTLSGNRDTLWHLFNTLQRRPGWVEYFIAALRGCELVDLADEVASVYQSYQPRTS","Homo sapiens","MAVS, IPS1, KIAA1271, VISA","Mitochondrial antiviral-signaling protein","1","2MS7"
"2MS8",,"SOLUTION NMR",,,,,,,"10.1073/pnas.1513119113",,"2MS8",11.82,,,"Solution NMR structure of MAVS CARD","GSMPFAEDKTYKYICRNFSNFCNVDVVEILPYLPCLTARDQDRLRATCTLSGNRDTLWHLFNTLQRRPGWVEYFIAALRGCELVDLADEVASVYQSYQPRTS","Homo sapiens","MAVS, IPS1, KIAA1271, VISA","Mitochondrial antiviral-signaling protein","1","2MS8"
"2MSG",,"SOLID-STATE NMR",,,,,,,"10.1002/pro.2654",,"2MSG",8.19,,,"Solid-state NMR structure of ubiquitin","MQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLR","Homo sapiens","UBB","Ubiquitin","1","2MSG"
"2MSU",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M114.596692",,"2MSU",2.19,,,"NMR structure of Kindlin-2 F2 339-358","SDKEVDEVDAALSDLEITLE","Homo sapiens","FERMT2, KIND2, MIG2, PLEKHC1","Fermitin family homolog 2","1","2MSU"
"2MSV",,"SOLUTION NMR",,,,,,,"10.1016/j.str.2014.07.014",,"2MSV",18.9,,,"Solution structure of the MLKL N-terminal domain","GSPGISGGGGGILENLKHIITLGQVIHKRCEEMKYCKKQCRRLGHRVLGLIKPLEMLQDQGKRSVPSEKLTTAMNRFKAALEEANGEIEKFSNRSNICRFLTASQDKILFKDVNRKLSDVWKELSLLLQVEQRMPVSPISQGASWAQEDQQDADEDRRAFQMLRRD","Homo sapiens","MLKL","Mixed lineage kinase domain-like protein","1","2MSV"
"2MSX",,"SOLUTION NMR",,,,,,,"10.1042/BJ20141236",,"2MSX",12.84,,,"The solution structure of the MANEC-type domain from Hepatocyte Growth Factor Inhibitor 1 reveals an unexpected PAN/apple domain-type fold","GADCLNSFTAGVPGFVLDTQASVSNGATFLESPTVRRGWDCVRACCTTQNCNLALVELQPDRGEDAIAACFLINCLYEQNFVCKFAPREGFINYLTREVYRSYRQLVDHHHHHH","Homo sapiens","SPINT1, HAI1, UNQ223/PRO256","Kunitz-type protease inhibitor 1","1","2MSX"
"2MSY",,"SOLUTION NMR",,,,,,,"10.1016/j.bbapap.2015.02.009",,"2MSY",8.68,,,"Solution structure of Hox homeodomain","ANWIHARSTRKKRCPYTKYQTLELEKEFLFNMYLTRDRRYEVARVLNLTERQVKIWFQNRRMKMKKMN","Homo sapiens","HOXC9, HOX3B","Homeobox protein Hox-C9","1","2MSY"
"2MT5",,"SOLUTION NMR",,,,,,,"10.1016/j.molcel.2014.09.009",,"2MT5",8.25,,,"Isolated Ring domain","GSVANDENCGICRMAFNGCCPDCKVPGDDCPLVWGQCSHCFHMHCILKWLHAQQVQQHCPMCRQEWKFKE","Homo sapiens","ANAPC11, HSPC214","Anaphase-promoting complex subunit 11","1","2MT5"
"2MT6",,"SOLUTION NMR",,,,,,,"10.1038/nchembio.1700",,"2MT6",17.35,,,"Solution structure of the human ubiquitin conjugating enzyme Ube2w","MASMQKRLQKELLALQNDPPPGMTLNEKSVQNSITQWIVDMEGAPGTLYEGEKFQLLFKFSSRYPFDSPQVMFTGENIPVHPHVYSNGHICLSILTEDWSPALSVQSVCLSIISMLSSCKEKRRPPDNSFYVRTCNKNPKKTKWWYHDDTC","Homo sapiens","UBE2W, UBC16","Ubiquitin-conjugating enzyme E2 W","1","2MT6"
"2MTF",,"SOLUTION NMR",,,,,,,"10.1093/nar/gku1287",,"2MTF",13.54,,,"Solution structure of the La motif of human LARP6","GTASGGENEREDLEQEWKPPDEELIKKLVDQIEFYFSDENLEKDAFLLKHVRRNKLGYVSVKLLTSFKKVKHLTRDWRTTAHALKYSVVLELNEDHRKVRRTTPVPLFPNENLPS","Homo sapiens","LARP6","La-related protein 6","1","2MTF"
"2MTG",,"SOLUTION NMR",,,,,,,"10.1093/nar/gku1287",,"2MTG",13.43,,,"Solution structure of the RRM1 of human LARP6","GNENLPSKMLLVYDLYLSPKLWALATPQKNGRVQEKVMEHLLKLFGTFGVISSVRILKPGRELPPDIRRISSRYSQVGTQECAIVEFEEVEAAIKAHEFMITESQGKENMKAVLIGMKP","Homo sapiens","LARP6","La-related protein 6","1","2MTG"
"2MTN",,"SOLUTION NMR",,,,,,,"10.1182/blood-2014-01-550079",,"2MTN",18.21,,,"Solution structure of MLL-IBD complex","GPAMAPGFDAALQVSAAIGTNLRRFRAVFGESGGGGGSGEDEQFLGFGSDEEVRVRGSVKKVEKKRETSMDSRLQRIHAEIKNSLKIDNLDVNRCIEALDELASLQVTMQQAQKHTEMITTLKKIRRFKVSQVIMEKSTMLYNKFKNMFLVGEGDSVITQVLNK","Homo sapiens","ALL1, CXXC7, DFS70, HRX, HTRX, KMT2A, LEDGF, MLL, MLL1, PSIP1, PSIP2, TRX1","Histone-lysine N-methyltransferase 2A, PC4 and SFRS1-interacting protein fusion","1","2MTN"
"2MUL",,"SOLUTION NMR",,,,,,,,,"2MUL",5.66,,,"Solution Structure of the UBM1 domain of human HUWE1/ARF-BP1","TSSEEEDPLAGISLPEGVDPSFLAALPDDIRREVLQNQLGIRPPTRTAPSTNS","Homo sapiens","HUWE1, KIAA0312, KIAA1578, UREB1, HSPC272","E3 ubiquitin-protein ligase HUWE1","1","2MUL"
"2MUQ",,"SOLUTION NMR",,,,,,,"10.1093/nar/gku1153",,"2MUQ",4.92,,,"Solution Structure of the Human FAAP20 UBZ","SHMGAAALRSCPMCQKEFAPRLTQLDVDSHLAQCLAESTEDVTW","Homo sapiens","C1orf86, FAAP20, FP7162","Fanconi anemia-associated protein of 20 kDa","1","2MUQ"
"2MUU",,"SOLUTION NMR",,,,,,,"10.1042/BJ20150088",,"2MUU",14.56,,,"The Proteolytic Activity of Ubiquitin-specific Protease 28 Is Modulated by the N-terminal Domain","GSMTAELQQDDAAGAADGHGSSCQMLLNQLREITGIQDPSFLHEALKASNGDITQAVSLLTDERVKEPSQDTVATEPSEVEGSAANKEVLAKVIDLTHDNKDDLQAAIALSLLESPKIQADGVDKLAAALEHHHHHH","Homo sapiens","USP28, KIAA1515","Ubiquitin carboxyl-terminal hydrolase 28","1","2MUU"
"2MUX",,"SOLUTION NMR",,,,,,,,,"2MUX",18.33,,,"SUMO2 non-covalently interacts with USP25 and downregulates its activity","MGSSHHHHHHSSGLVPRGSHMTVEQNVLQQSAAQKHQQTFLNQLREITGINDTQILQQALKDSNGNLELAVAFLTAKNAKTPQQEETTYYQTALPGNDRYISVGSQADTNVIDLTGDDKDDLQRAIALSLAESNRAFRETGITDEEQAISRVLEASIAENKACLKR","Homo sapiens","USP25, USP21","Ubiquitin carboxyl-terminal hydrolase 25","1","2MUX"
"2MV1",,"SOLUTION NMR",,,,,,,"10.1021/cb500918v",,"2MV1",5.97,,,"Solution NMR structure of Human Relaxin-2","QLYSALANKCCHVGCTKRSLARFCX","Homo sapiens","RLN2","Relaxin A chain","2","2MV1"
,,,,,,,,,,,,,,,,"DSWMEEVIKLCGRELVRAQIAICGMSTWSX","Homo sapiens","RLN2","Relaxin B chain","1","2MV1"
"2MV6",,"SOLUTION NMR",,,,,,,"10.1016/j.bpj.2014.10.013",,"2MV6",5.45,,,"Solution structure of the transmembrane domain and the juxta-membrane domain of the Erythropoietin Receptor in micelles","MSEPVSLLTPSDLDPLILTLSLILVVILVLLTVLALLSHRRALKQKIWP","Homo sapiens","EPOR","Erythropoietin receptor","1","2MV6"
"2MVC",,"SOLUTION NMR",,,,,,,"10.1371/journal.pone.0112883",,"2MVC",5.82,,,"Solution structure of human insulin at pH 1.9","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","Insulin A chain","1","2MVC"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFYTPKT","Homo sapiens","INS","Insulin B chain","2","2MVC"
"2MVD",,"SOLUTION NMR",,,,,,,"10.1371/journal.pone.0112883",,"2MVD",5.79,,,"Solution structure of [GlnB22]-insulin mutant at pH 1.9","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","Insulin A chain","1","2MVD"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGEQGFFYTPKT","Homo sapiens","INS","Insulin B chain","2","2MVD"
"2MVK",,"SOLUTION NMR",,,,,,,"10.1038/srep10324",,"2MVK",3.18,,,"Solution structure of phosphorylated cytosolic part of Trop2","TNRRKSGKYKKVEIKELGELRKEPSL","Homo sapiens","TACSTD2, GA733-1, M1S1, TROP2","Tumor-associated calcium signal transducer 2","1","2MVK"
"2MVL",,"SOLUTION NMR",,,,,,,"10.1038/srep10324",,"2MVL",3.1,,,"Solution structure of cytosolic part of Trop2","TNRRKSGKYKKVEIKELGELRKEPSL","Homo sapiens","TACSTD2, GA733-1, M1S1, TROP2","Tumor-associated calcium signal transducer 2","1","2MVL"
"2MVM",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M114.628594",,"2MVM",5,,,"Solution structure of eEF1Bdelta CAR domain","GPGSEDDDIDLFGSDNEEEDKEAAQLREERLRQYAEKKAKKPAL","Homo sapiens","EEF1D, EF1D","Elongation factor 1-delta","1","2MVM"
"2MVN",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M114.628594",,"2MVN",5,,,"Solution structure of eEF1Bdelta CAR domain in TCTP-bound state","GPGSEDDDIDLFGSDNEEEDKEAAQLREERLRQYAEKKAKKPAL","Homo sapiens","EEF1D, EF1D","Elongation factor 1-delta","1","2MVN"
"2MVW",,"SOLUTION NMR",,,,,,,"10.1007/s10858-014-9869-4",,"2MVW",12.15,,,"Solution structure of the TRIM19 B-box1 (B1) of human promyelocytic leukemia (PML)","GSRQIVDAQAVCTRCKESADFWCFECEQLLCAKCFEAHQWFLKHEARPLAE","Homo sapiens","PML, MYL, PP8675, RNF71, TRIM19","Protein PML","1","2MVW"
"2MVX",,"SOLID-STATE NMR",,,,,,,"10.1002/anie.201408598",,"2MVX",42.07,,,"Atomic-resolution 3D structure of amyloid-beta fibrils: the Osaka mutation","DAEFRHDSGYEVHHQKLVFFADVGSNKGAIIGLMVGGVV","Homo sapiens","A4, AD1, APP","Amyloid beta A4 protein","1","2MVX"
"2MW5",,"SOLUTION NMR",,,,,,,,,"2MW5",11.15,,,"Backbone fold of Human Small Ubiquitin like Modifier protein-1 (SUMO-1) based on Prot3D-NMR approach.","MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGG","Homo sapiens","SUMO1, SMT3C, SMT3H3, UBL1, OK/SW-cl.43","Small ubiquitin-related modifier 1","1","2MW5"
"2MW8",,"SOLUTION NMR",,,,,,,,,"2MW8",8.32,,,"Solution structure of SATB1 homeodomain","GSHMNRQKTRPRTKISVEALGILQSFIQDVGLYPDEEAIQTLSAQLDLPKYTIIKFFQNQRYYLKHHGKLK","Homo sapiens","SATB1","DNA-binding protein SATB1","1","2MW8"
"2MW9",,"SOLUTION NMR",,,,,,,"10.1073/pnas.1420914111",,"2MW9",4.36,,,"NMR structure of FBP28 WW2 Y438R mutant","GATAVSEWTERKTADGKTYYYNNRTLESTWEKPQELK","Homo sapiens","CA150, TAF2S, TCERG1","Transcription elongation regulator 1","1","2MW9"
"2MWA",,"SOLUTION NMR",,,,,,,"10.1073/pnas.1420914111",,"2MWA",4.31,,,"NMR structure of FBP28 WW2 mutant Y446L","GATAVSEWTEYKTADGKTLYYNNRTLESTWEKPQELK","Homo sapiens","CA150, TAF2S, TCERG1","Transcription elongation regulator 1","1","2MWA"
"2MWB",,"SOLUTION NMR",,,,,,,"10.1073/pnas.1420914111",,"2MWB",4.33,,,"FBP28 WW2 mutant W457F","GATAVSEWTEYKTADGKTYYYNNRTLESTFEKPQELK","Homo sapiens","CA150, TAF2S, TCERG1","Transcription elongation regulator 1","1","2MWB"
"2MWC",,"SOLUTION NMR",,,,,,,,,"2MWC",11.42,,,"Solution structure of human obscurin Ig58","TAKNTVVRGLENVEALEGGEALFECQLSQPEVAAHTWLLDDEPVRTSENAEVVFFENGLRHLLLLKNLRPQDSCRVTFLAGDMVTSAFLTVRGGLEHHHHHH","Homo sapiens","OBSCN, KIAA1556, KIAA1639","Obscurin","1","2MWC"
"2MWD",,"SOLUTION NMR",,,,,,,"10.1073/pnas.1420914111",,"2MWD",3.46,,,"NMR structure of FBP28 WW2 mutant Y438R DNDC","SEWTERKTADGKTYYYNNRTLESTWEKP","Homo sapiens","CA150, TAF2S, TCERG1","Transcription elongation regulator 1","1","2MWD"
"2MWE",,"SOLUTION NMR",,,,,,,"10.1073/pnas.1420914111",,"2MWE",3.42,,,"NMR structure of FBP28 WW2 mutant Y438R, L453A DNDC","SEWTERKTADGKTYYYNNRTAESTWEKP","Homo sapiens","CA150, TAF2S, TCERG1","Transcription elongation regulator 1","1","2MWE"
"2MWF",,"SOLUTION NMR",,,,,,,"10.1073/pnas.1420914111",,"2MWF",3.96,,,"NMR structure of FBP28 WW2 mutant Y438R DN","SEWTERKTADGKTYYYNNRTLESTWEKPQELK","Homo sapiens","CA150, TAF2S, TCERG1","Transcription elongation regulator 1","1","2MWF"
"2MWI",,"SOLUTION NMR",,,,,,,"10.1093/nar/gkv068",,"2MWI",14.06,,,"The structure of the carboxy-terminal domain of DNTTIP1","GAREGPKWDPARLNESTTFVLGSRANKALGMGGTRGRIYIKHPHLFKYAADPQDKHWLAEQHHMRATGGKMAYLLIEEDIRDLAASDDYRGCLDLKLEELKSFVLPSWMVEKMRKYMETLRT","Homo sapiens","DNTTIP1, C20orf167, TDIF1","Deoxynucleotidyltransferase terminal-interacting protein 1","1","2MWI"
"2MWX",,"SOLUTION NMR",,,,,,,"10.1007/s10858-015-9901-3",,"2MWX",6.24,,,"The RING Domain of human Promyelocytic Leukemia Protein (PML)","EEEFQFLRCQQCQAEAKCPKLLPCLHTLCSGCLEASGMQCPICQAPWPLGADTPAL","Homo sapiens","PML, MYL, PP8675, RNF71, TRIM19","Protein PML","1","2MWX"
"2MX4",,"SOLUTION NMR",,,,,,,"10.1038/nature13999",,"2MX4",5.09,,,"NMR structure of Phosphorylated 4E-BP2","PTRTVAISDAAQLPHDYCTTPGGTLFSTTPGGTRIIYDRKFLLDR","Homo sapiens","EIF4EBP2","Eukaryotic translation initiation factor 4E-binding protein 2","1","2MX4"
"2MX7",,"SOLUTION NMR",,,,,,,,,"2MX7",12.29,,,"Solution structure of the internal EH domain of gamma-synergin","SMFPSQDPAQPRMPPWIYNESLVPDAYKKILETTMTPTGIDTAKLYPILMSSGLPRETLGQIWALANRTTPGKLTKEELYTVLAMIAVTQRGVPAMSPDALNQFPAAPIPTL","Homo sapiens","SYNRG, AP1GBP1, SYNG","Synergin gamma","1","2MX7"
"2MXC",,"SOLUTION NMR",,,,,,,"10.1038/s41467-018-03370-1",,"2MXC",19.95,,,"Solution structure of the full length sorting nexin 3","MAHHHHHHVGTAETVADTRRLITKPQNLNDAYGPPSNFLEIDVSNPQTVGVGRGRFTTYEIRVKTNLPIFKLKESTVRRRYSDFEWLRSELERESKVVVPPLPGKAFLRQLPFRGDDGIFDDNFIEERKQGLEQFINKVAGHPLAQNERCLHMFLQDEIIDKSYTPSKIRHA","Homo sapiens","SNX3","Sorting nexin-3","1","2MXC"
"2MXP",,"SOLUTION NMR",,,,,,,"10.1080/15548627.2015.1082025",,"2MXP",3.95,,,"Solution structure of NDP52 ubiquitin-binding zinc finger","QMQPLCFNCPICDKIFPATEKQIFEDHVFCHSL","Homo sapiens","CALCOCO2, NDP52","Calcium-binding and coiled-coil domain-containing protein 2","1","2MXP"
"2MXT",,"SOLUTION NMR",,,,,,,,,"2MXT",9.49,,,"NMR structure of the acidic domain of SYNCRIP (hnRNPQ)","GSENFQTLLDAGLPQKVAEKLDEIYVAGLVAHSDLDERAIEALKEFNEDGALAVLQQFKDSDLSHVQNKSAFLCGVMKTYRQREK","Homo sapiens","SYNCRIP, HNRPQ, NSAP1","Heterogeneous nuclear ribonucleoprotein Q","1","2MXT"
"2MXU",,"SOLID-STATE NMR",,,,,,,"10.1038/nsmb.2991",,"2MXU",54.24,,,"42-Residue Beta Amyloid Fibril","DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA","Homo sapiens","APP, A4, AD1","Amyloid beta A4 protein","1","2MXU"
"2MXV",,"SOLUTION NMR",,,,,,,,,"2MXV",5.02,,,"NMR structure of the first Zinc Finger domain of RBM10","GHMPKINEDWLCNKCGVQNFKRREKCFKCGVPKSEAEQKLPLG","Homo sapiens","RBM10, DXS8237E, GPATC9, GPATCH9, KIAA0122","RNA-binding protein 10","1","2MXV"
"2MXW",,"SOLUTION NMR",,,,,,,,,"2MXW",10.86,,,"Solution NMR Structure of the OCRE Domain of RBM10","GHMQESYSQYPVPDVSTYQYDETSGYYYDPQTGLYYDPNSQYYYNAQSQQYLYWDGERRTYVPALEQSADGHKETGAPSKEGKEKKEKHKTK","Homo sapiens","DXS8237E, GPATC9, GPATCH9, KIAA0122, RBM10","RNA-binding protein 10","1","2MXW"
"2MY7",,"SOLUTION NMR",,,,,,,"10.1016/j.bpj.2019.11.3392",,"2MY7",10.93,,,"NMR Structure of unfolding intermediate state of RRM-3 domain of ETR-3","GSHMQKEGPEGANLFIYHLPQEFGDQDILQMFMPFGNVISAKVFIDKQTNLSKCFGFVSYDNPVSAQAAIQAMNGFQIGMKRLKVQLKRSKNDSKPY","Homo sapiens","CELF2, BRUNOL3, CUGBP2, ETR3, NAPOR","CUGBP Elav-like family member 2","1","2MY7"
"2MY8",,"SOLUTION NMR",,,,,,,"10.1016/j.bpj.2019.11.3392",,"2MY8",10.93,,,"NMR Structure of RRM-3 domain of ETR-3","GSHMQKEGPEGANLFIYHLPQEFGDQDILQMFMPFGNVISAKVFIDKQTNLSKCFGFVSYDNPVSAQAAIQAMNGFQIGMKRLKVQLKRSKNDSKPY","Homo sapiens","CELF2, BRUNOL3, CUGBP2, ETR3, NAPOR","CUGBP Elav-like family member 2","1","2MY8"
"2MY9",,"SOLUTION NMR",,,,,,,"10.1016/j.febslet.2015.04.002",,"2MY9",14.05,,,"Solution structure of N-terminal domain of human TIG3","MASPHQEPKPGDLIEIFRLGYEHWALYIGDGYVIHLAPPSEYPGAGSSSVFSVLSNSAEVKRERLEDVVGGCCYRVNNSLDHEYQPRPVEVIISSAKEMVGQKMKYSIVSRNCEHFVTQLRYGKS","Homo sapiens","RARRES3, RIG1, TIG3, PLAAT4","Retinoic acid receptor responder protein 3","1","2MY9"
"2MYL",,"SOLUTION NMR",,,,,,,"10.1371/journal.pone.0121149",,"2MYL",2.39,,,"Cullin3 - BTB interface: a novel target for stapled peptides","NSGLSFELLYRLAYTMVLHK","Homo sapiens","CUL3, KIAA0617","Cullin-3","1","2MYL"
"2MYM",,"SOLUTION NMR",,,,,,,"10.1371/journal.pone.0121149",,"2MYM",2.45,,,"Cullin3 - BTB interface: a novel target for stapled peptides","NSGLSFEELYRNLYTMVLHK","Homo sapiens","CUL3, KIAA0617","Cullin-3","1","2MYM"
"2MYQ",,"SOLUTION NMR",,,,,,,"10.1002/cbic.201500197",,"2MYQ",4.97,,,"NMR structure of an Odin-Sam1 fragment","XSKLLLNGFDDVHFLGSNVMEEQDLRDIGISDPQHRRKLLQAARX","Homo sapiens","ANKS1A, ANKS1, KIAA0229, ODIN","Ankyrin repeat and SAM domain-containing protein 1A","1","2MYQ"
"2MZ7",,"SOLUTION NMR",,,,,,,"10.1002/anie.201501714",,"2MZ7",4.89,,,"Structure of Tau(267-312) bound to Microtubules","KHQPGGGKVQIINKKLDLSNVQSKCGSKDNIKHVPGGGSVQIVYKP","Homo sapiens","MAPT, MAPTL, MTBT1, TAU","Microtubule-associated protein tau","1","2MZ7"
"2MZE",,"SOLUTION NMR",,,,,,,"10.1016/j.str.2015.08.013",,"2MZE",28.12,,,"NMR Solution Structure of the PRO Form of Human Matrilysin (proMMP-7)","LPLPQEAGGMSELQWEQAQDYLKRFYLYDSETKNANSLEAKLKEMQKFFGLPITGMLNSRVIEIMQKPRCGVPDVAEYSLFPNSPKWTSKVVTYRIVSYTRDLPHITVDRLVSKALNMWGKEIPLHFRKVVWGTADIMIGFARGAHGDSYPFDGPGNTLAHAFAPGTGLGGDAHFDEDERWTDGSSLGINFLYAATHALGHSLGMGHSSDPNAVMYPTYGNGDPQNFKLSQDDIKGIQKLYGKRSNSRKK","Homo sapiens","MMP7, MPSL1, PUMP1","Matrilysin","1","2MZE"
"2MZH",,"SOLUTION NMR",,,,,,,"10.1016/j.str.2015.08.013",,"2MZH",114.14,,,"NMR Solution Structure of the PRO Form of Human Matrilysin (proMMP-7) in Complex with Zwitterionic Membrane","LPQEAGGMSELQWEQAQDYLKRFYLYDSETKNANSLEAKLKEMQKFFGLPITGMLNSRVIEIMQKPRCGVPDVAEYSLFPNSPKWTSKVVTYRIVSYTRDLPHITVDRLVSKALNMWGKEIPLHFRKVVWGTADIMIGFARGAHGDSYPFDGPGNTLAHAFAPGTGLGGDAHFDEDERWTDGSSLGINFLYAATHALGHSLGMGHSSDPNAVMYPTYGNGDPQNFKLSQDDIKGIQKLYGKRSNSRKK","Homo sapiens","MMP7, MPSL1, PUMP1","Matrilysin","1","2MZH"
"2MZI",,"SOLUTION NMR",,,,,,,"10.1016/j.str.2015.08.013",,"2MZI",116.47,,,"NMR Solution Structure of the PRO Form of Human Matrilysin (proMMP-7) in Complex with Anionic Membrane","LPLPQEAGGMSELQWEQAQDYLKRFYLYDSETKNANSLEAKLKEMQKFFGLPITGMLNSRVIEIMQKPRCGVPDVAEYSLFPNSPKWTSKVVTYRIVSYTRDLPHITVDRLVSKALNMWGKEIPLHFRKVVWGTADIMIGFARGAHGDSYPFDGPGNTLAHAFAPGTGLGGDAHFDEDERWTDGSSLGINFLYAATHALGHSLGMGHSSDPNAVMYPTYGNGDPQNFKLSQDDIKGIQKLYGKRSNSRKK","Homo sapiens","MMP7, MPSL1, PUMP1","Matrilysin","1","2MZI"
"2MZN",,"SOLUTION NMR",,,,,,,"10.1016/j.molcel.2015.05.013",,"2MZN",13.53,,,"NMR structure of the HLTF HIRAN domain in its DNA-bound conformation","GSDEEVDSVLFGSLRGHVVGLRYYTGVVNNNEMVALQRDPNNPYDKNAIKVNNVNGNQVGHLKKELAGALAYIMDNKLAQIEGVVPFGANNAFTMPLHMTFWGKEENRKAVSDQLKKHGFKL","Homo sapiens","HLTF, HIP116A, RNF80, SMARCA3, SNF2L3, ZBU1","Helicase-like transcription factor","1","2MZN"
"2MZU",,"SOLUTION NMR",,,,,,,"10.1007/s10858-015-9917-8",,"2MZU",18.04,,,"Extending the eNOE data set of large proteins by evaluation of NOEs with unresolved diagonals","MVNPTVFFDIAVDGEPLGRVSFELFADKVPKTAENFRALSTGEKGFGYKGSCFHRIIPGFMCQGGDFTRHNGTGGKSIYGEKFEDENFILKHTGPGILSMANAGPNTNGSQFFICTAKTEWLDGKHVVFGKVKEGMNIVEAMERFGSRNGKTSKKITIADCGQLE","Homo sapiens","PPIA, CYPA","Peptidyl-prolyl cis-trans isomerase A","1","2MZU"
"2MZX",,"SOLUTION NMR",,,,,,,"10.1111/febs.13243",,"2MZX",1.39,,,"CCR5-ECL2 helical structure, residues Q186-T195","QYQFWKNFQT","Homo sapiens","CCR5, CMKBR5","C-C chemokine receptor type 5","1","2MZX"
"2N03",,"SOLUTION NMR",,,,,,,,,"2N03",23.76,,,"Solution NMR Structure plectin repeat domain 6 (4403-4606) of Plectin from Homo sapiens, Northeast Structural Genomics Consortium (NESG) Target HR6354E","MGHHHHHHSHMQLASWSDPTEETGPVAGILDTETLEKVSITEAMHRNLVDNITGQRLLEAQACTGGIIDPSTGERFPVTDAVNKGLVDKIMVDRINLAQKAFCGFEDPRTKTKMSAAQALKKGWLYYEAGQRFLEVQYLTGGLIEPDTPGRVPLDEALQRGTVDARTAQKLRDVGAYSKYLTCPKTKLKISYKDALDRSMVEEGTGLRLLEAAAQ","Homo sapiens","PLEC, PLEC1","Plectin","1","2N03"
"2N04",,"SOLUTION NMR",,,,,,,"10.1016/j.str.2016.06.009",,"2N04",11.98,,,"Solution Structure of the phosphorylated N-terminal region of Human Cysteine String Protein (CSP)","MRSPGMADQRQRSLSTSGESLYHVLGLDKNATSDDIKKSYRKLALKYHPDKNPDNPEAADKFKEINNAHAILTDATKRNIYDKYGSLGLYVAEQFGEENVNTYFV","Homo sapiens","DNAJC5, CSP, CLN4","DnaJ homolog subfamily C member 5","1","2N04"
"2N05",,"SOLUTION NMR",,,,,,,"10.1016/j.str.2016.06.009",,"2N05",11.9,,,"Solution Structure of the non-phosphorylated N-terminal region of Human Cysteine String Protein (CSP)","MRSPGMADQRQRSLSTSGESLYHVLGLDKNATSDDIKKSYRKLALKYHPDKNPDNPEAADKFKEINNAHAILTDATKRNIYDKYGSLGLYVAEQFGEENVNTYFV","Homo sapiens","DNAJC5, CSP, CLN4","DnaJ homolog subfamily C member 5","1","2N05"
"2N06",,"SOLUTION NMR",,,,,,,"10.1016/j.jmb.2016.01.016",,"2N06",10.74,,,"Mdmx-298","QINQVRPKLPLLKILHAAGAQGEMFTVKEVMHYLGQYIMVKQLYDQQEQHMVYCGGDLLGELLGRQSFSVKDPSPLYDMLRKNLVTLAT","Homo sapiens","MDM4, MDMX","Protein Mdm4","1","2N06"
"2N0A",,"SOLID-STATE NMR",,,,,,,"10.1038/nsmb.3194",,"2N0A",144.76,,,"Atomic-resolution structure of alpha-synuclein fibrils","MDVFMKGLSKAKEGVVAAAEKTKQGVAEAAGKTKEGVLYVGSKTKEGVVHGVATVAEKTKEQVTNVGGAVVTGVTAVAQKTVEGAGSIAAATGFVKKDQLGKNEEGAPQEGILEDMPVDPDNEAYEMPSEEGYQDYEPEA","Homo sapiens","SNCA, NACP, PARK1","Alpha-synuclein","1","2N0A"
"2N0B",,"SOLUTION NMR",,,,,,,,,"2N0B",1.12,,,"NMR structure of Neuromedin C in aqueous solution","GNHWAVGHLMX","Homo sapiens","GRP","Neuromedin C (NMC)","1","2N0B"
"2N0C",,"SOLUTION NMR",,,,,,,,,"2N0C",1.12,,,"NMR structure of Neuromedin C in 10% TFE","GNHWAVGHLMX","Homo sapiens","GRP","Neuromedin C (NMC)","1","2N0C"
"2N0D",,"SOLUTION NMR",,,,,,,,,"2N0D",1.12,,,"NMR structure of Neuromedin C in 25% TFE","GNHWAVGHLMX","Homo sapiens","GRP","Neuromedin C (NMC)","1","2N0D"
"2N0E",,"SOLUTION NMR",,,,,,,,,"2N0E",1.12,,,"NMR structure of Neuromedin C in 40% TFE","GNHWAVGHLMX","Homo sapiens","GRP","Neuromedin C (NMC)","1","2N0E"
"2N0F",,"SOLUTION NMR",,,,,,,,,"2N0F",1.12,,,"NMR structure of Neuromedin C in 60% TFE","GNHWAVGHLMX","Homo sapiens","GRP","Neuromedin C (NMC)","1","2N0F"
"2N0G",,"SOLUTION NMR",,,,,,,,,"2N0G",1.12,,,"NMR structure of Neuromedin C in 90% TFE","GNHWAVGHLMX","Homo sapiens","GRP","Neuromedin C (NMC)","1","2N0G"
"2N0H",,"SOLUTION NMR",,,,,,,,,"2N0H",1.12,,,"NMR structure of Neuromedin C in presence of SDS micelles","GNHWAVGHLMX","Homo sapiens","GRP","Neuromedin C (NMC)","1","2N0H"
"2N0K",,"SOLUTION NMR",,,,,,,"10.7554/eLife.07304",,"2N0K",20.4,,,"Chemical shift assignments and structure of the alpha-crystallin domain from human, HSPB5","GLSEMRLEKDRFSVNLDVKHFSPEELKVKVLGDVIEVHGKHEERQDEHGFISREFHRKYRIPADVDPLTITSSLSSDGVLTVDGPRKQV","Homo sapiens","CRYA2, CRYAB, HSPB5","Alpha-crystallin B chain","1","2N0K"
"2N0T",,"SOLUTION NMR",,,,,,,"10.1002/anie.201503698",,"2N0T",18.04,,,"Structural ensemble of the enzyme cyclophilin reveals an orchestrated mode of action at atomic resolution","MVNPTVFFDIAVDGEPLGRVSFELFADKVPKTAENFRALSTGEKGFGYKGSCFHRIIPGFMCQGGDFTRHNGTGGKSIYGEKFEDENFILKHTGPGILSMANAGPNTNGSQFFICTAKTEWLDGKHVVFGKVKEGMNIVEAMERFGSRNGKTSKKITIADCGQLE","Homo sapiens","PPIA, CYPA","Peptidyl-prolyl cis-trans isomerase A","1","2N0T"
"2N0U",,"SOLUTION NMR",,,,,,,"10.1016/j.jmb.2016.01.016",,"2N0U",10.74,,,"Mdmx-057","QINQVRPKLPLLKILHAAGAQGEMFTVKEVMHYLGQYIMVKQLYDQQEQHMVYCGGDLLGELLGRQSFSVKDPSPLYDMLRKNLVTLAT","Homo sapiens","MDM4, MDMX","Protein Mdm4","1","2N0U"
"2N0W",,"SOLUTION NMR",,,,,,,"10.1016/j.jmb.2016.01.016",,"2N0W",10.8,,,"Mdmx-SJ212","QINQVRPKLPLLKILHAAGAQGEMFTVKEVMHYLGQYIMVKQLYDQQEQHMVYCGGDLLGELLGRQSFSVKDPSPLYDMLRKNLVTLAT","Homo sapiens","MDM4, MDMX","Protein Mdm4","1","2N0W"
"2N0X",,"SOLUTION NMR",,,,,,,"10.1016/j.celrep.2015.03.061",,"2N0X",1.83,,,"Three dimensional structure of EPI-X4, a human albumin-derived peptide that regulates innate immunity through the CXCR4/CXCL12 chemotactic axis and antagonizes HIV-1 entry","LVRYTKKVPQVSTPTL","Homo sapiens","ALB, GIG20, GIG42, PRO0903, PRO1708, PRO2044, PRO2619, PRO2675, UNQ696/PRO1341","Serum albumin","1","2N0X"
"2N0Z",,"SOLUTION NMR",,,,,,,"10.1016/j.celrep.2016.01.079",,"2N0Z",5.92,,,"Solution structure of MyUb (1080-1122) of human Myosin VI","GPLGSPNSGTKKYDLSKWKYAELRDTINTSCDIELLAACREEFHRRLKVYH","Homo sapiens","MYO6, KIAA0389","Unconventional myosin-VI","1","2N0Z"
"2N10",,"SOLUTION NMR",,,,,,,"10.1016/j.celrep.2016.01.079",,"2N10",7.06,,,"Solution structure of MyUb (1080-1131) of human Myosin VI","GPLGSPNSGTKKYDLSKWKYAELRDTINTSCDIELLAACREEFHRRLKVYHAWKSKNKKR","Homo sapiens","MYO6, KIAA0389","Unconventional myosin-VI","1","2N10"
"2N11",,"SOLUTION NMR",,,,,,,"10.1016/j.celrep.2016.01.079",,"2N11",8.4,,,"Solution structure of human Myosin VI isoform3 (998-1071)","QQQAVLEQERRDRELALRIAQSEAELISDEAQADLALRRSLDSYPVSKNDGTRPKMTPEQMAKEMSEFLSRGPA","Homo sapiens","MYO6, KIAA0389","Unconventional myosin-VI","1","2N11"
"2N12",,"SOLUTION NMR",,,,,,,"10.1038/nsmb.3187",,"2N12",9.58,,,"Solution structure of human Myosin VI isoform3 (1050-1131)","RPKMTPEQMAKEMSEFLSRGPAVLATKAAAGTKKYDLSKWKYAELRDTINTSCDIELLAACREEFHRRLKVYHAWKSKNKKR","Homo sapiens","MYO6, KIAA0389","Unconventional myosin-VI","1","2N12"
"2N14",,"SOLUTION NMR",,,,,,,"10.1016/j.jmb.2016.01.016",,"2N14",10.74,,,"Mdmx-295","QINQVRPKLPLLKILHAAGAQGEMFTVKEVMHYLGQYIMVKQLYDQQEQHMVYCGGDLLGELLGRQSFSVKDPSPLYDMLRKNLVTLAT","Homo sapiens","MDM4, MDMX","Protein Mdm4","1","2N14"
"2N16",,"SOLUTION NMR",,,,,,,"10.1073/pnas.1422605112",,"2N16",2.36,,,"Solution structure of G-quadruplex recognition domain of RHAU","SMHPGHLKGREIGMWYAKKQ","Homo sapiens","DHX36, DDX36, KIAA1488, MLEL1, RHAU","ATP-dependent RNA helicase DHX36","1","2N16"
"2N19",,"SOLUTION NMR",,,,,,,"10.7554/eLife.07888",,"2N19",9.63,,,"STIL binding to the Polo-box domain 3 of PLK4 regulates centriole duplication","GSAQLLKSVFVKNVGWATQLTSGAVWVQFNDGSQLVVQAGVSSISYTSPNGQTTRYGENEKLPDYIKQKLQCLSSILLMFSNPTPNFH","Homo sapiens","PLK4, SAK, STK18","Serine/threonine-protein kinase PLK4","1","2N19"
"2N1B",,"SOLUTION NMR",,,,,,,,,"2N1B",29.4,,,"NMR solution structure of nucleotide-free Ran GTPase","MRGSHHHHHHGMASMTGGQQMGRDLYDDDDKDPSSRSAAGTMAAQGEPQVQFKLVLVGDGGTGKTTFVKRHLTGEFEKKYVATLGVEVHPLVFHTNRGPIKFNVWDTAGQEKFGGLRDGYYIQAQCAIIMFDVTSRVTYKNVPNWHRDLVRVCENIPIVLCGNKVDIKDRKVKAKSIVFHRKKNLQYYDISAKSNYNFEKPFLWLARKLIGDPNLEFVAMPALAPPEVVMDPALAAQYEHDLEVAQTTALPDEDDDLEFEA","Homo sapiens","ARA24, OK/SW-cl.81, RAN","GTP-binding nuclear protein Ran","1","2N1B"
"2N1I",,"SOLUTION NMR",,,,,,,,,"2N1I",19.17,,,"Structure of the PR domain from PRDM16","GSGFPTSEDFTPKEGSPYEAPVYIPEDIPIPADFELRESSIPGAGLGVWAKRKMEAGERLGPCVVVPRAAAKETDFGWEQILTDVEVSPQEGCITKISEDLGSEKFCVDANQAGAGSWLKYIRVACSCDDQNLTMCQISEQIYYKVIKDIEPGEELLVHVKEGVYPLGTVPPGLDE","Homo sapiens","PRDM16, KIAA1675, MEL1, PFM13","PR domain zinc finger protein 16","1","2N1I"
"2N1K",,"SOLUTION NMR",,,,,,,"10.1021/acs.biochem.5b00818",,"2N1K",11.34,,,"Structure of the Third Type III Domain from Human Fibronectin","GSHMGTTTAPDAPPDPTVDQVDDTSIVVRWSRPQAPITGYRIVYSPSVEGSSTELNLPETANSVTLSDLQPGVQYNITIYAVEENQESTPVVIQQETTGTPRSDGT","Homo sapiens","FN1, FN","Fibronectin","1","2N1K"
"2N1L",,"SOLUTION NMR",,,,,,,,,"2N1L",13.11,,,"Solution structure of the BCOR PUFD","SDVFEFEFSETPLLPSYNIQVSVAQGPRNWLLLSDVLKKLKMSSRIFRSNFPNVEIVTIAEAEFYRQVSASLLFSSSKDLEAFNPESKELLDLVEFTNEIQTLLGSSVEWLHPSD","Homo sapiens","BCOR, KIAA1575","BCL-6 corepressor","1","2N1L"
"2N1U",,"SOLUTION NMR",,,,,,,"10.1002/pro.2849",,"2N1U",8.19,,,"Structure of SAP30L corepressor protein","GSYGQSCCLIEDGERCVRPAGNASFSKRVQKSISQKKLKLDIDKSVRHLYICDFHKNFIQSVRNKRKRKT","Homo sapiens","SAP30L, NS4ATP2","Histone deacetylase complex subunit SAP30L","1","2N1U"
"2N1V",,"SOLUTION NMR",,,,,,,,,"2N1V",12.77,,,"Solution structure of human SUMO1","MGSSHHHHHHSQDPMSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGG","Homo sapiens","OK/SW-cl.43, SMT3C, SMT3H3, SUMO1, UBL1","Small ubiquitin-related modifier 1","1","2N1V"
"2N1W",,"SOLUTION NMR",,,,,,,,,"2N1W",12.24,,,"Solution structure of human SUMO2","MGSSHHHHHHSQDPMADEKPKEGVKTENNDHINLKVAGQDGSVVQFKIKRHTPLSKLMKAYCERQGLSMRQIRFRFDGQPINETDTPAQLEMEDEDTIDVFQQQTGG","Homo sapiens","SMT3B, SMT3H2, SUMO2","Small ubiquitin-related modifier 2","1","2N1W"
"2N25",,"SOLUTION NMR",,,,,,,"10.1016/j.bbrc.2016.03.034",,"2N25",12.87,,,"Solution structure of Miz-1 zinc finger 2","MVIHKCEDCGKEFTHTGNFKRHIRIHTGEKPFSCRECSKAFSDPAACKAHEKTHSPLKPYGCEECGKSYRLISLLNLHKKRHSGEARYRCEDCGKLFTTSGNLKRHQLVHSG","Homo sapiens","MIZ1, ZBTB17, ZNF151, ZNF60","Zinc finger and BTB domain-containing protein 17","1","2N25"
"2N26",,"SOLUTION NMR",,,,,,,"10.1016/j.bbrc.2016.03.034",,"2N26",12.93,,,"Solution structure of Miz-1 zinc fingers 3 and 4","MVIHKCEDCGKEFTHTGNFKRHIRIHTGEKPFSCRECSKAFSDPAACKAHEKTHSPLKPYGCEECGKSYRLISLLNLHKKRHSGEARYRCEDCGKLFTTSGNLKRHQLVHSG","Homo sapiens","MIZ1, ZBTB17, ZNF151, ZNF60","Zinc finger and BTB domain-containing protein 17","1","2N26"
"2N27",,"SOLUTION NMR",,,,,,,"10.1002/1873-3468.12267",,"2N27",17.19,,,"Competitive inhibition of TRPV1 calmodulin interaction by vanilloids","ADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTIDFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADIDGDGQVNYEEFVQMMTAK","Homo sapiens","CALM1, CALM, CAM, CAM1","Calmodulin","1","2N27"
"2N2A",,"SOLUTION NMR",,,,,,,"10.1016/j.jmb.2015.11.007",,"2N2A",13.02,,,"Spatial structure of HER2/ErbB2 dimeric transmembrane domain in the presence of cytoplasmic juxtamembrane domains","AEQRASPLTSIISAVVGILLVVVLGVVFGILIKRRQQKIRKYTMRRLLQETELVEPLG","Homo sapiens","ERBB2, HER2, MLN19, NEU, NGL","Receptor tyrosine-protein kinase erbB-2","1","2N2A"
"2N2C",,"SOLUTION NMR",,,,,,,,,"2N2C",4.34,,,"NMR Structure of TDP-43 prion-like hydrophobic helix in DPC","MGGGMNFGAFSINPAMMAAAQAALQSSWGMMGMLASQQNQSGP","Homo sapiens","TARDBP, TDP43","TAR DNA-binding protein 43","1","2N2C"
"2N2F",,"SOLUTION NMR",,,,,,,"10.1073/pnas.1510117112",,"2N2F",1.61,,,"Solution NMR structure of Dynorphin 1-13 bound to Kappa Opioid Receptor","YGGFLRRIRPKLK","Homo sapiens","PDYN","Dynorphin A(1-13)","1","2N2F"
"2N2K",,"SOLUTION NMR",,,,,,,"10.7554/eLife.05767",,"2N2K",17.1,,,"Ensemble structure of the closed state of Lys63-linked diubiquitin in the absence of a ligand","MQIFVKTLTGKTITLEVEPSDTIECVKAKIQDKEGIPPDQQRLIFAGCQLEDGRTLSDYNIQKESTLHLVLRLRGG","Homo sapiens","UBC","ubiquitin","1","2N2K"
,,,,,,,,,,,,,,,,"MQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVL","Homo sapiens","UBC","ubiquitin","2","2N2K"
"2N2N",,"SOLUTION NMR",,,,,,,"10.1016/j.str.2015.07.017",,"2N2N",11.5,,,"Tom1 negatively modulates binding of Tollip to phosphatidylinositol 3-phosphate via a coupled folding and binding mechanism","GPLGSEQIGKLRSELEMVSGNVRVMSEMLTELVPTQAEPADLELLQELNRTCRAMQQRVLELIPQIANEQLTEELLIVNDNLNNVFLRHERFERFRTGQT","Homo sapiens","TOM1","Target of Myb protein 1","1","2N2N"
"2N2V",,"SOLUTION NMR",,,,,,,"10.1038/srep19431",,"2N2V",5.76,,,"Solution structure of [B26-B29 triazole cross-linked]-insulin analogue at pH 1.9","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","Insulin A chain","1","2N2V"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFVTPXT","Homo sapiens","INS","Insulin B chain","2","2N2V"
"2N2W",,"SOLUTION NMR",,,,,,,"10.1038/srep19431",,"2N2W",5.76,,,"Solution structure of [B26-B29 triazole cross-linked]-insulin analogue at pH 8.0","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","Insulin A chain","1","2N2W"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFVTPXT","Homo sapiens","INS","Insulin B chain","2","2N2W"
"2N2X",,"SOLUTION NMR",,,,,,,"10.1038/srep19431",,"2N2X",5.73,,,"Solution structure of [GlyB24,B27-B29 triazole cross-linked]-insulin analogue at pH 1.9","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","Insulin A chain","1","2N2X"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGGFYVPXT","Homo sapiens","INS","Insulin B chain","2","2N2X"
"2N31",,"SOLUTION NMR",,,,,,,"10.1016/j.str.2015.07.017",,"2N31",6.13,,,"Tom1 negatively modulates binding of Tollip to phosphatidylinositol 3-phosphate via a coupled folding and binding mechanism","GPLGSMATTVSTQRGPVYIGELPQDFLRITPTQQQRQVQLDAQAAQQLQYGGAVGTVG","Homo sapiens","TOLLIP","Toll interacting protein variant","1","2N31"
"2N39",,"SOLUTION NMR",,,,,,,"10.1016/j.jmb.2016.08.028",,"2N39",12.9,,,"NMR solution structure of a C-terminal domain of the chromodomain helicase DNA-binding protein 1","GPLGSLDQKTFSICKERMRPVKAALKQLDRPEKGLSEREQLEHTRQCLIKIGDHITECLKEYTNPEQIKQWRKNLWIFVSKFTEFDARKLHKLYKHAIKKRQESQQNS","Homo sapiens","CHD1","Chromodomain-helicase-DNA-binding protein 1","1","2N39"
"2N3J",,"SOLUTION NMR",,,,,,,"10.1007/s10858-015-9973-0",,"2N3J",21.79,,,"Solution Structure of the alpha-crystallin domain from the redox-sensitive chaperone, HSPB1","MQLSSGVSEIRHTADRWRVSLDVNHFAPDELTVKTKDGVVEITGKHEERQDEHGYISRCFTRKYTLPPGVDPTQVSSSLSPEGTLTVEAPMPKLATQS","Homo sapiens","HSPB1, HSP27, HSP28","Heat shock protein beta-1","1","2N3J"
"2N3X",,"SOLUTION NMR",,,,,,,"10.1038/srep23928",,"2N3X",5.21,,,"Solution Structure of TDP-43 Amyloidogenic Core Region","MNFGAFSINPAMMAAAQAALQSSWGMMGMLASQQNQSGPSGNNQNQGNMQ","Homo sapiens","TARDBP, TDP43","TAR DNA-binding protein 43","1","2N3X"
"2N3Y",,"SOLUTION NMR",,,,,,,"10.1073/pnas.1618008114",,"2N3Y",12.3,,,"NMR structure of the Y48pCMF variant of human cytochrome c in its reduced state","GDVEKGKKIFIMKCSQCHTVEKGGKHKTGPNLHGLFGRKTGQAPGYSFTAANKNKGIIWGEDTLMEYLENPKKYIPGTKMIFVGIKKKEERADLIAYLKKATNE","Homo sapiens","CYCS, CYC","Cytochrome c","1","2N3Y"
"2N40",,"SOLUTION NMR",,,,,,,"10.1021/acs.biochem.5b01148",,"2N40",10.95,,,"Solution structure of the link module of human tsg-6 in presence of a chondroitin 4-sulfate hexasaccharide","GVYHREARSGKYKLTYAEAKAVCEFEGGHLATYKQLEAARKIGFHVCAAGWMAKGRVGYPIVKPGPNCGFGKTGIIDYGIRLNRSERWDAYCYNPHAK","Homo sapiens","TNFAIP6, TSG6","Tumor necrosis factor-inducible gene 6 protein","1","2N40"
"2N42",,"SOLUTION NMR",,,,,,,"10.1038/nmeth.3455",,"2N42",19.39,,,"EC-NMR Structure of Human H-RasT35S mutant protein Determined by Combining Evolutionary Couplings (EC) and Sparse NMR Data","GPLGSDMTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPSIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHQYREQIKRVKDSDDVPMVLVGNKCDLAARTVESRQAQDLARSYGIPYIETSAKTRQGVEDAFYTLVREIRQH","Homo sapiens","HRAS, HRAS1","GTPase HRas","1","2N42"
"2N46",,"SOLUTION NMR",,,,,,,"10.1038/nmeth.3455",,"2N46",19.39,,,"EC-NMR Structure of Human H-RasT35S mutant protein Determined by Combining Evolutionary Couplings (EC) and Sparse NMR Data","GPLGSDMTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPSIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHQYREQIKRVKDSDDVPMVLVGNKCDLAARTVESRQAQDLARSYGIPYIETSAKTRQGVEDAFYTLVREIRQH","Homo sapiens","HRAS, HRAS1","GTPase HRas","1","2N46"
"2N4G",,"SOLUTION NMR",,,,,,,"10.1038/srep23928",,"2N4G",5.27,,,"Solution Structure of the G335D Mutant of TDP-43 Amyloidogenic Core Region","MNFGAFSINPAMMAAAQAALQSSWDMMGMLASQQNQSGPSGNNQNQGNMQ","Homo sapiens","TARDBP, TDP43","TAR DNA-binding protein 43","1","2N4G"
"2N4H",,"SOLUTION NMR",,,,,,,"10.1038/srep23928",,"2N4H",5.24,,,"Solution Structure of the Q343R Mutant of TDP-43 Amyloidogenic Core Region","MNFGAFSINPAMMAAAQAALQSSWGMMGMLASRQNQSGPSGNNQNQGNMQ","Homo sapiens","TARDBP, TDP43","TAR DNA-binding protein 43","1","2N4H"
"2N4P",,"SOLUTION NMR",,,,,,,"10.1111/febs.13651",,"2N4P",9.85,,,"Solution structure of the n-terminal domain of tdp-43","MAGSHHHHHHGSMSEYIRVTEDENDEPIEIPSEDDGTVLLSTVTAQFPGACGLRYRNPVSQCMRGVRLVEGILHAPDAGWGNLVYVVNY","Homo sapiens","TARDBP, TDP43","TAR DNA-binding protein 43","1","2N4P"
"2N4R",,"SOLUTION NMR",,,,,,,"10.1073/pnas.1518298112",,"2N4R",4.37,,,"NMR structure of Fbp28 WW domain L453D mutant","GATAVSEWTEYKTADGKTYYYNNRTDESTWEKPQELK","Homo sapiens","TCERG1, CA150, TAF2S","Transcription elongation regulator 1","1","2N4R"
"2N4S",,"SOLUTION NMR",,,,,,,"10.1073/pnas.1518298112",,"2N4S",4.38,,,"NMR structure of Fbp28 WW domain L453E mutant","GATAVSEWTEYKTADGKTYYYNNRTEESTWEKPQELK","Homo sapiens","TCERG1, CA150, TAF2S","Transcription elongation regulator 1","1","2N4S"
"2N4T",,"SOLUTION NMR",,,,,,,"10.1073/pnas.1518298112",,"2N4T",4.44,,,"NMR structure of Fbp28 WW domain L453W mutant","GATAVSEWTEYKTADGKTYYYNNRTWESTWEKPQELK","Homo sapiens","TCERG1, CA150, TAF2S","Transcription elongation regulator 1","1","2N4T"
"2N4U",,"SOLUTION NMR",,,,,,,"10.1073/pnas.1518298112",,"2N4U",4.4,,,"NMR structure of Fbp28 WW domain E454Y mutant","GATAVSEWTEYKTADGKTYYYNNRTLYSTWEKPQELK","Homo sapiens","TCERG1, CA150, TAF2S","Transcription elongation regulator 1","1","2N4U"
"2N4V",,"SOLUTION NMR",,,,,,,"10.1073/pnas.1518298112",,"2N4V",4.38,,,"NMR structure of Fbp28 WW domain T456D mutant","GATAVSEWTEYKTADGKTYYYNNRTLESDWEKPQELK","Homo sapiens","TCERG1, CA150, TAF2S","Transcription elongation regulator 1","1","2N4V"
"2N4W",,"SOLUTION NMR",,,,,,,"10.1073/pnas.1518298112",,"2N4W",4.43,,,"NMR structure of Fbp28 WW domain T456Y mutant","GATAVSEWTEYKTADGKTYYYNNRTLESYWEKPQELK","Homo sapiens","TCERG1, CA150, TAF2S","Transcription elongation regulator 1","1","2N4W"
"2N51",,"SOLUTION NMR",,,,,,,"10.1007/s10858-016-0012-6",,"2N51",14.89,,,"NMR structure of the C-terminal region of human eukaryotic elongation factor 1B","GPGSEDDDIDLFGSDNEEEDKEAAQLREERLRQYAEKKAKKPALVAKSSILLDVKPWDDETDMAQLEACVRSIQLDGLVWGASKLVPVGYGIRKLQIQCVVEDDKVGTDLLEEEITKFEEHVQSVDIAAFNKI","Homo sapiens","EEF1D, EF1D","Elongation factor 1-delta","1","2N51"
"2N52",,"SOLUTION NMR",,,,,,,"10.1016/j.bbrc.2016.01.172",,"2N52",6.41,,,"The solution structure of the kallikrein inhibitor SPINK6","VFSQGGQVDCGEFQDTKVYCTRESNPHCGSDGQTYGNKCAFCKAIVKSGGKISLKHPGKC","Homo sapiens","SPINK6, UNQ844/PRO1782","Serine protease inhibitor Kazal-type 6","1","2N52"
"2N54",,"SOLUTION NMR",,,,,,,"10.1021/acschembio.5b00542",,"2N54",20.7,,,"Solution structure of a disulfide stabilized XCL1 dimer","VGSEVSDKRTCVSLTTQRLPVSRIKTYTITEGSLRCVIFITKRGLKVCCDPQATWVRDVVRSMDRKSNTRNNMIQTKPTGTQQSTNTAVTLTG","Homo sapiens","XCL1, LTN, SCYC1","Lymphotactin","1","2N54"
"2N56",,"SOLUTION NMR",,,,,,,,,"2N56",11.22,,,"Ig59 domain of human obscurin A","WRLEILELLKNAAVRAGAQACFTCTLSEAVPVGEASWYINGAAVQPDDSDWTVTADGSHHALLLRSAQPHHAGEVTFACRDAVASARLTVLGLPDGLEHHHHHH","Homo sapiens","OBSCN, KIAA1556, KIAA1639","Obscurin","1","2N56"
"2N5E",,"SOLUTION NMR",,,,,,,"10.1038/nsmb.3345",,"2N5E",38.92,,,"The 3D solution structure of discoidal high-density lipoprotein particles","STFSKLREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAKVQPYLDDFQKKWQEEMELYRQKVEPLGEEMRDRARAHVDALRTHLAPYSDELRQRLAARLEALKENGGARLAEYHAKATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ","Homo sapiens","APOA1","Apolipoprotein A-I","1","2N5E"
"2N5M",,"SOLUTION NMR",,,,,,,,,"2N5M",6.3,,,"Unveiling the structural determinants of KIAA0323 binding preference for NEDD8","GGIRKTRETERLRRQLLEVFWGQDHKVDFILQREPYCRDINQLSEALLSLNF","Homo sapiens","KHNYN, KIAA0323","Protein KHNYN","1","2N5M"
"2N5N",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M115.683227",,"2N5N",9.57,,,"Structure of an N-terminal domain of CHD4","GPLGSSKEPKSSAQLLEDWGMEDIDHVFSEEDYRTLTNYKAFSQFVRPLIAAKNPKIAVSKMMMVLGAKWREFSTNNPFKGSSGAS","Homo sapiens","CHD4","Chromodomain-helicase-DNA-binding protein 4","1","2N5N"
"2N5R",,"SOLUTION NMR",,,,,,,"10.1371/journal.pone.0141692",,"2N5R",1.56,,,"NMR structure of cFLIP-derived calmodulin binding peptide","VRRFDLLKRILK","Homo sapiens","CFLAR, CASH, CASP8AP1, CLARP, MRIT","CASP8 and FADD-like apoptosis regulator","1","2N5R"
"2N5S",,"SOLUTION NMR",,,,,,,"10.1021/acs.biochem.5b00851",,"2N5S",5.98,,,"Spatial structure of EGFR transmembrane and juxtamembrane domains in DPC micelles","GSCKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEGG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","2N5S"
"2N5X",,"SOLUTION NMR",,,,,,,"10.1007/s10858-015-9988-6",,"2N5X",10.2,,,"C-terminal domain of Cdc37 cochaperone","GHMGPGGLDPVEVYESLPEELQKCFDVKDVQMLQDAISKMDPTDAKYHMQRCIDSGLWVPNSKASEAKEGEEAGPGDPLLEAVPKTGDEKDVSV","Homo sapiens","CDC37, CDC37A","Hsp90 co-chaperone Cdc37","1","2N5X"
"2N64",,"SOLUTION NMR",,,,,,,"10.1126/scisignal.aad6275",,"2N64",26.29,,,"NMR Structure of the C-terminal Coiled-Coil Domain of CIN85","GHMEGKPKMEPAASSQAAVEELRTQVRELRSIIETMKDQQKREIKQLLSELDEEKKIRLRLQMEVNDIKKALQSK","Homo sapiens","SH3KBP1, CIN85","SH3 domain-containing kinase-binding protein 1","1","2N64"
"2N6A",,"SOLUTION NMR",,,,,,,,,"2N6A",19.64,,,"NMR structure of a human calmodulin/connexin-36 peptide hybrid","HHHHHHTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTIDFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADIDGDGQVNYEEFVQMMTGASTAAGSGWRKIKLAVRGAQAKRK","Homo sapiens","CALM1, CALM, CAM, CAM1, GJD2, GJA9","human calmodulin/connexin-36 peptide hybrid","1","2N6A"
"2N6D",,"SOLUTION NMR",,,,,,,,,"2N6D",19.16,,,"NMR structure of the 140-315 fragment of the N-acetylglucosamine-1-phosphate transferase, alpha and beta subunits","MKVPMLVLDPALPANITLKDLPSLYPSFHSASDIFNVAKPKNPSTNVSVVVFDSTKDVEDAHSGLLKGNSRQTVWRGYLTTDKEVPGLVLMQDLAFLSGFPPTFKETNQLKTKLPENLSSKVKLLQLYSEASVALLKLNNPKDFQELNKQTKKNMTIDGKELTISPAYLLWD","Homo sapiens","GNPTAB, GNPTA, KIAA1208","N-acetylglucosamine-1-phosphotransferase subunits alpha/beta","1","2N6D"
"2N6F",,"SOLUTION NMR",,,,,,,"10.1111/febs.13686",,"2N6F",15.35,,,"Structure of Pleiotrophin","GKKEKPEKKVKKSDCGEWQWSVCVPTSGDCGLGTREGTRTGAECKQTMKTQRCKIPCNWKKQFGAECKYQFQAWGECDLNTALKTRTGSLKRALHNAECQKTVTISKPCGKLTKPKPQAESKKKKKEGKKQEKMLD","Homo sapiens","HBNF1, NEGF1, PTN","Pleiotrophin","1","2N6F"
"2N72",,"SOLUTION NMR",,,,,,,"10.1038/srep23641",,"2N72",8.29,,,"Solution structure of the Q domain from ACBD3","MQQKQQIMAALNSQTAVQFQQYAAQQYPGNYEQQQILIRQLQEQHYQQYMQQLYQVQLAQQQAALQKQQ","Homo sapiens","ACBD3, GCP60, GOCAP1, GOLPH1","Golgi resident protein GCP60","1","2N72"
"2N79",,"SOLUTION NMR",,,,,,,"10.1016/j.yjmcc.2015.08.017",,"2N79",10.09,,,"The structural and functional effects of the Familial Hypertrophic Cardiomyopathy-linked cardiac troponin C mutation, L29Q","MDDIYKAAVEQLTEEQKNEFKAAFDIFVQGAEDGSISTKELGKVMRMLGQNPTPEELQEMIDEVDEDGSGTVDFDEFLVMMVRSMKDDS","Homo sapiens","TNNC1, TNNC","Troponin C, slow skeletal and cardiac muscles","1","2N79"
"2N7A",,"SOLUTION NMR",,,,,,,"10.1073/pnas.1602214113",,"2N7A",16.67,,,"Solution structure of the human Siglec-8 lectin domain","MEGDRQYGDGYLLQVQELVTVQEGLSVHVPCSFSYPQDGWTDSDPVHGYWFRAGDRPYQDAPVATNNPDREVQAETQGRFQLLGDIWSNDCSLSIRDARKRDKGSYFFRLERGSMKWSYKSQLNYKTKQLSVFVTALTHGSLVPR","Homo sapiens","SAF2, SIGLEC8","Sialic acid-binding Ig-like lectin 8","1","2N7A"
"2N7B",,"SOLUTION NMR",,,,,,,"10.1073/pnas.1602214113",,"2N7B",17.64,,,"Solution structure of the human Siglec-8 lectin domain in complex with 6'sulfo sialyl Lewisx","MEGDRQYGDGYLLQVQELVTVQEGLSVHVPCSFSYPQDGWTDSDPVHGYWFRAGDRPYQDAPVATNNPDREVQAETQGRFQLLGDIWSNDCSLSIRDARKRDKGSYFFRLERGSMKWSYKSQLNYKTKQLSVFVTALTHGSLVPR","Homo sapiens","SIGLEC8, SAF2","Sialic acid-binding Ig-like lectin 8","1","2N7B"
"2N7D",,"SOLUTION NMR",,,,,,,"10.1038/srep30443",,"2N7D",11.14,,,"Solution structure of the UBL domain of human Ddi2","MGHHHHHHHHHHSSGHIEGRHMLLTVYCVRRDLSEVTFSLQVDADFELHNFRALCELESGIPAAESQIVYAERPLTDNHRSLASYGLKDGDVVILRQ","Homo sapiens","DDI2","Protein DDI1 homolog 2","1","2N7D"
"2N7G",,"SOLUTION NMR",,,,,,,"10.1038/srep23712",,"2N7G",17.44,,,"Structure of the cyclic nucleotide-binding homology domain of the hERG channel","MHHHHHHSSGVDLGTENLYFQSMRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRD","Homo sapiens","KCNH2, ERG, ERG1, HERG","Potassium voltage-gated channel subfamily H member 2","1","2N7G"
"2N7I",,"SOLUTION NMR",,,,,,,"10.1038/ncomms11578",,"2N7I",3.96,,,"NMR structure of the prolactin receptor transmembrane domain","GSFTMNDTTVWISVAVLSAVICLIIVWAVALKGYSMV","Homo sapiens","PRLR","Prolactin receptor","1","2N7I"
"2N7L",,"SOLUTION NMR",,,,,,,,,"2N7L",16.26,,,"NMR structure of the N-domain of troponin C bound to the switch region of troponin I and the covalent levosimendan analog i9","MHHHHHHGGLVPRGSMDDIYKAAVEQLTEEQKNEFKAAFDIFVLGAEDGSISTKELGKVMRMLGQNPTPEELQEMIDEVDEDGSGTVDFDEFLVMMVRXMKDDSENLYFQGRRVRISADAMMQALLGARAKESLDLRAHLK","Homo sapiens","TNNC, TNNC1, TNNI3","Troponin C/Troponin I chimera","1","2N7L"
"2N7Q",,"SOLUTION NMR",,,,,,,"10.1038/srep19522",,"2N7Q",5.99,,,"Structure of the transmembrane domain of human nicastrin in SDS micelles","MAHHHHHHASKELELITLTVGFGILIFSLIVTYCINAKADVLFIAPREPGAVSY","Homo sapiens","NCSTN, KIAA0253, UNQ1874/PRO4317","Nicastrin","1","2N7Q"
"2N7R",,"SOLUTION NMR",,,,,,,"10.1038/srep19522",,"2N7R",5.99,,,"Structure of the transmembrane domain of human nicastrin in DPC micelles","MAHHHHHHASKELELITLTVGFGILIFSLIVTYCINAKADVLFIAPREPGAVSY","Homo sapiens","NCSTN, KIAA0253, UNQ1874/PRO4317","Nicastrin","1","2N7R"
"2N7Y",,"SOLUTION NMR",,,,,,,"10.1038/s41598-017-18951-1",,"2N7Y",8.12,,,"NMR structure of metal-binding domain 1 of ATP7B","AGHMQVATSTVRILGMTCQSCVKSIEDRISNLKGIISMKVSLEQGSATVKYVPSVVCLQQVCHQIGDMGFEASIAE","Homo sapiens","ATP7B, PWD, WC1, WND","Copper-transporting ATPase 2","1","2N7Y"
"2N7Z",,"SOLUTION NMR",,,,,,,"10.7554/eLife.11692",,"2N7Z",12.12,,,"Solution structure of RIP2 CARD","GIAQQWIQSKREDIVNQMTEACLNQSLDALLSRDLIMKEDYELVSTKPTRTSKVRQLLDTTDIQGEEFAKVIVQKLKDNKQMGLQPYPEILVVSRSPSLNLLQNKS","Homo sapiens","RIPK2, CARDIAK, RICK, RIP2, UNQ277/PRO314/PRO34092","Receptor-interacting serine/threonine-protein kinase 2","1","2N7Z"
"2N8A",,"SOLUTION NMR",,,,,,,"10.1016/j.molcel.2015.10.032",,"2N8A",38.11,,,"1H, 13C and 15N chemical shift assignments and solution structure for PARP-1 F1F2 domains in complex with a DNA single-strand break","MAESSDKLYRVEYAKSGRASCKKCSESIPKDSLRMAIMVQSPMFDGKVPHWYHFSCFWKVGHSIRHPDVEVDGFSELRWDDQQKVKKTAEAGGVTGKGQDGIGSKAEKTLGDFAAEYAKSNRSTCKGCMEKIEKGQVRLSKKMVDPEKPQLGMIDRWYHPGCFVKNREELGFRPEYSASQLKGFSLLATEDKEALKKQLPGVKSEGKRKGDEVD","Homo sapiens","PARP1, ADPRT, PPOL","Poly [ADP-ribose] polymerase 1","1","2N8A"
,,,,,,,,,,,,,,,,"GCTGGCTTCGTAAGAAGCCAGCTCGCGGTCAGCTTGCTGACCGCG",,,"DNA (45-MER)","2","2N8A"
"2N8G",,"SOLUTION NMR",,,,,,,,,"2N8G",8.32,,,"NMR Structure of the homeodomain transcription factor Gbx1[E23R,R58E] from Homo sapiens","GAPGGKSRRRRTAFTSEQLLELRKEFHCKKYLSLTERSQIAHALKLSEVQVKIWFQNERAKWKRIKAGNVS","Homo sapiens","GBX1","Homeobox protein GBX-1","1","2N8G"
"2N8R",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M115.703124",,"2N8R",28.36,,,"Productive complex between MMP-12 and synthetic triple-helical collagen, revealed through paramagnetic NMR","FREMPGGPVWRKHYITYRINNYTPDMNREDVDYAIRKAFQVWSNVTPLKFSKINTGMADILVVFARGAHGDFHAFDGKGGILAHAFGPGSGIGGDAHFDEDEFWTTHSGGTNLFLTAVHEIGHSLGLGHSSDPKAVMFPTYKYVDINTFRLSADDIRGIQSLYG","Homo sapiens","MMP12, HME","Macrophage metalloelastase","1","2N8R"
,,,,,,,,,,,,,,,,"GPPGPPGPPGPPGPPGVVGEQGEQGPPGPPGPPGPP",,,"Collagen triple helix repeat family protein","2","2N8R"
"2N8Y",,"SOLUTION NMR",,,,,,,"10.1038/srep27383",,"2N8Y",17.03,,,"Holo form of Calmodulin-Like Domain of Human Non-Muscle alpha-actinin 1","GSSISQEQMNEFRASFNHFDRDHSGTLGPEEFKACLISLGYDIGNDPQGEAEFARIMSIVDPNRLGVVTFQAFIDFMSRETADTDTADQVMASFKILAGDKNYITMDELRRELPPDQAEYCIARMAPYTGPDSVPGALDYMSFSTALYGESDL","Homo sapiens","ACTN1","Alpha-actinin-1","1","2N8Y"
"2N8Z",,"SOLUTION NMR",,,,,,,"10.1038/srep27383",,"2N8Z",16.99,,,"Apo form of Calmodulin-Like Domain of Human Non-Muscle alpha-actinin 1","GSSISQEQMNEFRASFNHFDRDHSGTLGPEEFKACLISLGYDIGNDPQGEAEFARIMSIVDPNRLGVVTFQAFIDFMSRETADTDTADQVMASFKILAGDKNYITMDELRRELPPDQAEYCIARMAPYTGPDSVPGALDYMSFSTALYGESDL","Homo sapiens","ACTN1","Alpha-actinin-1","1","2N8Z"
"2N90",,"SOLUTION NMR",,,,,,,"10.1074/jbc.RA119.011312",,"2N90",8.43,,,"TrkA transmembrane domain NMR structure in DPC micelles","MKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKAGRRNK","Homo sapiens","NTRK1, MTC, TRK, TRKA","High affinity nerve growth factor receptor","1","2N90"
"2N97",,"SOLUTION NMR",,,,,,,"10.7554/eLife.11692",,"2N97",21.06,,,"DD homodimer","KGDGGLYSSLPPAKREEVEKLLNGSAGDTWRHLAGELGYQPEHIDSFTHEACPVRALLASWATQDSATLDALLAALRRIQRADLVESLCSESTATSPV","Homo sapiens","NGFR, TNFRSF16","Tumor necrosis factor receptor superfamily member 16","1","2N97"
"2N99",,"SOLUTION NMR",,,,,,,"10.1038/srep30698",,"2N99",8.16,,,"Solution structure of the SLURP-2, a secreted isoform of Lynx1","MIWCHQCTGFGGCSHGSRCLRDSTHCVTTATRVLSNTEDLPLVTKMCHIGCPDIPSLGLGPYVSIACCQTSLCNHD","Homo sapiens","LYNX1, SLURP2","Ly-6/neurotoxin-like protein 1","1","2N99"
"2N9C",,"SOLUTION NMR",,,,,,,"10.1002/pro.2916",,"2N9C",2.12,,,"NRAS Isoform 5","MTEYKLVVVGAGGVGKSHVW","Homo sapiens","NRAS, HRAS1","GTPase NRas","1","2N9C"
"2N9D",,"SOLUTION NMR",,,,,,,"10.1016/j.dib.2016.02.042",,"2N9D",11.5,,,"Structure analysis of the Tom1 GAT domain reveals distinct ligand-specific conformational states","GPLGSEQIGKLRSELEMVSGNVRVMSEMLTELVPTQAEPADLELLQELNRTCRAMQQRVLELIPQIANEQLTEELLIVNDNLNNVFLRHERFERFRTGQT","Homo sapiens","TOM1","Target of Myb protein 1","1","2N9D"
"2N9I",,"SOLUTION NMR",,,,,,,"10.1016/j.bbrc.2015.12.079",,"2N9I",12.26,,,"Solution structure of reduced human cytochrome c","GDVEKGKKIFIMKCSQCHTVEKGGKHKTGPNLHGLFGRKTGQAPGYSYTAANKNKGIIWGEDTLMEYLENPKKYIPGTKMIFVGIKKKEERADLIAYLKKATNE","Homo sapiens","CYCS, CYC","Cytochrome c","1","2N9I"
"2N9J",,"SOLUTION NMR",,,,,,,"10.1016/j.bbrc.2015.12.079",,"2N9J",12.26,,,"Solution structure of oxidized human cytochrome c","GDVEKGKKIFIMKCSQCHTVEKGGKHKTGPNLHGLFGRKTGQAPGYSYTAANKNKGIIWGEDTLMEYLENPKKYIPGTKMIFVGIKKKEERADLIAYLKKATNE","Homo sapiens","CYCS, CYC","Cytochrome c","1","2N9J"
"2N9O",,"SOLUTION NMR",,,,,,,"10.1038/srep26433",,"2N9O",4.77,,,"Solution structure of RNF126 N-terminal zinc finger domain","GSMAEASPHPGRYFCHCCSVEIVPRLPDYICPRCESGFIEEL","Homo sapiens","RNF126","E3 ubiquitin-protein ligase RNF126","1","2N9O"
"2NA2",,"SOLUTION NMR",,,,,,,,,"2NA2",8.97,,,"DROSHA QUAD MUTANT DOUBLE-STRANDED RNA BINDING COMPETENT","GPGNDPISQLQQCCLTLRTEGKEPDIPLYKTLQTVGPSHARTYTVAVYFKGERIGCGKGPSKKQAKMGAAMDALEKYNFPQM","Homo sapiens","DROSHA, RN3, RNASE3L, RNASEN","Ribonuclease 3","1","2NA2"
"2NA3",,"SOLUTION NMR",,,,,,,,,"2NA3",1.58,,,"NMR Structure of KR-12: A minimalized domain derived from the human cathelicidin LL-37","KRIVQRIKDFLR","Homo sapiens","CAMP, CAP18, FALL39, HSD26","Antibacterial protein LL-37","1","2NA3"
"2NA5",,"SOLUTION NMR",,,,,,,"10.1002/cmdc.201600073",,"2NA5",5.51,,,"NMR solution structure of vitamin B12 conjugates of PYY3-36","IXPEAPGEDASPEELNRYYASLRHYLNLVTRQRY","Homo sapiens","PYY","Peptide YY","1","2NA5"
"2NA7",,"SOLUTION NMR",,,,,,,"10.1016/j.molcel.2016.01.009",,"2NA7",9.92,,,"Transmembrane domain of human Fas/CD95 death receptor","RSNLGWLSLLLLPIPLIVWVKRKEVQKT","Homo sapiens","FAS, APT1, FAS1, TNFRSF6","Tumor necrosis factor receptor superfamily member 6","1","2NA7"
"2NA8",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M116.733683",,"2NA8",5.15,,,"Transmembrane Structure of the Cytokine Receptor Common Subunit beta","GKRSWDTESVLPMWVLALIVIFLTIAVLLALRFCGIYGYRLRRK","Homo sapiens","CSF2RB, IL3RB, IL5RB","Cytokine receptor common subunit beta","1","2NA8"
"2NA9",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M116.733683",,"2NA9",5.12,,,"Transmembrane Structure of the P441A Mutant of the Cytokine Receptor Common Subunit beta","GKRSWDTESVLAMWVLALIVIFLTIAVLLALRFCGIYGYRLRRK","Homo sapiens","CSF2RB, IL3RB, IL5RB","Cytokine receptor common subunit beta","1","2NA9"
"2NAM",,"SOLUTION NMR",,,,,,,"10.1016/j.bbamem.2016.06.027",,"2NAM",16.84,,,"Full-length WT SOD1 in DPC MICELLE","MGHHHHHHATKAVCVLKGDGPVQGIINFEQKESNGPVKVWGSIKGLTEGLHGFHVHEFGDNTAGCTSAGPHFNPLSRKHGGPKDEERHVGDLGNVTADKDGVADVSIEDSVISLSGDHCIIGRTLVVHEKADDLGKGGNEESTKTGNAGSRLACGVIGIAQ","Homo sapiens","SOD1","Superoxide dismutase [Cu-Zn]","1","2NAM"
"2NAN",,"SOLUTION NMR",,,,,,,,,"2NAN",16.23,,,"NMR structure of human DCL-1 (CD302) extracellular domain","MDCPSSTWIQFQDSCYIFLQEAIKVESIEDVRNQCTDHGADMISIHNEEENAFILDTLKKQWKGPDDILLGMFYDTDDASFKWFDNSNMTFDKWTDQDDDEDLVDTCAFLHIKTGEWKKGNCEVSSVEGTLCKTAIPYKR","Homo sapiens","CD302, CLEC13A, DCL1, KIAA0022","CD302 antigen","1","2NAN"
"2NAO",,"SOLUTION NMR",,,,,,,"10.1073/pnas.1600749113",,"2NAO",27.12,,,"Atomic resolution structure of a disease-relevant Abeta(1-42) amyloid fibril","DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA","Homo sapiens","APP, A4, AD1","Beta-amyloid protein 42","1","2NAO"
"2NAQ",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M116.741082",,"2NAQ",10.64,,,"3D NMR solution structure of NLRP3 PYD","MASTRCKLARYLEDLEDVDLKKFKMHLEDYPPQKGCIPLPRGQTEKADHVDLATLMIDFNGEEKAWAMAVWIFAAINRRDLYEKAKRDEPK","Homo sapiens","NLRP3, C1orf7, CIAS1, NALP3, PYPAF1","NACHT, LRR and PYD domains-containing protein 3","1","2NAQ"
"2NAT",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M116.719575",,"2NAT",3.6,,,"Structural insights into interaction of KYE28 and lipopolysachharide","KYEITTIHNLFRKLTHRLFRRNFGYTLR","Homo sapiens","SERPIND1, HCF2","Heparin cofactor 2","1","2NAT"
"2NBB",,"SOLUTION NMR",,,,,,,,,"2NBB",12.93,,,"NMR structure of the Acidic domain of SYNCRIP (24-140)","GSENFQTLLDAGLPQKVAEKLDEIYVAGLVAHSDLDERAIEALKEFNEDGALAVLQQFKDSDLSHVQNKSAFLCGVMKTYRQREKQGTKVADSSKGPDEAKIKALLERTGYTLDVTTG","Homo sapiens","SYNCRIP, HNRPQ, NSAP1","Heterogeneous nuclear ribonucleoprotein Q","1","2NBB"
"2NBD",,"SOLUTION NMR",,,,,,,"10.1002/pro.2940",,"2NBD",8.55,,,"Solution structure of V26A mutant of Ubiquitin at pH 6.0","MQIFVKTLTGKTITLEVEPSDTIENAKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGG","Homo sapiens","UBA52, UBCEP2","entity","1","2NBD"
"2NBE",,"SOLUTION NMR",,,,,,,"10.1002/pro.2940",,"2NBE",8.55,,,"Solution structure of V26A mutant of Ubiquitin at pH 2.0","MQIFVKTLTGKTITLEVEPSDTIENAKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGG","Homo sapiens","UBA52, UBCEP2","entity","1","2NBE"
"2NBO",,"SOLUTION NMR",,,,,,,"10.1038/nsmb.3380",,"2NBO",13.78,,,"Solution structure of the F87M/L110M variant of transthyretin in the monomeric state","GPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPMHEHAEVVFTANDSGPRRYTIAAMLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","2NBO"
"2NBP",,"SOLUTION NMR",,,,,,,"10.1002/anie.201608516",,"2NBP",13.81,,,"Solution structure of the T119M variant of transthyretin in its monomeric state","GPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPMHEHAEVVFTANDSGPRRYTIAAMLSPYSYSTMAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","2NBP"
"2NBQ",,"SOLUTION NMR",,,,,,,"10.1021/acs.biochem.6b00382",,"2NBQ",24.5,,,"NMR Structure of the C-Terminal Domain of human APOBEC3B","MEILRYLMDPDTFTFNFNNDPLVLRRRQTYLCYEVERLDNGTWVLMDQHMGFLCNEAKNLLCGFYGRHAELRFLDLVPSLQLDPAQIYRVTWFISWSPCFSWGCAGEVRAFLQENTHVRLRIFAARIYDYDPLYKEALQMLRDAGAQVSIMTYDEFEYCWDTFVYRQGCPFQPWDGLEEHSQALSGRLRAILQNQGNLEHHHHHH","Homo sapiens","APOBEC3B","DNA dC->dU-editing enzyme APOBEC-3B","1","2NBQ"
"2NBR",,"SOLUTION NMR",,,,,,,"10.1021/acs.biochem.6b00359",,"2NBR",20.77,,,"The Solution Structure of Human gammaC-crystallin","GKITFYEDRAFQGRSYETTTDCPNLQPYFSRCNSIRVESGCWMLYERPNYQGQQYLLRRGEYPDYQQWMGLSDSIRSCCLIPQTVSHRLRLYEREDHKGLMMELSEDCPSIQDRFHLSEIRSLHVLEGCWVLYELPNYRGRQYLLRPQEYRRCQDWGAMDAKAGSLRRVVDLY","Homo sapiens","CRYGC, CRYG3","Gamma-crystallin C","1","2NBR"
"2NC3",,"SOLUTION NMR",,,,,,,"10.1021/jacs.6b02879",,"2NC3",4.03,,,"Solution Structure of N-Allosylated Pin1 WW Domain","KLPPGWEKRMFANGTVYYFNHITNASQFERPSG","Homo sapiens",,"Pin1 WW Domain","1","2NC3"
"2NC4",,"SOLUTION NMR",,,,,,,"10.1021/jacs.6b02879",,"2NC4",4.03,,,"Solution Structure of N-Galactosylated Pin1 WW Domain","KLPPGWEKRMFANGTVYYFNHITNASQFERPSG","Homo sapiens",,"Pin1 WW Domain","1","2NC4"
"2NC5",,"SOLUTION NMR",,,,,,,"10.1021/jacs.6b02879",,"2NC5",4,,,"Solution Structure of N-Xylosylated Pin1 WW Domain","KLPPGWEKRMFANGTVYYFNHITNASQFERPSG","Homo sapiens",,"Pin1 WW Domain","1","2NC5"
"2NC6",,"SOLUTION NMR",,,,,,,"10.1021/jacs.6b02879",,"2NC6",4.03,,,"Solution Structure of N-L-idosylated Pin1 WW Domain","KLPPGWEKRMFANGTVYYFNHITNASQFERPSG","Homo sapiens",,"Pin1 WW Domain","1","2NC6"
"2NC9",,"SOLUTION NMR",,,,,,,"10.1038/s41598-020-71969-w",,"2NC9",15.57,,,"Apo solution structure of Hop TPR2A","ENKKQALKEKELGNDAYKKKDFDTALKHYDKAKELDPTNMTYITNQAAVYFEKGDYNKCRELCEKAIEVGRENREDYRQIAKAYARIGNSYFKEEKYKDAIHFYNKSLAEHRTPDVLKKCQQAEKILKEQE","Homo sapiens","STIP1","Stress-induced-phosphoprotein 1","1","2NC9"
"2NCA",,"SOLUTION NMR",,,,,,,"10.1016/j.molcel.2016.04.005",,"2NCA",15.41,,,"Structural Model for the N-terminal Domain of Human Cdc37","GHMVDYSVWDHIEVSDDEDETHPNIDTASLFRWRHQARVERMEQFQKEKEELDRGCRECKRKVAECQRKLKELEVAEGGKAELERLQAEAQQLRKEERSWEQKLEEMRKKEKSMPWNVDTLSKDGFSK","Homo sapiens","CDC37, CDC37A","Hsp90 co-chaperone Cdc37","1","2NCA"
"2NCL",,"SOLUTION NMR",,,,,,,"10.7554/eLife.16673",,"2NCL",9.31,,,"Solution structure of BOLA3 from Homo sapiens","ATQTEGELRVTQILKEKFPRATAIKVTDISGGCGAMYEIKIESEEFKEKRTVQQHQMVNQALKEEIKEMHGLRIFTSVPKR","Homo sapiens","BOLA3","BolA-like protein 3","1","2NCL"
"2NCN",,"SOLUTION NMR",,,,,,,"10.1038/s41598-019-48155-8",,"2NCN",14.8,,,"Solution Structure of the Autophagy-Related Protein LC3C","GSMPPPQKIPSVRPFKQRKSLAIRQEEVAGIRAKFPNKIPVVVERYPRETFLPPLDKTKFLVPQELTMTQFLSIIRSRMVLRATEAFYLLVNNKSLVSMSATMAEIYRDYKDEDGFVYMTYASQETFG","Homo sapiens","MAP1LC3C","Autophagy-Related Protein LC3C","1","2NCN"
"2NCU",,"SOLUTION NMR",,,,,,,"10.1038/s41598-017-00188-7",,"2NCU",2.75,,,"NMR structure of KYE21 in LPS micelles","KYEITTIHNLFRKLTHRLFRR","Homo sapiens","SERPIND1, HCF2","Heparin cofactor 2","1","2NCU"
"2NCV",,"SOLUTION NMR",,,,,,,,,"2NCV",2.76,,,"NMR structure of RWS21 structure in LPS micelles","RWSITTIHNLFRKLTHRLFRR","Homo sapiens","SERPIND1, HCF2","Heparin cofactor 2","1","2NCV"
"2NCW",,"SOLUTION NMR",,,,,,,"10.1038/s41598-017-00188-7",,"2NCW",3.31,,,"NMR structure of WWWKYE21 structure in LPS micelles","WWWKYEITTIHNLFRKLTHRLFRR","Homo sapiens","SERPIND1, HCF2","Heparin cofactor 2","1","2NCW"
"2ND5",,"SOLUTION NMR",,,,,,,,,"2ND5",12.43,,,"Lysine dimethylated FKBP12","GPSMGVQVETISPGDGRTFPKRGQTCVVHYTGMLEDGKKFDSSRDRNKPFKFMLGKQEVIRGWEEGVAQMSVGQRAKLTISPDYAYGATGHPGIIPPHATLVFDVELLKLE","Homo sapiens","FKBP1A, FKBP1, FKBP12","Peptidyl-prolyl cis-trans isomerase FKBP1A","1","2ND5"
"2NDF",,"SOLUTION NMR",,,,,,,"10.1016/j.str.2016.05.023",,"2NDF",17.98,,,"Solution NMR structures of AF9 yeats domain in complex with histon H3 acetylation at K18","GSHMASSCAVQVKLELGHRAQVRKKPTVEGFTHDWMVFVRGPEHSNIQHFVEKVVFHLHESFPRPKRVCKDPPYKVEESGYAGFILPIEVYFKNKEEPRKVRFDYDLFLHLEGHPPVNHLRCEKLTFNNPTEDFRRKLLKA","Homo sapiens","MLLT3, AF9, YEATS3","Protein AF-9","1","2NDF"
,,,,,,,,,,,,,,,,"GGKAPRKQLATKA",,,"Histone H3 peptide","2","2NDF"
"2NDG",,"SOLUTION NMR",,,,,,,"10.1016/j.str.2016.05.023",,"2NDG",18.01,,,"Solution NMR structures of AF9 yeats domain in complex with histone H3 crotonylation at K18","GSHMASSCAVQVKLELGHRAQVRKKPTVEGFTHDWMVFVRGPEHSNIQHFVEKVVFHLHESFPRPKRVCKDPPYKVEESGYAGFILPIEVYFKNKEEPRKVRFDYDLFLHLEGHPPVNHLRCEKLTFNNPTEDFRRKLLKA","Homo sapiens","MLLT3, AF9, YEATS3","Protein AF-9","1","2NDG"
,,,,,,,,,,,,,,,,"GGKAPRXQLATKA",,,"Histone H3 peptide","2","2NDG"
"2NDH",,"SOLUTION NMR",,,,,,,"10.1073/pnas.1701868114",,"2NDH",15.73,,,"NMR solution structure of MAL/TIRAP TIR domain (C116A)","SSRWSKDYDVCVCHSEEDLVAAQDLVSYLEGSTASLRAFLQLRDATPGGAIVSELCQALSSSHCRVLLITPGFLQDPWCKYQMLQALTEAPGAEGCTIPLLSGLSRAAYPPELRFMYYVDGRGPDGGFRQVKEAVMRYLQTLS","Homo sapiens","TIRAP, MAL","Toll/interleukin-1 receptor domain-containing adapter protein","1","2NDH"
"2NDJ",,"SOLUTION NMR",,,,,,,"10.1126/sciadv.1501228",,"2NDJ",12.8,,,"Structural Basis for KCNE3 and Estrogen Modulation of the KCNQ1 Channel","MGHHHHHHGMETTNGTETWYESLHAVLKALNATLHSNLLCRPGPGLGPDNQTEERRASLPGRDDNSYMYILFVMFLFAVTVGSLILGYTRSRKVDKRSDPYHVYIKNRVSMI","Homo sapiens","KCNE3, MiRP2","Potassium voltage-gated channel subfamily E member 3","1","2NDJ"
"2NDK",,"SOLUTION NMR",,,,,,,"10.1038/s41598-017-13600-z",,"2NDK",4.83,,,"20 lowest energy ensemble of dermcidin (DCD1L) NMR structure","SSLLEKGLDGAKKAVGGLGKLGKDAVEDLESVGKGAVHDVKDVLDSVL","Homo sapiens","DCD, AIDD, DSEP","Dermcidin","1","2NDK"
"2NLB",,"X-RAY DIFFRACTION",2.23,44.73,"VAPOR DIFFUSION",6.5,"PEG 8000, AMMONIUM SULFATE, SODIUM CACODYLATE, pH 6.5, vapor diffusion, temperature 293K",293,"10.1074/jbc.M607210200",,"2NLB",16.07,"1.85","1.85","Human beta-defensin-1 (Mutant Asn4Ala)","DHYACVSSGGQCLYSACPIFTKIQGTCYRGKAKCCK","Homo sapiens","DEFB1, BD1, HBD1","Beta-defensin 1","1","2NLB"
"2NLC",,"X-RAY DIFFRACTION",2.18,43.54,"VAPOR DIFFUSION",7,"PEG 8000, LITHIUM SULFATE, pH 7.0, vapor diffusion, temperature 293K",293,"10.1074/jbc.M607210200",,"2NLC",16.33,"1.65","1.65","Human beta-defensin-1 (mutant Ser8Ala)","DHYNCVSAGGQCLYSACPIFTKIQGTCYRGKAKCCK","Homo sapiens","DEFB1, BD1, HBD1","Beta-defensin 1","1","2NLC"
"2NLD",,"X-RAY DIFFRACTION",1.93,36.17,"VAPOR DIFFUSION",4.6,"PEG 4000, AMMONIUM SULFATE, SODIUM ACETATE, GLYCEROL, pH 4.6, vapor diffusion, temperature 293K",293,"10.1074/jbc.M607210200",,"2NLD",8.02,"1.49","1.49","Human beta-defensin-1 (Mutant Gln11Ala)","DHYNCVSSGGACLYSACPIFTKIQGTCYRGKAKCCK","Homo sapiens","DEFB1, BD1, HBD1","Beta-defensin 1","1","2NLD"
"2NLE",,"X-RAY DIFFRACTION",1.9,35.36,"VAPOR DIFFUSION",4.6,"PEG 4000, AMMONIUM SULFATE, SODIUM ACETATE, GLYCEROL, pH 4.6, vapor diffusion, temperature 293K",293,"10.1074/jbc.M607210200",,"2NLE",8.14,"1.35","1.35","Human beta-defensin-1 (Mutant Gln11Ala)","DHYNCVSSGGQCAYSACPIFTKIQGTCYRGKAKCCK","Homo sapiens","DEFB1, BD1, HBD1","Beta-defensin 1","1","2NLE"
"2NLF",,"X-RAY DIFFRACTION",2.51,51.04,"VAPOR DIFFUSION",4.6,"PEG 4000, AMMONIUM SULFATE, SODIUM ACETATE, pH 4.6, vapor diffusion, temperature 293K",293,"10.1074/jbc.M607210200",,"2NLF",8.3,"1.45","1.45","Human beta-defensin-1 (Mutant Leu13Glu)","DHYNCVSSGGQCEYSACPIFTKIQGTCYRGKAKCCK","Homo sapiens","DEFB1, BD1, HBD1","Beta-defensin 1","1","2NLF"
"2NLG",,"X-RAY DIFFRACTION",2.17,43.42,"VAPOR DIFFUSION",6.5,"PEG 8000, AMMONIUM SULFATE, SODIUM CACODYLATE, pH 6.5, vapor diffusion, temperature 293K",293,"10.1074/jbc.M607210200",,"2NLG",16.53,"1.65","1.65","Human beta-defensin-1 (Mutant Lys22Glu)","DHYNCVSSGGQCLYSACPIFTEIQGTCYRGKAKCCK","Homo sapiens","DEFB1, BD1, HBD1","Beta-defensin 1","1","2NLG"
"2NLH",,"X-RAY DIFFRACTION",2.23,44.95,"VAPOR DIFFUSION",,"PEG 4000, AMMONIUM SULFATE, vapor diffusion, temperature 293K",293,"10.1074/jbc.M607210200",,"2NLH",16.17,"1.85","1.85","Human beta-defensin-1 (Mutant GLN24ALA)","DHYNCVSSGGQCLYSACPIFTKIAGTCYRGKAKCCK","Homo sapiens","DEFB1, BD1, HBD1","Beta-defensin 1","1","2NLH"
"2NLK",,"X-RAY DIFFRACTION",3.27,62.35,"VAPOR DIFFUSION, SITTING DROP",8,"10% PEG 10K, 100mM Imidazole, pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.cell.2008.11.038",,"2NLK",71.77,"2.4","2.4","Crystal structure of D1 and D2 catalytic domains of human Protein Tyrosine Phosphatase Gamma (D1+D2 PTPRG)","MAIPVKQFVKHIGELYSNNQHGFSEDFEEVQRCTADMNITAEHSNHPENKHKNRYINILAYDHSRVKLRPLPGKDSKHSDYINANYVDGYNKAKAYIATQGPLKSTFEDFWRMIWEQNTGIIVMITNLVEKGRRKCDQYWPTENSEEYGNIIVTLKSTKIHACYTVRRFSIRNTKVKKGQKGNPKGRQNERVVIQYHYTQWPDMGVPEYALPVLTFVRRSSAARMPETGPVLVHCSAGVGRTGTYIVIDSMLQQIKDKSTVNVLGFLKHIRTQRNYLVQTEEQYIFIHDALLEAILGKETEVSSNQLHSYVNSILIPGVGGKTRLEKQFKLVTQCNAKYVECFSAQKECNKEKNRNSSVVPSERARVGLAPLPGMKGTDYINASYIMGYYRSNEFIITQHPLPHTTKDFWRMIWDHNAQIIVMLPDNQSLAEDEFVYWPSREESMNCEAFTVTLISKDRLCLSNEEQIIIHDFILEATQDDYVLEVRHFQCPKWPNPDAPISSTFELINVIKEEALTRDGPTIVHDEYGAVSAGMLCALTTLSQQLENENAVDVFQVAKMINLMRPGVFTDIEQYQFIYKAMLSLVSTKENGNGPMTVDKNGAVLIADESDPAESMESLVAHHHHHH","Homo sapiens","PTPRG, PTPG","Protein tyrosine phosphatase, receptor type, G variant (Fragment)","1","2NLK"
"2NLP",,"X-RAY DIFFRACTION",2.29,46.22,"VAPOR DIFFUSION",7.5,"LITHIUM SULFATE, HEPES, pH 7.5, vapor diffusion, temperature 293K",293,"10.1074/jbc.M607210200",,"2NLP",16.34,"1.85","1.85","Human beta-defensin-1 (Mutant Gln24Glu)","DHYNCVSSGGQCLYSACPIFTKIEGTCYRGKAKCCK","Homo sapiens","DEFB1, BD1, HBD1","Beta-defensin 1","1","2NLP"
"2NLQ",,"X-RAY DIFFRACTION",2.33,47.21,"VAPOR DIFFUSION",,"PEG 8000, AMMONIUM SULFATE, vapor diffusion, temperature 293K",293,"10.1074/jbc.M607210200",,"2NLQ",16.18,"1.8","1.8","Human beta-defensin-1 (Mutant Lys31Ala)","DHYNCVSSGGQCLYSACPIFTKIQGTCYRGAAKCCK","Homo sapiens","DEFB1, BD1, HBD1","Beta-defensin 1","1","2NLQ"
"2NLS",,"X-RAY DIFFRACTION",1.82,32.46,"VAPOR DIFFUSION",7.5,"ISO-PROPANOL, SODIUM CITRATE, HEPES-NA, pH 7.5, vapor diffusion, temperature 293K",293,"10.1074/jbc.M607210200",,"2NLS",3.94,"0.98","0.98","Human beta-defensin-1 (Mutant Gln24Ala)","DHYNCVSSGGQCLYSACPIFTKIQGTCYRGEAKCCK","Homo sapiens","DEFB1, BD1, HBD1","Beta-defensin 1","1","2NLS"
"2NLU",,"SOLUTION NMR",,,,,,,"10.1016/j.jmb.2007.01.010",,"2NLU",23.13,,,"Domain-Swapped Dimer of the PWWP Module of Human Hepatoma-derived Growth Factor","MSRSNRQKEYKCGDLVFAKMKGYPHWPARIDEMPEAAVKSTANKYQVFFFGTHETAFLGPKDLFPYEESKEKFGKPNKRKGFSEGLWEIENNPTVKASGY","Homo sapiens","HDGF, HMG1L2","Hepatoma-derived growth factor","1","2NLU"
"2NLW",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M610860200",,"2NLW",11.96,,,"Solution structure of the RRM domain of human eukaryotic initiation factor 3b","GDVLKDRPQEADGIDSVIVVDNVPQVGPDRLEKLKNVIHKIFSKFGKITNDFYPEEDGKTKGYIFLEYASPAHAVDAVKNADGYKLDKQHTFRVNLFTDFDKYMT","Homo sapiens","EIF3S9, EIF3B","Eukaryotic translation initiation factor 3 subunit 9","1","2NLW"
"2NML",,"X-RAY DIFFRACTION",2.29,46.28,"VAPOR DIFFUSION, HANGING DROP",5.6,"PEG 4000, isopropanol, trisodium citrate dihydrate, pH 5.6, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1002/prot.21343",,"2NML",12.27,"1.55","1.55","Crystal structure of HEF2/ERH at 1.55 A resolution","MSHTILLVQPTKRPEGRTYADYESVNECMEGVCKMYEEHLKRMNPNSPSITYDISQLFDFIDDLADLSCLVYRADTQTYQPYNKDWIKEKIYVLLRRQAQQAGK","Homo sapiens","ERH","Enhancer of rudimentary homolog","1","2NML"
"2NMM",,"X-RAY DIFFRACTION",2.2,44.08,"VAPOR DIFFUSION, HANGING DROP",5.5,"2M Ammonium Sulfate, 50 mM Bis-Tris, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"2NMM",46.42,"2.7","2.7","Crystal structure of human phosphohistidine phosphatase. Northeast Structural Genomics Consortium target HR1409","MGHHHHHHSHMAVADLALIPDVDIDSDGVFKYVLIRVHSAPRSGAPAAESKEIVRGYKWAEYHADIYDKVSGDMQKQGCDCECLGGGRISHQSQDKKIHVYGYSMAYGPAQHAISTEKIKAKYPDYEVTWANDGY","Homo sapiens","PHPT1, PHP14, CGI-202, HSPC141","14 kDa phosphohistidine phosphatase","1","2NMM"
"2NMN",,"X-RAY DIFFRACTION",2.21,44.23,"VAPOR DIFFUSION, HANGING DROP",7,"31% PEG 6000, 100mM MgCl2, 8mM beta-mercaptoethanol, 100mM Tris-HCL, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1107/S090744490605270X",,"2NMN",16.04,"2.45","2.45","Crystal structure of human galectin-3 carbohydrate-recognising domain at 2.45 angstrom resolution","PLIVPYNLPLPGGVVPRMLITILGTVKPNANRIALDFQRGNDVAFHFNPRFNENNRRVIVCNTKLDNNWGREERQSVFPFESGKPFKIQVLVEPDHFKVAVNDAHLLQYNHRVKKLNEISKLGISGDIDLTSASYTMI","Homo sapiens","LGALS3, MAC2","Galectin-3","1","2NMN"
"2NMO",,"X-RAY DIFFRACTION",2.07,40.61,"VAPOR DIFFUSION, HANGING DROP",7,"31% PEG 6000, 100mM MgCl2, 8mM beta mercaptoethanol, 100mM Tris-HCL, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1107/S090744490605270X",,"2NMO",16.26,"1.35","1.35","Crystal structure of human galectin-3 carbohydrate-recognition domain at 1.35 angstrom resolution","PLIVPYNLPLPGGVVPRMLITILGTVKPNANRIALDFQRGNDVAFHFNPRFNENNRRVIVCNTKLDNNWGREERQSVFPFESGKPFKIQVLVEPDHFKVAVNDAHLLQYNHRVKKLNEISKLGISGDIDLTSASYTMI","Homo sapiens","LGALS3, MAC2","Galectin-3","1","2NMO"
"2NMP",,"X-RAY DIFFRACTION",2.33,47.17,"VAPOR DIFFUSION, SITTING DROP",5.6,"15% PEG3350, 200mM Ammonium Citrate, pH 5.6, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1074/jbc.M805459200",,"2NMP",178.08,"2.6","2.6","Crystal structure of human Cystathionine gamma lyase","SMQEKDASSQGFLPHFQHFATQAIHVGQDPEQWTSRAVVPPISLSTTFKQGAPGQHSGFEYSRSGNPTRNCLEKAVAALDGAKYCLAFASGLAATVTITHLLKAGDQIICMDDVYGGTNRYFRQVASEFGLKISFVDCSKIKLLEAAITPETKLVWIETPTNPTQKVIDIEGCAHIVHKHGDIILVVDNTFMSPYFQRPLALGADISMYSATKYMNGHSDVVMGLVSVNCESLHNRLRFLQNSLGAVPSPIDCYLCNRGLKTLHVRMEKHFKNGMAVAQFLESNPWVEKVIYPGLPSHPQHELVKRQCTGCTGMVTFYIKGTLQHAEIFLKNLKLFTLAESLGGFESLAELPAIMTHASVLKNDRDVLGISDTLIRLSVGLEDEEDLLEDLDQALKAAHPPSG","Homo sapiens","CTH","Cystathionine gamma-lyase","1","2NMP"
"2NMS",,"X-RAY DIFFRACTION",2.21,43.74,"VAPOR DIFFUSION, SITTING DROP",8,"0.25M potassium thiocyanate, 25% (w/v) PEG MME 2000, pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 293.15K",293.15,"10.1016/j.jmb.2007.01.011",,"2NMS",13.98,"2.6","2.6","The Crystal Structure of the Extracellular Domain of the Inhibitor Receptor Expressed on Myeloid Cells IREM-1","RGIPQITGPTTVNGLERGSLTVQCVYRSGWETYLKWWCRGAIWRDCKILVKTSGSEQEVKRDRVSIKDNQKNRTFTVTMEDLMKTDADTYWCGIEKTGNDLGVTVQVTIDPAPVTQEETSSSPT","Homo sapiens","CD300LF, CLM1, IGSF13, IREM1, NKIR, CD300F, UNQ3105/PRO10111","CMRF35-like-molecule 1","1","2NMS"
"2NMX",,"X-RAY DIFFRACTION",2.4,48.66,,7,"PEG 3350, NaCl, HEPES, Tris, pH 7.0, vapor diffusion, temperature 277K, pH 7.00",277,"10.1021/ja068359w","M25","2NMX",58.31,"1.55","1.55","Structure of inhibitor binding to Carbonic Anhydrase I","ASPDWGYDDKNGPEQWSKLYPIANGNNQSPVDIKTSETKHDTSLKPISVSYNPATAKEIINVGHSFHVNFEDNDNRSVLKGGPFSDSYRLFQFHFHWGSTNEHGSEHTVDGVKYSAELHVAHWNSAKYSSLAEAASKADGLAVIGVLMKVGEANPKLQKVLDALQAIKTKGKRAPFTNFDPSTLLPSSLDFWTYPGSLTHPPLYESVTWIICKESISVSSEQLAQFRSLLSNVEGDNAVPMQHNNRPTQPLKGRTVRASF","Homo sapiens","CA1","Carbonic anhydrase 1","1","2NMX"
"2NN1",,"X-RAY DIFFRACTION",2.39,48.47,"VAPOR DIFFUSION",7,"PEG 3350, NaCl, HEPES, Tris, pH 7.0, vapor diffusion, temperature 277K",277,"10.1021/ja068359w","M28","2NN1",58.28,"1.65","1.65","Structure of inhibitor binding to Carbonic Anhydrase I","ASPDWGYDDKNGPEQWSKLYPIANGNNQSPVDIKTSETKHDTSLKPISVSYNPATAKEIINVGHSFHVNFEDNDNRSVLKGGPFSDSYRLFQFHFHWGSTNEHGSEHTVDGVKYSAELHVAHWNSAKYSSLAEAASKADGLAVIGVLMKVGEANPKLQKVLDALQAIKTKGKRAPFTNFDPSTLLPSSLDFWTYPGSLTHPPLYESVTWIICKESISVSSEQLAQFRSLLSNVEGDNAVPMQHNNRPTQPLKGRTVRASF","Homo sapiens","CA1","Carbonic anhydrase 1","1","2NN1"
"2NN2",,"X-RAY DIFFRACTION",2.69,54.29,"VAPOR DIFFUSION, HANGING DROP",5.4,"0.7 M sodium citrate, pH 5.4, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1110/ps.062660907",,"2NN2",28.33,"2.1","2.1","Crystal structure of the BTB domain from the LRF/ZBTB7 transcriptional regulator","GSMAGGVDGPIGIPFPDHSSDILSGLNEQRTQGLLCDVVILVEGREFPTHRSVLAACSQYFKKLFTSGAVVDQQNVYEIDFVSAEALTALMDFAYTATLTVSTANVGDILSAARLLEIPAVSHVCADLLDRQI","Homo sapiens","ZBTB7A, FBI1, LRF, ZBTB7, ZNF857A","Zinc finger and BTB domain-containing protein 7A","1","2NN2"
"2NN7",,"X-RAY DIFFRACTION",2.39,48.47,"VAPOR DIFFUSION",7,"PEG 3350, NaCl, HEPES, Tris, pH 7.0, vapor diffusion, temperature 277K",277,"10.1021/ja068359w","M29","2NN7",58.27,"1.85","1.85","Structure of inhibitor binding to Carbonic Anhydrase I","ASPDWGYDDKNGPEQWSKLYPIANGNNQSPVDIKTSETKHDTSLKPISVSYNPATAKEIINVGHSFHVNFEDNDNRSVLKGGPFSDSYRLFQFHFHWGSTNEHGSEHTVDGVKYSAELHVAHWNSAKYSSLAEAASKADGLAVIGVLMKVGEANPKLQKVLDALQAIKTKGKRAPFTNFDPSTLLPSSLDFWTYPGSLTHPPLYESVTWIICKESISVSSEQLAQFRSLLSNVEGDNAVPMQHNNRPTQPLKGRTVRASF","Homo sapiens","CA1","Carbonic anhydrase 1","1","2NN7"
"2NN8",,"X-RAY DIFFRACTION",2.09,41.26,"VAPOR DIFFUSION, HANGING DROP",7,"31% PEG 6000, 100mM MgCL2, 8mM beta mercaptoethanol, 100mM Tris-HCL, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1107/S090744490605270X",,"2NN8",16.51,"1.35","1.35","Crystal structure of human galectin-3 carbohydrate-recognition domain with lactose bound, at 1.35 angstrom resolution","PLIVPYNLPLPGGVVPRMLITILGTVKPNANRIALDFQRGNDVAFHFNPRFNENNRRVIVCNTKLDNNWGREERQSVFPFESGKPFKIQVLVEPDHFKVAVNDAHLLQYNHRVKKLNEISKLGISGDIDLTSASYTMI","Homo sapiens","LGALS3, MAC2","Galectin-3","1","2NN8"
"2NNG",,"X-RAY DIFFRACTION",2.08,40.78,"VAPOR DIFFUSION",7.7,"(NH4)2SO4, Tris, pH 7.7, vapor diffusion, temperature 277K",277,"10.1021/ja068359w","ZYX","2NNG",29.86,"1.2","1.2","Structure of inhibitor binding to Carbonic Anhydrase II","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","2NNG"
"2NNH",,"X-RAY DIFFRACTION",3.89,68.37,"VAPOR DIFFUSION, SITTING DROP",7.5,"PEG 3350, HEPES, LiSO4, MeOH, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 294K",294,"10.1074/jbc.M802180200",,"2NNH",111.25,"2.6","2.6","CYP2C8dH complexed with 2 molecules of 9-cis retinoic acid","MAKKTSSKGKLPPGPTPLPIIGNMLQIDVKDICKSFTNFSKVYGPVFTVYFGMNPIVVFHGYEAVKEALIDNGEEFSGRGNSPISQRITKGLGIISSNGKRWKEIRRFSLTTLRNFGMGKRSIEDRVQEEAHCLVEELRKTKASPCDPTFILGCAPCNVICSVVFQKRFDYKDQNFLTLMKRFNENFRILNSPWIQVCNNFPLLIDCFPGTHNKVLKNVALTRSYIREKVKEHQASLDVNNPRDFIDCFLIKMEQEKDNQKSEFNIENLVGTVADLFVAGTETTSTTLRYGLLLLLKHPEVTAKVQEEIDHVIGRHRSPCMQDRSHMPYTDAVVHEIQRYSDLVPTGVPHAVTTDTKFRNYLIPKGTTIMALLTSVLHDDKEFPNPNIFDPGHFLDKNGNFKKSDYFMPFSAGKRICAGEGLARMELFLFLTTILQNFNLKSVDDLKNLNTTAVTKGIVSLPPSYQICFIPVHHHH","Homo sapiens","CYP2C8","Cytochrome P450 2C8","1","2NNH"
"2NNI",,"X-RAY DIFFRACTION",3.96,68.95,"VAPOR DIFFUSION, SITTING DROP",7.5,"PEG 3350, HEPES, LiSO4, MeOH, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 294K",294,"10.1074/jbc.M802180200","MTK","2NNI",55.61,"2.8","2.8","CYP2C8dH complexed with montelukast","MAKKTSSKGKLPPGPTPLPIIGNMLQIDVKDICKSFTNFSKVYGPVFTVYFGMNPIVVFHGYEAVKEALIDNGEEFSGRGNSPISQRITKGLGIISSNGKRWKEIRRFSLTTLRNFGMGKRSIEDRVQEEAHCLVEELRKTKASPCDPTFILGCAPCNVICSVVFQKRFDYKDQNFLTLMKRFNENFRILNSPWIQVCNNFPLLIDCFPGTHNKVLKNVALTRSYIREKVKEHQASLDVNNPRDFIDCFLIKMEQEKDNQKSEFNIENLVGTVADLFVAGTETTSTTLRYGLLLLLKHPEVTAKVQEEIDHVIGRHRSPCMQDRSHMPYTDAVVHEIQRYSDLVPTGVPHAVTTDTKFRNYLIPKGTTIMALLTSVLHDDKEFPNPNIFDPGHFLDKNGNFKKSDYFMPFSAGKRICAGEGLARMELFLFLTTILQNFNLKSVDDLKNLNTTAVTKGIVSLPPSYQICFIPVHHHH","Homo sapiens","CYP2C8","Cytochrome P450 2C8","1","2NNI"
"2NNJ",,"X-RAY DIFFRACTION",3.91,68.53,"VAPOR DIFFUSION, SITTING DROP",7.5,"PEG 3350, HEPES, LiSO4, MeOH, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 294K",294,"10.1074/jbc.M802180200","225","2NNJ",55.6,"2.28","2.28","CYP2C8dH complexed with felodipine","MAKKTSSKGKLPPGPTPLPIIGNMLQIDVKDICKSFTNFSKVYGPVFTVYFGMNPIVVFHGYEAVKEALIDNGEEFSGRGNSPISQRITKGLGIISSNGKRWKEIRRFSLTTLRNFGMGKRSIEDRVQEEAHCLVEELRKTKASPCDPTFILGCAPCNVICSVVFQKRFDYKDQNFLTLMKRFNENFRILNSPWIQVCNNFPLLIDCFPGTHNKVLKNVALTRSYIREKVKEHQASLDVNNPRDFIDCFLIKMEQEKDNQKSEFNIENLVGTVADLFVAGTETTSTTLRYGLLLLLKHPEVTAKVQEEIDHVIGRHRSPCMQDRSHMPYTDAVVHEIQRYSDLVPTGVPHAVTTDTKFRNYLIPKGTTIMALLTSVLHDDKEFPNPNIFDPGHFLDKNGNFKKSDYFMPFSAGKRICAGEGLARMELFLFLTTILQNFNLKSVDDLKNLNTTAVTKGIVSLPPSYQICFIPVHHHH","Homo sapiens","CYP2C8","Cytochrome P450 2C8","1","2NNJ"
"2NNO",,"X-RAY DIFFRACTION",2.08,40.81,"VAPOR DIFFUSION",7.7,"(NH4)2SO4, Tris, pH 7.7, vapor diffusion, temperature 277K",277,"10.1021/ja068359w","M28","2NNO",30.12,"1.01","1.01","Structure of inhibitor binding to Carbonic Anhydrase II","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","2NNO"
"2NNQ",,"X-RAY DIFFRACTION",2.25,45.25,,5.6,"~70% saturated ammonium sulfate, pH 5.6, vapor diffusion, hanging drop, temperature 293K, pH 5.60",293,"10.1016/j.bmcl.2006.12.044","T4B","2NNQ",15.28,"1.8","1.8","Crystal structure of human adipocyte fatty acid binding protein in complex with ((2'-(5-ethyl-3,4-diphenyl-1H-pyrazol-1-yl)-3-biphenylyl)oxy)acetic acid","CDAFVGTWKLVSSENFDDYMKEVGVGFATRKVAGMAKPNMIISVNGDVITIKSESTFKNTEISFILGQEFDEVTADDRKVKSTITLDGGVLVHVQKWDGKSTTIKRKREDDKLVVECVMKGVTSTRVYERA","Homo sapiens","FABP4","Fatty acid-binding protein, adipocyte","1","2NNQ"
"2NNS",,"X-RAY DIFFRACTION",2.06,40.35,"VAPOR DIFFUSION",7.7,"(NH4)2SO4, Tris, pH 7.7, vapor diffusion, temperature 277K",277,"10.1021/ja068359w","CL, M25","2NNS",30.18,"1.03","1.03","Structure of inhibitor binding to Carbonic Anhydrase II","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","2NNS"
"2NNT",,"SOLID-STATE NMR",,,,,,,"10.1073/pnas.0607815103",,"2NNT",18.5,,,"General structural motifs of amyloid protofilaments","GSMGATAVSEWTEYKTADGKTFYYNNRTLESTWEKPQELK","Homo sapiens","TCERG1, CA150, TAF2S","Transcription elongation regulator 1","1","2NNT"
"2NNV",,"X-RAY DIFFRACTION",2.06,40.37,"VAPOR DIFFUSION",7.7,"(NH4)2SO4, Tris, pH 7.7, vapor diffusion, temperature 277K",277,"10.1021/ja068359w","M29","2NNV",30.18,"1.1","1.1","Structure of inhibitor binding to Carbonic Anhydrase II","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","2NNV"
"2NNX",,"X-RAY DIFFRACTION",2.93,57.98,"VAPOR DIFFUSION, HANGING DROP",5.8,"25% PEG 550MME, 0.1M MES, 0.01M zinc sulfate, pH 5.8, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1074/jbc.M604503200",,"2NNX",64.07,"2.3","2.3","Crystal Structure of the H46R, H48Q double mutant of human [Cu-Zn] Superoxide Dismutase","XATKAVCVLKGDGPVQGIINFEQKESNGPVKVWGSIKGLTEGLHGFRVQEFGDNTAGCTSAGPHFNPLSRKHGGPKDEERHVGDLGNVTADKDGVADVSIEDSVISLSGDHCIIGRTLVVHEKADDLGKGGNEESTKTGNAGSRLACGVIGIAQ","Homo sapiens","SOD1","SUPEROXIDE DISMUTASE [CU-ZN]","1","2NNX"
"2NNY",,"X-RAY DIFFRACTION",3.02,59.31,"VAPOR DIFFUSION, SITTING DROP",5.6,"0.2 M ammonium acetate  
28% PEG 2000  
0.1 M  sodium citrate, pH 5.6, VAPOR DIFFUSION, SITTING DROP, temperature 100K, temperature 298K",298,"10.1038/emboj.2008.117",,"2NNY",53.88,"2.58","2.58","Crystal structure of the Ets1 dimer DNA complex.","TAGACAGGAAGCACTTCCTGGAG",,,"5'-D(*T*AP*GP*AP*CP*AP*GP*GP*AP*AP*GP*CP*AP*CP*TP*TP*CP*CP*TP*GP*GP*AP*G)-3'","1","2NNY"
,,,,,,,,,,,,,,,,"ACTCCAGGAAGTGCTTCCTGTCT",,,"5'-D(*A*CP*TP*CP*CP*AP*GP*GP*AP*AP*GP*TP*GP*CP*TP*TP*CP*CP*TP*GP*TP*CP*T)-3'","2","2NNY"
,,,,,,,,,,,,,,,,"MKHHHHHPMVPSYDSFDSEDYPAALPNHKPKGTFKDYVRDRADLNKDKPVIPAAALAGYTGSGPIQLWQFLLELLTDKSSQSFISWTGDGWEFKLSDPDEVARRWGKRKNKPKMNYEKLSRGLRYYYDKNIIHKTAGKRYVYRFVSDLQSLLGYTPEELHAMLDVKPDADE","Homo sapiens","ETS1, EWSR2","C-ets-1 protein","3","2NNY"
"2NO0",,"X-RAY DIFFRACTION",2.23,44.9,"VAPOR DIFFUSION, HANGING DROP",7.5,"Reservoir containing 0.95-1.5M trisodium citrate dihydrate and 100mM HEPES, pH 7.5., VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/jm0700215",,"2NO0",66.7,"1.8","1.8","C4S dCK variant of dCK in complex with gemcitabine+ADP","MGSSHHHHHHSSGLVPRGSHMATPPKRSSPSFSASSEGTRIKKISIEGNIAAGKSTFVNILKQLSEDWEVVPEPVARWSNVQSTQDEFEELTMSQKNGGNVLQMMYEKPERWSFTFQTYACLSRIRAQLASLNGKLKDAEKPVLFFERSVYSDRYIFASNLYESESMNETEWTIYQDWHDWMNNQFGQSLELDGIIYLQATPETCLHRIYLRGRNEEQGIPLEYLEKLHYKHESWLLHRTLKTNFDYLQEVPILTLDVNEDFKDKYESLVEKVKEFLSTL","Homo sapiens","DCK","Deoxycytidine kinase","1","2NO0"
"2NO1",,"X-RAY DIFFRACTION",2.25,45.31,"VAPOR DIFFUSION, HANGING DROP",7.5,"Reservoir containing 0.95-1.5M trisodium citrate dihydrate and 100mM HEPES, pH 7.5., VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/jm0700215",,"2NO1",66.63,"1.91","1.91","C4S dCK variant of dCK in complex with D-dC+ADP","MGSSHHHHHHSSGLVPRGSHMATPPKRSSPSFSASSEGTRIKKISIEGNIAAGKSTFVNILKQLSEDWEVVPEPVARWSNVQSTQDEFEELTMSQKNGGNVLQMMYEKPERWSFTFQTYACLSRIRAQLASLNGKLKDAEKPVLFFERSVYSDRYIFASNLYESESMNETEWTIYQDWHDWMNNQFGQSLELDGIIYLQATPETCLHRIYLRGRNEEQGIPLEYLEKLHYKHESWLLHRTLKTNFDYLQEVPILTLDVNEDFKDKYESLVEKVKEFLSTL","Homo sapiens","DCK","deoxycytidine kinase","1","2NO1"
"2NO2",,"X-RAY DIFFRACTION",4.64,73.51,"VAPOR DIFFUSION, HANGING DROP",6.5,"25% (v/v) PEG 3350, 0.2 M Li2SO4, 0.1 M Bis-Tris, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.jmb.2006.12.052",,"2NO2",12.04,"2.8","2.8","Crystal structure of the DLLRKN-containing coiled-coil domain of Huntingtin-interacting protein 1","GSHADLLRKNAEVTKQVSMARQAQVDLEREKKELEDSLERISDQGQRKTQEQLEVLESLKQELATSQRELQVLQGSLETSAQSEANWAAEFAELEKERDSLVSGAAH","Homo sapiens","HIP1","Huntingtin-interacting protein 1","1","2NO2"
"2NO3",,"X-RAY DIFFRACTION",4.97,75.24,"VAPOR DIFFUSION",6.2,"PROTEIN WAS PREINCUBATED WITH THE JIP1 PEPTIDE AT A 5X MOLAR EXCESS. PROTEIN CONCENTRATION 9- 12.6 MG/ML. HANGING DROPS CONSISTED OF 2UL PROTEIN PLUS 2 UL WELL SOLUTION. WELL SOLUTION:2.8-3.1 M AMMONIUM SULFATE, 10- 14% GLYCEROL. FOR CO-CRYSTALLIZATION EXPERIMENT WITH THE COMPOUND, THE COMPOUND WAS DISSOLVED IN DMSO AT 100 MM CONCENTRATION. ALLOW TO INCUBATE FOR AT LEAST AN HOUR ON ICE. SOLUTION WAS SPUN FOR 5 MINUTES AT 2000G PRIOR TO SETTING UP FOR CRYSTALLIZATION., pH 6.20, VAPOR DIFFUSION, temperature 277.0K",277,"10.1016/j.bmcl.2006.10.093","859","2NO3",89.56,"3.2","3.2","Novel 4-anilinopyrimidines as potent JNK1 Inhibitors","MSRSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKEVMDLEHHHHHH","Homo sapiens","MAPK8, JNK1, PRKM8, SAPK1, SAPK1C","Mitogen-activated protein kinase 8","1","2NO3"
,,,,,,,,,,,,,,,,"RPKRPTTLNLF",,,"C-JUN-AMINO-TERMINAL KINASE-INTERACTING protein 1","2","2NO3"
"2NO6",,"X-RAY DIFFRACTION",2.25,45.39,"VAPOR DIFFUSION, HANGING DROP",7.5,"Reservoir containing 0.95-1.5M trisodium citrate dihydrate and 100mM HEPES, pH 7.5., VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/jm0700215",,"2NO6",66.67,"1.9","1.9","C4S dCK variant of dCK in complex with FTC+ADP","MGSSHHHHHHSSGLVPRGSHMATPPKRSSPSFSASSEGTRIKKISIEGNIAAGKSTFVNILKQLSEDWEVVPEPVARWSNVQSTQDEFEELTMSQKNGGNVLQMMYEKPERWSFTFQTYACLSRIRAQLASLNGKLKDAEKPVLFFERSVYSDRYIFASNLYESESMNETEWTIYQDWHDWMNNQFGQSLELDGIIYLQATPETCLHRIYLRGRNEEQGIPLEYLEKLHYKHESWLLHRTLKTNFDYLQEVPILTLDVNEDFKDKYESLVEKVKEFLSTL","Homo sapiens","DCK","deoxycytidine kinase","1","2NO6"
"2NO7",,"X-RAY DIFFRACTION",2.25,45.37,"VAPOR DIFFUSION, HANGING DROP",7.5,"Reservoir containing 0.95-1.5M trisodium citrate dihydrate and 100mM HEPES, pH 7.5., VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/jm0700215",,"2NO7",66.63,"1.7","1.7","C4S dCK variant of dCK in complex with L-dC+ADP","MGSSHHHHHHSSGLVPRGSHMATPPKRSSPSFSASSEGTRIKKISIEGNIAAGKSTFVNILKQLSEDWEVVPEPVARWSNVQSTQDEFEELTMSQKNGGNVLQMMYEKPERWSFTFQTYACLSRIRAQLASLNGKLKDAEKPVLFFERSVYSDRYIFASNLYESESMNETEWTIYQDWHDWMNNQFGQSLELDGIIYLQATPETCLHRIYLRGRNEEQGIPLEYLEKLHYKHESWLLHRTLKTNFDYLQEVPILTLDVNEDFKDKYESLVEKVKEFLSTL","Homo sapiens","DCK","deoxycytidine kinase","1","2NO7"
"2NO9",,"X-RAY DIFFRACTION",2.26,45.63,"VAPOR DIFFUSION, HANGING DROP",7.5,"Reservoir containing 0.95-1.5M trisodium citrate dihydrate and 100mM HEPES, pH 7.5., VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1093/nar/gkl1038",,"2NO9",66.6,"2.15","2.15","The structure of deoxycytidine kinase complexed with troxacitabine and ADP.","MGSSHHHHHHSSGLVPRGSHMATPPKRSSPSFSASSEGTRIKKISIEGNIAAGKSTFVNILKQLSEDWEVVPEPVARWSNVQSTQDEFEELTMSQKNGGNVLQMMYEKPERWSFTFQTYACLSRIRAQLASLNGKLKDAEKPVLFFERSVYSDRYIFASNLYESESMNETEWTIYQDWHDWMNNQFGQSLELDGIIYLQATPETCLHRIYLRGRNEEQGIPLEYLEKLHYKHESWLLHRTLKTNFDYLQEVPILTLDVNEDFKDKYESLVEKVKEFLSTL","Homo sapiens","DCK","deoxycytidine kinase","1","2NO9"
"2NOA",,"X-RAY DIFFRACTION",2.24,45.15,"VAPOR DIFFUSION, HANGING DROP",7.5,"Reservoir containing 0.95-1.5M trisodium citrate dihydrate and 100mM HEPES, pH 7.5., VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1093/nar/gkl1038",,"2NOA",66.63,"1.8","1.8","The structure of deoxycytidine kinase complexed with lamivudine and ADP.","MGSSHHHHHHSSGLVPRGSHMATPPKRSSPSFSASSEGTRIKKISIEGNIAAGKSTFVNILKQLSEDWEVVPEPVARWSNVQSTQDEFEELTMSQKNGGNVLQMMYEKPERWSFTFQTYACLSRIRAQLASLNGKLKDAEKPVLFFERSVYSDRYIFASNLYESESMNETEWTIYQDWHDWMNNQFGQSLELDGIIYLQATPETCLHRIYLRGRNEEQGIPLEYLEKLHYKHESWLLHRTLKTNFDYLQEVPILTLDVNEDFKDKYESLVEKVKEFLSTL","Homo sapiens","DCK","deoxycytidine kinase","1","2NOA"
"2NOB",,"X-RAY DIFFRACTION",2.85,56.77,"VAPOR DIFFUSION, HANGING DROP",6.5,"PEG 8000, Ca(OAc)2, Na cacodylate, pH 6.5, vapor diffusion, hanging drop, temperature 277K",277,"10.1074/jbc.M608989200",,"2NOB",46.04,"2.1","2.1","Structure of catalytically inactive H270A human 8-oxoguanine glycosylase crosslinked to 8-oxoguanine DNA","TGGTAGACCTGGACGC",,,"5'-D(*T*GP*GP*TP*AP*GP*AP*CP*CP*TP*GP*GP*AP*CP*GP*C)-3'","1","2NOB"
,,,,,,,,,,,,,,,,"GCGTCCAGGTCTACC",,,"5'-D(*G*CP*GP*TP*CP*CP*AP*(G42)P*GP*TP*CP*TP*AP*CP*C)-3'","2","2NOB"
,,,,,,,,,,,,,,,,"AMADIGSEFGHRTLASTPALWASIPCPRSELRLDLVLPSGQSFRWREQSPAHWSGVLADQVWTLTQTEEQLHCTVYRGDKSQASRPTPDELEAVRKYFQLDVTLAQLYHHWGSVDSHFQEVAQKFQGVRLLRQDPIECLFSFICSSCNNIARITGMVERLCQAFGPRLIQLDDVTYHGFPSLQALAGPEVEAHLRKLGLGYRARYVSASARAILEEQGGLAWLQQLRESSYEEAHKALCILPGVGTQVADCICLMALDKPQAVPVDVAMWHIAQRDYSWHPTTSQAKGPSPQTNKELGNFFRSLWGPYAGWAQAVLFSADLRQSR","Homo sapiens","OGG1, MMH, MUTM, OGH1","N-glycosylase/DNA lyase","3","2NOB"
"2NOE",,"X-RAY DIFFRACTION",2.83,56.53,"VAPOR DIFFUSION, HANGING DROP",6.5,"PEG 8000, Ca(OAc)2, Na cacodylate, pH 6.5, vapor diffusion, hanging drop, temperature 277K",277,"10.1074/jbc.M608989200",,"2NOE",45.83,"2.2","2.2","Structure of catalytically inactive G42A human 8-oxoguanine glycosylase complexed to 8-oxoguanine DNA","GGTAGACCTGGACGC",,,"5'-D(*G*GP*TP*AP*GP*AP*CP*CP*TP*GP*GP*AP*CP*GP*C)-3'","1","2NOE"
,,,,,,,,,,,,,,,,"GCGTCCAGGTCTACC",,,"5'-D(*G*CP*GP*TP*CP*CP*AP*(G42)P*GP*TP*CP*TP*AP*CP*C)-3'","2","2NOE"
,,,,,,,,,,,,,,,,"AMADIGSEFGHRTLASTPALWASIPCPRSELRLDLVLPSAQSFRWREQSPAHWSGVLADQVWTLTQTEEQLHCTVYRGDKSQASRPTPDELEAVRKYFQLDVTLAQLYHHWGSVDSHFQEVAQKFQGVRLLRQDPIECLFSFICSSNNNIARITGMVERLCQAFGPRLIQLDDVTYHGFPSLQALAGPEVEAHLRKLGLGYRARYVSASARAILEEQGGLAWLQQLRESSYEEAHKALCILPGVGTQVADCICLMALDKPQAVPVDVHMWHIAQRDYSWHPTTSQAKGPSPQTNKELGNFFRSLWGPYAGWAQAVLFSADLRQSR","Homo sapiens","OGG1, MMH, MUTM, OGH1","N-glycosylase/DNA lyase","3","2NOE"
"2NOF",,"X-RAY DIFFRACTION",2.85,56.77,"VAPOR DIFFUSION, HANGING DROP",6,"PEG 8000, CaCl2, Na cacodylate, pH 6.0, vapor diffusion, hanging drop, temperature 277K",277,"10.1074/jbc.M608989200",,"2NOF",45.79,"2.35","2.35","Structure of Q315F human 8-oxoguanine glycosylase proximal crosslink to 8-oxoguanine DNA","GGTAGACCTGGACGC",,,"5'-D(*GP*GP*TP*AP*GP*AP*CP*CP*TP*GP*GP*AP*CP*GP*C)-3'","1","2NOF"
,,,,,,,,,,,,,,,,"GCGTCCAGGTCTACC",,,"5'-D(*GP*CP*GP*TP*C*CP*AP*(G42)P*GP*TP*CP*TP*AP*CP*C)-3'","2","2NOF"
,,,,,,,,,,,,,,,,"AMADIGSEFGHRTLASTPALWASIPCPRSELRLDLVLPSGQSFRWREQSPAHWSGVLADQVWTLTQTEEQLHCTVYRGDKSQASRPTPDELEAVRKYFQLDVTLAQLYHHWGSVDSHFQEVAQKFQGVRLLRQDPIECLFSFICSSCNNIARITGMVERLCQAFGPRLIQLDDVTYHGFPSLQALAGPEVEAHLRKLGLGYRARYVSASARAILEEQGGLAWLQQLRESSYEEAHKALCILPGVGTKVADCICLMALDKPQAVPVDVHMWHIAQRDYSWHPTTSQAKGPSPQTNKELGNFFRSLWGPYAGWAFAVLFSADLRQSR","Homo sapiens","OGG1, MMH, MUTM, OGH1","N-glycosylase/DNA lyase","3","2NOF"
"2NOH",,"X-RAY DIFFRACTION",2.85,56.79,"VAPOR DIFFUSION, HANGING DROP",6.5,"PEG 8000, Ca(OAc)2, Na cacodylate, pH 6.5, vapor diffusion, hanging drop, temperature 277K",277,"10.1074/jbc.M608989200",,"2NOH",45.76,"2.01","2.01","Structure of catalytically inactive Q315A human 8-oxoguanine glycosylase complexed to 8-oxoguanine DNA","GGTAGACCTGGACGC",,,"5'-D(*GP*GP*TP*AP*GP*AP*CP*CP*TP*GP*GP*AP*CP*GP*C)-3'","1","2NOH"
,,,,,,,,,,,,,,,,"GCGTCCAGGTCTACC",,,"5'-D(*GP*CP*GP*TP*CP*CP*AP*(G42)P*GP*TP*CP*TP*AP*CP*C)-3'","2","2NOH"
,,,,,,,,,,,,,,,,"AMADIGSEFGHRTLASTPALWASIPCPRSELRLDLVLPSGQSFRWREQSPAHWSGVLADQVWTLTQTEEQLHCTVYRGDKSQASRPTPDELEAVRKYFQLDVTLAQLYHHWGSVDSHFQEVAQKFQGVRLLRQDPIECLFSFICSSNNNIARITGMVERLCQAFGPRLIQLDDVTYHGFPSLQALAGPEVEAHLRKLGLGYRARYVSASARAILEEQGGLAWLQQLRESSYEEAHKALCILPGVGTQVADCICLMALDKPQAVPVDVHMWHIAQRDYSWHPTTSQAKGPSPQTNKELGNFFRSLWGPYAGWAAAVLFSADLRQSR","Homo sapiens","OGG1, MMH, MUTM, OGH1","N-glycosylase/DNA lyase","3","2NOH"
"2NOI",,"X-RAY DIFFRACTION",2.8,56.03,"VAPOR DIFFUSION, HANGING DROP",6,"PEG 8000, CaCl2, Na cacodylate, pH 6.0, vapor diffusion, hanging drop, temperature 277K",277,"10.1074/jbc.M608989200",,"2NOI",45.76,"2.35","2.35","Structure of G42A human 8-oxoguanine glycosylase crosslinked to undamaged G-containing DNA","GGTAGACCTGGACGC",,,"5'-D(*GP*GP*TP*AP*GP*AP*CP*CP*TP*GP*GP*AP*CP*GP*C)-3'","1","2NOI"
,,,,,,,,,,,,,,,,"GCGTCCAGGTCTACC",,,"5'-D(*GP*CP*GP*TP*C*CP*AP*GP*GP*TP*CP*TP*AP*CP*C)-3'","2","2NOI"
,,,,,,,,,,,,,,,,"AMADIGSEFGHRTLASTPALWASIPCPRSELRLDLVLPSAQSFRWREQSPAHWSGVLADQVWTLTQTEEQLHCTVYRGDKSQASRPTPDELEAVRKYFQLDVTLAQLYHHWGSVDSHFQEVAQKFQGVRLLRQDPIECLFSFICSSCNNIARITGMVERLCQAFGPRLIQLDDVTYHGFPSLQALAGPEVEAHLRKLGLGYRARYVSASARAILEEQGGLAWLQQLRESSYEEAHKALCILPGVGTQVADCICLMALDKPQAVPVDVHMWHIAQRDYSWHPTTSQAKGPSPQTNKELGNFFRSLWGPYAGWAQAVLFSADLRQSR","Homo sapiens","OGG1, MMH, MUTM, OGH1","N-glycosylase/DNA lyase","3","2NOI"
"2NOL",,"X-RAY DIFFRACTION",2.8,56.06,"VAPOR DIFFUSION, HANGING DROP",6,"PEG 8000, CaCl2, Na cacodylate, pH 6.0, vapor diffusion, hanging drop, temperature 277K",277,"10.1074/jbc.M608989200",,"2NOL",45.83,"2.57","2.57","Structure of catalytically inactive human 8-oxoguanine glycosylase distal crosslink to oxoG DNA","GGTAGACCTGGACGC",,,"5'-D(*GP*GP*TP*AP*GP*AP*CP*CP*TP*GP*GP*AP*CP*GP*C)-3'","1","2NOL"
,,,,,,,,,,,,,,,,"GCGTCCAGGTCTACC",,,"5'-D(*GP*CP*GP*TP*CP*CP*AP*(G42)P*GP*TP*CP*TP*AP*CP*C)-3'","2","2NOL"
,,,,,,,,,,,,,,,,"AMADIGSEFGHRTLASTPALWASIPCPRSELRLDLVLPSGQSFRWREQSPAHWSGVLADQVWTLTQTEEQLHCTVYRGDKSQASRPTPDELEAVRKYFQLDVTLAQLYHHWGSVDSHFQEVAQKFQGVRLLRQDPIECLFSFICSSNNNIARITGMVERLCQAFGPRLIQLDDVTYHGFPSLQALAGPEVEAHLRKLGLGYRARYVSASARAILEEQGGLAWLQQLRESSYEEAHKALCILPGVGTQVADCICLMALDKPQAVPVDVHMWHIAQRDYSWHPTTSQAKGPCPQTNKELGNFFRSLWGPYAGWAQAVLFSADLRQSR","Homo sapiens","OGG1, MMH, MUTM, OGH1","N-glycosylase/DNA lyase","3","2NOL"
"2NOY",,"X-RAY DIFFRACTION",2.17,43.44,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1M CaCl2, 14%(w/v) PEG 400, 7.5%(w/v) PEG 1500, 0.05M sodium Hepes (pH 7.5), VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1016/j.jmb.2006.11.076",,"2NOY",27.5,"1.8","1.8","Crystal structure of transthyretin mutant I84S at PH 7.5","GPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGSSPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","2NOY"
"2NOZ",,"X-RAY DIFFRACTION",2.81,56.25,"VAPOR DIFFUSION, HANGING DROP",6,"PEG 8000, CaCl2, Na cacodylate, pH 6.0, vapor diffusion, hanging drop, temperature 277K, VAPOR DIFFUSION, HANGING DROP",277,"10.1074/jbc.M608989200",,"2NOZ",45.85,"2.43","2.43","Structure of Q315F human 8-oxoguanine glycosylase distal crosslink to 8-oxoguanine DNA","GGTAGACCTGGACGC",,,"5'-D(*GP*G*TP*AP*GP*AP*CP*CP*TP*GP*GP*AP*CP*GP*C)-3'","1","2NOZ"
,,,,,,,,,,,,,,,,"GCGTCCAGGTCTACC",,,"5'-D(*G*CP*GP*TP*CP*CP*AP*(G42)P*GP*TP*CP*TP*AP*CP*C)-3'","2","2NOZ"
,,,,,,,,,,,,,,,,"AMADIGSEFGHRTLASTPALWASIPCPRSELRLDLVLPSGQSFRWREQSPAHWSGVLADQVWTLTQTEEQLHCTVYRGDKSQASRPTPDELEAVRKYFQLDVTLAQLYHHWGSVDSHFQEVAQKFQGVRLLRQDPIECLFSFICSSNNNIARITGMVERLCQAFGPRLIQLDDVTYHGFPSLQALAGPEVEAHLRKLGLGYRARYVSASARAILEEQGGLAWLQQLRESSYEEAHKALCILPGVGTKVADCICLMALDKPQAVPVDVHMWHIAQRDYSWHPTTSQAKGPCPQTNKELGNFFRSLWGPYAGWAFAVLFSADLRQSR","Homo sapiens","OGG1, MMH, MUTM, OGH1","N-glycosylase/DNA lyase","3","2NOZ"
"2NP8",,"X-RAY DIFFRACTION",2.63,53.16,"VAPOR DIFFUSION",,"7% (w/v) PEG 400, 2.2 M ammonium sulfate, 0.1 M HEPES pH 7.5, VAPOR DIFFUSION, temperature 293K",293,"10.1016/j.bmcl.2006.10.086","CC3","2NP8",32.05,"2.25","2.25","Structural Basis for the Inhibition of Aurora A Kinase by a Novel Class of High Affinity Disubstituted Pyrimidine Inhibitors","GAMGSKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPS","Homo sapiens","AIK, AURKA, AIRK1, ARK1, AURA, AYK1, BTAK, IAK1, STK15, STK6","Serine/threonine-protein kinase 6","1","2NP8"
"2NPA",,"X-RAY DIFFRACTION",2.79,55.98,"VAPOR DIFFUSION, HANGING DROP",7.5,"6% PEG 10K. 0.1M Hepes, 6% ethylene glycol, pH 7.5, VAPOR DIFFUSION, HANGING DROP",,"10.1016/j.bmcl.2006.11.050","MMB","2NPA",65.6,"2.3","2.3","the crystal structure of the human PPARaplpha ligand binding domain in complex with a a-hydroxyimino phenylpropanoic acid","ETADLKSLAKRIYEAYLKNFNMNKVKARVILSGAASNNPPFVIHDMETLCMAEKTLVAKLVANGIQNKEAEVRIFHCCQCTSVETVTELTEFAKAIPGFANLDLNDQVTLLKYGVYEAIFAMLSSVMNKDGMLVAYGNGFITREFLKSLRKPFCDIMEPKFDFAMKFNALELDDSDISLFVAAIICCGDRPGLLNVGHIEKMQEGIVHVLRLHLQSNHPDDIFLFPKLLQKMADLRQLVTEHAQLVQIIKKTESDAALHPLLQEIYRDMY","Homo sapiens","PPARA, NR1C1, PPAR","Peroxisome proliferator-activated receptor alpha","1","2NPA"
,,,,,,,,,,,,,,,,"LTERHKILHRLLQEG",,,"SRC- peptide from Nuclear receptor coactivator 1","2","2NPA"
"2NPL",,"SOLUTION NMR",,,,,,,"10.1110/ps.062643507",,"2NPL",10.54,,,"NMR Structure of CARD d2 Domain","GSSGARCYVDGSEEIGSDFKIKCEPKEGSLPLQYEWQKLSDSQKMPTSWLAEMTSSVISVKNASSEYSGTYSCTVRNRVGSDQCLLRLNVVPPSNK","Homo sapiens","CXADR, CAR","Coxsackievirus and Adenovirus Receptor","1","2NPL"
"2NPQ",,"X-RAY DIFFRACTION",2.25,45.24,"VAPOR DIFFUSION, SITTING DROP",7.25,"15% PEG 3350, 0.2M KF, 0.1M Hepes pH 7.25, 25mM BOG, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.jmb.2007.09.002","BOG","2NPQ",42.83,"1.8","1.8","A Novel Lipid Binding Site in the p38 alpha MAP Kinase","MAHHHHHHSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES","Homo sapiens","MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2, SAPK2A","Mitogen-activated protein kinase 14","1","2NPQ"
"2NPU",,"SOLUTION NMR",,,,,,,"10.1038/sj.onc.1210693",,"2NPU",15.36,,,"The solution structure of the rapamycin-binding domain of mTOR (FRB)","MSYYHHHHHHDYDIPTTENLYFQGAMELIRVPILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQ","Homo sapiens","MTOR, FRAP, FRAP1, FRAP2, RAFT1, RAPT1","FKBP12-rapamycin complex-associated protein","1","2NPU"
"2NQ3",,"X-RAY DIFFRACTION",3.34,63.16,"VAPOR DIFFUSION, HANGING DROP",6,"The protein at 20 mg/ml was dissolved in 20 mM Tris-HCl, pH 8.0, 0.15 M NaCl, 5% 
glycerol, 2 mM DTT, and mixed 1:1 with well solution that was 20% PEG3350, 
0.1 M bis-Tris, pH 6.0, 0.2 M NH4OAc, 1 mM DTT, VAPOR DIFFUSION, HANGING DROP, temperature 298.0K",298,,,"2NQ3",19.24,"1.8","1.8","Crystal structure of the C2 Domain of Human Itchy Homolog E3 Ubiquitin Protein Ligase","MHHHHHHSSGRENLYFQGMSDSGSQLGSMGSLTMKSQLQITVISAKLKENKKNWFGPSPYVEVTVDGQSKKTEKCNNTNSPKWKQPLTVIVTPVSKLHFRVWSHQTLKSDVLLGTAALDIYETLKSNNMKLEEVVVTLQLGGDKEPTETIGDLSICLDGLQLESEVVTNGETT","Homo sapiens","ITCH","Itchy homolog E3 ubiquitin protein ligase","1","2NQ3"
"2NQ6",,"X-RAY DIFFRACTION",2.4,48.81,"VAPOR DIFFUSION, HANGING DROP",6,"6% PEG 10 000, 100 mM HEPES, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1073/pnas.0608389103","HM4","2NQ6",37.57,"1.5","1.5","Crystal structure of human methionine aminopeptidase type 1 in complex with 3-tert-Butoxycarbonylaminopyridine-2-carboxylic acid thiazole-2-ylamide","MGSSHHHHHHSSGLVPRGSHMLEDPYRYTGKLRPHYPLMPTRPVPSYIQRPDYADHPLGMSESEQALKGTSQIKLLSSEDIEGMRLVCRLAREVLDVAAGMIKPGVTTEEIDHAVHLACIARNCYPSPLNYYNFPKSCCTSVNEVICHGIPDRRPLQEGDIVNVDITLYRNGYHGDLNETFFVGEVDDGARKLVQTTYECLMQAIDAVKPGVRYRELGNIIQKHAQANGFSVVRSYCGHGIHKLFHTAPNVPHYAKNKAVGVMKSGHVFTIEPMICEGGWQDETWPDGWTAVTRDGKRSAQFEHTLLVTDTGCEILTRRLDSARPHFMS","Homo sapiens","METAP1, KIAA0094","Methionine aminopeptidase 1","1","2NQ6"
"2NQ7",,"X-RAY DIFFRACTION",2.34,47.42,"VAPOR DIFFUSION, HANGING DROP",6,"6% PEG 10 000, 100 mM HEPES, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1073/pnas.0608389103","HM5","2NQ7",37.55,"1.6","1.6","Crystal structure of type 1 human methionine aminopeptidase in complex with 3-(2,2-Dimethylpropionylamino)pyridine-2-carboxylic acid thiazole-2-ylamide","MGSSHHHHHHSSGLVPRGSHMLEDPYRYTGKLRPHYPLMPTRPVPSYIQRPDYADHPLGMSESEQALKGTSQIKLLSSEDIEGMRLVCRLAREVLDVAAGMIKPGVTTEEIDHAVHLACIARNCYPSPLNYYNFPKSCCTSVNEVICHGIPDRRPLQEGDIVNVDITLYRNGYHGDLNETFFVGEVDDGARKLVQTTYECLMQAIDAVKPGVRYRELGNIIQKHAQANGFSVVRSYCGHGIHKLFHTAPNVPHYAKNKAVGVMKSGHVFTIEPMICEGGWQDETWPDGWTAVTRDGKRSAQFEHTLLVTDTGCEILTRRLDSARPHFMS","Homo sapiens","METAP1, KIAA0094","Methionine aminopeptidase 1","1","2NQ7"
"2NQC",,"X-RAY DIFFRACTION",1.95,36.91,"VAPOR DIFFUSION, HANGING DROP",8.5,"17.5% PEG 10000, 0.2M imidazole malate, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.jmb.2007.02.018",,"2NQC",14.3,"2.05","2.05","Crystal structure of ig-like domain 23 from human filamin C","GSHMASMTGGQQMGRGSGSHMASMTGGQQMGRGSRVGEQSQAGDPGLVSAYGPGLEGGTTGVSSEFIVNTLNAGSGALSVTIDGPSKVQLDCRECPEGHVVTYTPMAPGNYLIAIKYGGPQHIVGSPFKAKVTGPRLS","Homo sapiens","FLNC, ABPL, FLN2","Filamin-C","1","2NQC"
"2NR1",,"SOLUTION NMR",,,,,,,"10.1038/7610",,"2NR1",2.77,,,"TRANSMEMBRANE SEGMENT 2 OF NMDA RECEPTOR NR1, NMR, 10 STRUCTURES","GSNGDALTLSSAMWFSWGVLLNSGIGE","Homo sapiens","GRIN1, NMDAR1","NR1 M2","1","2NR1"
"2NR2",,"SOLUTION NMR",,,,,,,"10.1007/s10858-006-9117-7",,"2NR2",8.58,,,"The MUMO (minimal under-restraining minimal over-restraining) method for the determination of native states ensembles of proteins","MQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGG","Homo sapiens","UBC","Ubiquitin","1","2NR2"
"2NRU",,"X-RAY DIFFRACTION",2.66,53.77,"EVAPORATION",6.4,"2.6 - 2.9 M ammonium sulfate, PH 6.4-7.9, EVAPORATION, temperature 293K",293,"10.1016/j.str.2006.11.001","T12","2NRU",140.27,"2","2","Crystal structure of IRAK-4","ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS","Homo sapiens","IRAK4","Interleukin-1 receptor-associated kinase 4","1","2NRU"
"2NRY",,"X-RAY DIFFRACTION",2.61,52.88,"EVAPORATION",6.4,"2.6 - 2.9 M ammonium sulfate, PH 6.4-7.9 , EVAPORATION, temperature 293K",293,"10.1016/j.str.2006.11.001",,"2NRY",139.86,"2.15","2.15","Crystal structure of IRAK-4","ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS","Homo sapiens","IRAK4","interleukin-1 receptor-associated kinase 4","1","2NRY"
"2NS2",,"X-RAY DIFFRACTION",2.15,42.68,"VAPOR DIFFUSION, HANGING DROP",8.5,"Ammonium Sulfate, Tris, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 288K",288,"10.1074/jbc.M604029200",,"2NS2",55.24,"2.2","2.2","Crystal Structure of Spindlin1","GPLGSMMKKRTSHKKHRSSVGPSKPVSQPRRNIVGCRIQHGWKEGNGPVTQWKGTVLDQVPVNPSLYLIKYDGFDCVYGLELNKDERVSALEVLPDRVATSRISDAHLADTMIGKAVEHMFETEDGSKDEWRGMVLARAPVMNTWFYITYEKDPVLYMYQLLDDYKEGDLRIMPDSNDSPPAEREPGEVVDSLVGKQVEYAKEDGSKRTGMVIHQVEAKPSVYFIKFDDDFHIYVYDLVKTS","Homo sapiens","SPIN, OCR, SPIN1","Spindlin-1","1","2NS2"
"2NSI",,"X-RAY DIFFRACTION",5.13,78,,5,"pH 5.0",,"10.1074/jbc.274.30.21276","ITU","2NSI",203.53,"3","3","HUMAN INDUCIBLE NITRIC OXIDE SYNTHASE, ZN-FREE, SEITU COMPLEX","LDATPLSSPRHVRIKNWGSGMTFQDTLHHKAKGILTCRSKSCLGSIMTPKSLTRGPRDKPTPPDELLPQAIEFVNQYYGSFKEAKIEEHLARVEAVTKEIETTGTYQLTGDELIFATKQAWRNAPRCIGRIQWSNLQVFDARSCSTAREMFEHICRHVRYSTNNGNIRSAITVFPQRSDGKHDFRVWNAQLIRYAGYQMPDGSIRGDPANVEFTQLCIDLGWKPKYGRFDVVPLVLQANGRDPELFEIPPDLVLEVAMEHPKYEWFRELELKWYALPAVANMLLEVGGLEFPGCPFNGWYMGTEIGVRDFCDVQRYNILEEVGRRMGLETHKLASLWKDQAVVEINIAVLHSFQKQNVTIMDHHSAAESFMKYMQNEYRSRGGCPADWIWLVPPMSGSITPVFHQEMLNYVLSPFYYYQVEAWKTHVWQDE","Homo sapiens","NOS2, NOS2A","PROTEIN (NITRIC OXIDE SYNTHASE)","1","2NSI"
"2NSM",,"X-RAY DIFFRACTION",3.55,65.38,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1M Hepes, 2M Ammonium sulfate, 5mM EDTA, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1016/j.jmb.2006.11.025",,"2NSM",51.23,"2.1","2.1","Crystal structure of the human carboxypeptidase N (Kininase I) catalytic domain","KLAFRHHRYDDLVRTLYKVQNECPGITRVYSIGRSVEGRHLYVLEFSDHPGIHEPLEPEVKYVGNMHGNEALGRELMLQLSEFLCEEFRNRNQRIVQLIQDTRIHILPSMNPDGYEVAAAQGPNKPGYLVGRNNANGVDLNRNFPDLNTYIYYNEKYGGPNHHLPLPDNWKSQVEPETRAVIRWMHSFNFVLSANLHGGAVVANYPYDKSFEHRVRGVRRTASTPTPDDKLFQKLAKVYSYAHGWMFQGWNCGDYFPDGITNGASWYSLSKGMQDFNYLHTNCFEITLELSCDKFPPEEELQREWLGNKEALIQFLEQVHQGIKGMVLDQNYNNLANAVISVSGINHDVTSGDHGDYFRLLLPGIYTVSATAPGYDPETVTVTVGPAEPTLVNFHLKRSIPQVSPVRRAPSRRHGVRAKVQPQARKKEMEMRQLQRGPA","Homo sapiens","CPN1, ACBP","Carboxypeptidase N catalytic chain","1","2NSM"
"2NSN",,"X-RAY DIFFRACTION",2.76,55.51,"VAPOR DIFFUSION",4.7,"15% PEG 3000, 100mM acetate, 20mgs/ml protein, pH 4.7, VAPOR DIFFUSION, temperature 277K",277,"10.1016/j.bbrc.2006.11.122",,"2NSN",10.98,"2","2","Crystal structure of Caspace Activation and Recruitment Domain (CARD) of NOD1","SHPHIQLLKSNRELLVTHIRNTQCLVDNLLKNDYFSAEDAEIVCACPTQPDKVRKILDLVQSKGEEVSEFFLYLLQQLADAYVDLRPWLLEIGLE","Homo sapiens","CARD4, NOD1","Caspase recruitment domain-containing protein 4","1","2NSN"
"2NSQ",,"X-RAY DIFFRACTION",2.05,40.06,,6.5,"14% PEG 4000, 0.2 M NaOAc, pH 6.5, 1 mM DTT. 20% Ethylene glycol added as cryoprotectant, VAPOR DIFFUSION, HANGING DROP, temperature 298.0K, pH 6.50",298,,,"2NSQ",18.09,"1.85","1.85","Crystal structure of the C2 domain of the human E3 ubiquitin-protein ligase NEDD4-like protein","GMATGLGEPVYGLSEDEGESRILRVKVVSGIDLAKKDIFGASDPYVKLSLYVADENRELALVQTKTIKKTLNPKWNEEFYFRVNPSNHRLLFEVFDENRLTRDDFLGQVDVPLSHLPTEDPTMERPYTFKDFLLRPRSHKSRVKGFLRLKMAYMP","Homo sapiens","NEDD4L, KIAA0439, NEDL3","E3 ubiquitin-protein ligase NEDD4-like protein","1","2NSQ"
"2NSU","27","ELECTRON MICROSCOPY",,,,,,,"10.1073/pnas.0701574104",,"2NSU",143.25,"27, 27",,"Crystal structure of the ectodomain of human transferrin receptor fitted into a cryo-EM reconstruction of canine parvovirus and feline transferrin receptor complex","LYWDDLKRKLSEKLDSTDFTSTIKLLNENSYVPREAGSQKDENLALYVENEFREFKLSKVWRDQHFVKIQVKDSAQNSVIIVDKNGRLVYLVENPGGYVAYSKAATVTGKLVHANFGTKKDFEDLYTPVNGSIVIVRAGKITFAEKVANAESLNAIGVLIYMDQTKFPIVNAELSFFGHAHLGTGDPYTPGFPSFNHTQFPPSRSSGLPNIPVQTISRAAAEKLFGNMEGDCPSDWKTDSTCRMVTSESKNVKLTVSNVLKEIKILNIFGVIKGFVEPDHYVVVGAQRDAWGPGAAKSGVGTALLLKLAQMFSDMVLKDGFQPSRSIIFASWSAGDFGSVGATEWLEGYLSSLHLKAFTYINLDKAVLGTSNFKVSASPLLYTLIEKTMQNVKHPVTGQFLYQDSNWASKVEKLTLDNAAFPFLAYSGIPAVSFCFCEDTDYPYLGTTMDTYKELIERIPELNKVARAAAEVAGQFVIKLTHDVELNLDYEEYNSQLLSFVRDLNQYRADIKEMGLSLQWLYSARGDFFRATSRLTTDFGNAEKTDRFVMKKLNDRVMRVEYHFLSPYVSPKESPFRHVFWGSGSHTLPALLENLKLRKQNNGAFNETLFRNQLALATWTIQGAANALSGDVWDIDNEF","Homo sapiens","TFRC","Transferrin receptor protein 1","1","2NSU"
"2NSX",,"X-RAY DIFFRACTION",3.22,61.76,"VAPOR DIFFUSION, HANGING DROP",4.5,"1 M Ammonium Sulfate 
0.17 M Guanidinium HCl 
0.02 M KCl 
0.1 M Acetate buffer pH 4.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1038/nchembio850","IFM, GIF","2NSX",225.87,"2.11","2.11","Structure of acid-beta-glucosidase with pharmacological chaperone provides insight into Gaucher disease","ARPCIPKSFGYSSVVCVCNATYCDSFDPPTFPALGTFSRYESTRSGRRMELSMGPIQANHTGTGLLLTLQPEQKFQKVKGFGGAMTDAAALNILALSPPAQNLLLKSYFSEEGIGYNIIRVPMASCDFSIRTYTYADTPDDFQLHNFSLPEEDTKLKIPLIHRALQLAQRPVSLLASPWTSPTWLKTNGAVNGKGSLKGQPGDIYHQTWARYFVKFLDAYAEHKLQFWAVTAENEPSAGLLSGYPFQCLGFTPEHQRDFIARDLGPTLANSTHHNVRLLMLDDQRLLLPHWAKVVLTDPEAAKYVHGIAVHWYLDFLAPAKATLGETHRLFPNTMLFASEACVGSKFWEQSVRLGSWDRGMQYSHSIITNLLYHVVGWTDWNLALNPEGGPNWVRNFVDSPIIVDITKDTFYKQPMFYHLGHFSKFIPEGSQRVGLVASQKNDLDAVALMHPDGSAVVVVLNRSSKDVPLTIKDPAVGFLETISPGYSIHTYLWHRQ","Homo sapiens","GBA, GC, GLUC","Glucosylceramidase","1","2NSX"
"2NT0",,"X-RAY DIFFRACTION",3.17,61.24,"VAPOR DIFFUSION, HANGING DROP",4.5,"1 M Ammonium Sulfate 
0.17 M Guanidinium HCl 
0.02 M KCl 
0.1 M Acetate buffer pH 4.5 
 
Cryoprotectant includes 20% glycerol, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1038/nchembio850",,"2NT0",226.79,"1.79","1.79","Acid-beta-glucosidase low pH, glycerol bound","ARPCIPKSFGYSSVVCVCNATYCDSFDPPTFPALGTFSRYESTRSGRRMELSMGPIQANHTGTGLLLTLQPEQKFQKVKGFGGAMTDAAALNILALSPPAQNLLLKSYFSEEGIGYNIIRVPMASCDFSIRTYTYADTPDDFQLHNFSLPEEDTKLKIPLIHRALQLAQRPVSLLASPWTSPTWLKTNGAVNGKGSLKGQPGDIYHQTWARYFVKFLDAYAEHKLQFWAVTAENEPSAGLLSGYPFQCLGFTPEHQRDFIARDLGPTLANSTHHNVRLLMLDDQRLLLPHWAKVVLTDPEAAKYVHGIAVHWYLDFLAPAKATLGETHRLFPNTMLFASEACVGSKFWEQSVRLGSWDRGMQYSHSIITNLLYHVVGWTDWNLALNPEGGPNWVRNFVDSPIIVDITKDTFYKQPMFYHLGHFSKFIPEGSQRVGLVASQKNDLDAVALMHPDGSAVVVVLNRSSKDVPLTIKDPAVGFLETISPGYSIHTYLWHRQ","Homo sapiens","GBA, GC, GLUC","Glucosylceramidase","1","2NT0"
"2NT1",,"X-RAY DIFFRACTION",3.25,62.11,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.8 M Na dihydrogen phosphate 
0.8 M K dihydrogen phosphate 
0.1 M Hepes buffer pH 7.5 
Cryoprotected in 2 M Lithium sulfate, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1038/nchembio850",,"2NT1",230.85,"2.3","2.3","Structure of acid-beta-glucosidase at neutral pH","ARPCIPKSFGYSSVVCVCNATYCDSFDPPTFPALGTFSRYESTRSGRRMELSMGPIQANHTGTGLLLTLQPEQKFQKVKGFGGAMTDAAALNILALSPPAQNLLLKSYFSEEGIGYNIIRVPMASCDFSIRTYTYADTPDDFQLHNFSLPEEDTKLKIPLIHRALQLAQRPVSLLASPWTSPTWLKTNGAVNGKGSLKGQPGDIYHQTWARYFVKFLDAYAEHKLQFWAVTAENEPSAGLLSGYPFQCLGFTPEHQRDFIARDLGPTLANSTHHNVRLLMLDDQRLLLPHWAKVVLTDPEAAKYVHGIAVHWYLDFLAPAKATLGETHRLFPNTMLFASEACVGSKFWEQSVRLGSWDRGMQYSHSIITNLLYHVVGWTDWNLALNPEGGPNWVRNFVDSPIIVDITKDTFYKQPMFYHLGHFSKFIPEGSQRVGLVASQKNDLDAVALMHPDGSAVVVVLNRSSKDVPLTIKDPAVGFLETISPGYSIHTYLWHRQ","Homo sapiens","GBA, GC, GLUC","Glucosylceramidase","1","2NT1"
"2NT2",,"X-RAY DIFFRACTION",1.95,37.08,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.1M Tris-HCl, pH 8.5, 25% PEG3350, 8% Ethanol, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1002/prot.21399",,"2NT2",51.49,"2.1","2.1","Crystal Structure of Slingshot phosphatase 2","MDSPTQIFEHVFLGSEWNASNLEDLQNRGVRYILNVTREIDNFFPGVFEYHNIRVYDEEATDLLAYWNDTYKFISKAKKHGSKCLVHSKMGVSRSASTVIAYAMKEYGWNLDRAYDYVKERRTVTKPNPSFMRQLEEYQGILLAR","Homo sapiens","SSH2, KIAA1725, SSH2L","Protein phosphatase Slingshot homolog 2","1","2NT2"
"2NT7",,"X-RAY DIFFRACTION",3.36,63.4,"VAPOR DIFFUSION, HANGING DROP",7,"17% PEG 4000, 0.15M MgCl2, 0.1M HEPES, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 278K",278,"10.1016/j.bmcl.2007.02.043","902","2NT7",35.45,"2.1","2.1","Crystal structure of PTP1B-inhibitor complex","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPCRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTCGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLDMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDL","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","2NT7"
"2NTA",,"X-RAY DIFFRACTION",3.36,63.42,"VAPOR DIFFUSION, HANGING DROP",7,"17% PEG 4000, 0.15M MgCl2, 0.1M Hepes, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 278K",278,"10.1016/j.bmcl.2007.02.043","521","2NTA",35.15,"2.1","2.1","Crystal Structure of PTP1B-inhibitor Complex","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPCRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTCGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLDMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDL","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","2NTA"
"2NTD",,"X-RAY DIFFRACTION",2.89,57.48,"VAPOR DIFFUSION, HANGING DROP",7.5,"3.6M sodium formate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.jmb.2007.05.065",,"2NTD",67.26,"2.52","2.52","Human fibroblast growth factor-1 (140 amino acid form) with Cys117Val/Pro134Cys mutations","HHHHHHFNLPPGNYKKPKLLYCSNGGHFLRILPDGTVDGTRDRSDQHIQLQLSAESVGEVYIKSTETGQYLAMDTDGLLYGSQTPNEECLFLERLEENHYNTYISKKHAEKNWFVGLKKNGSVKRGPRTHYGQKAILFLCLPVSSD","Homo sapiens","FGF1, FGFA","Acidic fibroblast growth factor 1","1","2NTD"
"2NTE",,"X-RAY DIFFRACTION",2.63,53.25,"VAPOR DIFFUSION, SITTING DROP",6.5,"100mM MES, 20% PEG 8K, 150mM Ammonium Sulfate, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1021/bi700323t",,"2NTE",48.81,"1.9","1.9","Crystal Structure of the BARD1 BRCT Domains","GPLVLIGSGLSSEQQKMLSELAVILKAKKYTEFDSTVTHVVVPGDAVQSTLKCMLGILNGCWILKFEWVKACLRRKVCEQEEKYEIPEGPRRSRLNREQLLPKLFDGCYFYLWGTFKHHPKDNLIKLVTAGGGQILSRKPKPDSDVTQTINTVAYHARPDSDQRFCTQYIIYEDLCNYHPERVRQGKVWKAPSSWFIDCVMSFELLPLDS","Homo sapiens","BARD1","BRCA1-associated RING domain protein 1","1","2NTE"
"2NTR",,"X-RAY DIFFRACTION",2.83,56.49,"VAPOR DIFFUSION, SITTING DROP",7.5,"1.5M Lithium sulfate, 0.1M HEPES Buffer, pH 7.5. Crystals were grown with L124671, and L304507 was back soak, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1016/j.bmcl.2006.11.003",,"2NTR",45.69,"1.8","1.8","Crystal structure of Human Bace-1 bound to inhibitor","MLPRETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGAWAGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYN","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","2NTR"
"2NV7",,"X-RAY DIFFRACTION",2.07,40.48,"VAPOR DIFFUSION, HANGING DROP",8,"precipitant: PEG3350, Mg formate, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1016/j.bmcl.2006.11.066","555","2NV7",56.68,"2.1","2.1","Crystal Structure of Estrogen Receptor Beta Complexed with WAY-555","LSPEQLVLTLLEAEPPHVLISRPSAPFTEASMMMSLTKLADKELVHMISWAKKIPGFVELSLFDQVRLLESCWMEVLMMGLMWRSIDHPGKLIFAPDLVLDRDEGKCVEGILEIFDMLLATTSRFRELKLQHKEYLCVKAMILLNSSMYPLVTATQDADSSRKLAHLLNAVTDALVWVIAKSGISSQQQSMRLANLLMLLSHVRHASNKGMEHLLNMKCKNVVPVYDLLLEMLNAHVL","Homo sapiens","ESR2, ESTRB, NR3A2","Estrogen receptor beta","1","2NV7"
,,,,,,,,,,,,,,,,"HKLVQLLTTT",,,"Nuclear receptor coactivator 1","2","2NV7"
"2NVC",,"X-RAY DIFFRACTION",2.17,43.4,"VAPOR DIFFUSION, HANGING DROP",5,"120mM ammonium citrate, 20% PEG 6000, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.jmb.2007.03.021","ITA","2NVC",37.04,"1.65","1.65","Human Aldose Reductase complexed with novel naphtho[1,2-d]isothiazole acetic acid derivative (3)","MASRILLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGKEFFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAKHNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVCALLSCTSHKDYPFHEEF","Homo sapiens","hALR2, AKR1B1, ALDR1, ALR2","Aldose reductase","1","2NVC"
"2NVD",,"X-RAY DIFFRACTION",2.15,42.7,"VAPOR DIFFUSION, HANGING DROP",5,"120mM ammonium citrate, 20% PEG 6000, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.jmb.2007.03.021","ITB","2NVD",37.65,"1.55","1.55","Human Aldose Reductase complexed with novel naphtho[1,2-d]isothiazole acetic acid derivative (2)","MASRILLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGKEFFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAKHNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVCALLSCTSHKDYPFHEEF","Homo sapiens","hALR2, AKR1B1, ALDR1, ALR2","Aldose reductase","1","2NVD"
"2NVH",,"X-RAY DIFFRACTION",3.22,61.75,,7.5,"Well solution of 2.2 - 2.8 M ammonium sulfate, 100 mM Tris, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K, pH 7.50",298,"10.1073/pnas.0609442104",,"2NVH",17.59,"1.53","1.53","Determination of Solvent Content in Cavities in Interleukin-1 Using Experimentally-Phased Electron Density","APVRSLNCTLRDSQQKSLVMSGPYELKALHLQGQDMEQQVVFSMSFVQGEESNDKIPVALGLKEKNLYLSCVLKDDKPTLQLESVDPKNYPKKKMEKRFVFNKIEINNKLEFESAQFPNWYISTSQAENMPVFLGGTKGGQDITDFTMQFVSS","Homo sapiens","IL1B, IL1F2","Interleukin-1 beta","1","2NVH"
"2NWG",,"X-RAY DIFFRACTION",2.33,47.26,"Soaking",8.5,"Grown in 2M Ammonium Sulfate, 0.1M TrisHCl pH 8.50. Soaked in 20 mM PEG-8000, 1M TrisHCl pH 8.5, 16 mM disaccharide. , Soaking, temperature 298K",298,"10.1074/jbc.M608796200",,"2NWG",17.14,"2.07","2.07","Structure of CXCL12:heparin disaccharide complex","MKPVSLSYRCPCRFFESHIARANVKHLKILNTPNCALQIVARLKNNNRQVCIDPKLKWIQEYLEKALN","Homo sapiens","CXCL12, SDF1, SDF1A, SDF1B","Stromal cell-derived factor 1","1","2NWG"
"2NWM",,"SOLUTION NMR",,,,,,,"10.1016/j.bbrc.2007.04.029",,"2NWM",7.69,,,"Solution structure of the first SH3 domain of human Vinexin and its interaction with the peptides from Vinculin","MKAARLKFDFQAQSPKELTLQKGDIVYIHKEVDKNWLEGEHHGRLGIFPANYVEVLPLEHHHHHH","Homo sapiens","Vinexin, SORBS3, SCAM1","Vinexin","1","2NWM"
"2NWN",,"X-RAY DIFFRACTION",2.1,37.38,"VAPOR DIFFUSION, SITTING DROP",4.5,"0.05M sodium citrate, 1.95M (NH4)2SO4, 0.05% NaN3, 5% PEG 400, pH 4.50, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1016/j.jsb.2007.06.003",,"2NWN",29.94,"2.15","2.15","New Pharmacophore for Serine Protease Inhibition Revealed by Crystal Structure of Human Urokinase-type Plasminogen Activator Complexed with a Cyclic Peptidyl Inhibitor, upain-1","IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTIALPSMYNDPQFGTSCEITGFGKEQSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHTKEENGLAL","Homo sapiens","PLAU","Plasminogen activator, urokinase","1","2NWN"
,,,,,,,,,,,,,,,,"CSWRGLENHRMC",,,"upain-1","2","2NWN"
"2NWO",,"X-RAY DIFFRACTION",2.15,42.66,"VAPOR DIFFUSION, HANGING DROP",8.2,"50 mM Tris-Cl pH 8.2, 2.6 M ammonium sulfate, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/bi602620k",,"2NWO",29.35,"1.7","1.7","Structural and kinetic effect of hydrophobic mutations in the active site of human carbonic anhydrase II","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNLGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","2NWO"
"2NWP",,"X-RAY DIFFRACTION",2.15,42.68,"VAPOR DIFFUSION, HANGING DROP",6,"50 mM Tris-Cl pH 6.0, 2.6 M ammonium sulfate, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/bi602620k","SO4","2NWP",29.45,"1.8","1.8","Structural and kinetic effects of hydrophobic mutations in the active site of human carbonic anhydrase II","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNLGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","carbonic anhydrase 2","1","2NWP"
"2NWY",,"X-RAY DIFFRACTION",2.14,42.47,"VAPOR DIFFUSION, HANGING DROP",8.2,"50 mM Tris-Cl pH 8.2, 2.6 M ammonium sulfate, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/bi602620k",,"2NWY",29.35,"1.65","1.65","Structural and kinetic effects of hydrophobic mutations on the active site of human carbonic anhydrase II","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFLVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","carbonic anhydrase 2","1","2NWY"
"2NWZ",,"X-RAY DIFFRACTION",2.14,42.42,"VAPOR DIFFUSION, HANGING DROP",6,"50 mM Tris-Cl pH 6, 2.6 M ammonium sulfate, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/bi602620k","SO4","2NWZ",29.45,"1.8","1.8","Structural and kinetic effects of hydrophobic mutations on the active site of human carbonic anhydrase II","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFLVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","carbonic anhydrase 2","1","2NWZ"
"2NXB",,"X-RAY DIFFRACTION",2.31,46.65,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.20M KSCN, 0.1M BTPop, 20% PEG3350, 10% EtGly, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.cell.2012.02.013",,"2NXB",29.63,"1.4","1.4","Crystal structure of human Bromodomain containing protein 3 (BRD3)","SMPEVSNPSKPGRKTNQLQYMQNVVVKTLWKHQFAWPFYQPVDAIKLNLPDYHKIIKNPMDMGTIKKRLENNYYWSASECMQDFNTMFTNCYIYNKPTDDIVLMAQALEKIFLQKVAQMPQEE","Homo sapiens","BRD3, KIAA0043, RING3L","Bromodomain-containing protein 3","1","2NXB"
"2NXP",,"X-RAY DIFFRACTION",2.47,50.22,"VAPOR DIFFUSION",7.1,"0.1M Tris-HCl, 0.6M calcium chloride, 20% PEG 4000, pH 7.1, VAPOR DIFFUSION, temperature 295K",295,"10.1073/pnas.0610297104",,"2NXP",151.06,"2.17","2.17","Structure of NTD2 domain of the human TAF5 subunit of TFIID","GSVAVEDQPDVSAVLSAYNQQGDPTMYEEYYSGLKHFIECSLDCHRAELSQLFYPLFVHMYLELVYNQHENEAKSFFEKFHGDQECYYQDDLRVLSSLTKKEHMKGNETMLDFRTSKFVLRISRDSYQLLKRHLQEKQNNQIWNIVQEHLYIDIFD","Homo sapiens","TAF5, TAF2D","Transcription initiation factor TFIID subunit 5","1","2NXP"
"2NXR",,"X-RAY DIFFRACTION",2.15,42.73,"VAPOR DIFFUSION, HANGING DROP",8.2,"50 mM Tris-Cl pH 8.2, 2.6 M ammonium sulfate, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/bi602620k","SO4","2NXR",29.43,"1.7","1.7","Structural effects of hydrophobic mutations on the active site of human carbonic anhydrase II","MSHHWGFGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","carbonic anhydrase 2","1","2NXR"
"2NXS",,"X-RAY DIFFRACTION",2.15,42.83,"VAPOR DIFFUSION, HANGING DROP",10,"50 mM Tris-Cl pH 10, 2.6 M ammonium sulfate, pH 10.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/bi602620k","SO4","2NXS",29.43,"1.8","1.8","Structural and kinetic effects of hydrophobic mutations in the active site of human carbonic anhydrase II","MSHHWGFGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","carbonic anhydrase 2","1","2NXS"
"2NXT",,"X-RAY DIFFRACTION",2.09,41.24,"VAPOR DIFFUSION, HANGING DROP",9,"100 mM Tris-Cl pH 9, 1.2 M sodium citrate, pH 9.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/bi602620k",,"2NXT",29.34,"1.15","1.15","Structural and kinetic effects of hydrophobic mutations in the active site of human carbonic anhydrase II","MSHHWGFGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","carbonic anhydrase 2","1","2NXT"
"2NYR",,"X-RAY DIFFRACTION",2.28,45.96,"VAPOR DIFFUSION, HANGING DROP",6.5,"25% PEG 3350, 200mM NaCl, 0.1M Tris-HCl, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 300K",300,"10.1016/j.str.2007.02.002","SVR","2NYR",60.28,"2.06","2.06","Crystal Structure of Human Sirtuin Homolog 5 in Complex with Suramin","GSARPSSSMADFRKFFAKAKHIVIISGAGVSAESGVPTFRGAGGYWRKWQAQDLATPLAFAHNPSRVWEFYHYRREVMGSKEPNAGHRAIAECETRLGKQGRRVVVITQNIDELHRKAGTKNLLEIHGSLFKTRCTSCGVVAENYKSPICPALSGKGAPEPGTQDASIPVEKLPRCEEAGCGGLLRPHVVWFGENLDPAILEEVDRELAHCDLCLVVGTSSVVYPAAMFAPQVAARGVPVAEFNTETTPATNRFRFHFQGPCGTTLPEALA","Homo sapiens","SIRT5, SIR2L5","NAD-dependent deacetylase sirtuin-5","1","2NYR"
"2NYT",,"X-RAY DIFFRACTION",2.39,48.44,"VAPOR DIFFUSION, HANGING DROP",5.6,"85mM NaCitrate, 160mM LiSO4, 24% (wt/vol) PEG, 15% glycerol, pH 5.6, VAPOR DIFFUSION, HANGING DROP, temperature 291.15K",291.15,"10.1038/nature05492",,"2NYT",87.38,"2.5","2.5","The APOBEC2 Crystal Structure and Functional Implications for AID","GSGGGMIVTGERLPANFFKFQFRNVEYSSGRNKTFLCYVVEAQGKGGQVQASRGYLEDEHAAAHAEEAFFNTILPAFDPALRYNVTWYVSSSPCAACADRIIKTLSKTKNLRLLILVGRLFMWEEPEIQAALKKLKEAGCKLRIMKPQDFEYVWQNFVEQEEGESKAFQPWEDIQENFLYYEEKLADILK","Homo sapiens","APOBEC2","Probable C->U-editing enzyme APOBEC-2","1","2NYT"
"2NYU",,"X-RAY DIFFRACTION",2.22,44.6,"VAPOR DIFFUSION, HANGING DROP",,"20% PEG 3350, 0.2M Potassium phosphate, VAPOR DIFFUSION, HANGING DROP, temperature 297K",297,,,"2NYU",44.22,"1.76","1.76","Crystal Structure of Human FtsJ homolog 2 (E.coli) protein in complex with S-adenosylmethionine","SYRSRSAFKLLEVNERHQILRPGLRVLDCGAAPGAWSQVAVQKVNAAGTDPSSPVGFVLGVDLLHIFPLEGATFLCPADVTDPRTSQRILEVLPGRRADVILSDMAPNATGFRDLDHDRLISLCLTLLSVTPDILQPGGTFLCKTWAGSQSRRLQRRLTEEFQNVRIIKPEASRKESSEVYFLATQYHGRKGTVKQ","Homo sapiens","FTSJ2, FJH1, MRM2","Putative ribosomal RNA methyltransferase 2","1","2NYU"
"2NZ2",,"X-RAY DIFFRACTION",2.34,47.44,"VAPOR DIFFUSION",7,"16% PEG 3350, 0.15M DL-MALIC ACID, pH 7.0, VAPOR DIFFUSION, temperature 293K",293,"10.1107/S0907444907067455",,"2NZ2",47.01,"2.4","2.4","Crystal structure of human argininosuccinate synthase in complex with aspartate and citrulline","SMSSKGSVVLAYSGGLDTSCILVWLKEQGYDVIAYLANIGQKEDFEEARKKALKLGAKKVFIEDVSREFVEEFIWPAIQSSALYEDRYLLGTSLARPCIARKQVEIAQREGAKYVSHGATGKGNDQVRFELSCYSLAPQIKVIAPWRMPEFYNRFKGRNDLMEYAKQHGIPIPVTPKNPWSMDENLMHISYEAGILENPKNQAPPGLYTKTQDPAKAPNTPDILEIEFKKGVPVKVTNVKDGTTHQTSLELFMYLNEVAGKHGVGRIDIVENRFIGMKSRGIYETPAGTILYHAHLDIEAFTMDREVRKIKQGLGLKFAELVYTGFWHSPECEFVRHCIAKSQERVEGKVQVSVLKGQVYILGRESPLSLYNEELVSMNVQGDYEPTDATGFININSLRLKEYHRLQSKVTAK","Homo sapiens","ASS1, ASS","Argininosuccinate synthase","1","2NZ2"
"2NZ4",,"X-RAY DIFFRACTION",2.45,49.78,"VAPOR DIFFUSION, SITTING DROP",6.8,"11% PEG 8000, 9% DMSO, 0.02M sodium cacodylate pH 6.8, 0.02M magnesium chloride, 0.15M potassium chloride, 0.002M glucosamine 6 phosphate, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1016/j.chembiol.2006.12.005",,"2NZ4",244.4,"2.498","2.498","Structural investigation of the GlmS ribozyme bound to its catalytic cofactor","AAGCGCCAGAACU",,,"substrate strand RNA 13-mer","1","2NZ4"
,,,,,,,,,,,,,,,,"ETRPNHTIYINNLNEKIKKDELKKSLHAIFSRFGQILDILVSRSLKMRGQAFVIFKEVSSATNALRSMQGFPFYDKPMRIQYAKTDSDIIAKMK","Homo sapiens","SNRPA","U1 Small Nuclear Ribonucleoprotein A","3","2NZ4"
,,,,,,,,,,,,,,,,"GGCACCAUUGCACUCCGGUGCCAGUUGACGAGGUGGGGUUUAUCGAGAUUUCGGCGGAUGACUCCCGGUUGUUCAUCACAACCGCAAGCUUUUACUUAAAUCAUUAAGGUGACUUAGUGGACAAAGGUGAAAGUGUGAUGA",,,"GlmS ribozyme","2","2NZ4"
"2NZ6",,"X-RAY DIFFRACTION",2.43,49.42,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.01M NiCl2, 0.1M TRIS, pH 8.5, 1M Li2SO4, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.cell.2008.11.038",,"2NZ6",37.29,"2.3","2.3","Crystal structure of the PTPRJ inactivating mutant C1239S","MHHHHHHSSGVDLGTENLYFQSMKLIRVENFEAYFKKQQADSNCGFAEEYEDLKLVGISQPKYAAELAENRGKNRYNNVLPYDISRVKLSVQTHSTDDYINANYMPGYHSKKDFIATQGPLPNTLKDFWRMVWEKNVYAIIMLTKCVEQGRTKCEEYWPSKQAQDYGDITVAMTSEIVLPEWTIRDFTVKNIQTSESHPLRQFHFTSWPDHGVPDTTDLLINFRYLVRDYMKQSPPESPILVHSSAGVGRTGTFIAIDRLIYQIENENTVDVYGIVYDLRMHRPLMVQTEDQYVFLNQCVLDIVRSQKDSKVDLIY","Homo sapiens","PTPRJ, DEP1","Receptor-type tyrosine-protein phosphatase eta","1","2NZ6"
"2NZ7",,"X-RAY DIFFRACTION",3.21,61.69,"VAPOR DIFFUSION, SITTING DROP",6,"20 % PEG 6000, 0.067 M MES (pH 6.0), 0.1 M diammonium hydrogen citrate, 0.09 M NaI, 0.001 M DTT, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1021/bi7016602",,"2NZ7",22.73,"1.9","1.9","Crystal Structure Analysis of Caspase-recruitment Domain (CARD) of Nod1","MEIIPSESHPHIQLLKSNRELLVTHIRNTQCLVDNLLKNDYFSAEDAEIVCACPTQPDKVRKILDLVQSKGEEVSEFFLYLLQQLADAYVDLRPWLLE","Homo sapiens","CARD4, NOD1","Caspase recruitment domain-containing protein 4","1","2NZ7"
"2NZI",,"X-RAY DIFFRACTION",4.52,72.78,"VAPOR DIFFUSION, HANGING DROP",5.5,"2.1M NaCl, 0.1M MES, 0.6M Li2SO4, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1096/fj.06-7644com",,"2NZI",67.84,"2.9","2.9","Crystal structure of domains A168-A170 from titin","GAMAPHFKEELRNLNVRYQSNATLVCKVTGHPKPIVKWYRQGKEIIADGLKYRIQEFKGGYHQLIIASVTDDDATVYQVRATNQGGSVSGTASLEVEVPAKIHLPKTLEGMGAVHALRGEVVSIKIPFSGKPDPVITWQKGQDLIDNNGHYQVIVTRSFTSLVFPNGVERKDAGFYVVCAKNRFGIDQKTVELDVADVPDPPRGVKVSDVSRDSVNLTWTEPASDGGSKITNYIVEKCATTAERWLRVGQARETRYTVINLFGKTSYQFRVIAENKFGLSKPSEPSEPTITKEDKTRAMNYDEEV","Homo sapiens","TTN","Titin","1","2NZI"
"2NZJ",,"X-RAY DIFFRACTION",2.37,48.08,"VAPOR DIFFUSION, SITTING DROP",7.7,"34 % (w/v) PEG3350, 0.26M NaCl, 0.1 M HEPES, pH 7.7, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,,,"2NZJ",79.92,"2.5","2.5","The crystal structure of REM1 in complex with GDP","SMALYRVVLLGDPGVGKTSLASLFAGKQERDLHEQLGEDVYERTLTVDGEDTTLVVVDTWEAEKLDKSWSQESCLQGGSAYVIVYSIADRGSFESASELRIQLRRTHQADHVPIILVGNKADLARCREVSVEEGRACAVVFDCKFIETSATLQHNVAELFEGVVRQLRLRRRDSA","Homo sapiens","REM1, GES, REM","GTP-binding protein REM 1","1","2NZJ"
"2NZL",,"X-RAY DIFFRACTION",2.17,43.32,,7,"0.1M MMT, 30.0% PEG 1K, VAPOR DIFFUSION, SITTING DROP, temperature 293K, pH 7.00",293,,,"2NZL",44.07,"1.35","1.35","Crystal structure of human hydroxyacid oxidase 1","MHHHHHHSSGVDLGTENLYFQSMLPRLICINDYEQHAKSVLPKSIYDYYRSGANDEETLADNIAAFSRWKLYPRMLRNVAETDLSTSVLGQRVSMPICVGATAMQRMAHVDGELATVRACQSLGTGMMLSSWATSSIEEVAEAGPEALRWLQLYIYKDREVTKKLVRQAEKMGYKAIFVTVDTPYLGNRLDDVRNRFKLPPQLRMKNFETSTLSFSPEENFGDDSGLAAYVAKAIDPSISWEDIKWLRRLTSLPIVAKGILRGDDAREAVKHGLNGILVSNHGARQLDGVPATIDVLPEIVEAVEGKVEVFLDGGVRKGTDVLKALALGAKAVFVGRPIVWGLAFQGEKGVQDVLEILKEEFRLAMALSGCQNVKVIDKTLVRKNPLAVSKI","Homo sapiens","HAO1, GOX1","Hydroxyacid oxidase 1","1","2NZL"
"2NZT",,"X-RAY DIFFRACTION",3,58,"VAPOR DIFFUSION, SITTING DROP",8.5,"16% PEG3350, 0.2M sodium malonate, 0.1M BTP, 10% ethylene glycol, 0.001M DDT, pH 8.5, vapor diffusion, sitting drop, temperature 291K",291,"10.1042/BSR20171666",,"2NZT",202.99,"2.45","2.45","Crystal structure of human hexokinase II","GSDQVQKVDQYLYHMRLSDETLLEISKRFRKEMEKGLGATTHPTAAVKMLPTFVRSTPDGTEHGEFLALDLGGTNFRVLWVKVTDNGLQKVEMENQIYAIPEDIMRGSGTQLFDHIAECLANFMDKLQIKDKKLPLGFTFSFPCHQTKLDESFLVSWTKGFKSSGVEGRDVVALIRKAIQRRGDFDIDIVAVVNDTVGTMMTCGYDDHNCEIGLIVGTGSNACYMEEMRHIDMVEGDEGRMCINMEWGAFGDDGSLNDIRTEFDQEIDMGSLNPGKQLFEKMISGMYMGELVRLILVKMAKEELLFGGKLSPELLNTGRFETKDISDIEGEKDGIRKAREVLMRLGLDPTQEDCVATHRICQIVSTRSASLCAATLAAVLQRIKENKGEERLRSTIGVDGSVYKKHPHFAKRLHKTVRRLVPGCDVRFLRSEDGSGKGAAMVTAVAYRLADQHRARQKTLEHLQLSHDQLLEVKRRMKVEMERGLSKETHASAPVKMLPTYVCATPDGTEKGDFLALDLGGTNFRVLLVRVRNGKWGGVEMHNKIYAIPQEVMHGTGDELFDHIVQCIADFLEYMGMKGVSLPLGFTFSFPCQQNSLDESILLKWTKGFKASGCEGEDVVTLLKEAIHRREEFDLDVVAVVNDTVGTMMTCGFEDPHCEVGLIVGTGSNACYMEEMRNVELVEGEEGRMCVNMEWGAFGDNGCLDDFRTEFDVAVDELSLNPGKQRFEKMISGMYLGEIVRNILIDFTKRGLLFRGRISERLKTRGIFETKFLSQIESDCLALLQVRAILQHLGLESTCDDSIIVKEVCTVVARRAAQLCGAGMAAVVDRIRENRGLDALKVTVGVDGTLYKLHPHFAKVMHETVKDLAPKCDVSFLQSEDGSGKGAALITAVACRIREAGQ","Homo sapiens","HK2","Hexokinase-2","1","2NZT"
,,,3,58
"2O02",,"X-RAY DIFFRACTION",2.92,57.92,"VAPOR DIFFUSION, SITTING DROP",6.5,"pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 285K",285,"10.1038/sj.emboj.7601530",,"2O02",55.61,"1.5","1.5","Phosphorylation independent interactions between 14-3-3 and Exoenzyme S: from structure to pathogenesis","MDKNELVQKAKLAEQAERYDDMAACMKSVTEQGAELSNEERNLLSVAYKNVVGARRSSWRVVSSIEQKTEGAEKKQQMAREYREKIETELRDICNDVLSLLEKFLIPNASQAESKVFYLKMKGDYYRYLAEVAAGDDKKGIVDQSQQAYQEAFEISKKEMQPTHPIRLGLALNFSVFYYEILNSPEKACSLAKTAFDEAIAELDTLSEESYKDSTLIMQLLRDNLTLWTS","Homo sapiens","YWHAZ","14-3-3 protein zeta/delta","1","2O02"
,,,,,,,,,,,,,,,,"GHGQGLLDALDLAS",,,"ExoS (416-430) peptide","2","2O02"
"2O05",,"X-RAY DIFFRACTION",2.12,41.93,"VAPOR DIFFUSION, HANGING DROP",7,"20% PEG 3350, 0.2M MG(OAC)2, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 300K",300,"10.1021/bi602498k",,"2O05",68.6,"2","2","Human spermidine synthase","GSMEPGPDGPAASGPAAIREGWFRETCSLWPGQALSLQVEQLLHHRRSRYQDILVFRSKTYGNVLVLDGVIQCTERDEFSYQEMIANLPLCSHPNPRKVLIIGGGDGGVLREVVKHPSVESVVQCEIDEDVIQVSKKFLPGMAIGYSSSKLTLHVGDGFEFMKQNQDAFDVIITDSSDPMGPAESLFKESYYQLMKTALKEDGVLCCQGECQWLHLDLIKEMRQFCQSLFPVVAYAYCTIPTYPSGQIGFMLCSKNPSTNFQEPVQPLTQQQVAQMQLKYYNSDVHRAAFVLPEFARKALNDVS","Homo sapiens","SRM, SPS1, SRML1","Spermidine synthase","1","2O05"
"2O06",,"X-RAY DIFFRACTION",2.47,50.11,"VAPOR DIFFUSION, HANGING DROP",7,"20% PEG 3350, 0.2M Mg(OAC)2, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 300K",300,"10.1021/bi602498k",,"2O06",68.85,"2","2","Human spermidine synthase","GSMEPGPDGPAASGPAAIREGWFRETCSLWPGQALSLQVEQLLHHRRSRYQDILVFRSKTYGNVLVLDGVIQCTERDEFSYQEMIANLPLCSHPNPRKVLIIGGGDGGVLREVVKHPSVESVVQCEIDEDVIQVSKKFLPGMAIGYSSSKLTLHVGDGFEFMKQNQDAFDVIITDSSDPMGPAESLFKESYYQLMKTALKEDGVLCCQGECQWLHLDLIKEMRQFCQSLFPVVAYAYCTIPTYPSGQIGFMLCSKNPSTNFQEPVQPLTQQQVAQMQLKYYNSDVHRAAFVLPEFARKALNDVS","Homo sapiens","SRM, SPS1, SRML1","Spermidine synthase","1","2O06"
"2O07",,"X-RAY DIFFRACTION",2.13,42.21,"VAPOR DIFFUSION, HANGING DROP",7,"20% PEG 3350, 0.2M Mg(OAc)2, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 300K",300,"10.1021/bi602498k",,"2O07",68.89,"1.89","1.89","Human spermidine synthase","GSMEPGPDGPAASGPAAIREGWFRETCSLWPGQALSLQVEQLLHHRRSRYQDILVFRSKTYGNVLVLDGVIQCTERDEFSYQEMIANLPLCSHPNPRKVLIIGGGDGGVLREVVKHPSVESVVQCEIDEDVIQVSKKFLPGMAIGYSSSKLTLHVGDGFEFMKQNQDAFDVIITDSSDPMGPAESLFKESYYQLMKTALKEDGVLCCQGECQWLHLDLIKEMRQFCQSLFPVVAYAYCTIPTYPSGQIGFMLCSKNPSTNFQEPVQPLTQQQVAQMQLKYYNSDVHRAAFVLPEFARKALNDVS","Homo sapiens","SRM, SPS1, SRML1","Spermidine synthase","1","2O07"
"2O0L",,"X-RAY DIFFRACTION",2.13,42.21,"VAPOR DIFFUSION, HANGING DROP",7,"20% PEG 3350, 0.2M Mg(OAc)2, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 300K",300,"10.1021/bi602498k",,"2O0L",68.72,"1.99","1.99","Human spermidine synthase","GSMEPGPDGPAASGPAAIREGWFRETCSLWPGQALSLQVEQLLHHRRSRYQDILVFRSKTYGNVLVLDGVIQCTERDEFSYQEMIANLPLCSHPNPRKVLIIGGGDGGVLREVVKHPSVESVVQCEIDEDVIQVSKKFLPGMAIGYSSSKLTLHVGDGFEFMKQNQDAFDVIITDSSDPMGPAESLFKESYYQLMKTALKEDGVLCCQGECQWLHLDLIKEMRQFCQSLFPVVAYAYCTIPTYPSGQIGFMLCSKNPSTNFQEPVQPLTQQQVAQMQLKYYNSDVHRAAFVLPEFARKALNDVS","Homo sapiens","SRM, SPS1, SRML1","Spermidine synthase","1","2O0L"
"2O0O",,"X-RAY DIFFRACTION",3.29,62.66,"VAPOR DIFFUSION, HANGING DROP",6.9,"0.2 M Magnesium Format, pH 6.9, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.bbrc.2007.09.097",,"2O0O",61.51,"3","3","Crystal structure of TL1A","LKGQEFAPSHQQVYAPLRADGDKPRAHLTVVRQTPTQHFKNQFPALHWEHELGLAFTKNRMNYTNKFLLIPESGDYFIYSQVTFRGMTSECSEIRQAGRPNKPDSITVVITKVTDSYPEPTQLLMGTKSVCEVGSNWFQPIYLGAMFSLQEGDKLMVNVSDISLVDYTKEDKTFFGAFLL","Homo sapiens","TNFSF15, TL1, VEGI","TNF superfamily ligand TL1A","1","2O0O"
"2O0U",,"X-RAY DIFFRACTION",2.42,49.26,"VAPOR DIFFUSION, HANGING DROP",7.4,"50mM Tris/HCl, 18-22% PEG3350, 0.2M KF, pH 7.4, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.bmcl.2006.12.003","C0M","2O0U",42.53,"2.1","2.1","Crystal structure of human JNK3 complexed with N-{3-cyano-6-[3-(1-piperidinyl)propanoyl]-4,5,6,7-tetrahydrothieno[2,3-c]pyridin-2-yl}-1-naphthalenecarboxamide","MSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVMNSE","Homo sapiens","MAPK10, JNK3, JNK3A, PRKM10, SAPK1B","Mitogen-activated protein kinase 10","1","2O0U"
"2O10",,"SOLUTION NMR",,,,,,,,,"2O10",6.91,,,"Solution structure of the N-terminal LIM domain of MLP/CRP3","GAKCGACEKTVYHAEEIQCNGRSFHKTCFHCMACRKALDSTTVAAHESEIYCKVCYGRRY","Homo sapiens","CSRP3, CLP, MLP","Muscle LIM protein","1","2O10"
"2O13",,"SOLUTION NMR",,,,,,,,,"2O13",6.55,,,"Solution structure of the C-terminal LIM domain of MLP/CRP3","KCPRCGKSVYAAEKVMGGGKPWHKTCFRCAICGKSLESTNVTDKDGELYCKVCYAKNF","Homo sapiens","CSRP3, CLP, MLP","Muscle LIM protein","1","2O13"
"2O1F",,"X-RAY DIFFRACTION",2.29,46.31,"VAPOR DIFFUSION, HANGING DROP",7.5,"ADA, manganese chloride, ammonium sulfate, MPD, glycerol, PEG 4000, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1074/jbc.M610998200",,"2O1F",35.15,"1.99","1.99","Natural Occuring Mutation of Human ABO(H) galactosyltransferase: GTB/M214R","AIGEFMVSLPRMVYPQPKVLTPCRKDVLVVTPWLAPIVWEGTFNIDILNEQFRLQNTTIGLTVFAIKKYVAFLKLFLETAEKHFMVGHRVHYYVFTDQPAAVPRVTLGTGRQLSVLEVGAYKRWQDVSMRRMEMISDFCERRFLSEVDYLVCVDVDREFRDHVGVEILTPLFGTLHPSFYGSSREAFTYERRPQSQAYIPKDEGDFYYMGAFFGGSVQEVQRLTRACHQAMMVDQANGIEAVWHDESHLNKYLLRHKPTKVLSPEYLWDQQLLGWPAVLRKLRFTAVPKNHQAVRNP","Homo sapiens","ABO","ABO glycosyltransferase","1","2O1F"
"2O1G",,"X-RAY DIFFRACTION",2.31,46.65,"VAPOR DIFFUSION, HANGING DROP",7.5,"ADA, manganese chloride, ammonium sulfate, MPD, glycerol, PEG 4000, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1074/jbc.M610998200",,"2O1G",35.5,"1.71","1.71","Natural occurring mutant of Human ABO(H) Galactosyltransferase: GTB/M214T","AIGEFMVSLPRMVYPQPKVLTPCRKDVLVVTPWLAPIVWEGTFNIDILNEQFRLQNTTIGLTVFAIKKYVAFLKLFLETAEKHFMVGHRVHYYVFTDQPAAVPRVTLGTGRQLSVLEVGAYKRWQDVSMRRMEMISDFCERRFLSEVDYLVCVDVDTEFRDHVGVEILTPLFGTLHPSFYGSSREAFTYERRPQSQAYIPKDEGDFYYMGAFFGGSVQEVQRLTRACHQAMMVDQANGIEAVWHDESHLNKYLLRHKPTKVLSPEYLWDQQLLGWPAVLRKLRFTAVPKNHQAVRNP","Homo sapiens","ABO","ABO glycosyltransferase","1","2O1G"
"2O1H",,"X-RAY DIFFRACTION",2.28,46.08,"VAPOR DIFFUSION, HANGING DROP",7.5,"ADA, manganese chloride, ammonium sulfate, MPD, glycerol, PEG 4000,, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1074/jbc.M610998200",,"2O1H",35.96,"1.67","1.67","Naturally occurring mutation of Humna ABO(H) Galactosyltransferase in complex with UDP: GTB/M214T_UDP","AIGEFMVSLPRMVYPQPKVLTPCRKDVLVVTPWLAPIVWEGTFNIDILNEQFRLQNTTIGLTVFAIKKYVAFLKLFLETAEKHFMVGHRVHYYVFTDQPAAVPRVTLGTGRQLSVLEVGAYKRWQDVSMRRMEMISDFCERRFLSEVDYLVCVDVDTEFRDHVGVEILTPLFGTLHPSFYGSSREAFTYERRPQSQAYIPKDEGDFYYMGAFFGGSVQEVQRLTRACHQAMMVDQANGIEAVWHDESHLNKYLLRHKPTKVLSPEYLWDQQLLGWPAVLRKLRFTAVPKNHQAVRNP","Homo sapiens","ABO","ABO glycosyltransferase","1","2O1H"
"2O1Y",,"SOLUTION NMR",,,,,,,"10.1021/jm061152t",,"2O1Y",21.5,,,"Solution structure of the anti-apoptotic protein Bcl-xL in complex with an acyl-sulfonamide-based ligand","MSMAMSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERLEHHHHHH","Homo sapiens","BCL2L1, BCL2L, BCLX","Apoptosis regulator Bcl-X","1","2O1Y"
"2O21",,"SOLUTION NMR",,,,,,,"10.1021/jm061152t",,"2O21",19.85,,,"Solution structure of the anti-apoptotic protein Bcl-2 in complex with an acyl-sulfonamide-based ligand","HAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDDVEENRTEAPEGTESEVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMR","Homo sapiens","BCL2","Apoptosis regulator Bcl-2","1","2O21"
"2O22",,"SOLUTION NMR",,,,,,,"10.1021/jm061152t","LIU","2O22",19.75,,,"Solution structure of the anti-apoptotic protein Bcl-2 in complex with an acyl-sulfonamide-based ligand","HAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDDVEENRTEAPEGTESEVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMR","Homo sapiens","BCL2","Apoptosis regulator Bcl-2","1","2O22"
"2O23",,"X-RAY DIFFRACTION",2.5,50.83,"VAPOR DIFFUSION, SITTING DROP",7,"25.5% PEG 3350, 15% glycerol, 0.17 M ammonium sulfate, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,,,"2O23",55.99,"1.2","1.2","The structure of wild-type human HADH2 (17beta-hydroxysteroid dehydrogenase type 10) bound to NAD+ at 1.2 A","GHMAAACRSVKGLVAVITGGASGLGLATAERLVGQGASAVLLDLPNSGGEAQAKKLGNNCVFAPADVTSEKDVQTALALAKGKFGRVDVAVNCAGIAVASKTYNLKKGQTHTLEDFQRVLDVNLMGTFNVIRLVAGEMGQNEPDQGGQRGVIINTASVAAFEGQVGQAAYSASKGGIVGMTLPIARDLAPIGIRVMTIAPGLFGTPLLTSLPEKVCNFLASQVPFPSRLGDPAEYAHLVQAIIENPFLNGEVIRLDGAIRMQPGS","Homo sapiens","HADH2, HSD17B10, ERAB, MRPP2, SCHAD, SDR5C1, XH98G2","HADH2 protein","1","2O23"
"2O28",,"X-RAY DIFFRACTION",2.44,49.61,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1M BICINE pH 9.0, 27% PEG3350, 0.2M MgCl2, PH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 300K",300,,,"2O28",43.39,"1.8","1.8","Crystal Structure of GNPNAT1","MKPDETPMFDPSLLKEVDWSQNTATFSPAISPTHPGEGLVLRPLCTADLNRGFFKVLGQLTETGVVSPEQFMKSFEHMKKSGDYYVTVVEDVTLGQIVATATLIIEHKFIHSCAKRGRVEDVVVSDECRGKQLGKLLLSTLTLLSKKLNCYKITLECLPQNVGFYKKFGYTVSEENYMCRRFLK","Homo sapiens","GNPNAT1, GNA1","Glucosamine 6-phosphate N-acetyltransferase","1","2O28"
"2O2F",,"SOLUTION NMR",,,,,,,"10.1021/jm061152t",,"2O2F",17.06,,,"Solution structure of the anti-apoptotic protein Bcl-2 in complex with an acyl-sulfonamide-based ligand","GYDNREIVMKYIHYKLSQRGYEWDEVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGP","Homo sapiens","BCL2","Apoptosis regulator Bcl-2","1","2O2F"
"2O2K",,"X-RAY DIFFRACTION",2.77,55.62,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1M Tris/HCl, 0.1-0.4M sodium acetate, 10-12% PEG 8000, 10-12% PEG 1000, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 292.0K",292,"10.1111/j.1742-4658.2006.05618.x",,"2O2K",81.06,"1.6","1.6","Crystal Structure of the Activation Domain of Human Methionine Synthase Isoform/Mutant D963E/K1071N","MKERRYLPLSQARKSGFQMDWLSEPHPVKPTFIGTQVFEEYDLQKLVDYIDWKPFFDVWQLRGKYPNRGFPKIFNDKTVGGEARKVYDDAHNMLNTLISQKKLRARGVVGFWPAQSIQDDIHLYAEAAVPQAAEPIATFYGLRQQAENDSASTEPYYCLSDFIAPLHSGIRDYLGLFAVACFGVEELSKAYEDDGDDYSSIMVKALGDRLAEAFAEELHERVRRELWAYCGSEQLDVADLRRLRYKGIRPAPGYPSQPDHTEKLTMWRLADIEQSTGIRLTESLAMAPASAVSGLYFSNLKSKYFAVGKISKDQVEDYALRKNISVAEVEKWLGPILGYDTDKLAAALEHHHHHH","Homo sapiens","MTR","Methionine synthase","1","2O2K"
"2O2M",,"SOLUTION NMR",,,,,,,"10.1021/jm061152t",,"2O2M",16.77,,,"Solution structure of the anti-apoptotic protein Bcl-xL in complex with an acyl-sulfonamide-based ligand","SQSNRELVVDFLSYKLSQKGYSAGGGGGGGGMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYG","Homo sapiens","BCL2L1, BCL2L, BCLX","Apoptosis regulator Bcl-X","1","2O2M"
"2O2N",,"SOLUTION NMR",,,,,,,"10.1021/jm061152t",,"2O2N",16.82,,,"Solution structure of the anti-apoptotic protein Bcl-xL in complex with an acyl-sulfonamide-based ligand","SQSNRELVVDFLSYKLSQKGYSAGGGGGGGGMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYG","Homo sapiens","BCL2L1, BCL2L, BCLX","Apoptosis regulator Bcl-X","1","2O2N"
"2O2O",,"SOLUTION NMR",,,,,,,,,"2O2O",10.5,,,"Solution structure of domain B from human CIN85 PROTEIN","SMTGGQQMGTNKRGERRRRRCQVAFSYLPQNDDELELKVGDIIEVVGEVEEGWWEGVLNGKTGMFPSNFIKELSGESDELGISQDEHHHHHH","Homo sapiens","SH3KBP1, CIN85","SH3-domain kinase-binding protein 1","1","2O2O"
"2O2T",,"X-RAY DIFFRACTION",2.26,55.38,"VAPOR DIFFUSION, SITTING DROP",7,"0.5% Jeffamine 2001, 1.1M Sodium Malonate, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,,,"2O2T",25.8,"2.7","2.7","The crystal structure of the 1st PDZ domain of MPDZ","SMPACDEFDQLIKNMAQGRHVEVFELLKPPSGGLGFSVVGLRSENRGELGIFVQEIQEGSVAHRDGRLKETDQILAINGQALDQTITHQQAISILQKAKDTVQLVIARGSLPQYYKV","Homo sapiens","MPDZ, MUPP1","Multiple PDZ domain protein","1","2O2T"
"2O2U",,"X-RAY DIFFRACTION",2.39,48.46,"VAPOR DIFFUSION, HANGING DROP",7.4,"50mM Tris/HCl, 18-22% PEG3350, 0.2M KF, pH 7.4, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.bmcl.2006.12.003","738","2O2U",42.36,"2.45","2.45","Crystal structure of human JNK3 complexed with N-(3-cyano-4,5,6,7-tetrahydro-1-benzothien-2-yl)-2-fluorobenzamide","MSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVMNSE","Homo sapiens","MAPK10, JNK3, JNK3A, PRKM10, SAPK1B","Mitogen-activated protein kinase 10","1","2O2U"
"2O2W",,"POWDER DIFFRACTION",2.11,41.31,"SMALL TUBES",7.5,"TRIS/HCL 0.025M, NaCl 0.9M, pH 7.5, SMALL TUBES, temperature 292K",292,"10.1021/ja073846c",,"2O2W",7.7,,,"Extending powder diffraction to proteins: structure solution of the second SH3 domain from ponsin","GIDPFTGEAIAKFNFNGDTQVEMSFRKGERITLLRQVDENWYEGRIPGTSRQGIFPITYVDVIKRPL","Homo sapiens","SORBS1, KIAA0894, KIAA1296, SH3D5","Ponsin","1","2O2W"
"2O31",,"X-RAY DIFFRACTION",2.02,38.54,"VAPOR DIFFUSION, SITTING DROP",7,"15% v/v Tascinamine, 0.1M HEPES, 2% w/v PEG 3350, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 292K",292,"10.1021/ja073846c",,"2O31",7.79,"1.5","1.5","Crystal structure of the second SH3 domain from ponsin","GIDPFTGEAIAKFNFNGDTQVEMSFRKGERITLLRQVDENWYEGRIPGTSRQGIFPITYVDVIKRPL","Homo sapiens","SORBS1, KIAA0894, KIAA1296, SH3D5","Ponsin","1","2O31"
"2O36",,"X-RAY DIFFRACTION",2.65,53.62,"VAPOR DIFFUSION, HANGING DROP",6.5,"pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1074/jbc.M609897200",,"2O36",77.55,"1.95","1.95","Crystal structure of engineered thimet oligopeptidase with neurolysin specificity in neurotensin cleavage site","SPCSVVNDLRWDLSAQQIEERTRELIEQTKRVYDQVGTQEFEDVSYESTLKALADVEVTYTVQRNILDFPQHVSPSKDIRTASTEADKKLSEFDVEMSMREDVYQRIVWLQEKVQKDSLRPEAARYLERLIKLGRRNGLHLPRETQENIKRIKKKLSLLCIDFNKNLNEDTTFLPFTLQELGGLPEDFLNSLEKMEDGKLKVTLKYPHYFPLLKKCHVPETRRKVEEAFNSRCKEENSAILKELVTLRAQKSRLLGFHTHADYVLEMNMAKTSQTVATFLDELAQKLKPLGEQERAVILELKRAECERRGLPFDGRIRAWDMRYYMNQVEETRYCVDQNLLKEYFPVQVVTHGLLGIYQELLGLAFHHEEGASAWHEDVRLYTARDAASGEVVGKFYLDLYPREGKYGHAACFGLQPGCLRQDGSRQIAIAAMVANFTKPTADAPSLLQHDEVRTYFHEFGHVMHQLCSQAEFAMFSGTHVETDFVEAPSQMLENWVWEQEPLLRMSRHYRTGSAVPRELLEKLIESRQANTGLFNLRQIVLAKVDQALHTQTDADPAEEYARLCQEILGVPATPGTNMPATFGHLAGGYDAQYYGYLWSEVYSMDMFHTRFKQEGVLNSKVGMDYRSCILRPGGSEDASAMLRRFLGRDPKQDAFLLSKGLQVGGCEPEPQVC","Homo sapiens","THOP1","Thimet oligopeptidase","1","2O36"
"2O3D",,"SOLUTION NMR",,,,,,,"10.1038/sj.embor.7401031",,"2O3D",12.93,,,"Structure of human SF2/ASF RNA recognition motif 2 (RRM2)","MAPRGRYGPPSRRSENRVVVSGLPPSGSWQDLKDHMREAGDVCYADVYRDGTGVVEFVRKEDMTYAVRKLDNTKFRSHEGETAYIRVKVDGPRSPSYGRSRSRSRSRSRSLEH","Homo sapiens","SFRS1, ASF, SF2, SF2P33, SRSF1, OK/SW-cl.3","Splicing factor, arginine/serine-rich 1","1","2O3D"
"2O3H",,"X-RAY DIFFRACTION",2.38,48.22,"VAPOR DIFFUSION, HANGING DROP",6,"20% PEG 8000, 100 mM MES pH 6.0, 7.5 mM samarium acetate, 4% dioxane, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.mrfmmm.2008.04.008",,"2O3H",32.55,"1.9","1.9","Crystal structure of the human C65A Ape","GSHMASEGPALYEDPPDQKTSPSGKPATLKIASWNVDGLRAWIKKKGLDWVKEEAPDILCLQETKCSENKLPAELQELPGLSHQYWSAPSDKEGYSGVGLLSRQCPLKVSYGIGDEEHDQEGRVIVAEFDSFVLVTAYVPNAGRGLVRLEYRQRWDEAFRKFLKGLASRKPLVLCGDLNVAHEEIDLRNPKGNKKNAGFTPQERQGFGELLQAVPLADSFRHLYPNTPYAYTFWTYMMNARSKNVGWRLDYFLLSHSLLPALCDSKIRSKALGSDHCPITLYLAL","Homo sapiens","APEX1, APE, APEX, APX, HAP1, REF1, APE1","DNA-(apurinic or apyrimidinic site) lyase","1","2O3H"
"2O3M",,"SOLUTION NMR",,,,,,,"10.1021/ja068739h",,"2O3M",7.03,,,"Monomeric G-DNA tetraplex from human C-kit promoter","AGGGAGGGCGCTGGGAGGAGGG","Homo sapiens",,"5'-D(*AP*GP*GP*GP*AP*GP*GP*GP*CP*GP*CP*TP*GP*GP*GP*AP*GP*GP*AP*GP*GP*G)-3'","1","2O3M"
"2O3P",,"X-RAY DIFFRACTION",3.31,62.82,"VAPOR DIFFUSION, SITTING DROP",6.5,"NA ACETATE, IMIDAZOLE, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1158/1535-7163.MCT-06-0397","QUE","2O3P",34.27,"2.24","2.24","Crystal structure of Pim1 with Quercetin","KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPSKVDHHHHHH","Homo sapiens","PIM1","Proto-oncogene serine/threonine-protein kinase Pim-1","1","2O3P"
"2O3Q",,"X-RAY DIFFRACTION",2.32,46.93,"VAPOR DIFFUSION, HANGING DROP",6.5,"100 mM MES, 12% PEG4000, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 300K",300,"10.1074/jbc.M609093200",,"2O3Q",61.84,"1.98","1.98","Structural Basis for Formation and Hydrolysis of Calcium Messenger Cyclic ADP-ribose by Human CD38","KREAEARWRQTWSGPGTTKRFPETVLARCVKYTEIHPEMRHVDCQSVWDAFKGAFISKHPCDITEEDYQPLMKLGTQTVPCNKILLWSRIKDLAHQFTQVQRDMFTLEDTLLGYLADDLTWCGEFDTSKINYQSCPDWRKDCSNNPVSVFWKTVSRRFAEAACDVVHVMLDGSRSKIFDKDSTFGSVQVHNLQPEKVQTLEAWVIHGGREDSRDLCQDPTIKELESIISKRNIQFSCKNIYRPDKFLQCVKNPEDSSCTSEI","Homo sapiens","CD38","ADP-ribosyl cyclase 1","1","2O3Q"
"2O3R",,"X-RAY DIFFRACTION",2.31,46.73,"VAPOR DIFFUSION, HANGING DROP",6,"100 mM MES, 15% PEG4000, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 300K",300,"10.1074/jbc.M609093200",,"2O3R",61.82,"1.75","1.75","Structural Basis for Formation and Hydrolysis of Calcium Messenger Cyclic ADP-ribose by Human CD38","KREAEARWRQTWSGPGTTKRFPETVLARCVKYTEIHPEMRHVDCQSVWDAFKGAFISKHPCDITEEDYQPLMKLGTQTVPCNKILLWSRIKDLAHQFTQVQRDMFTLEDTLLGYLADDLTWCGEFDTSKINYQSCPDWRKDCSNNPVSVFWKTVSRRFAEAACDVVHVMLDGSRSKIFDKDSTFGSVDVHNLQPEKVQTLEAWVIHGGREDSRDLCQDPTIKELESIISKRNIQFSCKNIYRPDKFLQCVKNPEDSSCTSEI","Homo sapiens","CD38","ADP-ribosyl cyclase 1","1","2O3R"
"2O3S",,"X-RAY DIFFRACTION",2.41,49.02,"VAPOR DIFFUSION, HANGING DROP",6,"100 mM MES, 13% PEG4000, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 300K",300,"10.1074/jbc.M609093200",,"2O3S",61.68,"1.5","1.5","Structural Basis for Formation and Hydrolysis of Calcium Messenger Cyclic ADP-ribose by Human CD38","KREAEAFWRQTWSGPGTTKRFPETVLARCVKYTEIHPEMRHVDCQSVWDAFKGAFISKHPCDITEEDYQPLMKLGTQTVPCNKILLWSRIKDLAHQFTQVQRDMFTLEDTLLGYLADDLTWCGEFDTSKINYQSCPDWRKDCSNNPVSVFWKTVSRRFAEAACDVVHVMLDGSRSKIFDKDSTFGSVGVHNLQPEKVQTLEAWVIHGGREDSRDLCQDPTIKELESIISKRNIQFSCKNIYRPDKFLQCVKNPEDSSCTSEI","Homo sapiens","CD38","ADP-ribosyl cyclase 1","1","2O3S"
"2O3T",,"X-RAY DIFFRACTION",2.31,46.85,"VAPOR DIFFUSION, HANGING DROP",6.5,"100 mM MES, 12% PEG4000, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 300K",300,"10.1074/jbc.M609093200",,"2O3T",61.32,"1.68","1.68","Structural Basis for Formation and Hydrolysis of Calcium Messenger Cyclic ADP-ribose by Human CD38","KREAEARWRQTWSGPGTTKRFPETVLARCVKYTEIHPEMRHVDCQSVWDAFKGAFISKHPCDITEEDYQPLMKLGTQTVPCNKILLWSRIKDLAHQFTQVQRDMFTLEDTLLGYLADDLTWCGEFDTSKINYQSCPDWRKDCSNNPVSVFWKTVSRRFAEAACDVVHVMLDGSRSKIFDKDSTFGSVQVHNLQPEKVQTLEAWVIHGGREDSRDLCQDPTIKELESIISKRNIQFSCKNIYRPDKFLQCVKNPEDSSCTSEI","Homo sapiens","CD38","ADP-ribosyl cyclase 1","1","2O3T"
"2O3U",,"X-RAY DIFFRACTION",2.3,46.52,"VAPOR DIFFUSION, HANGING DROP",6.5,"100 mM MES, 12% PEG4000, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 300K",300,"10.1074/jbc.M609093200",,"2O3U",62.12,"2.11","2.11","Structural Basis for Formation and Hydrolysis of Calcium Messenger Cyclic ADP-ribose by Human CD38","KREAEARWRQTWSGPGTTKRFPETVLARCVKYTEIHPEMRHVDCQSVWDAFKGAFISKHPCDITEEDYQPLMKLGTQTVPCNKILLWSRIKDLAHQFTQVQRDMFTLEDTLLGYLADDLTWCGEFDTSKINYQSCPDWRKDCSNNPVSVFWKTVSRRFAEAACDVVHVMLDGSRSKIFDKDSTFGSVQVHNLQPEKVQTLEAWVIHGGREDSRDLCQDPTIKELESIISKRNIQFSCKNIYRPDKFLQCVKNPEDSSCTSEI","Homo sapiens","CD38","ADP-ribosyl cyclase 1","1","2O3U"
"2O49",,"X-RAY DIFFRACTION",2.23,50.83,"VAPOR DIFFUSION, SITTING DROP",8,"20% PEG 20000, 0.05M TrisHCl, 0.01M magnesium chloride, 20% ethylene glycol, pH 8.00, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1093/nar/gkm504",,"2O49",18.28,"2","2","Crystal Structure of the N-terminal CUT domain of SATB1 Bound to Matrix Attachment Region DNA","GCTAATATATGC",,,"DNA (5'-D(*DGP*DCP*DTP*DAP*DAP*DTP*DAP*DTP*DAP*DTP*DGP*DC)-3')","1","2O49"
,,,,,,,,,,,,,,,,"GCATATATTAGC",,,"DNA (5'-D(*DGP*DCP*DAP*DTP*DAP*DTP*DAP*DTP*DTP*DAP*DGP*DC)-3')","2","2O49"
,,,,,,,,,,,,,,,,"GSHMNTEVSSEIYQWVRDELKRAGISQAVFARVAFNRTQGLLSEILRKEEDPKTASQSLLVNLRAMQNFLQLPEAERDRIYQDERERSLRKRK","Homo sapiens","SATB1","DNA-binding protein SATB1","3","2O49"
"2O4A",,"X-RAY DIFFRACTION",2.43,54.91,"VAPOR DIFFUSION, SITTING DROP",8,"20% PEG 20000, 0.05M TrisHCl, 0.01M magnesium sulfate, 20% ethylene glycol, pH 8.00, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1093/nar/gkm504",,"2O4A",18.28,"1.75","1.75","Crystal Structure of the N-terminal CUT Domain of SATB1 Bound to Matrix Attachment Region DNA","GCTAATATATGC",,,"DNA (5'-D(*DGP*DCP*DTP*DAP*DAP*DTP*DAP*DTP*DAP*DTP*DGP*DC)-3')","1","2O4A"
,,,,,,,,,,,,,,,,"GCATATATTAGC",,,"DNA (5'-D(*DGP*DCP*DAP*DTP*DAP*DTP*DAP*DTP*DTP*DAP*DGP*DC)-3')","2","2O4A"
,,,,,,,,,,,,,,,,"GSHMNTEVSSEIYQWVRDELKRAGISQAVFARVAFNRTQGLLSEILRKEEDPKTASQSLLVNLRAMQNFLQLPEAERDRIYQDERERSLRKRK","Homo sapiens","SATB1","DNA-binding protein SATB1","3","2O4A"
"2O4H",,"X-RAY DIFFRACTION",3.74,67.1,"VAPOR DIFFUSION, HANGING DROP",6,"8-10 mg/ml Protein, 50 mM Sodium citrate pH 6.0, 300 mM K2HPO4, 15-19% PEG 3350, VAPOR DIFFUSION, HANGING DROP, temperature 293.0K",293,"10.1021/bi702400x","AS9","2O4H",72.12,"2.7","2.7","Human brain aspartoacylase complex with intermediate analog (N-phosphonomethyl-L-aspartate)","MTSCHIAEEHIQKVAIFGGTHGNELTGVFLVKHWLENGAEIQRTGLEVKPFITNPRAVKKCTRYIDCDLNRIFDLENLGKKMSEDLPYEVRRAQEINHLFGPKDSEDSYDIIFDLHNTTSNMGCTLILEDSRNNFLIQMFHYIKTSLAPLPCYVYLIEHPSLKYATTRSIAKYPVGIEVGPQPQGVLRADILDQMRKMIKHALDFIHHFNEGKEFPPCAIEVYKIIEKVDYPRDENGEIAAIIHPNLQDQDWKPLHPGDPMFLTLDGKTIPLGGDCTVYPVFVNEAAYYEKKEAFAKTTKLTLNAKSIRCCLH","Homo sapiens","ASPA, ACY2, ASP","Aspartoacylase","1","2O4H"
"2O4X",,"X-RAY DIFFRACTION",3.18,61.28,"VAPOR DIFFUSION, HANGING DROP",4.2,"2.0 MICROLITER DROPS CONTAINING EQUAL VOLUMES OF PROTEIN CONCENTRATE (10.0mg/ml), RESERVOIR SOLUTION 
 CONTAING 20% PEG 8000, 100.0mM PHOSPHATE, 0.1M HEPES pH 4.2  
, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,,,"2O4X",34.96,"2","2","Crystal structure of human P100 tudor domain","SASYKPVFVTEITDDLHFYVQDVETGTQFEKLMENMRNDIASHPPVEGSYAPRRGEFCIAKFVDGEWYRARVEKVESPAKIHVFYIDYGNREVLPSTRLGTLSPAFSTRVLPAQATEYAFAFIQVPQDDDARTDAVDSVVRDIQNTQCLLNVEHLSAGCPHVTLQFADSKGDVGLGLVKEGLVMVEVRKEKQFQKVITEYLNAQESAKSARLNLWRY","Homo sapiens","SND1, TDRD11","Staphylococcal nuclease domain-containing protein 1","1","2O4X"
,,,,,,,,,,,,,,,,"TQFEKLMENMRNDIASHPPVEGSYAPRRGEFCIAKFVDGEWYRARVEKVESPAKIHVFYIDYGNREVLPSTRLGTLSPAFSTRVLPAQATE","Homo sapiens","SND1, TDRD11","Staphylococcal nuclease domain-containing protein 1","2","2O4X"
"2O4Z",,"X-RAY DIFFRACTION",2.08,40.92,"VAPOR DIFFUSION, HANGING DROP",,"Tris.HCl, pH 7.7-7.8, sodium 4-(hydroxymercury)benzoate , VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.bmcl.2007.02.068","HSW","2O4Z",29.67,"2.1","2.1","Crystal structure of the Carbonic Anhydrase II complexed with hydroxysulfamide inhibitor","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","2O4Z"
"2O52",,"X-RAY DIFFRACTION",2.295,46.42,"VAPOR DIFFUSION, SITTING DROP",6.5,"18% PEG8000, 0.2M magnesium acetate, 0.1M sodium cacodylate, pH 6.5, vapor diffusion, sitting drop, temperature 291K",291,,,"2O52",45.76,"2.2","2.2","Crystal structure of human RAB4B in complex with GDP","MGSSHHHHHHSSGLVPRGSIWSDFLFKFLVIGSAGTGKSCLLHQFIENKFKQDSNHTIGVEFGSRVVNVGGKTVKLQIWDTAGQERFRSVTRSYYRGAAGALLVYDITSRETYNSLAAWLTDARTLASPNIVVILCGNKKDLDPEREVTFLEASRFAQENELMFLETSALTGENVEEAFLKCARTILNKIDSGELDPERM","Homo sapiens","RAB4B, PP1596","Ras-related protein Rab-4B","1","2O52"
"2O53",,"X-RAY DIFFRACTION",3.76,67.26,"VAPOR DIFFUSION, HANGING DROP",6,"Protein concentration 8-10 mg/ml, 0.05 M Sodium citrate pH 6.0, 0.3 M K2HPO4, 19% PEG 3350, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/bi702400x",,"2O53",72.08,"2.7","2.7","Crystal structure of apo-Aspartoacylase from human brain","MTSCHIAEEHIQKVAIFGGTHGNELTGVFLVKHWLENGAEIQRTGLEVKPFITNPRAVKKCTRYIDCDLNRIFDLENLGKKMSEDLPYEVRRAQEINHLFGPKDSEDSYDIIFDLHNTTSNMGCTLILEDSRNNFLIQMFHYIKTSLAPLPCYVYLIEHPSLKYATTRSIAKYPVGIEVGPQPQGVLRADILDQMRKMIKHALDFIHHFNEGKEFPPCAIEVYKIIEKVDYPRDENGEIAAIIHPNLQDQDWKPLHPGDPMFLTLDGKTIPLGGDCTVYPVFVNEAAYYEKKEAFAKTTKLTLNAKSIRCCLH","Homo sapiens","ASPA, ACY2, ASP","Aspartoacylase","1","2O53"
"2O5K",,"X-RAY DIFFRACTION",2.49,50.63,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M HEPES Na, 0.1M Proline, 20% PEG3350, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.bmcl.2007.07.056","HBM","2O5K",42.78,"3.2","3.2","Crystal Structure of GSK3beta in complex with a benzoimidazol inhibitor","MHHHHHHSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATILIPPHARIQAAASTPTN","Homo sapiens","GSK3B","Glycogen synthase kinase-3 beta","1","2O5K"
"2O63",,"X-RAY DIFFRACTION",3.35,63.27,"VAPOR DIFFUSION, SITTING DROP",6.5,"NA ACETATE, IMIDAZOLE, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1158/1535-7163.MCT-06-0397","MYC","2O63",34.36,"2","2","Crystal structure of Pim1 with Myricetin","KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPSKVDHHHHHH","Homo sapiens","PIM1","Proto-oncogene serine/threonine-protein kinase Pim-1","1","2O63"
"2O64",,"X-RAY DIFFRACTION",3.3,62.72,"VAPOR DIFFUSION, SITTING DROP",6.5,"NA ACETATE, IMIDAZOLE, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1158/1535-7163.MCT-06-0397","MYU","2O64",34.29,"2.44","2.44","Crystal structure of Pim1 with Quercetagetin","KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPSKVDHHHHHH","Homo sapiens","PIM1","Proto-oncogene serine/threonine-protein kinase Pim-1","1","2O64"
"2O65",,"X-RAY DIFFRACTION",3.34,63.17,"VAPOR DIFFUSION, SITTING DROP",6.5,"NA ACETATE, IMIDAZOLE, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1158/1535-7163.MCT-06-0397","MYF","2O65",34.2,"2.85","2.85","Crystal structure of Pim1 with Pentahydroxyflavone","KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPSKVDHHHHHH","Homo sapiens","PIM1","Proto-oncogene serine/threonine-protein kinase Pim-1","1","2O65"
"2O6G",,"X-RAY DIFFRACTION",4.82,74.47,"VAPOR DIFFUSION, HANGING DROP",8,"100 mM Tris, 20% (w/v) PEG 6000, 500 mM NH4OAc, 100 mM NaCl, 5 mM MgCl2, 5% glycerol, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 294K",294,"10.1016/j.cell.2007.05.019",,"2O6G",91.72,"3.1","3.1","Crystal structure of IRF-3 bound to the interferon-b enhancer","TAAATGACATAGGGAAACTGAAAGGGAAAGTGAAAGTGGGAAATTCCTCTGAATAGA",,,"interferon-b enhancer","1","2O6G"
,,,,,,,,,,,,,,,,"ATCTATTCAGAGGAATTTCCCACTTTCACTTTCCCTTTCAGTTTCCCTATGTCATTT",,,"interferon-b enhancer","2","2O6G"
,,,,,,,,,,,,,,,,"MGTPKPRILPWLVSQLDLGQLEGVAWVNKSRTRFRIPWKHGLRQDAQQEDFGIFQAWAEATGAYVPGRDKPDLPTWKRNFRSALNRKEGLRLAEDRSKDPHDPHKIYEFVNSGVGDFSQPDTS","Homo sapiens","IRF3","Interferon regulatory factor 3","3","2O6G"
"2O6L",,"X-RAY DIFFRACTION",2.05,39.97,"VAPOR DIFFUSION, HANGING DROP",7.4,"12-16% PEG 4000, 100 mM K2CO3, 100 mM Tris, pH 7.4, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1016/j.jmb.2007.03.066",,"2O6L",38.25,"1.8","1.8","Crystal Structure of the UDP-Glucuronic Acid Binding Domain of the Human Drug Metabolizing UDP-Glucuronosyltransferase 2B7","SNAAKPLPKEMEDFVQSSGENGVVVFSLGSMVSNMTEERANVIASALAQIPQKVLWRFDGNKPDTLGLNTRLYKWIPQNDLLGHPKTRAFITHGGANGIYEAIYHGIPMVGIPLFADQPDNIAHMKARGAAVRVDFNTMSSTDLLNALKRVINDPSYKENVMKLSRIQHD","Homo sapiens","UGT2B7, UGTB2B9","UDP-glucuronosyltransferase 2B7","1","2O6L"
"2O6V",,"X-RAY DIFFRACTION",2.31,46.65,"VAPOR DIFFUSION, HANGING DROP",6.5,"2M ammonium sulfate, 4% PEG 400, 0.1M MES, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 298.0K",298,"10.1016/j.jmb.2006.12.065",,"2O6V",69.59,"2.2","2.2","Crystal structure and solution NMR studies of Lys48-linked tetraubiquitin at neutral pH","MQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGG","Homo sapiens","UBC","Ubiquitin","1","2O6V"
,,,,,,,,,,,,,,,,"MQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQRESTLHLVLRLRGG","Homo sapiens","UBC","Ubiquitin","2","2O6V"
,,,,,,,,,,,,,,,,"MQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGRQLEDGRTLSDYNIQRESTLHLVLRLRGG","Homo sapiens","UBC","Ubiquitin","3","2O6V"
"2O71",,"X-RAY DIFFRACTION",2.25,45.27,"VAPOR DIFFUSION, HANGING DROP",,"1 ml of protein solution (4-6 mg/ml in 20 mM Tris at pH 8.0, 150 mM NaCl, mixed with 1 ml of a reservoir solution 2M Na/K phosphate at pH 7.0, VAPOR DIFFUSION, HANGING DROP",,"10.1016/j.jmb.2005.12.082",,"2O71",13.22,"2","2","Crystal structure of RAIDD DD","MTDLPAGDRLTGIPSHILNSSPSDRQINQLAQRLGPEWEPMVLSLGLSQTDIYRCKANHPHNVQSQVVEAFIRWRQRFGKQATFQSLHNGLRAVEVDPSLLLHMLEELEHHHHHH","Homo sapiens","CRADD, RAIDD","Death domain-containing protein CRADD","1","2O71"
"2O72",,"X-RAY DIFFRACTION",3.38,63.65,"VAPOR DIFFUSION, HANGING DROP",7.5,"10% PEG 8000, 0.2M calcium chloride, 5% DMSO, 0.1M Hepes, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 4K, temperature 277K",277,"10.1016/j.jmb.2007.08.011",,"2O72",23.34,"2","2","Crystal Structure Analysis of human E-cadherin (1-213)","DWVIPPISSPENEKGPFPKNLVQIKSNKDKEGKVFYSITGQGADTPPVGVFIIERETGWLKVTEPLDRERIATYTLFSHAVSSNGNAVEDPMEILITVTDQNDNKPEFTQEVFKGSVMEGALPGTSVMEVTATDADDDVNTYNAAIAYTILSQDPELPDKNMFTINRNTGVISVVTTGLDRESFPTYTLVVQAADLQGEGLSTTATAVITVTD","Homo sapiens","CDH1, CDHE, UVO","Epithelial-cadherin","1","2O72"
"2O7N",,"X-RAY DIFFRACTION",2.54,51.5,,8.9,"78% (W/V) SODIUM CITRATE, 3% (V/V) ETHYLENE GLYCOL, 0.1 M SODIUM CITRATE, PH 5.6 (FINAL PH 8.9), VAPOR DIFFUSION, HANGING DROP, temperature 293K, pH 8.90",293,"10.1016/j.bmcl.2007.01.036","2O7","2O7N",21.34,"1.75","1.75","CD11A (LFA1) I-domain complexed with 7A-[(4-cyanophenyl)methyl]-6-(3,5-dichlorophenyl)-5-oxo-2,3,5,7A-tetrahydro-1H-pyrrolo[1,2-A]pyrrole-7-carbonitrile","GSHMNVDLVFLFDGSMSLQPDEFQKILDFMKDVMKKLSNTSYQFAAVQFSTSYKTEFDFSDYVKRKDPDALLKHVKHMLLLTNTFGAINYVATEVFREELGARPDATKVLIIITDGEATDSGNIDAAKDIIRYIIGIGKHFQTKESQETLHKFASKPASEFVKILDTFEKLKDLFTELQKKIY","Homo sapiens","ITGAL, CD11A","Integrin alpha-L","1","2O7N"
"2O7U",,"X-RAY DIFFRACTION",2.63,53.22,"VAPOR DIFFUSION, HANGING DROP",7.4,"Protein: 35mg/ml, 0.1M ammonium bicarbonate. Well: 20% PEG 3350, 0.2 M potassium acetate, pH 7.4, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1107/S0907444907000182",,"2O7U",335.98,"2.8","2.8","Crystal structure of K206E/K296E mutant of the N-terminal half molecule of human transferrin","VPDKTVRWCAVSEHEATKCQSFRDHMKSVIPSDGPSVACVKKASYLDCIRAIAANEADAVTLDAGLVYDAYLAPNNLKPVVAEFYGSKEDPQTFYYAVAVVKKDSGFQMNQLRGKKSCHTGLGRSAGWNIPIGLLYCDLPEPRKPLEKAVANFFSGSCAPCADGTDFPQLCQLCPGCGCSTLNQYFGYSGAFKCLKDGAGDVAFVEHSTIFENLANKADRDQYELLCLDNTRKPVDEYKDCHLAQVPSHTVVARSMGGKEDLIWELLNQAQEHFGKDKSKEFQLFSSPHGKDLLFEDSAHGFLKVPPRMDAKMYLGYEYVTAIRNLREGTCPEAPTD","Homo sapiens","TF, PRO1400","Serotransferrin","1","2O7U"
"2O84",,"X-RAY DIFFRACTION",2.34,47.51,"VAPOR DIFFUSION, HANGING DROP",7.4,"Protein: 35mg/ml, 0.1M ammonium bicrbonate. Well: 18% PEG3350, 0.2M potassium acetate, pH 7.4, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1107/S0907444907000182",,"2O84",37.37,"2.6","2.6","Crystal structure of K206E mutant of N-lobe human transferrin","VPDKTVRWCAVSEHEATKCQSFRDHMKSVIPSDGPSVACVKKASYLDCIRAIAANEADAVTLDAGLVYDAYLAPNNLKPVVAEFYGSKEDPQTFYYAVAVVKKDSGFQMNQLRGKKSCHTGLGRSAGWNIPIGLLYCDLPEPRKPLEKAVANFFSGSCAPCADGTDFPQLCQLCPGCGCSTLNQYFGYSGAFKCLKDGAGDVAFVEHSTIFENLANKADRDQYELLCLDNTRKPVDEYKDCHLAQVPSHTVVARSMGGKEDLIWELLNQAQEHFGKDKSKEFQLFSSPHGKDLLFKDSAHGFLKVPPRMDAKMYLGYEYVTAIRNLREGTCPEAPTD","Homo sapiens","TF, PRO1400","Serotransferrin","1","2O84"
"2O8J",,"X-RAY DIFFRACTION",2.45,49.83,"VAPOR DIFFUSION, HANGING DROP",6.5,"peg 3350, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 300K",300,"10.1371/journal.pone.0008570","SAH","2O8J",132.43,"1.8","1.8","Human euchromatic histone methyltransferase 2","NRAIRTEKIICRDVARGYENVPIPCVNGVDGEPCPEDYKYISENCETSTMNIDRNITHLQHCTCVDDCSSSNCLCGQLSIRCWYDKDGRLLQEFNKIEPPLIFECNQACSCWRNCKNRVVQSGIKVRLQLYRTAKMGWGVRALQTIPQGTFICEYVGELISDAEADVREDDSYLFDLDNKDGEVYCIDARYYGNISRFINHLCDPNIIPVRVFMLHQDLRFPRIAFFSSRDIRTGEELGFDYGDRFWDIKSKYFTCQCGSEKCKHSAEAIALEQSRLARLD","Homo sapiens","EHMT2, BAT8, G9A, NG36, C6orf30, KMT1C","Histone-lysine N-methyltransferase, H3 lysine-9 specific 3","1","2O8J"
"2O8T",,"X-RAY DIFFRACTION",2.11,41.61,"VAPOR DIFFUSION, SITTING DROP",4.5,"0.05M sodium citrate (pH4.5) buffer, 1.95M (NH4)2SO4, 0.05% NaN3, 5% PEG400, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,,,"2O8T",29.22,"1.45","1.45","Crystal Structure and Binding Epitopes of Urokinase-type Plasminogen Activator (C122A/N145Q) in complex with Inhibitors","IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTIALPSMYNDPQFGTSCEITGFGKEQSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHTKEENGLAL","Homo sapiens","PLAU","Urokinase plasminogen activator","1","2O8T"
"2O8U",,"X-RAY DIFFRACTION",2.06,40.33,"VAPOR DIFFUSION, SITTING DROP",4.5,"0.05M sodium citrate (pH4.5) buffer, 1.95M (NH4)2SO4, 0.05% NaN3, 5% PEG400, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,,,"2O8U",29.06,"1.7","1.7","Crystal Structure and Binding Epitopes of Urokinase-type Plasminogen Activator (C122A/N145Q/S195A) in complex with Inhibitors","IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTIALPSMYNDPQFGTSCEITGFGKEQSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDAGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHTKEENGLAL","Homo sapiens","PLAU","Urokinase plasminogen activator","1","2O8U"
"2O8W",,"X-RAY DIFFRACTION",2.11,41.58,"VAPOR DIFFUSION, SITTING DROP",4.5,"0.05M sodium citrate (pH4.5) buffer, 1.95M (NH4)2SO4, 0.05% NaN3, 5% PEG400, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,,"PL0","2O8W",28.85,"1.86","1.86","Crystal Structure and Binding Epitopes of Urokinase-type Plasminogen Activator (C122A/N145Q/S195A) in complex with Inhibitors","IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTIALPSMYNDPQFGTSCEITGFGKEQSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDAGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHTKEENGLAL","Homo sapiens","PLAU","Urokinase plasminogen activator","1","2O8W"
"2O8Y",,"X-RAY DIFFRACTION",2.77,55.53,"VAPOR DIFFUSION, HANGING DROP",7.5,"1 uL protein(14.5 mg/mL in 50 mM Tris-HCl pH 7.6, 250 mM NaCl, 250 mM TCEP, and 100 mM EDTA supplemented with 2 mM ADP and 4 mM MgCl2 prior to crystallization) and 1 uL of reservoir solution (100 mM HEPES pH 7.5, 20-25% PEG 3350, 200 mM ammonium sulfate), VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"2O8Y",67.99,"2.4","2.4","Apo IRAK4 Kinase Domain","TRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS","Homo sapiens","IRAK4","Interleukin-1 receptor-associated kinase 4","1","2O8Y"
"2O93",,"X-RAY DIFFRACTION",3,58.95,"VAPOR DIFFUSION, HANGING DROP",7,"50mM Hepes pH 7.0, 15mM Magnesium Acetate, 250mM Ammonium Acetate, 7.5% PEG 4000, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1016/j.str.2008.01.020",,"2O93",118.04,"3.05","3.05","Crystal structure of NFAT bound to the HIV-1 LTR tandem kappaB enhancer element","AGGGACTTTCCGCTGGGGACTTTCC",,,"kappaB enhancer element, DNA 25-mer","1","2O93"
,,,,,,,,,,,,,,,,"TGGAAAGTCCCCAGCGGAAAGTCCC",,,"kappaB enhancer element, DNA 25-mer","2","2O93"
,,,,,,,,,,,,,,,,"MRGSHHHHHHTAPHASSVPLEWPLSSQSGSYELRIEVQPKPHHRAHYETEGSRGAVKAPTGGHPVVQLHGYMENKPLGLQIFIGTADERILKPHAFYQVHRITGKTVTTTSYEKIVGNTKVLEIPLEPKNNMRATIDCAGILKLRNADIELRKGETDIGRKNTRVRLVFRVHIPESSGRIVSLQTASNPIECSQRSAHELPMVERQDTDSCLVYGGQQMILTGQNFTSESKVVFTEKTTDGQQIWEMEATVDKDKSQPNMLFVEIPEYRNKHIRTPVKVNFYVINGKRKRSQPQHFTYHPV","Homo sapiens","NFATC2, NFAT1, NFATP","actor of activated T-cells, cytoplasmic 2","3","2O93"
"2O94",,"X-RAY DIFFRACTION",3.05,59.71,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.540M LITHIUM SULFATE 55mM HEPES PH7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1073/pnas.0608041104",,"2O94",54.65,"3","3","The 97H/F mutant Structure of a glutamine-rich domain from histone deacetylase 4","GSSHHHHHHSSGLVPRGSHMAEPALREQQLQQELLALKQKQQIQRQILIAEFQRQFEQLSRQHEAQLHEHIKQQQEMLAMKHQQELLEHQRKLERHRQEQELEKQHREQKLQ","Homo sapiens","HDAC4, KIAA0288","Histone deacetylase 4","1","2O94"
"2O95",,"X-RAY DIFFRACTION",3.25,62.2,"VAPOR DIFFUSION, HANGING DROP",4.2,"0.1M phosphate-citrate buffer, 20% PEG 1000, 0.2M LiSO4, 10mM MnCl2 as additive, pH 4.2, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1016/j.jmb.2007.04.084",,"2O95",44,"1.95","1.95","Crystal Structure of the Metal-Free Dimeric Human Mov34 MPN domain (residues 1-186)","GMPELAVQKVVVHPLVLLSVVDHFNRIGKVGNQKRVVGVLLGSWQKKVLDVSNSFAVPFDEDDKDDSVWFLDHDYLENMYGMFKKVNARERIVGWYHTGPKLHKNDIAINELMKRYCPNSVLVIIDVKPKDLGLPTEAYISVEEVHDDGTPTSKTFEHVTSEIGAEEAEEVGVEHLLRDIKDTTVGT","Homo sapiens","PSMD7, MOV34L","26S proteasome non-ATPase regulatory subunit 7","1","2O95"
"2O96",,"X-RAY DIFFRACTION",3.53,65.12,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.1M citrate, 0,2M NH4OAc, 30% PEG 4000, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1016/j.jmb.2007.04.084",,"2O96",40.3,"3","3","Crystal Structure of the Metal-Free Dimeric Human Mov34 MPN domain (residues 1-177)","GMPELAVQKVVVHPLVLLSVVDHFNRIGKVGNQKRVVGVLLGSWQKKVLDVSNSFAVPFDEDDKDDSVWFLDHDYLENMYGMFKKVNARERIVGWYHTGPKLHKNDIAINELMKRYCPNSVLVIIDVKPKDLGLPTEAYISVEEVHDDGTPTSKTFEHVTSEIGAEEAEEVGVEHLLR","Homo sapiens","PSMD7, MOV34L","26S proteasome non-ATPase regulatory subunit 7","1","2O96"
"2O9I",,"X-RAY DIFFRACTION",2.83,56.5,"VAPOR DIFFUSION, HANGING DROP",7.1,"50 mM Imidizole, 10% 2-propanol (v/v), pH 7.1, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1016/j.bmc.2006.12.026","444","2O9I",72.07,"2.8","2.8","Crystal Structure of the Human Pregnane X Receptor LBD in complex with an SRC-1 coactivator peptide and T0901317","GLTEEQRMMIRELMDAQMKTFDTTFSHFKNFRLPGVLSSGCELPESLQAPSREEAAKWSQVRKDLCSLKVSLQLRGEDGSVWNYKPPADSGGKEIFSLLPHMADMSTYMFKGIISFAKVISYFRDLPIEDQISLLKGAAFELSQLRFNTVFNAETGTWECGRLSYCLEDTAGGFQQLLLEPMLKFHYMLKKLQLHEEEYVLMQAISLFSPDRPGVLQHRVVDQLQEQFAITLKSYIECNRPQPAHRFLFLKIMAMLTELRSINAQHTQRLLRIQDIHPFATPLMQELFGITGS","Homo sapiens","NR1I2, PXR","Orphan nuclear receptor PXR","1","2O9I"
,,,,,,,,,,,,,,,,"SLTERHKILHRLLQE",,,"Nuclear Receptor Coactivator 1 isoform 3","2","2O9I"
"2O9K",,"X-RAY DIFFRACTION",2.2,44.14,"VAPOR DIFFUSION, HANGING DROP",6.5,"20% PEG 5000 MME, 0.1M BIS-TRIS, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 300K, pH 6.50",300,"10.1038/sj.emboj.7601316",,"2O9K",71.31,"1.9","1.9","WDR5 in Complex with Dimethylated H3K4 Peptide","GSTQSKPTPVKPNYALKFTLAGHTKAVSSVKFSPNGEWLASSSADKLIKIWGAYDGKFEKTISGHKLGISDVAWSSDSNLLVSASDDKTLKIWDVSSGKCLKTLKGHSNYVFCCNFNPQSNLIVSGSFDESVRIWDVKTGKCLKTLPAHSDPVSAVHFNRDGSLIVSSSYDGLCRIWDTASGQCLKTLIDDDNPPVSFVKFSPNGKYILAATLDNTLKLWDYSKGKCLKTYTGHKNEKYCIFANFSVTGGKWIVSGSEDNLVYIWNLQTKEIVQKLQGHTDVVISTACHPTENIIASAALENDKTIKLWKSDC","Homo sapiens","WDR5, BIG3","WD repeat protein 5","1","2O9K"
,,,,,,,,,,,,,,,,"ARTKQTARKST",,,"H3 HISTONE","2","2O9K"
"2O9S",,"X-RAY DIFFRACTION",2.03,39.4,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.5M KSCN, 0.1M Tris/HCl, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 292K",292,"10.1016/j.jmb.2007.03.050",,"2O9S",7.87,"0.83","0.83","The second SH3 domain from ponsin","GIDPFTGEAIAKFNFNGDTQVEMSFRKGERITLLRQVDENWYEGRIPGTSRQGIFPITYVDVIKRPL","Homo sapiens","SORBS1, KIAA0894, KIAA1296, SH3D5","Ponsin","1","2O9S"
"2O9V",,"X-RAY DIFFRACTION",1.74,29.11,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.2M Sodium Acetate, 0.1M Sodium Cacodylate, 30% (w/v) PEG 8000, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 292K",292,"10.1016/j.jmb.2007.03.050",,"2O9V",8.68,"1.63","1.63","The second SH3 domain from Ponsin in complex with the paxillin proline rich region","GIDPFTGEAIAKFNFNGDTQVEMSFRKGERITLLRQVDENWYEGRIPGTSRQGIFPITYVDVIKRPL","Homo sapiens","SORBS1, KIAA0894, KIAA1296, SH3D5","Ponsin","1","2O9V"
,,,,,,,,,,,,,,,,"VPPPVPPPPS",,,"Paxillin","2","2O9V"
"2OAG",,"X-RAY DIFFRACTION",2.85,56.8,"VAPOR DIFFUSION, HANGING DROP",,"VAPOR DIFFUSION, HANGING DROP",,"10.1016/j.bmcl.2007.01.026","DLI","2OAG",337.46,"2.3","2.3","Crystal structure of human dipeptidyl peptidase IV (DPPIV) with pyrrolidine-constrained phenethylamine 29g","SRKTYTLTDYLKNTYRLKLYSLRWISDHEYLYKQENNILVFNAEYGNSSVFLENSTFDEFGHSINDYSISPDGQFILLEYNYVKQWRHSYTASYDIYDLNKRQLITEERIPNNTQWVTWSPVGHKLAYVWNNDIYVKIEPNLPSYRITWTGKEDIIYNGITDWVYEEEVFSAYSALWWSPNGTFLAYAQFNDTEVPLIEYSFYSDESLQYPKTVRVPYPKAGAVNPTVKFFVVNTDSLSSVTNATSIQITAPASMLIGDHYLCDVTWATQERISLQWLRRIQNYSVMDICDYDESSGRWNCLVARQHIEMSTTGWVGRFRPSEPHFTLDGNSFYKIISNEEGYRHICYFQIDKKDCTFITKGTWEVIGIEALTSDYLYYISNEYKGMPGGRNLYKIQLSDYTKVTCLSCELNPERCQYYSVSFSKEAKYYQLRCSGPGLPLYTLHSSVNDKGLRVLEDNSALDKMLQNVQMPSKKLDFIILNETKFWYQMILPPHFDKSKKYPLLLDVYAGPCSQKADTVFRLNWATYLASTENIIVASFDGRGSGYQGDKIMHAINRRLGTFEVEDQIEAARQFSKMGFVDNKRIAIWGWSYGGYVTSMVLGSGSGVFKCGIAVAPVSRWEYYDSVYTERYMGLPTPEDNLDHYRNSTVMSRAENFKQVEYLLIHGTADDNVHFQQSAQISKALVDVGVDFQAMWYTDEDHGIASSTAHQHIYTHMSHFIKQCFS","Homo sapiens","DPP4, ADCP2, CD26","Dipeptidyl peptidase 4","1","2OAG"
"2OAH",,"X-RAY DIFFRACTION",2.83,56.49,"VAPOR DIFFUSION, SITTING DROP",7.5,"1.5M LITHIUM SULFATE, 0.1M HEPES BUFFER, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K, PH 7.50. Crystals were grown with L124671 and L304507 was back soak, temperature 273K",273,"10.1016/j.bmcl.2006.12.051","QIN","2OAH",45.63,"1.8","1.8","Crystal Structure of Human Beta Secretase Complexed with inhibitor","MLPRETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGAWAGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYN","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","2OAH"
"2OAT",,"X-RAY DIFFRACTION",2.65,50.9,,7.9,"(2S,5S)5FMORN-OAT WAS CO-CRYSTALLIZED FROM 6-10% PEG 6000, 1MM DTT, 120-160 MM NACL, 10-20% GLYCEROL, 50 MM TRICIN, PH 7.9.",,"10.1006/jmbi.1998.2289",,"2OAT",146.9,"1.95","1.95","ORNITHINE AMINOTRANSFERASE COMPLEXED WITH 5-FLUOROMETHYLORNITHINE","MFSKLAHLQRFAVLSRGVHSSVASATSVATKKTVQGPPTSDDIFEREYKYGAHNYHPLPVALERGKGIYLWDVEGRKYFDFLSSYSAVNQGHCHPKIVNALKSQVDKLTLTSRAFYNNVLGEYEEYITKLFNYHKVLPMNTGVEAGETACKLARKWGYTVKGIQKYKAKIVFAAGNFWGRTLSAISSSTDPTSYDGFGPFMPGFDIIPYNDLPALERALQDPNVAAFMVEPIQGEAGVVVPDPGYLMGVRELCTRHQVLFIADEIQTGLARTGRWLAVDYENVRPDIVLLGKALSGGLYPVSAVLCDDDIMLTIKPGEHGSTYGGNPLGCRVAIAALEVLEEENLAENADKLGIILRNELMKLPSDVVTAVRGKGLLNAIVIKETKDWDAWKVCLRLRDNGLLAKPTHGDIIRFAPPLVIKEDELRESIEIINKTILSF","Homo sapiens","OAT","ORNITHINE AMINOTRANSFERASE","1","2OAT"
"2OAX",,"X-RAY DIFFRACTION",2.22,44.59,"VAPOR DIFFUSION, HANGING DROP",6.8,"HEPES 100 mM, pH 6.8, 230 mM NaCl, 25% PEG4000, VAPOR DIFFUSION, HANGING DROP, temperature 297K",297,"10.1124/mol.107.036459","SNL","2OAX",180.71,"2.29","2.29","Crystal structure of the S810L mutant mineralocorticoid receptor associated with SC9420","GSSRALTPSPVMVLENIEPEIVYAGYDSSKPDTAENLLSTLNRLAGKQMIQVVKWAKVLPGFKNLPLEDQITLIQYSWMCLLSFALSWRSYKHTNSQFLYFAPDLVFNEEKMHQSAMYELCQGMHQISLQFVRLQLTFEEYTIMKVLLLLSTIPKDGLKSQAAFEEMRTNYIKELRKMVTKAPNNSGQSWQRFYQLTKLLDSMHDLVSDLLEFCFYTFRESHALKVEFPAMLVEIISDQLPKVESGNAKPLYFHRK","Homo sapiens","NR3C2, MCR, MLR","Mineralocorticoid receptor","1","2OAX"
"2OAY",,"X-RAY DIFFRACTION",3.04,59.59,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.85 M NaH2PO4, 0.85 M KH2PO4, 0.1 M HEPES, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1074/jbc.M700841200",,"2OAY",44.4,"2.35","2.35","Crystal structure of latent human C1-inhibitor","YVHHHHHHTGSFCPGPVTLCSDLESHSTEAVLGDALVDFSLKLYHAFSAMKKVETNMAFSPFSIASLLTQVLLGAGENTKTNLESILSYPKDFTCVHQALKGFTTKGVTSVSQIFHSPDLAIRDTFVNASRTLYSSSPRVLSNNSDANLELINTWVAKNTNNKISRLLDSLPSDTRLVLLNAIYLSAKWKTTFDPKKTRMEPFHFKNSVIKVPMMNSKKYPVAHFIDQTLKAKVGQLQLSHNLSLVILVPQNLKHRLEDMEQALSPSVFKAIMEKLEMSKFQPTLLTLPRIKVTTSQDMLSIMEKLEFFDFSYDLNLCGLTEDPDLQVSAMQHQTVLELTETGVEAAAASAISVARTLLVFEVQQPFLFMLWDQQHKFPVFMGRVYDPRA","Homo sapiens","SERPING1, C1IN, C1NH","Plasma protease C1 inhibitor","1","2OAY"
"2OAZ",,"X-RAY DIFFRACTION",2.72,54.83,,,,,"10.1021/jm061182w","I96","2OAZ",41.82,"1.9","1.9","Human Methionine Aminopeptidase-2 Complexed with SB-587094","KVQTDPPSVPICDLYPNGVFPKGQECEYPPTQDGRTAAWRTTSEEKKALDQASEEIWNDFREAAEAHRQVRKYVMSWIKPGMTMIEICEKLEDCSRKLIKENGLNAGLAFPTGCSLNNCAAHYTPNAGDTTVLQYDDICKIDFGTHISGRIIDCAFTVTFNPKYDTLLKAVKDATNTGIKCAGIDVRLCDVGEAIQEVMESYEVEIDGKTYQVKPIRNLNGHSIGQYRIHAGKTVPIIKGGEATRMEEGEVYAIETFGSTGKGVVHDDMECSHYMKNFDVGHVPIRLPRTKHLLNVINENFGTLAFCRRWLDRLGESKYLMALKNLCDLGIVDPYPPLCDIKGSYTAQFEHTILLRPTCKEVVSRGDDY","Homo sapiens","METAP2, MNPEP, P67EIF2","human Methionine Amino Peptidase 2","1","2OAZ"
"2OB0",,"X-RAY DIFFRACTION",2.7,54.44,,7.5,"Reservoir: 0.1 M Sodium acetate pH 5.0, 16% PEG3350, 10 mM DTT, 0.1% Dioxane. Protein: 11.8 mg/mL + 3-fold molar excess of ACOA in 20 mM Hepes pH 7.5, 0.1 M NaCl, 2.5 % 1,2-propandiol, and 10 mM DTT. Cryo: 75% reservoir + 25% MPD, VAPOR DIFFUSION, HANGING DROP, temperature 298K, pH 7.50",298,,,"2OB0",61.03,"1.8","1.8","Human MAK3 homolog in complex with Acetyl-CoA","GSKGSRIELGDVTPHNIKQLKRLNQVIFPVSYNDKFYKDVLEVGELAKLAYFNDIAVGAVCCRVDHSQNQKRLYIMTLGCLAPYRRLGIGTKMLNHVLNICEKDGTFDNIYLHVQISNESAIDFYRKFGFEIIETKKNYYKRIEPADAHVLQKNLKVPSGQNADVQKTDN","Homo sapiens","NAT13, NAA50, MAK3, NAT5","Human MAK3 homolog","1","2OB0"
"2OB4",,"X-RAY DIFFRACTION",2.13,42.21,"VAPOR DIFFUSION, HANGING DROP",8.5,"The protein was dissolved at 42 mg/ml in 20 mM Tris-HCl, pH 8.0, 0.15 M NaCl, 5% glycerol and 2 mM DTT. Crystals were grown in hanging drops by mixing 2 microL protein solution with 2 microL well solution (28% PEG 4000, 0.1 M Tris-HCl, pH 8.5, 0.2 M MgCl2, 1 mM DTT and 7.5 mM glycyl-glycyl-glycine) at 21 deg C. For cryoprotection, the crystals were soaked in the well solution supplemented with 25% ethylene glycol, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1074/mcp.O111.013706",,"2OB4",20.5,"2.4","2.4","Human Ubiquitin-Conjugating Enzyme CDC34","GSPSSQKALLLELKGLQEEPVEGFRVTLVDEGDLYNWEVAIFGPPNTYYEGGYFKARLKFPIDYPYSPPAFRFLTKMWHPNIYETGDVCISILHPPVDDPQSGELPSERWNPTQNVRTILLSVISLLNEPNTFSPANVDASVMYRKWKESKGKDREYTDIIRKQVLGTKVDAERDGVKVP","Homo sapiens","CDC34, UBE2R1, UBCH3","Ubiquitin-conjugating enzyme E2-32 kDa complementing","1","2OB4"
"2OBD",,"X-RAY DIFFRACTION",4.15,70.34,"VAPOR DIFFUSION, HANGING DROP",7.5,"~30% PDE 400, 0.2M MgCl2, HEPES 0.1M, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1038/nsmb1197",,"2OBD",57.49,"2.1","2.1","Crystal Structure of Cholesteryl Ester Transfer Protein","ASKGTSHEAGIVCRITKPALLVLNHETAKVIQTAFQRASYPDITGEKAMMLLGQVKYGLHNIQISHLSIASSQVELVEAKSIDVSIQDVSVVFKGTLKYGYTTAWWLGIDQSIDFEIDSAIDLQINTQLTADSGRVRTDAPDCYLSFHKLLLHLQGEREPGWIKQLFTNFISFTLKLVLKGQICKEINVISNIMADFVQTRAASILSDGDIGVDISLTGDPVITASYLESHHKGHFIYKDVSEDLPLPTFSPTLLGDSRMLYFWFSERVFHSLAKVAFQDGRLMLSLMGDEFKAVLETWGFNTNQEIFQEVVGGFPSQAQVTVHCLKMPKISCQNKGVVVDSSVMVKFLFPRPDQQHSVAYTFEEDIVTTVQASYSKKKLFLSLLDFQITPKTVSNLTESSSESIQSFLQSMITAVGIPEVMSRLEVVFTALMNSKGVSLFDIINPEIITRDGFLLLQMDFGFPEHLLVDFLQSLS","Homo sapiens","CETP","Cholesteryl ester transfer protein","1","2OBD"
"2OBF",,"X-RAY DIFFRACTION",3.32,62.91,"VAPOR DIFFUSION, HANGING DROP",5.5,"6% PEG6K, 0.25M LiCl, 0.1M cacodylate, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/jm0703385","F83, SAH","2OBF",65.05,"2.3","2.3","Structure of K57A hPNMT with inhibitor 3-Hydroxymethyl-7-(N-4-chlorophenylaminosulfonyl)-THIQ and AdoHcy (SAH)","MSGADRSPNAGAAPDSAPGQAAVASAYQRFEPRAYLRNNYAPPRGDLCNPNGVGPWALRCLAQTFATGEVSGRTLIDIGSGPTVYQLLSACSHFEDITMTDFLEVNRQELGRWLQEEPGAFNWSMYSQHACLIEGKGECWQDKERQLRARVKRVLPIDVHQPQPLGAGSPAPLPADALVSAFCLEAVSPDLASFQRALDHITTLLRPGGHLLLIGALEESWYLAGEARLTVVPVSEEEVREALVRSGYKVRDLRTYIMPAHLQTGVDDVKGVFFAWAQKVGLEHHHHHH","Homo sapiens","PNMT, PENT","Phenylethanolamine N-methyltransferase","1","2OBF"
"2OBH",,"X-RAY DIFFRACTION",2.52,51.15,"VAPOR DIFFUSION, SITTING DROP",9,"30% MPEG 550, 0.1M NaCl, 0.1M Bicine pH 9.0, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1016/j.jmb.2007.08.046",,"2OBH",37.42,"1.8","1.8","Centrin-XPC peptide","TEEQKQEIREAFDLFDADGTGTIDVKELKVAMRALGFEPKKEEIKKMISEIDKEGTGKMNFGDFLTVMTQKMSEKDTKEEILKAFKLFDDDETGKISFKNLKRVAKELGENLTDEELQEMIDEADRDGDGEVSEQEFLRIMKK","Homo sapiens","CETN2, CALT, CEN2","Centrin-2","1","2OBH"
,,,,,,,,,,,,,,,,"XNWKLLAKGLLIRERLKR",,,"DNA-repair protein complementing XP-C cells","2","2OBH"
"2OBI",,"X-RAY DIFFRACTION",3.17,61.22,"VAPOR DIFFUSION, HANGING DROP",6.5,"15% PEG 8000, 0.1M MES buffer, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1021/bi700840d",,"2OBI",20.96,"1.55","1.55","Crystal structure of the Selenocysteine to Cysteine Mutant of human phospholipid hydroperoxide glutathione peroxidase (GPx4)","MRGSHHHHHHGSACCASRDDWRCARSMHEFSAKDIDGHMVNLDKYRGFVCIVTNVASQCGKTEVNYTQLVDLHARYAECGLRILAFPCNQFGKQEPGSNEEIKEFAAGYNVKFDMFSKICVNGDDAHPLWKWMKIQPKGKGILGNAIKWNFTKFLIDKNGCVVKRYGPMEEPLVIEKDLPHYF","Homo sapiens","GPX4","Phospholipid hydroperoxide glutathione peroxidase (GPX4)","1","2OBI"
"2OBJ",,"X-RAY DIFFRACTION",2.9,57.65,"VAPOR DIFFUSION, SITTING DROP",5,"1M ammonium phosphate (dibasic), 300mM NaCl, 100mM citrate buffer, pH 5.0, VAPOR DIFFUSION, SITTING DROP, temperature 296K",296,"10.1016/j.bmcl.2006.12.086","VRV","2OBJ",38.35,"2.5","2.5","Crystal structure of human PIM-1 Kinase in complex with inhibitor","MGSSHHHHHHSSGLVPRGSHMLLSKINSLAHLRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPSK","Homo sapiens","PIM1","Proto-oncogene serine/threonine-protein kinase Pim-1","1","2OBJ"
"2OBV",,"X-RAY DIFFRACTION",2.14,42.54,"VAPOR DIFFUSION, SITTING DROP",8,"200 mM NaF, 20 % PEG 3350, 10 % ethylene glycol, pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,,,"2OBV",43.67,"2.05","2.05","Crystal structure of the human S-adenosylmethionine synthetase 1 in complex with the product","FQSMGVFMFTSESVGEGHPDKICDQISDAVLDAHLKQDPNAKVACETVCKTGMVLLCGEITSMAMVDYQRVVRDTIKHIGYDDSAKGFDFKTCNVLVALEQQSPDIAQCVHLDRNEEDVGAGDQGLMFGYATDETEECMPLTIILAHKLNARMADLRRSGLLPWLRPDSKTQVTVQYMQDNGAVIPVRIHTIVISVQHNEDITLEEMRRALKEQVIRAVVPAKYLDEDTVYHLQPSGRFVIGGPQGDAGVTGRKIIVDTYGGWGAHGGGAFSGKDYTKVDRSAAYAARWVAKSLVKAGLCRRVLVQVSYAIGVAEPLSISIFTYGTSQKTERELLDVVHKNFDLRPGVIVRDLDLKKPIYQKTACYGHFGRSEFPWEVPRKLVF","Homo sapiens","MAT1A, AMS1, MATA1","S-adenosylmethionine synthetase isoform type-1","1","2OBV"
"2OBY",,"X-RAY DIFFRACTION",2.78,55.68,"VAPOR DIFFUSION, HANGING DROP",8.5,"30 % PEG 4000, 0.1 M Tris, 0.2 M sodium acetate, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,,,"2OBY",184.12,"3","3","Crystal structure of Human P53 inducible oxidoreductase (TP53I3,PIG3)","GSPGIPMLAVHFDKPGGPENLYVKEVAKPSPGEGEVLLKVAASALNRADLMQRQGQYDPPPGASNILGLEASGHVAELGPGCQGHWKIGDTAMALLPGGGQAQYVTVPEGLLMPIPEGLTLTQAAAIPEAWLTAFQLLHLVGNVQAGDYVLIHAGLSGVGTAAIQLTRMAGAIPLVTAGSQKKLQMAEKLGAAAGFNYKKEDFSEATLKFTKGAGVNLILDCIGGSYWEKNVNCLALDGRWVLYGLMGGGDINGPLFSKLLFKRGSLITSLLRSRDNKYKQMLVNAFTEQILPHFSTEGPQRLLPVLDRIYPVTEIQEAHKYMEANKNIGKIVLELPQ","Homo sapiens","TP53I3, PIG3","Putative quinone oxidoreductase","1","2OBY"
"2OC2",,"X-RAY DIFFRACTION",2.34,47.42,"VAPOR DIFFUSION, HANGING DROP",4.7,"13.5% PEG 4000, 0.12M Na Malonate, 90mM Na Acetate pH 4.7, 9uM Zn Acetate , VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1074/jbc.M110.167866","RX3","2OC2",69.05,"2.25","2.25","Structure of testis ACE with RXPA380","LVTDEAEASKFVEEYDRTSQVVWNEYAEANWNYNTNITTETSKILLQKNMQIANHTLKYGTQARKFDVNQLQNTTIKRIIKKVQDLERAALPAQELEEYNKILLDMETTYSVATVCHPNGSCLQLEPDLTNVMATSRKYEDLLWAWEGWRDKAGRAILQFYPKYVELINQAARLNGYVDAGDSWRSMYETPSLEQDLERLFQELQPLYLNLHAYVRRALHRHYGAQHINLEGPIPAHLLGNMWAQTWSNIYDLVVPFPSAPSMDTTEAMLKQGWTPRRMFKEADDFFTSLGLLPVPPEFWNKSMLEKPTDGREVVCHASAWDFYNGKDFRIKQCTTVNLEDLVVAHHEMGHIQYFMQYKDLPVALREGANPGFHEAIGDVLALSVSTPKHLHSLNLLSSEGGSDEHDINFLMKMALDKIAFIPFSYLVDQWRWRVFDGSITKENYNQEWWSLRLKYQGLCPPVPRTQGDFDPGAKFHIPSSVPYIRYFVSFIIQFQFHEALCQAAGHTGPLHKCDIYQSKEAGQRLATAMKLGFSRPWPEAMQLITGQPNMSASAMLSYFKPLLDWLRTENELHGEKLGWPQYNWTPNSAR","Homo sapiens","ACE, DCP, DCP1","Angiotensin-converting enzyme, somatic isoform","1","2OC2"
"2OC3",,"X-RAY DIFFRACTION",2.06,40.24,,6.8,"0.1M HEPES, 25% PEG-3350, 6% Jeffamine M-600, pH 6.8, temperature 277K",277,"10.1016/j.cell.2008.11.038",,"2OC3",34.3,"1.5","1.5","Crystal Structure of the Catalytic Domain of Human Protein Tyrosine Phosphatase non-receptor Type 18","GPLGSPGIPDSARSFLERLEARGGREGAVLAGEFSDIQACSAAWKADGVCSTVAGSRPENVRKNRYKDVLPYDQTRVILSLLQEEGHSDYINGNFIRGVDGSLAYIATQGPLPHTLLDFWRLVWEFGVKVILMACREIENGRKRCERYWAQEQEPLQTGLFCITLIKEKWLNEDIMLRTLKVTFQKESRSVYQLQYMSWPDRGVPSSPDHMLAMVEEARRLQGSGPEPLCVHCSAGCGRTGVLCTVDYVRQLLLTQMIPPDFSLFDVVLKMRKQRPAAVQTEEQYRFLYHTVAQMFCSTLQNA","Homo sapiens","PTPN18, BDP1","Tyrosine-protein phosphatase non-receptor type 18","1","2OC3"
"2OC4",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, SITTING DROP",4.6,"0.1 M Sodium Acetate, 4.0 M Ammonium Acetate, pH 4.6, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1021/bi700147b","IMH","2OC4",32.52,"2.592","2.592","Crystal structure of human purine nucleoside phosphorylase mutant H257D with Imm-H","MENGYTYEDYKNTAEWLLSHTKHRPQVAIICGSGLGGLTDKLTQAQIFDYSEIPNFPRSTVPGHAGRLVFGFLNGRACVMMQGRFHMYEGYPLWKVTFPVRVFHLLGVDTLVVTNAAGGLNPKFEVGDIMLIRDHINLPGFSGQNPLRGPNDERFGDRFPAMSDAYDRTMRQRALSTWKQMGEQRELQEGTYVMVAGPSFETVAECRVLQKLGADAVGMSTVPEVIVARHCGLRVFGFSLITNKVIMDYESLEKANDEEVLAAGKQAAQKLEQFVSILMASIPLPDKAS","Homo sapiens","NP, PNP","Purine nucleoside phosphorylase","1","2OC4"
"2OC9",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, SITTING DROP",4.6,"0.1 M Sodium Acetate, 4.0 M Ammonium Acetate, pH 4.6, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1021/bi700147b","IMH","2OC9",32.47,"2.59","2.59","Crystal structure of human purine nucleoside phosphorylase mutant H257G with Imm-H","MENGYTYEDYKNTAEWLLSHTKHRPQVAIICGSGLGGLTDKLTQAQIFDYSEIPNFPRSTVPGHAGRLVFGFLNGRACVMMQGRFHMYEGYPLWKVTFPVRVFHLLGVDTLVVTNAAGGLNPKFEVGDIMLIRDHINLPGFSGQNPLRGPNDERFGDRFPAMSDAYDRTMRQRALSTWKQMGEQRELQEGTYVMVAGPSFETVAECRVLQKLGADAVGMSTVPEVIVARHCGLRVFGFSLITNKVIMDYESLEKANGEEVLAAGKQAAQKLEQFVSILMASIPLPDKAS","Homo sapiens","NP, PNP","Purine nucleoside phosphorylase","1","2OC9"
"2OCB",,"X-RAY DIFFRACTION",3.5,65,"VAPOR DIFFUSION, HANGING DROP",7.5,"2M ammonium sulfate, 0.2M sodium chloride, 0.1M HEPES, pH 7.5, vapor diffusion, hanging drop, temperature 291K",291,,,"2OCB",21.11,"2.2","2.2","Crystal structure of human RAB9B in complex with a GTP analogue","GSGKSLLLKVILLGDGGVGKSSLMNRYVTNKFDSQAFHTIGVEFLNRDLEVDGRFVTLQIWDTAGQERFKSLRTPFYRGADCCLLTFSVDDRQSFENLGNWQKEFIYYADVKDPEHFPFVVLGNKVDKEDRQVTTEEAQTWCMENGDYPYLETSAKDDTNVTVAFEEAVRQVLAVEEQLE","Homo sapiens","RAB9B, RAB9L","Ras-related protein Rab-9B","1","2OCB"
"2OCG",,"X-RAY DIFFRACTION",3.42,63.98,"VAPOR DIFFUSION, SITTING DROP",7,"15% PEG 4,000, 0.1 M MOPS, 0.1 M MnSO4,                             pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1074/jbc.M709530200",,"2OCG",29.04,"1.75","1.75","Crystal structure of human valacyclovir hydrolase","SVTSAKVAVNGVQLHYQQTGEGDHAVLLLPGMLGSGETDFGPQLKNLNKKLFTVVAWDPRGYGHSRPPDRDFPADFFERDAKDAVDLMKALKFKKVSLLGWSDGGITALIAAAKYPSYIHKMVIWGANAYVTDEDSMIYEGIRDVSKWSERTRKPLEALYGYDYFARTCEKWVDGIRQFKHLPDGNICRHLLPRVQCPALIVHGEKDPLVPRFHADFIHKHVKGSRLHLMPEGKHNLHLRFADEFNKLAEDFLQ","Homo sapiens","BPHL, MCNAA","Valacyclovir hydrolase","1","2OCG"
"2OCI",,"X-RAY DIFFRACTION",3.4,63.84,"VAPOR DIFFUSION, SITTING DROP",7,"15-16% PEG 4,000, 0.1 M MOPS, 0.1 M MNSO4, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1074/jbc.M709530200",,"2OCI",29.13,"1.9","1.9","Crystal structure of valacyclovir hydrolase complexed with a product analogue","SVTSAKVAVNGVQLHYQQTGEGDHAVLLLPGMLGSGETDFGPQLKNLNKKLFTVVAWDPRGYGHSRPPDRDFPADFFERDAKDAVDLMKALKFKKVSLLGWSDGGITALIAAAKYPSYIHKMVIWGANAYVTDEDSMIYEGIRDVSKWSERTRKPLEALYGYDYFARTCEKWVDGIRQFKHLPDGNICRHLLPRVQCPALIVHGEKDPLVPRFHADFIHKHVKGSRLHLMPEGKHNLHLRFADEFNKLAEDFLQ","Homo sapiens","BPHL, MCNAA","Valacyclovir hydrolase","1","2OCI"
"2OCJ",,"X-RAY DIFFRACTION",2.05,40,"VAPOR DIFFUSION, SITTING DROP",7.6,"2 ul protein solution (5 mg/ml protein in 20 mM Tris, pH 7.6, 150 mM NaCl, 10 mM DTT) were mixed with 2 ul reservoir buffer consisting of 100 mM Hepes, pH 7.6, 10 mM DTT, and 14-21% (w/v) polyethylene glycol (PEG) 4000 above 500 ul reservoir buffer. Colorless plate-shaped crystals were obtained within a few days. VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1107/S0907444906048499",,"2OCJ",98.61,"2.05","2.05","Human p53 core domain in the absence of DNA","SSSVPSQKTYQGSYGFRLGFLHSGTAKSVTCTYSPALNKMFCQLAKTCPVQLWVDSTPPPGTRVRAMAIYKQSQHMTEVVRRCPHHERCSDSDGLAPPQHLIRVEGNLRVEYLDDRNTFRHSVVVPYEPPEVGSDCTTIHYNYMCNSSCMGGMNRRPILTIITLEDSSGNLLGRNSFEVRVCACPGRDRRTEEENLRKKGEPHHELPPGSTKRALPNNT","Homo sapiens","TP53, P53","P53 TUMOR SUPPRESSOR","1","2OCJ"
"2OCK",,"X-RAY DIFFRACTION",3.42,64.01,"VAPOR DIFFUSION, SITTING DROP",7,"12% PEG 4,000, 0.1 M MOPS, 0.1 M MNSO4, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1074/jbc.M709530200",,"2OCK",28.95,"1.85","1.85","Crystal structure of valacyclovir hydrolase D123N mutant","SVTSAKVAVNGVQLHYQQTGEGDHAVLLLPGMLGSGETDFGPQLKNLNKKLFTVVAWDPRGYGHSRPPDRDFPADFFERDAKDAVDLMKALKFKKVSLLGWSNGGITALIAAAKYPSYIHKMVIWGANAYVTDEDSMIYEGIRDVSKWSERTRKPLEALYGYDYFARTCEKWVDGIRQFKHLPDGNICRHLLPRVQCPALIVHGEKDPLVPRFHADFIHKHVKGSRLHLMPEGKHNLHLRFADEFNKLAEDFLQ","Homo sapiens","BPHL, MCNAA","Valacyclovir hydrolase","1","2OCK"
"2OCL",,"X-RAY DIFFRACTION",3.39,63.72,"VAPOR DIFFUSION, SITTING DROP",7,"16% PEG 4,000, 0.1 M MOPS, 0.1 M MNSO4, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1074/jbc.M709530200",,"2OCL",28.93,"1.9","1.9","Crystal structure of valacyclovir hydrolase S122A mutant","SVTSAKVAVNGVQLHYQQTGEGDHAVLLLPGMLGSGETDFGPQLKNLNKKLFTVVAWDPRGYGHSRPPDRDFPADFFERDAKDAVDLMKALKFKKVSLLGWADGGITALIAAAKYPSYIHKMVIWGANAYVTDEDSMIYEGIRDVSKWSERTRKPLEALYGYDYFARTCEKWVDGIRQFKHLPDGNICRHLLPRVQCPALIVHGEKDPLVPRFHADFIHKHVKGSRLHLMPEGKHNLHLRFADEFNKLAEDFLQ","Homo sapiens","BPHL, MCNAA","Valacyclovir hydrolase","1","2OCL"
"2OCP",,"X-RAY DIFFRACTION",2.79,55.86,"VAPOR DIFFUSION, HANGING DROP",6.5,"PEG 4000, AMMONIUM ACETATE, pH 6.50, VAPOR DIFFUSION, HANGING DROP, temperature 287K",287,"10.1038/89661",,"2OCP",230.48,"2.8","2.8","Crystal Structure of Human Deoxyguanosine Kinase","GPRRLSIEGNIAVGKSTFVKLLTKTYPEWHVATEPVATWQNIQAAGNQKACTAQSLGNLLDMMYREPARWSYTFQTFSFLSRLKVQLEPFPEKLLQARKPVQIFERSVYSDRYIFAKNLFENGSLSDIEWHIYQDWHSFLLWEFASRITLHGFIYLQASPQVCLKRLYQRAREEEKGIELAYLEQLHGQHEAWLIHKTTKLHFEALMNIPVLVLDVNDDFSEEVTKQEDLMREVNTFVKNL","Homo sapiens","DGUOK, DGK","Deoxyguanosine kinase","1","2OCP"
"2OCS",,"X-RAY DIFFRACTION",1.93,36.23,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG 3350, 0.20M KSCN, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,,,"2OCS",9.91,"1.5","1.5","The crystal structure of the first PDZ domain of human NHERF-2 (SLC9A3R2)","MPRLCRLVRGEQGYGFHLHGEKGRRGQFIRRVEPGSPAEAAALRAGDRLVEVNGVNVEGETHHQVVQRIKAVEGQTRLLVVDQEDTSV","Homo sapiens","SLC9A3R2, NHERF2","Na(+)/H(+) exchange regulatory cofactor NHE-RF2","1","2OCS"
"2OCT",,"X-RAY DIFFRACTION",2.12,41.97,"VAPOR DIFFUSION, SITTING DROP",7.5,"30 % MPD, 0.1 M HEPES, 1.4-butanediol as additive, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,"10.1016/j.jmb.2006.12.025",,"2OCT",22.33,"1.4","1.4","Stefin B (Cystatin B) tetramer","MMSGAPSATQPATAETQHIADQVRSQLEEKYNKKFPVFKAVSFKSQVVAGTNYFIKVHVGDEDFVHLRVFQSLPHENKSLTLSNYQTNKAKHDELTYF","Homo sapiens","CSTB, CST6, STFB","Cystatin B","1","2OCT"
"2OCW",,"SOLUTION SCATTERING",,,,,,,"10.1074/jbc.M701281200",,"2OCW",64.36,,,"Solution structure of human secretory component","KSPIFGPEEVNSVEGNSVSITCYYPPTSVNRHTRKYWCRQGARGGCITLISSEGYVSSKYAGRANLTNFPENGTFVVNIAQLSQDDSGRYKCGLGINSRGLSFDVSLEVSQGPGLLNDTKVYTVDLGRTVTINCPFKTENAQKRKSLYKQIGLYPVLVIDSSGYVNPNYTGRIRLDIQGTGQLLFSVVINQLRLSDAGQYLCQAGDDSNSNKKNADLQVLKPEPELVYEDLRGSVTFHCALGPEVANVAKFLCRQSSGENCDVVVNTLGKRAPAFEGRILLNPQDKDGSFSVVITGLRKEDAGRYLCGAHSDGQLQEGSPIQAWQLFVNEESTIPRSPTVVKGVAGSSVAVLCPYNRKESKSIKYWCLWEGAQNGRCPLLVDSEGWVKAQYEGRLSLLEEPGNGTFTVILNQLTSRDAGFYWCLTNGDTLWRTTVEIKIIEGEPNLKVPGNVTAVLGETLKVPCHFPCKFSSYEKYWCKWNNTGCQALPSQDEGPSKAFVNCDENSRLVSLTLNLVTRADEGWYWCGVKQGHFYGETAAVYVAVEERKAAGSRDVSLAKADAAPDEKVLDSGFREIENKAIQDPR","Homo sapiens","PIGR","Polymeric-immunoglobulin receptor","1","2OCW"
"2OD1",,"SOLUTION NMR",,,,,,,"10.1016/j.ccr.2007.04.010",,"2OD1",6.67,,,"Solution structure of the MYND domain from human AML1-ETO","GSPNSGSPNSDSSESCWNCGRKASETCSGCNTARYCGSFCQHKDWEKHHHICGQTLQAQQ","Homo sapiens","AML1-ETO, RUNX1T1, AML1T1, CBFA2T1, CDR, ETO, MTG8, ZMYND2","Protein CBFA2T1","1","2OD1"
"2OD3",,"X-RAY DIFFRACTION",2.51,51.01,"VAPOR DIFFUSION, HANGING DROP",,"20% PEG 3350, 0.2M lithium acetate, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1074/jbc.M701323200",,"2OD3",34.58,"1.75","1.75","Human thrombin chimera with human residues 184a, 186, 186a, 186b, 186c and 222 replaced by murine thrombin equivalents.","TFGSGEADCGLRPLFEKKSLEDKTERELLESYIDGR","Homo sapiens","F2","Thrombin light chain","1","2OD3"
,,,,,,,,,,,,,,,,"IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGFKVNDTKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRKGKYGFYTHVFRLKKWIQKVIDQFGE","Homo sapiens","F2","Thrombin heavy chain","2","2OD3"
"2ODB",,"X-RAY DIFFRACTION",3.44,64.2,"VAPOR DIFFUSION, SITTING DROP",4.5,"0.1M acetate, 2M (NH4)2SO4, pH 4.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,,,"2ODB",26.31,"2.4","2.4","The crystal structure of human cdc42 in complex with the CRIB domain of human p21-activated kinase 6 (PAK6)","SMQTIKCVVVGDGAVGKTCLLISYTTNKFPSEYVPTVFDNYAVTVMIGGEPYTLGLFDTAGQEDYDRLRPLSYPQTDVFLVCFSVVSPSSFENVKEKWVPEITHHCPKTPFLLVGTQIDLRDDPSTIEKLAKNKQKPITPETAEKLARDLKAVKYVECSALTQKGLKNVFDEAILAALEPPEPKKSRRCVLL","Homo sapiens","CDC42","Human Cell Division Cycle 42 (CDC42)","1","2ODB"
,,,,,,,,,,,,,,,,"EISAPQNFQHRVHTSFDPKEGKFVGLPPQWQNILD",,,"Serine/threonine-protein kinase PAK 6","2","2ODB"
"2ODC",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M700576200",,"2ODC",5.72,,,"LEM-domain of the nuclear envelope protein emerin","HDNYADLSDTELTTLLRRYNIPHGPVVGSTRRLYEKKIFEYETQRRR","Homo sapiens","EMD, EDMD, STA","Emerin","1","2ODC"
"2ODP",,"X-RAY DIFFRACTION",2.82,56.35,"VAPOR DIFFUSION, HANGING DROP",7.5,"20% PEG 10000, 0.1M HEPES, 0.3M glycyl-glycyl-glycine, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1016/j.jmb.2006.12.039",,"2ODP",59.18,"1.9","1.9","Complement component C2a, the catalytic fragment of C3- and C5-convertase of human complement","KIQIQRSGHLNLYLLLDASQSVSENDFLIFKESASLMVDRIFSFEINVSVAIITFASEPKVLMSVLNDNSRDMTEVISSLENANYKDHENGTGTNTYAALNSVYLMMNNQMRLLGMETMAWQEIRHAIILLTDGKSNMGGSPKTAVDHIREILNINQKRNDYLDIYAIGVGKLDVDWRELNELGSKKDGERHAFILQDTKALHQVFEHMLDVSKLTDTICGVGNMSANASDQERTPWHVTIKPKSQETCRGALISDQWVLTAAHCFRDGNDHSLWRVNVGDPKSQWGKEFLIEKAVISPGFDVFAKKNQGILEFYGDDIALLKLAQKVKMSTHARPICLPCTMEANLALRRPQGSTCRDHENELLNKQSVPAHFVALNGSKLNINLKMGVEWTSCAEVVSQEKTMFPNLTDVREVVTDQFLCSGTQEDESPCKGESGGAVFLERRFRFFQVGLVSWGLYNPCLGSADKNSRKRAPRSKVPPPRDFHINLFRMQPWLRQHLGDVLNFLPL","Homo sapiens","C2, hCG_43694","Complement C2","1","2ODP"
"2ODQ",,"X-RAY DIFFRACTION",2.9,57.62,"VAPOR DIFFUSION, HANGING DROP",7.5,"20% PEG 10000, 0.1M HEPES, 0.3M glycyl-glycyl-glycine, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1016/j.jmb.2006.12.039",,"2ODQ",59.16,"2.3","2.3","Complement component C2a, the catalytic fragment of C3- and C5-convertase of human complement","KIQIQRSGHLNLYLLLDASQSVSENDFLIFKESASLMVDRIFSFEINVSVAIITFASEPKVLMSVLNDNSRDMTEVISSLENANYKDHENGTGTNTYAALNSVYLMMNNQMRLLGMETMAWQEIRHAIILLTDGKSNMGGSPKTAVDHIREILNINQKRNDYLDIYAIGVGKLDVDWRELNELGSKKDGERHAFILQDTKALHQVFEHMLDVSKLTDTICGVGNMSANASDQERTPWHVTIKPKSQETCRGALISDQWVLTAAHCFRDGNDHSLWRVNVGDPKSQWGKEFLIEKAVISPGFDVFAKKNQGILEFYGDDIALLKLAQKVKMSTHARPICLPCTMEANLALRRPQGSTCRDHENELLNKQSVPAHFVALNGSKLNINLKMGVEWTSCAEVVSQEKTMFPNLTDVREVVTDQFLCSGTQEDESPCKGESGGAVFLERRFRFFQVGLVSWGLYNPCLGSADKNSRKRAPRSKVPPPRDFHINLFRMQPWLRQHLGDVLNFLPL","Homo sapiens","C2, hCG_43694","Complement C2","1","2ODQ"
"2ODT",,"X-RAY DIFFRACTION",2.16,43.06,"VAPOR DIFFUSION, HANGING DROP",7.8,"1.6 M Citrate, Tris buffer, 0.1 M, pH 7.8, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"2ODT",37.42,"2.01","2.01","Structure of human Inositol 1,3,4-trisphosphate 5/6-kinase","SMQTFLKGKRVGYWLSEKKIKKLNFQAFAELCRKRGMEVVQLNLSRPIEEQGPLDVIIHKLTDVILEADQNDSQSLELVHRFQEYIDAHPETIVLDPLPAIRTLLDRSKSYELIRKIEAYMEDDRICSPPFMELTSLCGDDTMRLLEKNGLTFPFICKTRVAHGTNSHEMAIVFNQEGLNAIQPPCVVQNFINHNAVLYKVFVVGESYTVVQRPSLKNFSAGTSDRESIFFNSHNVSKPESSSVLTELDKIEGVFERPSDEVIRELSRALRQALGVSLFGIDIIINNQTGQHAVIDINAFPGYEGVSEFFTDLLNHIATVLQGQSTAM","Homo sapiens","ITPK1","Inositol-tetrakisphosphate 1-kinase","1","2ODT"
"2ODU",,"X-RAY DIFFRACTION",2.28,46.2,"VAPOR DIFFUSION, HANGING DROP",4.6,"0.1M Citrate Phosphate pH 4.6, 10% 1,2-propanediol, 5% PEG 3000, 4% Glycerol, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1016/j.jmb.2007.02.090",,"2ODU",27.48,"2.3","2.3","Crystal structure of a fragment of the plakin domain of plectin","GSHMRANELQLRWQEYRELVLLLLQWMRHHTAAFEERRFPSSFEEIEILWSQFLKFKEMELPAKEADKNRSKGIYQSLEGAVQAGQLKVPPGYHPLDVEKEWGKLHVAILEREKQLRSEFERLECLQRIVTKLQMEAGLCEEQLNQADALLQSDVRLLAAGKVPQRAGEVERDLDKADSMIRLLFNDVQTLKDGRHPQGEQMYRRVYRLHKRLVAIRTEYNLRLKAGVAAPATQV","Homo sapiens","PLEC1, PLEC","Plectin 1","1","2ODU"
"2ODV",,"X-RAY DIFFRACTION",2.28,46.2,"VAPOR DIFFUSION, HANGING DROP",4.6,"0.1M Citrate Phosphate pH 4.6, 24% 1,2-propanediol, 6% PEG 3000, 3% Glycerol, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1016/j.jmb.2007.02.090",,"2ODV",27.5,"2.05","2.05","Crystal structure of a fragment of the plakin domain of plectin, Cys to Ala mutant.","GSHMRANELQLRWQEYRELVLLLLQWMRHHTAAFEERRFPSSFEEIEILWSQFLKFKEMELPAKEADKNRSKGIYQSLEGAVQAGQLKVPPGYHPLDVEKEWGKLHVAILEREKQLRSEFERLEALQRIVTKLQMEAGLAEEQLNQADALLQSDVRLLAAGKVPQRAGEVERDLDKADSMIRLLFNDVQTLKDGRHPQGEQMYRRVYRLHKRLVAIRTEYNLRLKAGVAAPATQV","Homo sapiens","PLEC1, PLEC","Plectin 1","1","2ODV"
"2OEH",,"SOLUTION NMR",,,,,,,"10.1021/bi061738h",,"2OEH",21.52,,,"Determination of the Three-dimensional Structure of the Mrf2-DNA Complex Using Paramagnetic Spin Labeling","TACAATATAACGTCG",,,"5'-D(P*TP*AP*CP*AP*AP*TP*AP*TP*AP*AP*CP*GP*TP*CP*G)-3'","1","2OEH"
,,,,,,,,,,,,,,,,"CGACGTTATATTGT",,,"5'-D(P*CP*GP*AP*CP*GP*TP*TP*AP*TP*AP*TP*TP*GP*T)-3'","2","2OEH"
,,,,,,,,,,,,,,,,"RADEQAFLVALYKYMKERKTPIERIPYLGFKQINLWTMFQAAQKLGGYETITARRQWKHIYDELGGNPGSTSAATCTRRHYERLILPYERFIKGEEDKPLPPIKPRK","Homo sapiens","ARID5B, DESRT, MRF2","AT-rich interactive domain-containing protein 5B","3","2OEH"
"2OEI",,"X-RAY DIFFRACTION",2.56,51.87,"VAPOR DIFFUSION, SITTING DROP",7.6,"1.3 M sodium citrate, 0.1M hepes, pH 7.6, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.jmb.2007.06.064",,"2OEI",5.1,"1.35","1.35","Crystal structure of human FE65-WW domain in complex with human Mena peptide","GSDLPAGWMRVQDTSGTYYWHIPTGTTQWEPPGRASPS","Homo sapiens","APBB1, FE65, RIR","Amyloid beta A4 protein-binding family B member 1","1","2OEI"
,,,,,,,,,,,,,,,,"PPPPPPLPP",,,"poly-proline peptide","2","2OEI"
"2OEV",,"X-RAY DIFFRACTION",3.12,60.58,"VAPOR DIFFUSION, SITTING DROP",7,"8% PEG 4000, 0.1M ammonium acetate, 0.1M magnesium acetate, 0.05M hepes, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 286K",286,"10.1016/j.cell.2007.01.035",,"2OEV",78.97,"3.3","3.3","Crystal structure of ALIX/AIP1","GIDPFTHMATFISVQLKKTSEVDLAKPLVKFIQQTYPSGGEEQAQYCRAAEELSKLRRAAVGRPLDKHEGALETLLRYYDQICSIEPKFPFSENQICLTFTWKDAFDKGSLFGGSVKLALASLGYEKSCVLFNCAALASQIAAEQNLDNDEGLKIAAKHYQFASGAFLHIKETVLSALSREPTVDISPDTVGTLSLIMLAQAQEVFFLKATRDKMKDAIIAKLANQAADYFGDAFKQCQYKDTLPKEVFPVLAAKHCIMQANAEYHQSILAKQQYYFGEEIARLQHAAELIKTVASRYDEYVNVKDFSDKINRALAAAKKDNDFIYHDRVPDLKDLDPIGKATLVKSTPVNVPISQKFTDLFEKMVPVSVQQSLAAYNQRKADLVNRSIAQMREATTLANGVLASLNLPAAIEDVSGDTVPQSILTKSRSVIEQGGIQTVDQLIKELPELLQRNREILDESLRLLDEEEATDNDLRAKFKERWQRTPSNELYKPLRAEGTNFRTVLDKAVQADGQVKECYQSHRDTIVLLCKPEPELNAAIPSANPAKTMQGSEVVNVLKSLLSNLDEVKKEREGLENDLKSVNFDMTSKFLTALAQDGVINEEALSVTELDRVYGGLTTKVQESLKKQEGLLKNIQVSHQEFSKMKQSNNEANLREEVLKNLATAYDNFVELVANLKEGTKFYNELTEILVRFQNKCSDIVFAR","Homo sapiens","PDCD6IP, AIP1, ALIX, KIAA1375","Programmed cell death 6-interacting protein","1","2OEV"
"2OEW",,"X-RAY DIFFRACTION",2.89,57.38,"VAPOR DIFFUSION, SITTING DROP",6.5,"10% PEG 20000, 0.1M NaMES, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 286K",286,"10.1016/j.cell.2007.01.035",,"2OEW",42.74,"2.55","2.55","Structure of ALIX/AIP1 Bro1 Domain","MHHHHHHHHHHSGQNLYFQGHMATFISVQLKKTSEVDLAKPLVKFIQQTYPSGGEEQAQYCRAAEELSKLRRAAVGRPLDKHEGALETLLRYYDQICSIEPKFPFSENQICLTFTWKDAFDKGSLFGGSVKLALASLGYEKSCVLFNCAALASQIAAEQNLDNDEGLKIAAKHYQFASGAFLHIKETVLSALSREPTVDISPDTVGTLSLIMLAQAQEVFFLKATRDKMKDAIIAKLANQAADYFGDAFKQCQYKDTLPKEVFPVLAAKHCIMQANAEYHQSILAKQQKKFGEEIARLQHAAELIKTVASRYDEYVNVKDFSDKINRALAAAKKDNDFIYHDRVPDLKDLDPIGKATLVKSTPVNVPISQKFTDLFEKMV","Homo sapiens","PDCD6IP, AIP1, ALIX, KIAA1375","Programmed cell death 6-interacting protein","1","2OEW"
"2OEX",,"X-RAY DIFFRACTION",2.57,52.21,"VAPOR DIFFUSION, SITTING DROP",8,"14% PEG 3350, 0.16M magnesium formate, pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.cell.2007.01.035",,"2OEX",79.34,"2.58","2.58","Structure of ALIX/AIP1 V Domain","GIDPFTHMPVSVQQSLAAYNQRKADLVNRSIAQMREATTLANGVLASLNLPAAIEDVSGDTVPQSILTKSRSVIEQGGIQTVDQLIKELPELLQRNREILDESLRLLDEEEATDNDLRAKFKERWQRTPSNELYKPLRAEGTNFRTVLDKAVQADGQVKECYQSHRDTIVLLCKPEPELNAAIPSANPAKTMQGSEVVNVLKSLLSNLDEVKKEREGLENDLKSVNFDMTSKFLTALAQDGVINEEALSVTELDRVYGGLTTKVQESLKKQEGLLKNIQVSHQEFSKMKQSNNEANLREEVLKNLATAYDNFVELVANLKEGTKFYNELTEILVRFQNKCSDIVFARKTER","Homo sapiens","PDCD6IP, AIP1, ALIX, KIAA1375","Programmed cell death 6-interacting protein","1","2OEX"
"2OF0",,"X-RAY DIFFRACTION",2.97,58.53,"VAPOR DIFFUSION, HANGING DROP",6.6,"20-22.5% (w/v) PEG 5000 monomethylether (MME), 200 mM sodium citrate (pH 6.6), 200 mM ammonium iodide, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm0611962","CMZ","2OF0",45.57,"2.25","2.25","X-ray crystal structure of beta secretase complexed with compound 5","RETDEEPEEPGKKGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYN","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","2OF0"
"2OF2",,"X-RAY DIFFRACTION",2.32,47,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.2 M Li2SO4, 25-35% PEG4000, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.bmcl.2007.01.048","547","2OF2",31.74,"2","2","crystal structure of furanopyrimidine 8 bound to lck","KPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT","Homo sapiens","LCK","Proto-oncogene tyrosine-protein kinase LCK","1","2OF2"
"2OF4",,"X-RAY DIFFRACTION",2.29,46.31,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.2 M Li2SO4, 25-35% PEG4000, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.bmcl.2007.01.048","979","2OF4",31.75,"2.7","2.7","crystal structure of furanopyrimidine 1 bound to lck","KPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT","Homo sapiens","LCK","Proto-oncogene tyrosine-protein kinase LCK","1","2OF4"
"2OFS",,"X-RAY DIFFRACTION",2.06,40.32,"VAPOR DIFFUSION, HANGING DROP",3.5,"0.1 M sodium citrate, 16 % polyethylene glycol 6000, 5% isopropanol, pH 3.5, VAPOR DIFFUSION, HANGING DROP, temperature 294K",294,"10.1107/S0907444907015557",,"2OFS",8.77,"2.12","2.12","Crystal structure of human CD59","FLQCYNCPNPTADCKTAVQCSSDFDACLITKAGLQVYNKCWKFEHCNFNDVTTRLRENELTYYCCKKDLCNFNEQ","Homo sapiens","CD59, MIC11, MIN1, MIN2, MIN3, MSK21","CD59 glycoprotein","1","2OFS"
"2OFU",,"X-RAY DIFFRACTION",2.3,46.63,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.2 M Li2SO4, 25-25% PEG4000, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/jm060435i","1N9, PTR","2OFU",32.43,"2","2","x-ray crystal structure of 2-aminopyrimidine carbamate 43 bound to Lck","PQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT","Homo sapiens","LCK","Proto-oncogene tyrosine-protein kinase LCK","1","2OFU"
"2OFV",,"X-RAY DIFFRACTION",2.71,54.56,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.3 M MgAcetate, 5-12.5% PEG8000, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/jm0605482","242","2OFV",64.96,"2","2","crystal structure of aminoquinazoline 1 bound to Lck","TQKPQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE","Homo sapiens","LCK","Proto-oncogene tyrosine-protein kinase LCK","1","2OFV"
"2OFW",,"X-RAY DIFFRACTION",2.28,46,"VAPOR DIFFUSION, HANGING DROP",,"reservoir: 18-20% PEG 3350, 0.25 M calcium acetate  
protein solution: 5-8 mg/ml protein, 3 mM APS, 5 mM MgCl2, 50 mM Tris pH 7.5, 50 mM KCl, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1016/j.jmb.2007.01.025","ADX","2OFW",191.78,"2.05","2.05","Crystal structure of the APSK domain of human PAPSS1 complexed with 2 APS molecules","QGHMRATNVTYQAHHVSRNKRGQVVGTRGGFRGCTIWLTGLSGAGKTTVSMALEEYLVCHGIPCYTLDGDNIRQGLNKNLGFSPEDREENVRRIAEVAKLFADAGLVCITSFISPYTQDRNNARQIHEGASLPFFEVFVDAPLHVCEQRDVKGLYKKARAGEIKGFTGIDSEYEKPEAPELVLKTDSCDVNDCVQQVVELLNERDILP","Homo sapiens","PAPSS1, ATPSK1, PAPSS","APS kinase domain of the PAPS synthetase 1","1","2OFW"
"2OFX",,"X-RAY DIFFRACTION",1.99,38.29,"VAPOR DIFFUSION, HANGING DROP",7.3,"reservoir: 0.2-0.4mM ammonium dihydrogenphosphate  
protein solution: 6 mg/ml protein, 2 mM PAPS, 2 mM ADP, 5 mM MgCl2, 50 mM Tris pH 7.5, 50 mM KCl 
, pH 7.3, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.jmb.2007.01.025",,"2OFX",48.16,"1.9","1.9","crystal structure of the APSK domain of human PAPSS1 in complex with ADPMg and PAPS","QGHMATNVTYQAHHVSRNKRGQVVGTRGGFRGCTVWLTGLSGAGKTTVSMALEEYLVCHGIPCYTLDGDNIRQGLNKNLGFSPEDREENVRRIAEVAKLFADAGLVCITSFISPYTQDRNNARQIHEGASLPFFEVFVDAPLHVCEQRDVKGLYKKARAGEIKGFTGIDSEYEKPEAPELVLKTDSCDVNDCVQQVVELLQERDIVP","Homo sapiens","PAPSS1, ATPSK1, PAPSS","Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthetase 1","1","2OFX"
"2OG8",,"X-RAY DIFFRACTION",2.72,54.81,"VAPOR DIFFUSION, HANGING DROP",6,"1.0 M LiCl, 10-22.5% PEG4000, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/jm0605482","1N8","2OG8",62.16,"2.3","2.3","crystal structure of aminoquinazoline 36 bound to Lck","DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA","Homo sapiens","LCK","Proto-oncogene tyrosine-protein kinase LCK","1","2OG8"
"2OGQ",,"X-RAY DIFFRACTION",2.3,46.55,"VAPOR DIFFUSION",9,"0.1 M Sodium Chloride, 0.1 M Bicine, 20% w/v Polyethylene Glycol Monomethyl Ether 550, pH 9.0, VAPOR DIFFUSION, temperature 289K",289,"10.1073/pnas.0609131104",,"2OGQ",27.5,"1.95","1.95","Molecular and structural basis of Plk1 substrate recognition: Implications in centrosomal localization","ETGEVVDCHLSDMLQQLHSVNASKPSERGLVRQEEAEDPACIPIFWVSKWVDYSDKYGLGYQLCDNSVGVLFNDSTRLILYNDGDSLQYIERDGTESYLTVSSHPNSLMKKITLLKYFRNYMSEHLLKAGANITPREGDELARLPYLRTWFRTRSAIILHLSNGSVQINFFQDHTKLILCPLMAAVTYIDEKRDFRTYRLSLLEEYGCCKELASRLRYARTMVDKLLSSRSASNRLKAS","Homo sapiens","PLK1, PLK","Serine/threonine-protein kinase PLK1","1","2OGQ"
"2OGV",,"X-RAY DIFFRACTION",2.37,48.07,"VAPOR DIFFUSION, HANGING DROP",6.2,"30% PEG 8000, 0.2M Ammonium sulfate, 0.1M MES pH 6.2, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.jmb.2007.01.036",,"2OGV",35.79,"2.7","2.7","Crystal Structure of the Autoinhibited Human c-Fms Kinase Domain","KPKYQVRWKIIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDR","Homo sapiens","CSF1R, FMS","Macrophage colony-stimulating factor 1 receptor precursor","1","2OGV"
,,,,,,,,,,,,,,,,,"Homo sapiens","CSF1R, FMS"
"2OGZ",,"X-RAY DIFFRACTION",2.55,51.82,"VAPOR DIFFUSION",8,"PEG4000, SODIUM ACETATE, pH 8, VAPOR DIFFUSION, temperature 293K",293,"10.1016/j.bmcl.2006.12.074","U1N","2OGZ",169.58,"2.1","2.1","Crystal structure of DPP-IV complexed with Lilly aryl ketone inhibitor","SRKTYTLTDYLKNTYRLKLYSLRWISDHEYLYKQENNILVFNAEYGNSSVFLENSTFDEFGHSINDYSISPDGQFILLEYNYVKQWRHSYTASYDIYDLNKRQLITEERIPNNTQWVTWSPVGHKLAYVWNNDIYVKIEPNLPSYRITWTGKEDIIYNGITDWVYEEEVFSAYSALWWSPNGTFLAYAQFNDTEVPLIEYSFYSDESLQYPKTVRVPYPKAGAVNPTVKFFVVNTDSLSSVTNATSIQITAPASMLIGDHYLCDVTWATQERISLQWLRRIQNYSVMDICDYDESSGRWNCLVARQHIEMSTTGWVGRFRPSEPHFTLDGNSFYKIISNEEGYRHICYFQIDKKDCTFITKGTWEVIGIEALTSDYLYYISNEYKGMPGGRNLYKIQLSDYTKVTCLSCELNPERCQYYSVSFSKEAKYYQLRCSGPGLPLYTLHSSVNDKGLRVLEDNSALDKMLQNVQMPSKKLDFIILNETKFWYQMILPPHFDKSKKYPLLLDVYAGPCSQKADTVFRLNWATYLASTENIIVASFDGRGSGYQGDKIMHAINRRLGTFEVEDQIEAARQFSKMGFVDNKRIAIWGWSYGGYVTSMVLGSGSGVFKCGIAVAPVSRWEYYDSVYTERYMGLPTPEDNLDHYRNSTVMSRAENFKQVEYLLIHGTADDNVHFQQSAQISKALVDVGVDFQAMWYTDEDHGIASSTAHQHIYTHMSHFIKQCFSLP","Homo sapiens","DPP4, ADCP2, CD26","Dipeptidyl peptidase","1","2OGZ"
"2OH2",,"X-RAY DIFFRACTION",3.54,65.28,,,,,,,"2OH2",135.98,"3.05","3.05","Ternary Complex of Human DNA Polymerase","GGGGGAAGGACCC",,,"5'-D(*GP*GP*G*GP*GP*AP*AP*GP*GP*AP*CP*CP*C)-3'","1","2OH2"
,,,,,,,,,,,,,,,,"TTCCAGGGTCCTTCCCCC",,,"5'-D(*TP*T*CP*CP*AP*GP*GP*GP*TP*CP*CP*TP*TP*CP*CP*CP*CP*C)-3'","2","2OH2"
,,,,,,,,,,,,,,,,"MGLNDNKAGMEGLDKEKINKIIMEATKGSRFYGNELKKEKQVNQRIENMMQQKAQITSQQLRKAQLQVDRFAMELEQSRNLSNTIVHIDMDAFYAAVEMRDNPELKDKPIAVGSMSMLSTSNYHARRFGVRAAMPGFIAKRLCPQLIIVPPNFDKYRAVSKEVKEILADYDPNFMAMSLDEAYLNITKHLEERQNWPEDKRRYFIKMGSSVENDNPGKEVNKLSEHERSISPLLFEESPSDVQPPGDPFQVNFEEQNNPQILQNSVVFGTSAQEVVKEIRFRIEQKTTLTASAGIAPNTMLAKVCSDKNKPNGQYQILPNRQAVMDFIKDLPIRKVSGIGKVTEKMLKALGIITCTELYQQRALLSLLFSETSWHYFLHISLGLGSTHLTRDGERKSMSVERTFSEINKAEEQYSLCQELCSELAQDLQKERLKGRTVTIKLKNVNFEVKTRASTVSSVVSTAEEIFAIAKELLKTEIDADFPHPLRLRLMGVRISSFPNEEDRKHQQ","Homo sapiens","POLK, DINB1","DNA polymerase kappa","3","2OH2"
"2OH4",,"X-RAY DIFFRACTION",2.5,51.1,"VAPOR DIFFUSION, HANGING DROP",7.2,"pH 7.2, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/jm0611051","GIG","2OH4",37.1,"2.05","2.05","Crystal structure of Vegfr2 with a benzimidazole-urea inhibitor","HMDPDELPLDEHCERLPYDASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQD","Homo sapiens","KDR, FLK1, VEGFR2","Vascular endothelial growth factor receptor 2","1","2OH4"
,,,,,,,,,,,,,,,,,"Homo sapiens","KDR, FLK1, VEGFR2"
"2OHF",,"X-RAY DIFFRACTION",3.47,64.55,"VAPOR DIFFUSION, HANGING DROP",8,"12% PEG 3350, 50 mM TRIS/HCl, 10 mM MgCl2, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1074/jbc.M700541200",,"2OHF",45.31,"2.7","2.7","Crystal structure of human OLA1 in complex with AMPPCP","MPPKKGGDGIKPPPIIGRFGTSLKIGIVGLPNVGKSTFFNVLTNSQASAENFPFCTIDPNESRVPVPDERFDFLCQYHKPASKIPAFLNVVDIAGLVKGAHNGQGLGNAFLSHISACDGIFHLTRAFEDDDITHVEGSVDPIRDIEIIHEELQLKDEEMIGPIIDKLEKVAVRGGDKKLKPEYDIMCKVKSWVIDQKKPVRFYHDWNDKEIEVLNKHLFLTSKPMVYLVNLSEKDYIRKKNKWLIKIKEWVDKYDPGALVIPFSGALELKLQELSAEERQKYLEANMTQSALPKIIKAGFAALQLEYFFTAGPDEVRAWTIRKGTKAPQAAGKIHTDFEKGFIMAEVMKYEDFKEEGSENAVKAAGKYRQQGRNYIVEDGDIIFFKFNTPQQPKKK","Homo sapiens","GTPBP9, OLA1, PRO2455, PTD004","GTP-binding protein 9","1","2OHF"
"2OHK",,"X-RAY DIFFRACTION",2.87,57.09,"VAPOR DIFFUSION, HANGING DROP",6.6,"20-22.5% (w/v) PEG 5000 monomethylether (MME), 200 mM sodium citrate (pH 6.6), 200 mM ammonium iodide, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm0611962","1SQ","2OHK",45.44,"2.2","2.2","X-ray crystal structure of beta secretase complexed with 1-amino-isoquinoline","RETDEEPEEPGKKGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYN","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","2OHK"
"2OHL",,"X-RAY DIFFRACTION",2.87,57.18,"VAPOR DIFFUSION, HANGING DROP",6.6,"20-22.5% (w/v) PEG 5000 monomethylether (MME), 200 mM sodium citrate (pH 6.6), 200 mM ammonium iodide, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm0611962","2AQ","2OHL",45.44,"2.65","2.65","X-ray crystal structure of beta secretase complexed with 2-aminoquinoline","RETDEEPEEPGKKGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYN","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","2OHL"
"2OHM",,"X-RAY DIFFRACTION",2.81,56.3,"VAPOR DIFFUSION, HANGING DROP",6.6,"20-22.5% (w/v) PEG 5000 monomethylether (MME), 200 mM sodium citrate (pH 6.6), 200 mM ammonium iodide, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm0611962","8AP","2OHM",45.37,"2.7","2.7","X-ray crystal structure of beta secretase complexed with N~3~-benzylpyridine-2,3-diamine","RETDEEPEEPGKKGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYN","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","2OHM"
"2OHN",,"X-RAY DIFFRACTION",2.87,57.15,"VAPOR DIFFUSION, HANGING DROP",6.6,"20-22.5% (w/v) PEG 5000 monomethylether (MME), 200 mM sodium citrate (pH 6.6), 200 mM ammonium iodide, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm0611962",,"2OHN",45.49,"2.15","2.15","X-ray crystal structure of beta secretase complexed with 4-(4-fluorobenzyl)piperidine","RETDEEPEEPGKKGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYN","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","2OHN"
"2OHP",,"X-RAY DIFFRACTION",2.86,56.99,,6.6,"20-22.5% (w/v) PEG 5000 monomethylether (MME), 200 mM sodium citrate (pH 6.6), 200 mM ammonium iodide, VAPOR DIFFUSION, HANGING DROP, temperature 293K, pH 6.60",293,"10.1021/jm061197u","6IP","2OHP",45.41,"2.25","2.25","X-ray crystal structure of beta secretase complexed with compound 3","RETDEEPEEPGKKGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYN","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","2OHP"
"2OHQ",,"X-RAY DIFFRACTION",2.87,57.11,"VAPOR DIFFUSION, HANGING DROP",6.6,"20-22.5% (w/v) PEG 5000 monomethylether (MME), 200 mM sodium citrate (pH 6.6), 200 mM ammonium iodide, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm061197u","7IP","2OHQ",45.57,"2.1","2.1","X-ray crystal structure of beta secretase complexed with compound 4","RETDEEPEEPGKKGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYN","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","2OHQ"
"2OHR",,"X-RAY DIFFRACTION",2.83,56.53,"VAPOR DIFFUSION, HANGING DROP",6.6,"20-22.5% (w/v) PEG 5000 monomethylether (MME), 200 mM sodium citrate (pH 6.6), 200 mM ammonium iodide, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm061197u","8IP","2OHR",45.54,"2.25","2.25","X-ray crystal structure of beta secretase complexed with compound 6a","RETDEEPEEPGKKGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYN","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","2OHR"
"2OHS",,"X-RAY DIFFRACTION",2.81,56.26,"VAPOR DIFFUSION, HANGING DROP",6.6,"20-22.5% (w/v) PEG 5000 monomethylether (MME), 200 mM sodium citrate (pH 6.6), 200 mM ammonium iodide, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm061197u","9IP","2OHS",45.48,"2.45","2.45","X-ray crystal structure of beta secretase complexed with compound 6b","RETDEEPEEPGKKGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYN","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","2OHS"
"2OHT",,"X-RAY DIFFRACTION",2.9,57.52,"VAPOR DIFFUSION, HANGING DROP",6.6,"20-22.5% (w/v) PEG 5000 monomethylether (MME), 200 mM sodium citrate (pH 6.6), 200 mM ammonium iodide, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm061197u","IP6","2OHT",45.61,"2.3","2.3","X-ray crystal structure of beta secretase complexed with compound 7","RETDEEPEEPGKKGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYN","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","2OHT"
"2OHU",,"X-RAY DIFFRACTION",2.83,56.49,"VAPOR DIFFUSION, HANGING DROP",6.6,"20-22.5% (w/v) PEG 5000 monomethylether (MME), 200 mM sodium citrate (pH 6.6), 200 mM ammonium iodide, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm061197u","IP7","2OHU",45.72,"2.35","2.35","X-ray crystal structure of beta secretase complexed with compound 8b","RETDEEPEEPGKKGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYN","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","2OHU"
"2OI0",,"X-RAY DIFFRACTION",2.02,39.19,"VAPOR DIFFUSION, HANGING DROP",6.5,"30% PGME 550, 0.1M BIS-TRIS, 50 mM CaCl2, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 298.0K",298,"10.1016/j.bmcl.2007.01.064","283","2OI0",30.41,"2","2","Crystal structure analysis 0f the TNF-a Coverting Enzyme (TACE) in complexed with Aryl-sulfonamide","ADPDPMKNTCKLLVVADHRFYRYMGRGEESTTTNYLIELIDRVDDIYRNTAWDNAGFKGYGIQIEQIRILKSPQEVKPGEKHYNMAKSYPNEEKDAWDVKMLLEQFSFDIAEEASKVCLAHLFTYQDFDMGTLGLAYVGSPRANSHGGVCPKAYYSPVGKKNIYLNSGLTSTKNYGKTILTKEADLVTTHELGHNFGAEHDPDGLAECAPNEDQGGKYVMYPIAVSGDHENNKMFSQCSKQSIYKTIESKAQECFQERSNKVIEGR","Homo sapiens","TACE, ADAM17, CSVP","TNF- a Converting Enzyme (TACE)","1","2OI0"
"2OI3",,"SOLUTION NMR",,,,,,,"10.1016/j.jmb.2006.11.013",,"2OI3",10.87,,,"NMR Structure Analysis of the Hematopoetic Cell Kinase SH3 Domain complexed with an artificial high affinity ligand (PD1)","GPLGSPGPNSHNSNTPGIREAGSEDIIVVALYDYEAIHHEDLSFQKGDQMVVLEESGEWWKARSLATRKEGYIPSNYVARVDSLET","Homo sapiens","HCK","Tyrosine-protein kinase HCK","1","2OI3"
,,,,,,,,,,,,,,,,"XHSKYPLPPLPSLX",,,"artificial peptide PD1","2","2OI3"
"2OI4",,"X-RAY DIFFRACTION",3.14,60.87,"VAPOR DIFFUSION, SITTING DROP",6.5,"100mM BIS-TRIS PROPANE, 0.2M MgCl2, 20% PEG 3350, 10% ETHILENE GLYCOL, 0.3% DMSO, SITTING DROP, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1039/b700433h","JM1","2OI4",36.59,"2.2","2.2","Crystal structure of human PIM1 in complex with fluorinated ruthenium pyridocarbazole","MLLSKINSLAHLRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPSK","Homo sapiens","PIM1","Proto-oncogene serine/threonine-protein kinase Pim-1","1","2OI4"
"2OIB",,"X-RAY DIFFRACTION",2.65,53.51,"VAPOR DIFFUSION, HANGING DROP",7,"2.3M sodium malonate, 0.1M sodium acetate, 0.01M DTT, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.4049/jimmunol.178.5.2641",,"2OIB",135.82,"2","2","Crystal structure of IRAK4 kinase domain apo form","VSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS","Homo sapiens","IRAK4","Interleukin-1 receptor-associated kinase 4","1","2OIB"
"2OIC",,"X-RAY DIFFRACTION",2.99,58.82,"VAPOR DIFFUSION, HANGING DROP",7,"2.3M sodium malonate, 0.1M sodium acetate, 0.01M DTT, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.4049/jimmunol.178.5.2641","STU","2OIC",137.69,"2.4","2.4","Crystal structure of IRAK4 kinase domain complexed with staurosporine","VSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS","Homo sapiens","IRAK4","Interleukin-1 receptor-associated kinase 4","1","2OIC"
"2OID",,"X-RAY DIFFRACTION",2.7,54.44,"VAPOR DIFFUSION, HANGING DROP",7,"2.3M sodium malonate, 0.1M sodium acetate, 0.01M DTT, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.4049/jimmunol.178.5.2641",,"2OID",137.85,"2.3","2.3","Crystal structure of IRAK4 kinase domain complexed with AMPPNP","VSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS","Homo sapiens","IRAK4","Interleukin-1 receptor-associated kinase 4","1","2OID"
"2OIH",,"X-RAY DIFFRACTION",3.07,59.95,"VAPOR DIFFUSION, HANGING DROP",6,"containing 5-10% (v/v) MPD, 50 mM sodium cacodylate, pH 6.0, 40-80 mM NaCl, 30 mM SrCl2, and 15-50 mM spermine   HCl, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.str.2007.01.017",,"2OIH",38.73,"2.4","2.4","Hepatitis Delta Virus gemonic ribozyme precursor with C75U mutation and bound to monovalent cation Tl+","GAUGGCCGGCAUGGUCCCAGCCUCCUCGCUGGCGCCGGCUGGGCAACACCAUUGCACUCCGGUGGUGAAUGGGAC",,,"HDV ribozyme","1","2OIH"
,,,,,,,,,,,,,,,,"MAVPETRPNHTIYINNLNEKIKKDELKKSLHAIFSRFGQILDILVSRSLKMRGQAFVIFKEVSSATNALRSMQGFPFYDKPMRIQYAKTDSDIIAKMKGT","Homo sapiens","SNRPA","U1 small nuclear ribonucleoprotein A","2","2OIH"
"2OII",,"SOLUTION NMR",,,,,,,,,"2OII",51.68,,,"Structure of EMILIN-1 C1q-like domain","MRGSHHHHHHGSPVPQVAFSAALSLPRSEPGTVPFDRVLLNDGGYYDPETGVFTAPLAGRYLLSAVLTGHRHEKVEAVLSRSNQGVARVDSGGYEPEGLENKPVAESQPSPGTLGVFSLILPLQAGDTVCVDLVMGQLAHSEEPLTIFSGALLYGDPELEHA","Homo sapiens","EMILIN1, EMI","EMILIN-1","1","2OII"
"2OIL",,"X-RAY DIFFRACTION",2.15,42.9,"VAPOR DIFFUSION, SITTING DROP",,"20% peg-3350, 0.2M ammonium chloride, vapor diffusion, sitting drop, temperature 291K, VAPOR DIFFUSION, SITTING DROP",291,,,"2OIL",22.02,"2.3","2.3","Crystal structure of human RAB25 in complex with GDP","MGSSHHHHHHSSGLVPRGSEDYNFVFKVVLIGESGVGKTNLLSRFTRNEFSHDSRTTIGVEFSTRTVMLGTAAVKAQIWDTAGLERYRAITSAYYRGAVGALLVFDLTKHQTYAVVERWLKELYDHAEATIVVMLVGNKSDLSQAREVPTEEARMFAENNGLLFLETSALDSTNVELAFETVLKEIFAKVSKQ","Homo sapiens","RAB25, CATX8","Ras-related protein Rab-25","1","2OIL"
"2OIT",,"X-RAY DIFFRACTION",2.26,45.68,"VAPOR DIFFUSION, HANGING DROP",6.5,"100 mM MES pH 6. 
23-27 % PEG 2,000 MME, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 294.0K",294,"10.1073/pnas.0610828104",,"2OIT",48.31,"1.65","1.65","Crystal Structure of the N-terminal Domain of the Human Proto-oncogene Nup214/CAN","MGDEMDAMIPEREMKDFQFRALKKVRIFDSPEELPKERSSLLAVSNKYGLVFAGGASGLQIFPTKNLLIQNKPGDDPNKIVDKVQGLLVPMKFPIHHLALSCDNLTLSACMMSSEYGSIIAFFDVRTFSNEAKQQKRPFAYHKLLKDAGGMVIDMKWNPTVPSMVAVCLADGSIAVLQVTETVKVCATLPSTVAVTSVCWSPKGKQLAVGKQNGTVVQYLPTLQEKKVIPCPPFYESDHPVRVLDVLWIGTYVFAIVYAAADGTLETSPDVVMALLPKKEEKHPEIFVNFMEPCYGSCTERQHHYYLSYIEEWDLVLAASAASTEVSILARQSDQINWESWLLEDSSRAELPVTDKSDDSLPMGVVVDYTNQVEITISDEKTLPPAPVLMLLSTDGVLCPFYMINQNPGVKSLIKTPERLSLEGERQPKSPGST","Homo sapiens","NUP214, CAIN, CAN, KIAA0023","Nucleoporin 214kDa","1","2OIT"
"2OJ2",,"SOLUTION NMR",,,,,,,"10.1016/j.jmb.2006.11.013",,"2OJ2",10.87,,,"NMR Structure Analysis of the Hematopoetic Cell Kinase SH3 Domain complexed with an artificial high affinity ligand (PD1)","GPLGSPGPNSHNSNTPGIREAGSEDIIVVALYDYEAIHHEDLSFQKGDQMVVLEESGEWWKARSLATRKEGYIPSNYVARVDSLET","Homo sapiens","HCK","Hematopoetic Cell Kinase, SH3 domain","1","2OJ2"
,,,,,,,,,,,,,,,,"XHSKYPLPPLPSLX",,,"artificial peptide PD1","2","2OJ2"
"2OJ3",,"X-RAY DIFFRACTION",3.03,59.46,"VAPOR DIFFUSION, HANGING DROP",6,"5-10% (v/v) MPD, 50 mM sodium cacodylate, pH 6.0, 40-80 mM NaCl, 30 mM SrCl2, and 15-50 mM spermine   HCl, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.str.2007.01.017",,"2OJ3",37.82,"2.9","2.9","Hepatitis Delta Virus ribozyme precursor structure, with C75U mutation, bound to Tl+ and cobalt hexammine (Co(NH3)63+)","GAUGGCCGGCAUGGUCCCAGCCUCCUCGCUGGCGCCGGCUGGGCAACACCAUUGCACUCCGGUGGUGAAUGGGAC",,,"HDV RIBOZYME","1","2OJ3"
,,,,,,,,,,,,,,,,"MAVPETRPNHTIYINNLNEKIKKDELKKSLHAIFSRFGQILDILVSRSLKMRGQAFVIFKEVSSATNALRSMQGFPFYDKPMRIQYAKTDSDIIAKMKGT","Homo sapiens","SNRPA","U1 small nuclear ribonucleoprotein A","2","2OJ3"
"2OJ4",,"X-RAY DIFFRACTION",3.18,61.28,"VAPOR DIFFUSION, HANGING DROP",6.5,"28% PEG 4000, 0.15M magnesium chloride, 0.1M glycine, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 288K",288,"10.1016/j.jsb.2010.03.009",,"2OJ4",14.9,"2.3","2.3","Crystal structure of RGS3 RGS domain","SEEALKWGESLEKLLVHKYGLAVFQAFLRTEFSEENLEFWLACEDFKKVKSQSKMASKAKKIFAEYIAIQACKEVNLDSYTREHTKDNLQSVTRGCFDLAQKRIFGLMEKDSYPRFLRSDLYLDLIN","Homo sapiens","RGS3","Regulator of G-protein signaling 3","1","2OJ4"
"2OJ9",,"X-RAY DIFFRACTION",2.38,48.35,,,"VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.bmcl.2007.01.102","BMI","2OJ9",35.44,"2","2","Structure of IGF-1R kinase domain complexed with a benzimidazole inhibitor","MVSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYSEENK","Homo sapiens","IGF1R","Insulin-like growth factor 1 receptor precursor (EC 2.7.10.1) (Insulin-like growth factor I receptor) (IGF-I receptor) (CD221 antigen)","1","2OJ9"
"2OJG",,"X-RAY DIFFRACTION",2.24,45.18,"VAPOR DIFFUSION",7.2,"protein: 14 mg/ml, 20 mM Tris, pH 7.0, 5 mM DTT, 200 mM NaCl. precipitant: 100 mM HEPES, pH 7.2, 28-30% PEG-MME-2000, 200 mM Ammonium Sulfate, 20 mM 2-ME, VAPOR DIFFUSION, temperature 298K",298,"10.1021/jm061381f","19A","2OJG",43.99,"2","2","Crystal structure of ERK2 in complex with N,N-dimethyl-4-(4-phenyl-1H-pyrazol-3-yl)-1H-pyrrole-2-carboxamide","MGSSHHHHHHSSGLVPRGSHMAAAAAAGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS","Homo sapiens","MAPK1, ERK2, PRKM1, PRKM2","Mitogen-activated protein kinase 1","1","2OJG"
"2OJI",,"X-RAY DIFFRACTION",2.19,43.93,"VAPOR DIFFUSION, HANGING DROP",7.2,"protein: 14 mg/ml, 20 mM Tris, pH 7.0, 5 mM DTT, 200 mM NaCl. precipitant: 100 mM HEPES, pH 7.2, 28-30% PEG-MME-2000, 200 mM Ammonium Sulfate, 20 mM 2-ME, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/jm061381f","33A","2OJI",44.09,"2.6","2.6","Crystal structure of ERK2 in complex with N-benzyl-4-(4-(3-chlorophenyl)-1H-pyrazol-3-yl)-1H-pyrrole-2-carboxamide","MGSSHHHHHHSSGLVPRGSHMAAAAAAGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS","Homo sapiens","MAPK1, ERK2, PRKM1, PRKM2","Mitogen-activated protein kinase 1","1","2OJI"
"2OJJ",,"X-RAY DIFFRACTION",2.19,43.74,"VAPOR DIFFUSION, HANGING DROP",7.2,"protein: 14 mg/ml, 20 mM Tris, pH 7.0, 5 mM DTT, 200 mM NaCl. precipitant: 100 mM HEPES, pH 7.2, 28-30% PEG-MME-2000, 200 mM Ammonium Sulfate, 20 mM 2-ME, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/jm061381f","82A","2OJJ",44.17,"2.4","2.4","Crystal structure of ERK2 in complex with (S)-N-(1-(3-chloro-4-fluorophenyl)-2-hydroxyethyl)-4-(4-(3-chlorophenyl)-1H-pyrazol-3-yl)-1H-pyrrole-2-carboxamide","MGSSHHHHHHSSGLVPRGSHMAAAAAAGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS","Homo sapiens","MAPK1, ERK2, PRKM1, PRKM2","Mitogen-activated protein kinase 1","1","2OJJ"
"2OJQ",,"X-RAY DIFFRACTION",3.01,59.08,"VAPOR DIFFUSION, HANGING DROP",8.5,"13-15% PEG 6000, 6-10% ethylene glycol, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 100K",,"10.1038/nsmb1203",,"2OJQ",39.19,"2.87","2.87","Crystal structure of Alix V domain","GAMGSPVSVQQSLAAYNQRKADLVNRSIAQMREATTLANGVLASLNLPAAIEDVSGDTVPQSILTKSRSVIEQGGIQTVDQLIKELPELLQRNREILDESLRLLDEEEATDNDLRAKFKERWQRTPSNELYKPLRAEGTNFRTVLDKAVQADGQVKECYQSHRDTIVLLCKPEPELNAAIPSANPAKTMQGSEVVSVLKSLLSNLDEVKKEREGLENDLKSVNFDMTSKFLTALAQDGVINEEALSVTELDRVYGGLTTKVQESLKKQEGLLKNIQVSHQEFSKMKQSNNEANLREEVLKNLATAYDNFVELVANLKEGTKFYNELTEILVRFQNKCSDIVFARKTER","Homo sapiens","PDCD6IP, AIP1, ALIX, KIAA1375","Programmed cell death 6-interacting protein","1","2OJQ"
"2OJR",,"X-RAY DIFFRACTION",4.48,72.52,,7.5,"0.1M HEPES pH 7.5, 3.7 M NaCl, 33% MPD, VAPOR DIFFUSION, HANGING DROP, temperature 298K, pH 7.50",298,"10.1021/ja070481n",,"2OJR",12.76,"2.6","2.6","Structure of ubiquitin solved by SAD using the Lanthanide-Binding Tag","GPGYIDTNNDGWIEGDELYIDTNNDGWIEGDELLAMQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGG","Homo sapiens","UBC","Ubiquitin","1","2OJR"
"2OJW",,"X-RAY DIFFRACTION",2.41,49,,7.5,"10% Isopropanol, 200 mM NaCl, 100 mM HEPES, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K, pH 7.50",277,"10.1016/j.jmb.2007.10.029",,"2OJW",221.26,"2.05","2.05","Crystal structure of human glutamine synthetase in complex with ADP and phosphate","MHHHHHHSSGVDLGTENLYFQSMASSHLNKGIKQVYMSLPQGEKVQAMYIWIDGTGEGLRCKTRTLDSEPKCVEELPEWNFDGSSTLQSEGSNSDMYLVPAAMFRDPFRKDPNKLVLCEVFKYNRRPAETNLRHTCKRIMDMVSNQHPWFGMEQEYTLMGTDGHPFGWPSNGFPGPQGPYYCGVGADRAYGRDIVEAHYRACLYAGVKIAGTNAEVMPAQWEFQIGPCEGISMGDHLWVARFILHRVCEDFGVIATFDPKPIPGNWNGAGCHTNFSTKAMREENGLKYIEEAIEKLSKRHQYHIRAYDPKGGLDNARRLTGFHETSNINDFSAGVANRSASIRIPRTVGQEKKGYFEDRRPSANCDPFSVTEALIRTCLLNETG","Homo sapiens","GLUL, GLNS","Glutamine synthetase","1","2OJW"
"2OJX",,"X-RAY DIFFRACTION",1.84,33.25,"VAPOR DIFFUSION, HANGING DROP",7.5,"20 % PEG 10000, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1073/pnas.0609131104",,"2OJX",28.42,"2.85","2.85","Molecular and structural basis of polo-like kinase 1 substrate recognition: Implications in centrosomal localization","ETGEVVDCHLSDMLQQLHSVNASKPSERGLVRQEEAEDPACIPIFWVSKWVDYSDKYGLGYQLCDNSVGVLFNDSTRLILYNDGDSLQYIERDGTESYLTVSSHPNSLMKKITLLKYFRNYMSEHLLKAGANITPREGDELARLPYLRTWFRTRSAIILHLSNGSVQINFFQDHTKLILCPLMAAVTYIDEKRDFRTYRLSLLEEYGCCKELASRLRYARTMVDKLLSSRSASNRLKAS","Homo sapiens","PLK1, PLK","Serine/threonine-protein kinase PLK1","1","2OJX"
,,,,,,,,,,,,,,,,"LLCSTPNGL",,,"Synthetic peptide","2","2OJX"
"2OK1",,"X-RAY DIFFRACTION",2.34,47.52,"VAPOR DIFFUSION, HANGING DROP",7.5,"18-20% (v/v) polyethylene glycol monomethyl ether (average Mr =550), 10% (v/v) ethylene glycol, 20mM BME, 100mM HEPES, pH7.5), VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/jm061381f","33A","2OK1",42.49,"2.4","2.4","Crystal structure of JNK3 bound to N-benzyl-4-(4-(3-chlorophenyl)-1H-pyrazol-3-yl)-1H-pyrrole-2-carboxamide","MGSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVMNSE","Homo sapiens","MAPK10, JNK3, JNK3A, PRKM10, SAPK1B","Mitogen-activated protein kinase 10","1","2OK1"
"2OK3",,"X-RAY DIFFRACTION",2.23,44.86,"VAPOR DIFFUSION, HANGING DROP",8.3,"0.1mol/L Tris(pH=8.3), 0.01mol/L nickel(II)chloride hexahydrate, 17%(w/v) PEGMME2000, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,,,"2OK3",18.29,"2","2","X-ray structure of human cyclophilin J at 2.0 angstrom","MSVTLHTDVGDIKIEVFCERTPKTCENFLALCASNYYNGCIFHRNIKGFMVQTGDPTGTGRGGNSIWGKKFEDEYSEYLKHNVRGVVSMANNGPNTNGSQFFITYGKQPHLDMKYTVFGKVIDGLETLDELEKLPVNEKTYRPLNDVHIKDITIHANPFAQ","Homo sapiens","PPIL3b, PPIL3","Peptidyl-prolyl cis-trans isomerase-like 3","1","2OK3"
"2OK5",,"X-RAY DIFFRACTION",2.79,55.98,"VAPOR DIFFUSION, HANGING DROP",6.5,"12% PEG 1500, 0.02 M Malic acid, 0.04 M MES, 0.04 M TRIS, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1038/nsmb1210",,"2OK5",87.74,"2.3","2.3","Human Complement factor B","GSHHHHHHGSTPWSLARPQGSCSLEGVEIKGGSFRLLQEGQALEYVCPSGFYPYPVQTRTCRSTGSWSTLKTQDQKTVRKAECRAIHCPRPHDFENGEYWPRSPYYNVSDEISFHCYDGYTLRGSANRTCQVNGRWSGQTAICDNGAGYCSNPGIPIGTRKVGSQYRLEDSVTYHCSRGLTLRGSQRRTCQEGGSWSGTEPSCQDSFMYDTPQEVAEAFLSSLTETIEGVDAEDGHGPGEQQKRKIVLDPSGSMNIYLVLDGSDSIGASNFTGAKKCLVNLIEKVASYGVKPRYGLVTYATYPKIWVKVSEADSSNADWVTKQLNEINYEDHKLKSGTNTKKALQAVYSMMSWPDDVPPEGWNRTRHVIILMTDGLHNMGGDPITVIDEIRDLLYIGKDRKNPREDYLDVYVFGVGPLVNQVNINALASKKDNEQHVFKVKDMENLEDVFYQMIDESQSLSLCGMVWEHRKGTDYHKQPWQAKISVIRPSKGHESCMGAVVSEYFVLTAAHCFTVDDKEHSIKVSVGGEKRDLEIEVVLFHPNYNINGKKEAGIPEFYDYDVALIKLKNKLKYGQTIRPICLPCTEGTTRALRLPPTTTCQQQKEELLPAQDIKALFVSEEEKKLTRKEVYIKNGDKKGSCERDAQYAPGYDKVKDISEVVTPRFLCTGGVSPYADPNTCRGDSGGPLIVHKRSRFIQVGVISWGVVDVCKNQKRQKQVPAHARDFHINLFQVLPWLKEKLQDEDLGFLAAA","Homo sapiens","CFB, BF, BFD","Complement factor B","1","2OK5"
"2OKJ",,"X-RAY DIFFRACTION",2.23,44.83,"VAPOR DIFFUSION, HANGING DROP",6.3,"18% PEG8,000, 100 mM MES, pH 6.3, 10 mM 2-mercaptoethanol and 20  mM CaCl2, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1038/nsmb1228",,"2OKJ",115.31,"2.3","2.3","The X-ray crystal structure of the 67kDa isoform of Glutamic Acid Decarboxylase (GAD67)","TDFSNLFARDLLPAKNGEEQTVQFLLEVVDILLNYVRKTFDRSTKVLDFHHPHQLLEGMEGFNLELSDHPESLEQILVDCRDTLKYGVRTGHPRFFNQLSTGLDIIGLAGEWLTSTANTNMFTYEIAPVFVLMEQITLKKMREIVGWSSKDGDGIFSPGGAISNMYSIMAARYKYFPEVKTKGMAAVPKLVLFTSEQSHYSIKKAGAALGFGTDNVILIKCNERGKIIPADFEAKILEAKQKGYVPFYVNATAGTTVYGAFDPIQEIADICEKYNLWLHVDAAWGGGLLMSRKHRHKLNGIERANSVTWNPHKMMGVLLQCSAILVKEKGILQGCNQMCAGYLFQPDKQYDVSYDTGDKAIQCGRHVDIFKFWLMWKAKGTVGFENQINKCLELAEYLYAKIKNREEFEMVFNGEPEHTNVCFWYIPQSLRGVPDSPQRREKLHKVAPKIKALMMESGTTMVGYQPQGDKANFFRMVISNPAATQSDIDFLIEEIERLGQDLHH","Homo sapiens","GAD1, GAD, GAD67","Glutamate decarboxylase 1","1","2OKJ"
"2OKK",,"X-RAY DIFFRACTION",2.05,39.91,"VAPOR DIFFUSION, HANGING DROP",6.2,"20% ethanol, 100  mM MES, 10 mM 2-mercaptoethanol, 20 mM CaCl2, pH 6.2, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1038/nsmb1228",,"2OKK",57.08,"2.3","2.3","The X-ray crystal structure of the 65kDa isoform of Glutamic Acid Decarboxylase (GAD65)","NYAFLHATDLLPACDGERPTLAFLQDVMNILLQYVVKSFDRSTKVIDFHYPNELLQEYNWELADQPQNLEEILMHCQTTLKYAIKTGHPRYFNQLSTGLDMVGLAADWLTSTANTNMFTYEIAPVFVLLEYVTLKKMREIIGWPGGSGDGIFSPGGAISNMYAMMIARFKMFPEVKEKGMAALPRLIAFTSEHSHFSLKKGAAALGIGTDSVILIKCDERGKMIPSDLERRILEAKQKGFVPFLVSATAGTTVYGAFDPLLAVADICKKYKIWMHVDAAWGGGLLMSRKHKWKLSGVERANSVTWNPHKMMGVPLQCSALLVREEGLMQNCNQMHASYLFQQDKHYDLSYDTGDKALQCGRHVDVFKLWLMWRAKGTTGFEAHVDKCLELAEYLYNIIKNREGYEMVFDGKPQHTNVCFWYIPPSLRTLEDNEERMSRLSKVAPVIKARMMEYGTTMVSYQPLGDKVNFFRMVISNPAATHQDIDFLIEEIERLGQD","Homo sapiens","GAD2, GAD65","Glutamate decarboxylase 2","1","2OKK"
"2OKN",,"X-RAY DIFFRACTION",2.74,55.16,"VAPOR DIFFUSION, SITTING DROP",7,"1.5M sodium/potassium phosphate, 0.05M sodium chloride, 0.02% sodium acide, 0.02M dithiothreitol, 0.02M manganese chloride, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,,,"2OKN",109.83,"2.45","2.45","Crystal Strcture of Human Prolidase","GSAAATGPSFWLGNETLKVPLALFALNRQRLCERLRKNPAVQAGSIVVLQGGEETQRYCTDTGVLFRQESFFHWAFGVTEPGCYGVIDVDTGKSTLFVPRLPASHATWMGKIHSKEHFKEKYAVDDVQYVDEIASVLTSQKPSVLLTLRGVNTDSGSVCREASFDGISKFEVNNTILHPEIVECRVFKTDMELEVLRYTNKISSEAHREVMKAVKVGMKEYELESLFEHYCYSRGGMRHSSYTCICGSGENSAVLHYGHAGAPNDRTIQNGDMCLFDMGGEYYCFASDITCSFPANGKFTADQKAVYEAVLRSSRAVMGAMKPGVWWPDMHRLADRIHLEELAHMGILSGSVDAMVQAHLGAVFMPHGLGHFLGIDVHDVGGYPEGVERIDEPGLRSLRTARHLQPGMVLTVEPGIYFIDHLLDEALADPARASFFNREVLQRFRGFGGVRIEEDVVVTDSGIELLTCVPRTVEEIEACMAGCDKAFTPFSGPK","Homo sapiens","PEPD, PRD","Xaa-Pro dipeptidase","1","2OKN"
"2OKR",,"X-RAY DIFFRACTION",2.6,52.67,"VAPOR DIFFUSION, HANGING DROP",7.2,"25% Peg 3350, 250 mM Sodium Formate, pH 7.2, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1074/jbc.M611165200",,"2OKR",89.62,"2","2","Crystal Structure of the P38a-MAPKAP kinase 2 Heterodimer","GSHMLEMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES","Homo sapiens","MAPK14, CSBP, CSBP1, CSBP2, MXI2, CSPB1, SAPK2A","Mitogen-activated protein kinase 14","1","2OKR"
,,,,,,,,,,,,,,,,"IKIKKIEDASNPLLLKRRKKARAL",,,"MAP kinase-activated protein kinase 2","2","2OKR"
"2OKV",,"X-RAY DIFFRACTION",1.98,37.92,"VAPOR DIFFUSION, HANGING DROP",6.5,"10% PEG 8000, 200 mM KCl, 50 mM sodium cacodylate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 290K",290,"10.1074/jbc.M609632200",,"2OKV",93.94,"2","2","c-Myc DNA Unwinding Element Binding Protein","MKAVVQRVTRASVTVGGEQISAIGRGICVLLGISLEDTQKELEHMVRKILNLRVFEDESGKHWSKSVMDKQYEILCVSQFTLQCVLKGNKPDFHLAMPTEQAEGFYNSFLEQLRKTYRPELIKDGKFGAYMQVHIQNDGPVTIELESPAPGTATSDPKQLSKLEKQQQRKEKTRAKGPSESSKERNTPRKEDRSASSGAEGDVSSEREP","Homo sapiens","HARS2, C20orf88, DTD1, DUEB","Probable D-tyrosyl-tRNA(Tyr) deacylase 1","1","2OKV"
"2OL2",,"X-RAY DIFFRACTION",2.51,51.02,"VAPOR DIFFUSION, HANGING DROP",,"6% PEG 3350, 0.04M ammonium citrate,10% glycerol, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1074/jbc.M701074200",,"2OL2",89.15,"2","2","High Resolution Structure of Native PCI in Space Group P21","MGHHHHHHHHHHSSGHIDDDDKHMVGATVAPSSRRDFTFDLYRALASAAPSQNIFFSPVSISMSLAMLSLGAGSSTKMQILEGLGLNLQKSSEKELHRGFQQLLQELNQPRDGFQLSLGNALFTDLVVDLQDTFVSAMKTLYLADTFPTNFRDSAGAMKQINDYVAKQTKGKIVDLLKNLDSNAVVIMVNYIFFKAKWETSFNHKGTQEQDFYVTSETVVRVPMMSREDQYHYLLDRNLSCRVVGVPYQGNATALFILPSEGKMQQVENGLSEKTLRKWLKMFKKRQLELYLPKFSIEGSYQLEKVLPSLGISNVFTSHADLSGISNHSNIQVSEMVHKAVVEVDESGTRAAAATGTIFTFRSARLNSQRLVFNRPFLMFIVDNNILFLGKVNRP","Homo sapiens","SERPINA5, PCI, PLANH3, PROCI","Plasma serine protease inhibitor","1","2OL2"
"2OLD",,"X-RAY DIFFRACTION",3.6,65.86,"VAPOR DIFFUSION, SITTING DROP",4,"2.88M NaH2PO4, 0.72M K2HPO4, 0.1M Na2HPO4/Citric Acid pH4.0, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,"10.1107/S0907444907021981",,"2OLD",46.06,"2.6","2.6","Bence Jones KWR Protein- Immunoglobulin Light Chain Dimer, P3(2)21 Crystal Form","QSALPQPASVSGSPGQSITISCTGTSSDVGGYDLVSWYQHHPGGAPKLIIYEVTNRPSGVSDRFSGSKSGNTASLTISGLQAEDEADYYCSSYASGSTPRIFGGGTRLTVLGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS","Homo sapiens",,"Bence Jones KWR Protein - Immunoglobulin Light Chain","1","2OLD"
"2OLE",,"X-RAY DIFFRACTION",2.73,54.88,"VAPOR DIFFUSION, HANGING DROP",8,"24% PEG 4000, 0.1M Tris, 0.3M Sodium acetate, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1016/j.bmcl.2007.01.111","KR2","2OLE",169.76,"2.4","2.4","Crystal Structure Of Human Dipeptidyl Peptidase IV (DPPIV) Complex With Cyclic Hydrazine Derivatives","SRKTYTLTDYLKNTYRLKLYSLRWISDHEYLYKQENNILVFNAEYGNSSVFLENSTFDEFGHSINDYSISPDGQFILLEYNYVKQWRHSYTASYDIYDLNKRQLITEERIPNNTQWVTWSPVGHKLAYVWNNDIYVKIEPNLPSYRITWTGKEDIIYNGITDWVYEEEVFSAYSALWWSPNGTFLAYAQFNDTEVPLIEYSFYSDESLQYPKTVRVPYPKAGAVNPTVKFFVVNTDSLSSVTNATSIQITAPASMLIGDHYLCDVTWATQERISLQWLRRIQNYSVMDICDYDESSGRWNCLVARQHIEMSTTGWVGRFRPSEPHFTLDGNSFYKIISNEEGYRHICYFQIDKKDCTFITKGTWEVIGIEALTSDYLYYISNEYKGMPGGRNLYKIQLSDYTKVTCLSCELNPERCQYYSVSFSKEAKYYQLRCSGPGLPLYTLHSSVNDKGLRVLEDNSALDKMLQNVQMPSKKLDFIILNETKFWYQMILPPHFDKSKKYPLLLDVYAGPCSQKADTVFRLNWATYLASTENIIVASFDGRGSGYQGDKIMHAINRRLGTFEVEDQIEAARQFSKMGFVDNKRIAIWGWSYGGYVTSMVLGSGSGVFKCGIAVAPVSRWEYYDSVYTERYMGLPTPEDNLDHYRNSTVMSRAENFKQVEYLLIHGTADDNVHFQQSAQISKALVDVGVDFQAMWYTDEDHGIASSTAHQHIYTHMSHFIKQCFSLP","Homo sapiens","chromosome 2, DPP4, ADCP2, CD26","Dipeptidyl peptidase 4","1","2OLE"
"2OLM",,"X-RAY DIFFRACTION",2.3,45.6,"VAPOR DIFFUSION, SITTING DROP",7,"2.27M Ammonium phosphate, 0.09M BTP, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,,,"2OLM",16.51,"1.48","1.48","ArfGap domain of HIV-1 Rev binding protein","GSSAKRKQEEKHLKMLRDMTGLPHNRKCFDCDQRGPTYVNMTVGSFVCTSCSGSLRGLNPPHRVKSISMTTFTQQEIEFLQKHGNEVCKQIWLGLFDDRSSAIPDFRDPQKVKEFLQEKYEKKRWYVPPEQAKVVASVHA","Homo sapiens","HRB, RAB, RIP, AGFG1","Nucleoporin-like protein RIP","1","2OLM"
"2OLY",,"X-RAY DIFFRACTION",2.44,49.53,"VAPOR DIFFUSION, HANGING DROP",7,"2.5M NaCl, 4M urea, 100mM phosphate buffer, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1186/1472-6807-7-83",,"2OLY",36.61,"1.7","1.7","Structure of human insulin in presence of urea at pH 7.0","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","Insulin A chain","1","2OLY"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFYTPKT","Homo sapiens","INS","Insulin B chain","2","2OLY"
"2OLZ",,"X-RAY DIFFRACTION",2.44,49.64,"VAPOR DIFFUSION, HANGING DROP",7,"15mM Na-SCN, 5%(v/v) ethanol, 200mM phosphate buffer pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1186/1472-6807-7-83",,"2OLZ",35.91,"1.7","1.7","Structure of human insulin in presence of thiocyanate at pH 7.0","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","Insulin A","1","2OLZ"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFYTPKT","Homo sapiens","INS","Insulin B","2","2OLZ"
"2OM0",,"X-RAY DIFFRACTION",3.45,64.35,"VAPOR DIFFUSION, HANGING DROP",6.5,"2M NaCl, 3M urea, 100mM phosphate buffer, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1186/1472-6807-7-83",,"2OM0",108.03,"2.05","2.05","Structure of human insulin in presence of urea at pH 6.5","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","Insulin A chain","1","2OM0"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFYTPKT","Homo sapiens","INS","Insulin B chain","2","2OM0"
"2OM1",,"X-RAY DIFFRACTION",3.47,64.55,"VAPOR DIFFUSION, HANGING DROP",6.5,"15mM Na-SCN, 5%(v/v) ethanol, 200mM phosphate buffer, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1186/1472-6807-7-83",,"2OM1",107.53,"1.97","1.97","Structure of human insulin in presence of thiocyanate at pH 6.5","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","Insulin A chain","1","2OM1"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFYTPKT","Homo sapiens","INS","Insulin B chain","2","2OM1"
"2OM2",,"X-RAY DIFFRACTION",3.26,62.21,"VAPOR DIFFUSION, SITTING DROP",5,"1.55M Ammonium Sulfate, 100 mM Sodium Acetate pH 5.0, 10% Glycerol, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.jmb.2007.05.096",,"2OM2",83.44,"2.2","2.2","Crystal Structure Of Human G[alpha]i1 Bound To The Goloco Motif Of Rgs14","GAREVKLLLLGAGESGKSTIVKQMKIIHEAGYSEEECKQYKAVVYSNTIQSIIAIIRAMGRLKIDFGDSARADDARQLFVLAGAAEEGFMTAELAGVIKRLWKDSGVQACFNRSREYQLNDSAAYYLNDLDRIAQPNYIPTQQDVLRTRVKTTGIVETHFTFKDLHFKMFDVGGQRSERKKWIHCFEGVTAIIFCVALSDYDLVLAEDEEMNRMHESMKLFDSICNNKWFTDTSIILFLNKKDLFEEKIKKSPLTICYPEYAGSNTYEEAAAYIQCQFEDLNKRKDTKEIYTHFTCATDTKNVQFVFDAVTDVIIKNNLKDCGLF","Homo sapiens","GNAI1","Guanine nucleotide-binding protein G(i), alpha-1 subunit","1","2OM2"
,,,,,,,,,,,,,,,,"DIEGLVELLNRVQSSGAHDQRGLLRKEDLVLPEFLQ",,,"Regulator of G-protein signalling 14 GoLoco motif peptide","2","2OM2"
"2OM5",,"X-RAY DIFFRACTION",2.39,48.53,"VAPOR DIFFUSION, SITTING DROP",8.5,"PEG 20k, potassium chloride, tris, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1110/ps.072802707",,"2OM5",42.21,"3.07","3.07","N-Terminal Fragment of Human TAX1","TFGPVFEDQPLSVLFPEESTEEQVLLACRARASPPATYRWKMNGTEMKLEPGSRHQLVGGNLVIMNPTKAQDAGVYQCLASNPVGTVVSREAILRFGFLQEFSKEERDPVKAHEGWGVMLPCNPPAHYPGLSYRWLLNEFPNFIPTDGRHFVSQTTGNLYIARTNASDLGNYSCLATSHMDFSTKSVFSKFAQLNLAAEDTRLFAPSIKARFPAETYALVGQQVTLECFAFGNPVPRIKWRKVDGSLSPQWTTAEPTLQIPSVSFEDEGTYECEAENSKGRDTVQGRIIVQAQPEWLKVISDTEADIGSNLRWGCAAAGKPRPTVRWLRNGEPLASQNRVEVLAGDLRFSKLSLEDSGMYQCVAENKHGTIYASAELAVQA","Homo sapiens","CNTN2, TAG1, TAX, AXT, TAX1","Contactin 2","1","2OM5"
"2OM9",,"X-RAY DIFFRACTION",3.82,67.82,,,"4M sodium formate, VAPOR DIFFUSION, HANGING DROP, temperature 283K",283,"10.1074/jbc.M702538200",,"2OM9",130.14,"2.8","2.8","Ajulemic acid, a synthetic cannabinoid bound to PPAR gamma","GSHMLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","2OM9"
"2OMB",,"X-RAY DIFFRACTION",3.52,65.03,"VAPOR DIFFUSION, SITTING DROP",8,"1.5 M Ammonium Sulfate, 0.1M Tris/HCl pH8.0, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,"10.1107/S0907444907021981",,"2OMB",91.85,"2.9","2.9","Bence Jones KWR Protein- Immunoglobulin Light Chain Dimer, P3(1)21 Crystal Form","QSALPQPASVSGSPGQSITISCTGTSSDVGGYDLVSWYQHHPGGAPKLIIYEVTNRPSGVSDRFSGSKSGNTASLTISGLQAEDEADYYCSSYASGSTPRIFGGGTRLTVLGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS","Homo sapiens",,"Bence Jones KWR Protein - Immunoglobulin Light Chain","1","2OMB"
"2OME",,"X-RAY DIFFRACTION",2.84,56.74,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.2M KSCN, 0.1M BIS-TRIS PROPANE, 20% PEG3350, 10% ETHYLENE GLYCOL, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,,,"2OME",303.5,"2.8","2.8","Crystal structure of human CTBP2 dehydrogenase complexed with NAD(H)","SMHPRPLVALLDGRDCTVEMPILKDLATVAFCDAQSTQEIHEKVLNEAVGAMMYHTITLTREDLEKFKALRVIVRIGSGYDNVDIKAAGELGIAVCNIPSAAVEETADSTICHILNLYRRNTWLYQALREGTRVQSVEQIREVASGAARIRGETLGLIGFGRTGQAVAVRAKAFGFSVIFYDPYLQDGIERSLGVQRVYTLQDLLYQSDCVSLHCNLNEHNHHLINDFTIKQMRQGAFLVNAARGGLVDEKALAQALKEGRIRGAALDVHESEPFSFAQGPLKDAPNLICTPHTAWYSEQASLEMREAAATEIRRAITGRIPESLRNCVNKEFFVT","Homo sapiens","CTBP2","C-terminal-binding protein 2","1","2OME"
"2OMG",,"X-RAY DIFFRACTION",2.33,47.18,"VAPOR DIFFUSION, HANGING DROP",7.3,"60mM m-cresol, 3M urea, 1.0 mg/ml protamine sulphate, 400mM NaCl, 40mM phosphate buffer, pH 7.3, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1016/j.ejps.2007.01.003",,"2OMG",18.49,"1.52","1.52","Structure of human insulin cocrystallized with protamine and urea","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","Insulin A chain","1","2OMG"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFYTPKT","Homo sapiens","INS","Insulin B chain","2","2OMG"
"2OMH",,"X-RAY DIFFRACTION",2.31,46.7,"VAPOR DIFFUSION, HANGING DROP",7.3,"500mM NaCl, 2.5M urea, 1.2mg/ml ARG-12 peptide, 50mM resorcinol, 50mM phosphate buffer, pH 7.3, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1016/j.ejps.2007.01.003",,"2OMH",18.24,"1.36","1.36","Structure of human insulin cocrystallized with ARG-12 peptide in presence of urea","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","Insulin A chain","1","2OMH"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFYTPKT","Homo sapiens","INS","Insulin B chain","2","2OMH"
"2OMI",,"X-RAY DIFFRACTION",2.3,46.63,"VAPOR DIFFUSION, HANGING DROP",7.3,"50mM resorcinol, 400mM NaCl, 1.0mg/ml protamine 30mM phosphate buffer, pH 7.3, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1016/j.ejps.2007.01.003",,"2OMI",35.77,"2.24","2.24","Structure of human insulin cocrystallized with protamine","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","Insulin A chain","1","2OMI"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFYTPKT","Homo sapiens","INS","Insulin B chain","2","2OMI"
"2OMJ",,"SOLUTION NMR",,,,,,,,,"2OMJ",9.37,,,"solution structure of LARG PDZ domain","GSHMGLVQRCVIIQKDDNGFGLTVSGDNPVFVQSVKEDGAAMRAGVQTGDRIIKVNGTLVTHSNHLEVVKLIKSGSYVALTVQGRPPGS","Homo sapiens","ARHGEF12, KIAA0382, LARG","Rho guanine nucleotide exchange factor 12","1","2OMJ"
"2OMN",,"X-RAY DIFFRACTION",2.35,47.75,"VAPOR DIFFUSION, SITTING DROP",8,"1.5M Ammonium Sulfate, 0.1M Tris/HCl pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,"10.1107/S0907444907021981",,"2OMN",45.78,"2.2","2.2","Bence Jones KWR Protein- Immunoglobulin Light Chain Dimer, P4(3)2(1)2 Crystal Form","QSALPQPASVSGSPGQSITISCTGTSSDVGGYDLVSWYQHHPGGAPKLIIYEVTNRPSGVSDRFSGSKSGNTASLTISGLQAEDEADYYCSSYASGSTPRIFGGGTRLTVLGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS","Homo sapiens",,"Bence Jones KWR Protein - Immunoglobulin Light Chain","1","2OMN"
"2ON3",,"X-RAY DIFFRACTION",2.13,42.15,"VAPOR DIFFUSION, SITTING DROP",6.5,"25% PEG3350, 0.2 M ammonium acetate, 0.1 M Bis-Tris, 2 mM APA, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 288.15K",288.15,"10.1042/BJ20070188","XAP","2ON3",102.59,"3","3","A structural insight into the inhibition of human and Leishmania donovani ornithine decarboxylases by 3-aminooxy-1-aminopropane","MNNFGNEEFDCHFLDEGFTAKDILDQKINEVSSSDDKDAFYVADLGDILKKHLRWLKALPRVTPFYAVKCNDSKAIVKTLAATGTGFDCASKTEIQLVQSLGVPPERIIYANPCKQVSQIKYAANNGVQMMTFDSEVELMKVARAHPKAKLVLRIATDDSKAVCRLSVKFGATLRTSRLLLERAKELNIDVVGVSFHVGSGCTDPETFVQAISDARCVFDMGAEVGFSMYLLDIGGGFPGSEDVKLKFEEITGVINPALDKYFPSDSGVRIIAEPGRYYVASAFTLAVNIIAKKIVLKEQTGSDDEDESSEQTFMYYVNDGVYGSFNCILYDHAHVKPLLQKRPKPDEKYYSSSIWGPTCDGLDRIVERCDLPEMHVGDWMLFENMGAYTVAAASTFNGFQRPTIYYVMSGPAWQLMQQFQNPDFPPEVEEQDASTLPVSCAWESGMKRHRAACASASINV","Homo sapiens","ODC1","Ornithine decarboxylase","1","2ON3"
"2ON6",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, SITTING DROP",4.6,"0.1 M Sodium Acetate, 4.0 M Ammonium Acetate, pH 4.6, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1021/bi700147b","IMH","2ON6",32.46,"2.503","2.503","Crystal structure of human purine nucleoside phosphorylase mutant H257F with Imm-H","MENGYTYEDYKNTAEWLLSHTKHRPQVAIICGSGLGGLTDKLTQAQIFDYSEIPNFPRSTVPGHAGRLVFGFLNGRACVMMQGRFHMYEGYPLWKVTFPVRVFHLLGVDTLVVTNAAGGLNPKFEVGDIMLIRDHINLPGFSGQNPLRGPNDERFGDRFPAMSDAYDRTMRQRALSTWKQMGEQRELQEGTYVMVAGPSFETVAECRVLQKLGADAVGMSTVPEVIVARHCGLRVFGFSLITNKVIMDYESLEKANFEEVLAAGKQAAQKLEQFVSILMASIPLPDKAS","Homo sapiens","NP, PNP","Purine nucleoside phosphorylase","1","2ON6"
"2ONB",,"X-RAY DIFFRACTION",3.02,59.29,"VAPOR DIFFUSION, HANGING DROP",8.5,"30 mM ammonium sulfate, 30 mM 40% PEG 4K, 0.1 M Tris pH 8.5, 20 mM 2-ME, VAPOR DIFFUSION, HANGING DROP, temperature 290K",290,"10.1021/bi061309j","7PA","2ONB",36.43,"2.7","2.7","Human Thymidylate Synthase at low salt conditions with PDPA bound","MPVAGSELPRRPLPPAAQERDAEPRPPHGELQYLGQIQHILRCGVRKDDRTGTGTLSVFGMQARYSLRDEFPLLTTKRVFWKGVLEELLWFIKGSTNAKELSSKGVKIWDANGSRDFLDSLGFSTREEGDLGPVYGFQWRHFGAEYRDMESDYSGQGVDQLQRVIDTIKTNPDDRRIIMCAWNPRDLPLMALPPCHALCQFYVVNSELSCQLYQRSGDMGLGVPFNIASYALLTYMIAHITGLKPGDFIHTLGDAHIYLNHIEPLKIQLQREPRPFPKLRILRKVEKIDDFKAEDFQIEGYNPHPTIKMEMAV","Homo sapiens","TYMS, TS, OK/SW-cl.29","Thymidylate synthetase","1","2ONB"
"2ONC",,"X-RAY DIFFRACTION",2.94,58.21,"VAPOR DIFFUSION, HANGING DROP",8.5,"20% PEG2000MME, 0.1M Bicine, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/jm070104l","SY1","2ONC",346.99,"2.55","2.55","Crystal structure of human DPP-4","HHASAKTYTLTDYLKNTYRLKLYSLRWISDHEYLYKQENNILVFNAEYGNSSVFLENSTFDEFGHSINDYSISPDGQFILLEYNYVKQWRHSYTASYDIYDLNKRQLITEERIPNNTQWVTWSPVGHKLAYVWNNDIYVKIEPNLPSYRITWTGKEDIIYNGITDWVYEEEVFSAYSALWWSPNGTFLAYAQFNDTEVPLIEYSFYSDESLQYPKTVRVPYPKAGAVNPTVKFFVVNTDSLSSVTNATSIQITAPASMLIGDHYLCDVTWATQERISLQWLRRIQNYSVMDICDYDESSGRWNCLVARQHIEMSTTGWVGRFRPSEPHFTLDGNSFYKIISNEEGYRHICYFQIDKKDCTFITKGTWEVIGIEALTSDYLYYISNEYKGMPGGRNLYKIQLSDYTKVTCLSCELNPERCQYYSVSFSKEAKYYQLRCSGPGLPLYTLHSSVNDKGLRVLEDNSALDKMLQNVQMPSKKLDFIILNETKFWYQMILPPHFDKSKKYPLLLDVYAGPCSQKADTVFRLNWATYLASTENIIVASFDGRGSGYQGDKIMHAINRRLGTFEVEDQIEAARQFSKMGFVDNKRIAIWGWSYGGYVTSMVLGSGSGVFKCGIAVAPVSRWEYYDSVYTERYMGLPTPEDNLDHYRNSTVMSRAENFKQVEYLLIHGTADDNVHFQQSAQISKALVDVGVDFQAMWYTDEDHGIASSTAHQHIYTHMSHFIKQCFSLP","Homo sapiens","DPP4, ADCP2, CD26","Dipeptidyl peptidase 4","1","2ONC"
"2ONI",,"X-RAY DIFFRACTION",2.95,58.38,"VAPOR DIFFUSION, HANGING DROP",7,"THE PROTEIN WAS DISSOLVED AT 10 mg/mL IN 10 mM TRIS-HCL, PH 8.0, 
100 mM NaCl, 2% GLYCEROL AND 1 mM DTT. CRYSTALS WERE GROWN BY 
VAPOR DIFFUSION, HANGING DROPS BY MIXING 2 MICROL PROTEIN SOLUTION 
WITH 2 MICROL WELL SOLUTION (1.7 M SODIUM/POTASSIUM PHOSPHATE, PH 6.0, 
1 mM DTT) AT TEMPERATURE 294.0K. FOR CRYOPROTECTION, THE CRYSTALS WERE 
SOAKED IN 2 M SODIUM-POTASSIUM PHOSPHATE, pH 7.0, 1 mM DTT, 25% 
ETHYLENE GLYCOL AND 2 mG/mL SEMETNEDD4L.574.947.",294,,,"2ONI",47.27,"2.2","2.2","Catalytic Domain of the Human NEDD4-like E3 Ligase","MHHHHHHSSGRENLYFQGSREFKQKYDYFRKKLKKPADIPNRFEMKLHRNNIFEESYRRIMSVKRPDVLKARLWIEFESEKGLDYGGVAREWFFLLSKEMFNPYYGLFEYSATDNYTLQINPNSGLCNEDHLSYFTFIGRVAGLAVFHGKLLDGFFIRPFYKMMLGKQITLNDMESVDSEYYNSLKWILENDPTELDLMFCIDEENFGQTYQVDLKPNGSEIMVTNENKREYIDLVIQWRFVNRVQKQMNAFLEGFTELLPIDLIKIFDENELELLMCGLGDVDVNDWRQHSIYKNGYCPNHPVIQWFWKAVLLMDAEKRIRLLQFVTGTSRVPMNGFAELYGSNGPQLFTIEQWGSPEKLPRAHTCFNRLDLPPYETFEDLREKLLMAVEN","Homo sapiens","NEDD4L, KIAA0439, NEDL3","E3 ubiquitin-protein ligase NEDD4-like protein","1","2ONI"
"2ONM",,"X-RAY DIFFRACTION",2.44,49.53,"VAPOR DIFFUSION",6.8,"100 mM ACES (N-[2-Acetamido]-2-aminoethane sulfonic acid), 10mM MgCl2, 100 mM Guanidine HCl, 15% w/v PEG 6000, 8mM DTT, pH 6.8, VAPOR DIFFUSION, temperature 293K",293,"10.1074/jbc.M607959200",,"2ONM",662.78,"2.5","2.5","Human Mitochondrial Aldehyde Dehydrogenase Asian Variant, ALDH2*2, complexed with NAD+","SAAATQAVPAPNQQPEVFCNQIFINNEWHDAVSRKTFPTVNPSTGEVICQVAEGDKEDVDKAVKAARAAFQLGSPWRRMDASHRGRLLNRLADLIERDRTYLAALETLDNGKPYVISYLVDLDMVLKCLRYYAGWADKYHGKTIPIDGDFFSYTRHEPVGVCGQIIPWNFPLLMQAWKLGPALATGNVVVMKVAEQTPLTALYVANLIKEAGFPPGVVNIVPGFGPTAGAAIASHEDVDKVAFTGSTEIGRVIQVAAGSSNLKRVTLELGGKSPNIIMSDADMDWAVEQAHFALFFNQGQCCCAGSRTFVQEDIYDEFVERSVARAKSRVVGNPFDSKTEQGPQVDETQFKKILGYINTGKQEGAKLLCGGGIAADRGYFIQPTVFGDVQDGMTIAKEEIFGPVMQILKFKTIEEVVGRANNSTYGLAAAVFTKDLDKANYLSQALQAGTVWVNCYDVFGAQSPFGGYKMSGSGRELGEYGLQAYTKVKTVTVKVPQKNS","Homo sapiens","ALDH2, ALDM","Aldehyde dehydrogenase, mitochondrial precursor","1","2ONM"
"2ONN",,"X-RAY DIFFRACTION",2.16,43.03,"VAPOR DIFFUSION",6.6,"100 mM ACES (N-[2-Acetamido]-2-aminoethane sufonic acid), 10mM MgCl2, 100 mM Guanidine HCl, 16% w/v PEG 6000, 4 mM DTT, pH 6.6, vapor diffusion, temperature 293K",293,"10.1074/jbc.M607959200",,"2ONN",435.76,"2.75","2.75","Arg475Gln Mutant of Human Mitochondrial Aldehyde Dehydrogenase, Apo form","SAAATQAVPAPNQQPEVFCNQIFINNEWHDAVSRKTFPTVNPSTGEVICQVAEGDKEDVDKAVKAARAAFQLGSPWRRMDASHRGRLLNRLADLIERDRTYLAALETLDNGKPYVISYLVDLDMVLKCLRYYAGWADKYHGKTIPIDGDFFSYTRHEPVGVCGQIIPWNFPLLMQAWKLGPALATGNVVVMKVAEQTPLTALYVANLIKEAGFPPGVVNIVPGFGPTAGAAIASHEDVDKVAFTGSTEIGRVIQVAAGSSNLKRVTLELGGKSPNIIMSDADMDWAVEQAHFALFFNQGQCCCAGSRTFVQEDIYDEFVERSVARAKSRVVGNPFDSKTEQGPQVDETQFKKILGYINTGKQEGAKLLCGGGIAADRGYFIQPTVFGDVQDGMTIAKEEIFGPVMQILKFKTIEEVVGRANNSTYGLAAAVFTKDLDKANYLSQALQAGTVWVNCYDVFGAQSPFGGYKMSGSGQELGEYGLQAYTEVKTVTVKVPQKNS","Homo sapiens","ALDH2, ALDM","Aldehyde dehydrogenase","1","2ONN"
"2ONO",,"X-RAY DIFFRACTION",2.069,41.15,,6.6,"100 mM ACES (N-[2-Acetamido]-2-aminoethane sufonic acid), 5 mM MgCl2, 100 mM Guanidine HCl, 18% w/v PEG 6000, 6 mM DTT, pH 6.6, vapor diffusion, temperature 293K, pH 6.60",293,"10.1074/jbc.M607959200",,"2ONO",435.76,"2.15","2.15","Arg475Gln Mutant of Mitochondrial Aldehyde Dehydrogenase, apo form, pseudo-merohedrally twinned","SAAATQAVPAPNQQPEVFCNQIFINNEWHDAVSRKTFPTVNPSTGEVICQVAEGDKEDVDKAVKAARAAFQLGSPWRRMDASHRGRLLNRLADLIERDRTYLAALETLDNGKPYVISYLVDLDMVLKCLRYYAGWADKYHGKTIPIDGDFFSYTRHEPVGVCGQIIPWNFPLLMQAWKLGPALATGNVVVMKVAEQTPLTALYVANLIKEAGFPPGVVNIVPGFGPTAGAAIASHEDVDKVAFTGSTEIGRVIQVAAGSSNLKRVTLELGGKSPNIIMSDADMDWAVEQAHFALFFNQGQCCCAGSRTFVQEDIYDEFVERSVARAKSRVVGNPFDSKTEQGPQVDETQFKKILGYINTGKQEGAKLLCGGGIAADRGYFIQPTVFGDVQDGMTIAKEEIFGPVMQILKFKTIEEVVGRANNSTYGLAAAVFTKDLDKANYLSQALQAGTVWVNCYDVFGAQSPFGGYKMSGSGQELGEYGLQAYTEVKTVTVKVPQKNS","Homo sapiens","ALDH2, ALDM","Aldehyde dehydrogenase","1","2ONO"
"2ONP",,"X-RAY DIFFRACTION",2.19,43.91,"VAPOR DIFFUSION",6.6,"100 mM ACES (N-[2-Acetamido]-2-aminoethane sufonic acid), 10mM MgCl2, 100 mM Guanidine HCl, 16% w/v PEG 6000, 8 mM DTT, pH 6.6, vapor diffusion, temperature 293K",293,"10.1074/jbc.M607959200",,"2ONP",445.52,"2","2","Arg475Gln Mutant of Human Mitochondrial Aldehyde Dehydrogenase, complexed with NAD+","SAAATQAVPAPNQQPEVFCNQIFINNEWHDAVSRKTFPTVNPSTGEVICQVAEGDKEDVDKAVKAARAAFQLGSPWRRMDASHRGRLLNRLADLIERDRTYLAALETLDNGKPYVISYLVDLDMVLKCLRYYAGWADKYHGKTIPIDGDFFSYTRHEPVGVCGQIIPWNFPLLMQAWKLGPALATGNVVVMKVAEQTPLTALYVANLIKEAGFPPGVVNIVPGFGPTAGAAIASHEDVDKVAFTGSTEIGRVIQVAAGSSNLKRVTLELGGKSPNIIMSDADMDWAVEQAHFALFFNQGQCCCAGSRTFVQEDIYDEFVERSVARAKSRVVGNPFDSKTEQGPQVDETQFKKILGYINTGKQEGAKLLCGGGIAADRGYFIQPTVFGDVQDGMTIAKEEIFGPVMQILKFKTIEEVVGRANNSTYGLAAAVFTKDLDKANYLSQALQAGTVWVNCYDVFGAQSPFGGYKMSGSGQELGEYGLQAYTEVKTVTVKVPQKNS","Homo sapiens","ALDH2, ALDM","Aldehyde dehydrogenase","1","2ONP"
"2ONY",,"X-RAY DIFFRACTION",3.26,62.22,"VAPOR DIFFUSION, HANGING DROP",5.5,"8% PEG6K, 0.25M LiCl, 0.1M cacodylate, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/jm0703385","SAH, TMJ","2ONY",64.88,"2.6","2.6","Structure of hPNMT with inhibitor 7-(N-4-chlorophenylaminosulfonyl)-THIQ and AdoHcy","MSGADRSPNAGAAPDSAPGQAAVASAYQRFEPRAYLRNNYAPPRGDLCNPNGVGPWKLRCLAQTFATGEVSGRTLIDIGSGPTVYQLLSACSHFEDITMTDFLEVNRQELGRWLQEEPGAFNWSMYSQHACLIEGKGECWQDKERQLRARVKRVLPIDVHQPQPLGAGSPAPLPADALVSAFCLEAVSPDLASFQRALDHITTLLRPGGHLLLIGALEESWYLAGEARLTVVPVSEEEVREALVRSGYKVRDLRTYIMPAHLQTGVDDVKGVFFAWAQKVGLEHHHHHH","Homo sapiens","PNMT, PENT","Phenylethanolamine N-methyltransferase","1","2ONY"
"2ONZ",,"X-RAY DIFFRACTION",3.3,62.68,"VAPOR DIFFUSION, HANGING DROP",5.6,"PEG6K, LiCl, cacodylate, pH 5.6, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/jm0703385","SAH, TMJ","2ONZ",64.99,"2.8","2.8","Structure of K57A hPNMT with inhibitor 7-(N-4-chlorophenylaminosulfonyl)-THIQ and AdoHcy","MSGADRSPNAGAAPDSAPGQAAVASAYQRFEPRAYLRNNYAPPRGDLCNPNGVGPWALRCLAQTFATGEVSGRTLIDIGSGPTVYQLLSACSHFEDITMTDFLEVNRQELGRWLQEEPGAFNWSMYSQHACLIEGKGECWQDKERQLRARVKRVLPIDVHQPQPLGAGSPAPLPADALVSAFCLEAVSPDLASFQRALDHITTLLRPGGHLLLIGALEESWYLAGEARLTVVPVSEEEVREALVRSGYKVRDLRTYIMPAHLQTGVDDVKGVFFAWAQKVGLEHHHHHH","Homo sapiens","PNMT, PENT","Phenylethanolamine N-methyltransferase","1","2ONZ"
"2OO0",,"X-RAY DIFFRACTION",2.92,57.93,"VAPOR DIFFUSION, SITTING DROP",6.5,"25% PEG3350, 0.2 M ammonium acetate, O.1M MES, 2mM XAP, 0.3 % cadaverine, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 288.15K",288.15,"10.1042/BJ20070188","XAP, PLP","2OO0",105.71,"1.9","1.9","A structural insight into the inhibition of human and Leishmania donovani ornithine decarboxylases by 3-aminooxy-1-aminopropane","AGENLYFQSLMNNFGNEEFDCHFLDEGFTAKDILDQKINEVSSSDDKDAFYVADLGDILKKHLRWLKALPRVTPFYAVKCNDSKAIVKTLAATGTGFDCASKTEIQLVQSLGVPPERIIYANPCKQVSQIKYAANNGVQMMTFDSEVELMKVARAHPKAKLVLRIATDDSKAVCRLSVKFGATLRTSRLLLERAKELNIDVVGVSFHVGSGCTDPETFVQAISDARCVFDMGAEVGFSMYLLDIGGGFPGSEDVKLKFEEITGVINPALDKYFPSDSGVRIIAEPGRYYVASAFTLAVNIIAKKIVLKEQTGSDDEDESSEQTFMYYVNDGVYGSFNCILYDHAHVKPLLQKRPKPDEKYYSSSIWGPTCDGLDRIVERCDLPEMHVGDWMLFENMGAYTVAAASTFNGFQRPTIYYVMSGPAWQLMQQFQNPDFPPEVEEQDASTLPVSCAWESGMKRHRAACASASINV","Homo sapiens","odc, ODC1","Ornithine decarboxylase","1","2OO0"
"2OO1",,"X-RAY DIFFRACTION",2.9,57.65,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.2M NaF, 0.1M BTProp, 20% PEG3350, 10% EtGly, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.cell.2012.02.013",,"2OO1",54.14,"1.7","1.7","Crystal structure of the Bromo domain 2 of human Bromodomain containing protein 3 (BRD3)","SMGKLSEHLRYCDSILREMLSKKHAAYAWPFYKPVDAEALELHDYHDIIKHPMDLSTVKRKMDGREYPDAQGFAADVRLMFSNCYKYNPPDHEVVAMARKLQDVFEMRFAKMP","Homo sapiens","BRD3, KIAA0043, RING3L","Bromodomain-containing protein 3","1","2OO1"
"2OO4",,"X-RAY DIFFRACTION",2.28,46.11,,6.5,"100 mM BisTris, 200mM MgCl2, 18% PEG3350, 10% glycerol, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1038/nsmb1227",,"2OO4",52.97,"2.003","2.003","Structure of LNR-HD (Negative Regulatory Region) from human Notch 2","GATCLSQYCADKARDGVCDEACNSHACQWDGGDCSLTMENPWANCSSPLPCWDYINNQCDELCNTVECLFDNFECQGNSKTCKYDKYCADHFKDNHCNQGCNSEECGWDGLDCAADQPENLAEGTLVIVVLMPPEQLLQDARSFLRALGTLLHTNLRIKRDSQGELMVYPYYGEVAGSKVFLEIDNRQCVQDSDHCFKNTDAAAALLASHAIQGTLSYPLVSVVSESLTPERTQ","Homo sapiens","NOTCH2","Neurogenic locus notch homolog protein 2","1","2OO4"
,,,,,,,"100mM Tris, 200mM MgCl2, 24% PEG3350, 10% glycerol, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298
"2OO8",,"X-RAY DIFFRACTION",2.45,49.71,"VAPOR DIFFUSION, HANGING DROP",7,"14-18 % (w/v) PEG 3350, and 0.2 M tri-Potassium Citrate (pH 6.5-7.5), and 2% (v/v) isopropanol, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.bmcl.2007.02.067","RAJ","2OO8",36.79,"2.2","2.2","Synthesis, Structural Analysis, and SAR Studies of Triazine Derivatives as Potent, Selective Tie-2 Inhibitors","KNNPDPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLYEKFTYAGIDCSAEEAA","Homo sapiens","TEK, TIE2, VMCM, VMCM1","Angiopoietin-1 receptor","1","2OO8"
"2OO9",,"X-RAY DIFFRACTION",3.05,59.61,"VAPOR DIFFUSION, HANGING DROP",8.5,"3.8M sodium formate, 0.1M Tris, 4% (v/v) glycerol, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1074/jbc.M703333200",,"2OO9",15.52,"2.1","2.1","crystal structure of the UBA domain from human c-Cbl ubiquitin ligase","GSQLSSEIENLMSQGYSYQDIQKALVIAQNNIEMAKNILREFAAAS","Homo sapiens","CBL, CBL2, RNF55","E3 ubiquitin-protein ligase CBL","1","2OO9"
"2OOA",,"X-RAY DIFFRACTION",1.99,38.12,"VAPOR DIFFUSION, HANGING DROP",8.2,"1.2M sodium/potassium phosphate, 12% glycerol, pH 8.2, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.molcel.2007.06.023",,"2OOA",11.41,"1.56","1.56","crystal structure of the UBA domain from Cbl-b ubiquitin ligase","GSGPEAALENVDAKIAKLMGEGYAFEEVKRALEIAQNNVEVARSILREFAFP","Homo sapiens","CBLB, RNF56, Nbla00127","E3 ubiquitin-protein ligase CBL-B","1","2OOA"
"2OOH",,"X-RAY DIFFRACTION",3.67,66.45,"VAPOR DIFFUSION, HANGING DROP",7.5,"50% saturated ammonium sulfate, 4% isopropanol, 0.1 M tris(hydroxymethyl)aminomethane,mixed with protein:inhibitor complex in a 1:1 ratio, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 296K",296,"10.1074/jbc.M701825200","OX3","2OOH",38.51,"1.85","1.85","Crystal Structure of MIF bound to a Novel Inhibitor, OXIM-11","PMFIVNTNVPRASVPDGFLSELTQQLAQATGKPPQYIAVHVVPDQLMAFGGSSEPCALCSLHSIGKIGGAQNRSYSKLLCGLLAERLRISPDRVYINYYDMNAANVGWNNSTFA","Homo sapiens","MIF, GLIF, MMIF","Macrophage migration inhibitory factor","1","2OOH"
"2OOQ",,"X-RAY DIFFRACTION",2.21,44.28,"VAPOR DIFFUSION, SITTING DROP",7,"0.2M LiCl, 0.1M HEPES, 20.0% PEG 6000, 10.0% Ethylene glycol, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.cell.2008.11.038",,"2OOQ",66.18,"1.8","1.8","Crystal Structure of the Human Receptor Phosphatase PTPRT","SMAIRVADLLQHITQMKRGQGYGFKEEYEALPEGQTASWDTAKEDENRNKNRYGNIISYDHSRVRLLVLDGDPHSDYINANYIDGYHRPRHYIATQGPMQETVKDFWRMIWQENSASIVMVTNLVEVGRVKCVRYWPDDTEVYGDIKVTLIETEPLAEYVIRTFTVQKKGYHEIRELRLFHFTSWPDHGVPCYATGLLGFVRQVKFLNPPEAGPIVVHCSAGAGRTGCFIAIDTMLDMAENEGVVDIFNCVRELRAQRVNLVQTEEQYVFVHDAILEACLCGNTAI","Homo sapiens","PTPRT, KIAA0283","Receptor-type tyrosine-protein phosphatase T","1","2OOQ"
"2OOT",,"X-RAY DIFFRACTION",3.29,62.63,"VAPOR DIFFUSION, HANGING DROP",8,"33% (v/v) pentaerythritol propoxylate PO/OH 5/4, 13% (w/v) PEG 3350, 100 mM Tris-HCl, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1107/S174430910700379X",,"2OOT",82.55,"1.64","1.64","A High Resolution Structure of Ligand-free Human Glutamate Carboxypeptidase II","RSKSSNEATNITPKHNMKAFLDELKAENIKKFLYNFTQIPHLAGTEQNFQLAKQIQSQWKEFGLDSVELAHYDVLLSYPNKTHPNYISIINEDGNEIFNTSLFEPPPPGYENVSDIVPPFSAFSPQGMPEGDLVYVNYARTEDFFKLERDMKINCSGKIVIARYGKVFRGNKVKNAQLAGAKGVILYSDPADYFAPGVKSYPDGWNLPGGGVQRGNILNLNGAGDPLTPGYPANEYAYRRGIAEAVGLPSIPVHPIGYYDAQKLLEKMGGSAPPDSSWRGSLKVPYNVGPGFTGNFSTQKVKMHIHSTNEVTRIYNVIGTLRGAVEPDRYVILGGHRDSWVFGGIDPQSGAAVVHEIVRSFGTLKKEGWRPRRTILFASWDAEEFGLLGSTEWAEENSRLLQERGVAYINADSSIEGNYTLRVDCTPLMYSLVHNLTKELKSPDEGFEGKSLYESWTKKSPSPEFSGMPRISKLGSGNDFEVFFQRLGIASGRARYTKNWETNKFSGYPLYHSVYETYELVEKFYDPMFKYHLTVAQVRGGMVFELANSIVLPFDCRDYAVVLRKYADKIYSISMKHPQEMKTYSVSFDSLFSAVKNFTEIASKFSERLQDFDKSNPIVLRMMNDQLMFLERAFIDPLGLPDRPFYRHVIYAPSSHNKYAGESFPGIYDALFDIESKVDPSKAWGEVKRQIYVAAFTVQAAAETLSEVA","Homo sapiens","FOLH1, FOLH, NAALAD1, PSM, PSMA, GIG27","Glutamate carboxypeptidase 2","1","2OOT"
"2OOW",,"X-RAY DIFFRACTION",2.7,54.37,"VAPOR DIFFUSION, HANGING DROP",7.5,"50% saturated ammonium sulfate, 4% isopropanol, 0.1 
M tris(hydroxymethyl)aminomethan; mixed with protein:inhibitor complex in a 1:1 ratio, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 296K",296,"10.1074/jbc.M701825200",,"2OOW",38.81,"1.75","1.75","MIF Bound to a Fluorinated OXIM Derivative","PMFIVNTNVPRASVPDGFLSELTQQLAQATGKPPQYIAVHVVPDQLMAFGGSSEPCALCSLHSIGKIGGAQNRSYSKLLCGLLAERLRISPDRVYINYYDMNAANVGWNNSTFA","Homo sapiens","MIF, GLIF, MMIF","Macrophage migration inhibitory factor","1","2OOW"
"2OOZ",,"X-RAY DIFFRACTION",2.72,54.8,"VAPOR DIFFUSION, HANGING DROP",7.5,"50% saturated ammonium sulfate, 4% isopropanol, 0.1 
M tris(hydroxymethyl)aminomethan; mixed with protein:inhibitor complex in a 1:1 ratio, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 296K",296,"10.1074/jbc.M701825200","OX5","2OOZ",38.35,"1.8","1.8","Macrophage Migration Inhibitory Factor (MIF) Complexed with OXIM6 (an OXIM Derivative Not Containing a Ring in its R-group)","PMFIVNTNVPRASVPDGFLSELTQQLAQATGKPPQYIAVHVVPDQLMAFGGSSEPCALCSLHSIGKIGGAQNRSYSKLLCGLLAERLRISPDRVYINYYDMNAANVGWNNSTFA","Homo sapiens","MIF, GLIF, MMIF","Macrophage migration inhibitory factor","1","2OOZ"
"2OP3",,"X-RAY DIFFRACTION",2.82,56.44,"VAPOR DIFFUSION, SITTING DROP",,"0.1M NaAcetate, 20% Peg-8000 and 2.0M Li2SO4, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1021/jm070111+","TF5","2OP3",50.64,"1.6","1.6","The structure of cathepsin S with a novel 2-arylphenoxyacetaldehyde inhibitor derived by the Substrate Activity Screening (SAS) method","NRILPDSVDWREKGCVTEVKYQGSCGACWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEI","Homo sapiens","CATHS, CTSS","Cathepsin S","1","2OP3"
"2OP7",,"SOLUTION NMR",,,,,,,,,"2OP7",4.71,,,"WW4","NEEPLPEGWEIRYTREGVRYFVDHNTRTTTFKDPRNGKS","Homo sapiens","WWP1","NEDD4-like E3 ubiquitin-protein ligase WWP1","1","2OP7"
"2OPB",,"X-RAY DIFFRACTION",3.29,62.59,"VAPOR DIFFUSION, HANGING DROP",5.8,"8% PEG6K, 0.25 M LiCl, 0.1 M cacodylate, pH 5.8, vapor diffusion, hanging drop, temperature 298K",298,"10.1021/jm0703385","SAH, F21","2OPB",65.1,"2.8","2.8","Structure of K57A hPNMT with inhibitor 3-fluoromethyl-7-thiomorpholinosulfonamide-THIQ and AdoHcy","MSGADRSPNAGAAPDSAPGQAAVASAYQRFEPRAYLRNNYAPPRGDLCNPNGVGPWALRCLAQTFATGEVSGRTLIDIGSGPTVYQLLSACSHFEDITMTDFLEVNRQELGRWLQEEPGAFNWSMYSQHACLIEGKGECWQDKERQLRARVKRVLPIDVHQPQPLGAGSPAPLPADALVSAFCLEAVSPDLASFQRALDHITTLLRPGGHLLLIGALEESWYLAGEARLTVVPVSEEEVREALVRSGYKVRDLRTYIMPAHLQTGVDDVKGVFFAWAQKVGLEHHHHHH","Homo sapiens","PNMT, PENT","Phenylethanolamine N-methyltransferase","1","2OPB"
"2OPG",,"X-RAY DIFFRACTION",2.46,48.76,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.1M BIS-TRIS, 20% mPEG 5000, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,,,"2OPG",21.5,"1.5","1.5","The crystal structure of the 10th PDZ domain of MPDZ","SMGCETTIEISKGRTGLGLSIVGGSDTLLGAIIIHEVYEEGAACKDGRLWAGDQILEVNGIDLRKATHDEAINVLRQTPQRVRLTLYRDEAPYKSTRL","Homo sapiens","MPDZ, MUPP1","Multiple PDZ domain protein","1","2OPG"
"2OPH",,"X-RAY DIFFRACTION",2.99,57.32,"VAPOR DIFFUSION, HANGING DROP",8,"PEG 4000, SODIUM ACETATE, TRIS, PH 8.00, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K",293,"10.1016/j.bmcl.2007.02.066","277","2OPH",174.78,"2.4","2.4","Human dipeptidyl peptidase IV in complex with an alpha amino acid inhibitor","TRKTYTLTDYLKNTYRLKLYSLRWISDHEYLYKQENNILVFNAEYGNSSVFLENSTFDEFGHSINDYSISPDGQFILLEYNYVKQWRHSYTASYDIYDLNKRQLITEERIPNNTQWVTWSPVGHKLAYVWNNDIYVKIEPNLPSYRITWTGKEDIIYNGITDWVYEEEVFSAYSALWWSPNGTFLAYAQFNDTEVPLIEYSFYSDESLQYPKTVRVPYPKAGAVNPTVKFFVVNTDSLSSVTNATSIQITAPASMLIGDHYLCDVTWATQERISLQWLRRIQNYSVMDICDYDESSGRWNCLVARQHIEMSTTGWVGRFRPSEPHFTLDGNSFYKIISNEEGYRHICYFQIDKKDCTFITKGTWEVIGIEALTSDYLYYISNEYKGMPGGRNLYKIQLSDYTKVTCLSCELNPERCQYYSVSFSKEAKYYQLRCSGPGLPLYTLHSSVNDKGLRVLEDNSALDKMLQNVQMPSKKLDFIILNETKFWYQMILPPHFDKSKKYPLLLDVYAGPCSQKADTVFRLNWATYLASTENIIVASFDGRGSGYQGDKIMHAINRRLGTFEVEDQIEAARQFSKMGFVDNKRIAIWGWSYGGYVTSMVLGSGSGVFKCGIAVAPVSRWEYYDSVYTERYMGLPTPEDNLDHYRNSTVMSRAENFKQVEYLLIHGTADDNVHFQQSAQISKALVDVGVDFQAMWYTDEDHGIASSTAHQHIYTHMSHFIKQCFSLP","Homo sapiens","DPP4, ADCP2, CD26","Dipeptidyl peptidase 4 soluble form","1","2OPH"
"2OPM",,"X-RAY DIFFRACTION",2.33,49.07,"VAPOR DIFFUSION, HANGING DROP",4.2,"10% PEG 2K, 0.5M Phosphate Citrate buffer, pH 4.2, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/ja808285e",,"2OPM",43.58,"2.4","2.4","Human Farnesyl Diphosphate Synthase Complexed with Bisphosphonate BPH-461","GSSHHHHHHSSGRENLYFQGHMNGDQNSDVYAQEKQDFVQHFSQIVRVLTEDEMGHPEIGDAIARLKEVLEYNAIGGKYNRGLTVVVAFRELVEPRKQDADSLQRAWTVGWCVELLQAFFLVADDIMDSSLTRRGQICWYQKPGVGLDAINDANLLEACIYRLLKLYCREQPYYLNLIELFLQSSYQTEIGQTLDLLTAPQGNVDLVRFTEKRYKSIVKYKTAFYSFYLPIAAAMYMAGIDGEKEHANAKKILLEMGEFFQIQDDYLDLFGDPSVTGKIGTDIQDNKCSWLVVQCLQRATPEQYQILKENYGQKEAEKVARVKALYEELDLPAVFLQYEEDSYSHIMALIEQYAAPLPPAVFLGLARKIYKRRK","Homo sapiens","FDPS, FPS, KIAA1293","Farnesyl pyrophosphate synthetase (FPP synthetase) (FPS) (Farnesyl diphosphate synthetase) [Includes: Dimethylallyltranstransferase (EC 2.5.1.1); Geranyltranstransferase (EC 2.5.1.10)]","1","2OPM"
"2OPN",,"X-RAY DIFFRACTION",2.33,49.19,"VAPOR DIFFUSION, SITTING DROP",4.2,"10% PEG 4K, 0.5M Phosphate Citrate buffer, pH 4.2, VAPOR DIFFUSION, SITTING DROP",,,"SUF","2OPN",43.54,"2.7","2.7","Human Farnesyl Diphosphate Synthase Complexed with Bisphosphonate BPH-527","GSSHHHHHHSSGRENLYFQGHMNGDQNSDVYAQEKQDFVQHFSQIVRVLTEDEMGHPEIGDAIARLKEVLEYNAIGGKYNRGLTVVVAFRELVEPRKQDADSLQRAWTVGWCVELLQAFFLVADDIMDSSLTRRGQICWYQKPGVGLDAINDANLLEACIYRLLKLYCREQPYYLNLIELFLQSSYQTEIGQTLDLLTAPQGNVDLVRFTEKRYKSIVKYKTAFYSFYLPIAAAMYMAGIDGEKEHANAKKILLEMGEFFQIQDDYLDLFGDPSVTGKIGTDIQDNKCSWLVVQCLQRATPEQYQILKENYGQKEAEKVARVKALYEELDLPAVFLQYEEDSYSHIMALIEQYAAPLPPAVFLGLARKIYKRRK","Homo sapiens","FDPS, FPS, KIAA1293","Farnesyl pyrophosphate synthetase (FPP synthetase) (FPS) (Farnesyl diphosphate synthetase) [Includes: Dimethylallyltranstransferase (EC 2.5.1.1); Geranyltranstransferase (EC 2.5.1.10)]","1","2OPN"
"2OPU",,"SOLUTION NMR",,,,,,,"10.1038/nsmb.1558",,"2OPU",9.41,,,"Solution NMR Structure of the First Domain of KSRP","ISSQLGPIHPPPRTSMTEEYRVPDGMVGLIIGRGGEQINKIQQDSGCKVQISPDSGGLPERSVSLTGAPESVQKAKMMLDDIVSRGRGG","Homo sapiens","KHSRP, FUBP2","KHSRP protein","1","2OPU"
"2OPV",,"SOLUTION NMR",,,,,,,,,"2OPV",9.19,,,"Solution NMR Structure of the Second Domain of KSRP","GQFHDNANGGQNGTVQEIMIPAGKAGLVIGKGGETIKQLQERAGVKMILIQDGSQNTNVDKPLRIIGDPYKVQQACEMVMDILRE","Homo sapiens","KHSRP, FUBP2","KHSRP protein","1","2OPV"
"2OPW",,"X-RAY DIFFRACTION",3.07,59.92,"VAPOR DIFFUSION, HANGING DROP",7,"7% PEG3350, 200mM Calcium acetate, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"2OPW",32.45,"1.9","1.9","Crystal structure of human phytanoyl-CoA dioxygenase PHYHD1 (apo)","MACLSPSQLQKFQQDGFLVLEGFLSAEECVAMQQRIGEIVAEMDVPLHCRTEFSTQEEEQLRAQGSTDYFLSSGDKIRFFFEKGVFDEKGNFLVPPEKSINKIGHALHAHDPVFKSITHSFKVQTLARSLGLQMPVVVQSMYIFKQPHFGGEVSPHQDASFLYTEPLGRVLGVWIAVEDATLENGCLWFIPGSHTSGVSRRMVRAPVGSAPGTSFLGSEPARDNSLFVPTPVQRGALVLIHGEVVHKSKQNLSDRSRQAYTFHLMEASGTTWSPENWLQPTAELPFPQLYT","Homo sapiens","PHYHD1","PHYHD1 protein","1","2OPW"
"2OPY",,"X-RAY DIFFRACTION",5.43,77.33,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M HEPES, 4.3 M NaCl, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.bmc.2007.02.010","CO9","2OPY",12.78,"2.8","2.8","Smac mimic bound to BIR3-XIAP","NFPNSTNLPRNPSMADYEARIFTFGTWIYSVNKEQLARAGFYALGEGDKVKCFHCGGGLTDWKPSEDPWEQHAKWYPGCKYLLEQKGQEYINNIHLTHSLEECLVR","Homo sapiens","BIRC4, API3, IAP3, XIAP","Baculoviral IAP repeat-containing protein 4","1","2OPY"
"2OPZ",,"X-RAY DIFFRACTION",3.95,68.85,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1M MES, 1.6M magnesium sulfate heptahydrate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.bmc.2007.02.010",,"2OPZ",52.41,"3","3","AVPF bound to BIR3-XIAP","NFPNSTNLPRNPSMADYEARIFTFGTWIYSVNKEQLARAGFYALGEGDKVKCFHCGGGLTDWKPSEDPWEQHAKWYPGCKYLLEQKGQEYINNIHLTHSLEECLVRTTE","Homo sapiens","BIRC4, API3, IAP3, XIAP","Baculoviral IAP repeat-containing protein 4","1","2OPZ"
,,,,,,,,,,,,,,,,"AVPF",,,"AVPF (Smac homologue, N-terminal tetrapeptide)","2","2OPZ"
"2OQ0",,"X-RAY DIFFRACTION",2.22,44.6,"VAPOR DIFFUSION, SITTING DROP",8.5,"26% PEG 6000, 0.1M TRIS-HCl pH 8.5, 0.2M MgCl2, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,,,"2OQ0",96.66,"2","2","Crystal Structure of the First HIN-200 Domain of Interferon-Inducible Protein 16","GSHMQVTPRRNVLQKRPVIVKVLSTTKPFEYETPEMEKKIMFHATVATQTQFFHVKVLNTSLKEKFNGKKIIIISDYLEYDSLLEVNEESTVSEAGPNQTFEVPNKIINRAKETLKIDILHKQASGNIVYGVFMLHKKTVNQKTTIYEIQDDRGKMDVVGTGQCHNIPCEEGDKLQLFCFRLRKKNQMSKLISEMHSFIQIKKKTN","Homo sapiens","IFI16, IFNGIP1","Gamma-interferon-inducible protein Ifi-16","1","2OQ0"
"2OQ1",,"X-RAY DIFFRACTION",2.48,50.46,"VAPOR DIFFUSION, HANGING DROP",6.2,"20%PEG 4000, 50mM sodium citrate,100 mM ammonium acetate, 20mM DTT, pH 6.2, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1038/377032a0",,"2OQ1",31.63,"1.9","1.9","Tandem SH2 domains of ZAP-70 with 19-mer zeta1 peptide","DPAAHLPFFYGSISRAEAEEHLKLAGMADGLFLLRQCLRSLGGYVLSLVHDVRFHHFPIERQLNGTYAIAGGKAHCGPAELCEFYSRDPDGLPCNLRKPCNRPSGLEPQPGVFDCLRDAMVRDYVRQTWKLEGEALEQAIISQAPQVEKLIATTAHERMPWYHSSLTREEAERKLYSGAQTDGKFLLRPRKEQGTYALSLIYGKTVYHYLISQDKAGKYCIPEGTKFDTLWQLVEYLKLKADGLIYCLKEACPN","Homo sapiens","ZAP70, SRK","Tyrosine-protein kinase ZAP-70","1","2OQ1"
,,,,,,,,,,,,,,,,"NQLYNELNLGRREEYDVLD",,,"T-cell surface glycoprotein CD3 zeta chain","2","2OQ1"
"2OQ5",,"X-RAY DIFFRACTION",2.64,53.41,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.1 M Tris , 8 % (m/w) PEG 8000 , pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 298.0K",298,"10.1111/j.1742-4658.2007.05756.x",,"2OQ5",25.64,"1.61","1.61","Crystal structure of DESC1, a new member of the type II transmembrane serine proteinases family","IVGGTEVEEGEWPWQASLQWDGSHRCGATLINATWLVSAAHCFTTYKNPARWTASFGVTIKPSKMKRGLRRIIVHEKYKHPSHDYDISLAELSSPVPYTNAVHRVCLPDASYEFQPGDVMFVTGFGALKNDGYSQNHLRQAQVTLIDATTCNEPQAYNDAITPRMLCAGSLEGKTDACQGDSGGPLVSSDARDIWYLAGIVSWGDECAKPNKPGVYTRVTALRDWITSKTGI","Homo sapiens","TMPRSS11E, DESC1, TMPRSS11E2, UNQ742/PRO1461","Transmembrane protease, serine 11E","1","2OQ5"
"2OQ6",,"X-RAY DIFFRACTION",2.49,50.52,,5.5,"0.1 M citrate, 4mM NiCl2, 20% PEG 3350, VAPOR DIFFUSION, SITTING DROP, temperature 277K, pH 5.50",277,"10.1038/nature05971","OGA","2OQ6",90.98,"2","2","Crystal structure of JMJD2A complexed with histone H3 peptide trimethylated at Lys9","MHHHHHHSSGVDLGTENLYFQSMASESETLNPSARIMTFYPTMEEFRNFSRYIAYIESQGAHRAGLAKVVPPKEWKPRASYDDIDDLVIPAPIQQLVTGQSGLFTQYNIQKKAMTVREFRKIANSDKYCTPRYSEFEELERKYWKNLTFNPPIYGADVNGTLYEKHVDEWNIGRLRTILDLVEKESGITIEGVNTPYLYFGMWKTSFAWHTEDMDLYSINYLHFGEPKSWYSVPPEHGKRLERLAKGFFPGSAQSCEAFLRHKMTLISPLMLKKYGIPFDKVTQEAGEFMITFPYGYHAGFNHGFNCAESTNFATRRWIEYGKQAVLCSCRKDMVKISMDVFVRKFQPERYKLWKAGKDNTVIDHTLPTPEAAEFLKESEL","Homo sapiens","JMJD2A, JHDM3A, JMJD2, KIAA0677, KDM4A","JmjC domain-containing histone demethylation protein 3A","1","2OQ6"
,,,,,,,,,,,,,,,,"ARKSTGGK",,,"synthetic peptide","2","2OQ6"
"2OQ7",,"X-RAY DIFFRACTION",2.43,49.32,"VAPOR DIFFUSION, SITTING DROP",5.5,"20% PEG 3350, 0.1M citrate, 2 mM NiCl2, pH 5.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1038/nature05971","OGA","2OQ7",89.19,"2.15","2.15","The crystal structure of JMJD2A complexed with Ni and N-oxalylglycine","MHHHHHHSSGVDLGTENLYFQSMASESETLNPSARIMTFYPTMEEFRNFSRYIAYIESQGAHRAGLAKVVPPKEWKPRASYDDIDDLVIPAPIQQLVTGQSGLFTQYNIQKKAMTVREFRKIANSDKYCTPRYSEFEELERKYWKNLTFNPPIYGADVNGTLYEKHVDEWNIGRLRTILDLVEKESGITIEGVNTPYLYFGMWKTSFAWHTEDMDLYSINYLHFGEPKSWYSVPPEHGKRLERLAKGFFPGSAQSCEAFLRHKMTLISPLMLKKYGIPFDKVTQEAGEFMITFPYGYHAGFNHGFNCAESTNFATRRWIEYGKQAVLCSCRKDMVKISMDVFVRKFQPERYKLWKAGKDNTVIDHTLPTPEAAEFLKESEL","Homo sapiens","JMJD2A, JHDM3A, JMJD2, KIAA0677, KDM4A","JmjC domain-containing histone demethylation protein 3A","1","2OQ7"
"2OQI",,"X-RAY DIFFRACTION",2.83,56.55,"VAPOR DIFFUSION, HANGING DROP",,"VAPOR DIFFUSION, HANGING DROP, temperature 298.0K",298,"10.1021/jm061436d","GGO","2OQI",338.24,"2.8","2.8","Human Dipeptidyl Peptidase IV (DPP4) with Piperidinone-constrained phenethylamine","SRKTYTLTDYLKNTYRLKLYSLRWISDHEYLYKQENNILVFNAEYGNSSVFLENSTFDEFGHSINDYSISPDGQFILLEYNYVKQWRHSYTASYDIYDLNKRQLITEERIPNNTQWVTWSPVGHKLAYVWNNDIYVKIEPNLPSYRITWTGKEDIIYNGITDWVYEEEVFSAYSALWWSPNGTFLAYAQFNDTEVPLIEYSFYSDESLQYPKTVRVPYPKAGAVNPTVKFFVVNTDSLSSVTNATSIQITAPASMLIGDHYLCDVTWATQERISLQWLRRIQNYSVMDICDYDESSGRWNCLVARQHIEMSTTGWVGRFRPSEPHFTLDGNSFYKIISNEEGYRHICYFQIDKKDCTFITKGTWEVIGIEALTSDYLYYISNEYKGMPGGRNLYKIQLSDYTKVTCLSCELNPERCQYYSVSFSKEAKYYQLRCSGPGLPLYTLHSSVNDKGLRVLEDNSALDKMLQNVQMPSKKLDFIILNETKFWYQMILPPHFDKSKKYPLLLDVYAGPCSQKADTVFRLNWATYLASTENIIVASFDGRGSGYQGDKIMHAINRRLGTFEVEDQIEAARQFSKMGFVDNKRIAIWGWSYGGYVTSMVLGSGSGVFKCGIAVAPVSRWEYYDSVYTERYMGLPTPEDNLDHYRNSTVMSRAENFKQVEYLLIHGTADDNVHFQQSAQISKALVDVGVDFQAMWYTDEDHGIASSTAHQHIYTHMSHFIKQCFSLP","Homo sapiens","DPP4, ADCP2, CD26","Dipeptidyl peptidase 4 (Dipeptidyl peptidase IV) (DPP IV) (T-cell activation antigen CD26) (TP103) (Adenosine deaminase complexing protein 2) (ADABP)","1","2OQI"
"2OQP",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M701313200",,"2OQP",15.62,,,"Solution structure of human interleukin-21","MQGQDRHMIRMRQLIDIVDQLKNYVNDLVPEFLPAPEDVETNCEWSAFSCFQKAQLKSANTGNNERIINVSIKKLKRKPPSTNAGRRQKHRLTCPSCDSYEKKPPKEFLERFKSLLQKMIHQHLSSRTHGSEDS","Homo sapiens","IL21","Interleukin-21","1","2OQP"
"2OQS",,"SOLUTION NMR",,,,,,,"10.1021/bi700879k",,"2OQS",11.19,,,"Structure of the hDLG/SAP97 PDZ2 in complex with HPV-18 papillomavirus E6 peptide","MEIKLIKGPKGLGFSIAGGVGNQHIPGDNSIYVTKIIEGGAAHKDGKLQIGDKLLAVNNVCLEEVTHEEAVTALKNTSDFVYLKVAKPTGSHHHHHH","Homo sapiens","DLG1","Disks large homolog 1","1","2OQS"
,,,,,,,,,,,,,,,,"RRETQV",,,"C-terminal HPV-18 E6 peptide","2","2OQS"
"2OQV",,"X-RAY DIFFRACTION",2.65,53.59,"VAPOR DIFFUSION, HANGING DROP",,"VAPOR DIFFUSION, HANGING DROP, temperature 298.0K",298,"10.1021/jm061436d","MA9","2OQV",168.97,"2.8","2.8","Human Dipeptidyl Peptidase IV (DPP4) with piperidine-constrained phenethylamine","SRKTYTLTDYLKNTYRLKLYSLRWISDHEYLYKQENNILVFNAEYGNSSVFLENSTFDEFGHSINDYSISPDGQFILLEYNYVKQWRHSYTASYDIYDLNKRQLITEERIPNNTQWVTWSPVGHKLAYVWNNDIYVKIEPNLPSYRITWTGKEDIIYNGITDWVYEEEVFSAYSALWWSPNGTFLAYAQFNDTEVPLIEYSFYSDESLQYPKTVRVPYPKAGAVNPTVKFFVVNTDSLSSVTNATSIQITAPASMLIGDHYLCDVTWATQERISLQWLRRIQNYSVMDICDYDESSGRWNCLVARQHIEMSTTGWVGRFRPSEPHFTLDGNSFYKIISNEEGYRHICYFQIDKKDCTFITKGTWEVIGIEALTSDYLYYISNEYKGMPGGRNLYKIQLSDYTKVTCLSCELNPERCQYYSVSFSKEAKYYQLRCSGPGLPLYTLHSSVNDKGLRVLEDNSALDKMLQNVQMPSKKLDFIILNETKFWYQMILPPHFDKSKKYPLLLDVYAGPCSQKADTVFRLNWATYLASTENIIVASFDGRGSGYQGDKIMHAINRRLGTFEVEDQIEAARQFSKMGFVDNKRIAIWGWSYGGYVTSMVLGSGSGVFKCGIAVAPVSRWEYYDSVYTERYMGLPTPEDNLDHYRNSTVMSRAENFKQVEYLLIHGTADDNVHFQQSAQISKALVDVGVDFQAMWYTDEDHGIASSTAHQHIYTHMSHFIKQCFS","Homo sapiens","DPP4, ADCP2, CD26","Dipeptidyl peptidase 4 (Dipeptidyl peptidase IV) (DPP IV)","1","2OQV"
"2OR3",,"X-RAY DIFFRACTION",2.33,47.32,"VAPOR DIFFUSION, HANGING DROP",6,"28% PEG 4000, 200 mM ammonium sulfate, 50 mM sodium acetate, 2.5 mM epigallocatechin 3-gallate, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/bi800282d",,"2OR3",40.03,"1.2","1.2","Pre-oxidation Complex of Human DJ-1","MASKRALVILAKGAEEMETVIPVDVMRRAGIKVTVAGLAGKDPVQCSRDVVICPDASLEDAKKEGPYDVVVLPGGNLGAQNLSESAAVKEILKEQENRKGLIAAICAGPTALLAHEIGFGSKVTTHPLAKDKMMNGGHYTYSENRVEKDGLILTSRGPGTSFEFALAIVEALNGKEVAAQVKAPLVLKD","Homo sapiens","PARK7","Protein DJ-1","1","2OR3"
"2OR4",,"X-RAY DIFFRACTION",3.32,62.95,"VAPOR DIFFUSION, HANGING DROP",8,"33% (v/v) pentaerythritol propoxylate PO/OH 5/4, 13% (w/v) PEG 3350, 100 mM Tris-HCl, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm070133w","QUS","2OR4",82.94,"1.62","1.62","A high resolution crystal structure of human glutamate carboxypeptidase II in complex with quisqualic acid","RSKSSNEATNITPKHNMKAFLDELKAENIKKFLYNFTQIPHLAGTEQNFQLAKQIQSQWKEFGLDSVELAHYDVLLSYPNKTHPNYISIINEDGNEIFNTSLFEPPPPGYENVSDIVPPFSAFSPQGMPEGDLVYVNYARTEDFFKLERDMKINCSGKIVIARYGKVFRGNKVKNAQLAGAKGVILYSDPADYFAPGVKSYPDGWNLPGGGVQRGNILNLNGAGDPLTPGYPANEYAYRRGIAEAVGLPSIPVHPIGYYDAQKLLEKMGGSAPPDSSWRGSLKVPYNVGPGFTGNFSTQKVKMHIHSTNEVTRIYNVIGTLRGAVEPDRYVILGGHRDSWVFGGIDPQSGAAVVHEIVRSFGTLKKEGWRPRRTILFASWDAEEFGLLGSTEWAEENSRLLQERGVAYINADSSIEGNYTLRVDCTPLMYSLVHNLTKELKSPDEGFEGKSLYESWTKKSPSPEFSGMPRISKLGSGNDFEVFFQRLGIASGRARYTKNWETNKFSGYPLYHSVYETYELVEKFYDPMFKYHLTVAQVRGGMVFELANSIVLPFDCRDYAVVLRKYADKIYSISMKHPQEMKTYSVSFDSLFSAVKNFTEIASKFSERLQDFDKSNPIVLRMMNDQLMFLERAFIDPLGLPDRPFYRHVIYAPSSHNKYAGESFPGIYDALFDIESKVDPSKAWGEVKRQIYVAAFTVQAAAETLSEVA","Homo sapiens","FOLH1, FOLH, NAALAD1, PSM, PSMA, GIG27","Glutamate carboxypeptidase 2","1","2OR4"
"2ORJ",,"X-RAY DIFFRACTION",3.25,62.18,"VAPOR DIFFUSION, HANGING DROP",7.5,"150mM NaCl, 10mM CaCl2, 12% PEG 8000, 100mM HEPES, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 290K",290,"10.1021/bi700037x",,"2ORJ",52.84,"1.8","1.8","crystal structure of the trimeric neck and carbohydrate recognition domain of human surfactant protein D in complex with N-acetyl mannosamine","AMADIGSDVASLRQQVEALQGQVQHLQAAFSQYKKVELFPNGQSVGEKIFKTAGFVKPFTEAQLLCTQAGGQLASPRSAAENAALQQLVVAKNEAAFLSMTDSKTEGKFTYPTGESLVYSNWAPGEPNDDGGSEDCVEIFTNGKWNDRACGEKRLVVCEF","Homo sapiens","SFTPD, PSPD, SFTP4, COLEC7","Pulmonary surfactant-associated protein D","1","2ORJ"
"2ORK",,"X-RAY DIFFRACTION",3.21,61.72,"VAPOR DIFFUSION, HANGING DROP",7.5,"150mM NaCl, 10mM CaCl2, 12% PEG 8000, 100mM HEPES , pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 290K",290,"10.1021/bi700037x","IPD","2ORK",52.69,"1.89","1.89","crystal structure of the trimeric neck and carbohydrate recognition domain of human surfactant protein D in complex with inositol-1-phosphate","AMADIGSDVASLRQQVEALQGQVQHLQAAFSQYKKVELFPNGQSVGEKIFKTAGFVKPFTEAQLLCTQAGGQLASPRSAAENAALQQLVVAKNEAAFLSMTDSKTEGKFTYPTGESLVYSNWAPGEPNDDGGSEDCVEIFTNGKWNDRACGEKRLVVCEF","Homo sapiens","SFTPD, PSPD, SFTP4, COLEC7","Pulmonary surfactant-associated protein D","1","2ORK"
"2ORV",,"X-RAY DIFFRACTION",2.9,57.59,"VAPOR DIFFUSION, HANGING DROP",4.8,"2.8 M NaCl, 0.1M MES, 0.1M NaH2PO4, 0.1M KH2PO4, pH 4.8, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.jmb.2007.02.104","4TA","2ORV",52.51,"2.3","2.3","human Thymidine Kinase 1 in complex with TP4A","MSCINLPTVLPGSPSKTRGQIQVILGPMFSGKSTELMRRVRRFQIAQYKCLVIKYAKDTRYSSSFCTHDRNTMEALPACLLRDVAQEALGVAVIGIDEGQFFPDIVEFCEAMANAGKTVIVAALDGTFQRKPFGAILNLVPLAESVVKLTAVCMECFREAAYTKRLGTEKEVEVIGGADKYHSVCRLCYFKKASGQPAGPDNAANCPVPGKPGEAVAARKLFAPQQILQCSPAN","Homo sapiens","TK1","Thymidine kinase","1","2ORV"
"2OS2",,"X-RAY DIFFRACTION",2.35,47.57,"VAPOR DIFFUSION, SITTING DROP",5.5,"20% PEG 3350, 0.1 M Citrate, 2 mM NiCl2, pH 5.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1038/nature05971","OGA","2OS2",91.75,"2.3","2.3","Crystal structure of JMJD2A complexed with histone H3 peptide trimethylated at Lys36","MHHHHHHSSGVDLGTENLYFQSMASESETLNPSARIMTFYPTMEEFRNFSRYIAYIESQGAHRAGLAKVVPPKEWKPRASYDDIDDLVIPAPIQQLVTGQSGLFTQYNIQKKAMTVREFRKIANSDKYCTPRYSEFEELERKYWKNLTFNPPIYGADVNGTLYEKHVDEWNIGRLRTILDLVEKESGITIEGVNTPYLYFGMWKTSFAWHTEDMDLYSINYLHFGEPKSWYSVPPEHGKRLERLAKGFFPGSAQSCEAFLRHKMTLISPLMLKKYGIPFDKVTQEAGEFMITFPYGYHAGFNHGFNCAESTNFATRRWIEYGKQAVLCSCRKDMVKISMDVFVRKFQPERYKLWKAGKDNTVIDHTLPTPEAAEFLKESEL","Homo sapiens","JMJD2A, JHDM3A, JMJD2, KIAA0677, KDM4A","JmjC domain-containing histone demethylation protein 3A","1","2OS2"
,,,,,,,,,,,,,,,,"STGGVKKPHRY",,,"histone 3 peptide","2","2OS2"
"2OS6",,"SOLUTION NMR",,,,,,,,,"2OS6",10.29,,,"Solution structure of LARG PDZ domain in complex with C-terminal octa-peptide of Plexin B1","GSHMGLVQRCVIIQKDDNGFGLTVSGDNPVFVQSVKEDGAAMRAGVQTGDRIIKVNGTLVTHSNHLEVVKLIKSGSYVALTVQGRPPGS","Homo sapiens","ARHGEF12, KIAA0382, LARG","Rho guanine nucleotide exchange factor 12","1","2OS6"
,,,,,,,,,,,,,,,,"VENKVTDL",,,"C-terminal peptide of Plexin-B1","2","2OS6"
"2OS9",,"X-RAY DIFFRACTION",3.25,62.13,"VAPOR DIFFUSION, HANGING DROP",7.5,"150mM NaCl, 10mM CaCl2, 12% PEG 8000, 100mM HEPES, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 290K",290,"10.1021/bi700037x","INS","2OS9",52.72,"1.7","1.7","crystal structure of the trimeric neck and carbohydrate recognition domain of human surfactant protein D in complex with myoinositol","AMADIGSDVASLRQQVEALQGQVQHLQAAFSQYKKVELFPNGQSVGEKIFKTAGFVKPFTEAQLLCTQAGGQLASPRSAAENAALQQLVVAKNEAAFLSMTDSKTEGKFTYPTGESLVYSNWAPGEPNDDGGSEDCVEIFTNGKWNDRACGEKRLVVCEF","Homo sapiens","SFTPD, PSPD, SFTP4, COLEC7","Pulmonary surfactant-associated protein D","1","2OS9"
"2OSA",,"X-RAY DIFFRACTION",2.51,51.02,"VAPOR DIFFUSION, SITTING DROP",7,"30% Jeffamine ED-2001, 0.1M HEPES pH 7.0, 0.1 M Adenosine-5-triphosphate disodium salt, VAPOR DIFFUSION, SITTING DROP, temperature 298.0K",298,,,"2OSA",23.14,"1.8","1.8","The Rho-GAP domain of human N-chimaerin","GSKHVKKVYSCDLTTLVKAHTTKRPMVVDMCIREIESRGLNSEGLYRVSGFSDLIEDVKMAFDRDGEKADISVNMYEDINIITGALKLYFRDLPIPLITYDAYPKFIESAKIMDPDEQLETLHEALKLLPPAHCETLRYLMAHLKRVTLHEKENLMNAENLGIVFGPTLMRSPELDAMAALNDIRYQRLVVELLIKNEDILF","Homo sapiens","CHN1, ARHGAP2, CHN","N-chimaerin","1","2OSA"
"2OSC",,"X-RAY DIFFRACTION",2.45,49.71,"VAPOR DIFFUSION, HANGING DROP",7,"14-18 % (w/v) PEG 3350, and 0.2 M tri-Potassium Citrate (pH 6.5-7.5), and 2% (v/v) isopropanol, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.bmcl.2007.02.067","MUH","2OSC",36.7,"2.8","2.8","Synthesis, Structural Analysis, and SAR Studies of Triazine Derivatives as Potent, Selective Tie-2 Inhibitors","KNNPDPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLYEKFTYAGIDCSAEEAA","Homo sapiens","TEK, TIE2, VMCM, VMCM1","Angiopoietin-1 receptor","1","2OSC"
"2OSF",,"X-RAY DIFFRACTION",2.16,42.94,"VAPOR DIFFUSION, HANGING DROP",7.8,"Tris-HCL, AMMONIUM SULFATE, pH 7.8, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/bi702385k","TH0","2OSF",29.55,"1.6","1.6","Inhibition of Carbonic Anhydrase II by Thioxolone: A Mechanistic and Structural Study","SHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","2OSF"
,,,,,"VAPOR DIFFUSION, HANGING DROP",7.8,"Tris-HCl, sodium citrate, pH 7.8, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277
"2OSG",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M703826200",,"2OSG",18.55,,,"Solution Structure and Binding Property of the Domain-swapped Dimer of ZO2PDZ2","MIGVLLMKSRANEEYGLRLGSQIFVKEMTRTGLATKDGNLHEGDIILKINGTVTENMSLTDARKLIEKSRGKLQLVVLRDSLE","Homo sapiens","TJP2, X104, ZO2","Tight junction protein ZO-2","1","2OSG"
"2OSM",,"X-RAY DIFFRACTION",2.17,43.4,"VAPOR DIFFUSION, HANGING DROP",7.8,"Tris-HCl, sodium citrate, pH 7.8, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/bi702385k","HTS","2OSM",29.35,"1.6","1.6","Inhibition of Carbonic Anhydrase II by Thioxolone: A Mechanistic and Structural Study","SHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","2OSM"
"2OSS",,"X-RAY DIFFRACTION",2.14,42.59,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.2M NaNO3, 20% PEG3350, 10% Ethylene glycol, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.cell.2012.02.013",,"2OSS",15.29,"1.35","1.35","Crystal structure of the Bromo domain 1 in human Bromodomain Containing Protein 4 (BRD4)","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","2OSS"
"2OT7",,"X-RAY DIFFRACTION",2.41,48.96,"VAPOR DIFFUSION, SITTING DROP",5.5,"20% PEG 3350, 100 mM Citrate, 2 mM NiCl, pH 5.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1038/nature05971","OGA","2OT7",90.92,"2.135","2.135","Crystal structure of JMJD2A complexed with histone H3 peptide monomethylated at Lys9","MHHHHHHSSGVDLGTENLYFQSMASESETLNPSARIMTFYPTMEEFRNFSRYIAYIESQGAHRAGLAKVVPPKEWKPRASYDDIDDLVIPAPIQQLVTGQSGLFTQYNIQKKAMTVREFRKIANSDKYCTPRYSEFEELERKYWKNLTFNPPIYGADVNGTLYEKHVDEWNIGRLRTILDLVEKESGITIEGVNTPYLYFGMWKTSFAWHTEDMDLYSINYLHFGEPKSWYSVPPEHGKRLERLAKGFFPGSAQSCEAFLRHKMTLISPLMLKKYGIPFDKVTQEAGEFMITFPYGYHAGFNHGFNCAESTNFATRRWIEYGKQAVLCSCRKDMVKISMDVFVRKFQPERYKLWKAGKDNTVIDHTLPTPEAAEFLKESEL","Homo sapiens","JMJD2A, JHDM3A, JMJD2, KIAA0677, KDM4A","JmjC domain-containing histone demethylation protein 3A","1","2OT7"
,,,,,,,,,,,,,,,,"ARKSTGGK",,,"histone 3 K9 monomethyl","2","2OT7"
"2OTK",,"SOLUTION NMR",,,,,,,"10.1073/pnas.0711731105",,"2OTK",19.97,,,"Structure of Alzheimer Ab peptide in complex with an engineered binding protein","DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVV","Homo sapiens","APP, A4, AD1","Amyloid beta A4 protein","1","2OTK"
,,,,,,,,,,,,,,,,"GSSHHHHHHLQVDNKFNKEMASAGGEIVYLPNLNPDQLCAFIHSLHDDPSQSANLLAEAKKLNDAQAPKVD",,,"ZAb3 Affibody dimer","2","2OTK"
"2OTP",,"X-RAY DIFFRACTION",2.29,46.41,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.6M MgSO4, 0.1M Tris-Cl, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 291.15K",291.15,,,"2OTP",43.82,"2.6","2.6","Crystal Structure of Immunoglobulin-Like Transcript 1 (ILT1/LIR7/LILRA2)","GHLPKPTLWAEPGSVIIQGSPVTLRCQGSLQAEEYHLYRENKSASWVRRIQEPGKNGQFPIPSITWEHAGRYHCQYYSHNHSSEYSDPLELVVTGAYSKPTLSALPSPVVTLGGNVTLQCVSQVAFDGFILCKEGEDEHPQCLNSHSHARGWSWAIFSVGPVSPSRRWSYRCYAYDSNSPYVWSLPSDLLELLVPG","Homo sapiens","LILRA2, ILT1, LIR7","Leukocyte immunoglobulin-like receptor subfamily A member 2","1","2OTP"
"2OTT",,"X-RAY DIFFRACTION",4.06,69.72,"VAPOR DIFFUSION",7.4,"10mM Hepes, 300mM Na,Cl pH7.4, VAPOR DIFFUSION, temperature 289K",289,"10.1074/jbc.M611699200",,"2OTT",21.82,"2.5","2.5","Crystal structure of CD5_DIII","PAVESRLVGGSSICEGTVEVRQGAQWAALCDSSSARSSLRWEEVCREQQCGSVNSYRVLDAGDPTSRGLFCPHQKLSQCHELWERNSYCKKVFVTCQD","Homo sapiens","CD5, LEU1","T-cell surface glycoprotein CD5","1","2OTT"
"2OU2",,"X-RAY DIFFRACTION",2.94,58.14,"VAPOR DIFFUSION, HANGING DROP",6.6,"Purified HTATIP was complexed with acetylcoenzyme A (AcCoA) (Sigma) at 1:10 molar ratio of protein:AcCoA and crystallized using the hanging drop vapor diffusion method at 20 deg C by mixing 1 microliter of the protein solution with 1 microliter of the reservoir solution containing 16% PEG3350, 0.2 M ammonium acetate, 0.1 M Bis-Tris, pH 6.6., VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"2OU2",33.82,"2.3","2.3","Acetyltransferase domain of Human HIV-1 Tat interacting protein, 60kDa, isoform 3","TRMKNIECIELGRHRLKPWYFSPYPQELTTLPVLYLCEFCLKYGRSLKCLQRHLTKCDLRHPPGNEIYRKGTISFFEIDGRKNKSYSQNLCLLAKCFLDHKTLYYDTDPFLFYVMTEYDCKGFHIVGYFSKEKESTEDYNVACILTLPPYQRRGYGKLLIEFSYELSKVEGKTGTPEKPLSDLGLLSYRSYWSQTILEILMGLKSESGERPQITINEISEITSIKKEDVISTLQYLNLINYYKGQYILTLSEDIVDGHERAMLKRLLRIDSKCLHFTPKD","Homo sapiens","HTATIP, TIP60, KAT5","Histone acetyltransferase HTATIP","1","2OU2"
"2OU7",,"X-RAY DIFFRACTION",2.57,52.11,"VAPOR DIFFUSION, HANGING DROP",7.5,"Protein buffer: 50 mM HEPES, pH 7.5, 5 mM TCEP. Protein was incubated on ice with 5 mM ligand (1:20 dilution of 100 mM stock in H2O for AMPPNP or DMSO for PHA-680626) for 0.5-1 h, followed by a brief centrifugation step and drop setting at RT (0.5 microliter protein + 0.5 microliter reservoir solution consisting of 500 mM magnesium acetate, 10 % PEG 4000 and 0.3 mM zinc acetate for AMPPNP, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/bi602474j","ANP","2OU7",38.37,"2.4","2.4","Structure of the Catalytic Domain of Human Polo-like Kinase 1","GPAPADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPRFSIAPSSLDPSNRKPLTVLNK","Homo sapiens","PLK1, PLK","Serine/threonine-protein kinase PLK1","1","2OU7"
"2OUC",,"X-RAY DIFFRACTION",2.46,50.09,"VAPOR DIFFUSION, SITTING DROP",4.5,"100 mM sodium acetate (pH 4.5), and 2.3-2.5 M ammonium acetate, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1110/ps.062712807",,"2OUC",32.47,"2.2","2.2","Crystal structure of the MAP kinase binding domain of MKP5","KIIYPNDLAKKMTKCSKSHLPSQGPVIIDCRPFMEYNKSHIQGAVHINCADKISRRRLQQGKITVLDLISCREGKDSFKRIFSKEIIVYDENTNEPSRVMPSQPLHIVLESLKREGKEPLVLKGGLSSFKQNHENLCDNSKE","Homo sapiens","MKP5, DUSP10","Dual specificity protein phosphatase 10","1","2OUC"
"2OUD",,"X-RAY DIFFRACTION",4.77,74.2,"VAPOR DIFFUSION, SITTING DROP",6,"100 mM Bis-tris (pH 6.0), and 2.7-3.0 M sodium chloride, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1110/ps.062712807",,"2OUD",20.27,"2.8","2.8","Crystal structure of the catalytic domain of human MKP5","PDIENAELTPILPFLFLGNEQDAQDLDTMQRLNIGYVINVTTHLPLYHYEKGLFNYKRLPATDSNKQNLRQYFEEAFEFIEEAHQCGKGLLIHCQAGVSRSATIVIAYLMKHTRMTMTDAYKFVKGKRPIISPNLNFMGQLLEFEEDLNNGVTPRILTPKLMGVETVVKEAAALEHH","Homo sapiens","MKP5, DUSP10","Dual specificity protein phosphatase 10","1","2OUD"
"2OUH",,"X-RAY DIFFRACTION",1.82,32.24,"VAPOR DIFFUSION, HANGING DROP",4.6,"30% PEG1500, 0.08M Sodium acetate, pH 4.6, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1074/jbc.M705203200",,"2OUH",55.69,"2.4","2.4","Crystal structure of the Thrombospondin-1 N-terminal domain in complex with fractionated Heparin DP10","RSPWNRIPESGGDNSVFDIFELTGAARKGSGRRLVKGPDPSSPAFRIEDANLIPPVPDDKFQDLVDAVRTEKGFLLLASLRQMKKTRGTLLALERKDHSGQVFSVVSNGKAGTLDLSLTVQGKQHVVSVEEALLATGQWKSITLFVQEDRAQLYIDCEKMENAELDVPIQSVFTRDLASIARLRIAKGGVNDNFQGVLQNVRFVFGTTPEDILRNKGCSSSTSVLLTLDNNVVNGSSPAIRTNTGHHHHHH","Homo sapiens","THBS1, TSP, TSP1","Thrombospondin-1","1","2OUH"
"2OUJ",,"X-RAY DIFFRACTION",1.93,36.21,"VAPOR DIFFUSION, HANGING DROP",4.6,"30% PEG1500, 0.08M Sodium acetate, pH 4.6, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1074/jbc.M705203200",,"2OUJ",27.56,"1.9","1.9","The crystal structure of the Thrombospondin-1 N-terminal domain in complex with fractionated Heparin DP8","RSPWNRIPESGGDNSVFDIFELTGAARKGSGRRLVKGPDPSSPAFRIEDANLIPPVPDDKFQDLVDAVRTEKGFLLLASLRQMKKTRGTLLALERKDHSGQVFSVVSNGKAGTLDLSLTVQGKQHVVSVEEALLATGQWKSITLFVQEDRAQLYIDCEKMENAELDVPIQSVFTRDLASIARLRIAKGGVNDNFQGVLQNVRFVFGTTPEDILRNKGCSSSTSVLLTLDNNVVNGSSPAIRTNTGHHHHHH","Homo sapiens","THBS1, TSP, TSP1","Thrombospondin-1","1","2OUJ"
"2OUN",,"X-RAY DIFFRACTION",2.16,42.98,"VAPOR DIFFUSION, HANGING DROP",7.5,"The native PDE10A2 crystals were grown against a well buffer of 0.1 M HEPES (pH 7.5), 0.2 M MgCl2, 50 mM beta-mercaptoethanol(BME), and 16% PEG3350. The complex of PDE10A2-AMP was prepared by soaking the crystals in 20 mM cAMP, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1073/pnas.0700279104",,"2OUN",77.14,"1.56","1.56","crystal structure of PDE10A2 in complex with AMP","SHMSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWIS","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","2OUN"
"2OUO",,"X-RAY DIFFRACTION",2.37,48.2,"VAPOR DIFFUSION, SITTING DROP",7,"0.1M MIB, 30% PEG 1000, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.cell.2012.02.013",,"2OUO",15.25,"1.89","1.89","Crystal Structure of the Bromo domain 2 in human Bromodomain Containing Protein 4 (BRD4)","SMKDVPDSQQHPAPEKSSKVSEQLKCCSGILKEMFAKKHAAYAWPFYKPVDVEALGLHDYCDIIKHPMDMSTIKSKLEAREYRDAQEFGADVRLMFSNCYKYNPPDHEVVAMARKLQDVFEMRFAKMPDE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","2OUO"
"2OUP",,"X-RAY DIFFRACTION",2.15,42.67,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M HEPES (pH 7.5), 0.2 M MgCl2, 50 mM beta-mercaptoethanol(BME), and 16% PEG3350, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1073/pnas.0700279104",,"2OUP",76.79,"1.56","1.56","crystal structure of PDE10A","SHMSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWIS","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","2OUP"
"2OUQ",,"X-RAY DIFFRACTION",2.11,41.65,"VAPOR DIFFUSION, HANGING DROP",7.5,"soaked the PDE10A2 crystals in 30 mM cGMP in a buffer of 16% PEG8000, 0.1 M HEPES (pH 7.5), 0.1 M MgCl2, 60 mM BME for 1.5 hours, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1073/pnas.0700279104",,"2OUQ",77.15,"1.9","1.9","crystal structure of PDE10A2 in complex with GMP","SHMSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWIS","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","2OUQ"
"2OUR",,"X-RAY DIFFRACTION",2.04,39.71,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M HEPES, pH 7.5, 0.1 M MgCl2, 100 mM BME, and 13% PEG3350, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1073/pnas.0700279104",,"2OUR",76.9,"1.45","1.45","crystal structure of PDE10A2 mutant D674A in complex with cAMP","SHMSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACALCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWIS","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","2OUR"
"2OUS",,"X-RAY DIFFRACTION",2.14,42.47,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M HEPES, pH 7.5, 0.1 M MgCl2, 100 mM BME, and 13% PEG3350, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1073/pnas.0700279104",,"2OUS",76.57,"1.45","1.45","crystal structure of PDE10A2 mutant D674A","SHMSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACALCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWIS","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","2OUS"
"2OUU",,"X-RAY DIFFRACTION",2.01,38.77,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M HEPES, pH 7.5, 0.1 M MgCl2, 100 mM BME, and 13% PEG3350. The D674A mutant crystals were soaked in 30 mM cGMP in a buffer of 16% PEG8000, 0.1 M HEPES, pH 7.5, 0.1 M MgCl2, 60 mM BME for 1.5 hours, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1073/pnas.0700279104",,"2OUU",77.61,"1.52","1.52","crystal structure of PDE10A2 mutant D674A in complex with cGMP","SHMSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACALCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWIS","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","2OUU"
"2OUV",,"X-RAY DIFFRACTION",2.14,42.56,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M HEPES, pH 7.5, 0.1 M MgCl2, 100 mM BME, and 13% PEG3350, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1073/pnas.0700279104",,"2OUV",76.79,"1.56","1.56","crystal structure of pde10a2 mutant of D564N","SHMSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHNLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWIS","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","2OUV"
"2OUY",,"X-RAY DIFFRACTION",2.07,40.49,"VAPOR DIFFUSION, HANGING DROP",7.5,"D564N and D674A mutants were crystallized against a well buffer of 0.1 M HEPES, pH 7.5, 0.1 M MgCl2, 100 mM BME, and 13% PEG3350. The D564N crystals were soaked in 20 mM cAMP in a buffer of 16% PEG8000, 0.1 M HEPES, pH 7.5, 0.1 M MgCl2, 60 mM BME for 1.5 hours, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1073/pnas.0700279104",,"2OUY",77.12,"1.9","1.9","crystal structure of pde10a2 mutant D564A in complex with cAMP.","SHMSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHNLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWIS","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","2OUY"
"2OUZ",,"X-RAY DIFFRACTION",2.4,48.68,"VAPOR DIFFUSION, HANGING DROP",6.7,"0.1 M NaHEPES, 0.5 M NaCl, 6% ethylene glycol, 10-12%PEG 8000, 5mM DTT, pH 6.7, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1110/ps.062729207","C3D","2OUZ",29.3,"2","2","Crystal Structure of Estrogen Receptor alpha-lasofoxifene complex","SKKNSLALSLTADQMVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLECAWLEILMIGLVWRSMEHPGKLLFAPNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGMEHLYSMKCKNVVPLYDLLLEMLDAHRLHAPT","Homo sapiens","ESR1, ESR, NR3A1","Estrogen receptor","1","2OUZ"
"2OVA",,"X-RAY DIFFRACTION",2.2,44.07,"VAPOR DIFFUSION, HANGING DROP",4,"0.1 M sodium citrate and 24-26% PEG 4000, pH 4.0, VAPOR DIFFUSION, HANGING DROP, temperature 290K",290,"10.1016/j.bbapap.2007.03.004",,"2OVA",20.34,"1.5","1.5","X-ray structure of Human Complement Protein C8gamma Y83W Mutant","QKPQRPRRPASPISTIQPKANFDAQQFAGTWLLVAVGSAARFLQEQGHRAEATTLHVAPQGTAMAVSTFRKLDGICWQVRQLWGDTGVLGRFLLQARGARGAVHVVVAETDYQSFAVLYLERAGQLSVKLYARSLPVSDSVLSGFEQRVQEAHLTEDQIFYFPKYGFCEAADQFHVLDEVRR","Homo sapiens","C8G","Complement component 8, gamma polypeptide","1","2OVA"
"2OVC",,"X-RAY DIFFRACTION",2.17,43.25,"VAPOR DIFFUSION, HANGING DROP",5.5,"45% MPD, 0.2M ammonium acetate, 0.1M Bis-Tris, pH 5.5, vapor diffusion, hanging drop, temperature 289K",289,"10.1016/j.neuron.2007.02.010",,"2OVC",3.74,"2.07","2.07","Crystal structure of a coiled-coil tetramerization domain from Kv7.4 channels","GAVDEISMMGRVVKVEKQVQSIEHKLDLLLGFY","Homo sapiens","KCNQ4","Potassium voltage-gated channel subfamily KQT member 4","1","2OVC"
"2OVD",,"X-RAY DIFFRACTION",2.18,43.65,"VAPOR DIFFUSION, HANGING DROP",4,"0.1 M sodium citrate and 25-27% PEG 4000. 
Sodium laurate (Sigma) was solubilized in methanol/water and used to prepare a 0.9 mM solution in 0.1M imidazole containing 32% PEG 4000, pH 7.0, pH 4.0, VAPOR DIFFUSION, HANGING DROP, temperature 290K",290,"10.1016/j.bbapap.2007.03.004",,"2OVD",20.52,"1.8","1.8","Crystal Structure of Human Complement Protein C8gamma with Laurate","QKPQRPRRPASPISTIQPKANFDAQQFAGTWLLVAVGSAARFLQEQGHRAEATTLHVAPQGTAMAVSTFRKLDGICWQVRQLYGDTGVLGRFLLQARGARGAVHVVVAETDYQSFAVLYLERAGQLSVKLYARSLPVSDSVLSGFEQRVQEAHLTEDQIFYFPKYGFCEAADQFHVLDEVRR","Homo sapiens","C8G","Complement component 8, gamma polypeptide","1","2OVD"
"2OVE",,"X-RAY DIFFRACTION",2.23,44.89,"VAPOR DIFFUSION, HANGING DROP",4,"0.1 M sodium citrate and 25-27% PEG 4000, pH 4.0, VAPOR DIFFUSION, HANGING DROP, temperature 290K",290,"10.1016/j.bbapap.2007.03.004",,"2OVE",20.32,"2","2","Crystal Structure of Recombinant Human Complement Protein C8gamma","QKPQRPRRPASPISTIQPKANFDAQQFAGTWLLVAVGSAARFLQEQGHRAEATTLHVAPQGTAMAVSTFRKLDGICWQVRQLYGDTGVLGRFLLQARGARGAVHVVVAETDYQSFAVLYLERAGQLSVKLYARSLPVSDSVLSGFEQRVQEAHLTEDQIFYFPKYGFCEAADQFHVLDEVRR","Homo sapiens","C8G","Complement component 8, gamma polypeptide","1","2OVE"
"2OVH",,"X-RAY DIFFRACTION",3.21,61.67,"VAPOR DIFFUSION, HANGING DROP",8,"0.1M Tris, 0.4M NaCl, 10% PEG 3350, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1210/me.2006-0524","AS0","2OVH",31.92,"2","2","Progesterone Receptor with Bound Asoprisnil and a Peptide from the Co-Repressor SMRT","GQDIQLIPPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFHKK","Homo sapiens","PGR, NR3C3","Progesterone receptor","1","2OVH"
,,,,,,,,,,,,,,,,"TNMGLEAIIRKALMGKY",,,"SMRT peptide","2","2OVH"
"2OVJ",,"X-RAY DIFFRACTION",2.12,41.86,"VAPOR DIFFUSION, SITTING DROP",5.5,"25% PEG 3350, 0.1M BIS-TRIS, pH 5.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,,,"2OVJ",23.06,"1.49","1.49","The crystal structure of the human Rac GTPase activating protein 1 (RACGAP1) MgcRacGAP.","SMEGMLADFVSQTSPMIPSIVVHCVNEIEQRGLTETGLYRISGCDRTVKELKEKFLRVKTVPLLSKVDDIHAICSLLKDFLRNLKEPLLTFRLNRAFMEAAEITDEDNSIAAMYQAVGELPQANRDTLAFLMIHLQRVAQSPHTKMDVANLAKVFGPTIVAHAVPNPDPVTMLQDIKRQPKVVERLLSLPLEYWSQFMMVE","Homo sapiens","RACGAP1, KIAA1478, MGCRACGAP","Rac GTPase-activating protein 1","1","2OVJ"
"2OVM",,"X-RAY DIFFRACTION",3.1,60.35,,8,"0.1M Tris, 0.15M NaCl, 10% glycerol, pH 8.0, spontaneous crystallization, temperature 277K",277,"10.1210/me.2006-0524",,"2OVM",32.65,"2.6","2.6","Progesterone Receptor with Bound Asoprisnil and a Peptide from the Co-Repressor NCoR","GQDIQLIPPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFHKK","Homo sapiens","PGR, NR3C3","Progesterone receptor","1","2OVM"
,,,,,,,,,,,,,,,,"GHSFADPASNLGLEDIIRKALMGSF",,,"NCoR","2","2OVM"
"2OVX",,"X-RAY DIFFRACTION",2.76,55.48,,5,"3.0 M NaCl, 0.1 M citric acid, VAPOR DIFFUSION, SITTING DROP, temperature 293K, pH 5.00",293,"10.1016/j.jmb.2007.05.068","4MR","2OVX",37.51,"2","2","MMP-9 active site mutant with barbiturate inhibitor","FEGDLKWHHHNITYWIQNYSEDLPRAVIDDAFARAFALWSAVTPLTFTRVYSRDADIVIQFGVAEHGDGYPFDGKDGLLAHAFPPGPGIQGDAHFDDDELWSLGKGQGYSLFLVAAHQFGHALGLDHSSVPEALMYPMYRFTEGPPLHKDDVNGIRHLY","Homo sapiens","MMP9, CLG4B","Matrix metalloproteinase-9 (EC 3.4.24.35) (MMP-9) (92 kDa type IV collagenase) (92 kDa gelatinase) (Gelatinase B) (GELB)","1","2OVX"
,,,,,,,,,,,,,,,,,"Homo sapiens","MMP9, CLG4B"
"2OVZ",,"X-RAY DIFFRACTION",2.83,56.58,,8,"3.0 M NaCl, 0.1 M Tris, VAPOR DIFFUSION, SITTING DROP, temperature 293K, pH 8.0, pH 8.00",293,"10.1016/j.jmb.2007.05.068","5MR","2OVZ",37.67,"2","2","MMP-9 active site mutant with phosphinate inhibitor","FEGDLKWHHHNITYWIQNYSEDLPRAVIDDAFARAFALWSAVTPLTFTRVYSRDADIVIQFGVAEHGDGYPFDGKDGLLAHAFPPGPGIQGDAHFDDDELWSLGKGQGYSLFLVAAHQFGHALGLDHSSVPEALMYPMYRFTEGPPLHKDDVNGIRHLY","Homo sapiens","MMP9, CLG4B","Matrix metalloproteinase-9 (EC 3.4.24.35) (MMP-9) (92 kDa type IV collagenase) (92 kDa gelatinase) (Gelatinase B) (GELB)","1","2OVZ"
,,,,,,,,,,,,,,,,,"Homo sapiens","MMP9, CLG4B"
"2OW0",,"X-RAY DIFFRACTION",2.77,55.61,,8,"4.0 M NaCl, 0.1 M Hepes,VAPOR DIFFUSION, SITTING DROP, temperature 293.0K, pH 8.0, pH 8.00",293,"10.1016/j.jmb.2007.05.068","6MR","2OW0",37.64,"2","2","MMP-9 active site mutant with iodine-labeled carboxylate inhibitor","FEGDLKWHHHNITYWIQNYSEDLPRAVIDDAFARAFALWSAVTPLTFTRVYSRDADIVIQFGVAEHGDGYPFDGKDGLLAHAFPPGPGIQGDAHFDDDELWSLGKGQGYSLFLVAAHQFGHALGLDHSSVPEALMYPMYRFTEGPPLHKDDVNGIRHLY","Homo sapiens","MMP9, CLG4B","Matrix metalloproteinase-9 (MMP-9) (92 kDa type IV collagenase) (92 kDa gelatinase) (Gelatinase B) (GELB)","1","2OW0"
,,,,,,,,,,,,,,,,,"Homo sapiens","MMP9, CLG4B"
"2OW1",,"X-RAY DIFFRACTION",2.83,56.47,,,,,"10.1016/j.jmb.2007.05.068","7MR","2OW1",37.25,"2.2","2.2","MMP-9 active site mutant with trifluoromethyl hydroxamate inhibitor","FEGDLKWHHHNITYWIQNYSEDLPRAVIDDAFARAFALWSAVTPLTFTRVYSRDADIVIQFGVAEHGDGYPFDGKDGLLAHAFPPGPGIQGDAHFDDDELWSLGKGQGYSLFLVAAHQFGHALGLDHSSVPEALMYPMYRFTEGPPLHKDDVNGIRHLY","Homo sapiens","MMP9, CLG4B","Matrix metalloproteinase-9 (MMP-9) (92 kDa type IV collagenase) (92 kDa gelatinase) (Gelatinase B) (GELB)","1","2OW1"
,,,,,,,,,,,,,,,,,"Homo sapiens","MMP9, CLG4B"
"2OW2",,"X-RAY DIFFRACTION",2.8,56.05,,4,"3.0 M NaCl, 0.1 M citric acid, VAPOR DIFFUSION, SITTING DROP, temperature 293.0K, pH 4.0, pH 4.00",293,"10.1016/j.jmb.2007.05.068","8MR","2OW2",36.91,"2.9","2.9","MMP-9 active site mutant with difluoro butanoic acid inhibitor","FEGDLKWHHHNITYWIQNYSEDLPRAVIDDAFARAFALWSAVTPLTFTRVYSRDADIVIQFGVAEHGDGYPFDGKDGLLAHAFPPGPGIQGDAHFDDDELWSLGKGQGYSLFLVAAHQFGHALGLDHSSVPEALMYPMYRFTEGPPLHKDDVNGIRHLY","Homo sapiens","MMP9, CLG4B","Matrix metalloproteinase-9 (MMP-9) (92 kDa type IV collagenase) (92 kDa gelatinase) (Gelatinase B) (GELB)","1","2OW2"
,,,,,,,,,,,,,,,,,"Homo sapiens","MMP9, CLG4B"
"2OW3",,"X-RAY DIFFRACTION",3.44,64.2,,9,"PEG2000, BICINE pH9.0",,"10.1016/j.bmcl.2007.02.059","BIM","2OW3",81.25,"2.8","2.8","Glycogen synthase kinase-3 beta in complex with bis-(indole)maleimide pyridinophane inhibitor","SKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATILIPPHARIQA","Homo sapiens","GSK3B","Glycogen synthase kinase-3 beta","1","2OW3"
"2OW9",,"X-RAY DIFFRACTION",2.4,48.7,"VAPOR DIFFUSION, HANGING DROP",7,"Protein concentration: 7-20 mg/ml. Well solution: 18-22% PEG MME 5000, 0.2M Lithium sulfate, 0.1M Hepes buffer. 2-4 microliter drops with 1:1 ratio of protein complex solution and well solution, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1074/jbc.M703286200","SP6","2OW9",39.71,"1.74","1.74","Crystal structure analysis of the MMP13 catalytic domain in complex with specific inhibitor","MASYNVFPRTLKWSKMNLTYRIVNYTPDMTHSEVEKAFKKAFKVWSDVTPLNFTRLHDGIADIMISFGIKEHGDFYPFDGPSGLLAHAFPPGPNYGGDAHFDDDETWTSSSKGYNLFLVAAHEFGHSLGLDHSKDPGALMFPIYTYTGKSHFMLPDDDVQGIQSLYGPGD","Homo sapiens","MMP13","Collagenase 3","1","2OW9"
"2OWB",,"X-RAY DIFFRACTION",2.64,53.35,"VAPOR DIFFUSION, HANGING DROP",7.5,"Protein buffer: 50 mM HEPES, pH 7.5, 5 mM TCEP. Protein was incubated on ice with 5 mM ligand (1:20 dilution of 100 mM stock in H2O for AMPPNP or DMSO for PHA-680626) for 0.5-1 h, followed by a brief centrifugation step and drop setting at RT (0.5 microliter protein + 0.5 microliter reservoir solution consisting of 500 mM magnesium acetate, 10 % PEG 4000 and 0.3 mM zinc acetate for AMPPNP, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/bi602474j","626","2OWB",38.27,"2.1","2.1","Structure of the Catalytic Domain of Human Polo-like Kinase 1","GPAPADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPRFSIAPSSLDPSNRKPLTVLNK","Homo sapiens","PLK1, PLK","Serine/threonine-protein kinase PLK1","1","2OWB"
"2OWI",,"SOLUTION NMR",,,,,,,"10.1073/pnas.0801508105",,"2OWI",17.79,,,"Solution structure of the RGS domain from human RGS18","SMVSPEEAVKWGESFDKLLSHRDGLEAFTRFLKTEFSEENIEFWIACEDFKKSKGPQQIHLKAKAIYEKFIQTDAPKEVNLDFHTKEVITNSITQPTLHSFDAAQSRVYQLMEQDSYTRFLKSDIYLDLMEGRPQRPTNLRRRSRSFTCNE","Homo sapiens","RGS18, RGS13","Regulator of G-protein signaling 18","1","2OWI"
"2OX0",,"X-RAY DIFFRACTION",2.4,48.78,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1M Citrate, 4mM NiCl2, 20% PEG 3350, pH 5.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1038/nature05971","OGA","2OX0",90.98,"1.95","1.95","Crystal structure of JMJD2A complexed with histone H3 peptide dimethylated at Lys9","MHHHHHHSSGVDLGTENLYFQSMASESETLNPSARIMTFYPTMEEFRNFSRYIAYIESQGAHRAGLAKVVPPKEWKPRASYDDIDDLVIPAPIQQLVTGQSGLFTQYNIQKKAMTVREFRKIANSDKYCTPRYSEFEELERKYWKNLTFNPPIYGADVNGTLYEKHVDEWNIGRLRTILDLVEKESGITIEGVNTPYLYFGMWKTSFAWHTEDMDLYSINYLHFGEPKSWYSVPPEHGKRLERLAKGFFPGSAQSCEAFLRHKMTLISPLMLKKYGIPFDKVTQEAGEFMITFPYGYHAGFNHGFNCAESTNFATRRWIEYGKQAVLCSCRKDMVKISMDVFVRKFQPERYKLWKAGKDNTVIDHTLPTPEAAEFLKESEL","Homo sapiens","JMJD2A, JHDM3A, JMJD2, KIAA0677, KDM4A","JmjC domain-containing histone demethylation protein 3A","1","2OX0"
,,,,,,,,,,,,,,,,"ARKSTGGK",,,"synthetic peptide","2","2OX0"
"2OX8",,"X-RAY DIFFRACTION",1.9,35.39,"VAPOR DIFFUSION, HANGING DROP",7,"The protein solution contained 10mg ml-1 protein, 8mM CaCl2 , 8mM Tris pH=7.8, 20mM NaCl and 10mM Lewisx.  The reservoir solution contained 8% Peg 8K, 0.2M ZnAc2 and 0.1 M Tris, pH 7.0. , VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1074/jbc.M701624200",,"2OX8",67.56,"2.5","2.5","Human Scavenger Receptor C-type Lectin carbohydrate-recognition domain.","EDNSCPPHWKNFTDKCYYFSVEKEIFEDAKLFCEDKSSHLVFINTREEQQWIKKQMVGRESHWIGLTDSERENEWKWLDGTSPDYKNWKAGQPDNWGHGHGPGEDCAGLIYAGQWNDFQCEDVNNFICEKDRETVLSSAL","Homo sapiens","SRCL, COLEC12, CLP1, NSR2, SCARA4","Scavenger receptor with C-type lectin type I","1","2OX8"
"2OXC",,"X-RAY DIFFRACTION",2.5,50.78,"VAPOR DIFFUSION, SITTING DROP",5.2,"12% PEG3350, 200 mM Sodium chloride, 100 mM Bis-Tris, pH 5.2, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,,,"2OXC",51.21,"1.3","1.3","Human DEAD-box RNA helicase DDX20, DEAD domain in complex with ADP","SMRTAQDLSSPRTRTGDVLLAEPADFESLLLSRPVLEGLRAAGFERPSPVQLKAIPLGRCGLDLIVQAKSGTGKTCVFSTIALDSLVLENLSTQILILAPTREIAVQIHSVITAIGIKMEGLECHVFIGGTPLSQDKTRLKKCHIAVGSPGRIKQLIELDYLNPGSIRLFILDEADKLLEEGSFQEQINWIYSSLPASKQMLAVSATYPEFLANALTKYMRDPTFVRLNS","Homo sapiens","DDX20, DP103, GEMIN3","Probable ATP-dependent RNA helicase DDX20","1","2OXC"
"2OXE",,"X-RAY DIFFRACTION",3.5,64.85,,5.5,"1.17M Ammonium sulfate, 0.1M Sodium cacodylate pH 5.5, 0.04M NaCl, cryoprotected with 15% glycerol, VAPOR DIFFUSION, HANGING DROP, temperature 298K, pH 5.50",298,"10.1021/bi8005576",,"2OXE",105.92,"2.8","2.8","Structure of the Human Pancreatic Lipase-related Protein 2","AAKEVCYGQLGCFSDEKPWAGTLQRPVKLLPWSPEDIDTRFLLYTNENPNNFQLITGTEPDTIEASNFQLDRKTRFIIHGFLDKAEDSWPSDMCKKMFEVEKVNCICVDWRHGSRAMYTQAVQNIRVVGAETAFLIQALSTQLGYSLEDVHVIGHSLGAHTAAEAGRRLGGRVGRITGLDPAGPCFQDEPEEVRLDPSDAVFVDVIHTDSSPIVPSLGFGMSQKVGHLDFFPNGGKEMPGCKKNVLSTITDIDGIWEGIGGFVSCNHLRSFEYYSSSVLNPDGFLGYPCASYDEFQESKCFPCPAEGCPKMGHYADQFKGKTSAVEQTFFLNTGESGNFTSWRYKVSVTLSGKEKVNGYIRIALYGSNENSKQYEIFKGSLKPDASHTCAIDVDFNVGKIQKVKFLWNKRGINLSEPKLGASQITVQSGEDGTEYNFCSSDTVEENVLQSLYPCEFVEHHHHHHHH","Homo sapiens","PNLIPRP2, PLRP2","Pancreatic lipase-related protein 2","1","2OXE"
"2OXM",,"X-RAY DIFFRACTION",2.48,50.45,"VAPOR DIFFUSION, HANGING DROP",6.5,"A solution of human UNG2 (22 mg/ml) in 50 mM Tris-OAc buffer pH 7.0, 150 mM NaCl and 1mM DTT was mixed with T/M duplex DNA (2.5 mM)m incubate at room Temperature for 30 min. and then centrifugate at 10000 g for 5 min.Co-crystallizarion condition were 22% PEG 4000, 100 MM HEPES pH 6.5 and 1mM DTT, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1038/nature06131",,"2OXM",31.32,"2.5","2.5","Crystal structure of a UNG2/modified DNA complex that represent a stabilized short-lived extrahelical state in ezymatic DNA base flipping","TGTTATCTT",,,"DNA (5'-D(*TP*GP*TP*TP*AP*TP*CP*TP*T)-3')","1","2OXM"
,,,,,,,,,,,,,,,,"AAAGATNACA",,,"DNA (5'-D(*AP*AP*AP*GP*AP*TP*(4MF)P*AP*CP*A)-3')","2","2OXM"
,,,,,,,,,,,,,,,,"MEFFGESWKKHLSGEFGKPYFIKLMGFVAEERKHYTVYPPPHQVFTWTQMCDIKDVKVVILGQDPYHGPNQAHGLCFSVQRPVPPPPSLENIYKELSTDIEDFVHPGHGDLSGWAKQGVLLLNAVLTVRAHQANSHKERGWEQFTDAVVSWLNQNSNGLVFLLWGSYAQKKGSAIDRKRHHVLQTAHPSPLSVYRGFFGCRHFSKTNELLQKSGKKPIDWKEL","Homo sapiens","UNG, DGU, UNG1, UNG15","Uracil-DNA glycosylase","3","2OXM"
"2OXU",,"X-RAY DIFFRACTION",2.17,43.4,"VAPOR DIFFUSION, SITTING DROP",8,"0.1 M Tris-HCl, 30% PEG6000, pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1002/anie.200603100",,"2OXU",17.87,"1.24","1.24","Uninhibited form of human MMP-12","MGPVWRKHYITYRINNYTPDMNREDVDYAIRKAFQVWSNVTPLKFSKINTGMADILVVFARGAHGDDHAFDGKGGILAHAFGPGSGIGGDAHFDEDEFWTTHSGGTNLFLTAVHEIGHSLGLGHSSDPKAVMFPTYKYVDINTFRLSADDIRGIQSLYG","Homo sapiens","MMP12, HME","Macrophage metalloelastase","1","2OXU"
"2OXW",,"X-RAY DIFFRACTION",2.15,42.81,"VAPOR DIFFUSION, SITTING DROP",8,"0.1 M Tris-HCl, 30% PEG6000, pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1002/anie.200603100",,"2OXW",18.13,"1.15","1.15","Human MMP-12 complexed with the peptide IAG","MGPVWRKHYITYRINNYTPDMNREDVDYAIRKAFQVWSNVTPLKFSKINTGMADILVVFARGAHGDDHAFDGKGGILAHAFGPGSGIGGDAHFDEDEFWTTHSGGTNLFLTAVHEIGHSLGLGHSSDPKAVMFPTYKYVDINTFRLSADDIRGIQSLYG","Homo sapiens","MMP12, HME","Macrophage metalloelastase","1","2OXW"
,,,,,,,,,,,,,,,,"IAG",,,"ILE-ALA-GLY peptide","2","2OXW"
"2OXZ",,"X-RAY DIFFRACTION",2.1,41.56,"VAPOR DIFFUSION, SITTING DROP",8,"0.1 M Tris-HCl, 30% PEG6000, pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1002/anie.200603100",,"2OXZ",18.43,"1.9","1.9","Human MMP-12 in complex with two peptides PQG and IAG","MGPVWRKHYITYRINNYTPDMNREDVDYAIRKAFQVWSNVTPLKFSKINTGMADILVVFARGAHGDDHAFDGKGGILAHAFGPGSGIGGDAHFDEDEFWTTHSGGTNLFLTAVHEIGHSLGLGHSSDPKAVMFPTYKYVDINTFRLSADDIRGIQSLYG","Homo sapiens","MMP12, HME","Macrophage metalloelastase","1","2OXZ"
,,,,,,,,,,,,,,,,"PQG",,,"PRO-GLN-GLY peptide","2","2OXZ"
,,,,,,,,,,,,,,,,"IAG",,,"ILE-ALA-GLY peptide","3","2OXZ"
"2OY2",,"X-RAY DIFFRACTION",2.38,48.31,"VAPOR DIFFUSION, SITTING DROP",8,"0.1M Tris-HCl, 20% PEG3350, 200mM acetohydroxamic acid, 0.2M MgCl2, pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1002/anie.200603100",,"2OY2",36.16,"1.5","1.5","Human MMP-8 in complex with peptide IAG","NPKWERTNLTYRIRNYTPQLSEAEVERAIKDAFELWSVASPLIFTRISQGEADINIAFYQRDHGDNSPFDGPNGILAHAFQPGQGIGGDAHFDAEETWTNTSANYNLFLVAAHEFGHSLGLAHSSDPGALMYPNYAFRETSNYSLPQDDIDGIQAIYG","Homo sapiens","MMP8, CLG1","Neutrophil collagenase","1","2OY2"
,,,,,,,,,,,,,,,,"IAG",,,"ILE-ALA-GLY peptide","2","2OY2"
"2OY4",,"X-RAY DIFFRACTION",2.58,52.25,"VAPOR DIFFUSION, SITTING DROP",8,"0.1M Tris-HCl, 20% PEG3350, 200mM acetohydroxamic acid, 0.2M MgCl2, pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1002/anie.200603100",,"2OY4",35.65,"1.7","1.7","Uninhibited human MMP-8","NPKWERTNLTYRIRNYTPQLSEAEVERAIKDAFELWSVASPLIFTRISQGEADINIAFYQRDHGDNSPFDGPNGILAHAFQPGQGIGGDAHFDAEETWTNTSANYNLFLVAAHEFGHSLGLAHSSDPGALMYPNYAFRETSNYSLPQDDIDGIQAIYG","Homo sapiens","MMP8, CLG1","Neutrophil collagenase","1","2OY4"
"2OYC",,"X-RAY DIFFRACTION",2.37,48.15,"VAPOR DIFFUSION, SITTING DROP",5.6,"40% PEG4000, 0.1M Sodium citrate pH 5.6, 20% Isopropanol, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1007/s10969-007-9036-1",,"2OYC",33.41,"1.72","1.72","Crystal structure of human pyridoxal phosphate phosphatase","MSLARCERLRGAALRDVLGRAQGVLFDCDGVLWNGERAVPGAPELLERLARAGKAALFVSNNSRRARPELALRFARLGFGGLRAEQLFSSALCAARLLRQRLPGPPDAPGAVFVLGGEGLRAELRAAGLRLAGDPSAGDGAAPRVRAVLVGYDEHFSFAKLREACAHLRDPECLLVATDRDPWHPLSDGSRTPGTGSLAAAVETASGRQALVVGKPSPYMFECITENFSIDPARTLMVGDRLETDILFGHRCGMTTVLTLTGVSRLEEAQAYLAAGQHDLVPHYYVESIADLTEGLEDEGHHHHHH","Homo sapiens","PDXP, PLP, PLPP, CIN","Pyridoxal phosphate phosphatase","1","2OYC"
"2OYT",,"X-RAY DIFFRACTION",2.57,52.11,"VAPOR DIFFUSION, HANGING DROP",7,"Recombinat human UNG2 (22 mg/ml) in 50 mM tris-OAc buffer pH 7.0, 150 mM NaCl and 1mM DTT was mixed with T/M DNA duplex (2.5 mM) inclubate at room T for 30 min and then centrifugate at 10000 g for 5 min. Co-crystallization conditions 22-25% PEG 4000, 10mM Hepes pH 6.5, 1mM DTT, 0.5 % v/v dioxane, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1038/nature06131",,"2OYT",31.21,"2","2","Crystal Structure of UNG2/DNA(TM)","MEFFGESWKKHLSGEFGKPYFIKLMGFVAEERKHYTVYPPPHQVFTWTQMCDIKDVKVVILGQDPYHGPNQAHGLCFSVQRPVPPPPSLENIYKELSTDIEDFVHPGHGDLSGWAKQGVLLLNAVLTVRAHQANSHKERGWEQFTDAVVSWLNQNSNGLVFLLWGSYAQKKGSAIDRKRHHVLQTAHPSPLSVYRGFFGCRHFSKTNELLQKSGKKPIDWKEL","Homo sapiens","UNG, DGU, UNG1, UNG15","Uracil-DNA glycosylase","1","2OYT"
,,,,,,,,,,,,,,,,"TGTXATCTT",,,"DNA strand1","2","2OYT"
,,,,,,,,,,,,,,,,"AAAGATNACA",,,"DNA strand2","3","2OYT"
"2OZ7",,"X-RAY DIFFRACTION",2.29,46.3,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.6 M sodium citrate, 0.1 M Hepes pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1074/jbc.M611711200","CA4","2OZ7",29.43,"1.8","1.8","Crystal structure of the human androgen receptor T877A mutant ligand-binding domain with cyproterone acetate","PIFLNVLEAIEPGVVCAGHDNNQPDSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWMGLMVFAMGWRSFTNVNSRMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKNQKFFDELRMNYIKELDRIIACKRKNPTSCSRRFYQLTKLLDSVQPIARELHQFAFDLLIKSHMVSVDFPEMMAEIISVQVPKILSGKVKPIYFHTQ","Homo sapiens","AR, DHTR, NR3C4","Androgen receptor","1","2OZ7"
"2OZF",,"X-RAY DIFFRACTION",2.88,57.28,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2M NaNO3, 0.1M BTProp, 20% PEG 3350, 10% Ethylene glycol, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,,,"2OZF",9.94,"1.5","1.5","The crystal structure of the 2nd PDZ domain of the human NHERF-1 (SLC9A3R1)","SMLRPRLCTMKKGPSGYGFNLHSDKSKPGQFIRSVDPDSPAEASGLRAQDRIVEVNGVCMEGKQHGDVVSAIRAGGDETKLLVVDRETETSL","Homo sapiens","SLC9A3R1, NHERF, NHERF1","Ezrin-radixin-moesin-binding phosphoprotein 50","1","2OZF"
"2OZO",,"X-RAY DIFFRACTION",2.37,48.05,"VAPOR DIFFUSION, HANGING DROP",,"0.05 M NaSCN, 21% PEG3350, protein mixed with 9 mM n-decyl-beta-D-thiomaltopyranoside, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.cell.2007.03.039",,"2OZO",69.88,"2.6","2.6","Autoinhibited intact human ZAP-70","MPDPAAHLPFFYGSISRAEAEEHLKLAGMADGLFLLRQCLRSLGGYVLSLVHDVRFHHFPIERQLNGTYAIAGGKAHCGPAELCEFYSRDPDGLPCNLRKPCNRPSGLEPQPGVFDCLRDAMVRDYVRQTWKLEGEALEQAIISQAPQVEKLIATTAHERMPWYHSSLTREEAERKLYSGAQTDGKFLLRPRKEQGTYALSLIYGKTVYHYLISQDKAGKYCIPEGTKFDTLWQLVEYLKLKADGLIYCLKEACPNSSASNASGAAAPTLPAHPSTLTHPQRRIDTLNSDGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGGSALEVA","Homo sapiens","ZAP70, SRK","Tyrosine-protein kinase ZAP-70","1","2OZO"
"2OZR",,"X-RAY DIFFRACTION",2.14,42.44,"VAPOR DIFFUSION, HANGING DROP",7.5,"Dissolved in DMSO inhibitor was mixed with protein (protein concentration: 1mg/ml) at 5:1 ratio, 0.1 M acetohydrohamic acid added. Ternary complex was concentrated (to 17 mg/ml protien concentration). 1-2 uL hagind drops were mixed with same amount of reservoit solution (2.1 M ammonium sulfate in 0.1 M Hepes buffer) , pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1074/jbc.M703286200","GG1","2OZR",158.26,"2.3","2.3","MMP13 Catalytic Domain Complexed with 4-{[1-methyl-2,4-dioxo-6-(3-phenylprop-1-yn-1-yl)-1,4-dihydroquinazolin-3(2H)-yl]methyl}benzoic acid","MASYNVFPRTLKWSKMNLTYRIVNYTPDMTHSEVEKAFKKAFKVWSDVTPLNFTRLHDGIADIMISFGIKEHGDFYPFDGPSGLLAHAFPPGPNYGGDAHFDDDETWTSSSKGYNLFLVAAHEFGHSLGLDHSKDPGALMFPIYTYTGKSHFMLPDDDVQGIQSLYGPGD","Homo sapiens","MMP13","Collagenase 3","1","2OZR"
"2OZU",,"X-RAY DIFFRACTION",2.5,50.83,"VAPOR DIFFUSION, HANGING DROP",6,"12% PEG 5000, 0.1 M Bis-Tris, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 300K",300,,,"2OZU",34.63,"2.3","2.3","Crystal structure of human MYST histone acetyltransferase 3 in complex with acetylcoenzyme A","GVTGPPDPQVRCPSVIEFGKYEIHTWYSSPYPQEYSRLPKLYLCEFCLKYMKSRTILQQHMKKCGWFHPPANEIYRKNNISVFEVDGNVSTIYCQNLCLLAKLFLDHKTLYYDVEPFLFYVLTQNDVKGCHLVGYFSKEKHCQQKYNVSCIMILPQYQRKGYGRFLIDFSYLLSKREGQAGSPEKPLSDLGRLSYMAYWKSVILECLYHQNDKQISIKKLSKLTGICPQDITSTLHHLRMLDFRSDQFVIIRREKLIQDHMAKLQLNLRPVDVDPECLRWTPVI","Homo sapiens","MYST3, MOZ, RUNXBP2, ZNF220, KAT6A","Histone acetyltransferase MYST3","1","2OZU"
"2OZW",,"SOLUTION NMR",,,,,,,,,"2OZW",13.95,,,"Solution structure of human phosphohistidine phosphatase 1 with phosphate ligand","MAVADLALIPDVDIDSDGVFKYVLIRVHSAPRSGAPAAESKEIVRGYKWAEYHADIYDKVSGDMQKQGCDCECLGGGRISHQSQDKKIHVYGYSMAYGPAQHAISTEKIKAKYPDYEVTWANDGY","Homo sapiens","PHPT1, PHP14, CGI-202, HSPC141","14 kDa phosphohistidine phosphatase","1","2OZW"
"2OZX",,"SOLUTION NMR",,,,,,,"10.1042/BJ20081571",,"2OZX",13.85,,,"Solution structure of human phosphohistidine phosphatase 1 in phosphate free form","MAVADLALIPDVDIDSDGVFKYVLIRVHSAPRSGAPAAESKEIVRGYKWAEYHADIYDKVSGDMQKQGCDCECLGGGRISHQSQDKKIHVYGYSMAYGPAQHAISTEKIKAKYPDYEVTWANDGY","Homo sapiens","PHPT1, PHP14, CGI-202, HSPC141","14 kDa phosphohistidine phosphatase","1","2OZX"
"2P01",,"SOLUTION NMR",,,,,,,"10.1110/ps.072865407",,"2P01",37.85,,,"The structure of receptor-associated protein(RAP)","YSREKNQPKPSPKRESGEEFRMEKLNQLWEKAQRLHLPPVRLAELHADLKIQERDELAWKKLKLDGLDEDGEKEARLIRNLNVILAKYGLDGKKDARQVTSNSLSGTQEDGLDDPRLEKLWHKAKTSGKFSGEELDKLWREFLHHKEKVHEYNVLLETLSRTEEIHENVISPSDLSDIKGSVLHSRHTELKEKLRSINQGLDRLRRVSHQGYSTEAEFEEPRVIDLWDLAQSANLTDKELEAFREELKHFEAKIEKHNHYQKQLEIAHEKLRHAESVGDGERVSRSREKHALLEGRTKELGYTVKKHLQDLSGRISRARHNEL","Homo sapiens","LRPAP1, A2MRAP","Alpha-2-macroglobulin receptor-associated protein","1","2P01"
"2P02",,"X-RAY DIFFRACTION",2.15,42.85,"VAPOR DIFFUSION, SITTING DROP",8,"0.2M Lithium chloride, 0.1M Tris-HCl, 20% PEG 6000, 10.0% Ethylene glycol, pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,,,"2P02",44.24,"1.21","1.21","Crystal structure of the alpha subunit of human S-adenosylmethionine synthetase 2","SMNGQLNGFHEAFIEEGTFLFTSESVGEGHPDKICDQISDAVLDAHLQQDPDAKVACETVAKTGMILLAGEITSRAAVDYQKVVREAVKHIGYDDSSKGFDYKTCNVLVALEQQSPDIAQGVHLDRNEEDIGAGDQGLMFGYATDETEECMPLTIVLAHKLNAKLAELRRNGTLPWLRPDSKTQVTVQYMQDRGAVLPIRVHTIVISVQHDEEVCLDEMRDALKEKVIKAVVPAKYLDEDTIYHLQPSGRFVIGGPQGDAGLTGRKIIVDTYGGWGAHGGGAFSGKDYTKVDRSAAYAARWVAKSLVKGGLCRRVLVQVSYAIGVSHPLSISIFHYGTSQKSERELLEIVKKNFDLRPGVIVRDLDLKKPIYQRTAAYGHFGRDSFPWEVPKKLKY","Homo sapiens","MAT2A, AMS2, MATA2","S-adenosylmethionine synthetase isoform type-2","1","2P02"
"2P03",,"SOLUTION NMR",,,,,,,"10.1110/ps.072865407",,"2P03",37.85,,,"The structure of receptor-associated protein(RAP)","YSREKNQPKPSPKRESGEEFRMEKLNQLWEKAQRLHLPPVRLAELHADLKIQERDELAWKKLKLDGLDEDGEKEARLIRNLNVILAKYGLDGKKDARQVTSNSLSGTQEDGLDDPRLEKLWHKAKTSGKFSGEELDKLWREFLHHKEKVHEYNVLLETLSRTEEIHENVISPSDLSDIKGSVLHSRHTELKEKLRSINQGLDRLRRVSHQGYSTEAEFEEPRVIDLWDLAQSANLTDKELEAFREELKHFEAKIEKHNHYQKQLEIAHEKLRHAESVGDGERVSRSREKHALLEGRTKELGYTVKKHLQDLSGRISRARHNEL","Homo sapiens","LRPAP1, A2MRAP","Alpha-2-macroglobulin receptor-associated protein","1","2P03"
"2P0A",,"X-RAY DIFFRACTION",2.4,48.7,"VAPOR DIFFUSION, SITTING DROP",8.5,"1.26M (NH4)2SO4, 0.2M Li2SO4, Tris-HCl pH 8.5, 20 % Ethylene glycol added as cryoprotectant, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,,,"2P0A",78.99,"1.9","1.9","The crystal structure of human synapsin III (SYN3) in complex with AMPPNP","SMGLMEPPGPSTPIVQRPRILLVIDDAHTDWSKYFHGKKVNGEIEIRVEQAEFSELNLAAYVTGGCMVDMQVVRNGTKVVSRSFKPDFILVRQHAYSMALGEDYRSLVIGLQYGGLPAVNSLYSVYNFCSKPWVFSQLIKIFHSLGPEKFPLVEQTFFPNHKPMVTAPHFPVVVKLGHAHAGMGKIKVENQLDFQDITSVVAMAKTYATTEAFIDSKYDIRIQKIGSNYKAYMRTSISGNWKANTGSAMLEQVAMTERYRLWVDSCSEMFGGLDICAVKAVHSKDGRDYIIEVMDSSMPLIGEHVEEDRQLMADLVVSKMSQLPMPGGTAPSPLRPWAPQIKSA","Homo sapiens","SYN3","Synapsin-3","1","2P0A"
"2P0C",,"X-RAY DIFFRACTION",2.23,44.72,"VAPOR DIFFUSION, HANGING DROP",5.5,"The protein in 20mM Tris-HCl pH 8.0, 0.5M NaCl, 5% glycerol, 2mM BME, 2.5 mM AMP-PNP, 10 mM MgCl2, 5mM peptide (ADEPNYETWG) was mixed with crystallization buffer (15% PEG 8000, 0.2M ammonium sulfate, and 0.1 M Sodium cacodylate, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 298.0K",298,"10.1016/j.jsb.2008.10.003",,"2P0C",72.94,"2.4","2.4","Catalytic Domain of the Proto-oncogene Tyrosine-protein Kinase MER","MGSSHHHHHHSSGLVPRGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLPDV","Homo sapiens","MERTK, MER","Proto-oncogene tyrosine-protein kinase MER","1","2P0C"
"2P0D",,"X-RAY DIFFRACTION",2.03,39.44,"VAPOR DIFFUSION, HANGING DROP",7,"26% PEG4000, 100mM HEPES, 10% glycerol, 5mM DTT, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1074/jbc.M700505200","I3P","2P0D",14.85,"1.811","1.811","ArhGAP9 PH domain in complex with Ins(1,4,5)P3","GSRRASVGSHEVEKSGLLNMTKIAQGGRKLRKNWGPSWVVLTGNSLVFYREPPPTAPSSGWGPAGSRPESSVDLRGAALAHGRHLSSRRNVLHIRTIPGHEFLLQSDHETELRAWHRALRTVIERLVRW","Homo sapiens","ARHGAP9","Rho GTPase-activating protein 9","1","2P0D"
"2P0E",,"X-RAY DIFFRACTION",2.5,50.85,"VAPOR DIFFUSION",9,"20% PEG 3350, 0.2M Sodium phosphate monobasic, 0.1M Bicine, pH 9.0, VAPOR DIFFUSION, temperature 291K",291,"10.1371/journal.pbio.0050263",,"2P0E",24.76,"1.8","1.8","Human nicotinamide riboside kinase 1 in complex with tiazofurin","MGSSHHHHHHSSGLVPRGSKTFIIGISGVTNSGKTTLAKNLQKHLPNCSVISQDDFFKPESEIETDKNGFLQYDVLEALNMEKMMSAISCWMESARHSVVSTDQESAEEIPILIIEGFLLFNYKPLDTIWNRSYFLTIPYEECKRRRSTRVYQPPDSPGYFDGHVWPMYLKYRQEMQDITWEVVYLDGTKSEEDLFLQVYEDLIQEL","Homo sapiens","NRK1, C9orf95, NMRK1","Nicotinamide riboside kinase 1","1","2P0E"
"2P0F",,"X-RAY DIFFRACTION",2.12,42.11,"VAPOR DIFFUSION, HANGING DROP",7,"20% PEG4000, 100mM HEPES, 5% glycerol, 5mM DTT, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1074/jbc.M700505200",,"2P0F",14.52,"1.91","1.91","ArhGAP9 PH domain in complex with Ins(1,3,5)P3","GSRRASVGSHEVEKSGLLNMTKIAQGGRKLRKNWGPSWVVLTGNSLVFYREPPPTAPSSGWGPAGSRPESSVDLRGAALAHGRHLSSRRNVLHIRTIPGHEFLLQSDHETELRAWHRALRTVIERLVRW","Homo sapiens","ARHGAP9","Rho GTPase-activating protein 9","1","2P0F"
"2P0H",,"X-RAY DIFFRACTION",2.11,41.68,"VAPOR DIFFUSION, HANGING DROP",7,"20% PEG4000, 100 mM HEPES, 5% glycerol, 5mM DTT, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1074/jbc.M700505200",,"2P0H",14.85,"1.9","1.9","ArhGAP9 PH domain in complex with Ins(1,3,4)P3","GSRRASVGSHEVEKSGLLNMTKIAQGGRKLRKNWGPSWVVLTGNSLVFYREPPPTAPSSGWGPAGSRPESSVDLRGAALAHGRHLSSRRNVLHIRTIPGHEFLLQSDHETELRAWHRALRTVIERLVRW","Homo sapiens","ARHGAP9","Rho GTPase-activating protein 9","1","2P0H"
"2P0K",,"X-RAY DIFFRACTION",2.37,48.17,"VAPOR DIFFUSION, SITTING DROP",7,"20% PEG3350, 0.2M Ammonium Citrate, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 300K",300,,,"2P0K",24.33,"1.75","1.75","Crystal structure of SCMH1","HFTWDKYLKETCSVPAPVHCFKQSYTPPSNEFKISMKLEAQDPRNTTSTCIATVVGLTGARLRLRLDGSDNKNDFWRLVDSAEIQPIGNCEKNGGMLQPPLGFRLNASSWPMFLLKTLNGAEMAPIRIFHKEPPSPSHNFFKMGMKLEAVDRKNPHFICPATIGEVRGSEVLVTFDGWRGAFDYWCRFDSRDIFPVGWCSLTGDNLQPPGTK","Homo sapiens","SCMH1","Polycomb protein SCMH1","1","2P0K"
"2P0W",,"X-RAY DIFFRACTION",3.07,59.99,"VAPOR DIFFUSION, HANGING DROP",6.5,"12% PEG 20000, 0.1M MES pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 300K",300,,,"2P0W",80.91,"1.9","1.9","Human histone acetyltransferase 1 (HAT1)","GSKKLAEYKCNTNTAIELKLVRFPEDLENDIRTFFPEYTHQLFGDDETAFGYKGLKILLYYIAGSLSTMFRVEYASKVDENFDCVEADDVEGKIRQIIPPGFCTNTNDFLSLLEKEVDFKPFGTLLHTYSVLSPTGGENFTFQIYKADMTCRGFREYHERLQTFLMWFIETASFIDVDDERWHYFLVFEKYNKDGATLFATVGYMTVYNYYVYPDKTRPRVSQMLILTPFQGQGHGAQLLETVHRYYTEFPTVLDITAEDPSKSYVKLRDFVLVKLCQDLPCFSREKLMQGFNEDMAIEAQQKFKINKQHARRVYEILRLLVTD","Homo sapiens","HAT1, KAT1","Histone acetyltransferase type B catalytic subunit","1","2P0W"
,,,,,,,,,,,,,,,,"KGGKGLGKGGAKRHR",,,"Histone peptide H4","2","2P0W"
"2P15",,"X-RAY DIFFRACTION",2.11,41.62,"VAPOR DIFFUSION, SITTING DROP",8.5,"20% PEG 4000, 0.2M Ammonium sulfate, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1038/sj.embor.7400963","EZT","2P15",62.82,"1.94","1.94","Crystal structure of the ER alpha ligand binding domain with the agonist ortho-trifluoromethylphenylvinyl estradiol","SIKRSKKNSLALSLTADQMVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLECAWLEILMIGLVWRSMEHPGKLLFAPNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGMEHLYSMKCKNVVPLSDLLLEMLDAHRLHAPTS","Homo sapiens","ESR1, ESR, NR3A1","Estrogen receptor","1","2P15"
,,,,,,,,,,,,,,,,"KHKILHRLLQDSS",,,"GRIP peptide","2","2P15"
"2P16",,"X-RAY DIFFRACTION",2.54,51.64,,5.5,"200 mM Sodium Acetate, 18% PEG6000, vapor diffusion, hanging drop, temperature 277K, pH 5.5",277,"10.1021/jm070245n","GG2","2P16",32.54,"2.3","2.3","Factor Xa in Complex with the Inhibitor APIXABAN (BMS-562247) AKA 1-(4-METHOXYPHENYL)-7-OXO-6-(4-(2-OXO-1-PIPERIDINYL)PHENYL)-4,5,6,7-TETRAHYDRO-1H-PYRAZOLO[3, 4-C]PYRIDINE-3-CARBOXAMIDE","IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT","Homo sapiens","F10","Coagulation factor X (EC 3.4.21.6) (Stuart factor) (Stuart-Prower factor)","1","2P16"
,,,,,,,,,,,,,,,,"KLCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACIPTGPYPCGKQTLE","Homo sapiens","F10","Coagulation factor X (EC 3.4.21.6) (Stuart factor) (Stuart-Prower factor)","2","2P16"
"2P1B",,"X-RAY DIFFRACTION",2.15,42.7,"VAPOR DIFFUSION, HANGING DROP",6.5,"50MM AMMONIUM SULFATE, 50MM BIS-TRIS PH 6.5, 30%(W/V) PENTAERYTHRITOL ETHOXYLATE (15/4 EO/OH), pH 6.50, VAPOR DIFFUSION, HANGING DROP, temperature 297K",297,"10.1002/prot.21504",,"2P1B",135.44,"2.75","2.75","Crystal structure of human nucleophosmin-core","MSPLRPQNYLFGCELKADKDYHFKVDNDENEHQLSLRTVSLGAGAKDELHIVEAEAMNYEGSPIKVTLATLKMSVQPTVSLGGFEITPPVVLRLKCGSGPVHISGQHLVAVEEDLEHHHHHH","Homo sapiens","NPM1, NPM","Nucleophosmin","1","2P1B"
"2P1F",,"X-RAY DIFFRACTION",2.23,44.85,"VAPOR DIFFUSION, HANGING DROP",8.4,"2.28M Ammonium sulfate, pH 8.4, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"2P1F",32.26,"1.76","1.76","Human UMP Synthase (C-terminal Domain-Orotidine 5'-Monophosphate Decarboxylase)","DAETVGRVKRFIQENVFVAANHNGSPLSIKEAPKELSFGARAELPRIHPVASKLLRLMQKKETNLCLSADVSLARELLQLADALGPSICMLKTHVDILNDFTLDVMKELITLAKCHEFLIFEDRKFADIGNTVKKQYEGGIFKIASWADLVNAHVVPGSGVVKGLQEVGLPLHRGCLLIAEMSSTGSLATGDYTRAAVRMAEEHSEFVVGFISGSRVSMKPEFLHLTPGVQLEAGGDNLGQQYNSPQEVIGKRGSDIIIVGRGIISAADRLEAAEMYRKAAWEAYLSRLGV","Homo sapiens","UMPS, OK/SW-cl.21","Uridine 5'-monophosphate synthase","1","2P1F"
"2P1H",,"X-RAY DIFFRACTION",2.02,39.04,"VAPOR DIFFUSION, HANGING DROP",6.1,"200 mM Tris-HCl, pH 6.1, 200 mM zinc acetate, 17% PEG 6000, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1016/j.jmb.2007.02.105",,"2P1H",11.18,"1.59","1.59","Rapid Folding and Unfolding of Apaf-1 CARD","GSMDAKARNCLLQHREALEKDIKTSYIMDHMISDGFLTISEEEKVRNEPTQQQRAAMLIKMILKKDNDSYVSFYNALLHEGYKDLAALLHDGIP","Homo sapiens","APAF1, KIAA0413","Apoptotic protease-activating factor 1","1","2P1H"
"2P1T",,"X-RAY DIFFRACTION",2.04,39.63,"VAPOR DIFFUSION, HANGING DROP",8.5,"16% PEG 3350, 0.1M Tris, 1M ammonium acetate, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 298.0K",298,"10.1073/pnas.0705356104",,"2P1T",28.82,"1.8","1.8","Crystal structure of the ligand binding domain of the retinoid X receptor alpha in complex with 3-(2'-methoxy)-tetrahydronaphtyl cinnamic acid and a fragment of the coactivator TIF-2","TSSANEDMPVERILEAELAVEPKTETYVEANMGLNPSSPNDPVTNICQAADKQLFTLVEWAKRIPHFSELPLDDQVILLRAGWNELLIASFSHRSIAVKDGILLATGLHVHRNSAHSAGVGAIFDRVLTELVSKMRDMQMDKTELGCLRAIVLFNPDSKGLSNPAEVEALREKVYASLEAYCKHKYPEQPGRFAKLLLRLPALRSIGLKCLEHLFFFKLIGDTPIDTFLMEMLEAPHQMT","Homo sapiens","RXRA, NR2B1","Retinoic acid receptor RXR-alpha","1","2P1T"
,,,,,,,,,,,,,,,,"KHKILHRLLQDSS",,,"Nuclear receptor coactivator 2 peptide","2","2P1T"
"2P1U",,"X-RAY DIFFRACTION",2.21,44.37,"VAPOR DIFFUSION, SITTING DROP",8.5,"14% PEG 10000, 0.1M Tris, 1M ammonium chloride, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1073/pnas.0705356104",,"2P1U",28.83,"2.2","2.2","Crystal structure of the ligand binding domain of the retinoid X receptor alpha in complex with 3-(2'-ethoxy)-tetrahydronaphtyl cinnamic acid and a fragment of the coactivator TIF-2","TSSANEDMPVERILEAELAVEPKTETYVEANMGLNPSSPNDPVTNICQAADKQLFTLVEWAKRIPHFSELPLDDQVILLRAGWNELLIASFSHRSIAVKDGILLATGLHVHRNSAHSAGVGAIFDRVLTELVSKMRDMQMDKTELGCLRAIVLFNPDSKGLSNPAEVEALREKVYASLEAYCKHKYPEQPGRFAKLLLRLPALRSIGLKCLEHLFFFKLIGDTPIDTFLMEMLEAPHQMT","Homo sapiens","RXRA, NR2B1","Retinoic acid receptor RXR-alpha","1","2P1U"
,,,,,,,,,,,,,,,,"KHKILHRLLQDSS",,,"Nuclear receptor coactivator 2 peptide","2","2P1U"
"2P1V",,"X-RAY DIFFRACTION",2.05,39.88,"VAPOR DIFFUSION, HANGING DROP",7.5,"24% PEG 4000, 0.1M Tris, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1073/pnas.0705356104",,"2P1V",28.84,"2.2","2.2","Crystal structure of the ligand binding domain of the retinoid X receptor alpha in complex with 3-(2'-propoxy)-tetrahydronaphtyl cinnamic acid and a fragment of the coactivator TIF-2","TSSANEDMPVERILEAELAVEPKTETYVEANMGLNPSSPNDPVTNICQAADKQLFTLVEWAKRIPHFSELPLDDQVILLRAGWNELLIASFSHRSIAVKDGILLATGLHVHRNSAHSAGVGAIFDRVLTELVSKMRDMQMDKTELGCLRAIVLFNPDSKGLSNPAEVEALREKVYASLEAYCKHKYPEQPGRFAKLLLRLPALRSIGLKCLEHLFFFKLIGDTPIDTFLMEMLEAPHQMT","Homo sapiens","RXRA, NR2B1","Retinoic acid receptor RXR-alpha","1","2P1V"
,,,,,,,,,,,,,,,,"KHKILHRLLQDSS",,,"Nuclear receptor coactivator 2 peptide","2","2P1V"
"2P23",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, HANGING DROP",5.75,"100 mM tri-sodium citrate, 14% PEG 1000, pH 5.75, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1128/MCB.02249-06",,"2P23",43.43,"1.8","1.8","Crystal structure of human FGF19","RPLAFSDAGPHVHYGWGDPIRLRHLYTSGPHGLSSCFLRIRADGVVDCARGQSAHSLLEIKAVALRTVAIKGVHSVRYLCMGADGKMQGLLQYSEEDCAFEEEIRPDGYNVYRSEKHRLPVSLSSAKQRQLYKNRGFLPLSHFLPMLPMVPEEPEDLRGHLESDMFSSPLETDSMDPFGLVTGLEAVRSPSFEK","Homo sapiens","FGF19, UNQ334/PRO533","Fibroblast growth factor 19","1","2P23"
"2P26",,"X-RAY DIFFRACTION",1.89,34.87,"VAPOR DIFFUSION, HANGING DROP",4.6,"0.2M Magnesium acetate, 0.1M sodium acetate, pH4.6, 18% PEG3350, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1074/jbc.M701670200",,"2P26",31.72,"1.75","1.75","Structure of the PHE2 and PHE3 fragments of the integrin beta2 subunit","QECTKFKVSSCRECIESGPGCTWCQKLNFTGPGDPDSIRCDTRPQLLMRGCAADDIMDPTSLAETQEDHNGGQKQLSPQKVTLYLRPGQAAAFNVTFRRAKLSSRVFLDHNALPDTLKVTYDSFCSNGVTHRNQPRGDCDGVQINVPITFQVKVTATECIQEQSFVIRALGFTDIVTVQVLPQCECRCRDQSRDRSLCHGKGFLECGICRCDTGYIGKNCECQTQGRSSQELEGSCRKDNNSIICSGLGDCVCGQCLCHTSDVPGKLIYGQYCEHHHHHH","Homo sapiens","ITGB2","Integrin beta-2","1","2P26"
,,,,,,,,,,,,,,,,,"Homo sapiens","ITGB2"
"2P27",,"X-RAY DIFFRACTION",2.36,47.99,"VAPOR DIFFUSION, SITTING DROP",8.5,"100mM Tris-HCl pH 8.5, 17% PEG 20000, 100mM Magnesium chloride, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1007/s10969-007-9036-1",,"2P27",33.17,"1.9","1.9","Crystal Structure of Human Pyridoxal Phosphate Phosphatase with Mg2+ at 1.9 A resolution","MSLARCERLRGAALRDVLGRAQGVLFDCDGVLWNGERAVPGAPELLERLARAGKAALFVSNNSRRARPELALRFARLGFGGLRAEQLFSSALCAARLLRQRLPGPPDAPGAVFVLGGEGLRAELRAAGLRLAGDPSAGDGAAPRVRAVLVGYDEHFSFAKLREACAHLRDPECLLVATDRDPWHPLSDGSRTPGTGSLAAAVETASGRQALVVGKPSPYMFECITENFSIDPARTLMVGDRLETDILFGHRCGMTTVLTLTGVSRLEEAQAYLAAGQHDLVPHYYVESIADLTEGLEDEGHHHHHH","Homo sapiens","PDXP, PLP, PLPP, CIN","Pyridoxal phosphate phosphatase","1","2P27"
"2P28",,"X-RAY DIFFRACTION",2.39,48.58,"VAPOR DIFFUSION, HANGING DROP",,"0.2M ammonium sulphate, 15% PEG4000, 5% isopropanol, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1074/jbc.M701670200",,"2P28",35.14,"2.2","2.2","Structure of the PHE2 and PHE3 fragments of the integrin beta2 subunit","QECTKFKVSSCRECIESGPGCTWCQKLNFTGPGDPDSIRCDTRPQLLMRGCAADDIMDPTSLAETQEDHNGGQKQLSPQKVTLYLRPGQAAAFNVTFRRA","Homo sapiens","ITGB2, CD18, MFI7","Integrin beta-2","1","2P28"
,,,,,,,,,,,,,,,,"KLSSRVFLDHNALPDTLKVTYDSFCSNGVTHRNQPRGDCDGVQINVPITFQVKVTATECIQEQSFVIRALGFTDIVTVQVLPQCECRCRDQSRDRSLCHGKGFLECGICRCDTGYIGKNCECQTQGRSSQELEGSCRKDNNSIICSGLGDCVCGQCLCHTSDVPGKLIYGQYCECDTINCERYNGQVCGGPGRGLCFCGKCRCHPGFEGSACQHHHH","Homo sapiens","ITGB2, CD18, MFI7","Integrin beta-2","2","2P28"
"2P2H",,"X-RAY DIFFRACTION",3.7,66.79,"VAPOR DIFFUSION, HANGING DROP",8,"pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/jm061107l","994","2P2H",36.72,"1.95","1.95","Crystal structure of the VEGFR2 kinase domain in complex with a pyridinyl-triazine inhibitor","EHAERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQDRHHHHHH","Homo sapiens","KDR, FLK1","Vascular endothelial growth factor receptor 2","1","2P2H"
,,,,,,,,,,,,,,,,,"Homo sapiens","KDR, FLK1"
"2P2I",,"X-RAY DIFFRACTION",2.27,45.78,"VAPOR DIFFUSION, HANGING DROP",8,"pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/jm061107l","608","2P2I",73.36,"2.4","2.4","Crystal structure of the VEGFR2 kinase domain in complex with a nicotinamide inhibitor","EHAERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQDRHHHHHH","Homo sapiens","KDR, FLK1","Vascular endothelial growth factor receptor 2","1","2P2I"
,,,,,,,,,,,,,,,,,"Homo sapiens","KDR, FLK1"
"2P2L",,"X-RAY DIFFRACTION",3.55,65.34,"VAPOR DIFFUSION, HANGING DROP",6,"100mM MES pH6.0, 15mM ZnSO4, 10% PEGMME 550., VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1107/S0907444907010888",,"2P2L",64.22,"1.9","1.9","Rac1-GDP-Zinc Complex","GSKLMQAIKCVVVGDGAVGKTCLLISYTTNAFPGEYIPTVFDNYSANVMVDGKPVNLGLWDTAGQEDYDRLRPLSYPQTDVSLICFSLVSPASFENVRAKWYPEVRHHCPNTPIILVGTKLDLRDDKDTIEKLKEKKLTPITYPQGLAMAKEIGAVKYLECSALTQRGLKTVFDEAIRAVLCPPPVKK","Homo sapiens","RAC1, TC25, MIG5","Ras-related C3 botulinum toxin substrate 1","1","2P2L"
"2P2R",,"X-RAY DIFFRACTION",2.78,55.71,"VAPOR DIFFUSION, HANGING DROP",8.18,"2M ammonium sulfate, 80 mM lithium sulfate, 100 mM CAPS, pH 8.18, 5% glycerol, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1093/nar/gkm139",,"2P2R",10.31,"1.6","1.6","Crystal structure of the third KH domain of human Poly(C)-Binding Protein-2 in complex with C-rich strand of human telomeric DNA","AACCCTA",,,"C-rich strand of human telomeric DNA","1","2P2R"
,,,,,,,,,,,,,,,,"KAQTTSHELTIPNDLIGCIIGRQGAKINEIRQMSGAQIKIANPVEGSTDRQVTITGSAASISLAQYLINVRLSSET","Homo sapiens","PCBP2","Poly(rC)-binding protein 2","2","2P2R"
"2P31",,"X-RAY DIFFRACTION",1.95,36.96,"VAPOR DIFFUSION, SITTING DROP",7,"25% PEG 3350, 200 mM Ammoniun sulfate, 17% Glycerol, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,,,"2P31",41.27,"2","2","Crystal structure of human glutathione peroxidase 7","MHHHHHHSSGVDLGTENLYFQSMQQEQDFYDFKAVNIRGKLVSLEKYRGSVSLVVNVASECGFTDQHYRALQQLQRDLGPHHFNVLAFPCNQFGQQEPDSNKEIESFARRTYSVSFPMFSKIAVTGTGAHPAFKYLAQTSGKEPTWNFWKYLVAPDGKVVGAWDPTVSVEEVRPQITALVR","Homo sapiens","GPX7, GPX6, UNQ469/PRO828","Glutathione peroxidase 7","1","2P31"
"2P33",,"X-RAY DIFFRACTION",2.36,47.9,,,,,"10.1016/j.bmcl.2007.03.078","J07","2P33",42.52,"2.4","2.4","Synthesis and SAR of Aminopyrimidines as Novel c-Jun N-Terminal Kinase (JNK) Inhibitors","MGSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVMNSE","Homo sapiens","MAPK10, JNK3, JNK3A, PRKM10, SAPK1B","c-Jun N-terminal kinase 3","1","2P33"
"2P39",,"X-RAY DIFFRACTION",2.17,43.37,"VAPOR DIFFUSION, HANGING DROP",8.5,"100 mM Tris-HCl, 1.0 M (NH4)2SO4, 10 mM [Co(NH3)6]Cl3, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1128/MCB.02249-06",,"2P39",18.84,"1.5","1.5","Crystal structure of human FGF23","YPNASPLLGSSWGGLIHLYTATARNSYHLQIHKNGHVDGAPHQTIYSALMIRSEDAGFVVITGVMSRRYLCMDFRGNIFGSHYFDPENCRFQHQTLENGYDVYHSPQYHFLVSLGRAKRAFLPGMNPPPYSQFLSRRNEIPLIHFNTPIPRRHTR","Homo sapiens","FGF23, HYPF, UNQ3027/PRO9828","Fibroblast growth factor 23","1","2P39"
"2P3G",,"X-RAY DIFFRACTION",4.5,72.66,"VAPOR DIFFUSION, HANGING DROP",5.4,"Protein solution (5 mg/ml) euqilibrated against 1.6 - 2.0 M sodium malonate at pH 5.4, VAPOR DIFFUSION, HANGING DROP, temperature 298.0K",298,"10.1021/jm0611004","F10","2P3G",38.21,"3.8","3.8","Crystal structure of a pyrrolopyridine inhibitor bound to MAPKAP Kinase-2","QFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIK","Homo sapiens","MAPKAPK2","MAP kinase-activated protein kinase 2","1","2P3G"
"2P3T",,"X-RAY DIFFRACTION",2.44,51.2,"VAPOR DIFFUSION, HANGING DROP",7.5,"A three-fold excess of the inhibitor was added to the DES-GLA-FACTOR XA. the protein was then concentrated to 12-17 MG/ML. Crystals were grown using 2 UL of complex with 2 UL of reservoir containing 15-21% PEG1500 and 10 MM CACL2, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1021/jm070125f","993","2P3T",32.58,"1.92","1.92","Crystal structure of human factor XA complexed with 3-Chloro-4-(2-methylamino-imidazol-1-ylmethyl)-thiophene-2-carboxylic acid [4-chloro-2-(5-chloro-pyridin-2-ylcarbamoyl)-6-methoxy-phenyl]-amide","KLCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACIPTGPYPCGKQTLE","Homo sapiens","F10","Coagulation factor X","1","2P3T"
,,,,,,,,,,,,,,,,"IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMK","Homo sapiens","F10","Coagulation factor X","2","2P3T"
"2P3U",,"X-RAY DIFFRACTION",2.44,51.2,"EVAPORATION",7.5,"A THREE-FOLD EXCESS OF 3-Chloro-4-(2-methylamino-imidazol-1-ylmethyl)-thiophene-2-carboxylic acid [4-chloro-2-(5-chloro-pyridin-2-ylcarbamoyl)-6-methoxy-phenyl]-amide WAS ADDED TO THE DES-GLA-FACTOR XA. THE PROTEIN WAS THEN CONCENTRATED TO 12-17 MG/ML. CRYSTALS WERE GROWN USING 2 UL OF COMPLEX WITH 2 UL OF RESERVOIR CONTAINING 15-21% PEG1500 AND 10 MM CACL2. 30-40 UL SITTING DROPS CONTAINING SATURATED INHIBITOR (5 MM) IN 21% PEG1500, 5 MM CACL2, 20 MM NACL, 25 MM TRIS PH 7.5 (CRYSTAL SOAKING SOLUTION) WERE EQUILIBRATED OVER A 1 ML RESERVOIR CONTAINING THE CRYSTAL SOAKING SOLUTION FOR 1 TO 2 DAYS. A SINGLE FACTOR XA CRYSTAL WAS TRANSFERRED USING A MOUNTED CRYOLOOP INTO ONE OF THESE SITTING DROPS AND ALLOWED TO SOAK FOR THREE OR MORE DAYS, EVAPORATION, temperature 295K",295,,,"2P3U",32.57,"1.62","1.62","Crystal structure of human factor XA complexed with 3-chloro-N-(4-chloro-2-{[(5-chloropyridin-2-yl)amino]carbonyl}-6-methoxyphenyl)-4-[(1-methyl-1H-imidazol-2-yl)methyl]thiophene-2-carboxamide {Pfizer 320663}","KLCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACIPTGPYPCGKQTLE","Homo sapiens","F10","Coagulation factor X","1","2P3U"
,,,,,,,,,,,,,,,,"IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMK","Homo sapiens","F10","Coagulation factor X","2","2P3U"
"2P3W",,"X-RAY DIFFRACTION",2.19,43.81,"VAPOR DIFFUSION",6.5,"0.1 M Bis-Tris, 0.2 M MgCl2, and 25% PEG 3350, pH 6.5, VAPOR DIFFUSION, temperature 292K",292,"10.1110/ps.073049407",,"2P3W",24.35,"1.7","1.7","Crystal Structure of the HtrA3 PDZ Domain Bound to a Phage-Derived Ligand (FGRWV)","GSHMKRFIGIRMRTITPSLVDELKASNPDFPEVSSGIYVQEVAPNSPSQRGGIQDGDIIVKVNGRPLVDSSELQEAVLTESPLLLEVRRGNDDLLFSIAPEVVMGGGFGRWV","Homo sapiens","HTRA3, PRSP","Probable serine protease HTRA3","1","2P3W"
"2P4E",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, HANGING DROP",8.5,"25% PEG 1500, 50 mM Tris-HCl buffer, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 300K",300,"10.1038/nsmb1235",,"2P4E",149.32,"1.98","1.98","Crystal Structure of PCSK9","MGTVSSRRSWWPLPLLLLLLLLLGPAGARAQEDEDGDYEELVLALRSEEDGLAEAPEHGTTATFHRCAKDPWRLPGTYVVVLKEETHLSQSERTARRLQAQAARRGYLTKILHVFHGLLPGFLVKMSGDLLELALKLPHVDYIEEDSSVFAQSIPWNLERITPPRYRADEYQPPDGGSLVEVYLLDTSIQSDHREIEGRVMVTDFENVPEEDGTRFHRQASKCDSHGTHLAGVVSGRDAGVAKGASMRSLRVLNCQGKGTVSGTLIGLEFIRKSQLVQPVGPLVVLLPLAGGYSRVLNAACQRLARAGVVLVTAAGNFRDDACLYSPASAPEVITVGATNAQDQPVTLGTLGTNFGRCVDLFAPGEDIIGASSDCSTCFVSQSGTSQAAAHVAGIAAMMLSAEPELTLAELRQRLIHFSAKDVINEAWFPEDQRVLTPNLVAALPPSTHGAGWQLFCRTVWSAHSGPTRMATAIARCAPDEELLSCSSFSRSGKRRGERMEAQGGKLVCRAHNAFGGEGVYAIARCCLLPQANCSVHTAPPAEASMGTRVHCHQQGHVLTGCSSHWEVEDLGTHKPPVLRPRGQPNQCVGHREASIHASCCHAPGLECKVKEHGIPAPQEQVTVACEEGWTLTGCSALPGTSHVLGAYAVDNTCVVRSRDVSTTGSTSEEAVTAVAICCRSRHLAQASQELQ","Homo sapiens","PCSK9, NARC1, PSEC0052","Proprotein convertase subtilisin/kexin type 9","1","2P4E"
"2P4I",,"X-RAY DIFFRACTION",2.46,49.95,"VAPOR DIFFUSION",7,"14-18% PEG 3350, 0.2M tri-Potassium Citrate (pH 6.5-7.5) and 2% isopropanol., pH 7.0, VAPOR DIFFUSION, temperature 298K",298,"10.1021/jm061107l","MR9","2P4I",73.64,"2.5","2.5","Evolution of a highly Selective and Potent 2-(Pyridin-2-yl)-1,3,5-triazine Tie-2 Kinase Inhibitor","KNNPDPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLYEKFTYAGIDCSAEEAA","Homo sapiens","TEK, TIE2, VMCM, VMCM1","Angiopoietin-1 receptor","1","2P4I"
"2P4J",,"X-RAY DIFFRACTION",2.83,56.49,"VAPOR DIFFUSION, HANGING DROP",6.5,"CRYSTALLIZATION CONDITIONS: APO ENZYME CRYSTAL WAS OBTAINED AT 15 mg/ml, 13% PEG 8000, PH 6.5 IN SODIUM CACODYLATE BUFFER. THE APO ENZYME CRYSTAL WAS SOAKED IN CONCENTRATED INHIBITOR SOLUTION TO MAKE THE ENZYME/INHIBITOR COMPLEX CRYSTAL FOR X-RAY DATA COLLECTION, VAPOR DIFFUSION, HANGING DROP, temperature 290K",290,"10.1021/jm061338s","23I","2P4J",176.06,"2.5","2.5","Crystal structure of beta-secretase bond to an inhibitor with Isophthalamide Derivatives at P2-P3","GSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYN","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","2P4J"
"2P4K",,"X-RAY DIFFRACTION",2.19,43.92,"VAPOR DIFFUSION, SITTING DROP",7.8,"25 MM K2HPO4, 22% POLYETHYLENE GLYCOL (PEG) 2000 MONOMETHYL ETHER, pH 7.8, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1021/bi8023288",,"2P4K",88.96,"1.48","1.48","Contribution to Structure and Catalysis of Tyrosine 34 in Human Manganese Superoxide Dismutase","KHSLPDLPYDYGALEPHINAQIMQLHHSKHHAANVNNLNVTEEKYQEALAKGDVTAQIALQPALKFNGGGHINHSIFWTNLSPNGGGEPKGELLEAIKRDFGSFDKFKEKLTAASVGVQGSGWGWLGFNKERGHLQIAACPNQDPLQGTTGLIPLLGIDVWEHAYYLQYKNVRPDYLKAIWNVINWENVTERYMACKK","Homo sapiens","SOD2","Superoxide dismutase","1","2P4K"
"2P4Y",,"X-RAY DIFFRACTION",2.52,51.15,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.95M Trisodium citrate, 0.1M Tris-HCl pH 8.5, 1mM TCEP, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1124/mol.107.041202","C03","2P4Y",64.46,"2.25","2.25","Crystal structure of human PPAR-gamma-ligand binding domain complexed with an indole-based modulator","GSQLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","2P4Y"
"2P54",,"X-RAY DIFFRACTION",2.49,50.52,"VAPOR DIFFUSION, HANGING DROP",7,"7% PEG 3350, 200 mM NaF, 12% 2,5-hexanediol, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1021/jm058056x","735","2P54",32.27,"1.79","1.79","a crystal structure of PPAR alpha bound with SRC1 peptide and GW735","DLKSLAKRIYEAYLKNFNMNKVKARVILSGKASNNPPFVIHDMETLCMAEKTLVAKLVANGIQNKEAEVRIFHCCQCTSVETVTELTEFAKAIPGFANLDLNDQVTLLKYGVYEAIFAMLSSVMNKDGMLVAYGNGFITREFLKSLRKPFCDIMEPKFDFAMKFNALELDDSDISLFVAAIICCGDRPGLLNVGHIEKMQEGIVHVLRLHLQSNHPDDIFLFPKLLQKMADLRQLVTEHAQLVQIIKKTESDAALHPLLQEIYRDMY","Homo sapiens","PPARA, NR1C1, PPAR","Peroxisome proliferator-activated receptor alpha","1","2P54"
,,,,,,,,,,,,,,,,"ARHKILHRLLQE",,,"Nuclear receptor coactivator 1","2","2P54"
"2P55",,"X-RAY DIFFRACTION",3.37,63.46,,,,,"10.1021/jm0704548",,"2P55",37.74,"2.8","2.8","X-ray structure of the human mitogen-activated protein kinase kinase 1 (MEK1) in a complex with ligand and MgATP","MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWLCSTIGLNQPSTPTHAAGV","Homo sapiens","MAP2K1, MEK1, PRKMK1","Dual specificity mitogen-activated protein kinase kinase 1","1","2P55"
"2P57",,"X-RAY DIFFRACTION",2.2,44.1,"VAPOR DIFFUSION, SITTING DROP",4.6,"3.2M sodium formate, .09M sodium acetate, pH 4.6, vapor diffusion, sitting drop, temperature 291K",291,,,"2P57",16.17,"1.8","1.8","GAP domain of ZNF289, an ID1-regulated zinc finger protein","MHHHHHHSSGLVPRGSAEPNKTEIQTLFKRLRAVPTNKACFDCGAKNPSWASITYGVFLCIDCSGVHRSLGVHLSFIRSTELDSNWNWFQLRCMQVGGNANATAFFRQHGCTANDANTKYNSRAAQMYREKIRQLGSAALARHG","Homo sapiens","ZNF289, ARFGAP2, Nbla10535","GTPase-activating protein ZNF289","1","2P57"
"2P5B",,"X-RAY DIFFRACTION",2.55,51.71,"EVAPORATION",,"EVAPORATION",,"10.1073/pnas.0704525104","OGA","2P5B",87.21,"1.99","1.99","The complex structure of JMJD2A and trimethylated H3K36 peptide","GSMASESETLNPSARIMTFYPTMEEFRNFSRYIAYIESQGAHRAGLAKVVPPKEWKPRASYDDIDDLVIPAPIQQLVTGQSGLFTQYNIQKKAMTVREFRKIANSDKYCTPRYSEFEELERKYWKNLTFNPPIYGADVNGTLYEKHVDEWNIGRLRTILDLVEKESGITIEGVNTPYLYFGMWKTSFAWHTEDMDLYSINYLHFGEPKSWYSVPPEHGKRLERLAKGFFPGSAQSCEAFLRHKMTLISPLMLKKYGIPFDKVTQEAGEFMITFPYGYHAGFNHGFNCAESTNFATRRWIEYGKQAVLCSCRKDMVKISMDVFVRKFQPERYKLWKAGKDNTVIDHTLPTPEA","Homo sapiens","JMJD2A, JHDM3A, JMJD2, KIAA0677, KDM4A","JmjC domain-containing histone demethylation protein 3A","1","2P5B"
,,,,,,,,,,,,,,,,"RKSAPATGGVKKPHRYRPGTVL",,,"Histone H3","2","2P5B"
"2P5S",,"X-RAY DIFFRACTION",2.57,52.07,"VAPOR DIFFUSION, SITTING DROP",,"20% PEG-3350, 0.2M KF, vapor diffusion, sitting drop",,,,"2P5S",45.02,"2.15","2.15","RAB domain of human RASEF in complex with GDP","MGSSHHHHHHSSGLVPRGSAKSFSSQKAYKIVLAGDAAVGKSSFLMRLCKNEFRENISATLGVDFQMKTLIVDGERTVLQLWDTAGQERFRSIAKSYFRKADGVLLLYDVTCEKSFLNIREWVDMIEDAAHETVPIMLVGNKADIRDTAATEGQKCVPGHFGEKLAMTYGALFCETSAKDGSNIVEAVLHLAREVKKRT","Homo sapiens","RASEF, RAB45","RAS and EF-hand domain containing","1","2P5S"
"2P5X",,"X-RAY DIFFRACTION",2.47,50.22,"VAPOR DIFFUSION, HANGING DROP",7,"15% PEG 3350, 0.1 M Succinic acid, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 300K",300,"10.1016/j.chembiol.2013.09.011",,"2P5X",51.83,"2","2","Crystal structure of Maf domain of human N-acetylserotonin O-methyltransferase-like protein","LLHKRVVLASASPRRQEILSNAGLRFEVVPSKFKEKLDKASFATPYGYAMETAKQKALEVANRLYQKDLRAPDVVIGADTIVTVGGLILEKPVDKQDAYRMLSRLSGREHSVFTGVAIVHCSSKDHQLDTRVSEFYEETKVKFSELSEELLWEYVHSGEPMDKAGGYGIQALGGMLVESVHGDFLNVVGFPLNHFCKQLVKLYYPPRPEDLRRSVKHDSIPAADTFEDLS","Homo sapiens","ASMTL","N-acetylserotonin O-methyltransferase-like protein","1","2P5X"
"2P64",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, HANGING DROP",7.5,"200 mM MgCl2, 5 mM CdCl2, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.cell.2007.04.042",,"2P64",12.76,"2.5","2.5","D domain of b-TrCP","GAASYEKEKELCVKYFEQWSESDQVEFVEHLISQMCHYQHGHINSYLKPMLQ","Homo sapiens","BTRC, BTRCP, FBW1A, FBXW1A","F-box/WD repeat protein 1A","1","2P64"
"2P66",,"X-RAY DIFFRACTION",2.42,49.11,"VAPOR DIFFUSION, SITTING DROP",6.5,"100 mM Bis-Tris, pH 6.5, 300 mM Sodium Acetate, 16% PEG-3350, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1016/j.dnarep.2005.08.009",,"2P66",48.33,"2.5","2.5","Human DNA Polymerase beta complexed with tetrahydrofuran (abasic site) containing DNA","CCGACAGCGCATCAGC",,,"DNA (5'-D(*CP*CP*GP*AP*CP*AP*GP*CP*GP*CP*AP*TP*CP*AP*GP*C)-3')","1","2P66"
,,,,,,,,,,,,,,,,"GCTGATGCGCC",,,"DNA (5'-D(*GP*CP*TP*GP*AP*TP*GP*CP*GP*CP*C)-3')","2","2P66"
,,,,,,,,,,,,,,,,"NGTCGG",,,"DNA (5'-D(P*(3DR)P*GP*TP*CP*GP*G)-3')","3","2P66"
,,,,,,,,,,,,,,,,"MSKRKAPQETLNGGITDMLTELANFEKNVSQAIHKYNAYRKAASVIAKYPHKIKSGAEAKKLPGVGTKIAEKIDEFLATGKLRKLEKIRQDDTSSSINFLTRVSGIGPSAARKFVDEGIKTLEDLRKNEDKLNHHQRIGLKYFGDFEKRIPREEMLQMQDIVLNEVKKVDSEYIATVCGSFRRGAESSGDMDVLLTHPSFTSESTKQPKLLHQVVEQLQKVHFITDTLSKGETKFMGVCQLPSKNDEKEYPHRRIDIRLIPKDQYYCGVLYFTGSDIFNKNMRAHALEKGFTINEYTIRPLGVTGVAGEPLPVDSEKDIFDYIQWKYREPKDRSE","Homo sapiens","POLB","DNA polymerase beta","4","2P66"
"2P69",,"X-RAY DIFFRACTION",2.38,48.43,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1 M Citric acid pH 5.5, 20% PEG 3000, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1007/s10969-007-9036-1",,"2P69",33.43,"2.25","2.25","Crystal Structure of Human Pyridoxal Phosphate Phosphatase with PLP","MSLARCERLRGAALRDVLGRAQGVLFDCDGVLWNGERAVPGAPELLERLARAGKAALFVSNNSRRARPELALRFARLGFGGLRAEQLFSSALCAARLLRQRLPGPPDAPGAVFVLGGEGLRAELRAAGLRLAGDPSAGDGAAPRVRAVLVGYDEHFSFAKLREACAHLRDPECLLVATDRDPWHPLSDGSRTPGTGSLAAAVETASGRQALVVGKPSPYMFECITENFSIDPARTLMVGDRLETDILFGHRCGMTTVLTLTGVSRLEEAQAYLAAGQHDLVPHYYVESIADLTEGLEDEGHHHHHH","Homo sapiens","PDXP, PLP, PLPP, CIN","Pyridoxal phosphate phosphatase","1","2P69"
"2P6N",,"X-RAY DIFFRACTION",2.41,48.93,,5.5,"25% PEG 3350, 200mM Lithium sulfate, 100mM Bis-Tris, pH 5.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K, pH 5.50",293,"10.1371/journal.pone.0012791",,"2P6N",42.34,"2.6","2.6","Human DEAD-box RNA helicase DDX41, helicase domain","MHHHHHHSSGVDLGTENLYFQSMGAASLDVIQEVEYVKEEAKMVYLLECLQKTPPPVLIFAEKKADVDAIHEYLLLKGVEAVAIHGGKDQEERTKAIEAFREGKKDVLVATDVASKGLDFPAIQHVINYDMPEEIENYVHRIGRTGCSGNTGIATTFINKACDESVLMDLKALLLEAKQKVPPVLQVLHCG","Homo sapiens","DDX41, ABS","ATP-dependent RNA helicase DDX41","1","2P6N"
"2P6V",,"X-RAY DIFFRACTION",4.21,70.77,"VAPOR DIFFUSION, HANGING DROP",6.6,"Crystals of methylated hTAF4-TAFH containing SeMet were grown by hanging drop vapor diffusion at 22 C by mixing equal volumes of protein solution and crystallization buffer (200 mM ammonium acetate, 2.2 M ammonium sulfate and 150 mM sodium bromide). , pH 6.6, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1073/pnas.0608570104",,"2P6V",12.75,"2","2","Structure of TAFH domain of the human TAF4 subunit of TFIID","TVPGATTTSSAATETMENVKKCKNFLSTLIKLASSGKQSTETAANVKELVQNLLDGKIEAEDFTSRLYRELNSSPQPYLVPFLKRSLPALRQLTPDSAAFIQQSQQQPPPPTSQ","Homo sapiens","TAF4, TAF2C, TAF2C1, TAF4A, TAFII130, TAFII135","Transcription initiation factor TFIID subunit 4","1","2P6V"
"2P6X",,"X-RAY DIFFRACTION",2.36,47.9,"VAPOR DIFFUSION, SITTING DROP",7.9,"100 mM Bicine pH 7.9, 25% PEG 10000, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.cell.2008.11.038",,"2P6X",73.31,"1.9","1.9","Crystal structure of human tyrosine phosphatase PTPN22","MDQREILQKFLDEAQSKKITKEEFANEFLKLKRQSTKYKADKTYPTTVAEKPKNIKKNRYKDILPYDYSRVELSLITSDEDSSYINANFIKGVYGPKAYIATQGPLSTTLLDFWRMIWEYSVLIIVMACMEYEMGKKKCERYWAEPGEMQLEFGPFSVSCEAEKRKSDYIIRTLKVKFNSETRTIYQFHYKNWPDHDVPSSIDPILELIWDVRCYQEDDSVPICIHCSAGCGRTGVICAIDYTWMLLKDGIIPENFSVFSLIREMRTQRPSLVQTQEQYELVYNAVLELFKRQMDVIRDKHSAHHHHHH","Homo sapiens","PTPN22, PTPN8","Tyrosine-protein phosphatase non-receptor type 22","1","2P6X"
"2P7A",,"X-RAY DIFFRACTION",2.49,50.7,"VAPOR DIFFUSION, HANGING DROP",8.5,"22.6% polyethylene glycol 4000, 0.1M Tris pH 8.5 and 0.2M Sodium acetate, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.jsbmb.2007.06.006","43M","2P7A",28.53,"2.3","2.3","Crystal Structure of Estrogen Related Receptor g in complex with 3-methyl phenol","MGSSHHHHHHSSGLVPRGSHMPAKKPYNKIVSHLLVAEPEKIYAMPDPTVPDSDIKALTTLCDLADRELVVIIGWAKHIPGFSTLSLADQMSLLQSAWMEILILGVVYRSLSFEDELVYADDYIMDEDQSKLAGLLDLNNAILQLVKKYKSMKLEKEEFVTLKAIALANSDSMHIEDVEAVQKLQDVLHEALQDYEAGQHMEDPRRAGKMLMTLPLLRQTSTKAVQHFYNIKLEGKVPMHKLFLEMLEAKV","Homo sapiens","ESRRG, ERR3, ERRG2, KIAA0832, NR3B3","Estrogen-related receptor gamma","1","2P7A"
"2P7G",,"X-RAY DIFFRACTION",2.47,50.11,"VAPOR DIFFUSION, HANGING DROP",8.5,"22.6% polyethylene glycol 4000, 0.1M Tris, pH 8.5 and 0.2M Sodium Acetate, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.jsbmb.2007.06.006","2OH","2P7G",28.64,"2.1","2.1","X-ray Structure of Estrogen Related Receptor g in complex with Bisphenol A.","MGSSHHHHHHSSGLVPRGSHMPAKKPYNKIVSHLLVAEPEKIYAMPDPTVPDSDIKALTTLCDLADRELVVIIGWAKHIPGFSTLSLADQMSLLQSAWMEILILGVVYRSLSFEDELVYADDYIMDEDQSKLAGLLDLNNAILQLVKKYKSMKLEKEEFVTLKAIALANSDSMHIEDVEAVQKLQDVLHEALQDYEAGQHMEDPRRAGKMLMTLPLLRQTSTKAVQHFYNIKLEGKVPMHKLFLEMLEAKV","Homo sapiens","ESRRG, ERR3, ERRG2, KIAA0832, NR3B3","Estrogen-related receptor gamma","1","2P7G"
"2P7Z",,"X-RAY DIFFRACTION",2.47,50.12,"VAPOR DIFFUSION, HANGING DROP",8.5,"22.6% polyethylene glycol 4000, 0.1M Tris pH 8.5 and 0.2M sodium acetate, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.jsbmb.2007.06.006","OHT","2P7Z",28.77,"2.5","2.5","Estrogen Related Receptor Gamma in complex with 4-hydroxy-tamoxifen","MGSSHHHHHHSSGLVPRGSHMPAKKPYNKIVSHLLVAEPEKIYAMPDPTVPDSDIKALTTLCDLADRELVVIIGWAKHIPGFSTLSLADQMSLLQSAWMEILILGVVYRSLSFEDELVYADDYIMDEDQSKLAGLLDLNNAILQLVKKYKSMKLEKEEFVTLKAIALANSDSMHIEDVEAVQKLQDVLHEALQDYEAGQHMEDPRRAGKMLMTLPLLRQTSTKAVQHFYNIKLEGKVPMHKLFLEMLEAKV","Homo sapiens","ESRRG, ERR3, ERRG2, KIAA0832, NR3B3","Estrogen-related receptor gamma","1","2P7Z"
"2P82",,"X-RAY DIFFRACTION",2.67,53.98,"VAPOR DIFFUSION, HANGING DROP",5.4,"Protein concentration 10 mg/mL. Reservoir: 23.5% PEG3350, 0.2M NaCl, 0.1M SPG buffer pH 5.4, 5% ethylene glycol. Cryoprotected in 20% ethylene glycol, VAPOR DIFFUSION, HANGING DROP, temperature 291.0K",291,,,"2P82",163.26,"2.1","2.1","Cysteine protease ATG4A","MHHHHHHSSGRENLYFQGPDTDELVWILGKQHLLKTEKSKLLSDISARLWFTYRRKFSPIGGTGPSSDAGWGCMLRCGQMMLAQALICRHLGRDWSWEKQKEQPKEYQRILQCFLDRKDCCYSIHQMAQMGVGEGKSIGEWFGPNTVAQVLKKLALFDEWNSLAVYVSMDNTVVIEDIKKMCRVLPLSADTAGDRPPDSLTASNQSKGTSAYCSAWKPLLLIVPLRLGINQINPVYVDAFKECFKMPQSLGALGGKPNNAYYFIGFLGDELIFLDPHTTQTFVDTEENGTVNDQTFHCLQSPQRMNILNLDPSVALGFFCKEEKDFDNWCSLVQKEILKENLRMFELVQKHPSHW","Homo sapiens","ATG4A, APG4A, AUTL2","Cysteine protease ATG4A","1","2P82"
"2P83",,"X-RAY DIFFRACTION",2.75,55.28,"VAPOR DIFFUSION",5.6,"1.0M ammonium phosphate, 0.1M ammonium citrate , pH 5.6, VAPOR DIFFUSION, temperature 293K",293,"10.1016/j.bmcl.2007.03.096","MR0","2P83",152.96,"2.5","2.5","Potent and selective isophthalamide S2 hydroxyethylamine inhibitor of BACE1","MASMTGGQQMGRGSMAGVLPAHGTQHGIRLPLRSGLGGAPLGLRLPRETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDES","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","2P83"
"2P85",,"X-RAY DIFFRACTION",2.71,54.58,"VAPOR DIFFUSION, HANGING DROP",,"Ammonium Sulfate, Hepes, PEG 2000 monomethyl ether , VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1074/jbc.M702361200",,"2P85",333.93,"2.35","2.35","Structure of Human Lung Cytochrome P450 2A13 with indole bound in two alternate conformations","MAKKTSSKGKLPPGPTPLPFIGNYLQLNTEQMYNSLMKISERYGPVFTIHLGPRRVVVLCGHDAVKEALVDQAEEFSGRGEQATFDWLFKGYGVAFSNGERAKQLRRFSIATLRGFGVGKRGIEERIQEEAGFLIDALRGTHGANIDPTFFLSRTVSNVISSIVFGDRFDYEDKEFLSLLRMMLGSFQFTATSTGQLYEMFSSVMKHLPGPQQQAFKELQGLEDFIAKKVEHNQRTLDPNSPRDFIDSFLIRMQEEEKNPNTEFYLKNLVMTTLNLFFAGTETVSTTLRYGFLLLMKHPEVEAKVHEEIDRVIGKNRQPKFEDRAKMPYTEAVIHEIQRFGDMLPMGLAHRVNKDTKFRDFFLPKGTEVFPMLGSVLRDPRFFSNPRDFNPQHFLDKKGQFKKSDAFVPFSIGKRYCFGEGLARMELFLFFTTIMQNFRFKSPQSPKDIDVSPKHVGFATIPRNYTMSFLPRHHHH","Homo sapiens","CYP2A13","Cytochrome P450 2A13","1","2P85"
"2P8E",,"X-RAY DIFFRACTION",2.09,41.2,"VAPOR DIFFUSION",7.5,"100mM Hepes pH 7.5, 20% PEG 4000, 10% Isopropanol, VAPOR DIFFUSION, temperature 294K",294,"10.1007/s10969-007-9036-1",,"2P8E",68.66,"1.816","1.816","Crystal structure of the serine/threonine phosphatase domain of human PPM1B","MSLGAFLDKPKTEKHNAHGAGNGLRYGLSSMQGWRVEMEDAHTAVVGIPHGLEDWSFFAVYDGHAGSRVANYCSTHLLEHITTNEDFRAAGKSGSALELSVENVKNGIRTGFLKIDEYMRNFSDLRNGMDRSGSTAVGVMISPKHIYFINCGDSRAVLYRNGQVCFSTQDHKPCNPREKERIQNAGGSVMIQRVNGSLAVSRALGDYDYKCVDGKGPTEQLVSPEPEVYEILRAEEDEFIILACDGIWDVMSNEELCEYVKSRLEVSDDLENVCNWVVDTCLHKGSRDNMSIVLVCFSNEGHHHHHH","Homo sapiens","PPM1B, PP2CB","PPM1B beta isoform variant 6","1","2P8E"
"2P8H",,"X-RAY DIFFRACTION",2.83,56.49,"VAPOR DIFFUSION, SITTING DROP",7.5,"1.5M LITHIUM SULFATE, 0.1M HEPES BUFFER, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K, PH 7.50. Crystals were grown with L124671 and L304507 was back soak",293,"10.1002/cmdc.200700038","MY9","2P8H",45.78,"1.8","1.8","Crystal structure of human beta secretase complexed with inhibitor","MLPRETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGAWAGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYN","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","2P8H"
"2P8L",,"X-RAY DIFFRACTION",3.34,63.13,"VAPOR DIFFUSION, HANGING DROP",5.6,"0.1M NaCitrate, 20% 2-propanol, 16-20% PEG 4K, pH 5.6, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.jmb.2008.09.024",,"2P8L",49.97,"2.44","2.44","Crystal structure of the HIV-1 Cross Neutralizing Monoclonal Antibody 2F5 in complex with gp41 Peptide ELLELDKWASLWN","ALQLTQSPSSLSASVGDRITITCRASQGVTSALAWYRQKPGSPPQLLIYDASSLESGVPSRFSGSGSGTEFTLTISTLRPEDFATYYCQQLHFYPHTFGGGTRVDVRRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYECEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"nmAb 2F5, light chain","1","2P8L"
,,,,,,,,,,,,,,,,"RITLKESGPPLVKPTQTLTLTCSFSGFSLSDFGVGVGWIRQPPGKALEWLAIIYSDDDKRYSPSLNTRLTITKDTSKNQVVLVMTRVSPVDTATYFCAHRRGPTTLFGVPIARGPVNAMDVWGQGITVTISSTSTKGPSVFPLAPSSKSTAGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYTCNVNHKPSNTKVDKRVEPKSC","Homo sapiens",,"nmAb 2F5, heavy chain","2","2P8L"
,,,,,,,,,,,,,,,,"ELLELDKWASLNW",,,"gp41 peptide","3","2P8L"
"2P8M",,"X-RAY DIFFRACTION",2.3,46.43,"VAPOR DIFFUSION, HANGING DROP",5.6,"The Fab' fragment is first dialysed against 10mM NaPhosphate, pH 6.9, 0.05% Tween-20. Then, it is crystallized with conditions 0.1M NaCitrate, 20% 2-propanol, and 16-20% PEG 4K, pH 5.6, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.jmb.2008.09.024",,"2P8M",49.97,"2.7","2.7","Crystal structure of the HIV-1 Cross Neutralizing Monoclonal Antibody 2F5 in complex with gp41 Peptide ELLELDKWASLWN in new crystal form","ALQLTQSPSSLSASVGDRITITCRASQGVTSALAWYRQKPGSPPQLLIYDASSLESGVPSRFSGSGSGTEFTLTISTLRPEDFATYYCQQLHFYPHTFGGGTRVDVRRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYECEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"nmAb 2F5, light chain","1","2P8M"
,,,,,,,,,,,,,,,,"RITLKESGPPLVKPTQTLTLTCSFSGFSLSDFGVGVGWIRQPPGKALEWLAIIYSDDDKRYSPSLNTRLTITKDTSKNQVVLVMTRVSPVDTATYFCAHRRGPTTLFGVPIARGPVNAMDVWGQGITVTISSTSTKGPSVFPLAPSSKSTAGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYTCNVNHKPSNTKVDKRVEPKSC","Homo sapiens",,"nmAb 2F5, heavy chain","2","2P8M"
,,,,,,,,,,,,,,,,"ELLELDKWASLWN",,,"gp41 peptide","3","2P8M"
"2P8P",,"X-RAY DIFFRACTION",3.38,63.59,"VAPOR DIFFUSION, HANGING DROP",5.6,"0.1M NaCitrate, 20% 2-propanol, 16-20% PEG 4K, pH 5.6, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.jmb.2008.09.024",,"2P8P",49.61,"2.7","2.7","Crystal structure of the HIV-1 Cross Neutralizing Monoclonal Antibody 2F5 in complex with gp41 Peptide LELDKWASLW[N-Ac]","ALQLTQSPSSLSASVGDRITITCRASQGVTSALAWYRQKPGSPPQLLIYDASSLESGVPSRFSGSGSGTEFTLTISTLRPEDFATYYCQQLHFYPHTFGGGTRVDVRRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYECEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"nmAb 2F5, light chain","1","2P8P"
,,,,,,,,,,,,,,,,"RITLKESGPPLVKPTQTLTLTCSFSGFSLSDFGVGVGWIRQPPGKALEWLAIIYSDDDKRYSPSLNTRLTITKDTSKNQVVLVMTRVSPVDTATYFCAHRRGPTTLFGVPIARGPVNAMDVWGQGITVTISSTSTKGPSVFPLAPSSKSTAGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYTCNVNHKPSNTKVDKRVEPKSC","Homo sapiens",,"nmAb 2F5, heavy chain","2","2P8P"
,,,,,,,,,,,,,,,,"LELDKWASLWX",,,"gp41 peptide","3","2P8P"
"2P8Q",,"X-RAY DIFFRACTION",2.6,52.74,"VAPOR DIFFUSION, HANGING DROP",6,"22%PEG 8000, 0.05M Sodium Chloride, 0.1M MES, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 285K",285,"10.1074/jbc.M709093200",,"2P8Q",102.29,"2.35","2.35","Crystal Structure of human Importin beta bound to the Snurportin1 IBB-domain","MELITILEKTVSPDRLELEAAQKFLERAAVENLPTFLVELSRVLANPGNSQVARVAAGLQIKNSLTSKDPDIKAQYQQRWLAIDANARREVKNYVLQTLGTETYRPSSASQCVAGIACAEIPVNQWPELIPQLVANVTNPNSTEHMKESTLEAIGYICQDIDPEQLQDKSNEILTAIIQGMRKEEPSNNVKLAATNALLNSLEFTKANFDKESERHFIMQVVCEATQCPDTRVRVAALQNLVKIMSLYYQYMETYMGPALFAITIEAMKSDIDEVALQGIEFWSNVCDEEMDLAIEASEAAEQGRPPEHTSKFYAKGALQYLVPILTQTLTKQDENDDDDDWNPCKAAGVCLMLLATCCEDDIVPHVLPFIKEHIKNPDWRYRDAAVMAFGCILEGPEPSQLKPLVIQAMPTLIELMKDPSVVVRDTAAWTVGRICELLPEAAINDVYLAPLLQCLIEGLSAEPRVASNVCWAFSSLAEAAYEAADVADDQEEPATYCLSSSFELIVQKLLETTDRPDGHQNNLRSSAYESLMEIVKNSAKDCYPAVQKTTLVIMERLQQVLQMESHIQSTSDRIQFNDLQSLLCATLQNVLRKVQHQDALQISDVVMASLLRMFQSTAGSGGVQEDALMAVSTLVEVLGGEFLKYMEAFKPFLGIGLKNYAEYQVCLAAVGLVGDLCRALQSNIIPFCDEVMQLLLENLGNENVHRSVKPQILSVFGDIALAIGGEFKKYLEVVLNTLQQASQAQVDKSDYDMVDYLNELRESCLEAYTGIVQGLKGDQENVHPDVMLVQPRVEFILSFIDHIAGDEDHTDGVVACAAGLIGDLCTAFGKDVLKLVEARPMIHELLTEGRRSKTNKAKTLATWATKELRKLKNQA","Homo sapiens","KPNB1, NTF97","Importin beta-1 subunit","1","2P8Q"
,,,,,,,,,,,,,,,,"HPRLSQYKSKYSSLEQSERRRRLLELQKSKRLDYVNHARR",,,"Snurportin-1","2","2P8Q"
"2P8S",,"X-RAY DIFFRACTION",2.99,59.15,"VAPOR DIFFUSION, HANGING DROP",8,"PEG 4000, SODIUM ACETATE, TRIS, pH 8.00, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.bmcl.2007.03.095","417","2P8S",174.96,"2.2","2.2","Human dipeptidyl peptidase IV/CD26 in complex with a cyclohexalamine inhibitor","TRKTYTLTDYLKNTYRLKLYSLRWISDHEYLYKQENNILVFNAEYGNSSVFLENSTFDEFGHSINDYSISPDGQFILLEYNYVKQWRHSYTASYDIYDLNKRQLITEERIPNNTQWVTWSPVGHKLAYVWNNDIYVKIEPNLPSYRITWTGKEDIIYNGITDWVYEEEVFSAYSALWWSPNGTFLAYAQFNDTEVPLIEYSFYSDESLQYPKTVRVPYPKAGAVNPTVKFFVVNTDSLSSVTNATSIQITAPASMLIGDHYLCDVTWATQERISLQWLRRIQNYSVMDICDYDESSGRWNCLVARQHIEMSTTGWVGRFRPSEPHFTLDGNSFYKIISNEEGYRHICYFQIDKKDCTFITKGTWEVIGIEALTSDYLYYISNEYKGMPGGRNLYKIQLSDYTKVTCLSCELNPERCQYYSVSFSKEAKYYQLRCSGPGLPLYTLHSSVNDKGLRVLEDNSALDKMLQNVQMPSKKLDFIILNETKFWYQMILPPHFDKSKKYPLLLDVYAGPCSQKADTVFRLNWATYLASTENIIVASFDGRGSGYQGDKIMHAINRRLGTFEVEDQIEAARQFSKMGFVDNKRIAIWGWSYGGYVTSMVLGSGSGVFKCGIAVAPVSRWEYYDSVYTERYMGLPTPEDNLDHYRNSTVMSRAENFKQVEYLLIHGTADDNVHFQQSAQISKALVDVGVDFQAMWYTDEDHGIASSTAHQHIYTHMSHFIKQCFSLP","Homo sapiens","DPP4, ADCP2, CD26","DIPEPTIDYL PEPTIDASE IV SOLUBLE FORM","1","2P8S"
"2P8U",,"X-RAY DIFFRACTION",2.37,48.2,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.2M (NH4)2SO4, 0.1M Bis-Tris pH 6.5, 25% PEG 3350, VAPOR DIFFUSION, SITTING DROP, temperature 297K",297,"10.1016/j.jmb.2010.03.034",,"2P8U",108.29,"2","2","Crystal structure of human 3-hydroxy-3-methylglutaryl CoA synthase I","MHHHHHHSSGVDLGTENLYFQSMDVGIVALEIYFPSQYVDQAELEKYDGVDAGKYTIGLGQAKMGFCTDREDINSLCMTVVQNLMERNNLSYDCIGRLEVGTETIIDKSKSVKTNLMQLFEESGNTDIEGIDTTNACYGGTAAVFNAVNWIESSSWDGRYALVVAGDIAVYATGNARPTGGVGAVALLIGPNAPLIFERGLRGTHMQHAYDFYKPDMLSEYPIVDGKLSIQCYLSALDRCYSVYCKKIHAQWQKEGNDKDFTLNDFGFMIFHSPYCKLVQKSLARMLLNDFLNDQNRDKNSIYSGLEAFGDVKLEDTYFDRDVEKAFMKASSELFSQKTKASLLVSNQNGNMYTSSVYGSLASVLAQYSPQQLAGKRIGVFSYGSGLAATLYSLKVTQDATPGSALDKITASLCDLKSRLDSRTGVAPDVFAENMKLREDTHHLVNYIPQGSIDSLFEGTWYLVRVDEKHRRTYARRP","Homo sapiens","HMGCS1, HMGCS","Hydroxymethylglutaryl-CoA synthase, cytoplasmic","1","2P8U"
"2P8V",,"X-RAY DIFFRACTION",2.16,43.14,"VAPOR DIFFUSION, HANGING DROP",7.4,"0.2M HEPES pH 7.0-7.4, 30% PEG3350, 105 mM ammonium sulfate, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1126/science.1151227",,"2P8V",13.27,"1.85","1.85","Crystal structure of human Homer3 EVH1 domain","STAREQPIFSTRAHVFQIDPATKRNWIPAGKHALTVSYFYDATRNVYRIISIGGAKAIINSTVTPNMTFTKTSQKFGQWADSRANTVYGLGFASEQHLTQFAEKFQEVKEAARLARE","Homo sapiens","HOMER3","Homer protein homolog 3","1","2P8V"
"2P93",,"X-RAY DIFFRACTION",2.54,51.48,"VAPOR DIFFUSION, HANGING DROP",5.5,"200 mM Sodium Acetate, pH 5.5, 18% PEG6000, vapor diffusion, hanging drop, temperature 277K",277,"10.1016/j.bmcl.2007.06.029","ME1","2P93",32.44,"1.9","1.9","Factor xa in complex with the inhibitor 5-chloro-N-(2-(4-(2-oxopyridin-1(2H)-yl)benzamido)ethyl)thiophene-2-carboxamide","IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT","Homo sapiens","F10","Factor Xa","1","2P93"
,,,,,,,,,,,,,,,,"KLCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACIPTGPYPCGKQTLE","Homo sapiens","F10","Factor Xa","2","2P93"
"2P94",,"X-RAY DIFFRACTION",2.53,51.45,"VAPOR DIFFUSION, HANGING DROP",5.5,"200 mM Sodium Acetate, pH 5.5, 18% PEG6000, vapor diffusion, hanging drop, temperature 277K",277,"10.1016/j.bmcl.2007.06.029","ME4","2P94",32.53,"1.8","1.8","Factor xa in complex with the inhibitor 3-chloro-N-((1R,2S)-2-(4-(2-oxopyridin-1(2H)-yl)benzamido)cyclohexyl)-1H-indole-6-carboxamide","IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT","Homo sapiens","F10","Factor Xa","1","2P94"
,,,,,,,,,,,,,,,,"KLCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACIPTGPYPCGKQTLE","Homo sapiens","F10","Factor Xa","2","2P94"
"2P95",,"X-RAY DIFFRACTION",2.56,52.02,"VAPOR DIFFUSION, HANGING DROP",5.5,"200 mM Sodium Acetate, pH 5.5, 18% PEG6000, vapor diffusion, hanging drop, temperature 277K",277,"10.1016/j.bmcl.2007.06.029","ME5","2P95",32.48,"2.2","2.2","Factor xa in complex with the inhibitor 5-chloro-N-((1R,2S)-2-(4-(2-oxopyridin-1(2H)-YL)benzamido) cyclopentyl)thiophene-2-carboxamide","IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT","Homo sapiens","F10","Factor Xa","1","2P95"
,,,,,,,,,,,,,,,,"KLCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACIPTGPYPCGKQTLE","Homo sapiens","F10","Factor Xa","2","2P95"
"2P9R",,"X-RAY DIFFRACTION",3.04,59.56,"VAPOR DIFFUSION, HANGING DROP",6.6,"11% PEG 3350, 200mM di-ammonium hydrogen citrate, pH 6.6, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1042/BJ20070764",,"2P9R",23.35,"2.3","2.3","Human alpha2-macroglogulin is composed of multiple domains, as predicted by homology with complement component C3","DSLVFVQTDKSIYKPGQTVKFRVVSMDENFHPLNELIPLVYIQDPKGNRIAQWQSFQLEGGLKQFSFPLSSEPFQGSYKVVVQKKSGGRTEHPFTVEEFVLP","Homo sapiens","A2M, CPAMD5, FWP007","Alpha-2-macroglobulin","1","2P9R"
"2PA1",,"X-RAY DIFFRACTION",2.79,55.9,"VAPOR DIFFUSION, SITTING DROP",4.6,"30 % PEG Monomethylether 2000, 0.2M Ammonium sulfate, 0.1 M Sodium acetate, pH 4.6, VAPOR DIFFUSION, SITTING DROP, temperature 294K",294,"10.1002/pro.349",,"2PA1",9.42,"1.7","1.7","Structure of the PDZ domain of human PDLIM2 bound to a C-terminal extension from human beta-tropomyosin","SMALTVDVAGPAPWGFRITGGRDFHTPIMVTKVAERGKAKDADLRPGDIIVAINGESAEGMLHAEAQSKIRQSPSPLRLQLDRITSL","Homo sapiens","PDLIM2, PP6345","PDZ and LIM domain protein 2","1","2PA1"
"2PA2",,"X-RAY DIFFRACTION",2.16,43.15,"VAPOR DIFFUSION, SITTING DROP",6.4,"1.0M di-sodium hydroxyl phosphate, 1.0M potassium dihydroxyl phosphate, pH 4.5 100mM sodium acetate , pH 6.4, VAPOR DIFFUSION, SITTING DROP, temperature 293.0K",293,"10.1016/j.jmb.2008.01.003",,"2PA2",34.47,"2.5","2.5","Crystal structure of human Ribosomal protein L10 core domain","GSFDLGRKKAKVDEFPLCGHMVSDEYEQLSSEALEAARICANKYMVKSCGKDGFHIRVRLHPFHVIRINKMLSCAGADRLQTGMRGAFGKPQGTVARVHIGQVIMSIRTKLQNKEHVIEALRRAKFKFPGRQKIHISKKWGFTKFNADEFE","Homo sapiens","RPL10, DXS648E, QM","60S ribosomal protein L10","1","2PA2"
"2PA5",,"X-RAY DIFFRACTION",1.99,38.31,"VAPOR DIFFUSION, SITTING DROP",6.15,"25% PEG 3350, 0.2 M Potassium thiocyanate, 10% Ethylene glycol, 0.1 M Bis-Tris propane pH 6.15, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.cell.2008.11.038",,"2PA5",72.97,"1.6","1.6","Crystal structure of human protein tyrosine phosphatase PTPN9","MSVHVPGPHAMTIQELVDYVNARQKQGIYEEYEDIRRENPVGTFHCSMSPGNLEKNRYGDVPCLDQTRVKLTKRSGHTQTDYINASFMDGYKQKNAYIGTQGPLENTYRDFWLMVWEQKVLVIVMTTRFEEGGRRKCGQYWPLEKDSRIRFGFLTVTNLGVENMNHYKKTTLEIHNTEERQKRQVTHFQFLSWPDYGVPSSAASLIDFLRVVRNQQSLAVSNMGARSKGQCPEPPIVVHCSAGIGRTGTFCSLDICLAQLEELGTLNVFQTVSRMRTQRAFSIQTPEQYYFCYKAILEFAEKEGMVSAHHHHHH","Homo sapiens","PTPN9","Tyrosine-protein phosphatase non-receptor type 9","1","2PA5"
"2PAB",,"X-RAY DIFFRACTION",2.23,44.84,,,,,"10.1016/0022-2836(78)90368-6",,"2PAB",27.55,"1.8","1.8","STRUCTURE OF PREALBUMIN, SECONDARY, TERTIARY AND QUATERNARY INTERACTIONS DETERMINED BY FOURIER REFINEMENT AT 1.8 ANGSTROMS","GPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEQFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","TRANSTHYRETIN PRECURSOR","1","2PAB"
"2PAH",,"X-RAY DIFFRACTION",3.36,60,,7,"0.6 M MGSO4, 0.2 M NAK TARTRATE, 10% PEG-4000, 0.1 M BIS-TRIS PROPANE (PH 7.0)",,"10.1074/jbc.273.27.16962",,"2PAH",77.4,"3.1","3.1","TETRAMERIC HUMAN PHENYLALANINE HYDROXYLASE","VPWFPRTIQELDRFANQILSYGAELDADHPGFKDPVYRARRKQFADIAYNYRHGQPIPRVEYMEEEKKTWGTVFKTLKSLYKTHACYEYNHIFPLLEKYCGFHEDNIPQLEDVSQFLQTCTGFRLRPVAGLLSSRDFLGGLAFRVFHCTQYIRHGSKPMYTPEPDICHELLGHVPLFSDRSFAQFSQEIGLASLGAPDEYIEKLATIYWFTVEFGLCKQGDSIKAYGAGLLSSFGELQYCLSEKPKLLPLELEKTAIQNYTVTEFQPLYYVAESFNDAKEKVRNFAATIPRPFSVRYDPYTQRIEVLDNTQQLKILADSINSEIGILCSALQKIK","Homo sapiens","PAH","PROTEIN (PHENYLALANINE HYDROXYLASE)","1","2PAH"
"2PB7",,"X-RAY DIFFRACTION",2.54,51.52,"VAPOR DIFFUSION, HANGING DROP",7,"14-19% PEG 3350, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,,,"2PB7",26.79,"1.9","1.9","Crystal Structure of the SRA domain of the human UHRF1 protein","GHMKECTIVPSNHYGPIPGIPVGTMWRFRVQVSESGVHRPHVAGIHGRSNDGAYSLVLAGGYEDDVDHGNFFTYTGSGGRDLSGNKRTAEQSCDQKLTNTNRALALNCFAPINDQEGAEAKDWRSGKPVRVVRNVKGGKNSKYAPAEGNRYDGIYKVVKYWPEKGKSGFLVWRYLLRRDDDEPGPWTKEGKDRIKKLGLTMQYPEGYLEALANREREKENSKREEEEQQEGGFASPRTG","Homo sapiens","UHRF1, ICBP90, NP95, RNF106","E3 ubiquitin-protein ligase UHRF1","1","2PB7"
"2PBC",,"X-RAY DIFFRACTION",2.02,39.08,"VAPOR DIFFUSION, HANGING DROP",8,"32% PEG MME550, CRYOPROTECTED IN PARATONE-N, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 298.0K",298,,,"2PBC",45.16,"1.8","1.8","FK506-binding protein 2","GSPIKSRKGDVLHMHYTGKLEDGTEFDSSLPQNQPFVFSLGTGQVIKGWDQGLLGMCEGEKRKLVIPSELGYGERGAPPKIPGGATLVFEVELLKIERRTEL","Homo sapiens","FKBP2, FKBP13","FK506-binding protein 2","1","2PBC"
"2PBH",,"X-RAY DIFFRACTION",2.35,48,,7.2,"PROTEIN WAS CRYSTALLIZED FROM 2 M AMMONIUM SULFATE, 700 MM TRIS, PH 7.2",,"10.1016/0014-5793(96)00309-2",,"2PBH",35.23,"3.3","3.3","CRYSTAL STRUCTURE OF HUMAN PROCATHEPSIN B AT 3.3 ANGSTROM RESOLUTION","MRSRPSFHPLSDELVNYVNKRNTTWQAGHNFYNVDMSYLKRLCGTFLGGPKPPQRVMFTEDLKLPASFDAREQWPQCPTIKEIRDQGSCGSCWAFGAVEAISDRICIHTNAHVSVEVSAEDLLTCCGSMCGDGCNGGYPAEAWNFWTRKGLVSGGLYESHVGCRPYSIPPCEHHVNGSRPPCTGEGDTPKCSKICEPGYSPTYKQDKHYGYNSYSVSNSEKDIMAEIYKNGPVEGAFSVYSDFLLYKSGVYQHVTGEMMGGHAIRILGWGVENGTPYWLVANSWNTDWGDNGFFKILRGQDHCGIESEVVAGIPRTD","Homo sapiens","CTSB, CPSB","PROCATHEPSIN B","1","2PBH"
"2PBN",,"X-RAY DIFFRACTION",3.12,60.59,"VAPOR DIFFUSION",6.5,"100mM Sodium MES pH 6.5, 22% PEG 8000, 200mM Ammonium sulfate, VAPOR DIFFUSION, temperature 294K",294,"10.1007/s10969-007-9036-1",,"2PBN",36.19,"1.7","1.7","Crystal structure of the human tyrosine receptor phosphate gamma","SLPIPDDMEAIPVKQFVKHIGELYSNNQHGFSEDFEEVQRCTADMNITAEHSNHPENKHKNRYINILAYDHSRVKLRPLPGKDSKHSDYINANYVDGYNKAKAYIATQGPLKSTFEDFWRMIWEQNTGIIVMITNLVEKGRRKCDQYWPTENSEEYGNIIVTLKSTKIHACYTVRRFSIRNTKVKKGQKGNPKGRQNERVVIQYHYTQWPDMGVPEYALPVLTFVRRSSAARMPETGPVLVHCSAGVGRTGTYIVIDSMLQQIKDKSTVNVLGFLKHIRTQRNYLVQTEEQYIFIHDALLEAILGKETEVSSN","Homo sapiens","PTPRG, PTPG","Receptor-type tyrosine-protein phosphatase gamma","1","2PBN"
"2PCU",,"X-RAY DIFFRACTION",2.13,42.32,"VAPOR DIFFUSION, SITTING DROP",7.5,"Crystals were obtained from sitting drops subjected to vapor diffusion and containing consisting of 100nL of hCPA4:hexapeptide (15 mg/mL in 5mM Tris  HCl pH 7.5) and 100nL of reservoir solution (0.2M potassium thiocyanate / 20% PEG 3350). Crystallisation drops were dispensed on 96x3-well Greiner plates by a Tecan robot and a Cartesian nanodrop robot (Genomic Solutions) at the joint IBMB-CSIC/Barcelona Science Park Automated Crystallization Platform (PAC). Crystals appeared after incubation for 10-15 days in a Bruker steady-temperature crystal farm at 4  C., VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1021/bi700480b",,"2PCU",35.43,"1.6","1.6","Human carboxypeptidase A4 in complex with a cleaved hexapeptide.","NNFNYGAYHSLEAIYHEMDNIAADFPDLARRVKIGHSFENRPMYVLKFSTGKGVRRPAVWLNAGIHSREWISQATAIWTARKIVSDYQRDPAITSILEKMDIFLLPVANPDGYVYTQTQNRLWRKTRSRNPGSSCIGADPNRNWNASFAGKGASDNPCSEVYHGPHANSEVEVKSVVDFIQKHGNFKGFIDLHSYSQLLMYPYGYSVKKAPDAEELDKVARLAAKALASVSGTEYQVGPTCTTVYPASGSSIDWAYDNGIKFAFTFELRDTGTYGFLLPANQIIPTAEETWLGLKTIMEHVRDNL","Homo sapiens","CPA4, CPA3, UNQ694/PRO1339","Carboxypeptidase A4","1","2PCU"
,,,,,,,,,,,,,,,,"FNRPV",,,"peptide","2","2PCU"
"2PCX",,"X-RAY DIFFRACTION",1.84,33.11,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1M ammonium acetate, 25% PEG 3350, 0.1M HEPES, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 300K",300,"10.1107/S0907444908003338",,"2PCX",24.87,"1.54","1.54","Crystal structure of p53DBD(R282Q) at 1.54-angstrom Resolution","HHHHHHSSSVPSQKTYQGSYGFRLGFLHSGTAKSVTCTYSPALNKMFCQLAKTCPVQLWVDSTPPPGTRVRAMAIYKQSQHMTEVVRRCPHHERCSDSDGLAPPQHLIRVEGNLRVEYLDDRNTFRHSVVVPYEPPEVGSDCTTIHYNYMCNSSCMGGMNRRPILTIITLEDSSGNLLGRNSFEVRVCACPGRDQRTEEENLRKKSSVVNSSCMGGMCRR","Homo sapiens","TP53, P53","Cellular tumor antigen p53","1","2PCX"
"2PD5",,"X-RAY DIFFRACTION",2.2,44.87,"VAPOR DIFFUSION, HANGING DROP",5,"20 % PEG 6000 in 120 mM ammonium citrate, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.jmb.2008.03.063","ZST","2PD5",37.08,"1.6","1.6","Human aldose reductase mutant V47I complexed with zopolrestat","MASRILLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHIYQNENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGKEFFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAKHNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVCALLSCTSHKDYPFHEEF","Homo sapiens","ALR2, AKR1B1, ALDR1","Aldose reductase","1","2PD5"
"2PD6",,"X-RAY DIFFRACTION",1.98,37.78,"VAPOR DIFFUSION, SITTING DROP",6.5,"200 mM sodium fluoride, 20% PEG3350, 10% ethylene glycol plus 5mM NAD+, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,,,"2PD6",112.52,"2","2","Structure of human hydroxysteroid dehydrogenase type 8, HSD17B8","MQNRLRSALALVTGAGSGIGRAVSVRLAGEGATVAACDLDRAAAQETVRLLGGPGSKEGPPRGNHAAFQADVSEARAARCLLEQVQACFSRPPSVVVSCAGITQDEFLLHMSEDDWDKVIAVNLKGTFLVTQAAAQALVSNGCRGSIINISSIVGKVGNVGQTNYAASKAGVIGLTQTAARELGRHGIRCNSVLPGFIATPMTQKVPQKVVDKITEMIPMGHLGDPEDVADVVAFLASEDSGYITGTSVEVTGGLFMAENLYFQ","Homo sapiens","HSD17B8, FABGL, HKE6, RING2, SDR30C1","Estradiol 17-beta-dehydrogenase 8","1","2PD6"
"2PD9",,"X-RAY DIFFRACTION",2.2,43.46,"VAPOR DIFFUSION, HANGING DROP",5,"20 % PEG 6000 in 120 mM Ammonium citrate, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.jmb.2008.03.063","FID","2PD9",36.93,"1.55","1.55","Human aldose reductase mutant V47I complexed with fidarestat.","MASRILLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHIYQNENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGKEFFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAKHNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVCALLSCTSHKDYPFHEEF","Homo sapiens","ALR2, AKR1B1, ALDR1","Aldose reductase","1","2PD9"
"2PDB",,"X-RAY DIFFRACTION",2.2,44.66,"VAPOR DIFFUSION, HANGING DROP",5,"20 % PEG 6000 in 12o mM ammonium citrate, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.jmb.2008.03.063","ZST","2PDB",37.01,"1.6","1.6","Human aldose reductase mutant F121P complexed with zopolrestat.","MASRILLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGKEPFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAKHNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVCALLSCTSHKDYPFHEEF","Homo sapiens","ALR2, AKR1B1, ALDR1","Aldose reductase","1","2PDB"
"2PDC",,"X-RAY DIFFRACTION",2.2,44.69,"VAPOR DIFFUSION, HANGING DROP",5,"20 % PEG 6000 in 120 mM ammonium citrate, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.jmb.2008.03.063","393","2PDC",36.96,"1.65","1.65","Human aldose reductase mutant F121P complexed with IDD393.","MASRILLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGKEPFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAKHNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVCALLSCTSHKDYPFHEEF","Homo sapiens","ALR2, AKR1B1, ALDR1","Aldose reductase","1","2PDC"
"2PDF",,"X-RAY DIFFRACTION",2.2,44.54,"VAPOR DIFFUSION, HANGING DROP",5,"20 % PEG 6000 in 120 mM ammonium citrate, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.jmb.2008.03.063","ZST","2PDF",37.05,"1.56","1.56","Human aldose reductase mutant L300P complexed with zopolrestat.","MASRILLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGKEFFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAKHNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVCAPLSCTSHKDYPFHEEF","Homo sapiens","ALR2, AKR1B1, ALDR1","Aldose reductase","1","2PDF"
"2PDG",,"X-RAY DIFFRACTION",1.88,43.06,"VAPOR DIFFUSION, HANGING DROP",5,"20 % PEG 6000 in 120 mM ammonium citrate, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.jmb.2008.03.063","47D","2PDG",36.99,"1.42","1.42","Human aldose reductase with uracil-type inhibitor at 1.42A.","MASRILLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGKEFFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAKHNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVCALLSCTSHKDYPFHEEF","Homo sapiens","ALR2, AKR1B1, ALDR1","Aldose reductase","1","2PDG"
"2PDH",,"X-RAY DIFFRACTION",2.2,44.19,"VAPOR DIFFUSION, HANGING DROP",5,"20 % PEG 6000 in 120 mM ammonium citrate, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.jmb.2008.03.063","47D","2PDH",36.98,"1.45","1.45","Human aldose reductase mutant L300P complexed with uracil-type inhibitor at 1.45 A.","MASRILLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGKEFFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAKHNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVCAPLSCTSHKDYPFHEEF","Homo sapiens","ALR2, AKR1B1, ALDR1","Aldose reductase","1","2PDH"
"2PDI",,"X-RAY DIFFRACTION",2.2,43.48,"VAPOR DIFFUSION, HANGING DROP",5,"20 % PEG 6000 in 120 mM ammonium citrate, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.jmb.2008.03.063","ZST","2PDI",37.02,"1.55","1.55","Human aldose reductase mutant L300A complexed with zopolrestat at 1.55 A.","MASRILLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGKEFFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAKHNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVCAALSCTSHKDYPFHEEF","Homo sapiens","ALR2, AKR1B1, ALDR1","Aldose reductase","1","2PDI"
"2PDJ",,"X-RAY DIFFRACTION",2.2,43.44,"VAPOR DIFFUSION, HANGING DROP",5,"20 % PEG 6000 in 120 mM ammonium citrate, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.jmb.2008.03.063","393","2PDJ",36.96,"1.57","1.57","Human aldose reductase mutant L300A complexed with IDD393.","MASRILLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGKEFFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAKHNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVCAALSCTSHKDYPFHEEF","Homo sapiens","ALR2, AKR1B1, ALDR1","Aldose reductase","1","2PDJ"
"2PDK",,"X-RAY DIFFRACTION",2.2,43.29,"VAPOR DIFFUSION, HANGING DROP",5,"20 % PEG 6000 in 120 mM ammonium citrate, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.jmb.2008.03.063","SBI","2PDK",36.9,"1.55","1.55","Human aldose reductase mutant L301M complexed with sorbinil.","MASRILLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGKEFFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAKHNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVCALMSCTSHKDYPFHEEF","Homo sapiens","ALR2, AKR1B1, ALDR1","Aldose reductase","1","2PDK"
"2PDL",,"X-RAY DIFFRACTION",2.2,43.09,"VAPOR DIFFUSION, HANGING DROP",5,"20 % PEG 6000 in 120 mM ammonium citrate, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.jmb.2008.03.063","TOL","2PDL",37.02,"1.47","1.47","Human aldose reductase mutant L301M complexed with tolrestat.","MASRILLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGKEFFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAKHNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVCALMSCTSHKDYPFHEEF","Homo sapiens","ALR2, AKR1B1, ALDR1","Aldose reductase","1","2PDL"
"2PDM",,"X-RAY DIFFRACTION",2.2,43.06,"VAPOR DIFFUSION, HANGING DROP",5,"20 % PEG 6000 in 120 mM ammonium citrate, pH 5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.jmb.2008.03.063","ZST","2PDM",37.13,"1.75","1.75","Human aldose reductase mutant S302R complexed with zopolrestat.","MASRILLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGKEFFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAKHNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVCALLRCTSHKDYPFHEEF","Homo sapiens","ALR2, AKR1B1, ALDR1","Aldose reductase","1","2PDM"
"2PDN",,"X-RAY DIFFRACTION",2.2,44.49,"VAPOR DIFFUSION, HANGING DROP",5,"20 % PEG 6000 in 120 mM ammonium citrate, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.jmb.2008.03.063","47D","2PDN",37.06,"1.7","1.7","Human aldose reductase mutant S302R complexed with uracil-type inhibitor.","MASRILLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGKEFFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAKHNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVCALLRCTSHKDYPFHEEF","Homo sapiens","ALR2, AKR1B1, ALDR1","Aldose reductase","1","2PDN"
"2PDP",,"X-RAY DIFFRACTION",2.2,44.64,"VAPOR DIFFUSION, HANGING DROP",5,"20 % PEG 6000 in 120 mM ammonium citrate, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.jmb.2008.03.063","393","2PDP",37.08,"1.65","1.65","Human aldose reductase mutant S302R complexed with IDD 393.","MASRILLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGKEFFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAKHNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVCALLRCTSHKDYPFHEEF","Homo sapiens","ALR2, AKR1B1, ALDR1","Aldose reductase","1","2PDP"
"2PDQ",,"X-RAY DIFFRACTION",2.2,44.55,"VAPOR DIFFUSION, HANGING DROP",5,"20 % PEG 6000 in 120 mM ammonium citrate, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.jmb.2008.03.063","47D","2PDQ",37.01,"1.73","1.73","Human aldose reductase mutant C303D complexed with uracil-type inhibitor.","MASRILLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGKEFFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAKHNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVCALLSDTSHKDYPFHEEF","Homo sapiens","ALR2, AKR1B1, ALDR1","Aldose reductase","1","2PDQ"
"2PDU",,"X-RAY DIFFRACTION",2.2,44.48,"VAPOR DIFFUSION, HANGING DROP",5,"20 % PEG 6000 in 120 mM ammonium citrate, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.jmb.2008.03.063","393","2PDU",37.02,"1.55","1.55","Human aldose reductase mutant C303D complexed with IDD393.","MASRILLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGKEFFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAKHNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVCALLSDTSHKDYPFHEEF","Homo sapiens","ALR2, AKR1B1, ALDR1","Aldose reductase","1","2PDU"
"2PDW",,"X-RAY DIFFRACTION",2.2,43.86,"VAPOR DIFFUSION, HANGING DROP",5,"20 % PEG 6000 in 120 mM ammonium citrate, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.jmb.2008.03.063","FID","2PDW",36.93,"1.55","1.55","Human aldose reductase mutant C303D complexed with fidarestat.","MASRILLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGKEFFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAKHNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVCALLSDTSHKDYPFHEEF","Homo sapiens","ALR2, AKR1B1, ALDR1","Aldose reductase","1","2PDW"
"2PDX",,"X-RAY DIFFRACTION",2.2,44.1,"VAPOR DIFFUSION, HANGING DROP",5,"20 % PEG 6000 in 120 mM ammonium citrate, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.jmb.2008.03.063","ZST","2PDX",37.14,"1.65","1.65","Human aldose reductase double mutant S302R-C303D complexed with zopolrestat.","MASRILLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGKEFFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAKHNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVCALLRDTSHKDYPFHEEF","Homo sapiens","ALR2, AKR1B1, ALDR1","Aldose reductase","1","2PDX"
"2PDY",,"X-RAY DIFFRACTION",2.2,43.43,"VAPOR DIFFUSION, HANGING DROP",5,"20 % PEG 6000 in 120 mM ammonium citrate, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.jmb.2008.03.063","FID","2PDY",37,"1.65","1.65","Human aldose reductase double mutant S302R-C303D complexed with fidarestat.","MASRILLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGKEFFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAKHNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVCALLRDTSHKDYPFHEEF","Homo sapiens","ALR2, AKR1B1, ALDR1","Aldose reductase","1","2PDY"
"2PE0",,"X-RAY DIFFRACTION",3.2,62,,7.5,"AMMONIUM SULFATE, TRIS, EDTA, VAPOR DIFFUSION, HANGING DROP, temperature 298K, pH 7.50",298,"10.1016/j.bmcl.2007.04.071","39Z","2PE0",33.84,"2.35","2.35","CRYSTAL STRUCTURE OF HUMAN PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1 (PDK1) 5-Hydroxy-3-[1-(1H-pyrrol-2-yl)-eth-(Z)-ylidene]-1,3-dihydro-indol-2-one COMPLEX","PRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLT","Homo sapiens","PDPK1, PDK1","3-phosphoinositide-dependent protein kinase 1","1","2PE0"
"2PE1",,"X-RAY DIFFRACTION",3.2,62,,7.5,"AMMONIUM SULFATE, TRIS, EDTA, VAPOR DIFFUSION, HANGING DROP, temperature 298K, pH 7.50",298,"10.1016/j.bmcl.2007.04.071","517","2PE1",33.97,"2.14","2.14","CRYSTAL STRUCTURE OF HUMAN PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1 (PDK1) {2-Oxo-3-[1-(1H-pyrrol-2-yl)-eth-(Z)-ylidene]-2,3-dihydro-1H-indol-5-yl}-urea {BX-517} COMPLEX","PRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLT","Homo sapiens","PDPK1, PDK1","3-phosphoinositide-dependent protein kinase 1","1","2PE1"
"2PE2",,"X-RAY DIFFRACTION",3.2,62,"VAPOR DIFFUSION, HANGING DROP",7.5,"AMMONIUM SULFATE, TRIS, EDTA, VAPOR DIFFUSION, HANGING DROP, temperature 298K, pH 7.50",298,"10.1016/j.bmcl.2007.05.060","464","2PE2",34.65,"2.13","2.13","CRYSTAL STRUCTURE OF HUMAN PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1 (PDK1) 3-{5-[2-Oxo-5-ureido-1,2-dihydro-indol-(3Z)-ylidenemethyl]-1H-pyrrol-3-yl}-N-(2-piperidin-1-yl-ethyl)-benzamide COMPLEX","PRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLT","Homo sapiens","PDPK1, PDK1","3-phosphoinositide-dependent protein kinase 1","1","2PE2"
"2PE4",,"X-RAY DIFFRACTION",3.71,66.82,"VAPOR DIFFUSION, HANGING DROP",4.6,"1.5 M sodium chloride, 10% ethanol, 3% galactose, pH 4.6, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/bi700382g",,"2PE4",49.42,"2","2","Structure of Human Hyaluronidase 1, a Hyaluronan Hydrolyzing Enzyme Involved in Tumor Growth and Angiogenesis","RSFRGPLLPNRPFTTVWNANTQWCLERHGVDVDVSVFDVVANPGQTFRGPDMTIFYSSQLGTYPYYTPTGEPVFGGLPQNASLIAHLARTFQDILAAIPAPDFSGLAVIDWEAWRPRWAFNWDTKDIYRQRSRALVQAQHPDWPAPQVEAVAQDQFQGAARAWMAGTLQLGRALRPRGLWGFYGFPDCYNYDFLSPNYTGQCPSGIRAQNDQLGWLWGQSRALYPSIYMPAVLEGTGKSQMYVQHRVAEAFRVAVAAGDPNLPVLPYVQIFYDTTNHFLPLDELEHSLGESAAQGAAGVVLWVSWENTRTKESCQAIKEYMDTTLGPFILNVTSGALLCSQALCSGHGRCVRRTSHPKALLLLNPASFSIQLTPGGGPLSLRGALSLEDQAQMAVEFKCRCYPGWQAPWCERKSMWTGHHHHHH","Homo sapiens","HYAL1, LUCA1","Hyaluronidase-1","1","2PE4"
"2PE8",,"X-RAY DIFFRACTION",3.05,59.71,"VAPOR DIFFUSION, HANGING DROP",8.5,"22% PEG 3,350, 0.2 M MgCl2, 0.1 M Tris pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1038/nsmb1260",,"2PE8",11.69,"2","2","Crystal structure of the UHM domain of human SPF45 (free form)","GAMGKCPTKVVLLRNMVGAGEVDEDLEVETKEECEKYGKVGKCVIFEIPGAPDDEAVRIFLEFERVESAIKAVVDLNGRYFGGRVVKACFYNLDKFRVLDLAEQV","Homo sapiens","RBM17, SPF45","Splicing factor 45","1","2PE8"
"2PE9",,"SOLUTION NMR",,,,,,,"10.1021/ja071185d",,"2PE9",17.15,,,"NMR Based Structure of the Open Conformation of LYS48-Linked Di-UBiquitin Using Experimental Global Rotational Diffusion Tensor from NMR Relaxation Measurements","MQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGG","Homo sapiens","UBC","Ubiquitin","1","2PE9"
"2PEA",,"SOLUTION NMR",,,,,,,"10.1021/ja071185d",,"2PEA",17.15,,,"NMR Based Structure of the Closed Conformation of LYS48-Linked Di-Ubiquitin Using Experimental Global Rotational Diffusion Tensor from NMR Relaxation Measurements","MQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGG","Homo sapiens","UBC","Ubiquitin","1","2PEA"
"2PEH",,"X-RAY DIFFRACTION",2.13,42.33,"VAPOR DIFFUSION, SITTING DROP",6,"25% (w/v) PEG 1,500, 0.1 M Malonate, Imidazole, Borate buffer pH 6.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1038/nsmb1260",,"2PEH",25.99,"2.11","2.11","Crystal structure of the UHM domain of human SPF45 in complex with SF3b155-ULM5","GAMGKCPTKVVLLRNMVGAGEVDEDLEVETKEECEKYGKVGKCVIFEIPGAPDDEAVRIFLEFERVESAIKAVVDLNGRYFGGRVVKACFYNLDKFRVLDLAEQV","Homo sapiens","RBM17, SPF45","Splicing factor 45","1","2PEH"
,,,,,,,,,,,,,,,,"KRKSRWDETP",,,"Splicing factor 3B subunit 1","2","2PEH"
"2PER",,"X-RAY DIFFRACTION",2.11,41.85,"VAPOR DIFFUSION, HANGING DROP",6.9,"35% PEG 400, 0.1M ammonium acetate, 0.1M Bis-Tris, pH 6.9, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1002/prot.21922",,"2PER",30.76,"2","2","Crystal Structure of Human Chloride Intracellular Channel protein 2","MGSSHHHHHHSSGLVPRGSHMSGLRPGTQVDPEIELFVKAGSDGESIGNCPFCQRLFMILWLKGVKFNVTTVDMTRKPEELKDLAPGTNPPFLVYNKELKTDFIKIEEFLEQTLAPPRYPHLSPKYKESFDVGCNLFAKFSAYIKNTQKEANKNFEKSLLKEFKRLDDYLNTPLLDEIDPDSAEEPPVSRRLFLDGDQLTLADCSLLPKLNIIKVAAKKYRDFDIPAEFSGVWRYLHNAYAREEFTHTCPEDKEIENTYANVAKQKS","Homo sapiens","CLIC2","Chloride intracellular channel protein 2","1","2PER"
"2PET",,"X-RAY DIFFRACTION",2.52,51.14,"VAPOR DIFFUSION, HANGING DROP",6.4,"12% PEG 20000, 6% heaxane-1,2-diol, 0.1M MES, pH 6.4, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1182/blood-2007-06-094748",,"2PET",25.65,"1.7","1.7","Lutheran glycoprotein, N-terminal domains 1 and 2.","EVRLSVPPLVEVMRGKSVILDCTPTGTHDHYMLEWFLTDRSGARPRLASAEMQGSELQVTMHDTRGRSPPYQLDSQGRLVLAEAQVGDERDYVCVVRAGAAGTAEATARLNVFAKPEATEVSPNKGTLSVMEDSAQEIATCNSRNGNPAPKITWYRNGQRLEVPVEMNPEGYMTSRTVREASGLLSLTSTLYLRLRKDDRDASFHCAAHYSLPEGRHGRLDSPTFHLTLHY","Homo sapiens","BCAM, LU, MSK19","Lutheran blood group glycoprotein","1","2PET"
"2PEV",,"X-RAY DIFFRACTION",2.16,42.97,"VAPOR DIFFUSION, HANGING DROP",5,"micro-seeding, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 297K",297,"10.1002/prot.24136","FID, LDT","2PEV",37.57,"0.9","0.9","Complex of Aldose Reductase with NADP+ and simaltaneously bound competetive inhibitors Fidarestat and IDD594. Concentration of Fidarestat in soaking solution exceeds concentration of IDD594.","MASRILLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGKEFFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAKHNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVCALLSCTSHKDYPFHEEF","Homo sapiens","AKR1B1, ALDR1, ALR2","Aldose reductase","1","2PEV"
"2PEY",,"X-RAY DIFFRACTION",2.3,46.62,"VAPOR DIFFUSION, HANGING DROP",5,"reservoir: 16-20% PEG 3350, 0.25-0.15 M diammonium hydrogen citrate, drop: 3.2 mg/ml protein solution, 2mM dADP, 2mM APS, 5mM MgCl2, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1074/jbc.M701713200",,"2PEY",41,"1.88","1.88","Crystal structure of deletion mutant of APS-kinase domain of human PAPS-synthetase 1","GHMRGCTVWLTGLSGAGKTTVSMALEEYLVCHGIPCYTLDGDNIRQGLNKNLGFSPEDREENVRRIAEVAKLFADAGLVCITSFISPYTQDRNNARQIHEGASLPFFEVFVDAPLHVCEQRDVKGLYKKARAGEIKGFTGIDSEYEKPEAPELVLKTDSCDVNDCVQQVVELLQERDIV","Homo sapiens","PAPSS1, ATPSK1, PAPSS","Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthetase 1 (PAPS synthetase 1) (PAPSS 1) (Sulfurylase kinase 1) (SK1) (SK 1)","1","2PEY"
"2PEZ",,"X-RAY DIFFRACTION",2.33,47.15,"VAPOR DIFFUSION, HANGING DROP",5,"reservoir: 16-20% PEG 3350, 0.25-0.15 M diammonium hydrogen citrate, drop: 3.2 mg/ml protein, 2mM dADP, 2mM PAPS, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1074/jbc.M701713200",,"2PEZ",41.06,"1.4","1.4","Crystal structrue of deletion mutant of APS-kinase domain of human PAPS-synthetase 1 in complex with cyclic PAPS and dADP","GHMRGCTVWLTGLSGAGKTTVSMALEEYLVCHGIPCYTLDGDNIRQGLNKNLGFSPEDREENVRRIAEVAKLFADAGLVCITSFISPYTQDRNNARQIHEGASLPFFEVFVDAPLHVCEQRDVKGLYKKARAGEIKGFTGIDSEYEKPEAPELVLKTDSCDVNDCVQQVVELLQERDIV","Homo sapiens","PAPSS1, ATPSK1, PAPSS","Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthetase 1 (PAPS synthetase 1) (PAPSS 1) (Sulfurylase kinase 1) (SK1) (SK 1)","1","2PEZ"
"2PF5",,"X-RAY DIFFRACTION",4.12,70.14,"VAPOR DIFFUSION, SITTING DROP",7.5,"A 2.5 ul drop formed from equal amounts of protein solution (7 mg/ml solution in approximately 25mM TrisHCl and 75mM NaCl) and well solution was equilibrated against 1 ml well solution (2 M Ammonium Sulphate, 2 % v/v PEG 400 and 0.1M Sodium Hepes (pH 7.5)), VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.jmb.2007.05.073",,"2PF5",57,"1.9","1.9","Crystal Structure of the Human TSG-6 Link Module","GVYHREARSGKYKLTYAEAKAVCEFEGGHLATYKQLEAARKIGFHVCAAGWMAKGRVGYPIVKPGPNCGFGKTGIIDYGIRLNRSERWDAYCYNPHAK","Homo sapiens","TNFAIP6, TSG6","Tumor necrosis factor-inducible protein TSG-6","1","2PF5"
"2PF6",,"X-RAY DIFFRACTION",1.97,37.62,"VAPOR DIFFUSION, HANGING DROP",5.6,"18% PEG4000, 0.2M ammonium acetate, 0.1M sodium citrate, pH 5.6, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1182/blood-2007-06-094748",,"2PF6",51.3,"2.2","2.2","Lutheran glycoprotein, N-terminal domains 1 and 2","EVRLSVPPLVEVMRGKSVILDCTPTGTHDHYMLEWFLTDRSGARPRLASAEMQGSELQVTMHDTRGRSPPYQLDSQGRLVLAEAQVGDERDYVCVVRAGAAGTAEATARLNVFAKPEATEVSPNKGTLSVMEDSAQEIATCNSRNGNPAPKITWYRNGQRLEVPVEMNPEGYMTSRTVREASGLLSLTSTLYLRLRKDDRDASFHCAAHYSLPEGRHGRLDSPTFHLTLHY","Homo sapiens","BCAM, LU, MSK19","Lutheran blood group glycoprotein","1","2PF6"
"2PF8",,"X-RAY DIFFRACTION",2.17,43.39,"VAPOR DIFFUSION, HANGING DROP",5,"micro-seeding, pH 5, VAPOR DIFFUSION, HANGING DROP, temperature 297K",297,"10.1002/prot.24136","FID, LDT","2PF8",37.76,"0.85","0.85","Complex of Aldose Reductase with NADP+ and simaltaneously bound competetive inhibitors Fidarestat and IDD594. Concentration of Fidarestat in soaking solution is equal to concentration of IDD594.","MASRILLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGKEFFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAKHNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVCALLSCTSHKDYPFHEEF","Homo sapiens","AKR1B1, ALDR1, ALR2","Aldose reductase","1","2PF8"
"2PFG",,"X-RAY DIFFRACTION",2.37,48.15,"VAPOR DIFFUSION, HANGING DROP",6.8,"pH 6.8, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1039/b707602a",,"2PFG",31.52,"1.54","1.54","Crystal structure of human CBR1 in complex with BiGF2.","SSGIHVALVTGGNKGIGLAIVRDLCRLFSGDVVLTARDVTRGQAAVQQLQAEGLSPRFHQLDIDDLQSIRALRDFLRKEYGGLDVLVNNAGIAFKVADPTPFHIQAEVTMKTNFFGTRDVCTELLPLIKPQGRVVNVSSIMSVRALKSCSPELQQKFRSETITEEELVGLMNKFVEDTKKGVHQKEGWPSSAYGVTKIGVTVLSRIHARKLSEQRKGDKILLNACCPGWVRTDMAGPKATKSPEEGAETPVYLALLPPDAEGPHGQFVSEKRVEQW","Homo sapiens","CBR1, CBR, CRN, SDR21C1","Carbonyl reductase [NADPH] 1","1","2PFG"
"2PFH",,"X-RAY DIFFRACTION",2.15,42.77,"VAPOR DIFFUSION, HANGING DROP",5,"micro-seeding, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 297K",297,"10.1002/prot.24136","FID, LDT","2PFH",37.76,"0.85","0.85","Complex of Aldose Reductase with NADP+ and simaltaneously bound competetive inhibitors Fidarestat and IDD594. Concentration of Fidarestat in soaking solution is less than concentration of IDD594.","MASRILLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGKEFFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAKHNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVCALLSCTSHKDYPFHEEF","Homo sapiens","AKR1B1, ALDR1, ALR2","Aldose reductase","1","2PFH"
"2PFI",,"X-RAY DIFFRACTION",2.47,50.19,"VAPOR DIFFUSION, SITTING DROP",8.5,"20% PEG 4000, 100mM KI, 60mM Tris-HCl, 150mM NaCl, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 277.0K",277,"10.1016/j.str.2007.04.013",,"2PFI",36.53,"1.6","1.6","Crystal structure of the cytoplasmic domain of the human chloride channel ClC-Ka","PRILGRNIGSHHVRVEHFMNHSITTLAKDTPLEEVVKVVTSTDVTEYPLVESTESQILVGIVQRAQLVQALQAEPPSRAPGHQQCLQDILARGCPTEPVTLTLFSETTLHQAQNLFKLLNLQSLFVTSRGRAVGCVSWVEMKKAISNLTNPPAPKEFLEVLFQG","Homo sapiens","CLCNKA","Chloride channel protein ClC-Ka","1","2PFI"
"2PFN",,"X-RAY DIFFRACTION",2.7,54.46,"VAPOR DIFFUSION, HANGING DROP",5.5,"10-20% 2-propanol, 0.2 M sodium citrate and 0.1M sodium cacodylate , pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 278K",278,"10.1016/j.dnarep.2007.03.005",,"2PFN",44.41,"1.9","1.9","Na in the active site of DNA Polymerase lambda","CGGCAGTACTG",,,"Template","1","2PFN"
,,,,,,,,,,,,,,,,"CAGTAC",,,"Primer","2","2PFN"
,,,,,,,,,,,,,,,,"GCCG",,,"Downstream Primer","3","2PFN"
,,,,,,,,,,,,,,,,"MAQPSSQKATNHNLHITEKLEVLAKAYSVQGDKWRALGYAKAINALKSFHKPVTSYQEACSIPGIGKRMAEKIIEILESGHLRKLDHISESVPVLELFSNIWGAGTKTAQMWYQQGFRSLEDIRSQASLTTQQAIGLKHYSDFLERMPREEATEIEQTVQKAAQAFNSGLLCVACGSYRRGKATCGDVDVLITHPDGRSHRGIFSRLLDSLRQEGFLTDDLVSQEENGQQQKYLGVCRLPGPGRRHRRLDIIVVPYSEFACALLYFTGSAHFNRSMRALAKTKGMSLSEHALSTAVVRNTHGAKVGPGRVLPTPTEKDVFRLLGLPYREPAERDW","Homo sapiens","POLL","DNA polymerase lambda","4","2PFN"
"2PFO",,"X-RAY DIFFRACTION",2.74,55.1,"VAPOR DIFFUSION, HANGING DROP",5.5,"10-20% 2-propanol, 0.2 M sodium citrate and 0.1M sodium cacodylate , pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 278K",278,"10.1016/j.dnarep.2007.03.005",,"2PFO",44.51,"2","2","DNA Polymerase lambda in complex with DNA and dUPNPP","CGGCAGTACTG",,,"Template","1","2PFO"
,,,,,,,,,,,,,,,,"CAGTAC",,,"Primer","2","2PFO"
,,,,,,,,,,,,,,,,"GCCG",,,"Downstream Primer","3","2PFO"
,,,,,,,,,,,,,,,,"MAQPSSQKATNHNLHITEKLEVLAKAYSVQGDKWRALGYAKAINALKSFHKPVTSYQEACSIPGIGKRMAEKIIEILESGHLRKLDHISESVPVLELFSNIWGAGTKTAQMWYQQGFRSLEDIRSQASLTTQQAIGLKHYSDFLERMPREEATEIEQTVQKAAQAFNSGLLCVACGSYRRGKATCGDVDVLITHPDGRSHRGIFSRLLDSLRQEGFLTDDLVSQEENGQQQKYLGVCRLPGPGRRHRRLDIIVVPYSEFACALLYFTGSAHFNRSMRALAKTKGMSLSEHALSTAVVRNTHGAKVGPGRVLPTPTEKDVFRLLGLPYREPAERDW","Homo sapiens","POLL","DNA polymerase lambda","4","2PFO"
"2PFP",,"X-RAY DIFFRACTION",2.8,56.04,"VAPOR DIFFUSION, HANGING DROP",5.5,"10-20% 2-propanol, 0.2 M sodium citrate and 0.1M sodium cacodylate , pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 278K",278,"10.1016/j.dnarep.2007.03.005",,"2PFP",44.43,"2.1","2.1","DNA Polymerase lambda in complex with DNA and dCTP","CGGCGGTACTG",,,"Template","1","2PFP"
,,,,,,,,,,,,,,,,"CAGTAC",,,"Primer","2","2PFP"
,,,,,,,,,,,,,,,,"GCCG",,,"Downstream Primer","3","2PFP"
,,,,,,,,,,,,,,,,"MAQPSSQKATNHNLHITEKLEVLAKAYSVQGDKWRALGYAKAINALKSFHKPVTSYQEACSIPGIGKRMAEKIIEILESGHLRKLDHISESVPVLELFSNIWGAGTKTAQMWYQQGFRSLEDIRSQASLTTQQAIGLKHYSDFLERMPREEATEIEQTVQKAAQAFNSGLLCVACGSYRRGKATCGDVDVLITHPDGRSHRGIFSRLLDSLRQEGFLTDDLVSQEENGQQQKYLGVCRLPGPGRRHRRLDIIVVPYSEFACALLYFTGSAHFNRSMRALAKTKGMSLSEHALSTAVVRNTHGAKVGPGRVLPTPTEKDVFRLLGLPYREPAERDW","Homo sapiens","POLL","DNA polymerase lambda","4","2PFP"
"2PFQ",,"X-RAY DIFFRACTION",2.8,56.08,"VAPOR DIFFUSION, HANGING DROP",5.5,"10-20% 2-propanol, 0.2 M sodium citrate and 0.1M sodium cacodylate , pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 278K",278,"10.1016/j.dnarep.2007.03.005",,"2PFQ",44.94,"2.1","2.1","Manganese promotes catalysis in a DNA polymerase lambda-DNA crystal","CGGCGGTACTG",,,"Template","1","2PFQ"
,,,,,,,,,,,,,,,,"CAGTACC",,,"Primer","2","2PFQ"
,,,,,,,,,,,,,,,,"GCCG",,,"Downstream Primer","3","2PFQ"
,,,,,,,,,,,,,,,,"MAQPSSQKATNHNLHITEKLEVLAKAYSVQGDKWRALGYAKAINALKSFHKPVTSYQEACSIPGIGKRMAEKIIEILESGHLRKLDHISESVPVLELFSNIWGAGTKTAQMWYQQGFRSLEDIRSQASLTTQQAIGLKHYSDFLERMPREEATEIEQTVQKAAQAFNSGLLCVACGSYRRGKATCGDVDVLITHPDGRSHRGIFSRLLDSLRQEGFLTDDLVSQEENGQQQKYLGVCRLPGPGRRHRRLDIIVVPYSEFACALLYFTGSAHFNRSMRALAKTKGMSLSEHALSTAVVRNTHGAKVGPGRVLPTPTEKDVFRLLGLPYREPAERDW","Homo sapiens","POLL","DNA polymerase lambda","4","2PFQ"
"2PFR",,"X-RAY DIFFRACTION",3.5,64.7,"VAPOR DIFFUSION, SITTING DROP",8.5,"2.5 M Ammonium sulfate, 0.1M TRIS, pH 8.5, vapor diffusion, sitting drop, temperature 291K",291,,,"2PFR",69.79,"1.92","1.92","Human N-acetyltransferase 2","GGSGSDIEAYFERIGYKNSRNKLDLETLTDILEHQIRAVPFENLNMHCGQAMELGLEAIFDHIVRRNRGGWCLQVNQLLYWALTTIGFQTTMLGGYFYIPPVNKYSTGMVHLLLQVTIDGRNYIVDAGSGSSSQMWQPLELISGKDQPQVPCIFCLTEERGIWYLDQIRREQYITNKEFLNSHLLPKKKHQKIYLFTLEPRTIEDFESMNTYLQTSPTSSFITTSFCSLQTPEGVYCLVGFILTYRKFNYKDNTDLVEFKTLTEEEVEEVLKNIFKISLGRNLVPKPGDGSLTI","Homo sapiens","NAT2, AAC2","Arylamine N-acetyltransferase 2","1","2PFR"

"2PG2",,"X-RAY DIFFRACTION",2.71,54.63,"VAPOR DIFFUSION, HANGING DROP",6,"100 mM Bis-Tris (pH 6.0) 200 mM ammonium sulfate, and 18-20% PEG 3350. 10 mM SrCl2, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.bmcl.2007.04.076","K01","2PG2",83.74,"1.849","1.849","Crystal structure of KSP in complex with ADP and thiophene containing inhibitor 15","MASQPNSSAKKKEEKGKNIQVVVRCRPFNLAERKASAHSIVECDPVRKEVSVRTGGLADKSSRKTYTFDMVFGASTKQIDVYRSVVCPILDEVIMGYNCTIFAYGQTGTGKTFTMEGERSPNEEYTWEEDPLAGIIPRTLHQIFEKLTDNGTEFSVKVSLLEIYNEELFDLLNPSSDVSERLQMFDDPRNKRGVIIKGLEEITVHNKDEVYQILEKGAAKRTTAATLMNAYSSRSHSVFSVTIHMKETTIDGEELVKIGKLNLVDLAGSENIGRSGAVDKRAREAGNINQSLLTLGRVITALVERTPHVPYRESKLTRILQDSLGGRTRTSIIATISPASLNLEETLSTLEYAHRAKNILNKPEVNQK","Homo sapiens","KIF11, EG5, KNSL1, TRIP5","Kinesin-like protein KIF11","1","2PG2"
"2PG5",,"X-RAY DIFFRACTION",2.65,53.6,"VAPOR DIFFUSION, SITTING DROP",8.5,"PEG3350, Tris, ammonium sulfate, Anapoe-35, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1016/j.abb.2007.04.028",,"2PG5",221.46,"1.95","1.95","Crystal Structure of Human Microsomal P450 2A6 N297Q","MAKKTSSKGKLPPGPTPLPFIGNYLQLNTEQMYNSLMKISERYGPVFTIHLGPRRVVVLCGHDAVREALVDQAEEFSGRGEQATFDWVFKGYGVVFSNGERAKQLRRFSIATLRDFGVGKRGIEERIQEEAGFLIDALRGTGGANIDPTFFLSRTVSNVISSIVFGDRFDYKDKEFLSLLRMMLGIFQFTSTSTGQLYEMFSSVMKHLPGPQQQAFQLLQGLEDFIAKKVEHNQRTLDPNSPRDFIDSFLIRMQEEEKNPNTEFYLKNLVMTTLQLFIGGTETVSTTLRYGFLLLMKHPEVEAKVHEEIDRVIGKNRQPKFEDRAKMPYMEAVIHEIQRFGDVIPMSLARRVKKDTKFRDFFLPKGTEVYPMLGSVLRDPSFFSNPQDFNPQHFLNEKGQFKKSDAFVPFSIGKRNCFGEGLARMELFLFFTTVMQNFRLKSSQSPKDIDVSPKHVGFATIPRNYTMSFLPRHHHH","Homo sapiens","CYP2A6, CYP2A13","Cytochrome P450 2A6","1","2PG5"
"2PG6",,"X-RAY DIFFRACTION",2.65,53.6,"VAPOR DIFFUSION, SITTING DROP",8.5,"PEG3350, Tris, ammonium sulfate, Anapoe-35, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1016/j.abb.2007.04.028",,"2PG6",221.17,"2.53","2.53","Crystal Structure of Human Microsomal P450 2A6 L240C/N297Q","MAKKTSSKGKLPPGPTPLPFIGNYLQLNTEQMYNSLMKISERYGPVFTIHLGPRRVVVLCGHDAVREALVDQAEEFSGRGEQATFDWVFKGYGVVFSNGERAKQLRRFSIATLRDFGVGKRGIEERIQEEAGFLIDALRGTGGANIDPTFFLSRTVSNVISSIVFGDRFDYKDKEFLSLLRMMLGIFQFTSTSTGQLYEMFSSVMKHLPGPQQQAFQCLQGLEDFIAKKVEHNQRTLDPNSPRDFIDSFLIRMQEEEKNPNTEFYLKNLVMTTLQLFIGGTETVSTTLRYGFLLLMKHPEVEAKVHEEIDRVIGKNRQPKFEDRAKMPYMEAVIHEIQRFGDVIPMSLARRVKKDTKFRDFFLPKGTEVYPMLGSVLRDPSFFSNPQDFNPQHFLNEKGQFKKSDAFVPFSIGKRNCFGEGLARMELFLFFTTVMQNFRLKSSQSPKDIDVSPKHVGFATIPRNYTMSFLPRHHHH","Homo sapiens","CYP2A6, CYP2A13","Cytochrome P450 2A6","1","2PG6"
"2PG7",,"X-RAY DIFFRACTION",2.69,54.21,"VAPOR DIFFUSION, SITTING DROP",8.5,"PEG3350, Tris, Ammonium sulfate, Anapoe-35, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1016/j.abb.2007.04.028",,"2PG7",221.15,"2.8","2.8","Crystal Structure of Human Microsomal P450 2A6 N297Q/I300V","MAKKTSSKGKLPPGPTPLPFIGNYLQLNTEQMYNSLMKISERYGPVFTIHLGPRRVVVLCGHDAVREALVDQAEEFSGRGEQATFDWVFKGYGVVFSNGERAKQLRRFSIATLRDFGVGKRGIEERIQEEAGFLIDALRGTGGANIDPTFFLSRTVSNVISSIVFGDRFDYKDKEFLSLLRMMLGIFQFTSTSTGQLYEMFSSVMKHLPGPQQQAFQLLQGLEDFIAKKVEHNQRTLDPNSPRDFIDSFLIRMQEEEKNPNTEFYLKNLVMTTLQLFVGGTETVSTTLRYGFLLLMKHPEVEAKVHEEIDRVIGKNRQPKFEDRAKMPYMEAVIHEIQRFGDVIPMSLARRVKKDTKFRDFFLPKGTEVYPMLGSVLRDPSFFSNPQDFNPQHFLNEKGQFKKSDAFVPFSIGKRNCFGEGLARMELFLFFTTVMQNFRLKSSQSPKDIDVSPKHVGFATIPRNYTMSFLPRHHHH","Homo sapiens","CYP2A6, CYP2A13","Cytochrome P450 2A6","1","2PG7"
"2PGB",,"X-RAY DIFFRACTION",2.11,41.72,"VAPOR DIFFUSION, HANGING DROP",8.5,"25% PEG 4000, 0.2 M Lithium Sulfate and 0.1 M TRIS- HCl pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1074/jbc.M703202200",,"2PGB",34.23,"1.54","1.54","Inhibitor-free human thrombin mutant C191A-C220A","TFGSGEADCGLRPLFEKKSLEDKTERELLESYIDGR","Homo sapiens","F2","Prothrombin","1","2PGB"
,,,,,,,,,,,,,,,,"IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDAAEGDSGGPFVMKSPFNNRWYQMGIVSWGEGADRDGKYGFYTHVFRLKKWIQKVIDQFGE","Homo sapiens","F2","Prothrombin","2","2PGB"
"2PGJ",,"X-RAY DIFFRACTION",2.31,46.7,"VAPOR DIFFUSION, HANGING DROP",6,"100 mM MES, pH 6.0, and 10% PEG 4000, VAPOR DIFFUSION, HANGING DROP, temperature 300K",300,"10.1074/jbc.M701653200","N1C","2PGJ",61.3,"1.71","1.71","Catalysis associated conformational changes revealed by human cd38 complexed with a non-hydrolyzable substrate analog","KREAEARWRQTWSGPGTTKRFPETVLARCVKYTEIHPEMRHVDCQSVWDAFKGAFISKHPCDITEEDYQPLMKLGTQTVPCNKILLWSRIKDLAHQFTQVQRDMFTLEDTLLGYLADDLTWCGEFDTSKINYQSCPDWRKDCSNNPVSVFWKTVSRRFAEAACDVVHVMLDGSRSKIFDKDSTFGSVEVHNLQPEKVQTLEAWVIHGGREDSRDLCQDPTIKELESIISKRNIQFSCKNIYRPDKFLQCVKNPEDSSCTSEI","Homo sapiens","CD38","ADP-ribosyl cyclase 1","1","2PGJ"
"2PGL",,"X-RAY DIFFRACTION",2.3,46.58,"VAPOR DIFFUSION, HANGING DROP",6,"100 mM MES, pH 6.0, and 15% PEG 4000, VAPOR DIFFUSION, HANGING DROP, temperature 300K",300,"10.1074/jbc.M701653200","N1C","2PGL",61.3,"1.76","1.76","Catalysis associated conformational changes revealed by human CD38 complexed with a non-hydrolyzable substrate analog","KREAEARWRQTWSGPGTTKRFPETVLARCVKYTEIHPEMRHVDCQSVWDAFKGAFISKHPCDITEEDYQPLMKLGTQTVPCNKILLWSRIKDLAHQFTQVQRDMFTLEDTLLGYLADDLTWCGEFDTSKINYQSCPDWRKDCSNNPVSVFWKTVSRRFAEAACDVVHVMLDGSRSKIFDKDSTFGSVQVHNLQPEKVQTLEAWVIHGGREDSRDLCQDPTIKELESIISKRNIQFSCKNIYRPDKFLQCVKNPEDSSCTSEI","Homo sapiens","CD38","ADP-ribosyl cyclase 1","1","2PGL"
"2PGQ",,"X-RAY DIFFRACTION",2.34,47.49,"VAPOR DIFFUSION, HANGING DROP",6.3,"20% PEG 3350 and 0.2 M Zinc Acetate, VAPOR DIFFUSION, HANGING DROP, temperature 295K, pH 6.3",295,"10.1074/jbc.M703202200",,"2PGQ",35.87,"1.8","1.8","Human thrombin mutant C191A-C220A in complex with the inhibitor PPACK","EYQTFFNPRTFGSGEADCGLRPLFEKKSLEDKTERELLESYIDGR","Homo sapiens","F2","Thrombin light chain","1","2PGQ"
,,,,,,,,,,,,,,,,"IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDAAEGDSGGPFVMKSPFNNRWYQMGIVSWGEGADRDGKYGFYTHVFRLKKWIQKVIDQFGE","Homo sapiens","F2","Thrombin heavy chain","2","2PGQ"
"2PGT",,"X-RAY DIFFRACTION",2.4,49,"VAPOR DIFFUSION, HANGING DROP",7,"CRYSTALS WERE GROWN IN HANGING DROPS WHICH INITIALLY CONSISTED OF 5.9 MG/ML PROTEIN IN 0.1 M HEPES BUFFER (PH 7.0) CONTAINING 8.3 MM S-HEXYLGLUTATHIONE AND 1.0 M BUFFERED (PH 7.0) AMMONIUM SULFATE. THE DROPS WERE EQUILIBRATED AT 293 K AGAINST WELL SOLUTION CONTAINING BETWEEN 1.9 - 2.0 M AMMONIUM SULFATE IN 0.1 M HEPES BUFFER (PH 7.0)., vapor diffusion - hanging drop",,"10.1021/bi970805s",,"2PGT",48.3,"1.9","1.9","CRYSTAL STRUCTURE OF HUMAN GLUTATHIONE S-TRANSFERASE P1-1[V104] COMPLEXED WITH (9R,10R)-9-(S-GLUTATHIONYL)-10-HYDROXY-9,10-DIHYDROPHENANTHRENE","MPPYTVVYFPVRGRCAALRMLLADQGQSWKEEVVTVETWQEGSLKASCLYGQLPKFQDGDLTLYQSNTILRHLGRTLGLYGKDQQEAALVDMVNDGVEDLRCKYVSLIYTNYEAGKDDYVKALPGQLKPFETLLSQNQGGKTFIVGDQISFADYNLLDLLLIHEVLAPGCLDAFPLLSAYVGRLSARPKLKAFLASPEYVNLPINGNGKQ","Homo sapiens","GTP_HUMAN, GSTP1, FAEES3, GST3","GLUTATHIONE S-TRANSFERASE","1","2PGT"
"2PGV",,"X-RAY DIFFRACTION",2.26,45.57,"VAPOR DIFFUSION, HANGING DROP",7.5,"6.8 mgml-1 GTB, 70 mM N-(2-acetamido)-2-iminodiacetic acid (ADA), pH 7.5, 50 mM CH3COONa, pH 4.6, 40 mM NaCl, 5   8 mM MnCl2, 2.5% (v/v) 2-methyl-2,4-pentanediol (MPD), 5% (v/v) glycerol, 2% (w/v) PEG 4000 and 0.3   0.5 mM 3-chloro-Hg-2-methoxy-propylurea suspended over a 1 ml reservoir solution (50 mM ADA, pH 7.5, 10 mM MnCl2, 100 mM ammonium sulfate, 5% (v/v) MPD, 10% (v/v) glycerol and 8   10% (w/v) PEG 4000), VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1107/S0907444907026479",,"2PGV",34.58,"1.79","1.79","GTB C209A","MVSLPRMVYPQPKVLTPCRKDVLVVTPWLAPIVWEGTFNIDILNEQFRLQNTTIGLTVFAIKKYVAFLKLFLETAEKHFMVGHRVHYYVFTDQPAAVPRVTLGTGRQLSVLEVGAYKRWQDVSMRRMEMISDFCERRFLSEVDYLVAVDVDMEFRDHVGVEILTPLFGTLHPSFYGSSREAFTYERRPQSQAYIPKDEGDFYYMGAFFGGSVQEVQRLTRACHQAMMVDQANGIEAVWHDESHLNKYLLRHKPTKVLSPEYLWDQQLLGWPAVLRKLRFTAVPKNHQAVRNP","Homo sapiens","ABO","Glycoprotein-fucosylgalactoside alpha-galactosyltransferase","1","2PGV"
"2PGY",,"X-RAY DIFFRACTION",2.39,48.58,,,,,"10.1107/S0907444907026479",,"2PGY",33.98,"2.39","2.39","GTB C209A, no Hg","MVSLPRMVYPQPKVLTPCRKDVLVVTPWLAPIVWEGTFNIDILNEQFRLQNTTIGLTVFAIKKYVAFLKLFLETAEKHFMVGHRVHYYVFTDQPAAVPRVTLGTGRQLSVLEVGAYKRWQDVSMRRMEMISDFCERRFLSEVDYLVAVDVDMEFRDHVGVEILTPLFGTLHPSFYGSSREAFTYERRPQSQAYIPKDEGDFYYMGAFFGGSVQEVQRLTRACHQAMMVDQANGIEAVWHDESHLNKYLLRHKPTKVLSPEYLWDQQLLGWPAVLRKLRFTAVPKNHQAVRNP","Homo sapiens","ABO","Glycoprotein-fucosylgalactoside alpha-galactosyltransferase","1","2PGY"
"2PH6",,"X-RAY DIFFRACTION",2.83,56.49,"VAPOR DIFFUSION, SITTING DROP",7.5,"1.5M LITHIUM SULFATE, 0.1M HEPES BUFFER, Crystals were grown with L124671 and L304507 was back soak, pH 7.50, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1016/j.bmcl.2007.04.072","712","2PH6",45.76,"2","2","Crystal Structure of Human Beta Secretase Complexed with inhibitor","MLPRETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGAWAGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYN","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","2PH6"
"2PH8",,"X-RAY DIFFRACTION",2.82,56.35,"VAPOR DIFFUSION, SITTING DROP",7.5,"Crystals were grown with L124671 and inhibitor was back soaked in the crystal at pH 5.0. 1.5M LITHIUM SULFATE, 0.1M HEPES BUFFER, pH 7.50, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.bmcl.2007.08.040","35A","2PH8",45.77,"1.7","1.7","Crystal Structure of Human Beta Secretase Complexed with inhibitor","MLPRETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGAWAGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYN","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","2PH8"
"2PHA",,"X-RAY DIFFRACTION",2.38,48.38,"VAPOR DIFFUSION, HANGING DROP",7,"18-22% Jeffamine ED-2001, 0.1M Hepes (pH 7.0), VAPOR DIFFUSION, HANGING DROP, temperature 294K",294,"10.1021/ja071567j",,"2PHA",69.78,"1.9","1.9","Crystal structure of native, unliganded human arginase at 1.90 resolution","MSAKSRTIGIIGAPFSKGQPRGGVEEGPTVLRKAGLLEKLKEQECDVKDYGDLPFADIPNDSPFQIVKNPRSVGKASEQLAGKVAEVKKNGRISLVLGGDHSLAIGSISGHARVHPDLGVIWVDAHTDINTPLTTTSGNLHGQPVSFLLKELKGKIPDVPGFSWVTPCISAKDIVYIGLRDVDPGEHYILKTLGIKYFSMTEVDRLGIGKVMEETLSYLLGRKKRPIHLSFDVDGLDPSFTPATGTPVVGGLTYREGLYITEEIYKTGLLSGLDIMEVNPSLGKTPEEVTRTVNTAVAITLACFGLAREGNHKPIDYLNPPK","Homo sapiens","ARG1","Arginase-1","1","2PHA"
"2PHB",,"X-RAY DIFFRACTION",2.49,50.59,,,,,"10.1111/j.1747-0285.2007.00539.x","230","2PHB",32.43,"2.3","2.3","An Orally Efficacious Factor Xa Inhibitor","IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT","Homo sapiens","F10","Coagulation factor X, heavy chain","1","2PHB"
,,,,,,,,,,,,,,,,"LCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACIPTGPYPCGKQTLE","Homo sapiens","F10","Coagulation factor X, light chain","2","2PHB"
"2PHO",,"X-RAY DIFFRACTION",2.37,48.12,"VAPOR DIFFUSION, HANGING DROP",7,"12-22% Jeffamine ED-2001, 0.1 M Hepes, pH 7.0, 1.4 mM thiosemicarbazide, VAPOR DIFFUSION, HANGING DROP, temperature 294K",294,"10.1021/ja071567j","TSZ","2PHO",69.87,"1.95","1.95","Crystal structure of human arginase I complexed with thiosemicarbazide at 1.95 resolution","MSAKSRTIGIIGAPFSKGQPRGGVEEGPTVLRKAGLLEKLKEQECDVKDYGDLPFADIPNDSPFQIVKNPRSVGKASEQLAGKVAEVKKNGRISLVLGGDHSLAIGSISGHARVHPDLGVIWVDAHTDINTPLTTTSGNLHGQPVSFLLKELKGKIPDVPGFSWVTPCISAKDIVYIGLRDVDPGEHYILKTLGIKYFSMTEVDRLGIGKVMEETLSYLLGRKKRPIHLSFDVDGLDPSFTPATGTPVVGGLTYREGLYITEEIYKTGLLSGLDIMEVNPSLGKTPEEVTRTVNTAVAITLACFGLAREGNHKPIDYLNPPK","Homo sapiens","ARG1","Arginase-1","1","2PHO"
"2PI0",,"X-RAY DIFFRACTION",2.74,55.16,"VAPOR DIFFUSION, HANGING DROP",7,"12%PEG 400,200mM NaCl, pH 7., VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.molcel.2007.04.022",,"2PI0",73.27,"2.31","2.31","Crystal Structure of IRF-3 bound to the PRDIII-I regulatory element of the human interferon-B enhancer","CATAGGAAAACTGAAAGGGAGAAGTGAAAGTG",,,"PRDIII-I region of human interferon-B promoter strand 1","1","2PI0"
,,,,,,,,,,,,,,,,"CACTTTCACTTCTCCCTTTCAGTTTTCCTATG",,,"PRDIII-I region of human interferon-B promoter strand 2","2","2PI0"
,,,,,,,,,,,,,,,,"GSHMGTPKPRILPWLVSQLDLGQLEGVAWVNKSRTRFRIPWKHGLRQDAQQEDFGIFQAWAEATGAYVPGRDKPDLPTWKRNFRSALNRKEGLRLAEDRSKDPHDPHKIYEFVNSG","Homo sapiens","IRF3","Interferon regulatory factor 3","3","2PI0"
"2PID",,"X-RAY DIFFRACTION",2.05,40.01,,6.5,"3 mg/ml protein, 30% (m/v) PEG 4000, 200 mM Ammonium acetate, 100 mM sodium acetate pH 4.6,  
100 mM Tris-HCl pH 7.5, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K, pH 6.50",293,"10.1016/j.str.2007.09.018",,"2PID",80.94,"2.2","2.2","Crystal structure of human mitochondrial tyrosyl-tRNA synthetase in complex with an adenylate analog","MRGSHSGAQGLLAAQKARGLFKDFFPETGTKIELPELFDRGTASFPQTIYCGFDPTADSLHVGHLLALLGLFHLQRAGHNVIALVGGATARLGDPSGRTKEREALETERVRANARALRLGLEALAANHQQLFTDGRSWGSFTVLDNSAWYQKQHLVDFLAAVGGHFRMGTLLSRQSVQLRLKSPEGMSLAEFFYQVLQAYDFYYLFQRYGCRVQLGGSDQLGNIMSGYEFINKLTGEDVFGITVPLITSTTGAKLGKSAGNAVWLNRDKTSPFELYQFFVRQPDDSVERYLKLFTFLPLPEIDHIMQLHVKEPERRGPQKRLAAEVTKLVHGREGLDSAKRCTQALYHRSHHHHHH","Homo sapiens","YARS2, CGI-04","Tyrosyl-tRNA synthetase","1","2PID"
"2PIE",,"X-RAY DIFFRACTION",2.39,48.51,"batch crystallization",8,"4 mM Tris pH 8, 4 mM NaCl, 0.4 mM DTT, pH 8.0, batch crystallization, temperature 277K",277,"10.1016/j.cell.2007.09.041",,"2PIE",16.81,"1.35","1.35","Crystal structure of the FHA domain of RNF8 in complex with its optimal phosphopeptide","GAHMAGGRSWCLRRVGMSAGWLLLEDGCEVTVGRGFGVTYQLVSKICPLMISRNHCVLKQNPEGQWTIMDNKSLNGVWLNRARLEPLRVYSIHQGDYIQLGVPLENKENAEYEYEVTEEDWETIYPCLSPKNDQMIEK","Homo sapiens","RNF8, KIAA0646","E3 ubiquitin-protein ligase RNF8","1","2PIE"
,,,,,,,,,,,,,,,,"ELKTERY",,,"phosphopeptide","2","2PIE"
"2PIN",,"X-RAY DIFFRACTION",2.46,49.92,"VAPOR DIFFUSION, HANGING DROP",,"VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1210/me.2007-0174","4HY, LEG","2PIN",59.02,"2.3","2.3","Thyroid receptor beta in complex with inhibitor","GHKPEPTDEEWELIKTVTEAHVATNAQGSHWKQKRKFLPEDIGQAPIVNAPEGGKVDLEAFSHFTKIITPAITRVVDFAKKLPMFCELPCEDQIILLKGCCMEIMSLRAAVRYDPESETLTLNGEMAVTRGQLKNGGLGVVSDAIFRLGMSLSSFNLDDTEVALLQAVLLMSSDRPGLACVERIEKYQDSFLLAFEHYINYRKHHVTHFWPKLLMKVTDLRMIGACHASRFLHMKVECPTELFPPLFLEVFED","Homo sapiens","THRB, ERBA2, NR1A2, THR1","Thyroid hormone receptor beta-1","1","2PIN"
"2PIO",,"X-RAY DIFFRACTION",2.17,43.35,"VAPOR DIFFUSION, SITTING DROP",,"VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1073/pnas.0708036104","DHT","2PIO",29.93,"2.03","2.03","Androgen receptor LBD with small molecule","CQPIFLNVLEAIEPGVVCAGHDNNQPDSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWMGLMVFAMGWRSFTNVNSRMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKNQKFFDELRMNYIKELDRIIACKRKNPTSCSRRFYQLTKLLDSVQPIARELHQFTFDLLIKSHMVSVDFPEMMAEIISVQVPKILSGKVKPIYFHTQ","Homo sapiens","AR, DHTR, NR3C4","Androgen receptor","1","2PIO"
"2PIP",,"X-RAY DIFFRACTION",2.19,43.93,"VAPOR DIFFUSION, SITTING DROP",,"VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1073/pnas.0708036104","DHT","2PIP",30.33,"1.8","1.8","Androgen receptor LBD with small molecule","CQPIFLNVLEAIEPGVVCAGHDNNQPDSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWMGLMVFAMGWRSFTNVNSRMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKNQKFFDELRMNYIKELDRIIACKRKNPTSCSRRFYQLTKLLDSVQPIARELHQFTFDLLIKSHMVSVDFPEMMAEIISVQVPKILSGKVKPIYFHTQ","Homo sapiens","AR, DHTR, NR3C4","Androgen receptor","1","2PIP"
"2PIQ",,"X-RAY DIFFRACTION",2.3,46.57,"VAPOR DIFFUSION, SITTING DROP",,"VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1073/pnas.0708036104","DHT","2PIQ",29.96,"2.4","2.4","androgen receptor LBD with small molecule","CQPIFLNVLEAIEPGVVCAGHDNNQPDSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWMGLMVFAMGWRSFTNVNSRMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKNQKFFDELRMNYIKELDRIIACKRKNPTSCSRRFYQLTKLLDSVQPIARELHQFTFDLLIKSHMVSVDFPEMMAEIISVQVPKILSGKVKPIYFHTQ","Homo sapiens","AR, DHTR, NR3C4","Androgen receptor","1","2PIQ"
"2PIR",,"X-RAY DIFFRACTION",2.2,44.17,"VAPOR DIFFUSION, SITTING DROP",,"VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1073/pnas.0708036104","DHT","2PIR",29.79,"2.1","2.1","Androgen receptor LBD with small molecule","CQPIFLNVLEAIEPGVVCAGHDNNQPDSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWMGLMVFAMGWRSFTNVNSRMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKNQKFFDELRMNYIKELDRIIACKRKNPTSCSRRFYQLTKLLDSVQPIARELHQFTFDLLIKSHMVSVDFPEMMAEIISVQVPKILSGKVKPIYFHTQ","Homo sapiens","AR, DHTR, NR3C4","Androgen receptor","1","2PIR"
"2PIT",,"X-RAY DIFFRACTION",2.22,44.55,"VAPOR DIFFUSION, SITTING DROP",,"VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1073/pnas.0708036104","DHT, 4HY","2PIT",30.29,"1.76","1.76","Androgen receptor LBD with small molecule","CQPIFLNVLEAIEPGVVCAGHDNNQPDSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWMGLMVFAMGWRSFTNVNSRMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKNQKFFDELRMNYIKELDRIIACKRKNPTSCSRRFYQLTKLLDSVQPIARELHQFTFDLLIKSHMVSVDFPEMMAEIISVQVPKILSGKVKPIYFHTQ","Homo sapiens","AR, DHTR, NR3C4","Androgen receptor","1","2PIT"
"2PIU",,"X-RAY DIFFRACTION",2.3,46.63,"VAPOR DIFFUSION, SITTING DROP",,"VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1073/pnas.0708036104","DHT, 4HY","2PIU",30.81,"2.12","2.12","Androgen receptor LBD with small molecule","CQPIFLNVLEAIEPGVVCAGHDNNQPDSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWMGLMVFAMGWRSFTNVNSRMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKNQKFFDELRMNYIKELDRIIACKRKNPTSCSRRFYQLTKLLDSVQPIARELHQFTFDLLIKSHMVSVDFPEMMAEIISVQVPKILSGKVKPIYFHTQ","Homo sapiens","AR, DHTR, NR3C4","Androgen receptor","1","2PIU"
"2PIV",,"X-RAY DIFFRACTION",2.31,46.77,"VAPOR DIFFUSION, SITTING DROP",,"VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1073/pnas.0708036104","DHT, T3","2PIV",30.31,"1.95","1.95","Androgen receptor with small molecule","CQPIFLNVLEAIEPGVVCAGHDNNQPDSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWMGLMVFAMGWRSFTNVNSRMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKNQKFFDELRMNYIKELDRIIACKRKNPTSCSRRFYQLTKLLDSVQPIARELHQFTFDLLIKSHMVSVDFPEMMAEIISVQVPKILSGKVKPIYFHTQ","Homo sapiens","AR, DHTR, NR3C4","Androgen receptor","1","2PIV"
"2PIW",,"X-RAY DIFFRACTION",2.28,45.99,"VAPOR DIFFUSION, SITTING DROP",,"VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1073/pnas.0708036104","DHT, T3","2PIW",30.87,"2.58","2.58","Androgen receptor with small molecule","CQPIFLNVLEAIEPGVVCAGHDNNQPDSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWMGLMVFAMGWRSFTNVNSRMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKNQKFFDELRMNYIKELDRIIACKRKNPTSCSRRFYQLTKLLDSVQPIARELHQFTFDLLIKSHMVSVDFPEMMAEIISVQVPKILSGKVKPIYFHTQ","Homo sapiens","AR, DHTR, NR3C4","Androgen receptor","1","2PIW"
"2PIX",,"X-RAY DIFFRACTION",2.3,46.59,"VAPOR DIFFUSION, SITTING DROP",,"VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1073/pnas.0708036104","DHT, FLF","2PIX",29.85,"2.4","2.4","AR LBD with small molecule","CQPIFLNVLEAIEPGVVCAGHDNNQPDSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWMGLMVFAMGWRSFTNVNSRMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKNQKFFDELRMNYIKELDRIIACKRKNPTSCSRRFYQLTKLLDSVQPIARELHQFTFDLLIKSHMVSVDFPEMMAEIISVQVPKILSGKVKPIYFHTQ","Homo sapiens","AR, DHTR, NR3C4","Androgen receptor","1","2PIX"
"2PJL",,"X-RAY DIFFRACTION",2.23,44.83,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.2M MgCl2, 12%PEG400, 0.1M HEPES, pH7.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1074/jbc.M703337200","047","2PJL",54.7,"2.3","2.3","Crystal Structure of Human Estrogen-Related Receptor alpha in Complex with a Synthetic Inverse Agonist reveals its Novel Molecular Mechanism","GSSHHHHHHLEVLFQGPVNALVSHLLVVEPEKLYAMPDPAGPDGHLPAVATLSDLFDREIVVTISWAKSIPGFSSLSLSDQMSVLQSVWMEVLVLGVAQRSLPLQDELAFAEDLVLDEEGARAAGLGELGAALLQLVRRLQALRLEREEYVLLKALALANSDSVHIEDAEAVEQLREALHEALLEYEAGRAGPGGGAERRRAGRLLLTLPLLRQTAGKVLAHFYGVKLEGKVPMHKLFLEMLEAMMD","Homo sapiens","ESRRA, ERR1, ESRL1, NR3B1","Steroid hormone receptor ERR1","1","2PJL"
"2PJT",,"X-RAY DIFFRACTION",2.15,42.67,"VAPOR DIFFUSION, HANGING DROP",7,"20% PEG 3350, 0.2M MgCl2, 0.1M Hepes pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 300K",300,"10.1016/j.bmc.2007.06.031","347","2PJT",77.22,"2.8","2.8","Crystal structure of the catalytic domain of MMP-13 complexed with WAY-344","YNVFPRTLKWSKMNLTYRIVNYTPDMTHSEVEKAFKKAFKVWSDVTPLNFTRLHDGIADIMISFGIKEHGDFYPFDGPSGLLAHAFPPGPNYGGDAHFDDDETWTSSSKGYNLFLVAAHEFGHSLGLDHSKDPGALMFPIYTYTGKSHFMLPDDDVQGIQSLYGP","Homo sapiens","MMP13","Collagenase 3","1","2PJT"
"2PK4",,"X-RAY DIFFRACTION",2.02,39.16,,,,,"10.1021/bi00107a030","ACA","2PK4",9.3,"2.25","2.25","THE REFINED STRUCTURE OF THE EPSILON-AMINOCAPROIC ACID COMPLEX OF HUMAN PLASMINOGEN KRINGLE","QDCYHGDGQSYRGTSSTTTTGKKCQSWSSMTPHRHQKTPENYPNAGLTMNYCRNPDADKGPWCFTTDPSVRWEYCNLKKC","Homo sapiens","PLG","HUMAN PLASMINOGEN KRINGLE 4","1","2PK4"
"2PKD",,"X-RAY DIFFRACTION",2.55,51.75,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG3350, 0.3 M MgCl2, 0.1 M, HEPES, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 294K",294,"10.1073/pnas.0703893104",,"2PKD",76.01,"2.043","2.043","Crystal structure of CD84: Insite into SLAM family function","MKDSEIFTVNGILGESVTFPVNIQEPRQVKIIAWTSKTSVAYVTPGDSETAPVVTVTHRNYYERIHALGPNYNLVISDLRMEDAGDYKADINTQADPYTTTKRYNLQIYRR","Homo sapiens","CD84, SLAMF5","SLAM family member 5","1","2PKD"
"2PKL",,"X-RAY DIFFRACTION",2.23,44.9,"VAPOR DIFFUSION, SITTING DROP",,"VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1073/pnas.0708036104","DHT, 4HY","2PKL",30.71,"2.49","2.49","Androgen receptor LBD with small molecule","CQPIFLNVLEAIEPGVVCAGHDNNQPDSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWMGLMVFAMGWRSFTNVNSRMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKNQKFFDELRMNYIKELDRIIACKRKNPTSCSRRFYQLTKLLDSVQPIARELHQFTFDLLIKSHMVSVDFPEMMAEIISVQVPKILSGKVKPIYFHTQ","Homo sapiens","AR, DHTR, NR3C4","Androgen receptor","1","2PKL"
,,,,,,,,,,,,,,,,"KLLF",,,"ARA70 peptide","2","2PKL"
"2PKS",,"X-RAY DIFFRACTION",2.7,53.3,"VAPOR DIFFUSION, HANGING DROP",7.3,"27% PEG8000, 0.1M SODIUM PHOSPHATE, PH 7.3, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K",298,"10.1039/b705344d","G44","2PKS",33.55,"2.5","2.5","Thrombin in complex with inhibitor","ADCGLRPLFEKKSLEDKTERELLESYI","Homo sapiens","F2","Thrombin light chain","1","2PKS"
,,,2.7,53.3,,,,,,,,,,,,"IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKET","Homo sapiens","F2","Thrombin heavy chain fragment","2","2PKS"
,,,,,,,,,,,,,,,,"GQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQ","Homo sapiens","F2","Thrombin heavy chain fragment","3","2PKS"
,,,,,,,,,,,,,,,,"DFEEIPGEYL",,,"Hirudin","4","2PKS"
"2PKT",,"X-RAY DIFFRACTION",2.74,55.13,"VAPOR DIFFUSION, SITTING DROP",6.5,"40% PEG 300, 0.2M Calcium acetate, 0.1M Cacodylate, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1002/pro.349",,"2PKT",10.21,"1.5","1.5","Crystal structure of the human CLP-36 (PDLIM1) bound to the C-terminal peptide of human alpha-actinin-1","SMTTQQIDLQGPGPWGFRLVGGKDFEQPLAISRVTPGSKAALANLCIGDVITAIDGENTSNMTHLEAQNRIKGCTDNLTLTVARSEHESDL","Homo sapiens","PDLIM1, CLIM1, CLP36","PDZ and LIM domain protein 1","1","2PKT"
"2PL0",,"X-RAY DIFFRACTION",3.04,59.51,"VAPOR DIFFUSION, HANGING DROP",7.5,"1.5 M ammonium sulfate, 100 mM HEPES pH 7.5, 1% PEG-3350, 10 mM DTT, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1002/prot.21633","STI","2PL0",33.89,"2.8","2.8","LCK bound to imatinib","GSHMQTQKPQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQYQPQP","Homo sapiens","LCK","Proto-oncogene tyrosine-protein kinase LCK","1","2PL0"
"2PL3",,"X-RAY DIFFRACTION",3.33,63.02,"VAPOR DIFFUSION, SITTING DROP",8.5,"20% Ethanol, 50mM Sodium chloride, 100mM Tris-HCl, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1371/journal.pone.0012791",,"2PL3",27.23,"2.15","2.15","Human DEAD-box RNA helicase DDX10, DEAD domain in complex with ADP","SMQVERESISRLMQNYEKINVNEITRFSDFPLSKKTLKGLQEAQYRLVTEIQKQTIGLALQGKDVLGAAKTGSGKTLAFLVPVLEALYRLQWTSTDGLGVLIISPTRELAYQTFEVLRKVGKNHDFSAGLIIGGKDLKHEAERINNINILVCTPGRLLQHMDETVSFHATDLQMLVLDEADRILDMGFADTMNAVIENLPKKRQTLLFSATQTKSVKDLARLSLKNPEYVWVHEKA","Homo sapiens","DDX10","Probable ATP-dependent RNA helicase DDX10","1","2PL3"
"2PLA",,"X-RAY DIFFRACTION",4,69.27,"VAPOR DIFFUSION, SITTING DROP",6.2,"50% PEG 300, 0.2M Sodium chloride, 0.1M Sodium potassium phosphate, pH 6.2, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,,,"2PLA",78.1,"2.51","2.51","Crystal structure of human glycerol-3-phosphate dehydrogenase 1-like protein","MAAAPLKVCIVGSGNWGSAVAKIIGNNVKKLQKFASTVKMWVFEETVNGRKLTDIINNDHENVKYLPGHKLPENVVAMSNLSEAVQDADLLVFVIPHQFIHRICDEITGRVPKKALGITLIKGIDEGPEGLKLISDIIREKMGIDISVLMGANIANEVAAEKFCETTIGSKVMENGLLFKELLQTPNFRITVVDDADTVELCGALKNIVAVGAGFCDGLRCGDNTKAAVIRLGLMEMIAFARIFCKGQVSTATFLESCGVADLITTCYGGRNRRVAEAFARTGKTIEELEKEMLNGQKLQGPQTSAEVYRILKQKGLLDKFPLFTAVYQICYESRPVQEMLSCLQSHPE","Homo sapiens","GPD1L, KIAA0089","Glycerol-3-phosphate dehydrogenase 1-like protein","1","2PLA"
"2PLL",,"X-RAY DIFFRACTION",2.38,48.23,"VAPOR DIFFUSION, HANGING DROP",6.6,"0.1 M Bis-Tris (pH 5.5), 10-20% (wt/vol) Peg-3350, pH 6.6, VAPOR DIFFUSION, HANGING DROP, temperature 294K",294,"10.1016/j.abb.2007.04.036","ABH","2PLL",70.16,"1.9","1.9","Crystal structure of perdeuterated human arginase I","MSAKSRTIGIIGAPFSKGQPRGGVEEGPTVLRKAGLLEKLKEQECDVKDYGDLPFADIPNDSPFQIVKNPRSVGKASEQLAGKVAEVKKNGRISLVLGGDHSLAIGSISGHARVHPDLGVIWVDAHTDINTPLTTTSGNLHGQPVSFLLKELKGKIPDVPGFSWVTPCISAKDIVYIGLRDVDPGEHYILKTLGIKYFSMTEVDRLGIGKVMEETLSYLLGRKKRPIHLSFDVDGLDPSFTPATGTPVVGGLTYREGLYITEEIYKTGLLSGLDIMEVNPSLGKTPEEVTRTVNTAVAITLACFGLAREGNHKPIDYLNPPK","Homo sapiens","ARG1","arginase-1","1","2PLL"
"2PLZ",,"X-RAY DIFFRACTION",1.9,35.13,"VAPOR DIFFUSION, HANGING DROP",7,"1.0 M Lithium sulfate, 2% (w/v) PEG8000, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1074/jbc.M611003200",,"2PLZ",4.44,"1.36","1.36","Arg-modified human beta-defensin 1 (HBD1)","DHYNCVSSGGQCLYSACPIFTRIQGTCYRGRARCCR","Homo sapiens","DEFB1, BD1, HBD1","Beta-defensin 1","1","2PLZ"
"2PM1",,"X-RAY DIFFRACTION",2.09,41.17,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.2 M sodium citrate, 0.1 M HEPES, 20 (v/v/) iso-Propanol, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"2PM1",3.28,"1.6","1.6","Derivative of human alpha-defensin 1 (HNP1)","ACYCRIPACIAGEAAYGTCIYQGALWAFCC","Homo sapiens","DEFA1, DEF1, DEFA2, MRS, DEFA1B","Neutrophil defensin 1 (HNP-1) (HP-1) (HP1) (Defensin, alpha 1)","1","2PM1"
"2PM4",,"X-RAY DIFFRACTION",3.05,59.63,"VAPOR DIFFUSION, HANGING DROP",,"0.4 M ammonium phosphate monobasic, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1074/jbc.M611003200",,"2PM4",6.82,"1.95","1.95","Human alpha-defensin 1 (multiple Arg->Lys mutant)","DCYCRIPACIAGEKKYGTCIYQGKLWAFCC","Homo sapiens","DEFA1, DEF1, DEFA2, DEFA3, DEF3","Neutrophil defensin 1 (HNP-1) (HP-1) (HP1) (Defensin, alpha 1)","1","2PM4"
"2PM5",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, HANGING DROP",5.6,"0.1 M sodium citrate tribasic dihydrate, pH 5.6, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"2PM5",6.83,"2.4","2.4","Human alpha-defensin 1 derivative (HNP1)","DCYCRIPACIAGEAAYGTCIYQGALWAFCC","Homo sapiens","DEFA1, DEF1, DEFA2, DEFA3, DEF3","Neutrophil defensin 1 (HNP-1) (HP-1) (HP1) (Defensin, alpha 1)","1","2PM5"
"2PM8",,"X-RAY DIFFRACTION",3.1,60.28,"VAPOR DIFFUSION, SITTING DROP",8.5,"Ammonium sulphate, pH 8.5, VAPOR DIFFUSION, SITTING DROP",,"10.1107/S1744309107037335",,"2PM8",133.07,"2.8","2.8","Crystal structure of recombinant full length human butyrylcholinesterase","EDDIIIATKNGKVRGMQLTVFGGTVTAFLGIPYAQPPLGRLRFKKPQSLTKWSDIWNATKYANSCCQNIDQSFPGFHGSEMWNPNTDLSEDCLYLNVWIPAPKPKNATVLIWIYGGGFQTGTSSLHVYDGKFLARVERVIVVSMNYRVGALGFLALPGNPEAPGNMGLFDQQLALQWVQKNIAAFGGNPKSVTLFGESAGAASVSLHLLSPGSHSLFTRAILQSGSFNAPWAVTSLYEARNRTLNLAKLTGCSRENETEIIKCLRNKDPQEILLNEAFVVPYGTPLSVNFGPTVDGDFLTDMPDILLELGQFKKTQILVGVNKDEGTAFLVYGAPGFSKDNNSIITRKEFQEGLKIFFPGVSEFGKESILFHYTDWVDDQRPENYREALGDVVGDYNFICPALEFTKKFSEWGNNAFFYYFEHRSSKLPWPEWMGVMHGYEIEFVFGLPLERRDQYTKAEEILSRSIVKRWANFAKYGNPQETQNQSTSWPVFKSTEQKYLTLNTESTRIMTKLRAQQCRFWTSFFPKVLEMTGNIDEAEWEWKAGFHRWNNYMMDWKNQFNDYTSKKESCVGL","Homo sapiens","BCHE, CHE1","Cholinesterase","1","2PM8"
"2PME",,"X-RAY DIFFRACTION",3.35,63.27,,,,,"10.1073/pnas.0703908104",,"2PME",78.7,"2.9","2.9","The Apo crystal Structure of the glycyl-tRNA synthetase","MDGAGAEEVLAPLRLAVRQQGDLVRKLKEDKAPQVDVDKAVAELKARKRVLEAKELALQPKDDIVDRAKMEDTLKRRFFYDQAFAIYGGVSGLYDFGPVGCALKNNIIQTWRQHFIQEEQILEIDCTMLTPEPVLKTSGHVDKFADFMVKDVKNGECFRADHLLKAHLQKLMSDKKCSVEKKSEMESVLAQLDNYGQQELADLFVNYNVKSPITGNDLSPPVSFNLMFKTFIGPGGNMPGYLRPETAQGIFLNFKRLLEFNQGKLPFAAAQIGNSFRNEISPRSGLIRVREFTMAEIEHFVDPSEKDHPKFQNVADLHLYLYSAKAQVSGQSARKMRLGDAVEQGVINNTVLGYFIGRIYLYLTKVGISPDKLRFRQHMENEMAHYACDCWDAESKTSYGWIEIVGCADRSCYDLSCHARATKVPLVAEKPLKEPKTVNVVQFEPSKGAIGKAYKKDAKLVMEYLAICDECYITEMEMLLNEKGEFTIETEGKTFQLTKDMINVKRFQKTLYVEEVVPNVIEPSFGLGRIMYTVFEHTFHVREGDEQRTFFSFPAVVAPFKCSVLPLSQNQEFMPFVKELSEALTRHGVSHKVDDSSGSIGRRYARTDEIGVAFGVTIDFDTVNKTPHTATLRDRDSMRQIRAEISELPSIVQDLANGNITWADVEARYPLFEGQETGKKETIEELEHHHHHH","Homo sapiens","GARS, GARS1","Glycyl-tRNA synthetase","1","2PME"
"2PMF",,"X-RAY DIFFRACTION",3.32,62.9,,,,,"10.1073/pnas.0703908104",,"2PMF",78.93,"2.85","2.85","The crystal structure of a human glycyl-tRNA synthetase mutant","MDGAGAEEVLAPLRLAVRQQGDLVRKLKEDKAPQVDVDKAVAELKARKRVLEAKELALQPKDDIVDRAKMEDTLKRRFFYDQAFAIYGGVSGLYDFGPVGCALKNNIIQTWRQHFIQEEQILEIDCTMLTPEPVLKTSGHVDKFADFMVKDVKNGECFRADHLLKAHLQKLMSDKKCSVEKKSEMESVLAQLDNYGQQELADLFVNYNVKSPITGNDLSPPVSFNLMFKTFIGPGGNMPGYLRPETAQGIFLNFKRLLEFNQGKLPFAAAQIGNSFRNEISPRSGLIRVREFTMAEIEHFVDPSEKDHPKFQNVADLHLYLYSAKAQVSGQSARKMRLGDAVEQGVINNTVLGYFIGRIYLYLTKVGISPDKLRFRQHMENEMAHYACDCWDAESKTSYGWIEIVGCADRSCYDLSCHARATKVPLVAEKPLKEPKTVNVVQFEPSKGAIGKAYKKDAKLVMEYLAICDECYITEMEMLLNEKGEFTIETEGKTFQLTKDMINVKRFQKTLYVEEVVPNVIEPSFRLGRIMYTVFEHTFHVREGDEQRTFFSFPAVVAPFKCSVLPLSQNQEFMPFVKELSEALTRHGVSHKVDDSSGSIGRRYARTDEIGVAFGVTIDFDTVNKTPHTATLRDRDSMRQIRAEISELPSIVQDLANGNITWADVEARYPLFEGQETGKKETIEELEHHHHHH","Homo sapiens","GARS, GARS1","Glycyl-tRNA synthetase","1","2PMF"
"2PMV",,"X-RAY DIFFRACTION",2.56,51.9,"VAPOR DIFFUSION, SITTING DROP",6,"10% PEG20000, 100mM MES, 20mM CaCL2 and 9mM BaCL2, pH 6.0, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,"10.1073/pnas.0703228104",,"2PMV",177.3,"2.6","2.6","Crystal Structure of Human Intrinsic Factor- Cobalamin Complex at 2.6 A Resolution","STQTQSSCSVPSAQEPLVNGIQVLMENSVTSSAYPNPSILIAMNLAGAYNLKAQKLLTYQLMSSDNNDLTIGHLGLTIMALTSSCRDPGDKVSILQRQMENWAPSSPNAEASAFYGPSLAILALCQKNSEATLPIAVRFAKTLLANSSPFNVDTGAMATLALTCMYNKIPVGSEEGYRSLFGQVLKDIVEKISMKIKDNGIIGDIYSTGLAMQALSVTPEPSKKEWNCKKTTDMILNEIKQGKFHNPMSIAQILPSLKGKTYLDVPQVTCSPDHEVQPTLPSNPGPGPTSASNITVIYTINNQLRGVELLFNETINVSVKSGSVLLVVLEEAQRKNPMFKFETTMTSWGLVVSSINNIAENVNHKTYWQFLSGVTPLNEGVADYIPFNHEHITANFTQY","Homo sapiens","CBLIF, GIF, IFMH","Gastric intrinsic factor","1","2PMV"
"2PMW",,"X-RAY DIFFRACTION",2.35,47.68,"VAPOR DIFFUSION, HANGING DROP",7.8,"0.1 M Tris (pH 7.8) 
0.2 M (NH4)2SO4 
13% PEG 3350, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.str.2007.04.004",,"2PMW",71.66,"2.3","2.3","The Crystal Structure of Proprotein convertase subtilisin kexin type 9 (PCSK9)","GAMGQEDEDGDYEELVLALRSEEDGLAEAPEHGTTATFHRCAKDPWRLPGTYVVVLKEETHLSQSERTARRLQAQAARRGYLTKILHVFHGLLPGFLVKMSGDLLELALKLPHVDYIEEDSSVFAQ","Homo sapiens","PCSK9, NARC1, PSEC0052","Proprotein convertase subtilisin/kexin type 9","1","2PMW"
,,,,,,,,,,,,,,,,"SIPWNLERITPPRYRADEYQPPDGGSLVEVYLLDTSIQSDHREIEGRVMVTDFENVPEEDGTRFHRQASKCDSHGTHLAGVVSGRDAGVAKGASMRSLRVLNCQGKGTVSGTLIGLEFIRKSQLVQPVGPLVVLLPLAGGYSRVLNAACQRLARAGVVLVTAAGNFRDDACLYSPASAPEVITVGATNAQDQPVTLGTLGTNFGRCVDLFAPGEDIIGASSDCSTCFVSQSGTSQAAAHVAGIAAMMLSAEPELTLAELRQRLIHFSAKDVINEAWFPEDQRVLTPNLVAALPPSTHGAGWQLFCRTVWSAHSGPTRMATAVARCAPDEELLSCSSFSRSGKRRGERMEAQGGKLVCRAHNAFGGEGVYAIARCCLLPQANCSVHTAPPAEASMGTRVHCHQQGHVLTGCSSHWEVEDLGTHKPPVLRPRGQPNQCVGHREASIHASCCHAPGLECKVKEHGIPAPQEQVTVACEEGWTLTGCSALPGTSHVLGAYAVDNTCVVRSRDVSTTGSTSEGAVTAVAICCRSRHLAQASQELQ","Homo sapiens","PCSK9, NARC1, PSEC0052","Proprotein convertase subtilisin/kexin type 9","2","2PMW"
"2PMY",,"X-RAY DIFFRACTION",2.31,46.74,"VAPOR DIFFUSION",5,"0.6M Ammonium sulfate, 0.1M Sodium cacodylate, 0.01M Magnesium chloride, pH 5.0, VAPOR DIFFUSION, temperature 291K",291,,,"2PMY",20.89,"2.3","2.3","EF-hand domain of human RASEF","MHHHHHHSSGRENLYFQGADGDGEELARLRSVFAACDANRSGRLEREEFRALCTELRVRPADAEAVFQRLDADRDGAITFQEFARGFLGSL","Homo sapiens","RASEF, RP11-158H18.1-001, RAB45","RAS and EF-hand domain-containing protein","1","2PMY"
"2PN7",,"X-RAY DIFFRACTION",2.08,40.75,"VAPOR DIFFUSION, HANGING DROP",3.9,"2 micro L of Selenomethionine containing GGCT (15mg/ml in 20 mM Tris/HCL 0,1mM dithiothreitol pH8.0) was mixed with equal volumes of gamma-glu-glu dipeptide (40mM) and well solution. The well contained 1ml of a solution comprising PEG 4000 (22.5% w/v), 100mM sodium formate buffer pH3.9, 200mM ammonium acetate. , VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1074/jbc.M803623200",,"2PN7",42.06,"2.41","2.41","Human gamma-glutamyl cyclotransferase","MANSGCKDVTGPDEESFLYFAYGSNLLTERIHLRNPSAAFFCVARLQDFKLDFGNSQGKTSQTWHGGIATIFQSPGDEVWGVVWKMNKSNLNSLDEQEGVKSGMYVVIEVKVATQEGKEITCRSYLMTNYESAPPSPQYKKIICMGAKENGLPLEYQEKLKAIEPNDYTGKVSEEIEDIIKKGETQTL","Homo sapiens","C7orf24, GGCT, CRF21","human gamma-glutamyl cyclotransferase","1","2PN7"
"2PN8",,"X-RAY DIFFRACTION",2.93,58,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M HEPES pH 7.5, 10% PEG 10000, 8% Ethylene glycol, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"2PN8",240.31,"1.8","1.8","Crystal structure of human peroxiredoxin 4 (thioredoxin peroxidase)","MHHHHHHSSGVDLGTENLYFQSMPAPYWEGTAVIDGEFKELKLTDYRGKYLVFFFYPLDFTFVCPTEIIAFGDRLEEFRSINTEVVACSVDSQFTHLAWINTPRRQGGLGPIRIPLLSDLTHQISKDYGVYLEDSGHTLRGLFIIDDKGILRQITLNDLPVGRSVDETLRLVQAFQYTDKHGEVCPAGWKPGSETIIPDPAGKLKYFDKLN","Homo sapiens","PRDX4","Peroxiredoxin-4","1","2PN8"
"2PNJ",,"X-RAY DIFFRACTION",2.81,56.23,"MICROBATCH",6.5,"MICROBATCH UNDER OIL (70:30 PARAFFIN/SILICONE OIL MIXTURE) METHO USING 2 microliter DROPS CONTAINING EQUAL VOLUMES OF PROTEIN SOLUTION (64 MG/ML IN 50 MM TRIS MOPS, 0.1M KCL, 1% NA-CHOLATE, 250 MM IMIDAZOLE, PH 8.1) AND PRECIPITANT SOLUTION (0.2 M SODIUM ACETAT TRI HYDRATE, 0.1 M SODIUM CACODYLATE, PH 6.5 IN 30%W/V POLYETHYL GLYCOL 8000 (HAMPTON CRYSTAL SCREEN I-28, HAMPTON RESEARCH), pH 6.50, temperature 291K",291,"10.1021/bi700151f",,"2PNJ",84.92,"2.35","2.35","Crystal structure of human ferrochelatase mutant with Phe 337 replaced by Ala","RKPKTGILMLNMGGPETLGDVHDFLLRLFLDRDLMTLPIQNKLAPFIAKRLTPKIQEQYRRIGGGSPIKIWTSKQGEGMVKLLDELSPNTAPHKYYIGFRYVHPLTEEAIEEMERDGLERAIAFTQYPQYSCSTTGSSLNAIYRYYNQVGRKPTMKWSTIDRWPTHHLLIQCFADHILKELDHFPLEKRSEVVILFSAHSLPMSVVNRGDPYPQEVSATVQKVMERLEYCNPYRLVWQSKVGPMPWLGPQTDESIKGLCERGRKNILLVPIAATSDHIETLYELDIEYSQVLAKECGVENIRRAESLNGNPLFSKALADLVHSHIQSNELCSKQLTLSCPLCVNPVCRETKSFFTSQQL","Homo sapiens","FECH","Ferrochelatase, mitochondrial","1","2PNJ"
"2PNO",,"X-RAY DIFFRACTION",4.26,71.16,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1M Hepes/NaOH, 30%(v/v) PEG400, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1038/nature05936",,"2PNO",241.73,"3.3","3.3","Crystal structure of human leukotriene C4 synthase","MKDEVALLAAVTLLGVLLQAYFSLQVISARRAFRVSPPLTTGPPEFERVYRAQVNCSEYFPLFLATLWVAGIFFHEGAAALCGLVYLFARLRYFQGYARSAQLRLAPLYASARALWLLVALAALGLLAHFLPAALRAALLGRLRTLLPWAHHHHHH","Homo sapiens","LTC4S","Leukotriene C4 synthase","1","2PNO"
"2PNT",,"X-RAY DIFFRACTION",2.79,55.84,"VAPOR DIFFUSION, SITTING DROP",7.7,"1.26M NaH2PO4, 0.14M K2HPO4, pH 7.7, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1002/pro.349",,"2PNT",22.14,"2.148","2.148","Crystal structure of the PDZ domain of human GRASP (GRP1) in complex with the C-terminal peptide of the metabotropic glutamate receptor type 1","SMQQRKVLTLEKEDNQTFGFEIQTYGLHHREEQRVEMVTFVCRVHESSPAQLAGLTPGDTIASVNGLNVEGIRHREIVDIIKASGNVLRLETLYSSTL","Homo sapiens","GRASP, TAMALIN","General receptor for phosphoinositides 1-associated scaffold protein","1","2PNT"
"2PNU",,"X-RAY DIFFRACTION",2.03,39.46,"VAPOR DIFFUSION, HANGING DROP",6,"0.1M MES pH 6, 0.8M Na/K tartrate, 0.45M MgSO4, 0.4M NDSB195, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1074/jbc.M705524200",,"2PNU",31.89,"1.65","1.65","Crystal structure of human androgen receptor ligand-binding domain in complex with EM-5744","ETTQKLTVSHIEGYECQPIFLNVLEAIEPGVVCAGHDNNQPDSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWMGLMVFAMGWRSFTNVNSRMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKNQKFFDELRMNYIKELDRIIACKRKNPTSCSRRFYQLTKLLDSVQPIARELHQFTFDLLIKSHMVSVDFPEMMAEIISVQVPKILSGKVKPIYFHTQ","Homo sapiens","AR, DHTR, NR3C4","Androgen receptor","1","2PNU"
"2PNX",,"X-RAY DIFFRACTION",2.12,42.04,"VAPOR DIFFUSION, SITTING DROP",6.5,"1.6 M sodium citrate tribasic dihydrate pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 291.15K",291.15,"10.1016/j.molcel.2008.12.016",,"2PNX",15.56,"1.8","1.8","The PHD finger of ING4 in complex with an H3K4Me3 histone peptide","GSNEPTYCLCHQVSYGEMIGCDNPDCSIEWFHFACVGLTTKPRGKWFCPRCSQER","Homo sapiens","ING4, My036","Inhibitor of growth protein 4","1","2PNX"
,,,,,,,,,,,,,,,,"ARTKQTARKSTG",,,"H3K4Me3 peptide","2","2PNX"
"2PNY",,"X-RAY DIFFRACTION",2.25,45.24,"VAPOR DIFFUSION, SITTING DROP",7,"Protein buffer: 10 mg/mL Protein, 0.1 M NaCl, 0.05 M Tris-HCl pH 8.0, 0.001 M TCEP, 0.001 M CaCl2, 0.001 M MgCl2, 0.001 M MnCl2. Precipitant: 2 M Na/K PO4, pH 7.0. Cryoprotectant: 20% Glycerol, VAPOR DIFFUSION, SITTING DROP, temperature 291.0K",291,,,"2PNY",29.37,"1.81","1.81","Structure of Human Isopentenyl-diphosphate Delta-isomerase 2","MGSSHHHHHHSSGLVPRGSMSDINLDWVDRRQLQRLEEMLIVVDENDKVIGADTKRNCHLNENIEKGLLHRAFSVVLFNTKNRILIQQRSDTKVTFPGYFTDSCSSHPLYNPAELEEKDAIGVRRAAQRRLQAELGIPGEQISPEDIVFMTIYHHKAKSDRIWGEHEICYLLLVRKNVTLNPDPSETKSILYLSQEELWELLEREARGEVKVTPWLRTIAERFLYRWWPHLDDVTPFVELHKIHRV","Homo sapiens","IDI2","Isopentenyl-diphosphate Delta-isomerase 2","1","2PNY"
"2PO5",,"X-RAY DIFFRACTION",2.73,54.94,"VAPOR DIFFUSION, HANGING DROP",7.5,"CRYSTALS WERE GROWN BY HANGING DROP VAPOR DIFFUSION USING 2 MICROLITER DROPS CONTAINING EQUAL VOLUMES OF PROTEIN SOLUTION (50 MG/ML IN 50 MM TRIS MOPS, 0.1M KCL, 1% NA- CHOLATE, 250 MM IMIDAZOLE, PH 8.1) AND PRECIPITANT SOLUTION (0.1 M HEPES PH 7.5, 0.2 M AMMONIUM SULFATE, 34% PEG 400, 0.1 M SODIUM PHOSPHATE)., pH 7.50, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/bi700151f",,"2PO5",85,"2.2","2.2","Crystal structure of human ferrochelatase mutant with His 263 replaced by Cys","RKPKTGILMLNMGGPETLGDVHDFLLRLFLDRDLMTLPIQNKLAPFIAKRLTPKIQEQYRRIGGGSPIKIWTSKQGEGMVKLLDELSPNTAPHKYYIGFRYVHPLTEEAIEEMERDGLERAIAFTQYPQYSCSTTGSSLNAIYRYYNQVGRKPTMKWSTIDRWPTHHLLIQCFADHILKELDHFPLEKRSEVVILFSACSLPMSVVNRGDPYPQEVSATVQKVMERLEYCNPYRLVWQSKVGPMPWLGPQTDESIKGLCERGRKNILLVPIAFTSDHIETLYELDIEYSQVLAKECGVENIRRAESLNGNPLFSKALADLVHSHIQSNELCSKQLTLSCPLCVNPVCRETKSFFTSQQL","Homo sapiens","FECH","Ferrochelatase, mitochondrial","1","2PO5"
"2PO7",,"X-RAY DIFFRACTION",2.77,55.64,"VAPOR DIFFUSION, HANGING DROP",7.5,"CRYSTALS WERE GROWN BY HANGING DROP VAPOR DIFFUSION USING 2 MICROLITER DROPS CONTAINING EQUAL VOLUMES OF PROTEIN SOLUTION (45 MG/ML IN 50 MM TRIS MOPS, 0.1M KCL, 1% NA- CHOLATE, 250 MM IMIDAZOLE, PH 8.1) AND PRECIPITANT SOLUTION (0.1 M HEPES PH 7.5, 0.2 M AMMONIUM SULFATE, 34% PEG 400, 0.1 M SODIUM PHOSPHATE)., pH 7.50, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/bi700151f",,"2PO7",84.94,"2.2","2.2","Crystal structure of human ferrochelatase mutant with His 341 replaced by Cys","RKPKTGILMLNMGGPETLGDVHDFLLRLFLDQDLMTLPIQNKLAPFIAKRLTPKIQEQYRRIGGGSPIKIWTSKQGEGMVKLLDELSPNTAPHKYYIGFRYVHPLTEEAIEEMERDGLERAIAFTQYPQYSCSTTGSSLNAIYRYYNQVGRKPTMKWSTIDRWPTHHLLIQCFADHILKELDHFPLEKRSEVVILFSAHSLPMSVVNRGDPYPQEVSATVQKVMERLEYCNPYRLVWQSKVGPMPWLGPQTDESIKGLCERGRKNILLVPIAFTSDCIETLYELDIEYSQVLAKECGVENIRRAESLNGNPLFSKALADLVHSHIQSNELCSKQLTLSCPLCVNPVCRETKSFFTSQQL","Homo sapiens","FECH","Ferrochelatase, mitochondrial","1","2PO7"
"2POB",,"X-RAY DIFFRACTION",2.68,54.05,"VAPOR DIFFUSION, HANGING DROP",7.5,"100mM Hepes and 1.4M sodium citrate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.bmcl.2007.04.111","GW4","2POB",62.85,"2.3","2.3","PPARgamma Ligand binding domain complexed with a farglitazar analogue gw4709","PESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","2POB"
"2POG",,"X-RAY DIFFRACTION",2.31,46.78,"VAPOR DIFFUSION",8,"0.1 M Tris-HCl, pH 8.0, 0.2 M MgCl2, 20 % PEG 4000 and 10% ethylene glycol., VAPOR DIFFUSION, temperature 289K",289,"10.1016/j.bmcl.2007.04.051","WST","2POG",57.16,"1.84","1.84","Benzopyrans as Selective Estrogen Receptor b Agonists (SERBAs). Part 2: Structure Activity Relationship Studies on the Benzopyran Scaffold.","NSLALSLTADQMVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLESAWLEILMIGLVWRSMEHPGKLLFAPNLLLDRNQGKSVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGMEHLYSMKSKNVVPLYDLLLEMLDAHRLHA","Homo sapiens","ESR1, ESR, NR3A1","Estrogen receptor","1","2POG"
"2POI",,"X-RAY DIFFRACTION",2.48,50.36,"VAPOR DIFFUSION, HANGING DROP",7.5,"1.5M NaCl, 10% methanol, 0.1M Hepes, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1016/j.molcel.2007.05.006",,"2POI",10.56,"1.8","1.8","Crystal structure of XIAP BIR1 domain (I222 form)","GSHMKTCVPADINKEEEFVEEFNRLKTFANFPSGSPVSASTLARAGFLYTGEGDTVRCFSCHAAVDRWQYGDSAVGRHRKVSPNCRFINGFYLE","Homo sapiens","BIRC4, API3, IAP3, XIAP","Baculoviral IAP repeat-containing protein 4","1","2POI"
"2POJ",,"SOLUTION NMR",,,,,,,"10.1016/j.jmb.2007.10.028",,"2POJ",18.43,,,"NMR Solution Structure of the Inhibitor-Free State of Macrophage Metalloelastase (MMP-12)","FREMPGGPVWRKHYITYRINNYTPDMNREDVDYAIRKAFQVWSNVTPLKFSKINTGMADILVVFARGAHGDFHAFDGKGGILAHAFGPGSGIGGDAHFDEDEFWTTHSGGTNLFLTAVHAIGHSLGLGHSSDPKAVMFPTYKYVDINTFRLSADDIRGIQSLYG","Homo sapiens","MMP12, HME","Macrophage metalloelastase","1","2POJ"
"2POM",,"X-RAY DIFFRACTION",4.71,73.89,"VAPOR DIFFUSION, HANGING DROP",7.5,"1.5M Li2SO4, 0.1M Hepes, 1mM MnCl2, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1016/j.molcel.2007.05.006",,"2POM",40.84,"2.27","2.27","TAB1 with manganese ion","GSMAAQRRSLLQSEQQPSWTDDLPLCHLSGVGSASNRSYSADGKGTESHPPEDSWLKFRSENNCFLYGVFNGYDGNRVTNFVAQRLSAELLLGQLNAEHAEADVRRVLLQAFDVVERSFLESIDDALAEKASLQSQLPEGVPQHQLPPQYQKILERLKTLEREISGGAMAVVAVLLNNKLYVANVGTNRALLCKSTVDGLQVTQLNVDHTTENEDELFRLSQLGLDAGKIKQVGIICGQESTRRIGDYKVKYGYTDIDLLSAAKSKPIIAEPEIHGAQPLDGVTGFLVLMSEGLYKALEAAHGPGQANQEIAAMIDTEFAKQTSLDAVAQAVVDRVKRIHSDTFASGGERARFCPRHEDMTLLVRNFGYPLG","Homo sapiens","MAP3K7IP1, TAB1","Mitogen-activated protein kinase kinase kinase 7-interacting protein 1","1","2POM"
"2POU",,"X-RAY DIFFRACTION",2.05,40.08,"VAPOR DIFFUSION, HANGING DROP",8.2,"2.5M Ammonium Sulphate, 0.3M Sodium Chloride, 0.1M TRIS-Hydrochloride, 1mM DTT, pH 8.2, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.bmcl.2007.05.045","I7A","2POU",29.66,"1.6","1.6","The crystal structure of the human carbonic anhydrase II in complex with 4,5-dichloro-benzene-1,3-disulfonamide","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","2POU"
"2POV",,"X-RAY DIFFRACTION",2.06,40.33,"VAPOR DIFFUSION, HANGING DROP",8.2,"2.5 M AMMONIUM SULPHATE, 0.3 M SODIUM CHLORIDE, 0.1 M TRIS/HCL, 1MM DTT, pH 8.2, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.bmcl.2007.05.045","I7B","2POV",29.51,"1.6","1.6","The crystal structure of the human carbonic anhydrase II in complex with 4-amino-6-chloro-benzene-1,3-disulfonamide","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASF","Homo sapiens","CA2","Carbonic anhydrase 2","1","2POV"
"2POW",,"X-RAY DIFFRACTION",2.07,40.59,"VAPOR DIFFUSION, HANGING DROP",8.2,"2.5M AMMONIUM SULPHATE, 0.3M SODIUM CHLORIDE, 0.1M TRIS-HYDROCHLORIDE, 1mM DTT, pH 8.2, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.bmcl.2007.05.045","I7C","2POW",29.67,"1.75","1.75","The crystal structure of the human carbonic anhydrase II in complex with 4-amino-6-trifluoromethyl-benzene-1,3-disulfonamide","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","2POW"
"2PP4",,"SOLUTION NMR",,,,,,,"10.1038/nsmb1258",,"2PP4",12.14,,,"Solution Structure of ETO-TAFH refined in explicit solvent","GARQLSKLKRFLTTLQQYGNDISPEIGERVRTLVLGLVNSTLTIEEFHSKLQEATNFPLRPFVIPFLKANLPLLQRELLHCARLAKQNPAQYLAQHEQLLLDASTTS","Homo sapiens","RUNX1T1, AML1T1, CBFA2T1, CDR, ETO, MTG8, ZMYND2","Protein ETO","1","2PP4"
"2PPH",,"SOLUTION NMR",,,,,,,"10.1021/bi701341n",,"2PPH",11.19,,,"solution structure of human MEKK3 PB1 domain","MQSDVRIKFEHNGERRIIAFSRPVKYEDVEHKVTTVFGQPLDLHYMNNELSILLKNQDDLDKAIDILDRSSSMKSLRILLLSQDRNLEHHHHHH","Homo sapiens","MEKK3, MAP3K3, MAPKKK3","Mitogen-activated protein kinase kinase kinase 3","1","2PPH"
"2PPI",,"X-RAY DIFFRACTION",3.67,66.47,"VAPOR DIFFUSION, SITTING DROP",6,"0.1 M NaNO3, 0.1 M Na2SO4, 0.05 M Na/KPO4, 0.0285 M (NH4)2SO4, 30% PEG3350, 10% Ethylene glycol pH 6.0, VAPOR DIFFUSION, SITTING DROP, temperature 282K",282,,,"2PPI",16.35,"2.4","2.4","Structure of the BTB (Tramtrack and Bric a brac) domain of human Gigaxonin","MHHHHHHSSGVDLGTENLYFQSMAVSDPQHAARLLRALSSFREESRFCDAHLVLDGEEIPVQKNILAAASPYIRTKLNYNPPKDDGSTYKIELEGISVMVMREILDYIFSGQIRLNEDTIQDVVQAADLLLLTDLKTLCCEFLE","Homo sapiens","GAN, GAN1, KLHL16","Gigaxonin","1","2PPI"
"2PPL",,"X-RAY DIFFRACTION",2.8,56.08,,6.5,"20% PEG 4000, 0.2M Ca acetate, 0.1 Na cacodylate, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 291.0K, pH 6.50",291,,,"2PPL",54.22,"2.2","2.2","Human Pancreatic lipase-related protein 1","APEHHHHHHDYDIPTTENLYFQGAMKEVCYEDLGCFSDTEPWGGTAIRPLKILPWSPEKIGTRFLLYTNENPNNFQILLLSDPSTIEASNFQMDRKTRFIIHGFIDKGDESWVTDMCKKLFEVEEVNCICVDWKKGSQATYTQAANNVRVVGAQVAQMLDILLTEYSYPPSKVHLIGHSLGAHVAGEAGSKTPGLSRITGLDPVEASFESTPEEVRLDPSDADFVDVIHTDAAPLIPFLGFGTNQQMGHLDFFPNGGESMPGCKKNALSQIVDLDGIWAGTRDFVACNHLRSYKYYLESILNPDGFAAYPCTSYKSFESDKCFPCPDQGCPQMGHYADKFAGRTSEEQQKFFLNTGEASNFARWRYGVSITLSGRTATGQIKVALFGNKGNTHQYSIFRGILKPGSTHSYEFDAKLDVGTIDKVKFLWNNNVINPTLPKVGATKITVQKGEEKTVYNFCSEDTVREDTLLTLTPCPSLSRSTRGS","Homo sapiens","PNLIPRP1, PLRP1","Pancreatic lipase-related protein 1","1","2PPL"
"2PPN",,"X-RAY DIFFRACTION",2.25,45.36,"VAPOR DIFFUSION, HANGING DROP",7,"1.9-2.1 M Sodium Maleonate  
50 mM DMSO 
Slow buffer exchange into 2.5 M 
Sodium Maleoneate no DMSO, 
in 10 minute steps for freezing, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1002/prot.22176",,"2PPN",11.84,"0.92","0.92","Crystal structure of FKBP12","GVQVETISPGDGRTFPKRGQTCVVHYTGMLEDGKKFDSSRDRNKPFKFMLGKQEVIRGWEEGVAQMSVGQRAKLTISPDYAYGATGHPGIIPPHATLVFDVELLKLE","Homo sapiens","FKBP1A, FKBP1, FKBP12","FK506-binding protein 1A","1","2PPN"
"2PPO",,"X-RAY DIFFRACTION",2.27,45.78,"VAPOR DIFFUSION, HANGING DROP",7,"1.9-2.1 M Sodium Maleonate, 50 mM DMSO, Slow buffer exchange into 2.5 M Sodium Maleoneate no DMSO, in 10 minute steps for freezing, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1002/prot.22176",,"2PPO",11.78,"1.29","1.29","Crystal structure of E60A mutant of FKBP12","GVQVETISPGDGRTFPKRGQTCVVHYTGMLEDGKKFDSSRDRNKPFKFMLGKQEVIRGWAEGVAQMSVGQRAKLTISPDYAYGATGHPGIIPPHATLVFDVELLKLE","Homo sapiens","FKBP1A, FKBP1, FKBP12","FK506-binding protein 1A","1","2PPO"
"2PPP",,"X-RAY DIFFRACTION",2.22,44.64,"VAPOR DIFFUSION, HANGING DROP",7,"1.9-2.1 M Sodium Maleonate, 50 mM DMSO, Slow buffer exchange into 2.5 M Sodium Maleoneate no DMSO, in 10 minute steps for freezing, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1002/prot.22176",,"2PPP",11.84,"0.94","0.94","Crystal structure of E60Q mutant of FKBP12","GVQVETISPGDGRTFPKRGQTCVVHYTGMLEDGKKFDSSRDRNKPFKFMLGKQEVIRGWQEGVAQMSVGQRAKLTISPDYAYGATGHPGIIPPHATLVFDVELLKLE","Homo sapiens","FKBP1A, FKBP1, FKBP12","FK506-binding protein 1A","1","2PPP"
"2PQ5",,"X-RAY DIFFRACTION",2.58,52.35,"VAPOR DIFFUSION, SITTING DROP",5,"25% PEG3350, 0.15 M Ammonium citrate pH 5.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,,,"2PQ5",92.54,"2.3","2.3","Crystal structure of Dual specificity protein phosphatase 13 (DUSP13)","MDSLQKQDLRRPKIHGAVQASPYQPPTLASLQRLLWVRQAATLNHIDEVWPSLFLGDAYAARDKSKLIQLGITHVVNAAAGKFQVDTGAKFYRGMSLEYYGIEADDNPFFDLSVYFLPVARYIRAALSVPQGRVLVHCAMGVSRSATLVLAFLMIYENMTLVEAIQTVQAHRNICPNSGFLRQLQVLDNRLGRETGRFAHHHHHH","Homo sapiens","DUSP13, TMDP, DUSP13B","Dual specificity protein phosphatase 13","1","2PQ5"
"2PQ8",,"X-RAY DIFFRACTION",2.3,45.1,"VAPOR DIFFUSION",,"24% PEG3350, 0.2 M Ammonium chloride, VAPOR DIFFUSION, temperature 291K",291,,,"2PQ8",33.39,"1.45","1.45","MYST histone acetyltransferase 1","GSTKVKYVDKIHIGNYEIDAWYFSPFPEDYGKQPKLWLCEYCLKYMKYEKSYRFHLGQCQWRQPPGKEIYRKSNISVHEVDGKDHKIYCQNLCLLAKLFLDHRTLYFDVEPFVFYILTEVDRQGAHIVGYFSKEKESPDGNNVACILTLPPYQRRGYGKFLIAFSYELSKLESTVGSPEKPLSDLGKLSYRSYWSWVLLENLRDFRGTLSIKDLSQMTSITQNDIISTLQSLNMVKYWKGQHVICVTPKLVEEHLKSAQYKKPPITVDSVCLKWAPPK","Homo sapiens","MYST1, MOF, PP7073, KAT8","Probable histone acetyltransferase MYST1","1","2PQ8"
"2PQF",,"X-RAY DIFFRACTION",3.3,62.72,,4.3,"9% PEG 6000, 100mM Na Citrate, 2% DMSO, pH 4.3, VAPOR DIFFUSION, SITTING DROP, temperature 298K, pH 4.30",298,"10.1074/jbc.M114.630160",,"2PQF",138.92,"2.2","2.2","Human Poly(ADP-Ribose) Polymerase 12, Catalytic fragment in complex with an inhibitor 3-Aminobenzoic acid","SMDSSALPDPGFQKITLSSSSEEYQKVWNLFNRTLPFYFVQKIERVQNLALWEVYQWQKGQMQKQNGGKAVDERQLFHGTSAIFVDAICQQNFDWRVCGVHGTSYGKGSYFARDAAYSHHYSKSDTQTHTMFLARVLVGEFVRGNASFVRPPAKEGWSNAFYDSCVNSVSDPSIFVIFEKHQVYPEYVIQYTTSSKPS","Homo sapiens","PARP12, ZC3HDC1","Poly [ADP-ribose] polymerase 12","1","2PQF"
"2PQK",,"X-RAY DIFFRACTION",2.64,53.43,"VAPOR DIFFUSION, HANGING DROP",7,"0.2M zinc acetate, 0.1M imidazole, 20% PEG 3350, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1002/pro.329",,"2PQK",21.54,"2","2","X-ray crystal structure of human Mcl-1 in complex with Bim BH3","GSDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGG","Homo sapiens","MCL1, BCL2L3","Induced myeloid leukemia cell differentiation protein Mcl-1","1","2PQK"
,,,,,,,,,,,,,,,,"GGSGRPEIWIAQELRRIGDEFNAYYARRV",,,"Bim BH3 peptide","2","2PQK"
"2PQT",,"X-RAY DIFFRACTION",2,38.9,"VAPOR DIFFUSION, HANGING DROP",8.5,"30% PEG4000, 0.2 M NaOAc, 0.1 M Tris-HCl, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1074/jbc.M704138200",,"2PQT",34.44,"1.78","1.78","Human N-acetyltransferase 1","GSGSGSDIEAYFERIGYKKSRNKLDLETLTDILQHQIRAVPFENLNIHCGDAMDLGLEAIFDQVVRRNRGGWXLQVNHLLYWALTTIGFETTMLGGYVYSTPAKKYSTGMIHLLLQVTIDGRNYIVDAGFGRSYQMWQPLELISGKDQPQVPCVFRLTEENGFWYLDQIRREQYIPNEEFLHSDLLEDSKYRKIYSFTLKPRTIEDFESMNTYLQTSPSSVFTSKSFCSLQTPDGVHCLVGFTLTHRRFNYKDNTDLIEFKTLSEEEIEKVLKNIFNISLQRKLVPKHGDRFFTI","Homo sapiens","NAT1, AAC1","Arylamine N-acetyltransferase 1","1","2PQT"
"2PQU",,"X-RAY DIFFRACTION",2.45,49.71,"VAPOR DIFFUSION, HANGING DROP",6.1,"25% PEG 8000, 100 mM sodium acetate, 100 mM sodium cacodylate  , pH 6.1, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1261/rna.410107",,"2PQU",39.77,"2.12","2.12","Crystal structure of KH1 domain of human PCBP2 complexed to single-stranded 12-mer telomeric dna","AACCCTAACCCT",,,"12-mer C-rich strand of human telomeric DNA","1","2PQU"
,,,,,,,,,,,,,,,,"KNVTLTIRLLMHGKEVGSIIGKKGESVKKMREESGARINISEGNCPERIITLAGPTNAIFKAFAMIIDKLEED","Homo sapiens","PCBP2","Poly(rC)-binding protein 2","2","2PQU"
"2PQW",,"X-RAY DIFFRACTION",4.66,73.58,"VAPOR DIFFUSION, HANGING DROP",4.6,"0.1M Sodium acetate pH 4.6, 4% PEG 4000, VAPOR DIFFUSION, HANGING DROP, temperature 300K",300,"10.1038/nsmb1340",,"2PQW",38.51,"2","2","Crystal structure of L3MBTL1 in complex with H4K20Me2 (residues 17-25), trigonal form","GEKKECWSWESYLEEQKAITAPVSLFQDSQAVTHNKNGFKLGMKLEGIDPQHPSMYFILTVAEVCGYRLRLHFDGYSECHDFWVNANSPDIHPAGWFEKTGHKLQPPKGYKEEEFSWSQYLRSTRAQAAPKHLFVSQSHSPPPLGFQVGMKLEAVDRMNPSLVCVASVTDVVDSRFLVHFDNWDDTYDYWCDPSSPYIHPVGWCQKQGKPLTPPQDYPDPDNFCWEKYLEETGASAVPTWAFKVRPPHSFLVNMKLEAVDRRNPALIRVASVEDVEDHRIKIHFDGWSHGYDFWIDADHPDIHPAGWCSKTGHPLQPPLGPRE","Homo sapiens","L3MBTL, KIAA0681, L3MBT, L3MBTL1","Lethal(3)malignant brain tumor-like protein","1","2PQW"
,,,,,,,,,,,,,,,,"RHRKVLRDN",,,"Histone H4","2","2PQW"
"2PR3",,"X-RAY DIFFRACTION",2.49,50.59,,,,,"10.1111/j.1747-0285.2007.00520.x","237","2PR3",32.53,"1.5","1.5","Factor XA inhibitor","IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT","Homo sapiens","F10","COAGULATION FACTOR X, HEAVY CHAIN","1","2PR3"
,,,,,,,,,,,,,,,,"LCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACIPTGPYPCGKQTLE","Homo sapiens","F10","COAGULATION FACTOR X, LIGHT CHAIN","2","2PR3"
"2PR4",,"X-RAY DIFFRACTION",2.38,48.27,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.5M Li2SO4, 15% PEG 8000, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.jmb.2008.09.024",,"2PR4",48.37,"2.05","2.05","Crystal Structure of Fab' from the HIV-1 Neutralizing Antibody 2F5","ALQLTQSPSSLSASVGDRITITCRASQGVTSALAWYRQKPGSPPQLLIYDASSLESGVPSRFSGSGSGTEFTLTISTLRPEDFATYYCQQLHFYPHTFGGGTRVDVRRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYECEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"nmAb 2F5 Fab' Heavy Chain","1","2PR4"
,,,,,,,,,,,,,,,,"RITLKESGPPLVKPTQTLTLTCSFSGFSLSDFGVGVGWIRQPPGKALEWLAIIYSDDDKRYSPSLNTRLTITKDTSKNQVVLVMTRVSPVDTATYFCAHRRGPTTLFGVPIARGPVNAMDVWGQGITVTISSTSTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYTCNVNHKPSNTKVDKRVEPKSC","Homo sapiens",,"nmAb 2F5 Fab' light Chain","2","2PR4"
"2PRH",,"X-RAY DIFFRACTION",3.64,66.22,"VAPOR DIFFUSION, HANGING DROP",4.8,"0.1M acetate, 1.6-2.4M ammonium sulphate, 30% glycerol, pH 4.8, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/bi8003318","238","2PRH",41.06,"2.4","2.4","The structures of apo- and inhibitor bound human dihydroorotate dehydrogenase reveal conformational flexibility within the inhibitor binding site","MATGDERFYAEHLMPTLQGLLDPESAHRLAVRFTSLGLLPRARFQDSDMLEVRVLGHKFRNPVGIAAGFDKHGEAVDGLYKMGFGFVEIGSVTPKPQEGNPRPRVFRLPEDQAVINRYGFNSHGLSVVEHRLRARQQKQAKLTEDGLPLGVNLGKNKTSVDAAEDYAEGVRVLGPLADYLVVNVSSPNTAGLRSLQGKAELRRLLTKVLQERDGLRRVHRPAVLVKIAPDLTSQDKEDIASVVKELGIDGLIVTNTTVSRPAGLQGALRSETGGLSGKPLRDLSTQTIREMYALTQGRVPIIGVGGVSSGQDALEKIRAGASLVQLYTALTFWGPPVVGKVKRELEALLKEQGFGGVTDAIGADHRR","Homo sapiens","DHODH","Dihydroorotate dehydrogenase, mitochondrial","1","2PRH"
"2PRL",,"X-RAY DIFFRACTION",3.61,65.94,"VAPOR DIFFUSION, HANGING DROP",4.8,"DROPS WERE FORMED BY MIXING EQUAL AMOUNTS OF 18-24 MG/ML PROTEIN IN
100 MM HEPES PH 7.0, 400 MM NACL, 30% GLYCEROL, 1 MM EDTA AND 10 MM
N,N- DIMETHYLUNDECYLAMIN-N-OXIDE (C11DAO) WITH A PRECIPITANT SOLUTION
OF 0.1 M ACETATE PH 4.8 40 MM C11DAO, 20.8 MM
N,-DIMETHYLDECYLAMINE-N-OXIDE (DDAO), 2 MM DIHYDROOROTATE (DHO) THE
HANGING DROPS WERE INCUBATED AGAINST 0.5 ML RESERVOIR OF 0.1 M ACETATE
PH 4.8, 1.6-2.2 M AMMONIUM SULFATE AND 30% GLYCEROL., VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/bi8003318","R2C","2PRL",41.22,"2.1","2.1","The structures of apo- and inhibitor bound human dihydroorotate dehydrogenase reveal conformational flexibility within the inhibitor binding site","MATGDERFYAEHLMPTLQGLLDPESAHRLAVRFTSLGLLPRARFQDSDMLEVRVLGHKFRNPVGIAAGFDKHGEAVDGLYKMGFGFVEIGSVTPKPQEGNPRPRVFRLPEDQAVINRYGFNSHGLSVVEHRLRARQQKQAKLTEDGLPLGVNLGKNKTSVDAAEDYAEGVRVLGPLADYLVVNVSSPNTAGLRSLQGKAELRRLLTKVLQERDGLRRVHRPAVLVKIAPDLTSQDKEDIASVVKELGIDGLIVTNTTVSRPAGLQGALRSETGGLSGKPLRDLSTQTIREMYALTQGRVPIIGVGGVSSGQDALEKIRAGASLVQLYTALTFWGPPVVGKVKRELEALLKEQGFGGVTDAIGADHRR","Homo sapiens","DHODH","Dihydroorotate dehydrogenase, mitochondrial","1","2PRL"
"2PRM",,"X-RAY DIFFRACTION",3.62,65.99,"VAPOR DIFFUSION, HANGING DROP",4.8,"DROPS WERE FORMED BY MIXING EQUAL AMOUNTS OF 18-24 MG/ML PROTEIN IN
100 MM HEPES PH 7.0, 400 MM NACL, 30% GLYCEROL, 1 MM EDTA AND 10 MM
N,N- DIMETHYLUNDECYLAMIN-N-OXIDE (C11DAO) WITH A PRECIPITANT SOLUTION
OF 0.1 M ACETATE PH 4.8 40 MM C11DAO, 20.8 MM N,
N-DIMETHYLDECYLAMINE-N-OXIDE (DDAO), 2 MM DIHYDROOROTATE (DHO) THE
HANGING DROPS WERE INCUBATED AGAINST 0.5 ML RESERVOIR OF 0.1 M ACETATE
PH 4.8, 1.6-2.2 M AMMONIUM SULFATE AND 30% GLYCEROL., VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/bi8003318",,"2PRM",40.47,"3","3","The structures of apo- and inhibitor bound human dihydroorotate dehydrogenase reveal conformational flexibility within the inhibitor binding site","MATGDERFYAEHLMPTLQGLLDPESAHRLAVRFTSLGLLPRARFQDSDMLEVRVLGHKFRNPVGIAAGFDKHGEAVDGLYKMGFGFVEIGSVTPKPQEGNPRPRVFRLPEDQAVINRYGFNSHGLSVVEHRLRARQQKQAKLTEDGLPLGVNLGKNKTSVDAAEDYAEGVRVLGPLADYLVVNVSSPNTAGLRSLQGKAELRRLLTKVLQERDGLRRVHRPAVLVKIAPDLTSQDKEDIASVVKELGIDGLIVTNTTVSRPAGLQGALRSETGGLSGKPLRDLSTQTIREMYALTQGRVPIIGVGGVSSGQDALEKIRAGASLVQLYTALTFWGPPVVGKVKRELEALLKEQGFGGVTDAIGADHRR","Homo sapiens","DHODH","Dihydroorotate dehydrogenase, mitochondrial","1","2PRM"
"2PRT",,"X-RAY DIFFRACTION",3.97,69.04,,6.7,"10 mM d11-Tris/HCl, 20 mM KCl, 5uM ZnSO4, 2mM NaN3, 10% D2O, pH 6.7, SMALL TUBES, temperature 277K, pH 6.70",277,"10.1016/j.jmb.2007.07.017",,"2PRT",23.32,"3.15","3.15","Structure of the Wilms Tumor Suppressor Protein Zinc Finger Domain Bound to DNA","CGCGGGGGCGTCTG",,,"DNA (5'-D(*CP*GP*CP*GP*GP*GP*GP*GP*CP*GP*TP*CP*TP*G)-3')","1","2PRT"
,,,,,,,,,,,,,,,,"CAGACGCCCCCGCG",,,"DNA (5'-D(*CP*AP*GP*AP*CP*GP*CP*CP*CP*CP*CP*GP*CP*G)-3')","2","2PRT"
,,,,,,,,,,,,,,,,"ASEKRPFMCAYPGCNKRYFKLSHLQMHSRKHTGEKPYQCDFKDCERRFSRSDQLKRHQRRHTGVKPFQCKTCQRKFSRSDHLKTHTRTHTGEKPFSCRWPSCQKKFARSDELVRHHNMH","Homo sapiens","WT1","Wilms tumor 1","3","2PRT"
"2PRU",,"SOLUTION NMR",,,,,,,"10.1002/prot.22037",,"2PRU",21.19,,,"NMR Structure of Human apoS100B at 10C","SELEKAMVALIDVFHQYSGREGDKHKLKKSELKELINNELSHFLEEIKEQEVVDKVMETLDNDGDGECDFQEFMAFVAMVTTACHEFFEHE","Homo sapiens","S100B","Protein S100-B","1","2PRU"
"2PSN",,"X-RAY DIFFRACTION",3.2,61.62,"VAPOR DIFFUSION, HANGING DROP",7.5,"20% to 24% (w/v) PEG 3350, 100 mM Tris-HCl  (pH 7.5), 200 mM ammoniumsulfate, 1 mM DTT., VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,,,"2PSN",189.49,"2.2","2.2","Crystal structure of enolase1","MSILKIHAREIFDSRGNPTVEVDLFTSKGLFRAAVPSGASTGIYEALELRDNDKTRYMGKGVSKAVEHINKTIAPALVSKKLNVTEQEKIDKLMIEMDGTENKSKFGANAILGVSLAVCKAGAVEKGVPLYRHIADLAGNSEVILPVPAFNVINGGSHAGNKLAMQEFMILPVGAANFREAMRIGAEVYHNLKNVIKEKYGKDATNVGDEGGFAPNILENKEGLELLKTAIGKAGYTDKVVIGMDVAASEFFRSGKYDLDFKSPDDPSRYISPDQLADLYKSFIKDYPVVSIEDPFDQDDWGAWQKFTASAGIQVVGDDLTVTNPKRIAKAVNEKSCNCLLLKVNQIGSVTESLQACKLAQANGWGVMVSHRSGETEDTFIADLVVGLCTGQIKTGAPCRSERLAKYNQLLRIEEELGSKAKFAGRNFRNPLAK","Homo sapiens","ENO1, ENO1L1, MBPB1, MPB1","Alpha-enolase","1","2PSN"
"2PSO",,"X-RAY DIFFRACTION",4.08,69.82,"VAPOR DIFFUSION, HANGING DROP",8,"20 % MPD, 100 mM Tris-HCl, 125 mM NaCl, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1371/journal.pone.0019521",,"2PSO",80.87,"2.8","2.8","Human StarD13 (DLC2) lipid transfer and protein localization domain","MHHHHHHSSGVDLGTENLYFQSMEESGATFHTYLNHLIQGLQKEAKEKFKGWVTCSSTDNTDLAFKKVGDGNPLKLWKASVEVEAPPSVVLNRVLRERHLWDEDFVQWKVVETLDRQTEIYQYVLNSMAPHPSRDFVVLRTWKTDLPKGMCTLVSLSVEHEEAQLLGGVRAVVMDSQYLIEPCGSGKSRLTHICRIDLKGHSPEWYSKGFGHLCAAEVARIRNSFQPLIAEGPETKI","Homo sapiens","STARD13, DLC2, GT650","StAR-related lipid transfer protein 13","1","2PSO"
"2PSQ",,"X-RAY DIFFRACTION",2.46,50.02,"VAPOR DIFFUSION, HANGING DROP",7.5,"100mM HEPES pH7.5, 20% PEG 4000, 200mM (NH4)2SO4, 3% C2H4O, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.molcel.2007.06.028",,"2PSQ",84.66,"2.4","2.4","Crystal Structure of Unphosphorylated Unactivated Wild Type FGF Receptor 2 (FGFR2) Kinase Domain","MGSSHHHHHHSQDPPAVHKLTKRIPLRRQVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEE","Homo sapiens","FGFR2, BEK, KSAM, KGFR","Fibroblast growth factor receptor 2","1","2PSQ"
"2PSR",,"X-RAY DIFFRACTION",3.06,59.7,,6.7,"pH 6.7",,"10.1021/bi982483d",,"2PSR",11.45,"2.05","2.05","HUMAN PSORIASIN (S100A7) CA2+ AND ZN2+ BOUND FORM (CRYSTAL FORM II)","SNTQAERSIIGMIDMFHKYTRRDDKIDKPSLLTMMKENFPNFLSACDKKGTNYLADVFEKKDKNEDKKIDFSEFLSLLGDIATDYHKQSHGAAPCSGGSQ","Homo sapiens","S100A7, PSOR1, S100A7C","PSORIASIN","1","2PSR"
"2PSW",,"X-RAY DIFFRACTION",2.7,54.49,"VAPOR DIFFUSION, HANGING DROP",7.5,"Reservoir: 0.1 M Sodium acetate pH 5.0, 16% PEG3350, 10 mM DTT, 0.1% Dioxane. Protein: 11.8 mg/mL + 3-fold molar excess of CoA in 20 mM HEPES pH 7.5, 0.1 M NaCl, 2.5% 1,2-Propanediol, and 10 mM DTT. Cryo: 75% Reservoir  + 25% MPD, VAPOR DIFFUSION, HANGING DROP, temperature 298.0K",298,,,"2PSW",60.9,"2.1","2.1","Human MAK3 homolog in complex with CoA","GSKGSRIELGDVTPHNIKQLKRLNQVIFPVSYNDKFYKDVLEVGELAKLAYFNDIAVGAVCCRVDHSQNQKRLYIMTLGCLAPYRRLGIGTKMLNHVLNICEKDGTFDNIYLHVQISNESAIDFYRKFGFEIIETKKNYYKRIEPADAHVLQKNLKVPSGQNADVQKTDN","Homo sapiens","NAT13, MAK3, NAT5, NAA50","N-acetyltransferase 13","1","2PSW"
"2PUY",,"X-RAY DIFFRACTION",2.06,40.18,"VAPOR DIFFUSION, HANGING DROP",6.5,"20% Isopropanol, 5-10% polyethylene glycol 4000, 100mM MES 6.2-6.5, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1038/nature06034",,"2PUY",15.43,"1.43","1.43","Crystal Structure of the BHC80 PHD finger","HMIHEDFCSVCRKSGQLLMCDTCSRVYHLDCLDPPLKTIPKGMWICPRCQDQMLKKEEAI","Homo sapiens","PHF21A, BHC80, KIAA1696, BM-006","PHD finger protein 21A","1","2PUY"
,,,,,,,,,,,,,,,,"ARTKQTARKS",,,"Histone H3","2","2PUY"
"2PV0",,"X-RAY DIFFRACTION",5.89484,79.134293,"VAPOR DIFFUSION, HANGING DROP",9,"0.4-0.6 M sodium citrate, 0.1 M bicine, pH 9.0, VAPOR DIFFUSION, HANGING DROP, temperature 300K",300,"10.1038/nature05987",,"2PV0",131.18,"3.3","3.3","DNA methyltransferase 3 like protein (DNMT3L)","MAAIPALDPEAEPSMDVILVGSSELSSSVSPGTGRDLIAYEVKANQRNIEDICICCGSLQVHTQHPLFEGGICAPCKDKFLDALFLYDDDGYQSYCSICCSGETLLICGNPDCTRCYCFECVDSLVGPGTSGKVHAMSNWVCYLCLPSSRSGLLQRRRKWRSQLKAFYDRESENPLEMFETVPVWRRQPVRVLSLFEDIKKELTSLGFLESGSDPGQLKHVVDVTDTVRKDVEEWGPFDLVYGATPPLGHTCDRPPSWYLFQFHRLLQYARPKPGSPGPFFWMFVDNLVLNKEDLDVASRFLEMEPVTIPDVHGGSLQNAVRVWSNIPAIRSRHWALVSEEELSLLAQNKQSSKLAAKWPTKLVKNCFLPLREYFKYFSTELTSSL","Homo sapiens","DNMT3L","DNA (cytosine-5)-methyltransferase 3-like","1","2PV0"
,,,,,"VAPOR DIFFUSION, HANGING DROP",7.5,"12% polyethylene 3350, 0.2 M sodium citrate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 300K",300
"2PVC",,"X-RAY DIFFRACTION",5.89,79.13,,7.5,"12 % polyethylene glycol, 0.2 M sodium citrate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 300K, pH 7.50",300,"10.1038/nature05987",,"2PVC",133.51,"3.69","3.69","DNMT3L recognizes unmethylated histone H3 lysine 4","MAAIPALDPEAEPSMDVILVGSSELSSSVSPGTGRDLIAYEVKANQRNIEDICICCGSLQVHTQHPLFEGGICAPCKDKFLDALFLYDDDGYQSYCSICCSGETLLICGNPDCTRCYCFECVDSLVGPGTSGKVHAMSNWVCYLCLPSSRSGLLQRRRKWRSQLKAFYDRESENPLEMFETVPVWRRQPVRVLSLFEDIKKELTSLGFLESGSDPGQLKHVVDVTDTVRKDVEEWGPFDLVYGATPPLGHTCDRPPSWYLFQFHRLLQYARPKPGSPGPFFWMFVDNLVLNKEDLDVASRFLEMEPVTIPDVHGGSLQNAVRVWSNIPAIRSRHWALVSEEELSLLAQNKQSSKLAAKWPTKLVKNCFLPLREYFKYFSTELTSSL","Homo sapiens","DNMT3L","DNA (cytosine-5)-methyltransferase 3-like","1","2PVC"
,,,,,,,,,,,,,,,,"ARTKQTA",,,"Histone H3 peptide","2","2PVC"
"2PVF",,"X-RAY DIFFRACTION",2.32,47.08,"VAPOR DIFFUSION, HANGING DROP",7.5,"100mM HEPES pH7.5, 27% PEG 4000, 200mM (NH4)2SO4, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.molcel.2007.06.028",,"2PVF",40.87,"1.8","1.8","Crystal Structure of Tyrosine Phosphorylated Activated FGF Receptor 2 (FGFR2) Kinase Domain in Complex with ATP Analog and Substrate Peptide","TTNEEYLDLSQPLEQ",,,"Fibroblast growth factor receptor 2","2","2PVF"
,,,,,,,,,,,,,,,,"MGSSHHHHHHSQDPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEEYLDLSQPLEQ","Homo sapiens","FGFR2, BEK, KSAM, KGFR","Fibroblast growth factor receptor 2","1","2PVF"
"2PVR",,"X-RAY DIFFRACTION",1.97,37.57,"VAPOR DIFFUSION, SITTING DROP",7.5,"PEGmme 5000, ammonium sulfate, MES, adenylyl imidodiphosphate, magnesium chloride, peptide RRRADDSDDDDD, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.jmb.2007.04.068",,"2PVR",40.63,"1.605","1.605","Crystal structure of the catalytic subunit of protein kinase CK2 (C-terminal deletion mutant 1-335) in complex with two sulfate ions","SGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQARMG","Homo sapiens","CSNK2A1, CK2A1","Casein kinase II subunit alpha, catalytic subunit","1","2PVR"
"2PVS",,"X-RAY DIFFRACTION",3.6,65.81,"VAPOR DIFFUSION, HANGING DROP",6.7,"6 microliter of protein (14.5 mg/ml in 0.2 M NaCl, 25 mM Tris-HCl, pH 8.0) and 2 microliter of 2.05 M Ammonium sulphate, 0.1 M Hepes, pH 6.7, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/bi8005576",,"2PVS",101.21,"3","3","Structure of human pancreatic lipase related protein 2 mutant N336Q","KEVCYGQLGCFSDEKPWAGTLQRPVKLLPWSPEDIDTRFLLYTNENPNNFQLITGTEPDTIEASNFQLDRKTRFIIHGFLDKAEDSWPSDMCKKMFEVEKVNCICVDWRHGSRAMYTQAVQNIRVVGAETAFLIQALSTQLGYSLEDVHVIGHSLGAHTAAEAGRRLGGRVGRITGLDPAGPCFQDEPEEVRLDPSDAVFVDVIHTDSSPIVPSLGFGMSQKVGHLDFFPNGGKEMPGCKKNVLSTITDIDGIWEGIGGFVSCNHLRSFEYYSSSVLNPDGFLGYPCASYDEFQESKCFPCPAEGCPKMGHYADQFKGKTSAVEQTFFLNTGESGQFTSWRYKVSVTLSGKEKVNGYIRIALYGSNENSKQYEIFKGSLKPDASHTCAIDVDFNVGKIQKVKFLWNKRGINLSEPKLGASQITVQSGEDGTEYNFCSSDTVEENVLQSLYPC","Homo sapiens","PNLIPRP2, PLRP2","Pancreatic lipase-related protein 2","1","2PVS"
"2PVV",,"X-RAY DIFFRACTION",3.29,62.62,"VAPOR DIFFUSION, HANGING DROP",8,"33% (v/v) pentaerythritol propoxylate PO/OH 5/4, 1   3% (w/v) PEG 3350, 100 mM Tris-HCl, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm070133w","OSE","2PVV",82.94,"2.11","2.11","Structure of human glutamate carboxypeptidase II (GCPII) in complex with L-serine-O-sulfate","RSKSSNEATNITPKHNMKAFLDELKAENIKKFLYNFTQIPHLAGTEQNFQLAKQIQSQWKEFGLDSVELAHYDVLLSYPNKTHPNYISIINEDGNEIFNTSLFEPPPPGYENVSDIVPPFSAFSPQGMPEGDLVYVNYARTEDFFKLERDMKINCSGKIVIARYGKVFRGNKVKNAQLAGAKGVILYSDPADYFAPGVKSYPDGWNLPGGGVQRGNILNLNGAGDPLTPGYPANEYAYRRGIAEAVGLPSIPVHPIGYYDAQKLLEKMGGSAPPDSSWRGSLKVPYNVGPGFTGNFSTQKVKMHIHSTNEVTRIYNVIGTLRGAVEPDRYVILGGHRDSWVFGGIDPQSGAAVVHEIVRSFGTLKKEGWRPRRTILFASWDAEEFGLLGSTEWAEENSRLLQERGVAYINADSSIEGNYTLRVDCTPLMYSLVHNLTKELKSPDEGFEGKSLYESWTKKSPSPEFSGMPRISKLGSGNDFEVFFQRLGIASGRARYTKNWETNKFSGYPLYHSVYETYELVEKFYDPMFKYHLTVAQVRGGMVFELANSIVLPFDCRDYAVVLRKYADKIYSISMKHPQEMKTYSVSFDSLFSAVKNFTEIASKFSERLQDFDKSNPIVLRMMNDQLMFLERAFIDPLGLPDRPFYRHVIYAPSSHNKYAGESFPGIYDALFDIESKVDPSKAWGEVKRQIYVAAFTVQAAAETLSEVA","Homo sapiens","FOLH1, FOLH, NAALAD1, PSM, PSMA, GIG27","Glutamate carboxypeptidase 2","1","2PVV"
"2PVW",,"X-RAY DIFFRACTION",3.32,62.99,"VAPOR DIFFUSION, HANGING DROP",8,"33% (v/v) pentaerythritol propoxylate PO/OH 5/4, 1   3% (w/v) PEG 3350, 100 mM Tris-HCl, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm070133w","G88","2PVW",82.98,"1.71","1.71","A high resolution structure of human glutamate carboxypeptidase II (GCPII) in complex with 2-(phosphonomethyl)pentanedioic acid (2-PMPA)","RSKSSNEATNITPKHNMKAFLDELKAENIKKFLYNFTQIPHLAGTEQNFQLAKQIQSQWKEFGLDSVELAHYDVLLSYPNKTHPNYISIINEDGNEIFNTSLFEPPPPGYENVSDIVPPFSAFSPQGMPEGDLVYVNYARTEDFFKLERDMKINCSGKIVIARYGKVFRGNKVKNAQLAGAKGVILYSDPADYFAPGVKSYPDGWNLPGGGVQRGNILNLNGAGDPLTPGYPANEYAYRRGIAEAVGLPSIPVHPIGYYDAQKLLEKMGGSAPPDSSWRGSLKVPYNVGPGFTGNFSTQKVKMHIHSTNEVTRIYNVIGTLRGAVEPDRYVILGGHRDSWVFGGIDPQSGAAVVHEIVRSFGTLKKEGWRPRRTILFASWDAEEFGLLGSTEWAEENSRLLQERGVAYINADSSIEGNYTLRVDCTPLMYSLVHNLTKELKSPDEGFEGKSLYESWTKKSPSPEFSGMPRISKLGSGNDFEVFFQRLGIASGRARYTKNWETNKFSGYPLYHSVYETYELVEKFYDPMFKYHLTVAQVRGGMVFELANSIVLPFDCRDYAVVLRKYADKIYSISMKHPQEMKTYSVSFDSLFSAVKNFTEIASKFSERLQDFDKSNPIVLRMMNDQLMFLERAFIDPLGLPDRPFYRHVIYAPSSHNKYAGESFPGIYDALFDIESKVDPSKAWGEVKRQIYVAAFTVQAAAETLSEVA","Homo sapiens","FOLH1, FOLH, NAALAD1, PSM, PSMA, GIG27","Glutamate carboxypeptidase 2","1","2PVW"
"2PVY",,"X-RAY DIFFRACTION",2.31,46.73,"VAPOR DIFFUSION, HANGING DROP",7.5,"100mM HEPES pH7.5, 25% PEG 4000, 200mM (NH4)2SO4, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.molcel.2007.06.028",,"2PVY",150.79,"2.2","2.2","Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic K659N Mutation Responsible for an Unclassified Craniosynostosis Syndrome.","MGSSHHHHHHSQDPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEE","Homo sapiens","FGFR2, BEK, KSAM, KGFR","Fibroblast growth factor receptor 2","1","2PVY"
"2PW1",,"X-RAY DIFFRACTION",3.36,63.39,"VAPOR DIFFUSION, HANGING DROP",5.6,"0.1M NaCitrate, AS 1.6M, pH 5.6, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1128/JVI.01604-09",,"2PW1",49.35,"2.6","2.6","Crystal structure of the HIV-1 Cross Neutralizing Monoclonal Antibody 2F5 in complex with gp41 Peptide ELDKWNSL","ALQLTQSPSSLSASVGDRITITCRASQGVTSALAWYRQKPGSPPQLLIYDASSLESGVPSRFSGSGSGTEFTLTISTLRPEDFATYYCQQLHFYPHTFGGGTRVDVRRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYECEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"2F5 Fab fragment heavy chain","1","2PW1"
,,,,,,,,,,,,,,,,"RITLKESGPPLVKPTQTLTLTCSFSGFSLSDFGVGVGWIRQPPGKALEWLAIIYSDDDKRYSPSLNTRLTITKDTSKNQVVLVMTRVSPVDTATYFCAHRRGPTTLFGVPIARGPVNAMDVWGQGITVTISSTSTKGPSVFPLAPSSKSTAGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYTCNVNHKPSNTKVDKRVEPKSC","Homo sapiens",,"2F5 Fab fragment light chain","2","2PW1"
,,,,,,,,,,,,,,,,"ELDKWNSL",,,"peptide epitope","3","2PW1"
"2PW2",,"X-RAY DIFFRACTION",3.27,62.42,"VAPOR DIFFUSION, HANGING DROP",5.6,"0.1M Na Citrate, AS 1.6M, pH 5.6, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1128/JVI.01604-09",,"2PW2",49.37,"2.55","2.55","Crystal structure of the HIV-1 Cross Neutralizing Monoclonal Antibody 2F5 in complex with gp41 Peptide ELDKWKSL","ALQLTQSPSSLSASVGDRITITCRASQGVTSALAWYRQKPGSPPQLLIYDASSLESGVPSRFSGSGSGTEFTLTISTLRPEDFATYYCQQLHFYPHTFGGGTRVDVRRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYECEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"2F5 Fab' heavy chain","1","2PW2"
,,,,,,,,,,,,,,,,"RITLKESGPPLVKPTQTLTLTCSFSGFSLSDFGVGVGWIRQPPGKALEWLAIIYSDDDKRYSPSLNTRLTITKDTSKNQVVLVMTRVSPVDTATYFCAHRRGPTTLFGVPIARGPVNAMDVWGQGITVTISSTSTKGPSVFPLAPSSKSTAGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYTCNVNHKPSNTKVDKRVEPKSC","Homo sapiens",,"2F5 Fab' light chain","2","2PW2"
,,,,,,,,,,,,,,,,"ELDKWKSL",,,"peptide epitope","3","2PW2"
"2PW3",,"X-RAY DIFFRACTION",2.54,51.6,"VAPOR DIFFUSION, HANGING DROP",7.5,"well buffer of 0.1 M HEPES pH 7.5, 0.1 M MgCl2, 12% PEG3350, 30% ethylene glycol, and 10% isopropanol, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.jmb.2007.05.060",,"2PW3",76.2,"1.56","1.56","Structure of the PDE4D-cAMP complex","TEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHNVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQ","Homo sapiens","PDE4D, DPDE3","cAMP-specific 3',5'-cyclic phosphodiesterase 4D","1","2PW3"
"2PWL",,"X-RAY DIFFRACTION",2.64,53.33,"VAPOR DIFFUSION, HANGING DROP",7.5,"100mM HEPES pH7.5, 25% PEG 4000, 200mM (NH4)2SO4, 8% C3H5(OH)3, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.molcel.2007.06.028",,"2PWL",75.66,"2.4","2.4","Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic N549H Mutation Responsible for Crouzon Syndrome.","MGSSHHHHHHSQDPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEE","Homo sapiens","FGFR2, BEK, KSAM, KGFR","Fibroblast growth factor receptor 2","1","2PWL"
"2PX6",,"X-RAY DIFFRACTION",1.97,37.53,"VAPOR DIFFUSION, HANGING DROP",4.3,"50mM sodium dihydrogen phosphate, 30-35% PEG 3350, 30mM dithiothreitol, pH 4.3, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1038/nsmb1265",,"2PX6",70.64,"2.3","2.3","Crystal structure of the thioesterase domain of human fatty acid synthase inhibited by Orlistat","GSHNLACPTPKEDGLAQQQTQLNLRSLLVNPEGPTLMRLNSVQSSERPLFLVHPIEGSTTVFHSLASRLSIPTYGLQCTRAAPLDSIHSLAAYYIDCIRQVQPEGPYRVAGYSYGACVAFEMCSQLQAQQSPAPTHNSLFLFDGSPTYVLAYTQSYRAKLTPGCEAEAETEAICFFVQQFTDMEHNRVLEALLPLKGLEERVAAAVDLIIKSHQGLDRQELSFAARSFYYKLRAAEQYTPKAKYHGNVMLLRAKTGGAYGEDLGADYNLSQVCDGKVSVHVIEGDHRTLLEGSGLESIISIIHSSLAEPRVSVREG","Homo sapiens","FAS, FASN","Thioesterase domain","1","2PX6"
"2PXI",,"X-RAY DIFFRACTION",2.23,44.74,"VAPOR DIFFUSION, SITTING DROP",7.5,"50 mM Imidazole, 350 mM Sodium Acetate, PEG 3350 16%, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1021/ja072127v",,"2PXI",48.45,"2.1","2.1","Ternary complex of DNA polymerase beta with a dideoxy terminated primer and 2'-deoxyguanosine 5'-beta, gamma-monofluoromethylene triphosphate","CCGACCGCGCATCAGC",,,"5'-D(*CP*CP*GP*AP*CP*CP*GP*CP*GP*CP*AP*TP*CP*AP*GP*C)-3'","1","2PXI"
,,,,,,,,,,,,,,,,"GCTGATGCGC",,,"5'-D(*GP*CP*TP*GP*AP*TP*GP*CP*GP*(DOC))-3'","2","2PXI"
,,,,,,,,,,,,,,,,"GTCGG",,,"5'-D(P*GP*TP*CP*GP*G)-3'","3","2PXI"
,,,,,,,,,,,,,,,,"MSKRKAPQETLNGGITDMLTELANFEKNVSQAIHKYNAYRKAASVIAKYPHKIKSGAEAKKLPGVGTKIAEKIDEFLATGKLRKLEKIRQDDTSSSINFLTRVSGIGPSAARKFVDEGIKTLEDLRKNEDKLNHHQRIGLKYFGDFEKRIPREEMLQMQDIVLNEVKKVDSEYIATVCGSFRRGAESSGDMDVLLTHPSFTSESTKQPKLLHQVVEQLQKVHFITDTLSKGETKFMGVCQLPSKNDEKEYPHRRIDIRLIPKDQYYCGVLYFTGSDIFNKNMRAHALEKGFTINEYTIRPLGVTGVAGEPLPVDSEKDIFDYIQWKYREPKDRSE","Homo sapiens","POLB","DNA polymerase beta","4","2PXI"
"2PXJ",,"X-RAY DIFFRACTION",2.53,51.48,"VAPOR DIFFUSION, HANGING DROP",8.5,"15-17% PEG 5000 mme, pH 8.5, VAPOR DIFFUSION, HANGING DROP",,"10.1073/pnas.0704525104","OGA","2PXJ",86.11,"2","2","The complex structure of JMJD2A and monomethylated H3K36 peptide","ASESETLNPSARIMTFYPTMEEFRNFSRYIAYIESQGAHRAGLAKVVPPKEWKPRASYDDIDDLVIPAPIQQLVTGQSGLFTQYNIQKKAMTVREFRKIANSDKYCTPRYSEFEELERKYWKNLTFNPPIYGADVNGTLYEKHVDEWNIGRLRTILDLVEKESGITIEGVNTPYLYFGMWKTSFAWHTEDMDLYSINYLHFGEPKSWYSVPPEHGKRLERLAKGFFPGSAQSCEAFLRHKMTLISPLMLKKYGIPFDKVTQEAGEFMITFPYGYHAGFNHGFNCAESTNFATRRWIEYGKQAVLCSCRKDMVKISMDVFVRKFQPERYKLWKAGKDNTVIDHTLPTP","Homo sapiens","JMJD2A, JHDM3A, JMJD2, KIAA0677, KDM4A","JmjC domain-containing histone demethylation protein 3A","1","2PXJ"
,,,,,,,,,,,,,,,,"RKSAPATGGVKKPHRYRPGTVL",,,"monomethylated Histone H3K36 peptide","2","2PXJ"
"2PXX",,"X-RAY DIFFRACTION",1.8,32.2,"VAPOR DIFFUSION",5.5,"28% PEG3350, 0.1 M Ammonium sulfate, 0.1 M Bis-Tris, pH 5.5, VAPOR DIFFUSION, temperature 291K",291,"10.1002/prot.22299",,"2PXX",24.3,"1.3","1.3","Human putative methyltransferase MGC2408","GSGYREVEYWDQRYQGAADSAPYDWFGDFSSFRALLEPELRPEDRILVLGCGNSALSYELFLGGFPNVTSVDYSSVVVAAMQACYAHVPQLRWETMDVRKLDFPSASFDVVLEKGTLDALLAGERDPWTVSSEGVHTVDQVLSEVSRVLVPGGRFISMTSAAPHFRTRHYAQAYYGWSLRHATYGSGFHFHLYLMHKGGKLSVAQLALGAQILSP","Homo sapiens","MGC2408, EEF1AKMT4","Uncharacterized protein MGC2408","1","2PXX"
"2PY1",,"SOLUTION NMR",,,,,,,"10.1021/ja071442e",,"2PY1",14.37,,,"Solution structure of human liver fatty acid binding protein","GSMSFSGKYQLQSQENFEAFMKAIGLPEELIQKGKDIKGVSEIVQNGKHFKFTITAGSKVIQNEFTVGEECELETMTGEKVKTVVQLEGDNKLVTTFKNIKSVTELNGDIITNTMTLGDIVFKRISKRI","Homo sapiens","FABP1, FABPL","Fatty acid-binding protein, liver","1","2PY1"
"2PY3",,"X-RAY DIFFRACTION",2.62,52.99,"VAPOR DIFFUSION, HANGING DROP",7.5,"100mM HEPES pH7.5, 25% PEG 4000, 200mM (NH4)2SO4, 2% C3H5(OH)3, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.molcel.2007.06.028",,"2PY3",75.57,"2.3","2.3","Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic E565G Mutation Responsible for Pfeiffer Syndrome","MGSSHHHHHHSQDPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEE","Homo sapiens","FGFR2, BEK, KSAM, KGFR","Fibroblast growth factor receptor 2","1","2PY3"
"2PY9",,"X-RAY DIFFRACTION",2.41,48.9,"VAPOR DIFFUSION, HANGING DROP",6.1,"25% PEG 8000, 100mM sodium acetate, 100mM sodium cacodylate pH 6.1, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1261/rna.410107",,"2PY9",40.09,"2.56","2.56","Protein-RNA Interaction involving KH1 domain from Human Poly(C)-Binding Protein-2","AACCCUAACCCU",,,"12-mer C-rich strand of human telomeric RNA","1","2PY9"
,,,,,,,,,,,,,,,,"KNVTLTIRLLMHGKEVGSIIGKKGESVKKMREESGARINISEGNCPERIITLAGPTNAIFKAFAMIIDKLEED","Homo sapiens","PCBP2","Poly(rC)-binding protein 2","2","2PY9"
"2PZ1",,"X-RAY DIFFRACTION",2.1,41.48,"VAPOR DIFFUSION, SITTING DROP",7,"100 mM HEPES pH 7, 20 % PEG 3350, 200 mM magnesium acetate, 10% glycerol, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1038/nsmb1290",,"2PZ1",53.94,"2.25","2.25","Crystal Structure of Auto-inhibited Asef","GAMSSSHHYSHPGGGGEQLAINELISDGSVVCAEALWDHVTMDDQELGFKAGDVIEVMDATNREWWWGRVADGEGWFPASFVRLRVNQDEPADDDAPLAGNSGAEDGGAEAQSSKDQMRTNVINEILSTERDYIKHLRDICEGYVRQCRKRADMFSEEQLRTIFGNIEDIYRCQKAFVKALEQRFNRERPHLSELGACFLEHQADFQIYSEYCNNHPNACVELSRLTKLSKYVYFFEACRLLQKMIDISLDGFLLTPVQKICKYPLQLAELLKYTHPQHRDFKDVEAALHAMKNVAQLINERKRRLENIDKIAQWQSSIEDWEGEDLLVRSSELIYSGELTRVTQPQAKSQQRMFFLFDHQLIYCKKDLLRRDVLYYKGRLDMDGLEVVDLEDGKDRDLHVSIKNAFRLHRGATGDSHLLCTRKPEQKQRWLKAFAREREQVQLDQETGFSITELQRKQAMLNASK","Homo sapiens","ARHGEF4, KIAA1112","Rho guanine nucleotide exchange factor 4","1","2PZ1"
"2PZ5",,"X-RAY DIFFRACTION",2.61,52.8,"VAPOR DIFFUSION, HANGING DROP",7.5,"100mM HEPES pH7.5, 25% PEG 4000, 200mM (NH4)2SO4, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.molcel.2007.06.028",,"2PZ5",75.69,"2.4","2.4","Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic N549T Mutation Responsible for Pfeiffer Syndrome","MGSSHHHHHHSQDPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEE","Homo sapiens","FGFR2, BEK, KSAM, KGFR","Fibroblast growth factor receptor 2","1","2PZ5"
"2PZD",,"X-RAY DIFFRACTION",3.36,63.43,"VAPOR DIFFUSION",5.6,"0.1 M sodium citrate, 1.0 M monoammonium dihydrogen phosphate, pH 5.6, VAPOR DIFFUSION, temperature 292K",292,"10.1110/ps.072833207",,"2PZD",25.31,"2.75","2.75","Crystal Structure of the HtrA2/Omi PDZ Domain Bound to a Phage-Derived Ligand (WTMFWV)","GSHMRRYIGVMMLTLSPSILAELQLREPSFPDVQHGVLIHKVILGSPAHRAGLRPGDVILAIGEQMVQNAEDVYEAVRTQSQLAVQIRRGRETLTLYVTPEVTEGGGWTMFWV","Homo sapiens","HTRA2, OMI, PRSS25","Serine protease HTRA2","1","2PZD"
"2PZE",,"X-RAY DIFFRACTION",2.09,41.11,"VAPOR DIFFUSION",7.5,"Protein: 9.5mg/ml NBD1, 0.15M NaCl, 0.01M methionine, 0.01M HEPES pH 7.5, 10% glycerol, 0.001M TCEP, 0.002M ATP; Well: 0.1M Hepes pH 7.5, 25% PEG 6K; Cryo: 25% DMSO, vapor diffusion, temperature 281K",281,"10.1093/protein/gzq004","ATP","2PZE",52.11,"1.7","1.7","Minimal human CFTR first nucleotide binding domain as a head-to-tail dimer","SLTTTEVVMENVTAFWEEGGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMMIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMG","Homo sapiens","CFTR, ABCC7","Cystic fibrosis transmembrane conductance regulator","1","2PZE"
,,,,,,,,,,,,,,,,,"Homo sapiens","CFTR, ABCC7"
"2PZF",,"X-RAY DIFFRACTION",2.1,41.33,"VAPOR DIFFUSION",8.5,"Protein: 9.5mg/ml NBD1, 0.15M NaCl, 0.01M methionine, 0.01M HEPES pH 7.5, 10% glycerol, 0.001M TCEP, 0.002M ATP; Well: 0.1M Tris pH 8.5, 35% PEG 4K, 0.2M NaAcetate; Cryo: 25% DMSO, vapor diffusion, temperature 281K",281,"10.1093/protein/gzq004",,"2PZF",51.82,"2","2","Minimal human CFTR first nucleotide binding domain as a head-to-tail dimer with delta F508","SLTTTEVVMENVTAFWEEGGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMMIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMG","Homo sapiens","CFTR, ABCC7","Cystic fibrosis transmembrane conductance regulator","1","2PZF"
,,,,,,,,,,,,,,,,,"Homo sapiens","CFTR, ABCC7"
"2PZG",,"X-RAY DIFFRACTION",2.33,47.27,"VAPOR DIFFUSION",6.5,"Protein: 9.5mg/ml NBD1, 0.15M NaCl, 0.01M methionine, 0.01M HEPES pH 7.5, 10% glycerol, 0.001M TCEP, 0.002M ATP; Well: 0.1M Hepes pH 6.5, 25% PEG 10K ; Cryo: 25% glycerol, vapor diffusion, temperature 281K",281,"10.1093/protein/gzq004",,"2PZG",55.47,"1.8","1.8","Minimal human CFTR first nucleotide binding domain as a monomer","SLQKQEYKTLEYNLTTTEVVMENVTAFWEEGGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMMIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMG","Homo sapiens","CFTR, ABCC7","Cystic fibrosis transmembrane conductance regulator","1","2PZG"
,,,,,,,,,,,,,,,,,"Homo sapiens","CFTR, ABCC7"
"2PZN",,"X-RAY DIFFRACTION",2.21,44.49,"VAPOR DIFFUSION, HANGING DROP",5,"Protein was co-crystallized with NADP+ (Sigma) and inhibitor (ratios protein/coenzyme/inhibitor = 1/2/2). Previously equilibrated (ammonium citrate buffer, PEG 6000 (15%)) hanging drops were seeded with stock seed solutions diluted 100 times. Cryofreezing was carried out through quick transfers into a stabilization solution (25% PEG 6000), then into a cryo-protecting solution (40% PEG 6000) and finally into either liquid nitrogen or ethane, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,,"393","2PZN",37.01,"1","1","The crystallographic structure of Aldose Reductase IDD393 complex confirms Leu300 as a specificity determinant","MASRILLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGKEFFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAKHNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVCALLSCTSHKDYPFHEEF","Homo sapiens","ALDR1, AKR1B1, ALR2","Aldose reductase","1","2PZN"
"2PZP",,"X-RAY DIFFRACTION",2.61,52.79,"VAPOR DIFFUSION, HANGING DROP",7.5,"100mM HEPES pH7.5, 25% PEG 4000, 200mM (NH4)2SO4, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.molcel.2007.06.028",,"2PZP",75.71,"2.4","2.4","Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic K526E Mutation Responsible for Crouzon Syndrome","MGSSHHHHHHSQDPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEE","Homo sapiens","FGFR2, BEK, KSAM, KGFR","Fibroblast growth factor receptor 2","1","2PZP"
"2PZR",,"X-RAY DIFFRACTION",2.65,53.59,"VAPOR DIFFUSION, HANGING DROP",7.5,"100mM HEPES pH7.5, 28% PEG 4000, 300mM (NH4)2SO4, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.molcel.2007.06.028",,"2PZR",75.67,"3","3","Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic K641R Mutation Responsible for Pfeiffer Syndrome","MGSSHHHHHHSQDPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEE","Homo sapiens","FGFR2, BEK, KSAM, KGFR","Fibroblast growth factor receptor 2","1","2PZR"
"2PZY",,"X-RAY DIFFRACTION",3.29,62.65,"VAPOR DIFFUSION, HANGING DROP",7.5,"100 mM HEPES pH 7.5, 1.85 M AMMONIUM SULFATE, vapor diffusion, hanging drop, temperature 297K",297,"10.1016/j.bmcl.2007.05.101","B18","2PZY",151.43,"2.9","2.9","Structure of MK2 Complexed with Compound 76","QQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMR","Homo sapiens","MAPKAPK2","MAP kinase-activated protein kinase 2","1","2PZY"
"2Q0B",,"X-RAY DIFFRACTION",2.66,53.74,"VAPOR DIFFUSION, HANGING DROP",7.5,"100mM HEPES pH7.5, 19% PEG 4000, 300mM (NH4)2SO4, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.molcel.2007.06.028",,"2Q0B",75.5,"2.9","2.9","Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic E565A Mutation Responsible for Pfeiffer Syndrome","MGSSHHHHHHSQDPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEE","Homo sapiens","FGFR2, BEK, KSAM, KGFR","Fibroblast growth factor receptor 2","1","2Q0B"
"2Q0N",,"X-RAY DIFFRACTION",2.94,58.21,"VAPOR DIFFUSION, SITTING DROP",8,"1.7M Ammonium sulfate, 15% PEG400, 1M Tris-HCl pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,,,"2Q0N",36.24,"1.75","1.75","Structure of human p21 activating kinase 4 (PAK4) in complex with a consensus peptide","SPQREPQRVSHEQFRAALQLVVDPGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPASIVPLMRQNRTR","Homo sapiens","PAK4, KIAA1142","Serine/threonine-protein kinase PAK 4","1","2Q0N"
,,,,,,,,,,,,,,,,"RRRRRSWYFDG",,,"Synthetic peptide","2","2Q0N"
"2Q0Z",,"X-RAY DIFFRACTION",2.45,49.7,"VAPOR DIFFUSION, SITTING DROP",5.6,"0.2M K/Na tartrate, 0.1M Sodium citrate pH 5.6, 1M Ammonium sulfate, 0.5M Imidazole pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,,,"2Q0Z",39.09,"2","2","Crystal structure of Q9P172/Sec63 from Homo sapiens. Northeast Structural Genomics Target HR1979.","MGHHHHHHSHMDVAPLNLGMIAAYYYINYTTIELFSMSLNAKTKVRGLIEIISNAAEYENIPIRHHEDNLLRQLAQKVPHKLNNPKFNDPHVKTNLLLQAHLSRMQLSAELQSDTEEILSKAIRLIQACVDVLSSNGWLSPALAAMELAQMVTQAMWSKDSYLKQLPHFTSEHIKRCTDKGVESVFDIMEMEDEERNALLQLTDSQIADVARFCNRYPNIELSYEVVDKDSIRSGGPVVVLVQLEREEEVTGPVIAPLFPQKREEGWWVVIGDAKSNSLISIKRLTLQQKAKVKLDFVAPATGAHNYTLYFMSDAYMGCDQEYKFSVDVKEAETDSDSD","Homo sapiens","SNRNP200, ASCC3L1, HELIC2, KIAA0788","Protein PRO2281","1","2Q0Z"
"2Q11",,"X-RAY DIFFRACTION",3.03,59.37,"VAPOR DIFFUSION, HANGING DROP",5.5,"25% PEGMME5K 
0.2 M Ammonium Iodide, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 278K",278,"10.1021/jm0705408","XX4","2Q11",131.19,"2.4","2.4","Structure of BACE complexed to compound 1","SFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPQVTVRANIAAITESDKFFIQGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLQQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTQQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYN","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","2Q11"
"2Q12",,"X-RAY DIFFRACTION",2.02,39.22,"VAPOR DIFFUSION, HANGING DROP",8,"0.1 M magnesium formate, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1038/sj.emboj.7601771",,"2Q12",31.16,"1.79","1.79","Crystal Structure of BAR domain of APPL1","GSHMDKLPIEETLEDSPQTRSLLGVFEEDATAISNYMNQLYQAMHRIYDAQNELSAATHLTSKLLKEYEKQRFPLGGDDEVMSSTLQQFSKVIDELSSCHAVLSTQLADAMMFPITQFKERDLKEILTLKEVFQIASNDHDAAINRYSRLSKKRENDKVKYEVTEDVYTSRKKQHQTMMHYFCALNTLQYKKKIALLEPLLGYMQAQISFFKMGSENLNEQLEEFLANIGTSVQNVRREMDSDIETMQQTIEDLEVASDPLYVPD","Homo sapiens","APPL1, APPL, DIP13A, KIAA1428","DCC-interacting protein 13 alpha","1","2Q12"
"2Q13",,"X-RAY DIFFRACTION",2.26,45.54,"VAPOR DIFFUSION, HANGING DROP",8,"6% PEG6000, 0.6M NaCl, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1038/sj.emboj.7601771",,"2Q13",44.17,"2.05","2.05","Crystal structure of BAR-PH domain of APPL1","GSHMDKLPIEETLEDSPQTRSLLGVFEEDATAISNYMNQLYQAMHRIYDAQNELSAATHLTSKLLKEYEKQRFPLGGDDEVMSSTLQQFSKVIDELSSCHAVLSTQLADAMMFPITQFKERDLKEILTLKEVFQIASNDHDAAINRYSRLSKKRENDKVKYEVTEDVYTSRKKQHQTMMHYFCALNTLQYKKKIALLEPLLGYMQAQISFFKMGSENLNEQLEEFLANIGTSVQNVRREMDSDIETMQQTIEDLEVASDPLYVPDPDPTKFPVNRNLTRKAGYLNARNKTGLVSSTWDRQFYFTQGGNLMSQARGDVAGGLAMDIDNCSVMAVDCEDRRYCFQITSFDGKKSSILQAESKKDHEEWICTINNISKQIYLSENPEE","Homo sapiens","APPL1, APPL, DIP13A, KIAA1428","DCC-interacting protein 13 alpha","1","2Q13"
"2Q15",,"X-RAY DIFFRACTION",2.99,58.83,"VAPOR DIFFUSION, SITTING DROP",6.6,"22.5% (w/v) PEG 5000 monomethylethyl (MME), 200 mM sodium citrate, 200 mM ammonium iodide, pH 6.6, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1021/jm0705408","3MR","2Q15",43.48,"2.4","2.4","Structure of BACE complexed to compound 3a","EMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPQVTVRANIAAITESDKFFIQGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLQQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTQQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYN","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","2Q15"
"2Q1B",,"X-RAY DIFFRACTION",2.2,43,"VAPOR DIFFUSION, SITTING DROP",8.5,"2.6-2.8M ammonium sulfate, 0.1M Tris-HCl, 0.001M chloro-mercury-benzoate, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1002/anie.200701189","LSA","2Q1B",29.93,"1.7","1.7","Carbonic Anhydrase II in Complex with Saccharin","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","2Q1B"
"2Q1E",,"X-RAY DIFFRACTION",4.75,74.11,"VAPOR DIFFUSION, HANGING DROP",7.4,"Mother Liquor: 15-30% (w/v) PEG 4K, 0.2 M Li2SO4, 0.1 M TRIS pH 7.9-8.9. Protein: 890 micromolar in 10 mM TRIS, pH 7.4, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1074/jbc.M705347200",,"2Q1E",47.92,"2.55","2.55","Altered dimer interface decreases stability in an amyloidogenic kappa1 Bence Jones protein.","ATDIQMTQSPSSLSASVGDRVTITCQASQDINNYLIWYQQKPGQAPKLLIYDASTLETGVPSRFSGSGSGTEFTFTISSLQPEDLATYHCQQYDNLPYTFGQGTKLEIK","Homo sapiens","mutant of Vk1 O18/O8 germline","Amyloidogenic immunoglobulin light chain protein AL-09","1","2Q1E"
"2Q1J",,"X-RAY DIFFRACTION",2.54,51.58,,5.9,"25% PEG 600, 0.3 M NACL, 0.1 M MES, PH 5.9, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 294K, pH 5.90",,"10.1016/j.bmc.2006.02.040","FXI","2Q1J",32.51,"1.9","1.9","The discovery of glycine and related amino acid-based factor xa inhibitors","LCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACIPTGPYPCGKQTLE","Homo sapiens","F10","Factor X light chain (EC 3.4.21.6)","2","2Q1J"
,,,,,,,,,,,,,,,,"IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT","Homo sapiens","F10","Activated factor Xa heavy chain (EC 3.4.21.6)","1","2Q1J"
"2Q1L",,"X-RAY DIFFRACTION",2.34,47.43,,,,,"10.1016/j.bmcl.2007.05.096","882","2Q1L",192.22,"2.05","2.05","Design and Synthesis of Pyrrole-based, Hepatoselective HMG-CoA Reductase Inhibitors","HHHHHHEPRPNEECLQILGNAEKGAKFLSDAEIIQLVNAKHIPAYKLETLIETHERGVSIRRQLLSKKLSEPSSLQYLPYRDYNYSLVMGACCENVIGYMPIPVGVAGPLCLDEKEFQVPMATTEGCLVASTNRGCRAIGLGGGASSRVLADGMTRGPVVRLPRACDSAEVKAWLETSEGFAVIKEAFDSTSRFARLQKLHTSIAGRNLYIRFQSRSGDAMGMNMISKGTEKALSKLHEYFPEMQILAVSGNYCTDKKPAAINWIEGRGKSVVCEAVIPAKVVREVLKTTTEAMIEVNINKNLVGSAMAGSIGGYNAHAANIVTAIYIACGQDAAQNVGSSNCITLMEASGPTNEDLYISCTMPSIEIGTVGGGTNLLPQQACLQMLGVQGACKDNPGENARQLARIVCGTVMAGELSLMAALAAGHLVKSHMIHNRSKIN","Homo sapiens","HMGCR","3-hydroxy-3-methylglutaryl-coenzyme A reductase","1","2Q1L"
"2Q1M",,"X-RAY DIFFRACTION",2.76,55.37,"VAPOR DIFFUSION, SITTING DROP",4.5,"25% PEG 3350, 0.1 M Sodium Acetate  pH 4.5, Vapor diffusion, Sitting drop, temperature 298K",298,"10.1073/pnas.0709264104",,"2Q1M",14.69,"2.3","2.3","Crystal Structure of human GITRL","GSHMETAKEPCMAKFGPLPSKWQMASSEPPCVNKVSDWKLEILQNGLYLIYGQVAPNANYNDVAPFEVRLYKNKDMIQTLTNKSKIQNVGGTYELHVGDTIDLIFNSEHQVLKNNTYWGIILLANPQFIS","Homo sapiens","TNFSF18, AITRL, GITRL, TL6, UNQ149/PRO175","Tumor necrosis factor ligand superfamily member 18","1","2Q1M"
"2Q20",,"X-RAY DIFFRACTION",3.29,62.63,"VAPOR DIFFUSION, HANGING DROP",,"Protein: 890 micromolar in 10 mM TRIS pH 7.4. Mother Liquor: 15-30% (w/v) PEG 4K, 0.2 Li2SO4, 0.1 M TRIS pH 7.9-8.9, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1074/jbc.M705347200",,"2Q20",23.94,"1.3","1.3","Structure of the germline Vk1 O18/O8 light chain variable domain homodimer","STDIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPYTFGQGTKLEIK","Homo sapiens","Vk1 O18/O8 light chain germline, IGKV1-33","Vk1 O18/O8 germline light chain variable domain","1","2Q20"
"2Q21",,"X-RAY DIFFRACTION",2.68,54.17,,,,,"10.1016/0022-2836(91)90753-s",,"2Q21",20.03,"2.2","2.2","CRYSTAL STRUCTURES AT 2.2 ANGSTROMS RESOLUTION OF THE CATALYTIC DOMAINS OF NORMAL RAS PROTEIN AND AN ONCOGENIC MUTANT COMPLEXED WITH GSP","MTEYKLVVVGAVGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHQYREQIKRVKDSDDVPMVLVGNKCDLAARTVESRQAQDLARSYGIPYIETSAKTRQGVEDAFYTLVREIRQHKLRKL","Homo sapiens","HRAS, HRAS1","C-H-RAS P21 PROTEIN CATALYTIC DOMAIN","1","2Q21"
"2Q2F",,"X-RAY DIFFRACTION",1.97,37.48,"VAPOR DIFFUSION, HANGING DROP",4.6,"Protein buffer: 100mM NaCl, 50mM Tris-HCl pH 8.0, 1mM EDTA, 2mM CaCl2, 5mM Beta-mercaptoethanol. Crystallization buffer: 13% PEG2000 MME, 0.1M Sodium acetate pH 4.6, 0.1M KSCN. Cryo: 30% Glycerol, VAPOR DIFFUSION, HANGING DROP, temperature 298.0K",298,,,"2Q2F",10.95,"1.5","1.5","Structure of the human Selenoprotein S (VCP-interacting membrane protein)","MHHHHHHSSGRENLYFQGSARLRALRQRQLDRAAAAVEPDVVVKRQEALAAARLKMQEELNAQVEKHKEKLKQLEEEKRRQKIEMWDSM","Homo sapiens","SELS, VIMP, AD-015, SBBI8, SELENOS","Selenoprotein S","1","2Q2F"
"2Q2Y",,"X-RAY DIFFRACTION",2.68,54.06,"VAPOR DIFFUSION, HANGING DROP",8,"PEG3350, Potassium Phosphate, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.bmcl.2007.07.074","MKR","2Q2Y",83.71,"2.5","2.5","Crystal Structure of KSP in complex with Inhibitor 1","ASQPNSSAKKKEEKGKNIQVVVRCRPFNLAERKASAHSIVECDPVRKEVSVRTGGLADKSSRKTYTFDMVFGASTKQIDVYRSVVCPILDEVIMGYNCTIFAYGQTGTGKTFTMEGERSPNEEYTWEEDPLAGIIPRTLHQIFEKLTDNGTEFSVKVSLLEIYNEELFDLLNPSSDVSERLQMFDDPRNKRGVIIKGLEEITVHNKDEVYQILEKGAAKRTTAATLMNAYSSRSHSVFSVTIHMKETTIDGEELVKIGKLNLVDLAGSENIGRSGAVDKRAREAGNINQSLLTLGRVITALVERTPHVPYRESKLTRILQDSLGGRTRTSIIATISPASLNLEETLSTLEYAHRAKNILNKPEVNQK","Homo sapiens","KIF11, EG5, KNSL1, TRIP5","Kinesin-like protein KIF11","1","2Q2Y"
"2Q2Z",,"X-RAY DIFFRACTION",2.7,54.37,"VAPOR DIFFUSION, HANGING DROP",8,"PEG3350, Potassium Phosphate, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.bmcl.2007.07.074","MKK","2Q2Z",83.68,"3","3","Crystal Structure of KSP in Complex with Inhibitor 22","ASQPNSSAKKKEEKGKNIQVVVRCRPFNLAERKASAHSIVECDPVRKEVSVRTGGLADKSSRKTYTFDMVFGASTKQIDVYRSVVCPILDEVIMGYNCTIFAYGQTGTGKTFTMEGERSPNEEYTWEEDPLAGIIPRTLHQIFEKLTDNGTEFSVKVSLLEIYNEELFDLLNPSSDVSERLQMFDDPRNKRGVIIKGLEEITVHNKDEVYQILEKGAAKRTTAATLMNAYSSRSHSVFSVTIHMKETTIDGEELVKIGKLNLVDLAGSENIGRSGAVDKRAREAGNINQSLLTLGRVITALVERTPHVPYRESKLTRILQDSLGGRTRTSIIATISPASLNLEETLSTLEYAHRAKNILNKPEVNQK","Homo sapiens","KIF11, EG5, KNSL1, TRIP5","Kinesin-like protein KIF11","1","2Q2Z"
"2Q32",,"X-RAY DIFFRACTION",2.6,52.6,"VAPOR DIFFUSION, HANGING DROP",8.5,"Protein solution (5 mg/ml Protein, 0.050 M Potassium chloride, 0.005 M Tris-HCl pH 8.5) mixed in a 1.5:1 ratio with the well solution (40% PEG 1500, 0.20 M Potassium glutamate, 0.10 M Triethanolamine, pH 8.5). Cryoprotected with well solution, VAPOR DIFUSSION, HANGING DROP, temperature 277K, VAPOR DIFFUSION, HANGING DROP",277,"10.1074/jbc.M707396200",,"2Q32",62.28,"2.4","2.4","Crystal structure of human heme oxygenase-2 C127A (HO-2)","MSAEVETSEGVDESEKKNSGALEKENQMRMADLSELLKEGTKEAHDRAENTQFVKDFLKGNIKKELFKLATTALYFTYSALEEEMERNKDHPAFAPLYFPMELHRKEALTKDMEYFFGENWEEQVQAPKAAQKYVERIHYIGQNEPELLVAHAYTRYMGDLSGGQVLKKVAQRALKLPSTGEGTQFYLFENVDNAQQFKQLYRARMNALDLNMKTKERIVEEANKAFEYNMQIFNELDQAGSTLARETLEDGFPVHDGKGDMRK","Homo sapiens","Hs.284279, HMOX2, HO2","Heme oxygenase 2","1","2Q32"
"2Q38",,"X-RAY DIFFRACTION",2.08,40.95,"VAPOR DIFFUSION, SITTING DROP",8,"2.5 M ammonium sulfate, 0.1 M tris hydrochloride, 0.3 M natrium chloride, 0.15 mM p-Chlormercuricbenzoic acid, pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1002/anie.200701189","LSA","2Q38",30.32,"1.95","1.95","Carbonic Anhydrase II in complex with Saccharin at 1.95 Angstrom","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","2Q38"
"2Q3E",,"X-RAY DIFFRACTION",2.76,55.38,"VAPOR DIFFUSION, SITTING DROP",6.5,"16% PEG 3350, 8% EG, 160 mM NaBr, 80 mM BTP., pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1074/jbc.M111.234682",,"2Q3E",640.21,"2","2","Structure of human UDP-glucose dehydrogenase complexed with NADH and UDP-glucose","SMFEIKKICCIGAGYVGGPTCSVIAHMCPEIRVTVVDVNESRINAWNSPTLPIYEPGLKEVVESCRGKNLFFSTNIDDAIKEADLVFISVNTPTKTYGMGKGRAADLKYIEACARRIVQNSNGYKIVTEKSTVPVRAAESIRRIFDANTKPNLNLQVLSNPEFLAEGTAIKDLKNPDRVLIGGDETPEGQRAVQALCAVYEHWVPREKILTTNTWSSELSKLAANAFLAQRISSINSISALCEATGADVEEVATAIGMDQRIGNKFLKASVGFGGSCFQKDVLNLVYLCEALNLPEVARYWQQVIDMNDYQRRRFASRIIDSLFNTVTDKKIAILGFAFKKDTGDTRESSSIYISKYLMDEGAHLHIYDPKVPREQIVVDLSHPGVSEDDQVSRLVTISKDPYEACDGAHAVVICTEWDMFKELDYERIHKKMLKPAFIFDGRRVLDGLHNELQTIGFQIETIGKKV","Homo sapiens","UGDH","UDP-glucose 6-dehydrogenase","1","2Q3E"
"2Q3F",,"X-RAY DIFFRACTION",2.35,47.65,"VAPOR DIFFUSION",8.4,"31% PEG4000, 0.2M sodium acetate and 0.1M Tris HCl, pH 8.4, VAPOR DIFFUSION, temperature 298K",298,,,"2Q3F",43.35,"2.1","2.1","X-ray crystal structure of putative human Ras-related GTP binding D in complex with GMPPNP","GEVKPRILLMGLRRSGKSSIQKVVFHKMSPNETLFLESTNKICREDVSNSSFVNFQIWDFPGQIDFFDPTFDYEMIFRGTGALIFVIDSQDDYMEALARLHLTVTRAYKVNTDINFEVFIHKVDGLSDDHKIETQRDIHQRANDDLADAGLEKIHLSFYLTSIYDHSIFEAFSKVVQKLIP","Homo sapiens","RRAGD","Ras-related GTP-binding protein D","1","2Q3F"
"2Q3G",,"X-RAY DIFFRACTION",1.96,37.38,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1M HEPES;  10% isopropanol;  20% PEG 4K, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1002/pro.349",,"2Q3G",18.83,"1.11","1.11","Structure of the PDZ domain of human PDLIM7 bound to a C-terminal extension from human beta-tropomyosin","SMDSFKVVLEGPAPWGFRLQGGKDFNVPLSISRLTPGGKAAQAGVAVGDWVLSIDGENAGSLTHIEAQNKIRACGERLSLGLSRAITSL","Homo sapiens","PDLIM7, ENIGMA","PDZ and LIM domain protein 7","1","2Q3G"
"2Q3H",,"X-RAY DIFFRACTION",2.4,48.83,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2M MgCl2;  0.1M TRIS;  25% PEG 3350, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,,,"2Q3H",22.15,"1.73","1.73","The crystal structure of RhouA in the GDP-bound state.","SMGPGEPGGRGRAGGAEGRGVKCVLVGDGAVGKTSLVVSYTTNGYPTEYIPTAFDNFSAVVSVDGRPVRLQLCDTAGQDEFDKLRPLCYTNTDIFLLCFSVVSPSSFQNVSEKWVPEIRCHCPKAPIILVGTQSDLREDVKVLIELDKCKEKPVPEEAAKLLAEEIKAASYIECSALTQKNLKEVFDAAIVAGIQYSDTQQ","Homo sapiens","RHOU, ARHU, CDC42L1, G28K, WRCH1, SB128","Ras homolog gene family, member U","1","2Q3H"
"2Q3Z",,"X-RAY DIFFRACTION",2.54,51.64,"VAPOR DIFFUSION, HANGING DROP",7.25,"100 mM HEPES pH 7.25, 1.25M Amm. sulfate, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1371/journal.pbio.0050327",,"2Q3Z",78.45,"2","2","Transglutaminase 2 undergoes large conformational change upon activation","MAEELVLERCDLELETNGRDHHTADLCREKLVVRRGQPFWLTLHFEGRNYQASVDSLTFSVVTGPAPSQEAGTKARFPLRDAVEEGDWTATVVDQQDCTLSLQLTTPANAPIGLYRLSLEASTGYQGSSFVLGHFILLFNAWCPADAVYLDSEEERQEYVLTQQGFIYQGSAKFIKNIPWNFGQFQDGILDICLILLDVNPKFLKNAGRDCSRRSSPVYVGRVGSGMVNCNDDQGVLLGRWDNNYGDGVSPMSWIGSVDILRRWKNHGCQRVKYGQCWVFAAVACTVLRCLGIPTRVVTNYNSAHDQNSNLLIEYFRNEFGEIQGDKSEMIWNFHCWVESWMTRPDLQPGYEGWQALDPTPQEKSEGTYCCGPVPVRAIKEGDLSTKYDAPFVFAEVNADVVDWIQQDDGSVHKSINRSLIVGLKISTKSVGRDEREDITHTYKYPEGSSEEREAFTRANHLNKLAEKEETGMAMRIRVGQSMNMGSDFDVFAHITNNTAEEYVCRLLLCARTVSYNGILGPECGTKYLLNLTLEPFSEKSVPLCILYEKYRDCLTESNLIKVRALLVEPVINSYLLAERDLYLENPEIKIRILGEPKQKRKLVAEVSLQNPLPVALEGCTFTVEGAGLTEEQKTVEIPDPVEAGEEVKVRMDLVPLHMGLHKLVVNFESDKLKAVKGFRNVIIGPA","Homo sapiens","TGM2","Transglutaminase 2","1","2Q3Z"
,,,,,,,,,,,,,,,,"XPXLPFX",,,"Polypeptide","2","2Q3Z"
"2Q4K",,"X-RAY DIFFRACTION",2.73,58.8,,,,,"10.1016/j.str.2007.06.019",,"2Q4K",82.8,"2.5","2.5","Ensemble refinement of the protein crystal structure of gene product from Homo sapiens Hs.433573","MEPGEELEEEGSPGGREDGFTAEHLAAEAMAADMDPWLVFDARTTPATELDAWLAKYPPSQVTRYGDPGSPNSEPVGWIAVYGQGYSPNSGDVQGLQAAWEALQTSGRPITPGTLRQLAITHHVLSGKWLMHLAPGFKLDHAWAGIARAVVEGRLQVAKVSPRAKEGGRQVICVYTDDFTDRLGVLEADSAIRAAGIKCLLTYKPDVYTYLGIYRANRWHLCPTLYESRFQLGGSARGSRVLDRANNVELT","Homo sapiens","C11orf68, BLES03, Hs.433573","Uncharacterized protein C11orf68","1","2Q4K"
"2Q4Q",,"X-RAY DIFFRACTION",2.2,44.3,,,,,"10.1016/j.str.2007.06.019",,"2Q4Q",26.8,"2.59","2.59","Ensemble refinement of the protein crystal structure of gene product from Homo sapiens Hs.95870","STSPEIASLSWGQMKVKGSNTTYKDCKVWPGGSRTWDWRETGTEHSPGVQPADVKEVVEKGVQTLVIGRGMSEALKVPSSTVEYLKKHGIDVRVLQTEQAVKEYNALVAQGVRVGGVFHSTC","Homo sapiens","C11orf67, PTD015, Hs.503357, AAMDC","UPF0366 protein C11orf67","1","2Q4Q"
"2Q4R",,"X-RAY DIFFRACTION",2.6,51.9,,,,,"10.1016/j.str.2007.06.019",,"2Q4R",28.55,"2.09","2.09","Ensemble refinement of the protein crystal structure of human phosphomannomutase 2 (PMM2)","SAAPGPALCLFDVDGTLTAPRQKITKEMDDFLQKLRQKIKIGVVGGSDFEKVQEQLGNDVVEKYDYVFPENGLVAYKDGKLLCRQNIQSHLGEALIQDLINYCLSYIAKIKLPKKRGTFIEFRNGMLNVSPIGRSCSQEERIEFYELDKKENIRQKFVADLRKEFAGKGLTFSIGGQISFDVFPDGWDKRYCLRHVENDGYKTIYFFGDKTMPGGNDHEIFTDPRTMGYSVTAPEDTRRICELLFS","Homo sapiens","PMM2, HS.459855","Phosphomannomutase 2","1","2Q4R"
"2Q4V",,"X-RAY DIFFRACTION",2.6,52.6,,,,,"10.1016/j.str.2007.06.019",,"2Q4V",39.27,"1.842","1.842","Ensemble refinement of the protein crystal structure of thialysine n-acetyltransferase (SSAT2) from Homo sapiens","SASVRIREAKEGDCGDILRLIRELAEFEKLSDQVKISEEALRADGFGDNPFYHCLVAEILPAPGKLLGPCVVGYGIYYFIYSTWKGRTIYLEDIYVMPEYRGQGIGSKIIKKVAEVALDKGCSQFRLAVLDWNQRAMDLYKALGAQDLTEAEGWHFFCFQGEATRKLAGK","Homo sapiens","SAT2, SSAT2","Diamine acetyltransferase 2","1","2Q4V"
"2Q50",,"X-RAY DIFFRACTION",2.58,52.41,,,,,"10.1016/j.str.2007.06.019",,"2Q50",143.61,"2.45","2.45","Ensemble refinement of the protein crystal structure of a glyoxylate/hydroxypyruvate reductase from Homo sapiens","SRPVRLMKVFVTRRIPAEGRVALARAADCEVEQWDSDEPIPAKELERGVAGAHGLLCLLSDHVDKRILDAAGANLKVISTMSVGIDHLALDEIKKRGIRVGYTPDVLTDTTAELAVSLLLTTCRRLPEAIEEVKNGGWTSWKPLWLCGYGLTQSTVGIIGLGRIGQAIARRLKPFGVQRFLYTGRQPRPEEAAEFQAEFVSTPELAAQSDFIVVACSLTPATEGLCNKDFFQKMKETAVFINISRGDVVNQDDLYQALASGKIAAAGLDVTSPEPLPTNHPLLTLKNCVILPHIGSATHRTRNTMSLLAANNLLAGLRGEPMPSELKL","Homo sapiens","GRHPR, GLXR, MSTP035","Glyoxylate reductase/hydroxypyruvate reductase","1","2Q50"
"2Q51",,"X-RAY DIFFRACTION",3.8,67.6,,,,,"10.1016/j.str.2007.06.019",,"2Q51",73.27,"2.8","2.8","Ensemble refinement of the protein crystal structure of an aspartoacylase from Homo sapiens","AIATSCHIAEEHIQKVAIFGGTHGNELTGVFLVKHWLENGAEIQRTGLEVKPFITNPRAVKKCTRYIDCDLNRIFDLENLGKKMSEDLPYEVRRAQEINHLFGPKDSEDSYDIIFDLHNTTSNMGCTLILEDSRNNFLIQMFHYIKTSLAPLPCYVYLIEHPSLKYATTRSIAKYPVGIEVGPQPQGVLRADILDQMRKMIKHALDFIHHFNEGKEFPPCAIEVYKIIEKVDYPRDENGEIAAIIHPNLQDQDWKPLHPGDPMFLTLDGKTIPLGGDCTVYPVFVNEAAYYEKKEAFAKTTKLTLNAKSIRCCLH","Homo sapiens","ASPA, ACY2, ASP","Aspartoacylase","1","2Q51"
"2Q53",,"X-RAY DIFFRACTION",2.2,42.5,,,,,"10.1002/prot.21719",,"2Q53",42.35,"2.01","2.01","Ensemble refinement of the crystal structure of uncharacterized protein loc79017 from Homo sapiens","SANSGCKDVTGPDEESFLYFAYGSNLLTERIHLRNPSAAFFCVARLQDFKLDFGNSQGKTSQTWHGGIATIFQSPGDEVWGVVWKMNKSNLNSLDEQEGVKSGMYVVIEVKVATQEGKEITCRSYLMTNYESAPPSPQYKKIICMGAKENGLPLEYQEKLKAIEPNDYTGKVSEEIEDIIKKGETQTL","Homo sapiens","C7orf24, GGCT, CRF21","Uncharacterized protein C7orf24","1","2Q53"
"2Q59",,"X-RAY DIFFRACTION",2.64,53.33,"VAPOR DIFFUSION, HANGING DROP",8,"1.4 M sodium citrate, 0.125 M Tris 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.str.2007.07.014","240","2Q59",63.72,"2.2","2.2","Crystal Structure of PPARgamma LBD bound to full agonist MRL20","SNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","Peroxisome Proliferator-Activated Receptor gamma","1","2Q59"
,,,,,,,,,,,,,,,,"SNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","Peroxisome Proliferator-Activated Receptor gamma","2","2Q59"
"2Q5A",,"X-RAY DIFFRACTION",2.82,56.32,"VAPOR DIFFUSION, HANGING DROP",7.5,"M Ammonium Sulfate, 1% PEG400, 100mM HEPES, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/cb7000044",,"2Q5A",19.63,"1.5","1.5","human Pin1 bound to L-PEPTIDE","GSHGMADEEKLPPGWEKAMSRSSGRVYYFNHITNASQWERPSGNSSSGGKNGQGEPARVRCSHLLVKHSQSRRPSSWRQEKITRTKEEALELINGYIQKIKSGEEDFESLASQFSDCSSAKARGDLGAFSRGQMQKPFEDASFALRTGEMSGPVFTDSGIHIILRTE","Homo sapiens","PIN1","Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1","1","2Q5A"
,,,,,,,,,,,,,,,,"XFTXAQX",,,"Five residue peptide","2","2Q5A"
"2Q5E",,"X-RAY DIFFRACTION",3.2,61.53,"VAPOR DIFFUSION",7,"2.8 M Sodium acetate, pH 7.0, VAPOR DIFFUSION, temperature 294K",294,"10.1007/s10969-007-9036-1",,"2Q5E",170.12,"2.51","2.51","Crystal structure of human carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 2","SLGTCLLPEVTEEDQGRICVVIDLDETLVHSSFKPINNADFIVPIEIEGTTHQVYVLKRPYVDEFLRRMGELFECVLFTASLAKYADPVTDLLDRCGVFRARLFRESCVFHQGCYVKDLSRLGRDLRKTLILDNSPASYIFHPENAVPVQSWFDDMADTELLNLIPIFEELSGAEDVYTSLGQLRAP","Homo sapiens","CTDSP2, NIF2, OS4, SCP2","Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 2","1","2Q5E"
"2Q5G",,"X-RAY DIFFRACTION",2.49,50.67,"VAPOR DIFFUSION, HANGING DROP",7.5,"pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.bmcl.2007.05.079","1FA","2Q5G",66.17,"2.7","2.7","Ligand binding domain of PPAR delta receptor in complex with a partial agonist","HHHHHHGSQYNPQVADLKAFSKHIYNAYLKNFNMTKKKARSILTGKASHTAPFVIHDIETLWQAEKGLVWKQLVNGLPPYKEISVHVFYRCQCTTVETVRELTEFAKSIPSFSSLFLNDQVTLLKYGVHEAIFAMLASIVNKDGLLVANGSGFVTREFLRSLRKPFSDIIEPKFEFAVKFNALELDDSDLALFIAAIILCGDRPGLMNVPRVEAIQDTILRALEFHLQANHPDAQYLFPKLLQKMADLRQLVTEHAQMMQRIKKTETETSLHPLLQEIYKDMY","Homo sapiens","PPARD, NR1C2, PPARB","Peroxisome proliferator-activated receptor delta","1","2Q5G"
"2Q5H",,"X-RAY DIFFRACTION",3.37,63.46,"VAPOR DIFFUSION, SITTING DROP",8.5,"20% PEG 3350, 0.2M Sodium bromide, 0.1M Bis-Tris propane, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.febslet.2007.05.046",,"2Q5H",78.46,"3","3","Crystal structure of apo-wildtype Glycyl-tRNA synthetase","MDGAGAEEVLAPLRLAVRQQGDLVRKLKEDKAPQVDVDKAVAELKARKRVLEAKELALQPKDDIVDRAKMEDTLKRRFFYDQAFAIYGGVSGLYDFGPVGCALKNNIIQTWRQHFIQEEQILEIDCTMLTPEPVLKTSGHVDKFADFMVKDVKNGECFRADHLLKAHLQKLMSDKKCSVEKKSEMESVLAQLDNYGQQELADLFVNYNVKSPITGNDLSPPVSFNLMFKTFIGPGGNMPGYLRPETAQGIFLNFKRLLEFNQGKLPFAAAQIGNSFRNEISPRSGLIRVREFTMAEIEHFVDPSEKDHPKFQNVADLHLYLYSAKAQVSGQSARKMRLGDAVEQGVINNTVLGYFIGRIYLYLTKVGISPDKLRFRQHMENEMAHYACDCWDAESKTSYGWIEIVGCADRSCYDLSCHARATKVPLVAEKPLKEPKTVNVVQFEPSKGAIGKAYKKDAKLVMEYLAICDECYITEMEMLLNEKGEFTIETEGKTFQLTKDMINVKRFQKTLYVEEVVPNVIEPSFGLGRIMYTVFEHTFHVREGDEQRTFFSFPAVVAPFKCSVLPLSQNQEFMPFVKELSEALTRHGVSHKVDDSSGSIGRRYARTDEIGVAFGVTIDFDTVNKTPHTATLRDRDSMRQIRAEISELPSIVQDLANGNITWADVEARYPLFEGQETGKKETIEEHHHHHH","Homo sapiens","GARS, GARS1","Glycyl-tRNA synthetase","1","2Q5H"
"2Q5I",,"X-RAY DIFFRACTION",3.36,63.44,"VAPOR DIFFUSION, SITTING DROP",6.5,"20% PEG 3350, 0.2M Na2SO4, 0.1M Bis-Tris propane, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.febslet.2007.05.046",,"2Q5I",78.78,"2.8","2.8","Crystal structure of apo S581L Glycyl-tRNA synthetase mutant","MDGAGAEEVLAPLRLAVRQQGDLVRKLKEDKAPQVDVDKAVAELKARKRVLEAKELALQPKDDIVDRAKMEDTLKRRFFYDQAFAIYGGVSGLYDFGPVGCALKNNIIQTWRQHFIQEEQILEIDCTMLTPEPVLKTSGHVDKFADFMVKDVKNGECFRADHLLKAHLQKLMSDKKCSVEKKSEMESVLAQLDNYGQQELADLFVNYNVKSPITGNDLSPPVSFNLMFKTFIGPGGNMPGYLRPETAQGIFLNFKRLLEFNQGKLPFAAAQIGNSFRNEISPRSGLIRVREFTMAEIEHFVDPSEKDHPKFQNVADLHLYLYSAKAQVSGQSARKMRLGDAVEQGVINNTVLGYFIGRIYLYLTKVGISPDKLRFRQHMENEMAHYACDCWDAESKTSYGWIEIVGCADRSCYDLSCHARATKVPLVAEKPLKEPKTVNVVQFEPSKGAIGKAYKKDAKLVMEYLAICDECYITEMEMLLNEKGEFTIETEGKTFQLTKDMINVKRFQKTLYVEEVVPNVIEPSFGLGRIMYTVFEHTFHVREGDEQRTFFSFPAVVAPFKCSVLPLSQNQEFMPFVKELLEALTRHGVSHKVDDSSGSIGRRYARTDEIGVAFGVTIDFDTVNKTPHTATLRDRDSMRQIRAEISELPSIVQDLANGNITWADVEARYPLFEGQETGKKETIEEHHHHHH","Homo sapiens","GARS, GARS1","Glycyl-tRNA synthetase","1","2Q5I"
"2Q5P",,"X-RAY DIFFRACTION",2.58,52.36,"VAPOR DIFFUSION, HANGING DROP",8,"1.4M sodium citrate, 0.125M Tris 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.str.2007.07.014","241","2Q5P",63.65,"2.3","2.3","Crystal Structure of PPARgamma bound to partial agonist MRL24","SNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","Peroxisome Proliferator-Activated Receptor gamma","1","2Q5P"
"2Q5S",,"X-RAY DIFFRACTION",2.58,52.31,"VAPOR DIFFUSION, HANGING DROP",8,"1.4M sodium citrate, 0.125M Tris8.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.str.2007.07.014","NZA","2Q5S",63.45,"2.05","2.05","Crystal Structure of PPARgamma bound to partial agonist nTZDpa","SNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","Peroxisome Proliferator-Activated Receptor gamma","1","2Q5S"
"2Q5X",,"X-RAY DIFFRACTION",3.15,60.89,"VAPOR DIFFUSION, HANGING DROP",4.6,"4.5M sodium formate, pH 4.6, vapor diffusion, hanging drop, temperature 296K",296,"10.1110/ps.073311808",,"2Q5X",17.54,"1.9","1.9","Crystal Structure of the C-terminal domain of hNup98","GIILTKVGYYTIPSMDDLAKITNEKGECIVSDFTIGRKGYGSIYFEGDVNLTNLNLDDIVHIRRKEVVVYLDDNQKPPVGEGLNRKAEVTLDGVWPTDKTSRCLIKSPDRLADINYEGRLEAVSRKQGAQFKEYRPETGSWVFKVSHFAKYGLQD","Homo sapiens","NUP98, ADAR2","Nuclear pore complex protein Nup98","1","2Q5X"
"2Q5Y",,"X-RAY DIFFRACTION",3.19,61.42,"VAPOR DIFFUSION, HANGING DROP",8.1,"0.1M Tris, 0.2M MgAc2, 22% PEG8000, microseeding, pH 8.1, vapor diffusion, hanging drop, temperature 296K",296,"10.1110/ps.073311808",,"2Q5Y",36.03,"2.3","2.3","Crystal Structure of the C-terminal domain of hNup98","MHPAGIILTKVGYYTIPSMDDLAKITNEKGECIVSDFTIGRKGYGSIYFEGDVNLTNLNLDDIVHIRRKEVVVYLDDNQKPPVGEGLNRKAEVTLDGVWPTDKTSRCLIKSPDRLADINYEGRLEAVSRKQGAQFKEYRPETGSWVFKVSHF","Homo sapiens","NUP98, ADAR2","Nuclear pore complex protein Nup98","1","2Q5Y"
,,,,,,,,,,,,,,,,"SKYGLQD",,,"Nuclear pore complex protein Nup96","2","2Q5Y"
"2Q61",,"X-RAY DIFFRACTION",2.6,52.68,"VAPOR DIFFUSION, HANGING DROP",8,"1.4M sodium citrate, 0.125M Tris 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.str.2007.07.014",,"2Q61",63.38,"2.197","2.197","Crystal Structure of PPARgamma ligand binding domain bound to partial agonist SR145","SNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","Peroxisome Proliferator-Activated Receptor gamma","1","2Q61"
"2Q6B",,"X-RAY DIFFRACTION",2.34,47.43,"VAPOR DIFFUSION",8.5,"PEG 4000 21 % (w/v), TRIS (pH=8.5) 100 millimolar, Li2SO4 200 millimolar, DTT 50 millimolar , VAPOR DIFFUSION",,"10.1016/j.bmcl.2007.05.097","HR2","2Q6B",192.39,"2","2","Design and synthesis of novel, conformationally restricted HMG-COA reductase inhibitors","HHHHHHEPRPNEECLQILGNAEKGAKFLSDAEIIQLVNAKHIPAYKLETLIETHERGVSIRRQLLSKKLSEPSSLQYLPYRDYNYSLVMGACCENVIGYMPIPVGVAGPLCLDEKEFQVPMATTEGCLVASTNRGCRAIGLGGGASSRVLADGMTRGPVVRLPRACDSAEVKAWLETSEGFAVIKEAFDSTSRFARLQKLHTSIAGRNLYIRFQSRSGDAMGMNMISKGTEKALSKLHEYFPEMQILAVSGNYCTDKKPAAINWIEGRGKSVVCEAVIPAKVVREVLKTTTEAMIEVNINKNLVGSAMAGSIGGYNAHAANIVTAIYIACGQDAAQNVGSSNCITLMEASGPTNEDLYISCTMPSIEIGTVGGGTNLLPQQACLQMLGVQGACKDNPGENARQLARIVCGTVMAGELSLMAALAAGHLVKSHMIHNRSKIN","Homo sapiens","HMGCR","3-hydroxy-3-methylglutaryl-coenzyme A reductase","1","2Q6B"
"2Q6C",,"X-RAY DIFFRACTION",2.43,49.46,"VAPOR DIFFUSION",,"VAPOR DIFFUSION",,"10.1016/j.bmcl.2007.05.097","HR1","2Q6C",192.53,"2","2","Design and synthesis of novel, conformationally restricted HMG-COA reductase inhibitors","HHHHHHEPRPNEECLQILGNAEKGAKFLSDAEIIQLVNAKHIPAYKLETLIETHERGVSIRRQLLSKKLSEPSSLQYLPYRDYNYSLVMGACCENVIGYMPIPVGVAGPLCLDEKEFQVPMATTEGCLVASTNRGCRAIGLGGGASSRVLADGMTRGPVVRLPRACDSAEVKAWLETSEGFAVIKEAFDSTSRFARLQKLHTSIAGRNLYIRFQSRSGDAMGMNMISKGTEKALSKLHEYFPEMQILAVSGNYCTDKKPAAINWIEGRGKSVVCEAVIPAKVVREVLKTTTEAMIEVNINKNLVGSAMAGSIGGYNAHAANIVTAIYIACGQDAAQNVGSSNCITLMEASGPTNEDLYISCTMPSIEIGTVGGGTNLLPQQACLQMLGVQGACKDNPGENARQLARIVCGTVMAGELSLMAALAAGHLVKSHMIHNRSKIN","Homo sapiens","HMGCR","3-hydroxy-3-methylglutaryl-coenzyme A reductase","1","2Q6C"
"2Q6R",,"X-RAY DIFFRACTION",2.61,52.96,"VAPOR DIFFUSION, HANGING DROP",8,"1.4M sodium citrate, 0.125M Tris 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.str.2007.07.014",,"2Q6R",63.44,"2.407","2.407","Crystal structure of PPAR gamma complexed with partial agonist SF147","SNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","Peroxisome Proliferator-Activated Receptor gamma","1","2Q6R"
"2Q6S",,"X-RAY DIFFRACTION",2.64,53.41,"VAPOR DIFFUSION, HANGING DROP",8,"1.4M sodium citrate, 0.125 M Tris 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.str.2007.07.014","PLB","2Q6S",62.99,"2.4","2.4","2.4 angstrom crystal structure of PPAR gamma complexed to BVT.13 without co-activator peptides","SNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","Peroxisome Proliferator-Activated Receptor gamma","1","2Q6S"
"2Q6Z",,"X-RAY DIFFRACTION",2.79,55.95,"VAPOR DIFFUSION, SITTING DROP",7,"Protein at 6.5 mg/ml in 50mM Tris, pH 7.5, 1mM BME was mixed 5 parts to 3 parts of precipitant (1.7M citrate, pH 7.0), VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1016/j.trsl.2006.08.006",,"2Q6Z",39.86,"2","2","Uroporphyrinogen Decarboxylase G168R single mutant apo-enzyme","FPELKNDTFLRAAWGEETDYTPVWCMRQAGRYLPEFRETRAAQDFFSTCRSPEACCELTLQPLRRFPLDAAIIFSDILVVPQALGMEVTMVPGKGPSFPEPLREEQDLERLRDPEVVASELGYVFQAITLTRQRLAGRVPLIGFAGAPWTLMTYMVERGGSSTMAQAKRWLYQRPQASHQLLRILTDALVPYLVGQVVAGAQALQLFESHAGHLGPQLFNKFALPYIRDVAKQVKARLREAGLAPVPMIIFAKDGHFALEELAQAGYEVVGLDWTVAPKKARECVGKTVTLQGNLDPCALYASEEEIGQLVKQMLDDFGPHRYIANLGHGLYPDMDPEHVGAFVDAVHKHSRLLRQ","Homo sapiens","UROD","Uroporphyrinogen decarboxylase","1","2Q6Z"
"2Q70",,"X-RAY DIFFRACTION",2.35,47.76,"VAPOR DIFFUSION, HANGING DROP",8,"0.1M Tris, 0.2M magnesium chloride, 20% PEG 4000, 10% ethylene glycol, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1016/j.bmcl.2007.06.052","DC8","2Q70",57.23,"1.95","1.95","Estrogen receptor alpha ligand-binding domain complxed to a benzopyran ligand","NSLALSLTADQMVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLESAWLEILMIGLVWRSMEHPGKLLFAPNLLLDRNQGKSVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGMEHLYSMKSKNVVPLYDLLLEMLDAHRLHA","Homo sapiens","ESR1, ESR, NR3A1","Estrogen receptor","1","2Q70"
"2Q71",,"X-RAY DIFFRACTION",2.76,55.45,"VAPOR DIFFUSION, SITTING DROP",7,"Protien at 6.5 mg/ml in 50mM Tris, pH 7.5, 1mM BME was mixed 5 parts to 3 parts of precipitant (1.7M citrate, pH 7.0) and equilibrated by sitting drop vapor diffusion against a well of precipitant., VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1016/j.trsl.2006.08.006",,"2Q71",40.52,"1.9","1.9","Uroporphyrinogen Decarboxylase G168R single mutant enzyme in complex with coproporphyrinogen-III","FPELKNDTFLRAAWGEETDYTPVWCMRQAGRYLPEFRETRAAQDFFSTCRSPEACCELTLQPLRRFPLDAAIIFSDILVVPQALGMEVTMVPGKGPSFPEPLREEQDLERLRDPEVVASELGYVFQAITLTRQRLAGRVPLIGFAGAPWTLMTYMVERGGSSTMAQAKRWLYQRPQASHQLLRILTDALVPYLVGQVVAGAQALQLFESHAGHLGPQLFNKFALPYIRDVAKQVKARLREAGLAPVPMIIFAKDGHFALEELAQAGYEVVGLDWTVAPKKARECVGKTVTLQGNLDPCALYASEEEIGQLVKQMLDDFGPHRYIANLGHGLYPDMDPEHVGAFVDAVHKHSRLLRQ","Homo sapiens","UROD","Uroporphyrinogen decarboxylase","1","2Q71"
"2Q7D",,"X-RAY DIFFRACTION",2.5,50.76,"VAPOR DIFFUSION, SITTING DROP",5.6,"0.1M Na Citrate, 0.2M K/Na Tartrate, 2M (NH4)2SO4, pH 5.6, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1074/jbc.M703121200",,"2Q7D",80.45,"1.6","1.6","Crystal Structure of Human Inositol 1,3,4-Trisphosphate 5/6-kinase (ITPK1) in complex with AMPPNP and Mn2+","GSDKIHHHHHHMQTFLKGKRVGYWLSEKKIKKLNFQAFAELCRKRGMEVVQLNLSRPIEEQGPLDVIIHKLTDVILEADQNDSQSLELVHRFQEYIDAHPETIVLDPLPAIRTLLDRSKSYELIRKIEAYMEDDRICSPPFMELTSLCGDDTMRLLEKNGLTFPFICKTRVAHGTNSHEMAIVFNQEGLNAIQPPCVVQNFINHNAVLYKVFVVGESYTVVQRPSLKNFSAGTSDRESIFFNSHNVSKPESSSVLTELDKIEGVFERPSDEVIRELSRALRQALGVSLFGIDIIINNQTGQHAVIDINAFPGYEGVSEFFTDLLNHIATVLQGQSTAMAATGDVAL","Homo sapiens","ITPK1","Inositol-tetrakisphosphate 1-kinase","1","2Q7D"
"2Q7I",,"X-RAY DIFFRACTION",2.1,41.56,,,,,"10.1074/jbc.M703268200","TES","2Q7I",31.85,"1.87","1.87","The Wild Type Androgen Receptor Ligand Binding Domain Bound with Testosterone and an AR 20-30 Peptide","HIEGYECQPIFLNVLEAIEPGVVCAGHDNNQPDSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWMGLMVFAMGWRSFTNVNSRMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKNQKFFDELRMNYIKELDRIIACKRKNPTSCSRRFYQLTKLLDSVQPIARELHQFTFDLLIKSHMVSVDFPEMMAEIISVQVPKILSGKVKPIYFHTQ","Homo sapiens","AR, DHTR, NR3C4","Androgen receptor","1","2Q7I"
,,,,,,,,,,,,,,,,"RGAFQNLFQSV","Homo sapiens","AR, DHTR, NR3C4","Androgen receptor","2","2Q7I"
"2Q7K",,"X-RAY DIFFRACTION",2.09,41.06,,,,,"10.1074/jbc.M703268200","TES","2Q7K",31.87,"1.8","1.8","The Androgen Receptor Prostate Cancer Mutant H874Y Ligand Binding Domain Bound with Testosterone and an AR 20-30 Peptide","HIEGYECQPIFLNVLEAIEPGVVCAGHDNNQPDSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWMGLMVFAMGWRSFTNVNSRMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKNQKFFDELRMNYIKELDRIIACKRKNPTSCSRRFYQLTKLLDSVQPIARELYQFTFDLLIKSHMVSVDFPEMMAEIISVQVPKILSGKVKPIYFHTQ","Homo sapiens","AR, DHTR, NR3C4","Androgen receptor","1","2Q7K"
,,,,,,,,,,,,,,,,"RGAFQNLFQSV","Homo sapiens","AR, DHTR, NR3C4","Androgen receptor","2","2Q7K"
"2Q7M",,"X-RAY DIFFRACTION",5.272281,76.670441,"VAPOR DIFFUSION, SITTING DROP",5.6,"10% PEG4000, 0.32 LiCl2, 1mM TCEP , pH 5.6, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1126/science.1144346","2CS","2Q7M",112.19,"4.25","4.25","Crystal structure of human FLAP with MK-591","MDQETVGNVVLLAIVTLISVVQNGFFAHKVEHESRTQNGRSFQRTGTLAFERVYTANQNCVDAYPTFLAVLWSAGLLCSQVPAAFAGLMYLFVRQKYFVGYLGERTQSTPGYIFGKRIILFLFLMSVAGIFNYYLIFFFGSDFENYIATISTTISPLLLIP","Homo sapiens","ALOX5AP, FLAP","Arachidonate 5-lipoxygenase-activating protein","1","2Q7M"
"2Q7O",,"X-RAY DIFFRACTION",5.11,75.95,"VAPOR DIFFUSION, SITTING DROP",5,"1.8 M Ammonium dihydrogen phosphate, 100 mM sodium citrate, pH 5.0, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1021/ja710733g","IMH","2Q7O",32.55,"2.9","2.9","Structure of human purine nucleoside phosphorylase in complex with L-Immucillin-H","MENGYTYEDYKNTAEWLLSHTKHRPQVAIICGSGLGGLTDKLTQAQIFDYSEIPNFPRSTVPGHAGRLVFGFLNGRACVMMQGRFHMYEGYPLWKVTFPVRVFHLLGVDTLVVTNAAGGLNPKFEVGDIMLIRDHINLPGFSGQNPLRGPNDERFGDRFPAMSDAYDRTMRQRALSTWKQMGEQRELQEGTYVMVAGPSFETVAECRVLQKLGADAVGMSTVPEVIVARHCGLRVFGFSLITNKVIMDYESLEKANHEEVLAAGKQAAQKLEQFVSILMASIPLPDKAS","Homo sapiens","NP, PNP","Purine nucleoside phosphorylase","1","2Q7O"
"2Q7R",,"X-RAY DIFFRACTION",5.21,76.41,,5.6,"10% PEG 4000, 0.32 LiCl2, 1 mM TCEP, pH 5.6, VAPOR DIFFUSION, SITTING DROP, temperature 298K, pH 5.60",298,"10.1126/science.1144346",,"2Q7R",113.65,"4","4","Crystal structure of human FLAP with an iodinated analog of MK-591","MDQETVGNVVLLAIVTLISVVQNGFFAHKVEHESRTQNGRSFQRTGTLAFERVYTANQNCVDAYPTFLAVLWSAGLLCSQVPAAFAGLMYLFVRQKYFVGYLGERTQSTPGYIFGKRIILFLFLMSVAGIFNYYLIFFFGSDFENYIATISTTISPLLLIP","Homo sapiens","ALOX5AP, FLAP","Arachidonate 5-lipoxygenase-activating protein","1","2Q7R"
"2Q7Z",,"SOLUTION SCATTERING",,,,,,,"10.1016/j.jmb.2007.09.085",,"2Q7Z",212.4,,,"Solution Structure of the 30 SCR domains of human Complement Receptor 1","QCNAPEWLPFARPTNLTDEFEFPIGTYLNYECRPGYSGRPFSIICLKNSVWTGAKDRCRRKSCRNPPDPVNGMVHVIKGIQFGSQIKYSCTKGYRLIGSSSATCIISGDTVIWDNETPICDRIPCGLPPTITNGDFISTNRENFHYGSVVTYRCNPGSGGRKVFELVGEPSIYCTSNDDQVGIWSGPAPQCIIPNKCTPPNVENGILVSDNRSLFSLNEVVEFRCQPGFVMKGPRRVKCQALNKWEPELPSCSRVCQPPPDVLHAERTQRDKDNFSPGQEVFYSCEPGYDLRGAASMRCTPQGDWSPAAPTCEVKSCDDFMGQLLNGRVLFPVNLQLGAKVDFVCDEGFQLKGSSASYCVLAGMESLWNSSVPVCEQIFCPSPPVIPNGRHTGKPLEVFPFGKAVNYTCDPHPDRGTSFDLIGESTIRCTSDPQGNGVWSSPAPRCGILGHCQAPDHFLFAKLKTQTNASDFPIGTSLKYECRPEYYGRPFSITCLDNLVWSSPKDVCKRKSCKTPPDPVNGMVHVITDIQVGSRINYSCTTGHRLIGHSSAECILSGNAAHWSTKPPICQRIPCGLPPTIANGDFISTNRENFHYGSVVTYRCNPGSGGRKVFELVGEPSIYCTSNDDQVGIWSGPAPQCIIPNKCTPPNVENGILVSDNRSLFSLNEVVEFRCQPGFVMKGPRRVKCQALNKWEPELPSCSRVCQPPPDVLHAERTQRDKDNFSPGQEVFYSCEPGYDLRGAASMRCTPQGDWSPAAPTCEVKSCDDFMGQLLNGRVLFPVNLQLGAKVDFVCDEGFQLKGSSASYCVLAGMESLWNSSVPVCEQIFCPSPPVIPNGRHTGKPLEVFPFGKAVNYTCDPHPDRGTSFDLIGESTIRCTSDPQGNGVWSSPAPRCGILGHCQAPDHFLFAKLKTQTNASDFPIGTSLKYECRPEYYGRPFSITCLDNLVWSSPKDVCKRKSCKTPPDPVNGMVHVITDIQVGSRINYSCTTGHRLIGHSSAECILSGNTAHWSTKPPICQRIPCGLPPTIANGDFISTNRENFHYGSVVTYRCNLGSRGRKVFELVGEPSIYCTSNDDQVGIWSGPAPQCIIPNKCTPPNVENGILVSDNRSLFSLNEVVEFRCQPGFVMKGPRRVKCQALNKWEPELPSCSRVCQPPPEILHGEHTPSHQDNFSPGQEVFYSCEPGYDLRGAASLHCTPQGDWSPEAPRCAVKSCDDFLGQLPHGRVLFPLNLQLGAKVSFVCDEGFRLKGSSVSHCVLVGMRSLWNNSVPVCEHIFCPNPPAILNGRHTGTPSGDIPYGKEISYTCDPHPDRGMTFNLIGESTIRCTSDPHGNGVWSSPAPRCELSVRAGHCKTPEQFPFASPTIPINDFEFPVGTSLNYECRPGYFGKMFSISCLENLVWSSVEDNCRRKSCGPPPEPFNGMVHINTDTQFGSTVNYSCNEGFRLIGSPSTTCLVSGNNVTWDKKAPICEIISCEPPPTISNGDFYSNNRTSFHNGTVVTYQCHTGPDGEQLFELVGERSIYCTSKDDQVGVWSSPPPRCISTNKCTAPEVENAIRVPGNRSFFSLTEIIRFRCQPGFVMVGSHTVQCQTNGRWGPKLPHCSRVCQPPPEILHGEHTLSHQDNFSPGQEVFYSCEPSYDLRGAASLHCTPQGDWSPEAPRCTVKSCDDFLGQLPHGRVLLPLNLQLGAKVSFVCDEGFRLKGRSASHCVLAGMKALWNSSVPVCEQIFCPNPPAILNGRHTGTPFGDIPYGKEISYACDTHPDRGMTFNLIGESSIRCTSDPQGNGVWSSPAPRCELSVPAACPHPPKIQNGHYIGGHVSLYLPGMTISYICDPGYLLVGKGFIFCTDQGIWSQLDHYCKEVNCSFPLFMNGISKELEMKKVYHYGDYVTLKCEDGYTLEGSPWSQCQADDRWDPPLAKCTSRAHDA","Homo sapiens","CR1, C3BR","Complement receptor type 1","1","2Q7Z"
"2Q80",,"X-RAY DIFFRACTION",2.51,51.06,"VAPOR DIFFUSION, SITTING DROP",5.5,"25% PEG 3350, 0.2M MG FORMATE, pH 5.50, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1074/jbc.M602603200","GRG","2Q80",213.01,"2.7","2.7","Crystal structure of human geranylgeranyl pyrophosphate synthase bound to GGPP","SMEKTQETVQRILLEPYKYLLQLPGKQVRTKLSQAFNHWLKVPEDKLQIIIEVTEMLHNASLLIDDIEDNSKLRRGFPVAHSIYGIPSVINSANYVYFLGLEKVLTLDHPDAVKLFTRQLLELHQGQGLDIYWRDNYTCPTEEEYKAMVLQKTGGLFGLAVGLMQLFSDYKEDLKPLLNTLGLFFQIRDDYANLHSKEYSENKSFCEDLTEGKFSFPTIHAIWSRPESTQVQNILRQRTENIDIKKYCVHYLEDVGSFEYTRNTLKELEAKAYKQIDARGGNPELVALVKHLSKMFKEENE","Homo sapiens","GGPS1","Geranylgeranyl pyrophosphate synthetase","1","2Q80"
"2Q81",,"X-RAY DIFFRACTION",2.34,47.35,"VAPOR DIFFUSION, HANGING DROP",7.5,"20% PEG 3350, 20% PEG 400, 200 mM MgCl2, 100 mM HEPES pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1016/j.jmb.2007.08.026",,"2Q81",52.48,"2.1","2.1","Crystal Structure of the Miz-1 BTB/POZ domain","GPLGSDFPQHSQHVLEQLNQQRQLGLLCDCTFVVDGVHFKAHKAVLAACSEYFKMLFVDQKDVVHLDISNAAGLGQVLEFMYTAKLSLSPENVDDVLAVATFLQMQDIITACHALKSLA","Homo sapiens","ZBTB17, MIZ1, ZNF151, ZNF60","Miz-1 protein","1","2Q81"
"2Q87",,"X-RAY DIFFRACTION",2.24,45.12,"VAPOR DIFFUSION, HANGING DROP",,"VAPOR DIFFUSION, HANGING DROP, temperature 293.15K",293.15,,,"2Q87",36.6,"1.7","1.7","The Crystal Structure of the Human IRp60 Ectodomain","SKARTVAGPVGGSLSVQCPYEKEHRTLNKYWCRPPQIFLCDKIVETKGSAGKRNGRVSIRDSPANLSFTVTLENLTEEDAGTYWCGVDTPWLQDFHDPVVEVEVSVFPAS","Homo sapiens","CD300A, CMRF35H, IGSF12, HSPC083","CMRF35-H antigen","1","2Q87"
"2Q8C",,"X-RAY DIFFRACTION",2.58,52.36,,,,,"10.1038/nsmb1273",,"2Q8C",85.48,"2.047","2.047","Crystal structure of JMJD2A in ternary complex with an histone H3K9me3 peptide and 2-oxoglutarate","GSMASESETLNPSARIMTFYPTMEEFRNFSRYIAYIESQGAHRAGLAKVVPPKEWKPRASYDDIDDLVIPAPIQQLVTGQSGLFTQYNIQKKAMTVREFRKIANSDKYCTPRYSEFEELERKYWKNLTFNPPIYGADVNGTLYEKHVDEWNIGRLRTILDLVEKESGITIEGVNTPYLYFGMWKTSFAWHTEDMDLYSINYLHFGEPKSWYSVPPEHGKRLERLAKGFFPGSAQSCEAFLRHKMTLISPLMLKKYGIPFDKVTQEAGEFMITFPYGYHAGFNHGFNCAESTNFATRRWIEYGKQAVLCSCRKDMVKISMDVFVRKFQPERYKLWKAGKDNTVIDHTLPTPEA","Homo sapiens","JMJD2A, JHDM3A, JMJD2, KIAA0677, KDM4A","JmjC domain-containing histone demethylation protein 3A","1","2Q8C"
,,,,,,,,,,,,,,,,"ARTKQTARKSTGGKA",,,"HISTONE 3 PEPTIDE","2","2Q8C"
"2Q8D",,"X-RAY DIFFRACTION",2.61,52.81,,,,,"10.1038/nsmb1273",,"2Q8D",85.78,"2.29","2.29","Crystal structure of JMJ2D2A in ternary complex with histone H3-K36me2 and succinate","GSMASESETLNPSARIMTFYPTMEEFRNFSRYIAYIESQGAHRAGLAKVVPPKEWKPRASYDDIDDLVIPAPIQQLVTGQSGLFTQYNIQKKAMTVREFRKIANSDKYCTPRYSEFEELERKYWKNLTFNPPIYGADVNGTLYEKHVDEWNIGRLRTILDLVEKESGITIEGVNTPYLYFGMWKTSFAWHTEDMDLYSINYLHFGEPKSWYSVPPEHGKRLERLAKGFFPGSAQSCEAFLRHKMTLISPLMLKKYGIPFDKVTQEAGEFMITFPYGYHAGFNHGFNCAESTNFATRRWIEYGKQAVLCSCRKDMVKISMDVFVRKFQPERYKLWKAGKDNTVIDHTLPTPEA","Homo sapiens","JMJD2A, JHDM3A, JMJD2, KIAA0677, KDM4A","JmjC domain-containing histone demethylation protein 3A","1","2Q8D"
,,,,,,,,,,,,,,,,"RKSAPATGGVKKPHRY",,,"HISTONE 3 peptide","2","2Q8D"
"2Q8E",,"X-RAY DIFFRACTION",2.56,51.88,,,,,"10.1038/nsmb1273","OGA","2Q8E",85.87,"2.05","2.05","Specificity and Mechanism of JMJD2A, a Trimethyllysine-Specific Histone Demethylase","GSMASESETLNPSARIMTFYPTMEEFRNFSRYIAYIESQGAHRAGLAKVVPPKEWKPRASYDDIDDLVIPAPIQQLVTGQSGLFTQYNIQKKAMTVREFRKIANSDKYCTPRYSEFEELERKYWKNLTFNPPIYGADVNGTLYEKHVDEWNIGRLRTILDLVEKESGITIEGVNTPYLYFGMWKTSFAWHTEDMDLYSINYLHFGEPKSWYSVPPEHGKRLERLAKGFFPGSAQSCEAFLRHKMTLISPLMLKKYGIPFDKVTQEAGEFMITFPYGYHAGFNHGFNCAESTNFATRRWIEYGKQAVLCSCRKDMVKISMDVFVRKFQPERYKLWKAGKDNTVIDHTLPTPEA","Homo sapiens","JMJD2A, JHDM3A, JMJD2, KIAA0677, KDM4A","JmjC domain-containing histone demethylation protein 3A","1","2Q8E"
,,,,,,,,,,,,,,,,"RKSAPATGGVKKPHRY",,,"histone 3 peptide","2","2Q8E"
"2Q8F",,"X-RAY DIFFRACTION",2.87,57.12,"VAPOR DIFFUSION, HANGING DROP",5.6,"0.42 M NaK tartrate, 0.1 M Na citrate, pH 5.6, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.str.2007.07.001",,"2Q8F",46.4,"2.03","2.03","Structure of pyruvate dehydrogenase kinase isoform 1","SDSGSSPASERGVPGQVDFYARFSPSPLSMKQFLDFGSVNACEKTSFMFLRQELPVRLANIMKEISLLPDNLLRTPSVQLVQSWYIQSLQELLDFKDKSAEDAKAIYDFTDTVIRIRNRHNDVIPTMAQGVIEYKESFGVDPVTSQNVQYFLDRFYMSRISIRMLLNQHSLLFGGKGKGSPSHRKHIGSINPNCNVLEVIKDGYENARRLCDLYYINSPELELEELNAKSPGQPIQVVYVPSHLYHMVFELFKNAMRATMEHHANRGVYPPIQVHVTLGNEDLTVKMSDRGGGVPLRKIDRLFNYMYSTAPRPRVETSRAVPLAGFGYGLPISRLYAQYFQGDLKLYSLEGYGTDAVIYIKALSTDSIERLPVYNKAAWKHYNTNHEADDWCVPSREPKDMTTFRSA","Homo sapiens","PDK1, PDHK1","[Pyruvate dehydrogenase [lipoamide]] kinase isozyme 1","1","2Q8F"
"2Q8G",,"X-RAY DIFFRACTION",2.82,56.41,"VAPOR DIFFUSION, HANGING DROP",5.6,"AZD75445 was generously supplied by Dr. Rachel Mayers at AstraZeneca, 0.42 M NaK tartrate, 0.1 M Na citrate, pH 5.6, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.str.2007.07.001","AZX","2Q8G",46.88,"1.9","1.9","Structure of pyruvate dehydrogenase kinase isoform 1 in complex with glucose-lowering drug AZD7545","SDSGSSPASERGVPGQVDFYARFSPSPLSMKQFLDFGSVNACEKTSFMFLRQELPVRLANIMKEISLLPDNLLRTPSVQLVQSWYIQSLQELLDFKDKSAEDAKAIYDFTDTVIRIRNRHNDVIPTMAQGVIEYKESFGVDPVTSQNVQYFLDRFYMSRISIRMLLNQHSLLFGGKGKGSPSHRKHIGSINPNCNVLEVIKDGYENARRLCDLYYINSPELELEELNAKSPGQPIQVVYVPSHLYHMVFELFKNAMRATMEHHANRGVYPPIQVHVTLGNEDLTVKMSDRGGGVPLRKIDRLFNYMYSTAPRPRVETSRAVPLAGFGYGLPISRLYAQYFQGDLKLYSLEGYGTDAVIYIKALSTDSIERLPVYNKAAWKHYNTNHEADDWCVPSREPKDMTTFRSA","Homo sapiens","PDK1, PDHK1","[Pyruvate dehydrogenase [lipoamide]] kinase isozyme 1","1","2Q8G"
"2Q8H",,"X-RAY DIFFRACTION",2.88,57.29,,5.6,"0.42 M NaK tartrate, 0.1 M Na citrate, pH 5.6, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.str.2007.07.001","TF4","2Q8H",46.53,"2","2","Structure of pyruvate dehydrogenase kinase isoform 1 in complex with dichloroacetate (DCA)","SDSGSSPASERGVPGQVDFYARFSPSPLSMKQFLDFGSVNACEKTSFMFLRQELPVRLANIMKEISLLPDNLLRTPSVQLVQSWYIQSLQELLDFKDKSAEDAKAIYDFTDTVIRIRNRHNDVIPTMAQGVIEYKESFGVDPVTSQNVQYFLDRFYMSRISIRMLLNQHSLLFGGKGKGSPSHRKHIGSINPNCNVLEVIKDGYENARRLCDLYYINSPELELEELNAKSPGQPIQVVYVPSHLYHMVFELFKNAMRATMEHHANRGVYPPIQVHVTLGNEDLTVKMSDRGGGVPLRKIDRLFNYMYSTAPRPRVETSRAVPLAGFGYGLPISRLYAQYFQGDLKLYSLEGYGTDAVIYIKALSTDSIERLPVYNKAAWKHYNTNHEADDWCVPSREPKDMTTFRSA","Homo sapiens","PDK1, PDHK1","[Pyruvate dehydrogenase [lipoamide]] kinase isozyme 1","1","2Q8H"
"2Q8K",,"X-RAY DIFFRACTION",2.8,56.01,"VAPOR DIFFUSION, HANGING DROP",5,"2.3 M Ammoniumsulfate, 0.1M Citric acid, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.febslet.2007.08.024",,"2Q8K",45.4,"1.6","1.6","The crystal structure of Ebp1","MGHHHHHHSGEDEQQEQTIAEDLVVTKYKMGGDIANRVLRSLVEASSSGVSVLSLCEKGDAMIMEETGKIFKKEKEMKKGIAFPTSISVNNCVCHFSPLKSDQDYILKEGDLVKIDLGVHVDGFIANVAHTFVVDVAQGTQVTGRKADVIKAAHLCAEAALRLVKPGNQNTQVTEAWNKVAHSFNCTPIEGMLSHQLKQHVIDGEKTIIQNPTDQQKKDHEKAEFEVHEVYAVDVLVSSGEGKAKDAGQRTTIYKRDPSKQYGLKMKTSRAFFSEVERRFDAMPFTLRAFEDEKKARMGVVECAKHELLQPFNVLYEKEGEFVAQFKFTVLLMPNGPMRITSGPFEPDLYKSEMEVQDAELKALLQSSASRKTQKKKKKKASKTAENATSGETLEENEAGD","Homo sapiens","PA2G4, EBP1","Proliferation-associated protein 2G4","1","2Q8K"
"2Q8R",,"X-RAY DIFFRACTION",2.21,44.27,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.2M magnesium acetate, 0.1M sodium cacodylate pH 6.5, 20% PEG 8000, VAPOR DIFFUSION, HANGING DROP, temperature 298.0K",298,"10.1021/bi700936w",,"2Q8R",31.25,"1.82","1.82","Structural and Functional Characterization of CC Chemokine CCL14","GPYHPSECCFTYTTYKIPRQRIMDYYETNSQCSKPGIVFITKRGHSVCTNPSDKWVQDYIKDMKEN","Homo sapiens","CCL14, NCC2, SCYA14","CCL14","1","2Q8R"
"2Q8S",,"X-RAY DIFFRACTION",2.71,54.55,"VAPOR DIFFUSION, HANGING DROP",8,"100 mM Immidizole, 860 mM Sodium Citrate, Glycerol 5 % (v/v)  , pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.bmc.2008.03.043","L92","2Q8S",62.41,"2.3","2.3","X-ray Crystal structure of the nuclear hormone receptor PPAR-gamma in a complex with a PPAR gamma/alpha dual agonist","ESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","2Q8S"
"2Q8T",,"X-RAY DIFFRACTION",2.69,54.24,"VAPOR DIFFUSION, HANGING DROP",7.2,"0.2 M sodium formate, 20% w/v PEG 3350, pH 7.2, VAPOR DIFFUSION, HANGING DROP, temperature 298.0K",298,"10.1021/bi700936w",,"2Q8T",34.76,"2.23","2.23","Crystal Structure of the CC chemokine CCL14","TKTESSSRGPYHPSECCFTYTTYKIPRQRIMDYYETNSQCSKPGIVFITKRGHSVCTNPSDKWVQDYIKDMKEN","Homo sapiens","CCL14, NCC2, SCYA14","CCL14","1","2Q8T"
"2Q91",,"X-RAY DIFFRACTION",2.37,48.11,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.05M ammonium sulfate, 0.05M Bis-Tris, 27.5% pentaethythritol-pthoxylate, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 294K",294,"10.1021/bi702537s",,"2Q91",23.65,"1.63","1.63","Structure of the Ca2+-Bound Activated Form of the S100A4 Metastasis Factor","MACPLEKALDVMVSTFHKYSGKEGDKFKLNKSELKELLTRELPSFLGKRTDEAAFQKLMSNLDSNRDNEVDFQEYCVFLSCIAMMCNEFFEGFPDKQPRKK","Homo sapiens","S100A4, CAPL, MTS1","S100A4 Metastasis Factor","1","2Q91"
"2Q98",,"X-RAY DIFFRACTION",2.41,48.93,"VAPOR DIFFUSION, HANGING DROP",8.5,"100 mM Tris-HCl pH 8.5, 675 mM K2HPO4, 45 mM (NH4)2PO4, 50 mM LiSO4, 7.5 % glycerol, 8% PEG4000, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1074/jbc.M704364200",,"2Q98",22.36,"2.7","2.7","X-ray structure of a prolactin antagonist","MRSQVTLRDLFDRAVVLSHYIHNLSSEMFSEFDKRYTHGRGFITKAINSCHTSSLATPEDKEQAQQMNQKDFLSLIVSILRSWNEPLYHLVTEVRGMQEAPEAILSKAVEIEEQTKRLLERMELIVSQVHPETKENEIYPVWSGLPSLQMADEESRLSAYYNLLHCLRRDSHKIDNYLKLLKCRIIHNNNC","Homo sapiens","PRL","Prolactin","1","2Q98"
"2Q9F",,"X-RAY DIFFRACTION",2.4,48.2,"VAPOR DIFFUSION, SITTING DROP",4.6,"PEG8000, Potassium Phosphate, Glycerol, NaCl, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 291K, pH 4.6, VAPOR DIFFUSION, SITTING DROP",291,"10.1073/pnas.0803717105","C3S","2Q9F",53.86,"1.9","1.9","Crystal structure of human cytochrome P450 46A1 in complex with cholesterol-3-sulphate","MAKKDEVGGRVLQDVFLDWAKKYGPVVRVNVFHKTSVIVTSPESVKKFLMSTKYNKDSKMYRALQTVFGERLFGQGLVSECNYERWHKQRRVIDLAFSRSSLVSLMETFNEKAEQLVEILEAKADGQTPVSMQDMLTYTAMDILAKAAFGMETSMLLGAQKPLSQAVKLMLEGITASRNTLAKFLPGKRKQLREVRESIRFLRQVGRDWVQRRREALKRGEEVPADILTQILKAEEGAQDDEGLLDNFVTFFIAGHETSANHLAFTVMELSRQPEIVARLQAEVDEVIGSKRYLDFEDLGRLQYLSQVLKESLRLYPPAWGTFRLLEEETLIDGVRVPGNTPLLFSTYVMGRMDTYFEDPLTFNPDRFGPGAPKPRFTYFPFSLGHRSCIGQQFAQMEVKVVMAKLLQRLEFRLVPGQRFGLQEQATLKPLDPVLCTLRPRGWQPAPPPPPCHHHH","Homo sapiens","CYP46A1, CYP46","Cytochrome P450 46A1","1","2Q9F"
"2Q9G",,"X-RAY DIFFRACTION",2.54,51.65,"VAPOR DIFFUSION, SITTING DROP",4.6,"PEG8000, Potassium Phosphate, Glycerol, NaCl, PH 4.6, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 291K, VAPOR DIFFUSION, SITTING DROP",291,"10.1073/pnas.0803717105",,"2Q9G",52.93,"2.4","2.4","Crystal structure of human cytochrome P450 46A1","MAKKDEVGGRVLQDVFLDWAKKYGPVVRVNVFHKTSVIVTSPESVKKFLMSTKYNKDSKMYRALQTVFGERLFGQGLVSECNYERWHKQRRVIDLAFSRSSLVSLMETFNEKAEQLVEILEAKADGQTPVSMQDMLTYTAMDILAKAAFGMETSMLLGAQKPLSQAVKLMLEGITASRNTLAKFLPGKRKQLREVRESIRFLRQVGRDWVQRRREALKRGEEVPADILTQILKAEEGAQDDEGLLDNFVTFFIAGHETSANHLAFTVMELSRQPEIVARLQAEVDEVIGSKRYLDFEDLGRLQYLSQVLKESLRLYPPAWGTFRLLEEETLIDGVRVPGNTPLLFSTYVMGRMDTYFEDPLTFNPDRFGPGAPKPRFTYFPFSLGHRSCIGQQFAQMEVKVVMAKLLQRLEFRLVPGQRFGLQEQATLKPLDPVLCTLRPRGWQPAPPPPPCHHHH","Homo sapiens","CYP46A1, CYP46","Cytochrome P450 46A1","1","2Q9G"
"2Q9P",,"X-RAY DIFFRACTION",1.9,35.4,"VAPOR DIFFUSION, SITTING DROP",4.5,"30% PEG 8000, 200 mM LiCl, 5 mM MgCl2, 20 mM NaF, 5 mM IP6, pH 4.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1002/prot.22489",,"2Q9P",23.04,"1.65","1.65","Human diphosphoinositol polyphosphate phosphohydrolase 1, Mg-F complex","MHHHHHHSSGVDLGTENLYFQSMMKLKSNQTRTYDGDGYKKRAACLCFRSESEEEVLLVSSSRHPDRWIVPGGGMEPEEEPSVAAVREVCEEAGVKGTLGRLVGIFENQERKHRTYVYVLIVTEVLEDWEDSVNIGRKREWFKIEDAIKVLQYHKPVQASYFETLRQGYSANNGTPVVATTYSVSAQSSMSGIR","Homo sapiens","NUDT3, DIPP, DIPP1","Diphosphoinositol polyphosphate phosphohydrolase 1","1","2Q9P"
"2Q9V",,"X-RAY DIFFRACTION",2,38.36,"VAPOR DIFFUSION, SITTING DROP",8.5,"1:2 Protein:Well solution ratio, 20% PEG 3350, 10% Ethylene glycol, 200 mM Sodium acetate, 100 mM BTP pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,,,"2Q9V",9.88,"2","2","Crystal structure of the C890S mutant of the 4th PDZ domain of human membrane associated guanylate kinase","SMEQDIFLWRKETGFGFRILGGNEPGEPIYIGHIVPLGAADTDGRLRSGDELISVDGTPVIGKSHQLVVQLMQQAAKQGHVNLTVRQTRL","Homo sapiens","MAGI1, BAIAP1, BAP1, TNRC19, AIP3","Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1","1","2Q9V"
"2Q9X",,"X-RAY DIFFRACTION",1.82,32.52,"VAPOR DIFFUSION, HANGING DROP",7.5,"15% PEG 8000, 100mM TrisHCl, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"2Q9X",15.86,"1.7","1.7","Crystal structure of highly stable mutant Q40P/S47I/H93G of human fibroblast growth factor-1","FNLPPGNYKKPKLLYCSNGGHFLRILPDGTVDGTRDRSDPHIQLQLIAESVGEVYIKSTETGQYLAMDTDGLLYGSQTPNEECLFLERLEENGYNTYISKKHAEKNWFVGLKKNGSCKRGPRTHYGQKAILFLPLPVSSD","Homo sapiens","FGF1, FGFA","Heparin-binding growth factor 1","1","2Q9X"
"2QA5",,"X-RAY DIFFRACTION",2.6,52.67,"VAPOR DIFFUSION, HANGING DROP",9,"5% PEG 6000, 0.1M BICINE, pH 9.0, 0.1M Glycine, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1038/nature06052",,"2QA5",73.96,"3.4","3.4","Crystal structure of Sept2 G-domain","MSKQQPTQFINPETPGYVGFANLPNQVHRKSVKKGFEFTLMVVGESGLGKSTLINSLFLTDLYPERVIPGAAEKIERTVQIEASTVEIEERGVKLRLTVVDTPGYGDAINCRDCFKTIISYIDEQFERYLHDESGLNRRHIIDNRVHCCFYFISPFGHGLKPLDVAFMKAIHNKVNIVPVIAKADTLTLKERERLKKRILDEIEEHNIKIYHLPDAESDEDEDFKEQTRLLKASIPFSVVGSNQLIEAKGKKVRGRLYPWGVVEVENPEHNDFLKLRTMLITHMQDLQEVTQDLHYENFRSERLKRGGRKVENED","Homo sapiens","SEPT2, DIFF6, KIAA0158, NEDD5, SEPTIN2","Septin-2","1","2QA5"
"2QA7",,"X-RAY DIFFRACTION",2.65,57.89,"VAPOR DIFFUSION, HANGING DROP",7,"15% PEG 3350, 0.1 M succinate, 0.2 M potassium sodium tartrate, 0.01 M nickle chloride, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.jmb.2007.11.036",,"2QA7",53.91,"2.8","2.8","Crystal structure of Huntingtin-interacting protein 1 (HIP1) coiled-coil domain with a basic surface suitable for HIP-protein interactor (HIPPI)","GSKDEKDHLIERLYREISGLKAQLENMKTESQRVVLQLKGHVSELEADLAEQQHLRQQAADDCEFLRAELDELRRQREDTEKAQRSLSEIERKAQANEQRYSKLKEKYSELVQN","Homo sapiens","HIP1","Huntingtin-interacting protein 1","1","2QA7"
"2QB5",,"X-RAY DIFFRACTION",2.46,49.95,"VAPOR DIFFUSION, SITTING DROP",5.6,"0.1M NA CITRATE PH 5.6, 0.2M K/NA  TARTRATE, 2M (NH4)2SO4      , VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1074/jbc.M703121200",,"2QB5",80.55,"1.8","1.8","Crystal Structure of Human Inositol 1,3,4-Trisphosphate 5/6-Kinase (ITPK1) in Complex with ADP and Mn2+","MGSDKIHHHHHHMQTFLKGKRVGYWLSEKKIKKLNFQAFAELCRKRGMEVVQLNLSRPIEEQGPLDVIIHKLTDVILEADQNDSQSLELVHRFQEYIDAHPETIVLDPLPAIRTLLDRSKSYELIRKIEAYMEDDRICSPPFMELTSLCGDDTMRLLEKNGLTFPFICKTRVAHGTNSHEMAIVFNQEGLNAIQPPCVVQNFINHNAVLYKVFVVGESYTVVQRPSLKNFSAGTSDRESIFFNSHNVSKPESSSVLTELDKIEGVFERPSDEVIRELSRALRQALGVSLFGIDIIINNQTGQHAVIDINAFPGYEGVSEFFTDLLNHIATVLQGQSTAMAATGDVAL","Homo sapiens","ITPK1","Inositol-tetrakisphosphate 1-kinase","1","2QB5"
"2QBP",,"X-RAY DIFFRACTION",3.38,63.61,,7,"17% PEG 4000, 0.15M MAGNESIUM CHLORIDE, 0.1M HEPES, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 278K, pH 7.00",,"10.1021/jm0702478","527","2QBP",35.44,"2.5","2.5","Crystal structure of ptp1b-inhibitor complex","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPCRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTCGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDL","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","2QBP"
"2QBQ",,"X-RAY DIFFRACTION",3.37,63.49,,7,"17% PEG 4000, 0.15M MGCL2, 0.1M HEPES, PH 7.0, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 278K, pH 7.00",,"10.1021/jm0702478","4B3","2QBQ",35.34,"2.1","2.1","Crystal structure of ptp1b-inhibitor complex","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPCRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTCGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDL","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","2QBQ"
"2QBR",,"X-RAY DIFFRACTION",3.44,64.19,,7,"17% PEG 4000, 0.15M MGCL2, 0.1M HEPES, PH 7.0, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 278K, pH 7.00",,"10.1021/jm0702478","910","2QBR",35.3,"2.3","2.3","Crystal structure of ptp1b-inhibitor complex","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPCRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTCGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDL","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","2QBR"
"2QBS",,"X-RAY DIFFRACTION",3.38,63.64,,7,"17% PEG 4000, 0.15M MGCL2, 0.1M HEPES, PH 7.0, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 278K, pH 7.00",,"10.1021/jm0702478","024","2QBS",35.29,"2.1","2.1","Crystal structure of ptp1b-inhibitor complex","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPCRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTCGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDL","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","2QBS"
"2QBW",,"X-RAY DIFFRACTION",2.98,58.66,"VAPOR DIFFUSION, HANGING DROP",9,"1M (NH4)2HPO4, 0.1M Tris-HCl, pH 9, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1073/pnas.0801097105",,"2QBW",21.89,"1.8","1.8","The crystal structure of PDZ-Fibronectin fusion protein","SPELGFSISGGVGGRGNPFRPDDDGIFVTRVQPEGPASKLLQPGDKIIQANGYSFINIEHGQAVSLLKTFQNTVELIIVREVGNGAKQEIRVRVEKDGGSGGVSSVPTNLEVVAATPTSLLISWDASYYGVSYYRITYGETGGNSPVQEFTVPYSSSTATISGLKPGVDYTITVYAYSDYYGSHHYSPISINYRT","Homo sapiens","ERBB2IP, ERBIN, KIAA1225, LAP2","PDZ-Fibronectin fusion protein","1","2QBW"
,,,,,,,,,,,,,,,,"PQPVDSWV",,,"Polypeptide","2","2QBW"
"2QBX",,"X-RAY DIFFRACTION",2.18,43.46,"VAPOR DIFFUSION, SITTING DROP",7.2,"100 mM Hepes, pH 7.2, 100 mM ammonium sulfate, and 20% PEG-3350, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1074/jbc.M706340200",,"2QBX",51.5,"2.3","2.3","EphB2/SNEW Antagonistic Peptide Complex","MVSAIVLYVLLAAAAHSAFAAMVHHHHHHSAEETLMDSTTATAELGWMVHPPSGWEEVSGYDENMNTIRTYQVCNVFESSQNNWLRTKFIRRRGAHRIHVEMKFSVRDCSSIPSVPGSCKETFNLYYYEADFDSATKTFPNWMENPWVKVDTIAADESFSQVDLGGRVMKINTEVRSFGPVSRSGFYLAFQDYGGCMSLIAVRVFYRK","Homo sapiens","EPHB2, DRT, EPHT3, EPTH3, ERK, HEK5, TYRO5","Ephrin type-B receptor 2","1","2QBX"
,,,,,,,,,,,,,,,,"SNEWIQPRLPQH",,,"antagonistic peptide","2","2QBX"
"2QC7",,"X-RAY DIFFRACTION",2.42,49.22,"VAPOR DIFFUSION, HANGING DROP",,"10 mg/ml protein in 5 mM HEPES, pH 7.5, 25 mM NaCl, 0.0025% (v/v) beta-mercaptoethanol was equlibrated with a reservoir containing 0.45 M (NH4)2SO4, 0.1 M sodium acetate buffer, pH 4.5 and 18-20% (w/v) PEG 2000 monomethyl ether. Crystals of about 0.1 mm in size grew in two days.   , VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.jmb.2008.11.052",,"2QC7",54.44,"2.9","2.9","Crystal structure of the protein-disulfide isomerase related chaperone ERp29","MVHTKGALPLDTVTFYKVIPKSKFVLVKFDTQYPYGEKQDEFKRLAENSASSDDLLVAEVGISDYGDKLNMELSEKYKLDKESYPVFYLFRDGDFENPVPYTGAVKVGAIQRWLKGQGVYLGMPGCLPVYDALAGEFIRASGVEARQALLKQGQDNLSSVKETQKKWAEQYLKIMGKILDQGEDFPASEMTRIARLIEKNKMSDGKKEELQKSLNILTAFQKKGAEKEELGSRSHHHHHH","Homo sapiens","ERP29, C12orf8, ERP28","Endoplasmic reticulum protein ERp29","1","2QC7"
"2QC8",,"X-RAY DIFFRACTION",2.48,50.31,,7,"1.1M Sodium malonate, 0.5% Jeffamine ED-2001, 0.1M HEPES, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 298K, pH 7.00",298,"10.1016/j.jmb.2007.10.029",,"2QC8",442.52,"2.6","2.6","Crystal structure of human glutamine synthetase in complex with ADP and methionine sulfoximine phosphate","MHHHHHHSSGVDLGTENLYFQSMASSHLNKGIKQVYMSLPQGEKVQAMYIWIDGTGEGLRCKTRTLDSEPKCVEELPEWNFDGSSTLQSEGSNSDMYLVPAAMFRDPFRKDPNKLVLCEVFKYNRRPAETNLRHTCKRIMDMVSNQHPWFGMEQEYTLMGTDGHPFGWPSNGFPGPQGPYYCGVGADRAYGRDIVEAHYRACLYAGVKIAGTNAEVMPAQWEFQIGPCEGISMGDHLWVARFILHRVCEDFGVIATFDPKPIPGNWNGAGCHTNFSTKAMREENGLKYIEEAIEKLSKRHQYHIRAYDPKGGLDNARRLTGFHETSNINDFSAGVANRSASIRIPRTVGQEKKGYFEDRRPSANCDPFSVTEALIRTCLLNETG","Homo sapiens","GLUL, GLNS","Glutamine synthetase","1","2QC8"
"2QCC",,"X-RAY DIFFRACTION",2.49,50.51,"VAPOR DIFFUSION, SITTING DROP",8,"ammonium sulfate, pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,"10.1016/j.str.2007.10.020",,"2QCC",56.98,"1.85","1.85","Crystal structure of the orotidine-5'-monophosphate decarboxylase domain of human UMP synthase, apo form","GAMELSFGARAELPRIHPVASKLLRLMQKKETNLCLSADVSLARELLQLADALGPSICMLKTHVDILNDFTLDVMKELITLAKCHEFLIFEDRKFADIGNTVKKQYEGGIFKIASWADLVNAHVVPGSGVVKGLQEVGLPLHRGCLLIAEMSSTGSLATGDYTRAAVRMAEEHSEFVVGFISGSRVSMKPEFLHLTPGVQLEAGGDNLGQQYNSPQEVIGKRGSDIIIVGRGIISAADRLEAAEMYRKAAWEAYLSRLGV","Homo sapiens","UMPS, OK/SW-cl.21","Orotidine 5'- phosphate decarboxylase (OMPdecase)","1","2QCC"
"2QCD",,"X-RAY DIFFRACTION",2.44,49.56,,,,,"10.1016/j.str.2007.10.020","UMP","2QCD",57.28,"2.03","2.03","Crystal structure of the orotidine-5'-monophosphate decarboxylase domain of human UMP synthase bound to UMP","GAMELSFGARAELPRIHPVASKLLRLMQKKETNLCLSADVSLARELLQLADALGPSICMLKTHVDILNDFTLDVMKELITLAKCHEFLIFEDRKFADIGNTVKKQYEGGIFKIASWADLVNAHVVPGSGVVKGLQEVGLPLHRGCLLIAEMSSTGSLATGDYTRAAVRMAEEHSEFVVGFISGSRVSMKPEFLHLTPGVQLEAGGDNLGQQYNSPQEVIGKRGSDIIIVGRGIISAADRLEAAEMYRKAAWEAYLSRLGV","Homo sapiens","UMPS, OK/SW-cl.21","Uridine 5'-monophosphate synthase (UMP synthase)","1","2QCD"
,,,,,,,,,,,,,,,,"GAMELSFGARAELPRIHPVASKLLRLMQKKETNLCLSADVSLARELLQLADALGPSICMLKTHVDILNDFTLDVMKELITLAKCHEFLIFEDRKFADIGNTVKKQYEGGIFKIASWADLVNAHVVPGSGVVKGLQEVGLPLHRGCLLIAEMSSTGSLATGDYTRAAVRMAEEHSEFVVGFISGSRVSMKPEFLHLTPGVQLEAGGDNLGQQYNSPQEVIGKRGSDIIIVGRGIISAADRLEAAEMYRKAAWEAYLSRLGV","Homo sapiens","UMPS, OK/SW-cl.21","Uridine 5'-monophosphate synthase (UMP synthase)","2","2QCD"
"2QCE",,"X-RAY DIFFRACTION",2.47,50.21,"VAPOR DIFFUSION, SITTING DROP",8,"pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,"10.1016/j.str.2007.10.020",,"2QCE",28.65,"1.43","1.43","Crystal structure of the orotidine-5'-monophosphate decarboxylase domain of human UMP synthase bound to sulfate, glycerol, and chloride","GAMELSFGARAELPRIHPVASKLLRLMQKKETNLCLSADVSLARELLQLADALGPSICMLKTHVDILNDFTLDVMKELITLAKCHEFLIFEDRKFADIGNTVKKQYEGGIFKIASWADLVNAHVVPGSGVVKGLQEVGLPLHRGCLLIAEMSSTGSLATGDYTRAAVRMAEEHSEFVVGFISGSRVSMKPEFLHLTPGVQLEAGGDNLGQQYNSPQEVIGKRGSDIIIVGRGIISAADRLEAAEMYRKAAWEAYLSRLGV","Homo sapiens","UMPS, OK/SW-cl.21","Uridine 5'-monophosphate synthase (UMP synthase)","1","2QCE"
"2QCF",,"X-RAY DIFFRACTION",2.4,48.85,"VAPOR DIFFUSION, SITTING DROP",8,"pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,"10.1016/j.str.2007.10.020","5FU","2QCF",28.77,"1.22","1.22","Crystal structure of the orotidine-5'-monophosphate decarboxylase domain (Asp312Asn mutant) of human UMP synthase bound to 5-fluoro-UMP","GAMELSFGARAELPRIHPVASKLLRLMQKKETNLCLSADVSLARELLQLADALGPSICMLKTHVDILNDFTLDVMKELITLAKCHEFLIFENRKFADIGNTVKKQYEGGIFKIASWADLVNAHVVPGSGVVKGLQEVGLPLHRGCLLIAEMSSTGSLATGDYTRAAVRMAEEHSEFVVGFISGSRVSMKPEFLHLTPGVQLEAGGDNLGQQYNSPQEVIGKRGSDIIIVGRGIISAADRLEAAEMYRKAAWEAYLSRLGV","Homo sapiens","UMPS, OK/SW-cl.21","Uridine 5'-monophosphate synthase (UMP synthase)","1","2QCF"
"2QCG",,"X-RAY DIFFRACTION",2.4,48.73,"VAPOR DIFFUSION, SITTING DROP",8,"pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,"10.1016/j.str.2007.10.020","5BU","2QCG",57.41,"1.75","1.75","Crystal structure of the orotidine-5'-monophosphate decarboxylase domain of human UMP synthase bound to 5-bromo-UMP","GAMELSFGARAELPRIHPVASKLLRLMQKKETNLCLSADVSLARELLQLADALGPSICMLKTHVDILNDFTLDVMKELITLAKCHEFLIFEDRKFADIGNTVKKQYEGGIFKIASWADLVNAHVVPGSGVVKGLQEVGLPLHRGCLLIAEMSSTGSLATGDYTRAAVRMAEEHSEFVVGFISGSRVSMKPEFLHLTPGVQLEAGGDNLGQQYNSPQEVIGKRGSDIIIVGRGIISAADRLEAAEMYRKAAWEAYLSRLGV","Homo sapiens","UMPS, OK/SW-cl.21","Uridine 5'-monophosphate synthase (UMP synthase)","1","2QCG"
"2QCH",,"X-RAY DIFFRACTION",2.47,50.2,"VAPOR DIFFUSION, SITTING DROP",8,"pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,"10.1016/j.str.2007.10.020","5IU","2QCH",58.34,"1.95","1.95","Crystal structure of the orotidine-5'-monophosphate decarboxylase domain of human UMP synthase bound to 5-iodo-UMP","GAMELSFGARAELPRIHPVASKLLRLMQKKETNLCLSADVSLARELLQLADALGPSICMLKTHVDILNDFTLDVMKELITLAKCHEFLIFEDRKFADIGNTVKKQYEGGIFKIASWADLVNAHVVPGSGVVKGLQEVGLPLHRGCLLIAEMSSTGSLATGDYTRAAVRMAEEHSEFVVGFISGSRVSMKPEFLHLTPGVQLEAGGDNLGQQYNSPQEVIGKRGSDIIIVGRGIISAADRLEAAEMYRKAAWEAYLSRLGV","Homo sapiens","UMPS, OK/SW-cl.21","Uridine 5'-monophosphate synthase (UMP synthase)","1","2QCH"
"2QCJ",,"X-RAY DIFFRACTION",2.19,43.87,"EVAPORATION",5.6,"20% PEG 3350, pH 5.6, EVAPORATION, temperature 293K",293,,,"2QCJ",73.52,"3","3","Native Structure of Lyp","HHHHHHSSGLVPRGSHMASMDQREILQKFLDEAQSKKITKEEFANEFLKLKRQSTKYKADKTYPTTVAEKPKNIKKNRYKDILPYDYSRVELSLITSDEDSSYINANFIKGVYGPKAYIATQGPLSTTLLDFWRMIWEYSVLIIVMACMEYEMGKKKCERYWAEPGEMQLEFGPFSVSCEAEKRKSDYIIRTLKVKFNSETRTIYQFHYKNWPDHDVPSSIDPILELIWDVRCYQEDDSVPICIHCSAGCGRTGVICAIDYTWMLLKDGIIPENFSVFSLIREMRTQRPSLVQTQEQYELVYNAVLELFKRQM","Homo sapiens","PTPN22, PTPN8","Tyrosine-protein phosphatase non-receptor type 22","1","2QCJ"
"2QCL",,"X-RAY DIFFRACTION",2.44,49.51,"VAPOR DIFFUSION, SITTING DROP",8,"pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,"10.1016/j.str.2007.10.020",,"2QCL",57.43,"1.85","1.85","Crystal structure of the orotidine-5'-monophosphate decarboxylase domain (Asp312Asn mutant) of human UMP synthase bound to OMP","GAMELSFGARAELPRIHPVASKLLRLMQKKETNLCLSADVSLARELLQLADALGPSICMLKTHVDILNDFTLDVMKELITLAKCHEFLIFENRKFADIGNTVKKQYEGGIFKIASWADLVNAHVVPGSGVVKGLQEVGLPLHRGCLLIAEMSSTGSLATGDYTRAAVRMAEEHSEFVVGFISGSRVSMKPEFLHLTPGVQLEAGGDNLGQQYNSPQEVIGKRGSDIIIVGRGIISAADRLEAAEMYRKAAWEAYLSRLGV","Homo sapiens","UMPS, OK/SW-cl.21","Uridine 5'-monophosphate synthase (UMP synthase)","1","2QCL"
"2QCM",,"X-RAY DIFFRACTION",2.47,50.14,"VAPOR DIFFUSION, SITTING DROP",8,"pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,"10.1016/j.str.2007.10.020","JW5","2QCM",28.69,"1.67","1.67","Crystal structure of the orotidine-5'-monophosphate decarboxylase domain (Asp312Asn mutant) of human UMP synthase bound to 6-hydroxymethyl-UMP","GAMELSFGARAELPRIHPVASKLLRLMQKKETNLCLSADVSLARELLQLADALGPSICMLKTHVDILNDFTLDVMKELITLAKCHEFLIFENRKFADIGNTVKKQYEGGIFKIASWADLVNAHVVPGSGVVKGLQEVGLPLHRGCLLIAEMSSTGSLATGDYTRAAVRMAEEHSEFVVGFISGSRVSMKPEFLHLTPGVQLEAGGDNLGQQYNSPQEVIGKRGSDIIIVGRGIISAADRLEAAEMYRKAAWEAYLSRLGV","Homo sapiens","UMPS, OK/SW-cl.21","Uridine 5'-monophosphate synthase (UMP synthase)","1","2QCM"
"2QCN",,"X-RAY DIFFRACTION",2.44,49.54,"VAPOR DIFFUSION, SITTING DROP",8,"pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,"10.1016/j.str.2007.10.020","U5P","2QCN",57.53,"1.85","1.85","Covalent complex of the orotidine-5'-monophosphate decarboxylase domain of human UMP synthase with 6-iodo-UMP","GAMELSFGARAELPRIHPVASKLLRLMQKKETNLCLSADVSLARELLQLADALGPSICMLKTHVDILNDFTLDVMKELITLAKCHEFLIFEDRKFADIGNTVKKQYEGGIFKIASWADLVNAHVVPGSGVVKGLQEVGLPLHRGCLLIAEMSSTGSLATGDYTRAAVRMAEEHSEFVVGFISGSRVSMKPEFLHLTPGVQLEAGGDNLGQQYNSPQEVIGKRGSDIIIVGRGIISAADRLEAAEMYRKAAWEAYLSRLGV","Homo sapiens","UMPS, OK/SW-cl.21","Uridine 5'-monophosphate synthase","1","2QCN"
"2QCQ",,"X-RAY DIFFRACTION",3.68,66.62,"VAPOR DIFFUSION, HANGING DROP",5.6,"26% tert-butanol and 0.1 M Na Citrate, pH 5.6, VAPOR DIFFUSION, HANGING DROP, temperature 296K",296,"10.1021/bi700907k",,"2QCQ",24.84,"2.21","2.21","Crystal structure of Bone Morphogenetic Protein-3 (BMP-3)","QWIEPRNCARRYLKVDFADIGWSEWIISPKSFDAYYCSGACQFPMPKSLKPSNHATIQSIVRAVGVVPGIPEPCCVPEKMSSLSILFFDENKNVVLKVYPNMTVESCACR","Homo sapiens","BMP3, BMP3A","Bone morphogenetic protein 3","1","2QCQ"
"2QCT",,"X-RAY DIFFRACTION",2.06,40.41,"EVAPORATION",7.2,"0.2M sodium formate, 20% PEG3350, 2.5% ethyl glycerol, pH 7.2, EVAPORATION, temperature 293K",293,,,"2QCT",74.1,"2.8","2.8","Structure of Lyp with inhibitor I-C11","HHHHHHSSGLVPRGSHMASMDQREILQKFLDEAQSKKITKEEFANEFLKLKRQSTKYKADKTYPTTVAEKPKNIKKNRYKDILPYDYSRVELSLITSDEDSSYINANFIKGVYGPKAYIATQGPLSTTLLDFWRMIWEYSVLIIVMACMEYEMGKKKCERYWAEPGEMQLEFGPFSVSCEAEKRKSDYIIRTLKVKFNSETRTIYQFHYKNWPDHDVPSSIDPILELIWDVRCYQEDDSVPICIHCSAGCGRTGVICAIDYTWMLLKDGIIPENFSVFSLIREMRTQRPSLVQTQEQYELVYNAVLELFKRQM","Homo sapiens","PTPN22, PTPN8","Tyrosine-protein phosphatase non-receptor type 22","1","2QCT"
"2QCW",,"X-RAY DIFFRACTION",4.02,69.4,"VAPOR DIFFUSION, HANGING DROP",7.5,"15% 2-methyl-2,4-pentanediol (MPD), 0.2 M Tri-Na Citrate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 296K",296,"10.1021/bi700907k",,"2QCW",29.78,"2.49","2.49","Crystal Structure of Bone Morphogenetic Protein-6 (BMP-6)","QQSRNRSTQSQDVARVSSASDYNSSELKTACRKHELYVSFQDLGWQDWIIAPKGYAANYCDGECSFPLNAHMNATNHAIVQTLVHLMNPEYVPKPCCAPTKLNAISVLYFDDNSNVILKKYRNMVVRACGCH","Homo sapiens","BMP6, VGR","Bone morphogenetic protein 6","1","2QCW"
"2QD0",,"X-RAY DIFFRACTION",2.28,46.02,"VAPOR DIFFUSION, HANGING DROP",8,"100 mM Tris-HCl, 18% PEG 3350 , 200 mM KI., pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1073/pnas.0702426104",,"2QD0",19.11,"1.81","1.81","Crystal structure of mitoNEET","GSKRFYVKDHRNKAMINLHIQKDNPKIVHAFDMEDLGDKAVYCRCWRSKKFPFCDGAHTKHNEETGDNVGPLIIKKKETAS","Homo sapiens","ZCD1, C10orf70, CISD1, MDS029","Zinc finger CDGSH domain-containing protein 1","1","2QD0"
,,,,,"VAPOR DIFFUSION, HANGING DROP",7.4,"100 mM Tris-HCl, 30% PEG 2000 ,100 mM NaCl, pH 7.4, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293
"2QD1",,"X-RAY DIFFRACTION",2.66,53.69,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.05 M ammonium acetate, 0.05M Bis-Tris, pH 6.5 and 40% (v/v) pentaerythritol ethoxylate (15/4 EO/OH), VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1016/j.jmb.2007.08.040",,"2QD1",169.68,"2.2","2.2","2.2 Angstrom Structure of the human ferrochelatase variant E343K with substrate bound","RKPKTGILMLNMGGPETLGDVHDFLLRLFLDRDLMTLPIQNKLAPFIAKRRTPKIQEQYRRIGGGSPIKIWTSKQGEGMVKLLDELSPNTAPHKYYIGFRYVHPLTEEAIEEMERDGLERAIAFTQYPQYSCSTTGSSLNAIYRYYNQVGRKPTMKWSTIDRWPTHHLLIQCFADHILKELDHFPLEKRSEVVILFSAHSLPMSVVNRGDPYPQEVSATVQKVMERLEYCNPYRLVWQSKVGPMPWLGPQTDESIKGLCERGRKNILLVPIAFTSDHIKTLYELDIEYSQVLAKECGVENIRRAESLNGNPLFSKALADLVHSHIQSNELCSKQLTLSCPLCVNPVCRETKSFFTSQQL","Homo sapiens","FECH","Ferrochelatase","1","2QD1"
"2QD2",,"X-RAY DIFFRACTION",2.65,53.55,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.05M ammonium acetate, 0.05M Bis-Tris, pH 6.5 and 40% (v/v) pentaerythritol ethoxylate (15/4 EO/OH), VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1016/j.jmb.2007.08.040",,"2QD2",85.75,"2.2","2.2","F110A variant of human ferrochelatase with protoheme bound","RKPKTGILMLNMGGPETLGDVHDFLLRLFLDRDLMTLPIQNKLAPAIAKRRTPKIQEQYRRIGGGSPIKIWTSKQGEGMVKLLDELSPNTAPHKYYIGFRYVHPLTEEAIEEMERDGLERAIAFTQYPQYSCSTTGSSLNAIYRYYNQVGRKPTMKWSTIDRWPTHHLLIQCFADHILKELDHFPLEKRSEVVILFSAHSLPMSVVNRGDPYPQEVSATVQKVMERLEYCNPYRLVWQSKVGPMPWLGPQTDESIKGLCERGRKNILLVPIAFTSDHIETLYELDIEYSQVLAKECGVENIRRAESLNGNPLFSKALADLVHSHIQSNELCSKQLTLSCPLCVNPVCRETKSFFTSQQL","Homo sapiens","DKFZp686P18130, FECH","Ferrochelatase","1","2QD2"
"2QD3",,"X-RAY DIFFRACTION",2.77,55.61,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.05M ammonium sulfate, 0.05M Bis-Tris, pH 6.5 and 40% (v/v) pentaerythritol ethoxylate (15/4 EO/OH), VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1016/j.jmb.2007.08.040",,"2QD3",85.46,"2.2","2.2","Wild type human ferrochelatase crystallized with ammonium sulfate","RKPKTGILMLNMGGPETLGDVHDFLLRLFLDRDLMTLPIQNKLAPFIAKRRTPKIQEQYRRIGGGSPIKIWTSKQGEGMVKLLDELSPNTAPHKYYIGFRYVHPLTEEAIEEMERDGLERAIAFTQYPQYSCSTTGSSLNAIYRYYNQVGRKPTMKWSTIDRWPTHHLLIQCFADHILKELDHFPLEKRSEVVILFSAHSLPMSVVNRGDPYPQEVSATVQKVMERLEYCNPYRLVWQSKVGPMPWLGPQTDESIKGLCERGRKNILLVPIAFTSDHIETLYELDIEYSQVLAKECGVENIRRAESLNGNPLFSKALADLVHSHIQSNELCSKQLTLSCPLCVNPVCRETKSFFTSQQL","Homo sapiens","FECH","Ferrochelatase","1","2QD3"
"2QD4",,"X-RAY DIFFRACTION",2.72,54.77,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.150 MgCl2, 0.05M Bis-Tris, pH 6.5 and 40% (v/v) pentaerythritol ethoxylate (15/4 EO/OH), VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1016/j.jmb.2007.08.040",,"2QD4",85.46,"2","2","Wild type human ferrochelatase crystallized with MnCl2","RKPKTGILMLNMGGPETLGDVHDFLLRLFLDRDLMTLPIQNKLAPFIAKRRTPKIQEQYRRIGGGSPIKIWTSKQGEGMVKLLDELSPNTAPHKYYIGFRYVHPLTEEAIEEMERDGLERAIAFTQYPQYSCSTTGSSLNAIYRYYNQVGRKPTMKWSTIDRWPTHHLLIQCFADHILKELDHFPLEKRSEVVILFSAHSLPMSVVNRGDPYPQEVSATVQKVMERLEYCNPYRLVWQSKVGPMPWLGPQTDESIKGLCERGRKNILLVPIAFTSDHIETLYELDIEYSQVLAKECGVENIRRAESLNGNPLFSKALADLVHSHIQSNELCSKQLTLSCPLCVNPVCRETKSFFTSQQL","Homo sapiens","FECH","Ferrochelatase","1","2QD4"
"2QD5",,"X-RAY DIFFRACTION",2.67,53.86,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.05M ammonium acetate, 0.05M Bis-Tris, pH 6.5 and 40% (v/v) pentaerythritol ethoxylate , VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1016/j.jmb.2007.08.040",,"2QD5",86.19,"2.3","2.3","Structure of wild type human ferrochelatase in complex with a lead-porphyrin compound","RKPKTGILMLNMGGPETLGDVHDFLLRLFLDRDLMTLPIQNKLAPFIAKRRTPKIQEQYRRIGGGSPIKIWTSKQGEGMVKLLDELSPNTAPHKYYIGFRYVHPLTEEAIEEMERDGLERAIAFTQYPQYSCSTTGSSLNAIYRYYNQVGRKPTMKWSTIDRWPTHHLLIQCFADHILKELDHFPLEKRSEVVILFSAHSLPMSVVNRGDPYPQEVSATVQKVMERLEYCNPYRLVWQSKVGPMPWLGPQTDESIKGLCERGRKNILLVPIAFTSDHIETLYELDIEYSQVLAKECGVENIRRAESLNGNPLFSKALADLVHSHIQSNELCSKQLTLSCPLCVNPVCRETKSFFTSQQL","Homo sapiens","FECH","Ferrochelatase","1","2QD5"
"2QD9",,"X-RAY DIFFRACTION",2.3,46.51,,,,,"10.1016/j.bmcl.2007.07.029","LGF","2QD9",42.66,"1.7","1.7","P38 Alpha Map Kinase inhibitor based on heterobicyclic scaffolds","MAHHHHHSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES","Homo sapiens","MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2, SAPK2A","Mitogen-activated protein kinase 14","1","2QD9"
"2QDC",,"X-RAY DIFFRACTION",4.19,70.67,"VAPOR DIFFUSION, SITTING DROP",5.6,"0.1 M ACETIC ACID, 2.0 M SODIUM/POTASSIUM PHOSPHATE, pH 5.6, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1021/bi801724n",,"2QDC",35.67,"2","2","Crystal structure of the HePTP catalytic domain D236A mutant","MGSDKIHHHHHHMNTPREVTLHFLRTAGHPLTRWALQRQPPSPKQLEEEFLKIPSNFVSPEDLDIPGHASKDRYKTILPNPQSRVCLGRAQSQEDGDYINANYIRGYDGKEKVYIATQGPMPNTVSDFWEMVWQEEVSLIVMLTQLREGKEKCVHYWPTEEETYGPFQIRIQDMKECPEYTVRQLTIQYQEERRSVKHILFSAWPAHQTPESAGPLLRLVAEVEESPETAAHPGPIVVHCSAGIGRTGCFIATRIGCQQLKARGEVDILGIVCQLRLDRGGMIQTAEQYQFLHHTLALYAGQLPEEPSP","Homo sapiens","PTPN7","Tyrosine-protein phosphatase non-receptor type 7","1","2QDC"
"2QDJ",,"X-RAY DIFFRACTION",2.67,53.94,"VAPOR DIFFUSION, HANGING DROP",8,"0.2 M Na acetate, 25% (w/v) PEG 4000, 0.1 M Tris, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.molcel.2007.08.023",,"2QDJ",35.43,"2","2","Crystal structure of the Retinoblastoma protein N-domain provides insight into tumor suppression, ligand interaction and holoprotein architecture","TEEPDFTALCQKLKIPDHVRERAWLTWEKVSSVDGVLGGYIQKKKELWGICIFIAAVDLDEMSFTFTELQKNIEISVHKFFNLLKEIDTSTKVDNAMSRLLKKYDVLFALFSKLERTCELIYLTQPSSSISTEINSALVLKVSWITFLLAKGEVLQMEDDLVISFQLMLCVLDYFIKLSPPMLLKEPYKTAVIPINGSPRTPRRGQNRSARIAKQLENDTRIIEVLCKEHECNIDEVKNVYFKNFIPFMNSLGLVTSNGLPEVENLSKRYEEIYLKNKDLDARLFLDHDKTLQTDSIDSFETQR","Homo sapiens","RB1","Retinoblastoma-associated protein","1","2QDJ"
"2QDM",,"X-RAY DIFFRACTION",2.38,48.32,"VAPOR DIFFUSION, SITTING DROP",4.6,"1.5 M AMMONIUM CHLORIDE, 0.1 M SODIUM ACETATE, pH 4.6, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,,,"2QDM",35.41,"2.05","2.05","Crystal structure of the HePTP catalytic domain C270S/D236A/Q314A mutant","MGSDKIHHHHHHMNTPREVTLHFLRTAGHPLTRWALQRQPPSPKQLEEEFLKIPSNFVSPEDLDIPGHASKDRYKTILPNPQSRVCLGRAQSQEDGDYINANYIRGYDGKEKVYIATQGPMPNTVSDFWEMVWQEEVSLIVMLTQLREGKEKCVHYWPTEEETYGPFQIRIQDMKECPEYTVRQLTIQYQEERRSVKHILFSAWPAHQTPESAGPLLRLVAEVEESPETAAHPGPIVVHSSAGIGRTGCFIATRIGCQQLKARGEVDILGIVCQLRLDRGGMIATAEQYQFLHHTLALYAGQLPEEPSP","Homo sapiens","PTPN7","Tyrosine-protein phosphatase non-receptor type 7","1","2QDM"
"2QDP",,"X-RAY DIFFRACTION",4.18,70.6,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.07 M AMMONIUM ACETATE, 0.07 M BIS-TRIS, 12% POLYETHYLENE GLYCOL 10000, pH 5.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,,,"2QDP",35.41,"2.72","2.72","Crystal structure of the HePTP catalytic domain C270S mutant crystallized in ammonium acetate","MGSDKIHHHHHHMNTPREVTLHFLRTAGHPLTRWALQRQPPSPKQLEEEFLKIPSNFVSPEDLDIPGHASKDRYKTILPNPQSRVCLGRAQSQEDGDYINANYIRGYDGKEKVYIATQGPMPNTVSDFWEMVWQEEVSLIVMLTQLREGKEKCVHYWPTEEETYGPFQIRIQDMKECPEYTVRQLTIQYQEERRSVKHILFSAWPDHQTPESAGPLLRLVAEVEESPETAAHPGPIVVHSSAGIGRTGCFIATRIGCQQLKARGEVDILGIVCQLRLDRGGMIQTAEQYQFLHHTLALYAGQLPEEPSP","Homo sapiens","PTPN7","Tyrosine-protein phosphatase non-receptor type 7","1","2QDP"
"2QE3",,"X-RAY DIFFRACTION",3.48,64.7,,8.5,"10 MM CACL2, 100 MM TRIS, PH 8.50, 20% METHONAL, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 290K, temperature 298.0K",298,"10.1021/bi900031w",,"2QE3",20.95,"2.5","2.5","Crystal structure of human tl1a extracellular domain","GSHMLKGQEFAPSHQQVYAPLRADGDKPRAHLTVVRQTPTQHFKNQFPALHWEHELGLAFTKNRMNYTNKFLLIPESGDYFIYSQVTFRGMTSECSEIRQAGRPNKPDSITVVITKVTDSYPEPTQLLMGTKSVCEVGSNWFQPIYLGAMFSLQEGDKLMVNVSDISLVDYTKEDKTFFGAFLL","Homo sapiens","TNFSF15, TL1, VEGI","TNF superfamily ligand TL1A","1","2QE3"
"2QE4",,"X-RAY DIFFRACTION",2.09,41.13,"VAPOR DIFFUSION, HANGING DROP",6.8,"100 mM MES pH 6.8, 0.5 M MgCl2, 15% w/v PEG 4000, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.bmcl.2007.07.009","JJ3","2QE4",57.25,"2.4","2.4","Estrogen receptor alpha ligand-binding domain in complex with a benzopyran agonist","NSLALSLTADQMVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLESAWLEILMIGLVWRSMEHPGKLLFAPNLLLDRNQGKSVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGMEHLYSMKSKNVVPLYDLLLEMLDAHRLHA","Homo sapiens","ESR1, ESR, NR3A1","Estrogen receptor","1","2QE4"
"2QEL",,"X-RAY DIFFRACTION",2.04,39.84,"VAPOR DIFFUSION, HANGING DROP",8,"0.1M Tris, 2.4M Ammonium sulphate, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1107/S1744309107033957",,"2QEL",55.07,"2.29","2.29","Crystal structure of the highly amyloidogenic transthyretin mutant TTR G53S/E54D/L55S- heated protein","GPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESSDSHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","2QEL"
"2QEP",,"X-RAY DIFFRACTION",2.29,46.39,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.2 M Na/KPO4, 0.1 M Bis-tris-propane pH 6.5, 20.0% PEG 3350, 10.0% Ethylene glycol, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.cell.2008.11.038",,"2QEP",69.99,"2.5","2.5","Crystal structure of the D1 domain of PTPRN2 (IA2beta)","MSEEPVQSNMDISTGHMILSYMEDHLKNKNRLEKEWEALCAYQAEPNSSFVAQREENVPKNRSLAVLTYDHSRVLLKAENSHSHSDYINASPIMDHDPRNPAYIATQGPLPATVADFWQMVWESGCVVIVMLTPLAENGVRQCYHYWPDEGSNLYHIYEVNLVSEHIWCEDFLVRSFYLKNLQTNETRTVTQFHFLSWYDRGVPSSSRSLLDFRRKVNKCYRGRSCPIIVHCSDGAGRSGTYVLIDMVLNKMAKGAKEIDIAATLEHLRDQRPGMVQTKEQFEFALTAVAEEVNAILAHHHHHH","Homo sapiens","PTPRN2, KIAA0387","Receptor-type tyrosine-protein phosphatase N2","1","2QEP"
"2QF6",,"X-RAY DIFFRACTION",3.45,64.3,"VAPOR DIFFUSION, HANGING DROP",6.5,"22 %(w/v) PEG 8000, 0.1 M Na cacodylate, 0.2 M Ammonium Sulfate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1111/j.1747-0285.2007.00535.x","A56","2QF6",93.86,"3.1","3.1","HSP90 complexed with A56322","VETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYETLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","2QF6"
"2QFB",,"X-RAY DIFFRACTION",3.1,60.27,"VAPOR DIFFUSION, SITTING DROP",10,"0.1 M CHES, 18% w/v PEG 8000, pH 10.0, VAPOR DIFFUSION, SITTING DROP, temperature 293.15K",293.15,"10.1016/j.molcel.2007.10.032",,"2QFB",169.19,"3","3","Crystal structure of the regulatory domain of human RIG-I with bound Zn","MGSSHHHHHHSSGLVPRGSHMDKENKKLLCRKCKALACYTADVRVIEECHYTVLGDAFKECFVSRPHPKPKQFSSFEKRAKIFCARQNCSHDWGIHVKYKTFEIPVIKIESFVVEDIATGVQTLYSKWKDFHFEKIPFDPAEMSK","Homo sapiens","DDX58","Probable ATP-dependent RNA helicase DDX58","1","2QFB"
"2QFD",,"X-RAY DIFFRACTION",3.04,59.51,"VAPOR DIFFUSION, SITTING DROP",10,"0.1 M CHES pH 10.0, 18% w/v PEG 8000, VAPOR DIFFUSION, SITTING DROP, temperature 293.15K",293.15,"10.1016/j.molcel.2007.10.032",,"2QFD",170.54,"2.7","2.7","Crystal structure of the regulatory domain of human RIG-I with bound Hg","MGSSHHHHHHSSGLVPRGSHMDKENKKLLCRKCKALACYTADVRVIEECHYTVLGDAFKECFVSRPHPKPKQFSSFEKRAKIFCARQNCSHDWGIHVKYKTFEIPVIKIESFVVEDIATGVQTLYSKWKDFHFEKIPFDPAEMSK","Homo sapiens","DDX58","Probable ATP-dependent RNA helicase DDX58","1","2QFD"
"2QFE",,"X-RAY DIFFRACTION",2.23,44.75,"VAPOR DIFFUSION, HANGING DROP",7,"The crystals were grown in 1.4 M NaKPO4 pH 7.0, by mixing equal volumes of the precipitant solution and 13 mg/mL protein 
in binding buffer (500 mM NaCl, 50 mM Tris pH 8.0). The  
crystal was soaked for 1 hour in a solution containing 2 M NaBr., VAPOR DIFFUSION, HANGING DROP, temperature 298.0K",298,,,"2QFE",17.89,"1.45","1.45","Distal C2-Like Domain of Human Calpain-7","MGSSHHHHHHSSGLVPRGSPYTLSKRINGKWSGQSAGGCGNFQETHKNNPIYQFHIEKTGPLLIELRGPRQYSVGFEVVTVSTLGDPGPHGFLRKSSGDYRCGFCYLELENIPSGIFNIIPSTFLPKQEGPFFLDFNSIIPIKITQLQ","Homo sapiens","CAPN7, PALBH","Calpain-7","1","2QFE"
"2QFG",,"SOLUTION SCATTERING",,,,,,,"10.1016/j.jmb.2007.09.026",,"2QFG",35.43,,,"Solution Structure of the N-terminal SCR-1/5 fragment of Complement Factor H.","EFEDCNELPPRRNTEILTGSWSDQTYPEGTQAIYKCRPGYRSLGNVIMVCRKGEWVALNPLRKCQKRPCGHPGDTPFGTFTLTGGNVFEYGVKAVYTCNEGYQLLGEINYRECDTDGWTNDIPICEVVKCLPVTAPENGKIVSSAMEPDREYHFGQAVRFVCNSGYKIEGDEEMHCSDDGFWSKEKPKCVEISCKSPDVINGSPISQKIIYKENERFQYKCNMGYEYSERGDAVCTESGWRPLPSCEEKSCDNPYIPNGDYSPLRIKHRTGDEITYQCRNGFYPATRGNTAKCTSTGWIPAPRCTLHHHHHH","Homo sapiens","CFH, HF, HF1, HF2","Complement factor H","1","2QFG"
"2QFH",,"SOLUTION SCATTERING",,,,,,,"10.1016/j.jmb.2007.09.026",,"2QFH",37.63,,,"Solution Structure of the C-terminal SCR-16/20 fragment of Complement Factor H.","EAEAEFGLPCKSPPEISHGVVAHMSDSYQYGEEVTYKCFEGFGIDGPAIAKCLGEKWSHPPSCIKTDCLSLPSFENAIPMGEKKDVYKAGEQVTYTCATYYKMDGASNVTCINSRWTGRPTCRDTSCVNPPTVQNAYIVSRQMSKYPSGERVRYQCRSPYEMFGDEEVMCLNGNWTEPPQCKDSTGKCGPPPPIDNGDITSFPLSVYAPASSVEYQCQNLYQLEGNKRITCRNGQWSEPPKCLHPCVISREIMENYNIALRWTAKQKLYSRTGESVEFVCKRGYRLSSRSHTLRTTCWDGKLEYPTCAKRPLEQKLISEEDLNSAVDHHHHHH","Homo sapiens","CFH, HF, HF1, HF2","Complement factor H","1","2QFH"
"2QFJ",,"X-RAY DIFFRACTION",1.52,27.9,"VAPOR DIFFUSION, HANGING DROP",8.5,"Reservoir: 0.1 M Tris-HCl, 32% PEG 4000, pH 8.5
 mixed 1:1 with protein/DNA complex in 20 mM Tris-HCl (pH 8.0), 100 mM NaCl, vapor diffusion, hanging drop",,"10.1038/sj.emboj.7601936",,"2QFJ",54.51,"2.1","2.1","Crystal Structure of First Two RRM Domains of FIR Bound to ssDNA from a Portion of FUSE","TCGGGATTTTTTATTTTGTGTTATT",,,"DNA (5'-D(*DTP*DCP*DGP*DGP*DGP*DAP*DTP*DTP*DTP*DTP*DTP*DTP*DAP*DTP*DTP*DTP*DTP*DGP*DTP*DGP*DTP*DTP*DAP*DTP*DT)-3')","1","2QFJ"
,,,,,,,,,,,,,,,,"GSHMASMTGGQQMGRGSAAQRQGALAIMSRVYVGSIYYELGEDTIRQAFAPFGPIKSIDMSWDSVTMKHKGFAFVEYEVPEAAQLALEQMNSVMLGGRNIKVGRPSNIGQAQPIIDQLAEEARAFNRIYVASVHQDLSDDDIKSVFEAFGKIKSATLARDPTTGKHKGYGFIEYEKAQSSQDAVSSMNLFDLGGQYLRVGKAVTPPMPLLTPATPG","Homo sapiens","FIR, SIAHBP1, PUF60, ROBPI","FBP-interacting repressor","2","2QFJ"
"2QFO",,"X-RAY DIFFRACTION",3.03,59.39,"VAPOR DIFFUSION, HANGING DROP",8.5,"Protein at 35 mg/ml with a reservoir of 22-30 % (w/v) PEG4000, 0.1 M Tris-HCl PH 8.5, 0.2 M MgCl2, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1111/j.1747-0285.2007.00535.x","A13, A51","2QFO",46.63,"1.68","1.68","HSP90 complexed with A143571 and A516383","VETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","2QFO"
"2QFZ",,"X-RAY DIFFRACTION",2.5,49.5,"VAPOR DIFFUSION",7.5,"28.0% PEG400, 0.2M Calcium chloride, 0.1M Sodium HEPES, pH 7.5, VAPOR DIFFUSION, temperature 291K",291,,,"2QFZ",82.02,"2.1","2.1","Crystal structure of human TBC1 domain family member 22A","MHHHHHHSSGRENLYFQGSEREASRLDKFKQLLAGPNTDLEELRRLSWSGIPKPVRPMTWKLLSGYLPANVDRRPATLQRKQKEYFAFIEHYYDSRNDEVHQDTYRQIHIDIPRMSPEALILQPKVTEIFERILFIWAIRHPASGYVQGINDLVTPFFVVFICEYIEAEEVDTVDVSGVPAEVLCNIEADTYWCMSKLLDGIQDNYTFAQPGIQMKVKMLEELVSRIDEQVHRHLDQHEVRYLQFAFRWMNNLLMREVPLRCTIRLWDTYQSEPDGFSHFHLYVCAAFLVRWRKEILEEKDFQELLLFLQNLPTAHWDDEDISLLLAEAYRLKFAFADAPNHYKK","Homo sapiens","TBC1D22A, C22orf4","TBC1 domain family member 22A","1","2QFZ"
"2QG0",,"X-RAY DIFFRACTION",3,59.02,"VAPOR DIFFUSION, HANGING DROP",6.5,"40 mg/ml protein with a reservoir solution of 20-28 %(w/v)PEG 3350, 0.1 M Bis-Tris-Propane PH 6.5, 0.2 M Sodium chloride, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1111/j.1747-0285.2007.00535.x","A94","2QG0",47.05,"1.85","1.85","HSP90 complexed with A943037","VETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","2QG0"
"2QG1",,"X-RAY DIFFRACTION",2.05,39.96,"VAPOR DIFFUSION, SITTING DROP",4,"0.8M (NH4)2SO4, 0.1M Citrate pH 4.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,,,"2QG1",9.7,"1.4","1.4","Crystal structure of the 11th PDZ domain of MPDZ (MUPP1)","SMSDTLTIGLQKKPGKGLGLSIVGKRNDTGVFVSDIVKGGIADADGRLMQGDQILMVNGEDVRNATQEAVAALLKCSLGTVTLEVGRISTYV","Homo sapiens","MPDZ, MUPP1","Multiple PDZ domain protein","1","2QG1"
"2QG2",,"X-RAY DIFFRACTION",3.24,62.04,"VAPOR DIFFUSION, HANGING DROP",6.5,"40 mg/ml protein with a reservoir solution of 8-18 %(w/v) PMME 2000, 0.1 M sodium cacodylate PH 6.5, 0.2 M MgCl2, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1111/j.1747-0285.2007.00535.x","A91","2QG2",23.47,"1.8","1.8","HSP90 complexed with A917985","VETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYETLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","2QG2"
"2QG4",,"X-RAY DIFFRACTION",3.06,59.75,"VAPOR DIFFUSION, SITTING DROP",6.5,"20% PEG 3350, 10% Ethylene glycol, 0.2 M NaBr, 0.1 M Bis-tris-propane, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1074/jbc.M111.234682",,"2QG4",427.15,"2.1","2.1","Crystal structure of human UDP-glucose dehydrogenase product complex with UDP-glucuronate","SMFEIKKICCIGAGYVGGPTCSVIAHMCPEIRVTVVDVNESRINAWNSPTLPIYEPGLKEVVESCRGKNLFFSTNIDDAIKEADLVFISVNTPTKTYGMGKGRAADLKYIEACARRIVQNSNGYKIVTEKSTVPVRAAESIRRIFDANTKPNLNLQVLSNPEFLAEGTAIKDLKNPDRVLIGGDETPEGQRAVQALCAVYEHWVPREKILTTNTWSSELSKLAANAFLAQRISSINSISALCEATGADVEEVATAIGMDQRIGNKFLKASVGFGGSCFQKDVLNLVYLCEALNLPEVARYWQQVIDMNDYQRRRFASRIIDSLFNTVTDKKIAILGFAFKKDTGDTRESSSIYISKYLMDEGAHLHIYDPKVPREQIVVDLSHPGVSEDDQVSRLVTISKDPYEACDGAHAVVICTEWDMFKELDYERIHKKMLKPAFIFDGRRVLDGLHNELQTIGFQIETIGKKV","Homo sapiens","UGDH","UDP-glucose 6-dehydrogenase","1","2QG4"
"2QG6",,"X-RAY DIFFRACTION",2.55,51.8,"VAPOR DIFFUSION, SITTING DROP",7.8,"28% (w/v) PEG 3350, 200 mM NH4Cl, 5 mM DTT, 5 mM Na2HPO, pH 7.8, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1016/j.str.2007.06.017",,"2QG6",23.97,"1.5","1.5","Crystal structure of human nicotinamide riboside kinase (NRK1) in complex with nicotinamide mononucleotide (NMN)","MKTFIIGISGVTNSGKTTLAKNLQKHLPNCSVISQDDFFKPESEIETDKNGFLQYDVLEALNMEKMMSAISCWMESARHSVVSTDQESAEEIPILIIEGFLLFNYKPLDTIWNRSYFLTIPYEECKRRRSTRVYQPPDSPGYFDGHVWPMYLKYRQEMQDITWEVVYLDGTKSEEDLFLQVYEDLIQELAKQKCLQVTA","Homo sapiens","NRK1, C9orf95, NMRK1","Nicotinamide riboside kinase 1","1","2QG6"
"2QGB",,"X-RAY DIFFRACTION",2.33,42.39,"VAPOR DIFFUSION, SITTING DROP",5.5,"The WT-TTR was concentrated to 4 mg/mL in 10 mM NaPi, 100 mM KCl, at pH 7.6 and co-crystallized at room temperature using the vapor-diffusion sitting drop method.  Crystals were grown from 1.395 M sodium citrate, 3.5% v/v glycerol at pH 5.5.  The crystals were frozen using a cryo-protectant solution of 1.395 M sodium citrate, pH 5.5, containing 10% v/v glycerol., VAPOR DIFFUSION, SITTING DROP, temperature 298.0K",298,"10.1021/jm0708735",,"2QGB",27.55,"1.4","1.4","Human transthyretin (TTR) in Apo-form","GPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","2QGB"
"2QGC",,"X-RAY DIFFRACTION",2.35,42.67,"VAPOR DIFFUSION, SITTING DROP",5.5,"The WT-TTR was concentrated to 4 mg/mL in 10 mM NaPi, 100 mM KCl, at pH 7.6 and co-crystallized at room temperature with inhibitors using the vapor-diffusion sitting drop method.  Crystals were grown from 1.395 M sodium citrate, 3.5% v/v glycerol at pH 5.5.  The crystals were frozen using a cryo-protectant solution of 1.395 M sodium citrate, pH 5.5, containing 10% v/v glycerol., VAPOR DIFFUSION, SITTING DROP, temperature 298.0K",298,"10.1021/jm0708735",,"2QGC",28.03,"1.3","1.3","Human transthyretin (TTR) complexed with 2-(3,5-Dimethyl-4-hydroxyphenyl)benzoxazole","GPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","2QGC"
"2QGD",,"X-RAY DIFFRACTION",2.36,42.91,"VAPOR DIFFUSION, SITTING DROP",5.5,"The WT-TTR was concentrated to 4 mg/mL in 10 mM NaPi, 100 mM KCl, at pH 7.6 and co-crystallized at room temperature with inhibitors using the vapor-diffusion sitting drop method.  Crystals were grown from 1.395 M sodium citrate, 3.5% v/v glycerol at pH 5.5.  The crystals were frozen using a cryo-protectant solution of 1.395 M sodium citrate, pH 5.5, containing 10% v/v glycerol., VAPOR DIFFUSION, SITTING DROP, temperature 298.0K",298,"10.1021/jm0708735",,"2QGD",28.29,"1.5","1.5","Human transthyretin (TTR) complexed with 2-(3,5-Dibromo-4-hydroxyphenyl)benzoxazole","GPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","2QGD"
"2QGE",,"X-RAY DIFFRACTION",2.36,42.93,"VAPOR DIFFUSION, SITTING DROP",5.5,"The WT-TTR was concentrated to 4 mg/mL in 10 mM NaPi, 100 mM KCl, at pH 7.6 and co-crystallized at room temperature with inhibitors using the vapor-diffusion sitting drop method.  Crystals were grown from 1.395 M sodium citrate, 3.5% v/v glycerol at pH 5.5.  The crystals were frozen using a cryo-protectant solution of 1.395 M sodium citrate, pH 5.5, containing 10% v/v glycerol., VAPOR DIFFUSION, SITTING DROP, temperature 298.0K",298,"10.1021/jm0708735",,"2QGE",28,"1.45","1.45","Human transthyretin (TTR) complexed with 2-(3,5-Dimethylphenyl)benzoxazole","GPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","2QGE"
"2QGX",,"X-RAY DIFFRACTION",2.41,48.98,"VAPOR DIFFUSION",7.5,"22% PEG4000, 0.1 M Tris-Cl, pH7.5, 0.12 M MgCl2, 1 mM DTT, vapor diffusion, temperature 298K",298,"10.1074/mcp.O111.013706",,"2QGX",75.47,"2.56","2.56","Ubiquitin-conjugating enzyme E2Q","GSGSVQATDRLMKELRDIYRSQSFKGGNYAVELVNDSLYDWNVKLLKVDQDSALHNDLQILKEKEGADFILLNFSFKDNFPFDPPFVRVVSPVLSGGYVLGGGAICMELLTKQGWSSAYSIESVIMQISATLVKGKARVQFGANKSQYSLTRAQQSYKSLVQIHEKNGW","Homo sapiens","UBE2Q1, NICE5, UBE2Q, PRO3094","Ubiquitin-conjugating enzyme E2 Q1","1","2QGX"
"2QH7",,"X-RAY DIFFRACTION",1.91,35.73,,,,,"10.1073/pnas.0707189104",,"2QH7",18.25,"1.5","1.5","MitoNEET is a uniquely folded 2Fe-2S outer mitochondrial membrane protein stabilized by pioglitazone","RFYVKDHRNKAMINLHIQKDNPKIVHAFDMEDLGDKAVYCRCWRSKKFPFCDGAHTKHNEETGDNVGPLIIKKKET","Homo sapiens","ZCD1, CISD1, C10orf70, MDS029","Zinc finger CDGSH-type domain 1","1","2QH7"
"2QHM",,"X-RAY DIFFRACTION",2.34,47.51,"VAPOR DIFFUSION, HANGING DROP",6.8,"13% PEG 8K, 0.1M ammonium sulfate, 2% glycerol, 0.1M sodium cacodylate buffer, pH 6.8, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.bmcl.2007.07.051","7CS","2QHM",37.21,"2","2","crystal structure of Chek1 in complex with inhibitor 2a","MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGFSKHIQSNLDFSPVNSASRTPGSGWSKEHHHHHH","Homo sapiens","CHEK1, CHK1","Serine/threonine-protein kinase Chk1","1","2QHM"
"2QHN",,"X-RAY DIFFRACTION",2.33,47.19,"VAPOR DIFFUSION, HANGING DROP",6.8,"13% PEG 8K, 0.1M ammonium sulfate, 2% glycerol, 0.1M sodium cacodylate buffer, pH 6.8, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.bmcl.2007.07.051","582","2QHN",37.15,"1.7","1.7","Crystal Structure of Chek1 in Complex with Inhibitor 1a","MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGFSKHIQSNLDFSPVNSASRTPGSGWSKEHHHHHH","Homo sapiens","CHEK1, CHK1","Serine/threonine-protein kinase Chk1","1","2QHN"
"2QIC",,"X-RAY DIFFRACTION",2.17,43.26,"VAPOR DIFFUSION, HANGING DROP",7,"0.01 M NiCl2 6H20, 0.1 M Tris, 20% polyethylene glycol monomethyl ether 2K, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.jmb.2008.04.061",,"2QIC",8.56,"2.1","2.1","Crystal Structure of the ING1 PHD Finger in complex with a Histone H3K4ME3 peptide","GSDLPIDPNEPTYCLCNQVSYGEMIGCDNDECPIEWFHFSCVGLNHKPKGKWYCPKCRGENE","Homo sapiens","ING1","Inhibitor of growth protein 1","1","2QIC"
,,,,,,,,,,,,,,,,"ARTKQTARKSTG",,,"H3K4ME3 PEPTIDE","2","2QIC"
"2QIS",,"X-RAY DIFFRACTION",2.44,49.61,"VAPOR DIFFUSION, SITTING DROP",7,"0.20 M NH4Cl, 20.0% PEG 6000, 10.0% Ethylene glycol, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,,"RIS","2QIS",43.36,"1.8","1.8","Crystal structure of human farnesyl pyrophosphate synthase T210S mutant bound to risedronate","GSSHHHHHHSSGRENLYFQGHMNGDQNSDVYAQEKQDFVQHFSQIVRVLTEDEMGHPEIGDAIARLKEVLEYNAIGGKYNRGLTVVVAFRELVEPRKQDADSLQRAWTVGWCVELLQAFFLVADDIMDSSLTRRGQICWYQKPGVGLDAINDANLLEACIYRLLKLYCREQPYYLNLIELFLQSSYQTEIGQTLDLLTAPQGNVDLVRFTEKRYKSIVKYKSAFYSFYLPIAAAMYMAGIDGEKEHANAKKILLEMGEFFQIQDDYLDLFGDPSVTGKIGTDIQDNKCSWLVVQCLQRATPEQYQILKENYGQKEAEKVARVKALYEELDLPAVFLQYEEDSYSHIMALIEQYAAPLPPAVFLGLARKIYKRRK","Homo sapiens","FDPS, FPS, KIAA1293","Farnesyl pyrophosphate synthetase","1","2QIS"
"2QIU",,"X-RAY DIFFRACTION",1.96,37.35,"VAPOR DIFFUSION, HANGING DROP",6.7,"Sodium Citrate, Acetone, Zinc Sulphate, pH 6.7, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.biochi.2007.09.012",,"2QIU",12.08,"2","2","Structure of Human Arg-Insulin","RGIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","Insulin","1","2QIU"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFYTPKT","Homo sapiens","INS","Insulin","2","2QIU"
"2QJ2",,"X-RAY DIFFRACTION",2.1,41.56,"VAPOR DIFFUSION, HANGING DROP",8,"50 mM ammonium sulfate, 26-29% PEG 4000 (w/w), 100 mM Tris-HCl pH 8.0, 0.5 mM beta-octyl glucoside, and 5% ethylene glycol , VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1073/pnas.0704290104",,"2QJ2",42.7,"1.81","1.81","A Mechanistic Basis for Converting a Receptor Tyrosine Kinase Agonist to an Antagonist","GSYAEGQRKRRNTIHEFKKSAKTTLIKIDPALKIKTKKVNTADQCANRCTRNKGLPFTCKAFVFDKARKQCLWFPFNSMSSGVKKEFGHEFDLYENKDYIRNCIIGKGRSYKGTVSITKSGIKCQPWSSMIPHEHSFLPSSYRGKDLQENYCRNPRGEEGGPWCFTSNPEVRYEVCDIPQCSEV","Homo sapiens","HGF, HPTA","Hepatocyte growth factor","1","2QJ2"
"2QJF",,"X-RAY DIFFRACTION",2.36,47.79,"VAPOR DIFFUSION, HANGING DROP",7,"mother liquor: 10% PEG 10K, 0.1M HEPES pH 7.0; protein solution: 10mg/ml, ATP-sulfurylase, 5mM APS, 25mM TRIS/HCl pH 7.5, 25mM KCl, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,,,"2QJF",94.35,"2.2","2.2","Crystal structure of ATP-sulfurylase domain of human PAPS synthetase 1","LQERDIVPVDASYEVKELYVPENKLHLAKTDAETLPALKINKVDMQWVQVLAEGWATPLNGFMREREYLQCLHFDCLLDGGVINLSVPIVLTATHEDKERLDGCTAFALMYEGRRVAILRNPEFFEHRKEERCARQWGTTCKNHPYIKMVMEQGDWLIGGDLQVLDRVYWNDGLDQYRLTPTELKQKFKDMNADAVFAFQLRNPVHNGHALLMQDTHKQLLERGYRRPVLLLHPLGGWTKDDDVPLMWRMKQHAAVLEEGVLNPETTVVAIFPSPMMYAGPTEVQWHCRARMVAGANFYIVGRDPAGMPHPETGKDLYEPSHGAKVLTMAPGLITLEIVPFRVAAYNKKKKRMDYYDSEHHEDFEFISGTRMRKLAREGQKPPEGFMAPKAWTVLTEYYKSLEKA","Homo sapiens","PAPSS1, ATPSK1, PAPSS","Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthetase 1","1","2QJF"
"2QJR",,"X-RAY DIFFRACTION",2.75,55.21,"VAPOR DIFFUSION, HANGING DROP",,"VAPOR DIFFUSION, HANGING DROP",,"10.1016/j.bmcl.2007.07.081","PZF","2QJR",177.62,"2.2","2.2","dipepdyl peptidase IV in complex with inhibitor PZF","GTDDATADSRKTYTLTDYLKNTYRLKLYSLRWISDHEYLYKQENNILVFNAEYGNSSVFLENSTFDEFGHSINDYSISPDGQFILLEYNYVKQWRHSYTASYDIYDLNKRQLITEERIPNNTQWVTWSPVGHKLAYVWNNDIYVKIEPNLPSYRITWTGKEDIIYNGITDWVYEEEVFSAYSALWWSPNGTFLAYAQFNDTEVPLIEYSFYSDESLQYPKTVRVPYPKAGAVNPTVKFFVVNTDSLSSVTNATSIQITAPASMLIGDHYLCDVTWATQERISLQWLRRIQNYSVMDICDYDESSGRWNCLVARQHIEMSTTGWVGRFRPSEPHFTLDGNSFYKIISNEEGYRHICYFQIDKKDCTFITKGTWEVIGIEALTSDYLYYISNEYKGMPGGRNLYKIQLSDYTKVTCLSCELNPERCQYYSVSFSKEAKYYQLRCSGPGLPLYTLHSSVNDKGLRVLEDNSALDKMLQNVQMPSKKLDFIILNETKFWYQMILPPHFDKSKKYPLLLDVYAGPCSQKADTVFRLNWATYLASTENIIVASFDGRGSGYQGDKIMHAINRRLGTFEVEDQIEAARQFSKMGFVDNKRIAIWGWSYGGYVTSMVLGSGSGVFKCGIAVAPVSRWEYYDSVYTERYMGLPTPEDNLDHYRNSTVMSRAENFKQVEYLLIHGTADDNVHFQQSAQISKALVDVGVDFQAMWYTDEDHGIASSTAHQHIYTHMSHFIKQCFSLPLVPRGSHHHHHH","Homo sapiens","DPP4, ADCP2, CD26","Dipeptidyl peptidase 4 membrane form","1","2QJR"
"2QJZ",,"X-RAY DIFFRACTION",2.07,40.72,"VAPOR DIFFUSION, HANGING DROP",7,"11.5% 2-propanol, 190 mM Sodium citrate, 100 mM Hepes, Protein concentration 20 mg/ml, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.molcel.2007.07.023",,"2QJZ",28.91,"1.25","1.25","Structural Basis of Microtubule Plus End Tracking by XMAP215, CLIP-170 and EB1","GSDNLSRHDMLAWINESLQLNLTKIEQLCSGAAYCQFMDMLFPGSIALKKVKFQAKLEHEYIQNFKILQAGFKRMGVDKIIPVDKLVKGKFQDNFEFVQWFKKFFDANYDGKDYDPVAARQGQ","Homo sapiens","MAPRE1","Microtubule-associated protein RP/EB family member 1","1","2QJZ"
"2QK0",,"X-RAY DIFFRACTION",1.82,32.39,"VAPOR DIFFUSION, HANGING DROP",9,"1.2 M Sodium malonate, 100 mM Glycine, 1.1 mM Lanthanum chloride, Protein concentration 15 mg/ml, pH 9.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.molcel.2007.07.023",,"2QK0",8.24,"2","2","Structural Basis of Microtubule Plus End Tracking by XMAP215, CLIP-170 and EB1","GSDFRVGERVWVNGNKPGFIQFLGETQFAPGQWAGIVLDEPIGKNDGSVAGVRYFQCEPLKGIFTRPSKMTRKV","Homo sapiens","CLIP1, CYLN1, RSN","CAP-Gly domain-containing linker protein 1","1","2QK0"
"2QK4",,"X-RAY DIFFRACTION",3.21,61.65,"VAPOR DIFFUSION, HANGING DROP",5.2,"16% PEG 3350, 0.3M LiSO4, 100 mM Bis-Tris pH 5.2, VAPOR DIFFUSION, HANGING DROP, temperature 298.0K",298,"10.1093/nar/gkq595",,"2QK4",98.2,"2.45","2.45","Human glycinamide ribonucleotide synthetase","MHHHHHHSSGVDLGTENLYFQSMAARVLIIGSGGREHTLAWKLAQSHHVKQVLVAPGNAGTACSEKISNTAISISDHTALAQFCKEKKIEFVVVGPEAPLAAGIVGNLRSAGVQCFGPTAEAAQLESSKRFAKEFMDRHGIPTAQWKAFTKPEEACSFILSADFPALVVKASGLAAGKGVIVAKSKEEACKAVQEIMQEKAFGAAGETIVIEELLDGEEVSCLCFTDGKTVAPMPPAQDHKRLLEGDGGPNTGGMGAYCPAPQVSNDLLLKIKDTVLQRTVDGMQQEGTPYTGILYAGIMLTKNGPKVLEFNCRFGDPECQVILPLLKSDLYEVIQSTLDGLLCTSLPVWLENHTALTVVMASKGYPGDYTKGVEITGFPEAQALGLEVFHAGTALKNGKVVTHGGRVLAVTAIRENLISALEEAKKGLAAIKFEGAIYRKDIGFRAIAFLQ","Homo sapiens","GART, PGFT, PRGS","Trifunctional purine biosynthetic protein adenosine-3","1","2QK4"
"2QK5",,"X-RAY DIFFRACTION",2.88,57.27,"VAPOR DIFFUSION, HANGING DROP",,"VAPOR DIFFUSION, HANGING DROP",,"10.1016/j.bmcl.2007.10.116","CS5","2QK5",89.04,"2.2","2.2","Structure of BACE1 bound to SCH626485","AAGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNI","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","2QK5"
"2QK9",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, HANGING DROP",5.6,"1.5 M ammonium sulfate, 0.1 M Na citrate (pH 5.6) 20mM ATP or 3% 1,6-diaminohexane, VAPOR DIFFUSION, HANGING DROP, temperature 294K",294,"10.1016/j.molcel.2007.08.015",,"2QK9",29.55,"2.55","2.55","Human RNase H catalytic domain mutant D210N in complex with 18-mer RNA/DNA hybrid","AGUGCGACACCUGAUUCC",,,"5'-R(*AP*GP*UP*GP*CP*GP*AP*CP*AP*CP*CP*UP*GP*AP*UP*UP*CP*C)-3'","1","2QK9"
,,,,,,,,,,,,,,,,"GGAATCAGGTGTCGCACT",,,"5'-D(*GP*GP*AP*AP*TP*CP*AP*GP*GP*TP*GP*TP*CP*GP*CP*AP*CP*T)-3'","2","2QK9"
,,,,,,,,,,,,,,,,"GSHMGDFVVVYTDGCCSSNGRRRPRAGIGVYWGPGHPLNVGIRLPGRQTNQRAEIHAACKAIEQAKTQNINKLVLYTNSMFTINGITNWVQGWKKNGWKTSAGKEVINKEDFVALERLTQGMDIQWMHVPGHSGFIGNEEADRLAREGAKQSED","Homo sapiens","RNASEH1, RNH1","Ribonuclease H1","3","2QK9"
"2QKA",,"X-RAY DIFFRACTION",2.64,53.32,"VAPOR DIFFUSION",8,"2.5M ammonium sulfate, 0.1M malic acid, 0.1M imidazole, pH 8.0, VAPOR DIFFUSION, temperature 300K",300,"10.1021/bi7014103",,"2QKA",43.91,"2.2","2.2","Structural and Kinetic Study of the Differences between Human and E.coli Manganese Superoxide Dismutases","KHSLPDLPYDYGALEPHINAQIMQLHHSKHHAAYVNNLNVTEEKYQEALAKGDVTAQIALQPALKANGGGHINHSIFWTNLSPNGGGEPKGELLEAIKRDFGSFDKFKEKLTAASVGVQGSGWGWLGFNKERGHLQIAACPNQDPLQGTTGLIPLLGIDVWEHAYYLQYKNVRPDYLKAIWNVINWENVTERYMAC","Homo sapiens","SOD2","Superoxide dismutase [Mn]","1","2QKA"
"2QKB",,"X-RAY DIFFRACTION",2.49,50.63,"VAPOR DIFFUSION, HANGING DROP",8.5,"15% PEG 3350, 0.1 M LiSO4, 0.1 M Tris, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 294K",294,"10.1016/j.molcel.2007.08.015",,"2QKB",47.43,"2.4","2.4","Human RNase H catalytic domain mutant D210N in complex with 20-mer RNA/DNA hybrid","GGAGUGCGACACCUGAUUCC",,,"5'-R(*GP*GP*AP*GP*UP*GP*CP*GP*AP*CP*AP*CP*CP*UP*GP*AP*UP*UP*CP*C)-3')","1","2QKB"
,,,,,,,,,,,,,,,,"GGAATCAGGTGTCGCACTCT",,,"5'-D(*DGP*DGP*DAP*DAP*DTP*DCP*DAP*DGP*DGP*DTP*DGP*DTP*DCP*DGP*DCP*DAP*DCP*DTP*DCP*DT)-3'","2","2QKB"
,,,,,,,,,,,,,,,,"GSHMGDFVVVYTDGCCSSNGRRRPRAGIGVYWGPGHPLNVGIRLPGRQTNQRAEIHAACKAIEQAKTQNINKLVLYTNSMFTINGITNWVQGWKKNGWKTSAGKEVINKEDFVALERLTQGMDIQWMHVPGHSGFIGNEEADRLAREGAKQSED","Homo sapiens","RNASEH1, RNH1","Ribonuclease H1","3","2QKB"
"2QKC",,"X-RAY DIFFRACTION",2.62,53.13,"VAPOR DIFFUSION, HANGING DROP",8,"2.5M ammonium sulfate, 0.1M malic acid, 0.1M imidazole, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 300K",300,"10.1021/bi7014103",,"2QKC",43.99,"2.3","2.3","Structural and Kinetic Study of the Differences between Human and E.coli Manganese Superoxide Dismutases","KHSLPDLPYDYGALEPHINAQIMQLHHSKHHAAYVNNLNVTEEKYQEALAKGDVTAQIALQPALKLNGGGHINHSIFWTNLSPNGGGEPKGELLEAIKRDFGSFDKFKEKLTAASVGVQGSGWGWLGFNKERGHLQIAACPNQDPLQGTTGLIPLLGIDVWEHAYYLQYKNVRPDYLKAIWNVINWENVTERYMAC","Homo sapiens","SOD2","Superoxide dismutase [Mn]","1","2QKC"
"2QKH",,"X-RAY DIFFRACTION",3.01,59.2,"VAPOR DIFFUSION, HANGING DROP",7.2,"100 mM HEPES, 1 M potassium-sodium tartrate, 9% Methyl-beta-cyclodextrin, pH 7.2, VAPOR DIFFUSION, HANGING DROP, temperature 288K",288,"10.1073/pnas.0706404104",,"2QKH",21.78,"1.9","1.9","Crystal structure of the extracellular domain of human GIP receptor in complex with the hormone GIP","YAEGTFISDYSIAMDKIHQQDFVNWLLAQKGKKNDWKHNITQ",,,"Glucose-dependent insulinotropic polypeptide","1","2QKH"
,,,,,,,,,,,,,,,,"GSSHHHHHHSSGLVPRGSHMETGSKGQTAGELYQRWERYRRECQETLAAAEPPSGLACNGSFDMYVCWDYAAPNATARASCPWYLPWHHHVAAGFVLRQCGSDGQWGLWRDHTQCENPEKNEAFLDQRLILERLQ","Homo sapiens","GIPR","Glucose-dependent insulinotropic polypeptide receptor","2","2QKH"
"2QKI",,"X-RAY DIFFRACTION",2.54,51.49,"VAPOR DIFFUSION, HANGING DROP",7,"PEG-MME 2000, KBr, Tris, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1074/jbc.M704587200",,"2QKI",273.11,"2.4","2.4","Human C3c in complex with the inhibitor compstatin","SPMYSIITPNILRLESEETMVLEAHDAQGDVPVTVTVHDFPGKKLVLSSEKTVLTPATNHMGNVTFTIPANREFKSEKGRNKFVTVQATFGTQVVEKVVLVSLQSGYLFIQTDKTIYTPGSTVLYRIFTVNHKLLPVGRTVMVNIENPEGIPVKQDSLSSQNQLGVLPLSWDIPELVNMGQWKIRAYYENSPQQVFSTEFEVKEYVLPSFEVIVEPTEKFYYIYNEKGLEVTITARFLYGKKVEGTAFVIFGIQDGEQRISLPESLKRIPIEDGSGEVVLSRKVLLDGVQNLRAEDLVGKSLYVSATVILHSGSDMVQAERSGIPIVTSPYQIHFTKTPKYFKPGMPFDLMVFVTNPDGSPAYRVPVAVQGEDTVQSLTQGDGVAKLSINTHPSQKPLSITVRTKKQELSEAEQATRTMQALPYSTVGNSNNYLHLSVLRTELRPGETLNVNFLLRMDRAHEAKIRYYTYLIMNKGRLLKAGRQVREPGQDLVVLPLSITTDFIPSFRLVAYYTLIGASGQREVVADSVWVDVKDSCVGSLVVKSGQSEDRQPVPGQQMTLKIEGDHGARVVLVAVDKGVFVLNKKNKLTQSKIWDVVEKADIGCTPGSGKDYAGVFSDAGLTFTSSSGQQTAQRAELQCPQP","Homo sapiens","C3, CPAMD1","Complement C3","1","2QKI"
,,,,,,,,,,,,,,,,"SNLDEDIIAEENIVSRSEFPESWLWNVEDLKEPPKNGISTKLMNIFLKDSITTWEILAVSMSDKKGICVADPFEVTVMQDFFIDLRLPYSVVRNEQVEIRAVLYNYRQNQELKVRVELLHNPAFCSLATTKRRHQQTVTIPPKSSLSVPYVIVPLKTGLQEVEVKAAVYHHFISDGVRKSLKVVPEGI","Homo sapiens","C3, CPAMD1","Complement C3","2","2QKI"
,,,,,,,,,,,,,,,,"SEETKENEGFTVTAEGKGQGTLSVVTMYHAKAKDQLTCNKFDLKVTIKPAPETEKRPQDAKNTMILEICTRYRGDQDATMSILDISMMTGFAPDTDDLKQLANGVDRYISKYELDKAFSDRNTLIIYLDKVSHSEDDCLAFKVHQYFNVELIQPGAVKVYAYYNLEESCTRFYHPEKEDGKLNKLCRDELCRCAEENCFIQKSDDKVTLEERLDKACEPGVDYVYKTRLVKVQLSNDFDEYIMAIEQTIKSGSDEVQVGQQRTFISPIKCREALKLEEKKHYLMWGLSSDFWGEKPNLSYIIGKDTWVEHWPEEDECQDEENQKQCQDLGAFTESMVVFGCPN","Homo sapiens","C3, CPAMD1","Complement C3","3","2QKI"
,,,,,,,,,,,,,,,,"XICVWQDWGAHRCTX",,,"compstatin","4","2QKI"
"2QKK",,"X-RAY DIFFRACTION",3.46,64.5,"VAPOR DIFFUSION, HANGING DROP",6,"12% isopropanol, 0.2 M calcium acetate, 0.1 M MES, 0.1 M LiCl, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 294K",294,"10.1016/j.molcel.2007.08.015",,"2QKK",241.52,"3.2","3.2","Human RNase H catalytic domain mutant D210N in complex with 14-mer RNA/DNA hybrid","CGACACCUGAUUCC",,,"5'-R(*CP*GP*AP*CP*AP*CP*CP*UP*GP*AP*UP*UP*CP*C)-3'","1","2QKK"
,,,,,,,,,,,,,,,,"GGAATCAGGTGTCG",,,"5'-D(*GP*GP*AP*AP*TP*CP*AP*GP*GP*TP*GP*TP*CP*G)-3'","2","2QKK"
,,,,,,,,,,,,,,,,"GSHMGDFVVVYTDGCCSSNGRRRPRAGIGVYWGPGHPLNVGIRLPGRQTNQRAEIHAACKAIEQAKTQNINKLVLYTNSMFTINGITNWVQGWKKNGWKTSAGKEVINKEDFVALERLTQGMDIQWMHVPGHSGFIGNEEADRLAREGAKQSED","Homo sapiens","RNASEH1, RNH1","Ribonuclease H1","3","2QKK"
"2QKQ",,"X-RAY DIFFRACTION",1.92,35.9,"VAPOR DIFFUSION, SITTING DROP",6.4,"2.3 M NaKPO4, pH 6.4, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,,,"2QKQ",18.17,"2.1","2.1","Structure of the SAM Domain of Human Ephrin Type-B Receptor 4","GHPLLDQRQPHYSAFGSVGEWLRAIKMGRYEESFAAAGFGSFELVSQISAEDLLRIGVTLAGHQKKILASVQHMKSQAKPGTP","Homo sapiens","EPHB4, HTK, TYRO11, MYK1","Ephrin type-B receptor 4","1","2QKQ"
"2QKY",,"X-RAY DIFFRACTION",2.87,57.07,"VAPOR DIFFUSION, SITTING DROP",8.5,"24% PEG MME 2K, 0.1M Bicine, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.bmcl.2007.05.046","13Z","2QKY",339.4,"3.1","3.1","complex structure of dipeptidyl peptidase IV and a oxadiazolyl ketone","TRKTYTLTDYLKNTYRLKLYSLRWISDHEYLYKQENNILVFNAEYGNSSVFLENSTFDEFGHSINDYSISPDGQFILLEYNYVKQWRHSYTASYDIYDLNKRQLITEERIPNNTQWVTWSPVGHKLAYVWNNDIYVKIEPNLPSYRITWTGKEDIIYNGITDWVYEEEVFSAYSALWWSPNGTFLAYAQFNDTEVPLIEYSFYSDESLQYPKTVRVPYPKAGAVNPTVKFFVVNTDSLSSVTNATSIQITAPASMLIGDHYLCDVTWATQERISLQWLRRIQNYSVMDICDYDESSGRWNCLVARQHIEMSTTGWVGRFRPSEPHFTLDGNSFYKIISNEEGYRHICYFQIDKKDCTFITKGTWEVIGIEALTSDYLYYISNEYKGMPGGRNLYKIQLSDYTKVTCLSCELNPERCQYYSVSFSKEAKYYQLRCSGPGLPLYTLHSSVNDKGLRVLEDNSALDKMLQNVQMPSKKLDFIILNETKFWYQMILPPHFDKSKKYPLLLDVYAGPCSQKADTVFRLNWATYLASTENIIVASFDGRGSGYQGDKIMHAINRRLGTFEVEDQIEAARQFSKMGFVDNKRIAIWGWSYGGYVTSMVLGSGSGVFKCGIAVAPVSRWEYYDSVYTERYMGLPTPEDNLDHYRNSTVMSRAENFKQVEYLLIHGTADDNVHFQQSAQISKALVDVGVDFQAMWYTDEDHGIASSTAHQHIYTHMSHFIKQCFSLP","Homo sapiens","DPP4, ADCP2, CD26","Dipeptidyl peptidase 4 (EC 3.4.14.5) (Dipeptidyl peptidase IV) (DPP IV) (T-cell activation antigen CD26) (TP103) (Adenosine deaminase complexing protein 2) (ADABP) (Dipeptidyl peptidase 4 soluble form) (Dipeptidyl peptidase IV soluble form)","1","2QKY"
"2QL1",,"X-RAY DIFFRACTION",2.68,54.14,"VAPOR DIFFUSION",8,"8% PEG 3350, 200 mM Zn Acetate, 5% Glycerol, 0.1 M Imidazole -Malate buffer, pH 8.0, VAPOR DIFFUSION, temperature 298.0K",298,"10.1016/j.molimm.2007.10.042",,"2QL1",27.34,"2.534","2.534","Structural Characterization of a Mutated, ADCC-Enhanced Human Fc Fragment","THTCPPCPAPELLGGPDVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPLPEEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPGK","Homo sapiens","IGHM, IGHG1","IGHM protein","1","2QL1"
"2QL5",,"X-RAY DIFFRACTION",3.25,62.19,"VAPOR DIFFUSION, HANGING DROP",7,"14.5% PEG 3350, 0.3M diammonium hydrogen citrate, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1111/j.1742-4658.2007.05994.x",,"2QL5",63.59,"2.34","2.34","Crystal Structure of caspase-7 with inhibitor AC-DMQD-CHO","AKPDRSSFVPSLFSKKKKNVTMRSIKTTRDRVPTYQYNMNFEKLGKCIIINNKNFDKVTGMGVRNGTDKDAEALFKCFRSLGFDVIVYNDCSCAKMQDLLKKASEEDHTNAACFACILLSHGEENVIYGKDGVTPIKDLTAHFRGDRCKTLLEKPKLFFIQACRGTELDDGIQ","Homo sapiens","CASP7, MCH3","Caspase-7","1","2QL5"
,,,,,,,,,,,,,,,,"ANPRYKIPVEADFLFAYSTVPGYYSWRSPGRGSWFVQALCSILEEHGKDLEIMQILTRVNDRVARHFESQSDDPHFHEKKQIPCVVSMLTKELYFSQ","Homo sapiens","CASP7, MCH3","Caspase-7","2","2QL5"
,,,,,,,,,,,,,,,,"XDMQX",,,"inhibitor","3","2QL5"
,,,,,,,,,,,,,,,,"QGHGE",,,"peptide","4","2QL5"
"2QL6",,"X-RAY DIFFRACTION",2.81,56.26,"VAPOR DIFFUSION, SITTING DROP",7.8,"8% (w/v) PEG 3350, 200 mM NH4Cl, 5 mM DTT, 5 mM Na2HPO, pH 7.8, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1016/j.str.2007.06.017",,"2QL6",387.71,"2.7","2.7","human nicotinamide riboside kinase (NRK1)","MKTFIIGISGVTNSGKTTLAKNLQKHLPNCSVISQDDFFKPESEIETDKNGFLQYDVLEALNMEKMMSAISCWMESARHSVVSTDQESAEEIPILIIEGFLLFNYKPLDTIWNRSYFLTIPYEECKRRRSTRVYQPPDSPGYFDGHVWPMYLKYRQEMQDITWEVVYLDGTKSEEDLFLQVYEDLIQELAKQKCLQVTA","Homo sapiens","NRK1, C9orf95, NMRK1","nicotinamide riboside kinase 1","1","2QL6"
"2QL7",,"X-RAY DIFFRACTION",3.31,62.85,"VAPOR DIFFUSION, HANGING DROP",6.7,"14.5% PEG 3350, 0.3M diammonium hydrogen citrate, 10mM DTT, pH 6.7, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1111/j.1742-4658.2007.05994.x",,"2QL7",63.52,"2.4","2.4","Crystal Structure of Caspase-7 with inhibitor AC-IEPD-CHO","AKPDRSSFVPSLFSKKKKNVTMRSIKTTRDRVPTYQYNMNFEKLGKCIIINNKNFDKVTGMGVRNGTDKDAEALFKCFRSLGFDVIVYNDCSCAKMQDLLKKASEEDHTNAACFACILLSHGEENVIYGKDGVTPIKDLTAHFRGDRCKTLLEKPKLFFIQACRGTELDDGIQ","Homo sapiens","CASP7, MCH3","Caspase-7","1","2QL7"
,,,,,,,,,,,,,,,,"ANPRYKIPVEADFLFAYSTVPGYYSWRSPGRGSWFVQALCSILEEHGKDLEIMQILTRVNDRVARHFESQSDDPHFHEKKQIPCVVSMLTKELYFSQ","Homo sapiens","CASP7, MCH3","Caspase-7","2","2QL7"
,,,,,,,,,,,,,,,,"XIEPX",,,"Inhibitor AC-IEPD_CHO","3","2QL7"
,,,,,,,,,,,,,,,,"QGHGE",,,"QGHGE","4","2QL7"
"2QL9",,"X-RAY DIFFRACTION",3.25,62.11,"VAPOR DIFFUSION, HANGING DROP",6.7,"14.5% PEG 3350, 0.3M diammonium hydrogen citrate, 10mM DTT, pH 6.7, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1111/j.1742-4658.2007.05994.x",,"2QL9",63.59,"2.14","2.14","Crystal Structure of Caspase-7 with inhibitor AC-DQMD-CHO","AKPDRSSFVPSLFSKKKKNVTMRSIKTTRDRVPTYQYNMNFEKLGKCIIINNKNFDKVTGMGVRNGTDKDAEALFKCFRSLGFDVIVYNDCSCAKMQDLLKKASEEDHTNAACFACILLSHGEENVIYGKDGVTPIKDLTAHFRGDRCKTLLEKPKLFFIQACRGTELDDGIQ","Homo sapiens","CASP7, MCH3","Caspase-7","1","2QL9"
,,,,,,,,,,,,,,,,"ANPRYKIPVEADFLFAYSTVPGYYSWRSPGRGSWFVQALCSILEEHGKDLEIMQILTRVNDRVARHFESQSDDPHFHEKKQIPCVVSMLTKELYFSQ","Homo sapiens","CASP7, MCH3","Caspase-7","2","2QL9"
,,,,,,,,,,,,,,,,"XDQMX",,,"Inhibitor AC-DQMD-CHO","3","2QL9"
,,,,,,,,,,,,,,,,"QGHGE",,,"PEPTIDE QGHGE","4","2QL9"
"2QLB",,"X-RAY DIFFRACTION",3.35,63.24,"VAPOR DIFFUSION, HANGING DROP",6.7,"14.5% PEG 3350, 0.3M diammonium hydrogen citrate, 10mM DTT, pH 6.7, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1111/j.1742-4658.2007.05994.x",,"2QLB",63.54,"2.25","2.25","Crystal Structure of caspase-7 with inhibitor AC-ESMD-CHO","AKPDRSSFVPSLFSKKKKNVTMRSIKTTRDRVPTYQYNMNFEKLGKCIIINNKNFDKVTGMGVRNGTDKDAEALFKCFRSLGFDVIVYNDCSCAKMQDLLKKASEEDHTNAACFACILLSHGEENVIYGKDGVTPIKDLTAHFRGDRCKTLLEKPKLFFIQACRGTELDDGIQ","Homo sapiens","CASP7, MCH3","Caspase-7","1","2QLB"
,,,,,,,,,,,,,,,,"ANPRYKIPVEADFLFAYSTVPGYYSWRSPGRGSWFVQALCSILEEHGKDLEIMQILTRVNDRVARHFESQSDDPHFHEKKQIPCVVSMLTKELYFSQ","Homo sapiens","CASP7, MCH3","Caspase-7","2","2QLB"
,,,,,,,,,,,,,,,,"XESMX",,,"Inhibitor AC-ESMD-CHO","3","2QLB"
,,,,,,,,,,,,,,,,"QGHGE",,,"Peptide QGHGE","4","2QLB"
"2QLD",,"X-RAY DIFFRACTION",4.57,73.11,"VAPOR DIFFUSION, HANGING DROP",5.5,"100mM Citric buffer, PEG400 25%, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1186/1472-6807-8-3",,"2QLD",20.74,"2.7","2.7","human Hsp40 Hdj1","KKQDPPVTHDLRVSLEEIYSGCTKKMKISHKRLNPDGKSIRNEDKILTIEVKKGWKEGTKITFPKEGDQTSNNIPADIVFVLKDKPHNIFKRDGSDVIYPARISLREALCGCTVNVPTLDGRTIPVVFKDVIRPGMRRKVPGEGLPLPKTPEKRGDLIIEFEVIFPERIPQTSRTVLEQVLPI","Homo sapiens","DNAJB1, DNAJ1, HDJ1, HSPF1","DnaJ homolog subfamily B member 1","1","2QLD"
"2QLF",,"X-RAY DIFFRACTION",3.24,62.09,"VAPOR DIFFUSION, HANGING DROP",6.7,"14.5% PEG 3350, 0.3M diammonium hydrogen citrate, 10mM DTT, pH 6.7, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1111/j.1742-4658.2007.05994.x",,"2QLF",63.34,"2.8","2.8","Crystal Structure of Caspase-7 with inhibitor AC-DNLD-CHO","AKPDRSSFVPSLFSKKKKNVTMRSIKTTRDRVPTYQYNMNFEKLGKCIIINNKNFDKVTGMGVRNGTDKDAEALFKCFRSLGFDVIVYNDCSCAKMQDLLKKASEEDHTNAACFACILLSHGEENVIYGKDGVTPIKDLTAHFRGDRCKTLLEKPKLFFIQACRGTELDDGIQ","Homo sapiens","CASP7, MCH3","Caspase-7","1","2QLF"
,,,,,,,,,,,,,,,,"ANPRYKIPVEADFLFAYSTVPGYYSWRSPGRGSWFVQALCSILEEHGKDLEIMQILTRVNDRVARHFESQSDDPHFHEKKQIPCVVSMLTKELYFSQ","Homo sapiens","CASP7, MCH3","Caspase-7","2","2QLF"
,,,,,,,,,,,,,,,,"XDNLX",,,"Inhibitor AC-DNLD-CHO","3","2QLF"
,,,,,,,,,,,,,,,,"QGHGE",,,"Peptide QGHGE","4","2QLF"
"2QLJ",,"X-RAY DIFFRACTION",3.34,63.12,"VAPOR DIFFUSION, HANGING DROP",6.7,"14.5% PEG 3350, 0.3M diammonium hydrogen citrate, 10mM DTT, pH 6.7, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1111/j.1742-4658.2007.05994.x",,"2QLJ",63.75,"2.6","2.6","Crystal Structure of Caspase-7 with Inhibitor AC-WEHD-CHO","AKPDRSSFVPSLFSKKKKNVTMRSIKTTRDRVPTYQYNMNFEKLGKCIIINNKNFDKVTGMGVRNGTDKDAEALFKCFRSLGFDVIVYNDCSCAKMQDLLKKASEEDHTNAACFACILLSHGEENVIYGKDGVTPIKDLTAHFRGDRCKTLLEKPKLFFIQACRGTELDDGIQ","Homo sapiens","CASP7, MCH3","Caspase-7","1","2QLJ"
,,,,,,,,,,,,,,,,"ANPRYKIPVEADFLFAYSTVPGYYSWRSPGRGSWFVQALCSILEEHGKDLEIMQILTRVNDRVARHFESQSDDPHFHEKKQIPCVVSMLTKELYFSQ","Homo sapiens","CASP7, MCH3","Caspase-7","2","2QLJ"
,,,,,,,,,,,,,,,,"XWEHX",,,"Inhibitor AC-WEHD-CHO","3","2QLJ"
,,,,,,,,,,,,,,,,"QGHGE",,,"Peptide QGHGE","4","2QLJ"
"2QLL",,"X-RAY DIFFRACTION",2.85,56.84,"VAPOR DIFFUSION, HANGING DROP",8,"8 mg/ml protein, 0.1 M TRIS, 8% PEG 8000, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1074/jbc.M706612200",,"2QLL",98.1,"2.56","2.56","Human liver glycogen phosphorylase- GL complex","MAKPLTDQEKRRQISIRGIVGVENVAELKKSFNRHLHFTLVKDRNVATTRDYYFALAHTVRDHLVGRWIRTQQHYYDKCPKRVYYLSLEFYMGRTLQNTMINLGLQNACDEAIYQLGLDIEELEEIEEDAGLGNGGLGRLAACFLDSMATLGLAAYGYGIRYEYGIFNQKIRDGWQVEEADDWLRYGNPWEKSRPEFMLPVHFYGKVEHTNTGTKWIDTQVVLALPYDTPVPGYMNNTVNTMRLWSARAPNDFNLRDFNVGDYIQAVLDRNLAENISRVLYPNDNFFEGKELRLKQEYFVVAATLQDIIRRFKASKFGSTRGAGTVFDAFPDQVAIQLNDTHPALAIPELMRIFVDIEKLPWSKAWELTQKTFAYTNHTVLPEALERWPVDLVEKLLPRHLEIIYEINQKHLDRIVALFPKDVDRLRRMSLIEEEGSKRINMAHLCIVGSHAVNGVAKIHSDIVKTKVFKDFSELEPDKFQNKTNGITPRRWLLLCNPGLAELIAEKIGEDYVKDLSQLTKLHSFLGDDVFLRELAKVKQENKLKFSQFLETEYKVKINPSSMFDVQVKRIHEYKRQLLNCLHVITMYNRIKKDPKKLFVPRTVIIGGKAAPGYHMAKMIIKLITSVADVVNNDPMVGSKLKVIFLENYRVSLAEKVIPATDLSEQISTAGTEASGTGNMKFMLNGALTIGTMDGANVEMAEEAGEENLFIFGMRIDDVAALDKKGYEAKEYYEALPELKLVIDQIDNGFFSPKQPDLFKDIINMLFYHDRFKVFADYEAYVKCQDKVSQLYMNPKAWNTMVLKNIAASGKFSSDRTIKEYAQNIWNVEPSDLKISLSNESNKVNGN","Homo sapiens","PYGL","Glycogen phosphorylase, liver form","1","2QLL"
,,,,,,,,,,,,,,,,"GPYY",,,"protein targeting to glycogen - GL","2","2QLL"
"2QLR",,"X-RAY DIFFRACTION",2.42,49.27,"VAPOR DIFFUSION, HANGING DROP",7.5,"100 mM HEPES, 15% PEG 10000, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1074/jbc.M708358200",,"2QLR",191.62,"2.3","2.3","Crystal structure of human kynurenine aminotransferase II","MNYARFITAASAARNPSPIRTMTDILSRGPKSMISLAGGLPNPNMFPFKTAVITVENGKTIQFGEEMMKRALQYSPSAGIPELLSWLKQLQIKLHNPPTIHYPPSQGQMDLCVTSGSQQGLCKVFEMIINPGDNVLLDEPAYSGTLQSLHPLGCNIINVASDESGIVPDSLRDILSRWKPEDAKNPQKNTPKFLYTVPNGNNPTGNSLTSERKKEIYELARKYDFLIIEDDPYYFLQFNKFRVPTFLSMDVDGRVIRADSFSKIISSGLRIGFLTGPKPLIERVILHIQVSTLHPSTFNQLMISQLLHEWGEEGFMAHVDRVIDFYSNQKDAILAAADKWLTGLAEWHVPAAGMFLWIKVKGINDVKELIEEKAVKMGVLMLPGNAFYVDSSAPSPYLRASFSSASPEQMDVAFQVLAQLIKESL","Homo sapiens","AADAT, KAT2, KYAT2","Kynurenine/alpha-aminoadipate aminotransferase mitochondrial","1","2QLR"
"2QLU",,"X-RAY DIFFRACTION",2.4,48.82,"VAPOR DIFFUSION, HANGING DROP",8,"45mM MES, 90mM ammonium sulfate, 11% polyethylene glycol monomethyl ether 5000, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1110/ps.073068407",,"2QLU",36.12,"2","2","Crystal structure of Activin receptor type II kinase domain from human","MHHHHHHSSGLVPRGSLQLLEIKARGRFGCVWKAQLMNDFVAVKIFPLQDKQSWQSEREIFSTPGMKHENLLQFIAAEKRGSNLEVELWLITAFHDKGSLTDYLKGNIITWNELCHVAETMSRGLSYLHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAADGPVDEYMLPFEEEIGQHPSLEELQEVVVHKKMRPTIKDHWLKHPGLAQLCVTIEECWDHDAEARLSAGCVEERVSLIRRSVNG","Homo sapiens","ACVR2B","Activin receptor type IIB","1","2QLU"
"2QLY",,"X-RAY DIFFRACTION",2.85,56.8,"VAPOR DIFFUSION, HANGING DROP",6.5,"20% PEG 3350, 0.2M sodium sulfate, 4% 1,1,1,3,3,3-hexafluoro-2-propanol, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.jmb.2007.10.069",,"2QLY",100.67,"2","2","Crystral Structure of the N-terminal Subunit of Human Maltase-Glucoamylase","SAECPVVNELERINCIPDQPPTKATCDQRGCCWNPQGAVSVPWCYYSKNHSYHVEGNLVNTNAGFTARLKNLPSSPVFGSNVDNVLLTAEYQTSNRFHFKLTDQTNNRFEVPHEHVQSFSGNAAASLTYQVEISRQPFSIKVTRRSNNRVLFDSSIGPLLFADQFLQLSTRLPSTNVYGLGEHVHQQYRHDMNWKTWPIFNRDTTPNGNGTNLYGAQTFFLCLEDASGLSFGVFLMNSNAMEVVLQPAPAITYRTIGGILDFYVFLGNTPEQVVQEYLELIGRPALPSYWALGFHLSRYEYGTLDNMREVVERNRAAQLPYDVQHADIDYMDERRDFTYDSVDFKGFPEFVNELHNNGQKLVIIVDPAISNNSSSSKPYGPYDRGSDMKIWVNSSDGVTPLIGEVWPGQTVFPDYTNPNCAVWWTKEFELFHNQVEFDGIWIDMNEVSNFVDGSVSGCSTNNLNNPPFTPRILDGYLFCKTLCMDAVQHWGKQYDIHNLYGYSMAVATAEAAKTVFPNKRSFILTRSTFAGSGKFAAHWLGDNTATWDDLRWSIPGVLEFNLFGIPMVGPDICGFALDTPEELCRRWMQLGAFYPFSRNHNGQGYKDQDPASFGADSLLLNSSRHYLNIRYTLLPYLYTLFFRAHSRGDTVARPLLHEFYEDNSTWDVHQQFLWGPGLLITPVLDEGAEKVMAYVPDAVWYDYETGSQVRWRKQKVEMELPGDKIGLHLRGGYIFPTQQPNTTTLASRKNPLGLIIALDENKEAKGELFWDDGETKDTVANKVYLLCEFSVTQNRLEVNISQSTYKDPNNLAFNEIKILGTEEPSNVTVKHNGVPSQTSPTVTYDSNLKVAIITDIDLLLGEAYTVEWAH","Homo sapiens","MGAM, MGA, MGAML","Maltase-glucoamylase, intestinal","1","2QLY"
"2QM4",,"X-RAY DIFFRACTION",2.72,54.82,"VAPOR DIFFUSION, HANGING DROP",6.5,"23% PEG 6000, 0.1M Bis-Tris-Propane, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 291.0K",291,"10.1038/sj.emboj.7601942",,"2QM4",108.24,"2.3","2.3","Crystal structure of human XLF/Cernunnos, a non-homologous end-joining factor","SGMEELEQGLLMQPWAWLQLAENSLLAKVFITKQGYALLVSDLQQVWHEQVDTSVVSQRAKELNKRLTAPPAAFLCHLDNLLRPLLKDAAHPSEATFSCDCVADALILRVRSELSGLPFYWNFHCMLASPSLVSQHLIRPLMGMSLALQCQVRELATLLHMKDLEIQDYQESGATLIRDRLKTEPFEENSFLEQFMIEKLPEACSIGDGKPFVMNLQDLYMAVTTQEVQVGQKHQ","Homo sapiens","NHEJ1, XLF","Non-homologous end-joining factor 1","1","2QM4"
"2QMD",,"X-RAY DIFFRACTION",2.88,57.22,"VAPOR DIFFUSION, HANGING DROP",,"VAPOR DIFFUSION, HANGING DROP",,"10.1016/j.bmcl.2007.10.116","CS7","2QMD",89.54,"1.65","1.65","Structure of BACE Bound to SCH722924","AAGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNI","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","2QMD"
"2QME",,"X-RAY DIFFRACTION",2.23,44.93,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.1 M Tris-HCl pH 8.5, 2 M (NH4)2S04, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,,,"2QME",24.73,"1.75","1.75","Crystal structure of human RAC3 in complex with CRIB domain of human p21-activated kinase 1 (PAK1)","SMQAIKCVVVGDGAVGKTCLLISYTTNAFPGEYIPTVFDNYSANVMVDGKPVNLGLWDTAGQEDYDRLRPLSYPQTDVFLICFSLVSPASFENVRAKWYPEVRHHCPHTPILLVGTKLDLRDDKDTIERLRDKKLAPITYPQGLAMAREIGSVKYLECSALTQRGLKTVFDEAIRAVLG","Homo sapiens","RAC3","Ras-related C3 botulinum toxin substrate 3","1","2QME"
,,,,,,,,,,,,,,,,"EISLPSDFEHTIHVGFDAVTGEFTGMPEQWARLLQT",,,"CRIB domain of the Serine/threonine-protein kinase PAK 1","2","2QME"
"2QMF",,"X-RAY DIFFRACTION",2.88,57.3,"VAPOR DIFFUSION, HANGING DROP",,"VAPOR DIFFUSION, HANGING DROP",,"10.1016/j.bmcl.2007.10.116","CS9","2QMF",89.37,"1.75","1.75","Structure of BACE Bound to SCH735310","AAGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNI","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","2QMF"
"2QMG",,"X-RAY DIFFRACTION",2.87,57.21,"VAPOR DIFFUSION, HANGING DROP",,"VAPOR DIFFUSION, HANGING DROP",,"10.1016/j.bmcl.2007.10.053","SC6","2QMG",89.39,"1.89","1.89","Structure of BACE Bound to SCH745966","AAGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNI","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","2QMG"
"2QMJ",,"X-RAY DIFFRACTION",2.64,53.33,"VAPOR DIFFUSION, HANGING DROP",6.5,"20% PEG 3350, 0.2M sodium sulfate, 4% 1,1,1,3,3,3-hexafluoro-2-propanol, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.jmb.2007.10.069",,"2QMJ",101.02,"1.9","1.9","Crystral Structure of the N-terminal Subunit of Human Maltase-Glucoamylase in Complex with Acarbose","SAECPVVNELERINCIPDQPPTKATCDQRGCCWNPQGAVSVPWCYYSKNHSYHVEGNLVNTNAGFTARLKNLPSSPVFGSNVDNVLLTAEYQTSNRFHFKLTDQTNNRFEVPHEHVQSFSGNAAASLTYQVEISRQPFSIKVTRRSNNRVLFDSSIGPLLFADQFLQLSTRLPSTNVYGLGEHVHQQYRHDMNWKTWPIFNRDTTPNGNGTNLYGAQTFFLCLEDASGLSFGVFLMNSNAMEVVLQPAPAITYRTIGGILDFYVFLGNTPEQVVQEYLELIGRPALPSYWALGFHLSRYEYGTLDNMREVVERNRAAQLPYDVQHADIDYMDERRDFTYDSVDFKGFPEFVNELHNNGQKLVIIVDPAISNNSSSSKPYGPYDRGSDMKIWVNSSDGVTPLIGEVWPGQTVFPDYTNPNCAVWWTKEFELFHNQVEFDGIWIDMNEVSNFVDGSVSGCSTNNLNNPPFTPRILDGYLFCKTLCMDAVQHWGKQYDIHNLYGYSMAVATAEAAKTVFPNKRSFILTRSTFAGSGKFAAHWLGDNTATWDDLRWSIPGVLEFNLFGIPMVGPDICGFALDTPEELCRRWMQLGAFYPFSRNHNGQGYKDQDPASFGADSLLLNSSRHYLNIRYTLLPYLYTLFFRAHSRGDTVARPLLHEFYEDNSTWDVHQQFLWGPGLLITPVLDEGAEKVMAYVPDAVWYDYETGSQVRWRKQKVEMELPGDKIGLHLRGGYIFPTQQPNTTTLASRKNPLGLIIALDENKEAKGELFWDDGETKDTVANKVYLLCEFSVTQNRLEVNISQSTYKDPNNLAFNEIKILGTEEPSNVTVKHNGVPSQTSPTVTYDSNLKVAIITDIDLLLGEAYTVEWAH","Homo sapiens","MGAM, MGA, MGAML","Maltase-glucoamylase, intestinal","1","2QMJ"
"2QMK",,"X-RAY DIFFRACTION",2.02,39.12,"VAPOR DIFFUSION, HANGING DROP",7.5,"60% 2-methylpentane-2,4-diol, 100 mM cacodylate, pH 7.50, VAPOR DIFFUSION, HANGING DROP, temperature 300K",300,"10.1021/bi701652t",,"2QMK",56.24,"2.3","2.3","Human pancreatic alpha-amylase complexed with nitrite","QYSPNTQQGRTSIVHLFEWRWVDIALECERYLAPKGFGGVQVSPPNENVAIYNPFRPWWERYQPVSYKLCTRSGNEDEFRNMVTRCNNVGVRIYVDAVINHMCGNAVSAGTSSTCGSYFNPGSRDFPAVPYSGWDFNDGKCKTGSGDIENYNDATQVRDCRLTGLLDLALEKDYVRSKIAEYMNHLIDIGVAGFRLDASKHMWPGDIKAILDKLHNLNSNWFPAGSKPFIYQEVIDLGGEPIKSSDYFGNGRVTEFKYGAKLGTVIRKWNGEKMSYLKNWGEGWGFVPSDRALVFVDNHDNQRGHGAGGASILTFWDARLYKMAVGFMLAHPYGFTRVMSSYRWPRQFQNGNDVNDWVGPPNNNGVIKEVTINPDTTCGNDWVCEHRWRQIRNMVIFRNVVDGQPFTNWYDNGSNQVAFGRGNRGFIVFNNDDWSFSLTLQTGLPAGTYCDVISGDKINGNCTGIKIYVSDDGKAHFSISNSAEDPFIAIHAESKL","Homo sapiens","AMY2A","Pancreatic alpha-amylase","1","2QMK"
"2QMR",,"X-RAY DIFFRACTION",3.79,67.54,"VAPOR DIFFUSION, HANGING DROP",7.5,"3.2 M potassium formate, 0.1 M HEPES pH 7.5 and 10% Glycerol, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.str.2007.09.009",,"2QMR",405.63,"3","3","Karyopherin beta2/transportin","MEYEWKPDEQGLQQILQLLKESQSPDTTIQRTVQQKLEQLNQYPDFNNYLIFVLTKLKSEDEPTRSLSGLILKNNVKAHFQNFPNGVTDFIKSECLNNIGDSSPLIRATVGILITTIASKGELQNWPDLLPKLCSLLDSEDYNTCEGAFGALQKICEDSAEILDSDVLDRPLNIMIPKFLQFFKHSSPKIRSHAVACVNQFIISRTQALMLHIDSFIENLFALAGDEEPEVRKNVCRALVMLLEVRMDRLLPHMHNIVEYMLQRTQDQDENVALEACEFWLTLAEQPICKDVLVRHLPKLIPVLVNGMKYSDIDIILLKGDVEEDETIPDSEQDIRPRFHRSRTVAQQHDEDGIEEEDDDDDEIDDDDTISDWNLRKCSAAALDVLANVYRDELLPHILPLLKELLFHHEWVVKESGILVLGAIAEGCMQGMIPYLPELIPHLIQCLSDKKALVRSITCWTLSRYAHWVVSQPPDTYLKPLMTELLKRILDSNKRVQEAACSAFATLEEEACTELVPYLAYILDTLVFAFSKYQHKNLLILYDAIGTLADSVGHHLNKPEYIQMLMPPLIQKWNMLKDEDKDLFPLLECLSSVATALQSGFLPYCEPVYQRCVNLVQKTLAQAMLNNAQPDQYEAPDKDFMIVALDLLSGLAEGLGGNIEQLVARSNILTLMYQCMQDKMPEVRQSSFALLGDLTKACFQHVKPCIADFMPILGTNLNPEFISVCNNATWAIGEISIQMGIEMQPYIPMVLHQLVEIINRPNTPKTLLENTAITIGRLGYVCPQEVAPMLQQFIRPWCTSLRNIRDNEEKDSAFRGICTMISVNPSGVIQDFIFFCDAVASWINPKDDLRDMFCKILHGFKNQVGDENWRRFSDQFPLPLKERLAAFYGV","Homo sapiens","TNPO1, KPNB2, MIP1, TRN","Transportin-1","1","2QMR"
"2QMS",,"X-RAY DIFFRACTION",1.93,36.3,"VAPOR DIFFUSION, HANGING DROP",6.1,"0.1M sodium citrate pH6.1, 22.5% PEG 4000, 0.2M Ammonium sulphate, 5 % glycerol, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1186/1472-6807-7-58",,"2QMS",55.44,"2.1","2.1","Crystal structure of a signaling molecule","GSPASGTSLSAAIHRTQLWFHGRISREESQRLIGQQGLVDGLFLVRESQRNPQGFVLSLCHLQKVKHYLILPSEEEGRLYFSMDDGQTRFTDLLQLVEFHQLNRGILPCLLRHCCTRVAL","Homo sapiens","GRB7","Growth factor receptor-bound protein 7","1","2QMS"
"2QMV",,"SOLUTION NMR",,,,,,,,,"2QMV",30.83,,,"High Resolution Structure of Peroxisone Proliferation-Activated Receptor gamma and Characterisation of its Interaction with the Co-activator Transcriptional Intermediary Factor 2","ESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDL","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","2QMV"
"2QMY",,"X-RAY DIFFRACTION",2.44,49.65,"VAPOR DIFFUSION, HANGING DROP",7,"ammonium sulfate (1.2-2 M), pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 300K",300,,,"2QMY",53.76,"2.5","2.5","Quinone Reductase 2 in complex with adrenochrome","AGKKVLIVYAHQEPKSFNGSLKNVAVDELSRQGCTVTVSDLYAMNFEPRATDKDITGTLSNPEVFNYGVETHEAYKQRSLASDITDEQKKVREADLVIFQFPLYWFSVPAILKGWMDRVLCQGFAFDIPGFYDSGLLQGKLALLSVTTGGTAEMYTKTGVNGDSRYFLWPLQHGTLHFCGFKVLAPQISFAPEIASEEERKGMVAAWSQRLQTIWKEEPIPCTAHWHFGQ","Homo sapiens","NQO2, NMOR2","Ribosyldihydronicotinamide dehydrogenase","1","2QMY"
"2QMZ",,"X-RAY DIFFRACTION",2.43,49.34,"VAPOR DIFFUSION, HANGING DROP",7,"Ammonium Sulfate (1.2-2 M), pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 300K",300,,,"2QMZ",53.71,"2.1","2.1","Quinone Reductase 2 in Complex with Dopamine","AGKKVLIVYAHQEPKSFNGSLKNVAVDELSRQGCTVTVSDLYAMNFEPRATDKDITGTLSNPEVFNYGVETHEAYKQRSLASDITDEQKKVREADLVIFQFPLYWFSVPAILKGWMDRVLCQGFAFDIPGFYDSGLLQGKLALLSVTTGGTAEMYTKTGVNGDSRYFLWPLQHGTLHFCGFKVLAPQISFAPEIASEEERKGMVAAWSQRLQTIWKEEPIPCTAHWHFGQ","Homo sapiens","NQO2, NMOR2","Ribosyldihydronicotinamide dehydrogenase","1","2QMZ"
"2QND",,"X-RAY DIFFRACTION",2.53,51.36,"VAPOR DIFFUSION, HANGING DROP",8,"50mM Tris-HCl, pH 8.0, 300mM NaCl, 5mM reduced L-Glutathione, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1016/j.str.2007.06.022",,"2QND",32.33,"1.9","1.9","Crystal Structure of the KH1-KH2 domains from human Fragile X Mental Retardation Protein","ASRFHEQFIVREDLMGLAIGTHGANIQQARKVPGVTAIDLDEDTCTFHIYGEDQDAVKKARSFLEFAEDVIQVPRNLVGKVIGKNGKLIQEIVDKSGVVRVRIEAENEKNVPQEEGMVPFVFVGTKDSIANATVLLDYHLNYLK","Homo sapiens","FMR1","FMR1 protein","1","2QND"
,,,,,,,,,,,,,,,,,"Homo sapiens","FMR1"
"2QNJ",,"X-RAY DIFFRACTION",2.74,55.13,"VAPOR DIFFUSION, HANGING DROP",7.5,"1.5M LiSO4, 100 mM HEPES pH7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1073/pnas.0703012104",,"2QNJ",75.34,"2.7","2.7","Kinase and Ubiquitin-associated domains of MARK3/Par-1","GAMGSDEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDELKPFVEPELDISDQKRIDIMVGMGYSQEEIQESLSKMKYDEITATYLLLGRKSSE","Homo sapiens","MARK3, CTAK1, EMK2","MAP/microtubule affinity-regulating kinase 3","1","2QNJ"
"2QNK",,"X-RAY DIFFRACTION",2.6,52.2,"VAPOR DIFFUSION, HANGING DROP",,"Protein solution (10 mg/ml Protein, 0.050 M Sodium chloride, 0.0031 M Sodium azide, 0.0003 M TCEP, 0.005 M Bis-Tris pH 7.0) mixed in a 1:1 ratio with the well solution (50% v/v 2-Methyl-2,4-pentanediol (MPD), 0.1 M PIPES pH 6.5) and cryoprotected with well solution, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,,,"2QNK",33.03,"1.6","1.6","Crystal structure of human 3-hydroxyanthranilate 3,4-dioxygenase","SERRLGVRAWVKENRGSFQPPVCNKLMHQEQLKVMFIGGPNTRKDYHIEEGEEVFYQLEGDMVLRVLEQGKHRDVVIRQGEIFLLPARVPHSPQRFANTVGLVVERRRLETELDGLRYYVGDTMDVLFEKWFYCKDLGTQLAPIIQEFFSSEQYRTGKPIPDQLLKEPPFPLSTRSIMEPMSLDAWLDSHHRELQAGTPLSLFGDTYETQVIAYGQGSSEGLRQNVDVWLWQLEGSSVVTMGGRRLSLAPDDSLLVLAGTSYAWERTQGSVALSVTQDPACKKPLG","Homo sapiens","HAAO","3-hydroxyanthranilate 3,4-dioxygenase","1","2QNK"
"2QNR",,"X-RAY DIFFRACTION",2.51,51.07,"VAPOR DIFFUSION",6.5,"PEG 3350, 0.2M Trilithium citrate, 0.1M Bis-Tris, pH 6.5, VAPOR DIFFUSION, temperature 291K",291,,,"2QNR",70.91,"2.6","2.6","Human septin 2 in complex with GDP","GSNLPNQVHRKSVKKGFEFTLMVVGESGLGKSTLINSLFLTDLYPERVISGAAEKIERTVQIEASTVEIEERGVKLRLTVVDTPGYGDAINCRDCFKTIISYIDEQFERYLHDESGLNRRHIIDNRVHCCFYFISPFGHGLKPLDVAFMKAIHNKVNIVPVIAKADTLTLKERERLKKRILDEIEEHNIKIYHLPDAESDEDEDFKEQTRLLKASIPFSVVGSNQLIEAKGKKVRGRLYPWGVVEVENPEHNDFLKLRTMLITHMQDLQEVTQDLHYENFRSERLKRGGRKVENEDMNKDQ","Homo sapiens","SEPT2, DIFF6, KIAA0158, NEDD5, SEPTIN2","Septin-2","1","2QNR"
"2QNV",,"X-RAY DIFFRACTION",2.43,49.37,"VAPOR DIFFUSION, HANGING DROP",8,"Precipitant: 10% Isopropanol;   
Cryoprotectant: done by serial dipping into 15%, 25% and 35% ethylene glycol, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,,,"2QNV",36.68,"2.8","2.8","Crystal Structure of the Pregnane X Receptor bound to Colupulone","MKKGHHHHHHGSERTGTQPLGVQGLTEEQRMMIRELMDAQMKTFDTTFSHFKNFRLPGVLSSGCELPESLQAPSREEAAKWSQVRKDLCSLKVSLQLRGEDGSVWNYKPPADSGGKEIFSLLPHMADMSTYMFKGIISFAKVISYFRDLPIEDQISLLKGAAFELCQLRFNTVFNAETGTWECGRLSYCLEDTAGGFQQLLLEPMLKFHYMLKKLQLHEEEYVLMQAISLFSPDRPGVLQHRVVDQLQEQFAITLKSYIECNRPQPAHRFLFLKIMAMLTELRSINAQHTQRLLRIQDIHPFATPLMQELFGITGS","Homo sapiens","NR1I2, PXR","Orphan nuclear receptor PXR","1","2QNV"
"2QO2",,"X-RAY DIFFRACTION",1.85,33.55,"VAPOR DIFFUSION, SITTING DROP",7.5,"20 mg/mL Protein, 25% PEG 3350, 0.2M Ammonium sulfate, 0.1M Hepes, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1016/j.str.2008.03.008",,"2QO2",42.04,"1.6","1.6","Human EphA3 kinase and juxtamembrane region, dephosphorylated, apo structure","GSDEKRLHFGNGHLKLPGLRTYVDPHTYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAARPSNLLLDQSNVDITTFRTTGDWLNGVWTAHCKEIFTGVEYSSCDTIAKIS","Homo sapiens","EPHA3, ETK, ETK1, HEK, TYRO4","Ephrin receptor","1","2QO2"
"2QO7",,"X-RAY DIFFRACTION",1.82,32.3,"VAPOR DIFFUSION, SITTING DROP",7.5,"20 mg/mL Protein, 25% PEG 3350, 0.2M Ammonium sulfate, 0.1M Hepes, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1016/j.str.2008.03.008",,"2QO7",42.84,"1.605","1.605","Human EphA3 kinase and juxtamembrane region, dephosphorylated, AMP-PNP bound","GSDEKRLHFGNGHLKLPGLRTYVDPHTYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAARPSNLLLDQSNVDITTFRTTGDWLNGVWTAHCKEIFTGVEYSSCDTIAKIS","Homo sapiens","EPHA3, ETK, ETK1, HEK, TYRO4","Ephrin receptor","1","2QO7"
"2QO8",,"X-RAY DIFFRACTION",2.08,40.95,,8.2,"AMMONIUM SULPHATE, SODIUM CHLORIDE, TRIS-HCl, pH 8.2, VAPOR DIFFUSION, HANGING DROP, temperature 277 K, temperature 277.0K, pH 8.20",277,"10.1002/cmdc.200700274","3CC","2QO8",30.07,"1.4","1.4","Crystal structure of the complex of hcaii with an indane-sulfonamide inhibitor","SHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","2QO8"
"2QO9",,"X-RAY DIFFRACTION",1.83,32.87,"VAPOR DIFFUSION, SITTING DROP",7.5,"20 mg/mL Protein, 25% PEG 3350, 0.2M Ammonium sulfate, 0.1M Hepes, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1016/j.str.2008.03.008",,"2QO9",42.49,"1.55","1.55","Human EphA3 kinase and juxtamembrane region, phosphorylated, AMP-PNP bound","GSDEKRLHFGNGHLKLPGLRTYVDPHTYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAARPSNLLLDQSNVDITTFRTTGDWLNGVWTAHCKEIFTGVEYSSCDTIAKIS","Homo sapiens","EPHA3, ETK, ETK1, HEK, TYRO4","Ephrin receptor","1","2QO9"
"2QOA",,"X-RAY DIFFRACTION",2.09,41.28,"VAPOR DIFFUSION, HANGING DROP",8.2,"AMMONIUM SULPHATE, SODIUM CHLORIDE, TRIS-HCl, pH 8.2, VAPOR DIFFUSION, HANGING DROP, temperature 277K, temperature 277.0K",277,"10.1002/cmdc.200700274","MAJ, CL","2QOA",30.07,"1.6","1.6","Crystal structure of the complex of hcaii with an indane-sulfonamide inhibitor","SHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","2QOA"
"2QOB",,"X-RAY DIFFRACTION",1.97,37.45,"VAPOR DIFFUSION, SITTING DROP",7.5,"20 mg/mL Protein, 25% PEG 3350, 0.2M Ammonium sulfate, 0.1M Hepes, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1016/j.str.2008.03.008",,"2QOB",38.73,"1.65","1.65","Human EphA3 kinase domain, base structure","GSTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAARPSNLLLDQSNVDITTFRTTGDWLNGVWTAHCKEIFTGVEYSSCDTIAKIS","Homo sapiens","EPHA3, ETK, ETK1, HEK, TYRO4","Ephrin receptor","1","2QOB"
"2QOC",,"X-RAY DIFFRACTION",2,38.45,"VAPOR DIFFUSION, SITTING DROP",7.5,"20 mg/mL Protein, 25% PEG 3350, 0.2M Ammonium sulfate, 0.1M Hepes, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1016/j.str.2008.03.008",,"2QOC",39.2,"1.25","1.25","Human EphA3 kinase domain, phosphorylated, AMP-PNP bound structure","GSTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAARPSNLLLDQSNVDITTFRTTGDWLNGVWTAHCKEIFTGVEYSSCDTIAKIS","Homo sapiens","EPHA3, ETK, ETK1, HEK, TYRO4","Ephrin receptor","1","2QOC"
"2QOD",,"X-RAY DIFFRACTION",1.84,33.02,"VAPOR DIFFUSION, SITTING DROP",7.5,"20 mg/mL Protein, 25% PEG 3350, 0.2M Ammonium sulfate, 0.1M Hepes, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1016/j.str.2008.03.008",,"2QOD",41.95,"1.15","1.15","Human EphA3 kinase and juxtamembrane region, Y602F mutant","GSDEKRLHFGNGHLKLPGLRTYVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAARPSNLLLDQSNVDITTFRTTGDWLNGVWTAHCKEIFTGVEYSSCDTIAKIS","Homo sapiens","EPHA3, ETK, ETK1, HEK, TYRO4","Ephrin receptor","1","2QOD"
"2QOE",,"X-RAY DIFFRACTION",3,58.95,"VAPOR DIFFUSION, HANGING DROP",8,"PEG4000, SODIUM ACETATE, TRIS, PH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.bmcl.2007.07.100","448","2QOE",174.52,"2.3","2.3","Human Dipeptidyl Peptidase IV in complex with a Triazolopiperazine-based beta amino acid Inhibitor","TRKTYTLTDYLKNTYRLKLYSLRWISDHEYLYKQENNILVFNAEYGNSSVFLENSTFDEFGHSINDYSISPDGQFILLEYNYVKQWRHSYTASYDIYDLNKRQLITEERIPNNTQWVTWSPVGHKLAYVWNNDIYVKIEPNLPSYRITWTGKEDIIYNGITDWVYEEEVFSAYSALWWSPNGTFLAYAQFNDTEVPLIEYSFYSDESLQYPKTVRVPYPKAGAVNPTVKFFVVNTDSLSSVTNATSIQITAPASMLIGDHYLCDVTWATQERISLQWLRRIQNYSVMDICDYDESSGRWNCLVARQHIEMSTTGWVGRFRPSEPHFTLDGNSFYKIISNEEGYRHICYFQIDKKDCTFITKGTWEVIGIEALTSDYLYYISNEYKGMPGGRNLYKIQLSDYTKVTCLSCELNPERCQYYSVSFSKEAKYYQLRCSGPGLPLYTLHSSVNDKGLRVLEDNSALDKMLQNVQMPSKKLDFIILNETKFWYQMILPPHFDKSKKYPLLLDVYAGPCSQKADTVFRLNWATYLASTENIIVASFDGRGSGYQGDKIMHAINRRLGTFEVEDQIEAARQFSKMGFVDNKRIAIWGWSYGGYVTSMVLGSGSGVFKCGIAVAPVSRWEYYDSVYTERYMGLPTPEDNLDHYRNSTVMSRAENFKQVEYLLIHGTADDNVHFQQSAQISKALVDVGVDFQAMWYTDEDHGIASSTAHQHIYTHMSHFIKQCFSLP","Homo sapiens","DPP4, ADCP2, CD26","Dipeptidyl peptidase 4","1","2QOE"
"2QOF",,"X-RAY DIFFRACTION",1.84,33.22,"VAPOR DIFFUSION, SITTING DROP",7.5,"20 mg/mL Protein, 25% PEG 3350, 0.2M Ammonium sulfate, 0.1M Hepes, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1016/j.str.2008.03.008",,"2QOF",42.03,"1.2","1.2","Human EphA3 kinase and juxtamembrane region, Y596F mutant","GSDEKRLHFGNGHLKLPGLRTFVDPHTYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAARPSNLLLDQSNVDITTFRTTGDWLNGVWTAHCKEIFTGVEYSSCDTIAKIS","Homo sapiens","EPHA3, ETK, ETK1, HEK, TYRO4","Ephrin receptor","1","2QOF"
"2QOI",,"X-RAY DIFFRACTION",1.83,32.92,"VAPOR DIFFUSION, SITTING DROP",7.5,"20 mg/mL Protein, 25% PEG 3350, 0.2M Ammonium sulfate, 0.1M Hepes, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1016/j.str.2008.03.008",,"2QOI",42.01,"1.25","1.25","Human EphA3 kinase and juxtamembrane region, Y596F:Y602F double mutant","GSDEKRLHFGNGHLKLPGLRTFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAARPSNLLLDQSNVDITTFRTTGDWLNGVWTAHCKEIFTGVEYSSCDTIAKIS","Homo sapiens","EPHA3, ETK, ETK1, HEK, TYRO4","Ephrin receptor","1","2QOI"
"2QOK",,"X-RAY DIFFRACTION",1.83,32.88,"VAPOR DIFFUSION, SITTING DROP",7.5,"20 mg/mL Protein, 25% PEG 3350, 0.2M Ammonium sulfate, 0.1M Hepes, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1016/j.str.2008.03.008",,"2QOK",41.99,"1.2","1.2","Human EphA3 kinase and juxtamembrane region, Y596F:Y602F:S768A triple mutant","GSDEKRLHFGNGHLKLPGLRTFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAARPSNLLLDQSNVDITTFRTTGDWLNGVWTAHCKEIFTGVEYSSCDTIAKIS","Homo sapiens","EPHA3, ETK, ETK1, HEK, TYRO4","Ephrin receptor","1","2QOK"
"2QOL",,"X-RAY DIFFRACTION",1.84,33.17,"VAPOR DIFFUSION, SITTING DROP",7.5,"20 mg/mL Protein, 25% PEG 3350, 0.2M Ammonium sulfate, 0.1M Hepes, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1016/j.str.2008.03.008",,"2QOL",41.9,"1.07","1.07","Human EphA3 kinase and juxtamembrane region, Y596:Y602:S768G triple mutant","GSDEKRLHFGNGHLKLPGLRTFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAARPSNLLLDQSNVDITTFRTTGDWLNGVWTAHCKEIFTGVEYSSCDTIAKIS","Homo sapiens","EPHA3, ETK, ETK1, HEK, TYRO4","Ephrin receptor","1","2QOL"
"2QON",,"X-RAY DIFFRACTION",1.86,33.81,"VAPOR DIFFUSION, SITTING DROP",7.5,"20 mg/mL Protein, 25% PEG 3350, 0.2M Ammonium sulfate, 0.1M Hepes, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1016/j.str.2008.03.008",,"2QON",42.01,"1.79","1.79","Human EphA3 kinase and juxtamembrane region, Y596F:Y602F:Y742A triple mutant","GSDEKRLHFGNGHLKLPGLRTFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAARPSNLLLDQSNVDITTFRTTGDWLNGVWTAHCKEIFTGVEYSSCDTIAKIS","Homo sapiens","EPHA3, ETK, ETK1, HEK, TYRO4","Ephrin receptor","1","2QON"
"2QOO",,"X-RAY DIFFRACTION",1.83,32.91,"VAPOR DIFFUSION, SITTING DROP",7.5,"20 mg/mL Protein, 25% PEG 3350, 0.2M Ammonium sulfate, 0.1M Hepes, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1016/j.str.2008.03.008",,"2QOO",41.92,"1.25","1.25","Human EphA3 kinase and juxtamembrane region, Y596F:Y602F:Y742F triple mutant","GSDEKRLHFGNGHLKLPGLRTFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAARPSNLLLDQSNVDITTFRTTGDWLNGVWTAHCKEIFTGVEYSSCDTIAKIS","Homo sapiens","EPHA3, ETK, ETK1, HEK, TYRO4","Ephrin receptor","1","2QOO"
"2QOQ",,"X-RAY DIFFRACTION",1.84,33.19,"VAPOR DIFFUSION, SITTING DROP",7.5,"20 mg/mL Protein, 25% PEG 3350, 0.2M Ammonium sulfate, 0.1M Hepes, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1016/j.str.2008.03.008",,"2QOQ",42.57,"1.6","1.6","Human EphA3 kinase and juxtamembrane region, base, AMP-PNP bound structure","GSDEKRLHFGNGHLKLPGLRTYVDPHTYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAARPSNLLLDQSNVDITTFRTTGDWLNGVWTAHCKEIFTGVEYSSCDTIAKIS","Homo sapiens","EPHA3, ETK, ETK1, HEK, TYRO4","Ephrin receptor","1","2QOQ"
"2QOS",,"X-RAY DIFFRACTION",2.63,53.21,"VAPOR DIFFUSION, HANGING DROP",8,"26-28% PEG6K, 0.1M Tris pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.molimm.2007.06.359",,"2QOS",20.56,"1.81","1.81","Crystal structure of complement protein C8 in complex with a peptide containing the C8 binding site on C8","ASPISTIQPKANFDAQQFAGTWLLVAVGSAARFLQEQGHRAEATTLHVAPQGTAMAVSTFRKLDGICWQVRQLYGDTGVLGRFLLQARGARGAVHVVVAETDYQSFAVLYLERAGQLSVKLYARSLPVSDSVLSGFEQRVQEAHLTEDQIFYFPKYGFCEAADQFHVLDEVRR","Homo sapiens","C8G","Complement component 8, gamma polypeptide","1","2QOS"
,,,,,,,,,,,,,,,,"LRYDSTAERLY",,,"Complement component C8 alpha chain","2","2QOS"
"2QP3",,"X-RAY DIFFRACTION",3.32,62.96,"VAPOR DIFFUSION",7.5,"(NH4)2SO4, NaCl, pH 7.5, vapor diffusion, temperature 291K",291,"10.1124/mol.107.041038",,"2QP3",33.99,"2.6","2.6","Identification and Characterization of Two Amino Acids Critical for the Substrate Inhibition of SULT2A1","SDDFLWFEGIAFPTMGFRSETLRKVRDEFVIRDEDVIILTYPKSGTNWLAEILCLMHSKGDAKWIQSVPIWERSPWVESEIGYTALSETESPRLFSSHLPIQLFPKSFFSSKAKVIYLMRNPRDVLVSGYFFWKNIKFIKKPKSWEEYFEWFCQGTVLYGSWFDHIHGWMPMREEKNFLLLSYEELKQDTGRTIEKICQFLGKTLEPEELNLILKNSSFQSMKENKMSNYSLLSVDYVVDKTQLLRKGVSGDWKNHFTVAQAEDFDKLFQEKMADLPRELFPWE","Homo sapiens","SULT2A1, HST, STD","Bile salt sulfotransferase","1","2QP3"
"2QP4",,"X-RAY DIFFRACTION",4.11,70.07,"VAPOR DIFFUSION",7.5,"(NH4)2SO4, NaCl, pH 7.5, vapor diffusion, temperature 291K",291,"10.1124/mol.107.041038",,"2QP4",34.07,"3","3","Identification and Characterization of Two Amino Acids Critical for the Substrate Inhibition of SULT2A1","SDDFLWFEGIAFPTMGFRSETLRKVRDEFVIRDEDVIILTYPKSGTNWLAEILCLMHSKGDAKWIQSVPIWERSPWVESEIGYTALSETESPRLFSSHLPIQLFPKSFFSSKAKVIYLMRNPRDVLVSGYFFWKNWKFIKKPKSWEEYFEWFCQGTVLYGSWFDHIHGWMPMREEKNFLLLSYEELKQDTGRTIEKICQFLGKTLEPEELNLILKNSSFQSMKENKMSNYSLLSVDYVVDKTQLLRKGVSGDWKNHFTVAQAEDFDKLFQEKMADLPRELFPWE","Homo sapiens","SULT2A1, HST, STD","Bile salt sulfotransferase","1","2QP4"
"2QP6",,"X-RAY DIFFRACTION",2.07,40.62,"VAPOR DIFFUSION, HANGING DROP",8.2,"AMMONIUM SULPHATE, SODIUM CHLORIDE, TRIS-HCl, pH 8.2, VAPOR DIFFUSION, HANGING DROP, temperature 277 K",277,"10.1021/jm800121c","MB1, CL","2QP6",30.02,"1.45","1.45","The crystal structure of the complex of hcaII with a bioreductive antitumor derivative","SHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","2QP6"
"2QP8",,"X-RAY DIFFRACTION",2.87,57.15,"VAPOR DIFFUSION, HANGING DROP",,"VAPOR DIFFUSION, HANGING DROP",,"10.1016/j.bmcl.2007.10.116","SC7","2QP8",89.3,"1.5","1.5","Structure of BACE Bound to SCH734723","AAGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNI","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","2QP8"
"2QPJ",,"X-RAY DIFFRACTION",2.34,47.45,"VAPOR DIFFUSION",7.5,"25% PEG 3350, 200mM ammonium sulfate, pH 7.5, VAPOR DIFFUSION, temperature 294K",294,"10.1107/S0907444907036281","I20","2QPJ",80.8,"2.05","2.05","Human NEP complexed with a bifunctional NEP/DPP IV inhibitor","GICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW","Homo sapiens","MME, EPN","Neprilysin","1","2QPJ"
"2QPP",,"X-RAY DIFFRACTION",2.6,51.6,"VAPOR DIFFUSION, HANGING DROP",,"Protein solution (5 mg/ml Protein, 1:1 ratio HEME, 2% DMSO, 0.050 M Potassium chloride, 0.050 M Tris-HCl pH 7.5) mixed in a 1.5:1 ratio with the Well solution (33% PEG DME 500, 0.020 M Magnesium chloride, 0.10 M HEPES pH 7.5). Cryoprotected with well solution, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1074/jbc.M707396200",,"2QPP",62.22,"2.61","2.61","Crystal structure of human heme oxygenase-2 C127A (HO-2) with bound heme","MSAEVETSEGVDESEKKNSGALEKENQMRMADLSELLKEGTKEAHDRAENTQFVKDFLKGNIKKELFKLATTALYFTYSALEEEMERNKDHPAFAPLYFPMELHRKEALTKDMEYFFGENWEEQVQAPKAAQKYVERIHYIGQNEPELLVAHAYTRYMGDLSGGQVLKKVAQRALKLPSTGEGTQFYLFENVDNAQQFKQLYRARMNALDLNMKTKERIVEEANKAFEYNMQIFNELDQAGSTLARETLEDGFPVHDGKGDMRK","Homo sapiens","HMOX2, HO2","Heme oxygenase 2","1","2QPP"
"2QPW",,"X-RAY DIFFRACTION",1.94,36.62,"VAPOR DIFFUSION, HANGING DROP",7,"22% PEG 5000 MME, 0.2 M Ammonium sulfate, 0.1 M MES pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1371/journal.pone.0008570",,"2QPW",17.05,"1.79","1.79","Methyltransferase domain of human PR domain-containing protein 2","GSNQNTTEPVAATETLAEVPEHVLRGLPEEVRLFPSAVDKTRIGVWATKPILKGKKFGPFVGDKKKRSQVKNNVYMWEVYYPNLGWMCIDATDPEKGNWLRYVNWACSGEEQNLFPLEINRAIYYKTLKPIAPGEELLVWYNGEDNPEI","Homo sapiens","PRDM2, RIZ, KMT8","PR domain zinc finger protein 2","1","2QPW"
"2QQ2",,"X-RAY DIFFRACTION",2.56,51.88,"VAPOR DIFFUSION, HANGING DROP",6,"0.1M Bis-Tris, 0.2mM MgCl2, 20% PEG 3350, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 298.0K",298,,,"2QQ2",256.67,"2.8","2.8","Crystal structure of C-terminal domain of Human acyl-CoA thioesterase 7","MHHHHHHSSGVDLGTENLYFQSMGDIVQPVLNPEPNTVSYSQSSLIHLVGPSDCTLHGFVHGGVTMKLMDEVAGIVAARHCKTNIVTASVDAINFHDKIRKGCVITISGRMTFTSNKSMEIEVLVDADPVVDSSQKRYRAASAFFTYVSLSQEGRSLPVPQLVPETEDEKKRFEEGKGRYLQMKAKRQGHAEP","Homo sapiens","ACOT7, BACH","Cytosolic acyl coenzyme A thioester hydrolase","1","2QQ2"
"2QQ5",,"X-RAY DIFFRACTION",2.21,44.46,"VAPOR DIFFUSION, SITTING DROP",7.5,"2.4M Na Malonate pH 7.0, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,,,"2QQ5",28.04,"1.8","1.8","Crystal structure of human SDR family member 1","APMNGQVCVVTGASRGIGRGIALQLCKAGATVYITGRHLDTLRVVAQEAQSLGGQCVPVVCDSSQESEVRSLFEQVDREQQGRLDVLVNNAYAGVQTILNTRNKAFWETPASMWDDINNVGLRGHYFCSVYGARLMVPAGQGLIVVISSPGSLQYMFNVPYGVGKAACDKLAADCAHELRRHGVSCVSLWPGIVQTELLKEHMAKEEVLQDPVLKQFKSAFSSAETTELSGKCVVALATDPNILSLSGKVLPSCDLARRY","Homo sapiens","DHRS1, SDR19C1","Dehydrogenase/reductase SDR family member 1","1","2QQ5"
"2QQ8",,"X-RAY DIFFRACTION",2.4,48.73,"VAPOR DIFFUSION",7.5,"25% PEG 4000, 0.2M Lithium sulfate, 0.1M Tris-HCl, pH 7.5, VAPOR DIFFUSION, temperature 291K",291,,,"2QQ8",38.64,"2","2","Crystal structure of the putative RabGAP domain of human TBC1 domain family member 14","MHHHHHHSSGRENLYFQGNAVLTWNNEILPNWETMWCSRKVRDLWWQGIPPSVRGKVWSLAIGNELNITHELFDICLARAKERWRSLSTGGSEVENEDAGFSAADREASLELIKLDISRTFPNLCIFQQGGPYHDMLHSILGAYTCYRPDVGYVQGMSFIAAVLILNLDTADAFIAFSNLLNKPCQMAFFRVDHGLMLTYFAAFEVFFEENLPKLFAHFKKNNLTPDIYLIDWIFTLYSKSLPLDLACRIWDVFCRDGEEFLFRTALGILKLFEDILTKMDFIHMAQFLTRLPEDLPAEELFASIATIQMQSRNKKWAQVLTALQKDSREMEKG","Homo sapiens","TBC1D14, KIAA1322","TBC1 domain family member 14","1","2QQ8"
,,,,,"VAPOR DIFFUSION",6.5,"2.0M Sodium chloride, 0.1M Sodium dihydrogen phosphate, 0.1M MES, 0.1M Potassium dihydrogen phosphate, pH 6.5, VAPOR DIFFUSION, temperature 291K",291
"2QQH",,"X-RAY DIFFRACTION",3.98,69.08,"VAPOR DIFFUSION, SITTING DROP",8,"1M LiSO4, 5mM NiCl2, 100mM Tris, pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 303K",303,"10.1126/science.1147103",,"2QQH",37.89,"2.5","2.5","Structure of C8a-MACPF reveals mechanism of membrane attack in complement immune defense","GSVRAIDEDCSQYEPIPGSQKAALGYNILTQEDAQSVYDASYYGGQCETVYNGEWRELRYDSTSERLYYGDDEKYFRKPYNFLKYHFEALADTGISSEFYDNANDLLSKVKKDKSDSFGVTIGIGPAGSPLLVGVGVSHSQDTSFLNELNKYNEKKFIFTRIFTKVQTAHFKMRKDDIMLDEGMLQSLMELPDQYNYGMYAKFINDYGTHYITSGSMGGIYEYILVIDKAKMESLGXXXXXXXXXXXXARKAMAVEDIISRVRGGSSGWSGGLAQNRSTITYRSWGRSLKYNPVVIDFEMQPIHEVLRHTSLGPLEAKRQNLRRALDQYLMAAA","Homo sapiens","C8A","Complement component C8 alpha chain","1","2QQH"
,,,,,,,,,,,,,,,,,"Homo sapiens","C8A"
"2QQI",,"X-RAY DIFFRACTION",2.28,46.16,"VAPOR DIFFUSION, SITTING DROP",,"20% PEG 3350, 0.2 M Sodium Fluoride, VAPOR DIFFUSION, SITTING DROP, temperature 292K",292,"10.1038/sj.emboj.7601906",,"2QQI",36.17,"1.8","1.8","Crystal Structure of the b1b2 Domains from Human Neuropilin-1","GSHMFKCMEALGMESGEIHSDQITASSQYSTNWSAERSRLNYPENGWTPGEDSYREWIQVDLGLLRFVTAVGTQGAISKETKKKYYVKTYKIDVSSNGEDWITIKEGNKPVLFQGNTNPTDVVVAVFPKPLITRFVRIKPATWETGISMRFEVYGCKITDYPCSGMLGMVSGLISDSQITSSNQGDRNWMPENIRLVTSRSGWALPPAPHSYINEWLQIDLGEEKIVRGIIIQGGKHRENKVFMRKFKIGYSNNGSDWKMIMDDSKRKAKSFEGNNNYDTPELRTFPALSTRFIRIYPERATHGGLGLRMELLGCEVE","Homo sapiens","NRP1, NRP, VEGF165R","Neuropilin-1","1","2QQI"
"2QQJ",,"X-RAY DIFFRACTION",2.14,42.4,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.1 M Bis-Tris, 20% PEG 5000 MME, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 297K",297,"10.1038/sj.emboj.7601906",,"2QQJ",36.78,"1.95","1.95","Crystal Structure of the b1b2 Domains from Human Neuropilin-2","GSHMFQCNVPLGMESGRIANEQISASSTYSDGRWTPQQSRLHGDDNGWTPNLDSNKEYLQVDLRFLTMLTAIATQGAISRETQNGYYVKSYKLEVSTNGEDWMVYRHGKNHKVFQANNDATEVVLNKLHAPLLTRFVRIRPQTWHSGIALRLELFGCRVTDAPCSNMLGMLSGLIADSQISASSTQEYLWSPSAARLVSSRSGWFPRIPQAQPGEEWLQVDLGTPKTVKGVIIQGARGGDSITAVEARAFVRKFKVSYSLNGKDWEYIQDPRTQQPKLFEGNMHYDTPDIRRFDPIPAQYVRVYPERWSPAGIGMRLEVLGCDWT","Homo sapiens","NRP2, VEGF165R2","Neuropilin-2","1","2QQJ"
"2QQM",,"X-RAY DIFFRACTION",2.33,47.14,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.1 M MES, 12% PEG 20000, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 297K",297,"10.1038/sj.emboj.7601906",,"2QQM",52.3,"2","2","Crystal Structure of the a2b1b2 Domains from Human Neuropilin-1","GSHMFKRGPECSQNYTTPSGVIKSPGFPEKYPNSLECTYIVFAPKMSEIILEFESFDLEPDSNPPGGMFCRYDRLEIWDGFPDVGPHIGRYCGQKTPGRIRSSSGILSMVFYTDSAIAKEGFSANYSVLQSSVSEDFKCMEALGMESGEIHSDQITASSQYSTNWSAERSRLNYPENGWTPGEDSYREWIQVDLGLLRFVTAVGTQGAISKETKKKYYVKTYKIDVSSNGEDWITIKEGNKPVLFQGNTNPTDVVVAVFPKPLITRFVRIKPATWETGISMRFEVYGCKITDYPCSGMLGMVSGLISDSQITSSNQGDRNWMPENIRLVTSRSGWALPPAPHSYINEWLQIDLGEEKIVRGIIIQGGKHRENKVFMRKFKIGYSNNGSDWKMIMDDSKRKAKSFEGNNNYDTPELRTFPALSTRFIRIYPERATHGGLGLRMELLGCEVE","Homo sapiens","NRP1, NRP, VEGF165R","Neuropilin-1","1","2QQM"
"2QQO",,"X-RAY DIFFRACTION",3.08,60.04,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1 M Hepes, 10% PEG 8000, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 297K",297,"10.1038/sj.emboj.7601906",,"2QQO",104.45,"2.3","2.3","Crystal Structure of the a2b1b2 Domains from Human Neuropilin-2","ADPGSEDCSKNFTSPNGTIESPGFPEKYPHNLDCTFTILAKPKMEIILQFLIFDLEHDPLQVGEGDCKYDWLDIWDGIPHVGPLIGKYCGTKTPSELRSSTGILSLTFHTDMAVAKDGFSARYYLVHQEPLENFQCNVPLGMESGRIANEQISASSTYSDGRWTPQQSRLHGDDNGWTPNLDSNKEYLQVDLRFLTMLTAIATQGAISRETQNGYYVKSYKLEVSTNGEDWMVYRHGKNHKVFQANNDATEVVLNKLHAPLLTRFVRIRPQTWHSGIALRLELFGCRVTDAPCSNMLGMLSGLIADSQISASSTQEYLWSPSAARLVSSRSGWFPRIPQAQPGEEWLQVDLGTPKTVKGVIIQGARGGDSITAVEARAFVRKFKVSYSLNGKDWEYIQDPRTQQPKLFEGNMHYDTPDIRRFDPIPAQYVRVYPERWSPAGIGMRLEVLGCDWTHHHHHH","Homo sapiens","NRP2, VEGF165R2","Neuropilin-2","1","2QQO"
"2QQR",,"X-RAY DIFFRACTION",3.72,66.93,"VAPOR DIFFUSION, HANGING DROP",,"2.0 M ammonium sulfate, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1038/nsmb1326",,"2QQR",27.68,"1.8","1.8","JMJD2A hybrid tudor domains","GHMQSITAGQKVISKHKNGRFYQCEVVRLTTETFYEVNFDDGSFSDNLYPEDIVSQDCLQFGPPAEGEVVQVRWTDGQVYGAKFVASHPIQMYQVEFEDGSQLVVKRDDVYTLDEELP","Homo sapiens","JMJD2A, JHDM3A, JMJD2, KIAA0677, KDM4A","JmjC domain-containing histone demethylation protein 3A","1","2QQR"
"2QQS",,"X-RAY DIFFRACTION",2.12,41.85,,,"293K",293,"10.1038/nsmb1326",,"2QQS",29.65,"2.82","2.82","JMJD2A tandem tudor domains in complex with a trimethylated histone H4-K20 peptide","GHMQSITAGQKVISKHKNGRFYQCEVVRLTTETFYEVNFDDGSFSDNLYPEDIVSQDCLQFGPPAEGEVVQVRWTDGQVYGAKFVASHPIQMYQVEFEDGSQLVVKRDDVYTLDEELP","Homo sapiens","JMJD2A, JHDM3A, JMJD2, KIAA0677, KDM4A","JmjC domain-containing histone demethylation protein 3A","1","2QQS"
,,,,,,,,,,,,,,,,"KRHRKVLRDN",,,"METHYLATED HISTONE H4 PEPTIDE","2","2QQS"
"2QR2",,"X-RAY DIFFRACTION",2.4,49,,7,"pH 7.0",,"10.1021/bi990799v",,"2QR2",53.74,"2.45","2.45","HUMAN QUINONE REDUCTASE TYPE 2, COMPLEX WITH MENADIONE","AGKKVLIVYAHQEPKSFNGSLKNVAVDELSRQGCTVTVSDLYAMNFEPRATDKDITGTLSNPEVFNYGVETHEAYKQRSLASDITDEQKKVREADLVIFQFPLYWFSVPAILKGWMDRVLCQGFAFDIPGFYDSGLLQGKLALLSVTTGGTAEMYTKTGVNGDSRYFLWPLQHGTLHFCGFKVLAPQISFAPEIASEEERKGMVAAWSQRLQTIWKEEPIPCTAHWHFGQ","Homo sapiens","NQO2, NMOR2","PROTEIN (QUINONE REDUCTASE TYPE 2)","1","2QR2"
"2QRA",,"X-RAY DIFFRACTION",1.85,33.35,"VAPOR DIFFUSION, HANGING DROP",6.5,"15% ethanol, 100mM sodium citrate, 200mM Li2SO4, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1016/j.jmb.2007.07.019",,"2QRA",50.09,"2.5","2.5","Crystal structure of XIAP BIR1 domain (P21 form)","MGSSHHHHHHSSGLVPRGSHMKTCVPADINKEEEFVEEFNRLKTFANFPSGSPVSASTLARAGFLYTGEGDTVRCFSCHAAVDRWQYGDSAVGRHRKVSPNCRFINGFYLE","Homo sapiens","BIRC4, API3, IAP3, XIAP","Baculoviral IAP repeat-containing protein 4","1","2QRA"
"2QRN",,"X-RAY DIFFRACTION",2.86,57.05,"VAPOR DIFFUSION, HANGING DROP",7,"16-17% ethanol,0.1 M HEPES, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1107/S0907444907048834",,"2QRN",133.84,"3.4","3.4","Human Deoxycytidine kinase dCMP, UDP, Mg ion product complex","MGSSHHHHHHSSGLVPRGSHMATPPKRSCPSFSASSEGTRIKKISIEGNIAAGKSTFVNILKQLCEDWEVVPEPVARWCNVQSTQDEFEELTMSQKNGGNVLQMMYEKPERWSFTFQTYACLSRIRAQLASLNGKLKDAEKPVLFFERSVYSDRYIFASNLYESECMNETEWTIYQDWHDWMNNQFGQSLELDGIIYLQATPETCLHRIYLRGRNEEQGIPLEYLEKLHYKHESWLLHRTLKTNFDYLQEVPILTLDVNEDFKDKYESLVEKVKEFLSTL","Homo sapiens","DCK","Deoxycytidine kinase","1","2QRN"
"2QRO",,"X-RAY DIFFRACTION",2.79,55.85,"VAPOR DIFFUSION, HANGING DROP",7,"16-17% ethanol, 8% glycerol, 0.1 M HEPES, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1107/S0907444907048834",,"2QRO",133.93,"3.45","3.45","Human Deoxycytidine kinase dAMP, UDP, Mg ion product complex","MGSSHHHHHHSSGLVPRGSHMATPPKRSCPSFSASSEGTRIKKISIEGNIAAGKSTFVNILKQLCEDWEVVPEPVARWCNVQSTQDEFEELTMSQKNGGNVLQMMYEKPERWSFTFQTYACLSRIRAQLASLNGKLKDAEKPVLFFERSVYSDRYIFASNLYESECMNETEWTIYQDWHDWMNNQFGQSLELDGIIYLQATPETCLHRIYLRGRNEEQGIPLEYLEKLHYKHESWLLHRTLKTNFDYLQEVPILTLDVNEDFKDKYESLVEKVKEFLSTL","Homo sapiens","DCK","Deoxycytidine kinase","1","2QRO"
"2QRZ",,"X-RAY DIFFRACTION",2.95,58.29,"VAPOR DIFFUSION, HANGING DROP",6,"12% PEG 6K, 100 mM Na Acetate, 50 mM MES, pH 6.0, 100 mM Ammonium Sulfate, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1074/jbc.M706271200",,"2QRZ",43.3,"2.4","2.4","Cdc42 bound to GMP-PCP: Induced Fit by Effector is Required","MQTIKCVVVGDGAVGKTCLLISYTTNKFPSEYVPTVFDNYAVTVMIGGEPYTLGLFDTAGQEDYDRLRPLSYPQTDVFLVCFSVVSPSSFENVKEKWVPEITHHCPKTPFLLVGTQIDLRDDPSTIEKLAKNKQKPITPETAEKLARDLKAVKYVECSALTQKGLKNVFDEAILAALEPPEPKKSRRCV","Homo sapiens","CDC42","Cell division control protein 42 homolog precursor","1","2QRZ"
"2QS9",,"X-RAY DIFFRACTION",1.9,35.43,"MICROBATCH UNDER OIL",5,"40% PEG 4000, 0.1M Magnesium nitrate, 0.1M Sodium acetate pH 5.0, MICROBATCH UNDER OIL, temperature 291K",291,"10.1002/prot.22278",,"2QS9",44.57,"1.72","1.72","Crystal structure of the human retinoblastoma-binding protein 9 (RBBP-9). NESG target HR2978","MASPSKAVIVPGNGGGDVTTHGWYGWVKKELEKIPGFQCLAKNMPDPITARESIWLPFMETELHCDEKTIIIGHSSGAIAAMRYAETHRVYAIVLVSAYTSDLGDENERASGYFTRPWQWEKIKANCPYIVQFGSTDDPFLPWKEQQEVADRLETKLHKFTDCGHFQNTEFHELITVVKSLLKVPALEHHHHHH","Homo sapiens","RBBP9, BOG, RBBP10","Retinoblastoma-binding protein 9","1","2QS9"
"2QSC",,"X-RAY DIFFRACTION",3.14,60.87,"VAPOR DIFFUSION",6,"PEG 8000, pH 6.0, VAPOR DIFFUSION, temperature 298K",298,"10.1016/j.jmb.2007.11.013",,"2QSC",49.82,"2.8","2.8","Crystal structure analysis of anti-HIV-1 V3-Fab F425-B4e8 in complex with a V3-peptide","NSVLTQSPSSLSASVGDRVTITCQASQDISNYLNWYQHKPGKAPKLLIYTASNLETGVPSRFSGGGSGTHFSFTITSLQPEDAATYFCQQYDNLGDLSFGGGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"Fab F425-B4e8, Light chain","1","2QSC"
,,,,,,,,,,,,,,,,"QVQLVQSGGGLVQPGGSLRLSCAAFGFNFSSYVMHWVRQAPGQGLEYLSAISSDGETTYHANSVKGRFTSSRDNSKNTLFLQMGSLRTEDVAVYYCARDRYYETSGSNAFDVWGQGTMVVVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSNFGTQTYTCNVDHKPSNTKVDKTVE","Homo sapiens",,"Fab F425-B4e8, Heavy chain","2","2QSC"
,,,,,,,,,,,,,,,,"RKRIHIGPGRAFYTT",,,"Envelope glycoprotein gp120","3","2QSC"
"2QSQ",,"X-RAY DIFFRACTION",5.63,78.14,"VAPOR DIFFUSION",7,"3.0 M NaCl, 100 mM Tris-HCl pH 7.0, temperature 277K, VAPOR DIFFUSION",277,"10.1111/j.1365-2958.2007.06054.x",,"2QSQ",25.3,"1.95","1.95","Crystal structure of the N-terminal domain of carcinoembryonic antigen (CEA)","AKLTIESTPFNVAEGKEVLLLVHNLPQHLFGYSWYKGERVDGNRQIIGYVIGTQQATPGPAYSGREIIYPNASLLIQNIIQNDAGFYTLHVIKSDLVNEEATGQFRVYPEL","Homo sapiens","CEACAM5, CEA","Carcinoembryonic antigen-related cell adhesion molecule 5","1","2QSQ"
"2QST",,"X-RAY DIFFRACTION",5.23,76.47,"VAPOR DIFFUSION",7,"2.5 M NaCl, 0.1 M Tris-HCl, pH 7.0, vapor diffusion, temperature 277K",277,"10.1111/j.1365-2958.2007.06054.x",,"2QST",24.87,"2.9","2.9","Crystal structure of the V39C mutant of the N-terminal domain of carcinoembryonic antigen (CEA)","AKLTIESTPFNVAEGKEVLLLVHNLPQHLFGYSWYKGERCDGNRQIIGYVIGTQQATPGPAYSGREIIYPNASLLIQNIIQNDAGFYTLHVIKSDLVNEEATGQFRVYPEL","Homo sapiens","CEACAM5, CEA","Carcinoembryonic antigen-related cell adhesion molecule 5","1","2QST"
"2QSY",,"X-RAY DIFFRACTION",2.47,50.21,"VAPOR DIFFUSION, SITTING DROP",7,"20% PEG 3350, 0.2M Sodium phosphate monobasic, 0.15M D(+)sucrose, 0.1M HEPES, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1371/journal.pbio.0050263",,"2QSY",24.82,"1.95","1.95","Human nicotinamide riboside kinase 1 in complex with ADP","MGSSHHHHHHSSGLVPRGSKTFIIGISGVTNSGKTTLAKNLQKHLPNCSVISQDDFFKPESEIETDKNGFLQYDVLEALNMEKMMSAISCWMESARHSVVSTDQESAEEIPILIIEGFLLFNYKPLDTIWNRSYFLTIPYEECKRRRSTRVYQPPDSPGYFDGHVWPMYLKYRQEMQDITWEVVYLDGTKSEEDLFLQVYEDLIQEL","Homo sapiens","NRK1, C9orf95, NMRK1","Nicotinamide riboside kinase 1","1","2QSY"
"2QSZ",,"X-RAY DIFFRACTION",2.55,51.74,"VAPOR DIFFUSION, SITTING DROP",7,"20% PEG 3350, 0.2M Sodium phosphate monobasic, 0.15M D(+)sucrose, 0.1M HEPES pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1371/journal.pbio.0050263",,"2QSZ",24.84,"1.9","1.9","Human nicotinamide riboside kinase 1 in complex with nicotinamide mononucleotide","MGSSHHHHHHSSGLVPRGSKTFIIGISGVTNSGKTTLAKNLQKHLPNCSVISQDDFFKPESEIETDKNGFLQYDVLEALNMEKMMSAISCWMESARHSVVSTDQESAEEIPILIIEGFLLFNYKPLDTIWNRSYFLTIPYEECKRRRSTRVYQPPDSPGYFDGHVWPMYLKYRQEMQDITWEVVYLDGTKSEEDLFLQVYEDLIQEL","Homo sapiens","NRK1, C9orf95, NMRK1","Nicotinamide riboside kinase 1","1","2QSZ"
"2QT0",,"X-RAY DIFFRACTION",2.16,43.13,"VAPOR DIFFUSION",8,"35% PEG 2000 MME, 0.1M Tris-HCl. The protein solution (40mg/mL) contained 0.01M Nicotinamide riboside, 0.01M AMPPNP and 0.02M Magnesium chloride, pH 8.0, VAPOR DIFFUSION, temperature 291K",291,"10.1371/journal.pbio.0050263",,"2QT0",25.16,"1.92","1.92","Human nicotinamide riboside kinase 1 in complex with nicotinamide riboside and an ATP analogue","MGSSHHHHHHSSGLVPRGSKTFIIGISGVTNSGKTTLAKNLQKHLPNCSVISQDDFFKPESEIETDKNGFLQYDVLEALNMEKMMSAISCWMESARHSVVSTDQESAEEIPILIIEGFLLFNYKPLDTIWNRSYFLTIPYEECKRRRSTRVYQPPDSPGYFDGHVWPMYLKYRQEMQDITWEVVYLDGTKSEEDLFLQVYEDLIQEL","Homo sapiens","NRK1, C9orf95, NMRK1","Nicotinamide riboside kinase 1","1","2QT0"
"2QT1",,"X-RAY DIFFRACTION",2.51,50.96,"VAPOR DIFFUSION",6,"15% PEG 3350, 0.2M Sodium phosphate monobasic, 0.1M Bis-Tris. The protein solution (40mg/mL) contained 0.01M Nicotinamide riboside, 0.01M AMPPNP and 0.02M Magnesium chloride, pH 6.0, VAPOR DIFFUSION, temperature 291K",291,"10.1371/journal.pbio.0050263",,"2QT1",24.72,"1.32","1.32","Human nicotinamide riboside kinase 1 in complex with nicotinamide riboside","MGSSHHHHHHSSGLVPRGSKTFIIGISGVTNSGKTTLAKNLQKHLPNCSVISQDDFFKPESEIETDKNGFLQYDVLEALNMEKMMSAISCWMESARHSVVSTDQESAEEIPILIIEGFLLFNYKPLDTIWNRSYFLTIPYEECKRRRSTRVYQPPDSPGYFDGHVWPMYLKYRQEMQDITWEVVYLDGTKSEEDLFLQVYEDLIQEL","Homo sapiens","NRK1, C9orf95, NMRK1","Nicotinamide riboside kinase 1","1","2QT1"
"2QT7",,"X-RAY DIFFRACTION",1.97,37.6,"VAPOR DIFFUSION, HANGING DROP",8.5,"25% (w/v) PEG 4000, 0.1 M Tris pH 8.5, 0.2 M CaCl2, VAPOR DIFFUSION, HANGING DROP, temperature 292K",292,"10.1074/jbc.M708144200",,"2QT7",19.8,"1.3","1.3","Crystallographic structure of the mature ectodomain of the human receptor-type protein-tyrosine phosphatase IA-2 at 1.30 Angstroms","AEEYGYIVTDQKPLSLAAGVKLLEILAEHVHMSSGSFINISVVGPALTFRIRHNEQNLSLADVTQQAGLVKSELEAQTGLQILQTGVGQRE","Homo sapiens","PTPRN, ICA3, ICA512","Receptor-type tyrosine-protein phosphatase-like N","1","2QT7"
"2QT9",,"X-RAY DIFFRACTION",2.87,57.21,"VAPOR DIFFUSION, HANGING DROP",8,"PEG4000, Sodium Acetate, TRIS, pH 8.0, vapor diffusion, hanging drop, temperature 293K, pH 8.000000, VAPOR DIFFUSION, HANGING DROP",293,"10.1016/j.bmcl.2007.08.049","524","2QT9",182.79,"2.1","2.1","Human dipeptidyl peptidase iv/cd26 in complex with a 4-aryl cyclohexylalanine inhibitor","MKTPWKVLLGLLGAAALVTIITVPVVLLNKGTDDATADTRKTYTLTDYLKNTYRLKLYSLRWISDHEYLYKQENNILVFNAEYGNSSVFLENSTFDEFGHSINDYSISPDGQFILLEYNYVKQWRHSYTASYDIYDLNKRQLITEERIPNNTQWVTWSPVGHKLAYVWNNDIYVKIEPNLPSYRITWTGKEDIIYNGITDWVYEEEVFSAYSALWWSPNGTFLAYAQFNDTEVPLIEYSFYSDESLQYPKTVRVPYPKAGAVNPTVKFFVVNTDSLSSVTNATSIQITAPASMLIGDHYLCDVTWATQERISLQWLRRIQNYSVMDICDYDESSGRWNCLVARQHIEMSTTGWVGRFRPSEPHFTLDGNSFYKIISNEEGYRHICYFQIDKKDCTFITKGTWEVIGIEALTSDYLYYISNEYKGMPGGRNLYKIQLSDYTKVTCLSCELNPERCQYYSVSFSKEAKYYQLRCSGPGLPLYTLHSSVNDKGLRVLEDNSALDKMLQNVQMPSKKLDFIILNETKFWYQMILPPHFDKSKKYPLLLDVYAGPCSQKADTVFRLNWATYLASTENIIVASFDGRGSGYQGDKIMHAINRRLGTFEVEDQIEAARQFSKMGFVDNKRIAIWGWSYGGYVTSMVLGSGSGVFKCGIAVAPVSRWEYYDSVYTERYMGLPTPEDNLDHYRNSTVMSRAENFKQVEYLLIHGTADDNVHFQQSAQISKALVDVGVDFQAMWYTDEDHGIASSTAHQHIYTHMSHFIKQCFSLP","Homo sapiens","DPP4, ADCP2, CD26","Dipeptidyl peptidase 4","1","2QT9"
"2QTB",,"X-RAY DIFFRACTION",2.86,57.07,"VAPOR DIFFUSION, HANGING DROP",8,"PEG4000, Sodium Acetate, TRIS, pH 8.000000, vapor diffusion, hanging drop, temperature 293K",293,"10.1016/j.bmcl.2007.08.049","474","2QTB",182.83,"2.25","2.25","Human dipeptidyl peptidase iv/cd26 in complex with a 4-aryl cyclohexylalanine inhibitor","MKTPWKVLLGLLGAAALVTIITVPVVLLNKGTDDATADTRKTYTLTDYLKNTYRLKLYSLRWISDHEYLYKQENNILVFNAEYGNSSVFLENSTFDEFGHSINDYSISPDGQFILLEYNYVKQWRHSYTASYDIYDLNKRQLITEERIPNNTQWVTWSPVGHKLAYVWNNDIYVKIEPNLPSYRITWTGKEDIIYNGITDWVYEEEVFSAYSALWWSPNGTFLAYAQFNDTEVPLIEYSFYSDESLQYPKTVRVPYPKAGAVNPTVKFFVVNTDSLSSVTNATSIQITAPASMLIGDHYLCDVTWATQERISLQWLRRIQNYSVMDICDYDESSGRWNCLVARQHIEMSTTGWVGRFRPSEPHFTLDGNSFYKIISNEEGYRHICYFQIDKKDCTFITKGTWEVIGIEALTSDYLYYISNEYKGMPGGRNLYKIQLSDYTKVTCLSCELNPERCQYYSVSFSKEAKYYQLRCSGPGLPLYTLHSSVNDKGLRVLEDNSALDKMLQNVQMPSKKLDFIILNETKFWYQMILPPHFDKSKKYPLLLDVYAGPCSQKADTVFRLNWATYLASTENIIVASFDGRGSGYQGDKIMHAINRRLGTFEVEDQIEAARQFSKMGFVDNKRIAIWGWSYGGYVTSMVLGSGSGVFKCGIAVAPVSRWEYYDSVYTERYMGLPTPEDNLDHYRNSTVMSRAENFKQVEYLLIHGTADDNVHFQQSAQISKALVDVGVDFQAMWYTDEDHGIASSTAHQHIYTHMSHFIKQCFSLP","Homo sapiens","DPP4, ADCP2, CD26","Dipeptidyl peptidase 4","1","2QTB"
"2QTL",,"X-RAY DIFFRACTION",2.21,44.42,"VAPOR DIFFUSION",7.5,"0.1M Tris Hcl, 0.2M KBr, 15% PEG 4000, pH 7.5, VAPOR DIFFUSION, temperature 277K",277,"10.1021/bi701209p",,"2QTL",60.86,"1.9","1.9","Crystal Structure of the FAD-containing FNR-like Module of Human Methionine Synthase Reductase","GSPEFGALPVASPASLRTDLVKSELLHIESQVELLRFDDSGRKDSEVLKQNAVNSNQSNVVIEDFESSLTRSVPPLSQASLNIPGLPPEYLQVHLQESLGQEESQVSVTSADPVFQVPISKAVQLTTNDAIKTTLLVELDISNTDFSYQPGDAFSVICPNSDSEVQSLLQRLQLEDKREHCVLLKIKADTKKKGATLPQHIPAGCSLQFIFTWCLEIRAIPKKAFLRALVDYTSDSAEKRRLQELCSKQGAADYSRFVRDACACLLDLLLAFPSCQPPLSLLLEHLPKLQPRPYSCASSSLFHPGKLHFVFNIVEFLSTATTEVLRKGVCTGWLALLVASVLQPNIHASHEDSGKALAPKISIFPRTTNSFHLPDDPSIPIIMVGPGTGIAPFIGFLQHREKLQEQHPDGNFGAMWLFFGCRHKDRDYLFRKELRHFLKHGILTHLKVSFSRDAPVGEEEAPAKYVQDNIQLHGQQVARILLQENGHIYVCGDAKNMAKDVHDALVQIISKEVGVEKLEAMKTLATLKEEKRYLQDIWS","Homo sapiens","MTRR","Methionine synthase reductase","1","2QTL"
"2QTU",,"X-RAY DIFFRACTION",2.51,50.97,"VAPOR DIFFUSION",8,"0.1 M Tris-HCl, 2 M NaCl, 4% PEG 6000, pH 8.0, VAPOR DIFFUSION, temperature 289K",289,"10.1016/j.bmcl.2007.08.009","3AS","2QTU",59.18,"2.53","2.53","Estrogen receptor beta ligand-binding domain complexed to a benzopyran ligand","MHHHHHHRELLLDALSPEQLVLTLLEAEPPHVLISRPSAPFTEASMMMSLTKLADKELVHMISWAKKIPGFVELSLFDQVRLLESCWMEVLMMGLMWRSIDHPGKLIFAPDLVLDRDEGKCVEGILEIFDMLLATTSRFRELKLQHKEYLCVKAMILLNSSMYPLVTATQDADSSRKLAHLLNAVTDALVWVIAKSGISSQQQSMRLANLLMLLSHVRHASNKGMEHLLNMKCKNVVPVYDLLLEMLNAHVLRGCKS","Homo sapiens","ESR2, ESTRB, NR3A2","Estrogen receptor beta","1","2QTU"
"2QTW",,"X-RAY DIFFRACTION",2.28,45.97,,10.5,"20% PEG6000, 0.2M sodium chloride, pH 10.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K, pH 10.50",298,"10.1073/pnas.0703402104",,"2QTW",72.55,"1.9","1.9","The Crystal Structure of PCSK9 at 1.9 Angstroms Resolution Reveals structural homology to Resistin within the C-terminal domain","RAQEDEDGDYEELVLALRSEEDGLAEAPEHGTTATFHRCAKDPWRLPGTYVVVLKEETHLSQSERTARRLQAQAARRGYLTKILHVFHGLLPGFLVKMSGDLLELALKLPHVDYIEEDSSVFAQ","Homo sapiens","PCSK9, NARC1, PSEC0052","Proprotein convertase subtilisin/kexin type 9 Propeptide","1","2QTW"
,,,,,,,,,,,,,,,,"SIPWNLERITPPRYRADEYQPPDGGSLVEVYLLDTSIQSDHREIEGRVMVTDFENVPEEDGTRFHRQASKCDSHGTHLAGVVSGRDAGVAKGASMRSLRVLNCQGKGTVSGTLIGLEFIRKSQLVQPVGPLVVLLPLAGGYSRVLNAACQRLARAGVVLVTAAGNFRDDACLYSPASAPEVITVGATNAQDQPVTLGTLGTNFGRCVDLFAPGEDIIGASSDCSTCFVSQSGTSQAAAHVAGIAAMMLSAEPELTLAELRQRLIHFSAKDVINEAWFPEDQRVLTPNLVAALPPSTHGAGWQLFCRTVWSAHSGPTRMATAIARCAPDEELLSCSSFSRSGKRRGERMEAQGGKLVCRAHNAFGGEGVYAIARCCLLPQANCSVHTAPPAEASMGTRVHCHQQGHVLTGCSSHWEVEDLGTHKPPVLRPRGQPNQCVGHREASIHASCCHAPGLECKVKEHGIPAPQEQVTVACEEGWTLTGCSALPGTSHVLGAYAVDNTCVVRSRDVSTTGSTSEEAVTAVAICCRSRHLAQASQELQHHHHHH","Homo sapiens","PCSK9, NARC1, PSEC0052","Proprotein convertase subtilisin/kexin type 9","2","2QTW"
"2QTZ",,"X-RAY DIFFRACTION",2.18,43.58,"VAPOR DIFFUSION",7.5,"0.1M Tris HCl, 0.2M KBr, 15% PEG 4000, crystals soaked in saturating levels of NADP+, pH 7.5, vapor diffusion, temperature 277K",277,"10.1021/bi701209p","NAP","2QTZ",61.59,"1.9","1.9","Crystal Structure of the NADP+-bound FAD-containing FNR-like Module of Human Methionine Synthase Reductase","GSPEFGALPVASPASLRTDLVKSELLHIESQVELLRFDDSGRKDSEVLKQNAVNSNQSNVVIEDFESSLTRSVPPLSQASLNIPGLPPEYLQVHLQESLGQEESQVSVTSADPVFQVPISKAVQLTTNDAIKTTLLVELDISNTDFSYQPGDAFSVICPNSDSEVQSLLQRLQLEDKREHCVLLKIKADTKKKGATLPQHIPAGCSLQFIFTWCLEIRAIPKKAFLRALVDYTSDSAEKRRLQELCSKQGAADYSRFVRDACACLLDLLLAFPSCQPPLSLLLEHLPKLQPRPYSCASSSLFHPGKLHFVFNIVEFLSTATTEVLRKGVCTGWLALLVASVLQPNIHASHEDSGKALAPKISIFPRTTNSFHLPDDPSIPIIMVGPGTGIAPFIGFLQHREKLQEQHPDGNFGAMWLFFGCRHKDRDYLFRKELRHFLKHGILTHLKVSFSRDAPVGEEEAPAKYVQDNIQLHGQQVARILLQENGHIYVCGDAKNMAKDVHDALVQIISKEVGVEKLEAMKTLATLKEEKRYLQDIWS","Homo sapiens","MTRR","Methionine synthase reductase","1","2QTZ"
"2QU2",,"X-RAY DIFFRACTION",2.07,40.57,"VAPOR DIFFUSION, HANGING DROP",5.4,"100 mM NaAcetate pH 5.4, 6% PEG 3350, VAPOR DIFFUSION, HANGING DROP",,"10.1016/j.bmcl.2007.08.010","251","2QU2",46.76,"2.6","2.6","BACE1 with Compound 1","ETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDESTHHHHHH","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","2QU2"
"2QU3",,"X-RAY DIFFRACTION",2.01,38.72,"VAPOR DIFFUSION, HANGING DROP",5.4,"100 mM NaAcetate pH 5.4, 6% PEG 3350, VAPOR DIFFUSION, HANGING DROP",,"10.1016/j.bmcl.2007.08.010","462","2QU3",46.87,"2","2","BACE1 with Compound 2","ETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDESTHHHHHH","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","2QU3"
"2QU5",,"X-RAY DIFFRACTION",3.89,68.39,"VAPOR DIFFUSION, HANGING DROP",8.2,"PEG 4000, lithum sulfate, Tris, pH 8.2, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/jm070034i","276","2QU5",36.75,"2.95","2.95","Crystal structure of the VEGFR2 kinase domain in complex with a benzimidazole inhibitor","EHAERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQDRHHHHHH","Homo sapiens","KDR, FLK1","Vascular endothelial growth factor receptor 2","1","2QU5"
,,,,,,,,,,,,,,,,,"Homo sapiens","KDR, FLK1"
"2QU6",,"X-RAY DIFFRACTION",2.31,46.76,"VAPOR DIFFUSION, HANGING DROP",8,"PEG 5000 MME, ammonium sulfate, sodium chloride, HEPES, isopropanol, beta-mercaptoethanol, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/jm070034i","857","2QU6",73.68,"2.1","2.1","Crystal structure of the VEGFR2 kinase domain in complex with a benzoxazole inhibitor","EHAERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQDRHHHHHH","Homo sapiens","KDR, FLK1","Vascular endothelial growth factor receptor 2","1","2QU6"
,,,,,,,,,,,,,,,,,"Homo sapiens","KDR, FLK1"
